id,start,end,Label
Ventricular,0,11,B-Multi-tissue_structure
fibrillation,12,24,O
due,25,28,O
to,29,31,O
long,32,36,O
QT,37,39,O
syndrome,40,48,O
probably,49,57,O
caused,58,64,O
by,65,67,O
clindamycin,68,79,O
.,79,80,O
Prolongation,81,93,O
of,94,96,O
QT,97,99,O
time,100,104,O
interval,105,113,O
may,114,117,O
be,118,120,O
provoked,121,129,O
by,130,132,O
a,133,134,O
limited,135,142,O
number,143,149,O
of,150,152,O
drugs,153,158,O
",",158,159,O
especially,160,170,O
macrolide,171,180,O
antibiotics,181,192,O
.,192,193,O
We,194,196,O
describe,197,205,O
a,206,207,O
case,208,212,O
of,213,215,O
QT,216,218,O
time,219,223,O
interval,224,232,O
prolongation,233,245,O
induced,246,253,O
by,254,256,O
clindamycin,257,268,O
with,269,273,O
subsequent,274,284,O
repeated,285,293,O
ventricular,294,305,B-Multi-tissue_structure
fibrillation,306,318,O
and,319,322,O
resuscitation,323,336,O
;,336,337,O
there,338,343,O
is,344,346,O
no,347,349,O
previous,350,358,O
report,359,365,O
in,366,368,O
the,369,372,O
literature,373,383,O
of,384,386,O
QT,387,389,O
time,390,394,O
prolongation,395,407,O
caused,408,414,O
by,415,417,O
lincosamides,418,430,O
.,430,431,O
Decontamination,0,15,O
of,16,18,O
medical,19,26,O
equipment,27,36,O
-,36,37,O
-,37,38,O
manufacturer,38,50,O
',50,51,O
s,51,52,O
problems,53,61,O
.,61,62,O
1,63,64,O
.,64,65,O
Small,66,71,O
items,72,77,O
sent,78,82,O
via,83,86,O
the,87,90,O
post,91,95,O
present,96,103,O
a,104,105,O
much,106,110,O
greater,111,118,O
hidden,119,125,O
hazard,126,132,O
and,133,136,O
a,137,138,O
higher,139,145,O
potential,146,155,O
for,156,159,O
catching,160,168,O
people,169,175,O
unawares,176,184,O
.,184,185,O
2,186,187,O
.,187,188,O
Large,189,194,O
items,195,200,O
accompanied,201,212,O
by,213,215,O
a,216,217,O
Decontamination,218,233,O
Certificate,234,245,O
need,246,250,O
to,251,253,O
be,254,256,O
treated,257,264,O
with,265,269,O
caution,270,277,O
because,278,285,O
only,286,290,O
those,291,296,O
surfaces,297,305,O
which,306,311,O
are,312,315,O
accessible,316,326,O
will,327,331,O
have,332,336,O
been,337,341,O
cleaned,342,349,O
;,349,350,O
as,351,353,O
soon,354,358,O
as,359,361,O
engineers,362,371,O
start,372,377,O
dismantling,378,389,O
equipment,390,399,O
",",399,400,O
areas,401,406,O
which,407,412,O
are,413,416,O
still,417,422,O
soiled,423,429,O
become,430,436,O
exposed,437,444,O
.,444,445,O
3,446,447,O
.,447,448,O
Total,449,454,O
co,455,457,O
-,457,458,O
operation,458,467,O
between,468,475,O
hospital,476,484,O
staff,485,490,O
and,491,494,O
service,495,502,O
engineers,503,512,O
is,513,515,O
necessary,516,525,O
to,526,528,O
resolve,529,536,O
these,537,542,O
problems,543,551,O
-,551,552,O
neither,552,559,O
can,560,563,O
work,564,568,O
safely,569,575,O
without,576,583,O
the,584,587,O
assistance,588,598,O
of,599,601,O
the,602,605,O
other,606,611,O
.,611,612,O
4,613,614,O
.,614,615,O
Many,616,620,O
products,621,629,O
in,630,632,O
use,633,636,O
in,637,639,O
hospitals,640,649,O
may,650,653,O
be,654,656,O
up,657,659,O
to,660,662,O
20,663,665,O
years,666,671,O
old,672,675,O
and,676,679,O
clearly,680,687,O
were,688,692,O
not,693,696,O
designed,697,705,O
to,706,708,O
facilitate,709,719,O
decontamination,720,735,O
and,736,739,O
therefore,740,749,O
present,750,757,O
far,758,761,O
greater,762,769,O
risk,770,774,O
to,775,777,O
all,778,781,O
concerned,782,791,O
.,791,792,O
5,793,794,O
.,794,795,O
For,796,799,O
the,800,803,O
future,804,810,O
there,811,816,O
a,817,818,O
clearly,819,826,O
a,827,828,O
responsibility,829,843,O
with,844,848,O
manufacturers,849,862,O
to,863,865,O
give,866,870,O
more,871,875,O
thought,876,883,O
to,884,886,O
the,887,890,O
design,891,897,O
of,898,900,O
their,901,906,O
equipment,907,916,O
so,917,919,O
that,920,924,O
decontamination,925,940,O
can,941,944,O
be,945,947,O
achieved,948,956,O
more,957,961,O
effectively,962,973,O
.,973,974,O
Enterococci,0,11,O
at,12,14,O
the,15,18,O
crossroads,19,29,O
of,30,32,O
food,33,37,O
safety,38,44,O
?,44,45,O
Enterococci,46,57,O
are,58,61,O
gram,62,66,O
-,66,67,O
positive,67,75,O
bacteria,76,84,O
and,85,88,O
fit,89,92,O
within,93,99,O
the,100,103,O
general,104,111,O
definition,112,122,O
of,123,125,O
lactic,126,132,O
acid,133,137,O
bacteria,138,146,O
.,146,147,O
Modern,148,154,O
classification,155,169,O
techniques,170,180,O
resulted,181,189,O
in,190,192,O
the,193,196,O
transfer,197,205,O
of,206,208,O
some,209,213,O
members,214,221,O
of,222,224,O
the,225,228,O
genus,229,234,O
Streptococcus,235,248,O
",",248,249,O
notably,250,257,O
some,258,262,O
of,263,265,O
the,266,269,O
Lancefield,270,280,O
',280,281,O
s,281,282,O
group,283,288,O
D,289,290,O
streptococci,291,303,O
",",303,304,O
to,305,307,O
the,308,311,O
new,312,315,O
genus,316,321,O
Enterococcus,322,334,O
.,334,335,O
Enterococci,336,347,O
can,348,351,O
be,352,354,O
used,355,359,O
as,360,362,O
indicators,363,373,O
of,374,376,O
faecal,377,383,B-Organism_substance
contamination,384,397,O
.,397,398,O
They,399,403,O
have,404,408,O
been,409,413,O
implicated,414,424,O
in,425,427,O
outbreaks,428,437,O
of,438,440,O
foodborne,441,450,O
illness,451,458,O
",",458,459,O
and,460,463,O
they,464,468,O
have,469,473,O
been,474,478,O
ascribed,479,487,O
a,488,489,O
beneficial,490,500,O
or,501,503,O
detrimental,504,515,O
role,516,520,O
in,521,523,O
foods,524,529,O
.,529,530,O
In,531,533,O
processed,534,543,O
meats,544,549,B-Organism_subdivision
",",549,550,O
enterococci,551,562,O
may,563,566,O
survive,567,574,O
heat,575,579,O
processing,580,590,O
and,591,594,O
cause,595,600,O
spoilage,601,609,O
",",609,610,O
though,611,617,O
in,618,620,O
certain,621,628,O
cheeses,629,636,O
the,637,640,O
growth,641,647,O
of,648,650,O
enterococci,651,662,O
contributes,663,674,O
to,675,677,O
ripening,678,686,O
and,687,690,O
development,691,702,O
of,703,705,O
product,706,713,O
flavour,714,721,O
.,721,722,O
Some,723,727,O
enterococci,728,739,O
of,740,742,O
food,743,747,O
origin,748,754,O
produce,755,762,O
bacteriocins,763,775,O
that,776,780,O
exert,781,786,O
anti,787,791,O
-,791,792,O
Listeria,792,800,O
activity,801,809,O
.,809,810,O
Enterococci,811,822,O
are,823,826,O
used,827,831,O
as,832,834,O
probiotics,835,845,O
to,846,848,O
improve,849,856,O
the,857,860,O
microbial,861,870,O
balance,871,878,O
of,879,881,O
the,882,885,O
intestine,886,895,B-Organ
",",895,896,O
or,897,899,O
as,900,902,O
a,903,904,O
treatment,905,914,O
for,915,918,O
gastroenteritis,919,934,O
in,935,937,O
humans,938,944,O
and,945,948,O
animals,949,956,O
.,956,957,O
On,958,960,O
the,961,964,O
other,965,970,O
hand,971,975,O
",",975,976,O
enterococci,977,988,O
have,989,993,O
become,994,1000,O
recognised,1001,1011,O
as,1012,1014,O
serious,1015,1022,O
nosocomial,1023,1033,O
pathogens,1034,1043,O
causing,1044,1051,O
bacteraemia,1052,1063,O
",",1063,1064,O
endocarditis,1065,1077,O
",",1077,1078,O
urinary,1079,1086,B-Multi-tissue_structure
tract,1087,1092,I-Multi-tissue_structure
and,1093,1096,O
other,1097,1102,O
infections,1103,1113,O
.,1113,1114,O
This,1115,1119,O
is,1120,1122,O
in,1123,1125,O
part,1126,1130,O
explained,1131,1140,O
by,1141,1143,O
the,1144,1147,O
resistance,1148,1158,O
of,1159,1161,O
some,1162,1166,O
of,1167,1169,O
these,1170,1175,O
bacteria,1176,1184,O
to,1185,1187,O
most,1188,1192,O
antibiotics,1193,1204,O
that,1205,1209,O
are,1210,1213,O
currently,1214,1223,O
in,1224,1226,O
use,1227,1230,O
.,1230,1231,O
Resistance,1232,1242,O
is,1243,1245,O
acquired,1246,1254,O
by,1255,1257,O
gene,1258,1262,O
transfer,1263,1271,O
systems,1272,1279,O
",",1279,1280,O
such,1281,1285,O
as,1286,1288,O
conjugative,1289,1300,B-Cellular_component
or,1301,1303,O
nonconjugative,1304,1318,B-Cellular_component
plasmids,1319,1327,I-Cellular_component
or,1328,1330,O
transposons,1331,1342,O
.,1342,1343,O
Virulence,1344,1353,O
of,1354,1356,O
enterococci,1357,1368,O
is,1369,1371,O
not,1372,1375,O
well,1376,1380,O
understood,1381,1391,O
but,1392,1395,O
adhesins,1396,1404,O
",",1404,1405,O
haemolysin,1406,1416,O
",",1416,1417,O
hyaluronidase,1418,1431,O
",",1431,1432,O
aggregation,1433,1444,O
substance,1445,1454,O
and,1455,1458,O
gelatinase,1459,1469,O
are,1470,1473,O
putative,1474,1482,O
virulence,1483,1492,O
factors,1493,1500,O
.,1500,1501,O
It,1502,1504,O
appears,1505,1512,O
that,1513,1517,O
foods,1518,1523,O
could,1524,1529,O
be,1530,1532,O
a,1533,1534,O
source,1535,1541,O
of,1542,1544,O
vancomycin,1545,1555,O
-,1555,1556,O
resistant,1556,1565,O
enterococci,1566,1577,O
.,1577,1578,O
This,1579,1583,O
review,1584,1590,O
addresses,1591,1600,O
the,1601,1604,O
issue,1605,1610,O
of,1611,1613,O
the,1614,1617,O
health,1618,1624,O
risk,1625,1629,O
of,1630,1632,O
foods,1633,1638,O
containing,1639,1649,O
enterococci,1650,1661,O
.,1661,1662,O
Obstructive,0,11,O
nephropathy,12,23,O
:,23,24,O
lessons,25,32,O
from,33,37,O
cystic,38,44,O
kidney,45,51,B-Organ
disease,52,59,O
.,59,60,O
Obstructive,61,72,O
nephropathy,73,84,O
is,85,87,O
one,88,91,O
of,92,94,O
the,95,98,O
most,99,103,O
important,104,113,O
causes,114,120,O
of,121,123,O
renal,124,129,B-Organ
failure,130,137,O
in,138,140,O
infants,141,148,O
and,149,152,O
children,153,161,O
",",161,162,O
while,163,168,O
polycystic,169,179,O
kidney,180,186,B-Organ
disease,187,194,O
(,195,196,O
PKD,196,199,O
),199,200,O
is,201,203,O
a,204,205,O
major,206,211,O
cause,212,217,O
of,218,220,O
renal,221,226,B-Organ
failure,227,234,O
in,235,237,O
the,238,241,O
adult,242,247,O
population,248,258,O
.,258,259,O
This,260,264,O
review,265,271,O
summarizes,272,282,O
the,283,286,O
evidence,287,295,O
that,296,300,O
there,301,306,O
may,307,310,O
be,311,313,O
a,314,315,O
number,316,322,O
of,323,325,O
mechanisms,326,336,O
common,337,343,O
to,344,346,O
the,347,350,O
pathophysiology,351,366,O
of,367,369,O
both,370,374,O
conditions,375,385,O
.,385,386,O
In,387,389,O
animal,390,396,O
models,397,403,O
of,404,406,O
obstructive,407,418,O
nephropathy,419,430,O
and,431,434,O
PKD,435,438,O
",",438,439,O
the,440,443,O
renal,444,449,B-Multi-tissue_structure
tubular,450,457,I-Multi-tissue_structure
expression,458,468,O
of,469,471,O
epidermal,472,481,O
growth,482,488,O
factor,489,495,O
is,496,498,O
suppressed,499,509,O
",",509,510,O
and,511,514,O
expression,515,525,O
of,526,528,O
clusterin,529,538,O
is,539,541,O
increased,542,551,O
",",551,552,O
both,553,557,O
of,558,560,O
which,561,566,O
suggest,567,574,O
arrested,575,583,O
maturation,584,594,O
or,595,597,O
dedifferentiation,598,615,O
of,616,618,O
the,619,622,O
tubular,623,630,B-Cell
cell,631,635,I-Cell
.,635,636,O
There,637,642,O
is,643,645,O
a,646,647,O
marked,648,654,O
increase,655,663,O
in,664,666,O
apoptosis,667,676,O
of,677,679,O
epithelial,680,690,B-Cell
cells,691,696,I-Cell
in,697,699,O
dilated,700,707,O
tubules,708,715,B-Multi-tissue_structure
",",715,716,O
associated,717,727,O
with,728,732,O
an,733,735,O
increase,736,744,O
in,745,747,O
apoptotic,748,757,O
stimuli,758,765,O
.,765,766,O
The,767,770,O
renin,771,776,O
-,776,777,O
angiotensin,777,788,O
system,789,795,O
is,796,798,O
activated,799,808,O
in,809,811,O
both,812,816,O
obstructive,817,828,O
nephropathy,829,840,O
and,841,844,O
PKD,845,848,O
",",848,849,O
which,850,855,O
may,856,859,O
contribute,860,870,O
to,871,873,O
tubular,874,881,B-Multi-tissue_structure
atrophy,882,889,O
and,890,893,O
interstitial,894,906,B-Immaterial_anatomical_entity
fibrosis,907,915,O
",",915,916,O
which,917,922,O
characterize,923,935,O
the,936,939,O
progression,940,951,O
of,952,954,O
both,955,959,O
conditions,960,970,O
.,970,971,O
Focal,972,977,O
cystic,978,984,O
dilatation,985,995,O
of,996,998,O
the,999,1002,O
tubule,1003,1009,B-Multi-tissue_structure
is,1010,1012,O
found,1013,1018,O
in,1019,1021,O
obstructive,1022,1033,O
nephropathy,1034,1045,O
",",1045,1046,O
while,1047,1052,O
tubular,1053,1060,B-Multi-tissue_structure
obstruction,1061,1072,O
is,1073,1075,O
present,1076,1083,O
in,1084,1086,O
cystic,1087,1093,O
kidney,1094,1100,B-Organ
disease,1101,1108,O
.,1108,1109,O
It,1110,1112,O
is,1113,1115,O
therefore,1116,1125,O
likely,1126,1132,O
that,1133,1137,O
elucidation,1138,1149,O
of,1150,1152,O
the,1153,1156,O
effects,1157,1164,O
of,1165,1167,O
mechanical,1168,1178,O
stretch,1179,1186,O
on,1187,1189,O
renal,1190,1195,B-Cell
tubular,1196,1203,I-Cell
epithelial,1204,1214,I-Cell
cells,1215,1220,I-Cell
will,1221,1225,O
contribute,1226,1236,O
to,1237,1239,O
our,1240,1243,O
understanding,1244,1257,O
of,1258,1260,O
both,1261,1265,O
conditions,1266,1276,O
.,1276,1277,O
Genuine,0,7,O
monovalent,8,18,O
ligands,19,26,O
of,27,29,O
TrkA,30,34,O
nerve,35,40,O
growth,41,47,O
factor,48,54,O
receptors,55,64,O
reveal,65,71,O
a,72,73,O
novel,74,79,O
pharmacological,80,95,O
mechanism,96,105,O
of,106,108,O
action,109,115,O
.,115,116,O
Developing,117,127,O
small,128,133,O
molecule,134,142,O
agonistic,143,152,O
ligands,153,160,O
for,161,164,O
tyrosine,165,173,O
kinase,174,180,O
receptors,181,190,O
has,191,194,O
been,195,199,O
difficult,200,209,O
",",209,210,O
and,211,214,O
it,215,217,O
is,218,220,O
generally,221,230,O
thought,231,238,O
that,239,243,O
such,244,248,O
ligands,249,256,O
require,257,264,O
bivalency,265,274,O
.,274,275,O
Moreover,276,284,O
",",284,285,O
multisubunit,286,298,O
receptors,299,308,O
are,309,312,O
difficult,313,322,O
to,323,325,O
target,326,332,O
",",332,333,O
because,334,341,O
each,342,346,O
subunit,347,354,O
contributes,355,366,O
to,367,369,O
ligand,370,376,O
affinity,377,385,O
",",385,386,O
and,387,390,O
each,391,395,O
subunit,396,403,O
may,404,407,O
have,408,412,O
distinct,413,421,O
and,422,425,O
sometimes,426,435,O
opposing,436,444,O
functions,445,454,O
.,454,455,O
Here,456,460,O
",",460,461,O
the,462,465,O
nerve,466,471,O
growth,472,478,O
factor,479,485,O
receptor,486,494,O
subunits,495,503,O
p75,504,507,O
and,508,511,O
the,512,515,O
tyrosine,516,524,O
kinase,525,531,O
TrkA,532,536,O
were,537,541,O
studied,542,549,O
using,550,555,O
artificial,556,566,O
ligands,567,574,O
that,575,579,O
bind,580,584,O
specifically,585,597,O
to,598,600,O
their,601,606,O
extracellular,607,620,B-Immaterial_anatomical_entity
domain,621,627,O
.,627,628,O
Bivalent,629,637,O
TrkA,638,642,O
ligands,643,650,O
afford,651,657,O
robust,658,664,O
signals,665,672,O
.,672,673,O
However,674,681,O
",",681,682,O
genuine,683,690,O
monomeric,691,700,O
and,701,704,O
monovalent,705,715,O
TrkA,716,720,O
ligands,721,728,O
afford,729,735,O
partial,736,743,O
agonism,744,751,O
",",751,752,O
activate,753,761,O
the,762,765,O
tyrosine,766,774,O
kinase,775,781,O
activity,782,790,O
",",790,791,O
cause,792,797,O
receptor,798,806,O
internalization,807,822,O
",",822,823,O
and,824,827,O
induce,828,834,O
survival,835,843,O
and,844,847,O
differentiation,848,863,O
in,864,866,O
cell,867,871,B-Cell
lines,872,877,I-Cell
and,878,881,O
primary,882,889,O
neurons,890,897,B-Cell
.,897,898,O
Monomeric,899,908,O
and,909,912,O
monovalent,913,923,O
TrkA,924,928,O
ligands,929,936,O
can,937,940,O
synergize,941,950,O
with,951,955,O
ligands,956,963,O
that,964,968,O
bind,969,973,O
the,974,977,O
p75,978,981,O
subunit,982,989,O
.,989,990,O
However,991,998,O
",",998,999,O
the,1000,1003,O
p75,1004,1007,O
ligands,1008,1015,O
used,1016,1020,O
in,1021,1023,O
this,1024,1028,O
study,1029,1034,O
must,1035,1039,O
be,1040,1042,O
bivalent,1043,1051,O
",",1051,1052,O
and,1053,1056,O
monovalent,1057,1067,O
p75,1068,1071,O
ligands,1072,1079,O
have,1080,1084,O
no,1085,1087,O
effect,1088,1094,O
.,1094,1095,O
These,1096,1101,O
findings,1102,1110,O
will,1111,1115,O
be,1116,1118,O
useful,1119,1125,O
in,1126,1128,O
designing,1129,1138,O
and,1139,1142,O
developing,1143,1153,O
screens,1154,1161,O
of,1162,1164,O
small,1165,1170,O
molecules,1171,1180,O
selective,1181,1190,O
for,1191,1194,O
tyrosine,1195,1203,O
kinase,1204,1210,O
receptors,1211,1220,O
and,1221,1224,O
indicate,1225,1233,O
that,1234,1238,O
strategies,1239,1249,O
for,1250,1253,O
designing,1254,1263,O
agonists,1264,1272,O
of,1273,1275,O
multisubunit,1276,1288,O
receptors,1289,1298,O
require,1299,1306,O
consideration,1307,1320,O
of,1321,1323,O
the,1324,1327,O
role,1328,1332,O
of,1333,1335,O
each,1336,1340,O
subunit,1341,1348,O
.,1348,1349,O
Last,1350,1354,O
",",1354,1355,O
the,1356,1359,O
strategy,1360,1368,O
of,1369,1371,O
using,1372,1377,O
anti,1378,1382,O
-,1382,1383,O
receptor,1383,1391,O
mAbs,1392,1396,O
and,1397,1400,O
small,1401,1406,O
molecule,1407,1415,O
hormone,1416,1423,O
mimics,1424,1430,O
as,1431,1433,O
receptor,1434,1442,O
ligands,1443,1450,O
could,1451,1456,O
be,1457,1459,O
applied,1460,1467,O
to,1468,1470,O
the,1471,1474,O
study,1475,1480,O
of,1481,1483,O
many,1484,1488,O
other,1489,1494,O
heteromeric,1495,1506,O
cell,1507,1511,B-Cellular_component
surface,1512,1519,I-Cellular_component
receptors,1520,1529,O
.,1529,1530,O
Application,0,11,O
of,12,14,O
microsatellite,15,29,O
PCR,30,33,O
techniques,34,44,O
in,45,47,O
the,48,51,O
identification,52,66,O
of,67,69,O
mixed,70,75,O
up,76,78,O
tissue,79,85,B-Tissue
specimens,86,95,I-Tissue
in,96,98,O
surgical,99,107,O
pathology,108,117,O
.,117,118,O
A,119,120,O
fragment,121,129,B-Pathological_formation
of,130,132,O
tumour,133,139,B-Pathological_formation
was,140,143,O
erroneously,144,155,O
mixed,156,161,O
up,162,164,O
with,165,169,O
an,170,172,O
endometrial,173,184,B-Tissue
biopsy,185,191,I-Tissue
.,191,192,O
Micro,193,198,O
-,198,199,O
satellite,199,208,O
polymerase,209,219,O
chain,220,225,O
reaction,226,234,O
(,235,236,O
PCR,236,239,O
),239,240,O
clearly,241,248,O
demonstrated,249,261,O
the,262,265,O
extraneous,266,276,O
nature,277,283,O
of,284,286,O
the,287,290,O
fragment,291,299,B-Pathological_formation
.,299,300,O
Micro,301,306,O
-,306,307,O
satellite,307,316,O
PCR,317,320,O
may,321,324,O
be,325,327,O
useful,328,334,O
for,335,338,O
the,339,342,O
identification,343,357,O
of,358,360,O
mis,361,364,O
-,364,365,O
labelled,365,373,O
or,374,376,O
mismatched,377,387,O
tissue,388,394,B-Tissue
fragments,395,404,I-Tissue
in,405,407,O
surgical,408,416,O
pathology,417,426,O
specimens,427,436,B-Tissue
.,436,437,O
Specific,0,8,O
subgroup,9,17,O
B,18,19,O
adenovirus,20,30,O
diagnosis,31,40,O
by,41,43,O
PCR,44,47,O
of,48,50,O
the,51,54,O
fibre,55,60,O
gene,61,65,O
.,65,66,O
OBJECTIVE,67,76,O
:,76,77,O
A,78,79,O
highly,80,86,O
sensitive,87,96,O
and,97,100,O
specific,101,109,O
PCR,110,113,O
assay,114,119,O
targeting,120,129,O
regions,130,137,O
of,138,140,O
the,141,144,O
fibre,145,150,O
gene,151,155,O
was,156,159,O
developed,160,169,O
for,170,173,O
the,174,177,O
identification,178,192,O
of,193,195,O
subgroup,196,204,O
B,205,206,O
adenovirus,207,217,O
strains,218,225,O
.,225,226,O
This,227,231,O
is,232,234,O
critical,235,243,O
",",243,244,O
since,245,250,O
these,251,256,O
adenovirus,257,267,O
strains,268,275,O
are,276,279,O
frequently,280,290,O
associated,291,301,O
with,302,306,O
severe,307,313,O
respiratory,314,325,B-Anatomical_system
infections,326,336,O
in,337,339,O
infants,340,347,O
and,348,351,O
new,352,355,O
-,355,356,O
borns,356,361,O
.,361,362,O
METHODS,363,370,O
:,370,371,O
Clinical,372,380,O
samples,381,388,B-Organism_substance
from,389,393,O
nasopharyngeal,394,408,B-Organism_substance
aspirates,409,418,I-Organism_substance
were,419,423,O
analysed,424,432,O
by,433,435,O
PCR,436,439,O
using,440,445,O
several,446,453,O
sets,454,458,O
of,459,461,O
primers,462,469,O
corresponding,470,483,O
to,484,486,O
sequences,487,496,O
of,497,499,O
the,500,503,O
gene,504,508,O
coding,509,515,O
for,516,519,O
the,520,523,O
fibre,524,529,O
protein,530,537,O
.,537,538,O
RESULTS,539,546,O
:,546,547,O
The,548,551,O
assay,552,557,O
allowed,558,565,O
the,566,569,O
detection,570,579,O
and,580,583,O
identification,584,598,O
of,599,601,O
all,602,605,O
the,606,609,O
genotypes,610,619,O
of,620,622,O
adenovirus,623,633,O
subgroup,634,642,O
B,643,644,O
",",644,645,O
based,646,651,O
on,652,654,O
the,655,658,O
size,659,663,O
of,664,666,O
the,667,670,O
amplified,671,680,O
product,681,688,O
when,689,693,O
analysed,694,702,O
on,703,705,O
polyacrilamide,706,720,O
gel,721,724,O
electrophoresis,725,740,O
.,740,741,O
Specifically,742,754,O
",",754,755,O
one,756,759,O
set,760,763,O
of,764,766,O
primers,767,774,O
was,775,778,O
able,779,783,O
to,784,786,O
amplify,787,794,O
DNA,795,798,O
of,799,801,O
subgroup,802,810,O
B,811,812,O
but,813,816,O
not,817,820,O
subgroup,821,829,O
C,830,831,O
and,832,835,O
E,836,837,O
viruses,838,845,O
.,845,846,O
CONCLUSION,847,857,O
:,857,858,O
The,859,862,O
detection,863,872,O
of,873,875,O
adenovirus,876,886,O
and,887,890,O
the,891,894,O
genotyping,895,905,O
can,906,909,O
be,910,912,O
done,913,917,O
on,918,920,O
a,921,922,O
routine,923,930,O
basis,931,936,O
by,937,939,O
a,940,941,O
PCR,942,945,O
assay,946,951,O
using,952,957,O
the,958,961,O
fibre,962,967,O
gene,968,972,O
as,973,975,O
a,976,977,O
target,978,984,O
.,984,985,O
The,986,989,O
assay,990,995,O
allows,996,1002,O
the,1003,1006,O
identification,1007,1021,O
of,1022,1024,O
ADV,1025,1028,O
subgroup,1029,1037,O
B,1038,1039,O
",",1039,1040,O
including,1041,1050,O
genotype,1051,1059,O
7h,1060,1062,O
",",1062,1063,O
which,1064,1069,O
is,1070,1072,O
the,1073,1076,O
single,1077,1083,O
most,1084,1088,O
important,1089,1098,O
viral,1099,1104,O
pathogen,1105,1113,O
associated,1114,1124,O
with,1125,1129,O
respiratory,1130,1141,B-Anatomical_system
diseases,1142,1150,O
in,1151,1153,O
infants,1154,1161,O
and,1162,1165,O
young,1166,1171,O
children,1172,1180,O
in,1181,1183,O
the,1184,1187,O
southern,1188,1196,O
part,1197,1201,O
of,1202,1204,O
South,1205,1210,O
America,1211,1218,O
.,1218,1219,O
[,0,1,O
Anesthetic,1,11,O
management,12,22,O
of,23,25,O
a,26,27,O
patient,28,35,O
with,36,40,O
Dyggve,41,47,O
-,47,48,O
Melchior,48,56,O
-,56,57,O
Clausen,57,64,O
syndrome,65,73,O
],73,74,O
.,74,75,O
The,76,79,O
Dyggve,80,86,O
-,86,87,O
Melchior,87,95,O
-,95,96,O
Clausen,96,103,O
syndrome,104,112,O
(,113,114,O
DMCS,114,118,O
),118,119,O
is,120,122,O
a,123,124,O
rare,125,129,O
autosomal,130,139,O
recessive,140,149,O
skeletal,150,158,B-Anatomical_system
dysplasia,159,168,O
characterized,169,182,O
by,183,185,O
short,186,191,O
-,191,192,O
trunk,192,197,B-Organism_subdivision
dwarfism,198,206,O
and,207,210,O
mental,211,217,O
retardation,218,229,O
.,229,230,O
A,231,232,O
49,233,235,O
-,235,236,O
year,236,240,O
-,240,241,O
old,241,244,O
male,245,249,O
with,250,254,O
DMCS,255,259,O
underwent,260,269,O
resection,270,279,O
arthroplasty,280,292,O
for,293,296,O
contracture,297,308,O
of,309,311,O
the,312,315,O
right,316,321,B-Multi-tissue_structure
hip,322,325,I-Multi-tissue_structure
joint,326,331,I-Multi-tissue_structure
under,332,337,O
general,338,345,O
anesthesia,346,356,O
using,357,362,O
thiamylal,363,372,O
",",372,373,O
nitrous,374,381,O
oxide,382,387,O
",",387,388,O
sevoflurane,389,400,O
",",400,401,O
and,402,405,O
vecuronium,406,416,O
.,416,417,O
Although,418,426,O
he,427,429,O
was,430,433,O
assumed,434,441,O
to,442,444,O
have,445,449,O
difficult,450,459,O
airway,460,466,B-Multi-tissue_structure
due,467,470,O
to,471,473,O
short,474,479,O
neck,480,484,B-Organism_subdivision
",",484,485,O
macroglossia,486,498,O
",",498,499,O
and,500,503,O
disturbance,504,515,O
of,516,518,O
neck,519,523,B-Organism_subdivision
flexion,524,531,O
",",531,532,O
tracheal,533,541,B-Multi-tissue_structure
intubation,542,552,O
was,553,556,O
not,557,560,O
difficult,561,570,O
.,570,571,O
No,572,574,O
complications,575,588,O
including,589,598,O
malignant,599,608,O
hyperthermia,609,621,O
were,622,626,O
observed,627,635,O
during,636,642,O
the,643,646,O
95,647,649,O
min,650,653,O
of,654,656,O
the,657,660,O
operation,661,670,O
.,670,671,O
Assembly,0,8,O
strategies,9,19,O
and,20,23,O
GTPase,24,30,O
regulation,31,41,O
of,42,44,O
the,45,48,O
eukaryotic,49,59,O
and,60,63,O
Escherichia,64,75,O
coil,76,80,O
translocons,81,92,B-Cellular_component
.,92,93,O
The,94,97,O
translocation,98,111,O
of,112,114,O
most,115,119,O
proteins,120,128,O
across,129,135,O
the,136,139,O
endoplasmic,140,151,B-Cellular_component
reticulum,152,161,I-Cellular_component
or,162,164,O
bacterial,165,174,O
inner,175,180,B-Cellular_component
membrane,181,189,I-Cellular_component
occurs,190,196,O
through,197,204,O
an,205,207,O
aqueous,208,215,B-Cellular_component
pore,216,220,I-Cellular_component
that,221,225,O
spans,226,231,O
the,232,235,O
membrane,236,244,B-Cellular_component
.,244,245,O
Substrates,246,256,O
that,257,261,O
are,262,265,O
translocated,266,278,O
co,279,281,O
-,281,282,O
translationally,282,297,O
across,298,304,O
the,305,308,O
membrane,309,317,B-Cellular_component
are,318,321,O
directed,322,330,O
to,331,333,O
the,334,337,O
translocation,338,351,B-Cellular_component
pore,352,356,I-Cellular_component
via,357,360,O
an,361,363,O
interaction,364,375,O
between,376,383,O
the,384,387,O
cytosolic,388,397,B-Organism_substance
signal,398,404,O
recognition,405,416,O
particle,417,425,O
and,426,429,O
its,430,433,O
membrane,434,442,B-Cellular_component
-,442,443,O
bound,443,448,O
receptor,449,457,O
.,457,458,O
Together,459,467,O
the,468,471,O
translocation,472,485,B-Cellular_component
pore,486,490,I-Cellular_component
and,491,494,O
the,495,498,O
receptor,499,507,O
are,508,511,O
referred,512,520,O
to,521,523,O
as,524,526,O
a,527,528,O
translocon,529,539,B-Cellular_component
.,539,540,O
By,541,543,O
studying,544,552,O
the,553,556,O
biogenesis,557,567,O
of,568,570,O
the,571,574,O
translocon,575,585,B-Cellular_component
a,586,587,O
number,588,594,O
of,595,597,O
alternate,598,607,O
targeting,608,617,O
and,618,621,O
membrane,622,630,B-Cellular_component
-,630,631,O
integration,631,642,O
pathways,643,651,O
have,652,656,O
been,657,661,O
discovered,662,672,O
that,673,677,O
operate,678,685,O
independently,686,699,O
of,700,702,O
the,703,706,O
signal,707,713,O
recognition,714,725,O
particle,726,734,O
(,735,736,O
SRP,736,739,O
),739,740,O
pathway,741,748,O
.,748,749,O
The,750,753,O
novel,754,759,O
assembly,760,768,O
strategies,769,779,O
of,780,782,O
the,783,786,O
translocon,787,797,B-Cellular_component
and,798,801,O
the,802,805,O
ways,806,810,O
in,811,813,O
which,814,819,O
these,820,825,O
components,826,836,O
interact,837,845,O
to,846,848,O
ensure,849,855,O
the,856,859,O
fidelity,860,868,O
and,869,872,O
unidirectionality,873,890,O
of,891,893,O
the,894,897,O
targeting,898,907,O
and,908,911,O
translocation,912,925,O
process,926,933,O
are,934,937,O
reviewed,938,946,O
here,947,951,O
.,951,952,O
Phonology,0,9,O
:,9,10,O
a,11,12,O
review,13,19,O
and,20,23,O
proposals,24,33,O
from,34,38,O
a,39,40,O
connectionist,41,54,O
perspective,55,66,O
.,66,67,O
A,68,69,O
parallel,70,78,O
distributed,79,90,O
processing,91,101,O
(,102,103,O
PDP,103,106,O
),106,107,O
model,108,113,O
of,114,116,O
phonological,117,129,O
processing,130,140,O
is,141,143,O
developed,144,153,O
",",153,154,O
including,155,164,O
components,165,175,O
to,176,178,O
support,179,186,O
repetition,187,197,O
",",197,198,O
auditory,199,207,O
processing,208,218,O
",",218,219,O
comprehension,220,233,O
",",233,234,O
and,235,238,O
language,239,247,O
production,248,258,O
.,258,259,O
From,260,264,O
the,265,268,O
performance,269,280,O
of,281,283,O
the,284,287,O
PDP,288,291,O
reading,292,299,O
model,300,305,O
of,306,308,O
Plaut,309,314,O
",",314,315,O
McClelland,316,326,O
",",326,327,O
Seidenberg,328,338,O
",",338,339,O
and,340,343,O
Patterson,344,353,O
(,354,355,O
1996,355,359,O
),359,360,O
",",360,361,O
it,362,364,O
is,365,367,O
inferred,368,376,O
that,377,381,O
the,382,385,O
acoustic,386,394,O
-,394,395,O
articulatory,395,407,O
motor,408,413,O
pattern,414,421,O
associator,422,432,O
that,433,437,O
supports,438,446,O
repetition,447,457,O
provides,458,466,O
the,467,470,O
basis,471,476,O
for,477,480,O
phonological,481,493,O
sequence,494,502,O
knowledge,503,512,O
.,512,513,O
From,514,518,O
the,519,522,O
observation,523,534,O
that,535,539,O
many,540,544,O
patients,545,553,O
make,554,558,O
phonemic,559,567,O
paraphasic,568,578,O
errors,579,585,O
in,586,588,O
language,589,597,O
production,598,608,O
",",608,609,O
as,610,612,O
in,613,615,O
repetition,616,626,O
",",626,627,O
it,628,630,O
is,631,633,O
argued,634,640,O
that,641,645,O
there,646,651,O
must,652,656,O
be,657,659,O
a,660,661,O
direct,662,668,O
link,669,673,O
between,674,681,O
distributed,682,693,O
concept,694,701,O
representations,702,717,O
(,718,719,O
lexical,719,726,O
semantic,727,735,O
knowledge,736,745,O
),745,746,O
and,747,750,O
this,751,755,O
network,756,763,O
representation,764,778,O
of,779,781,O
sequence,782,790,O
knowledge,791,800,O
.,800,801,O
In,802,804,O
this,805,809,O
way,810,813,O
",",813,814,O
both,815,819,O
lexical,820,827,O
semantic,828,836,O
and,837,840,O
phonotactic,841,852,O
constraints,853,864,O
are,865,868,O
brought,869,876,O
to,877,879,O
bear,880,884,O
on,885,887,O
language,888,896,O
production,897,907,O
.,907,908,O
The,909,912,O
literature,913,923,O
on,924,926,O
phonological,927,939,O
function,940,948,O
in,949,951,O
normal,952,958,O
subjects,959,967,O
(,968,969,O
slip,969,973,O
-,973,974,O
of,974,976,O
-,976,977,O
the,977,980,O
-,980,981,O
tongue,981,987,O
corpora,988,995,O
),995,996,O
and,997,1000,O
in,1001,1003,O
patients,1004,1012,O
with,1013,1017,O
aphasia,1018,1025,O
is,1026,1028,O
critically,1029,1039,O
reviewed,1040,1048,O
from,1049,1053,O
this,1054,1058,O
perspective,1059,1070,O
.,1070,1071,O
The,1072,1075,O
relationship,1076,1088,O
between,1089,1096,O
acoustic,1097,1105,O
and,1106,1109,O
articulatory,1110,1122,O
motor,1123,1128,O
representations,1129,1144,O
in,1145,1147,O
the,1148,1151,O
process,1152,1159,O
of,1160,1162,O
phonetic,1163,1171,O
perception,1172,1182,O
is,1183,1185,O
considered,1186,1196,O
.,1196,1197,O
Repetition,1198,1208,O
and,1209,1212,O
reproduction,1213,1225,O
conduction,1226,1236,O
aphasia,1237,1244,O
are,1245,1248,O
reviewed,1249,1257,O
in,1258,1260,O
detail,1261,1267,O
and,1268,1271,O
extended,1272,1280,O
consideration,1281,1294,O
is,1295,1297,O
given,1298,1303,O
to,1304,1306,O
the,1307,1310,O
representation,1311,1325,O
of,1326,1328,O
auditory,1329,1337,O
verbal,1338,1344,O
short,1345,1350,O
-,1350,1351,O
term,1351,1355,O
memory,1356,1362,O
in,1363,1365,O
the,1366,1369,O
model,1370,1375,O
.,1375,1376,O
Finally,1377,1384,O
",",1384,1385,O
the,1386,1389,O
PDP,1390,1393,O
model,1394,1399,O
is,1400,1402,O
reconciled,1403,1413,O
with,1414,1418,O
information,1419,1430,O
processing,1431,1441,O
models,1442,1448,O
of,1449,1451,O
phonological,1452,1464,O
processing,1465,1475,O
",",1475,1476,O
including,1477,1486,O
that,1487,1491,O
of,1492,1494,O
Lichtheim,1495,1504,O
",",1504,1505,O
and,1506,1509,O
with,1510,1514,O
current,1515,1522,O
knowledge,1523,1532,O
of,1533,1535,O
the,1536,1539,O
anatomic,1540,1548,O
localization,1549,1561,O
of,1562,1564,O
phonological,1565,1577,O
processing,1578,1588,O
.,1588,1589,O
Although,1590,1598,O
no,1599,1601,O
simulations,1602,1613,O
of,1614,1616,O
the,1617,1620,O
model,1621,1626,O
were,1627,1631,O
run,1632,1635,O
",",1635,1636,O
a,1637,1638,O
number,1639,1645,O
of,1646,1648,O
simulation,1649,1659,O
studies,1660,1667,O
are,1668,1671,O
proposed,1672,1680,O
.,1680,1681,O
Male,0,4,O
role,5,9,O
in,10,12,O
fertility,13,22,O
decisions,23,32,O
in,33,35,O
Robertsport,36,47,O
",",47,48,O
Liberia,49,56,O
:,56,57,O
an,58,60,O
experimental,61,73,O
exercise,74,82,O
for,83,86,O
policy,87,93,O
formulation,94,105,O
.,105,106,O
There,107,112,O
is,113,115,O
a,116,117,O
tendency,118,126,O
to,127,129,O
believe,130,137,O
that,138,142,O
in,143,145,O
African,146,153,O
societies,154,163,O
men,164,167,O
are,168,171,O
the,172,175,O
dominant,176,184,O
decision,185,193,O
makers,194,200,O
in,201,203,O
the,204,207,O
family,208,214,O
.,214,215,O
In,217,219,O
Robertsport,220,231,O
",",231,232,O
Liberia,233,240,O
",",240,241,O
there,242,247,O
are,248,251,O
indications,252,263,O
that,264,268,O
",",268,269,O
with,270,274,O
respect,275,282,O
to,283,285,O
fertility,286,295,O
regulation,296,306,O
",",306,307,O
the,308,311,O
dominance,312,321,O
of,322,324,O
the,325,328,O
husband,329,336,O
in,337,339,O
fertility,340,349,O
decisions,350,359,O
exists,360,366,O
",",366,367,O
but,368,371,O
it,372,374,O
is,375,377,O
also,378,382,O
apparent,383,391,O
that,392,396,O
many,397,401,O
of,402,404,O
these,405,410,O
decisions,411,420,O
are,421,424,O
made,425,429,O
jointly,430,437,O
by,438,440,O
both,441,445,O
husband,446,453,O
and,454,457,O
wife,458,462,O
.,462,463,O
Education,465,474,O
is,475,477,O
particularly,478,490,O
influential,491,502,O
in,503,505,O
the,506,509,O
joint,510,515,O
fertility,516,525,O
decision,526,534,O
-,534,535,O
making,535,541,O
process,542,549,O
.,549,550,O
The,552,555,O
100,556,559,O
husbands,560,568,O
sampled,569,576,O
in,577,579,O
1982,580,584,O
desired,585,592,O
a,593,594,O
large,595,600,O
number,601,607,O
of,608,610,O
children,611,619,O
and,620,623,O
had,624,627,O
experience,628,638,O
with,639,643,O
infant,644,650,O
and,651,654,O
child,655,660,O
mortality,661,670,O
.,670,671,O
If,673,675,O
family,676,682,O
planning,683,691,O
programs,692,700,O
should,701,707,O
attain,708,714,O
their,715,720,O
goals,721,726,O
",",726,727,O
men,728,731,O
should,732,738,O
be,739,741,O
more,742,746,O
involved,747,755,O
",",755,756,O
than,757,761,O
at,762,764,O
present,765,772,O
",",772,773,O
in,774,776,O
every,777,782,O
aspect,783,789,O
of,790,792,O
the,793,796,O
programs,797,805,O
.,805,806,O
Equally,808,815,O
important,816,825,O
is,826,828,O
the,829,832,O
urgency,833,840,O
for,841,844,O
studies,845,852,O
related,853,860,O
to,861,863,O
the,864,867,O
role,868,872,O
of,873,875,O
men,876,879,O
in,880,882,O
fertility,883,892,O
regulation,893,903,O
",",903,904,O
using,905,910,O
adequately,911,921,O
large,922,927,O
samples,928,935,O
.,935,936,O
Act,0,3,O
No,4,6,O
.,6,7,O
16,8,10,O
.,10,11,O
045,11,14,O
of,16,18,O
2,19,20,O
June,21,25,O
1989,26,30,O
prohibiting,31,42,O
all,43,46,O
discrimination,47,61,O
that,62,66,O
violates,67,75,O
the,76,79,O
principle,80,89,O
of,90,92,O
equality,93,101,O
of,102,104,O
treatment,105,114,O
and,115,118,O
opportunities,119,132,O
for,133,136,O
both,137,141,O
sexes,142,147,O
in,148,150,O
all,151,154,O
sectors,155,162,O
of,163,165,O
labor,166,171,O
activity,172,180,O
.,180,181,O
This,182,186,O
Uruguayan,187,196,O
Act,197,200,O
prohibits,201,210,O
discrimination,211,225,O
in,226,228,O
employment,229,239,O
with,240,244,O
respect,245,252,O
to,253,255,O
the,256,259,O
following,260,269,O
areas,270,275,O
",",275,276,O
among,277,282,O
others,283,289,O
:,289,290,O
1,291,292,O
),292,293,O
advertising,294,305,O
for,306,309,O
the,310,313,O
provision,314,323,O
of,324,326,O
positions,327,336,O
;,336,337,O
2,338,339,O
),339,340,O
selection,341,350,O
criteria,351,359,O
;,359,360,O
3,361,362,O
),362,363,O
recruitment,364,375,O
and,376,379,O
hiring,380,386,O
;,386,387,O
4,388,389,O
),389,390,O
evaluation,391,401,O
of,402,404,O
performance,405,416,O
criteria,417,425,O
;,425,426,O
5,427,428,O
),428,429,O
the,430,433,O
right,434,439,O
to,440,442,O
advancement,443,454,O
and,455,458,O
promotion,459,468,O
;,468,469,O
6,470,471,O
),471,472,O
labour,473,479,O
stability,480,489,O
;,489,490,O
7,491,492,O
),492,493,O
social,494,500,O
benefits,501,509,O
;,509,510,O
8,511,512,O
),512,513,O
suspension,514,524,O
and,525,528,O
dismissal,529,538,O
",",538,539,O
particularly,540,552,O
in,553,555,O
cases,556,561,O
involving,562,571,O
a,572,573,O
change,574,580,O
of,581,583,O
civil,584,589,O
status,590,596,O
",",596,597,O
pregnancy,598,607,O
",",607,608,O
or,609,611,O
nursing,612,619,O
;,619,620,O
9,621,622,O
),622,623,O
possibilities,624,637,O
for,638,641,O
professional,642,654,O
and,655,658,O
technical,659,668,O
education,669,678,O
or,679,681,O
retraining,682,692,O
;,692,693,O
and,694,697,O
10,698,700,O
),700,701,O
remuneration,702,714,O
criteria,715,723,O
.,723,724,O
Reserving,725,734,O
places,735,741,O
for,742,745,O
one,746,749,O
sex,750,753,O
because,754,761,O
of,762,764,O
the,765,768,O
presence,769,777,O
of,778,780,O
activities,781,791,O
in,792,794,O
which,795,800,O
the,801,804,O
sex,805,808,O
of,809,811,O
the,812,815,O
employee,816,824,O
is,825,827,O
essential,828,837,O
for,838,841,O
performance,842,853,O
or,854,856,O
to,857,859,O
comply,860,866,O
with,867,871,O
international,872,885,O
labor,886,891,O
treaties,892,900,O
does,901,905,O
not,906,909,O
constitute,910,920,O
discrimination,921,935,O
.,935,936,O
Nor,938,941,O
do,942,944,O
compensatory,945,957,O
acts,958,962,O
designed,963,971,O
to,972,974,O
promote,975,982,O
equality,983,991,O
of,992,994,O
opportunities,995,1008,O
and,1009,1012,O
treatment,1013,1022,O
of,1023,1025,O
both,1026,1030,O
sexes,1031,1036,O
in,1037,1039,O
concrete,1040,1048,O
situations,1049,1059,O
.,1059,1060,O
In,1061,1063,O
cases,1064,1069,O
where,1070,1075,O
the,1076,1079,O
provisions,1080,1090,O
of,1091,1093,O
this,1094,1098,O
Act,1099,1102,O
have,1103,1107,O
been,1108,1112,O
violated,1113,1121,O
",",1121,1122,O
specially,1123,1132,O
designated,1133,1143,O
judges,1144,1150,O
will,1151,1155,O
call,1156,1160,O
the,1161,1164,O
parties,1165,1172,O
together,1173,1181,O
and,1182,1185,O
may,1186,1189,O
adopt,1190,1195,O
measures,1196,1204,O
designed,1205,1213,O
to,1214,1216,O
end,1217,1220,O
the,1221,1224,O
situation,1225,1234,O
complained,1235,1245,O
of,1246,1248,O
.,1248,1249,O
If,1251,1253,O
they,1254,1258,O
deem,1259,1263,O
it,1264,1266,O
necessary,1267,1276,O
",",1276,1277,O
the,1278,1281,O
judges,1282,1288,O
may,1289,1292,O
institute,1293,1302,O
more,1303,1307,O
formal,1308,1314,O
proceedings,1315,1326,O
.,1326,1327,O
If,1329,1331,O
the,1332,1335,O
measures,1336,1344,O
adopted,1345,1352,O
are,1353,1356,O
not,1357,1360,O
carried,1361,1368,O
out,1369,1372,O
",",1372,1373,O
the,1374,1377,O
person,1378,1384,O
violating,1385,1394,O
the,1395,1398,O
law,1399,1402,O
is,1403,1405,O
subject,1406,1413,O
to,1414,1416,O
a,1417,1418,O
daily,1419,1424,O
fine,1425,1429,O
",",1429,1430,O
as,1431,1433,O
well,1434,1438,O
as,1439,1441,O
administrative,1442,1456,O
penalties,1457,1466,O
set,1467,1470,O
out,1471,1474,O
in,1475,1477,O
Act,1478,1481,O
15,1482,1484,O
.,1484,1485,O
903,1485,1488,O
of,1489,1491,O
10,1492,1494,O
November,1495,1503,O
1987,1504,1508,O
.,1508,1509,O
Adverse,1511,1518,O
decisions,1519,1528,O
may,1529,1532,O
be,1533,1535,O
appealed,1536,1544,O
.,1544,1545,O
The,1547,1550,O
state,1551,1556,O
is,1557,1559,O
also,1560,1564,O
to,1565,1567,O
undertake,1568,1577,O
educative,1578,1587,O
campaigns,1588,1597,O
to,1598,1600,O
create,1601,1607,O
interest,1608,1616,O
in,1617,1619,O
and,1620,1623,O
understanding,1624,1637,O
of,1638,1640,O
the,1641,1644,O
problems,1645,1653,O
affecting,1654,1663,O
women,1664,1669,O
workers,1670,1677,O
",",1677,1678,O
thus,1679,1683,O
promoting,1684,1693,O
awareness,1694,1703,O
in,1704,1706,O
such,1707,1711,O
workers,1712,1719,O
and,1720,1723,O
their,1724,1729,O
employers,1730,1739,O
of,1740,1742,O
their,1743,1748,O
situation,1749,1758,O
.,1758,1759,O
CXC,0,3,O
chemokine,4,13,O
receptors,14,23,O
in,24,26,O
the,27,30,O
central,31,38,B-Anatomical_system
nervous,39,46,I-Anatomical_system
system,47,53,I-Anatomical_system
:,53,54,O
Role,55,59,O
in,60,62,O
cerebellar,63,73,B-Multi-tissue_structure
neuromodulation,74,89,O
and,90,93,O
development,94,105,O
.,105,106,O
Chemokines,107,117,O
and,118,121,O
their,122,127,O
receptors,128,137,O
are,138,141,O
constitutively,142,156,O
present,157,164,O
in,165,167,O
the,168,171,O
central,172,179,B-Anatomical_system
nervous,180,187,I-Anatomical_system
system,188,194,I-Anatomical_system
(,195,196,O
CNS,196,199,B-Anatomical_system
),199,200,O
",",200,201,O
expressed,202,211,O
in,212,214,O
neurons,215,222,B-Cell
and,223,226,O
glial,227,232,B-Cell
cells,233,238,I-Cell
.,238,239,O
Much,240,244,O
evidence,245,253,O
suggests,254,262,O
that,263,267,O
",",267,268,O
beyond,269,275,O
their,276,281,O
involvement,282,293,O
in,294,296,O
neuroinflammation,297,314,O
",",314,315,O
these,316,321,O
proteins,322,330,O
play,331,335,O
a,336,337,O
role,338,342,O
in,343,345,O
neurodevelopment,346,362,O
and,363,366,O
neurophysiological,367,385,O
signaling,386,395,O
.,395,396,O
The,397,400,O
goal,401,405,O
of,406,408,O
this,409,413,O
review,414,420,O
is,421,423,O
to,424,426,O
summarize,427,436,O
recent,437,443,O
information,444,455,O
concerning,456,466,O
expression,467,477,O
",",477,478,O
signaling,479,488,O
",",488,489,O
and,490,493,O
function,494,502,O
of,503,505,O
CXC,506,509,O
chemokine,510,519,O
receptor,520,528,O
in,529,531,O
the,532,535,O
CNS,536,539,B-Anatomical_system
",",539,540,O
with,541,545,O
the,546,549,O
main,550,554,O
focus,555,560,O
on,561,563,O
the,564,567,O
developmental,568,581,O
and,582,585,O
neuromodulatory,586,601,O
actions,602,609,O
of,610,612,O
chemokines,613,623,O
in,624,626,O
the,627,630,O
cerebellum,631,641,B-Multi-tissue_structure
.,641,642,O
Combined,0,8,O
tracheal,9,17,B-Multi-tissue_structure
and,18,21,O
esophageal,22,32,B-Multi-tissue_structure
stenting,33,41,O
for,42,45,O
palliation,46,56,O
of,57,59,O
tracheoesophageal,60,77,B-Multi-tissue_structure
symptoms,78,86,O
from,87,91,O
mediastinal,92,103,B-Pathological_formation
lymphoma,104,112,I-Pathological_formation
.,112,113,O
Mediastinal,114,125,B-Pathological_formation
lymphoma,126,134,I-Pathological_formation
as,135,137,O
a,138,139,O
cause,140,145,O
of,146,148,O
tracheobronchial,149,165,B-Multi-tissue_structure
obstruction,166,177,O
is,178,180,O
uncommon,181,189,O
",",189,190,O
and,191,194,O
a,195,196,O
malignant,197,206,O
tracheoesophageal,207,224,B-Immaterial_anatomical_entity
fistula,225,232,I-Immaterial_anatomical_entity
in,233,235,O
the,236,239,O
setting,240,247,O
of,248,250,O
mediastinal,251,262,B-Pathological_formation
lymphoma,263,271,I-Pathological_formation
is,272,274,O
rare,275,279,O
.,279,280,O
Malignant,281,290,O
tracheoesophageal,291,308,B-Immaterial_anatomical_entity
fistulas,309,317,I-Immaterial_anatomical_entity
are,318,321,O
associated,322,332,O
with,333,337,O
pronounced,338,348,O
morbidity,349,358,O
and,359,362,O
mortality,363,372,O
.,372,373,O
We,374,376,O
describe,377,385,O
a,386,387,O
patient,388,395,O
with,396,400,O
mediastinal,401,412,B-Pathological_formation
lymphomatous,413,425,I-Pathological_formation
infiltration,426,438,O
resulting,439,448,O
in,449,451,O
tracheal,452,460,B-Multi-tissue_structure
obstruction,461,472,O
",",472,473,O
esophageal,474,484,B-Multi-tissue_structure
obstruction,485,496,O
",",496,497,O
and,498,501,O
tracheoesophageal,502,519,B-Immaterial_anatomical_entity
fistula,520,527,I-Immaterial_anatomical_entity
that,528,532,O
were,533,537,O
successfully,538,550,O
palliated,551,560,O
with,561,565,O
combined,566,574,O
airway,575,581,B-Multi-tissue_structure
and,582,585,O
esophageal,586,596,B-Multi-tissue_structure
stent,597,602,O
placement,603,612,O
.,612,613,O
Rural,0,5,O
/,5,6,O
urban,6,11,O
differences,12,23,O
in,24,26,O
access,27,33,O
to,34,36,O
and,37,40,O
utilization,41,52,O
of,53,55,O
services,56,64,O
among,65,70,O
people,71,77,O
in,78,80,O
Alabama,81,88,O
with,89,93,O
sickle,94,100,B-Cell
cell,101,105,I-Cell
disease,106,113,O
.,113,114,O
OBJECTIVE,115,124,O
:,124,125,O
This,126,130,O
study,131,136,O
examined,137,145,O
relationships,146,159,O
between,160,167,O
socioeconomic,168,181,O
factors,182,189,O
and,190,193,O
the,194,197,O
geographic,198,208,O
distribution,209,221,O
of,222,224,O
662,225,228,O
cases,229,234,O
of,235,237,O
sickle,238,244,B-Cell
cell,245,249,I-Cell
disease,250,257,O
in,258,260,O
Alabama,261,268,O
in,269,271,O
1999,272,276,O
-,276,277,O
2001,277,281,O
.,281,282,O
METHODS,283,290,O
:,290,291,O
Measures,292,300,O
of,301,303,O
community,304,313,O
distress,314,322,O
",",322,323,O
physical,324,332,O
functioning,333,344,O
",",344,345,O
and,346,349,O
medical,350,357,O
problems,358,366,O
were,367,371,O
used,372,376,O
in,377,379,O
analyzing,380,389,O
utilization,390,401,O
differences,402,413,O
between,414,421,O
individuals,422,433,O
with,434,438,O
sickle,439,445,B-Cell
cell,446,450,I-Cell
disease,451,458,O
living,459,465,O
in,466,468,O
urban,469,474,O
and,475,478,O
rural,479,484,O
areas,485,490,O
.,490,491,O
RESULTS,492,499,O
:,499,500,O
Utilization,501,512,O
of,513,515,O
comprehensive,516,529,O
sickle,530,536,B-Cell
cells,537,542,I-Cell
disease,543,550,O
services,551,559,O
was,560,563,O
lower,564,569,O
for,570,573,O
individuals,574,585,O
with,586,590,O
sickle,591,597,B-Cell
cell,598,602,I-Cell
disease,603,610,O
living,611,617,O
in,618,620,O
rural,621,626,O
areas,627,632,O
than,633,637,O
for,638,641,O
those,642,647,O
living,648,654,O
in,655,657,O
urban,658,663,O
areas,664,669,O
.,669,670,O
Rural,671,676,O
clients,677,684,O
reported,685,693,O
significantly,694,707,O
more,708,712,O
limitations,713,724,O
than,725,729,O
urban,730,735,O
clients,736,743,O
on,744,746,O
several,747,754,O
measures,755,763,O
of,764,766,O
physical,767,775,O
functioning,776,787,O
.,787,788,O
The,789,792,O
results,793,800,O
also,801,805,O
suggest,806,813,O
that,814,818,O
utilization,819,830,O
of,831,833,O
services,834,842,O
was,843,846,O
higher,847,853,O
for,854,857,O
those,858,863,O
with,864,868,O
more,869,873,O
medical,874,881,O
problems,882,890,O
and,891,894,O
those,895,900,O
who,901,904,O
lived,905,910,O
in,911,913,O
high,914,918,O
distress,919,927,O
areas,928,933,O
",",933,934,O
although,935,943,O
these,944,949,O
findings,950,958,O
did,959,962,O
not,963,966,O
meet,967,971,O
the,972,975,O
criterion,976,985,O
for,986,989,O
statistical,990,1001,O
significance,1002,1014,O
.,1014,1015,O
CONCLUSIONS,1016,1027,O
:,1027,1028,O
Conclusions,1029,1040,O
based,1041,1046,O
on,1047,1049,O
statistical,1050,1061,O
evidence,1062,1070,O
that,1071,1075,O
geographic,1076,1086,O
location,1087,1095,O
and,1096,1099,O
socioeconomic,1100,1113,O
factors,1114,1121,O
relate,1122,1128,O
to,1129,1131,O
significantly,1132,1145,O
different,1146,1155,O
health,1156,1162,O
care,1163,1167,O
service,1168,1175,O
experience,1176,1186,O
bear,1187,1191,O
important,1192,1201,O
implications,1202,1214,O
for,1215,1218,O
medical,1219,1226,O
and,1227,1230,O
health,1231,1237,O
care,1238,1242,O
support,1243,1250,O
systems,1251,1258,O
",",1258,1259,O
especially,1260,1270,O
on,1271,1273,O
the,1274,1277,O
community,1278,1287,O
level,1288,1293,O
.,1293,1294,O
Impact,0,6,O
of,7,9,O
technology,10,20,O
on,21,23,O
the,24,27,O
utilisation,28,39,O
of,40,42,O
positron,43,51,O
emission,52,60,O
tomography,61,71,O
in,72,74,O
lymphoma,75,83,B-Pathological_formation
:,83,84,O
current,85,92,O
and,93,96,O
future,97,103,O
perspectives,104,116,O
.,116,117,O
Positron,118,126,O
emission,127,135,O
tomography,136,146,O
(,147,148,O
PET,148,151,O
),151,152,O
has,153,156,O
now,157,160,O
gained,161,167,O
a,168,169,O
place,170,175,O
in,176,178,O
the,179,182,O
management,183,193,O
of,194,196,O
patients,197,205,O
with,206,210,O
cancer,211,217,B-Pathological_formation
",",217,218,O
including,219,228,O
those,229,234,O
with,235,239,O
Hodgkin,240,247,O
',247,248,O
s,248,249,O
disease,250,257,O
and,258,261,O
non,262,265,B-Pathological_formation
-,265,266,I-Pathological_formation
Hodgkin,266,273,I-Pathological_formation
',273,274,I-Pathological_formation
s,274,275,I-Pathological_formation
lymphoma,276,284,I-Pathological_formation
.,284,285,O
Restaging,286,295,O
studies,296,303,O
and,304,307,O
those,308,313,O
addressing,314,324,O
the,325,328,O
monitoring,329,339,O
of,340,342,O
response,343,351,O
to,352,354,O
treatment,355,364,O
are,365,368,O
especially,369,379,O
in,380,382,O
focus,383,388,O
.,388,389,O
Most,390,394,O
of,395,397,O
the,398,401,O
knowledge,402,411,O
gained,412,418,O
has,419,422,O
been,423,427,O
achieved,428,436,O
with,437,441,O
dedicated,442,451,O
BGO,452,455,O
-,455,456,O
based,456,461,O
PET,462,465,O
technology,466,476,O
",",476,477,O
but,478,481,O
there,482,487,O
are,488,491,O
a,492,493,O
number,494,500,O
of,501,503,O
developments,504,516,O
that,517,521,O
will,522,526,O
impact,527,533,O
on,534,536,O
the,537,540,O
use,541,544,O
of,545,547,O
this,548,552,O
metabolic,553,562,O
imaging,563,570,O
technique,571,580,O
in,581,583,O
the,584,587,O
investigation,588,601,O
of,602,604,O
patients,605,613,O
with,614,618,O
lymphoma,619,627,B-Pathological_formation
.,627,628,O
The,629,632,O
challenges,633,643,O
ahead,644,649,O
are,650,653,O
determined,654,664,O
by,665,667,O
the,668,671,O
need,672,676,O
for,677,680,O
high,681,685,O
-,685,686,O
quality,686,693,O
whole,694,699,O
-,699,700,O
body,700,704,O
imaging,705,712,O
associated,713,723,O
with,724,728,O
increased,729,738,O
patient,739,746,O
throughput,747,757,O
and,758,761,O
the,762,765,O
need,766,770,O
to,771,773,O
investigate,774,785,O
the,786,789,O
role,790,794,O
of,795,797,O
new,798,801,O
labelled,802,810,O
ligands,811,818,O
.,818,819,O
The,820,823,O
latter,824,830,O
are,831,834,O
likely,835,841,O
to,842,844,O
yield,845,850,O
new,851,854,O
insights,855,863,O
into,864,868,O
tumour,869,875,B-Cell
cell,876,880,I-Cell
characterisation,881,897,O
",",897,898,O
tumour,899,905,B-Pathological_formation
behaviour,906,915,O
and,916,919,O
tumour,920,926,B-Pathological_formation
outcome,927,934,O
assessment,935,945,O
.,945,946,O
The,947,950,O
study,951,956,O
of,957,959,O
new,960,963,O
radiolabelled,964,977,O
ligands,978,985,O
will,986,990,O
impose,991,997,O
further,998,1005,O
demands,1006,1013,O
for,1014,1017,O
rapid,1018,1023,O
dynamic,1024,1031,O
data,1032,1036,O
acquisition,1037,1048,O
and,1049,1052,O
accurate,1053,1061,O
tracer,1062,1068,O
quantification,1069,1083,O
.,1083,1084,O
Current,1085,1092,O
and,1093,1096,O
future,1097,1103,O
developments,1104,1116,O
in,1117,1119,O
PET,1120,1123,O
technology,1124,1134,O
range,1135,1140,O
from,1141,1145,O
the,1146,1149,O
use,1150,1153,O
of,1154,1156,O
new,1157,1160,O
detector,1161,1169,O
materials,1170,1179,O
to,1180,1182,O
different,1183,1192,O
detector,1193,1201,O
geometries,1202,1212,O
and,1213,1216,O
data,1217,1221,O
acquisition,1222,1233,O
modes,1234,1239,O
.,1239,1240,O
The,1241,1244,O
search,1245,1251,O
for,1252,1255,O
alternatives,1256,1268,O
to,1269,1271,O
BGO,1272,1275,O
scintillation,1276,1289,O
materials,1290,1299,O
for,1300,1303,O
PET,1304,1307,O
has,1308,1311,O
led,1312,1315,O
to,1316,1318,O
the,1319,1322,O
development,1323,1334,O
of,1335,1337,O
PET,1338,1341,O
instruments,1342,1353,O
utilising,1354,1363,O
new,1364,1367,O
crystals,1368,1376,O
such,1377,1381,O
as,1382,1384,O
LSO,1385,1388,O
and,1389,1392,O
GSO,1393,1396,O
.,1396,1397,O
The,1398,1401,O
use,1402,1405,O
of,1406,1408,O
these,1409,1414,O
new,1415,1418,O
detectors,1419,1428,O
and,1429,1432,O
the,1433,1436,O
increased,1437,1446,O
sensitivity,1447,1458,O
achieved,1459,1467,O
with,1468,1472,O
3D,1473,1475,O
data,1476,1480,O
acquisitions,1481,1493,O
represent,1494,1503,O
the,1504,1507,O
most,1508,1512,O
significant,1513,1524,O
current,1525,1532,O
developments,1533,1545,O
in,1546,1548,O
the,1549,1552,O
field,1553,1558,O
.,1558,1559,O
With,1560,1564,O
the,1565,1568,O
increasing,1569,1579,O
demands,1580,1587,O
imposed,1588,1595,O
on,1596,1598,O
the,1599,1602,O
clinical,1603,1611,O
utilisation,1612,1623,O
of,1624,1626,O
PET,1627,1630,O
",",1630,1631,O
issues,1632,1638,O
such,1639,1643,O
as,1644,1646,O
study,1647,1652,O
cost,1653,1657,O
and,1658,1661,O
patient,1662,1669,O
throughput,1670,1680,O
will,1681,1685,O
emerge,1686,1692,O
as,1693,1695,O
significant,1696,1707,O
future,1708,1714,O
factors,1715,1722,O
.,1722,1723,O
As,1724,1726,O
a,1727,1728,O
consequence,1729,1740,O
",",1740,1741,O
low,1742,1745,O
-,1745,1746,O
cost,1746,1750,O
units,1751,1756,O
are,1757,1760,O
being,1761,1766,O
offered,1767,1774,O
by,1775,1777,O
the,1778,1781,O
manufacturers,1782,1795,O
through,1796,1803,O
the,1804,1807,O
utilisation,1808,1819,O
of,1820,1822,O
gamma,1823,1828,O
camera,1829,1835,O
-,1835,1836,O
based,1836,1841,O
SPET,1842,1846,O
systems,1847,1854,O
for,1855,1858,O
PET,1859,1862,O
coincidence,1863,1874,O
imaging,1875,1882,O
.,1882,1883,O
Unfortunately,1884,1897,O
",",1897,1898,O
clinical,1899,1907,O
studies,1908,1915,O
in,1916,1918,O
lymphoma,1919,1927,B-Pathological_formation
and,1928,1931,O
other,1932,1937,O
cancers,1938,1945,B-Pathological_formation
have,1946,1950,O
already,1951,1958,O
demonstrated,1959,1971,O
the,1972,1975,O
limitations,1976,1987,O
of,1988,1990,O
this,1991,1995,O
technology,1996,2006,O
",",2006,2007,O
with,2008,2012,O
20,2013,2015,O
%,2015,2016,O
of,2017,2019,O
lesions,2020,2027,B-Pathological_formation
<,2028,2029,O
15,2029,2031,O
mm,2032,2034,O
in,2035,2037,O
size,2038,2042,O
escaping,2043,2051,O
detection,2052,2061,O
.,2061,2062,O
On,2063,2065,O
the,2066,2069,O
other,2070,2075,O
hand,2076,2080,O
",",2080,2081,O
the,2082,2085,O
recent,2086,2092,O
development,2093,2104,O
of,2105,2107,O
combined,2108,2116,O
PET,2117,2120,O
/,2120,2121,O
CT,2121,2123,O
devices,2124,2131,O
attempts,2132,2140,O
to,2141,2143,O
address,2144,2151,O
the,2152,2155,O
lack,2156,2160,O
of,2161,2163,O
anatomical,2164,2174,O
information,2175,2186,O
inherent,2187,2195,O
with,2196,2200,O
PET,2201,2204,O
images,2205,2211,O
",",2211,2212,O
taking,2213,2219,O
advantage,2220,2229,O
of,2230,2232,O
further,2233,2240,O
improvement,2241,2252,O
in,2253,2255,O
patient,2256,2263,O
throughput,2264,2274,O
and,2275,2278,O
hence,2279,2284,O
cost,2285,2289,O
-,2289,2290,O
effectiveness,2290,2303,O
.,2303,2304,O
Preliminary,2305,2316,O
studies,2317,2324,O
using,2325,2330,O
this,2331,2335,O
multimodality,2336,2349,O
imaging,2350,2357,O
approach,2358,2366,O
have,2367,2371,O
already,2372,2379,O
demonstrated,2380,2392,O
the,2393,2396,O
potential,2397,2406,O
of,2407,2409,O
the,2410,2413,O
technique,2414,2423,O
.,2423,2424,O
Although,2425,2433,O
the,2434,2437,O
potential,2438,2447,O
exists,2448,2454,O
",",2454,2455,O
certain,2456,2463,O
technical,2464,2473,O
issues,2474,2480,O
with,2481,2485,O
PET,2486,2489,O
/,2489,2490,O
CT,2490,2492,O
require,2493,2500,O
refinement,2501,2511,O
of,2512,2514,O
the,2515,2518,O
methodology,2519,2530,O
.,2530,2531,O
Such,2532,2536,O
issues,2537,2543,O
include,2544,2551,O
organ,2552,2557,B-Organ
movement,2558,2566,O
(,2567,2568,O
such,2568,2572,O
as,2573,2575,O
respiratory,2576,2587,B-Anatomical_system
motion,2588,2594,O
),2594,2595,O
",",2595,2596,O
which,2597,2602,O
strongly,2603,2611,O
influences,2612,2622,O
the,2623,2626,O
image,2627,2632,O
fusion,2633,2639,O
of,2640,2642,O
a,2643,2644,O
rapidly,2645,2652,O
acquired,2653,2661,O
CT,2662,2664,O
scan,2665,2669,O
with,2670,2674,O
the,2675,2678,O
slower,2679,2685,O
acquisition,2686,2697,O
of,2698,2700,O
a,2701,2702,O
PET,2703,2706,O
dataset,2707,2714,O
",",2714,2715,O
and,2716,2719,O
the,2720,2723,O
derivation,2724,2734,O
of,2735,2737,O
CT,2738,2740,O
-,2740,2741,O
based,2741,2746,O
attenuation,2747,2758,O
coefficients,2759,2771,O
in,2772,2774,O
the,2775,2778,O
presence,2779,2787,O
of,2788,2790,O
contrast,2791,2799,O
agents,2800,2806,O
or,2807,2809,O
metallic,2810,2818,O
implants,2819,2827,O
.,2827,2828,O
The,2829,2832,O
application,2833,2844,O
of,2845,2847,O
the,2848,2851,O
technology,2852,2862,O
for,2863,2866,O
radiotherapy,2867,2879,O
planning,2880,2888,O
also,2889,2893,O
poses,2894,2899,O
a,2900,2901,O
number,2902,2908,O
of,2909,2911,O
associated,2912,2922,O
challenges,2923,2933,O
.,2933,2934,O
Finally,2935,2942,O
",",2942,2943,O
the,2944,2947,O
development,2948,2959,O
of,2960,2962,O
dedicated,2963,2972,O
PET,2973,2976,O
systems,2977,2984,O
based,2985,2990,O
on,2991,2993,O
planar,2994,3000,O
detector,3001,3009,O
arrangements,3010,3022,O
with,3023,3027,O
new,3028,3031,O
detector,3032,3040,O
components,3041,3051,O
has,3052,3055,O
the,3056,3059,O
potential,3060,3069,O
to,3070,3072,O
improve,3073,3080,O
clinical,3081,3089,O
throughput,3090,3100,O
by,3101,3103,O
over,3104,3108,O
100,3109,3112,O
%,3112,3113,O
",",3113,3114,O
but,3115,3118,O
clinical,3119,3127,O
trials,3128,3134,O
using,3135,3140,O
such,3141,3145,O
systems,3146,3153,O
have,3154,3158,O
still,3159,3164,O
to,3165,3167,O
be,3168,3170,O
carried,3171,3178,O
out,3179,3182,O
in,3183,3185,O
order,3186,3191,O
to,3192,3194,O
establish,3195,3204,O
the,3205,3208,O
associated,3209,3219,O
whole,3220,3225,O
-,3225,3226,O
body,3226,3230,B-Organism_subdivision
image,3231,3236,O
quality,3237,3244,O
.,3244,3245,O
Stereoselective,0,15,O
synthesis,16,25,O
of,26,28,O
1,29,30,O
-,30,31,O
aminoalkanephosphonic,31,52,O
acids,53,58,O
with,59,63,O
two,64,67,O
chiral,68,74,O
centers,75,82,O
and,83,86,O
their,87,92,O
activity,93,101,O
towards,102,109,O
leucine,110,117,O
aminopeptidase,118,132,O
.,132,133,O
The,134,137,O
stereoselective,138,153,O
synthesis,154,163,O
of,164,166,O
1,167,168,O
-,168,169,O
amino,169,174,O
-,174,175,O
2,175,176,O
-,176,177,O
alkylalkanephosphonic,177,198,O
acids,199,204,O
",",204,205,O
namely,206,212,O
",",212,213,O
compounds,214,223,O
bearing,224,231,O
two,232,235,O
chiral,236,242,O
centers,243,250,O
",",250,251,O
was,252,255,O
achieved,256,264,O
by,265,267,O
the,268,271,O
condensation,272,284,O
of,285,287,O
hypophosphorous,288,303,O
acid,304,308,O
salts,309,314,O
of,315,317,O
(,318,319,O
R,319,320,O
),320,321,O
(,321,322,O
+,322,323,O
),323,324,O
or,325,327,O
(,328,329,O
S,329,330,O
),330,331,O
(,331,332,O
-,332,333,O
),333,334,O
-,334,335,O
N,335,336,O
-,336,337,O
alpha,337,342,O
-,342,343,O
methylbenzylamine,343,360,O
with,361,365,O
the,366,369,O
appropriate,370,381,O
aldehydes,382,391,O
in,392,394,O
isopropanol,395,406,O
.,406,407,O
Simultaneous,408,420,O
deprotection,421,433,O
and,434,437,O
oxidation,438,447,O
by,448,450,O
the,451,454,O
action,455,461,O
of,462,464,O
bromine,465,472,O
water,473,478,O
provided,479,487,O
equimolar,488,497,O
mixtures,498,506,O
of,507,509,O
the,510,513,O
RS,514,516,O
:,516,517,O
RR,517,519,O
and,520,523,O
SR,524,526,O
:,526,527,O
SS,527,529,O
diastereomers,530,543,O
of,544,546,O
desired,547,554,O
acids,555,560,O
.,560,561,O
They,562,566,O
appeared,567,575,O
to,576,578,O
act,579,582,O
as,583,585,O
moderate,586,594,O
inhibitors,595,605,O
of,606,608,O
kidney,609,615,B-Organ
leucine,616,623,O
aminopeptidase,624,638,O
with,639,643,O
potency,644,651,O
dependent,652,661,O
on,662,664,O
the,665,668,O
absolute,669,677,O
configuration,678,691,O
of,692,694,O
both,695,699,O
centers,700,707,O
of,708,710,O
chirality,711,720,O
.,720,721,O
[,0,1,O
Community,1,10,O
intervention,11,23,O
on,24,26,O
hypertension,27,39,O
and,40,43,O
stroke,44,50,O
],50,51,O
.,51,52,O
OBJECTIVE,53,62,O
:,62,63,O
To,64,66,O
evaluate,67,75,O
the,76,79,O
community,80,89,O
-,89,90,O
based,90,95,O
intervention,96,108,O
on,109,111,O
reduction,112,121,O
of,122,124,O
hypertension,125,137,O
and,138,141,O
stroke,142,148,O
in,149,151,O
different,152,161,O
age,162,165,O
groups,166,172,O
and,173,176,O
subtypes,177,185,O
hypertension,186,198,O
.,198,199,O
METHODS,200,207,O
:,207,208,O
In,209,211,O
6,212,213,O
cities,214,220,O
",",220,221,O
2,222,223,O
geographically,224,238,O
separated,239,248,O
communities,249,260,O
with,261,265,O
a,266,267,O
registered,268,278,O
population,279,289,O
about,290,295,O
10,296,298,O
000,299,302,O
of,303,305,O
each,306,310,O
were,311,315,O
selected,316,324,O
as,325,327,O
either,328,334,O
intervention,335,347,O
or,348,350,O
control,351,358,O
communities,359,370,O
.,370,371,O
A,372,373,O
cohort,374,380,O
containing,381,391,O
2,392,393,O
700,394,397,O
subjects,398,406,O
",",406,407,O
35,408,410,O
years,411,416,O
or,417,419,O
older,420,425,O
",",425,426,O
and,427,430,O
free,431,435,O
of,436,438,O
stroke,439,445,O
were,446,450,O
sampled,451,458,O
from,459,463,O
each,464,468,O
community,469,478,O
.,478,479,O
The,480,483,O
baseline,484,492,O
survey,493,499,O
was,500,503,O
conducted,504,513,O
to,514,516,O
screen,517,523,O
the,524,527,O
subjects,528,536,O
for,537,540,O
intervention,541,553,O
.,553,554,O
In,555,557,O
each,558,562,O
city,563,567,O
",",567,568,O
a,569,570,O
program,571,578,O
for,579,582,O
control,583,590,O
of,591,593,O
hypertension,594,606,O
",",606,607,O
heart,608,613,B-Organ
diseases,614,622,O
and,623,626,O
diabetes,627,635,O
was,636,639,O
initiated,640,649,O
in,650,652,O
the,653,656,O
intervention,657,669,O
cohort,670,676,O
and,677,680,O
health,681,687,O
education,688,697,O
was,698,701,O
provided,702,710,O
to,711,713,O
the,714,717,O
whole,718,723,O
intervention,724,736,O
community,737,746,O
.,746,747,O
A,748,749,O
follow,750,756,O
-,756,757,O
up,757,759,O
survey,760,766,O
was,767,770,O
conducted,771,780,O
3,781,782,O
years,783,788,O
later,789,794,O
.,794,795,O
RESULTS,796,803,O
:,803,804,O
Within,805,811,O
3,812,813,O
years,814,819,O
",",819,820,O
the,821,824,O
prevalence,825,835,O
of,836,838,O
hypertension,839,851,O
increased,852,861,O
in,862,864,O
both,865,869,O
intervention,870,882,O
and,883,886,O
control,887,894,O
cohorts,895,902,O
",",902,903,O
as,904,906,O
well,907,911,O
as,912,914,O
in,915,917,O
the,918,921,O
middle,922,928,O
and,929,932,O
elderly,933,940,O
cohorts,941,948,O
",",948,949,O
especially,950,960,O
in,961,963,O
the,964,967,O
middle,968,974,O
aged,975,979,O
in,980,982,O
control,983,990,O
group,991,996,O
.,996,997,O
Among,998,1003,O
hypertensives,1004,1017,O
in,1018,1020,O
the,1021,1024,O
intervention,1025,1037,O
cohort,1038,1044,O
",",1044,1045,O
the,1046,1049,O
rates,1050,1055,O
of,1056,1058,O
awareness,1059,1068,O
",",1068,1069,O
treatment,1070,1079,O
and,1080,1083,O
control,1084,1091,O
of,1092,1094,O
hypertension,1095,1107,O
got,1108,1111,O
improved,1112,1120,O
.,1120,1121,O
The,1122,1125,O
incidence,1126,1135,O
of,1136,1138,O
stroke,1139,1145,O
was,1146,1149,O
29,1150,1152,O
%,1152,1153,O
lower,1154,1159,O
(,1160,1161,O
HR,1161,1163,O
=,1164,1165,O
0,1166,1167,O
.,1167,1168,O
71,1168,1170,O
",",1170,1171,O
95,1172,1174,O
%,1174,1175,O
CI,1176,1178,O
:,1178,1179,O
0,1180,1181,O
.,1181,1182,O
58,1182,1184,O
-,1185,1186,O
0,1187,1188,O
.,1188,1189,O
87,1189,1191,O
),1191,1192,O
and,1193,1196,O
mortality,1197,1206,O
of,1207,1209,O
stroke,1210,1216,O
was,1217,1220,O
40,1221,1223,O
%,1223,1224,O
lower,1225,1230,O
(,1231,1232,O
HR,1232,1234,O
=,1235,1236,O
0,1237,1238,O
.,1238,1239,O
60,1239,1241,O
",",1241,1242,O
95,1243,1245,O
%,1245,1246,O
CI,1247,1249,O
:,1249,1250,O
0,1251,1252,O
.,1252,1253,O
42,1253,1255,O
-,1256,1257,O
0,1258,1259,O
.,1259,1260,O
86,1260,1262,O
),1262,1263,O
in,1264,1266,O
the,1267,1270,O
intervention,1271,1283,O
cohort,1284,1290,O
than,1291,1295,O
the,1296,1299,O
control,1300,1307,O
cohort,1308,1314,O
.,1314,1315,O
The,1316,1319,O
intervention,1320,1332,O
was,1333,1336,O
most,1337,1341,O
effective,1342,1351,O
in,1352,1354,O
reduction,1355,1364,O
of,1365,1367,O
stroke,1368,1374,O
for,1375,1378,O
those,1379,1384,O
with,1385,1389,O
isolated,1390,1398,O
systolic,1399,1407,O
hypertension,1408,1420,O
and,1421,1424,O
combined,1425,1433,O
systolic,1434,1442,O
and,1443,1446,O
diastolic,1447,1456,O
hypertension,1457,1469,O
(,1470,1471,O
All,1471,1474,O
P,1475,1476,O
<,1477,1478,O
0,1479,1480,O
.,1480,1481,O
05,1481,1483,O
),1483,1484,O
.,1484,1485,O
Meanwhile,1486,1495,O
",",1495,1496,O
all,1497,1500,O
-,1500,1501,O
cause,1501,1506,O
mortality,1507,1516,O
was,1517,1520,O
11,1521,1523,O
%,1523,1524,O
lower,1525,1530,O
(,1531,1532,O
HR,1532,1534,O
=,1535,1536,O
0,1537,1538,O
.,1538,1539,O
89,1539,1541,O
",",1541,1542,O
95,1543,1545,O
%,1545,1546,O
CI,1547,1549,O
:,1549,1550,O
0,1551,1552,O
.,1552,1553,O
78,1553,1555,O
-,1556,1557,O
0,1558,1559,O
.,1559,1560,O
99,1560,1562,O
),1562,1563,O
in,1564,1566,O
the,1567,1570,O
intervention,1571,1583,O
cohort,1584,1590,O
than,1591,1595,O
in,1596,1598,O
the,1599,1602,O
control,1603,1610,O
cohort,1611,1617,O
.,1617,1618,O
CONCLUSION,1619,1629,O
:,1629,1630,O
The,1631,1634,O
community,1635,1644,O
-,1644,1645,O
based,1645,1650,O
intervention,1651,1663,O
was,1664,1667,O
effective,1668,1677,O
in,1678,1680,O
controlling,1681,1692,O
the,1693,1696,O
development,1697,1708,O
of,1709,1711,O
hypertension,1712,1724,O
and,1725,1728,O
stroke,1729,1735,O
",",1735,1736,O
while,1737,1742,O
the,1743,1746,O
elderly,1747,1754,O
people,1755,1761,O
benefit,1762,1769,O
more,1770,1774,O
than,1775,1779,O
the,1780,1783,O
middle,1784,1790,O
aged,1791,1795,O
people,1796,1802,O
from,1803,1807,O
the,1808,1811,O
intervention,1812,1824,O
.,1824,1825,O
[,0,1,O
Laboratory,1,11,O
diagnostics,12,23,O
of,24,26,O
Crimean,27,34,O
hemorrhagic,35,46,O
fever,47,52,O
by,53,55,O
polymerase,56,66,O
chain,67,72,O
reaction,73,81,O
],81,82,O
.,82,83,O
Our,84,87,O
group,88,93,O
developed,94,103,O
",",103,104,O
within,105,111,O
the,112,115,O
present,116,123,O
case,124,128,O
study,129,134,O
",",134,135,O
two,136,139,O
techniques,140,150,O
',150,151,O
variations,152,162,O
",",162,163,O
i,164,165,O
.,165,166,O
e,166,167,O
.,167,168,O
a,169,170,O
single,171,177,O
-,177,178,O
step,178,182,O
RT,183,185,O
-,185,186,O
PCR,186,189,O
and,190,193,O
nested,194,200,O
RT,201,203,O
-,203,204,O
PCR,204,207,O
assays,208,214,O
",",214,215,O
for,216,219,O
the,220,223,O
purpose,224,231,O
of,232,234,O
detecting,235,244,O
the,245,248,O
Crimean,249,256,O
-,256,257,O
Congo,257,262,O
hemorrhagic,263,274,O
fever,275,280,O
RNA,281,284,O
virus,285,290,O
in,291,293,O
human,294,299,O
samples,300,307,O
.,307,308,O
The,309,312,O
above,313,318,O
assays,319,325,O
as,326,328,O
well,329,333,O
as,334,336,O
those,337,342,O
previously,343,353,O
recommended,354,365,O
by,366,368,O
the,369,372,O
Ministry,373,381,O
of,382,384,O
Health,385,391,O
of,392,394,O
the,395,398,O
Russian,399,406,O
Federation,407,417,O
were,418,422,O
simultaneously,423,437,O
used,438,442,O
in,443,445,O
14,446,448,O
clinical,449,457,O
samples,458,465,O
obtained,466,474,O
from,475,479,O
patients,480,488,O
with,489,493,O
Crimean,494,501,O
hemorrhagic,502,513,O
fever,514,519,O
.,519,520,O
After,521,526,O
assessing,527,536,O
the,537,540,O
detection,541,550,O
accuracy,551,559,O
",",559,560,O
it,561,563,O
was,564,567,O
found,568,573,O
that,574,578,O
the,579,582,O
developed,583,592,O
-,592,593,O
by,593,595,O
-,595,596,O
us,596,598,O
test,599,603,O
system,604,610,O
displayed,611,620,O
the,621,624,O
same,625,629,O
or,630,632,O
even,633,637,O
better,638,644,O
diagnostic,645,655,O
values,656,662,O
versus,663,669,O
the,670,673,O
previously,674,684,O
recommended,685,696,O
nested,697,703,O
RT,704,706,O
-,706,707,O
PCR,707,710,O
and,711,714,O
a,715,716,O
1000,717,721,O
-,721,722,O
fold,722,726,O
advantage,727,736,O
over,737,741,O
the,742,745,O
previously,746,756,O
recommended,757,768,O
single,769,775,O
-,775,776,O
step,776,780,O
RT,781,783,O
-,783,784,O
PCA,784,787,O
.,787,788,O
The,789,792,O
single,793,799,O
-,799,800,O
step,800,804,O
RT,805,807,O
-,807,808,O
PCR,808,811,O
assay,812,817,O
variation,818,827,O
is,828,830,O
always,831,837,O
more,838,842,O
preferable,843,853,O
in,854,856,O
sense,857,862,O
of,863,865,O
technical,866,875,O
and,876,879,O
economic,880,888,O
motivations,889,900,O
.,900,901,O
Finally,902,909,O
",",909,910,O
the,911,914,O
test,915,919,O
system,920,926,O
developed,927,936,O
by,937,939,O
us,940,942,O
has,943,946,O
every,947,952,O
reason,953,959,O
to,960,962,O
become,963,969,O
the,970,973,O
method,974,980,O
of,981,983,O
choice,984,990,O
in,991,993,O
routine,994,1001,O
PCR,1002,1005,O
diagnosis,1006,1015,O
of,1016,1018,O
Crimean,1019,1026,O
hemorrhagic,1027,1038,O
fever,1039,1044,O
after,1045,1050,O
all,1051,1054,O
official,1055,1063,O
trials,1064,1070,O
and,1071,1074,O
approvals,1075,1084,O
are,1085,1088,O
duly,1089,1093,O
complied,1094,1102,O
with,1103,1107,O
.,1107,1108,O
Prognostic,0,10,O
significance,11,23,O
and,24,27,O
correlation,28,39,O
with,40,44,O
survival,45,53,O
of,54,56,O
bcl,57,60,O
-,60,61,O
2,61,62,O
and,63,66,O
TGF,67,70,O
-,70,71,O
beta,71,75,O
RII,76,79,O
in,80,82,O
colon,83,88,B-Pathological_formation
cancer,89,95,I-Pathological_formation
.,95,96,O
Bcl,97,100,O
-,100,101,O
2,101,102,O
and,103,106,O
TGF,107,110,O
-,110,111,O
beta,111,115,O
receptors,116,125,O
type,126,130,O
II,131,133,O
(,134,135,O
RII,135,138,O
),138,139,O
in,140,142,O
colon,143,148,B-Pathological_formation
carcinomas,149,159,I-Pathological_formation
were,160,164,O
studied,165,172,O
in,173,175,O
a,176,177,O
series,178,184,O
of,185,187,O
113,188,191,O
patients,192,200,O
",",200,201,O
to,202,204,O
determine,205,214,O
their,215,220,O
prognostic,221,231,O
significance,232,244,O
and,245,248,O
to,249,251,O
correlate,252,261,O
their,262,267,O
expression,268,278,O
with,279,283,O
other,284,289,O
prognostic,290,300,O
indicators,301,311,O
.,311,312,O
Bcl,313,316,O
-,316,317,O
2,317,318,O
expression,319,329,O
in,330,332,O
the,333,336,O
tumor,337,342,B-Cell
cells,343,348,I-Cell
showed,349,355,O
a,356,357,O
reverse,358,365,O
relation,366,374,O
with,375,379,O
tumor,380,385,B-Pathological_formation
size,386,390,O
(,391,392,O
P,392,393,O
=,394,395,O
0,396,397,O
.,397,398,O
018,398,401,O
),401,402,O
",",402,403,O
histological,404,416,O
grade,417,422,O
(,423,424,O
P,424,425,O
=,426,427,O
0,428,429,O
.,429,430,O
04,430,432,O
),432,433,O
",",433,434,O
and,435,438,O
stage,439,444,O
(,445,446,O
P,446,447,O
=,448,449,O
0,450,451,O
.,451,452,O
013,452,455,O
),455,456,O
.,456,457,O
Univariate,458,468,O
survival,469,477,O
analysis,478,486,O
using,487,492,O
the,493,496,O
log,497,500,O
rank,501,505,O
test,506,510,O
showed,511,517,O
that,518,522,O
the,523,526,O
survival,527,535,O
of,536,538,O
patients,539,547,O
with,548,552,O
bcl,553,556,B-Pathological_formation
-,556,557,I-Pathological_formation
2,557,558,I-Pathological_formation
-,558,559,I-Pathological_formation
positive,559,567,I-Pathological_formation
tumors,568,574,I-Pathological_formation
was,575,578,O
significantly,579,592,O
better,593,599,O
than,600,604,O
the,605,608,O
survival,609,617,O
of,618,620,O
patients,621,629,O
with,630,634,O
bcl,635,638,B-Pathological_formation
-,638,639,I-Pathological_formation
2,639,640,I-Pathological_formation
-,640,641,I-Pathological_formation
negative,641,649,I-Pathological_formation
tumors,650,656,I-Pathological_formation
(,657,658,O
P,658,659,O
=,660,661,O
0,662,663,O
.,663,664,O
02,664,666,O
),666,667,O
.,667,668,O
However,669,676,O
",",676,677,O
when,678,682,O
entered,683,690,O
into,691,695,O
a,696,697,O
multivariate,698,710,O
analysis,711,719,O
model,720,725,O
",",725,726,O
it,727,729,O
was,730,733,O
not,734,737,O
found,738,743,O
to,744,746,O
be,747,749,O
of,750,752,O
independent,753,764,O
prognostic,765,775,O
significance,776,788,O
.,788,789,O
TGF,790,793,O
-,793,794,O
beta,794,798,O
RII,799,802,O
expression,803,813,O
was,814,817,O
correlated,818,828,O
with,829,833,O
stage,834,839,O
(,840,841,O
P,841,842,O
=,843,844,O
0,845,846,O
.,846,847,O
03,847,849,O
),849,850,O
",",850,851,O
while,852,857,O
no,858,860,O
statistically,861,874,O
significant,875,886,O
correlation,887,898,O
was,899,902,O
found,903,908,O
between,909,916,O
TGF,917,920,O
-,920,921,O
beta,921,925,O
RII,926,929,O
expression,930,940,O
and,941,944,O
histological,945,957,O
grade,958,963,O
or,964,966,O
survival,967,975,O
.,975,976,O
In,977,979,O
conclusion,980,990,O
",",990,991,O
these,992,997,O
results,998,1005,O
provide,1006,1013,O
additional,1014,1024,O
evidence,1025,1033,O
for,1034,1037,O
the,1038,1041,O
role,1042,1046,O
of,1047,1049,O
bcl,1050,1053,O
-,1053,1054,O
2,1054,1055,O
and,1056,1059,O
TGF,1060,1063,O
-,1063,1064,O
beta,1064,1068,O
RII,1069,1072,O
in,1073,1075,O
carcinogenesis,1076,1090,O
of,1091,1093,O
the,1094,1097,O
colon,1098,1103,B-Organ
",",1103,1104,O
while,1105,1110,O
they,1111,1115,O
do,1116,1118,O
not,1119,1122,O
support,1123,1130,O
the,1131,1134,O
use,1135,1138,O
of,1139,1141,O
these,1142,1147,O
factors,1148,1155,O
as,1156,1158,O
prognostic,1159,1169,O
markers,1170,1177,O
in,1178,1180,O
patients,1181,1189,O
with,1190,1194,O
colon,1195,1200,B-Pathological_formation
cancer,1201,1207,I-Pathological_formation
.,1207,1208,O
Antibiotic,0,10,O
-,10,11,O
induced,11,18,O
persistence,19,30,O
of,31,33,O
cytotoxic,34,43,O
Staphylococcus,44,58,O
aureus,59,65,O
in,66,68,O
non,69,72,B-Cell
-,72,73,I-Cell
phagocytic,73,83,I-Cell
cells,84,89,I-Cell
.,89,90,O
OBJECTIVES,91,101,O
:,101,102,O
After,103,108,O
infection,109,118,O
of,119,121,O
non,122,125,B-Cell
-,125,126,I-Cell
phagocytic,126,136,I-Cell
cells,137,142,I-Cell
",",142,143,O
some,144,148,O
Staphylococcus,149,163,O
aureus,164,170,O
strains,171,178,O
are,179,182,O
able,183,187,O
to,188,190,O
survive,191,198,O
and,199,202,O
kill,203,207,O
their,208,213,O
host,214,218,O
cells,219,224,B-Cell
.,224,225,O
The,226,229,O
purpose,230,237,O
of,238,240,O
this,241,245,O
study,246,251,O
was,252,255,O
to,256,258,O
determine,259,268,O
the,269,272,O
action,273,279,O
of,280,282,O
various,283,290,O
antibiotics,291,302,O
on,303,305,O
the,306,309,O
survival,310,318,O
of,319,321,O
host,322,326,O
cells,327,332,B-Cell
and,333,336,O
/,336,337,O
or,337,339,O
intracellular,340,353,B-Immaterial_anatomical_entity
S,354,355,O
.,355,356,O
aureus,357,363,O
.,363,364,O
METHODS,365,372,O
:,372,373,O
Murine,374,380,O
keratinocyte,381,393,B-Cell
(,394,395,O
PAM212,395,401,B-Cell
),401,402,O
and,403,406,O
fibroblast,407,417,B-Cell
(,418,419,O
mKSA,419,423,B-Cell
),423,424,I-Cell
cell,425,429,I-Cell
lines,430,435,I-Cell
were,436,440,O
infected,441,449,O
with,450,454,O
cytotoxic,455,464,O
S,465,466,O
.,466,467,O
aureus,468,474,O
and,475,478,O
cultured,479,487,O
in,488,490,O
the,491,494,O
presence,495,503,O
of,504,506,O
various,507,514,O
antibiotics,515,526,O
at,527,529,O
graded,530,536,O
concentrations,537,551,O
.,551,552,O
The,553,556,O
viability,557,566,O
of,567,569,O
host,570,574,O
cells,575,580,B-Cell
was,581,584,O
measured,585,593,O
24,594,596,O
h,597,598,O
after,599,604,O
infection,605,614,O
.,614,615,O
To,616,618,O
determine,619,628,O
the,629,632,O
bacterial,633,642,O
viability,643,652,O
within,653,659,O
host,660,664,O
cells,665,670,B-Cell
",",670,671,O
cellular,672,680,B-Organism_substance
lysates,681,688,I-Organism_substance
were,689,693,O
prepared,694,702,O
and,703,706,O
colony,707,713,O
forming,714,721,O
units,722,727,O
were,728,732,O
quantified,733,743,O
using,744,749,O
a,750,751,O
spiral,752,758,O
plater,759,765,O
.,765,766,O
Host,767,771,O
cells,772,777,B-Cell
infected,778,786,O
with,787,791,O
fluorescein,792,803,O
isothiocyanate,804,818,O
(,819,820,O
FITC,820,824,O
),824,825,O
-,825,826,O
labelled,826,834,O
S,835,836,O
.,836,837,O
aureus,838,844,O
were,845,849,O
analysed,850,858,O
by,859,861,O
flow,862,866,O
cytometry,867,876,O
and,877,880,O
microscopy,881,891,O
to,892,894,O
determine,895,904,O
the,905,908,O
subcellular,909,920,B-Cellular_component
localization,921,933,O
S,934,935,O
.,935,936,O
aureus,937,943,O
.,943,944,O
RESULTS,945,952,O
:,952,953,O
Oxacillin,954,963,O
",",963,964,O
vancomycin,965,975,O
",",975,976,O
gentamicin,977,987,O
",",987,988,O
ciprofloxacin,989,1002,O
and,1003,1006,O
trimethoprim,1007,1019,O
/,1019,1020,O
sulfamethoxazole,1020,1036,O
did,1037,1040,O
not,1041,1044,O
rescue,1045,1051,O
host,1052,1056,O
cells,1057,1062,B-Cell
from,1063,1067,O
cell,1068,1072,B-Cell
death,1073,1078,O
induced,1079,1086,O
by,1087,1089,O
intracellular,1090,1103,B-Immaterial_anatomical_entity
S,1104,1105,O
.,1105,1106,O
aureus,1107,1113,O
.,1113,1114,O
In,1115,1117,O
contrast,1118,1126,O
",",1126,1127,O
linezolid,1128,1137,O
",",1137,1138,O
rifampicin,1139,1149,O
",",1149,1150,O
azithromycin,1151,1163,O
",",1163,1164,O
clindamycin,1165,1176,O
",",1176,1177,O
erythromycin,1178,1190,O
and,1191,1194,O
quinupristin,1195,1207,O
/,1207,1208,O
dalfopristin,1208,1220,O
suppressed,1221,1231,O
the,1232,1235,O
cytotoxic,1236,1245,O
action,1246,1252,O
of,1253,1255,O
S,1256,1257,O
.,1257,1258,O
aureus,1259,1265,O
.,1265,1266,O
After,1267,1272,O
withdrawal,1273,1283,O
of,1284,1286,O
antibiotics,1287,1298,O
",",1298,1299,O
intracellular,1300,1313,B-Immaterial_anatomical_entity
S,1314,1315,O
.,1315,1316,O
aureus,1317,1323,O
regained,1324,1332,O
cytotoxic,1333,1342,O
activity,1343,1351,O
and,1352,1355,O
killed,1356,1362,O
their,1363,1368,O
host,1369,1373,O
cells,1374,1379,B-Cell
.,1379,1380,O
Only,1381,1385,O
rifampicin,1386,1396,O
was,1397,1400,O
able,1401,1405,O
to,1406,1408,O
eliminate,1409,1418,O
intracellular,1419,1432,B-Immaterial_anatomical_entity
S,1433,1434,O
.,1434,1435,O
aureus,1436,1442,O
completely,1443,1453,O
within,1454,1460,O
72,1461,1463,O
h,1464,1465,O
.,1465,1466,O
In,1467,1469,O
contrast,1470,1478,O
",",1478,1479,O
clindamycin,1480,1491,O
",",1491,1492,O
azithromycin,1493,1505,O
and,1506,1509,O
linezolid,1510,1519,O
induced,1520,1527,O
a,1528,1529,O
state,1530,1535,O
of,1536,1538,O
intracellular,1539,1552,B-Immaterial_anatomical_entity
persistence,1553,1564,O
of,1565,1567,O
viable,1568,1574,O
S,1575,1576,O
.,1576,1577,O
aureus,1578,1584,O
.,1584,1585,O
CONCLUSIONS,1586,1597,O
:,1597,1598,O
Antibiotics,1599,1610,O
commonly,1611,1619,O
used,1620,1624,O
for,1625,1628,O
the,1629,1632,O
management,1633,1643,O
of,1644,1646,O
S,1647,1648,O
.,1648,1649,O
aureus,1650,1656,O
infections,1657,1667,O
appear,1668,1674,O
to,1675,1677,O
create,1678,1684,O
a,1685,1686,O
niche,1687,1692,O
for,1693,1696,O
invasive,1697,1705,O
intracellular,1706,1719,B-Immaterial_anatomical_entity
S,1720,1721,O
.,1721,1722,O
aureus,1723,1729,O
",",1729,1730,O
which,1731,1736,O
may,1737,1740,O
play,1741,1745,O
an,1746,1748,O
important,1749,1758,O
role,1759,1763,O
for,1764,1767,O
persistence,1768,1779,O
and,1780,1783,O
recurrence,1784,1794,O
of,1795,1797,O
infection,1798,1807,O
.,1807,1808,O
Because,1809,1816,O
of,1817,1819,O
its,1820,1823,O
unique,1824,1830,O
ability,1831,1838,O
to,1839,1841,O
eliminate,1842,1851,O
intracellular,1852,1865,B-Immaterial_anatomical_entity
S,1866,1867,O
.,1867,1868,O
aureus,1869,1875,O
",",1875,1876,O
rifampicin,1877,1887,O
appears,1888,1895,O
to,1896,1898,O
be,1899,1901,O
valuable,1902,1910,O
for,1911,1914,O
the,1915,1918,O
treatment,1919,1928,O
of,1929,1931,O
invasive,1932,1940,O
S,1941,1942,O
.,1942,1943,O
aureus,1944,1950,O
infections,1951,1961,O
.,1961,1962,O
Full,0,4,O
sequencing,5,15,O
analysis,16,24,O
of,25,27,O
estrogen,28,36,O
receptor,37,45,O
-,45,46,O
alpha,46,51,O
gene,52,56,O
polymorphism,57,69,O
and,70,73,O
its,74,77,O
association,78,89,O
with,90,94,O
breast,95,101,B-Pathological_formation
cancer,102,108,I-Pathological_formation
risk,109,113,O
.,113,114,O
BACKGROUND,115,125,O
:,125,126,O
The,127,130,O
estrogen,131,139,O
receptor,140,148,O
plays,149,154,O
a,155,156,O
critical,157,165,O
role,166,170,O
in,171,173,O
breast,174,180,B-Pathological_formation
cancer,181,187,I-Pathological_formation
development,188,199,O
and,200,203,O
progression,204,215,O
.,215,216,O
So,217,219,O
the,220,223,O
genetic,224,231,O
polymorphism,232,244,O
of,245,247,O
ER,248,250,O
-,250,251,O
alpha,251,256,O
gene,257,261,O
could,262,267,O
affect,268,274,O
cancer,275,281,B-Pathological_formation
risk,282,286,O
and,287,290,O
phenotype,291,300,O
.,300,301,O
MATERIALS,302,311,O
AND,312,315,O
METHODS,316,323,O
:,323,324,O
We,325,327,O
fully,328,333,O
sequenced,334,343,O
the,344,347,O
ER,348,350,O
-,350,351,O
alpha,351,356,O
gene,357,361,O
to,362,364,O
investigate,365,376,O
its,377,380,O
single,381,387,O
nucleotide,388,398,O
polymorphisms,399,412,O
(,413,414,O
SNPs,414,418,O
),418,419,O
in,420,422,O
100,423,426,O
breast,427,433,B-Pathological_formation
cancer,434,440,I-Pathological_formation
patients,441,449,O
and,450,453,O
100,454,457,O
controls,458,466,O
.,466,467,O
RESULTS,468,475,O
:,475,476,O
Six,477,480,O
novel,481,486,O
polymorphism,487,499,O
in,500,502,O
the,503,506,O
control,507,514,O
and,515,518,O
11,519,521,O
in,522,524,O
cancer,525,531,B-Pathological_formation
patients,532,540,O
were,541,545,O
found,546,551,O
.,551,552,O
The,553,556,O
G,557,558,O
/,558,559,O
G,559,560,O
genotype,561,569,O
at,570,572,O
C975,573,577,O
G,578,579,O
and,580,583,O
A,584,585,O
/,585,586,O
A,586,587,O
genotype,588,596,O
at,597,599,O
G1782,600,605,O
A,606,607,O
had,608,611,O
a,612,613,O
protective,614,624,O
effect,625,631,O
against,632,639,O
breast,640,646,B-Pathological_formation
cancer,647,653,I-Pathological_formation
when,654,658,O
compared,659,667,O
to,668,670,O
other,671,676,O
genotypes,677,686,O
(,687,688,O
OR,688,690,O
=,691,692,O
0,693,694,O
.,694,695,O
3,695,696,O
and,697,700,O
0,701,702,O
.,702,703,O
3,703,704,O
",",704,705,O
respectively,706,718,O
),718,719,O
.,719,720,O
975G,721,725,O
allele,726,732,O
was,733,736,O
associated,737,747,O
inversely,748,757,O
with,758,762,O
the,763,766,O
p53,767,770,O
expression,771,781,O
and,782,785,O
positively,786,796,O
with,797,801,O
the,802,805,O
bcl,806,809,O
-,809,810,O
2,810,811,O
expression,812,822,O
in,823,825,O
cancer,826,832,B-Pathological_formation
with,833,837,O
borderline,838,848,O
significance,849,861,O
.,861,862,O
Combining,863,872,O
this,873,877,O
result,878,884,O
with,885,889,O
our,890,893,O
previous,894,902,O
study,903,908,O
",",908,909,O
these,910,915,O
associations,916,928,O
became,929,935,O
more,936,940,O
significant,941,952,O
(,953,954,O
p,954,955,O
=,956,957,O
0,958,959,O
.,959,960,O
005,960,963,O
and,964,967,O
0,968,969,O
.,969,970,O
019,970,973,O
",",973,974,O
respectively,975,987,O
),987,988,O
.,988,989,O
CONCLUSION,990,1000,O
:,1000,1001,O
Polymorphisms,1002,1015,O
in,1016,1018,O
ER,1019,1021,O
-,1021,1022,O
alpha,1022,1027,O
gene,1028,1032,O
can,1033,1036,O
affect,1037,1043,O
the,1044,1047,O
breast,1048,1054,B-Pathological_formation
cancer,1055,1061,I-Pathological_formation
susceptibility,1062,1076,O
and,1077,1080,O
may,1081,1084,O
be,1085,1087,O
related,1088,1095,O
to,1096,1098,O
other,1099,1104,O
protein,1105,1112,O
expression,1113,1123,O
",",1123,1124,O
such,1125,1129,O
as,1130,1132,O
p53,1133,1136,O
and,1137,1140,O
bcl,1141,1144,O
-,1144,1145,O
2,1145,1146,O
.,1146,1147,O
Covariance,0,10,O
structure,11,20,O
analysis,21,29,O
:,29,30,O
statistical,31,42,O
practice,43,51,O
",",51,52,O
theory,53,59,O
",",59,60,O
and,61,64,O
directions,65,75,O
.,75,76,O
Although,77,85,O
covariance,86,96,O
structure,97,106,O
analysis,107,115,O
is,116,118,O
used,119,123,O
increasingly,124,136,O
to,137,139,O
analyze,140,147,O
nonexperimental,148,163,O
data,164,168,O
",",168,169,O
important,170,179,O
statistical,180,191,O
requirements,192,204,O
for,205,208,O
its,209,212,O
proper,213,219,O
use,220,223,O
are,224,227,O
frequently,228,238,O
ignored,239,246,O
.,246,247,O
Valid,248,253,O
conclusions,254,265,O
about,266,271,O
the,272,275,O
adequacy,276,284,O
of,285,287,O
a,288,289,O
model,290,295,O
as,296,298,O
an,299,301,O
acceptable,302,312,O
representation,313,327,O
of,328,330,O
data,331,335,O
",",335,336,O
which,337,342,O
are,343,346,O
based,347,352,O
on,353,355,O
goodness,356,364,O
-,364,365,O
of,365,367,O
-,367,368,O
fit,368,371,O
test,372,376,O
statistics,377,387,O
and,388,391,O
standard,392,400,O
errors,401,407,O
of,408,410,O
parameter,411,420,O
estimates,421,430,O
",",430,431,O
rely,432,436,O
on,437,439,O
the,440,443,O
model,444,449,O
estimation,450,460,O
procedure,461,470,O
being,471,476,O
appropriate,477,488,O
for,489,492,O
the,493,496,O
data,497,501,O
.,501,502,O
Using,503,508,O
analogies,509,518,O
to,519,521,O
linear,522,528,O
regression,529,539,O
and,540,543,O
anova,544,549,O
",",549,550,O
this,551,555,O
review,556,562,O
examines,563,571,O
conditions,572,582,O
under,583,588,O
which,589,594,O
conclusions,595,606,O
drawn,607,612,O
from,613,617,O
various,618,625,O
estimation,626,636,O
methods,637,644,O
will,645,649,O
be,650,652,O
correct,653,660,O
and,661,664,O
the,665,668,O
consequences,669,681,O
of,682,684,O
ignoring,685,693,O
these,694,699,O
conditions,700,710,O
.,710,711,O
A,712,713,O
distinction,714,725,O
is,726,728,O
made,729,733,O
between,734,741,O
estimation,742,752,O
methods,753,760,O
that,761,765,O
are,766,769,O
either,770,776,O
correctly,777,786,O
or,787,789,O
incorrectly,790,801,O
specified,802,811,O
for,812,815,O
the,816,819,O
distribution,820,832,O
of,833,835,O
data,836,840,O
being,841,846,O
analyzed,847,855,O
",",855,856,O
and,857,860,O
it,861,863,O
is,864,866,O
shown,867,872,O
that,873,877,O
valid,878,883,O
conclusions,884,895,O
are,896,899,O
possible,900,908,O
even,909,913,O
under,914,919,O
misspecification,920,936,O
.,936,937,O
A,938,939,O
brief,940,945,O
example,946,953,O
illustrates,954,965,O
the,966,969,O
ideas,970,975,O
.,975,976,O
Internet,977,985,O
access,986,992,O
is,993,995,O
given,996,1001,O
to,1002,1004,O
a,1005,1006,O
computer,1007,1015,O
code,1016,1020,O
for,1021,1024,O
several,1025,1032,O
methods,1033,1040,O
that,1041,1045,O
are,1046,1049,O
not,1050,1053,O
available,1054,1063,O
in,1064,1066,O
programs,1067,1075,O
such,1076,1080,O
as,1081,1083,O
EQS,1084,1087,O
or,1088,1090,O
LISREL,1091,1097,O
.,1097,1098,O
Potent,0,6,O
antibacterial,7,20,O
activity,21,29,O
of,30,32,O
Y,33,34,O
-,34,35,O
754,35,38,O
",",38,39,O
a,40,41,O
novel,42,47,O
benzimidazole,48,61,O
compound,62,70,O
with,71,75,O
selective,76,85,O
action,86,92,O
against,93,100,O
Helicobacter,101,113,O
pylori,114,120,O
.,120,121,O
Y,122,123,O
-,123,124,O
754,124,127,O
",",127,128,O
a,129,130,O
novel,131,136,O
benzimidazole,137,150,O
compound,151,159,O
",",159,160,O
was,161,164,O
investigated,165,177,O
for,178,181,O
in,182,184,O
vitro,185,190,O
and,191,194,O
in,195,197,O
vivo,198,202,O
antibacterial,203,216,O
activity,217,225,O
.,225,226,O
Unlike,227,233,O
amoxicillin,234,245,O
",",245,246,O
clarithromycin,247,261,O
",",261,262,O
and,263,266,O
metronidazole,267,280,O
",",280,281,O
the,282,285,O
compound,286,294,O
had,295,298,O
no,299,301,O
activity,302,310,O
against,311,318,O
common,319,325,O
aerobic,326,333,O
and,334,337,O
anaerobic,338,347,O
bacteria,348,356,O
other,357,362,O
than,363,367,O
Helicobacter,368,380,O
pylori,381,387,O
.,387,388,O
The,389,392,O
minimum,393,400,O
inhibitory,401,411,O
concentration,412,425,O
of,426,428,O
Y,429,430,O
-,430,431,O
754,431,434,O
against,435,442,O
H,443,444,O
.,444,445,O
pylori,446,452,O
",",452,453,O
at,454,456,O
0,457,458,O
.,458,459,O
025,459,462,O
microg,463,469,O
/,469,470,O
ml,470,472,O
",",472,473,O
was,474,477,O
nearly,478,484,O
equal,485,490,O
to,491,493,O
that,494,498,O
of,499,501,O
amoxicillin,502,513,O
and,514,517,O
clarithromycin,518,532,O
.,532,533,O
The,534,537,O
respective,538,548,O
concentrations,549,563,O
of,564,566,O
Y,567,568,O
-,568,569,O
754,569,572,O
",",572,573,O
amoxicillin,574,585,O
",",585,586,O
clarithromycin,587,601,O
",",601,602,O
and,603,606,O
metronidazole,607,620,O
required,621,629,O
to,630,632,O
inhibit,633,640,O
90,641,643,O
%,643,644,O
of,645,647,O
39,648,650,O
isolates,651,659,O
of,660,662,O
H,663,664,O
.,664,665,O
pylori,666,672,O
were,673,677,O
0,678,679,O
.,679,680,O
05,680,682,O
",",682,683,O
0,684,685,O
.,685,686,O
39,686,688,O
",",688,689,O
6,690,691,O
.,691,692,O
25,692,694,O
",",694,695,O
and,696,699,O
25,700,702,O
microg,703,709,O
/,709,710,O
ml,710,712,O
",",712,713,O
indicating,714,724,O
the,725,728,O
potent,729,735,O
activity,736,744,O
of,745,747,O
Y,748,749,O
-,749,750,O
754,750,753,O
",",753,754,O
including,755,764,O
activity,765,773,O
against,774,781,O
clarithromycin,782,796,O
-,796,797,O
and,798,801,O
metronidazole,802,815,O
-,815,816,O
resistant,816,825,O
strains,826,833,O
.,833,834,O
The,835,838,O
anti,839,843,O
-,843,844,O
H,844,845,O
.,845,846,O
pylori,847,853,O
activity,854,862,O
of,863,865,O
Y,866,867,O
-,867,868,O
754,868,871,O
was,872,875,O
potent,876,882,O
even,883,887,O
at,888,890,O
pH,891,893,O
5,894,895,O
.,895,896,O
5,896,897,O
and,898,901,O
was,902,905,O
bactericidal,906,918,O
at,919,921,O
concentrations,922,936,O
of,937,939,O
0,940,941,O
.,941,942,O
1,942,943,O
microg,944,950,O
/,950,951,O
ml,951,953,O
and,954,957,O
above,958,963,O
.,963,964,O
Exposure,965,973,O
of,974,976,O
H,977,978,O
.,978,979,O
pylori,980,986,O
to,987,989,O
Y,990,991,O
-,991,992,O
754,992,995,O
did,996,999,O
not,1000,1003,O
result,1004,1010,O
in,1011,1013,O
the,1014,1017,O
induction,1018,1027,O
of,1028,1030,O
drug,1031,1035,O
-,1035,1036,O
resistant,1036,1045,O
mutation,1046,1054,O
.,1054,1055,O
Oral,1056,1060,O
administration,1061,1075,O
(,1076,1077,O
10,1077,1079,O
mg,1080,1082,O
/,1082,1083,O
kg,1083,1085,O
twice,1086,1091,O
a,1092,1093,O
day,1094,1097,O
for,1098,1101,O
7,1102,1103,O
days,1104,1108,O
),1108,1109,O
to,1110,1112,O
Mongolian,1113,1122,O
gerbils,1123,1130,O
infected,1131,1139,O
with,1140,1144,O
strain,1145,1151,O
ATCC,1152,1156,O
43504,1157,1162,O
demonstrated,1163,1175,O
that,1176,1180,O
Y,1181,1182,O
-,1182,1183,O
754,1183,1186,O
was,1187,1190,O
effective,1191,1200,O
in,1201,1203,O
H,1204,1205,O
.,1205,1206,O
pylori,1207,1213,O
eradication,1214,1225,O
and,1226,1229,O
that,1230,1234,O
its,1235,1238,O
eradication,1239,1250,O
efficacy,1251,1259,O
increased,1260,1269,O
in,1270,1272,O
line,1273,1277,O
with,1278,1282,O
the,1283,1286,O
progress,1287,1295,O
of,1296,1298,O
damage,1299,1305,O
to,1306,1308,O
the,1309,1312,O
gastric,1313,1320,B-Multi-tissue_structure
mucosa,1321,1327,I-Multi-tissue_structure
caused,1328,1334,O
by,1335,1337,O
H,1338,1339,O
.,1339,1340,O
pylori,1341,1347,O
infection,1348,1357,O
.,1357,1358,O
Y,1359,1360,O
-,1360,1361,O
754,1361,1364,O
was,1365,1368,O
also,1369,1373,O
efficacious,1374,1385,O
in,1386,1388,O
the,1389,1392,O
treatment,1393,1402,O
of,1403,1405,O
infection,1406,1415,O
by,1416,1418,O
the,1419,1422,O
clarithromycin,1423,1437,O
-,1437,1438,O
resistant,1438,1447,O
strain,1448,1454,O
OIT,1455,1458,O
-,1458,1459,O
36,1459,1461,O
.,1461,1462,O
The,1463,1466,O
results,1467,1474,O
obtained,1475,1483,O
lead,1484,1488,O
to,1489,1491,O
the,1492,1495,O
expectation,1496,1507,O
that,1508,1512,O
the,1513,1516,O
new,1517,1520,O
benzimidazole,1521,1534,O
Y,1535,1536,O
-,1536,1537,O
754,1537,1540,O
will,1541,1545,O
",",1545,1546,O
in,1547,1549,O
the,1550,1553,O
near,1554,1558,O
future,1559,1565,O
",",1565,1566,O
be,1567,1569,O
used,1570,1574,O
for,1575,1578,O
H,1579,1580,O
.,1580,1581,O
pylori,1582,1588,O
eradication,1589,1600,O
therapy,1601,1608,O
in,1609,1611,O
peptic,1612,1618,B-Pathological_formation
ulcer,1619,1624,I-Pathological_formation
patients,1625,1633,O
.,1633,1634,O
Active,0,6,O
respiratory,7,18,O
syncytial,19,28,O
virus,29,34,O
purified,35,43,O
by,44,46,O
ion,47,50,O
-,50,51,O
exchange,51,59,O
chromatography,60,74,O
:,74,75,O
characterization,76,92,O
of,93,95,O
binding,96,103,O
and,104,107,O
elution,108,115,O
requirements,116,128,O
.,128,129,O
Two,130,133,O
viruses,134,141,O
",",141,142,O
respiratory,143,154,O
syncytial,155,164,O
virus,165,170,O
(,171,172,O
RSV,172,175,O
),175,176,O
and,177,180,O
vesicular,181,190,O
stomatitis,191,201,O
virus,202,207,O
(,208,209,O
VSV,209,212,O
),212,213,O
were,214,218,O
used,219,223,O
to,224,226,O
evaluate,227,235,O
viral,236,241,O
purification,242,254,O
by,255,257,O
an,258,260,O
affinity,261,269,O
resin,270,275,O
column,276,282,O
(,283,284,O
Matrex,284,290,O
Cellufine,291,300,O
Sulfate,301,308,O
(,309,310,O
MCS,310,313,O
),313,314,O
;,314,315,O
Amicon,316,322,O
Division,323,331,O
",",331,332,O
WR,333,335,O
Grace,336,341,O
&,342,343,O
Co,344,346,O
.,346,347,O
),347,348,O
.,348,349,O
Viable,350,356,O
RSV,357,360,O
was,361,364,O
purified,365,373,O
significantly,374,387,O
from,388,392,O
crude,393,398,O
cell,399,403,B-Organism_substance
lysate,404,410,I-Organism_substance
by,411,413,O
a,414,415,O
single,416,422,O
pass,423,427,O
through,428,435,O
a,436,437,O
column,438,444,O
containing,445,455,O
the,456,459,O
anionic,460,467,O
MCS,468,471,O
resin,472,477,O
.,477,478,O
Most,479,483,O
cell,484,488,B-Cell
protein,489,496,O
and,497,500,O
albumin,501,508,O
eluted,509,515,O
from,516,520,O
the,521,524,O
MCS,525,528,O
resin,529,534,O
with,535,539,O
phosphate,540,549,O
buffered,550,558,O
saline,559,565,O
(,566,567,O
PBS,567,570,O
),570,571,O
but,572,575,O
RSV,576,579,O
eluted,580,586,O
at,587,589,O
high,590,594,O
ionic,595,600,O
strength,601,609,O
",",609,610,O
i,611,612,O
.,612,613,O
e,613,614,O
.,614,615,O
",",615,616,O
greater,617,624,O
than,625,629,O
or,630,632,O
equal,633,638,O
to,639,641,O
0,642,643,O
.,643,644,O
6,644,645,O
M,646,647,O
NaCl,648,652,O
.,652,653,O
Further,654,661,O
purification,662,674,O
was,675,678,O
possible,679,687,O
by,688,690,O
sucrose,691,698,O
step,699,703,O
gradient,704,712,O
centrifugation,713,727,O
.,727,728,O
The,729,732,O
RSV,733,736,O
prepared,737,745,O
by,746,748,O
column,749,755,O
purification,756,768,O
or,769,771,O
by,772,774,O
column,775,781,O
plus,782,786,O
sucrose,787,794,O
gradient,795,803,O
separation,804,814,O
was,815,818,O
both,819,823,O
intact,824,830,O
and,831,834,O
infective,835,844,O
.,844,845,O
RSV,846,849,O
and,850,853,O
pure,854,858,O
samples,859,866,O
of,867,869,O
VSV,870,873,O
were,874,878,O
used,879,883,O
to,884,886,O
optimize,887,895,O
ionic,896,901,O
strength,902,910,O
and,911,914,O
salts,915,920,O
for,921,924,O
elution,925,932,O
from,933,937,O
the,938,941,O
MCS,942,945,O
column,946,952,O
:,952,953,O
0,954,955,O
.,955,956,O
8,956,957,O
M,958,959,O
NaCl,960,964,O
removed,965,972,O
most,973,977,O
of,978,980,O
the,981,984,O
viral,985,990,O
protein,991,998,O
.,998,999,O
The,1000,1003,O
capacity,1004,1012,O
of,1013,1015,O
the,1016,1019,O
MCS,1020,1023,O
gel,1024,1027,O
for,1028,1031,O
RSV,1032,1035,O
or,1036,1038,O
VSV,1039,1042,O
was,1043,1046,O
found,1047,1052,O
to,1053,1055,O
be,1056,1058,O
about,1059,1064,O
0,1065,1066,O
.,1066,1067,O
6,1067,1068,O
-,1068,1069,O
0,1069,1070,O
.,1070,1071,O
8,1071,1072,O
mg,1073,1075,O
viral,1076,1081,O
protein,1082,1089,O
per,1090,1093,O
ml,1094,1096,O
of,1097,1099,O
hydrated,1100,1108,O
resin,1109,1114,O
.,1114,1115,O
Detergent,1116,1125,O
-,1125,1126,O
solubilized,1126,1137,O
viral,1138,1143,O
membrane,1144,1152,B-Cellular_component
proteins,1153,1161,O
bound,1162,1167,O
to,1168,1170,O
the,1171,1174,O
MCS,1175,1178,O
resin,1179,1184,O
in,1185,1187,O
0,1188,1189,O
.,1189,1190,O
145,1190,1193,O
M,1194,1195,O
NaCl,1196,1200,O
and,1201,1204,O
eluted,1205,1211,O
with,1212,1216,O
higher,1217,1223,O
salt,1224,1228,O
concentrations,1229,1243,O
.,1243,1244,O
Thus,1245,1249,O
",",1249,1250,O
this,1251,1255,O
resin,1256,1261,O
also,1262,1266,O
may,1267,1270,O
be,1271,1273,O
a,1274,1275,O
useful,1276,1282,O
aid,1283,1286,O
for,1287,1290,O
relatively,1291,1301,O
gentle,1302,1308,O
purification,1309,1321,O
of,1322,1324,O
these,1325,1330,O
proteins,1331,1339,O
.,1339,1340,O
Novel,0,5,O
insights,6,14,O
into,15,19,O
the,20,23,O
pathogenesis,24,36,O
of,37,39,O
uric,40,44,O
acid,45,49,O
nephrolithiasis,50,65,O
.,65,66,O
PURPOSE,67,74,O
OF,75,77,O
REVIEW,78,84,O
:,84,85,O
The,86,89,O
factors,90,97,O
involved,98,106,O
in,107,109,O
the,110,113,O
pathogenesis,114,126,O
of,127,129,O
uric,130,134,O
acid,135,139,O
nephrolithiasis,140,155,O
are,156,159,O
well,160,164,O
known,165,170,O
.,170,171,O
A,172,173,O
low,174,177,O
urinary,178,185,B-Organism_substance
pH,186,188,O
is,189,191,O
the,192,195,O
most,196,200,O
significant,201,212,O
element,213,220,O
in,221,223,O
the,224,227,O
generation,228,238,O
of,239,241,O
stones,242,248,B-Organism_substance
",",248,249,O
with,250,254,O
hyperuricosuria,255,270,O
being,271,276,O
a,277,278,O
less,279,283,O
common,284,290,O
finding,291,298,O
.,298,299,O
The,300,303,O
underlying,304,314,O
mechanism,315,324,O
(,324,325,O
s,325,326,O
),326,327,O
responsible,328,339,O
for,340,343,O
these,344,349,O
disturbances,350,362,O
remain,363,369,O
poorly,370,376,O
characterized,377,390,O
.,390,391,O
This,392,396,O
review,397,403,O
summarizes,404,414,O
previous,415,423,O
knowledge,424,433,O
and,434,437,O
highlights,438,448,O
some,449,453,O
recent,454,460,O
developments,461,473,O
in,474,476,O
the,477,480,O
pathophysiology,481,496,O
of,497,499,O
low,500,503,O
urine,504,509,B-Organism_substance
pH,510,512,O
and,513,516,O
hyperuricosuria,517,532,O
.,532,533,O
RECENT,534,540,O
FINDINGS,541,549,O
:,549,550,O
Epidemiological,551,566,O
and,567,570,O
metabolic,571,580,O
studies,581,588,O
have,589,593,O
indicated,594,603,O
an,604,606,O
association,607,618,O
between,619,626,O
uric,627,631,O
acid,632,636,O
nephrolithiasis,637,652,O
and,653,656,O
insulin,657,664,O
resistance,665,675,O
.,675,676,O
Some,677,681,O
potential,682,691,O
mechanisms,692,702,O
include,703,710,O
impaired,711,719,O
ammoniagenesis,720,734,O
caused,735,741,O
by,742,744,O
resistance,745,755,O
to,756,758,O
insulin,759,766,O
action,767,773,O
in,774,776,O
the,777,780,O
renal,781,786,B-Multi-tissue_structure
proximal,787,795,I-Multi-tissue_structure
tubule,796,802,I-Multi-tissue_structure
",",802,803,O
or,804,806,O
substrate,807,816,O
competition,817,828,O
by,829,831,O
free,832,836,O
fatty,837,842,O
acids,843,848,O
.,848,849,O
The,850,853,O
evaluation,854,864,O
of,865,867,O
a,868,869,O
large,870,875,O
Sicilian,876,884,O
kindred,885,892,O
recently,893,901,O
revealed,902,910,O
a,911,912,O
putative,913,921,O
genetic,922,929,O
locus,930,935,O
linked,936,942,O
to,943,945,O
uric,946,950,B-Organism_substance
acid,951,955,I-Organism_substance
stone,956,961,I-Organism_substance
disease,962,969,O
.,969,970,O
The,971,974,O
identification,975,989,O
of,990,992,O
novel,993,998,O
complementary,999,1012,O
DNA,1013,1016,O
has,1017,1020,O
provided,1021,1029,O
an,1030,1032,O
interesting,1033,1044,O
insight,1045,1052,O
into,1053,1057,O
the,1058,1061,O
renal,1062,1067,B-Organ
handling,1068,1076,O
of,1077,1079,O
uric,1080,1084,O
acid,1085,1089,O
",",1089,1090,O
including,1091,1100,O
one,1101,1104,O
genetic,1105,1112,O
cause,1113,1118,O
of,1119,1121,O
renal,1122,1127,B-Organ
uric,1128,1132,O
acid,1133,1137,O
wasting,1138,1145,O
.,1145,1146,O
SUMMARY,1147,1154,O
:,1154,1155,O
The,1156,1159,O
recognition,1160,1171,O
of,1172,1174,O
metabolic,1175,1184,O
",",1184,1185,O
molecular,1186,1195,O
",",1195,1196,O
and,1197,1200,O
genetic,1201,1208,O
factors,1209,1216,O
that,1217,1221,O
influence,1222,1231,O
urinary,1232,1239,B-Organism_substance
pH,1240,1242,O
",",1242,1243,O
and,1244,1247,O
uric,1248,1252,O
acid,1253,1257,O
metabolism,1258,1268,O
and,1269,1272,O
excretion,1273,1282,O
",",1282,1283,O
will,1284,1288,O
provide,1289,1296,O
novel,1297,1302,O
insights,1303,1311,O
into,1312,1316,O
the,1317,1320,O
pathogenesis,1321,1333,O
of,1334,1336,O
uric,1337,1341,B-Organism_substance
acid,1342,1346,I-Organism_substance
stones,1347,1353,I-Organism_substance
",",1353,1354,O
and,1355,1358,O
open,1359,1363,O
the,1364,1367,O
way,1368,1371,O
for,1372,1375,O
new,1376,1379,O
therapeutic,1380,1391,O
strategies,1392,1402,O
.,1402,1403,O
Flow,0,4,O
dynamics,5,13,O
of,14,16,O
the,17,20,O
internal,21,29,B-Multi-tissue_structure
thoracic,30,38,I-Multi-tissue_structure
and,39,42,O
radial,43,49,B-Multi-tissue_structure
artery,50,56,I-Multi-tissue_structure
T,57,58,O
-,58,59,O
graft,59,64,O
.,64,65,O
BACKGROUND,66,76,O
:,76,77,O
Complex,78,85,O
use,86,89,O
of,90,92,O
arterial,93,101,B-Multi-tissue_structure
conduits,102,110,I-Multi-tissue_structure
has,111,114,O
resurrected,115,126,O
concerns,127,135,O
about,136,141,O
the,142,145,O
adequacy,146,154,O
of,155,157,O
conduit,158,165,B-Multi-tissue_structure
flow,166,170,O
.,170,171,O
The,172,175,O
T,176,177,O
-,177,178,O
graft,178,183,O
is,184,186,O
the,187,190,O
extreme,191,198,O
example,199,206,O
of,207,209,O
this,210,214,O
trend,215,220,O
.,220,221,O
Our,222,225,O
purpose,226,233,O
was,234,237,O
to,238,240,O
identify,241,249,O
the,250,253,O
limitation,254,264,O
of,265,267,O
single,268,274,O
source,275,281,O
inflow,282,288,O
and,289,292,O
to,293,295,O
compare,296,303,O
flow,304,308,O
capacity,309,317,O
with,318,322,O
completion,323,333,O
coronary,334,342,B-Multi-tissue_structure
flow,343,347,O
.,347,348,O
METHODS,349,356,O
:,356,357,O
Between,358,365,O
February,366,374,O
1999,375,379,O
and,380,383,O
November,384,392,O
2001,393,397,O
",",397,398,O
372,399,402,O
patients,403,411,O
underwent,412,421,O
total,422,427,O
arterial,428,436,B-Multi-tissue_structure
revascularization,437,454,O
with,455,459,O
the,460,463,O
T,464,465,O
-,465,466,O
graft,466,471,O
alone,472,477,O
.,477,478,O
Intraoperative,479,493,O
flows,494,499,O
were,500,504,O
recorded,505,513,O
for,514,517,O
each,518,522,O
limb,523,527,B-Multi-tissue_structure
of,528,530,O
the,531,534,O
T,535,536,O
-,536,537,O
graft,537,542,O
before,543,549,O
and,550,553,O
after,554,559,O
distal,560,566,O
anastomoses,567,578,O
in,579,581,O
204,582,585,O
patients,586,594,O
.,594,595,O
Independent,596,607,O
predictors,608,618,O
of,619,621,O
T,622,623,O
-,623,624,O
graft,624,629,O
flow,630,634,O
were,635,639,O
identified,640,650,O
by,651,653,O
multivariate,654,666,O
analysis,667,675,O
.,675,676,O
RESULTS,677,684,O
:,684,685,O
Free,686,690,O
flow,691,695,O
for,696,699,O
the,700,703,O
radial,704,710,B-Multi-tissue_structure
arterial,711,719,I-Multi-tissue_structure
(,720,721,I-Multi-tissue_structure
RA,721,723,I-Multi-tissue_structure
),723,724,I-Multi-tissue_structure
limb,725,729,I-Multi-tissue_structure
was,730,733,O
161,734,737,O
+,738,739,O
/,739,740,O
-,740,741,O
81,742,744,O
mL,745,747,O
/,747,748,O
min,748,751,O
",",751,752,O
the,753,756,O
internal,757,765,B-Multi-tissue_structure
thoracic,766,774,I-Multi-tissue_structure
artery,775,781,I-Multi-tissue_structure
(,782,783,I-Multi-tissue_structure
ITA,783,786,I-Multi-tissue_structure
),786,787,I-Multi-tissue_structure
limb,788,792,I-Multi-tissue_structure
137,793,796,O
+,797,798,O
/,798,799,O
-,799,800,O
57,801,803,O
mL,804,806,O
/,806,807,O
min,807,810,O
(,811,812,O
combined,812,820,O
298,821,824,O
+,825,826,O
/,826,827,O
-,827,828,O
101,829,832,O
mL,833,835,O
/,835,836,O
min,836,839,O
),839,840,O
versus,841,847,O
simultaneous,848,860,O
limb,861,865,B-Multi-tissue_structure
flow,866,870,O
of,871,873,O
226,874,877,O
+,878,879,O
/,879,880,O
-,880,881,O
84,882,884,O
mL,885,887,O
/,887,888,O
min,888,891,O
giving,892,898,O
a,899,900,O
flow,901,905,O
restriction,906,917,O
of,918,920,O
24,921,923,O
%,923,924,O
+,925,926,O
/,926,927,O
-,927,928,O
14,929,931,O
%,931,932,O
.,932,933,O
Completion,934,944,O
coronary,945,953,B-Multi-tissue_structure
flow,954,958,O
was,959,962,O
88,963,965,O
+,966,967,O
/,967,968,O
-,968,969,O
49,970,972,O
mL,973,975,O
/,975,976,O
min,976,979,O
for,980,983,O
the,984,987,O
RA,988,990,B-Multi-tissue_structure
",",990,991,O
60,992,994,O
+,995,996,O
/,996,997,O
-,997,998,O
45,999,1001,O
mL,1002,1004,O
/,1004,1005,O
min,1005,1008,O
for,1009,1012,O
the,1013,1016,O
ITA,1017,1020,B-Multi-tissue_structure
",",1020,1021,O
and,1022,1025,O
140,1026,1029,O
+,1030,1031,O
/,1031,1032,O
-,1032,1033,O
70,1034,1036,O
mL,1037,1039,O
/,1039,1040,O
min,1040,1043,O
for,1044,1047,O
both,1048,1052,O
limbs,1053,1058,B-Multi-tissue_structure
simultaneously,1059,1073,O
to,1074,1076,O
give,1077,1081,O
a,1082,1083,O
flow,1084,1088,O
reserve,1089,1096,O
(,1097,1098,O
vs,1098,1100,O
simultaneous,1101,1113,O
free,1114,1118,O
flow,1119,1123,O
),1123,1124,O
of,1125,1127,O
160,1128,1131,O
%,1131,1132,O
or,1133,1135,O
1,1136,1137,O
.,1137,1138,O
6,1138,1139,O
.,1139,1140,O
Independent,1141,1152,O
predictors,1153,1163,O
of,1164,1166,O
completion,1167,1177,O
RA,1178,1180,B-Multi-tissue_structure
limb,1181,1185,I-Multi-tissue_structure
flow,1186,1190,O
are,1191,1194,O
RA,1195,1197,B-Multi-tissue_structure
proximal,1198,1206,O
diameter,1207,1215,O
(,1216,1217,O
p,1217,1218,O
=,1219,1220,O
0,1221,1222,O
.,1222,1223,O
005,1223,1226,O
),1226,1227,O
",",1227,1228,O
number,1229,1235,O
of,1236,1238,O
anastomoses,1239,1250,O
(,1251,1252,O
p,1252,1253,O
=,1254,1255,O
0,1256,1257,O
.,1257,1258,O
018,1258,1261,O
),1261,1262,O
",",1262,1263,O
and,1264,1267,O
target,1268,1274,O
stenosis,1275,1283,O
(,1284,1285,O
p,1285,1286,O
=,1287,1288,O
0,1289,1290,O
.,1290,1291,O
005,1291,1294,O
),1294,1295,O
.,1295,1296,O
CONCLUSIONS,1297,1308,O
:,1308,1309,O
A,1310,1311,O
flow,1312,1316,O
reserve,1317,1324,O
of,1325,1327,O
1,1328,1329,O
.,1329,1330,O
6,1330,1331,O
compares,1332,1340,O
favorably,1341,1350,O
with,1351,1355,O
an,1356,1358,O
ITA,1359,1362,B-Multi-tissue_structure
flow,1363,1367,O
reserve,1368,1375,O
of,1376,1378,O
1,1379,1380,O
.,1380,1381,O
8,1381,1382,O
at,1383,1385,O
1,1386,1387,O
-,1387,1388,O
month,1388,1393,O
postoperatively,1394,1409,O
and,1410,1413,O
1,1414,1415,O
.,1415,1416,O
8,1416,1417,O
for,1418,1421,O
both,1422,1426,O
the,1427,1430,O
ITA,1431,1434,B-Multi-tissue_structure
T,1435,1436,O
-,1436,1437,O
graft,1437,1442,O
and,1443,1446,O
the,1447,1450,O
ITA,1451,1454,B-Multi-tissue_structure
/,1454,1455,I-Multi-tissue_structure
RA,1455,1457,I-Multi-tissue_structure
T,1458,1459,O
-,1459,1460,O
graft,1460,1465,O
at,1466,1468,O
1,1469,1470,O
-,1470,1471,O
week,1471,1475,O
postoperatively,1476,1491,O
as,1492,1494,O
reported,1495,1503,O
by,1504,1506,O
others,1507,1513,O
.,1513,1514,O
Proximal,1515,1523,O
RA,1524,1526,B-Multi-tissue_structure
diameter,1527,1535,O
and,1536,1539,O
competitive,1540,1551,O
coronary,1552,1560,B-Multi-tissue_structure
flow,1561,1565,O
influence,1566,1575,O
completion,1576,1586,O
T,1587,1588,O
-,1588,1589,O
graft,1589,1594,O
flow,1595,1599,O
.,1599,1600,O
These,1601,1606,O
data,1607,1611,O
quantitate,1612,1622,O
the,1623,1626,O
limitation,1627,1637,O
of,1638,1640,O
single,1641,1647,O
source,1648,1654,O
inflow,1655,1661,O
of,1662,1664,O
the,1665,1668,O
T,1669,1670,O
-,1670,1671,O
graft,1671,1676,O
configuration,1677,1690,O
and,1691,1694,O
support,1695,1702,O
its,1703,1706,O
continued,1707,1716,O
use,1717,1720,O
.,1720,1721,O
Thiazole,0,8,O
orange,9,15,O
positive,16,24,O
platelets,25,34,B-Cell
in,35,37,O
a,38,39,O
dog,40,43,O
with,44,48,O
Evans,49,54,O
',54,55,O
syndrome,56,64,O
.,64,65,O
We,66,68,O
examined,69,77,O
transition,78,88,O
for,89,92,O
the,93,96,O
percentage,97,107,O
of,108,110,O
reticulated,111,122,B-Cell
platelets,123,132,I-Cell
(,133,134,O
RP,134,136,B-Cell
%,136,137,O
),137,138,O
and,139,142,O
platelet,143,151,B-Cell
count,152,157,O
in,158,160,O
a,161,162,O
canine,163,169,O
case,170,174,O
of,175,177,O
Evans,178,183,O
',183,184,O
syndrome,185,193,O
.,193,194,O
The,195,198,O
result,199,205,O
demonstrated,206,218,O
that,219,223,O
measurement,224,235,O
of,236,238,O
the,239,242,O
RP,243,245,B-Cell
%,245,246,O
can,247,250,O
be,251,253,O
useful,254,260,O
in,261,263,O
evaluating,264,274,O
platelet,275,283,B-Cell
production,284,294,O
in,295,297,O
the,298,301,O
bone,302,306,B-Multi-tissue_structure
marrow,307,313,I-Multi-tissue_structure
and,314,317,O
response,318,326,O
to,327,329,O
treatment,330,339,O
.,339,340,O
Human,0,5,O
cytomegalovirus,6,21,O
5,22,23,O
-,23,24,O
kilobase,24,32,O
immediate,33,42,O
-,42,43,O
early,43,48,O
RNA,49,52,O
is,53,55,O
a,56,57,O
stable,58,64,O
intron,65,71,O
.,71,72,O
Immediate,73,82,O
-,82,83,O
early,83,88,O
viral,89,94,O
gene,95,99,O
products,100,108,O
of,109,111,O
human,112,117,O
cytomegalovirus,118,133,O
(,134,135,O
HCMV,135,139,O
),139,140,O
are,141,144,O
derived,145,152,O
from,153,157,O
several,158,165,O
genomic,166,173,O
loci,174,178,O
and,179,182,O
largely,183,190,O
serve,191,196,O
to,197,199,O
establish,200,209,O
a,210,211,O
cellular,212,220,B-Cell
environment,221,232,O
conducive,233,242,O
to,243,245,O
viral,246,251,O
replication,252,263,O
.,263,264,O
We,265,267,O
have,268,272,O
further,273,280,O
examined,281,289,O
an,290,292,O
unusual,293,300,O
immediate,301,310,O
-,310,311,O
early,311,316,O
transcript,317,327,O
known,328,333,O
as,334,336,O
the,337,340,O
5,341,342,O
-,342,343,O
kb,343,345,O
RNA,346,349,O
",",349,350,O
concluding,351,361,O
that,362,366,O
it,367,369,O
is,370,372,O
a,373,374,O
stable,375,381,O
intron,382,388,O
encoded,389,396,O
by,397,399,O
HCMV,400,404,O
.,404,405,O
The,406,409,O
5,410,411,O
-,411,412,O
kb,412,414,O
RNA,415,418,O
is,419,421,O
highly,422,428,O
AT,429,431,O
rich,432,436,O
in,437,439,O
sequence,440,448,O
and,449,452,O
lacks,453,458,O
open,459,463,O
reading,464,471,O
frames,472,478,O
likely,479,485,O
to,486,488,O
be,489,491,O
translated,492,502,O
into,503,507,O
protein,508,515,O
.,515,516,O
We,517,519,O
confirmed,520,529,O
the,530,533,O
absence,534,541,O
of,542,544,O
polyadenylation,545,560,O
of,561,563,O
the,564,567,O
transcript,568,578,O
and,579,582,O
showed,583,589,O
that,590,594,O
it,595,597,O
is,598,600,O
primarily,601,610,O
nuclear,611,618,B-Cellular_component
localized,619,628,O
during,629,635,O
viral,636,641,O
infection,642,651,O
.,651,652,O
We,653,655,O
mapped,656,662,O
the,663,666,O
5,667,668,O
',668,669,O
end,670,673,O
of,674,676,O
the,677,680,O
5,681,682,O
-,682,683,O
kb,683,685,O
RNA,686,689,O
to,690,692,O
a,693,694,O
consensus,695,704,O
splice,705,711,O
donor,712,717,O
site,718,722,O
and,723,726,O
localized,727,736,O
the,737,740,O
3,741,742,O
',742,743,O
end,744,747,O
in,748,750,O
the,751,754,O
vicinity,755,763,O
of,764,766,O
a,767,768,O
splice,769,775,O
acceptor,776,784,O
site,785,789,O
.,789,790,O
In,791,793,O
transfection,794,806,O
studies,807,814,O
",",814,815,O
we,816,818,O
showed,819,825,O
that,826,830,O
the,831,834,O
5,835,836,O
-,836,837,O
kb,837,839,O
RNA,840,843,O
can,844,847,O
be,848,850,O
spliced,851,858,O
from,859,863,O
a,864,865,O
heterologous,866,878,O
primary,879,886,O
transcript,887,897,O
.,897,898,O
Using,899,904,O
bacterial,905,914,O
artificial,915,925,O
chromosome,926,936,B-Cellular_component
technology,937,947,O
",",947,948,O
we,949,951,O
constructed,952,963,O
a,964,965,O
viral,966,971,O
recombinant,972,983,O
containing,984,994,O
a,995,996,O
mutation,997,1005,O
in,1006,1008,O
the,1009,1012,O
5,1013,1014,O
',1014,1015,O
splice,1016,1022,O
donor,1023,1028,O
site,1029,1033,O
that,1034,1038,O
defines,1039,1046,O
the,1047,1050,O
5,1051,1052,O
',1052,1053,O
end,1054,1057,O
of,1058,1060,O
the,1061,1064,O
RNA,1065,1068,O
and,1069,1072,O
found,1073,1078,O
that,1079,1083,O
this,1084,1088,O
mutation,1089,1097,O
eliminates,1098,1108,O
expression,1109,1119,O
of,1120,1122,O
the,1123,1126,O
5,1127,1128,O
-,1128,1129,O
kb,1129,1131,O
RNA,1132,1135,O
during,1136,1142,O
viral,1143,1148,O
infection,1149,1158,O
.,1158,1159,O
This,1160,1164,O
mutant,1165,1171,O
grows,1172,1177,O
in,1178,1180,O
human,1181,1186,O
fibroblasts,1187,1198,B-Cell
without,1199,1206,O
complementation,1207,1222,O
.,1222,1223,O
Taken,1224,1229,O
together,1230,1238,O
",",1238,1239,O
these,1240,1245,O
data,1246,1250,O
support,1251,1258,O
the,1259,1262,O
conclusion,1263,1273,O
that,1274,1278,O
the,1279,1282,O
5,1283,1284,O
-,1284,1285,O
kb,1285,1287,O
RNA,1288,1291,O
is,1292,1294,O
a,1295,1296,O
stable,1297,1303,O
intron,1304,1310,O
expressed,1311,1320,O
by,1321,1323,O
HCMV,1324,1328,O
.,1328,1329,O
Reduced,0,7,O
prognostic,8,18,O
power,19,24,O
of,25,27,O
ventricular,28,39,B-Multi-tissue_structure
late,40,44,O
potentials,45,55,O
in,56,58,O
post,59,63,O
-,63,64,O
infarction,64,74,O
patients,75,83,O
of,84,86,O
the,87,90,O
reperfusion,91,102,O
era,103,106,O
.,106,107,O
AIMS,108,112,O
:,112,113,O
To,114,116,O
test,117,121,O
the,122,125,O
prognostic,126,136,O
value,137,142,O
of,143,145,O
ventricular,146,157,B-Multi-tissue_structure
late,158,162,O
potentials,163,173,O
(,174,175,O
LPs,175,178,O
),178,179,O
in,180,182,O
a,183,184,O
large,185,190,O
cohort,191,197,O
of,198,200,O
post,201,205,O
-,205,206,O
infarction,206,216,O
patients,217,225,O
in,226,228,O
the,229,232,O
modern,233,239,O
reperfusion,240,251,O
era,252,255,O
.,255,256,O
METHODS,257,264,O
AND,265,268,O
RESULTS,269,276,O
:,276,277,O
1800,278,282,O
consecutive,283,294,O
survivors,295,304,O
of,305,307,O
acute,308,313,O
myocardial,314,324,B-Multi-tissue_structure
infarction,325,335,O
in,336,338,O
sinus,339,344,B-Immaterial_anatomical_entity
rhythm,345,351,O
and,352,355,O
under,356,361,O
76,362,364,O
years,365,370,O
of,371,373,O
age,374,377,O
were,378,382,O
enrolled,383,391,O
.,391,392,O
Many,393,397,O
(,398,399,O
99,399,401,O
%,401,402,O
),402,403,O
of,404,406,O
the,407,410,O
patients,411,419,O
received,420,428,O
reperfusion,429,440,O
/,440,441,O
revascularization,441,458,O
therapy,459,466,O
(,467,468,O
91,468,470,O
%,470,471,O
percutaneous,472,484,O
coronary,485,493,B-Multi-tissue_structure
intervention,494,506,O
),506,507,O
and,508,511,O
up,512,514,O
-,514,515,O
to,515,517,O
-,517,518,O
date,518,522,O
pharmacological,523,538,O
treatment,539,548,O
(,549,550,O
99,550,552,O
%,552,553,O
aspirin,554,561,O
",",561,562,O
93,563,565,O
%,565,566,O
beta,567,571,O
-,571,572,O
blockers,572,580,O
",",580,581,O
90,582,584,O
%,584,585,O
ACE,586,589,O
-,589,590,O
inhibitors,590,600,O
",",600,601,O
and,602,605,O
85,606,608,O
%,608,609,O
statins,610,617,O
),617,618,O
.,618,619,O
LPs,620,623,O
were,624,628,O
calculated,629,639,O
in,640,642,O
968,643,646,O
patients,647,655,O
and,656,659,O
found,660,665,O
to,666,668,O
be,669,671,O
present,672,679,O
in,680,682,O
90,683,685,O
(,686,687,O
9,687,688,O
.,688,689,O
3,689,690,O
%,690,691,O
),691,692,O
.,692,693,O
The,694,697,O
primary,698,705,O
endpoint,706,714,O
was,715,718,O
the,719,722,O
composite,723,732,O
of,733,735,O
cardiac,736,743,B-Organ
death,744,749,O
and,750,753,O
serious,754,761,O
arrhythmic,762,772,O
events,773,779,O
.,779,780,O
The,781,784,O
secondary,785,794,O
endpoint,795,803,O
was,804,807,O
the,808,811,O
composite,812,821,O
of,822,824,O
sudden,825,831,O
cardiac,832,839,B-Organ
death,840,845,O
and,846,849,O
serious,850,857,O
arrhythmic,858,868,O
events,869,875,O
.,875,876,O
During,877,883,O
follow,884,890,O
-,890,891,O
up,891,893,O
(,894,895,O
median,895,901,O
34,902,904,O
months,905,911,O
),911,912,O
",",912,913,O
26,914,916,O
patients,917,925,O
reached,926,933,O
the,934,937,O
primary,938,945,O
endpoint,946,954,O
.,954,955,O
The,956,959,O
presence,960,968,O
of,969,971,O
LPs,972,975,O
was,976,979,O
not,980,983,O
significantly,984,997,O
associated,998,1008,O
with,1009,1013,O
the,1014,1017,O
primary,1018,1025,O
endpoint,1026,1034,O
in,1035,1037,O
univariable,1038,1049,O
or,1050,1052,O
multivariable,1053,1066,O
analysis,1067,1075,O
.,1075,1076,O
In,1077,1079,O
contrast,1080,1088,O
",",1088,1089,O
low,1090,1093,O
(,1094,1095,O
<,1095,1096,O
or,1097,1099,O
=,1100,1101,O
30,1102,1104,O
%,1104,1105,O
),1105,1106,O
left,1107,1111,B-Multi-tissue_structure
ventricular,1112,1123,I-Multi-tissue_structure
ejection,1124,1132,O
fraction,1133,1141,O
(,1142,1143,O
hazard,1143,1149,O
ratio,1150,1155,O
9,1156,1157,O
.,1157,1158,O
6,1158,1159,O
",",1159,1160,O
95,1161,1163,O
%,1163,1164,O
confidence,1165,1175,O
interval,1176,1184,O
4,1185,1186,O
.,1186,1187,O
1,1187,1188,O
-,1188,1189,O
22,1189,1191,O
.,1191,1192,O
4,1192,1193,O
),1193,1194,O
",",1194,1195,O
heart,1196,1201,B-Organ
rate,1202,1206,O
turbulence,1207,1217,O
category,1218,1226,O
2,1227,1228,O
(,1229,1230,O
7,1230,1231,O
.,1231,1232,O
5,1232,1233,O
",",1233,1234,O
2,1235,1236,O
.,1236,1237,O
4,1237,1238,O
-,1238,1239,O
23,1239,1241,O
.,1241,1242,O
9,1242,1243,O
),1243,1244,O
and,1245,1248,O
category,1249,1257,O
1,1258,1259,O
(,1260,1261,O
5,1261,1262,O
.,1262,1263,O
3,1263,1264,O
",",1264,1265,O
1,1266,1267,O
.,1267,1268,O
9,1268,1269,O
-,1269,1270,O
14,1270,1272,O
.,1272,1273,O
9,1273,1274,O
),1274,1275,O
were,1276,1280,O
significant,1281,1292,O
predictors,1293,1303,O
in,1304,1306,O
both,1307,1311,O
univariable,1312,1323,O
and,1324,1327,O
multivariable,1328,1341,O
analysis,1342,1350,O
.,1350,1351,O
CONCLUSION,1352,1362,O
:,1362,1363,O
Ventricular,1364,1375,B-Multi-tissue_structure
LPs,1376,1379,O
are,1380,1383,O
of,1384,1386,O
limited,1387,1394,O
use,1395,1398,O
for,1399,1402,O
risk,1403,1407,O
stratification,1408,1422,O
in,1423,1425,O
unselected,1426,1436,O
post,1437,1441,O
-,1441,1442,O
infarction,1442,1452,O
patients,1453,1461,O
in,1462,1464,O
the,1465,1468,O
modern,1469,1475,O
reperfusion,1476,1487,O
era,1488,1491,O
.,1491,1492,O
Bcl,0,3,O
-,3,4,O
2,4,5,O
decreases,6,15,O
cell,16,20,B-Cell
proliferation,21,34,O
and,35,38,O
promotes,39,47,O
accumulation,48,60,O
of,61,63,O
cells,64,69,B-Cell
in,70,72,O
S,73,74,O
phase,75,80,O
without,81,88,O
affecting,89,98,O
the,99,102,O
rate,103,107,O
of,108,110,O
apoptosis,111,120,O
in,121,123,O
human,124,129,O
ovarian,130,137,B-Cell
carcinoma,138,147,I-Cell
cells,148,153,I-Cell
.,153,154,O
OBJECTIVES,155,165,O
:,165,166,O
The,167,170,O
Bcl,171,174,O
-,174,175,O
2,175,176,O
protein,177,184,O
is,185,187,O
an,188,190,O
important,191,200,O
regulator,201,210,O
of,211,213,O
the,214,217,O
apoptotic,218,227,O
cascade,228,235,O
and,236,239,O
promotes,240,248,O
cell,249,253,B-Cell
survival,254,262,O
.,262,263,O
Bcl,264,267,O
-,267,268,O
2,268,269,O
can,270,273,O
also,274,278,O
delay,279,284,O
entry,285,290,O
into,291,295,O
the,296,299,O
cell,300,304,B-Cell
cycle,305,310,O
from,311,315,O
quiescence,316,326,O
.,326,327,O
In,328,330,O
the,331,334,O
present,335,342,O
study,343,348,O
",",348,349,O
we,350,352,O
used,353,357,O
two,358,361,O
isogenic,362,370,O
human,371,376,O
ovarian,377,384,B-Cell
carcinoma,385,394,I-Cell
cell,395,399,I-Cell
lines,400,405,I-Cell
",",405,406,O
which,407,412,O
expressed,413,422,O
differential,423,435,O
levels,436,442,O
of,443,445,O
Bcl,446,449,O
-,449,450,O
2,450,451,O
proteins,452,460,O
",",460,461,O
to,462,464,O
demonstrate,465,476,O
that,477,481,O
Bcl,482,485,O
-,485,486,O
2,486,487,O
may,488,491,O
regulate,492,500,O
the,501,504,O
growth,505,511,O
rates,512,517,O
of,518,520,O
adenocarcinoma,521,535,B-Cell
cells,536,541,I-Cell
.,541,542,O
METHODS,543,550,O
:,550,551,O
The,552,555,O
growth,556,562,O
rates,563,568,O
of,569,571,O
two,572,575,O
isogenic,576,584,O
ovarian,585,592,B-Cell
cancer,593,599,I-Cell
cell,600,604,I-Cell
lines,605,610,I-Cell
were,611,615,O
determined,616,626,O
by,627,629,O
XTT,630,633,O
assays,634,640,O
and,641,644,O
flow,645,649,O
cytometry,650,659,O
combined,660,668,O
with,669,673,O
PI,674,676,O
staining,677,685,O
.,685,686,O
Bcl,687,690,B-Cell
-,690,691,I-Cell
2,691,692,I-Cell
-,692,693,I-Cell
overexpressing,693,707,I-Cell
SKOV3,708,713,I-Cell
cells,714,719,I-Cell
were,720,724,O
modified,725,733,O
to,734,736,O
express,737,744,O
a,745,746,O
doxycycline,747,758,O
-,758,759,O
inducible,759,768,O
anti,769,773,O
-,773,774,O
Bcl,774,777,O
-,777,778,O
2,778,779,O
single,780,786,O
-,786,787,O
chain,787,792,O
antibody,793,801,O
and,802,805,O
the,806,809,O
effects,810,817,O
of,818,820,O
Bcl,821,824,O
-,824,825,O
2,825,826,O
protein,827,834,O
inhibition,835,845,O
on,846,848,O
cell,849,853,B-Cell
proliferation,854,867,O
and,868,871,O
apoptosis,872,881,O
were,882,886,O
assessed,887,895,O
.,895,896,O
RESULTS,897,904,O
:,904,905,O
We,906,908,O
demonstrate,909,920,O
that,921,925,O
Bcl,926,929,O
-,929,930,O
2,930,931,O
promotes,932,940,O
the,941,944,O
accumulation,945,957,O
of,958,960,O
proliferating,961,974,O
carcinoma,975,984,B-Cell
cells,985,990,I-Cell
in,991,993,O
S,994,995,O
phase,996,1001,O
.,1001,1002,O
The,1003,1006,O
Bcl,1007,1010,B-Cell
-,1010,1011,I-Cell
2,1011,1012,I-Cell
-,1012,1013,I-Cell
overexpressing,1013,1027,I-Cell
SKOV3,1028,1033,I-Cell
cell,1034,1038,I-Cell
line,1039,1043,I-Cell
proliferates,1044,1056,O
markedly,1057,1065,O
faster,1066,1072,O
and,1073,1076,O
shows,1077,1082,O
delayed,1083,1090,O
progression,1091,1102,O
to,1103,1105,O
G2M,1106,1109,O
phase,1110,1115,O
compared,1116,1124,O
to,1125,1127,O
its,1128,1131,O
low,1132,1135,O
Bcl,1136,1139,B-Cell
-,1139,1140,I-Cell
2,1140,1141,I-Cell
-,1141,1142,I-Cell
expressing,1142,1152,I-Cell
counterpart,1153,1164,I-Cell
SKOV3,1165,1170,I-Cell
.,1170,1171,I-Cell
ip1,1171,1174,I-Cell
cell,1175,1179,I-Cell
line,1180,1184,I-Cell
.,1184,1185,O
Single,1186,1192,O
-,1192,1193,O
chain,1193,1198,O
antibody,1199,1207,O
-,1207,1208,O
mediated,1208,1216,O
inhibition,1217,1227,O
of,1228,1230,O
Bcl,1231,1234,O
-,1234,1235,O
2,1235,1236,O
in,1237,1239,O
SKOV3,1240,1245,B-Cell
cells,1246,1251,I-Cell
was,1252,1255,O
associated,1256,1266,O
with,1267,1271,O
increased,1272,1281,O
growth,1282,1288,O
rates,1289,1294,O
and,1295,1298,O
more,1299,1303,O
rapid,1304,1309,O
cell,1310,1314,B-Cell
cycle,1315,1320,O
progression,1321,1332,O
.,1332,1333,O
Treatment,1334,1343,O
with,1344,1348,O
cisplatin,1349,1358,O
resulted,1359,1367,O
in,1368,1370,O
more,1371,1375,O
cells,1376,1381,B-Cell
accumulating,1382,1394,O
in,1395,1397,O
S,1398,1399,O
phase,1400,1405,O
in,1406,1408,O
Bcl,1409,1412,B-Cell
-,1412,1413,I-Cell
2,1413,1414,I-Cell
-,1414,1415,I-Cell
overexpressing,1415,1429,I-Cell
SKOV3,1430,1435,I-Cell
cells,1436,1441,I-Cell
",",1441,1442,O
while,1443,1448,O
the,1449,1452,O
inhibition,1453,1463,O
of,1464,1466,O
Bcl,1467,1470,O
-,1470,1471,O
2,1471,1472,O
abolished,1473,1482,O
delayed,1483,1490,O
entry,1491,1496,O
into,1497,1501,O
G2M,1502,1505,O
phase,1506,1511,O
without,1512,1519,O
affecting,1520,1529,O
cisplatin,1530,1539,O
-,1539,1540,O
induced,1540,1547,O
apoptosis,1548,1557,O
.,1557,1558,O
CONCLUSIONS,1559,1570,O
:,1570,1571,O
Our,1572,1575,O
results,1576,1583,O
suggest,1584,1591,O
that,1592,1596,O
",",1596,1597,O
in,1598,1600,O
ovarian,1601,1608,B-Cell
cancer,1609,1615,I-Cell
cells,1616,1621,I-Cell
",",1621,1622,O
Bcl,1623,1626,O
-,1626,1627,O
2,1627,1628,O
delays,1629,1635,O
cell,1636,1640,B-Cell
cycle,1641,1646,O
progression,1647,1658,O
by,1659,1661,O
promoting,1662,1671,O
accumulation,1672,1684,O
of,1685,1687,O
cells,1688,1693,B-Cell
in,1694,1696,O
S,1697,1698,O
phase,1699,1704,O
without,1705,1712,O
affecting,1713,1722,O
the,1723,1726,O
rate,1727,1731,O
of,1732,1734,O
apoptosis,1735,1744,O
.,1744,1745,O
Thus,1746,1750,O
",",1750,1751,O
in,1752,1754,O
addition,1755,1763,O
to,1764,1766,O
its,1767,1770,O
known,1771,1776,O
role,1777,1781,O
at,1782,1784,O
the,1785,1788,O
G0,1789,1791,O
/,1791,1792,O
G1,1792,1794,O
checkpoint,1795,1805,O
",",1805,1806,O
we,1807,1809,O
demonstrate,1810,1821,O
for,1822,1825,O
the,1826,1829,O
first,1830,1835,O
time,1836,1840,O
that,1841,1845,O
Bcl,1846,1849,O
-,1849,1850,O
2,1850,1851,O
also,1852,1856,O
regulates,1857,1866,O
the,1867,1870,O
S,1871,1872,O
phase,1873,1878,O
.,1878,1879,O
A,0,1,O
novel,2,7,O
conotoxin,8,17,O
from,18,22,O
Conus,23,28,O
delessertii,29,40,O
with,41,45,O
posttranslationally,46,65,O
modified,66,74,O
lysine,75,81,O
residues,82,90,O
.,90,91,O
A,92,93,O
major,94,99,O
peptide,100,107,O
",",107,108,O
de13a,109,114,O
from,115,119,O
the,120,123,O
crude,124,129,O
venom,130,135,B-Organism_substance
of,136,138,O
Conus,139,144,O
delessertii,145,156,O
collected,157,166,O
in,167,169,O
the,170,173,O
Yucatan,174,181,O
Channel,182,189,O
",",189,190,O
Mexico,191,197,O
",",197,198,O
was,199,202,O
purified,203,211,O
.,211,212,O
The,213,216,O
peptide,217,224,O
had,225,228,O
a,229,230,O
high,231,235,O
content,236,243,O
of,244,246,O
posttranslationally,247,266,O
modified,267,275,O
amino,276,281,O
acids,282,287,O
",",287,288,O
including,289,298,O
6,299,300,O
-,300,301,O
bromotryptophan,301,316,O
and,317,320,O
a,321,322,O
nonstandard,323,334,O
amino,335,340,O
acid,341,345,O
that,346,350,O
proved,351,357,O
to,358,360,O
be,361,363,O
5,364,365,O
-,365,366,O
hydroxylysine,366,379,O
.,379,380,O
This,381,385,O
is,386,388,O
the,389,392,O
first,393,398,O
report,399,405,O
of,406,408,O
5,409,410,O
-,410,411,O
hydroxylysine,411,424,O
residues,425,433,O
in,434,436,O
conotoxins,437,447,O
.,447,448,O
The,449,452,O
sequence,453,461,O
analysis,462,470,O
",",470,471,O
together,472,480,O
with,481,485,O
cDNA,486,490,O
cloning,491,498,O
and,499,502,O
a,503,504,O
mass,505,509,O
determination,510,523,O
(,524,525,O
monoisotopic,525,537,O
mass,538,542,O
of,543,545,O
3486,546,550,O
.,550,551,O
76,551,553,O
Da,554,556,O
),556,557,O
",",557,558,O
established,559,570,O
that,571,575,O
the,576,579,O
mature,580,586,O
toxin,587,592,O
has,593,596,O
the,597,600,O
sequence,601,609,O
DCOTSCOTTCANGWECCKGYOCVNKACSGCTH,610,642,O
",",642,643,O
where,644,649,O
O,650,651,O
is,652,654,O
4,655,656,O
-,656,657,O
hydroxyproline,657,671,O
",",671,672,O
W,673,674,O
6,675,676,O
-,676,677,O
bromotryptophan,677,692,O
",",692,693,O
and,694,697,O
K,698,699,O
5,700,701,O
-,701,702,O
hydroxylysine,702,715,O
",",715,716,O
the,717,720,O
asterisk,721,729,O
represents,730,740,O
the,741,744,O
amidated,745,753,O
C,754,755,O
-,755,756,O
terminus,756,764,O
",",764,765,O
and,766,769,O
the,770,773,O
calculated,774,784,O
monoisotopic,785,797,O
mass,798,802,O
is,803,805,O
3487,806,810,O
.,810,811,O
09,811,813,O
Da,814,816,O
.,816,817,O
The,818,821,O
eight,822,827,O
Cys,828,831,O
residues,832,840,O
are,841,844,O
arranged,845,853,O
in,854,856,O
a,857,858,O
pattern,859,866,O
(,867,868,O
C,868,869,O
-,869,870,O
C,870,871,O
-,871,872,O
C,872,873,O
-,873,874,O
CC,874,876,O
-,876,877,O
C,877,878,O
-,878,879,O
C,879,880,O
-,880,881,O
C,881,882,O
),882,883,O
not,884,887,O
described,888,897,O
previously,898,908,O
in,909,911,O
conotoxins,912,922,O
.,922,923,O
This,924,928,O
arrangement,929,940,O
",",940,941,O
for,942,945,O
which,946,951,O
we,952,954,O
propose,955,962,O
the,963,966,O
designation,967,978,O
of,979,981,O
framework,982,991,O
#,992,993,O
13,993,995,O
or,996,998,O
XIII,999,1003,O
",",1003,1004,O
differs,1005,1012,O
from,1013,1017,O
the,1018,1021,O
ones,1022,1026,O
(,1027,1028,O
C,1028,1029,O
-,1029,1030,O
C,1030,1031,O
-,1031,1032,O
CC,1032,1034,O
-,1034,1035,O
CC,1035,1037,O
-,1037,1038,O
C,1038,1039,O
-,1039,1040,O
C,1040,1041,O
and,1042,1045,O
C,1046,1047,O
-,1047,1048,O
C,1048,1049,O
-,1049,1050,O
C,1050,1051,O
-,1051,1052,O
C,1052,1053,O
-,1053,1054,O
CC,1054,1056,O
-,1056,1057,O
C,1057,1058,O
-,1058,1059,O
C,1059,1060,O
),1060,1061,O
present,1062,1069,O
in,1070,1072,O
other,1073,1078,O
conotoxins,1079,1089,O
which,1090,1095,O
also,1096,1100,O
contain,1101,1108,O
eight,1109,1114,O
Cys,1115,1118,O
residues,1119,1127,O
.,1127,1128,O
This,1129,1133,O
peptide,1134,1141,O
thus,1142,1146,O
defines,1147,1154,O
a,1155,1156,O
novel,1157,1162,O
class,1163,1168,O
of,1169,1171,O
conotoxins,1172,1182,O
",",1182,1183,O
with,1184,1188,O
a,1189,1190,O
new,1191,1194,O
posttranslational,1195,1212,O
modification,1213,1225,O
not,1226,1229,O
previously,1230,1240,O
found,1241,1246,O
in,1247,1249,O
other,1250,1255,O
Conus,1256,1261,O
peptide,1262,1269,O
families,1270,1278,O
.,1278,1279,O
Enhancement,0,11,O
of,12,14,O
skin,15,19,B-Organ
permeation,20,30,O
of,31,33,O
ketotifen,34,43,O
by,44,46,O
supersaturation,47,62,O
generated,63,72,O
by,73,75,O
amorphous,76,85,O
form,86,90,O
of,91,93,O
the,94,97,O
drug,98,102,O
.,102,103,O
Pressure,104,112,O
sensitive,113,122,O
adhesive,123,131,O
(,132,133,O
PSA,133,136,O
),136,137,O
matrices,138,146,O
containing,147,157,O
amorphous,158,167,O
ketotifen,168,177,O
were,178,182,O
prepared,183,191,O
and,192,195,O
evaluated,196,205,O
for,206,209,O
enhanced,210,218,O
skin,219,223,B-Organ
permeability,224,236,O
of,237,239,O
the,240,243,O
drug,244,248,O
.,248,249,O
A,250,251,O
solvent,252,259,O
casting,260,267,O
method,268,274,O
using,275,280,O
silicone,281,289,O
-,289,290,O
typed,290,295,O
PSA,296,299,O
was,300,303,O
employed,304,312,O
",",312,313,O
and,314,317,O
n,318,319,O
-,319,320,O
hexane,320,326,O
",",326,327,O
an,328,330,O
original,331,339,O
solvent,340,347,O
for,348,351,O
the,352,355,O
PSA,356,359,O
and,360,363,O
one,364,367,O
more,368,372,O
solvent,373,380,O
",",380,381,O
dichloromethane,382,397,O
",",397,398,O
tetrahydrofuran,399,414,O
",",414,415,O
acetone,416,423,O
",",423,424,O
ethyl,425,430,O
acetate,431,438,O
or,439,441,O
toluene,442,449,O
",",449,450,O
were,451,455,O
used,456,460,O
for,461,464,O
complete,465,473,O
dissolution,474,485,O
of,486,488,O
ketotifen,489,498,O
and,499,502,O
high,503,507,O
dispersion,508,518,O
in,519,521,O
an,522,524,O
amorphous,525,534,O
state,535,540,O
of,541,543,O
the,544,547,O
drug,548,552,O
.,552,553,O
Presence,554,562,O
of,563,565,O
the,566,569,O
amorphous,570,579,O
form,580,584,O
was,585,588,O
judged,589,595,O
based,596,601,O
on,602,604,O
the,605,608,O
in,609,611,O
vitro,612,617,O
drug,618,622,O
release,623,630,O
rate,631,635,O
from,636,640,O
the,641,644,O
matrix,645,651,O
.,651,652,O
As,653,655,O
a,656,657,O
result,658,664,O
",",664,665,O
dichloromethane,666,681,O
and,682,685,O
tetrahudrofuran,686,701,O
were,702,706,O
selected,707,715,O
as,716,718,O
appropriate,719,730,O
dilution,731,739,O
solvents,740,748,O
.,748,749,O
In,750,752,O
vitro,753,758,O
permeation,759,769,O
experiments,770,781,O
through,782,789,O
excised,790,797,O
hairless,798,806,O
mouse,807,812,O
skin,813,817,B-Organ
revealed,818,826,O
that,827,831,O
the,832,835,O
steady,836,842,O
-,842,843,O
state,843,848,O
flux,849,853,O
from,854,858,O
the,859,862,O
amorphous,863,872,O
ketotifen,873,882,O
-,882,883,O
dispersed,883,892,O
matrices,893,901,O
was,902,905,O
about,906,911,O
five,912,916,O
times,917,922,O
greater,923,930,O
than,931,935,O
that,936,940,O
of,941,943,O
the,944,947,O
crystalline,948,959,O
ketotifen,960,969,O
-,969,970,O
dispersed,970,979,O
matrices,980,988,O
",",988,989,O
and,990,993,O
that,994,998,O
the,999,1002,O
enhancement,1003,1014,O
ratio,1015,1020,O
was,1021,1024,O
in,1025,1027,O
good,1028,1032,O
agreement,1033,1042,O
with,1043,1047,O
the,1048,1051,O
solubility,1052,1062,O
ratio,1063,1068,O
of,1069,1071,O
the,1072,1075,O
amorphous,1076,1085,O
to,1086,1088,O
crystalline,1089,1100,O
form,1101,1105,O
of,1106,1108,O
the,1109,1112,O
drug,1113,1117,O
.,1117,1118,O
Comparison,1119,1129,O
of,1130,1132,O
the,1133,1136,O
skin,1137,1141,B-Organ
permeation,1142,1152,O
profiles,1153,1161,O
of,1162,1164,O
amorphous,1165,1174,O
ketotifen,1175,1184,O
-,1184,1185,O
dispersed,1185,1194,O
matrices,1195,1203,O
between,1204,1211,O
two,1212,1215,O
different,1216,1225,O
drug,1226,1230,O
contents,1231,1239,O
suggested,1240,1249,O
that,1250,1254,O
the,1255,1258,O
steady,1259,1265,O
-,1265,1266,O
state,1266,1271,O
flux,1272,1276,O
was,1277,1280,O
not,1281,1284,O
influenced,1285,1295,O
by,1296,1298,O
the,1299,1302,O
drug,1303,1307,O
content,1308,1315,O
.,1315,1316,O
In,1317,1319,O
addition,1320,1328,O
",",1328,1329,O
at,1330,1332,O
both,1333,1337,O
drug,1338,1342,O
contents,1343,1351,O
",",1351,1352,O
the,1353,1356,O
period,1357,1363,O
of,1364,1366,O
the,1367,1370,O
steady,1371,1377,O
-,1377,1378,O
state,1378,1383,O
permeation,1384,1394,O
coincided,1395,1404,O
with,1405,1409,O
the,1410,1413,O
time,1414,1418,O
until,1419,1424,O
the,1425,1428,O
amorphous,1429,1438,O
drug,1439,1443,O
was,1444,1447,O
depleted,1448,1456,O
from,1457,1461,O
the,1462,1465,O
matrix,1466,1472,O
.,1472,1473,O
These,1474,1479,O
results,1480,1487,O
suggest,1488,1495,O
that,1496,1500,O
the,1501,1504,O
increase,1505,1513,O
in,1514,1516,O
skin,1517,1521,B-Organ
permeation,1522,1532,O
of,1533,1535,O
ketotifen,1536,1545,O
from,1546,1550,O
PSA,1551,1554,O
matrix,1555,1561,O
was,1562,1565,O
due,1566,1569,O
to,1570,1572,O
the,1573,1576,O
supersaturation,1577,1592,O
generated,1593,1602,O
by,1603,1605,O
amorphous,1606,1615,O
form,1616,1620,O
",",1620,1621,O
and,1622,1625,O
that,1626,1630,O
the,1631,1634,O
amorphous,1635,1644,O
form,1645,1649,O
was,1650,1653,O
stable,1654,1660,O
during,1661,1667,O
the,1668,1671,O
application,1672,1683,O
period,1684,1690,O
.,1690,1691,O
Polybrominated,0,14,O
diphenyl,15,23,O
ethers,24,30,O
in,31,33,O
indoor,34,40,O
dust,41,45,O
in,46,48,O
Ottawa,49,55,O
",",55,56,O
Canada,57,63,O
:,63,64,O
implications,65,77,O
for,78,81,O
sources,82,89,O
and,90,93,O
exposure,94,102,O
.,102,103,O
Polybrominated,104,118,O
diphenyl,119,127,O
ethers,128,134,O
(,135,136,O
PBDEs,136,141,O
),141,142,O
are,143,146,O
widely,147,153,O
used,154,158,O
as,159,161,O
additive,162,170,O
flame,171,176,O
retardants,177,187,O
in,188,190,O
plastics,191,199,O
",",199,200,O
soft,201,205,O
furnishings,206,217,O
",",217,218,O
electrical,219,229,O
and,230,233,O
electronic,234,244,O
equipment,245,254,O
",",254,255,O
and,256,259,O
insulation,260,270,O
in,271,273,O
the,274,277,O
indoor,278,284,O
environment,285,296,O
",",296,297,O
and,298,301,O
may,302,305,O
be,306,308,O
released,309,317,O
indoors,318,325,O
via,326,329,O
volatilization,330,344,O
or,345,347,O
as,348,350,O
dusts,351,356,O
.,356,357,O
The,358,361,O
penta,362,367,O
-,367,368,O
and,368,371,O
octa,372,376,O
-,376,377,O
brominated,377,387,O
mixes,388,393,O
are,394,397,O
now,398,401,O
banned,402,408,O
in,409,411,O
most,412,416,O
parts,417,422,O
of,423,425,O
Europe,426,432,O
",",432,433,O
and,434,437,O
phasing,438,445,O
out,446,449,O
of,450,452,O
their,453,458,O
use,459,462,O
has,463,466,O
recently,467,475,O
begun,476,481,O
in,482,484,O
North,485,490,O
America,491,498,O
.,498,499,O
This,500,504,O
study,505,510,O
follows,511,518,O
a,519,520,O
previous,521,529,O
investigation,530,543,O
into,544,548,O
indoor,549,555,O
air,556,559,O
levels,560,566,O
of,567,569,O
PBDEs,570,575,O
.,575,576,O
House,577,582,O
dust,583,587,O
was,588,591,O
analyzed,592,600,O
from,601,605,O
the,606,609,O
family,610,616,O
vacuum,617,623,O
cleaners,624,632,O
of,633,635,O
68,636,638,O
of,639,641,O
the,642,645,O
same,646,650,O
74,651,653,O
randomly,654,662,O
selected,663,671,O
homes,672,677,O
",",677,678,O
in,679,681,O
Ottawa,682,688,O
",",688,689,O
Canada,690,696,O
during,697,703,O
the,704,707,O
winter,708,714,O
of,715,717,O
2002,718,722,O
-,722,723,O
2003,723,727,O
.,727,728,O
PBDEs,729,734,O
",",734,735,O
comprising,736,746,O
on,747,749,O
average,750,757,O
42,758,760,O
%,760,761,O
BDE,762,765,O
-,765,766,O
209,766,769,O
",",769,770,O
were,771,775,O
found,776,781,O
in,782,784,O
all,785,788,O
samples,789,796,O
.,796,797,O
The,798,801,O
levels,802,808,O
were,809,813,O
log,814,817,O
-,817,818,O
normally,818,826,O
distributed,827,838,O
with,839,843,O
a,844,845,O
geometric,846,855,O
mean,856,860,O
sigmaPBDE,861,870,O
of,871,873,O
2000,874,878,O
ng,879,881,O
g,882,883,O
(,883,884,O
-,884,885,O
1,885,886,O
),886,887,O
",",887,888,O
and,889,892,O
a,893,894,O
median,895,901,O
of,902,904,O
1800,905,909,O
ng,910,912,O
g,913,914,O
(,914,915,O
-,915,916,O
1,916,917,O
),917,918,O
dust,919,923,O
.,923,924,O
The,925,928,O
levels,929,935,O
in,936,938,O
dust,939,943,O
did,944,947,O
not,948,951,O
correlate,952,961,O
with,962,966,O
questionnaire,967,980,O
information,981,992,O
on,993,995,O
house,996,1001,O
characteristics,1002,1017,O
.,1017,1018,O
Correlations,1019,1031,O
were,1032,1036,O
found,1037,1042,O
between,1043,1050,O
pentamix,1051,1059,O
congener,1060,1068,O
levels,1069,1075,O
in,1076,1078,O
dust,1079,1083,O
and,1084,1087,O
in,1088,1090,O
air,1091,1094,O
from,1095,1099,O
the,1100,1103,O
same,1104,1108,O
homes,1109,1114,O
",",1114,1115,O
but,1116,1119,O
not,1120,1123,O
for,1124,1127,O
congeners,1128,1137,O
of,1138,1140,O
the,1141,1144,O
more,1145,1149,O
highly,1150,1156,O
brominated,1157,1167,O
mixes,1168,1173,O
.,1173,1174,O
Exposure,1175,1183,O
scenarios,1184,1193,O
are,1194,1197,O
presented,1198,1207,O
for,1208,1211,O
mean,1212,1216,O
and,1217,1220,O
high,1221,1225,O
dust,1226,1230,O
ingestion,1231,1240,O
rates,1241,1246,O
",",1246,1247,O
and,1248,1251,O
compared,1252,1260,O
against,1261,1268,O
exposures,1269,1278,O
from,1279,1283,O
other,1284,1289,O
pathways,1290,1298,O
",",1298,1299,O
for,1300,1303,O
both,1304,1308,O
adults,1309,1315,O
and,1316,1319,O
toddlers,1320,1328,O
(,1329,1330,O
6,1330,1331,O
months,1332,1338,O
-,1338,1339,O
2,1339,1340,O
years,1341,1346,O
),1346,1347,O
.,1347,1348,O
Assuming,1349,1357,O
a,1358,1359,O
mean,1360,1364,O
dust,1365,1369,O
ingestion,1370,1379,O
rate,1380,1384,O
and,1385,1388,O
median,1389,1395,O
dust,1396,1400,O
and,1401,1404,O
air,1405,1408,O
concentrations,1409,1423,O
",",1423,1424,O
adults,1425,1431,O
would,1432,1437,O
be,1438,1440,O
exposed,1441,1448,O
to,1449,1451,O
ca,1452,1454,O
.,1454,1455,O
7,1456,1457,O
.,1457,1458,O
5,1458,1459,O
ng,1460,1462,O
sigmaPBDE,1463,1472,O
d,1473,1474,O
(,1474,1475,O
-,1475,1476,O
1,1476,1477,O
),1477,1478,O
via,1479,1482,O
the,1483,1486,O
dust,1487,1491,O
ingestion,1492,1501,O
pathway,1502,1509,O
",",1509,1510,O
which,1511,1516,O
represents,1517,1527,O
approximately,1528,1541,O
14,1542,1544,O
%,1544,1545,O
of,1546,1548,O
total,1549,1554,O
daily,1555,1560,O
exposure,1561,1569,O
when,1570,1574,O
compared,1575,1583,O
to,1584,1586,O
diet,1587,1591,O
(,1592,1593,O
82,1593,1595,O
%,1595,1596,O
),1596,1597,O
and,1598,1601,O
inhalation,1602,1612,O
(,1613,1614,O
4,1614,1615,O
%,1615,1616,O
),1616,1617,O
.,1617,1618,O
However,1619,1626,O
",",1626,1627,O
for,1628,1631,O
toddlers,1632,1640,O
the,1641,1644,O
equivalent,1645,1655,O
intakes,1656,1663,O
would,1664,1669,O
be,1670,1672,O
99,1673,1675,O
ng,1676,1678,O
d,1679,1680,O
(,1680,1681,O
-,1681,1682,O
1,1682,1683,O
),1683,1684,O
",",1684,1685,O
representing,1686,1698,O
80,1699,1701,O
%,1701,1702,O
of,1703,1705,O
their,1706,1711,O
daily,1712,1717,O
PBDE,1718,1722,O
exposure,1723,1731,O
.,1731,1732,O
At,1733,1735,O
high,1736,1740,O
dust,1741,1745,O
ingestion,1746,1755,O
rates,1756,1761,O
these,1762,1767,O
values,1768,1774,O
increase,1775,1783,O
to,1784,1786,O
180,1787,1790,O
ng,1791,1793,O
d,1794,1795,O
(,1795,1796,O
-,1796,1797,O
1,1797,1798,O
),1798,1799,O
(,1800,1801,O
80,1801,1803,O
%,1803,1804,O
daily,1805,1810,O
intake,1811,1817,O
),1817,1818,O
for,1819,1822,O
adults,1823,1829,O
and,1830,1833,O
360,1834,1837,O
ng,1838,1840,O
d,1841,1842,O
(,1842,1843,O
-,1843,1844,O
1,1844,1845,O
),1845,1846,O
(,1847,1848,O
89,1848,1850,O
%,1850,1851,O
daily,1852,1857,O
intake,1858,1864,O
),1864,1865,O
for,1866,1869,O
toddlers,1870,1878,O
.,1878,1879,O
The,1880,1883,O
data,1884,1888,O
give,1889,1893,O
a,1894,1895,O
clearer,1896,1903,O
picture,1904,1911,O
of,1912,1914,O
sources,1915,1922,O
of,1923,1925,O
PBDE,1926,1930,O
exposure,1931,1939,O
in,1940,1942,O
the,1943,1946,O
home,1947,1951,O
environment,1952,1963,O
and,1964,1967,O
suggest,1968,1975,O
that,1976,1980,O
dust,1981,1985,O
could,1986,1991,O
be,1992,1994,O
a,1995,1996,O
significant,1997,2008,O
exposure,2009,2017,O
pathway,2018,2025,O
for,2026,2029,O
some,2030,2034,O
individuals,2035,2046,O
",",2046,2047,O
particularly,2048,2060,O
children,2061,2069,O
.,2069,2070,O
Pathogenesis,0,12,O
of,13,15,O
thrombosis,16,26,O
in,27,29,O
essential,30,39,O
thrombocythemia,40,55,O
and,56,59,O
polycythemia,60,72,O
vera,73,77,O
:,77,78,O
the,79,82,O
role,83,87,O
of,88,90,O
neutrophils,91,102,B-Cell
.,102,103,O
Thrombotic,104,114,O
complications,115,128,O
are,129,132,O
frequently,133,143,O
observed,144,152,O
in,153,155,O
patients,156,164,O
with,165,169,O
polycythemia,170,182,O
vera,183,187,O
(,188,189,O
PV,189,191,O
),191,192,O
and,193,196,O
essential,197,206,O
thrombocythemia,207,222,O
(,223,224,O
ET,224,226,O
),226,227,O
.,227,228,O
Abnormalities,229,242,O
of,243,245,O
red,246,249,B-Cell
blood,250,255,I-Cell
cells,256,261,I-Cell
and,262,265,O
platelets,266,275,B-Cell
arising,276,283,O
from,284,288,O
the,289,292,O
clonal,293,299,O
rearrangement,300,313,O
of,314,316,O
hematopoietic,317,330,B-Cell
cells,331,336,I-Cell
have,337,341,O
been,342,346,O
considered,347,357,O
",",357,358,O
although,359,367,O
causal,368,374,O
relationships,375,388,O
between,389,396,O
any,397,400,O
of,401,403,O
these,404,409,O
specific,410,418,O
abnormalities,419,432,O
and,433,436,O
thrombosis,437,447,O
have,448,452,O
not,453,456,O
been,457,461,O
clearly,462,469,O
established,470,481,O
.,481,482,O
The,483,486,O
involvement,487,498,O
of,499,501,O
neutrophils,502,513,B-Cell
and,514,517,O
macrophages,518,529,B-Cell
",",529,530,O
which,531,536,O
participate,537,548,O
in,549,551,O
thrombosis,552,562,O
and,563,566,O
hemostasis,567,577,O
",",577,578,O
has,579,582,O
been,583,587,O
insufficiently,588,602,O
explored,603,611,O
in,612,614,O
PV,615,617,O
and,618,621,O
ET,622,624,O
.,624,625,O
Persistent,626,636,O
activation,637,647,O
of,648,650,O
circulating,651,662,O
neutrophils,663,674,B-Cell
was,675,678,O
recently,679,687,O
demonstrated,688,700,O
in,701,703,O
ET,704,706,O
and,707,710,O
PV,711,713,O
patients,714,722,O
",",722,723,O
in,724,726,O
parallel,727,735,O
with,736,740,O
an,741,743,O
increase,744,752,O
in,753,755,O
plasma,756,762,B-Organism_substance
concentrations,763,777,O
of,778,780,O
endothelial,781,792,B-Tissue
damage,793,799,O
-,799,800,O
derived,800,807,O
and,808,811,O
prothrombotic,812,825,O
substances,826,836,O
.,836,837,O
Other,838,843,O
studies,844,851,O
have,852,856,O
explored,857,865,O
whether,866,873,O
the,874,877,O
augmentation,878,890,O
of,891,893,O
adhesion,894,902,O
of,903,905,O
neutrophils,906,917,B-Cell
may,918,921,O
affect,922,928,O
neutrophil,929,939,B-Cell
/,939,940,O
platelet,940,948,B-Cell
interaction,949,960,O
since,961,966,O
a,967,968,O
significant,969,980,O
increase,981,989,O
in,990,992,O
circulating,993,1004,O
neutrophil,1005,1015,B-Cell
/,1015,1016,O
platelet,1016,1024,B-Cell
aggregates,1025,1035,O
is,1036,1038,O
found,1039,1044,O
in,1045,1047,O
ET,1048,1050,O
and,1051,1054,O
PV,1055,1057,O
.,1057,1058,O
This,1059,1063,O
review,1064,1070,O
summarizes,1071,1081,O
the,1082,1085,O
current,1086,1093,O
knowledge,1094,1103,O
of,1104,1106,O
the,1107,1110,O
pathogenesis,1111,1123,O
of,1124,1126,O
thrombosis,1127,1137,O
in,1138,1140,O
PV,1141,1143,O
and,1144,1147,O
ET,1148,1150,O
",",1150,1151,O
with,1152,1156,O
emphasis,1157,1165,O
on,1166,1168,O
the,1169,1172,O
role,1173,1177,O
of,1178,1180,O
neutrophils,1181,1192,B-Cell
in,1193,1195,O
hemostasis,1196,1206,O
and,1207,1210,O
their,1211,1216,O
possible,1217,1225,O
involvement,1226,1237,O
in,1238,1240,O
the,1241,1244,O
mechanisms,1245,1255,O
of,1256,1258,O
the,1259,1262,O
acquired,1263,1271,O
thrombophilia,1272,1285,O
of,1286,1288,O
these,1289,1294,O
patients,1295,1303,O
.,1303,1304,O
Available,1305,1314,O
data,1315,1319,O
suggest,1320,1327,O
that,1328,1332,O
these,1333,1338,O
hemostatic,1339,1349,O
markers,1350,1357,O
deserve,1358,1365,O
to,1366,1368,O
be,1369,1371,O
included,1372,1380,O
in,1381,1383,O
prospective,1384,1395,O
clinical,1396,1404,O
studies,1405,1412,O
aimed,1413,1418,O
at,1419,1421,O
identifying,1422,1433,O
their,1434,1439,O
predictive,1440,1450,O
role,1451,1455,O
in,1456,1458,O
the,1459,1462,O
vascular,1463,1471,B-Multi-tissue_structure
complications,1472,1485,O
of,1486,1488,O
patients,1489,1497,O
with,1498,1502,O
ET,1503,1505,O
and,1506,1509,O
PV,1510,1512,O
.,1512,1513,O
Sensitivity,0,11,O
variation,12,21,O
in,22,24,O
two,25,28,O
-,28,29,O
center,29,35,O
holographic,36,47,O
recording,48,57,O
.,57,58,O
An,59,61,O
experimental,62,74,O
study,75,80,O
of,81,83,O
variation,84,93,O
of,94,96,O
sensitivity,97,108,O
with,109,113,O
recording,114,123,O
and,124,127,O
sensitizing,128,139,O
intensities,140,151,O
in,152,154,O
two,155,158,O
-,158,159,O
center,159,165,O
recording,166,175,O
is,176,178,O
presented,179,188,O
.,188,189,O
The,190,193,O
experimental,194,206,O
results,207,214,O
are,215,218,O
in,219,221,O
good,222,226,O
agreement,227,236,O
with,237,241,O
the,242,245,O
theoretical,246,257,O
predictions,258,269,O
.,269,270,O
It,271,273,O
is,274,276,O
shown,277,282,O
experimentally,283,297,O
",",297,298,O
for,299,302,O
what,303,307,O
is,308,310,O
to,311,313,O
our,314,317,O
knowledge,318,327,O
the,328,331,O
first,332,337,O
time,338,342,O
",",342,343,O
that,344,348,O
the,349,352,O
sensitivity,353,364,O
is,365,367,O
a,368,369,O
function,370,378,O
of,379,381,O
the,382,385,O
ratio,386,391,O
of,392,394,O
recording,395,404,O
to,405,407,O
sensitizing,408,419,O
intensities,420,431,O
and,432,435,O
not,436,439,O
the,440,443,O
absolute,444,452,O
intensities,453,464,O
.,464,465,O
Also,466,470,O
",",470,471,O
the,472,475,O
ratio,476,481,O
of,482,484,O
recording,485,494,O
to,495,497,O
sensitizing,498,509,O
intensities,510,521,O
should,522,528,O
be,529,531,O
small,532,537,O
to,538,540,O
obtain,541,547,O
high,548,552,O
sensitivity,553,564,O
values,565,571,O
.,571,572,O
We,573,575,O
also,576,580,O
report,581,587,O
the,588,591,O
highest,592,599,O
sensitivity,600,611,O
(,612,613,O
S,613,614,O
=,614,615,O
0,615,616,O
.,616,617,O
15,617,619,O
cm,620,622,O
/,622,623,O
J,623,624,O
),624,625,O
that,626,630,O
has,631,634,O
been,635,639,O
achieved,640,648,O
to,649,651,O
date,652,656,O
for,657,660,O
a,661,662,O
LiNbO3,663,669,O
:,669,670,O
Fe,670,672,O
:,672,673,O
Mn,673,675,O
crystal,676,683,O
.,683,684,O
Recent,0,6,O
advances,7,15,O
in,16,18,O
minisatellite,19,32,O
biology,33,40,O
.,40,41,O
Highly,42,48,O
polymorphic,49,60,O
tandemly,61,69,O
repeated,70,78,O
',79,80,O
minisatellite,80,93,O
',93,94,O
loci,95,99,O
are,100,103,O
very,104,108,O
abundant,109,117,O
in,118,120,O
the,121,124,O
human,125,130,O
genome,131,137,O
",",137,138,O
and,139,142,O
of,143,145,O
considerable,146,158,O
utility,159,166,O
in,167,169,O
human,170,175,O
genetic,176,183,O
analysis,184,192,O
.,192,193,O
This,194,198,O
review,199,205,O
describes,206,215,O
the,216,219,O
use,220,223,O
of,224,226,O
an,227,229,O
ordered,230,237,O
-,237,238,O
array,238,243,O
Charomid,244,252,O
library,253,260,O
in,261,263,O
the,264,267,O
systematic,268,278,O
and,279,282,O
efficient,283,292,O
cloning,293,300,O
of,301,303,O
these,304,309,O
regions,310,317,O
",",317,318,O
and,319,322,O
in,323,325,O
the,326,329,O
analysis,330,338,O
of,339,341,O
the,342,345,O
relative,346,354,O
overlap,355,362,O
between,363,370,O
the,371,374,O
different,375,384,O
probes,385,391,O
used,392,396,O
to,397,399,O
screen,400,406,O
for,407,410,O
hypervariable,411,424,O
loci,425,429,O
.,429,430,O
Recent,431,437,O
work,438,442,O
on,443,445,O
the,446,449,O
process,450,457,O
of,458,460,O
mutation,461,469,O
leading,470,477,O
to,478,480,O
the,481,484,O
generation,485,495,O
of,496,498,O
new,499,502,O
-,502,503,O
length,503,509,O
alleles,510,517,O
is,518,520,O
also,521,525,O
discussed,526,535,O
",",535,536,O
including,537,546,O
the,547,550,O
observation,551,562,O
that,563,567,O
at,568,570,O
least,571,576,O
some,577,581,O
mutations,582,591,O
may,592,595,O
be,596,598,O
due,599,602,O
to,603,605,O
unequal,606,613,O
exchanges,614,623,O
.,623,624,O
The,0,3,O
ictal,4,9,O
bradycardia,10,21,O
syndrome,22,30,O
:,30,31,O
localization,32,44,O
and,45,48,O
lateralization,49,63,O
.,63,64,O
PURPOSE,65,72,O
:,72,73,O
Previous,74,82,O
studies,83,90,O
have,91,95,O
established,96,107,O
the,108,111,O
importance,112,122,O
of,123,125,O
the,126,129,O
insular,130,137,B-Multi-tissue_structure
cortex,138,144,I-Multi-tissue_structure
and,145,148,O
temporal,149,157,B-Multi-tissue_structure
lobe,158,162,I-Multi-tissue_structure
in,163,165,O
cardiovascular,166,180,B-Anatomical_system
autonomic,181,190,O
modulation,191,201,O
.,201,202,O
Some,203,207,O
investigators,208,221,O
",",221,222,O
based,223,228,O
on,229,231,O
the,232,235,O
results,236,243,O
of,244,246,O
cortical,247,255,B-Multi-tissue_structure
stimulation,256,267,O
response,268,276,O
",",276,277,O
functional,278,288,O
imaging,289,296,O
",",296,297,O
EEG,298,301,O
recordings,302,312,O
of,313,315,O
seizures,316,324,O
",",324,325,O
and,326,329,O
lesional,330,338,O
studies,339,346,O
",",346,347,O
have,348,352,O
suggested,353,362,O
that,363,367,O
cardiac,368,375,B-Organ
sympathetic,376,387,O
and,388,391,O
parasympathetic,392,407,O
function,408,416,O
may,417,420,O
be,421,423,O
lateralized,424,435,O
",",435,436,O
with,437,441,O
sympathetic,442,453,O
representation,454,468,O
lateralized,469,480,O
to,481,483,O
the,484,487,O
right,488,493,B-Multi-tissue_structure
insula,494,500,I-Multi-tissue_structure
",",500,501,O
and,502,505,O
parasympathetic,506,521,O
",",521,522,O
to,523,525,O
the,526,529,O
left,530,534,B-Multi-tissue_structure
.,534,535,O
These,536,541,O
studies,542,549,O
have,550,554,O
suggested,555,564,O
that,565,569,O
ictal,570,575,O
bradycardia,576,587,O
is,588,590,O
most,591,595,O
commonly,596,604,O
a,605,606,O
manifestation,607,620,O
of,621,623,O
activation,624,634,O
of,635,637,O
the,638,641,O
left,642,646,B-Multi-tissue_structure
temporal,647,655,I-Multi-tissue_structure
and,656,659,O
insular,660,667,B-Multi-tissue_structure
cortex,668,674,I-Multi-tissue_structure
.,674,675,O
However,676,683,O
",",683,684,O
the,685,688,O
evidence,689,697,O
for,698,701,O
this,702,706,O
is,707,709,O
inconsistent,710,722,O
.,722,723,O
We,724,726,O
sought,727,733,O
to,734,736,O
assess,737,743,O
critically,744,754,O
the,755,758,O
predictable,759,770,O
value,771,776,O
of,777,779,O
ictal,780,785,O
bradycardia,786,797,O
for,798,801,O
seizure,802,809,O
localization,810,822,O
and,823,826,O
lateralization,827,841,O
.,841,842,O
METHODS,843,850,O
:,850,851,O
In,852,854,O
this,855,859,O
study,860,865,O
",",865,866,O
we,867,869,O
reviewed,870,878,O
the,879,882,O
localization,883,895,O
of,896,898,O
seizure,899,906,O
activity,907,915,O
in,916,918,O
13,919,921,O
consecutive,922,933,O
patients,934,942,O
with,943,947,O
ictal,948,953,O
bradycardia,954,965,O
diagnosed,966,975,O
during,976,982,O
prolonged,983,992,O
video,993,998,O
-,998,999,O
EEG,999,1002,O
monitoring,1003,1013,O
at,1014,1016,O
Mayo,1017,1021,O
Clinic,1022,1028,O
Rochester,1029,1038,O
.,1038,1039,O
The,1040,1043,O
localization,1044,1056,O
of,1057,1059,O
electrographic,1060,1074,O
seizure,1075,1082,O
activity,1083,1091,O
at,1092,1094,O
seizure,1095,1102,O
onset,1103,1108,O
and,1109,1112,O
bradycardia,1113,1124,O
onset,1125,1130,O
was,1131,1134,O
identified,1135,1145,O
in,1146,1148,O
all,1149,1152,O
patients,1153,1161,O
.,1161,1162,O
In,1163,1165,O
addition,1166,1174,O
",",1174,1175,O
we,1176,1178,O
performed,1179,1188,O
a,1189,1190,O
comprehensive,1191,1204,O
review,1205,1211,O
of,1212,1214,O
the,1215,1218,O
ictal,1219,1224,O
bradycardia,1225,1236,O
literature,1237,1247,O
focusing,1248,1256,O
on,1257,1259,O
localization,1260,1272,O
of,1273,1275,O
seizure,1276,1283,O
activity,1284,1292,O
in,1293,1295,O
ictal,1296,1301,O
bradycardia,1302,1313,O
cases,1314,1319,O
.,1319,1320,O
RESULTS,1321,1328,O
:,1328,1329,O
All,1330,1333,O
occurrences,1334,1345,O
of,1346,1348,O
ictal,1349,1354,O
bradycardia,1355,1366,O
in,1367,1369,O
the,1370,1373,O
13,1374,1376,O
identified,1377,1387,O
patients,1388,1396,O
were,1397,1401,O
associated,1402,1412,O
with,1413,1417,O
temporal,1418,1426,O
lobe,1427,1431,O
-,1431,1432,O
onset,1432,1437,O
seizures,1438,1446,O
.,1446,1447,O
However,1448,1455,O
",",1455,1456,O
no,1457,1459,O
consistent,1460,1470,O
lateralization,1471,1485,O
of,1486,1488,O
seizure,1489,1496,O
activity,1497,1505,O
was,1506,1509,O
found,1510,1515,O
at,1516,1518,O
onset,1519,1524,O
of,1525,1527,O
seizure,1528,1535,O
activity,1536,1544,O
or,1545,1547,O
at,1548,1550,O
onset,1551,1556,O
of,1557,1559,O
bradycardia,1560,1571,O
in,1572,1574,O
this,1575,1579,O
population,1580,1590,O
.,1590,1591,O
Seizure,1592,1599,O
activity,1600,1608,O
was,1609,1612,O
bilateral,1613,1622,O
at,1623,1625,O
bradycardia,1626,1637,O
onset,1638,1643,O
in,1644,1646,O
nine,1647,1651,O
of,1652,1654,O
13,1655,1657,O
patients,1658,1666,O
.,1666,1667,O
The,1668,1671,O
results,1672,1679,O
from,1680,1684,O
the,1685,1688,O
literature,1689,1699,O
review,1700,1706,O
also,1707,1711,O
showed,1712,1718,O
that,1719,1723,O
a,1724,1725,O
predominance,1726,1738,O
of,1739,1741,O
patients,1742,1750,O
had,1751,1754,O
bilateral,1755,1764,O
activity,1765,1773,O
at,1774,1776,O
bradycardia,1777,1788,O
onset,1789,1794,O
;,1794,1795,O
however,1796,1803,O
",",1803,1804,O
more,1805,1809,O
of,1810,1812,O
the,1813,1816,O
ictal,1817,1822,O
bradycardia,1823,1834,O
cases,1835,1840,O
from,1841,1845,O
the,1846,1849,O
literature,1850,1860,O
had,1861,1864,O
left,1865,1869,B-Multi-tissue_structure
hemispheric,1870,1881,I-Multi-tissue_structure
localization,1882,1894,O
of,1895,1897,O
seizure,1898,1905,O
onset,1906,1911,O
.,1911,1912,O
CONCLUSIONS,1913,1924,O
:,1924,1925,O
Ictal,1926,1931,O
bradycardia,1932,1943,O
most,1944,1948,O
often,1949,1954,O
occurs,1955,1961,O
in,1962,1964,O
association,1965,1976,O
with,1977,1981,O
bilateral,1982,1991,O
hemispheric,1992,2003,O
seizure,2004,2011,O
activity,2012,2020,O
and,2021,2024,O
is,2025,2027,O
not,2028,2031,O
a,2032,2033,O
consistent,2034,2044,O
lateralizing,2045,2057,O
sign,2058,2062,O
in,2063,2065,O
localizing,2066,2076,O
seizure,2077,2084,O
onset,2085,2090,O
.,2090,2091,O
Our,2092,2095,O
data,2096,2100,O
do,2101,2103,O
not,2104,2107,O
support,2108,2115,O
the,2116,2119,O
existence,2120,2129,O
of,2130,2132,O
a,2133,2134,O
strictly,2135,2143,O
unilateral,2144,2154,O
parasympathetic,2155,2170,O
cardiomotor,2171,2182,O
representation,2183,2197,O
in,2198,2200,O
the,2201,2204,O
left,2205,2209,O
hemisphere,2210,2220,O
",",2220,2221,O
as,2222,2224,O
has,2225,2228,O
been,2229,2233,O
suggested,2234,2243,O
.,2243,2244,O
Dendrimer,0,9,O
-,9,10,O
templated,10,19,O
Fe,20,22,O
nanoparticles,23,36,O
for,37,40,O
the,41,44,O
growth,45,51,O
of,52,54,O
single,55,61,O
-,61,62,O
wall,62,66,O
carbon,67,73,O
nanotubes,74,83,O
by,84,86,O
plasma,87,93,O
-,93,94,O
enhanced,94,102,O
CVD,103,106,O
.,106,107,O
A,108,109,O
fourth,110,116,O
-,116,117,O
generation,117,127,O
(,128,129,O
G4,129,131,O
),131,132,O
poly,133,137,O
(,137,138,O
amidoamine,138,148,O
),148,149,O
(,150,151,O
PAMAM,151,156,O
),156,157,O
dendrimer,158,167,O
(,168,169,O
G4,169,171,O
-,171,172,O
NH2,172,175,O
),175,176,O
has,177,180,O
been,181,185,O
used,186,190,O
as,191,193,O
a,194,195,O
template,196,204,O
to,205,207,O
deliver,208,215,O
nearly,216,222,O
monodispersed,223,236,O
catalyst,237,245,O
nanoparticles,246,259,O
to,260,262,O
SiO2,263,267,O
/,267,268,O
Si,268,270,O
",",270,271,O
Ti,272,274,O
/,274,275,O
Si,275,277,O
",",277,278,O
sapphire,279,287,O
",",287,288,O
and,289,292,O
porous,293,299,O
anodic,300,306,O
alumina,307,314,O
(,315,316,O
PAA,316,319,O
),319,320,O
substrates,321,331,O
.,331,332,O
Fe2O3,333,338,O
nanoparticles,339,352,O
obtained,353,361,O
after,362,367,O
calcination,368,379,O
of,380,382,O
the,383,386,O
immobilized,387,398,O
Fe3,399,402,O
+,402,403,O
/,403,404,O
G4,404,406,O
-,406,407,O
NH2,407,410,O
composite,411,420,O
served,421,427,O
as,428,430,O
catalytic,431,440,O
"""",441,442,O
seeds,442,447,O
"""",447,448,O
for,449,452,O
the,453,456,O
growth,457,463,O
of,464,466,O
single,467,473,O
-,473,474,O
wall,474,478,O
carbon,479,485,O
nanotubes,486,495,O
(,496,497,O
SWNTs,497,502,O
),502,503,O
by,504,506,O
microwave,507,516,O
plasma,517,523,O
-,523,524,O
enhanced,524,532,O
CVD,533,536,O
(,537,538,O
PECVD,538,543,O
),543,544,O
.,544,545,O
To,546,548,O
surmount,549,557,O
the,558,561,O
difficulty,562,572,O
associated,573,583,O
with,584,588,O
SWNT,589,593,O
growth,594,600,O
via,601,604,O
PECVD,605,610,O
",",610,611,O
reaction,612,620,O
conditions,621,631,O
that,632,636,O
promote,637,644,O
the,645,648,O
stabilization,649,662,O
of,663,665,O
Fe,666,668,O
nanoparticles,669,682,O
",",682,683,O
resulting,684,693,O
in,694,696,O
enhanced,697,705,O
SWNT,706,710,O
selectivity,711,722,O
and,723,726,O
quality,727,734,O
",",734,735,O
have,736,740,O
been,741,745,O
identified,746,756,O
.,756,757,O
In,758,760,O
particular,761,771,O
",",771,772,O
in,773,775,O
situ,776,780,O
annealing,781,790,O
of,791,793,O
Fe,794,796,O
catalyst,797,805,O
in,806,808,O
an,809,811,O
N2,812,814,O
atmosphere,815,825,O
was,826,829,O
found,830,835,O
to,836,838,O
improve,839,846,O
SWNT,847,851,O
selectivity,852,863,O
and,864,867,O
quality,868,875,O
.,875,876,O
H2,877,879,O
prereduction,880,892,O
at,893,895,O
900,896,899,O
degrees,900,907,O
C,908,909,O
for,910,913,O
5,914,915,O
min,916,919,O
was,920,923,O
also,924,928,O
found,929,934,O
to,935,937,O
enhance,938,945,O
SWNT,946,950,O
selectivity,951,962,O
and,963,966,O
quality,967,974,O
for,975,978,O
SiO2,979,983,O
/,983,984,O
Si,984,986,O
supported,987,996,O
catalyst,997,1005,O
",",1005,1006,O
albeit,1007,1013,O
of,1014,1016,O
lower,1017,1022,O
quality,1023,1030,O
for,1031,1034,O
sapphire,1035,1043,O
supported,1044,1053,O
catalyst,1054,1062,O
.,1062,1063,O
The,1064,1067,O
application,1068,1079,O
of,1080,1082,O
positive,1083,1091,O
dc,1092,1094,O
bias,1095,1099,O
voltage,1100,1107,O
(,1108,1109,O
+,1109,1110,O
200,1110,1113,O
V,1114,1115,O
),1115,1116,O
during,1117,1123,O
SWNT,1124,1128,O
growth,1129,1135,O
was,1136,1139,O
shown,1140,1145,O
to,1146,1148,O
be,1149,1151,O
very,1152,1156,O
effective,1157,1166,O
in,1167,1169,O
removing,1170,1178,O
amorphous,1179,1188,O
carbon,1189,1195,O
impurities,1196,1206,O
while,1207,1212,O
enhancing,1213,1222,O
graphitization,1223,1237,O
",",1237,1238,O
SWNT,1239,1243,O
selectivity,1244,1255,O
",",1255,1256,O
and,1257,1260,O
vertical,1261,1269,O
alignment,1270,1279,O
.,1279,1280,O
The,1281,1284,O
results,1285,1292,O
of,1293,1295,O
this,1296,1300,O
study,1301,1306,O
should,1307,1313,O
promote,1314,1321,O
the,1322,1325,O
use,1326,1329,O
of,1330,1332,O
exposed,1333,1340,O
Fe,1341,1343,O
nanoparticles,1344,1357,O
supported,1358,1367,O
on,1368,1370,O
different,1371,1380,O
substrates,1381,1391,O
for,1392,1395,O
the,1396,1399,O
growth,1400,1406,O
of,1407,1409,O
high,1410,1414,O
-,1414,1415,O
quality,1415,1422,O
SWNTs,1423,1428,O
by,1429,1431,O
PECVD,1432,1437,O
.,1437,1438,O
Fluoro,0,6,O
-,6,7,O
Jade,7,11,O
B,12,13,O
staining,14,22,O
following,23,32,O
zymosan,33,40,O
microinjection,41,55,O
into,56,60,O
the,61,64,O
spinal,65,71,B-Multi-tissue_structure
cord,72,76,I-Multi-tissue_structure
white,77,82,I-Multi-tissue_structure
matter,83,89,I-Multi-tissue_structure
.,89,90,O
1,91,92,O
.,92,93,O
The,94,97,O
fluorescein,98,109,O
derivate,110,118,O
Fluoro,119,125,O
-,125,126,O
Jade,126,130,O
B,131,132,O
(,133,134,O
FJB,134,137,O
),137,138,O
",",138,139,O
which,140,145,O
primarily,146,155,O
labels,156,162,O
dead,163,167,O
or,168,170,O
dying,171,176,O
neurons,177,184,B-Cell
",",184,185,O
was,186,189,O
used,190,194,O
to,195,197,O
study,198,203,O
the,204,207,O
acute,208,213,O
focal,214,219,O
inflammation,220,232,O
in,233,235,O
the,236,239,O
spinal,240,246,B-Multi-tissue_structure
cord,247,251,I-Multi-tissue_structure
white,252,257,I-Multi-tissue_structure
matter,258,264,I-Multi-tissue_structure
.,264,265,O
Inflammation,266,278,O
was,279,282,O
induced,283,290,O
by,291,293,O
microinjection,294,308,O
of,309,311,O
the,312,315,O
yeast,316,321,O
particulate,322,333,O
zymosan,334,341,O
to,342,344,O
evaluate,345,353,O
the,354,357,O
biological,358,368,O
effects,369,376,O
of,377,379,O
intraspinal,380,391,B-Cell
macrophages,392,403,I-Cell
activation,404,414,O
without,415,422,O
the,423,426,O
confounding,427,438,O
effects,439,446,O
of,447,449,O
physical,450,458,O
trauma,459,465,O
.,465,466,O
2,467,468,O
.,468,469,O
A,470,471,O
single,472,478,O
bolus,479,484,O
of,485,487,O
zymosan,488,495,O
(,496,497,O
Sigma,497,502,O
",",502,503,O
75,504,506,O
nL,507,509,O
),509,510,O
was,511,514,O
stereotaxically,515,530,O
injected,531,539,O
at,540,542,O
the,543,546,O
thoracic,547,555,B-Multi-tissue_structure
level,556,561,O
into,562,566,O
the,567,570,O
lateral,571,578,B-Multi-tissue_structure
white,579,584,I-Multi-tissue_structure
matter,585,591,I-Multi-tissue_structure
of,592,594,O
rat,595,598,O
spinal,599,605,B-Organ
cord,606,610,I-Organ
.,610,611,O
A,612,613,O
standard,614,622,O
Fluoro,623,629,O
-,629,630,O
Jade,630,634,O
B,635,636,O
staining,637,645,O
protocol,646,654,O
was,655,658,O
applied,659,666,O
to,667,669,O
spinal,670,676,B-Organ
cord,677,681,I-Organ
sections,682,690,O
at,691,693,O
6,694,695,O
",",695,696,O
12,697,699,O
",",699,700,O
24,701,703,O
h,704,705,O
and,706,709,O
2,710,711,O
",",711,712,O
4,713,714,O
days,715,719,O
postinjection,720,733,O
.,733,734,O
Neutral,735,742,O
Red,743,746,O
",",746,747,O
NADPH,748,753,O
-,753,754,O
diaphorase,754,764,O
",",764,765,O
Iba1,766,770,O
-,770,771,O
IR,771,773,O
",",773,774,O
and,775,778,O
DAPI,779,783,O
staining,784,792,O
protocols,793,802,O
accomplished,803,815,O
examination,816,827,O
of,828,830,O
the,831,834,O
cells,835,840,B-Cell
participating,841,854,O
in,855,857,O
the,858,861,O
acute,862,867,O
inflammatory,868,880,O
response,881,889,O
.,889,890,O
3,891,892,O
.,892,893,O
Zymosan,894,901,O
caused,902,908,O
formation,909,918,O
of,919,921,O
clearly,922,929,O
delineated,930,940,O
inflammation,941,953,B-Pathological_formation
lesions,954,961,I-Pathological_formation
localized,962,971,O
in,972,974,O
the,975,978,O
lateral,979,986,B-Multi-tissue_structure
white,987,992,I-Multi-tissue_structure
matter,993,999,I-Multi-tissue_structure
of,1000,1002,O
the,1003,1006,O
spinal,1007,1013,B-Organ
cord,1014,1018,I-Organ
.,1018,1019,O
Fluoro,1020,1026,O
-,1026,1027,O
Jade,1027,1031,O
B,1032,1033,O
stained,1034,1041,O
cells,1042,1047,B-Cell
in,1048,1050,O
the,1051,1054,O
area,1055,1059,O
of,1060,1062,O
inflammation,1063,1075,B-Pathological_formation
were,1076,1080,O
not,1081,1084,O
observed,1085,1093,O
at,1094,1096,O
12,1097,1099,O
h,1100,1101,O
postinjection,1102,1115,O
while,1116,1121,O
mild,1122,1126,O
FJB,1127,1130,O
staining,1131,1139,O
appeared,1140,1148,O
at,1149,1151,O
24,1152,1154,O
h,1155,1156,O
and,1157,1160,O
intense,1161,1168,O
staining,1169,1177,O
was,1178,1181,O
observed,1182,1190,O
at,1191,1193,O
2,1194,1195,O
and,1196,1199,O
4,1200,1201,O
days,1202,1206,O
postinjection,1207,1220,O
.,1220,1221,O
4,1222,1223,O
.,1223,1224,O
This,1225,1229,O
study,1230,1235,O
shows,1236,1241,O
that,1242,1246,O
the,1247,1250,O
acute,1251,1256,O
response,1257,1265,O
to,1266,1268,O
zymosan,1269,1276,O
-,1276,1277,O
induced,1277,1284,O
inflammation,1285,1297,O
in,1298,1300,O
the,1301,1304,O
rat,1305,1308,O
spinal,1309,1315,B-Multi-tissue_structure
cord,1316,1320,I-Multi-tissue_structure
white,1321,1326,I-Multi-tissue_structure
matter,1327,1333,I-Multi-tissue_structure
causes,1334,1340,O
a,1341,1342,O
gradual,1343,1350,O
appearance,1351,1361,O
of,1362,1364,O
phagocytic,1365,1375,B-Cell
microglia,1376,1385,I-Cell
/,1385,1386,O
macrophages,1386,1397,B-Cell
and,1398,1401,O
delayed,1402,1409,O
FJB,1410,1413,O
staining,1414,1422,O
of,1423,1425,O
the,1426,1429,O
inflammatory,1430,1442,B-Cell
cells,1443,1448,I-Cell
.,1448,1449,O
5,1450,1451,O
.,1451,1452,O
FJB,1453,1456,O
",",1456,1457,O
a,1458,1459,O
reliable,1460,1468,O
marker,1469,1475,O
of,1476,1478,O
dying,1479,1484,O
neurons,1485,1492,B-Cell
",",1492,1493,O
is,1494,1496,O
a,1497,1498,O
more,1499,1503,O
universal,1504,1513,O
agent,1514,1519,O
than,1520,1524,O
formerly,1525,1533,O
believed,1534,1542,O
.,1542,1543,O
One,1544,1547,O
possible,1548,1556,O
explanation,1557,1568,O
for,1569,1572,O
the,1573,1576,O
gradual,1577,1584,O
appearance,1585,1595,O
of,1596,1598,O
FJB,1599,1602,O
-,1602,1603,O
stained,1603,1610,O
cells,1611,1616,B-Cell
in,1617,1619,O
the,1620,1623,O
area,1624,1628,O
of,1629,1631,O
inflammation,1632,1644,B-Pathological_formation
is,1645,1647,O
that,1648,1652,O
specific,1653,1661,O
time,1662,1666,O
is,1667,1669,O
required,1670,1678,O
for,1679,1682,O
sufficient,1683,1693,O
levels,1694,1700,O
of,1701,1703,O
proteins,1704,1712,O
and,1713,1716,O
/,1716,1717,O
or,1717,1719,O
myelin,1720,1726,O
debris,1727,1733,O
of,1734,1736,O
axonal,1737,1743,O
origin,1744,1750,O
to,1751,1753,O
appear,1754,1760,O
in,1761,1763,O
the,1764,1767,O
cytoplasm,1768,1777,B-Organism_substance
of,1778,1780,O
phagocytic,1781,1791,B-Cell
microglia,1792,1801,I-Cell
/,1801,1802,O
macrophages,1802,1813,B-Cell
.,1813,1814,O
Changes,0,7,O
of,8,10,O
lymphocyte,11,21,B-Cell
subsets,22,29,O
in,30,32,O
leukemia,33,41,O
patients,42,50,O
who,51,54,O
received,55,63,O
allogenic,64,73,O
bone,74,78,B-Multi-tissue_structure
marrow,79,85,I-Multi-tissue_structure
transplantation,86,101,O
.,101,102,O
Proportional,103,115,O
changes,116,123,O
of,124,126,O
lymphocyte,127,137,B-Cell
subsets,138,145,O
in,146,148,O
the,149,152,O
peripheral,153,163,B-Organism_substance
blood,164,169,I-Organism_substance
were,170,174,O
monitored,175,184,O
by,185,187,O
two,188,191,O
-,191,192,O
color,192,197,O
flow,198,202,O
-,202,203,O
cytometry,203,212,O
in,213,215,O
seven,216,221,O
leukemia,222,230,O
patients,231,239,O
who,240,243,O
had,244,247,O
received,248,256,O
allogenic,257,266,O
bone,267,271,B-Multi-tissue_structure
marrow,272,278,I-Multi-tissue_structure
transplantation,279,294,O
(,295,296,O
BMT,296,299,O
),299,300,O
.,300,301,O
Lymphocyte,302,312,B-Cell
counts,313,319,O
",",319,320,O
and,321,324,O
proportions,325,336,O
of,337,339,O
T,340,341,B-Cell
and,342,345,O
B,346,347,B-Cell
-,347,348,I-Cell
cells,348,353,I-Cell
returned,354,362,O
to,363,365,O
normal,366,372,O
ranges,373,379,O
between,380,387,O
the,388,391,O
2nd,392,395,O
and,396,399,O
12th,400,404,O
months,405,411,O
after,412,417,O
BMT,418,421,O
.,421,422,O
Activated,423,432,O
T,433,434,B-Cell
-,434,435,I-Cell
cells,435,440,I-Cell
prominently,441,452,O
increased,453,462,O
after,463,468,O
BMT,469,472,O
",",472,473,O
and,474,477,O
the,478,481,O
values,482,488,O
gradually,489,498,O
returned,499,507,O
toward,508,514,O
normal,515,521,O
.,521,522,O
As,523,525,O
to,526,528,O
lymphocyte,529,539,B-Cell
subsets,540,547,O
",",547,548,O
the,549,552,O
proportions,553,564,O
of,565,567,O
CD,568,570,B-Cell
4,571,572,I-Cell
+,572,573,I-Cell
cells,574,579,I-Cell
had,580,583,O
remained,584,592,O
low,593,596,O
",",596,597,O
while,598,603,O
those,604,609,O
of,610,612,O
CD,613,615,B-Cell
8,616,617,I-Cell
+,617,618,I-Cell
cells,619,624,I-Cell
high,625,629,O
for,630,633,O
a,634,635,O
whole,636,641,O
observation,642,653,O
period,654,660,O
after,661,666,O
BMT,667,670,O
.,670,671,O
The,672,675,O
changes,676,683,O
of,684,686,O
CD,687,689,B-Cell
4,690,691,I-Cell
+,691,692,I-Cell
cells,693,698,I-Cell
were,699,703,O
caused,704,710,O
by,711,713,O
the,714,717,O
decrease,718,726,O
of,727,729,O
suppressor,730,740,B-Cell
-,740,741,I-Cell
inducer,741,748,I-Cell
T,749,750,I-Cell
-,750,751,I-Cell
cells,751,756,I-Cell
(,757,758,O
CD,758,760,O
4,761,762,O
+,762,763,O
Leu,764,767,O
8,768,769,O
+,769,770,O
),770,771,O
.,771,772,O
High,773,777,O
proportion,778,788,O
of,789,791,O
CD,792,794,B-Cell
8,795,796,I-Cell
+,796,797,I-Cell
cells,798,803,I-Cell
was,804,807,O
mainly,808,814,O
associated,815,825,O
with,826,830,O
increased,831,840,O
suppressor,841,851,B-Cell
T,852,853,I-Cell
-,853,854,I-Cell
cells,854,859,I-Cell
(,860,861,O
CD,861,863,O
8,864,865,O
+,865,866,O
CD,867,869,O
11,870,872,O
+,872,873,O
),873,874,O
.,874,875,O
Among,876,881,O
natural,882,889,B-Cell
killer,890,896,I-Cell
(,897,898,I-Cell
NK,898,900,I-Cell
),900,901,I-Cell
cells,902,907,I-Cell
",",907,908,O
highly,909,915,O
active,916,922,O
NK,923,925,B-Cell
cells,926,931,I-Cell
(,932,933,O
CD,933,935,O
16,936,938,O
+,938,939,O
CD,940,942,O
57,943,945,O
-,945,946,O
),946,947,O
markedly,948,956,O
increased,957,966,O
shortly,967,974,O
after,975,980,O
BMT,981,984,O
",",984,985,O
and,986,989,O
gradually,990,999,O
returned,1000,1008,O
to,1009,1011,O
normal,1012,1018,O
.,1018,1019,O
CD,1020,1022,B-Cell
16,1023,1025,I-Cell
-,1026,1027,I-Cell
CD,1027,1029,I-Cell
57,1030,1032,I-Cell
+,1032,1033,I-Cell
NK,1034,1036,I-Cell
cells,1037,1042,I-Cell
increased,1043,1052,O
beyond,1053,1059,O
normal,1060,1066,O
ranges,1067,1073,O
after,1074,1079,O
the,1080,1083,O
2nd,1084,1087,O
month,1088,1093,O
.,1093,1094,O
The,1095,1098,O
incidence,1099,1108,O
or,1109,1111,O
degree,1112,1118,O
of,1119,1121,O
acute,1122,1127,O
and,1128,1131,O
chronic,1132,1139,O
graft,1140,1145,B-Multi-tissue_structure
-,1145,1146,O
versus,1146,1152,O
-,1152,1153,O
host,1153,1157,O
diseases,1158,1166,O
(,1167,1168,O
GVHD,1168,1172,O
),1172,1173,O
did,1174,1177,O
not,1178,1181,O
correlate,1182,1191,O
with,1192,1196,O
the,1197,1200,O
changes,1201,1208,O
of,1209,1211,O
any,1212,1215,O
lymphocyte,1216,1226,B-Cell
subsets,1227,1234,O
.,1234,1235,O
The,1236,1239,O
present,1240,1247,O
results,1248,1255,O
suggest,1256,1263,O
that,1264,1268,O
the,1269,1272,O
increase,1273,1281,O
of,1282,1284,O
activated,1285,1294,O
T,1295,1296,B-Cell
-,1296,1297,I-Cell
cells,1297,1302,I-Cell
shortly,1303,1310,O
after,1311,1316,O
BMT,1317,1320,O
reflects,1321,1329,O
lymphocyte,1330,1340,B-Cell
reconstitution,1341,1355,O
.,1355,1356,O
The,1357,1360,O
prolonged,1361,1370,O
immune,1371,1377,O
deficiency,1378,1388,O
after,1389,1394,O
BMT,1395,1398,O
might,1399,1404,O
be,1405,1407,O
related,1408,1415,O
to,1416,1418,O
either,1419,1425,O
deficient,1426,1435,O
expression,1436,1446,O
of,1447,1449,O
homing,1450,1456,O
receptor,1457,1465,O
(,1466,1467,O
Leu,1467,1470,O
8,1471,1472,O
antigen,1473,1480,O
),1480,1481,O
on,1482,1484,O
CD,1485,1487,B-Cell
4,1488,1489,I-Cell
+,1489,1490,I-Cell
cells,1491,1496,I-Cell
or,1497,1499,O
increased,1500,1509,O
suppressor,1510,1520,B-Cell
T,1521,1522,I-Cell
-,1522,1523,I-Cell
cells,1523,1528,I-Cell
(,1529,1530,O
CD,1530,1532,O
8,1533,1534,O
+,1534,1535,O
CD,1536,1538,O
11,1539,1541,O
+,1541,1542,O
),1542,1543,O
.,1543,1544,O
In,1545,1547,O
addition,1548,1556,O
",",1556,1557,O
the,1558,1561,O
early,1562,1567,O
increase,1568,1576,O
of,1577,1579,O
NK,1580,1582,B-Cell
cells,1583,1588,I-Cell
after,1589,1594,O
BMT,1595,1598,O
may,1599,1602,O
compensate,1603,1613,O
for,1614,1617,O
the,1618,1621,O
immune,1622,1628,O
deficiency,1629,1639,O
in,1640,1642,O
BMT,1643,1646,O
patients,1647,1655,O
.,1655,1656,O
Fluoroscopically,0,16,O
guided,17,23,O
cervical,24,32,B-Organism_subdivision
prolotherapy,33,45,O
for,46,49,O
instability,50,61,O
with,62,66,O
blinded,67,74,O
pre,75,78,O
and,79,82,O
post,83,87,O
radiographic,88,100,O
reading,101,108,O
.,108,109,O
BACKGROUND,110,120,O
:,120,121,O
Several,122,129,O
authors,130,137,O
have,138,142,O
postulated,143,153,O
that,154,158,O
cervical,159,167,B-Organism_subdivision
instability,168,179,O
is,180,182,O
a,183,184,O
major,185,190,O
cause,191,196,O
of,197,199,O
traumatic,200,209,O
spinal,210,216,B-Organism_subdivision
pain,217,221,O
.,221,222,O
OBJECTIVE,223,232,O
:,232,233,O
The,234,237,O
purpose,238,245,O
of,246,248,O
this,249,253,O
prospective,254,265,O
case,266,270,O
series,271,277,O
study,278,283,O
(,284,285,O
n,285,286,O
=,287,288,O
6,289,290,O
),290,291,O
was,292,295,O
to,296,298,O
determine,299,308,O
if,309,311,O
proliferant,312,323,O
injections,324,334,O
have,335,339,O
an,340,342,O
effect,343,349,O
on,350,352,O
cervical,353,361,B-Organism_subdivision
translation,362,373,O
as,374,376,O
measured,377,385,O
by,386,388,O
a,389,390,O
blinded,391,398,O
reader,399,405,O
.,405,406,O
DESIGN,407,413,O
:,413,414,O
This,415,419,O
study,420,425,O
was,426,429,O
a,430,431,O
prospective,432,443,O
case,444,448,O
series,449,455,O
.,455,456,O
Study,457,462,O
participants,463,475,O
were,476,480,O
selected,481,489,O
from,490,494,O
patients,495,503,O
seen,504,508,O
for,509,512,O
the,513,516,O
primary,517,524,O
complaint,525,534,O
of,535,537,O
Motor,538,543,O
Vehicle,544,551,O
Collision,552,561,O
related,562,569,O
neck,570,574,B-Organism_subdivision
pain,575,579,O
in,580,582,O
a,583,584,O
private,585,592,O
sub,593,596,O
-,596,597,O
specialty,597,606,O
pain,607,611,O
clinic,612,618,O
.,618,619,O
METHODS,620,627,O
:,627,628,O
Flexion,629,636,O
and,637,640,O
extension,641,650,O
views,651,656,O
were,657,661,O
obtained,662,670,O
by,671,673,O
standard,674,682,O
radiographs,683,694,O
taken,695,700,O
with,701,705,O
a,706,707,O
C,708,709,O
-,709,710,O
Arm,710,713,O
fluoroscope,714,725,O
under,726,731,O
Valium,732,738,O
sedation,739,747,O
.,747,748,O
Patients,749,757,O
with,758,762,O
more,763,767,O
than,768,772,O
2,773,774,O
.,774,775,O
7,775,776,O
mm,777,779,O
of,780,782,O
absolute,783,791,O
cervical,792,800,B-Organism_subdivision
translation,801,812,O
and,813,816,O
at,817,819,O
least,820,825,O
50,826,828,O
%,828,829,O
reduction,830,839,O
of,840,842,O
cervical,843,851,B-Organism_subdivision
and,852,855,O
referred,856,864,O
pain,865,869,O
with,870,874,O
a,875,876,O
two,877,880,O
day,881,884,O
rigid,885,890,O
cervical,891,899,B-Organism_subdivision
immobilization,900,914,O
test,915,919,O
were,920,924,O
admitted,925,933,O
into,934,938,O
the,939,942,O
study,943,948,O
.,948,949,O
Participants,950,962,O
underwent,963,972,O
3,973,974,O
prolotherapy,975,987,O
injections,988,998,O
at,999,1001,O
all,1002,1005,O
sites,1006,1011,O
that,1012,1016,O
demonstrated,1017,1029,O
translation,1030,1041,O
.,1041,1042,O
The,1043,1046,O
difference,1047,1057,O
in,1058,1060,O
means,1061,1066,O
between,1067,1074,O
pre,1075,1078,O
-,1078,1079,O
test,1079,1083,O
and,1084,1087,O
post,1088,1092,O
-,1092,1093,O
test,1093,1097,O
measurements,1098,1110,O
(,1111,1112,O
flexion,1112,1119,O
translation,1120,1131,O
",",1131,1132,O
extension,1133,1142,O
translation,1143,1154,O
",",1154,1155,O
and,1156,1159,O
pain,1160,1164,O
VAS,1165,1168,O
scores,1169,1175,O
),1175,1176,O
were,1177,1181,O
assessed,1182,1190,O
by,1191,1193,O
a,1194,1195,O
Wilcoxon,1196,1204,O
signed,1205,1211,O
ranks,1212,1217,O
test,1218,1222,O
(,1223,1224,O
alpha,1224,1229,O
=,1230,1231,O
0,1232,1233,O
.,1233,1234,O
05,1234,1236,O
),1236,1237,O
.,1237,1238,O
RESULTS,1239,1246,O
:,1246,1247,O
The,1248,1251,O
mean,1252,1256,O
post,1257,1261,O
-,1261,1262,O
test,1262,1266,O
VAS,1267,1270,O
score,1271,1276,O
(,1277,1278,O
M,1278,1279,O
=,1279,1280,O
3,1281,1282,O
.,1282,1283,O
83,1283,1285,O
",",1285,1286,O
SD,1287,1289,O
=,1289,1290,O
2,1290,1291,O
.,1291,1292,O
3,1292,1293,O
",",1293,1294,O
t,1295,1296,O
=,1296,1297,O
2,1297,1298,O
.,1298,1299,O
889,1299,1302,O
),1302,1303,O
was,1304,1307,O
significantly,1308,1321,O
less,1322,1326,O
(,1327,1328,O
p,1328,1329,O
=,1329,1330,O
0,1330,1331,O
.,1331,1332,O
04,1332,1334,O
),1334,1335,O
than,1336,1340,O
the,1341,1344,O
mean,1345,1349,O
pre,1350,1353,O
-,1353,1354,O
test,1354,1358,O
VAS,1359,1362,O
score,1363,1368,O
(,1369,1370,O
M,1370,1371,O
=,1371,1372,O
5,1372,1373,O
.,1373,1374,O
75,1374,1376,O
",",1376,1377,O
SD,1378,1380,O
=,1380,1381,O
1,1381,1382,O
.,1382,1383,O
94,1383,1385,O
),1385,1386,O
.,1386,1387,O
The,1388,1391,O
correlation,1392,1403,O
between,1404,1411,O
difference,1412,1422,O
in,1423,1425,O
mean,1426,1430,O
extension,1431,1440,O
at,1441,1443,O
C2,1444,1446,O
-,1446,1447,O
3,1447,1448,O
and,1449,1452,O
C5,1453,1455,O
-,1455,1456,O
6,1456,1457,O
and,1458,1461,O
difference,1462,1472,O
in,1473,1475,O
mean,1476,1480,O
extension,1481,1490,O
was,1491,1494,O
significant,1495,1506,O
(,1507,1508,O
rho,1508,1511,O
=,1511,1512,O
0,1512,1513,O
.,1513,1514,O
89,1514,1516,O
",",1516,1517,O
p,1518,1519,O
=,1519,1520,O
0,1520,1521,O
.,1521,1522,O
02,1522,1524,O
and,1525,1528,O
rho,1529,1532,O
=,1532,1533,O
0,1533,1534,O
.,1534,1535,O
85,1535,1537,O
",",1537,1538,O
p,1539,1540,O
=,1540,1541,O
0,1541,1542,O
.,1542,1543,O
03,1543,1545,O
respectively,1546,1558,O
),1558,1559,O
.,1559,1560,O
Difference,1561,1571,O
in,1572,1574,O
mean,1575,1579,O
flexion,1580,1587,O
at,1588,1590,O
C3,1591,1593,O
-,1593,1594,O
4,1594,1595,O
and,1596,1599,O
C4,1600,1602,O
-,1602,1603,O
5,1603,1604,O
was,1605,1608,O
significantly,1609,1622,O
correlated,1623,1633,O
with,1634,1638,O
difference,1639,1649,O
in,1650,1652,O
mean,1653,1657,O
flexion,1658,1665,O
(,1666,1667,O
rho,1667,1670,O
=,1670,1671,O
0,1671,1672,O
.,1672,1673,O
88,1673,1675,O
",",1675,1676,O
p,1677,1678,O
=,1678,1679,O
0,1679,1680,O
.,1680,1681,O
02,1681,1683,O
and,1684,1687,O
rho,1688,1691,O
=,1691,1692,O
0,1692,1693,O
.,1693,1694,O
941,1694,1697,O
",",1697,1698,O
p,1699,1700,O
<,1701,1702,O
0,1702,1703,O
.,1703,1704,O
01,1704,1706,O
respectively,1707,1719,O
),1719,1720,O
.,1720,1721,O
CONCLUSIONS,1722,1733,O
:,1733,1734,O
The,1735,1738,O
results,1739,1746,O
of,1747,1749,O
this,1750,1754,O
study,1755,1760,O
demonstrate,1761,1772,O
statistically,1773,1786,O
significant,1787,1798,O
correlations,1799,1811,O
between,1812,1819,O
proliferant,1820,1831,O
injections,1832,1842,O
",",1842,1843,O
a,1844,1845,O
reduction,1846,1855,O
of,1856,1858,O
both,1859,1863,O
cervical,1864,1872,B-Organism_subdivision
flexion,1873,1880,O
and,1881,1884,O
extension,1885,1894,O
translation,1895,1906,O
",",1906,1907,O
as,1908,1910,O
well,1911,1915,O
as,1916,1918,O
a,1919,1920,O
reduction,1921,1930,O
in,1931,1933,O
pain,1934,1938,O
VAS,1939,1942,O
score,1943,1948,O
.,1948,1949,O
Since,1950,1955,O
patients,1956,1964,O
with,1965,1969,O
traumatic,1970,1979,O
cervical,1980,1988,B-Organism_subdivision
instability,1989,2000,O
have,2001,2005,O
few,2006,2009,O
viable,2010,2016,O
treatment,2017,2026,O
options,2027,2034,O
other,2035,2040,O
than,2041,2045,O
surgical,2046,2054,O
fusion,2055,2061,O
",",2061,2062,O
cervical,2063,2071,B-Organism_subdivision
proliferant,2072,2083,O
injections,2084,2094,O
under,2095,2100,O
C,2101,2102,O
-,2102,2103,O
Arm,2103,2106,O
fluoroscope,2107,2118,O
may,2119,2122,O
be,2123,2125,O
a,2126,2127,O
viable,2128,2134,O
treatment,2135,2144,O
option,2145,2151,O
.,2151,2152,O
[,0,1,O
The,1,4,O
prevalence,5,15,O
of,16,18,O
ADHD,19,23,O
and,24,27,O
attention,28,37,O
problems,38,46,O
in,47,49,O
preschool,50,59,O
-,59,60,O
aged,60,64,O
children,65,73,O
.,73,74,O
A,75,76,O
comparison,77,87,O
of,88,90,O
two,91,94,O
diagnostic,95,105,O
instruments,106,117,O
],117,118,O
.,118,119,O
OBJECTIVES,120,130,O
:,130,131,O
In,132,134,O
order,135,140,O
to,141,143,O
analyse,144,151,O
the,152,155,O
prevalence,156,166,O
of,167,169,O
ADHD,170,174,O
and,175,178,O
attention,179,188,O
problems,189,197,O
in,198,200,O
preschool,201,210,O
-,210,211,O
aged,211,215,O
children,216,224,O
",",224,225,O
mothers,226,233,O
were,234,238,O
asked,239,244,O
to,245,247,O
rate,248,252,O
their,253,258,O
children,259,267,O
using,268,273,O
two,274,277,O
measuring,278,287,O
instruments,288,299,O
.,299,300,O
METHODS,301,308,O
:,308,309,O
The,310,313,O
analysis,314,322,O
is,323,325,O
part,326,330,O
of,331,333,O
a,334,335,O
prospective,336,347,O
",",347,348,O
randomised,349,359,O
control,360,367,O
study,368,373,O
of,374,376,O
N,377,378,O
=,379,380,O
280,381,384,O
children,385,393,O
aged,394,398,O
three,399,404,O
to,405,407,O
six,408,411,O
years,412,417,O
",",417,418,O
whose,419,424,O
mothers,425,432,O
rated,433,438,O
them,439,443,O
using,444,449,O
the,450,453,O
Child,454,459,O
Behaviour,460,469,O
Checklist,470,479,O
/,479,480,O
CBCL,480,484,O
1,485,486,O
1,487,488,O
/,488,489,O
2,489,490,O
-,490,491,O
5,491,492,O
and,493,496,O
the,497,500,O
Parent,501,507,O
Rating,508,514,O
Scale,515,520,O
for,521,524,O
Attention,525,534,O
-,534,535,O
Deficit,535,542,O
Hyperactivity,543,556,O
Disorder,557,565,O
(,566,567,O
ADHD,567,571,O
),571,572,O
.,572,573,O
RESULTS,574,581,O
:,581,582,O
The,583,586,O
prevalence,587,597,O
rates,598,603,O
ranged,604,610,O
from,611,615,O
2,616,617,O
.,617,618,O
7,618,619,O
%,619,620,O
to,621,623,O
9,624,625,O
.,625,626,O
9,626,627,O
%,627,628,O
.,628,629,O
There,630,635,O
was,636,639,O
no,640,642,O
significant,643,654,O
gender,655,661,O
effect,662,668,O
in,669,671,O
this,672,676,O
age,677,680,O
group,681,686,O
.,686,687,O
CONCLUSIONS,688,699,O
:,699,700,O
The,701,704,O
study,705,710,O
delivers,711,719,O
initial,720,727,O
findings,728,736,O
and,737,740,O
provides,741,749,O
support,750,757,O
for,758,761,O
decisions,762,771,O
to,772,774,O
implement,775,784,O
in,785,787,O
Germany,788,795,O
new,796,799,O
assessment,800,810,O
methods,811,818,O
for,819,822,O
preschool,823,832,O
-,832,833,O
aged,833,837,O
children,838,846,O
with,847,851,O
ADHD,852,856,O
or,857,859,O
hyperkinetic,860,872,O
syndrome,873,881,O
.,881,882,O
Finally,883,890,O
",",890,891,O
the,892,895,O
different,896,905,O
rates,906,911,O
of,912,914,O
prevalence,915,925,O
and,926,929,O
the,930,933,O
implications,934,946,O
of,947,949,O
the,950,953,O
findings,954,962,O
for,963,966,O
epidemiology,967,979,O
and,980,983,O
the,984,987,O
prevention,988,998,O
of,999,1001,O
ADHD,1002,1006,O
and,1007,1010,O
attention,1011,1020,O
problems,1021,1029,O
among,1030,1035,O
preschool,1036,1045,O
-,1045,1046,O
aged,1046,1050,O
children,1051,1059,O
are,1060,1063,O
discussed,1064,1073,O
.,1073,1074,O
Medical,0,7,O
adherence,8,17,O
and,18,21,O
childhood,22,31,O
chronic,32,39,O
illness,40,47,O
:,47,48,O
family,49,55,O
daily,56,61,O
management,62,72,O
skills,73,79,O
and,80,83,O
emotional,84,93,O
climate,94,101,O
as,102,104,O
emerging,105,113,O
contributors,114,126,O
.,126,127,O
PURPOSE,128,135,O
OF,136,138,O
REVIEW,139,145,O
:,145,146,O
To,147,149,O
describe,150,158,O
recent,159,165,O
research,166,174,O
that,175,179,O
examines,180,188,O
family,189,195,O
factors,196,203,O
that,204,208,O
promote,209,216,O
or,217,219,O
derail,220,226,O
adherence,227,236,O
to,237,239,O
medical,240,247,O
regimens,248,256,O
for,257,260,O
children,261,269,O
with,270,274,O
chronic,275,282,O
health,283,289,O
conditions,290,300,O
",",300,301,O
primarily,302,311,O
asthma,312,318,O
",",318,319,O
diabetes,320,328,O
",",328,329,O
and,330,333,O
cystic,334,340,O
fibrosis,341,349,O
.,349,350,O
From,351,355,O
the,356,359,O
past,360,364,O
2,365,366,O
years,367,372,O
",",372,373,O
eight,374,379,O
correlational,380,393,O
studies,394,401,O
were,402,406,O
identified,407,417,O
which,418,423,O
specifically,424,436,O
examined,437,445,O
the,446,449,O
links,450,455,O
between,456,463,O
family,464,470,O
management,471,481,O
strategies,482,492,O
",",492,493,O
family,494,500,O
climate,501,508,O
and,509,512,O
medical,513,520,O
adherence,521,530,O
.,530,531,O
RECENT,532,538,O
FINDINGS,539,547,O
:,547,548,O
Findings,549,557,O
from,558,562,O
the,563,566,O
studies,567,574,O
suggest,575,582,O
that,583,587,O
team,588,592,O
-,592,593,O
based,593,598,O
management,599,609,O
strategies,610,620,O
and,621,624,O
cohesive,625,633,O
family,634,640,O
climate,641,648,O
promote,649,656,O
adherence,657,666,O
to,667,669,O
medical,670,677,O
treatments,678,688,O
over,689,693,O
time,694,698,O
.,698,699,O
Family,700,706,O
interactions,707,719,O
that,720,724,O
are,725,728,O
characterized,729,742,O
by,743,745,O
conflict,746,754,O
and,755,758,O
disengagement,759,772,O
tend,773,777,O
to,778,780,O
disrupt,781,788,O
adherence,789,798,O
and,799,802,O
inevitably,803,813,O
cause,814,819,O
a,820,821,O
decline,822,829,O
in,830,832,O
child,833,838,O
health,839,845,O
.,845,846,O
Moreover,847,855,O
",",855,856,O
these,857,862,O
findings,863,871,O
seem,872,876,O
to,877,879,O
be,880,882,O
moderated,883,892,O
by,893,895,O
child,896,901,O
age,902,905,O
in,906,908,O
that,909,913,O
poorer,914,920,O
adherence,921,930,O
often,931,936,O
occurs,937,943,O
when,944,948,O
a,949,950,O
child,951,956,O
reaches,957,964,O
adolescence,965,976,O
and,977,980,O
is,981,983,O
searching,984,993,O
for,994,997,O
greater,998,1005,O
autonomy,1006,1014,O
.,1014,1015,O
SUMMARY,1016,1023,O
:,1023,1024,O
Future,1025,1031,O
research,1032,1040,O
should,1041,1047,O
consider,1048,1056,O
the,1057,1060,O
challenges,1061,1071,O
in,1072,1074,O
measuring,1075,1084,O
medical,1085,1092,O
adherence,1093,1102,O
in,1103,1105,O
the,1106,1109,O
family,1110,1116,O
context,1117,1124,O
as,1125,1127,O
well,1128,1132,O
as,1133,1135,O
incorporating,1136,1149,O
more,1150,1154,O
naturalistic,1155,1167,O
studies,1168,1175,O
of,1176,1178,O
family,1179,1185,O
interactions,1186,1198,O
.,1198,1199,O
Randomized,1200,1210,O
controlled,1211,1221,O
trials,1222,1228,O
using,1229,1234,O
family,1235,1241,O
-,1241,1242,O
based,1242,1247,O
interventions,1248,1261,O
may,1262,1265,O
consider,1266,1274,O
focusing,1275,1283,O
on,1284,1286,O
medical,1287,1294,O
adherence,1295,1304,O
as,1305,1307,O
an,1308,1310,O
important,1311,1320,O
mediator,1321,1329,O
between,1330,1337,O
family,1338,1344,O
process,1345,1352,O
and,1353,1356,O
child,1357,1362,O
health,1363,1369,O
outcomes,1370,1378,O
.,1378,1379,O
The,0,3,O
relationship,4,16,O
between,17,24,O
brain,25,30,B-Organ
activity,31,39,O
and,40,43,O
peak,44,48,O
grip,49,53,O
force,54,59,O
is,60,62,O
modulated,63,72,O
by,73,75,O
corticospinal,76,89,B-Anatomical_system
system,90,96,I-Anatomical_system
integrity,97,106,O
after,107,112,O
subcortical,113,124,B-Multi-tissue_structure
stroke,125,131,O
.,131,132,O
In,133,135,O
healthy,136,143,O
human,144,149,O
subjects,150,158,O
",",158,159,O
the,160,163,O
relative,164,172,O
contribution,173,185,O
of,186,188,O
cortical,189,197,B-Multi-tissue_structure
regions,198,205,I-Multi-tissue_structure
to,206,208,O
motor,209,214,O
performance,215,226,O
varies,227,233,O
with,234,238,O
the,239,242,O
task,243,247,O
parameters,248,258,O
.,258,259,O
Additionally,260,272,O
",",272,273,O
after,274,279,O
stroke,280,286,O
",",286,287,O
recruitment,288,299,O
of,300,302,O
cortical,303,311,B-Multi-tissue_structure
areas,312,317,I-Multi-tissue_structure
during,318,324,O
a,325,326,O
simple,327,333,O
motor,334,339,O
task,340,344,O
varies,345,351,O
with,352,356,O
corticospinal,357,370,B-Anatomical_system
system,371,377,I-Anatomical_system
integrity,378,387,O
.,387,388,O
We,389,391,O
investigated,392,404,O
whether,405,412,O
the,413,416,O
pattern,417,424,O
of,425,427,O
motor,428,433,O
system,434,440,O
recruitment,441,452,O
in,453,455,O
a,456,457,O
task,458,462,O
involving,463,472,O
increasingly,473,485,O
forceful,486,494,O
hand,495,499,B-Organism_subdivision
grips,500,505,O
is,506,508,O
influenced,509,519,O
by,520,522,O
the,523,526,O
degree,527,533,O
of,534,536,O
corticospinal,537,550,B-Anatomical_system
system,551,557,I-Anatomical_system
damage,558,564,O
.,564,565,O
Nine,566,570,O
chronic,571,578,O
subcortical,579,590,B-Multi-tissue_structure
stroke,591,597,O
patients,598,606,O
and,607,610,O
nine,611,615,O
age,616,619,O
-,619,620,O
matched,620,627,O
controls,628,636,O
underwent,637,646,O
functional,647,657,O
magnetic,658,666,O
brain,667,672,B-Organ
imaging,673,680,O
whilst,681,687,O
performing,688,698,O
repetitive,699,709,O
isometric,710,719,O
hand,720,724,B-Organism_subdivision
grips,725,730,O
.,730,731,O
Target,732,738,O
grip,739,743,O
forces,744,750,O
were,751,755,O
varied,756,762,O
between,763,770,O
15,771,773,O
%,773,774,O
and,775,778,O
45,779,781,O
%,781,782,O
of,783,785,O
individual,786,796,O
maximum,797,804,O
grip,805,809,O
force,810,815,O
.,815,816,O
Corticospinal,817,830,O
system,831,837,O
functional,838,848,O
integrity,849,858,O
was,859,862,O
assessed,863,871,O
with,872,876,O
transcranial,877,889,O
magnetic,890,898,O
stimulation,899,910,O
.,910,911,O
Averaged,912,920,O
across,921,927,O
all,928,931,O
forces,932,938,O
",",938,939,O
there,940,945,O
was,946,949,O
more,950,954,O
task,955,959,O
-,959,960,O
related,960,967,O
activation,968,978,O
compared,979,987,O
with,988,992,O
rest,993,997,O
in,998,1000,O
the,1001,1004,O
secondary,1005,1014,O
motor,1015,1020,O
areas,1021,1026,O
of,1027,1029,O
patients,1030,1038,O
with,1039,1043,O
greater,1044,1051,O
corticospinal,1052,1065,B-Anatomical_system
system,1066,1072,I-Anatomical_system
damage,1073,1079,O
",",1079,1080,O
confirming,1081,1091,O
previous,1092,1100,O
reports,1101,1108,O
.,1108,1109,O
However,1110,1117,O
",",1117,1118,O
here,1119,1123,O
we,1124,1126,O
were,1127,1131,O
primarily,1132,1141,O
interested,1142,1152,O
in,1153,1155,O
regional,1156,1164,O
brain,1165,1170,B-Organ
activation,1171,1181,O
",",1181,1182,O
which,1183,1188,O
covaried,1189,1197,O
with,1198,1202,O
the,1203,1206,O
amount,1207,1213,O
of,1214,1216,O
force,1217,1222,O
generated,1223,1232,O
",",1232,1233,O
implying,1234,1242,O
a,1243,1244,O
prominent,1245,1254,O
executive,1255,1264,O
role,1265,1269,O
in,1270,1272,O
force,1273,1278,O
production,1279,1289,O
.,1289,1290,O
We,1291,1293,O
found,1294,1299,O
that,1300,1304,O
in,1305,1307,O
control,1308,1315,O
subjects,1316,1324,O
and,1325,1328,O
patients,1329,1337,O
with,1338,1342,O
lesser,1343,1349,O
corticospinal,1350,1363,B-Anatomical_system
system,1364,1370,I-Anatomical_system
damage,1371,1377,O
",",1377,1378,O
signal,1379,1385,O
change,1386,1392,O
increased,1393,1402,O
linearly,1403,1411,O
with,1412,1416,O
increasing,1417,1427,O
force,1428,1433,O
output,1434,1440,O
in,1441,1443,O
contralateral,1444,1457,O
primary,1458,1465,O
motor,1466,1471,B-Multi-tissue_structure
cortex,1472,1478,I-Multi-tissue_structure
",",1478,1479,O
supplementary,1480,1493,O
motor,1494,1499,O
area,1500,1504,O
and,1505,1508,O
ipsilateral,1509,1520,O
cerebellum,1521,1531,B-Multi-tissue_structure
.,1531,1532,O
In,1533,1535,O
contrast,1536,1544,O
",",1544,1545,O
in,1546,1548,O
patients,1549,1557,O
with,1558,1562,O
greater,1563,1570,O
corticospinal,1571,1584,B-Anatomical_system
system,1585,1591,I-Anatomical_system
damage,1592,1598,O
",",1598,1599,O
force,1600,1605,O
-,1605,1606,O
related,1606,1613,O
signal,1614,1620,O
changes,1621,1628,O
were,1629,1633,O
seen,1634,1638,O
mainly,1639,1645,O
in,1646,1648,O
contralesional,1649,1663,B-Multi-tissue_structure
dorsolateral,1664,1676,I-Multi-tissue_structure
premotor,1677,1685,I-Multi-tissue_structure
cortex,1686,1692,I-Multi-tissue_structure
",",1692,1693,O
bilateral,1694,1703,B-Multi-tissue_structure
ventrolateral,1704,1717,I-Multi-tissue_structure
premotor,1718,1726,I-Multi-tissue_structure
cortices,1727,1735,I-Multi-tissue_structure
and,1736,1739,O
contralesional,1740,1754,B-Multi-tissue_structure
cerebellum,1755,1765,I-Multi-tissue_structure
",",1765,1766,O
but,1767,1770,O
not,1771,1774,O
ipsilesional,1775,1787,B-Multi-tissue_structure
primary,1788,1795,I-Multi-tissue_structure
motor,1796,1801,I-Multi-tissue_structure
cortex,1802,1808,I-Multi-tissue_structure
.,1808,1809,O
These,1810,1815,O
findings,1816,1824,O
suggest,1825,1832,O
that,1833,1837,O
the,1838,1841,O
premotor,1842,1850,B-Multi-tissue_structure
cortices,1851,1859,I-Multi-tissue_structure
might,1860,1865,O
play,1866,1870,O
a,1871,1872,O
new,1873,1876,O
and,1877,1880,O
functionally,1881,1893,O
relevant,1894,1902,O
role,1903,1907,O
in,1908,1910,O
controlling,1911,1922,O
force,1923,1928,O
production,1929,1939,O
in,1940,1942,O
patients,1943,1951,O
with,1952,1956,O
more,1957,1961,O
severe,1962,1968,O
corticospinal,1969,1982,B-Anatomical_system
system,1983,1989,I-Anatomical_system
disruption,1990,2000,O
.,2000,2001,O
Characterization,0,16,O
of,17,19,O
transferrin,20,31,O
glycoforms,32,42,O
in,43,45,O
human,46,51,O
serum,52,57,B-Organism_substance
by,58,60,O
CE,61,63,O
-,63,64,O
UV,64,66,O
and,67,70,O
CE,71,73,O
-,73,74,O
ESI,74,77,O
-,77,78,O
MS,78,80,O
.,80,81,O
Human,82,87,O
transferrin,88,99,O
(,100,101,O
Tf,101,103,O
),103,104,O
is,105,107,O
a,108,109,O
model,110,115,O
glycoprotein,116,128,O
for,129,132,O
congenital,133,143,O
disorders,144,153,O
of,154,156,O
glycosylation,157,170,O
(,171,172,O
CDG,172,175,O
),175,176,O
diagnosis,177,186,O
.,186,187,O
In,188,190,O
the,191,194,O
last,195,199,O
few,200,203,O
years,204,209,O
",",209,210,O
new,211,214,O
CE,215,217,O
-,217,218,O
UV,218,220,O
methods,221,228,O
for,229,232,O
intact,233,239,O
Tf,240,242,O
glycoforms,243,253,O
analysis,254,262,O
have,263,267,O
been,268,272,O
developed,273,282,O
using,283,288,O
nonvolatile,289,300,O
BGEs,301,305,O
and,306,309,O
organic,310,317,O
modifiers,318,327,O
.,327,328,O
However,329,336,O
",",336,337,O
the,338,341,O
use,342,345,O
of,346,348,O
these,349,354,O
BGEs,355,359,O
does,360,364,O
not,365,368,O
allow,369,374,O
the,375,378,O
coupling,379,387,O
of,388,390,O
these,391,396,O
procedures,397,407,O
with,408,412,O
electrospray,413,425,O
MS,426,428,O
(,429,430,O
ESI,430,433,O
-,433,434,O
MS,434,436,O
),436,437,O
.,437,438,O
In,439,441,O
this,442,446,O
study,447,452,O
",",452,453,O
a,454,455,O
new,456,459,O
CE,460,462,O
-,462,463,O
UV,463,465,O
separation,466,476,O
method,477,483,O
of,484,486,O
Tf,487,489,O
glycoforms,490,500,O
is,501,503,O
developed,504,513,O
",",513,514,O
using,515,520,O
a,521,522,O
double,523,529,O
-,529,530,O
layer,530,535,O
stable,536,542,O
coating,543,550,O
and,551,554,O
a,555,556,O
volatile,557,565,O
BGE,566,569,O
based,570,575,O
on,576,578,O
ammonium,579,587,O
acetate,588,595,O
.,595,596,O
The,597,600,O
separation,601,611,O
method,612,618,O
is,619,621,O
optimized,622,631,O
using,632,637,O
standard,638,646,O
Tf,647,649,O
and,650,653,O
their,654,659,O
potential,660,669,O
is,670,672,O
demonstrated,673,685,O
applying,686,694,O
the,695,698,O
method,699,705,O
to,706,708,O
the,709,712,O
analysis,713,721,O
of,722,724,O
sera,725,729,B-Organism_substance
Tf,730,732,O
from,733,737,O
healthy,738,745,O
individuals,746,757,O
and,758,761,O
CDG,762,765,O
patients,766,774,O
.,774,775,O
The,776,779,O
CE,780,782,O
-,782,783,O
UV,783,785,O
separation,786,796,O
method,797,803,O
has,804,807,O
been,808,812,O
coupled,813,820,O
to,821,823,O
ESI,824,827,O
-,827,828,O
MS,828,830,O
detection,831,840,O
.,840,841,O
Main,842,846,O
parameters,847,857,O
such,858,862,O
as,863,865,O
sheath,866,872,O
liquid,873,879,O
composition,880,891,O
are,892,895,O
optimized,896,905,O
in,906,908,O
order,909,914,O
to,915,917,O
obtain,918,924,O
a,925,926,O
good,927,931,O
sensitivity,932,943,O
.,943,944,O
The,945,948,O
CE,949,951,O
-,951,952,O
ESI,952,955,O
-,955,956,O
MS,956,958,O
method,959,965,O
has,966,969,O
also,970,974,O
been,975,979,O
used,980,984,O
in,985,987,O
serum,988,993,B-Organism_substance
samples,994,1001,I-Organism_substance
obtaining,1002,1011,O
the,1012,1015,O
separation,1016,1026,O
of,1027,1029,O
the,1030,1033,O
different,1034,1043,O
proteins,1044,1052,O
present,1053,1060,O
in,1061,1063,O
serum,1064,1069,B-Organism_substance
and,1070,1073,O
partial,1074,1081,O
separation,1082,1092,O
of,1093,1095,O
Tf,1096,1098,O
glycoforms,1099,1109,O
.,1109,1110,O
Different,1111,1120,O
mass,1121,1125,O
spectra,1126,1133,O
and,1134,1137,O
deconvoluted,1138,1150,O
molecular,1151,1160,O
masses,1161,1167,O
were,1168,1172,O
obtained,1173,1181,O
for,1182,1185,O
each,1186,1190,O
sialoform,1191,1200,O
",",1200,1201,O
allowing,1202,1210,O
unequivocal,1211,1222,O
glycoform,1223,1232,O
identification,1233,1247,O
.,1247,1248,O
Selective,0,9,O
activation,10,20,O
of,21,23,O
mast,24,28,B-Cell
cells,29,34,I-Cell
in,35,37,O
rheumatoid,38,48,B-Tissue
synovial,49,57,I-Tissue
tissue,58,64,I-Tissue
results,65,72,O
in,73,75,O
production,76,86,O
of,87,89,O
TNF,90,93,O
-,93,94,O
alpha,94,99,O
",",99,100,O
IL,101,103,O
-,103,104,O
1beta,104,109,O
and,110,113,O
IL,114,116,O
-,116,117,O
1Ra,117,120,O
.,120,121,O
OBJECTIVES,122,132,O
AND,133,136,O
DESIGN,137,143,O
:,143,144,O
To,145,147,O
study,148,153,O
the,154,157,O
consequences,158,170,O
of,171,173,O
mast,174,178,B-Cell
cell,179,183,I-Cell
activation,184,194,O
in,195,197,O
human,198,203,O
synovial,204,212,B-Tissue
tissue,213,219,I-Tissue
.,219,220,O
METHODS,221,228,O
:,228,229,O
Synovial,230,238,B-Tissue
tissue,239,245,I-Tissue
was,246,249,O
obtained,250,258,O
from,259,263,O
18,264,266,O
RA,267,269,O
patients,270,278,O
and,279,282,O
mast,283,287,B-Cell
cells,288,293,I-Cell
was,294,297,O
selectively,298,309,O
activated,310,319,O
in,320,322,O
synovial,323,331,B-Tissue
tissue,332,338,I-Tissue
explant,339,346,O
cultures,347,355,O
.,355,356,O
Expression,357,367,O
of,368,370,O
TNF,371,374,O
-,374,375,O
alpha,375,380,O
",",380,381,O
IL,382,384,O
-,384,385,O
1beta,385,390,O
and,391,394,O
IL,395,397,O
-,397,398,O
1Ra,398,401,O
were,402,406,O
determined,407,417,O
and,418,421,O
tissue,422,428,B-Tissue
distribution,429,441,O
of,442,444,O
IL,445,447,O
-,447,448,O
1beta,448,453,O
was,454,457,O
studied,458,465,O
.,465,466,O
RESULTS,467,474,O
:,474,475,O
Compared,476,484,O
to,485,487,O
untreated,488,497,O
synovia,498,505,B-Tissue
",",505,506,O
selective,507,516,O
activation,517,527,O
of,528,530,O
synovial,531,539,B-Cell
mast,540,544,I-Cell
cells,545,550,I-Cell
increased,551,560,O
significantly,561,574,O
the,575,578,O
production,579,589,O
of,590,592,O
TNF,593,596,O
-,596,597,O
alpha,597,602,O
(,603,604,O
0,604,605,O
.,605,606,O
49,606,608,O
+,609,610,O
/,610,611,O
-,611,612,O
0,613,614,O
.,614,615,O
88,615,617,O
vs,618,620,O
.,620,621,O
4,622,623,O
.,623,624,O
56,624,626,O
+,627,628,O
/,628,629,O
-,629,630,O
3,631,632,O
.,632,633,O
18,633,635,O
pg,636,638,O
/,638,639,O
mg,639,641,O
wet,642,645,O
tissue,646,652,O
",",652,653,O
p,654,655,O
<,656,657,O
0,658,659,O
.,659,660,O
001,660,663,O
),663,664,O
and,665,668,O
IL,669,671,O
-,671,672,O
1beta,672,677,O
(,678,679,O
0,679,680,O
.,680,681,O
058,681,684,O
+,685,686,O
/,686,687,O
-,687,688,O
0,689,690,O
.,690,691,O
032,691,694,O
vs,695,697,O
.,697,698,O
2,699,700,O
.,700,701,O
55,701,703,O
+,704,705,O
/,705,706,O
-,706,707,O
1,708,709,O
.,709,710,O
98,710,712,O
pg,713,715,O
/,715,716,O
mg,716,718,O
wet,719,722,O
tissue,723,729,O
",",729,730,O
p,731,732,O
=,733,734,O
0,735,736,O
.,736,737,O
013,737,740,O
),740,741,O
.,741,742,O
The,743,746,O
expression,747,757,O
of,758,760,O
TNF,761,764,O
-,764,765,O
alpha,765,770,O
and,771,774,O
IL,775,777,O
-,777,778,O
1beta,778,783,O
mRNA,784,788,O
increased,789,798,O
significantly,799,812,O
(,813,814,O
19,814,816,O
-,816,817,O
fold,817,821,O
(,822,823,O
p,823,824,O
=,825,826,O
0,827,828,O
.,828,829,O
009,829,832,O
),832,833,O
and,834,837,O
13,838,840,O
-,840,841,O
fold,841,845,O
(,846,847,O
p,847,848,O
=,849,850,O
0,851,852,O
.,852,853,O
031,853,856,O
),856,857,O
",",857,858,O
respectively,859,871,O
),871,872,O
.,872,873,O
Mast,874,878,B-Cell
cell,879,883,I-Cell
activation,884,894,O
induced,895,902,O
IL,903,905,O
-,905,906,O
1beta,906,911,O
expression,912,922,O
in,923,925,O
particular,926,936,O
in,937,939,O
nearby,940,946,O
CD68,947,951,B-Cell
positive,952,960,I-Cell
synovial,961,969,I-Cell
macrophages,970,981,I-Cell
.,981,982,O
Secretion,983,992,O
of,993,995,O
IL,996,998,O
-,998,999,O
1Ra,999,1002,O
was,1003,1006,O
also,1007,1011,O
increased,1012,1021,O
but,1022,1025,O
to,1026,1028,O
a,1029,1030,O
lesser,1031,1037,O
degree,1038,1044,O
than,1045,1049,O
that,1050,1054,O
of,1055,1057,O
IL,1058,1060,O
-,1060,1061,O
1beta,1061,1066,O
.,1066,1067,O
CONCLUSIONS,1068,1079,O
:,1079,1080,O
Synovial,1081,1089,B-Cell
mast,1090,1094,I-Cell
cells,1095,1100,I-Cell
produce,1101,1108,O
proinflammmatory,1109,1125,O
cytokines,1126,1135,O
and,1136,1139,O
may,1140,1143,O
thus,1144,1148,O
contribute,1149,1159,O
to,1160,1162,O
the,1163,1166,O
inflammation,1167,1179,O
in,1180,1182,O
RA,1183,1185,O
.,1185,1186,O
Rapid,0,5,O
mixing,6,12,O
between,13,20,O
old,21,24,O
and,25,28,O
new,29,32,O
C,33,34,O
pools,35,40,O
in,41,43,O
the,44,47,O
canopy,48,54,O
of,55,57,O
mature,58,64,O
forest,65,71,O
trees,72,77,O
.,77,78,O
Stable,79,85,O
C,86,87,O
isotope,88,95,O
signals,96,103,O
in,104,106,O
plant,107,112,O
tissues,113,120,B-Tissue
became,121,127,O
a,128,129,O
key,130,133,O
tool,134,138,O
in,139,141,O
explaining,142,152,O
growth,153,159,O
responses,160,169,O
to,170,172,O
the,173,176,O
environment,177,188,O
.,188,189,O
The,190,193,O
technique,194,203,O
is,204,206,O
based,207,212,O
on,213,215,O
the,216,219,O
fundamental,220,231,O
assumption,232,242,O
that,243,247,O
the,248,251,O
isotopic,252,260,O
composition,261,272,O
of,273,275,O
a,276,277,O
given,278,283,O
unit,284,288,O
of,289,291,O
tissue,292,298,B-Tissue
(,299,300,O
e,300,301,O
.,301,302,O
g,302,303,O
.,303,304,O
a,305,306,O
tree,307,311,B-Tissue
ring,312,316,I-Tissue
),316,317,O
reflects,318,326,O
the,327,330,O
specific,331,339,O
C,340,341,O
uptake,342,348,O
conditions,349,359,O
in,360,362,O
the,363,366,O
leaf,367,371,B-Organ
at,372,374,O
a,375,376,O
given,377,382,O
time,383,387,O
.,387,388,O
Beyond,389,395,O
the,396,399,O
methodological,400,414,O
implications,415,427,O
of,428,430,O
any,431,434,O
deviation,435,444,O
from,445,449,O
this,450,454,O
assumption,455,465,O
",",465,466,O
it,467,469,O
is,470,472,O
of,473,475,O
physiological,476,489,O
interest,490,498,O
whether,499,506,O
new,507,510,O
C,511,512,O
is,513,515,O
transferred,516,527,O
directly,528,536,O
from,537,541,O
sources,542,549,O
(,550,551,O
a,551,552,O
photosynthesizing,553,570,O
leaf,571,575,B-Organ
),575,576,O
to,577,579,O
structural,580,590,O
sinks,591,596,O
(,597,598,O
e,598,599,O
.,599,600,O
g,600,601,O
.,601,602,O
adjacent,603,611,O
stem,612,616,B-Tissue
tissue,617,623,I-Tissue
),623,624,O
",",624,625,O
or,626,628,O
inherently,629,639,O
passes,640,646,O
through,647,654,O
existing,655,663,O
(,664,665,O
mobile,665,671,O
),671,672,O
C,673,674,O
pools,675,680,O
",",680,681,O
which,682,687,O
may,688,691,O
be,692,694,O
of,695,697,O
variable,698,706,O
(,707,708,O
older,708,713,O
),713,714,O
age,715,718,O
.,718,719,O
Here,720,724,O
",",724,725,O
we,726,728,O
explore,729,736,O
the,737,740,O
fate,741,745,O
of,746,748,O
(,749,750,O
13,750,752,O
),752,753,O
C,753,754,O
-,754,755,O
labelled,755,763,O
photosynthates,764,778,O
in,779,781,O
the,782,785,O
crowns,786,792,B-Organism_subdivision
of,793,795,O
a,796,797,O
30,798,800,O
-,800,801,O
35,801,803,O
m,804,805,O
tall,806,810,O
",",810,811,O
mixed,812,817,O
forest,818,824,O
using,825,830,O
a,831,832,O
canopy,833,839,O
crane,840,845,O
.,845,846,O
In,847,849,O
all,850,853,O
nine,854,858,O
study,859,864,O
species,865,872,O
labelled,873,881,O
C,882,883,O
reached,884,891,O
woody,892,897,B-Tissue
tissue,898,904,I-Tissue
within,905,911,O
2,912,913,O
-,913,914,O
9,914,915,O
h,916,917,O
after,918,923,O
labelling,924,933,O
.,933,934,O
Four,935,939,O
months,940,946,O
later,947,952,O
",",952,953,O
very,954,958,O
small,959,964,O
signals,965,972,O
were,973,977,O
left,978,982,O
in,983,985,O
branch,986,992,O
wood,993,997,O
of,998,1000,O
Tilia,1001,1006,O
suggesting,1007,1017,O
that,1018,1022,O
low,1023,1026,O
mixing,1027,1033,O
of,1034,1036,O
new,1037,1040,O
",",1040,1041,O
labelled,1042,1050,O
C,1051,1052,O
with,1053,1057,O
old,1058,1061,O
C,1062,1063,O
had,1064,1067,O
taken,1068,1073,O
place,1074,1079,O
.,1079,1080,O
In,1081,1083,O
contrast,1084,1092,O
",",1092,1093,O
signals,1094,1101,O
in,1102,1104,O
Fagus,1105,1110,O
and,1111,1114,O
Quercus,1115,1122,O
had,1123,1126,O
increased,1127,1136,O
",",1136,1137,O
indicating,1138,1148,O
more,1149,1153,O
intense,1154,1161,O
mixing,1162,1168,O
.,1168,1169,O
This,1170,1174,O
species,1175,1182,O
-,1182,1183,O
specific,1183,1191,O
mixing,1192,1198,O
of,1199,1201,O
new,1202,1205,O
with,1206,1210,O
old,1211,1214,O
C,1215,1216,O
pools,1217,1222,O
is,1223,1225,O
likely,1226,1232,O
to,1233,1235,O
mask,1236,1240,O
year,1241,1245,O
-,1245,1246,O
or,1247,1249,O
season,1250,1256,O
-,1256,1257,O
specific,1257,1265,O
linkages,1266,1274,O
between,1275,1282,O
tree,1283,1287,B-Tissue
ring,1288,1292,I-Tissue
formation,1293,1302,O
and,1303,1306,O
climate,1307,1314,O
and,1315,1318,O
has,1319,1322,O
considerable,1323,1335,O
implications,1336,1348,O
for,1349,1352,O
climate,1353,1360,O
reconstruction,1361,1375,O
using,1376,1381,O
stable,1382,1388,O
isotopes,1389,1397,O
as,1398,1400,O
proxies,1401,1408,O
for,1409,1412,O
past,1413,1417,O
climatic,1418,1426,O
conditions,1427,1437,O
.,1437,1438,O
M,0,1,O
.,1,2,O
leprae,3,9,O
-,9,10,O
and,11,14,O
BCG,15,18,O
-,18,19,O
induced,19,26,O
chemiluminescence,27,44,O
response,45,53,O
of,54,56,O
monocytes,57,66,B-Cell
from,67,71,O
leprosy,72,79,O
patients,80,88,O
and,89,92,O
healthy,93,100,O
subjects,101,109,O
:,109,110,O
effects,111,118,O
of,119,121,O
gamma,122,127,O
-,127,128,O
interferon,128,138,O
and,139,142,O
GM,143,145,O
-,145,146,O
CSF,146,149,O
.,149,150,O
Mycobacterium,151,164,O
leprae,165,171,O
",",171,172,O
in,173,175,O
contrast,176,184,O
to,185,187,O
BCG,188,191,O
",",191,192,O
failed,193,199,O
to,200,202,O
trigger,203,210,O
any,211,214,O
chemiluminescence,215,232,O
(,233,234,O
CL,234,236,O
),236,237,O
response,238,246,O
in,247,249,O
mononuclear,250,261,B-Cell
cells,262,267,I-Cell
from,268,272,O
either,273,279,O
leprosy,280,287,O
patients,288,296,O
or,297,299,O
healthy,300,307,O
subjects,308,316,O
",",316,317,O
a,318,319,O
deficit,320,327,O
not,328,331,O
reversed,332,340,O
by,341,343,O
either,344,350,O
interferon,351,361,O
-,361,362,O
gamma,362,367,O
or,368,370,O
GM,371,373,O
-,373,374,O
CSF,374,377,O
.,377,378,O
Chemiluminescence,379,396,O
responses,397,406,O
induced,407,414,O
without,415,422,O
mycobacteria,423,435,O
or,436,438,O
with,439,443,O
BCG,444,447,O
were,448,452,O
found,453,458,O
to,459,461,O
be,462,464,O
lower,465,470,O
in,471,473,O
leprosy,474,481,O
patients,482,490,O
than,491,495,O
in,496,498,O
controls,499,507,O
.,507,508,O
M,509,510,O
.,510,511,O
leprae,512,518,O
were,519,523,O
also,524,528,O
less,529,533,O
well,534,538,O
phagocytosed,539,551,O
than,552,556,O
BCG,557,560,O
.,560,561,O
However,562,569,O
",",569,570,O
there,571,576,O
was,577,580,O
a,581,582,O
significant,583,594,O
difference,595,605,O
in,606,608,O
phagocytosis,609,621,O
between,622,629,O
healthy,630,637,O
and,638,641,O
tuberculoid,642,653,O
leprosy,654,661,O
subjects,662,670,O
.,670,671,O
Phagocytosis,672,684,O
was,685,688,O
not,689,692,O
altered,693,700,O
by,701,703,O
the,704,707,O
addition,708,716,O
of,717,719,O
either,720,726,O
lymphokine,727,737,O
",",737,738,O
and,739,742,O
no,743,745,O
major,746,751,O
differences,752,763,O
between,764,771,O
healthy,772,779,O
subjects,780,788,O
and,789,792,O
patients,793,801,O
were,802,806,O
observed,807,815,O
.,815,816,O
Preincubating,817,830,O
mononuclear,831,842,B-Cell
cells,843,848,I-Cell
with,849,853,O
anti,854,858,O
-,858,859,O
mycobacteria,859,871,O
antibodies,872,882,O
(,883,884,O
lepromatous,884,895,O
patients,896,904,O
',904,905,O
sera,906,910,B-Organism_substance
),910,911,O
did,912,915,O
not,916,919,O
increase,920,928,O
the,929,932,O
CL,933,935,O
response,936,944,O
nor,945,948,O
the,949,952,O
phagocytosis,953,965,O
of,966,968,O
M,969,970,O
.,970,971,O
leprae,972,978,O
or,979,981,O
BCG,982,985,O
.,985,986,O
A,0,1,O
practical,2,11,O
interface,12,21,O
for,22,25,O
microfluidics,26,39,O
and,40,43,O
nanoelectrospray,44,60,O
mass,61,65,O
spectrometry,66,78,O
.,78,79,O
We,80,82,O
report,83,89,O
a,90,91,O
new,92,95,O
method,96,102,O
for,103,106,O
fabricating,107,118,O
nanospray,119,128,O
ionization,129,139,O
tips,140,144,O
for,145,148,O
MS,149,151,O
",",151,152,O
formed,153,159,O
from,160,164,O
glass,165,170,O
substrates,171,181,O
and,182,185,O
the,186,189,O
inert,190,195,O
polymer,196,203,O
",",203,204,O
parylene,205,213,O
-,213,214,O
C,214,215,O
.,215,216,O
Using,217,222,O
a,223,224,O
single,225,231,O
photolithography,232,248,O
step,249,253,O
",",253,254,O
the,255,258,O
emitters,259,267,O
are,268,271,O
formed,272,278,O
contiguously,279,291,O
with,292,296,O
microchannels,297,310,O
",",310,311,O
such,312,316,O
that,317,321,O
no,322,324,O
dead,325,329,O
volumes,330,337,O
are,338,341,O
observed,342,350,O
.,350,351,O
In,352,354,O
addition,355,363,O
",",363,364,O
because,365,372,O
the,373,376,O
devices,377,384,O
are,385,388,O
very,389,393,O
thin,394,398,O
(,399,400,O
approximately,400,413,O
0,414,415,O
.,415,416,O
3,416,417,O
mm,418,420,O
),420,421,O
and,422,425,O
the,426,429,O
tips,430,434,O
are,435,438,O
formed,439,445,O
at,446,448,O
rectangular,449,460,O
corners,461,468,O
",",468,469,O
the,470,473,O
Taylor,474,480,O
cone,481,485,O
volumes,486,493,O
are,494,497,O
small,498,503,O
",",503,504,O
which,505,510,O
makes,511,516,O
the,517,520,O
method,521,527,O
attractive,528,538,O
for,539,542,O
future,543,549,O
integration,550,561,O
with,562,566,O
microfluidic,567,579,O
separations,580,591,O
.,591,592,O
Device,593,599,O
performance,600,611,O
was,612,615,O
demonstrated,616,628,O
by,629,631,O
evaluating,632,642,O
diverse,643,650,O
analytes,651,659,O
",",659,660,O
ranging,661,668,O
from,669,673,O
synthetic,674,683,O
polymers,684,692,O
",",692,693,O
to,694,696,O
peptides,697,705,O
",",705,706,O
to,707,709,O
nucleic,710,717,O
acids,718,723,O
.,723,724,O
For,725,728,O
all,729,732,O
analytes,733,741,O
",",741,742,O
performance,743,754,O
was,755,758,O
similar,759,766,O
to,767,769,O
that,770,774,O
of,775,777,O
conventional,778,790,O
emitters,791,799,O
(,800,801,O
pulled,801,807,O
-,807,808,O
glass,808,813,O
capillaries,814,825,O
and,826,829,O
the,830,833,O
Agilent,834,841,O
HPLC,842,846,O
Chip,847,851,O
),851,852,O
with,853,857,O
the,858,861,O
advantage,862,871,O
of,872,874,O
rapid,875,880,O
",",880,881,O
batch,882,887,O
fabrication,888,899,O
of,900,902,O
identical,903,912,O
devices,913,920,O
.,920,921,O
Intraoperative,0,14,O
handling,15,23,O
and,24,27,O
wound,28,33,B-Pathological_formation
healing,34,41,O
of,42,44,O
arthroscopic,45,57,O
portal,58,64,O
wounds,65,71,B-Pathological_formation
:,71,72,O
a,73,74,O
clinical,75,83,O
study,84,89,O
comparing,90,99,O
nylon,100,105,O
suture,106,112,O
with,113,117,O
wound,118,123,B-Pathological_formation
closure,124,131,O
strips,132,138,O
.,138,139,O
This,140,144,O
prospective,145,156,O
",",156,157,O
single,158,164,O
-,164,165,O
centre,165,171,O
study,172,177,O
compared,178,186,O
wound,187,192,B-Pathological_formation
closure,193,200,O
methods,201,208,O
in,209,211,O
patients,212,220,O
undergoing,221,231,O
arthroscopy,232,243,O
.,243,244,O
Closure,245,252,O
of,253,255,O
arthroscopic,256,268,O
portal,269,275,O
wounds,276,282,B-Pathological_formation
with,283,287,O
sterile,288,295,O
adhesive,296,304,O
strips,305,311,O
is,312,314,O
effective,315,324,O
and,325,328,O
convenient,329,339,O
for,340,343,O
wound,344,349,B-Pathological_formation
management,350,360,O
.,360,361,O
The,362,365,O
method,366,372,O
was,373,376,O
associated,377,387,O
with,388,392,O
a,393,394,O
reduced,395,402,O
potential,403,412,O
for,413,416,O
infection,417,426,O
",",426,427,O
faster,428,434,O
renewal,435,442,O
of,443,445,O
tensile,446,453,O
strength,454,462,O
",",462,463,O
greater,464,471,O
cost,472,476,O
effectiveness,477,490,O
",",490,491,O
and,492,495,O
better,496,502,O
cosmetic,503,511,O
effects,512,519,O
comparing,520,529,O
with,530,534,O
suture,535,541,O
closure,542,549,O
.,549,550,O
This,551,555,O
method,556,562,O
of,563,565,O
wound,566,571,B-Pathological_formation
closure,572,579,O
may,580,583,O
also,584,588,O
reduce,589,595,O
the,596,599,O
incidence,600,609,O
of,610,612,O
needle,613,619,O
stick,620,625,O
injury,626,632,O
in,633,635,O
the,636,639,O
theatre,640,647,O
environment,648,659,O
.,659,660,O
Thereby,661,668,O
the,669,672,O
incidence,673,682,O
of,683,685,O
percutaneous,686,698,O
exposure,699,707,O
following,708,717,O
a,718,719,O
surgical,720,728,O
procedure,729,738,O
may,739,742,O
not,743,746,O
facilitate,747,757,O
transmission,758,770,O
of,771,773,O
blood,774,779,B-Organism_substance
borne,780,785,O
pathogens,786,795,O
such,796,800,O
as,801,803,O
human,804,809,O
immunodeficiency,810,826,O
virus,827,832,O
(,833,834,O
HIV,834,837,O
),837,838,O
",",838,839,O
hepatitis,840,849,O
C,850,851,O
virus,852,857,O
and,858,861,O
hepatitis,862,871,O
B,872,873,O
virus,874,879,O
.,879,880,O
As,881,883,O
a,884,885,O
result,886,892,O
it,893,895,O
may,896,899,O
reduce,900,906,O
litigation,907,917,O
in,918,920,O
today,921,926,O
',926,927,O
s,927,928,O
changing,929,937,O
healthcare,938,948,O
climate,949,956,O
.,956,957,O
Investigation,0,13,O
of,14,16,O
the,17,20,O
effect,21,27,O
of,28,30,O
kaolin,31,37,O
and,38,41,O
tissue,42,48,B-Tissue
-,48,49,O
factor,49,55,O
-,55,56,O
activated,56,65,O
citrated,66,74,O
whole,75,80,B-Organism_substance
blood,81,86,I-Organism_substance
",",86,87,O
on,88,90,O
clot,91,95,B-Organism_substance
-,95,96,O
forming,96,103,O
variables,104,113,O
",",113,114,O
as,115,117,O
evaluated,118,127,O
by,128,130,O
thromboelastography,131,150,O
.,150,151,O
BACKGROUND,152,162,O
:,162,163,O
The,164,167,O
Thrombelastograph,168,185,O
(,186,187,O
TEG,187,190,O
;,190,191,O
Haemoscope,192,202,O
Corp,203,207,O
.,207,208,O
),208,209,O
analyzes,210,218,O
clot,219,223,B-Organism_substance
formation,224,233,O
in,234,236,O
whole,237,242,B-Organism_substance
blood,243,248,I-Organism_substance
(,249,250,O
WB,250,252,B-Organism_substance
),252,253,O
and,254,257,O
treatment,258,267,O
based,268,273,O
on,274,276,O
this,277,281,O
analysis,282,290,O
has,291,294,O
been,295,299,O
shown,300,305,O
to,306,308,O
reduce,309,315,O
transfusion,316,327,O
requirements,328,340,O
in,341,343,O
liver,344,349,B-Organ
and,350,353,O
cardiac,354,361,B-Organ
surgery,362,369,O
when,370,374,O
compared,375,383,O
to,384,386,O
conventional,387,399,O
coagulation,400,411,O
analysis,412,420,O
.,420,421,O
Implementing,422,434,O
TEG,435,438,O
as,439,441,O
a,442,443,O
routine,444,451,O
laboratory,452,462,O
-,462,463,O
based,463,468,O
analysis,469,477,O
",",477,478,O
however,479,486,O
",",486,487,O
requires,488,496,O
validation,497,507,O
of,508,510,O
the,511,514,O
activators,515,525,O
employed,526,534,O
and,535,538,O
the,539,542,O
effect,543,549,O
of,550,552,O
storage,553,560,O
of,561,563,O
the,564,567,O
WB,568,570,B-Organism_substance
sample,571,577,O
in,578,580,O
citrate,581,588,O
before,589,595,O
analysis,596,604,O
.,604,605,O
STUDY,606,611,O
DESIGN,612,618,O
AND,619,622,O
METHODS,623,630,O
:,630,631,O
The,632,635,O
effect,636,642,O
of,643,645,O
kaolin,646,652,O
",",652,653,O
tissue,654,660,B-Tissue
factor,661,667,O
(,668,669,O
TF,669,671,O
),671,672,O
1,673,674,O
:,674,675,O
17,675,677,O
",",677,678,O
000,678,681,O
",",681,682,O
or,683,685,O
TF,686,688,O
1,689,690,O
:,690,691,O
42,691,693,O
",",693,694,O
500,694,697,O
on,698,700,O
TEG,701,704,O
clotting,705,713,O
time,714,718,O
(,719,720,O
R,720,721,O
),721,722,O
",",722,723,O
Angle,724,729,O
(,730,731,O
velocity,731,739,O
of,740,742,O
clot,743,747,B-Organism_substance
formation,748,757,O
),757,758,O
",",758,759,O
and,760,763,O
maximum,764,771,O
clot,772,776,B-Organism_substance
strength,777,785,O
(,786,787,O
amplitude,787,796,O
[,797,798,O
MA,798,800,O
],800,801,O
),801,802,O
were,803,807,O
evaluated,808,817,O
",",817,818,O
together,819,827,O
with,828,832,O
day,833,836,O
-,836,837,O
to,837,839,O
-,839,840,O
day,840,843,O
variation,844,853,O
",",853,854,O
the,855,858,O
coefficient,859,870,O
of,871,873,O
variance,874,882,O
(,883,884,O
CV,884,886,O
%,886,887,O
),887,888,O
",",888,889,O
and,890,893,O
the,894,897,O
effect,898,904,O
of,905,907,O
citrate,908,915,O
storage,916,923,O
time,924,928,O
.,928,929,O
RESULTS,930,937,O
:,937,938,O
Clot,939,943,B-Organism_substance
formation,944,953,O
variables,954,963,O
were,964,968,O
equally,969,976,O
affected,977,985,O
by,986,988,O
TF,989,991,O
1,992,993,O
:,993,994,O
17,994,996,O
",",996,997,O
000,997,1000,O
and,1001,1004,O
kaolin,1005,1011,O
activation,1012,1022,O
",",1022,1023,O
whereas,1024,1031,O
R,1032,1033,O
was,1034,1037,O
significantly,1038,1051,O
longer,1052,1058,O
when,1059,1063,O
TF,1064,1066,O
1,1067,1068,O
:,1068,1069,O
42,1069,1071,O
",",1071,1072,O
500,1072,1075,O
was,1076,1079,O
used,1080,1084,O
.,1084,1085,O
The,1086,1089,O
CV,1090,1092,O
for,1093,1096,O
the,1097,1100,O
different,1101,1110,O
variables,1111,1120,O
varied,1121,1127,O
from,1128,1132,O
3,1133,1134,O
to,1135,1137,O
13,1138,1140,O
percent,1141,1148,O
with,1149,1153,O
no,1154,1156,O
significant,1157,1168,O
differences,1169,1180,O
between,1181,1188,O
assays,1189,1195,O
.,1195,1196,O
Storage,1197,1204,O
of,1205,1207,O
citrated,1208,1216,O
WB,1217,1219,B-Organism_substance
significantly,1220,1233,O
affected,1234,1242,O
the,1243,1246,O
TEG,1247,1250,O
variables,1251,1260,O
in,1261,1263,O
a,1264,1265,O
hypercoagulable,1266,1281,O
direction,1282,1291,O
.,1291,1292,O
Only,1293,1297,O
the,1298,1301,O
R,1302,1303,O
",",1303,1304,O
however,1305,1312,O
",",1312,1313,O
was,1314,1317,O
significantly,1318,1331,O
affected,1332,1340,O
(,1341,1342,O
12,1342,1344,O
%,1344,1345,O
),1345,1346,O
when,1347,1351,O
samples,1352,1359,O
rested,1360,1366,O
for,1367,1370,O
0,1371,1372,O
and,1373,1376,O
30,1377,1379,O
minutes,1380,1387,O
were,1388,1392,O
evaluated,1393,1402,O
with,1403,1407,O
kaolin,1408,1414,O
as,1415,1417,O
the,1418,1421,O
activator,1422,1431,O
.,1431,1432,O
CONCLUSION,1433,1443,O
:,1443,1444,O
The,1445,1448,O
TEG,1449,1452,O
assays,1453,1459,O
evaluated,1460,1469,O
were,1470,1474,O
reproducible,1475,1487,O
and,1488,1491,O
present,1492,1499,O
with,1500,1504,O
an,1505,1507,O
acceptable,1508,1518,O
CV,1519,1521,O
%,1521,1522,O
for,1523,1526,O
routine,1527,1534,O
clinical,1535,1543,O
practice,1544,1552,O
.,1552,1553,O
Kaolin,1554,1560,O
and,1561,1564,O
TF,1565,1567,O
1,1568,1569,O
:,1569,1570,O
17,1570,1572,O
",",1572,1573,O
000,1573,1576,O
equally,1577,1584,O
affected,1585,1593,O
the,1594,1597,O
clot,1598,1602,B-Organism_substance
formation,1603,1612,O
variables,1613,1622,O
.,1622,1623,O
Storage,1624,1631,O
of,1632,1634,O
WB,1635,1637,B-Organism_substance
for,1638,1641,O
up,1642,1644,O
to,1645,1647,O
30,1648,1650,O
minutes,1651,1658,O
in,1659,1661,O
citrate,1662,1669,O
did,1670,1673,O
not,1674,1677,O
",",1677,1678,O
except,1679,1685,O
for,1686,1689,O
R,1690,1691,O
",",1691,1692,O
affect,1693,1699,O
clot,1700,1704,B-Organism_substance
formation,1705,1714,O
variables,1715,1724,O
when,1725,1729,O
kaolin,1730,1736,O
was,1737,1740,O
used,1741,1745,O
as,1746,1748,O
activator,1749,1758,O
allowing,1759,1767,O
for,1768,1771,O
immediate,1772,1781,O
analysis,1782,1790,O
when,1791,1795,O
the,1796,1799,O
sample,1800,1806,O
arrives,1807,1814,O
in,1815,1817,O
the,1818,1821,O
laboratory,1822,1832,O
.,1832,1833,O
[,0,1,O
TESE,1,5,O
and,6,9,O
mTESE,10,15,O
.,15,16,O
Therapeutic,17,28,O
options,29,36,O
in,37,39,O
male,40,44,O
infertility,45,56,O
due,57,60,O
to,61,63,O
testicular,64,74,B-Organ
azoospermia,75,86,O
],86,87,O
.,87,88,O
Modern,89,95,O
techniques,96,106,O
of,107,109,O
testicular,110,120,B-Cell
sperm,121,126,I-Cell
extraction,127,137,O
(,138,139,O
TESE,139,143,O
),143,144,O
make,145,149,O
it,150,152,O
possible,153,161,O
for,162,165,O
an,166,168,O
infertile,169,178,O
man,179,182,O
to,183,185,O
father,186,192,O
a,193,194,O
child,195,200,O
.,200,201,O
The,202,205,O
operations,206,216,O
are,217,220,O
standardized,221,233,O
to,234,236,O
a,237,238,O
large,239,244,O
extent,245,251,O
and,252,255,O
the,256,259,O
underlying,260,270,O
morphological,271,284,O
alterations,285,296,O
of,297,299,O
spermatogenesis,300,315,O
also,316,320,O
appear,321,327,O
to,328,330,O
be,331,333,O
sufficiently,334,346,O
known,347,352,O
.,352,353,O
Current,354,361,O
research,362,370,O
is,371,373,O
focused,374,381,O
on,382,384,O
prognostic,385,395,O
factors,396,403,O
for,404,407,O
the,408,411,O
testicular,412,422,B-Organ
material,423,431,O
that,432,436,O
determine,437,446,O
the,447,450,O
sperm,451,456,B-Cell
retrieval,457,466,O
rate,467,471,O
and,472,475,O
success,476,483,O
rates,484,489,O
after,490,495,O
in,496,498,O
vitro,499,504,O
fertilization,505,518,O
/,518,519,O
intracytoplasmic,519,535,O
sperm,536,541,B-Cell
injection,542,551,O
(,552,553,O
IVF,553,556,O
-,556,557,O
ICSI,557,561,O
),561,562,O
.,562,563,O
TESE,563,567,O
and,568,571,O
microTESE,572,581,O
are,582,585,O
accepted,586,594,O
standard,595,603,O
operations,604,614,O
for,615,618,O
testicular,619,629,B-Cell
sperm,630,635,I-Cell
retrieval,636,645,O
for,646,649,O
IVF,650,653,O
/,653,654,O
ICSI,654,658,O
.,658,659,O
Predictions,660,671,O
for,672,675,O
effective,676,685,O
sperm,686,691,B-Cell
recovery,692,700,O
are,701,704,O
addressed,705,714,O
.,714,715,O
Quantitative,0,12,O
retention,13,22,O
-,22,23,O
biological,23,33,O
activity,34,42,O
relationship,43,55,O
study,56,61,O
by,62,64,O
micellar,65,73,O
liquid,74,80,O
chromatography,81,95,O
.,95,96,O
In,97,99,O
a,100,101,O
previous,102,110,O
paper,111,116,O
",",116,117,O
the,118,121,O
usefulness,122,132,O
of,133,135,O
micellar,136,144,O
liquid,145,151,O
chromatography,152,166,O
(,167,168,O
MLC,168,171,O
),171,172,O
in,173,175,O
predicting,176,186,O
octanol,187,194,O
-,194,195,O
water,195,200,O
partition,201,210,O
coefficients,211,223,O
of,224,226,O
organic,227,234,O
compounds,235,244,O
was,245,248,O
reported,249,257,O
.,257,258,O
This,259,263,O
paper,264,269,O
is,270,272,O
the,273,276,O
first,277,282,O
successful,283,293,O
report,294,300,O
of,301,303,O
a,304,305,O
quantitative,306,318,O
retention,319,328,O
-,328,329,O
activity,329,337,O
relationship,338,350,O
study,351,356,O
using,357,362,O
the,363,366,O
retention,367,376,O
factor,377,383,O
in,384,386,O
MLC,387,390,O
for,391,394,O
predicting,395,405,O
the,406,409,O
biological,410,420,O
activity,421,429,O
of,430,432,O
a,433,434,O
group,435,440,O
of,441,443,O
phenolic,444,452,O
compounds,453,462,O
.,462,463,O
Excellent,464,473,O
correlation,474,485,O
was,486,489,O
obtained,490,498,O
between,499,506,O
the,507,510,O
capacity,511,519,O
factor,520,526,O
in,527,529,O
MLC,530,533,O
and,534,537,O
the,538,541,O
bioactivity,542,553,O
(,554,555,O
measured,555,563,O
as,564,566,O
log,567,570,O
1,571,572,O
/,572,573,O
C,573,574,O
",",574,575,O
where,576,581,O
C,582,583,O
is,584,586,O
the,587,590,O
50,591,593,O
%,593,594,O
inhibitory,595,605,O
growth,606,612,O
concentration,613,626,O
),626,627,O
of,628,630,O
26,631,633,O
para,634,638,O
-,638,639,O
substituted,639,650,O
phenols,651,658,O
.,658,659,O
A,660,661,O
single,662,668,O
MLC,669,672,O
retention,673,682,O
parameter,683,692,O
is,693,695,O
capable,696,703,O
of,704,706,O
describing,707,717,O
the,718,721,O
bioactivity,722,733,O
of,734,736,O
phenols,737,744,O
",",744,745,O
while,746,751,O
three,752,757,O
conventional,758,770,O
molecular,771,780,O
descriptors,781,792,O
(,793,794,O
log,794,797,O
P,798,799,O
(,799,800,O
ow,800,802,O
),802,803,O
",",803,804,O
pKa,805,808,O
",",808,809,O
and,810,813,O
R,814,815,O
),815,816,O
are,817,820,O
needed,821,827,O
to,828,830,O
achieve,831,838,O
a,839,840,O
similar,841,848,O
correlation,849,860,O
.,860,861,O
This,862,866,O
indicates,867,876,O
that,877,881,O
both,882,886,O
hydrophobic,887,898,O
and,899,902,O
electronic,903,913,O
interactions,914,926,O
are,927,930,O
incorporated,931,943,O
in,944,946,O
a,947,948,O
single,949,955,O
MLC,956,959,O
retention,960,969,O
parameter,970,979,O
",",979,980,O
which,981,986,O
is,987,989,O
due,990,993,O
to,994,996,O
the,997,1000,O
amphiphilic,1001,1012,O
nature,1013,1019,O
of,1020,1022,O
surfactants,1023,1034,O
in,1035,1037,O
the,1038,1041,O
system,1042,1048,O
.,1048,1049,O
In,1050,1052,O
situations,1053,1063,O
like,1064,1068,O
this,1069,1073,O
",",1073,1074,O
QRAR,1075,1079,O
is,1080,1082,O
a,1083,1084,O
suitable,1085,1093,O
alternative,1094,1105,O
to,1106,1108,O
QSAR,1109,1113,O
since,1114,1119,O
measuring,1120,1129,O
MLC,1130,1133,O
retention,1134,1143,O
is,1144,1146,O
much,1147,1151,O
easier,1152,1158,O
than,1159,1163,O
measuring,1164,1173,O
different,1174,1183,O
molecular,1184,1193,O
descriptors,1194,1205,O
needed,1206,1212,O
to,1213,1215,O
build,1216,1221,O
the,1222,1225,O
QSAR,1226,1230,O
model,1231,1236,O
.,1236,1237,O
Addition,1238,1246,O
of,1247,1249,O
10,1250,1252,O
%,1252,1253,O
2,1254,1255,O
-,1255,1256,O
propanol,1256,1264,O
to,1265,1267,O
a,1268,1269,O
micellar,1270,1278,O
system,1279,1285,O
(,1286,1287,O
hybrid,1287,1293,O
system,1294,1300,O
),1300,1301,O
proved,1302,1308,O
to,1309,1311,O
be,1312,1314,O
the,1315,1318,O
best,1319,1323,O
chromatographic,1324,1339,O
system,1340,1346,O
for,1347,1350,O
the,1351,1354,O
best,1355,1359,O
estimation,1360,1370,O
of,1371,1373,O
the,1374,1377,O
phenols,1378,1385,O
bioactivity,1386,1397,O
.,1397,1398,O
Other,1399,1404,O
chromatographic,1405,1420,O
factors,1421,1428,O
such,1429,1433,O
as,1434,1436,O
pH,1437,1439,O
and,1440,1443,O
stationary,1444,1454,O
phase,1455,1460,O
also,1461,1465,O
showed,1466,1472,O
significant,1473,1484,O
effect,1485,1491,O
on,1492,1494,O
the,1495,1498,O
correlation,1499,1510,O
between,1511,1518,O
capacity,1519,1527,O
factor,1528,1534,O
k,1535,1536,O
',1536,1537,O
and,1538,1541,O
log,1542,1545,O
1,1546,1547,O
/,1547,1548,O
C,1548,1549,O
.,1549,1550,O
Atypical,0,8,O
mycobacteriosis,9,24,O
of,25,27,O
the,28,31,O
larynx,32,38,B-Multi-tissue_structure
:,38,39,O
an,40,42,O
unusual,43,50,O
clinical,51,59,O
presentation,60,72,O
secondary,73,82,O
to,83,85,O
steroids,86,94,O
inhalation,95,105,O
.,105,106,O
Vocal,107,112,O
cords,113,118,O
stiffness,119,128,O
can,129,132,O
be,133,135,O
associated,136,146,O
with,147,151,O
a,152,153,O
variety,154,161,O
of,162,164,O
etiologic,165,174,O
agents,175,181,O
",",181,182,O
but,183,186,O
it,187,189,O
is,190,192,O
rarely,193,199,O
seen,200,204,O
with,205,209,O
atypical,210,218,O
mycobacteria,219,231,O
",",231,232,O
for,233,236,O
example,237,244,O
",",244,245,O
Mycobacterium,246,259,O
avium,260,265,O
complex,266,273,O
.,273,274,O
We,275,277,O
report,278,284,O
a,285,286,O
case,287,291,O
of,292,294,O
a,295,296,O
35,297,299,O
-,299,300,O
year,300,304,O
-,304,305,O
old,305,308,O
white,309,314,O
woman,315,320,O
who,321,324,O
is,325,327,O
and,328,331,O
was,332,335,O
maintained,336,346,O
on,347,349,O
inhaled,350,357,O
steroids,358,366,O
.,366,367,O
She,368,371,O
presented,372,381,O
with,382,386,O
hoarseness,387,397,O
and,398,401,O
low,402,405,O
-,405,406,O
grade,406,411,O
fever,412,417,O
",",417,418,O
but,419,422,O
her,423,426,O
medical,427,434,O
history,435,442,O
was,443,446,O
otherwise,447,456,O
unremarkable,457,469,O
.,469,470,O
Laryngoscopy,471,483,O
revealed,484,492,O
bilateral,493,502,O
scarring,503,511,O
of,512,514,O
the,515,518,O
vocal,519,524,B-Multi-tissue_structure
cords,525,530,I-Multi-tissue_structure
.,530,531,O
Vocal,532,537,B-Multi-tissue_structure
cord,538,542,I-Multi-tissue_structure
biopsies,543,551,O
were,552,556,O
performed,557,566,O
.,566,567,O
Histologic,568,578,O
examination,579,590,O
revealed,591,599,O
unremarkable,600,612,O
laryngeal,613,622,B-Multi-tissue_structure
mucosa,623,629,I-Multi-tissue_structure
",",629,630,O
except,631,637,O
for,638,641,O
abundant,642,650,O
subepithelial,651,664,B-Pathological_formation
non,665,668,I-Pathological_formation
-,668,669,I-Pathological_formation
necrotizing,669,680,I-Pathological_formation
granulomata,681,692,I-Pathological_formation
.,692,693,O
The,694,697,O
differential,698,710,O
diagnosis,711,720,O
included,721,729,O
sarcoid,730,737,B-Pathological_formation
",",737,738,O
Klebsiella,739,749,B-Pathological_formation
scleroma,750,758,I-Pathological_formation
",",758,759,O
and,760,763,O
tuberculosis,764,776,O
.,776,777,O
Special,778,785,O
stains,786,792,O
reviewed,793,801,O
abundant,802,810,O
acid,811,815,O
-,815,816,O
fast,816,820,O
bacilli,821,828,O
",",828,829,O
later,830,835,O
confirmed,836,845,O
by,846,848,O
a,849,850,O
DNA,851,854,O
assay,855,860,O
on,861,863,O
induced,864,871,O
deep,872,876,O
sputum,877,883,B-Organism_substance
",",883,884,O
consistent,885,895,O
with,896,900,O
M,901,902,O
avium,903,908,O
complex,909,916,O
.,916,917,O
Subsequently,918,930,O
",",930,931,O
steroids,932,940,O
were,941,945,O
withdrawn,946,955,O
",",955,956,O
and,957,960,O
the,961,964,O
patient,965,972,O
was,973,976,O
treated,977,984,O
with,985,989,O
a,990,991,O
multiple,992,1000,O
-,1000,1001,O
drug,1001,1005,O
antituberculous,1006,1021,O
regimen,1022,1029,O
and,1030,1033,O
had,1034,1037,O
a,1038,1039,O
full,1040,1044,O
recovery,1045,1053,O
.,1053,1054,O
This,1055,1059,O
unusual,1060,1067,O
clinical,1068,1076,O
presentation,1077,1089,O
of,1090,1092,O
the,1093,1096,O
atypical,1097,1105,O
mycobacteriosis,1106,1121,O
may,1122,1125,O
be,1126,1128,O
encountered,1129,1140,O
by,1141,1143,O
otolaryngologists,1144,1161,O
and,1162,1165,O
pathologists,1166,1178,O
",",1178,1179,O
and,1180,1183,O
it,1184,1186,O
is,1187,1189,O
critical,1190,1198,O
to,1199,1201,O
recognize,1202,1211,O
it,1212,1214,O
in,1215,1217,O
patients,1218,1226,O
immunocompromised,1227,1244,O
because,1245,1252,O
of,1253,1255,O
steroids,1256,1264,O
.,1264,1265,O
Are,0,3,O
former,4,10,O
female,11,17,O
elite,18,23,O
athletes,24,32,O
more,33,37,O
likely,38,44,O
to,45,47,O
experience,48,58,O
urinary,59,66,B-Organism_substance
incontinence,67,79,O
later,80,85,O
in,86,88,O
life,89,93,O
than,94,98,O
non,99,102,O
-,102,103,O
athletes,103,111,O
?,111,112,O
The,113,116,O
aim,117,120,O
of,121,123,O
the,124,127,O
present,128,135,O
study,136,141,O
was,142,145,O
to,146,148,O
investigate,149,160,O
whether,161,168,O
former,169,175,O
female,176,182,O
elite,183,188,O
athletes,189,197,O
are,198,201,O
more,202,206,O
likely,207,213,O
to,214,216,O
experience,217,227,O
urinary,228,235,B-Organism_substance
incontinence,236,248,O
(,249,250,O
UI,250,252,O
),252,253,O
later,254,259,O
in,260,262,O
life,263,267,O
than,268,272,O
non,273,276,O
-,276,277,O
athletes,277,285,O
and,286,289,O
to,290,292,O
assess,293,299,O
possible,300,308,O
risk,309,313,O
factors,314,321,O
for,322,325,O
UI,326,328,O
in,329,331,O
athletes,332,340,O
.,340,341,O
Three,342,347,O
hundred,348,355,O
and,356,359,O
thirty,360,366,O
-,366,367,O
one,367,370,O
former,371,377,O
elite,378,383,O
athletes,384,392,O
(,393,394,O
response,394,402,O
rate,403,407,O
81,408,410,O
%,410,411,O
),411,412,O
and,413,416,O
640,417,420,O
controls,421,429,O
replied,430,437,O
to,438,440,O
a,441,442,O
postal,443,449,O
questionnaire,450,463,O
including,464,473,O
validated,474,483,O
questions,484,493,O
on,494,496,O
UI,497,499,O
.,499,500,O
While,501,506,O
competing,507,516,O
in,517,519,O
sport,520,525,O
",",525,526,O
10,527,529,O
.,529,530,O
9,530,531,O
%,531,532,O
and,533,536,O
2,537,538,O
.,538,539,O
7,539,540,O
%,540,541,O
of,542,544,O
the,545,548,O
former,549,555,O
elite,556,561,O
athletes,562,570,O
reported,571,579,O
stress,580,586,O
urinary,587,594,B-Organism_substance
incontinence,595,607,O
(,608,609,O
SUI,609,612,O
),612,613,O
and,614,617,O
urge,618,622,O
incontinence,623,635,O
",",635,636,O
respectively,637,649,O
.,649,650,O
Presently,651,660,O
",",660,661,O
36,662,664,O
.,664,665,O
5,665,666,O
%,666,667,O
of,668,670,O
the,671,674,O
former,675,681,O
elite,682,687,O
athletes,688,696,O
and,697,700,O
36,701,703,O
.,703,704,O
9,704,705,O
%,705,706,O
of,707,709,O
the,710,713,O
controls,714,722,O
reported,723,731,O
SUI,732,735,O
.,735,736,O
9,737,738,O
.,738,739,O
1,739,740,O
%,740,741,O
and,742,745,O
9,746,747,O
.,747,748,O
4,748,749,O
%,749,750,O
reported,751,759,O
urge,760,764,O
incontinence,765,777,O
.,777,778,O
Among,779,784,O
former,785,791,O
elite,792,797,O
athletes,798,806,O
",",806,807,O
those,808,813,O
with,814,818,O
two,819,822,O
or,823,825,O
three,826,831,O
children,832,840,O
were,841,845,O
more,846,850,O
likely,851,857,O
than,858,862,O
nulliparous,863,874,O
women,875,880,O
to,881,883,O
have,884,888,O
UI,889,891,O
now,892,895,O
.,895,896,O
Also,897,901,O
",",901,902,O
among,903,908,O
former,909,915,O
athletes,916,924,O
",",924,925,O
UI,926,928,O
was,929,932,O
more,933,937,O
common,938,944,O
in,945,947,O
women,948,953,O
with,954,958,O
vs,959,961,O
those,962,967,O
without,968,975,O
UI,976,978,O
while,979,984,O
competing,985,994,O
(,995,996,O
odds,996,1000,O
ratio,1001,1006,O
8,1007,1008,O
.,1008,1009,O
57,1009,1011,O
",",1011,1012,O
95,1013,1015,O
%,1015,1016,O
confidence,1017,1027,O
interval,1028,1036,O
:,1036,1037,O
3,1038,1039,O
.,1039,1040,O
55,1040,1042,O
-,1042,1043,O
20,1043,1045,O
.,1045,1046,O
71,1046,1048,O
),1048,1049,O
.,1049,1050,O
Age,1051,1054,O
",",1054,1055,O
menopause,1056,1065,O
and,1066,1069,O
being,1070,1075,O
regularly,1076,1085,O
physically,1086,1096,O
active,1097,1103,O
now,1104,1107,O
were,1108,1112,O
not,1113,1116,O
associated,1117,1127,O
with,1128,1132,O
UI,1133,1135,O
in,1136,1138,O
either,1139,1145,O
group,1146,1151,O
.,1151,1152,O
Based,1153,1158,O
on,1159,1161,O
this,1162,1166,O
study,1167,1172,O
",",1172,1173,O
the,1174,1177,O
prevalence,1178,1188,O
of,1189,1191,O
UI,1192,1194,O
does,1195,1199,O
not,1200,1203,O
seem,1204,1208,O
to,1209,1211,O
be,1212,1214,O
higher,1215,1221,O
in,1222,1224,O
former,1225,1231,O
athletes,1232,1240,O
than,1241,1245,O
in,1246,1248,O
controls,1249,1257,O
.,1257,1258,O
However,1259,1266,O
",",1266,1267,O
the,1268,1271,O
results,1272,1279,O
indicate,1280,1288,O
that,1289,1293,O
UI,1294,1296,O
early,1297,1302,O
in,1303,1305,O
life,1306,1310,O
",",1310,1311,O
as,1312,1314,O
reported,1315,1323,O
during,1324,1330,O
elite,1331,1336,O
sport,1337,1342,O
",",1342,1343,O
is,1344,1346,O
a,1347,1348,O
strong,1349,1355,O
predictor,1356,1365,O
of,1366,1368,O
UI,1369,1371,O
later,1372,1377,O
in,1378,1380,O
life,1381,1385,O
.,1385,1386,O
Handling,0,8,O
within,9,15,O
run,16,19,O
retention,20,29,O
time,30,34,O
shifts,35,41,O
in,42,44,O
two,45,48,O
-,48,49,O
dimensional,49,60,O
chromatography,61,75,O
data,76,80,O
using,81,86,O
shift,87,92,O
correction,93,103,O
and,104,107,O
modeling,108,116,O
.,116,117,O
The,118,121,O
use,122,125,O
of,126,128,O
PARAFAC,129,136,O
for,137,140,O
modeling,141,149,O
GC,150,152,O
x,153,154,O
GC,155,157,O
-,157,158,O
TOFMS,158,163,O
peaks,164,169,O
is,170,172,O
well,173,177,O
documented,178,188,O
.,188,189,O
This,190,194,O
success,195,202,O
is,203,205,O
due,206,209,O
to,210,212,O
the,213,216,O
trilinear,217,226,O
structure,227,236,O
of,237,239,O
these,240,245,O
data,246,250,O
under,251,256,O
ideal,257,262,O
",",262,263,O
or,264,266,O
sufficiently,267,279,O
close,280,285,O
to,286,288,O
ideal,289,294,O
",",294,295,O
chromatographic,296,311,O
conditions,312,322,O
.,322,323,O
However,324,331,O
",",331,332,O
using,333,338,O
temperature,339,350,O
programming,351,362,O
to,363,365,O
cope,366,370,O
with,371,375,O
the,376,379,O
general,380,387,O
elution,388,395,O
problem,396,403,O
",",403,404,O
deviations,405,415,O
from,416,420,O
trilinearity,421,433,O
within,434,440,O
a,441,442,O
run,443,446,O
are,447,450,O
more,451,455,O
likely,456,462,O
to,463,465,O
be,466,468,O
seen,469,473,O
for,474,477,O
the,478,481,O
following,482,491,O
three,492,497,O
cases,498,503,O
:,503,504,O
(,505,506,O
1,506,507,O
),507,508,O
compounds,509,518,O
(,519,520,O
i,520,521,O
.,521,522,O
e,522,523,O
.,523,524,O
",",524,525,O
analytes,526,534,O
),534,535,O
severely,536,544,O
broadened,545,554,O
on,555,557,O
the,558,561,O
first,562,567,O
column,568,574,O
hence,575,580,O
defined,581,588,O
by,589,591,O
many,592,596,O
modulation,597,607,O
periods,608,615,O
",",615,616,O
(,617,618,O
2,618,619,O
),619,620,O
analytes,621,629,O
with,630,634,O
a,635,636,O
very,637,641,O
high,642,646,O
retention,647,656,O
factor,657,663,O
on,664,666,O
the,667,670,O
second,671,677,O
column,678,684,O
and,685,688,O
likely,689,695,O
wrapped,696,703,O
around,704,710,O
in,711,713,O
that,714,718,O
dimension,719,728,O
",",728,729,O
or,730,732,O
(,733,734,O
3,734,735,O
),735,736,O
with,737,741,O
fast,742,746,O
temperature,747,758,O
program,759,766,O
rates,767,772,O
.,772,773,O
This,774,778,O
deviation,779,788,O
from,789,793,O
trilinearity,794,806,O
is,807,809,O
seen,810,814,O
as,815,817,O
retention,818,827,O
time,828,832,O
-,832,833,O
shifted,833,840,O
peak,841,845,O
profiles,846,854,O
in,855,857,O
subsequent,858,868,O
modulation,869,879,O
periods,880,887,O
(,888,889,O
first,889,894,O
column,895,901,O
fractions,902,911,O
),911,912,O
.,912,913,O
In,914,916,O
this,917,921,O
report,922,928,O
",",928,929,O
a,930,931,O
relaxed,932,939,O
yet,940,943,O
powerful,944,952,O
version,953,960,O
of,961,963,O
PARAFAC,964,971,O
",",971,972,O
known,973,978,O
as,979,981,O
PARAFAC2,982,990,O
has,991,994,O
been,995,999,O
applied,1000,1007,O
to,1008,1010,O
handle,1011,1017,O
this,1018,1022,O
shift,1023,1028,O
within,1029,1035,O
the,1036,1039,O
model,1040,1045,O
step,1046,1050,O
by,1051,1053,O
allowing,1054,1062,O
generation,1063,1073,O
of,1074,1076,O
individual,1077,1087,O
peak,1088,1092,O
profiles,1093,1101,O
in,1102,1104,O
subsequent,1105,1115,O
first,1116,1121,O
column,1122,1128,O
fractions,1129,1138,O
.,1138,1139,O
An,1140,1142,O
alternative,1143,1154,O
approach,1155,1163,O
was,1164,1167,O
also,1168,1172,O
studied,1173,1180,O
",",1180,1181,O
utilizing,1182,1191,O
a,1192,1193,O
standard,1194,1202,O
retention,1203,1212,O
time,1213,1217,O
shift,1218,1223,O
correction,1224,1234,O
to,1235,1237,O
restore,1238,1245,O
the,1246,1249,O
data,1250,1254,O
trilinearity,1255,1267,O
structure,1268,1277,O
followed,1278,1286,O
by,1287,1289,O
PARAFAC,1290,1297,O
.,1297,1298,O
These,1299,1304,O
two,1305,1308,O
approaches,1309,1319,O
are,1320,1323,O
compared,1324,1332,O
when,1333,1337,O
identifying,1338,1349,O
and,1350,1353,O
quantifying,1354,1365,O
a,1366,1367,O
known,1368,1373,O
analyte,1374,1381,O
over,1382,1386,O
a,1387,1388,O
large,1389,1394,O
concentration,1395,1408,O
series,1409,1415,O
where,1416,1421,O
a,1422,1423,O
certain,1424,1431,O
shift,1432,1437,O
is,1438,1440,O
simulated,1441,1450,O
in,1451,1453,O
the,1454,1457,O
successive,1458,1468,O
first,1469,1474,O
column,1475,1481,O
fractions,1482,1491,O
.,1491,1492,O
Finally,1493,1500,O
",",1500,1501,O
the,1502,1505,O
methods,1506,1513,O
are,1514,1517,O
applied,1518,1525,O
to,1526,1528,O
real,1529,1533,O
chromatographic,1534,1549,O
data,1550,1554,O
showing,1555,1562,O
severely,1563,1571,O
shifted,1572,1579,O
peak,1580,1584,O
profiles,1585,1593,O
.,1593,1594,O
The,1595,1598,O
pros,1599,1603,O
and,1604,1607,O
cons,1608,1612,O
of,1613,1615,O
the,1616,1619,O
presented,1620,1629,O
approaches,1630,1640,O
are,1641,1644,O
discussed,1645,1654,O
in,1655,1657,O
relation,1658,1666,O
to,1667,1669,O
the,1670,1673,O
model,1674,1679,O
parameters,1680,1690,O
",",1690,1691,O
the,1692,1695,O
signal,1696,1702,O
-,1702,1703,O
to,1703,1705,O
-,1705,1706,O
noise,1706,1711,O
ratio,1712,1717,O
and,1718,1721,O
the,1722,1725,O
degree,1726,1732,O
of,1733,1735,O
shift,1736,1741,O
.,1741,1742,O
[,0,1,O
Incidence,1,10,O
of,11,13,O
fungal,14,20,O
infection,21,30,O
in,31,33,O
surgical,34,42,O
diseases,43,51,O
of,52,54,O
the,55,58,O
pancreas,59,67,B-Organ
],67,68,O
.,68,69,O
Recently,70,78,O
the,79,82,O
number,83,89,O
of,90,92,O
mycotic,93,100,O
infections,101,111,O
has,112,115,O
increased,116,125,O
significantly,126,139,O
.,139,140,O
Authors,141,148,O
have,149,153,O
observed,154,162,O
13,163,165,O
mycotic,166,173,O
infections,174,184,O
on,185,187,O
operated,188,196,O
patients,197,205,O
suffering,206,215,O
pancreatic,216,226,B-Organ
diseases,227,235,O
between,236,243,O
1984,244,248,O
and,249,252,O
1990,253,257,O
.,257,258,O
9,259,260,O
of,261,263,O
13,264,266,O
patients,267,275,O
had,276,279,O
pancreatic,280,290,B-Pathological_formation
abscesses,291,300,I-Pathological_formation
as,301,303,O
well,304,308,O
.,308,309,O
The,310,313,O
risk,314,318,O
factors,319,326,O
of,327,329,O
fungal,330,336,O
infections,337,347,O
are,348,351,O
analysed,352,360,O
.,360,361,O
It,362,364,O
is,365,367,O
important,368,377,O
to,378,380,O
take,381,385,O
differentiation,386,401,O
between,402,409,O
fungal,410,416,O
colonisation,417,429,O
and,430,433,O
septicaemia,434,445,O
caused,446,452,O
by,453,455,O
yeasts,456,462,O
.,462,463,O
Repeated,464,472,O
microbiological,473,488,O
examinations,489,501,O
can,502,505,O
promote,506,513,O
recognising,514,525,O
of,526,528,O
the,529,532,O
fungal,533,539,O
invasion,540,548,O
.,548,549,O
The,550,553,O
base,554,558,O
of,559,561,O
the,562,565,O
therapy,566,573,O
is,574,576,O
to,577,579,O
avoid,580,585,O
risk,586,590,O
factors,591,598,O
of,599,601,O
infections,602,612,O
and,613,616,O
to,617,619,O
use,620,623,O
antifungal,624,634,O
medication,635,645,O
in,646,648,O
time,649,653,O
.,653,654,O
[,0,1,O
Quantitative,1,13,O
analysis,14,22,O
of,23,25,O
regional,26,34,O
cerebral,35,43,B-Organ
blood,44,49,B-Organism_substance
flow,50,54,O
in,55,57,O
elderly,58,65,O
with,66,70,O
white,71,76,B-Pathological_formation
matter,77,83,I-Pathological_formation
lesions,84,91,I-Pathological_formation
],91,92,O
.,92,93,O
OBJECTIVE,94,103,O
:,103,104,O
To,105,107,O
observe,108,115,O
whether,116,123,O
the,124,127,O
severity,128,136,O
of,137,139,O
white,140,145,B-Pathological_formation
matter,146,152,I-Pathological_formation
lesions,153,160,I-Pathological_formation
(,161,162,O
WML,162,165,B-Pathological_formation
),165,166,O
is,167,169,O
related,170,177,O
to,178,180,O
ischemia,181,189,O
in,190,192,O
elderly,193,200,O
.,200,201,O
METHODS,202,209,O
:,209,210,O
WML,211,214,B-Pathological_formation
were,215,219,O
divided,220,227,O
into,228,232,O
2,233,234,O
categories,235,245,O
(,246,247,O
centrum,247,254,B-Multi-tissue_structure
semiovale,255,264,I-Multi-tissue_structure
and,265,268,O
periventricular,269,284,B-Multi-tissue_structure
regions,285,292,I-Multi-tissue_structure
),292,293,O
and,294,297,O
four,298,302,O
grades,303,309,O
(,310,311,O
grade,311,316,O
0,317,318,O
",",318,319,O
grade,320,325,O
1,326,327,O
",",327,328,O
grade,329,334,O
2,335,336,O
and,337,340,O
grade,341,346,O
3,347,348,O
),348,349,O
according,350,359,O
to,360,362,O
the,363,366,O
severity,367,375,O
of,376,378,O
WML,379,382,B-Pathological_formation
showing,383,390,O
on,391,393,O
the,394,397,O
FLAIR,398,403,O
sequence,404,412,O
of,413,415,O
MRI,416,419,O
using,420,425,O
modified,426,434,O
Fazekas,435,442,O
scale,443,448,O
.,448,449,O
The,450,453,O
values,454,460,O
of,461,463,O
regional,464,472,O
cerebral,473,481,B-Organ
blood,482,487,B-Organism_substance
flow,488,492,O
(,493,494,O
rCBF,494,498,O
),498,499,O
within,500,506,O
WML,507,510,B-Pathological_formation
and,511,514,O
other,515,520,O
brain,521,526,B-Organ
regions,527,534,O
were,535,539,O
measured,540,548,O
using,549,554,O
Xenon,555,560,O
contrast,561,569,O
CT,570,572,O
.,572,573,O
RESULTS,574,581,O
:,581,582,O
Mean,583,587,O
rCBF,588,592,O
(,593,594,O
ml,594,596,O
x,597,598,O
100,599,602,O
g,603,604,O
(,604,605,O
-,605,606,O
1,606,607,O
),607,608,O
x,609,610,O
min,611,614,O
(,614,615,O
-,615,616,O
1,616,617,O
),617,618,O
),618,619,O
within,620,626,O
lesions,627,634,B-Pathological_formation
around,635,641,O
periventricular,642,657,B-Multi-tissue_structure
areas,658,663,I-Multi-tissue_structure
",",663,664,O
in,665,667,O
right,668,673,O
and,674,677,O
left,678,682,O
centrum,683,690,B-Multi-tissue_structure
semiovale,691,700,I-Multi-tissue_structure
were,701,705,O
20,706,708,O
.,708,709,O
8,709,710,O
+,711,712,O
/,712,713,O
-,713,714,O
2,715,716,O
.,716,717,O
8,717,718,O
",",718,719,O
22,720,722,O
.,722,723,O
3,723,724,O
+,725,726,O
/,726,727,O
-,727,728,O
1,729,730,O
.,730,731,O
9,731,732,O
and,733,736,O
22,737,739,O
.,739,740,O
2,740,741,O
+,742,743,O
/,743,744,O
-,744,745,O
2,746,747,O
.,747,748,O
1,748,749,O
in,750,752,O
grade,753,758,O
0,759,760,O
;,760,761,O
20,762,764,O
.,764,765,O
3,765,766,O
+,767,768,O
/,768,769,O
-,769,770,O
2,771,772,O
.,772,773,O
5,773,774,O
",",774,775,O
21,776,778,O
.,778,779,O
3,779,780,O
+,781,782,O
/,782,783,O
-,783,784,O
1,785,786,O
.,786,787,O
0,787,788,O
and,789,792,O
21,793,795,O
.,795,796,O
0,796,797,O
+,798,799,O
/,799,800,O
-,800,801,O
1,802,803,O
.,803,804,O
8,804,805,O
in,806,808,O
grade1,809,815,O
;,815,816,O
16,817,819,O
.,819,820,O
3,820,821,O
+,822,823,O
/,823,824,O
-,824,825,O
2,826,827,O
.,827,828,O
0,828,829,O
",",829,830,O
15,831,833,O
.,833,834,O
6,834,835,O
+,836,837,O
/,837,838,O
-,838,839,O
1,840,841,O
.,841,842,O
7,842,843,O
and,844,847,O
15,848,850,O
.,850,851,O
9,851,852,O
+,853,854,O
/,854,855,O
-,855,856,O
0,857,858,O
.,858,859,O
9,859,860,O
in,861,863,O
grade,864,869,O
2,870,871,O
;,871,872,O
14,873,875,O
.,875,876,O
1,876,877,O
+,878,879,O
/,879,880,O
-,880,881,O
2,882,883,O
.,883,884,O
6,884,885,O
",",885,886,O
14,887,889,O
.,889,890,O
5,890,891,O
+,892,893,O
/,893,894,O
-,894,895,O
2,896,897,O
.,897,898,O
2,898,899,O
and,900,903,O
14,904,906,O
.,906,907,O
2,907,908,O
+,909,910,O
/,910,911,O
-,911,912,O
1,913,914,O
.,914,915,O
9,915,916,O
in,917,919,O
grade,920,925,O
3,926,927,O
respectively,928,940,O
.,940,941,O
The,942,945,O
severity,946,954,O
of,955,957,O
WML,958,961,B-Pathological_formation
is,962,964,O
associated,965,975,O
significantly,976,989,O
with,990,994,O
reduction,995,1004,O
of,1005,1007,O
rCBF,1008,1012,O
within,1013,1019,O
lesions,1020,1027,B-Pathological_formation
both,1028,1032,O
in,1033,1035,O
centrum,1036,1043,B-Multi-tissue_structure
semiovale,1044,1053,I-Multi-tissue_structure
and,1054,1057,O
periventricular,1058,1073,B-Multi-tissue_structure
regions,1074,1081,I-Multi-tissue_structure
(,1082,1083,O
all,1083,1086,O
P,1087,1088,O
<,1089,1090,O
0,1091,1092,O
.,1092,1093,O
05,1093,1095,O
),1095,1096,O
.,1096,1097,O
There,1098,1103,O
was,1104,1107,O
no,1108,1110,O
significant,1111,1122,O
difference,1123,1133,O
in,1134,1136,O
rCBF,1137,1141,O
values,1142,1148,O
between,1149,1156,O
grade,1157,1162,O
0,1163,1164,O
and,1165,1168,O
1,1169,1170,O
",",1170,1171,O
but,1172,1175,O
significant,1176,1187,O
differences,1188,1199,O
existed,1200,1207,O
between,1208,1215,O
grade,1216,1221,O
0,1222,1223,O
and,1224,1227,O
grades,1228,1234,O
2,1235,1236,O
and,1237,1240,O
3,1241,1242,O
",",1242,1243,O
between,1244,1251,O
grade,1252,1257,O
1,1258,1259,O
and,1260,1263,O
grades,1264,1270,O
2,1271,1272,O
and,1273,1276,O
3,1277,1278,O
(,1279,1280,O
all,1280,1283,O
P,1284,1285,O
<,1286,1287,O
0,1288,1289,O
.,1289,1290,O
05,1290,1292,O
),1292,1293,O
.,1293,1294,O
Statistical,1295,1306,O
significance,1307,1319,O
also,1320,1324,O
existed,1325,1332,O
between,1333,1340,O
the,1341,1344,O
severity,1345,1353,O
of,1354,1356,O
white,1357,1362,B-Pathological_formation
matter,1363,1369,I-Pathological_formation
lesions,1370,1377,I-Pathological_formation
and,1378,1381,O
rCBF,1382,1386,O
in,1387,1389,O
bilateral,1390,1399,O
temporal,1400,1408,B-Multi-tissue_structure
lobes,1409,1414,I-Multi-tissue_structure
and,1415,1418,O
lentiform,1419,1428,O
nucleases,1429,1438,O
(,1439,1440,O
P,1440,1441,O
<,1442,1443,O
0,1444,1445,O
.,1445,1446,O
05,1446,1448,O
),1448,1449,O
.,1449,1450,O
CONCLUSIONS,1451,1462,O
:,1462,1463,O
The,1464,1467,O
severity,1468,1476,O
of,1477,1479,O
WML,1480,1483,B-Pathological_formation
both,1484,1488,O
in,1489,1491,O
centrum,1492,1499,B-Multi-tissue_structure
semiovale,1500,1509,I-Multi-tissue_structure
and,1510,1513,O
periventricular,1514,1529,B-Pathological_formation
regions,1530,1537,I-Pathological_formation
is,1538,1540,O
associated,1541,1551,O
significantly,1552,1565,O
with,1566,1570,O
reduction,1571,1580,O
of,1581,1583,O
rCBF,1584,1588,O
within,1589,1595,O
lesions,1596,1603,B-Pathological_formation
.,1603,1604,O
Aging,0,5,O
affects,6,13,O
the,14,17,O
cardiovascular,18,32,B-Anatomical_system
responses,33,42,O
to,43,45,O
cold,46,50,O
stress,51,57,O
in,58,60,O
humans,61,67,O
.,67,68,O
Cardiovascular,69,83,B-Anatomical_system
-,83,84,O
related,84,91,O
mortality,92,101,O
peaks,102,107,O
during,108,114,O
cold,115,119,O
winter,120,126,O
months,127,133,O
",",133,134,O
particularly,135,147,O
in,148,150,O
older,151,156,O
adults,157,163,O
.,163,164,O
Acute,165,170,O
physiological,171,184,O
responses,185,194,O
",",194,195,O
such,196,200,O
as,201,203,O
increases,204,213,O
in,214,216,O
blood,217,222,B-Organism_substance
pressure,223,231,O
",",231,232,O
in,233,235,O
response,236,244,O
to,245,247,O
cold,248,252,O
exposure,253,261,O
may,262,265,O
contribute,266,276,O
to,277,279,O
these,280,285,O
associations,286,298,O
.,298,299,O
To,300,302,O
determine,303,312,O
whether,313,320,O
the,321,324,O
blood,325,330,B-Organism_substance
pressure,331,339,O
-,339,340,O
raising,340,347,O
effect,348,354,O
(,355,356,O
pressor,356,363,O
response,364,372,O
),372,373,O
of,374,376,O
non,377,380,O
-,380,381,O
internal,381,389,O
body,390,394,B-Organism_subdivision
temperature,395,406,O
-,406,407,O
reducing,407,415,O
cold,416,420,O
stress,421,427,O
is,428,430,O
greater,431,438,O
with,439,443,O
age,444,447,O
",",447,448,O
we,449,451,O
measured,452,460,O
physiological,461,474,O
responses,475,484,O
to,485,487,O
20,488,490,O
min,491,494,O
of,495,497,O
superficial,498,509,O
skin,510,514,B-Organ
cooling,515,522,O
",",522,523,O
via,524,527,O
water,528,533,O
-,533,534,O
perfused,534,542,O
suit,543,547,O
",",547,548,O
in,549,551,O
12,552,554,O
younger,555,562,O
[,563,564,O
25,564,566,O
+,567,568,O
/,568,569,O
-,569,570,O
1,571,572,O
(,573,574,O
SE,574,576,O
),576,577,O
yr,578,580,O
old,581,584,O
],584,585,O
and,586,589,O
12,590,592,O
older,593,598,O
(,599,600,O
65,600,602,O
+,603,604,O
/,604,605,O
-,605,606,O
2,607,608,O
yr,609,611,O
old,612,615,O
),615,616,O
adults,617,623,O
.,623,624,O
We,625,627,O
found,628,633,O
that,634,638,O
superficial,639,650,O
skin,651,655,B-Organ
cooling,656,663,O
elicited,664,672,O
an,673,675,O
increase,676,684,O
in,685,687,O
blood,688,693,B-Organism_substance
pressure,694,702,O
from,703,707,O
resting,708,715,O
levels,716,722,O
(,723,724,O
pressor,724,731,O
response,732,740,O
;,740,741,O
P,742,743,O
<,744,745,O
0,746,747,O
.,747,748,O
05,748,750,O
),750,751,O
in,752,754,O
younger,755,762,O
and,763,766,O
older,767,772,O
adults,773,779,O
.,779,780,O
However,781,788,O
",",788,789,O
the,790,793,O
magnitude,794,803,O
of,804,806,O
this,807,811,O
pressor,812,819,O
response,820,828,O
(,829,830,O
systolic,830,838,O
and,839,842,O
mean,843,847,O
blood,848,853,B-Organism_substance
pressure,854,862,O
),862,863,O
was,864,867,O
more,868,872,O
than,873,877,O
twofold,878,885,O
higher,886,892,O
in,893,895,O
older,896,901,O
adults,902,908,O
(,909,910,O
P,910,911,O
<,912,913,O
0,914,915,O
.,915,916,O
05,916,918,O
vs,919,921,O
.,921,922,O
younger,923,930,O
adults,931,937,O
),937,938,O
.,938,939,O
The,940,943,O
magnitude,944,953,O
of,954,956,O
the,957,960,O
pressor,961,968,O
response,969,977,O
was,978,981,O
similar,982,989,O
at,990,992,O
peripheral,993,1003,O
(,1004,1005,O
brachial,1005,1013,B-Organism_subdivision
),1013,1014,O
and,1015,1018,O
central,1019,1026,O
(,1027,1028,O
estimated,1028,1037,O
in,1038,1040,O
the,1041,1044,O
aorta,1045,1050,B-Multi-tissue_structure
),1050,1051,O
measurement,1052,1063,O
sites,1064,1069,O
.,1069,1070,O
Regression,1071,1081,O
analysis,1082,1090,O
revealed,1091,1099,O
that,1100,1104,O
aortic,1105,1111,B-Multi-tissue_structure
pulse,1112,1117,O
wave,1118,1122,O
velocity,1123,1131,O
",",1131,1132,O
a,1133,1134,O
measure,1135,1142,O
of,1143,1145,O
central,1146,1153,O
arterial,1154,1162,B-Multi-tissue_structure
stiffness,1163,1172,O
obtained,1173,1181,O
before,1182,1188,O
cooling,1189,1196,O
",",1196,1197,O
was,1198,1201,O
the,1202,1205,O
best,1206,1210,O
predictor,1211,1220,O
of,1221,1223,O
the,1224,1227,O
increased,1228,1237,O
pressor,1238,1245,O
response,1246,1254,O
to,1255,1257,O
superficial,1258,1269,O
skin,1270,1274,B-Organ
cooling,1275,1282,O
in,1283,1285,O
older,1286,1291,O
adults,1292,1298,O
",",1298,1299,O
explaining,1300,1310,O
approximately,1311,1324,O
63,1325,1327,O
%,1327,1328,O
of,1329,1331,O
its,1332,1335,O
variability,1336,1347,O
.,1347,1348,O
These,1349,1354,O
results,1355,1362,O
indicate,1363,1371,O
that,1372,1376,O
there,1377,1382,O
is,1383,1385,O
a,1386,1387,O
greater,1388,1395,O
pressor,1396,1403,O
response,1404,1412,O
to,1413,1415,O
non,1416,1419,O
-,1419,1420,O
internal,1420,1428,O
body,1429,1433,B-Organism_subdivision
temperature,1434,1445,O
-,1445,1446,O
reducing,1446,1454,O
cold,1455,1459,O
stress,1460,1466,O
with,1467,1471,O
age,1472,1475,O
in,1476,1478,O
humans,1479,1485,O
that,1486,1490,O
may,1491,1494,O
be,1495,1497,O
mediated,1498,1506,O
by,1507,1509,O
increased,1510,1519,O
levels,1520,1526,O
of,1527,1529,O
central,1530,1537,O
arterial,1538,1546,B-Multi-tissue_structure
stiffness,1547,1556,O
.,1556,1557,O
Magnesium,0,9,O
for,10,13,O
treatment,14,23,O
of,24,26,O
asthma,27,33,O
in,34,36,O
children,37,45,O
.,45,46,O
QUESTION,47,55,O
:,55,56,O
Magnesium,57,66,O
is,67,69,O
considered,70,80,O
adjuvant,81,89,O
therapy,90,97,O
for,98,101,O
moderate,102,110,O
to,111,113,O
severe,114,120,O
asthma,121,127,O
exacerbations,128,141,O
in,142,144,O
adults,145,151,O
",",151,152,O
but,153,156,O
can,157,160,O
it,161,163,O
be,164,166,O
used,167,171,O
to,172,174,O
treat,175,180,O
children,181,189,O
?,189,190,O
ANSWER,191,197,O
:,197,198,O
Magnesium,199,208,O
seems,209,214,O
to,215,217,O
be,218,220,O
beneficial,221,231,O
in,232,234,O
the,235,238,O
treatment,239,248,O
of,249,251,O
moderate,252,260,O
to,261,263,O
severe,264,270,O
asthma,271,277,O
in,278,280,O
children,281,289,O
.,289,290,O
It,291,293,O
is,294,296,O
a,297,298,O
safe,299,303,O
drug,304,308,O
to,309,311,O
administer,312,322,O
",",322,323,O
but,324,327,O
there,328,333,O
have,334,338,O
been,339,343,O
minor,344,349,O
side,350,354,O
effects,355,362,O
reported,363,371,O
",",371,372,O
such,373,377,O
as,378,380,O
epigastric,381,391,B-Organism_subdivision
or,392,394,O
facial,395,401,B-Organism_subdivision
warmth,402,408,O
",",408,409,O
flushing,410,418,O
",",418,419,O
pain,420,424,O
and,425,428,O
numbness,429,437,O
at,438,440,O
the,441,444,O
infusion,445,453,O
site,454,458,O
",",458,459,O
dry,460,463,O
mouth,464,469,B-Organism_subdivision
",",469,470,O
malaise,471,478,O
",",478,479,O
and,480,483,O
hypotension,484,495,O
.,495,496,O
Owing,497,502,O
to,503,505,O
its,506,509,O
bronchodilating,510,525,O
and,526,529,O
anti,530,534,O
-,534,535,O
inflammatory,535,547,O
effects,548,555,O
",",555,556,O
magnesium,557,566,O
is,567,569,O
an,570,572,O
encouraging,573,584,O
adjuvant,585,593,O
therapy,594,601,O
for,602,605,O
pediatric,606,615,O
patients,616,624,O
who,625,628,O
do,629,631,O
not,632,635,O
respond,636,643,O
to,644,646,O
conventional,647,659,O
treatment,660,669,O
in,670,672,O
acute,673,678,O
severe,679,685,O
exacerbations,686,699,O
.,699,700,O
Future,701,707,O
studies,708,715,O
should,716,722,O
focus,723,728,O
on,729,731,O
establishing,732,744,O
the,745,748,O
optimal,749,756,O
dosage,757,763,O
for,764,767,O
maximal,768,775,O
benefits,776,784,O
and,785,788,O
the,789,792,O
best,793,797,O
route,798,803,O
of,804,806,O
administration,807,821,O
.,821,822,O
Magnesium,823,832,O
should,833,839,O
also,840,844,O
be,845,847,O
considered,848,858,O
as,859,861,O
a,862,863,O
prophylactic,864,876,O
treatment,877,886,O
.,886,887,O
Effectiveness,0,13,O
of,14,16,O
different,17,26,O
approaches,27,37,O
for,38,41,O
establishing,42,54,O
cisplatin,55,64,O
-,64,65,O
induced,65,72,O
cochlear,73,81,B-Pathological_formation
lesions,82,89,I-Pathological_formation
in,90,92,O
mice,93,97,O
.,97,98,O
CONCLUSIONS,99,110,O
:,110,111,O
Mouse,112,117,O
cochleae,118,126,B-Multi-tissue_structure
are,127,130,O
highly,131,137,O
resistant,138,147,O
to,148,150,O
systemically,151,163,O
administered,164,176,O
cisplatin,177,186,O
.,186,187,O
However,188,195,O
",",195,196,O
cochlear,197,205,B-Pathological_formation
lesions,206,213,I-Pathological_formation
can,214,217,O
be,218,220,O
produced,221,229,O
effectively,230,241,O
in,242,244,O
mice,245,249,O
when,250,254,O
cisplatin,255,264,O
is,265,267,O
applied,268,275,O
locally,276,283,O
through,284,291,O
the,292,295,O
round,296,301,B-Immaterial_anatomical_entity
window,302,308,I-Immaterial_anatomical_entity
niche,309,314,I-Immaterial_anatomical_entity
or,315,317,O
tympanum,318,326,B-Multi-tissue_structure
.,326,327,O
OBJECTIVE,328,337,O
:,337,338,O
To,339,341,O
explore,342,349,O
the,350,353,O
optimal,354,361,O
approach,362,370,O
for,371,374,O
creating,375,383,O
cisplatin,384,393,O
-,393,394,O
induced,394,401,O
cochlear,402,410,B-Pathological_formation
lesions,411,418,I-Pathological_formation
in,419,421,O
mice,422,426,O
.,426,427,O
MATERIALS,428,437,O
AND,438,441,O
METHODS,442,449,O
:,449,450,O
Cisplatin,451,460,O
was,461,464,O
administered,465,477,O
to,478,480,O
adult,481,486,O
C57BL,487,492,O
/,492,493,O
6J,493,495,O
mice,496,500,O
via,501,504,O
four,505,509,O
approaches,510,520,O
:,520,521,O
(,522,523,O
1,523,524,O
),524,525,O
transtympanic,526,539,O
injection,540,549,O
",",549,550,O
(,551,552,O
2,552,553,O
),553,554,O
round,555,560,B-Immaterial_anatomical_entity
window,561,567,I-Immaterial_anatomical_entity
niche,568,573,I-Immaterial_anatomical_entity
injection,574,583,O
",",583,584,O
(,585,586,O
3,586,587,O
),587,588,O
intraperitoneal,589,604,O
injection,605,614,O
(,615,616,O
i,616,617,O
.,617,618,O
p,618,619,O
.,619,620,O
),620,621,O
at,622,624,O
4,625,626,O
mg,627,629,O
/,629,630,O
kg,630,632,O
/,632,633,O
day,633,636,O
for,637,640,O
4,641,642,O
consecutive,643,654,O
days,655,659,O
",",659,660,O
and,661,664,O
(,665,666,O
4,666,667,O
),667,668,O
one,669,672,O
15,673,675,O
mg,676,678,O
/,678,679,O
kg,679,681,O
dose,682,686,O
i,687,688,O
.,688,689,O
p,689,690,O
.,690,691,O
The,692,695,O
hearing,696,703,O
was,704,707,O
monitored,708,717,O
using,718,723,O
frequency,724,733,O
-,733,734,O
specific,734,742,O
auditory,743,751,O
brainstem,752,761,B-Multi-tissue_structure
responses,762,771,O
(,772,773,O
ABRs,773,777,O
),777,778,O
and,779,782,O
distortion,783,793,O
-,793,794,O
product,794,801,O
otoacoustic,802,813,O
emissions,814,823,O
(,824,825,O
DPOAEs,825,831,O
),831,832,O
.,832,833,O
Cochlear,834,842,B-Multi-tissue_structure
pathology,843,852,O
was,853,856,O
observed,857,865,O
in,866,868,O
cochleograms,869,881,O
with,882,886,O
Harris,887,893,O
',893,894,O
hematoxylin,895,906,O
staining,907,915,O
.,915,916,O
RESULTS,917,924,O
:,924,925,O
Cisplatin,926,935,O
applied,936,943,O
systemically,944,956,O
did,957,960,O
not,961,964,O
cause,965,970,O
any,971,974,O
significant,975,986,O
ABR,987,990,O
threshold,991,1000,O
elevation,1001,1010,O
across,1011,1017,O
the,1018,1021,O
frequencies,1022,1033,O
tested,1034,1040,O
(,1041,1042,O
2,1042,1043,O
-,1043,1044,O
32,1044,1046,O
kHz,1047,1050,O
),1050,1051,O
",",1051,1052,O
whereas,1053,1060,O
local,1061,1066,O
application,1067,1078,O
of,1079,1081,O
cisplatin,1082,1091,O
through,1092,1099,O
the,1100,1103,O
round,1104,1109,B-Immaterial_anatomical_entity
window,1110,1116,I-Immaterial_anatomical_entity
niche,1117,1122,I-Immaterial_anatomical_entity
or,1123,1125,O
tympanum,1126,1134,B-Multi-tissue_structure
resulted,1135,1143,O
in,1144,1146,O
significant,1147,1158,O
ABR,1159,1162,O
threshold,1163,1172,O
elevations,1173,1183,O
from,1184,1188,O
high,1189,1193,O
to,1194,1196,O
medium,1197,1203,O
frequencies,1204,1215,O
.,1215,1216,O
The,1217,1220,O
functional,1221,1231,O
changes,1232,1239,O
were,1240,1244,O
consistent,1245,1255,O
with,1256,1260,O
the,1261,1264,O
cochlear,1265,1273,B-Multi-tissue_structure
pathology,1274,1283,O
across,1284,1290,O
groups,1291,1297,O
.,1297,1298,O
Further,0,7,O
Characterization,8,24,O
of,25,27,O
Activin,28,35,O
A,36,37,O
-,37,38,O
induced,38,45,O
IgA,46,49,O
Response,50,58,O
in,59,61,O
Murine,62,68,O
B,69,70,B-Cell
Lymphocytes,71,82,I-Cell
.,82,83,O
We,84,86,O
have,87,91,O
recently,92,100,O
shown,101,106,O
that,107,111,O
activin,112,119,O
A,120,121,O
",",121,122,O
a,123,124,O
member,125,131,O
of,132,134,O
TGF,135,138,O
-,138,139,O
beta,139,143,O
superfamily,144,155,O
",",155,156,O
stimulates,157,167,O
mouse,168,173,O
B,174,175,B-Cell
cells,176,181,I-Cell
to,182,184,O
express,185,192,O
IgA,193,196,O
isotype,197,204,O
but,205,208,O
other,209,214,O
isotypes,215,223,O
.,223,224,O
In,225,227,O
the,228,231,O
present,232,239,O
study,240,245,O
",",245,246,O
we,247,249,O
further,250,257,O
characterized,258,271,O
effects,272,279,O
of,280,282,O
activin,283,290,O
A,291,292,O
on,293,295,O
B,296,297,B-Cell
cell,298,302,I-Cell
growth,303,309,O
and,310,313,O
IgA,314,317,O
expression,318,328,O
.,328,329,O
We,330,332,O
found,333,338,O
that,339,343,O
activin,344,351,O
A,352,353,O
did,354,357,O
not,358,361,O
have,362,366,O
effect,367,373,O
on,374,376,O
LPS,377,380,O
-,380,381,O
stimulated,381,391,O
cell,392,396,B-Cell
viability,397,406,O
.,406,407,O
In,408,410,O
parallel,411,419,O
",",419,420,O
CFSE,421,425,O
staining,426,434,O
analysis,435,443,O
revealed,444,452,O
that,453,457,O
activin,458,465,O
A,466,467,O
did,468,471,O
not,472,475,O
alter,476,481,O
cell,482,486,B-Cell
division,487,495,O
.,495,496,O
An,497,499,O
increase,500,508,O
of,509,511,O
IgA,512,515,O
secretion,516,525,O
by,526,528,O
activin,529,536,O
A,537,538,O
was,539,542,O
completely,543,553,O
abrogated,554,563,O
by,564,566,O
anti,567,571,O
-,571,572,O
activin,572,579,O
A,580,581,O
Ab,582,584,O
but,585,588,O
not,589,592,O
by,593,595,O
anti,596,600,O
-,600,601,O
TGFbeta1,601,609,O
Ab,610,612,O
.,612,613,O
In,614,616,O
the,617,620,O
same,621,625,O
conditions,626,636,O
",",636,637,O
no,638,640,O
other,641,646,O
isotypes,647,655,O
are,656,659,O
significantly,660,673,O
affected,674,682,O
by,683,685,O
each,686,690,O
antibody,691,699,O
treatment,700,709,O
.,709,710,O
Finally,711,718,O
",",718,719,O
activin,720,727,O
A,728,729,O
",",729,730,O
as,731,733,O
similar,734,741,O
to,742,744,O
TGF,745,748,O
-,748,749,O
beta1,749,754,O
",",754,755,O
increased,756,765,O
IgA,766,769,O
secretion,770,779,O
by,780,782,O
mesenteric,783,793,O
lymph,794,799,B-Cell
node,800,804,I-Cell
cells,805,810,I-Cell
.,810,811,O
These,812,817,O
results,818,825,O
suggest,826,833,O
that,834,838,O
activin,839,846,O
A,847,848,O
can,849,852,O
specifically,853,865,O
stimulate,866,875,O
IgA,876,879,O
response,880,888,O
",",888,889,O
independent,890,901,O
of,902,904,O
TGF,905,908,O
-,908,909,O
beta,909,913,O
in,914,916,O
the,917,920,O
gut,921,924,B-Organism_subdivision
.,924,925,O
Posterior,0,9,O
stabilization,10,23,O
of,24,26,O
the,27,30,O
cervical,31,39,B-Organism_subdivision
spine,40,45,I-Organism_subdivision
with,46,50,O
hook,51,55,O
plates,56,62,O
.,62,63,O
Hook,64,68,O
-,68,69,O
plate,69,74,O
fixation,75,83,O
is,84,86,O
designed,87,95,O
for,96,99,O
posterior,100,109,O
cervical,110,118,B-Organism_subdivision
stabilization,119,132,O
from,133,137,O
C2,138,140,O
to,141,143,O
C7,144,146,O
.,146,147,O
Indications,148,159,O
remain,160,166,O
the,167,170,O
same,171,175,O
as,176,178,O
for,179,182,O
standard,183,191,O
posterior,192,201,O
fixations,202,211,O
.,211,212,O
The,213,216,O
prime,217,222,O
indications,223,234,O
are,235,238,O
discoligamentous,239,255,O
injuries,256,264,O
.,264,265,O
The,266,269,O
plates,270,276,O
are,277,280,O
hooked,281,287,O
under,288,293,O
the,294,297,O
lower,298,303,B-Multi-tissue_structure
laminas,304,311,I-Multi-tissue_structure
and,312,315,O
attached,316,324,O
to,325,327,O
the,328,331,O
articular,332,341,B-Multi-tissue_structure
masses,342,348,I-Multi-tissue_structure
of,349,351,O
the,352,355,O
upper,356,361,O
vertebra,362,370,B-Organ
by,371,373,O
oblique,374,381,O
screws,382,388,O
.,388,389,O
An,390,392,O
H,393,394,O
-,394,395,O
graft,395,400,O
is,401,403,O
placed,404,410,O
between,411,418,O
the,419,422,O
spinous,423,430,O
processes,431,440,O
.,440,441,O
The,442,445,O
vertebrae,446,455,B-Organ
are,456,459,O
compressed,460,470,O
together,471,479,O
by,480,482,O
the,483,486,O
plates,487,493,O
at,494,496,O
three,497,502,O
points,503,509,O
",",509,510,O
the,511,514,O
facet,515,520,O
joints,521,527,O
",",527,528,O
and,529,532,O
graft,533,538,O
.,538,539,O
The,540,543,O
resulting,544,553,O
pre,554,557,O
-,557,558,O
stressed,558,566,O
system,567,573,O
is,574,576,O
stable,577,583,O
in,584,586,O
all,587,590,O
directions,591,601,O
.,601,602,O
A,603,604,O
protocol,605,613,O
for,614,617,O
safe,618,622,O
reduction,623,632,O
of,633,635,O
cervical,636,644,B-Organism_subdivision
dislocations,645,657,O
is,658,660,O
observed,661,669,O
.,669,670,O
Of,671,673,O
70,674,676,O
patients,677,685,O
treated,686,693,O
from,694,698,O
1979,699,703,O
to,704,706,O
1986,707,711,O
",",711,712,O
51,713,715,O
were,716,720,O
examined,721,729,O
12,730,732,O
-,732,733,O
54,733,735,O
months,736,742,O
after,743,748,O
surgery,749,756,O
.,756,757,O
All,758,761,O
fusions,762,769,O
consolidated,770,782,O
.,782,783,O
Two,784,787,O
neurologic,788,798,B-Anatomical_system
complications,799,812,O
not,813,816,O
attributable,817,829,O
to,830,832,O
the,833,836,O
fixation,837,845,O
occurred,846,854,O
.,854,855,O
Other,856,861,O
major,862,867,O
complications,868,881,O
were,882,886,O
not,887,890,O
seen,891,895,O
.,895,896,O
Is,0,2,O
the,3,6,O
elimination,7,18,O
of,19,21,O
HIV,22,25,O
infection,26,35,O
within,36,42,O
reach,43,48,O
in,49,51,O
the,52,55,O
United,56,62,O
States,63,69,O
?,69,70,O
Lessons,71,78,O
from,79,83,O
an,84,86,O
epidemiologic,87,100,O
transmission,101,113,O
model,114,119,O
.,119,120,O
Recent,121,127,O
estimates,128,137,O
show,138,142,O
that,143,147,O
the,148,151,O
transmission,152,164,O
rate,165,169,O
of,170,172,O
human,173,178,O
immunodeficiency,179,195,O
virus,196,201,O
(,202,203,O
HIV,203,206,O
),206,207,O
in,208,210,O
the,211,214,O
U,215,216,O
.,216,217,O
S,217,218,O
.,218,219,O
has,220,223,O
substantially,224,237,O
decreased,238,247,O
.,247,248,O
This,249,253,O
raises,254,260,O
the,261,264,O
question,265,273,O
",",273,274,O
is,275,277,O
elimination,278,289,O
of,290,292,O
HIV,293,296,O
infection,297,306,O
in,307,309,O
the,310,313,O
nation,314,320,O
feasible,321,329,O
in,330,332,O
the,333,336,O
foreseeable,337,348,O
future,349,355,O
?,355,356,O
We,357,359,O
demonstrate,360,371,O
that,372,376,O
if,377,379,O
the,380,383,O
HIV,384,387,O
transmission,388,400,O
rate,401,405,O
were,406,410,O
reduced,411,418,O
by,419,421,O
50,422,424,O
%,424,425,O
",",425,426,O
then,427,431,O
the,432,435,O
reproductive,436,448,O
rate,449,453,O
of,454,456,O
HIV,457,460,O
infection,461,470,O
would,471,476,O
drop,477,481,O
below,482,487,O
unity,488,493,O
and,494,497,O
lead,498,502,O
to,503,505,O
eventual,506,514,O
elimination,515,526,O
of,527,529,O
infection,530,539,O
.,539,540,O
In,541,543,O
recent,544,550,O
congressional,551,564,O
testimony,565,574,O
",",574,575,O
the,576,579,O
director,580,588,O
of,589,591,O
the,592,595,O
Centers,596,603,O
for,604,607,O
Disease,608,615,O
Control,616,623,O
and,624,627,O
Prevention,628,638,O
and,639,642,O
others,643,649,O
asserted,650,658,O
that,659,663,O
the,664,667,O
HIV,668,671,O
transmission,672,684,O
rate,685,689,O
can,690,693,O
be,694,696,O
halved,697,703,O
by,704,706,O
2020,707,711,O
",",711,712,O
if,713,715,O
not,716,719,O
earlier,720,727,O
",",727,728,O
provided,729,737,O
sufficient,738,748,O
investment,749,759,O
is,760,762,O
made,763,767,O
toward,768,774,O
achieving,775,784,O
this,785,789,O
goal,790,794,O
.,794,795,O
We,796,798,O
assert,799,805,O
that,806,810,O
if,811,813,O
adequate,814,822,O
investment,823,833,O
is,834,836,O
made,837,841,O
and,842,845,O
the,846,849,O
transmission,850,862,O
rate,863,867,O
is,868,870,O
in,871,873,O
fact,874,878,O
lowered,879,886,O
by,887,889,O
50,890,892,O
%,892,893,O
",",893,894,O
then,895,899,O
the,900,903,O
HIV,904,907,O
reproductive,908,920,O
rate,921,925,O
would,926,931,O
fall,932,936,O
below,937,942,O
unity,943,948,O
",",948,949,O
setting,950,957,O
the,958,961,O
stage,962,967,O
for,968,971,O
eventual,972,980,O
elimination,981,992,O
of,993,995,O
HIV,996,999,O
infection,1000,1009,O
in,1010,1012,O
the,1013,1016,O
U,1017,1018,O
.,1018,1019,O
S,1019,1020,O
.,1020,1021,O
Pain,0,4,O
assessment,5,15,O
by,16,18,O
continuous,19,29,O
EEG,30,33,O
:,33,34,O
association,35,46,O
between,47,54,O
subjective,55,65,O
perception,66,76,O
of,77,79,O
tonic,80,85,O
pain,86,90,O
and,91,94,O
peak,95,99,O
frequency,100,109,O
of,110,112,O
alpha,113,118,O
oscillations,119,131,O
during,132,138,O
stimulation,139,150,O
and,151,154,O
at,155,157,O
rest,158,162,O
.,162,163,O
Recordings,164,174,O
of,175,177,O
neurophysiological,178,196,O
brain,197,202,B-Organ
responses,203,212,O
to,213,215,O
noxious,216,223,O
stimuli,224,231,O
have,232,236,O
been,237,241,O
traditionally,242,255,O
based,256,261,O
on,262,264,O
short,265,270,O
stimuli,271,278,O
",",278,279,O
in,280,282,O
the,283,286,O
order,287,292,O
of,293,295,O
milliseconds,296,308,O
",",308,309,O
which,310,315,O
induce,316,322,O
distinct,323,331,O
event,332,337,O
-,337,338,O
related,338,345,O
potentials,346,356,O
(,357,358,O
ERPs,358,362,O
),362,363,O
.,363,364,O
However,365,372,O
",",372,373,O
using,374,379,O
such,380,384,O
stimuli,385,392,O
in,393,395,O
the,396,399,O
experimental,400,412,O
setting,413,420,O
is,421,423,O
disadvantageous,424,439,O
as,440,442,O
they,443,447,O
are,448,451,O
too,452,455,O
brief,456,461,O
to,462,464,O
faithfully,465,475,O
simulate,476,484,O
clinical,485,493,O
pain,494,498,O
.,498,499,O
We,500,502,O
aimed,503,508,O
at,509,511,O
utilizing,512,521,O
continuous,522,532,O
EEG,533,536,O
to,537,539,O
investigate,540,551,O
the,552,555,O
properties,556,566,O
of,567,569,O
peak,570,574,O
alpha,575,580,O
frequency,581,590,O
(,591,592,O
PAF,592,595,O
),595,596,O
as,597,599,O
an,600,602,O
objective,603,612,O
cortical,613,621,B-Multi-tissue_structure
measure,622,629,O
associated,630,640,O
with,641,645,O
subjective,646,656,O
perception,657,667,O
of,668,670,O
tonic,671,676,O
pain,677,681,O
.,681,682,O
Five,683,687,O
minute,688,694,O
long,695,699,O
continuous,700,710,O
EEG,711,714,O
was,715,718,O
recorded,719,727,O
in,728,730,O
18,731,733,O
healthy,734,741,O
volunteers,742,752,O
under,753,758,O
:,758,759,O
(,760,761,O
i,761,762,O
),762,763,O
resting,764,771,O
-,771,772,O
state,772,777,O
;,777,778,O
(,779,780,O
ii,780,782,O
),782,783,O
innocuous,784,793,O
temperature,794,805,O
;,805,806,O
and,807,810,O
(,811,812,O
iii,812,815,O
),815,816,O
psychophysically,817,833,O
-,833,834,O
anchored,834,842,O
noxious,843,850,O
temperature,851,862,O
.,862,863,O
Numerical,864,873,O
pain,874,878,O
scores,879,885,O
(,886,887,O
NPSs,887,891,O
),891,892,O
collected,893,902,O
during,903,909,O
the,910,913,O
application,914,925,O
of,926,928,O
tonic,929,934,O
noxious,935,942,O
stimuli,943,950,O
were,951,955,O
tested,956,962,O
for,963,966,O
correlation,967,978,O
with,979,983,O
peak,984,988,O
frequencies,989,1000,O
of,1001,1003,O
alpha,1004,1009,O
power,1010,1015,O
-,1015,1016,O
curves,1016,1022,O
derived,1023,1030,O
from,1031,1035,O
central,1036,1043,O
",",1043,1044,O
temporal,1045,1053,O
and,1054,1057,O
frontal,1058,1065,O
electrodes,1066,1076,O
.,1076,1077,O
NPSs,1078,1082,O
and,1083,1086,O
PAFs,1087,1091,O
remained,1092,1100,O
stable,1101,1107,O
throughout,1108,1118,O
the,1119,1122,O
recording,1123,1132,O
conditions,1133,1143,O
(,1144,1145,O
RM,1145,1147,O
-,1147,1148,O
ANOVAs,1148,1154,O
;,1154,1155,O
Ps,1156,1158,O
>,1158,1159,O
0,1159,1160,O
.,1160,1161,O
51,1161,1163,O
),1163,1164,O
.,1164,1165,O
In,1166,1168,O
the,1169,1172,O
noxious,1173,1180,O
condition,1181,1190,O
",",1190,1191,O
PAFs,1192,1196,O
obtained,1197,1205,O
at,1206,1208,O
the,1209,1212,O
bilateral,1213,1222,O
temporal,1223,1231,B-Multi-tissue_structure
scalp,1232,1237,I-Multi-tissue_structure
were,1238,1242,O
correlated,1243,1253,O
with,1254,1258,O
NPSs,1259,1263,O
(,1264,1265,O
Ps,1265,1267,O
<,1267,1268,O
0,1268,1269,O
.,1269,1270,O
001,1270,1273,O
),1273,1274,O
.,1274,1275,O
Moreover,1276,1284,O
",",1284,1285,O
resting,1286,1293,O
-,1293,1294,O
state,1294,1299,O
PAFs,1300,1304,O
recorded,1305,1313,O
at,1314,1316,O
the,1317,1320,O
bilateral,1321,1330,O
temporal,1331,1339,B-Multi-tissue_structure
scalp,1340,1345,I-Multi-tissue_structure
were,1346,1350,O
correlated,1351,1361,O
with,1362,1366,O
NPSs,1367,1371,O
reported,1372,1380,O
during,1381,1387,O
the,1388,1391,O
noxious,1392,1399,O
condition,1400,1409,O
(,1410,1411,O
Ps,1411,1413,O
<,1413,1414,O
0,1414,1415,O
.,1415,1416,O
01,1416,1418,O
),1418,1419,O
.,1419,1420,O
These,1421,1426,O
psychophysical,1427,1441,O
-,1441,1442,O
neurophysiological,1442,1460,O
relations,1461,1470,O
attest,1471,1477,O
to,1478,1480,O
the,1481,1484,O
properties,1485,1495,O
of,1496,1498,O
PAF,1499,1502,O
as,1503,1505,O
a,1506,1507,O
novel,1508,1513,O
cortical,1514,1522,B-Multi-tissue_structure
objective,1523,1532,O
measure,1533,1540,O
of,1541,1543,O
subjective,1544,1554,O
perception,1555,1565,O
of,1566,1568,O
tonic,1569,1574,O
pain,1575,1579,O
.,1579,1580,O
Moreover,1581,1589,O
",",1589,1590,O
resting,1591,1598,O
-,1598,1599,O
state,1599,1604,O
PAFs,1605,1609,O
might,1610,1615,O
hold,1616,1620,O
inherent,1621,1629,O
pain,1630,1634,O
modulation,1635,1645,O
attributes,1646,1656,O
",",1656,1657,O
possibly,1658,1666,O
enabling,1667,1675,O
the,1676,1679,O
prediction,1680,1690,O
of,1691,1693,O
individual,1694,1704,O
responsiveness,1705,1719,O
to,1720,1722,O
prolonged,1723,1732,O
pain,1733,1737,O
.,1737,1738,O
The,1739,1742,O
relevance,1743,1752,O
of,1753,1755,O
PAF,1756,1759,O
to,1760,1762,O
the,1763,1766,O
neural,1767,1773,B-Cell
processing,1774,1784,O
of,1785,1787,O
tonic,1788,1793,O
pain,1794,1798,O
may,1799,1802,O
indicate,1803,1811,O
its,1812,1815,O
potential,1816,1825,O
to,1826,1828,O
advance,1829,1836,O
pain,1837,1841,O
research,1842,1850,O
as,1851,1853,O
well,1854,1858,O
as,1859,1861,O
clinical,1862,1870,O
pain,1871,1875,O
characterization,1876,1892,O
.,1892,1893,O
Acoustic,0,8,O
trauma,9,15,O
evokes,16,22,O
hyperactivity,23,36,O
and,37,40,O
changes,41,48,O
in,49,51,O
gene,52,56,O
expression,57,67,O
in,68,70,O
guinea,71,77,O
-,77,78,O
pig,78,81,O
auditory,82,90,O
brainstem,91,100,B-Multi-tissue_structure
.,100,101,O
Hearing,102,109,O
loss,110,114,O
from,115,119,O
acoustic,120,128,O
trauma,129,135,O
is,136,138,O
a,139,140,O
risk,141,145,O
factor,146,152,O
for,153,156,O
tinnitus,157,165,O
.,165,166,O
Animal,167,173,O
models,174,180,O
using,181,186,O
acoustic,187,195,O
trauma,196,202,O
have,203,207,O
demonstrated,208,220,O
hyperactivity,221,234,O
in,235,237,O
central,238,245,O
auditory,246,254,O
pathways,255,263,O
",",263,264,O
which,265,270,O
has,271,274,O
been,275,279,O
suggested,280,289,O
as,290,292,O
a,293,294,O
substrate,295,304,O
for,305,308,O
tinnitus,309,317,O
.,317,318,O
We,319,321,O
used,322,326,O
a,327,328,O
guinea,329,335,O
-,335,336,O
pig,336,339,O
model,340,345,O
of,346,348,O
unilateral,349,359,O
acoustic,360,368,O
trauma,369,375,O
.,375,376,O
Within,377,383,O
the,384,387,O
same,388,392,O
animals,393,400,O
",",400,401,O
measurements,402,414,O
of,415,417,O
peripheral,418,428,O
hearing,429,436,O
loss,437,441,O
",",441,442,O
spontaneous,443,454,O
activity,455,463,O
of,464,466,O
single,467,473,O
neurons,474,481,B-Cell
in,482,484,O
the,485,488,O
inferior,489,497,B-Multi-tissue_structure
colliculus,498,508,I-Multi-tissue_structure
and,509,512,O
gene,513,517,O
expression,518,528,O
in,529,531,O
cochlear,532,540,B-Multi-tissue_structure
nucleus,541,548,I-Multi-tissue_structure
and,549,552,O
inferior,553,561,B-Multi-tissue_structure
colliculus,562,572,I-Multi-tissue_structure
were,573,577,O
combined,578,586,O
",",586,587,O
acutely,588,595,O
and,596,599,O
after,600,605,O
recovery,606,614,O
from,615,619,O
acoustic,620,628,O
trauma,629,635,O
.,635,636,O
Genes,637,642,O
investigated,643,655,O
related,656,663,O
to,664,666,O
inhibitory,667,677,O
(,678,679,O
GABA,679,683,O
-,683,684,O
A,684,685,O
receptor,686,694,O
subunit,695,702,O
alpha,703,708,O
1,709,710,O
;,710,711,O
glycine,712,719,O
receptor,720,728,O
subunit,729,736,O
alpha,737,742,O
1,743,744,O
),744,745,O
and,746,749,O
excitatory,750,760,O
neurotransmission,761,778,O
(,779,780,O
glutamate,780,789,O
decarboxylase,790,803,O
1,804,805,O
;,805,806,O
glutamate,807,816,O
receptor,817,825,O
AMPA,826,830,O
subunit,831,838,O
alpha,839,844,O
2,845,846,O
;,846,847,O
glutamate,848,857,O
receptor,858,866,O
NMDA,867,871,O
subunit,872,879,O
1,880,881,O
),881,882,O
",",882,883,O
regulation,884,894,O
of,895,897,O
transmitter,898,909,O
release,910,917,O
(,918,919,O
member,919,925,O
of,926,928,O
RAB,929,932,O
family,933,939,O
of,940,942,O
small,943,948,O
GTPase,949,955,O
;,955,956,O
RAB3,957,961,O
GTPase,962,968,O
activating,969,979,O
protein,980,987,O
subunit,988,995,O
1,996,997,O
),997,998,O
and,999,1002,O
neuronal,1003,1011,B-Cell
excitability,1012,1024,O
(,1025,1026,O
potassium,1026,1035,O
channel,1036,1043,O
subfamily,1044,1053,O
K,1054,1055,O
member,1056,1062,O
15,1063,1065,O
),1065,1066,O
.,1066,1067,O
Acoustic,1068,1076,O
trauma,1077,1083,O
resulted,1084,1092,O
in,1093,1095,O
unilateral,1096,1106,O
hearing,1107,1114,O
loss,1115,1119,O
and,1120,1123,O
hyperactivity,1124,1137,O
bilaterally,1138,1149,O
in,1150,1152,O
inferior,1153,1161,B-Multi-tissue_structure
colliculus,1162,1172,I-Multi-tissue_structure
.,1172,1173,O
Changes,1174,1181,O
in,1182,1184,O
expression,1185,1195,O
of,1196,1198,O
different,1199,1208,O
mRNAs,1209,1214,O
were,1215,1219,O
observed,1220,1228,O
in,1229,1231,O
ipsilateral,1232,1243,O
cochlear,1244,1252,B-Multi-tissue_structure
nucleus,1253,1260,I-Multi-tissue_structure
and,1261,1264,O
in,1265,1267,O
ipsi,1268,1272,O
-,1272,1273,O
and,1274,1277,O
contralateral,1278,1291,O
inferior,1292,1300,B-Multi-tissue_structure
colliculus,1301,1311,I-Multi-tissue_structure
",",1311,1312,O
immediately,1313,1324,O
after,1325,1330,O
acoustic,1331,1339,O
trauma,1340,1346,O
",",1346,1347,O
and,1348,1351,O
after,1352,1357,O
2,1358,1359,O
and,1360,1363,O
4,1364,1365,O
weeks,1366,1371,O
',1371,1372,O
recovery,1373,1381,O
.,1381,1382,O
Gene,1383,1387,O
expression,1388,1398,O
was,1399,1402,O
generally,1403,1412,O
reduced,1413,1420,O
immediately,1421,1432,O
after,1433,1438,O
trauma,1439,1445,O
",",1445,1446,O
followed,1447,1455,O
by,1456,1458,O
a,1459,1460,O
return,1461,1467,O
to,1468,1470,O
near,1471,1475,O
normal,1476,1482,O
levels,1483,1489,O
or,1490,1492,O
over,1493,1497,O
-,1497,1498,O
expression,1498,1508,O
as,1509,1511,O
recovery,1512,1520,O
time,1521,1525,O
increased,1526,1535,O
.,1535,1536,O
Different,1537,1546,O
mechanisms,1547,1557,O
appear,1558,1564,O
to,1565,1567,O
underlie,1568,1576,O
the,1577,1580,O
spontaneous,1581,1592,O
hyperactivity,1593,1606,O
observed,1607,1615,O
.,1615,1616,O
There,1617,1622,O
is,1623,1625,O
evidence,1626,1634,O
of,1635,1637,O
down,1638,1642,O
-,1642,1643,O
regulation,1643,1653,O
of,1654,1656,O
genes,1657,1662,O
associated,1663,1673,O
with,1674,1678,O
neuronal,1679,1687,B-Cell
inhibition,1688,1698,O
in,1699,1701,O
the,1702,1705,O
contralateral,1706,1719,O
inferior,1720,1728,B-Multi-tissue_structure
colliculus,1729,1739,I-Multi-tissue_structure
",",1739,1740,O
whereas,1741,1748,O
in,1749,1751,O
ipsilateral,1752,1763,O
cochlear,1764,1772,B-Multi-tissue_structure
nucleus,1773,1780,I-Multi-tissue_structure
",",1780,1781,O
competing,1782,1791,O
actions,1792,1799,O
of,1800,1802,O
inhibitory,1803,1813,O
and,1814,1817,O
excitatory,1818,1828,O
systems,1829,1836,O
seem,1837,1841,O
to,1842,1844,O
play,1845,1849,O
a,1850,1851,O
major,1852,1857,O
role,1858,1862,O
in,1863,1865,O
determining,1866,1877,O
overall,1878,1885,O
excitability,1886,1898,O
.,1898,1899,O
Yellow,0,6,O
-,6,7,O
green,7,12,O
52,13,15,O
.,15,16,O
3W,16,18,O
laser,19,24,O
at,25,27,O
556nm,28,33,O
based,34,39,O
on,40,42,O
frequency,43,52,O
doubling,53,61,O
of,62,64,O
a,65,66,O
diode,67,72,O
side,73,77,O
-,77,78,O
pumped,78,84,O
Q,85,86,O
-,86,87,O
switched,87,95,O
Nd,96,98,O
:,98,99,O
YAG,99,102,O
laser,103,108,O
.,108,109,O
We,110,112,O
demonstrate,113,124,O
a,125,126,O
high,127,131,O
-,131,132,O
power,132,137,O
556nm,138,143,O
yellow,144,150,O
-,150,151,O
green,151,156,O
laser,157,162,O
generated,163,172,O
by,173,175,O
intracavity,176,187,O
frequency,188,197,O
doubling,198,206,O
of,207,209,O
a,210,211,O
diode,212,217,O
side,218,222,O
-,222,223,O
pumped,223,229,O
Nd,230,232,O
:,232,233,O
YAG,233,236,O
laser,237,242,O
at,243,245,O
1112nm,246,252,O
.,252,253,O
A,254,255,O
symmetrical,256,267,O
L,268,269,O
-,269,270,O
shaped,270,276,O
flat,277,281,O
-,281,282,O
flat,282,286,O
cavity,287,293,O
was,294,297,O
employed,298,306,O
to,307,309,O
implement,310,319,O
efficient,320,329,O
operation,330,339,O
of,340,342,O
the,343,346,O
low,347,350,O
-,350,351,O
gain,351,355,O
1112nm,356,362,O
transition,363,373,O
and,374,377,O
to,378,380,O
achieve,381,388,O
good,389,393,O
power,394,399,O
scalability,400,411,O
.,411,412,O
The,413,416,O
coatings,417,425,O
of,426,428,O
the,429,432,O
cavity,433,439,O
mirrors,440,447,O
were,448,452,O
carefully,453,462,O
designed,463,471,O
to,472,474,O
optimize,475,483,O
the,484,487,O
performance,488,499,O
of,500,502,O
the,503,506,O
laser,507,512,O
",",512,513,O
and,514,517,O
a,518,519,O
92W,520,523,O
continuous,524,534,O
wave,535,539,O
laser,540,545,O
output,546,552,O
at,553,555,O
1112nm,556,562,O
was,563,566,O
achieved,567,575,O
when,576,580,O
the,581,584,O
pumping,585,592,O
power,593,598,O
of,599,601,O
the,602,605,O
laser,606,611,O
diodes,612,618,O
reached,619,626,O
960W,627,631,O
.,631,632,O
By,633,635,O
intracavity,636,647,O
frequency,648,657,O
doubling,658,666,O
of,667,669,O
the,670,673,O
fundamental,674,685,O
laser,686,691,O
in,692,694,O
a,695,696,O
lithium,697,704,O
triborate,705,714,O
crystal,715,722,O
",",722,723,O
the,724,727,O
maximum,728,735,O
power,736,741,O
of,742,744,O
the,745,748,O
frequency,749,758,O
-,758,759,O
doubled,759,766,O
output,767,773,O
at,774,776,O
556nm,777,782,O
was,783,786,O
found,787,792,O
to,793,795,O
be,796,798,O
as,799,801,O
high,802,806,O
as,807,809,O
52,810,812,O
.,812,813,O
3W,813,815,O
with,816,820,O
a,821,822,O
pulse,823,828,O
repetition,829,839,O
frequency,840,849,O
of,850,852,O
10kHz,853,858,O
.,858,859,O
This,860,864,O
corresponds,865,876,O
to,877,879,O
an,880,882,O
optical,883,890,O
-,890,891,O
to,891,893,O
-,893,894,O
optical,894,901,O
conversion,902,912,O
efficiency,913,923,O
of,924,926,O
about,927,932,O
5,933,934,O
.,934,935,O
4,935,936,O
%,936,937,O
.,937,938,O
Ventral,0,7,B-Multi-tissue_structure
and,8,11,O
dorsal,12,18,B-Multi-tissue_structure
striatal,19,27,I-Multi-tissue_structure
dopamine,28,36,O
efflux,37,43,O
and,44,47,O
behavior,48,56,O
in,57,59,O
rats,60,64,O
with,65,69,O
simple,70,76,O
vs,77,79,O
.,79,80,O
co,81,83,O
-,83,84,O
morbid,84,90,O
histories,91,100,O
of,101,103,O
cocaine,104,111,O
sensitization,112,125,O
and,126,129,O
neonatal,130,138,B-Pathological_formation
ventral,139,146,I-Pathological_formation
hippocampal,147,158,I-Pathological_formation
lesions,159,166,I-Pathological_formation
.,166,167,O
UNLABELLED,168,178,O
:,178,179,O
RATIONAL,180,188,O
:,188,189,O
Exposing,190,198,O
animal,199,205,O
models,206,212,O
of,213,215,O
mental,216,222,O
illness,223,230,O
to,231,233,O
addictive,234,243,O
drugs,244,249,O
provides,250,258,O
an,259,261,O
approach,262,270,O
to,271,273,O
understanding,274,287,O
the,288,291,O
neural,292,298,B-Multi-tissue_structure
etiology,299,307,O
of,308,310,O
dual,311,315,O
diagnosis,316,325,O
disorders,326,335,O
.,335,336,O
Previous,337,345,O
studies,346,353,O
have,354,358,O
shown,359,364,O
that,365,369,O
neonatal,370,378,B-Pathological_formation
ventral,379,386,I-Pathological_formation
hippocampal,387,398,I-Pathological_formation
lesions,399,406,I-Pathological_formation
(,407,408,O
NVHL,408,412,B-Pathological_formation
),412,413,O
in,414,416,O
rats,417,421,O
produce,422,429,O
features,430,438,O
of,439,441,O
both,442,446,O
schizophrenia,447,460,O
and,461,464,O
addiction,465,474,O
vulnerability,475,488,O
.,488,489,O
OBJECTIVE,490,499,O
:,499,500,O
This,501,505,O
study,506,511,O
investigated,512,524,O
ventral,525,532,B-Multi-tissue_structure
and,533,536,O
dorsal,537,543,B-Multi-tissue_structure
striatal,544,552,I-Multi-tissue_structure
dopamine,553,561,O
(,562,563,O
DA,563,565,O
),565,566,O
efflux,567,573,O
in,574,576,O
NVHL,577,581,B-Pathological_formation
rats,582,586,O
combined,587,595,O
with,596,600,O
behavioral,601,611,O
sensitization,612,625,O
to,626,628,O
cocaine,629,636,O
.,636,637,O
METHODS,638,645,O
:,645,646,O
Adult,647,652,O
NVHL,653,657,B-Pathological_formation
vs,658,660,O
.,660,661,O
SHAM,662,666,O
-,666,667,O
operated,667,675,O
rats,676,680,O
underwent,681,690,O
a,691,692,O
5,693,694,O
-,694,695,O
day,695,698,O
injection,699,708,O
series,709,715,O
of,716,718,O
cocaine,719,726,O
(,727,728,O
15,728,730,O
mg,731,733,O
/,733,734,O
kg,734,736,O
/,736,737,O
day,737,740,O
),740,741,O
vs,742,744,O
.,744,745,O
saline,746,752,O
.,752,753,O
One,754,757,O
week,758,762,O
later,763,768,O
",",768,769,O
rats,770,774,O
were,775,779,O
cannulated,780,790,O
in,791,793,O
nucleus,794,801,B-Multi-tissue_structure
accumbens,802,811,I-Multi-tissue_structure
SHELL,812,817,O
",",817,818,O
CORE,819,823,O
",",823,824,O
or,825,827,O
caudate,828,835,B-Multi-tissue_structure
-,835,836,I-Multi-tissue_structure
putamen,836,843,I-Multi-tissue_structure
.,843,844,O
Another,845,852,O
week,853,857,O
later,858,863,O
",",863,864,O
in,865,867,O
vivo,868,872,O
microdialysis,873,886,O
sampled,887,894,O
DA,895,897,O
during,898,904,O
locomotor,905,914,O
testing,915,922,O
in,923,925,O
which,926,931,O
a,932,933,O
single,934,940,O
cocaine,941,948,O
injection,949,958,O
(,959,960,O
15,960,962,O
mg,963,965,O
/,965,966,O
kg,966,968,O
),968,969,O
was,970,973,O
delivered,974,983,O
.,983,984,O
RESULTS,985,992,O
:,992,993,O
NVHLs,994,999,B-Pathological_formation
and,1000,1003,O
cocaine,1004,1011,O
history,1012,1019,O
significantly,1020,1033,O
increased,1034,1043,O
behavioral,1044,1054,O
activation,1055,1065,O
approximately,1066,1079,O
2,1080,1081,O
-,1081,1082,O
fold,1082,1086,O
over,1087,1091,O
SHAM,1092,1096,O
-,1096,1097,O
saline,1097,1103,O
history,1104,1111,O
rats,1112,1116,O
.,1116,1117,O
DA,1118,1120,O
efflux,1121,1127,O
curves,1128,1134,O
corresponded,1135,1147,O
time,1148,1152,O
dependently,1153,1164,O
with,1165,1169,O
the,1170,1173,O
cocaine,1174,1181,O
injection,1182,1191,O
and,1192,1195,O
locomotor,1196,1205,O
curves,1206,1212,O
and,1213,1216,O
varied,1217,1223,O
significantly,1224,1237,O
by,1238,1240,O
striatal,1241,1249,B-Multi-tissue_structure
region,1250,1256,I-Multi-tissue_structure
:,1256,1257,O
Baseline,1258,1266,O
DA,1267,1269,O
levels,1270,1276,O
increased,1277,1286,O
5,1287,1288,O
-,1288,1289,O
fold,1289,1293,O
while,1294,1299,O
cocaine,1300,1307,O
-,1307,1308,O
stimulated,1308,1318,O
DA,1319,1321,O
efflux,1322,1328,O
decreased,1329,1338,O
by,1339,1341,O
half,1342,1346,O
across,1347,1353,O
a,1354,1355,O
ventral,1356,1363,B-Multi-tissue_structure
to,1364,1366,O
dorsal,1367,1373,B-Multi-tissue_structure
striatal,1374,1382,I-Multi-tissue_structure
gradient,1383,1391,O
.,1391,1392,O
However,1393,1400,O
",",1400,1401,O
NVHLs,1402,1407,B-Pathological_formation
",",1407,1408,O
prior,1409,1414,O
cocaine,1415,1422,O
history,1423,1430,O
",",1430,1431,O
and,1432,1435,O
individual,1436,1446,O
differences,1447,1458,O
in,1459,1461,O
behavior,1462,1470,O
were,1471,1475,O
not,1476,1479,O
underpinned,1480,1491,O
by,1492,1494,O
differential,1495,1507,O
DA,1508,1510,O
efflux,1511,1517,O
overall,1518,1525,O
or,1526,1528,O
within,1529,1535,O
any,1536,1539,O
striatal,1540,1548,B-Multi-tissue_structure
region,1549,1555,I-Multi-tissue_structure
.,1555,1556,O
CONCLUSION,1557,1567,O
:,1567,1568,O
Differences,1569,1580,O
in,1581,1583,O
ventral,1584,1591,B-Multi-tissue_structure
/,1591,1592,O
dorsal,1592,1598,B-Multi-tissue_structure
striatal,1599,1607,I-Multi-tissue_structure
DA,1608,1610,O
efflux,1611,1617,O
are,1618,1621,O
not,1622,1625,O
present,1626,1633,O
in,1634,1636,O
and,1637,1640,O
are,1641,1644,O
not,1645,1648,O
required,1649,1657,O
for,1658,1661,O
producing,1662,1671,O
differential,1672,1684,O
levels,1685,1691,O
of,1692,1694,O
acute,1695,1700,O
cocaine,1701,1708,O
-,1708,1709,O
induced,1709,1716,O
behavioral,1717,1727,O
activation,1728,1738,O
in,1739,1741,O
NVHLs,1742,1747,B-Pathological_formation
with,1748,1752,O
and,1753,1756,O
without,1757,1764,O
a,1765,1766,O
behaviorally,1767,1779,O
sensitizing,1780,1791,O
cocaine,1792,1799,O
history,1800,1807,O
.,1807,1808,O
These,1809,1814,O
findings,1815,1823,O
suggest,1824,1831,O
other,1832,1837,O
neurotransmitter,1838,1854,O
systems,1855,1862,O
",",1862,1863,O
and,1864,1867,O
alterations,1868,1879,O
in,1880,1882,O
striatal,1883,1891,B-Multi-tissue_structure
network,1892,1899,O
function,1900,1908,O
post,1909,1913,O
-,1913,1914,O
synaptic,1914,1922,O
to,1923,1925,O
DA,1926,1928,O
transmission,1929,1941,O
are,1942,1945,O
more,1946,1950,O
important,1951,1960,O
to,1961,1963,O
understanding,1964,1977,O
the,1978,1981,O
interactive,1982,1993,O
effects,1994,2001,O
of,2002,2004,O
addictive,2005,2014,O
drugs,2015,2020,O
and,2021,2024,O
mental,2025,2031,O
illness,2032,2039,O
.,2039,2040,O
Predictive,0,10,O
value,11,16,O
of,17,19,O
serum,20,25,B-Organism_substance
carbohydrate,26,38,O
antigen,39,46,O
19,47,49,O
-,49,50,O
9,50,51,O
in,52,54,O
malignant,55,64,O
intraductal,65,76,O
papillary,77,86,B-Pathological_formation
mucinous,87,95,I-Pathological_formation
neoplasms,96,105,I-Pathological_formation
.,105,106,O
BACKGROUND,107,117,O
:,117,118,O
The,119,122,O
goal,123,127,O
of,128,130,O
the,131,134,O
present,135,142,O
study,143,148,O
was,149,152,O
to,153,155,O
evaluate,156,164,O
the,165,168,O
predictive,169,179,O
value,180,185,O
of,186,188,O
serum,189,194,B-Organism_substance
carbohydrate,195,207,O
antigen,208,215,O
19,216,218,O
-,218,219,O
9,219,220,O
(,221,222,O
CA,222,224,O
19,225,227,O
-,227,228,O
9,228,229,O
),229,230,O
in,231,233,O
the,234,237,O
diagnosis,238,247,O
of,248,250,O
malignant,251,260,O
intraductal,261,272,B-Pathological_formation
papillary,273,282,I-Pathological_formation
mucinous,283,291,I-Pathological_formation
neoplasms,292,301,I-Pathological_formation
of,302,304,O
pancreas,305,313,B-Organ
(,314,315,O
IPMNs,315,320,B-Pathological_formation
),320,321,O
.,321,322,O
METHODS,323,330,O
:,330,331,O
Eighty,332,338,O
-,338,339,O
six,339,342,O
patients,343,351,O
with,352,356,O
pathological,357,369,O
diagnosis,370,379,O
of,380,382,O
IPMNs,383,388,B-Pathological_formation
in,389,391,O
Zhongshan,392,401,O
Hospital,402,410,O
between,411,418,O
March,419,424,O
1999,425,429,O
and,430,433,O
November,434,442,O
2008,443,447,O
were,448,452,O
retrospectively,453,468,O
reviewed,469,477,O
.,477,478,O
Data,479,483,O
reflecting,484,494,O
clinical,495,503,O
characteristics,504,519,O
",",519,520,O
tumor,521,526,B-Pathological_formation
marker,527,533,O
level,534,539,O
",",539,540,O
and,541,544,O
prognosis,545,554,O
were,555,559,O
collected,560,569,O
.,569,570,O
The,571,574,O
potential,575,584,O
predictive,585,595,O
value,596,601,O
of,602,604,O
CA,605,607,O
19,608,610,O
-,610,611,O
9,611,612,O
was,613,616,O
analyzed,617,625,O
by,626,628,O
receiver,629,637,O
operating,638,647,O
characteristic,648,662,O
(,663,664,O
ROC,664,667,O
),667,668,O
curve,669,674,O
.,674,675,O
RESULTS,676,683,O
:,683,684,O
Eighty,685,691,O
-,691,692,O
six,692,695,O
consecutive,696,707,O
patients,708,716,O
with,717,721,O
IPMNs,722,727,B-Pathological_formation
all,728,731,O
underwent,732,741,O
surgical,742,750,O
intervention,751,763,O
.,763,764,O
A,765,766,O
high,767,771,O
level,772,777,O
of,778,780,O
CA,781,783,O
19,784,786,O
-,786,787,O
9,787,788,O
or,789,791,O
carcinoembryonic,792,808,O
antigen,809,816,O
(,817,818,O
CEA,818,821,O
),821,822,O
was,823,826,O
associated,827,837,O
with,838,842,O
more,843,847,O
advanced,848,856,O
stage,857,862,O
of,863,865,O
malignant,866,875,O
IPMNs,876,881,B-Pathological_formation
.,881,882,O
Carbohydrate,883,895,O
antigen,896,903,O
19,904,906,O
-,906,907,O
9,907,908,O
was,909,912,O
significant,913,924,O
for,925,928,O
judging,929,936,O
malignant,937,946,O
IPMNs,947,952,B-Pathological_formation
in,953,955,O
the,956,959,O
binary,960,966,O
logistic,967,975,O
regression,976,986,O
model,987,992,O
(,993,994,O
p,994,995,O
=,995,996,O
0,996,997,O
.,997,998,O
047,998,1001,O
),1001,1002,O
.,1002,1003,O
The,1004,1007,O
hazard,1008,1014,O
ratio,1015,1020,O
was,1021,1024,O
1,1025,1026,O
.,1026,1027,O
014,1027,1030,O
",",1030,1031,O
whose,1032,1037,O
95,1038,1040,O
.,1040,1041,O
0,1041,1042,O
%,1042,1043,O
confidence,1044,1054,O
interval,1055,1063,O
was,1064,1067,O
0,1068,1069,O
.,1069,1070,O
91,1070,1072,O
-,1072,1073,O
1,1073,1074,O
.,1074,1075,O
028,1075,1078,O
.,1078,1079,O
Receiver,1080,1088,O
operating,1089,1098,O
characteristic,1099,1113,O
analysis,1114,1122,O
showed,1123,1129,O
that,1130,1134,O
the,1135,1138,O
serum,1139,1144,B-Organism_substance
CA,1145,1147,O
19,1148,1150,O
-,1150,1151,O
9,1151,1152,O
level,1153,1158,O
had,1159,1162,O
good,1163,1167,O
predictive,1168,1178,O
value,1179,1184,O
for,1185,1188,O
malignant,1189,1198,O
or,1199,1201,O
invasive,1202,1210,O
IPMNs,1211,1216,B-Pathological_formation
",",1216,1217,O
postoperative,1218,1231,O
survival,1232,1240,O
",",1240,1241,O
and,1242,1245,O
disease,1246,1253,O
-,1253,1254,O
specific,1254,1262,O
recurrence,1263,1273,O
.,1273,1274,O
The,1275,1278,O
area,1279,1283,O
under,1284,1289,O
the,1290,1293,O
curve,1294,1299,O
(,1300,1301,O
AUC,1301,1304,O
),1304,1305,O
was,1306,1309,O
0,1310,1311,O
.,1311,1312,O
856,1312,1315,O
",",1315,1316,O
0,1317,1318,O
.,1318,1319,O
893,1319,1322,O
",",1322,1323,O
0,1324,1325,O
.,1325,1326,O
815,1326,1329,O
",",1329,1330,O
and,1331,1334,O
0,1335,1336,O
.,1336,1337,O
857,1337,1340,O
(,1341,1342,O
p,1342,1343,O
<,1343,1344,O
0,1344,1345,O
.,1345,1346,O
05,1346,1348,O
),1348,1349,O
",",1349,1350,O
respectively,1351,1363,O
.,1363,1364,O
According,1365,1374,O
to,1375,1377,O
the,1378,1381,O
follow,1382,1388,O
-,1388,1389,O
up,1389,1391,O
",",1391,1392,O
mean,1393,1397,O
survival,1398,1406,O
time,1407,1411,O
for,1412,1415,O
groups,1416,1422,O
with,1423,1427,O
CA,1428,1430,O
19,1431,1433,O
-,1433,1434,O
9,1434,1435,O
>,1435,1436,O
63,1436,1438,O
.,1438,1439,O
60,1439,1441,O
U,1442,1443,O
/,1443,1444,O
ml,1444,1446,O
was,1447,1450,O
dramatically,1451,1463,O
shorter,1464,1471,O
than,1472,1476,O
that,1477,1481,O
for,1482,1485,O
groups,1486,1492,O
with,1493,1497,O
CA,1498,1500,O
19,1501,1503,O
-,1503,1504,O
9,1504,1505,O
<,1505,1506,O
=,1506,1507,O
63,1507,1509,O
.,1509,1510,O
60,1510,1512,O
U,1513,1514,O
/,1514,1515,O
ml,1515,1517,O
(,1518,1519,O
57,1519,1521,O
.,1521,1522,O
38,1522,1524,O
+,1524,1525,O
/,1525,1526,O
-,1526,1527,O
2,1527,1528,O
.,1528,1529,O
85,1529,1531,O
versus,1532,1538,O
29,1539,1541,O
.,1541,1542,O
24,1542,1544,O
+,1544,1545,O
/,1545,1546,O
-,1546,1547,O
5,1547,1548,O
.,1548,1549,O
82,1549,1551,O
[,1552,1553,O
months,1553,1559,O
],1559,1560,O
;,1560,1561,O
p,1562,1563,O
<,1563,1564,O
0,1564,1565,O
.,1565,1566,O
01,1566,1568,O
),1568,1569,O
.,1569,1570,O
CONCLUSIONS,1571,1582,O
:,1582,1583,O
Serum,1584,1589,B-Organism_substance
CA,1590,1592,O
19,1593,1595,O
-,1595,1596,O
9,1596,1597,O
level,1598,1603,O
has,1604,1607,O
good,1608,1612,O
predictive,1613,1623,O
value,1624,1629,O
for,1630,1633,O
malignant,1634,1643,O
or,1644,1646,O
invasive,1647,1655,O
IPMNs,1656,1661,B-Pathological_formation
.,1661,1662,O
Patients,1663,1671,O
with,1672,1676,O
CA,1677,1679,O
19,1680,1682,O
-,1682,1683,O
9,1683,1684,O
>,1685,1686,O
63,1687,1689,O
.,1689,1690,O
60,1690,1692,O
U,1693,1694,O
/,1694,1695,O
ml,1695,1697,O
had,1698,1701,O
poor,1702,1706,O
postoperative,1707,1720,O
prognosis,1721,1730,O
in,1731,1733,O
IPMNs,1734,1739,B-Pathological_formation
.,1739,1740,O
Preoperative,1741,1753,O
abnormal,1754,1762,O
serum,1763,1768,B-Organism_substance
CA,1769,1771,O
19,1772,1774,O
-,1774,1775,O
9,1775,1776,O
might,1777,1782,O
be,1783,1785,O
predictive,1786,1796,O
for,1797,1800,O
an,1801,1803,O
aggressive,1804,1814,O
surgical,1815,1823,O
intervention,1824,1836,O
in,1837,1839,O
IPMNs,1840,1845,B-Pathological_formation
.,1845,1846,O
Saliva,0,6,O
proteins,7,15,O
of,16,18,O
vector,19,25,O
Culicoides,26,36,O
modify,37,43,O
structure,44,53,O
and,54,57,O
infectivity,58,69,O
of,70,72,O
bluetongue,73,83,O
virus,84,89,O
particles,90,99,O
.,99,100,O
Bluetongue,101,111,O
virus,112,117,O
(,118,119,O
BTV,119,122,O
),122,123,O
and,124,127,O
epizootic,128,137,O
haemorrhagic,138,150,O
disease,151,158,O
virus,159,164,O
(,165,166,O
EHDV,166,170,O
),170,171,O
are,172,175,O
related,176,183,O
orbiviruses,184,195,O
",",195,196,O
transmitted,197,208,O
between,209,216,O
their,217,222,O
ruminant,223,231,O
hosts,232,237,O
primarily,238,247,O
by,248,250,O
certain,251,258,O
haematophagous,259,273,O
midge,274,279,O
vectors,280,287,O
(,288,289,O
Culicoides,289,299,O
spp,300,303,O
.,303,304,O
),304,305,O
.,305,306,O
The,307,310,O
larger,311,317,O
of,318,320,O
the,321,324,O
BTV,325,328,O
outer,329,334,O
-,334,335,O
capsid,335,341,O
proteins,342,350,O
",",350,351,O
',352,353,O
VP2,353,356,O
',356,357,O
",",357,358,O
can,359,362,O
be,363,365,O
cleaved,366,373,O
by,374,376,O
proteases,377,386,O
(,387,388,O
including,388,397,O
trypsin,398,405,O
or,406,408,O
chymotrypsin,409,421,O
),421,422,O
",",422,423,O
forming,424,431,O
infectious,432,442,O
subviral,443,451,O
particles,452,461,O
(,462,463,O
ISVP,463,467,O
),467,468,O
which,469,474,O
have,475,479,O
enhanced,480,488,O
infectivity,489,500,O
for,501,504,O
adult,505,510,O
Culicoides,511,521,O
",",521,522,O
or,523,525,O
KC,526,528,B-Cell
cells,529,534,I-Cell
(,535,536,O
a,536,537,O
cell,538,542,B-Cell
-,542,543,I-Cell
line,543,547,I-Cell
derived,548,555,O
from,556,560,O
C,561,562,O
.,562,563,O
sonorensis,564,574,O
),574,575,O
.,575,576,O
We,577,579,O
demonstrate,580,591,O
that,592,596,O
VP2,597,600,O
present,601,608,O
on,609,611,O
purified,612,620,O
virus,621,626,O
particles,627,636,O
from,637,641,O
3,642,643,O
different,644,653,O
BTV,654,657,O
strains,658,665,O
can,666,669,O
also,670,674,O
be,675,677,O
cleaved,678,685,O
by,686,688,O
treatment,689,698,O
with,699,703,O
saliva,704,710,O
from,711,715,O
adult,716,721,O
Culicoides,722,732,O
.,732,733,O
The,734,737,O
saliva,738,744,O
proteins,745,753,O
from,754,758,O
C,759,760,O
.,760,761,O
sonorensis,762,772,O
(,773,774,O
a,774,775,O
competent,776,785,O
BTV,786,789,O
vector,790,796,O
),796,797,O
",",797,798,O
cleaved,799,806,O
BTV,807,810,O
-,810,811,O
VP2,811,814,O
more,815,819,O
efficiently,820,831,O
than,832,836,O
those,837,842,O
from,843,847,O
C,848,849,O
.,849,850,O
nubeculosus,851,862,O
(,863,864,O
a,864,865,O
less,866,870,O
competent,871,880,O
/,880,881,O
non,881,884,O
-,884,885,O
vector,885,891,O
species,892,899,O
),899,900,O
.,900,901,O
Electrophoresis,902,917,O
and,918,921,O
mass,922,926,O
spectrometry,927,939,O
identified,940,950,O
a,951,952,O
trypsin,953,960,O
-,960,961,O
like,961,965,O
protease,966,974,O
in,975,977,O
C,978,979,O
.,979,980,O
sonorensis,981,991,O
saliva,992,998,O
",",998,999,O
which,1000,1005,O
was,1006,1009,O
significantly,1010,1023,O
reduced,1024,1031,O
or,1032,1034,O
absent,1035,1041,O
from,1042,1046,O
C,1047,1048,O
.,1048,1049,O
nubeculosus,1050,1061,O
saliva,1062,1068,O
.,1068,1069,O
Incubating,1070,1080,O
purified,1081,1089,O
BTV,1090,1093,O
-,1093,1094,O
1,1094,1095,O
with,1096,1100,O
C,1101,1102,O
.,1102,1103,O
sonorensis,1104,1114,O
saliva,1115,1121,O
proteins,1122,1130,O
also,1131,1135,O
increased,1136,1145,O
their,1146,1151,O
infectivity,1152,1163,O
for,1164,1167,O
KC,1168,1170,B-Cell
cells,1171,1176,I-Cell
~,1177,1178,O
10,1178,1180,O
fold,1181,1185,O
",",1185,1186,O
while,1187,1192,O
infectivity,1193,1204,O
for,1205,1208,O
BHK,1209,1212,B-Cell
cells,1213,1218,I-Cell
was,1219,1222,O
reduced,1223,1230,O
by,1231,1233,O
2,1234,1235,O
-,1235,1236,O
6,1236,1237,O
fold,1238,1242,O
.,1242,1243,O
Treatment,1244,1253,O
of,1254,1256,O
an,1257,1259,O
',1260,1261,O
eastern,1261,1268,O
',1268,1269,O
strain,1270,1276,O
of,1277,1279,O
EHDV,1280,1284,O
-,1284,1285,O
2,1285,1286,O
with,1287,1291,O
saliva,1292,1298,O
proteins,1299,1307,O
of,1308,1310,O
either,1311,1317,O
C,1318,1319,O
.,1319,1320,O
sonorensis,1321,1331,O
or,1332,1334,O
C,1335,1336,O
.,1336,1337,O
nubeculosus,1338,1349,O
cleaved,1350,1357,O
VP2,1358,1361,O
",",1361,1362,O
but,1363,1366,O
a,1367,1368,O
',1369,1370,O
western,1370,1377,O
',1377,1378,O
strain,1379,1385,O
of,1386,1388,O
EHDV,1389,1393,O
-,1393,1394,O
2,1394,1395,O
remained,1396,1404,O
unmodified,1405,1415,O
.,1415,1416,O
These,1417,1422,O
results,1423,1430,O
indicate,1431,1439,O
that,1440,1444,O
temperature,1445,1456,O
",",1456,1457,O
strain,1458,1464,O
of,1465,1467,O
virus,1468,1473,O
and,1474,1477,O
protein,1478,1485,O
composition,1486,1497,O
of,1498,1500,O
Culicoides,1501,1511,O
saliva,1512,1518,O
(,1519,1520,O
particularly,1520,1532,O
its,1533,1536,O
protease,1537,1545,O
content,1546,1553,O
which,1554,1559,O
is,1560,1562,O
dependent,1563,1572,O
upon,1573,1577,O
vector,1578,1584,O
species,1585,1592,O
),1592,1593,O
",",1593,1594,O
can,1595,1598,O
all,1599,1602,O
play,1603,1607,O
a,1608,1609,O
significant,1610,1621,O
role,1622,1626,O
in,1627,1629,O
the,1630,1633,O
efficiency,1634,1644,O
of,1645,1647,O
VP2,1648,1651,O
cleavage,1652,1660,O
",",1660,1661,O
influencing,1662,1673,O
virus,1674,1679,O
infectivity,1680,1691,O
.,1691,1692,O
Saliva,1693,1699,O
of,1700,1702,O
several,1703,1710,O
other,1711,1716,O
arthropod,1717,1726,O
species,1727,1734,O
has,1735,1738,O
previously,1739,1749,O
been,1750,1754,O
shown,1755,1760,O
to,1761,1763,O
increase,1764,1772,O
transmission,1773,1785,O
",",1785,1786,O
infectivity,1787,1798,O
and,1799,1802,O
virulence,1803,1812,O
of,1813,1815,O
certain,1816,1823,O
arboviruses,1824,1835,O
",",1835,1836,O
by,1837,1839,O
modulating,1840,1850,O
and,1851,1854,O
/,1854,1855,O
or,1855,1857,O
suppressing,1858,1869,O
the,1870,1873,O
mammalian,1874,1883,O
immune,1884,1890,O
response,1891,1899,O
.,1899,1900,O
The,1901,1904,O
findings,1905,1913,O
presented,1914,1923,O
here,1924,1928,O
",",1928,1929,O
however,1930,1937,O
",",1937,1938,O
demonstrate,1939,1950,O
a,1951,1952,O
novel,1953,1958,O
mechanism,1959,1968,O
by,1969,1971,O
which,1972,1977,O
proteases,1978,1987,O
in,1988,1990,O
Culicoides,1991,2001,O
saliva,2002,2008,O
can,2009,2012,O
also,2013,2017,O
directly,2018,2026,O
modify,2027,2033,O
the,2034,2037,O
orbivirus,2038,2047,O
particle,2048,2056,O
structure,2057,2066,O
",",2066,2067,O
leading,2068,2075,O
to,2076,2078,O
increased,2079,2088,O
infectivity,2089,2100,O
specifically,2101,2113,O
for,2114,2117,O
Culicoides,2118,2128,O
cells,2129,2134,B-Cell
and,2135,2138,O
",",2138,2139,O
in,2140,2142,O
turn,2143,2147,O
",",2147,2148,O
efficiency,2149,2159,O
of,2160,2162,O
transmission,2163,2175,O
to,2176,2178,O
the,2179,2182,O
insect,2183,2189,O
vector,2190,2196,O
.,2196,2197,O
mirAct,0,6,O
:,6,7,O
a,8,9,O
web,10,13,O
tool,14,18,O
for,19,22,O
evaluating,23,33,O
microRNA,34,42,O
activity,43,51,O
based,52,57,O
on,58,60,O
gene,61,65,O
expression,66,76,O
data,77,81,O
.,81,82,O
MicroRNAs,83,92,O
(,93,94,O
miRNAs,94,100,O
),100,101,O
are,102,105,O
critical,106,114,O
regulators,115,125,O
in,126,128,O
the,129,132,O
complex,133,140,O
cellular,141,149,B-Cell
networks,150,158,O
.,158,159,O
The,160,163,O
mirAct,164,170,O
web,171,174,O
server,175,181,O
(,182,183,O
http,183,187,O
:,187,188,O
/,188,189,O
/,189,190,O
sysbio,190,196,O
.,196,197,O
ustc,197,201,O
.,201,202,O
edu,202,205,O
.,205,206,O
cn,206,208,O
/,208,209,O
software,209,217,O
/,217,218,O
mirAct,218,224,O
),224,225,O
is,226,228,O
a,229,230,O
tool,231,235,O
designed,236,244,O
to,245,247,O
investigate,248,259,O
miRNA,260,265,O
activity,266,274,O
based,275,280,O
on,281,283,O
gene,284,288,O
-,288,289,O
expression,289,299,O
data,300,304,O
by,305,307,O
using,308,313,O
the,314,317,O
negative,318,326,O
regulation,327,337,O
relationship,338,350,O
between,351,358,O
miRNAs,359,365,O
and,366,369,O
their,370,375,O
target,376,382,O
genes,383,388,O
.,388,389,O
mirAct,390,396,O
supports,397,405,O
multiple,406,414,O
-,414,415,O
class,415,420,O
data,421,425,O
and,426,429,O
enables,430,437,O
clustering,438,448,O
analysis,449,457,O
based,458,463,O
on,464,466,O
computationally,467,482,O
determined,483,493,O
miRNA,494,499,O
activity,500,508,O
.,508,509,O
Here,510,514,O
",",514,515,O
we,516,518,O
describe,519,527,O
the,528,531,O
framework,532,541,O
of,542,544,O
mirAct,545,551,O
",",551,552,O
demonstrate,553,564,O
its,565,568,O
performance,569,580,O
by,581,583,O
comparing,584,593,O
with,594,598,O
other,599,604,O
similar,605,612,O
programs,613,621,O
and,622,625,O
exemplify,626,635,O
its,636,639,O
applications,640,652,O
using,653,658,O
case,659,663,O
studies,664,671,O
.,671,672,O
Non,0,3,O
-,3,4,O
heart,4,9,B-Organ
-,9,10,O
beating,10,17,O
organ,18,23,B-Organ
donation,24,32,O
in,33,35,O
Italy,36,41,O
.,41,42,O
In,43,45,O
2007,46,50,O
the,51,54,O
non,55,58,O
-,58,59,O
heart,59,64,B-Organ
-,64,65,O
beating,65,72,O
organ,73,78,B-Organ
donation,79,87,O
(,88,89,O
NHBD,89,93,O
),93,94,O
"""",95,96,O
Programma,96,105,O
Alba,106,110,O
"""",110,111,O
(,112,113,O
Sunrise,113,120,O
Programme,121,130,O
),130,131,O
started,132,139,O
in,140,142,O
Pavia,143,148,O
",",148,149,O
Italy,150,155,O
.,155,156,O
The,157,160,O
initial,161,168,O
plan,169,173,O
was,174,177,O
to,178,180,O
cut,181,184,O
down,185,189,O
waiting,190,197,O
list,198,202,O
for,203,206,O
kidney,207,213,B-Organ
transplantation,214,229,O
",",229,230,O
while,231,236,O
its,237,240,O
final,241,246,O
aim,247,250,O
is,251,253,O
to,254,256,O
shorten,257,264,O
organ,265,270,B-Organ
transplantation,271,286,O
waiting,287,294,O
lists,295,300,O
.,300,301,O
When,302,306,O
compared,307,315,O
to,316,318,O
European,319,327,O
countries,328,337,O
and,338,341,O
the,342,345,O
USA,346,349,O
",",349,350,O
the,351,354,O
Italian,355,362,O
NHBD,363,367,O
program,368,375,O
has,376,379,O
taken,380,385,O
longer,386,392,O
to,393,395,O
get,396,399,O
established,400,411,O
.,411,412,O
Initially,413,422,O
Italian,423,430,O
physicians,431,441,O
were,442,446,O
not,447,450,O
entirely,451,459,O
aware,460,465,O
of,466,468,O
the,469,472,O
NHBD,473,477,O
organ,478,483,B-Organ
viability,484,493,O
for,494,497,O
transplantation,498,513,O
",",513,514,O
furthermore,515,526,O
ethical,527,534,O
issues,535,541,O
and,542,545,O
the,546,549,O
need,550,554,O
to,555,557,O
regulate,558,566,O
medical,567,574,O
requirements,575,587,O
to,588,590,O
Italian,591,598,O
law,599,602,O
slowed,603,609,O
down,610,614,O
the,615,618,O
NHBD,619,623,O
program,624,631,O
.,631,632,O
In,633,635,O
particular,636,646,O
",",646,647,O
Italian,648,655,O
legislation,656,667,O
provides,668,676,O
for,677,680,O
death,681,686,O
ascertainment,687,700,O
after,701,706,O
irreversible,707,719,O
cardiac,720,727,B-Organ
arrest,728,734,O
",",734,735,O
20,736,738,O
-,738,739,O
minute,739,745,O
flat,746,750,O
electrocardiogram,751,768,O
.,768,769,O
This,770,774,O
no,775,777,O
-,777,778,O
touch,778,783,O
period,784,790,O
is,791,793,O
longer,794,800,O
when,801,805,O
compared,806,814,O
to,815,817,O
worldwide,818,827,O
legislation,828,839,O
",",839,840,O
and,841,844,O
organ,845,850,B-Organ
viability,851,860,O
has,861,864,O
been,865,869,O
a,870,871,O
main,872,876,O
concern,877,884,O
for,885,888,O
Italian,889,896,O
transplant,897,907,O
doctors,908,915,O
over,916,920,O
the,921,924,O
years,925,930,O
.,930,931,O
However,932,939,O
",",939,940,O
recent,941,947,O
data,948,952,O
let,953,956,O
up,957,959,O
to,960,962,O
40,963,965,O
-,965,966,O
minute,966,972,O
warm,973,977,O
ischemia,978,986,O
time,987,991,O
to,992,994,O
preserve,995,1003,O
organ,1004,1009,B-Organ
viability,1010,1019,O
;,1019,1020,O
this,1021,1025,O
has,1026,1029,O
encouraged,1030,1040,O
Pavia,1041,1046,O
',1046,1047,O
s,1047,1048,O
group,1049,1054,O
to,1055,1057,O
establish,1058,1067,O
the,1068,1071,O
NHBD,1072,1076,O
"""",1077,1078,O
Programma,1078,1087,O
Alba,1088,1092,O
"""",1092,1093,O
.,1093,1094,O
It,1095,1097,O
was,1098,1101,O
designed,1102,1110,O
according,1111,1120,O
to,1121,1123,O
Italian,1124,1131,O
legislation,1132,1143,O
from,1144,1148,O
death,1149,1154,O
diagnosis,1155,1164,O
to,1165,1167,O
graft,1168,1173,B-Organ
placement,1174,1183,O
",",1183,1184,O
from,1185,1189,O
this,1190,1194,O
perspective,1195,1206,O
must,1207,1211,O
the,1212,1215,O
significant,1216,1227,O
role,1228,1232,O
of,1233,1235,O
the,1236,1239,O
Transplant,1240,1250,O
coordinator,1251,1262,O
be,1263,1265,O
recognized,1266,1276,O
.,1276,1277,O
Since,1278,1283,O
2007,1284,1288,O
seven,1289,1294,O
kidneys,1295,1302,B-Organ
have,1303,1307,O
been,1308,1312,O
gathered,1313,1321,O
from,1322,1326,O
seven,1327,1332,O
NHBD,1333,1337,O
.,1337,1338,O
Of,1339,1341,O
these,1342,1347,O
",",1347,1348,O
six,1349,1352,O
NHBD,1353,1357,O
kidneys,1358,1365,B-Organ
have,1366,1370,O
been,1371,1375,O
transplanted,1376,1388,O
.,1388,1389,O
Currently,1390,1399,O
",",1399,1400,O
four,1401,1405,O
patients,1406,1414,O
are,1415,1418,O
out,1419,1422,O
of,1423,1425,O
dialysis,1426,1434,O
.,1434,1435,O
This,1436,1440,O
report,1441,1447,O
is,1448,1450,O
a,1451,1452,O
detailed,1453,1461,O
description,1462,1473,O
of,1474,1476,O
NHBD,1477,1481,O
"""",1482,1483,O
Programma,1483,1492,O
Alba,1493,1497,O
"""",1497,1498,O
and,1499,1502,O
its,1503,1506,O
preliminary,1507,1518,O
results,1519,1526,O
.,1526,1527,O
Massive,0,7,O
osteolysis,8,18,O
in,19,21,O
a,22,23,O
dog,24,27,O
resembling,28,38,O
Gorham,39,45,O
',45,46,O
s,46,47,O
disease,48,55,O
in,56,58,O
humans,59,65,O
.,65,66,O
An,67,69,O
eight,70,75,O
-,75,76,O
month,76,81,O
-,81,82,O
old,82,85,O
mixed,86,91,O
-,91,92,O
breed,92,97,O
dog,98,101,O
was,102,105,O
presented,106,115,O
with,116,120,O
a,121,122,O
history,123,130,O
of,131,133,O
sudden,134,140,O
onset,141,146,O
pelvic,147,153,B-Organism_subdivision
limb,154,158,I-Organism_subdivision
lameness,159,167,O
.,167,168,O
Radiographic,169,181,O
and,182,185,O
computed,186,194,O
tomographic,195,206,O
examinations,207,219,O
demonstrated,220,232,O
an,233,235,O
osteolytic,236,246,O
process,247,254,O
involving,255,264,O
the,265,268,O
lumbar,269,275,B-Organ
spine,276,281,I-Organ
and,282,285,O
pelvis,286,292,B-Organ
.,292,293,O
A,294,295,O
comprehensive,296,309,O
work,310,314,O
-,314,315,O
up,315,317,O
including,318,327,O
serial,328,334,O
radiographic,335,347,O
skeletal,348,356,B-Anatomical_system
survey,357,363,O
",",363,364,O
biopsy,365,371,O
",",371,372,O
routine,373,380,O
laboratory,381,391,O
investigation,392,405,O
and,406,409,O
evaluation,410,420,O
of,421,423,O
parathyroid,424,435,O
hormone,436,443,O
(,444,445,O
PTH,445,448,O
),448,449,O
and,450,453,O
25,454,456,O
-,456,457,O
hydroxy,457,464,O
-,464,465,O
vitamin,465,472,O
D,473,474,O
levels,475,481,O
failed,482,488,O
to,489,491,O
reveal,492,498,O
any,499,502,O
underlying,503,513,O
cause,514,519,O
for,520,523,O
the,524,527,O
osteolysis,528,538,O
.,538,539,O
Conservative,540,552,O
treatment,553,562,O
using,563,568,O
the,569,572,O
bisphosphonate,573,587,O
drug,588,592,O
alendronate,593,604,O
and,605,608,O
oral,609,613,O
analgesic,614,623,O
medications,624,635,O
resulted,636,644,O
in,645,647,O
a,648,649,O
return,650,656,O
to,657,659,O
nearly,660,666,O
normal,667,673,O
long,674,678,O
-,678,679,O
term,679,683,O
function,684,692,O
",",692,693,O
despite,694,701,O
massive,702,709,O
lumbar,710,716,O
and,717,720,O
pelvic,721,727,O
osteolysis,728,738,O
.,738,739,O
The,740,743,O
clinical,744,752,O
",",752,753,O
radiological,754,766,O
and,767,770,O
histopathological,771,788,O
features,789,797,O
in,798,800,O
this,801,805,O
dog,806,809,O
are,810,813,O
reported,814,822,O
",",822,823,O
and,824,827,O
similarities,828,840,O
with,841,845,O
the,846,849,O
human,850,855,O
condition,856,865,O
known,866,871,O
as,872,874,O
Gorham,875,881,O
',881,882,O
s,882,883,O
disease,884,891,O
are,892,895,O
discussed,896,905,O
.,905,906,O
[,0,1,O
Rubella,1,8,O
in,9,11,O
Poland,12,18,O
in,19,21,O
2009,22,26,O
],26,27,O
.,27,28,O
In,29,31,O
Poland,32,38,O
",",38,39,O
7,40,41,O
",",41,42,O
587,42,45,O
cases,46,51,O
of,52,54,O
rubella,55,62,O
were,63,67,O
registered,68,78,O
in,79,81,O
2009,82,86,O
(,87,88,O
incidence,88,97,O
19,98,100,O
.,100,101,O
9,101,102,O
per,103,106,O
100,107,110,O
",",110,111,O
000,111,114,O
population,115,125,O
),125,126,O
.,126,127,O
According,128,137,O
to,138,140,O
a,141,142,O
new,143,146,O
rubella,147,154,O
case,155,159,O
definition,160,170,O
",",170,171,O
introduced,172,182,O
in,183,185,O
2009,186,190,O
",",190,191,O
7,192,193,O
(,194,195,O
0,195,196,O
.,196,197,O
1,197,198,O
%,198,199,O
),199,200,O
cases,201,206,O
were,207,211,O
classified,212,222,O
as,223,225,O
confirmed,226,235,O
cases,236,241,O
",",241,242,O
30,243,245,O
(,246,247,O
0,247,248,O
.,248,249,O
4,249,250,O
%,250,251,O
),251,252,O
as,253,255,O
probable,256,264,O
.,264,265,O
One,266,269,O
case,270,274,O
of,275,277,O
congenital,278,288,O
rubella,289,296,O
syndrome,297,305,O
was,306,309,O
reported,310,318,O
.,318,319,O
The,320,323,O
incidence,324,333,O
in,334,336,O
men,337,340,O
(,341,342,O
26,342,344,O
.,344,345,O
6,345,346,O
),346,347,O
was,348,351,O
1,352,353,O
.,353,354,O
9,354,355,O
-,355,356,O
times,356,361,O
higher,362,368,O
than,369,373,O
in,374,376,O
women,377,382,O
(,383,384,O
13,384,386,O
.,386,387,O
6,387,388,O
),388,389,O
.,389,390,O
The,391,394,O
highest,395,402,O
incidence,403,412,O
was,413,416,O
observed,417,425,O
in,426,428,O
children,429,437,O
aged,438,442,O
7,443,444,O
and,445,448,O
8,449,450,O
years,451,456,O
(,457,458,O
180,458,461,O
.,461,462,O
3,462,463,O
and,464,467,O
175,468,471,O
.,471,472,O
6,472,473,O
",",473,474,O
respectively,475,487,O
),487,488,O
.,488,489,O
No,490,492,O
rubella,493,500,O
deaths,501,507,O
were,508,512,O
registered,513,523,O
.,523,524,O
An,525,527,O
improvement,528,539,O
of,540,542,O
laboratory,543,553,O
diagnosis,554,563,O
of,564,566,O
reported,567,575,O
cases,576,581,O
is,582,584,O
necessary,585,594,O
to,595,597,O
assess,598,604,O
the,605,608,O
impact,609,615,O
of,616,618,O
2,619,620,O
-,620,621,O
dose,621,625,O
immunization,626,638,O
implemented,639,650,O
in,651,653,O
2003,654,658,O
on,659,661,O
rubella,662,669,O
epidemiology,670,682,O
in,683,685,O
Poland,686,692,O
.,692,693,O
Burns,0,5,O
from,6,10,O
hot,11,14,O
wheat,15,20,O
bags,21,25,O
:,25,26,O
a,27,28,O
public,29,35,O
safety,36,42,O
issue,43,48,O
.,48,49,O
Introduction,50,62,O
:,62,63,O
Wheat,64,69,O
bags,70,74,O
are,75,78,O
therapeutic,79,90,O
devices,91,98,O
that,99,103,O
are,104,107,O
heated,108,114,O
in,115,117,O
microwaves,118,128,O
and,129,132,O
commonly,133,141,O
used,142,146,O
to,147,149,O
provide,150,157,O
relief,158,164,O
from,165,169,O
muscle,170,176,B-Organ
and,177,180,O
joint,181,186,B-Multi-tissue_structure
pain,187,191,O
.,191,192,O
The,193,196,O
Royal,197,202,O
Adelaide,203,211,O
Hospital,212,220,O
Burns,221,226,O
Unit,227,231,O
has,232,235,O
observed,236,244,O
a,245,246,O
number,247,253,O
of,254,256,O
patients,257,265,O
with,266,270,O
significant,271,282,O
burn,283,287,O
injuries,288,296,O
resulting,297,306,O
from,307,311,O
their,312,317,O
use,318,321,O
.,321,322,O
Despite,323,330,O
their,331,336,O
dangers,337,344,O
",",344,345,O
the,346,349,O
products,350,358,O
come,359,363,O
with,364,368,O
limited,369,376,O
safety,377,383,O
information,384,395,O
.,395,396,O
Methods,397,404,O
:,404,405,O
Data,406,410,O
were,411,415,O
collected,416,425,O
from,426,430,O
the,431,434,O
Burns,435,440,O
Unit,441,445,O
database,446,454,O
for,455,458,O
all,459,462,O
patients,463,471,O
admitted,472,480,O
with,481,485,O
burns,486,491,O
due,492,495,O
to,496,498,O
hot,499,502,O
wheat,503,508,O
bags,509,513,O
from,514,518,O
2004,519,523,O
to,524,526,O
2009,527,531,O
.,531,532,O
This,533,537,O
was,538,541,O
analyzed,542,550,O
to,551,553,O
determine,554,563,O
the,564,567,O
severity,568,576,O
of,577,579,O
the,580,583,O
burn,584,588,O
injury,589,595,O
and,596,599,O
identify,600,608,O
any,609,612,O
predisposing,613,625,O
factors,626,633,O
.,633,634,O
An,635,637,O
experimental,638,650,O
study,651,656,O
was,657,660,O
performed,661,670,O
to,671,673,O
measure,674,681,O
the,682,685,O
temperature,686,697,O
of,698,700,O
wheat,701,706,O
bags,707,711,O
when,712,716,O
heated,717,723,O
to,724,726,O
determine,727,736,O
their,737,742,O
potential,743,752,O
for,753,756,O
causing,757,764,O
thermal,765,772,O
injury,773,779,O
.,779,780,O
Results,781,788,O
:,788,789,O
11,790,792,O
patients,793,801,O
were,802,806,O
admitted,807,815,O
with,816,820,O
burns,821,826,O
due,827,830,O
to,831,833,O
hot,834,837,O
wheat,838,843,O
bags,844,848,O
.,848,849,O
The,850,853,O
median,854,860,O
age,861,864,O
was,865,868,O
52,869,871,O
years,872,877,O
and,878,881,O
the,882,885,O
mean,886,890,O
total,891,896,O
body,897,901,B-Organism_subdivision
surface,902,909,I-Organism_subdivision
area,910,914,I-Organism_subdivision
was,915,918,O
1,919,920,O
.,920,921,O
1,921,922,O
%,922,923,O
.,923,924,O
All,925,928,O
burns,929,934,O
were,935,939,O
either,940,946,O
deep,947,951,O
dermal,952,958,B-Multi-tissue_structure
(,959,960,O
45,960,962,O
.,962,963,O
5,963,964,O
%,964,965,O
),965,966,O
or,967,969,O
full,970,974,O
thickness,975,984,O
(,985,986,O
54,986,988,O
.,988,989,O
5,989,990,O
%,990,991,O
),991,992,O
.,992,993,O
Ten,994,997,O
patients,998,1006,O
required,1007,1015,O
operative,1016,1025,O
management,1026,1036,O
.,1036,1037,O
Predisposing,1038,1050,O
factors,1051,1058,O
(,1059,1060,O
eg,1060,1062,O
",",1062,1063,O
neuropathy,1064,1074,O
),1074,1075,O
to,1076,1078,O
thermal,1079,1086,O
injury,1087,1093,O
were,1094,1098,O
identified,1099,1109,O
in,1110,1112,O
7,1113,1114,O
patients,1115,1123,O
.,1123,1124,O
The,1125,1128,O
experimental,1129,1141,O
study,1142,1147,O
showed,1148,1154,O
that,1155,1159,O
hot,1160,1163,O
wheat,1164,1169,O
bags,1170,1174,O
reached,1175,1182,O
temperatures,1183,1195,O
of,1196,1198,O
57,1199,1201,O
.,1201,1202,O
3degreesC,1202,1211,O
(,1212,1213,O
135,1213,1216,O
.,1216,1217,O
1degreesF,1217,1226,O
),1226,1227,O
when,1228,1232,O
heated,1233,1239,O
according,1240,1249,O
to,1250,1252,O
instructions,1253,1265,O
",",1265,1266,O
63,1267,1269,O
.,1269,1270,O
3degreesC,1270,1279,O
(,1280,1281,O
145,1281,1284,O
.,1284,1285,O
9degreesF,1285,1294,O
),1294,1295,O
in,1296,1298,O
a,1299,1300,O
1000,1301,1305,O
W,1306,1307,O
microwave,1308,1317,O
and,1318,1321,O
69,1322,1324,O
.,1324,1325,O
6degreesC,1325,1334,O
(,1335,1336,O
157,1336,1339,O
.,1339,1340,O
3degreesF,1340,1349,O
),1349,1350,O
on,1351,1353,O
reheating,1354,1363,O
.,1363,1364,O
Conclusions,1365,1376,O
:,1376,1377,O
Hot,1378,1381,O
wheat,1382,1387,O
bags,1388,1392,O
cause,1393,1398,O
serious,1399,1406,O
burn,1407,1411,O
injury,1412,1418,O
.,1418,1419,O
When,1420,1424,O
heated,1425,1431,O
improperly,1432,1442,O
",",1442,1443,O
they,1444,1448,O
can,1449,1452,O
reach,1453,1458,O
temperatures,1459,1471,O
high,1472,1476,O
enough,1477,1483,O
to,1484,1486,O
cause,1487,1492,O
epidermal,1493,1502,B-Multi-tissue_structure
necrosis,1503,1511,O
in,1512,1514,O
a,1515,1516,O
short,1517,1522,O
period,1523,1529,O
of,1530,1532,O
time,1533,1537,O
.,1537,1538,O
Patients,1539,1547,O
with,1548,1552,O
impaired,1553,1561,O
temperature,1562,1573,O
sensation,1574,1583,O
are,1584,1587,O
particularly,1588,1600,O
at,1601,1603,O
risk,1604,1608,O
.,1608,1609,O
There,1610,1615,O
should,1616,1622,O
be,1623,1625,O
greater,1626,1633,O
public,1634,1640,O
awareness,1641,1650,O
of,1651,1653,O
the,1654,1657,O
dangers,1658,1665,O
of,1666,1668,O
wheat,1669,1674,O
bag,1675,1678,O
use,1679,1682,O
and,1683,1686,O
more,1687,1691,O
specific,1692,1700,O
safety,1701,1707,O
warnings,1708,1716,O
on,1717,1719,O
the,1720,1723,O
products,1724,1732,O
.,1732,1733,O
The,0,3,O
enlarging,4,13,O
clinical,14,22,O
spectrum,23,31,O
of,32,34,O
Lyme,35,39,O
disease,40,47,O
:,47,48,O
Lyme,49,53,O
cerebral,54,62,B-Organ
vasculitis,63,73,O
",",73,74,O
a,75,76,O
new,77,80,O
disease,81,88,O
entity,89,95,O
.,95,96,O
The,97,100,O
case,101,105,O
of,106,108,O
a,109,110,O
patient,111,118,O
with,119,123,O
cerebral,124,132,B-Organ
vasculitis,133,143,O
with,144,148,O
a,149,150,O
right,151,156,B-Multi-tissue_structure
thalamic,157,165,I-Multi-tissue_structure
infarct,166,173,O
associated,174,184,O
with,185,189,O
cerebral,190,198,B-Organism_substance
spinal,199,205,I-Organism_substance
fluid,206,211,I-Organism_substance
Lyme,212,216,O
disease,217,224,O
is,225,227,O
presented,228,237,O
.,237,238,O
This,239,243,O
entity,244,250,O
has,251,254,O
not,255,258,O
been,259,263,O
described,264,273,O
in,274,276,O
the,277,280,O
United,281,287,O
States,288,294,O
",",294,295,O
and,296,299,O
only,300,304,O
one,305,308,O
similar,309,316,O
case,317,321,O
in,322,324,O
the,325,328,O
world,329,334,O
literature,335,345,O
could,346,351,O
be,352,354,O
found,355,360,O
.,360,361,O
The,362,365,O
patient,366,373,O
presented,374,383,O
with,384,388,O
a,389,390,O
progressive,391,402,O
headache,403,411,O
and,412,415,O
subsequent,416,426,O
development,427,438,O
of,439,441,O
grand,442,447,O
mal,448,451,O
seizure,452,459,O
activity,460,468,O
.,468,469,O
Lyme,470,474,O
disease,475,482,O
has,483,486,O
been,487,491,O
associated,492,502,O
with,503,507,O
cranial,508,515,B-Multi-tissue_structure
nerve,516,521,I-Multi-tissue_structure
palsies,522,529,O
",",529,530,O
peripheral,531,541,O
and,542,545,O
cranial,546,553,B-Organism_subdivision
radiculopathies,554,569,O
",",569,570,O
aseptic,571,578,O
meningitis,579,589,O
",",589,590,O
encephalitic,591,603,O
symptoms,604,612,O
",",612,613,O
chorea,614,620,O
",",620,621,O
and,622,625,O
demyelinating,626,639,O
polyneuropathy,640,654,O
presenting,655,665,O
like,666,670,O
Guillain,671,679,O
-,679,680,O
Barre,680,685,O
syndrome,686,694,O
.,694,695,O
These,696,701,O
syndromes,702,711,O
can,712,715,O
occur,716,721,O
separately,722,732,O
or,733,735,O
in,736,738,O
combination,739,750,O
.,750,751,O
Stroke,752,758,O
and,759,762,O
strokelike,763,773,O
syndromes,774,783,O
have,784,788,O
been,789,793,O
attributed,794,804,O
to,805,807,O
Lyme,808,812,O
disease,813,820,O
.,820,821,O
The,822,825,O
literature,826,836,O
concerning,837,847,O
the,848,851,O
neurologic,852,862,B-Anatomical_system
manifestations,863,877,O
of,878,880,O
Lyme,881,885,O
disease,886,893,O
is,894,896,O
reviewed,897,905,O
.,905,906,O
Gastric,0,7,B-Organ
microcirculatory,8,24,O
change,25,31,O
and,32,35,O
development,36,47,O
of,48,50,O
acute,51,56,O
gastric,57,64,B-Pathological_formation
mucosal,65,72,I-Pathological_formation
lesions,73,80,I-Pathological_formation
(,81,82,O
stress,82,88,B-Pathological_formation
ulcer,89,94,I-Pathological_formation
),94,95,O
.,95,96,O
Concerning,97,107,O
the,108,111,O
pathogenesis,112,124,O
of,125,127,O
acute,128,133,O
gastric,134,141,B-Pathological_formation
mucosal,142,149,I-Pathological_formation
lesions,150,157,I-Pathological_formation
",",157,158,O
gastric,159,166,B-Organ
microcirculatory,167,183,O
change,184,190,O
has,191,194,O
drawn,195,200,O
attention,201,210,O
as,211,213,O
an,214,216,O
important,217,226,O
factor,227,233,O
.,233,234,O
In,235,237,O
view,238,242,O
of,243,245,O
this,246,250,O
fact,251,255,O
",",255,256,O
gastric,257,264,B-Multi-tissue_structure
mucosal,265,272,I-Multi-tissue_structure
blood,273,278,B-Organism_substance
flow,279,283,O
and,284,287,O
microvascular,288,301,B-Tissue
structure,302,311,O
were,312,316,O
investigated,317,329,O
in,330,332,O
normal,333,339,O
and,340,343,O
in,344,346,O
burn,347,351,O
stressed,352,360,O
rats,361,365,O
.,365,366,O
Moreover,367,375,O
",",375,376,O
alterations,377,388,O
in,389,391,O
acid,392,396,O
and,397,400,O
pepsin,401,407,O
activities,408,418,O
in,419,421,O
by,422,424,O
morphological,425,438,O
and,439,442,O
biochemical,443,454,O
procedures,455,465,O
in,466,468,O
order,469,474,O
to,475,477,O
evaluate,478,486,O
the,487,490,O
relationship,491,503,O
between,504,511,O
defensive,512,521,O
and,522,525,O
aggressive,526,536,O
factors,537,544,O
of,545,547,O
the,548,551,O
gastric,552,559,B-Multi-tissue_structure
mucosa,560,566,I-Multi-tissue_structure
.,566,567,O
Gastric,568,575,B-Multi-tissue_structure
mucosal,576,583,I-Multi-tissue_structure
blood,584,589,B-Organism_substance
flow,590,594,O
decreased,595,604,O
significantly,605,618,O
in,619,621,O
early,622,627,O
period,628,634,O
after,635,640,O
induction,641,650,O
of,651,653,O
stress,654,660,O
(,661,662,O
p,662,663,O
less,664,668,O
than,669,673,O
0,674,675,O
.,675,676,O
01,676,678,O
),678,679,O
.,679,680,O
The,681,684,O
incidence,685,694,O
of,695,697,O
ulceration,698,708,O
showed,709,715,O
a,716,717,O
correlative,718,729,O
relation,730,738,O
with,739,743,O
the,744,747,O
decrease,748,756,O
of,757,759,O
mucosal,760,767,B-Multi-tissue_structure
blood,768,773,B-Organism_substance
flow,774,778,O
.,778,779,O
Reduction,780,789,O
of,790,792,O
blood,793,798,B-Organism_substance
flow,799,803,O
in,804,806,O
burn,807,811,O
was,812,815,O
due,816,819,O
to,820,822,O
opening,823,830,O
of,831,833,O
arteriovenular,834,848,B-Multi-tissue_structure
shunt,849,854,O
and,855,858,O
it,859,861,O
appeared,862,870,O
that,871,875,O
this,876,880,O
was,881,884,O
responsible,885,896,O
for,897,900,O
mucosal,901,908,B-Multi-tissue_structure
ischemia,909,917,O
and,918,921,O
congestion,922,932,O
.,932,933,O
Following,934,943,O
the,944,947,O
decrease,948,956,O
of,957,959,O
blood,960,965,B-Organism_substance
flow,966,970,O
",",970,971,O
acid,972,976,O
output,977,983,O
was,984,987,O
lower,988,993,O
in,994,996,O
stress,997,1003,O
than,1004,1008,O
that,1009,1013,O
in,1014,1016,O
control,1017,1024,O
.,1024,1025,O
Finally,1026,1033,O
",",1033,1034,O
the,1035,1038,O
results,1039,1046,O
of,1047,1049,O
these,1050,1055,O
studies,1056,1063,O
demonstrated,1064,1076,O
the,1077,1080,O
importance,1081,1091,O
of,1092,1094,O
defensive,1095,1104,O
factors,1105,1112,O
.,1112,1113,O
The,1114,1117,O
reduction,1118,1127,O
of,1128,1130,O
mucosal,1131,1138,B-Multi-tissue_structure
blood,1139,1144,B-Organism_substance
flow,1145,1149,O
resulted,1150,1158,O
in,1159,1161,O
the,1162,1165,O
sequence,1166,1174,O
of,1175,1177,O
events,1178,1184,O
that,1185,1189,O
led,1190,1193,O
to,1194,1196,O
formation,1197,1206,O
of,1207,1209,O
acute,1210,1215,O
gastric,1216,1223,B-Pathological_formation
mucosal,1224,1231,I-Pathological_formation
lesion,1232,1238,I-Pathological_formation
.,1238,1239,O
Type,0,4,O
-,4,5,O
A,5,6,O
cholecystokinin,7,22,O
receptors,23,32,O
in,33,35,O
CHP212,36,42,B-Cell
neuroblastoma,43,56,I-Cell
cells,57,62,I-Cell
:,62,63,O
evidence,64,72,O
for,73,76,O
association,77,88,O
with,89,93,O
G,94,95,O
protein,96,103,O
and,104,107,O
activation,108,118,O
of,119,121,O
phosphoinositide,122,138,O
hydrolysis,139,149,O
.,149,150,O
125I,151,155,O
-,155,156,O
Bolton,156,162,O
Hunter,163,169,O
-,169,170,O
cholecystokinin,170,185,O
octapeptide,186,197,O
(,198,199,O
BH,199,201,O
-,201,202,O
CCK8,202,206,O
),206,207,O
and,208,211,O
(,212,213,O
-,213,214,O
),214,215,O
-,215,216,O
[,216,217,O
3H,217,219,O
],219,220,O
L,220,221,O
-,221,222,O
364718,222,228,O
membrane,229,237,B-Cellular_component
binding,238,245,O
assays,246,252,O
were,253,257,O
used,258,262,O
to,263,265,O
identify,266,274,O
and,275,278,O
characterize,279,291,O
cholecystokinin,292,307,O
(,308,309,O
CCK,309,312,O
),312,313,O
receptors,314,323,O
in,324,326,O
CHP212,327,333,B-Cell
human,334,339,O
neuroblastoma,340,353,B-Cell
cells,354,359,I-Cell
.,359,360,O
The,361,364,O
ligand,365,371,O
binding,372,379,O
properties,380,390,O
of,391,393,O
CCK,394,397,O
receptors,398,407,O
in,408,410,O
these,411,416,O
cells,417,422,B-Cell
are,423,426,O
similar,427,434,O
to,435,437,O
those,438,443,O
found,444,449,O
in,450,452,O
pancreas,453,461,B-Organ
(,462,463,O
CCK,463,466,O
-,466,467,O
A,467,468,O
sites,469,474,O
),474,475,O
and,476,479,O
differ,480,486,O
from,487,491,O
the,492,495,O
predominant,496,507,O
type,508,512,O
of,513,515,O
CCK,516,519,O
binding,520,527,O
site,528,532,O
found,533,538,O
in,539,541,O
brain,542,547,B-Organ
(,548,549,O
CCK,549,552,O
-,552,553,O
B,553,554,O
sites,555,560,O
),560,561,O
.,561,562,O
The,563,566,O
specific,567,575,O
binding,576,583,O
of,584,586,O
125I,587,591,O
-,591,592,O
BH,592,594,O
-,594,595,O
CCK8,595,599,O
but,600,603,O
not,604,607,O
(,608,609,O
-,609,610,O
),610,611,O
-,611,612,O
[,612,613,O
3H,613,615,O
],615,616,O
L,616,617,O
-,617,618,O
364718,618,624,O
was,625,628,O
reduced,629,636,O
by,637,639,O
the,640,643,O
metabolically,644,657,O
stable,658,664,O
GTP,665,668,O
analog,669,675,O
guanosine,676,685,O
5,686,687,O
',687,688,O
-,688,689,O
(,689,690,O
beta,690,694,O
-,694,695,O
delta,695,700,O
-,700,701,O
imido,701,706,O
),706,707,O
trisphosphate,707,720,O
.,720,721,O
A,722,723,O
substantial,724,735,O
difference,736,746,O
in,747,749,O
the,750,753,O
Bmax,754,758,O
for,759,762,O
the,763,766,O
radiolabeled,767,779,O
agonist,780,787,O
(,788,789,O
125I,789,793,O
-,793,794,O
BH,794,796,O
-,796,797,O
CCK8,797,801,O
),801,802,O
and,803,806,O
antagonist,807,817,O
[,818,819,O
(,819,820,O
-,820,821,O
),821,822,O
-,822,823,O
[,823,824,O
3H,824,826,O
],826,827,O
L,827,828,O
-,828,829,O
364718,829,835,O
],835,836,O
was,837,840,O
noted,841,846,O
.,846,847,O
These,848,853,O
observations,854,866,O
are,867,870,O
consistent,871,881,O
with,882,886,O
CCK,887,890,O
receptors,891,900,O
existing,901,909,O
in,910,912,O
guanine,913,920,O
nucleotide,921,931,O
-,931,932,O
binding,932,939,O
protein,940,947,O
-,947,948,O
coupled,948,955,O
and,956,959,O
-,960,961,O
uncoupled,961,970,O
states,971,977,O
.,977,978,O
Similar,979,986,O
to,987,989,O
its,990,993,O
action,994,1000,O
in,1001,1003,O
pancreatic,1004,1014,B-Cell
acinar,1015,1021,I-Cell
cells,1022,1027,I-Cell
",",1027,1028,O
CCK8,1029,1033,O
(,1033,1034,O
S,1034,1035,O
),1035,1036,O
stimulated,1037,1047,O
the,1048,1051,O
accumulation,1052,1064,O
of,1065,1067,O
[,1068,1069,O
3H,1069,1071,O
],1071,1072,O
inositol,1072,1080,O
phosphates,1081,1091,O
in,1092,1094,O
cells,1095,1100,B-Cell
prelabeled,1101,1111,O
with,1112,1116,O
[,1117,1118,O
3H,1118,1120,O
],1120,1121,O
myo,1121,1124,O
-,1124,1125,O
inositol,1125,1133,O
(,1134,1135,O
EC50,1135,1139,O
=,1140,1141,O
3,1142,1143,O
.,1143,1144,O
2,1144,1145,O
+,1146,1147,O
/,1147,1148,O
-,1148,1149,O
0,1150,1151,O
.,1151,1152,O
4,1152,1153,O
nM,1154,1156,O
;,1156,1157,O
maximum,1158,1165,O
response,1166,1174,O
=,1175,1176,O
4,1177,1178,O
.,1178,1179,O
5,1179,1180,O
+,1181,1182,O
/,1182,1183,O
-,1183,1184,O
0,1185,1186,O
.,1186,1187,O
4,1187,1188,O
x,1189,1190,O
basal,1191,1196,O
),1196,1197,O
.,1197,1198,O
The,1199,1202,O
intrinsic,1203,1212,O
activity,1213,1221,O
of,1222,1224,O
CCK,1225,1228,O
analogues,1229,1238,O
in,1239,1241,O
stimulating,1242,1253,O
phosphoinositide,1254,1270,O
hydrolysis,1271,1281,O
was,1282,1285,O
substantially,1286,1299,O
less,1300,1304,O
than,1305,1309,O
their,1310,1315,O
reported,1316,1324,O
intrinsic,1325,1334,O
activity,1335,1343,O
in,1344,1346,O
stimulating,1347,1358,O
phosphoinositide,1359,1375,O
hydrolysis,1376,1386,O
in,1387,1389,O
pancreatic,1390,1400,B-Cell
acinar,1401,1407,I-Cell
cells,1408,1413,I-Cell
.,1413,1414,O
The,1415,1418,O
CHP212,1419,1425,B-Cell
neuroblastoma,1426,1439,I-Cell
cell,1440,1444,I-Cell
may,1445,1448,O
serve,1449,1454,O
as,1455,1457,O
a,1458,1459,O
useful,1460,1466,O
model,1467,1472,O
for,1473,1476,O
the,1477,1480,O
recently,1481,1489,O
reported,1490,1498,O
CCK,1499,1502,O
-,1502,1503,O
A,1503,1504,O
binding,1505,1512,O
site,1513,1517,O
found,1518,1523,O
in,1524,1526,O
the,1527,1530,O
central,1531,1538,B-Anatomical_system
nervous,1539,1546,I-Anatomical_system
system,1547,1553,I-Anatomical_system
.,1553,1554,O
Screening,0,9,O
method,10,16,O
for,17,20,O
insecticidal,21,33,O
activity,34,42,O
using,43,48,O
first,49,54,O
instars,55,62,O
of,63,65,O
black,66,71,O
blow,72,76,O
fly,77,80,O
(,81,82,O
Diptera,82,89,O
:,89,90,O
Calliphoridae,91,104,O
),104,105,O
.,105,106,O
A,107,108,O
bioassay,109,117,O
method,118,124,O
suitable,125,133,O
for,134,137,O
rapid,138,143,O
mass,144,148,O
screening,149,158,O
of,159,161,O
fermentation,162,174,O
and,175,178,O
synthetic,179,188,O
organic,189,196,O
compounds,197,206,O
for,207,210,O
insecticidal,211,223,O
activity,224,232,O
is,233,235,O
described,236,245,O
.,245,246,O
The,247,250,O
test,251,255,O
",",255,256,O
which,257,262,O
uses,263,267,O
first,268,273,O
instars,274,281,O
of,282,284,O
susceptible,285,296,O
black,297,302,O
blow,303,307,O
fly,308,311,O
",",311,312,O
Phormia,313,320,O
regina,321,327,O
(,328,329,O
Meigen,329,335,O
),335,336,O
",",336,337,O
in,338,340,O
a,341,342,O
bovine,343,349,O
serum,350,355,B-Organism_substance
medium,356,362,O
",",362,363,O
detects,364,371,O
insecticidal,372,384,O
activity,385,393,O
with,394,398,O
reproducible,399,411,O
results,412,419,O
.,419,420,O
It,421,423,O
is,424,426,O
capable,427,434,O
of,435,437,O
selecting,438,447,O
the,448,451,O
most,452,456,O
active,457,463,O
compound,464,472,O
in,473,475,O
structure,476,485,O
-,485,486,O
activity,486,494,O
relationships,495,508,O
by,509,511,O
minimum,512,519,O
effective,520,529,O
dose,530,534,O
concentration,535,548,O
studies,549,556,O
.,556,557,O
The,558,561,O
bioassay,562,570,O
system,571,577,O
is,578,580,O
easy,581,585,O
to,586,588,O
operate,589,596,O
and,597,600,O
requires,601,609,O
only,610,614,O
a,615,616,O
minute,617,623,O
quantity,624,632,O
of,633,635,O
chemical,636,644,O
compound,645,653,O
.,653,654,O
Early,0,5,O
post,6,10,O
-,10,11,O
mortem,11,17,O
metabolism,18,28,O
and,29,32,O
muscle,33,39,B-Organ
shortening,40,50,O
in,51,53,O
the,54,57,O
Pectoralis,58,68,O
major,69,74,O
muscle,75,81,B-Organ
of,82,84,O
broiler,85,92,O
chickens,93,101,O
.,101,102,O
Three,103,108,O
experiments,109,120,O
were,121,125,O
conducted,126,135,O
to,136,138,O
examine,139,146,O
the,147,150,O
effects,151,158,O
of,159,161,O
sodium,162,168,O
pentobarbital,169,182,O
(,183,184,O
SP,184,186,O
),186,187,O
",",187,188,O
iodoacetate,189,200,O
(,201,202,O
IO,202,204,O
),204,205,O
",",205,206,O
tubocurarine,207,219,O
(,220,221,O
TC,221,223,O
),223,224,O
",",224,225,O
and,226,229,O
surgical,230,238,O
denervation,239,250,O
(,251,252,O
DN,252,254,O
),254,255,O
on,256,258,O
early,259,264,O
rigor,265,270,O
development,271,282,O
in,283,285,O
broiler,286,293,O
breast,294,300,B-Organ
muscle,301,307,I-Organ
.,307,308,O
In,309,311,O
Experiment,312,322,O
1,323,324,O
",",324,325,O
birds,326,331,O
were,332,336,O
either,337,343,O
anesthetized,344,356,O
or,357,359,O
not,360,363,O
with,364,368,O
SP,369,371,O
before,372,378,O
receiving,379,388,O
an,389,391,O
injection,392,401,O
of,402,404,O
IO,405,407,O
or,408,410,O
TC,411,413,O
or,414,416,O
maintained,417,427,O
as,428,430,O
noninjected,431,442,O
controls,443,451,O
.,451,452,O
Experiment,453,463,O
2,464,465,O
was,466,469,O
identical,470,479,O
except,480,486,O
that,487,491,O
a,492,493,O
treatment,494,503,O
of,504,506,O
denervation,507,518,O
of,519,521,O
the,522,525,O
breast,526,532,B-Organ
muscle,533,539,I-Organ
was,540,543,O
added,544,549,O
.,549,550,O
Experiment,551,561,O
3,562,563,O
was,564,567,O
conducted,568,577,O
to,578,580,O
contrast,581,589,O
birds,590,595,O
at,596,598,O
1,599,600,O
day,601,604,O
(,605,606,O
DN1,606,609,O
),609,610,O
and,611,614,O
3,615,616,O
days,617,621,O
(,622,623,O
DN3,623,626,O
),626,627,O
denervation,628,639,O
prior,640,645,O
to,646,648,O
slaughter,649,658,O
to,659,661,O
nonoperated,662,673,O
controls,674,682,O
.,682,683,O
Measurements,684,696,O
of,697,699,O
muscle,700,706,B-Organ
lactate,707,714,O
",",714,715,O
ATP,716,719,O
",",719,720,O
R,721,722,O
value,723,728,O
(,729,730,O
ratio,730,735,O
of,736,738,O
inosine,739,746,O
to,747,749,O
adenine,750,757,O
nucleotides,758,769,O
),769,770,O
",",770,771,O
pH,772,774,O
",",774,775,O
sarcomere,776,785,B-Tissue
lengths,786,793,O
",",793,794,O
and,795,798,O
shear,799,804,O
were,805,809,O
used,810,814,O
to,815,817,O
evaluate,818,826,O
treatment,827,836,O
effects,837,844,O
.,844,845,O
Results,846,853,O
for,854,857,O
Experiment,858,868,O
1,869,870,O
showed,871,877,O
no,878,880,O
significant,881,892,O
differences,893,904,O
among,905,910,O
treatment,911,920,O
and,921,924,O
control,925,932,O
groups,933,939,O
for,940,943,O
ATP,944,947,O
and,948,951,O
lactate,952,959,O
contents,960,968,O
",",968,969,O
R,970,971,O
values,972,978,O
",",978,979,O
or,980,982,O
sarcomere,983,992,B-Tissue
lengths,993,1000,O
;,1000,1001,O
however,1002,1009,O
",",1009,1010,O
significantly,1011,1024,O
lower,1025,1030,O
pH,1031,1033,O
and,1034,1037,O
higher,1038,1044,O
shear,1045,1050,O
values,1051,1057,O
were,1058,1062,O
observed,1063,1071,O
for,1072,1075,O
control,1076,1083,O
birds,1084,1089,O
.,1089,1090,O
In,1091,1093,O
Experiment,1094,1104,O
2,1105,1106,O
",",1106,1107,O
no,1108,1110,O
significant,1111,1122,O
differences,1123,1134,O
were,1135,1139,O
observed,1140,1148,O
among,1149,1154,O
the,1155,1158,O
treatment,1159,1168,O
groups,1169,1175,O
for,1176,1179,O
ATP,1180,1183,O
",",1183,1184,O
R,1185,1186,O
values,1187,1193,O
",",1193,1194,O
or,1195,1197,O
sarcomere,1198,1207,B-Tissue
lengths,1208,1215,O
.,1215,1216,O
However,1217,1224,O
",",1224,1225,O
lactate,1226,1233,O
and,1234,1237,O
shear,1238,1243,O
values,1244,1250,O
were,1251,1255,O
significantly,1256,1269,O
lower,1270,1275,O
",",1275,1276,O
and,1277,1280,O
pH,1281,1283,O
higher,1284,1290,O
",",1290,1291,O
for,1292,1295,O
the,1296,1299,O
DN,1300,1302,O
and,1303,1306,O
SP,1307,1309,O
treated,1310,1317,O
birds,1318,1323,O
.,1323,1324,O
Experiment,1325,1335,O
3,1336,1337,O
resulted,1338,1346,O
in,1347,1349,O
lower,1350,1355,O
lactate,1356,1363,O
and,1364,1367,O
higher,1368,1374,O
pH,1375,1377,O
values,1378,1384,O
for,1385,1388,O
the,1389,1392,O
DN3,1393,1396,O
treatment,1397,1406,O
in,1407,1409,O
comparison,1410,1420,O
with,1421,1425,O
both,1426,1430,O
DN1,1431,1434,O
and,1435,1438,O
control,1439,1446,O
groups,1447,1453,O
.,1453,1454,O
Results,1455,1462,O
of,1463,1465,O
these,1466,1471,O
studies,1472,1479,O
indicate,1480,1488,O
that,1489,1493,O
the,1494,1497,O
use,1498,1501,O
of,1502,1504,O
SP,1505,1507,O
and,1508,1511,O
DN,1512,1514,O
can,1515,1518,O
be,1519,1521,O
used,1522,1526,O
to,1527,1529,O
alter,1530,1535,O
the,1536,1539,O
early,1540,1545,O
profiles,1546,1554,O
of,1555,1557,O
rigor,1558,1563,O
development,1564,1575,O
.,1575,1576,O
Anaplastic,0,10,B-Pathological_formation
and,11,14,I-Pathological_formation
sarcomatoid,15,26,I-Pathological_formation
carcinoma,27,36,I-Pathological_formation
of,37,39,O
the,40,43,O
small,44,49,B-Organ
intestine,50,59,I-Organ
:,59,60,O
a,61,62,O
clinicopathologic,63,80,O
study,81,86,O
.,86,87,O
Carcinomas,88,98,B-Pathological_formation
involving,99,108,O
the,109,112,O
jejunum,113,120,B-Multi-tissue_structure
and,121,124,O
ileum,125,130,B-Multi-tissue_structure
are,131,134,O
rare,135,139,O
tumors,140,146,B-Pathological_formation
.,146,147,O
During,148,154,O
a,155,156,O
review,157,163,O
of,164,166,O
small,167,172,B-Pathological_formation
intestinal,173,183,I-Pathological_formation
neoplasms,184,193,I-Pathological_formation
",",193,194,O
six,195,198,O
primary,199,206,O
carcinomas,207,217,B-Pathological_formation
of,218,220,O
jejunum,221,228,B-Multi-tissue_structure
or,229,231,O
ileum,232,237,B-Multi-tissue_structure
with,238,242,O
an,243,245,O
anaplastic,246,256,O
and,257,260,O
sarcomatoid,261,272,B-Pathological_formation
histology,273,282,O
were,283,287,O
identified,288,298,O
.,298,299,O
At,300,302,O
presentation,303,315,O
",",315,316,O
three,317,322,O
of,323,325,O
the,326,329,O
patients,330,338,O
had,339,342,O
symptoms,343,351,O
related,352,359,O
to,360,362,O
metastatic,363,373,O
disease,374,381,O
and,382,385,O
three,386,391,O
had,392,395,O
symptoms,396,404,O
referable,405,414,O
to,415,417,O
the,418,421,O
local,422,427,O
tumor,428,433,B-Pathological_formation
.,433,434,O
The,435,438,O
tumors,439,445,B-Pathological_formation
were,446,450,O
large,451,456,O
(,457,458,O
greater,458,465,O
than,466,470,O
4,471,472,O
.,472,473,O
5,473,474,O
cm,475,477,O
in,478,480,O
diameter,481,489,O
),489,490,O
",",490,491,O
usually,492,499,O
endophytic,500,510,O
masses,511,517,O
composed,518,526,O
of,527,529,O
large,530,535,O
cells,536,541,B-Cell
with,542,546,O
eosinophilic,547,559,B-Organism_substance
cytoplasm,560,569,I-Organism_substance
",",569,570,O
anaplastic,571,581,O
nuclei,582,588,B-Cellular_component
",",588,589,O
and,590,593,O
prominent,594,603,O
nucleoli,604,612,B-Cellular_component
.,612,613,O
In,614,616,O
many,617,621,O
areas,622,627,O
",",627,628,O
the,629,632,O
cells,633,638,B-Cell
had,639,642,O
a,643,644,O
spindled,645,653,O
configuration,654,667,O
.,667,668,O
Mucin,669,674,O
positivity,675,685,O
was,686,689,O
identified,690,700,O
in,701,703,O
all,704,707,O
six,708,711,O
cases,712,717,O
.,717,718,O
Electron,719,727,O
microscopic,728,739,O
findings,740,748,O
in,749,751,O
two,752,755,O
cases,756,761,O
were,762,766,O
indicative,767,777,O
of,778,780,O
epithelial,781,791,B-Tissue
differentiation,792,807,O
.,807,808,O
The,809,812,O
tumors,813,819,B-Pathological_formation
behaved,820,827,O
aggressively,828,840,O
;,840,841,O
all,842,845,O
five,846,850,O
patients,851,859,O
for,860,863,O
whom,864,868,O
there,869,874,O
was,875,878,O
clinical,879,887,O
follow,888,894,O
-,894,895,O
up,895,897,O
died,898,902,O
of,903,905,O
metastases,906,916,B-Pathological_formation
within,917,923,O
40,924,926,O
months,927,933,O
.,933,934,O
The,935,938,O
six,939,942,O
anaplastic,943,953,B-Pathological_formation
and,954,957,I-Pathological_formation
sarcomatoid,958,969,I-Pathological_formation
carcinomas,970,980,I-Pathological_formation
were,981,985,O
compared,986,994,O
with,995,999,O
29,1000,1002,O
typical,1003,1010,O
adenocarcinomas,1011,1026,B-Pathological_formation
arising,1027,1034,O
in,1035,1037,O
the,1038,1041,O
jejunum,1042,1049,B-Multi-tissue_structure
or,1050,1052,O
ileum,1053,1058,B-Multi-tissue_structure
.,1058,1059,O
Only,1060,1064,O
two,1065,1068,O
of,1069,1071,O
the,1072,1075,O
latter,1076,1082,O
group,1083,1088,O
had,1089,1092,O
symptoms,1093,1101,O
referable,1102,1111,O
to,1112,1114,O
distant,1115,1122,O
metastases,1123,1133,B-Pathological_formation
at,1134,1136,O
presentation,1137,1149,O
.,1149,1150,O
These,1151,1156,O
tumors,1157,1163,B-Pathological_formation
also,1164,1168,O
tended,1169,1175,O
to,1176,1178,O
be,1179,1181,O
smaller,1182,1189,O
at,1190,1192,O
presentation,1193,1205,O
(,1206,1207,O
11,1207,1209,O
tumors,1210,1216,B-Pathological_formation
were,1217,1221,O
less,1222,1226,O
than,1227,1231,O
4,1232,1233,O
cm,1234,1236,O
in,1237,1239,O
greatest,1240,1248,O
dimension,1249,1258,O
),1258,1259,O
.,1259,1260,O
Of,1261,1263,O
25,1264,1266,O
patients,1267,1275,O
with,1276,1280,O
typical,1281,1288,O
adenocarcinomas,1289,1304,B-Pathological_formation
who,1305,1308,O
had,1309,1312,O
acceptable,1313,1323,O
follow,1324,1330,O
-,1330,1331,O
up,1331,1333,O
",",1333,1334,O
18,1335,1337,O
(,1338,1339,O
72,1339,1341,O
%,1341,1342,O
),1342,1343,O
died,1344,1348,O
of,1349,1351,O
disease,1352,1359,O
and,1360,1363,O
five,1364,1368,O
(,1369,1370,O
20,1370,1372,O
%,1372,1373,O
),1373,1374,O
were,1375,1379,O
alive,1380,1385,O
with,1386,1390,O
no,1391,1393,O
evidence,1394,1402,O
of,1403,1405,O
disease,1406,1413,O
after,1414,1419,O
5,1420,1421,O
years,1422,1427,O
.,1427,1428,O
We,1429,1431,O
conclude,1432,1440,O
that,1441,1445,O
anaplastic,1446,1456,B-Pathological_formation
and,1457,1460,I-Pathological_formation
sarcomatoid,1461,1472,I-Pathological_formation
carcinoma,1473,1482,I-Pathological_formation
is,1483,1485,O
a,1486,1487,O
rare,1488,1492,O
variant,1493,1500,O
of,1501,1503,O
small,1504,1509,B-Pathological_formation
intestinal,1510,1520,I-Pathological_formation
carcinoma,1521,1530,I-Pathological_formation
with,1531,1535,O
an,1536,1538,O
aggressive,1539,1549,O
clinical,1550,1558,O
course,1559,1565,O
.,1565,1566,O
Time,0,4,O
course,5,11,O
of,12,14,O
transmitter,15,26,O
action,27,33,O
at,34,36,O
the,37,40,O
sympathetic,41,52,B-Tissue
neuroeffector,53,66,I-Tissue
junction,67,75,I-Tissue
in,76,78,O
rodent,79,85,O
vascular,86,94,B-Organ
and,95,98,O
non,99,102,B-Organ
-,102,103,I-Organ
vascular,103,111,I-Organ
smooth,112,118,I-Organ
muscle,119,125,I-Organ
.,125,126,O
1,127,128,O
.,128,129,O
Transmitter,130,141,O
release,142,149,O
from,150,154,O
sympathetic,155,166,B-Multi-tissue_structure
postganglionic,167,181,I-Multi-tissue_structure
nerve,182,187,I-Multi-tissue_structure
terminals,188,197,O
innervating,198,209,O
the,210,213,O
guinea,214,220,O
-,220,221,O
pig,221,224,O
and,225,228,O
mouse,229,234,O
vas,235,238,B-Multi-tissue_structure
deferens,239,247,I-Multi-tissue_structure
and,248,251,O
the,252,255,O
rat,256,259,O
tail,260,264,B-Multi-tissue_structure
artery,265,271,I-Multi-tissue_structure
has,272,275,O
been,276,280,O
studied,281,288,O
in,289,291,O
vitro,292,297,O
by,298,300,O
focal,301,306,O
extracellular,307,320,B-Immaterial_anatomical_entity
recording,321,330,O
with,331,335,O
particular,336,346,O
emphasis,347,355,O
on,356,358,O
the,359,362,O
time,363,367,O
course,368,374,O
of,375,377,O
transmitter,378,389,O
action,390,396,O
underlying,397,407,O
the,408,411,O
intracellular,412,425,B-Immaterial_anatomical_entity
potential,426,435,O
changes,436,443,O
.,443,444,O
2,445,446,O
.,446,447,O
In,448,450,O
the,451,454,O
absence,455,462,O
of,463,465,O
stimulation,466,477,O
",",477,478,O
spontaneous,479,490,O
excitatory,491,501,B-Tissue
junction,502,510,I-Tissue
currents,511,519,O
(,520,521,O
SEJCs,521,526,O
),526,527,O
were,528,532,O
recorded,533,541,O
with,542,546,O
amplitudes,547,557,O
up,558,560,O
to,561,563,O
500,564,567,O
microV,568,574,O
and,575,578,O
durations,579,588,O
between,589,596,O
40,597,599,O
and,600,603,O
100,604,607,O
ms,608,610,O
.,610,611,O
SEJCs,612,617,O
were,618,622,O
unaffected,623,633,O
by,634,636,O
the,637,640,O
competitive,641,652,O
alpha,653,658,O
-,658,659,O
adrenoceptor,659,671,O
antagonist,672,682,O
prazosin,683,691,O
but,692,695,O
blocked,696,703,O
by,704,706,O
alpha,707,712,O
",",712,713,O
beta,714,718,O
-,718,719,O
methylene,719,728,O
ATP,729,732,O
which,733,738,O
desensitizes,739,751,O
P2,752,754,O
-,754,755,O
purinoceptors,755,768,O
.,768,769,O
3,770,771,O
.,771,772,O
During,773,779,O
trains,780,786,O
of,787,789,O
supramaximal,790,802,O
stimuli,803,810,O
at,811,813,O
0,814,815,O
.,815,816,O
1,816,817,O
-,817,818,O
4,818,819,O
Hz,820,822,O
stimulus,823,831,O
locked,832,838,O
excitatory,839,849,B-Tissue
junction,850,858,I-Tissue
currents,859,867,O
(,868,869,O
EJCs,869,873,O
),873,874,O
were,875,879,O
evoked,880,886,O
intermittently,887,901,O
from,902,906,O
the,907,910,O
population,911,921,O
of,922,924,O
varicosities,925,937,O
located,938,945,O
under,946,951,O
the,952,955,O
suction,956,963,O
electrode,964,973,O
.,973,974,O
4,975,976,O
.,976,977,O
SEJCs,978,983,O
were,984,988,O
similar,989,996,O
in,997,999,O
amplitude,1000,1009,O
and,1010,1013,O
time,1014,1018,O
course,1019,1025,O
to,1026,1028,O
EJCs,1029,1033,O
evoked,1034,1040,O
by,1041,1043,O
low,1044,1047,O
-,1047,1048,O
frequency,1048,1057,O
stimulation,1058,1069,O
in,1070,1072,O
the,1073,1076,O
same,1077,1081,O
attachment,1082,1092,O
in,1093,1095,O
all,1096,1099,O
three,1100,1105,O
tissues,1106,1113,B-Tissue
.,1113,1114,O
5,1115,1116,O
.,1116,1117,O
SEJCs,1118,1123,O
recorded,1124,1132,O
using,1133,1138,O
either,1139,1145,O
a,1146,1147,O
conventional,1148,1160,O
AC,1161,1163,O
amplifier,1164,1173,O
or,1174,1176,O
a,1177,1178,O
patch,1179,1184,O
clamp,1185,1190,O
amplifier,1191,1200,O
had,1201,1204,O
the,1205,1208,O
same,1209,1213,O
time,1214,1218,O
course,1219,1225,O
.,1225,1226,O
6,1227,1228,O
.,1228,1229,O
These,1230,1235,O
studies,1236,1243,O
show,1244,1248,O
that,1249,1253,O
the,1254,1257,O
time,1258,1262,O
course,1263,1269,O
of,1270,1272,O
the,1273,1276,O
current,1277,1284,O
underlying,1285,1295,O
the,1296,1299,O
excitatory,1300,1310,B-Tissue
junction,1311,1319,I-Tissue
potential,1320,1329,O
is,1330,1332,O
brief,1333,1338,O
and,1339,1342,O
essentially,1343,1354,O
the,1355,1358,O
same,1359,1363,O
in,1364,1366,O
three,1367,1372,O
different,1373,1382,O
tissues,1383,1390,B-Tissue
.,1390,1391,O
The,1392,1395,O
prolonged,1396,1405,O
time,1406,1410,O
course,1411,1417,O
of,1418,1420,O
the,1421,1424,O
excitatory,1425,1435,B-Tissue
junction,1436,1444,I-Tissue
potential,1445,1454,O
in,1455,1457,O
different,1458,1467,O
tissues,1468,1475,B-Tissue
can,1476,1479,O
be,1480,1482,O
accounted,1483,1492,O
for,1493,1496,O
by,1497,1499,O
the,1500,1503,O
passive,1504,1511,O
membrane,1512,1520,B-Multi-tissue_structure
properties,1521,1531,O
.,1531,1532,O
Differential,0,12,O
secretion,13,22,O
of,23,25,O
proteins,26,34,O
and,35,38,O
glycoproteins,39,52,O
by,53,55,O
livers,56,62,B-Organ
of,63,65,O
immature,66,74,O
and,75,78,O
adult,79,84,O
rats,85,89,O
.,89,90,O
Effect,91,97,O
of,98,100,O
antimicrotubule,101,116,B-Cellular_component
drugs,117,122,O
.,122,123,O
This,124,128,O
study,129,134,O
was,135,138,O
initiated,139,148,O
to,149,151,O
re,152,154,O
-,154,155,O
examine,155,162,O
reported,163,171,O
differences,172,183,O
in,184,186,O
the,187,190,O
action,191,197,O
of,198,200,O
antimicrotubule,201,216,B-Cellular_component
agents,217,223,O
on,224,226,O
plasma,227,233,B-Organism_substance
protein,234,241,O
secretion,242,251,O
from,252,256,O
livers,257,263,B-Organ
of,264,266,O
immature,267,275,O
versus,276,282,O
adult,283,288,O
rats,289,293,O
.,293,294,O
The,295,298,O
aim,299,302,O
was,303,306,O
(,307,308,O
1,308,309,O
),309,310,O
to,311,313,O
determine,314,323,O
the,324,327,O
composition,328,339,O
and,340,343,O
to,344,346,O
monitor,347,354,O
the,355,358,O
secretion,359,368,O
of,369,371,O
various,372,379,O
plasma,380,386,B-Organism_substance
proteins,387,395,O
and,396,399,O
glycoproteins,400,413,O
from,414,418,O
liver,419,424,B-Multi-tissue_structure
slices,425,431,I-Multi-tissue_structure
labeled,432,439,O
in,440,442,O
vitro,443,448,O
with,449,453,O
specific,454,462,O
amino,463,468,O
acids,469,474,O
and,475,478,O
sugar,479,484,O
residues,485,493,O
",",493,494,O
and,495,498,O
(,499,500,O
2,500,501,O
),501,502,O
to,503,505,O
correlate,506,515,O
observed,516,524,O
differences,525,536,O
in,537,539,O
secretion,540,549,O
of,550,552,O
these,553,558,O
proteins,559,567,O
with,568,572,O
structural,573,583,O
changes,584,591,O
in,592,594,O
the,595,598,O
hepatocytes,599,610,B-Cell
of,611,613,O
the,614,617,O
different,618,627,O
aged,628,632,O
animals,633,640,O
.,640,641,O
For,642,645,O
the,646,649,O
most,650,654,O
part,655,659,O
",",659,660,O
slices,661,667,B-Multi-tissue_structure
of,668,670,O
liver,671,676,B-Organ
from,677,681,O
fetal,682,687,B-Developing_anatomical_structure
(,688,689,O
term,689,693,O
),693,694,O
",",694,695,O
neonatal,696,704,O
(,705,706,O
4,706,707,O
-,707,708,O
to,709,711,O
5,712,713,O
days,714,718,O
old,719,722,O
),722,723,O
",",723,724,O
and,725,728,O
adult,729,734,O
rats,735,739,O
(,740,741,O
70,741,743,O
days,744,748,O
old,749,752,O
),752,753,O
were,754,758,O
incubated,759,768,O
with,769,773,O
radioactive,774,785,O
amino,786,791,O
acids,792,797,O
or,798,800,O
various,801,808,O
tritiated,809,818,O
sugars,819,825,O
specific,826,834,O
for,835,838,O
N,839,840,O
-,840,841,O
linked,841,847,O
core,848,852,O
oligosaccharide,853,868,O
and,869,872,O
/,872,873,O
or,873,875,O
N,876,877,O
-,877,878,O
linked,878,884,O
terminal,885,893,O
oligosaccharide,894,909,O
chains,910,916,O
.,916,917,O
Our,918,921,O
findings,922,930,O
indicate,931,939,O
that,940,944,O
liver,945,950,B-Multi-tissue_structure
slices,951,957,I-Multi-tissue_structure
of,958,960,O
fetal,961,966,B-Developing_anatomical_structure
and,967,970,O
neonatal,971,979,O
rats,980,984,O
are,985,988,O
efficient,989,998,O
in,999,1001,O
synthesizing,1002,1014,O
plasma,1015,1021,B-Organism_substance
proteins,1022,1030,O
including,1031,1040,O
fully,1041,1046,O
glycosylated,1047,1059,O
glycoproteins,1060,1073,O
.,1073,1074,O
The,1075,1078,O
secretion,1079,1088,O
of,1089,1091,O
glycosylated,1092,1104,O
and,1105,1108,O
nonglycosylated,1109,1124,O
proteins,1125,1133,O
believed,1134,1142,O
to,1143,1145,O
be,1146,1148,O
processed,1149,1158,O
through,1159,1166,O
Golgi,1167,1172,B-Cellular_component
complexes,1173,1182,I-Cellular_component
was,1183,1186,O
inhibited,1187,1196,O
to,1197,1199,O
the,1200,1203,O
same,1204,1208,O
extent,1209,1215,O
(,1216,1217,O
approximately,1217,1230,O
70,1231,1233,O
-,1233,1234,O
80,1234,1236,O
%,1236,1237,O
),1237,1238,O
by,1239,1241,O
antimicrotubule,1242,1257,B-Cellular_component
agents,1258,1264,O
",",1264,1265,O
regardless,1266,1276,O
of,1277,1279,O
the,1280,1283,O
age,1284,1287,O
of,1288,1290,O
the,1291,1294,O
host,1295,1299,O
animal,1300,1306,O
.,1306,1307,O
However,1308,1315,O
",",1315,1316,O
other,1317,1322,O
proteins,1323,1331,O
and,1332,1335,O
glycoproteins,1336,1349,O
secreted,1350,1358,O
by,1359,1361,O
livers,1362,1368,B-Organ
of,1369,1371,O
immature,1372,1380,O
rats,1381,1385,O
were,1386,1390,O
found,1391,1396,O
to,1397,1399,O
be,1400,1402,O
relatively,1403,1413,O
insensitive,1414,1425,O
(,1426,1427,O
i,1427,1428,O
.,1428,1429,O
e,1429,1430,O
.,1430,1431,O
inhibited,1432,1441,O
to,1442,1444,O
only,1445,1449,O
30,1450,1452,O
-,1452,1453,O
40,1453,1455,O
%,1455,1456,O
),1456,1457,O
to,1458,1460,O
the,1461,1464,O
action,1465,1471,O
of,1472,1474,O
various,1475,1482,O
antimicrotubule,1483,1498,B-Cellular_component
drugs,1499,1504,O
.,1504,1505,O
The,1506,1509,O
glycoproteins,1510,1523,O
were,1524,1528,O
found,1529,1534,O
to,1535,1537,O
lack,1538,1542,O
N,1543,1544,O
-,1544,1545,O
linked,1545,1551,O
terminal,1552,1560,O
sugars,1561,1567,O
(,1568,1569,O
although,1569,1577,O
the,1578,1581,O
glycoproteins,1582,1595,O
did,1596,1599,O
contain,1600,1607,O
N,1608,1609,O
-,1609,1610,O
linked,1610,1616,O
core,1617,1621,O
sugars,1622,1628,O
),1628,1629,O
",",1629,1630,O
and,1631,1634,O
it,1635,1637,O
is,1638,1640,O
likely,1641,1647,O
that,1648,1652,O
the,1653,1656,O
drug,1657,1661,O
-,1661,1662,O
insensitive,1662,1673,O
proteins,1674,1682,O
bypassed,1683,1691,O
critical,1692,1700,O
glycosylating,1701,1714,O
sites,1715,1720,O
in,1721,1723,O
the,1724,1727,O
Golgi,1728,1733,B-Cellular_component
compartment,1734,1745,I-Cellular_component
prior,1746,1751,O
to,1752,1754,O
release,1755,1762,O
.,1762,1763,O
Overall,1764,1771,O
",",1771,1772,O
these,1773,1778,O
findings,1779,1787,O
support,1788,1795,O
earlier,1796,1803,O
data,1804,1808,O
showing,1809,1816,O
that,1817,1821,O
antimicrotubule,1822,1837,B-Cellular_component
drugs,1838,1843,O
have,1844,1848,O
a,1849,1850,O
special,1851,1858,O
impact,1859,1865,O
on,1866,1868,O
Golgi,1869,1874,B-Cellular_component
-,1874,1875,O
associated,1875,1885,O
events,1886,1892,O
in,1893,1895,O
liver,1896,1901,B-Cell
cells,1902,1907,I-Cell
.,1907,1908,O
To,1909,1911,O
what,1912,1916,O
extent,1917,1923,O
these,1924,1929,O
findings,1930,1938,O
are,1939,1942,O
related,1943,1950,O
to,1951,1953,O
the,1954,1957,O
action,1958,1964,O
of,1965,1967,O
microtubules,1968,1980,B-Cellular_component
remains,1981,1988,O
to,1989,1991,O
be,1992,1994,O
seen,1995,1999,O
.,1999,2000,O
Torsade,0,7,O
de,8,10,O
pointes,11,18,O
during,19,25,O
loading,26,33,O
with,34,38,O
amiodarone,39,49,O
.,49,50,O
Torsade,51,58,O
de,59,61,O
pointes,62,69,O
represents,70,80,O
a,81,82,O
potential,83,92,O
complication,93,105,O
of,106,108,O
chronic,109,116,O
amiodarone,117,127,O
therapy,128,135,O
.,135,136,O
Several,137,144,O
reports,145,152,O
have,153,157,O
emphasized,158,168,O
the,169,172,O
need,173,177,O
for,178,181,O
a,182,183,O
loading,184,191,O
dose,192,196,O
in,197,199,O
order,200,205,O
to,206,208,O
achieve,209,216,O
therapeutic,217,228,O
blood,229,234,B-Organism_substance
levels,235,241,O
rapidly,242,249,O
.,249,250,O
We,251,253,O
report,254,260,O
a,261,262,O
case,263,267,O
of,268,270,O
torsade,271,278,O
de,279,281,O
pointes,282,289,O
following,290,299,O
a,300,301,O
single,302,308,O
oral,309,313,O
dose,314,318,O
of,319,321,O
amiodarone,322,332,O
(,333,334,O
1400,334,338,O
mg,339,341,O
or,342,344,O
30,345,347,O
mg,348,350,O
kg,351,353,O
-,353,354,O
1,354,355,O
),355,356,O
administered,357,369,O
after,370,375,O
short,376,381,O
intravenous,382,393,B-Multi-tissue_structure
loading,394,401,O
for,402,405,O
prevention,406,416,O
of,417,419,O
paroxysmal,420,430,O
atrial,431,437,B-Multi-tissue_structure
flutter,438,445,O
.,445,446,O
Torsades,447,455,O
de,456,458,O
pointes,459,466,O
were,467,471,O
preceded,472,480,O
and,481,484,O
associated,485,495,O
with,496,500,O
marked,501,507,O
QT,508,510,O
prolongation,511,523,O
and,524,527,O
bradycardia,528,539,O
.,539,540,O
This,541,545,O
report,546,552,O
suggests,553,561,O
that,562,566,O
careful,567,574,O
monitoring,575,585,O
of,586,588,O
patients,589,597,O
undergoing,598,608,O
oral,609,613,O
amiodarone,614,624,O
loading,625,632,O
is,633,635,O
necessary,636,645,O
.,645,646,O
Unsatisfactory,0,14,O
forehead,15,23,B-Pathological_formation
scar,24,28,I-Pathological_formation
following,29,38,O
face,39,43,B-Organism_subdivision
lift,44,48,O
.,48,49,O
The,50,53,O
W,54,55,O
-,55,56,O
plasty,56,62,O
scar,63,67,B-Pathological_formation
revision,68,76,O
technique,77,86,O
has,87,90,O
been,91,95,O
found,96,101,O
to,102,104,O
be,105,107,O
effective,108,117,O
in,118,120,O
the,121,124,O
repair,125,131,O
of,132,134,O
the,135,138,O
difficult,139,148,O
and,149,152,O
cosmetically,153,165,O
unsatisfactory,166,180,O
hairline,181,189,B-Pathological_formation
scar,190,194,I-Pathological_formation
following,195,204,O
the,205,208,O
ill,209,212,O
-,212,213,O
advised,213,220,O
face,221,225,B-Organism_subdivision
lift,226,230,O
technique,231,240,O
that,241,245,O
excises,246,253,O
forehead,254,262,B-Multi-tissue_structure
skin,263,267,I-Multi-tissue_structure
.,267,268,O
Clinical,0,8,O
evaluation,9,19,O
of,20,22,O
radiotherapy,23,35,O
for,36,39,O
Graves,40,46,O
',46,47,O
ophthalmopathy,48,62,O
.,62,63,O
Seventeen,64,73,O
patients,74,82,O
with,83,87,O
moderately,88,98,O
severe,99,105,O
ophthalmopathy,106,120,O
due,121,124,O
to,125,127,O
Graves,128,134,O
',134,135,O
disease,136,143,O
were,144,148,O
treated,149,156,O
by,157,159,O
cobalt,160,166,O
or,167,169,O
supervoltage,170,182,O
radiotherapy,183,195,O
.,195,196,O
All,197,200,O
patients,201,209,O
complained,210,220,O
of,221,223,O
diplopia,224,232,O
.,232,233,O
The,234,237,O
mean,238,242,O
proptosis,243,252,O
value,253,258,O
was,259,262,O
21,263,265,O
.,265,266,O
4,266,267,O
mm,268,270,O
.,270,271,O
Three,272,277,O
patients,278,286,O
(,287,288,O
18,288,290,O
%,290,291,O
),291,292,O
showed,293,299,O
good,300,304,O
response,305,313,O
",",313,314,O
7,315,316,O
(,317,318,O
41,318,320,O
%,320,321,O
),321,322,O
moderate,323,331,O
and,332,335,O
7,336,337,O
minimal,338,345,O
or,346,348,O
no,349,351,O
response,352,360,O
.,360,361,O
Improvement,362,373,O
was,374,377,O
noted,378,383,O
mainly,384,390,O
in,391,393,O
soft,394,398,B-Tissue
tissue,399,405,I-Tissue
changes,406,413,O
and,414,417,O
diplopia,418,426,O
",",426,427,O
while,428,433,O
proptosis,434,443,O
decreased,444,453,O
in,454,456,O
only,457,461,O
5,462,463,O
patients,464,472,O
.,472,473,O
All,474,477,O
except,478,484,O
one,485,488,O
patient,489,496,O
who,497,500,O
had,501,504,O
marked,505,511,O
extraocular,512,523,B-Multi-tissue_structure
muscle,524,530,I-Multi-tissue_structure
involvement,531,542,O
revealed,543,551,O
by,552,554,O
computed,555,563,O
tomography,564,574,O
responded,575,584,O
to,585,587,O
treatment,588,597,O
.,597,598,O
These,599,604,O
data,605,609,O
indicate,610,618,O
that,619,623,O
radiotherapy,624,636,O
may,637,640,O
be,641,643,O
indicated,644,653,O
in,654,656,O
patients,657,665,O
with,666,670,O
progressive,671,682,O
ophthalmopathy,683,697,O
",",697,698,O
especially,699,709,O
in,710,712,O
those,713,718,O
who,719,722,O
are,723,726,O
associated,727,737,O
with,738,742,O
extraocular,743,754,B-Multi-tissue_structure
muscle,755,761,I-Multi-tissue_structure
enlargement,762,773,O
.,773,774,O
Management,0,10,O
of,11,13,O
the,14,17,O
tortuous,18,26,B-Multi-tissue_structure
internal,27,35,I-Multi-tissue_structure
carotid,36,43,I-Multi-tissue_structure
artery,44,50,I-Multi-tissue_structure
.,50,51,O
The,52,55,O
tortuous,56,64,B-Multi-tissue_structure
internal,65,73,I-Multi-tissue_structure
carotid,74,81,I-Multi-tissue_structure
artery,82,88,I-Multi-tissue_structure
as,89,91,O
the,92,95,O
basis,96,101,O
of,102,104,O
cerebral,105,113,B-Multi-tissue_structure
vascular,114,122,I-Multi-tissue_structure
insufficiency,123,136,O
is,137,139,O
a,140,141,O
controversial,142,155,O
entity,156,162,O
",",162,163,O
as,164,166,O
such,167,171,O
lesions,172,179,B-Pathological_formation
frequently,180,190,O
occur,191,196,O
without,197,204,O
neurologic,205,215,B-Anatomical_system
symptoms,216,224,O
.,224,225,O
However,226,233,O
",",233,234,O
some,235,239,O
tortuous,240,248,B-Multi-tissue_structure
vessels,249,256,I-Multi-tissue_structure
are,257,260,O
associated,261,271,O
with,272,276,O
significant,277,288,O
carotid,289,296,B-Multi-tissue_structure
atherosclerotic,297,312,O
disease,313,320,O
requiring,321,330,O
a,331,332,O
specific,333,341,O
surgical,342,350,O
approach,351,359,O
.,359,360,O
This,361,365,O
formed,366,372,O
the,373,376,O
basis,377,382,O
of,383,385,O
our,386,389,O
report,390,396,O
.,396,397,O
Symptoms,398,406,O
of,407,409,O
cerebrovascular,410,425,B-Multi-tissue_structure
insufficiency,426,439,O
in,440,442,O
association,443,454,O
with,455,459,O
a,460,461,O
tortuous,462,470,B-Multi-tissue_structure
internal,471,479,I-Multi-tissue_structure
carotid,480,487,I-Multi-tissue_structure
artery,488,494,I-Multi-tissue_structure
was,495,498,O
encountered,499,510,O
in,511,513,O
27,514,516,O
of,517,519,O
853,520,523,O
carotid,524,531,B-Multi-tissue_structure
endarterectomies,532,548,O
over,549,553,O
a,554,555,O
22,556,558,O
year,559,563,O
period,564,570,O
.,570,571,O
Stenosis,572,580,O
of,581,583,O
hemodynamic,584,595,O
significance,596,608,O
was,609,612,O
noted,613,618,O
in,619,621,O
nine,622,626,O
patients,627,635,O
and,636,639,O
irregularities,640,654,O
or,655,657,O
ulceration,658,668,O
were,669,673,O
noted,674,679,O
in,680,682,O
the,683,686,O
rest,687,691,O
.,691,692,O
With,693,697,O
the,698,701,O
standard,702,710,O
technique,711,720,O
of,721,723,O
carotid,724,731,B-Multi-tissue_structure
endarterectomy,732,746,O
",",746,747,O
removal,748,755,O
of,756,758,O
plaque,759,765,B-Cell
from,766,770,O
a,771,772,O
tortuous,773,781,B-Multi-tissue_structure
vessel,782,788,I-Multi-tissue_structure
leads,789,794,O
to,795,797,O
loss,798,802,O
of,803,805,O
the,806,809,O
stenting,810,818,O
effect,819,825,O
provided,826,834,O
by,835,837,O
the,838,841,O
plaque,842,848,B-Cell
such,849,853,O
that,854,858,O
angulation,859,869,O
occlusion,870,879,O
is,880,882,O
likely,883,889,O
to,890,892,O
occur,893,898,O
.,898,899,O
The,900,903,O
optimal,904,911,O
reconstruction,912,926,O
in,927,929,O
our,930,933,O
experience,934,944,O
is,945,947,O
eversion,948,956,O
endarterectomy,957,971,O
by,972,974,O
transection,975,986,O
and,987,990,O
lower,991,996,O
reimplantation,997,1011,O
of,1012,1014,O
the,1015,1018,O
internal,1019,1027,B-Multi-tissue_structure
carotid,1028,1035,I-Multi-tissue_structure
artery,1036,1042,I-Multi-tissue_structure
on,1043,1045,O
the,1046,1049,O
common,1050,1056,B-Multi-tissue_structure
carotid,1057,1064,I-Multi-tissue_structure
artery,1065,1071,I-Multi-tissue_structure
.,1071,1072,O
Our,1073,1076,O
experience,1077,1087,O
with,1088,1092,O
17,1093,1095,O
such,1096,1100,O
procedures,1101,1111,O
in,1112,1114,O
15,1115,1117,O
patients,1118,1126,O
has,1127,1130,O
been,1131,1135,O
presented,1136,1145,O
.,1145,1146,O
Rapid,0,5,O
enzyme,6,12,O
analysis,13,21,O
of,22,24,O
amniotic,25,33,B-Organism_substance
fluid,34,39,I-Organism_substance
phospholipids,40,53,O
containing,54,64,O
choline,65,72,O
:,72,73,O
a,74,75,O
comparison,76,86,O
with,87,91,O
the,92,95,O
lecithin,96,104,O
to,105,107,O
sphingomyelin,108,121,O
ratio,122,127,O
in,128,130,O
prenatal,131,139,O
assessment,140,150,O
of,151,153,O
fetal,154,159,B-Organ
lung,160,164,I-Organ
maturity,165,173,O
.,173,174,O
The,175,178,O
relation,179,187,O
between,188,195,O
the,196,199,O
choline,200,207,O
containing,208,218,O
surfactant,219,229,O
phospholipids,230,243,O
lecithin,244,252,O
and,253,256,O
sphingomyelin,257,270,O
in,271,273,O
amniotic,274,282,B-Organism_substance
fluid,283,288,I-Organism_substance
and,289,292,O
fetal,293,298,B-Organ
lung,299,303,I-Organ
maturity,304,312,O
is,313,315,O
well,316,320,O
established,321,332,O
.,332,333,O
An,334,336,O
enzymatic,337,346,O
method,347,353,O
that,354,358,O
had,359,362,O
been,363,367,O
automated,368,377,O
and,378,381,O
optimised,382,391,O
for,392,395,O
use,396,399,O
on,400,402,O
a,403,404,O
centrifugal,405,416,O
analyser,417,425,O
was,426,429,O
used,430,434,O
to,435,437,O
measure,438,445,O
the,446,449,O
total,450,455,O
choline,456,463,O
containing,464,474,O
phospholipids,475,488,O
in,489,491,O
amniotic,492,500,B-Organism_substance
fluid,501,506,I-Organism_substance
.,506,507,O
The,508,511,O
total,512,517,O
time,518,522,O
taken,523,528,O
for,529,532,O
this,533,537,O
assay,538,543,O
was,544,547,O
10,548,550,O
minutes,551,558,O
.,558,559,O
The,560,563,O
results,564,571,O
obtained,572,580,O
from,581,585,O
100,586,589,O
patient,590,597,O
samples,598,605,O
",",605,606,O
using,607,612,O
this,613,617,O
procedure,618,627,O
",",627,628,O
compared,629,637,O
favourably,638,648,O
with,649,653,O
the,654,657,O
results,658,665,O
obtained,666,674,O
by,675,677,O
the,678,681,O
thin,682,686,O
layer,687,692,O
chromatography,693,707,O
procedure,708,717,O
used,718,722,O
to,723,725,O
determine,726,735,O
the,736,739,O
lecithin,740,748,O
to,749,751,O
sphingomyelin,752,765,O
ratio,766,771,O
(,772,773,O
r,773,774,O
=,775,776,O
0,777,778,O
.,778,779,O
93,779,781,O
),781,782,O
.,782,783,O
A,784,785,O
clinical,786,794,O
study,795,800,O
of,801,803,O
60,804,806,O
patients,807,815,O
showed,816,822,O
that,823,827,O
this,828,832,O
assay,833,838,O
predicted,839,848,O
prenatal,849,857,O
respiratory,858,869,B-Anatomical_system
distress,870,878,O
syndrome,879,887,O
as,888,890,O
well,891,895,O
as,896,898,O
the,899,902,O
lecithin,903,911,O
to,912,914,O
sphingomyelin,915,928,O
ratios,929,935,O
.,935,936,O
The,937,940,O
advantage,941,950,O
of,951,953,O
this,954,958,O
assay,959,964,O
over,965,969,O
existing,970,978,O
procedures,979,989,O
is,990,992,O
that,993,997,O
it,998,1000,O
requires,1001,1009,O
minimum,1010,1017,O
preparation,1018,1029,O
of,1030,1032,O
the,1033,1036,O
specimen,1037,1045,B-Organism_substance
and,1046,1049,O
no,1050,1052,O
extraction,1053,1063,O
",",1063,1064,O
is,1065,1067,O
quick,1068,1073,O
",",1073,1074,O
and,1075,1078,O
shows,1079,1084,O
a,1085,1086,O
high,1087,1091,O
degree,1092,1098,O
of,1099,1101,O
precision,1102,1111,O
.,1111,1112,O
Differences,0,11,O
between,12,19,O
the,20,23,O
arterial,24,32,B-Multi-tissue_structure
and,33,36,O
the,37,40,O
venous,41,47,B-Multi-tissue_structure
pathomorphology,48,63,O
in,64,66,O
Buerger,67,74,O
',74,75,O
s,75,76,O
disease,77,84,O
.,84,85,O
Morphological,86,99,O
lesions,100,107,B-Pathological_formation
were,108,112,O
found,113,118,O
to,119,121,O
be,122,124,O
different,125,134,O
in,135,137,O
arteries,138,146,B-Multi-tissue_structure
and,147,150,O
in,151,153,O
veins,154,159,B-Multi-tissue_structure
",",159,160,O
in,161,163,O
9,164,165,O
cases,166,171,O
of,172,174,O
Buerger,175,182,O
',182,183,O
s,183,184,O
disease,185,192,O
.,192,193,O
The,194,197,O
arterial,198,206,B-Pathological_formation
lesions,207,214,I-Pathological_formation
were,215,219,O
not,220,223,O
characteristic,224,238,O
and,239,242,O
consisted,243,252,O
of,253,255,O
non,256,259,O
-,259,260,O
specific,260,268,O
inflammation,269,281,O
",",281,282,O
thrombosis,283,293,O
and,294,297,O
obliteration,298,310,O
which,311,316,O
also,317,321,O
occur,322,327,O
in,328,330,O
many,331,335,O
other,336,341,O
disease,342,349,O
.,349,350,O
In,351,353,O
contrast,354,362,O
",",362,363,O
in,364,366,O
addition,367,375,O
to,376,378,O
wall,379,383,B-Multi-tissue_structure
infiltration,384,396,O
and,397,400,O
thrombosis,401,411,O
",",411,412,O
the,413,416,O
veins,417,422,B-Multi-tissue_structure
showed,423,429,O
microabscesses,430,444,B-Pathological_formation
and,445,448,O
giant,449,454,B-Pathological_formation
cell,455,459,I-Pathological_formation
granulomas,460,470,I-Pathological_formation
",",470,471,O
which,472,477,O
we,478,480,O
believe,481,488,O
to,489,491,O
be,492,494,O
absent,495,501,O
in,502,504,O
all,505,508,O
other,509,514,O
known,515,520,O
diseases,521,529,O
.,529,530,O
The,531,534,O
affected,535,543,O
venous,544,550,B-Multi-tissue_structure
segment,551,558,O
exhibited,559,568,O
a,569,570,O
variety,571,578,O
of,579,581,O
lesions,582,589,B-Pathological_formation
.,589,590,O
In,591,593,O
the,594,597,O
earliest,598,606,O
period,607,613,O
",",613,614,O
the,615,618,O
morphological,619,632,O
aspect,633,639,O
of,640,642,O
inflammation,643,655,O
in,656,658,O
arteries,659,667,B-Multi-tissue_structure
and,668,671,O
veins,672,677,B-Multi-tissue_structure
was,678,681,O
fairly,682,688,O
similar,689,696,O
.,696,697,O
In,698,700,O
a,701,702,O
late,703,707,O
periods,708,715,O
",",715,716,O
that,717,721,O
is,722,724,O
those,725,730,O
of,731,733,O
vascular,734,742,B-Multi-tissue_structure
obliteration,743,755,O
",",755,756,O
the,757,760,O
arteries,761,769,B-Multi-tissue_structure
and,770,773,O
veins,774,779,B-Multi-tissue_structure
did,780,783,O
not,784,787,O
show,788,792,O
any,793,796,O
distinguishing,797,811,O
morphological,812,825,O
differences,826,837,O
.,837,838,O
Phosphorylation,0,15,O
-,15,16,O
induced,16,23,O
mobility,24,32,O
shift,33,38,O
in,39,41,O
phospholamban,42,55,O
in,56,58,O
sodium,59,65,O
dodecyl,66,73,O
sulfate,74,81,O
-,81,82,O
polyacrylamide,82,96,O
gels,97,101,O
.,101,102,O
Evidence,103,111,O
for,112,115,O
a,116,117,O
protein,118,125,O
structure,126,135,O
consisting,136,146,O
of,147,149,O
multiple,150,158,O
identical,159,168,O
phosphorylatable,169,185,O
subunits,186,194,O
.,194,195,O
Phosphorylation,196,211,O
of,212,214,O
purified,215,223,O
phospholamban,224,237,O
isolated,238,246,O
from,247,251,O
canine,252,258,O
cardiac,259,266,B-Cellular_component
sarcoplasmic,267,279,I-Cellular_component
reticulum,280,289,I-Cellular_component
vesicles,290,298,I-Cellular_component
decreased,299,308,O
the,309,312,O
electrophoretic,313,328,O
mobility,329,337,O
of,338,340,O
the,341,344,O
protein,345,352,O
in,353,355,O
sodium,356,362,O
dodecyl,363,370,O
sulfate,371,378,O
(,379,380,O
SDS,380,383,O
),383,384,O
-,384,385,O
polyacrylamide,385,399,O
gels,400,404,O
.,404,405,O
Different,406,415,O
mobility,416,424,O
forms,425,430,O
of,431,433,O
phospholamban,434,447,O
in,448,450,O
SDS,451,454,O
gels,455,459,O
were,460,464,O
visualized,465,475,O
both,476,480,O
by,481,483,O
direct,484,490,O
protein,491,498,O
staining,499,507,O
and,508,511,O
by,512,514,O
autoradiography,515,530,O
.,530,531,O
Unphosphorylated,532,548,O
phospholamban,549,562,O
migrated,563,571,O
with,572,576,O
an,577,579,O
apparent,580,588,O
Mr,589,591,O
=,592,593,O
25,594,596,O
",",596,597,O
000,597,600,O
in,601,603,O
SDS,604,607,O
gels,608,612,O
;,612,613,O
maximal,614,621,O
phosphorylation,622,637,O
of,638,640,O
phospholamban,641,654,O
by,655,657,O
cAMP,658,662,O
-,662,663,O
or,664,666,O
Ca2,667,670,O
+,670,671,O
-,671,672,O
calmodulin,672,682,O
-,682,683,O
dependent,683,692,O
protein,693,700,O
kinase,701,707,O
increased,708,717,O
the,718,721,O
apparent,722,730,O
Mr,731,733,O
to,734,736,O
27,737,739,O
",",739,740,O
000,740,743,O
.,743,744,O
Partial,745,752,O
phosphorylation,753,768,O
of,769,771,O
phospholamban,772,785,O
by,786,788,O
either,789,795,O
protein,796,803,O
kinase,804,810,O
gave,811,815,O
intermediate,816,828,O
mobility,829,837,O
forms,838,843,O
of,844,846,O
molecular,847,856,O
weights,857,864,O
between,865,872,O
25,873,875,O
",",875,876,O
000,876,879,O
and,880,883,O
27,884,886,O
",",886,887,O
000,887,890,O
",",890,891,O
suggesting,892,902,O
that,903,907,O
more,908,912,O
than,913,917,O
one,918,921,O
phosphorylation,922,937,O
site,938,942,O
was,943,946,O
present,947,954,O
on,955,957,O
the,958,961,O
holoprotein,962,973,O
for,974,977,O
each,978,982,O
activity,983,991,O
.,991,992,O
Boiling,993,1000,O
of,1001,1003,O
phospholamban,1004,1017,O
in,1018,1020,O
SDS,1021,1024,O
dissociated,1025,1036,O
the,1037,1040,O
holoprotein,1041,1052,O
into,1053,1057,O
an,1058,1060,O
apparently,1061,1071,O
homogeneous,1072,1083,O
class,1084,1089,O
of,1090,1092,O
low,1093,1096,O
molecular,1097,1106,O
weight,1107,1113,O
"""",1114,1115,O
monomers,1115,1123,O
.,1123,1124,O
"""",1124,1125,O
Only,1126,1130,O
two,1131,1134,O
mobility,1135,1143,O
forms,1144,1149,O
of,1150,1152,O
monomeric,1153,1162,O
phospholamban,1163,1176,O
were,1177,1181,O
observed,1182,1190,O
in,1191,1193,O
SDS,1194,1197,O
gels,1198,1202,O
after,1203,1208,O
phosphorylation,1209,1224,O
by,1225,1227,O
cAMP,1228,1232,O
-,1232,1233,O
dependent,1233,1242,O
protein,1243,1250,O
kinase,1251,1257,O
",",1257,1258,O
corresponding,1259,1272,O
to,1273,1275,O
9,1276,1277,O
-,1277,1278,O
kDa,1278,1281,O
dephospho,1282,1291,O
-,1291,1292,O
and,1293,1296,O
11,1297,1299,O
-,1299,1300,O
kDa,1300,1303,O
phosphoproteins,1304,1319,O
.,1319,1320,O
All,1321,1324,O
of,1325,1327,O
the,1328,1331,O
9,1332,1333,O
-,1333,1334,O
kDa,1334,1337,O
protein,1338,1345,O
could,1346,1351,O
be,1352,1354,O
phosphorylated,1355,1369,O
and,1370,1373,O
converted,1374,1383,O
into,1384,1388,O
the,1389,1392,O
11,1393,1395,O
-,1395,1396,O
kDa,1396,1399,O
mobility,1400,1408,O
form,1409,1413,O
",",1413,1414,O
suggesting,1415,1425,O
the,1426,1429,O
presence,1430,1438,O
of,1439,1441,O
only,1442,1446,O
one,1447,1450,O
site,1451,1455,O
of,1456,1458,O
phosphorylation,1459,1474,O
on,1475,1477,O
a,1478,1479,O
single,1480,1486,O
type,1487,1491,O
of,1492,1494,O
monomer,1495,1502,O
for,1503,1506,O
cAMP,1507,1511,O
-,1511,1512,O
dependent,1512,1521,O
protein,1522,1529,O
kinase,1530,1536,O
.,1536,1537,O
Simultaneous,1538,1550,O
phosphorylation,1551,1566,O
of,1567,1569,O
monomeric,1570,1579,O
phospholamban,1580,1593,O
by,1594,1596,O
cAMP,1597,1601,O
-,1601,1602,O
dependent,1602,1611,O
protein,1612,1619,O
kinase,1620,1626,O
and,1627,1630,O
Ca2,1631,1634,O
+,1634,1635,O
-,1635,1636,O
calmodulin,1636,1646,O
-,1646,1647,O
dependent,1647,1656,O
protein,1657,1664,O
kinase,1665,1671,O
gave,1672,1676,O
an,1677,1679,O
additional,1680,1690,O
mobility,1691,1699,O
form,1700,1704,O
of,1705,1707,O
the,1708,1711,O
protein,1712,1719,O
",",1719,1720,O
suggesting,1721,1731,O
that,1732,1736,O
different,1737,1746,O
sites,1747,1752,O
of,1753,1755,O
phosphorylation,1756,1771,O
were,1772,1776,O
present,1777,1784,O
for,1785,1788,O
each,1789,1793,O
activity,1794,1802,O
on,1803,1805,O
each,1806,1810,O
monomer,1811,1818,O
.,1818,1819,O
Incomplete,1820,1830,O
dissociation,1831,1843,O
of,1844,1846,O
the,1847,1850,O
holoprotein,1851,1862,O
by,1863,1865,O
boiling,1866,1873,O
it,1874,1876,O
in,1877,1879,O
a,1880,1881,O
relatively,1882,1892,O
low,1893,1896,O
concentration,1897,1910,O
of,1911,1913,O
SDS,1914,1917,O
facilitated,1918,1929,O
the,1930,1933,O
detection,1934,1943,O
of,1944,1946,O
five,1947,1951,O
major,1952,1957,O
mobility,1958,1966,O
forms,1967,1972,O
of,1973,1975,O
the,1976,1979,O
protein,1980,1987,O
in,1988,1990,O
SDS,1991,1994,O
gels,1995,1999,O
",",1999,2000,O
and,2001,2004,O
the,2005,2008,O
mobilities,2009,2019,O
of,2020,2022,O
all,2023,2026,O
of,2027,2029,O
these,2030,2035,O
forms,2036,2041,O
were,2042,2046,O
decreased,2047,2056,O
by,2057,2059,O
phosphorylation,2060,2075,O
.,2075,2076,O
We,2077,2079,O
propose,2080,2087,O
that,2088,2092,O
the,2093,2096,O
high,2097,2101,O
molecular,2102,2111,O
weight,2112,2118,O
form,2119,2123,O
of,2124,2126,O
phospholamban,2127,2140,O
is,2141,2143,O
a,2144,2145,O
multimer,2146,2154,O
of,2155,2157,O
electrophoretically,2158,2177,O
indistinguishable,2178,2195,O
monomers,2196,2204,O
",",2204,2205,O
each,2206,2210,O
of,2211,2213,O
which,2214,2219,O
contains,2220,2228,O
a,2229,2230,O
different,2231,2240,O
phosphorylation,2241,2256,O
site,2257,2261,O
for,2262,2265,O
cAMP,2266,2270,O
-,2270,2271,O
dependent,2271,2280,O
protein,2281,2288,O
kinase,2289,2295,O
activity,2296,2304,O
and,2305,2308,O
Ca2,2309,2312,O
+,2312,2313,O
-,2313,2314,O
calmodulin,2314,2324,O
-,2324,2325,O
dependent,2325,2334,O
protein,2335,2342,O
kinase,2343,2349,O
activity,2350,2358,O
.,2358,2359,O
Phosphorylation,2360,2375,O
of,2376,2378,O
phospholamban,2379,2392,O
at,2393,2395,O
multiple,2396,2404,O
sites,2405,2410,O
is,2411,2413,O
responsible,2414,2425,O
for,2426,2429,O
the,2430,2433,O
various,2434,2441,O
mobility,2442,2450,O
forms,2451,2456,O
of,2457,2459,O
the,2460,2463,O
holoprotein,2464,2475,O
detected,2476,2484,O
in,2485,2487,O
SDS,2488,2491,O
-,2491,2492,O
polyacrylamide,2492,2506,O
gels,2507,2511,O
.,2511,2512,O
Preliminary,0,11,O
evidence,12,20,O
for,21,24,O
a,25,26,O
pyridine,27,35,O
nucleotide,36,46,O
cycle,47,52,O
in,53,55,O
Bordetella,56,66,O
pertussis,67,76,O
.,76,77,O
Preliminary,78,89,O
evidence,90,98,O
that,99,103,O
Bordetella,104,114,O
pertussis,115,124,O
has,125,128,O
a,129,130,O
functional,131,141,O
pyridine,142,150,O
nucleotide,151,161,O
cycle,162,167,O
was,168,171,O
the,172,175,O
observation,176,187,O
that,188,192,O
[,193,194,O
14C,194,197,O
],197,198,O
-,198,199,O
nicotinic,199,208,O
acid,209,213,O
was,214,217,O
rapidly,218,225,O
metabolized,226,237,O
during,238,244,O
its,245,248,O
uptake,249,255,O
by,256,258,O
the,259,262,O
bacteria,263,271,O
to,272,274,O
pyridine,275,283,O
nucleotides,284,295,O
and,296,299,O
nicotinamide,300,312,O
.,312,313,O
Nicotinamide,314,326,O
deamidase,327,336,O
activity,337,345,O
",",345,346,O
necessary,347,356,O
for,357,360,O
the,361,364,O
completion,365,375,O
of,376,378,O
the,379,382,O
cycle,383,388,O
by,389,391,O
conversion,392,402,O
of,403,405,O
nicotinamide,406,418,O
to,419,421,O
nicotinic,422,431,O
acid,432,436,O
",",436,437,O
was,438,441,O
found,442,447,O
in,448,450,O
a,451,452,O
soluble,453,460,O
extract,461,468,O
(,469,470,O
20,470,472,O
000,473,476,O
X,477,478,O
g,479,480,O
supernatant,481,492,O
),492,493,O
of,494,496,O
B,497,498,O
.,498,499,O
pertussis,500,509,O
cell,510,514,B-Organism_substance
lysates,515,522,I-Organism_substance
.,522,523,O
Use,0,3,O
of,4,6,O
monoclonal,7,17,O
antibodies,18,28,O
to,29,31,O
investigate,32,43,O
a,44,45,O
possible,46,54,O
role,55,59,O
of,60,62,O
thyroglobulin,63,76,O
in,77,79,O
the,80,83,O
pathogenesis,84,96,O
of,97,99,O
Graves,100,106,O
',106,107,O
ophthalmopathy,108,122,O
.,122,123,O
One,124,127,O
possible,128,136,O
mechanism,137,146,O
for,147,150,O
Graves,151,157,O
',157,158,O
ophthalmopathy,159,173,O
is,174,176,O
that,177,181,O
the,182,185,O
progressive,186,197,O
orbital,198,205,B-Immaterial_anatomical_entity
inflammation,206,218,O
is,219,221,O
initiated,222,231,O
by,232,234,O
formation,235,244,O
of,245,247,O
thyroglobulin,248,261,O
(,262,263,O
Tg,263,265,O
),265,266,O
-,266,267,O
anti,267,271,O
-,271,272,O
Tg,272,274,O
immune,275,281,O
complexes,282,291,O
at,292,294,O
sites,295,300,O
of,301,303,O
Tg,304,306,O
binding,307,314,O
to,315,317,O
extraocular,318,329,B-Tissue
muscle,330,336,I-Tissue
membranes,337,346,I-Tissue
.,346,347,O
In,348,350,O
this,351,355,O
study,356,361,O
monoclonal,362,372,O
antibodies,373,383,O
(,384,385,O
MCAB,385,389,O
),389,390,O
against,391,398,O
human,399,404,O
Tg,405,407,O
were,408,412,O
used,413,417,O
as,418,420,O
probes,421,427,O
(,428,429,O
1,429,430,O
),430,431,O
to,432,434,O
identify,435,443,O
Tg,444,446,O
in,447,449,O
eye,450,453,B-Tissue
muscle,454,460,I-Tissue
membranes,461,470,I-Tissue
prepared,471,479,O
from,480,484,O
normal,485,491,O
subjects,492,500,O
and,501,504,O
(,505,506,O
2,506,507,O
),507,508,O
to,509,511,O
measure,512,519,O
binding,520,527,O
of,528,530,O
human,531,536,O
Tg,537,539,O
and,540,543,O
Tg,544,546,O
-,546,547,O
anti,547,551,O
-,551,552,O
Tg,552,554,O
immune,555,561,O
complexes,562,571,O
to,572,574,O
eye,575,578,B-Tissue
muscle,579,585,I-Tissue
membranes,586,595,I-Tissue
.,595,596,O
Reactivity,597,607,O
of,608,610,O
anti,611,615,O
-,615,616,O
Tg,616,618,O
MCAB,619,623,O
with,624,628,O
Tg,629,631,O
",",631,632,O
thyroid,633,640,B-Tissue
",",640,641,O
and,642,645,O
eye,646,649,B-Tissue
muscle,650,656,I-Tissue
membranes,657,666,I-Tissue
was,667,670,O
determined,671,681,O
by,682,684,O
binding,685,692,O
of,693,695,O
[,696,697,O
125I,697,701,O
],701,702,O
anti,702,706,O
-,706,707,O
Tg,707,709,O
monoclonal,710,720,O
antibody,721,729,O
",",729,730,O
an,731,733,O
enzyme,734,740,O
-,740,741,O
linked,741,747,O
immunosorbent,748,761,O
assay,762,767,O
(,768,769,O
ELISA,769,774,O
),774,775,O
",",775,776,O
and,777,780,O
the,781,784,O
indirect,785,793,O
immunofluorescence,794,812,O
technique,813,822,O
.,822,823,O
Seven,824,829,O
membrane,830,838,B-Tissue
fractions,839,848,I-Tissue
",",848,849,O
prepared,850,858,O
by,859,861,O
differential,862,874,O
sucrose,875,882,O
gradient,883,891,O
centrifugation,892,906,O
",",906,907,O
were,908,912,O
used,913,917,O
.,917,918,O
Whereas,919,926,O
[,927,928,O
125I,928,932,O
],932,933,O
anti,933,937,O
-,937,938,O
Tg,938,940,O
MCAB,941,945,O
bound,946,951,O
to,952,954,O
all,955,958,O
thyroid,959,966,B-Tissue
membrane,967,975,I-Tissue
fractions,976,985,I-Tissue
tested,986,992,O
",",992,993,O
no,994,996,O
[,997,998,O
125I,998,1002,O
],1002,1003,O
anti,1003,1007,O
-,1007,1008,O
Tg,1008,1010,O
bound,1011,1016,O
to,1017,1019,O
eye,1020,1023,B-Tissue
muscle,1024,1030,I-Tissue
membranes,1031,1040,I-Tissue
.,1040,1041,O
Similarly,1042,1051,O
",",1051,1052,O
reactivity,1053,1063,O
of,1064,1066,O
anti,1067,1071,O
-,1071,1072,O
Tg,1072,1074,O
MCAB,1075,1079,O
with,1080,1084,O
eye,1085,1088,B-Tissue
muscle,1089,1095,I-Tissue
membranes,1096,1105,I-Tissue
was,1106,1109,O
not,1110,1113,O
demonstrated,1114,1126,O
in,1127,1129,O
ELISA,1130,1135,O
or,1136,1138,O
immunofluorescence,1139,1157,O
tests,1158,1163,O
.,1163,1164,O
Although,1165,1173,O
Tg,1174,1176,O
-,1176,1177,O
anti,1177,1181,O
-,1181,1182,O
Tg,1182,1184,O
immune,1185,1191,O
complexes,1192,1201,O
bound,1202,1207,O
to,1208,1210,O
thyroid,1211,1218,B-Tissue
membranes,1219,1228,I-Tissue
",",1228,1229,O
such,1230,1234,O
complexes,1235,1244,O
did,1245,1248,O
not,1249,1252,O
bind,1253,1257,O
to,1258,1260,O
eye,1261,1264,B-Tissue
muscle,1265,1271,I-Tissue
membranes,1272,1281,I-Tissue
.,1281,1282,O
Significant,1283,1294,O
binding,1295,1302,O
of,1303,1305,O
[,1306,1307,O
125I,1307,1311,O
],1311,1312,O
human,1312,1317,O
Tg,1318,1320,O
to,1321,1323,O
eye,1324,1327,B-Tissue
muscle,1328,1334,I-Tissue
or,1335,1337,O
thyroid,1338,1345,B-Tissue
membranes,1346,1355,I-Tissue
was,1356,1359,O
not,1360,1363,O
demonstrated,1364,1376,O
for,1377,1380,O
any,1381,1384,O
membrane,1385,1393,B-Tissue
preparation,1394,1405,I-Tissue
.,1405,1406,O
On,1407,1409,O
the,1410,1413,O
other,1414,1419,O
hand,1420,1424,O
moderate,1425,1433,O
",",1433,1434,O
but,1435,1438,O
significant,1439,1450,O
",",1450,1451,O
binding,1452,1459,O
to,1460,1462,O
skeletal,1463,1471,B-Organ
muscle,1472,1478,I-Organ
was,1479,1482,O
shown,1483,1488,O
.,1488,1489,O
Similar,1490,1497,O
results,1498,1505,O
were,1506,1510,O
found,1511,1516,O
using,1517,1522,O
an,1523,1525,O
ELISA,1526,1531,O
.,1531,1532,O
Binding,1533,1540,O
of,1541,1543,O
[,1544,1545,O
125I,1545,1549,O
],1549,1550,O
anti,1550,1554,O
-,1554,1555,O
Tg,1555,1557,O
-,1557,1558,O
Tg,1558,1560,O
complexes,1561,1570,O
of,1571,1573,O
[,1574,1575,O
125I,1575,1579,O
],1579,1580,O
Tg,1580,1582,O
to,1583,1585,O
thyroid,1586,1593,B-Tissue
and,1594,1597,O
eye,1598,1601,B-Tissue
muscle,1602,1608,I-Tissue
membranes,1609,1618,I-Tissue
was,1619,1622,O
not,1623,1626,O
affected,1627,1635,O
by,1636,1638,O
the,1639,1642,O
presence,1643,1651,O
of,1652,1654,O
normal,1655,1661,O
human,1662,1667,O
serum,1668,1673,B-Organism_substance
",",1673,1674,O
phosphate,1675,1684,O
ions,1685,1689,O
",",1689,1690,O
pH,1691,1693,O
",",1693,1694,O
or,1695,1697,O
incubation,1698,1708,O
temperature,1709,1720,O
",",1720,1721,O
conditions,1722,1732,O
claimed,1733,1740,O
by,1741,1743,O
others,1744,1750,O
to,1751,1753,O
be,1754,1756,O
critical,1757,1765,O
for,1766,1769,O
Tg,1770,1772,O
and,1773,1776,O
Tg,1777,1779,O
-,1779,1780,O
anti,1780,1784,O
-,1784,1785,O
Tg,1785,1787,O
immune,1788,1794,O
complex,1795,1802,O
binding,1803,1810,O
.,1810,1811,O
Since,1812,1817,O
Tg,1818,1820,O
is,1821,1823,O
not,1824,1827,O
present,1828,1835,O
in,1836,1838,O
normal,1839,1845,O
human,1846,1851,O
eye,1852,1855,B-Tissue
muscle,1856,1862,I-Tissue
a,1863,1864,O
major,1865,1870,O
role,1871,1875,O
of,1876,1878,O
Tg,1879,1881,O
",",1881,1882,O
or,1883,1885,O
Tg,1886,1888,O
-,1888,1889,O
anti,1889,1893,O
-,1893,1894,O
Tg,1894,1896,O
immune,1897,1903,O
complexes,1904,1913,O
",",1913,1914,O
in,1915,1917,O
the,1918,1921,O
pathogenesis,1922,1934,O
of,1935,1937,O
Graves,1938,1944,O
',1944,1945,O
ophthalmopathy,1946,1960,O
appears,1961,1968,O
to,1969,1971,O
have,1972,1976,O
been,1977,1981,O
excluded,1982,1990,O
by,1991,1993,O
these,1994,1999,O
findings,2000,2008,O
.,2008,2009,O
Purification,0,12,O
and,13,16,O
characterization,17,33,O
of,34,36,O
various,37,44,O
esterases,45,54,O
from,55,59,O
rat,60,63,O
liver,64,69,B-Organ
.,69,70,O
The,71,74,O
major,75,80,O
rat,81,84,O
liver,85,90,B-Cellular_component
microsomal,91,101,I-Cellular_component
esterases,102,111,O
acting,112,118,O
on,119,121,O
o,122,123,O
-,123,124,O
nitrophenylacetate,124,142,O
with,143,147,O
isoelectric,148,159,O
points,160,166,O
5,167,168,O
.,168,169,O
0,169,170,O
",",170,171,O
5,172,173,O
.,173,174,O
5,174,175,O
",",175,176,O
6,177,178,O
.,178,179,O
1,179,180,O
and,181,184,O
6,185,186,O
.,186,187,O
4,187,188,O
were,189,193,O
resolved,194,202,O
by,203,205,O
isoelectric,206,217,O
focusing,218,226,O
.,226,227,O
Molecular,228,237,O
weights,238,245,O
were,246,250,O
determined,251,261,O
by,262,264,O
sedimentation,265,278,O
analysis,279,287,O
in,288,290,O
isokinetic,291,301,O
gradients,302,311,O
of,312,314,O
sucrose,315,322,O
and,323,326,O
",",326,327,O
after,328,333,O
purification,334,346,O
",",346,347,O
in,348,350,O
sodium,351,357,O
dodecyl,358,365,O
sulphate,366,374,O
/,374,375,O
polyacrylamide,375,389,O
gel,390,393,O
electrophoresis,394,409,O
.,409,410,O
Their,411,416,O
subunit,417,424,O
molecular,425,434,O
weights,435,442,O
were,443,447,O
between,448,455,O
57,456,458,O
000,459,462,O
and,463,466,O
60,467,469,O
000,470,473,O
.,473,474,O
They,475,479,O
behaved,480,487,O
as,488,490,O
monomers,491,499,O
except,500,506,O
the,507,510,O
pI,511,513,O
-,513,514,O
6,514,515,O
.,515,516,O
1,516,517,O
enzyme,518,524,O
which,525,530,O
behaved,531,538,O
as,539,541,O
a,542,543,O
trimer,544,550,O
.,550,551,O
Esterases,552,561,O
of,562,564,O
pI,565,567,O
5,568,569,O
.,569,570,O
0,570,571,O
",",571,572,O
pI,573,575,O
6,576,577,O
.,577,578,O
1,578,579,O
and,580,583,O
pI,584,586,O
6,587,588,O
.,588,589,O
4,589,590,O
behaved,591,598,O
like,599,603,O
glycoproteins,604,617,O
of,618,620,O
the,621,624,O
polymannose,625,636,O
type,637,641,O
in,642,644,O
the,645,648,O
presence,649,657,O
of,658,660,O
125I,661,665,O
-,665,666,O
labelled,666,674,O
concanavalin,675,687,O
A,688,689,O
.,689,690,O
Preparations,691,703,O
of,704,706,O
the,707,710,O
pI,711,713,O
-,713,714,O
5,714,715,O
.,715,716,O
0,716,717,O
enzyme,718,724,O
contained,725,734,O
two,735,738,O
esterases,739,748,O
of,749,751,O
highly,752,758,O
homologous,759,769,O
structure,770,779,O
.,779,780,O
Antibodies,781,791,O
directed,792,800,O
against,801,808,O
this,809,813,O
preparation,814,825,O
did,826,829,O
not,830,833,O
inhibit,834,841,O
but,842,845,O
precipitated,846,858,O
pI,859,861,O
-,861,862,O
5,862,863,O
.,863,864,O
0,864,865,O
esterase,866,874,O
activity,875,883,O
quantitatively,884,898,O
.,898,899,O
They,900,904,O
did,905,908,O
not,909,912,O
react,913,918,O
with,919,923,O
the,924,927,O
pI,928,930,O
-,930,931,O
6,931,932,O
.,932,933,O
1,933,934,O
and,935,938,O
pI,939,941,O
-,941,942,O
6,942,943,O
.,943,944,O
4,944,945,O
esterases,946,955,O
but,956,959,O
precipitated,960,972,O
several,973,980,O
nonimmunologically,981,999,O
related,1000,1007,O
esterases,1008,1017,O
.,1017,1018,O
Two,1019,1022,O
of,1023,1025,O
these,1026,1031,O
enzymes,1032,1039,O
were,1040,1044,O
inducible,1045,1054,O
by,1055,1057,O
phenobarbital,1058,1071,O
.,1071,1072,O
Total,1073,1078,O
activity,1079,1087,O
was,1088,1091,O
very,1092,1096,O
low,1097,1100,O
in,1101,1103,O
3,1104,1105,O
-,1105,1106,O
day,1106,1109,O
-,1109,1110,O
old,1110,1113,O
animals,1114,1121,O
.,1121,1122,O
Individual,1123,1133,O
esterase,1134,1142,O
activities,1143,1153,O
rose,1154,1158,O
at,1159,1161,O
different,1162,1171,O
rates,1172,1177,O
during,1178,1184,O
development,1185,1196,O
;,1196,1197,O
the,1198,1201,O
enzyme,1202,1208,O
focusing,1209,1217,O
near,1218,1222,O
pI,1223,1225,O
5,1226,1227,O
.,1227,1228,O
0,1228,1229,O
was,1230,1233,O
about,1234,1239,O
three,1240,1245,O
times,1246,1251,O
more,1252,1256,O
active,1257,1263,O
in,1264,1266,O
adult,1267,1272,O
females,1273,1280,O
than,1281,1285,O
in,1286,1288,O
males,1289,1294,O
.,1294,1295,O
All,1296,1299,O
microsomal,1300,1310,O
esterases,1311,1320,O
are,1321,1324,O
located,1325,1332,O
on,1333,1335,O
the,1336,1339,O
luminal,1340,1347,O
side,1348,1352,O
of,1353,1355,O
the,1356,1359,O
endoplasmic,1360,1371,B-Cellular_component
reticulum,1372,1381,I-Cellular_component
.,1381,1382,O
Hippocampal,0,11,B-Multi-tissue_structure
afterdischarge,12,26,O
interferes,27,37,O
with,38,42,O
storage,43,50,O
of,51,53,O
spatial,54,61,O
information,62,73,O
in,74,76,O
a,77,78,O
working,79,86,O
memory,87,93,O
test,94,98,O
.,98,99,O
In,100,102,O
an,103,105,O
attempt,106,113,O
to,114,116,O
impair,117,123,O
spatial,124,131,O
working,132,139,O
memory,140,146,O
by,147,149,O
reversible,150,160,O
functional,161,171,O
blockade,172,180,O
rather,181,187,O
than,188,192,O
by,193,195,O
irreversible,196,208,O
lesion,209,215,B-Pathological_formation
of,216,218,O
the,219,222,O
hippocampus,223,234,B-Multi-tissue_structure
",",234,235,O
eight,236,241,O
male,242,246,O
hooded,247,253,O
rats,254,258,O
were,259,263,O
trained,264,271,O
to,272,274,O
asymptotic,275,285,O
performance,286,297,O
of,298,300,O
1,301,302,O
.,302,303,O
2,303,304,O
to,305,307,O
1,308,309,O
.,309,310,O
4,310,311,O
errors,312,318,O
per,319,322,O
trial,323,328,O
in,329,331,O
the,332,335,O
spatial,336,343,O
12,344,346,O
-,346,347,O
choice,347,353,O
apparatus,354,363,O
(,364,365,O
Bure,366,370,O
s,371,372,O
et,373,375,O
al,376,378,O
.,378,379,O
1982,380,384,O
),384,385,O
",",385,386,O
formally,387,395,O
similar,396,403,O
to,404,406,O
the,407,410,O
radial,411,417,O
maze,418,422,O
.,422,423,O
The,424,427,O
rats,428,432,O
were,433,437,O
implanted,438,447,O
with,448,452,O
hippocampal,453,464,B-Multi-tissue_structure
stimulating,465,476,O
and,477,480,O
recording,481,490,O
electrodes,491,501,O
",",501,502,O
which,503,508,O
were,509,513,O
used,514,518,O
for,519,522,O
eliciting,523,532,O
and,533,536,O
monitoring,537,547,O
hippocampal,548,559,B-Multi-tissue_structure
afterdischarge,560,574,O
(,575,576,O
HAD,576,579,O
),579,580,O
lasting,581,588,O
for,589,592,O
at,593,595,O
least,596,601,O
20,602,604,O
s,605,606,O
.,606,607,O
In,608,610,O
Experiment,611,621,O
1,622,623,O
",",623,624,O
HAD,625,628,O
elicited,629,637,O
1,638,639,O
or,640,642,O
10,643,645,O
min,646,649,O
before,650,656,O
testing,657,664,O
increased,665,674,O
the,675,678,O
incidence,679,688,O
of,689,691,O
errors,692,698,O
to,699,701,O
2,702,703,O
.,703,704,O
75,704,706,O
or,707,709,O
2,710,711,O
.,711,712,O
50,712,714,O
per,715,718,O
trial,719,724,O
",",724,725,O
respectively,726,738,O
",",738,739,O
but,740,743,O
the,744,747,O
performance,748,759,O
still,760,765,O
remained,766,774,O
above,775,780,O
chance,781,787,O
level,788,793,O
(,794,795,O
4,795,796,O
.,796,797,O
18,797,799,O
),799,800,O
.,800,801,O
In,802,804,O
Experiment,805,815,O
2,816,817,O
",",817,818,O
interruption,819,831,O
of,832,834,O
the,835,838,O
trial,839,844,O
by,845,847,O
1,848,849,O
",",849,850,O
10,851,853,O
",",853,854,O
20,855,857,O
and,858,861,O
30,862,864,O
min,865,868,O
intervals,869,878,O
inserted,879,887,O
between,888,895,O
choices,896,903,O
6,904,905,O
and,906,909,O
7,910,911,O
increased,912,921,O
the,922,925,O
incidence,926,935,O
of,936,938,O
errors,939,945,O
in,946,948,O
choices,949,956,O
7,957,958,O
to,959,961,O
12,962,964,O
to,965,967,O
1,968,969,O
.,969,970,O
0,970,971,O
",",971,972,O
1,973,974,O
.,974,975,O
5,975,976,O
",",976,977,O
2,978,979,O
.,979,980,O
1,980,981,O
and,982,985,O
2,986,987,O
.,987,988,O
5,988,989,O
",",989,990,O
respectively,991,1003,O
.,1003,1004,O
HAD,1005,1008,O
elicited,1009,1017,O
immediately,1018,1029,O
after,1030,1035,O
choice,1036,1042,O
6,1043,1044,O
increased,1045,1054,O
error,1055,1060,O
incidence,1061,1070,O
in,1071,1073,O
the,1074,1077,O
subsequent,1078,1088,O
6,1089,1090,O
choices,1091,1098,O
performed,1099,1108,O
after,1109,1114,O
1,1115,1116,O
-,1116,1117,O
min,1117,1120,O
or,1121,1123,O
10,1124,1126,O
-,1126,1127,O
min,1127,1130,O
intervals,1131,1140,O
to,1141,1143,O
3,1144,1145,O
.,1145,1146,O
1,1146,1147,O
or,1148,1150,O
2,1151,1152,O
.,1152,1153,O
75,1153,1155,O
",",1155,1156,O
respectively,1157,1169,O
",",1169,1170,O
i,1171,1172,O
.,1172,1173,O
e,1173,1174,O
.,1174,1175,O
to,1176,1178,O
the,1179,1182,O
chance,1183,1189,O
level,1190,1195,O
of,1196,1198,O
3,1199,1200,O
errors,1201,1207,O
in,1208,1210,O
6,1211,1212,O
choices,1213,1220,O
.,1220,1221,O
It,1222,1224,O
is,1225,1227,O
concluded,1228,1237,O
that,1238,1242,O
HAD,1243,1246,O
elicits,1247,1254,O
transient,1255,1264,O
shortening,1265,1275,O
of,1276,1278,O
the,1279,1282,O
memory,1283,1289,O
span,1290,1294,O
for,1295,1298,O
newly,1299,1304,O
acquired,1305,1313,O
spatial,1314,1321,O
information,1322,1333,O
(,1334,1335,O
anterograde,1335,1346,O
effect,1347,1353,O
),1353,1354,O
and,1355,1358,O
erases,1359,1365,O
the,1366,1369,O
current,1370,1377,O
spatial,1378,1385,O
working,1386,1393,O
memory,1394,1400,O
record,1401,1407,O
(,1408,1409,O
retrograde,1409,1419,O
effect,1420,1426,O
),1426,1427,O
.,1427,1428,O
[,0,1,O
In,1,3,O
vitro,4,9,O
studies,10,17,O
of,18,20,O
the,21,24,O
thyroid,25,32,B-Organ
gland,33,38,I-Organ
regulation,39,49,O
principles,50,60,O
and,61,64,O
their,65,70,O
evaluation,71,81,O
],81,82,O
.,82,83,O
The,84,87,O
free,88,92,O
fractions,93,102,O
of,103,105,O
the,106,109,O
thyroid,110,117,O
hormone,118,125,O
further,126,133,O
the,134,137,O
metabolism,138,148,O
of,149,151,O
the,152,155,O
body,156,160,B-Cell
cells,161,166,I-Cell
and,167,170,O
regulate,171,179,O
the,180,183,O
synthesis,184,193,O
of,194,196,O
the,197,200,O
thyroid,201,208,O
hormone,209,216,O
.,216,217,O
Once,218,222,O
the,223,226,O
level,227,232,O
of,233,235,O
FT3,236,239,O
and,240,243,O
FT4,244,247,O
decreases,248,257,O
.,257,258,O
With,259,263,O
the,264,267,O
help,268,272,O
of,273,275,O
a,276,277,O
liberation,278,288,O
of,289,291,O
the,292,295,O
hormone,296,303,O
stimulating,304,315,O
the,316,319,O
thyroid,320,327,B-Organ
gland,328,333,I-Organ
from,334,338,O
the,339,342,O
anterior,343,351,B-Multi-tissue_structure
lobe,352,356,I-Multi-tissue_structure
of,357,359,O
the,360,363,O
pituitary,364,373,B-Organ
gland,374,379,I-Organ
the,380,383,O
lack,384,388,O
of,389,391,O
thyroid,392,399,O
hormone,400,407,O
is,408,410,O
corrected,411,420,O
.,420,421,O
The,422,425,O
synthesis,426,435,O
and,436,439,O
secretion,440,449,O
of,450,452,O
the,453,456,O
thyroid,457,464,B-Organ
gland,465,470,I-Organ
stimulating,471,482,O
hormone,483,490,O
is,491,493,O
induced,494,501,O
by,502,504,O
the,505,508,O
thyreotropin,509,521,O
releasing,522,531,O
hormone,532,539,O
which,540,545,O
is,546,548,O
given,549,554,O
by,555,557,O
the,558,561,O
hypothalamus,562,574,B-Multi-tissue_structure
.,574,575,O
Moreover,576,584,O
",",584,585,O
the,586,589,O
organism,590,598,O
is,599,601,O
able,602,606,O
as,607,609,O
needed,610,616,O
to,617,619,O
carry,620,625,O
out,626,629,O
the,630,633,O
monodiodation,634,647,O
of,648,650,O
LT4,651,654,O
to,655,657,O
biologically,658,670,O
active,671,677,O
LT3,678,681,O
or,682,684,O
biologically,685,697,O
inactive,698,706,O
so,707,709,O
-,709,710,O
called,710,716,O
revers,717,723,O
T3,724,726,O
(,727,728,O
RT3,728,731,O
),731,732,O
.,732,733,O
The,734,737,O
estimation,738,748,O
of,749,751,O
thyroid,752,759,B-Organ
gland,760,765,I-Organ
stimulating,766,777,O
hormone,778,785,O
before,786,792,O
and,793,796,O
30,797,799,O
minutes,800,807,O
after,808,813,O
intravenous,814,825,B-Multi-tissue_structure
application,826,837,O
of,838,840,O
thyreotropin,841,853,O
releasing,854,863,O
hormone,864,871,O
has,872,875,O
its,876,879,O
main,880,884,O
importance,885,895,O
for,896,899,O
the,900,903,O
early,904,909,O
recognition,910,921,O
of,922,924,O
a,925,926,O
disturbance,927,938,O
of,939,941,O
the,942,945,O
regulating,946,956,O
circle,957,963,O
hypophysis,964,974,O
-,974,975,O
thyroid,975,982,B-Organ
gland,983,988,I-Organ
",",988,989,O
above,990,995,O
all,996,999,O
in,1000,1002,O
the,1003,1006,O
diagnosis,1007,1016,O
of,1017,1019,O
clinically,1020,1030,O
not,1031,1034,O
yet,1035,1038,O
manifest,1039,1047,O
clinical,1048,1056,O
pictures,1057,1065,O
",",1065,1066,O
such,1067,1071,O
as,1072,1074,O
the,1075,1078,O
latent,1079,1085,O
hypothyreosis,1086,1099,O
and,1100,1103,O
the,1104,1107,O
latent,1108,1114,O
hyperthyreosis,1115,1129,O
",",1129,1130,O
respectively,1131,1143,O
(,1144,1145,O
Basedow,1145,1152,O
hyperthyreosis,1153,1167,O
and,1168,1171,O
thyroidal,1172,1181,O
autonomy,1182,1190,O
),1190,1191,O
.,1191,1192,O
According,1193,1202,O
to,1203,1205,O
the,1206,1209,O
questioning,1210,1221,O
the,1222,1225,O
estimations,1226,1237,O
of,1238,1240,O
the,1241,1244,O
levels,1245,1251,O
of,1252,1254,O
the,1255,1258,O
thyroid,1259,1266,O
hormones,1267,1275,O
and,1276,1279,O
of,1280,1282,O
the,1283,1286,O
thyroid,1287,1294,B-Organ
gland,1295,1300,I-Organ
stimulating,1301,1312,O
hormone,1313,1320,O
should,1321,1327,O
be,1328,1330,O
used,1331,1335,O
stepwise,1336,1344,O
.,1344,1345,O
Relationship,0,12,O
of,13,15,O
self,16,20,O
-,20,21,O
concept,21,28,O
during,29,35,O
late,36,40,O
pregnancy,41,50,O
to,51,53,O
neonatal,54,62,O
perception,63,73,O
and,74,77,O
parenting,78,87,O
profile,88,95,O
.,95,96,O
Thirty,97,103,O
-,103,104,O
one,104,107,O
gravidas,108,116,O
were,117,121,O
studied,122,129,O
to,130,132,O
examine,133,140,O
the,141,144,O
relationship,145,157,O
between,158,165,O
a,166,167,O
woman,168,173,O
',173,174,O
s,174,175,O
feelings,176,184,O
about,185,190,O
herself,191,198,O
during,199,205,O
late,206,210,O
pregnancy,211,220,O
",",220,221,O
her,222,225,O
perception,226,236,O
of,237,239,O
her,240,243,O
newborn,244,251,O
",",251,252,O
and,253,256,O
her,257,260,O
profile,261,268,O
of,269,271,O
parenting,272,281,O
.,281,282,O
The,283,286,O
Tennessee,287,296,O
Self,297,301,O
-,301,302,O
Concept,302,309,O
Scale,310,315,O
was,316,319,O
completed,320,329,O
during,330,336,O
the,337,340,O
third,341,346,O
trimester,347,356,O
of,357,359,O
pregnancy,360,369,O
",",369,370,O
the,371,374,O
Neonatal,375,383,O
Perception,384,394,O
Inventory,395,404,O
I,405,406,O
at,407,409,O
one,410,413,O
-,413,414,O
to,414,416,O
-,416,417,O
two,417,420,O
days,421,425,O
postpartum,426,436,O
",",436,437,O
and,438,441,O
the,442,445,O
Neonatal,446,454,O
Perception,455,465,O
Inventory,466,475,O
II,476,478,O
and,479,482,O
the,483,486,O
Michigan,487,495,O
Screening,496,505,O
Profile,506,513,O
of,514,516,O
Parenting,517,526,O
at,527,529,O
four,530,534,O
-,534,535,O
to,535,537,O
-,537,538,O
six,538,541,O
weeks,542,547,O
postpartum,548,558,O
.,558,559,O
When,560,564,O
considered,565,575,O
separately,576,586,O
",",586,587,O
no,588,590,O
positive,591,599,O
significant,600,611,O
relationships,612,625,O
were,626,630,O
found,631,636,O
between,637,644,O
scores,645,651,O
on,652,654,O
these,655,660,O
variables,661,670,O
.,670,671,O
However,672,679,O
",",679,680,O
all,681,684,O
subjects,685,693,O
with,694,698,O
negative,699,707,O
scores,708,714,O
on,715,717,O
both,718,722,O
self,723,727,O
-,727,728,O
concept,728,735,O
and,736,739,O
neonatal,740,748,O
perception,749,759,O
had,760,763,O
negative,764,772,O
scores,773,779,O
on,780,782,O
at,783,785,O
least,786,791,O
two,792,795,O
subscales,796,805,O
of,806,808,O
the,809,812,O
parenting,813,822,O
profile,823,830,O
.,830,831,O
Verrucous,0,9,B-Pathological_formation
carcinoma,10,19,I-Pathological_formation
of,20,22,O
the,23,26,O
endometrium,27,38,B-Multi-tissue_structure
-,38,39,O
-,39,40,O
a,40,41,O
unique,42,48,O
neoplasm,49,57,B-Pathological_formation
with,58,62,O
long,63,67,O
survival,68,76,O
.,76,77,O
A,78,79,O
case,80,84,O
of,85,87,O
verrucous,88,97,B-Pathological_formation
carcinoma,98,107,I-Pathological_formation
of,108,110,O
the,111,114,O
endometrium,115,126,B-Multi-tissue_structure
with,127,131,O
long,132,136,O
survival,137,145,O
is,146,148,O
described,149,158,O
.,158,159,O
It,160,162,O
represents,163,173,O
the,174,177,O
first,178,183,O
of,184,186,O
its,187,190,O
type,191,195,O
to,196,198,O
be,199,201,O
recorded,202,210,O
in,211,213,O
this,214,218,O
site,219,223,O
.,223,224,O
The,225,228,O
literature,229,239,O
on,240,242,O
verrucous,243,252,B-Pathological_formation
carcinoma,253,262,I-Pathological_formation
and,263,266,O
on,267,269,O
other,270,275,O
cases,276,281,O
of,282,284,O
squamous,285,293,B-Pathological_formation
carcinoma,294,303,I-Pathological_formation
of,304,306,O
the,307,310,O
endometrium,311,322,B-Multi-tissue_structure
is,323,325,O
briefly,326,333,O
reviewed,334,342,O
.,342,343,O
[,0,1,O
Organization,1,13,O
of,14,16,O
pectoral,17,25,B-Cell
muscle,26,32,I-Cell
motor,33,38,I-Cell
neurons,39,46,I-Cell
in,47,49,O
the,50,53,O
rat,54,57,O
.,57,58,O
Contribution,59,71,O
to,72,74,O
the,75,78,O
study,79,84,O
of,85,87,O
the,88,91,O
axillary,92,100,B-Multi-tissue_structure
arch,101,105,I-Multi-tissue_structure
(,106,107,O
Achselbogen,107,118,O
),118,119,O
],119,120,O
.,120,121,O
In,122,124,O
spite,125,130,O
of,131,133,O
their,134,139,O
role,140,144,O
of,145,147,O
the,148,151,O
forelimb,152,160,B-Organism_subdivision
activity,161,169,O
",",169,170,O
the,171,174,O
organization,175,187,O
of,188,190,O
the,191,194,O
mammalian,195,204,O
pectoral,205,213,B-Organ
muscles,214,221,I-Organ
remains,222,229,O
unclear,230,237,O
.,237,238,O
In,239,241,O
order,242,247,O
to,248,250,O
get,251,254,O
more,255,259,O
information,260,271,O
",",271,272,O
we,273,275,O
have,276,280,O
studied,281,288,O
",",288,289,O
qualitatively,290,303,O
and,304,307,O
quantitatively,308,322,O
",",322,323,O
the,324,327,O
motor,328,333,O
pools,334,339,O
of,340,342,O
the,343,346,O
various,347,354,O
pectoral,355,363,B-Organ
muscles,364,371,I-Organ
in,372,374,O
the,375,378,O
rat,379,382,O
(,383,384,O
musculus,384,392,B-Organ
pectoralis,393,403,I-Organ
major,404,409,I-Organ
",",409,410,O
musculus,411,419,B-Organ
pectoralis,420,430,I-Organ
minor,431,436,I-Organ
and,437,440,O
musculus,441,449,B-Organ
panniculus,450,460,I-Organ
carnosus,461,469,I-Organ
),469,470,O
.,470,471,O
The,472,475,O
method,476,482,O
applied,483,490,O
was,491,494,O
the,495,498,O
retrograde,499,509,O
transport,510,519,O
of,520,522,O
horseradish,523,534,O
peroxidase,535,545,O
by,546,548,O
the,549,552,O
peripheral,553,563,B-Multi-tissue_structure
nerves,564,570,I-Multi-tissue_structure
supplying,571,580,O
the,581,584,O
various,585,592,O
muscles,593,600,B-Organ
.,600,601,O
The,602,605,O
results,606,613,O
provided,614,622,O
the,623,626,O
precise,627,634,O
localization,635,647,O
within,648,654,O
the,655,658,O
ventral,659,666,B-Cellular_component
horn,667,671,I-Cellular_component
of,672,674,O
the,675,678,O
motor,679,684,B-Cell
neurons,685,692,I-Cell
from,693,697,O
the,698,701,O
pectoral,702,710,B-Organ
muscles,711,718,I-Organ
which,719,724,O
were,725,729,O
all,730,733,O
in,734,736,O
the,737,740,O
most,741,745,O
ventral,746,753,B-Multi-tissue_structure
part,754,758,I-Multi-tissue_structure
of,759,761,O
the,762,765,O
gray,766,770,B-Multi-tissue_structure
matter,771,777,I-Multi-tissue_structure
.,777,778,O
Three,779,784,O
distinct,785,793,O
motor,794,799,O
pools,800,805,O
were,806,810,O
observed,811,819,O
",",819,820,O
which,821,826,O
confirms,827,835,O
the,836,839,O
functional,840,850,O
identity,851,859,O
of,860,862,O
each,863,867,O
muscle,868,874,B-Organ
.,874,875,O
The,876,879,O
motor,880,885,B-Cell
neurons,886,893,I-Cell
of,894,896,O
m,897,898,O
.,898,899,O
panniculus,900,910,O
carnosus,911,919,O
exhibited,920,929,O
some,930,934,O
particularities,935,950,O
.,950,951,O
They,952,956,O
were,957,961,O
4,962,963,O
times,964,969,O
more,970,974,O
numerous,975,983,O
than,984,988,O
those,989,994,O
from,995,999,O
m,1000,1001,O
.,1001,1002,O
pectoralis,1003,1013,O
major,1014,1019,O
",",1019,1020,O
they,1021,1025,O
occupied,1026,1034,O
the,1035,1038,O
whole,1039,1044,O
ventral,1045,1052,B-Cellular_component
edge,1053,1057,I-Cellular_component
of,1058,1060,O
the,1061,1064,O
ventral,1065,1072,B-Cellular_component
horn,1073,1077,I-Cellular_component
",",1077,1078,O
from,1079,1083,O
its,1084,1087,O
medial,1088,1094,O
part,1095,1099,O
to,1100,1102,O
its,1103,1106,O
lateral,1107,1114,O
tip,1115,1118,O
.,1118,1119,O
The,1120,1123,O
cell,1124,1128,B-Cell
size,1129,1133,O
was,1134,1137,O
different,1138,1147,O
from,1148,1152,O
that,1153,1157,O
of,1158,1160,O
the,1161,1164,O
other,1165,1170,O
muscles,1171,1178,B-Organ
.,1178,1179,O
These,1180,1185,O
results,1186,1193,O
were,1194,1198,O
discussed,1199,1208,O
",",1208,1209,O
according,1210,1219,O
to,1220,1222,O
the,1223,1226,O
role,1227,1231,O
of,1232,1234,O
this,1235,1239,O
muscle,1240,1246,B-Organ
",",1246,1247,O
which,1248,1253,O
links,1254,1259,O
the,1260,1263,O
forelimb,1264,1272,B-Organism_subdivision
to,1273,1275,O
the,1276,1279,O
whole,1280,1285,O
trunk,1286,1291,B-Organism_subdivision
.,1291,1292,O
In,1293,1295,O
mammals,1296,1303,O
",",1303,1304,O
m,1305,1306,O
.,1306,1307,O
panniculus,1308,1318,O
carnosus,1319,1327,O
constitutes,1328,1339,O
",",1339,1340,O
with,1341,1345,O
musculus,1346,1354,B-Organ
latissimus,1355,1365,I-Organ
dorsi,1366,1371,I-Organ
",",1371,1372,O
the,1373,1376,O
axillary,1377,1385,B-Multi-tissue_structure
arch,1386,1390,I-Multi-tissue_structure
(,1391,1392,O
Achselbogen,1392,1403,O
),1403,1404,O
.,1404,1405,O
A,1406,1407,O
small,1408,1413,O
area,1414,1418,O
of,1419,1421,O
overlapping,1422,1433,O
between,1434,1441,O
the,1442,1445,O
motor,1446,1451,O
pools,1452,1457,O
of,1458,1460,O
these,1461,1466,O
two,1467,1470,O
muscles,1471,1478,B-Organ
was,1479,1482,O
observed,1483,1491,O
.,1491,1492,O
It,1493,1495,O
was,1496,1499,O
suggested,1500,1509,O
that,1510,1514,O
the,1515,1518,O
muscular,1519,1527,B-Cell
fibers,1528,1534,I-Cell
from,1535,1539,O
the,1540,1543,O
axillary,1544,1552,B-Multi-tissue_structure
arch,1553,1557,I-Multi-tissue_structure
were,1558,1562,O
innervated,1563,1573,O
by,1574,1576,O
the,1577,1580,O
same,1581,1585,O
",",1585,1586,O
well,1587,1591,O
-,1591,1592,O
defined,1592,1599,O
spinal,1600,1606,B-Organism_subdivision
area,1607,1611,I-Organism_subdivision
",",1611,1612,O
independent,1613,1624,O
of,1625,1627,O
the,1628,1631,O
muscle,1632,1638,B-Organ
from,1639,1643,O
which,1644,1649,O
they,1650,1654,O
originate,1655,1664,O
.,1664,1665,O
Additional,0,10,O
tests,11,16,O
of,17,19,O
interest,20,28,O
to,29,31,O
the,32,35,O
dermatologist,36,49,O
.,49,50,O
The,51,54,O
carcinoid,55,64,O
syndrome,65,73,O
and,74,77,O
its,78,81,O
clinical,82,90,O
manifestations,91,105,O
have,106,110,O
been,111,115,O
discussed,116,125,O
.,125,126,O
The,127,130,O
standard,131,139,O
laboratory,140,150,O
test,151,155,O
for,156,159,O
making,160,166,O
that,167,171,O
diagnosis,172,181,O
is,182,184,O
urinary,185,192,B-Organism_substance
5,193,194,O
-,194,195,O
HIAA,195,199,O
levels,200,206,O
but,207,210,O
newer,211,216,O
",",216,217,O
more,218,222,O
sensitive,223,232,O
tests,233,238,O
may,239,242,O
also,243,247,O
be,248,250,O
available,251,260,O
.,260,261,O
Central,0,7,B-Anatomical_system
nervous,8,15,I-Anatomical_system
system,16,22,I-Anatomical_system
infection,23,32,O
with,33,37,O
Eikenella,38,47,O
corrodens,48,57,O
:,57,58,O
report,59,65,O
of,66,68,O
two,69,72,O
cases,73,78,O
.,78,79,O
Two,80,83,O
cases,84,89,O
of,90,92,O
central,93,100,B-Anatomical_system
nervous,101,108,I-Anatomical_system
system,109,115,I-Anatomical_system
infections,116,126,O
from,127,131,O
which,132,137,O
E,138,139,O
.,139,140,O
corrodens,141,150,O
has,151,154,O
been,155,159,O
isolated,160,168,O
are,169,172,O
reported,173,181,O
.,181,182,O
The,183,186,O
portals,187,194,O
of,195,197,O
entry,198,203,O
",",203,204,O
clinical,205,213,O
course,214,220,O
",",220,221,O
and,222,225,O
antimicrobial,226,239,O
responses,240,249,O
conform,250,257,O
to,258,260,O
other,261,266,O
reports,267,274,O
in,275,277,O
the,278,281,O
literature,282,292,O
.,292,293,O
The,294,297,O
importance,298,308,O
of,309,311,O
obtaining,312,321,O
careful,322,329,O
anaerobic,330,339,O
cultures,340,348,O
is,349,351,O
emphasized,352,362,O
.,362,363,O
Comparative,0,11,O
immunohistochemical,12,31,O
study,32,37,O
of,38,40,O
primary,41,48,B-Pathological_formation
and,49,52,O
metastatic,53,63,B-Pathological_formation
carcinomas,64,74,I-Pathological_formation
of,75,77,O
the,78,81,O
liver,82,87,B-Organ
.,87,88,O
Distinguishing,89,103,O
primary,104,111,B-Pathological_formation
hepatocellular,112,126,I-Pathological_formation
carcinoma,127,136,I-Pathological_formation
(,137,138,O
HCC,138,141,B-Pathological_formation
),141,142,O
from,143,147,O
metastatic,148,158,B-Pathological_formation
carcinomas,159,169,I-Pathological_formation
to,170,172,O
the,173,176,O
liver,177,182,B-Organ
is,183,185,O
often,186,191,O
difficult,192,201,O
",",201,202,O
if,203,205,O
not,206,209,O
impossible,210,220,O
",",220,221,O
particularly,222,234,O
in,235,237,O
needle,238,244,B-Multi-tissue_structure
biopsy,245,251,I-Multi-tissue_structure
and,252,255,O
fine,256,260,B-Multi-tissue_structure
-,260,261,I-Multi-tissue_structure
needle,261,267,I-Multi-tissue_structure
aspiration,268,278,I-Multi-tissue_structure
specimens,279,288,I-Multi-tissue_structure
.,288,289,O
In,290,292,O
an,293,295,O
attempt,296,303,O
to,304,306,O
identify,307,315,O
a,316,317,O
specific,318,326,O
immunohistochemical,327,346,O
profile,347,354,O
that,355,359,O
would,360,365,O
distinguish,366,377,O
HCC,378,381,B-Pathological_formation
from,382,386,O
metastatic,387,397,B-Pathological_formation
carcinomas,398,408,I-Pathological_formation
",",408,409,O
we,410,412,O
studied,413,420,O
56,421,423,O
HCCs,424,428,O
",",428,429,O
8,430,431,O
cholangiocarcinomas,432,451,B-Pathological_formation
",",451,452,O
and,453,456,O
24,457,459,O
metastatic,460,470,B-Pathological_formation
adenocarcinomas,471,486,I-Pathological_formation
with,487,491,O
monoclonal,492,502,O
antibodies,503,513,O
to,514,516,O
alpha,517,522,O
-,522,523,O
fetoprotein,523,534,O
(,535,536,O
AFP,536,539,O
),539,540,O
",",540,541,O
keratin,542,549,O
(,550,551,O
AE1,551,554,O
",",554,555,O
AE3,556,559,O
",",559,560,O
and,561,564,O
CAM5,565,569,O
.,569,570,O
2,570,571,O
),571,572,O
",",572,573,O
Leu,574,577,O
-,577,578,O
M1,578,580,O
",",580,581,O
human,582,587,O
milk,588,592,O
fat,593,596,O
globule,597,604,O
(,605,606,O
HMFG,606,610,O
-,610,611,O
2,611,612,O
),612,613,O
",",613,614,O
tumor,615,620,B-Pathological_formation
-,620,621,O
associated,621,631,O
glycoprotein,632,644,O
-,644,645,O
72,645,647,O
(,647,648,O
B72,648,651,O
.,651,652,O
3,652,653,O
),653,654,O
",",654,655,O
epithelial,656,666,B-Tissue
specific,667,675,O
membrane,676,684,B-Cellular_component
antigen,685,692,O
(,693,694,O
Ber,694,697,O
-,697,698,O
EP4,698,701,O
),701,702,O
",",702,703,O
and,704,707,O
BCA,708,711,O
-,711,712,O
225,712,715,O
(,716,717,O
CU,717,719,O
-,719,720,O
18,720,722,O
),722,723,O
.,723,724,O
Both,725,729,O
monoclonal,730,740,O
and,741,744,O
polyclonal,745,755,O
(,756,757,O
mCEA,757,761,O
and,762,765,O
pCEA,766,770,O
),770,771,O
antibodies,772,782,O
to,783,785,O
carcinoembryonic,786,802,O
antigen,803,810,O
also,811,815,O
were,816,820,O
used,821,825,O
.,825,826,O
Metastatic,827,837,B-Pathological_formation
adenocarcinomas,838,853,I-Pathological_formation
were,854,858,O
often,859,864,O
positive,865,873,O
for,874,877,O
CU,878,880,O
-,880,881,O
18,881,883,O
(,883,884,O
71,884,886,O
%,886,887,O
),887,888,O
",",888,889,O
Leu,890,893,O
-,893,894,O
M1,894,896,O
(,897,898,O
75,898,900,O
%,900,901,O
),901,902,O
",",902,903,O
B72,904,907,O
.,907,908,O
3,908,909,O
(,910,911,O
50,911,913,O
%,913,914,O
),914,915,O
",",915,916,O
HMFG,917,921,O
-,921,922,O
2,922,923,O
(,924,925,O
67,925,927,O
%,927,928,O
),928,929,O
",",929,930,O
Ber,931,934,O
-,934,935,O
EP4,935,938,O
(,938,939,O
83,939,941,O
%,941,942,O
),942,943,O
and,944,947,O
mCEA,948,952,O
(,952,953,O
71,953,955,O
%,955,956,O
),956,957,O
.,957,958,O
Using,959,964,O
these,965,970,O
antibodies,971,981,O
",",981,982,O
the,983,986,O
frequency,987,996,O
of,997,999,O
positivity,1000,1010,O
for,1011,1014,O
HCC,1015,1018,B-Pathological_formation
was,1019,1022,O
9,1023,1024,O
%,1024,1025,O
",",1025,1026,O
16,1027,1029,O
%,1029,1030,O
",",1030,1031,O
11,1032,1034,O
%,1034,1035,O
",",1035,1036,O
20,1037,1039,O
%,1039,1040,O
",",1040,1041,O
36,1042,1044,O
%,1044,1045,O
",",1045,1046,O
and,1047,1050,O
11,1051,1053,O
%,1053,1054,O
",",1054,1055,O
respectively,1056,1068,O
.,1068,1069,O
CU,1070,1072,O
-,1072,1073,O
18,1073,1075,O
was,1076,1079,O
the,1080,1083,O
only,1084,1088,O
monoclonal,1089,1099,O
antibody,1100,1108,O
in,1109,1111,O
which,1112,1117,O
there,1118,1123,O
was,1124,1127,O
a,1128,1129,O
significant,1130,1141,O
difference,1142,1152,O
in,1153,1155,O
positive,1156,1164,O
rates,1165,1170,O
between,1171,1178,O
HCC,1179,1182,B-Pathological_formation
and,1183,1186,O
metastatic,1187,1197,B-Pathological_formation
adenocarcinomas,1198,1213,I-Pathological_formation
.,1213,1214,O
Most,1215,1219,O
HCCs,1220,1224,B-Pathological_formation
(,1225,1226,O
71,1226,1228,O
%,1228,1229,O
),1229,1230,O
revealed,1231,1239,O
a,1240,1241,O
bile,1242,1246,B-Multi-tissue_structure
canalicular,1247,1258,I-Multi-tissue_structure
staining,1259,1267,O
pattern,1268,1275,O
with,1276,1280,O
pCEA,1281,1285,O
.,1285,1286,O
Because,1287,1294,O
this,1295,1299,O
staining,1300,1308,O
pattern,1309,1316,O
was,1317,1320,O
absent,1321,1327,O
in,1328,1330,O
metastatic,1331,1341,B-Pathological_formation
carcinomas,1342,1352,I-Pathological_formation
",",1352,1353,O
pCEA,1354,1358,O
appears,1359,1366,O
to,1367,1369,O
be,1370,1372,O
useful,1373,1379,O
in,1380,1382,O
confirming,1383,1393,O
a,1394,1395,O
diagnosis,1396,1405,O
of,1406,1408,O
HCC,1409,1412,O
.,1412,1413,O
AE1,1414,1417,O
",",1417,1418,O
AE3,1419,1422,O
and,1423,1426,O
CAM5,1427,1431,O
.,1431,1432,O
2,1432,1433,O
antibodies,1434,1444,O
were,1445,1449,O
not,1450,1453,O
useful,1454,1460,O
in,1461,1463,O
distinguishing,1464,1478,O
HCC,1479,1482,B-Pathological_formation
from,1483,1487,O
metastatic,1488,1498,B-Pathological_formation
carcinomas,1499,1509,I-Pathological_formation
.,1509,1510,O
Each,1511,1515,O
cholangiocarcinoma,1516,1534,B-Pathological_formation
shared,1535,1541,O
a,1542,1543,O
staining,1544,1552,O
profile,1553,1560,O
similar,1561,1568,O
to,1569,1571,O
that,1572,1576,O
of,1577,1579,O
metastatic,1580,1590,B-Pathological_formation
carcinomas,1591,1601,I-Pathological_formation
.,1601,1602,O
Differential,0,12,O
effects,13,20,O
of,21,23,O
carbachol,24,33,O
on,34,36,O
calcium,37,44,O
entry,45,50,O
and,51,54,O
release,55,62,O
in,63,65,O
CHO,66,69,B-Cell
cells,70,75,I-Cell
expressing,76,86,O
the,87,90,O
m3,91,93,O
muscarinic,94,104,O
receptor,105,113,O
.,113,114,O
Calcium,115,122,O
signalling,123,133,O
was,134,137,O
examined,138,146,O
in,147,149,O
CHO,150,153,B-Cell
-,153,154,I-Cell
k1,154,156,I-Cell
cells,157,162,I-Cell
that,163,167,O
stably,168,174,O
express,175,182,O
the,183,186,O
m3,187,189,O
subtype,190,197,O
of,198,200,O
the,201,204,O
muscarinic,205,215,O
receptor,216,224,O
.,224,225,O
The,226,229,O
calcium,230,237,O
indicator,238,247,O
Fura,248,252,O
-,252,253,O
2,253,254,O
was,255,258,O
retained,259,267,O
in,268,270,O
these,271,276,O
cells,277,282,B-Cell
only,283,287,O
in,288,290,O
the,291,294,O
presence,295,303,O
of,304,306,O
probenecid,307,317,O
(,318,319,O
1,319,320,O
mM,321,323,O
),323,324,O
",",324,325,O
suggesting,326,336,O
that,337,341,O
Fura,342,346,O
-,346,347,O
2,347,348,O
efflux,349,355,O
was,356,359,O
mediated,360,368,O
by,369,371,O
an,372,374,O
organic,375,382,O
anion,383,388,O
transporter,389,400,O
.,400,401,O
The,402,405,O
addition,406,414,O
of,415,417,O
carbachol,418,427,O
(,428,429,O
CCh,429,432,O
),432,433,O
to,434,436,O
Fura,437,441,O
-,441,442,O
2,442,443,O
loaded,444,450,O
cells,451,456,B-Cell
in,457,459,O
suspension,460,470,O
caused,471,477,O
a,478,479,O
rapid,480,485,O
transient,486,495,O
increase,496,504,O
in,505,507,O
intracellular,508,521,B-Immaterial_anatomical_entity
calcium,522,529,O
[,530,531,O
Ca,531,533,O
],533,534,O
i,534,535,O
followed,536,544,O
by,545,547,O
a,548,549,O
smaller,550,557,O
sustained,558,567,O
plateau,568,575,O
phase,576,581,O
.,581,582,O
The,583,586,O
transient,587,596,O
rise,597,601,O
in,602,604,O
[,605,606,O
Ca,606,608,O
],608,609,O
i,609,610,O
was,611,614,O
dose,615,619,O
-,619,620,O
dependent,620,629,O
with,630,634,O
a,635,636,O
threshold,637,646,O
response,647,655,O
of,656,658,O
89,659,661,O
+,662,663,O
/,663,664,O
-,664,665,O
18,666,668,O
nM,669,671,O
above,672,677,O
baseline,678,686,O
with,687,691,O
10,692,694,O
nM,695,697,O
CCh,698,701,O
and,702,705,O
a,706,707,O
maximum,708,715,O
stimulation,716,727,O
of,728,730,O
734,731,734,O
+,735,736,O
/,736,737,O
-,737,738,O
46,739,741,O
nM,742,744,O
with,745,749,O
10,750,752,O
microM,753,759,O
CCh,760,763,O
.,763,764,O
This,765,769,O
phase,770,775,O
was,776,779,O
accompanied,780,791,O
by,792,794,O
a,795,796,O
similar,797,804,O
dose,805,809,O
-,809,810,O
dependent,810,819,O
stimulation,820,831,O
of,832,834,O
total,835,840,O
inositol,841,849,O
phosphate,850,859,O
production,860,870,O
and,871,874,O
was,875,878,O
assumed,879,886,O
to,887,889,O
be,890,892,O
generated,893,902,O
by,903,905,O
release,906,913,O
from,914,918,O
intracellular,919,932,B-Immaterial_anatomical_entity
stores,933,939,O
of,940,942,O
the,943,946,O
endoplasmic,947,958,B-Cellular_component
reticulum,959,968,I-Cellular_component
(,969,970,O
ER,970,972,B-Cellular_component
),972,973,O
.,973,974,O
The,975,978,O
sustained,979,988,O
increase,989,997,O
in,998,1000,O
[,1001,1002,O
Ca,1002,1004,O
],1004,1005,O
i,1005,1006,O
was,1007,1010,O
generated,1011,1020,O
by,1021,1023,O
entry,1024,1029,O
from,1030,1034,O
the,1035,1038,O
extracellular,1039,1052,B-Immaterial_anatomical_entity
bath,1053,1057,O
since,1058,1063,O
it,1064,1066,O
was,1067,1070,O
blocked,1071,1078,O
by,1079,1081,O
pretreatment,1082,1094,O
with,1095,1099,O
La3,1100,1103,O
+,1103,1104,O
(,1105,1106,O
1,1106,1107,O
microM,1108,1114,O
),1114,1115,O
and,1116,1119,O
was,1120,1123,O
absent,1124,1130,O
when,1131,1135,O
bath,1136,1140,O
calcium,1141,1148,O
was,1149,1152,O
chelated,1153,1161,O
with,1162,1166,O
EGTA,1167,1171,O
.,1171,1172,O
This,1173,1177,O
phase,1178,1183,O
was,1184,1187,O
not,1188,1191,O
dependent,1192,1201,O
on,1202,1204,O
CCh,1205,1208,O
dose,1209,1213,O
",",1213,1214,O
and,1215,1218,O
a,1219,1220,O
stimulation,1221,1232,O
of,1233,1235,O
[,1236,1237,O
Ca,1237,1239,O
],1239,1240,O
i,1240,1241,O
of,1242,1244,O
approximately,1245,1258,O
90,1259,1261,O
nM,1262,1264,O
above,1265,1270,O
baseline,1271,1279,O
was,1280,1283,O
observed,1284,1292,O
with,1293,1297,O
CCh,1298,1301,O
concentrations,1302,1316,O
between,1317,1324,O
50,1325,1327,O
nM,1328,1330,O
and,1331,1334,O
10,1335,1337,O
microM,1338,1344,O
.,1344,1345,O
With,1346,1350,O
this,1351,1355,O
dose,1356,1360,O
range,1361,1366,O
",",1366,1367,O
the,1368,1371,O
rate,1372,1376,O
of,1377,1379,O
Mn2,1380,1383,O
+,1383,1384,O
quenching,1385,1394,O
of,1395,1397,O
Fura,1398,1402,O
-,1402,1403,O
2,1403,1404,O
at,1405,1407,O
the,1408,1411,O
Ca,1412,1414,O
-,1414,1415,O
insensitive,1415,1426,O
excitation,1427,1437,O
wavelength,1438,1448,O
of,1449,1451,O
360,1452,1455,O
nm,1456,1458,O
was,1459,1462,O
likewise,1463,1471,O
maximally,1472,1481,O
stimulated,1482,1492,O
.,1492,1493,O
At,1494,1496,O
lower,1497,1502,O
CCh,1503,1506,O
concentrations,1507,1521,O
(,1522,1523,O
10,1523,1525,O
-,1525,1526,O
50,1526,1528,O
nM,1529,1531,O
),1531,1532,O
",",1532,1533,O
it,1534,1536,O
was,1537,1540,O
clear,1541,1546,O
that,1547,1551,O
the,1552,1555,O
activation,1556,1566,O
of,1567,1569,O
Ca,1570,1572,O
entry,1573,1578,O
could,1579,1584,O
not,1585,1588,O
be,1589,1591,O
dissociated,1592,1603,O
from,1604,1608,O
a,1609,1610,O
threshold,1611,1620,O
release,1621,1628,O
of,1629,1631,O
Ca,1632,1634,O
from,1635,1639,O
intracellular,1640,1653,B-Immaterial_anatomical_entity
stores,1654,1660,O
.,1660,1661,O
The,1662,1665,O
phorbol,1666,1673,O
ester,1674,1679,O
PMA,1680,1683,O
",",1683,1684,O
which,1685,1690,O
uncouples,1691,1700,O
the,1701,1704,O
muscarinic,1705,1715,O
receptor,1716,1724,O
from,1725,1729,O
phospholipase,1730,1743,O
C,1744,1745,O
",",1745,1746,O
reduced,1747,1754,O
the,1755,1758,O
transient,1759,1768,O
rise,1769,1773,O
in,1774,1776,O
[,1777,1778,O
Ca,1778,1780,O
],1780,1781,O
i,1781,1782,O
by,1783,1785,O
approximately,1786,1799,O
50,1800,1802,O
%,1802,1803,O
with,1804,1808,O
little,1809,1815,O
or,1816,1818,O
no,1819,1821,O
effect,1822,1828,O
on,1829,1831,O
Ca,1832,1834,O
entry,1835,1840,O
at,1841,1843,O
higher,1844,1850,O
CCh,1851,1854,O
levels,1855,1861,O
(,1862,1863,O
>,1863,1864,O
or,1865,1867,O
=,1868,1869,O
1,1870,1871,O
microM,1872,1878,O
),1878,1879,O
.,1879,1880,O
At,1881,1883,O
lower,1884,1889,O
CCh,1890,1893,O
concentrations,1894,1908,O
(,1909,1910,O
<,1910,1911,O
or,1912,1914,O
=,1915,1916,O
100,1917,1920,O
nM,1921,1923,O
),1923,1924,O
however,1925,1932,O
",",1932,1933,O
pretreatment,1934,1946,O
with,1947,1951,O
PMA,1952,1955,O
completely,1956,1966,O
blocked,1967,1974,O
all,1975,1978,O
Ca,1979,1981,O
mobilization,1982,1994,O
and,1995,1998,O
supports,1999,2007,O
the,2008,2011,O
contention,2012,2022,O
that,2023,2027,O
Ca,2028,2030,O
entry,2031,2036,O
is,2037,2039,O
coupled,2040,2047,O
to,2048,2050,O
Ca,2051,2053,O
release,2054,2061,O
from,2062,2066,O
stores,2067,2073,O
or,2074,2076,O
to,2077,2079,O
store,2080,2085,O
depletion,2086,2095,O
.,2095,2096,O
The,2097,2100,O
emptying,2101,2109,O
of,2110,2112,O
inositol,2113,2121,O
trisphosphate,2122,2135,O
-,2135,2136,O
sensitive,2136,2145,O
stores,2146,2152,O
with,2153,2157,O
thapsigargin,2158,2170,O
(,2171,2172,O
10,2172,2174,O
nM,2175,2177,O
),2177,2178,O
stimulated,2179,2189,O
Ca,2190,2192,O
entry,2193,2198,O
and,2199,2202,O
also,2203,2207,O
the,2208,2211,O
rate,2212,2216,O
of,2217,2219,O
Mn2,2220,2223,O
+,2223,2224,O
quenching,2225,2234,O
.,2234,2235,O
Store,2236,2241,O
depletion,2242,2251,O
by,2252,2254,O
incubation,2255,2265,O
in,2266,2268,O
Ca,2269,2271,O
-,2271,2272,O
free,2272,2276,O
media,2277,2282,O
likewise,2283,2291,O
stimulated,2292,2302,O
Mn2,2303,2306,O
+,2306,2307,O
uptake,2308,2314,O
without,2315,2322,O
a,2323,2324,O
rise,2325,2329,O
in,2330,2332,O
[,2333,2334,O
Ca,2334,2336,O
],2336,2337,O
i,2337,2338,O
.,2338,2339,O
Our,2340,2343,O
data,2344,2348,O
are,2349,2352,O
therefore,2353,2362,O
consistent,2363,2373,O
with,2374,2378,O
a,2379,2380,O
',2381,2382,O
capacitative,2382,2394,O
',2394,2395,O
coupling,2396,2404,O
model,2405,2410,O
",",2410,2411,O
whereby,2412,2419,O
the,2420,2423,O
activation,2424,2434,O
of,2435,2437,O
the,2438,2441,O
plasma,2442,2448,B-Cellular_component
membrane,2449,2457,I-Cellular_component
receptor,2458,2466,O
leads,2467,2472,O
to,2473,2475,O
an,2476,2478,O
InsP3,2479,2484,O
-,2484,2485,O
induced,2485,2492,O
change,2493,2499,O
in,2500,2502,O
the,2503,2506,O
degree,2507,2513,O
of,2514,2516,O
filling,2517,2524,O
of,2525,2527,O
the,2528,2531,O
ER,2532,2534,B-Cellular_component
Ca,2535,2537,O
pool,2538,2542,O
.,2542,2543,O
(,2543,2544,O
ABSTRACT,2544,2552,O
TRUNCATED,2553,2562,O
AT,2563,2565,O
400,2566,2569,O
WORDS,2570,2575,O
),2575,2576,O
Appetite,0,8,O
regulation,9,19,O
by,20,22,O
serotoninergic,23,37,O
mechanisms,38,48,O
and,49,52,O
effects,53,60,O
of,61,63,O
d,64,65,O
-,65,66,O
fenfluramine,66,78,O
.,78,79,O
In,80,82,O
this,83,87,O
literature,88,98,O
review,99,105,O
",",105,106,O
evidence,107,115,O
is,116,118,O
presented,119,128,O
for,129,132,O
the,133,136,O
theory,137,143,O
that,144,148,O
the,149,152,O
neurotransmitter,153,169,O
",",169,170,O
serotonin,171,180,O
(,181,182,O
5,182,183,O
-,183,184,O
hydroxytryptamine,184,201,O
",",201,202,O
5HT,203,206,O
),206,207,O
",",207,208,O
in,209,211,O
medial,212,218,B-Multi-tissue_structure
hypothalamic,219,231,I-Multi-tissue_structure
centres,232,239,I-Multi-tissue_structure
is,240,242,O
an,243,245,O
important,246,255,O
regulator,256,265,O
for,266,269,O
appetite,270,278,O
and,279,282,O
for,283,286,O
the,287,290,O
selection,291,300,O
of,301,303,O
major,304,309,O
food,310,314,O
constituents,315,327,O
.,327,328,O
High,329,333,O
local,334,339,O
levels,340,346,O
of,347,349,O
5HT,350,353,O
cause,354,359,O
a,360,361,O
reduction,362,371,O
of,372,374,O
appetite,375,383,O
and,384,387,O
a,388,389,O
preference,390,400,O
for,401,404,O
protein,405,412,O
",",412,413,O
low,414,417,O
levels,418,424,O
the,425,428,O
opposite,429,437,O
.,437,438,O
The,439,442,O
main,443,447,O
antagonistic,448,460,O
system,461,467,O
is,468,470,O
noradrenergic,471,484,O
.,484,485,O
The,486,489,O
drug,490,494,O
d,495,496,O
-,496,497,O
fenfluramine,497,509,O
mimics,510,516,O
the,517,520,O
effects,521,528,O
of,529,531,O
5HT,532,535,O
by,536,538,O
releasing,539,548,O
5HT,549,552,O
from,553,557,O
serotoninergic,558,572,O
nerve,573,578,B-Multi-tissue_structure
endings,579,586,O
and,587,590,O
inhibiting,591,601,O
its,602,605,O
neuronal,606,614,B-Cell
re,615,617,O
-,617,618,O
uptake,618,624,O
.,624,625,O
Further,626,633,O
experimental,634,646,O
data,647,651,O
prove,652,657,O
that,658,662,O
a,663,664,O
high,665,669,O
-,669,670,O
carbohydrate,670,682,O
",",682,683,O
low,684,687,O
-,687,688,O
protein,688,695,O
diet,696,700,O
promotes,701,709,O
uptake,710,716,O
of,717,719,O
serum,720,725,B-Organism_substance
tryptophan,726,736,O
in,737,739,O
the,740,743,O
brain,744,749,B-Organ
and,750,753,O
its,754,757,O
conversion,758,768,O
into,769,773,O
5HT,774,777,O
.,777,778,O
Hence,779,784,O
",",784,785,O
this,786,790,O
serotoninergic,791,805,O
system,806,812,O
may,813,816,O
function,817,825,O
as,826,828,O
a,829,830,O
self,831,835,O
-,835,836,O
regulatory,836,846,O
mechanism,847,856,O
.,856,857,O
In,858,860,O
patients,861,869,O
with,870,874,O
decreased,875,884,O
peripheral,885,895,O
insulin,896,903,O
sensitivity,904,915,O
",",915,916,O
the,917,920,O
system,921,927,O
may,928,931,O
be,932,934,O
disturbed,935,944,O
",",944,945,O
causing,946,953,O
overconsumption,954,969,O
of,970,972,O
carbohydrates,973,986,O
.,986,987,O
This,988,992,O
is,993,995,O
sometimes,996,1005,O
compulsive,1006,1016,O
(,1017,1018,O
"""",1018,1019,O
carbohydrate,1019,1031,O
craving,1032,1039,O
"""",1039,1040,O
),1040,1041,O
.,1041,1042,O
It,1043,1045,O
may,1046,1049,O
be,1050,1052,O
presumed,1053,1061,O
that,1062,1066,O
in,1067,1069,O
the,1070,1073,O
treatment,1074,1083,O
of,1084,1086,O
obesity,1087,1094,O
",",1094,1095,O
in,1096,1098,O
addition,1099,1107,O
to,1108,1110,O
the,1111,1114,O
use,1115,1118,O
of,1119,1121,O
serotoninergic,1122,1136,O
drugs,1137,1142,O
",",1142,1143,O
successes,1144,1153,O
with,1154,1158,O
reducing,1159,1167,O
diets,1168,1173,O
may,1174,1177,O
be,1178,1180,O
enhanced,1181,1189,O
by,1190,1192,O
including,1193,1202,O
periods,1203,1210,O
of,1211,1213,O
high,1214,1218,O
-,1218,1219,O
carbohydrate,1219,1231,O
",",1231,1232,O
low,1233,1236,O
-,1236,1237,O
protein,1237,1244,O
intake,1245,1251,O
.,1251,1252,O
It,1253,1255,O
would,1256,1261,O
be,1262,1264,O
worthwhile,1265,1275,O
to,1276,1278,O
explore,1279,1286,O
whether,1287,1294,O
similar,1295,1302,O
alimentary,1303,1313,O
self,1314,1318,O
-,1318,1319,O
regulatory,1319,1329,O
mechanisms,1330,1340,O
of,1341,1343,O
neurotransmitter,1344,1360,O
function,1361,1369,O
exist,1370,1375,O
in,1376,1378,O
other,1379,1384,O
regulatory,1385,1395,O
systems,1396,1403,O
.,1403,1404,O
[,0,1,O
Preliminary,1,12,O
results,13,20,O
of,21,23,O
observing,24,33,O
18,34,36,O
cases,37,42,O
of,43,45,O
retinoblastoma,46,60,B-Pathological_formation
carried,61,68,O
within,69,75,O
the,76,79,O
international,80,93,O
research,94,102,O
program,103,110,O
RICS,111,115,O
],115,116,O
.,116,117,O
In,118,120,O
the,121,124,O
years,125,130,O
1988,131,135,O
-,135,136,O
1989,136,140,O
",",140,141,O
the,142,145,O
Ophthalmological,146,162,O
Clinic,163,169,O
in,170,172,O
Cracow,173,179,O
took,180,184,O
part,185,189,O
in,190,192,O
the,193,196,O
International,197,210,O
Research,211,219,O
Programme,220,229,O
on,230,232,O
Retinoblastoma,233,247,B-Pathological_formation
as,248,250,O
one,251,254,O
of,255,257,O
28,258,260,O
clinical,261,269,O
centres,270,277,O
in,278,280,O
14,281,283,O
countries,284,293,O
.,293,294,O
The,295,298,O
study,299,304,O
included,305,313,O
18,314,316,O
children,317,325,O
with,326,330,O
retinoblastoma,331,345,B-Pathological_formation
",",345,346,O
in,347,349,O
most,350,354,O
cases,355,360,O
in,361,363,O
the,364,367,O
advanced,368,376,O
stadium,377,384,O
of,385,387,O
the,388,391,O
disease,392,399,O
.,399,400,O
As,401,403,O
a,404,405,O
rule,406,410,O
",",410,411,O
the,412,415,O
eyes,416,420,B-Organ
filled,421,427,O
with,428,432,O
tumours,433,440,B-Pathological_formation
were,441,445,O
enucleated,446,456,O
",",456,457,O
and,458,461,O
the,462,465,O
less,466,470,O
advanced,471,479,O
cases,480,485,O
were,486,490,O
treated,491,498,O
with,499,503,O
combined,504,512,O
methods,513,520,O
applying,521,529,O
radiation,530,539,O
with,540,544,O
60Co,545,549,O
plaques,550,557,O
with,558,562,O
xenon,563,568,O
arc,569,572,O
photocoagulation,573,589,O
",",589,590,O
cryopexy,591,599,O
",",599,600,O
and,601,604,O
chemotherapy,605,617,O
.,617,618,O
In,619,621,O
18,622,624,O
treated,625,632,O
children,633,641,O
23,642,644,O
eyes,645,649,B-Organ
were,650,654,O
enucleated,655,665,O
(,666,667,O
in,667,669,O
5,670,671,O
children,672,680,O
both,681,685,O
eyes,686,690,B-Organ
",",690,691,O
in,692,694,O
6,695,696,O
children,697,705,O
with,706,710,O
bilateral,711,720,O
retinoblastoma,721,735,B-Pathological_formation
1,736,737,O
eye,738,741,B-Organ
",",741,742,O
and,743,746,O
7,747,748,O
eyes,749,753,B-Organ
in,754,756,O
all,757,760,O
unilateral,761,771,O
cases,772,777,O
),777,778,O
.,778,779,O
Six,780,783,O
eyes,784,788,B-Organ
with,789,793,O
less,794,798,O
advanced,799,807,O
lesions,808,815,B-Pathological_formation
were,816,820,O
treated,821,828,O
with,829,833,O
combined,834,842,O
methods,843,850,O
.,850,851,O
One,852,855,O
child,856,861,O
died,862,866,O
because,867,874,O
of,875,877,O
metastases,878,888,B-Pathological_formation
to,889,891,O
the,892,895,O
brain,896,901,B-Organ
.,901,902,O
The,903,906,O
obtained,907,915,O
data,916,920,O
reveal,921,927,O
that,928,932,O
retinoblastoma,933,947,B-Pathological_formation
is,948,950,O
diagnosed,951,960,O
too,961,964,O
late,965,969,O
",",969,970,O
which,971,976,O
decreases,977,986,O
the,987,990,O
chance,991,997,O
of,998,1000,O
cure,1001,1005,O
and,1006,1009,O
causes,1010,1016,O
great,1017,1022,O
danger,1023,1029,O
for,1030,1033,O
the,1034,1037,O
life,1038,1042,O
of,1043,1045,O
the,1046,1049,O
child,1050,1055,O
.,1055,1056,O
Epilepsy,0,8,O
in,9,11,O
Down,12,16,O
syndrome,17,25,O
:,25,26,O
clinical,27,35,O
aspects,36,43,O
and,44,47,O
possible,48,56,O
mechanisms,57,67,O
.,67,68,O
Although,69,77,O
epilepsy,78,86,O
is,87,89,O
more,90,94,O
common,95,101,O
in,102,104,O
persons,105,112,O
with,113,117,O
trisomy,118,125,O
21,126,128,O
(,129,130,O
Down,130,134,O
syndrome,135,143,O
),143,144,O
than,145,149,O
in,150,152,O
the,153,156,O
general,157,164,O
population,165,175,O
",",175,176,O
the,177,180,O
mechanisms,181,191,O
by,192,194,O
which,195,200,O
seizures,201,209,O
are,210,213,O
generated,214,223,O
in,224,226,O
this,227,231,O
population,232,242,O
have,243,247,O
received,248,256,O
little,257,263,O
attention,264,273,O
.,273,274,O
It,275,277,O
is,278,280,O
likely,281,287,O
that,288,292,O
this,293,297,O
increased,298,307,O
seizure,308,315,O
susceptibility,316,330,O
is,331,333,O
due,334,337,O
to,338,340,O
a,341,342,O
combination,343,354,O
of,355,357,O
medical,358,365,O
risk,366,370,O
factors,371,378,O
and,379,382,O
inherent,383,391,O
neurologic,392,402,B-Anatomical_system
abnormalities,403,416,O
characteristic,417,431,O
of,432,434,O
Down,435,439,O
syndrome,440,448,O
.,448,449,O
In,450,452,O
this,453,457,O
review,458,464,O
clinical,465,473,O
aspects,474,481,O
of,482,484,O
seizures,485,493,O
among,494,499,O
individuals,500,511,O
with,512,516,O
Down,517,521,O
syndrome,522,530,O
were,531,535,O
described,536,545,O
and,546,549,O
possible,550,558,O
mechanisms,559,569,O
by,570,572,O
which,573,578,O
the,579,582,O
trisomy,583,590,O
21,591,593,O
brain,594,599,B-Organ
may,600,603,O
generate,604,612,O
seizures,613,621,O
were,622,626,O
explored,627,635,O
.,635,636,O
Chelation,0,9,O
treatment,10,19,O
of,20,22,O
neurological,23,35,B-Anatomical_system
Wilson,36,42,O
',42,43,O
s,43,44,O
disease,45,52,O
.,52,53,O
The,54,57,O
results,58,65,O
of,66,68,O
chelation,69,78,O
treatment,79,88,O
of,89,91,O
137,92,95,O
patients,96,104,O
presenting,105,115,O
with,116,120,O
neurological,121,133,B-Anatomical_system
Wilson,134,140,O
',140,141,O
s,141,142,O
disease,143,150,O
are,151,154,O
described,155,164,O
",",164,165,O
together,166,174,O
with,175,179,O
the,180,183,O
more,184,188,O
commonly,189,197,O
observed,198,206,O
toxic,207,212,O
reactions,213,222,O
to,223,225,O
the,226,229,O
various,230,237,O
drugs,238,243,O
employed,244,252,O
.,252,253,O
Fifty,254,259,O
-,259,260,O
seven,260,265,O
patients,266,274,O
made,275,279,O
an,280,282,O
excellent,283,292,O
response,293,301,O
to,302,304,O
treatment,305,314,O
and,315,318,O
became,319,325,O
symptom,326,333,O
free,334,338,O
.,338,339,O
Thirty,340,346,O
-,346,347,O
six,347,350,O
patients,351,359,O
made,360,364,O
a,365,366,O
good,367,371,O
recovery,372,380,O
",",380,381,O
but,382,385,O
were,386,390,O
left,391,395,O
with,396,400,O
some,401,405,O
minor,406,411,O
neurological,412,424,B-Anatomical_system
deficit,425,432,O
.,432,433,O
Twenty,434,440,O
-,440,441,O
four,441,445,O
patients,446,454,O
had,455,458,O
a,459,460,O
poor,461,465,O
response,466,474,O
:,474,475,O
although,476,484,O
the,485,488,O
disease,489,496,O
process,497,504,O
was,505,508,O
arrested,509,517,O
they,518,522,O
were,523,527,O
left,528,532,O
more,533,537,O
or,538,540,O
less,541,545,O
disabled,546,554,O
.,554,555,O
Twenty,556,562,O
patients,563,571,O
died,572,576,O
:,576,577,O
nine,578,582,O
had,583,586,O
little,587,593,O
or,594,596,O
no,597,599,O
treatment,600,609,O
",",609,610,O
but,611,614,O
11,615,617,O
died,618,622,O
despite,623,630,O
apparently,631,641,O
adequate,642,650,O
chelation,651,660,O
therapy,661,668,O
.,668,669,O
There,670,675,O
was,676,679,O
no,680,682,O
obvious,683,690,O
reason,691,697,O
for,698,701,O
this,702,706,O
failure,707,714,O
.,714,715,O
The,716,719,O
liver,720,725,B-Organ
copper,726,732,O
level,733,738,O
was,739,742,O
estimated,743,752,O
in,753,755,O
six,756,759,O
of,760,762,O
these,763,768,O
patients,769,777,O
:,777,778,O
it,779,781,O
was,782,785,O
still,786,791,O
significantly,792,805,O
elevated,806,814,O
in,815,817,O
only,818,822,O
one,823,826,O
",",826,827,O
but,828,831,O
in,832,834,O
all,835,838,O
four,839,843,O
in,844,846,O
whom,847,851,O
it,852,854,O
was,855,858,O
possible,859,867,O
to,868,870,O
make,871,875,O
the,876,879,O
determination,880,893,O
",",893,894,O
the,895,898,O
concentration,899,912,O
of,913,915,O
copper,916,922,O
in,923,925,O
the,926,929,O
basal,930,935,B-Multi-tissue_structure
ganglia,936,943,I-Multi-tissue_structure
was,944,947,O
in,948,950,O
excess,951,957,O
of,958,960,O
45,961,963,O
micrograms,964,974,O
/,974,975,O
g,975,976,O
wet,977,980,O
weight,981,987,O
.,987,988,O
It,989,991,O
was,992,995,O
not,996,999,O
apparent,1000,1008,O
why,1009,1012,O
adequate,1013,1021,O
therapy,1022,1029,O
failed,1030,1036,O
to,1037,1039,O
remove,1040,1046,O
copper,1047,1053,O
from,1054,1058,O
the,1059,1062,O
brains,1063,1069,B-Organ
of,1070,1072,O
these,1073,1078,O
patients,1079,1087,O
.,1087,1088,O
There,1089,1094,O
was,1095,1098,O
no,1099,1101,O
obvious,1102,1109,O
clinical,1110,1118,O
",",1118,1119,O
histological,1120,1132,O
or,1133,1135,O
biochemical,1136,1147,O
indicator,1148,1157,O
of,1158,1160,O
failure,1161,1168,O
to,1169,1171,O
respond,1172,1179,O
to,1180,1182,O
treatment,1183,1192,O
.,1192,1193,O
Initial,1194,1201,O
deterioration,1202,1215,O
before,1216,1222,O
improvement,1223,1234,O
was,1235,1238,O
seen,1239,1243,O
in,1244,1246,O
30,1247,1249,O
patients,1250,1258,O
:,1258,1259,O
the,1260,1263,O
prognosis,1264,1273,O
for,1274,1277,O
a,1278,1279,O
useful,1280,1286,O
recovery,1287,1295,O
was,1296,1299,O
not,1300,1303,O
necessarily,1304,1315,O
worse,1316,1321,O
than,1322,1326,O
that,1327,1331,O
in,1332,1334,O
patients,1335,1343,O
who,1344,1347,O
did,1348,1351,O
not,1352,1355,O
show,1356,1360,O
this,1361,1365,O
phenomenon,1366,1376,O
.,1376,1377,O
[,0,1,O
Prehospital,1,12,O
service,13,20,O
in,21,23,O
Denmark,24,31,O
],31,32,O
.,32,33,O
In,34,36,O
Denmark,37,44,O
",",44,45,O
emergency,46,55,O
ambulances,56,66,O
are,67,70,O
dispatched,71,81,O
by,82,84,O
41,85,87,O
centres,88,95,O
manned,96,102,O
either,103,109,O
by,110,112,O
trained,113,120,O
firemen,121,128,O
(,129,130,O
in,130,132,O
Copenhagen,133,143,O
),143,144,O
or,145,147,O
policemen,148,157,O
(,158,159,O
outside,159,166,O
Copenhagen,167,177,O
),177,178,O
.,178,179,O
In,180,182,O
1990,183,187,O
",",187,188,O
emergency,189,198,O
ambulance,199,208,O
calls,209,214,O
totalled,215,223,O
284,224,227,O
",",227,228,O
000,228,231,O
.,231,232,O
Utilisation,233,244,O
of,245,247,O
emergency,248,257,O
ambulance,258,267,O
services,268,276,O
increases,277,286,O
with,287,291,O
urbanisation,292,304,O
.,304,305,O
A,306,307,O
doctor,308,314,O
-,314,315,O
manned,315,321,O
ambulance,322,331,O
is,332,334,O
in,335,337,O
operation,338,347,O
in,348,350,O
Copenhagen,351,361,O
",",361,362,O
and,363,366,O
in,367,369,O
some,370,374,O
other,375,380,O
large,381,386,O
towns,387,392,O
anaesthesiology,393,408,O
and,409,412,O
intensive,413,422,O
care,423,427,O
teams,428,433,O
can,434,437,O
be,438,440,O
dispatched,441,451,O
from,452,456,O
hospital,457,465,O
to,466,468,O
give,469,473,O
on,474,476,O
-,476,477,O
the,477,480,O
-,480,481,O
spot,481,485,O
care,486,490,O
.,490,491,O
In,492,494,O
less,495,499,O
populated,500,509,O
areas,510,515,O
",",515,516,O
some,517,521,O
general,522,529,O
practitioners,530,543,O
give,544,548,O
advanced,549,557,O
life,558,562,O
-,562,563,O
support,563,570,O
.,570,571,O
Although,572,580,O
many,581,585,O
areas,586,591,O
are,592,595,O
serviced,596,604,O
by,605,607,O
ambulances,608,618,O
equipped,619,627,O
with,628,632,O
defibrillators,633,647,O
",",647,648,O
the,649,652,O
majority,653,661,O
of,662,664,O
patients,665,673,O
receive,674,681,O
only,682,686,O
basic,687,692,O
life,693,697,O
-,697,698,O
support,698,705,O
from,706,710,O
ambulance,711,720,O
personnel,721,730,O
.,730,731,O
New,732,735,O
initiatives,736,747,O
resulting,748,757,O
from,758,762,O
a,763,764,O
recent,765,771,O
report,772,778,O
by,779,781,O
a,782,783,O
commission,784,794,O
appointed,795,804,O
by,805,807,O
central,808,815,O
authorities,816,827,O
",",827,828,O
and,829,832,O
focused,833,840,O
on,841,843,O
prehospital,844,855,O
treatment,856,865,O
",",865,866,O
are,867,870,O
expected,871,879,O
to,880,882,O
improve,883,890,O
the,891,894,O
service,895,902,O
by,903,905,O
raising,906,913,O
the,914,917,O
level,918,923,O
of,924,926,O
training,927,935,O
given,936,941,O
to,942,944,O
ambulance,945,954,O
personnel,955,964,O
.,964,965,O
Cell,0,4,B-Cellular_component
surface,5,12,I-Cellular_component
binding,13,20,O
characteristics,21,36,O
correlate,37,46,O
with,47,51,O
consensus,52,61,O
type,62,66,O
I,67,68,O
interferon,69,79,O
enhanced,80,88,O
activity,89,97,O
.,97,98,O
The,99,102,O
binding,103,110,O
characteristics,111,126,O
of,127,129,O
a,130,131,O
genetically,132,143,O
engineered,144,154,O
consensus,155,164,O
interferon,165,175,O
with,176,180,O
unusually,181,190,O
high,191,195,O
biologic,196,204,O
activity,205,213,O
were,214,218,O
compared,219,227,O
to,228,230,O
the,231,234,O
characteristics,235,250,O
of,251,253,O
recombinant,254,265,O
interferon,266,276,O
-,276,277,O
alpha,277,282,O
2,283,284,O
.,284,285,O
Both,286,290,O
interferon,291,301,O
-,301,302,O
alpha,302,307,O
2,308,309,O
and,310,313,O
the,314,317,O
consensus,318,327,O
interferon,328,338,O
produced,339,347,O
typical,348,355,O
biphasic,356,364,O
Scatchard,365,374,O
plots,375,380,O
",",380,381,O
indicating,382,392,O
multiple,393,401,O
independent,402,413,O
binding,414,421,O
sites,422,427,O
.,427,428,O
The,429,432,O
consensus,433,442,O
interferon,443,453,O
",",453,454,O
which,455,460,O
exhibited,461,470,O
a,471,472,O
biologic,473,481,O
potency,482,489,O
more,490,494,O
than,495,499,O
10,500,502,O
-,502,503,O
fold,503,507,O
greater,508,515,O
than,516,520,O
all,521,524,O
other,525,530,O
type,531,535,O
I,536,537,O
interferons,538,549,O
",",549,550,O
also,551,555,O
exhibited,556,565,O
binding,566,573,O
site,574,578,O
affinities,579,589,O
greater,590,597,O
than,598,602,O
those,603,608,O
for,609,612,O
IFN,613,616,O
-,616,617,O
alpha,617,622,O
2b,623,625,O
.,625,626,O
In,627,629,O
addition,630,638,O
",",638,639,O
a,640,641,O
larger,642,648,O
number,649,655,O
of,656,658,O
high,659,663,O
",",663,664,O
and,665,668,O
low,669,672,O
-,672,673,O
affinity,673,681,O
cell,682,686,B-Cellular_component
surface,687,694,I-Cellular_component
sites,695,700,O
were,701,705,O
recognized,706,716,O
by,717,719,O
the,720,723,O
consensus,724,733,O
interferon,734,744,O
",",744,745,O
resulting,746,755,O
in,756,758,O
equivalent,759,769,O
numbers,770,777,O
of,778,780,O
sites,781,786,O
at,787,789,O
reduced,790,797,O
molar,798,803,O
concentrations,804,818,O
compared,819,827,O
to,828,830,O
IFN,831,834,O
-,834,835,O
a2b,835,838,O
.,838,839,O
Thus,840,844,O
",",844,845,O
at,846,848,O
any,849,852,O
given,853,858,O
biologic,859,867,O
activity,868,876,O
",",876,877,O
similar,878,885,O
numbers,886,893,O
of,894,896,O
sites,897,902,O
were,903,907,O
bound,908,913,O
by,914,916,O
the,917,920,O
consensus,921,930,O
interferon,931,941,O
and,942,945,O
IFN,946,949,O
-,949,950,O
alpha,950,955,O
2,956,957,O
",",957,958,O
despite,959,966,O
differences,967,978,O
in,979,981,O
their,982,987,O
molar,988,993,O
concentrations,994,1008,O
.,1008,1009,O
No,1010,1012,O
differences,1013,1024,O
in,1025,1027,O
internalization,1028,1043,O
kinetics,1044,1052,O
were,1053,1057,O
identified,1058,1068,O
between,1069,1076,O
the,1077,1080,O
two,1081,1084,O
interferons,1085,1096,O
",",1096,1097,O
indicating,1098,1108,O
that,1109,1113,O
the,1114,1117,O
differences,1118,1129,O
in,1130,1132,O
cell,1133,1137,B-Cellular_component
surface,1138,1145,I-Cellular_component
binding,1146,1153,O
may,1154,1157,O
be,1158,1160,O
sufficient,1161,1171,O
to,1172,1174,O
produce,1175,1182,O
the,1183,1186,O
differences,1187,1198,O
in,1199,1201,O
biologic,1202,1210,O
activity,1211,1219,O
.,1219,1220,O
Human,0,5,O
immunodeficiency,6,22,O
virus,23,28,O
type,29,33,O
1,34,35,O
viral,36,41,O
background,42,52,O
plays,53,58,O
a,59,60,O
major,61,66,O
role,67,71,O
in,72,74,O
development,75,86,O
of,87,89,O
resistance,90,100,O
to,101,103,O
protease,104,112,O
inhibitors,113,123,O
.,123,124,O
The,125,128,O
observed,129,137,O
in,138,140,O
vitro,141,146,O
and,147,150,O
in,151,153,O
vivo,154,158,O
benefit,159,166,O
of,167,169,O
combination,170,181,O
treatment,182,191,O
with,192,196,O
anti,197,201,O
-,201,202,O
human,202,207,O
immunodeficiency,208,224,O
virus,225,230,O
(,231,232,O
HIV,232,235,O
),235,236,O
agents,237,243,O
prompted,244,252,O
us,253,255,O
to,256,258,O
examine,259,266,O
the,267,270,O
potential,271,280,O
of,281,283,O
resistance,284,294,O
development,295,306,O
when,307,311,O
two,312,315,O
protease,316,324,O
inhibitors,325,335,O
are,336,339,O
used,340,344,O
concurrently,345,357,O
.,357,358,O
Recombinant,359,370,O
HIV,371,374,O
-,374,375,O
1,375,376,O
(,377,378,O
NL4,378,381,O
-,381,382,O
3,382,383,O
),383,384,O
proteases,385,394,O
containing,395,405,O
combined,406,414,O
resistance,415,425,O
mutations,426,435,O
associated,436,446,O
with,447,451,O
BMS,452,455,O
-,455,456,O
186318,456,462,O
and,463,466,O
A,467,468,O
-,468,469,O
77003,469,474,O
(,475,476,O
or,476,478,O
saquinavir,479,489,O
),489,490,O
were,491,495,O
either,496,502,O
inactive,503,511,O
or,512,514,O
had,515,518,O
impaired,519,527,O
enzyme,528,534,O
activity,535,543,O
.,543,544,O
Subsequent,545,555,O
construction,556,568,O
of,569,571,O
HIV,572,575,O
-,575,576,O
1,576,577,O
(,578,579,O
NL4,579,582,O
-,582,583,O
3,583,584,O
),584,585,O
proviral,586,594,O
clones,595,601,O
containing,602,612,O
the,613,616,O
same,617,621,O
mutations,622,631,O
yielded,632,639,O
viruses,640,647,O
that,648,652,O
were,653,657,O
severely,658,666,O
impaired,667,675,O
in,676,678,O
growth,679,685,O
or,686,688,O
nonviable,689,698,O
",",698,699,O
confirming,700,710,O
that,711,715,O
combination,716,727,O
therapy,728,735,O
may,736,739,O
be,740,742,O
advantageous,743,755,O
.,755,756,O
However,757,764,O
",",764,765,O
passage,766,773,O
of,774,776,O
BMS,777,780,O
-,780,781,O
186318,781,787,O
-,787,788,O
resistant,788,797,O
HIV,798,801,O
-,801,802,O
1,802,803,O
(,804,805,O
RF,805,807,O
),807,808,O
in,809,811,O
the,812,815,O
presence,816,824,O
of,825,827,O
either,828,834,O
saquinavir,835,845,O
or,846,848,O
SC52151,849,856,O
",",856,857,O
which,858,863,O
represented,864,875,O
sequential,876,886,O
drug,887,891,O
treatment,892,901,O
",",901,902,O
produced,903,911,O
viable,912,918,O
viruses,919,926,O
resistant,927,936,O
to,937,939,O
both,940,944,O
BMS,945,948,O
-,948,949,O
186318,949,955,O
and,956,959,O
the,960,963,O
second,964,970,O
compound,971,979,O
.,979,980,O
The,981,984,O
predominant,985,996,O
breakthrough,997,1009,O
virus,1010,1015,O
contained,1016,1025,O
the,1026,1029,O
G48V,1030,1034,O
/,1034,1035,O
A71T,1035,1039,O
/,1039,1040,O
V82A,1040,1044,O
protease,1045,1053,O
mutations,1054,1063,O
.,1063,1064,O
The,1065,1068,O
clone,1069,1074,O
-,1074,1075,O
purified,1075,1083,O
RF,1084,1086,O
(,1087,1088,O
G48V,1088,1092,O
/,1092,1093,O
A71T,1093,1097,O
/,1097,1098,O
V82A,1098,1102,O
),1102,1103,O
virus,1104,1109,O
",",1109,1110,O
unlike,1111,1117,O
the,1118,1121,O
corresponding,1122,1135,O
defective,1136,1145,O
NL4,1146,1149,O
-,1149,1150,O
3,1150,1151,O
triple,1152,1158,O
mutant,1159,1165,O
",",1165,1166,O
grew,1167,1171,O
well,1172,1176,O
and,1177,1180,O
displayed,1181,1190,O
cross,1191,1196,O
-,1196,1197,O
resistance,1197,1207,O
to,1208,1210,O
four,1211,1215,O
distinct,1216,1224,O
protease,1225,1233,O
inhibitors,1234,1244,O
.,1244,1245,O
Chimeric,1246,1254,O
virus,1255,1260,O
and,1261,1264,O
in,1265,1267,O
vitro,1268,1273,O
mutagenesis,1274,1285,O
studies,1286,1293,O
indicated,1294,1303,O
that,1304,1308,O
the,1309,1312,O
RF,1313,1315,O
-,1315,1316,O
specific,1316,1324,O
protease,1325,1333,O
sequence,1334,1342,O
",",1342,1343,O
specifically,1344,1356,O
the,1357,1360,O
Ile,1361,1364,O
at,1365,1367,O
residue,1368,1375,O
10,1376,1378,O
",",1378,1379,O
enabled,1380,1387,O
the,1388,1391,O
NL4,1392,1395,O
-,1395,1396,O
3,1396,1397,O
strain,1398,1404,O
with,1405,1409,O
the,1410,1413,O
triple,1414,1420,O
mutant,1421,1427,O
to,1428,1430,O
grow,1431,1435,O
.,1435,1436,O
Our,1437,1440,O
results,1441,1448,O
clearly,1449,1456,O
indicate,1457,1465,O
that,1466,1470,O
viral,1471,1476,O
genetic,1477,1484,O
background,1485,1495,O
will,1496,1500,O
play,1501,1505,O
a,1506,1507,O
key,1508,1511,O
role,1512,1516,O
in,1517,1519,O
determining,1520,1531,O
whether,1532,1539,O
cross,1540,1545,O
-,1545,1546,O
resistance,1546,1556,O
variants,1557,1565,O
will,1566,1570,O
arise,1571,1576,O
.,1576,1577,O
Referral,0,8,O
bias,9,13,O
among,14,19,O
health,20,26,O
workers,27,34,O
in,35,37,O
studies,38,45,O
using,46,51,O
hospitalization,52,67,O
as,68,70,O
a,71,72,O
proxy,73,78,O
measure,79,86,O
of,87,89,O
the,90,93,O
underlying,94,104,O
incidence,105,114,O
rate,115,119,O
.,119,120,O
Contacts,121,129,O
with,130,134,O
health,135,141,O
services,142,150,O
like,151,155,O
hospitals,156,165,O
or,166,168,O
general,169,176,O
practitioners,177,190,O
are,191,194,O
usually,195,202,O
the,203,206,O
only,207,211,O
available,212,221,O
proxy,222,227,O
measure,228,235,O
of,236,238,O
incidence,239,248,O
of,249,251,O
disease,252,259,O
in,260,262,O
studies,263,270,O
based,271,276,O
on,277,279,O
secondary,280,289,O
data,290,294,O
and,295,298,O
differential,299,311,O
referrals,312,321,O
or,322,324,O
care,325,329,O
-,329,330,O
seeking,330,337,O
behavior,338,346,O
often,347,352,O
bias,353,357,O
such,358,362,O
proxy,363,368,O
measures,369,377,O
.,377,378,O
In,379,381,O
former,382,388,O
analyses,389,397,O
based,398,403,O
on,404,406,O
the,407,410,O
Occupational,411,423,O
Hospitalization,424,439,O
Register,440,448,O
in,449,451,O
Denmark,452,459,O
assisting,460,469,O
nurses,470,476,O
had,477,480,O
high,481,485,O
Standardized,486,498,O
Hospitalization,499,514,O
Ratios,515,521,O
for,522,525,O
many,526,530,O
diseases,531,539,O
.,539,540,O
It,541,543,O
was,544,547,O
",",547,548,O
however,549,556,O
",",556,557,O
suspected,558,567,O
that,568,572,O
it,573,575,O
fully,576,581,O
or,582,584,O
partly,585,591,O
was,592,595,O
due,596,599,O
to,600,602,O
a,603,604,O
referral,605,613,O
bias,614,618,O
or,619,621,O
self,622,626,O
-,626,627,O
selection,627,636,O
to,637,639,O
hospital,640,648,O
treatment,649,658,O
rather,659,665,O
than,666,670,O
exposures,671,680,O
to,681,683,O
occupational,684,696,O
hazards,697,704,O
.,704,705,O
The,706,709,O
aim,710,713,O
of,714,716,O
the,717,720,O
present,721,728,O
study,729,734,O
is,735,737,O
to,738,740,O
evaluate,741,749,O
the,750,753,O
referral,754,762,O
bias,763,767,O
hypothesis,768,778,O
by,779,781,O
comparing,782,791,O
hospitalization,792,807,O
and,808,811,O
mortality,812,821,O
data,822,826,O
for,827,830,O
health,831,837,O
workers,838,845,O
for,846,849,O
a,850,851,O
disease,852,859,O
category,860,868,O
with,869,873,O
a,874,875,O
high,876,880,O
mortality,881,890,O
.,890,891,O
Cohorts,892,899,O
of,900,902,O
all,903,906,O
gainfully,907,916,O
employed,917,925,O
20,926,928,O
-,928,929,O
to,930,932,O
59,933,935,O
-,935,936,O
year,936,940,O
-,940,941,O
old,941,944,O
Danes,945,950,O
were,951,955,O
formed,956,962,O
in,963,965,O
order,966,971,O
to,972,974,O
compare,975,982,O
Standardized,983,995,O
Mortality,996,1005,O
Ratios,1006,1012,O
and,1013,1016,O
Standardized,1017,1029,O
Hospitalization,1030,1045,O
Ratios,1046,1052,O
of,1053,1055,O
ischemic,1056,1064,O
heart,1065,1070,B-Organ
disease,1071,1078,O
(,1079,1080,O
IHD,1080,1083,O
),1083,1084,O
in,1085,1087,O
occupational,1088,1100,O
groups,1101,1107,O
.,1107,1108,O
The,1109,1112,O
follow,1113,1119,O
-,1119,1120,O
up,1120,1122,O
period,1123,1129,O
was,1130,1133,O
10,1134,1136,O
years,1137,1142,O
.,1142,1143,O
For,1144,1147,O
most,1148,1152,O
of,1153,1155,O
the,1156,1159,O
investigated,1160,1172,O
occupational,1173,1185,O
groups,1186,1192,O
a,1193,1194,O
similar,1195,1202,O
disease,1203,1210,O
pattern,1211,1218,O
was,1219,1222,O
found,1223,1228,O
whether,1229,1236,O
hospitalization,1237,1252,O
or,1253,1255,O
death,1256,1261,O
was,1262,1265,O
used,1266,1270,O
as,1271,1273,O
the,1274,1277,O
outcome,1278,1285,O
measure,1286,1293,O
.,1293,1294,O
In,1295,1297,O
"""",1298,1299,O
nurse,1299,1304,O
assistants,1305,1315,O
"""",1315,1316,O
a,1317,1318,O
statistically,1319,1332,O
significant,1333,1344,O
higher,1345,1351,O
risk,1352,1356,O
was,1357,1360,O
",",1360,1361,O
however,1362,1369,O
",",1369,1370,O
found,1371,1376,O
using,1377,1382,O
hospitalization,1383,1398,O
due,1399,1402,O
to,1403,1405,O
IHD,1406,1409,O
as,1410,1412,O
the,1413,1416,O
end,1417,1420,O
point,1421,1426,O
rather,1427,1433,O
than,1434,1438,O
mortality,1439,1448,O
.,1448,1449,O
Additional,1450,1460,O
analysis,1461,1469,O
did,1470,1473,O
not,1474,1477,O
support,1478,1485,O
the,1486,1489,O
hypothesis,1490,1500,O
that,1501,1505,O
the,1506,1509,O
finding,1510,1517,O
could,1518,1523,O
be,1524,1526,O
explained,1527,1536,O
by,1537,1539,O
differentiated,1540,1554,O
hospitalization,1555,1570,O
due,1571,1574,O
to,1575,1577,O
social,1578,1584,O
factors,1585,1592,O
.,1592,1593,O
The,1594,1597,O
true,1598,1602,O
incidence,1603,1612,O
rates,1613,1618,O
of,1619,1621,O
the,1622,1625,O
disease,1626,1633,O
need,1634,1638,O
not,1639,1642,O
be,1643,1645,O
equally,1646,1653,O
well,1654,1658,O
described,1659,1668,O
by,1669,1671,O
proxy,1672,1677,O
measures,1678,1686,O
such,1687,1691,O
as,1692,1694,O
hospitalization,1695,1710,O
diagnosis,1711,1720,O
or,1721,1723,O
death,1724,1729,O
diagnosis,1730,1739,O
in,1740,1742,O
all,1743,1746,O
occupational,1747,1759,O
groups,1760,1766,O
.,1766,1767,O
Differential,1768,1780,O
access,1781,1787,O
to,1788,1790,O
medical,1791,1798,O
treatment,1799,1808,O
in,1809,1811,O
some,1812,1816,O
groups,1817,1823,O
may,1824,1827,O
lead,1828,1832,O
to,1833,1835,O
bias,1836,1840,O
when,1841,1845,O
hospital,1846,1854,O
data,1855,1859,O
are,1860,1863,O
used,1864,1868,O
as,1869,1871,O
proxy,1872,1877,O
measures,1878,1886,O
for,1887,1890,O
the,1891,1894,O
underlying,1895,1905,O
incidence,1906,1915,O
rates,1916,1921,O
.,1921,1922,O
Induction,0,9,O
of,10,12,O
p18INK4c,13,21,O
and,22,25,O
its,26,29,O
predominant,30,41,O
association,42,53,O
with,54,58,O
CDK4,59,63,O
and,64,67,O
CDK6,68,72,O
during,73,79,O
myogenic,80,88,O
differentiation,89,104,O
.,104,105,O
Terminal,106,114,O
cell,115,119,B-Cell
differentiation,120,135,O
involves,136,144,O
permanent,145,154,O
withdrawal,155,165,O
from,166,170,O
the,171,174,O
cell,175,179,B-Cell
division,180,188,O
cycle,189,194,O
.,194,195,O
The,196,199,O
inhibitors,200,210,O
of,211,213,O
cyclin,214,220,O
-,220,221,O
dependent,221,230,O
kinases,231,238,O
(,239,240,O
CDKs,240,244,O
),244,245,O
are,246,249,O
potential,250,259,O
molecules,260,269,O
functioning,270,281,O
to,282,284,O
couple,285,291,O
cell,292,296,B-Cell
cycle,297,302,O
arrest,303,309,O
and,310,313,O
cell,314,318,B-Cell
differentiation,319,334,O
.,334,335,O
In,336,338,O
murine,339,345,O
C2C12,346,351,B-Cell
myoblast,352,360,I-Cell
cells,361,366,I-Cell
",",366,367,O
G1,368,370,O
CDK,371,374,O
enzymes,375,382,O
(,383,384,O
CDK2,384,388,O
",",388,389,O
CDK4,390,394,O
",",394,395,O
and,396,399,O
CDK6,400,404,O
),404,405,O
associate,406,415,O
with,416,420,O
four,421,425,O
CDK,426,429,O
inhibitors,430,440,O
:,440,441,O
p18INK4c,442,450,O
",",450,451,O
p19INK4d,452,460,O
",",460,461,O
p21,462,465,O
",",465,466,O
and,467,470,O
p27Kip1,471,478,O
.,478,479,O
During,480,486,O
induced,487,494,O
myogenesis,495,505,O
",",505,506,O
p21,507,510,O
and,511,514,O
its,515,518,O
associated,519,529,O
CDK,530,533,O
proteins,534,542,O
underwent,543,552,O
an,553,555,O
initial,556,563,O
increase,564,572,O
followed,573,581,O
by,582,584,O
a,585,586,O
decrease,587,595,O
as,596,598,O
cells,599,604,B-Cell
became,605,611,O
terminally,612,622,O
differentiated,623,637,O
.,637,638,O
The,639,642,O
level,643,648,O
of,649,651,O
p27,652,655,O
protein,656,663,O
gradually,664,673,O
increased,674,683,O
",",683,684,O
but,685,688,O
the,689,692,O
amount,693,699,O
of,700,702,O
total,703,708,O
associated,709,719,O
CDK,720,723,O
proteins,724,732,O
remained,733,741,O
unchanged,742,751,O
.,751,752,O
p19,753,756,O
protein,757,764,O
decreased,765,774,O
gradually,775,784,O
during,785,791,O
differentiation,792,807,O
",",807,808,O
as,809,811,O
did,812,815,O
its,816,819,O
associated,820,830,O
CDK4,831,835,O
protein,836,843,O
.,843,844,O
In,845,847,O
contrast,848,856,O
",",856,857,O
p18,858,861,O
protein,862,869,O
increased,870,879,O
50,880,882,O
-,882,883,O
fold,883,887,O
",",887,888,O
from,889,893,O
negligible,894,904,O
levels,905,911,O
in,912,914,O
proliferating,915,928,O
myoblasts,929,938,B-Cell
to,939,941,O
clearly,942,949,O
detectable,950,960,O
levels,961,967,O
within,968,974,O
8,975,976,O
-,976,977,O
12,977,979,O
h,980,981,O
of,982,984,O
myogenic,985,993,O
induction,994,1003,O
.,1003,1004,O
This,1005,1009,O
initial,1010,1017,O
rise,1018,1022,O
was,1023,1026,O
followed,1027,1035,O
by,1036,1038,O
a,1039,1040,O
precipitous,1041,1052,O
increase,1053,1061,O
between,1062,1069,O
12,1070,1072,O
and,1073,1076,O
24,1077,1079,O
h,1080,1081,O
postinduction,1082,1095,O
",",1095,1096,O
with,1097,1101,O
p18,1102,1105,O
protein,1106,1113,O
finally,1114,1121,O
accumulating,1122,1134,O
to,1135,1137,O
its,1138,1141,O
highest,1142,1149,O
level,1150,1155,O
in,1156,1158,O
terminally,1159,1169,O
differentiated,1170,1184,O
cells,1185,1190,B-Cell
.,1190,1191,O
Induction,1192,1201,O
of,1202,1204,O
p18,1205,1208,O
correlated,1209,1219,O
with,1220,1224,O
increased,1225,1234,O
and,1235,1238,O
sequential,1239,1249,O
complex,1250,1257,O
formation,1258,1267,O
-,1267,1268,O
-,1268,1269,O
first,1269,1274,O
increasing,1275,1285,O
association,1286,1297,O
with,1298,1302,O
CDK6,1303,1307,O
and,1308,1311,O
then,1312,1316,O
with,1317,1321,O
CDK4,1322,1326,O
over,1327,1331,O
the,1332,1335,O
course,1336,1342,O
of,1343,1345,O
myogenic,1346,1354,O
differentiation,1355,1370,O
.,1370,1371,O
All,1372,1375,O
of,1376,1378,O
the,1379,1382,O
CDK6,1383,1387,O
and,1388,1391,O
half,1392,1396,O
of,1397,1399,O
the,1400,1403,O
CDK4,1404,1408,O
were,1409,1413,O
complexed,1414,1423,O
with,1424,1428,O
p18,1429,1432,O
in,1433,1435,O
terminally,1436,1446,O
differentiated,1447,1461,O
C2C12,1462,1467,B-Cell
cells,1468,1473,I-Cell
as,1474,1476,O
well,1477,1481,O
as,1482,1484,O
in,1485,1487,O
adult,1488,1493,O
mouse,1494,1499,O
muscle,1500,1506,B-Tissue
tissue,1507,1513,I-Tissue
.,1513,1514,O
Finally,1515,1522,O
",",1522,1523,O
kinase,1524,1530,O
activity,1531,1539,O
of,1540,1542,O
CDK2,1543,1547,O
and,1548,1551,O
CDK4,1552,1556,O
decreases,1557,1566,O
as,1567,1569,O
C2C12,1570,1575,B-Cell
cells,1576,1581,I-Cell
differentiate,1582,1595,O
",",1595,1596,O
whereas,1597,1604,O
the,1605,1608,O
CDK6,1609,1613,O
kinase,1614,1620,O
activity,1621,1629,O
is,1630,1632,O
low,1633,1636,O
in,1637,1639,O
both,1640,1644,O
proliferating,1645,1658,O
myoblasts,1659,1668,B-Cell
and,1669,1672,O
differentiated,1673,1687,O
myotubes,1688,1696,B-Tissue
.,1696,1697,O
Our,1698,1701,O
results,1702,1709,O
indicate,1710,1718,O
that,1719,1723,O
p18,1724,1727,O
may,1728,1731,O
play,1732,1736,O
a,1737,1738,O
critical,1739,1747,O
role,1748,1752,O
in,1753,1755,O
causing,1756,1763,O
and,1764,1767,O
/,1767,1768,O
or,1768,1770,O
maintaining,1771,1782,O
permanent,1783,1792,O
cell,1793,1797,B-Cell
cycle,1798,1803,O
arrest,1804,1810,O
associated,1811,1821,O
with,1822,1826,O
mature,1827,1833,O
muscle,1834,1840,B-Tissue
formation,1841,1850,O
.,1850,1851,O
Functional,0,10,O
model,11,16,O
of,17,19,O
benign,20,26,O
paroxysmal,27,37,O
positional,38,48,O
vertigo,49,56,O
using,57,62,O
an,63,65,O
isolated,66,74,O
frog,75,79,O
semicircular,80,92,B-Multi-tissue_structure
canal,93,98,I-Multi-tissue_structure
.,98,99,O
Bull,100,104,O
frogs,105,110,O
posterior,111,120,B-Multi-tissue_structure
semicircular,121,133,I-Multi-tissue_structure
canals,134,140,I-Multi-tissue_structure
(,141,142,O
psc,142,145,B-Multi-tissue_structure
),145,146,O
wee,147,150,O
used,151,155,O
to,156,158,O
simulate,159,167,O
the,168,171,O
condition,172,181,O
of,182,184,O
benign,185,191,O
paroxysmal,192,202,O
positional,203,213,O
vertigo,214,221,O
(,222,223,O
BPPV,223,227,O
),227,228,O
.,228,229,O
The,230,233,O
psc,234,237,B-Multi-tissue_structure
was,238,241,O
isolated,242,250,O
in,251,253,O
frog,254,258,O
Ringer,259,265,O
',265,266,O
s,266,267,O
solution,268,276,O
",",276,277,O
and,278,281,O
the,282,285,O
saccular,286,294,B-Organism_substance
otoconia,295,303,I-Organism_substance
were,304,308,O
used,309,313,O
as,314,316,O
a,317,318,O
responsible,319,330,O
material,331,339,O
to,340,342,O
stimulate,343,352,O
the,353,356,O
cupula,357,363,B-Multi-tissue_structure
.,363,364,O
When,365,369,O
the,370,373,O
otoconia,374,382,B-Organism_substance
were,383,387,O
placed,388,394,O
on,395,397,O
the,398,401,O
cupular,402,409,B-Multi-tissue_structure
surface,410,417,I-Multi-tissue_structure
to,418,420,O
mimic,421,426,O
the,427,430,O
condition,431,440,O
of,441,443,O
cupulolithiasis,444,459,O
",",459,460,O
the,461,464,O
psc,465,468,B-Multi-tissue_structure
ampullary,469,478,I-Multi-tissue_structure
nerve,479,484,I-Multi-tissue_structure
action,485,491,O
potentials,492,502,O
instantaneously,503,518,O
changed,519,526,O
according,527,536,O
to,537,539,O
the,540,543,O
direction,544,553,O
of,554,556,O
the,557,560,O
gravity,561,568,O
produced,569,577,O
by,578,580,O
otoconia,581,589,B-Organism_substance
.,589,590,O
When,591,595,O
the,596,599,O
otoconia,600,608,B-Organism_substance
were,609,613,O
dropped,614,621,O
into,622,626,O
the,627,630,O
canal,631,636,B-Multi-tissue_structure
to,637,639,O
mimic,640,645,O
the,646,649,O
condition,650,659,O
of,660,662,O
moving,663,669,O
otoconia,670,678,B-Organism_substance
in,679,681,O
the,682,685,O
canal,686,691,B-Multi-tissue_structure
",",691,692,O
the,693,696,O
action,697,703,O
potentials,704,714,O
changed,715,722,O
together,723,731,O
with,732,736,O
the,737,740,O
otoconial,741,750,B-Organism_substance
flow,751,755,O
after,756,761,O
a,762,763,O
latent,764,770,O
period,771,777,O
.,777,778,O
Both,779,783,O
cupulolithiasis,784,799,O
and,800,803,O
moving,804,810,O
otoconia,811,819,B-Organism_substance
are,820,823,O
possibly,824,832,O
valid,833,838,O
mechanisms,839,849,O
of,850,852,O
BPPV,853,857,O
",",857,858,O
since,859,864,O
they,865,869,O
effectively,870,881,O
stimulate,882,891,O
the,892,895,O
cupula,896,902,B-Multi-tissue_structure
.,902,903,O
However,904,911,O
",",911,912,O
moving,913,919,O
otoconia,920,928,B-Organism_substance
with,929,933,O
a,934,935,O
latent,936,942,O
period,943,949,O
would,950,955,O
better,956,962,O
explain,963,970,O
clinical,971,979,O
features,980,988,O
of,989,991,O
BPPV,992,996,O
.,996,997,O
[,0,1,O
Considerations,1,15,O
regarding,16,25,O
two,26,29,O
cases,30,35,O
of,36,38,O
macromastia,39,50,O
(,51,52,O
author,52,58,O
',58,59,O
s,59,60,O
transl,61,67,O
),67,68,O
],68,69,O
.,69,70,O
Two,71,74,O
cases,75,80,O
of,81,83,O
macromastia,84,95,O
have,96,100,O
been,101,105,O
shown,106,111,O
;,111,112,O
one,113,116,O
which,117,122,O
appeared,123,131,O
during,132,138,O
puberty,139,146,O
",",146,147,O
the,148,151,O
other,152,157,O
during,158,164,O
menopause,165,174,O
.,174,175,O
Histopathological,176,193,O
examination,194,205,O
has,206,209,O
demonstrated,210,222,O
for,223,226,O
the,227,230,O
both,231,235,O
cases,236,241,O
a,242,243,O
cystic,244,250,O
degeneracy,251,261,O
of,262,264,O
the,265,268,O
glandular,269,278,B-Tissue
tissue,279,285,I-Tissue
with,286,290,O
a,291,292,O
hyperplazia,293,304,O
and,305,308,O
hypertrophy,309,320,O
of,321,323,O
the,324,327,O
conjunctive,328,339,B-Tissue
tissue,340,346,I-Tissue
.,346,347,O
The,348,351,O
pathogeny,352,361,O
of,362,364,O
macromastia,365,376,O
is,377,379,O
being,380,385,O
discussed,386,395,O
and,396,399,O
it,400,402,O
is,403,405,O
demonstrated,406,418,O
both,419,423,O
the,424,427,O
role,428,432,O
of,433,435,O
hypophysis,436,446,O
hormones,447,455,O
(,456,457,O
prolactine,457,467,O
and,468,471,O
growth,472,478,O
hormone,479,486,O
),486,487,O
and,488,491,O
of,492,494,O
ovarian,495,502,B-Organ
hormones,503,511,O
(,512,513,O
estrogens,513,522,O
),522,523,O
.,523,524,O
The,525,528,O
treatment,529,538,O
was,539,542,O
surgical,543,551,O
for,552,555,O
the,556,559,O
both,560,564,O
cases,565,570,O
.,570,571,O
Procedural,0,10,O
memory,11,17,O
stimulation,18,29,O
in,30,32,O
Alzheimer,33,42,O
',42,43,O
s,43,44,O
disease,45,52,O
:,52,53,O
impact,54,60,O
of,61,63,O
a,64,65,O
training,66,74,O
programme,75,84,O
.,84,85,O
The,86,89,O
study,90,95,O
evaluates,96,105,O
the,106,109,O
efficacy,110,118,O
of,119,121,O
a,122,123,O
procedural,124,134,O
memory,135,141,O
stimulation,142,153,O
programme,154,163,O
in,164,166,O
mild,167,171,O
and,172,175,O
mild,176,180,O
-,180,181,O
moderate,181,189,O
Alzheimer,190,199,O
',199,200,O
s,200,201,O
disease,202,209,O
(,210,211,O
AD,211,213,O
),213,214,O
.,214,215,O
Twenty,216,222,O
basic,223,228,O
and,229,232,O
instrumental,233,245,O
activities,246,256,O
of,257,259,O
daily,260,265,O
living,266,272,O
have,273,277,O
been,278,282,O
selected,283,291,O
",",291,292,O
and,293,296,O
divided,297,304,O
into,305,309,O
two,310,313,O
groups,314,320,O
",",320,321,O
comparable,322,332,O
for,333,336,O
difficulty,337,347,O
.,347,348,O
Ten,349,352,O
normal,353,359,O
elderly,360,367,O
subjects,368,376,O
(,377,378,O
age,378,381,O
68,382,384,O
.,384,385,O
0,385,386,O
+,387,388,O
/,388,389,O
-,389,390,O
4,391,392,O
.,392,393,O
8,393,394,O
years,395,400,O
;,400,401,O
MMSE,402,406,O
score,407,412,O
:,412,413,O
28,414,416,O
.,416,417,O
7,417,418,O
+,419,420,O
/,420,421,O
-,421,422,O
0,423,424,O
.,424,425,O
9,425,426,O
;,426,427,O
education,428,437,O
:,437,438,O
7,439,440,O
.,440,441,O
6,441,442,O
+,443,444,O
/,444,445,O
-,445,446,O
3,447,448,O
.,448,449,O
5,449,450,O
years,451,456,O
),456,457,O
were,458,462,O
asked,463,468,O
to,469,471,O
perform,472,479,O
the,480,483,O
two,484,487,O
groups,488,494,O
of,495,497,O
daily,498,503,O
activities,504,514,O
and,515,518,O
the,519,522,O
time,523,527,O
required,528,536,O
to,537,539,O
perform,540,547,O
the,548,551,O
tasks,552,557,O
of,558,560,O
each,561,565,O
group,566,571,O
was,572,575,O
recorded,576,584,O
and,585,588,O
used,589,593,O
as,594,596,O
a,597,598,O
reference,599,608,O
.,608,609,O
Ten,610,613,O
mild,614,618,O
and,619,622,O
mild,623,627,O
-,627,628,O
moderate,628,636,O
AD,637,639,O
patients,640,648,O
(,649,650,O
age,650,653,O
77,654,656,O
.,656,657,O
2,657,658,O
+,659,660,O
/,660,661,O
-,661,662,O
5,663,664,O
.,664,665,O
3,665,666,O
years,667,672,O
;,672,673,O
MMSE,674,678,O
score,679,684,O
:,684,685,O
19,686,688,O
.,688,689,O
8,689,690,O
+,691,692,O
/,692,693,O
-,693,694,O
3,695,696,O
.,696,697,O
5,697,698,O
;,698,699,O
education,700,709,O
:,709,710,O
7,711,712,O
.,712,713,O
3,713,714,O
+,715,716,O
/,716,717,O
-,717,718,O
4,719,720,O
.,720,721,O
7,721,722,O
years,723,728,O
),728,729,O
without,730,737,O
major,738,743,O
behavioural,744,755,O
disturbances,756,768,O
constituted,769,780,O
the,781,784,O
experimental,785,797,O
group,798,803,O
.,803,804,O
Patients,805,813,O
were,814,818,O
evaluated,819,828,O
in,829,831,O
all,832,835,O
20,836,838,O
daily,839,844,O
activities,845,855,O
and,856,859,O
the,860,863,O
time,864,868,O
employed,869,877,O
was,878,881,O
recorded,882,890,O
at,891,893,O
baseline,894,902,O
and,903,906,O
after,907,912,O
a,913,914,O
3,915,916,O
-,916,917,O
week,917,921,O
training,922,930,O
(,931,932,O
1,932,933,O
h,934,935,O
/,935,936,O
d,936,937,O
",",937,938,O
5,939,940,O
d,941,942,O
/,942,943,O
week,943,947,O
),947,948,O
period,949,955,O
.,955,956,O
Five,957,961,O
patients,962,970,O
were,971,975,O
trained,976,983,O
during,984,990,O
the,991,994,O
3,995,996,O
weeks,997,1002,O
on,1003,1005,O
half,1006,1010,O
of,1011,1013,O
the,1014,1017,O
20,1018,1020,O
daily,1021,1026,O
activities,1027,1037,O
and,1038,1041,O
the,1042,1045,O
other,1046,1051,O
five,1052,1056,O
patients,1057,1065,O
were,1066,1070,O
trained,1071,1078,O
on,1079,1081,O
the,1082,1085,O
remainder,1086,1095,O
.,1095,1096,O
This,1097,1101,O
procedure,1102,1111,O
was,1112,1115,O
adopted,1116,1123,O
in,1124,1126,O
order,1127,1132,O
to,1133,1135,O
detect,1136,1142,O
separately,1143,1153,O
the,1154,1157,O
improvement,1158,1169,O
in,1170,1172,O
"""",1173,1174,O
trained,1174,1181,O
"""",1181,1182,O
and,1183,1186,O
"""",1187,1188,O
not,1188,1191,O
trained,1192,1199,O
"""",1199,1200,O
activities,1201,1211,O
",",1211,1212,O
allowing,1213,1221,O
to,1222,1224,O
control,1225,1232,O
better,1233,1239,O
the,1240,1243,O
effects,1244,1251,O
of,1252,1254,O
the,1255,1258,O
intervention,1259,1271,O
.,1271,1272,O
The,1273,1276,O
assessment,1277,1287,O
of,1288,1290,O
the,1291,1294,O
functional,1295,1305,O
impact,1306,1312,O
of,1313,1315,O
the,1316,1319,O
training,1320,1328,O
was,1329,1332,O
directly,1333,1341,O
measured,1342,1350,O
",",1350,1351,O
through,1352,1359,O
the,1360,1363,O
variation,1364,1373,O
of,1374,1376,O
time,1377,1381,O
employed,1382,1390,O
to,1391,1393,O
perform,1394,1401,O
tasks,1402,1407,O
before,1408,1414,O
and,1415,1418,O
after,1419,1424,O
training,1425,1433,O
.,1433,1434,O
After,1435,1440,O
3,1441,1442,O
weeks,1443,1448,O
of,1449,1451,O
training,1452,1460,O
a,1461,1462,O
significant,1463,1474,O
improvement,1475,1486,O
was,1487,1490,O
observed,1491,1499,O
for,1500,1503,O
the,1504,1507,O
trained,1508,1515,O
activities,1516,1526,O
",",1526,1527,O
from,1528,1532,O
3,1533,1534,O
.,1534,1535,O
6,1535,1536,O
to,1537,1539,O
1,1540,1541,O
.,1541,1542,O
9,1542,1543,O
standard,1544,1552,O
deviations,1553,1563,O
below,1564,1569,O
the,1570,1573,O
performance,1574,1585,O
of,1586,1588,O
the,1589,1592,O
normal,1593,1599,O
elderly,1600,1607,O
controls,1608,1616,O
(,1617,1618,O
P,1618,1619,O
<,1620,1621,O
0,1622,1623,O
.,1623,1624,O
05,1624,1626,O
),1626,1627,O
.,1627,1628,O
AD,1629,1631,O
patients,1632,1640,O
improved,1641,1649,O
also,1650,1654,O
in,1655,1657,O
not,1658,1661,O
-,1661,1662,O
trained,1662,1669,O
activities,1670,1680,O
from,1681,1685,O
3,1686,1687,O
.,1687,1688,O
5,1688,1689,O
to,1690,1692,O
2,1693,1694,O
.,1694,1695,O
7,1695,1696,O
standard,1697,1705,O
deviations,1706,1716,O
below,1717,1722,O
the,1723,1726,O
controls,1727,1735,O
',1735,1736,O
performance,1737,1748,O
(,1749,1750,O
P,1750,1751,O
<,1752,1753,O
0,1754,1755,O
.,1755,1756,O
05,1756,1758,O
),1758,1759,O
.,1759,1760,O
The,1761,1764,O
rehabilitation,1765,1779,O
of,1780,1782,O
activities,1783,1793,O
of,1794,1796,O
daily,1797,1802,O
living,1803,1809,O
through,1810,1817,O
developing,1818,1828,O
procedural,1829,1839,O
memory,1840,1846,O
strategies,1847,1857,O
may,1858,1861,O
be,1862,1864,O
effective,1865,1874,O
in,1875,1877,O
mild,1878,1882,O
and,1883,1886,O
mild,1887,1891,O
-,1891,1892,O
moderate,1892,1900,O
AD,1901,1903,O
patients,1904,1912,O
.,1912,1913,O
Some,0,4,O
findings,5,13,O
concerning,14,24,O
beliefs,25,32,O
about,33,38,O
alcoholism,39,49,O
.,49,50,O
The,51,54,O
beliefs,55,62,O
that,63,67,O
alcoholics,68,78,O
hold,79,83,O
about,84,89,O
alcoholism,90,100,O
and,101,104,O
themselves,105,115,O
",",115,116,O
and,117,120,O
the,121,124,O
beliefs,125,132,O
that,133,137,O
hospital,138,146,O
staff,147,152,O
and,153,156,O
other,157,162,O
personnel,163,172,O
hold,173,177,O
about,178,183,O
alcoholism,184,194,O
",",194,195,O
were,196,200,O
investigated,201,213,O
using,214,219,O
methods,220,227,O
derived,228,235,O
from,236,240,O
the,241,244,O
repertory,245,254,O
grid,255,259,O
",",259,260,O
with,261,265,O
anonymous,266,275,O
facial,276,282,B-Organism_subdivision
photographs,283,294,O
as,295,297,O
elements,298,306,O
.,306,307,O
Data,308,312,O
are,313,316,O
presented,317,326,O
as,327,329,O
to,330,332,O
the,333,336,O
degree,337,343,O
of,344,346,O
association,347,358,O
of,359,361,O
various,362,369,O
characteristics,370,385,O
with,386,390,O
alcoholism,391,401,O
for,402,405,O
the,406,409,O
various,410,417,O
groups,418,424,O
.,424,425,O
Differences,426,437,O
between,438,445,O
groups,446,452,O
",",452,453,O
and,454,457,O
overall,458,465,O
changes,466,473,O
during,474,480,O
group,481,486,O
psychotherapy,487,500,O
for,501,504,O
patients,505,513,O
were,514,518,O
small,519,524,O
.,524,525,O
The,526,529,O
relative,530,538,O
contribution,539,551,O
of,552,554,O
personal,555,563,O
and,564,567,O
shared,568,574,O
aspects,575,582,O
of,583,585,O
belief,586,592,O
was,593,596,O
measured,597,605,O
.,605,606,O
It,607,609,O
was,610,613,O
found,614,619,O
that,620,624,O
the,625,628,O
agreement,629,638,O
between,639,646,O
groups,647,653,O
was,654,657,O
high,658,662,O
and,663,666,O
closely,667,674,O
similar,675,682,O
to,683,685,O
that,686,690,O
predictable,691,702,O
from,703,707,O
consistencies,708,721,O
within,722,728,O
groups,729,735,O
.,735,736,O
It,737,739,O
is,740,742,O
concluded,743,752,O
that,753,757,O
there,758,763,O
may,764,767,O
be,768,770,O
a,771,772,O
very,773,777,O
general,778,785,O
stereotype,786,796,O
of,797,799,O
alcoholism,800,810,O
",",810,811,O
consistent,812,822,O
with,823,827,O
a,828,829,O
personality,830,841,O
disorder,842,850,O
concept,851,858,O
which,859,864,O
is,865,867,O
implicitly,868,878,O
held,879,883,O
even,884,888,O
in,889,891,O
the,892,895,O
face,896,900,O
of,901,903,O
nominal,904,911,O
acceptance,912,922,O
of,923,925,O
other,926,931,O
concepts,932,940,O
.,940,941,O
The,942,945,O
self,946,950,O
constructs,951,961,O
of,962,964,O
alcoholics,965,975,O
were,976,980,O
found,981,986,O
to,987,989,O
be,990,992,O
complex,993,1000,O
.,1000,1001,O
In,1002,1004,O
a,1005,1006,O
small,1007,1012,O
follow,1013,1019,O
-,1019,1020,O
up,1020,1022,O
study,1023,1028,O
of,1029,1031,O
patients,1032,1040,O
",",1040,1041,O
there,1042,1047,O
was,1048,1051,O
found,1052,1057,O
to,1058,1060,O
be,1061,1063,O
a,1064,1065,O
relationship,1066,1078,O
of,1079,1081,O
poor,1082,1086,O
outcome,1087,1094,O
with,1095,1099,O
tightness,1100,1109,O
of,1110,1112,O
construing,1113,1123,O
for,1124,1127,O
key,1128,1131,O
constructs,1132,1142,O
after,1143,1148,O
psychotherapy,1149,1162,O
.,1162,1163,O
The,1164,1167,O
implications,1168,1180,O
of,1181,1183,O
the,1184,1187,O
findings,1188,1196,O
are,1197,1200,O
discussed,1201,1210,O
briefly,1211,1218,O
.,1218,1219,O
Monitoring,0,10,O
the,11,14,O
efficiency,15,25,O
of,26,28,O
interferon,29,39,O
-,39,40,O
alpha,40,45,O
therapy,46,53,O
in,54,56,O
chronic,57,64,O
myelogenous,65,76,O
leukemia,77,85,O
(,86,87,O
CML,87,90,O
),90,91,O
patients,92,100,O
by,101,103,O
competitive,104,115,O
polymerase,116,126,O
chain,127,132,O
reaction,133,141,O
.,141,142,O
Interferon,143,153,O
alpha,154,159,O
(,160,161,O
IFN,161,164,O
-,164,165,O
alpha,165,170,O
),170,171,O
induces,172,179,O
cytogenetic,180,191,O
responses,192,201,O
of,202,204,O
variable,205,213,O
degree,214,220,O
in,221,223,O
patients,224,232,O
with,233,237,O
CML,238,241,O
.,241,242,O
We,243,245,O
sought,246,252,O
to,253,255,O
establish,256,265,O
the,266,269,O
relationship,270,282,O
between,283,290,O
BCR,291,294,O
-,294,295,O
ABL,295,298,O
transcript,299,309,O
numbers,310,317,O
measured,318,326,O
by,327,329,O
competitive,330,341,O
two,342,345,O
-,345,346,O
step,346,350,O
reverse,351,358,O
transcription,359,372,O
polymerase,373,383,O
chain,384,389,O
reaction,390,398,O
(,399,400,O
RT,400,402,O
-,402,403,O
PCR,403,406,O
),406,407,O
and,408,411,O
cytogenetic,412,423,O
status,424,430,O
in,431,433,O
CML,434,437,O
patients,438,446,O
treated,447,454,O
with,455,459,O
IFN,460,463,O
-,463,464,O
alpha,464,469,O
.,469,470,O
All,471,474,O
398,475,478,O
samples,479,486,O
from,487,491,O
163,492,495,O
patients,496,504,O
investigated,505,517,O
by,518,520,O
RT,521,523,O
-,523,524,O
PCR,524,527,O
were,528,532,O
positive,533,541,O
for,542,545,O
BCR,546,549,O
-,549,550,O
ABL,550,553,O
transcripts,554,565,O
.,565,566,O
In,567,569,O
order,570,575,O
to,576,578,O
standardize,579,590,O
results,591,598,O
for,599,602,O
variability,603,614,O
in,615,617,O
RNA,618,621,O
and,622,625,O
cDNA,626,630,O
quality,631,638,O
",",638,639,O
we,640,642,O
quantified,643,653,O
total,654,659,O
ABL,660,663,O
transcripts,664,675,O
in,676,678,O
each,679,683,O
sample,684,690,O
as,691,693,O
internal,694,702,O
control,703,710,O
.,710,711,O
The,712,715,O
BCR,716,719,O
-,719,720,O
ABL,720,723,O
/,723,724,O
ABL,724,727,O
ratios,728,734,O
correlated,735,745,O
with,746,750,O
the,751,754,O
cytogenetic,755,766,O
results,767,774,O
.,774,775,O
Quantitative,776,788,O
nested,789,795,O
PCR,796,799,O
allowed,800,807,O
the,808,811,O
detection,812,821,O
of,822,824,O
residual,825,833,O
BCR,834,837,O
-,837,838,O
ABL,838,841,O
transcripts,842,853,O
in,854,856,O
all,857,860,O
complete,861,869,O
cytogenetic,870,881,O
responders,882,892,O
on,893,895,O
IFN,896,899,O
-,899,900,O
alpha,900,905,O
.,905,906,O
We,907,909,O
conclude,910,918,O
that,919,923,O
competitive,924,935,O
PCR,936,939,O
with,940,944,O
internal,945,953,O
controls,954,962,O
is,963,965,O
a,966,967,O
reliable,968,976,O
method,977,983,O
for,984,987,O
monitoring,988,998,O
patients,999,1007,O
on,1008,1010,O
IFN,1011,1014,O
-,1014,1015,O
alpha,1015,1020,O
and,1021,1024,O
reduces,1025,1032,O
the,1033,1036,O
need,1037,1041,O
for,1042,1045,O
repeated,1046,1054,O
marrow,1055,1061,B-Multi-tissue_structure
investigations,1062,1076,O
.,1076,1077,O
[,0,1,O
Treatment,1,10,O
of,11,13,O
acute,14,19,O
liver,20,25,B-Organ
failure,26,33,O
in,34,36,O
children,37,45,O
],45,46,O
.,46,47,O
Among,48,53,O
the,54,57,O
main,58,62,O
causes,63,69,O
of,70,72,O
acute,73,78,O
liver,79,84,B-Organ
failure,85,92,O
(,93,94,O
ALF,94,97,O
),97,98,O
in,99,101,O
children,102,110,O
",",110,111,O
metabolic,112,121,O
diseases,122,130,O
(,131,132,O
especially,132,142,O
in,143,145,O
infants,146,153,O
),153,154,O
",",154,155,O
viral,156,161,O
and,162,165,O
toxin,166,171,O
or,172,174,O
drug,175,179,O
induced,180,187,O
hepatitis,188,197,O
are,198,201,O
the,202,205,O
most,206,210,O
frequent,211,219,O
.,219,220,O
The,221,224,O
cause,225,230,O
remains,231,238,O
",",238,239,O
however,240,247,O
",",247,248,O
undetermined,249,261,O
in,262,264,O
about,265,270,O
30,271,273,O
%,273,274,O
of,275,277,O
the,278,281,O
cases,282,287,O
.,287,288,O
Management,289,299,O
must,300,304,O
be,305,307,O
conducted,308,317,O
in,318,320,O
a,321,322,O
pediatric,323,332,O
hepatology,333,343,O
unit,344,348,O
or,349,351,O
intensive,352,361,O
care,362,366,O
unit,367,371,O
in,372,374,O
relation,375,383,O
with,384,388,O
a,389,390,O
pediatric,391,400,O
transplant,401,411,O
team,412,416,O
in,417,419,O
order,420,425,O
:,425,426,O
1,427,428,O
),428,429,O
to,430,432,O
perform,433,440,O
urgent,441,447,O
etiological,448,459,O
diagnosis,460,469,O
;,469,470,O
2,471,472,O
),472,473,O
to,474,476,O
initiate,477,485,O
specific,486,494,O
therapy,495,502,O
and,503,506,O
symptomatic,507,518,O
treatment,519,528,O
;,528,529,O
3,530,531,O
),531,532,O
to,533,535,O
evaluate,536,544,O
the,545,548,O
severity,549,557,O
and,558,561,O
prognosis,562,571,O
of,572,574,O
liver,575,580,B-Organ
disease,581,588,O
for,589,592,O
selection,593,602,O
of,603,605,O
children,606,614,O
for,615,618,O
emergency,619,628,O
liver,629,634,B-Organ
transplantation,635,650,O
;,650,651,O
4,652,653,O
),653,654,O
to,655,657,O
evaluate,658,666,O
contraindications,667,684,O
to,685,687,O
liver,688,693,B-Organ
transplantation,694,709,O
.,709,710,O
The,711,714,O
overall,715,722,O
survival,723,731,O
of,732,734,O
post,735,739,O
-,739,740,O
emergency,740,749,O
liver,750,755,B-Organ
transplantation,756,771,O
for,772,775,O
ALF,776,779,O
in,780,782,O
children,783,791,O
averages,792,800,O
65,801,803,O
%,803,804,O
.,804,805,O
Blind,0,5,O
separation,6,16,O
of,17,19,O
auditory,20,28,O
event,29,34,O
-,34,35,O
related,35,42,O
brain,43,48,B-Organ
responses,49,58,O
into,59,63,O
independent,64,75,O
components,76,86,O
.,86,87,O
Averaged,88,96,O
event,97,102,O
-,102,103,O
related,103,110,O
potential,111,120,O
(,121,122,O
ERP,122,125,O
),125,126,O
data,127,131,O
recorded,132,140,O
from,141,145,O
the,146,149,O
human,150,155,O
scalp,156,161,B-Multi-tissue_structure
reveal,162,168,O
electroencephalographic,169,192,O
(,193,194,O
EEG,194,197,O
),197,198,O
activity,199,207,O
that,208,212,O
is,213,215,O
reliably,216,224,O
time,225,229,O
-,229,230,O
locked,230,236,O
and,237,240,O
phase,241,246,O
-,246,247,O
locked,247,253,O
to,254,256,O
experimental,257,269,O
events,270,276,O
.,276,277,O
We,278,280,O
report,281,287,O
here,288,292,O
the,293,296,O
application,297,308,O
of,309,311,O
a,312,313,O
method,314,320,O
based,321,326,O
on,327,329,O
information,330,341,O
theory,342,348,O
that,349,353,O
decomposes,354,364,O
one,365,368,O
or,369,371,O
more,372,376,O
ERPs,377,381,O
recorded,382,390,O
at,391,393,O
multiple,394,402,O
scalp,403,408,B-Multi-tissue_structure
sensors,409,416,O
into,417,421,O
a,422,423,O
sum,424,427,O
of,428,430,O
components,431,441,O
with,442,446,O
fixed,447,452,O
scalp,453,458,B-Multi-tissue_structure
distributions,459,472,O
and,473,476,O
sparsely,477,485,O
activated,486,495,O
",",495,496,O
maximally,497,506,O
independent,507,518,O
time,519,523,O
courses,524,531,O
.,531,532,O
Independent,533,544,O
component,545,554,O
analysis,555,563,O
(,564,565,O
ICA,565,568,O
),568,569,O
decomposes,570,580,O
ERP,581,584,O
data,585,589,O
into,590,594,O
a,595,596,O
number,597,603,O
of,604,606,O
components,607,617,O
equal,618,623,O
to,624,626,O
the,627,630,O
number,631,637,O
of,638,640,O
sensors,641,648,O
.,648,649,O
The,650,653,O
derived,654,661,O
components,662,672,O
have,673,677,O
distinct,678,686,O
but,687,690,O
not,691,694,O
necessarily,695,706,O
orthogonal,707,717,O
scalp,718,723,B-Multi-tissue_structure
projections,724,735,O
.,735,736,O
Unlike,737,743,O
dipole,744,750,O
-,750,751,O
fitting,751,758,O
methods,759,766,O
",",766,767,O
the,768,771,O
algorithm,772,781,O
does,782,786,O
not,787,790,O
model,791,796,O
the,797,800,O
locations,801,810,O
of,811,813,O
their,814,819,O
generators,820,830,O
in,831,833,O
the,834,837,O
head,838,842,B-Organism_subdivision
.,842,843,O
Unlike,844,850,O
methods,851,858,O
that,859,863,O
remove,864,870,O
second,871,877,O
-,877,878,O
order,878,883,O
correlations,884,896,O
",",896,897,O
such,898,902,O
as,903,905,O
principal,906,915,O
component,916,925,O
analysis,926,934,O
(,935,936,O
PCA,936,939,O
),939,940,O
",",940,941,O
ICA,942,945,O
also,946,950,O
minimizes,951,960,O
higher,961,967,O
-,967,968,O
order,968,973,O
dependencies,974,986,O
.,986,987,O
Applied,988,995,O
to,996,998,O
detected,999,1007,O
-,1007,1008,O
and,1008,1011,O
undetected,1012,1022,O
-,1022,1023,O
target,1023,1029,O
ERPs,1030,1034,O
from,1035,1039,O
an,1040,1042,O
auditory,1043,1051,O
vigilance,1052,1061,O
experiment,1062,1072,O
",",1072,1073,O
the,1074,1077,O
algorithm,1078,1087,O
derived,1088,1095,O
ten,1096,1099,O
components,1100,1110,O
that,1111,1115,O
decomposed,1116,1126,O
each,1127,1131,O
of,1132,1134,O
the,1135,1138,O
major,1139,1144,O
response,1145,1153,O
peaks,1154,1159,O
into,1160,1164,O
one,1165,1168,O
or,1169,1171,O
more,1172,1176,O
ICA,1177,1180,O
components,1181,1191,O
with,1192,1196,O
relatively,1197,1207,O
simple,1208,1214,O
scalp,1215,1220,B-Multi-tissue_structure
distributions,1221,1234,O
.,1234,1235,O
Three,1236,1241,O
of,1242,1244,O
these,1245,1250,O
components,1251,1261,O
were,1262,1266,O
active,1267,1273,O
only,1274,1278,O
when,1279,1283,O
the,1284,1287,O
subject,1288,1295,O
detected,1296,1304,O
the,1305,1308,O
targets,1309,1316,O
",",1316,1317,O
three,1318,1323,O
other,1324,1329,O
components,1330,1340,O
only,1341,1345,O
when,1346,1350,O
the,1351,1354,O
target,1355,1361,O
went,1362,1366,O
undetected,1367,1377,O
",",1377,1378,O
and,1379,1382,O
one,1383,1386,O
in,1387,1389,O
both,1390,1394,O
cases,1395,1400,O
.,1400,1401,O
Three,1402,1407,O
additional,1408,1418,O
components,1419,1429,O
accounted,1430,1439,O
for,1440,1443,O
the,1444,1447,O
steady,1448,1454,O
-,1454,1455,O
state,1455,1460,O
brain,1461,1466,B-Organ
response,1467,1475,O
to,1476,1478,O
a,1479,1480,O
39,1481,1483,O
-,1483,1484,O
Hz,1484,1486,O
background,1487,1497,O
click,1498,1503,O
train,1504,1509,O
.,1509,1510,O
Major,1511,1516,O
features,1517,1525,O
of,1526,1528,O
the,1529,1532,O
decomposition,1533,1546,O
proved,1547,1553,O
robust,1554,1560,O
across,1561,1567,O
sessions,1568,1576,O
and,1577,1580,O
changes,1581,1588,O
in,1589,1591,O
sensor,1592,1598,O
number,1599,1605,O
and,1606,1609,O
placement,1610,1619,O
.,1619,1620,O
This,1621,1625,O
method,1626,1632,O
of,1633,1635,O
ERP,1636,1639,O
analysis,1640,1648,O
can,1649,1652,O
be,1653,1655,O
used,1656,1660,O
to,1661,1663,O
compare,1664,1671,O
responses,1672,1681,O
from,1682,1686,O
multiple,1687,1695,O
stimuli,1696,1703,O
",",1703,1704,O
task,1705,1709,O
conditions,1710,1720,O
",",1720,1721,O
and,1722,1725,O
subject,1726,1733,O
states,1734,1740,O
.,1740,1741,O
[,0,1,O
Extra,1,6,O
-,6,7,O
anatomic,7,15,O
bypass,16,22,O
from,23,27,O
the,28,31,O
ascending,32,41,B-Multi-tissue_structure
aorta,42,47,I-Multi-tissue_structure
to,48,50,O
the,51,54,O
supraceliac,55,66,O
abdominal,67,76,B-Multi-tissue_structure
aorta,77,82,I-Multi-tissue_structure
-,82,83,O
-,83,84,O
surgical,84,92,O
option,93,99,O
applied,100,107,O
to,108,110,O
reoperation,111,122,O
for,123,126,O
aortic,127,133,B-Multi-tissue_structure
coarctation,134,145,O
or,146,148,O
interruption,149,161,O
],161,162,O
.,162,163,O
The,164,167,O
optimal,168,175,O
approach,176,184,O
for,185,188,O
reoperation,189,200,O
following,201,210,O
repair,211,217,O
of,218,220,O
aortic,221,227,B-Multi-tissue_structure
coarctation,228,239,O
(,240,241,O
CoA,241,244,O
),244,245,O
or,246,248,O
interruption,249,261,O
(,262,263,O
IAA,263,266,O
),266,267,O
remains,268,275,O
controversial,276,289,O
.,289,290,O
Four,291,295,O
patients,296,304,O
underwent,305,314,O
extra,315,320,O
-,320,321,O
anatomic,321,329,O
bypass,330,336,O
for,337,340,O
restenosis,341,351,O
after,352,357,O
repair,358,364,O
of,365,367,O
CoA,368,371,O
or,372,374,O
IAA,375,378,O
.,378,379,O
The,380,383,O
age,384,387,O
ranged,388,394,O
from,395,399,O
4,400,401,O
to,402,404,O
12,405,407,O
years,408,413,O
.,413,414,O
The,415,418,O
initial,419,426,O
repairs,427,434,O
for,435,438,O
two,439,442,O
CoA,443,446,O
",",446,447,O
one,448,451,O
type,452,456,O
A,457,458,O
-,458,459,O
IAA,459,462,O
",",462,463,O
and,464,467,O
one,468,471,O
type,472,476,O
B,477,478,O
-,478,479,O
IAA,479,482,O
consisted,483,492,O
of,493,495,O
two,496,499,O
grafting,500,508,O
",",508,509,O
one,510,513,O
subclavian,514,524,O
arterial,525,533,B-Multi-tissue_structure
turning,534,541,O
-,541,542,O
down,542,546,O
aortoplasty,547,558,O
",",558,559,O
and,560,563,O
one,564,567,O
subclavian,568,578,O
flap,579,583,B-Multi-tissue_structure
aortoplasty,584,595,O
.,595,596,O
All,597,600,O
of,601,603,O
them,604,608,O
underwent,609,618,O
during,619,625,O
infancy,626,633,O
.,633,634,O
Preoperative,635,647,O
right,648,653,B-Organism_subdivision
arm,654,657,I-Organism_subdivision
systolic,658,666,O
pressure,667,675,O
ranged,676,682,O
from,683,687,O
140,688,691,O
to,692,694,O
190,695,698,O
mmHg,699,703,O
ar,704,706,O
rest,707,711,O
.,711,712,O
Through,713,720,O
a,721,722,O
midline,723,730,O
sternotomy,731,741,O
and,742,745,O
an,746,748,O
upper,749,754,O
laparotmy,755,764,O
incision,765,773,O
",",773,774,O
an,775,777,O
extra,778,783,O
-,783,784,O
anatomic,784,792,O
bypass,793,799,O
from,800,804,O
the,805,808,O
ascending,809,818,B-Multi-tissue_structure
aorta,819,824,I-Multi-tissue_structure
to,825,827,O
the,828,831,O
supraceliac,832,843,O
abdominal,844,853,B-Multi-tissue_structure
aorta,854,859,I-Multi-tissue_structure
was,860,863,O
employed,864,872,O
using,873,878,O
a,879,880,O
12,881,883,O
to,884,886,O
18,887,889,O
mm,890,892,O
tube,893,897,O
graft,898,903,O
.,903,904,O
All,905,908,O
patients,909,917,O
survived,918,926,O
surgeries,927,936,O
",",936,937,O
and,938,941,O
their,942,947,O
hypertension,948,960,O
markedly,961,969,O
improved,970,978,O
.,978,979,O
Our,980,983,O
experience,984,994,O
confirms,995,1003,O
safety,1004,1010,O
and,1011,1014,O
effectiveness,1015,1028,O
of,1029,1031,O
this,1032,1036,O
option,1037,1043,O
in,1044,1046,O
selected,1047,1055,O
young,1056,1061,O
patients,1062,1070,O
with,1071,1075,O
re,1076,1078,O
-,1078,1079,O
stenosis,1079,1087,O
of,1088,1090,O
following,1091,1100,O
repair,1101,1107,O
of,1108,1110,O
CoA,1111,1114,O
or,1115,1117,O
IAA,1118,1121,O
.,1121,1122,O
Effect,0,6,O
of,7,9,O
a,10,11,O
mutation,12,20,O
in,21,23,O
the,24,27,O
anticodon,28,37,O
of,38,40,O
human,41,46,O
mitochondrial,47,60,B-Cellular_component
tRNAPro,61,68,O
on,69,71,O
its,72,75,O
post,76,80,O
-,80,81,O
transcriptional,81,96,O
modification,97,109,O
pattern,110,117,O
.,117,118,O
Although,119,127,O
the,128,131,O
gene,132,136,O
sequences,137,146,O
of,147,149,O
all,150,153,O
22,154,156,O
tRNAs,157,162,O
encoded,163,170,O
in,171,173,O
the,174,177,O
human,178,183,O
mitochondrial,184,197,B-Cellular_component
genome,198,204,I-Cellular_component
are,205,208,O
known,209,214,O
",",214,215,O
little,216,222,O
information,223,234,O
exists,235,241,O
about,242,247,O
their,248,253,O
sequences,254,263,O
at,264,266,O
the,267,270,O
RNA,271,274,O
level,275,280,O
.,280,281,O
This,282,286,O
becomes,287,294,O
a,295,296,O
crucial,297,304,O
limitation,305,315,O
when,316,320,O
searching,321,330,O
for,331,334,O
a,335,336,O
molecular,337,346,O
understanding,347,360,O
of,361,363,O
the,364,367,O
growing,368,375,O
number,376,382,O
of,383,385,O
maternally,386,396,O
inherited,397,406,O
human,407,412,O
diseases,413,421,O
correlated,422,432,O
with,433,437,O
point,438,443,O
mutations,444,453,O
in,454,456,O
tRNA,457,461,O
genes,462,467,O
.,467,468,O
Here,469,473,O
we,474,476,O
describe,477,485,O
the,486,489,O
sequence,490,498,O
of,499,501,O
human,502,507,O
mt,508,510,O
-,510,511,O
tRNAPropurified,511,526,O
from,527,531,O
placenta,532,540,B-Organ
.,540,541,O
It,542,544,O
shows,545,550,O
absence,551,558,O
of,559,561,O
editing,562,569,O
events,570,576,O
in,577,579,O
this,580,584,O
tRNA,585,589,O
and,590,593,O
highlights,594,604,O
the,605,608,O
presence,609,617,O
of,618,620,O
eight,621,626,O
post,627,631,O
-,631,632,O
transcriptional,632,647,O
modifications,648,661,O
.,661,662,O
These,663,668,O
include,669,676,O
T54,677,680,O
",",680,681,O
never,682,687,O
found,688,693,O
so,694,696,O
far,697,700,O
in,701,703,O
an,704,706,O
animal,707,713,O
mt,714,716,O
-,716,717,O
tRNA,717,721,O
",",721,722,O
and,723,726,O
m1G37,727,732,O
",",732,733,O
a,734,735,O
modification,736,748,O
known,749,754,O
to,755,757,O
have,758,762,O
fundamental,763,774,O
functional,775,785,O
properties,786,796,O
in,797,799,O
a,800,801,O
number,802,808,O
of,809,811,O
canonical,812,821,O
tRNAs,822,827,O
.,827,828,O
Occurrence,829,839,O
of,840,842,O
m1G37,843,848,O
was,849,852,O
further,853,860,O
investigated,861,873,O
in,874,876,O
an,877,879,O
analysis,880,888,O
of,889,891,O
the,892,895,O
substrate,896,905,O
properties,906,916,O
of,917,919,O
in,920,922,O
vitro,923,928,O
transcripts,929,940,O
of,941,943,O
human,944,949,O
mt,950,952,O
-,952,953,O
tRNAProtowards,953,967,O
pure,968,972,O
Escherichia,973,984,O
coli,985,989,O
methylguanosine,990,1005,O
transferase,1006,1017,O
.,1017,1018,O
This,1019,1023,O
enzyme,1024,1030,O
properly,1031,1039,O
methylates,1040,1050,O
G37,1051,1054,O
in,1055,1057,O
mt,1058,1060,O
-,1060,1061,O
tRNA,1061,1065,O
and,1066,1069,O
is,1070,1072,O
sensitive,1073,1082,O
to,1083,1085,O
the,1086,1089,O
presence,1090,1098,O
of,1099,1101,O
a,1102,1103,O
second,1104,1110,O
G,1111,1112,O
at,1113,1115,O
position,1116,1124,O
36,1125,1127,O
",",1127,1128,O
neighboring,1129,1140,O
the,1141,1144,O
target,1145,1151,O
nucleotide,1152,1162,O
for,1163,1166,O
methylation,1167,1178,O
.,1178,1179,O
Since,1180,1185,O
mutation,1186,1194,O
of,1195,1197,O
nt,1198,1200,O
36,1201,1203,O
was,1204,1207,O
shown,1208,1213,O
to,1214,1216,O
be,1217,1219,O
correlated,1220,1230,O
with,1231,1235,O
myopathy,1236,1244,O
",",1244,1245,O
the,1246,1249,O
potential,1250,1259,O
consequences,1260,1272,O
of,1273,1275,O
non,1276,1279,O
-,1279,1280,O
modification,1280,1292,O
or,1293,1295,O
under,1296,1301,O
-,1301,1302,O
modification,1302,1314,O
of,1315,1317,O
mt,1318,1320,O
-,1320,1321,O
tRNA,1321,1325,O
nucleotides,1326,1337,O
in,1338,1340,O
expression,1341,1351,O
of,1352,1354,O
the,1355,1358,O
particular,1359,1369,O
myopathy,1370,1378,O
and,1379,1382,O
of,1383,1385,O
mitochondrial,1386,1399,B-Cellular_component
diseases,1400,1408,O
in,1409,1411,O
general,1412,1419,O
are,1420,1423,O
discussed,1424,1433,O
.,1433,1434,O
Clozapine,0,9,O
-,9,10,O
induced,10,17,O
agranulocytosis,18,33,O
and,34,37,O
thrombopenia,38,50,O
in,51,53,O
a,54,55,O
patient,56,63,O
with,64,68,O
dopaminergic,69,81,O
psychosis,82,91,O
.,91,92,O
In,93,95,O
patients,96,104,O
with,105,109,O
Parkinson,110,119,O
',119,120,O
disease,121,128,O
and,129,132,O
dopaminergic,133,145,O
psychosis,146,155,O
",",155,156,O
clozapine,157,166,O
treatment,167,176,O
is,177,179,O
recommended,180,191,O
as,192,194,O
the,195,198,O
drug,199,203,O
is,204,206,O
free,207,211,O
from,212,216,O
extrapyramidal,217,231,O
side,232,236,O
effects,237,244,O
and,245,248,O
does,249,253,O
not,254,257,O
worsen,258,264,O
motor,265,270,O
symptoms,271,279,O
of,280,282,O
the,283,286,O
underlying,287,297,O
disease,298,305,O
.,305,306,O
The,307,310,O
use,311,314,O
of,315,317,O
clozapine,318,327,O
",",327,328,O
however,329,336,O
",",336,337,O
is,338,340,O
limited,341,348,O
due,349,352,O
to,353,355,O
its,356,359,O
hematotoxic,360,371,O
side,372,376,O
effects,377,384,O
.,384,385,O
For,386,389,O
treatment,390,399,O
of,400,402,O
clozapine,403,412,O
-,412,413,O
induced,413,420,O
agranulocytosis,421,436,O
",",436,437,O
granulocyte,438,449,O
colony,450,456,O
-,456,457,O
stimulating,457,468,O
factors,469,476,O
(,477,478,O
G,478,479,O
-,479,480,O
CSF,480,483,O
),483,484,O
are,485,488,O
recommended,489,500,O
.,500,501,O
We,502,504,O
report,505,511,O
the,512,515,O
case,516,520,O
of,521,523,O
a,524,525,O
72,526,528,O
-,528,529,O
years,529,534,O
-,534,535,O
old,535,538,O
male,539,543,O
patient,544,551,O
with,552,556,O
clozapine,557,566,O
-,566,567,O
induced,567,574,O
agranulocytosis,575,590,O
and,591,594,O
thrombopenia,595,607,O
.,607,608,O
Neutropenia,609,620,O
was,621,624,O
successfully,625,637,O
treated,638,645,O
with,646,650,O
G,651,652,O
-,652,653,O
CSF,653,656,O
",",656,657,O
but,658,661,O
thrombopenia,662,674,O
persisted,675,684,O
and,685,688,O
resolved,689,697,O
spontaneously,698,711,O
after,712,717,O
14,718,720,O
days,721,725,O
.,725,726,O
Bone,727,731,B-Multi-tissue_structure
marrow,732,738,I-Multi-tissue_structure
toxicity,739,747,O
of,748,750,O
clozapine,751,760,O
is,761,763,O
not,764,767,O
restricted,768,778,O
to,779,781,O
white,782,787,B-Cell
cell,788,792,I-Cell
maturation,793,803,O
",",803,804,O
but,805,808,O
may,809,812,O
also,813,817,O
impair,818,824,O
thrombocytopoesis,825,842,O
.,842,843,O
Acylase,0,7,O
I,8,9,O
-,9,10,O
catalyzed,10,19,O
deacetylation,20,33,O
of,34,36,O
N,37,38,O
-,38,39,O
acetyl,39,45,O
-,45,46,O
L,46,47,O
-,47,48,O
cysteine,48,56,O
and,57,60,O
S,61,62,O
-,62,63,O
alkyl,63,68,O
-,68,69,O
N,69,70,O
-,70,71,O
acetyl,71,77,O
-,77,78,O
L,78,79,O
-,79,80,O
cysteines,80,89,O
.,89,90,O
The,91,94,O
aminoacylase,95,107,O
that,108,112,O
catalyzes,113,122,O
the,123,126,O
hydrolysis,127,137,O
of,138,140,O
N,141,142,O
-,142,143,O
acetyl,143,149,O
-,149,150,O
L,150,151,O
-,151,152,O
cysteine,152,160,O
(,161,162,O
NAC,162,165,O
),165,166,O
was,167,170,O
identified,171,181,O
as,182,184,O
acylase,185,192,O
I,193,194,O
after,195,200,O
purification,201,213,O
by,214,216,O
column,217,223,O
chromatography,224,238,O
and,239,242,O
electrophoretic,243,258,O
analysis,259,267,O
.,267,268,O
Rat,269,272,O
kidney,273,279,B-Organism_substance
cytosol,280,287,I-Organism_substance
was,288,291,O
fractionated,292,304,O
by,305,307,O
ammonium,308,316,O
sulfate,317,324,O
precipitation,325,338,O
",",338,339,O
and,340,343,O
the,344,347,O
proteins,348,356,O
were,357,361,O
separated,362,371,O
by,372,374,O
ion,375,378,O
-,378,379,O
exchange,379,387,O
column,388,394,O
chromatography,395,409,O
",",409,410,O
gel,411,414,O
-,414,415,O
filtration,415,425,O
column,426,432,O
chromatography,433,447,O
",",447,448,O
and,449,452,O
hydrophobic,453,464,O
interaction,465,476,O
column,477,483,O
chromatography,484,498,O
.,498,499,O
Acylase,500,507,O
activity,508,516,O
with,517,521,O
NAC,522,525,O
and,526,529,O
N,530,531,O
-,531,532,O
acetyl,532,538,O
-,538,539,O
L,539,540,O
-,540,541,O
methionine,541,551,O
(,552,553,O
NAM,553,556,O
),556,557,O
",",557,558,O
a,559,560,O
known,561,566,O
substrate,567,576,O
for,577,580,O
acylase,581,588,O
I,589,590,O
",",590,591,O
as,592,594,O
substrates,595,605,O
coeluted,606,614,O
during,615,621,O
all,622,625,O
chromatographic,626,641,O
steps,642,647,O
.,647,648,O
Sodium,649,655,O
dodecyl,656,663,O
sulfate,664,671,O
-,671,672,O
polyacrylamide,672,686,O
gel,687,690,O
electrophoresis,691,706,O
showed,707,713,O
that,714,718,O
the,719,722,O
protein,723,730,O
was,731,734,O
purified,735,743,O
to,744,746,O
near,747,751,O
homogeneity,752,763,O
and,764,767,O
had,768,771,O
a,772,773,O
subunit,774,781,O
Mr,782,784,O
of,785,787,O
43,788,790,O
000,791,794,O
",",794,795,O
which,796,801,O
is,802,804,O
identical,805,814,O
with,815,819,O
the,820,823,O
Mr,824,826,O
of,827,829,O
acylase,830,837,O
I,838,839,O
from,840,844,O
porcine,845,852,O
kidney,853,859,B-Organ
and,860,863,O
bovine,864,870,O
liver,871,876,B-Organ
.,876,877,O
n,878,879,O
-,879,880,O
Butylmalonic,880,892,O
acid,893,897,O
was,898,901,O
a,902,903,O
slow,904,908,O
-,908,909,O
binding,909,916,O
inhibitor,917,926,O
of,927,929,O
acylase,930,937,O
I,938,939,O
and,940,943,O
inhibited,944,953,O
the,954,957,O
deacetylation,958,971,O
of,972,974,O
NAC,975,978,O
with,979,983,O
a,984,985,O
Ki,986,988,O
of,989,991,O
192,992,995,O
+,996,997,O
/,997,998,O
-,998,999,O
27,1000,1002,O
microM,1003,1009,O
.,1009,1010,O
These,1011,1016,O
results,1017,1024,O
show,1025,1029,O
that,1030,1034,O
acylase,1035,1042,O
I,1043,1044,O
catalyzes,1045,1054,O
the,1055,1058,O
deacetylation,1059,1072,O
of,1073,1075,O
NAC,1076,1079,O
.,1079,1080,O
The,1081,1084,O
acylase,1085,1092,O
I,1093,1094,O
-,1094,1095,O
catalyzed,1095,1104,O
deacetylation,1105,1118,O
of,1119,1121,O
a,1122,1123,O
range,1124,1129,O
of,1130,1132,O
S,1133,1134,O
-,1134,1135,O
alkyl,1135,1140,O
-,1140,1141,O
N,1141,1142,O
-,1142,1143,O
acetyl,1143,1149,O
-,1149,1150,O
L,1150,1151,O
-,1151,1152,O
cysteines,1152,1161,O
",",1161,1162,O
their,1163,1168,O
carbon,1169,1175,O
and,1176,1179,O
oxygen,1180,1186,O
analogues,1187,1196,O
",",1196,1197,O
and,1198,1201,O
the,1202,1205,O
selenium,1206,1214,O
analogue,1215,1223,O
of,1224,1226,O
NAM,1227,1230,O
was,1231,1234,O
also,1235,1239,O
studied,1240,1247,O
with,1248,1252,O
porcine,1253,1260,O
kidney,1261,1267,B-Organ
acylase,1268,1275,O
I,1276,1277,O
.,1277,1278,O
The,1279,1282,O
specific,1283,1291,O
activity,1292,1300,O
of,1301,1303,O
the,1304,1307,O
acylase,1308,1315,O
I,1316,1317,O
-,1317,1318,O
catalyzed,1318,1327,O
deacetylation,1328,1341,O
of,1342,1344,O
these,1345,1350,O
substrates,1351,1361,O
was,1362,1365,O
related,1366,1373,O
to,1374,1376,O
their,1377,1382,O
calculated,1383,1393,O
molar,1394,1399,O
volumes,1400,1407,O
and,1408,1411,O
log,1412,1415,O
P,1416,1417,O
values,1418,1424,O
.,1424,1425,O
The,1426,1429,O
S,1430,1431,O
-,1431,1432,O
alkyl,1432,1437,O
-,1437,1438,O
N,1438,1439,O
-,1439,1440,O
acetyl,1440,1446,O
-,1446,1447,O
L,1447,1448,O
-,1448,1449,O
cysteines,1449,1458,O
with,1459,1463,O
short,1464,1469,O
(,1470,1471,O
C0,1471,1473,O
-,1473,1474,O
C3,1474,1476,O
),1476,1477,O
and,1478,1481,O
unbranched,1482,1492,O
S,1493,1494,O
-,1494,1495,O
alkyl,1495,1500,O
substituents,1501,1513,O
were,1514,1518,O
good,1519,1523,O
acylase,1524,1531,O
I,1532,1533,O
substrates,1534,1544,O
",",1544,1545,O
whereas,1546,1553,O
the,1554,1557,O
S,1558,1559,O
-,1559,1560,O
alkyl,1560,1565,O
-,1565,1566,O
N,1566,1567,O
-,1567,1568,O
acetyl,1568,1574,O
-,1574,1575,O
L,1575,1576,O
-,1576,1577,O
cysteines,1577,1586,O
with,1587,1591,O
long,1592,1596,O
(,1597,1598,O
>,1598,1599,O
C3,1599,1601,O
),1601,1602,O
and,1603,1606,O
branched,1607,1615,O
S,1616,1617,O
-,1617,1618,O
alkyl,1618,1623,O
substituents,1624,1636,O
were,1637,1641,O
poLr,1642,1646,O
acylase,1647,1654,O
I,1655,1656,O
substrates,1657,1667,O
.,1667,1668,O
The,1669,1672,O
carbon,1673,1679,O
and,1680,1683,O
oxygen,1684,1690,O
analogues,1691,1700,O
of,1701,1703,O
S,1704,1705,O
-,1705,1706,O
methyl,1706,1712,O
-,1712,1713,O
N,1713,1714,O
-,1714,1715,O
acetyl,1715,1721,O
-,1721,1722,O
L,1722,1723,O
-,1723,1724,O
cysteine,1724,1732,O
and,1733,1736,O
the,1737,1740,O
carbon,1741,1747,O
analogue,1748,1756,O
of,1757,1759,O
S,1760,1761,O
-,1761,1762,O
ethyl,1762,1767,O
-,1767,1768,O
N,1768,1769,O
-,1769,1770,O
acetyl,1770,1776,O
-,1776,1777,O
L,1777,1778,O
-,1778,1779,O
cysteine,1779,1787,O
were,1788,1792,O
poor,1793,1797,O
acylase,1798,1805,O
I,1806,1807,O
substrates,1808,1818,O
",",1818,1819,O
whereas,1820,1827,O
the,1828,1831,O
selenium,1832,1840,O
analogue,1841,1849,O
of,1850,1852,O
NAM,1853,1856,O
was,1857,1860,O
a,1861,1862,O
good,1863,1867,O
acylase,1868,1875,O
I,1876,1877,O
substrate,1878,1887,O
.,1887,1888,O
Hemispheric,0,11,O
control,12,19,O
of,20,22,O
motor,23,28,O
function,29,37,O
:,37,38,O
a,39,40,O
whole,41,46,O
brain,47,52,B-Organ
echo,53,57,O
planar,58,64,O
fMRI,65,69,O
study,70,75,O
.,75,76,O
The,77,80,O
aim,81,84,O
of,85,87,O
this,88,92,O
study,93,98,O
was,99,102,O
to,103,105,O
explore,106,113,O
whether,114,121,O
recruitment,122,133,O
of,134,136,O
the,137,140,O
ipsilateral,141,152,B-Multi-tissue_structure
motor,153,158,I-Multi-tissue_structure
cortex,159,165,I-Multi-tissue_structure
during,166,172,O
non,173,176,O
-,176,177,O
dominant,177,185,O
motor,186,191,O
movement,192,200,O
reflects,201,209,O
left,210,214,B-Multi-tissue_structure
hemispheric,215,226,I-Multi-tissue_structure
control,227,234,O
of,235,237,O
motor,238,243,O
function,244,252,O
or,253,255,O
simply,256,262,O
the,263,266,O
greater,267,274,O
complexity,275,285,O
or,286,288,O
unfamiliarity,289,302,O
of,303,305,O
the,306,309,O
motor,310,315,O
task,316,320,O
.,320,321,O
BOLD,322,326,O
fMRI,327,331,O
was,332,335,O
performed,336,345,O
in,346,348,O
normal,349,355,O
right,356,361,O
-,361,362,O
handers,362,369,O
during,370,376,O
two,377,380,O
motor,381,386,O
tasks,387,392,O
:,392,393,O
(,394,395,O
1,395,396,O
),396,397,O
sequential,398,408,O
finger,409,415,B-Organism_subdivision
movements,416,425,O
(,426,427,O
SM,427,429,O
task,430,434,O
),434,435,O
with,436,440,O
the,441,444,O
right,445,450,O
or,451,453,O
left,454,458,O
hand,459,463,B-Organism_subdivision
;,463,464,O
and,465,468,O
(,469,470,O
2,470,471,O
),471,472,O
random,473,479,O
finger,480,486,B-Organism_subdivision
movements,487,496,O
(,497,498,O
RM,498,500,O
task,501,505,O
),505,506,O
with,507,511,O
the,512,515,O
right,516,521,O
hand,522,526,B-Organism_subdivision
.,526,527,O
In,528,530,O
all,531,534,O
subjects,535,543,O
",",543,544,O
activation,545,555,O
was,556,559,O
predominantly,560,573,O
in,574,576,O
the,577,580,O
contralateral,581,594,O
motor,595,600,O
areas,601,606,O
(,607,608,O
primary,608,615,O
sensorimotor,616,628,O
",",628,629,O
lateral,630,637,O
premotor,638,646,O
",",646,647,O
parietal,648,656,O
and,657,660,O
supplementary,661,674,O
motor,675,680,O
regions,681,688,O
),688,689,O
and,690,693,O
ipsilateral,694,705,B-Multi-tissue_structure
cerebellum,706,716,I-Multi-tissue_structure
.,716,717,O
While,718,723,O
the,724,727,O
ipsilateral,728,739,B-Multi-tissue_structure
motor,740,745,I-Multi-tissue_structure
areas,746,751,I-Multi-tissue_structure
were,752,756,O
also,757,761,O
activated,762,771,O
",",771,772,O
single,773,779,O
subject,780,787,O
analysis,788,796,O
revealed,797,805,O
these,806,811,O
areas,812,817,O
to,818,820,O
be,821,823,O
more,824,828,O
extensive,829,838,O
and,839,842,O
to,843,845,O
be,846,848,O
seen,849,853,O
in,854,856,O
more,857,861,O
subjects,862,870,O
during,871,877,O
the,878,881,O
non,882,885,O
-,885,886,O
dominant,886,894,O
hand,895,899,B-Organism_subdivision
SM,900,902,O
task,903,907,O
and,908,911,O
dominant,912,920,O
hand,921,925,B-Organism_subdivision
RM,926,928,O
task,929,933,O
than,934,938,O
during,939,945,O
the,946,949,O
more,950,954,O
familiar,955,963,O
dominant,964,972,O
hand,973,977,B-Organism_subdivision
SM,978,980,O
task,981,985,O
.,985,986,O
Similarly,987,996,O
",",996,997,O
group,998,1003,O
analysis,1004,1012,O
also,1013,1017,O
revealed,1018,1026,O
ipsilateral,1027,1038,O
activation,1039,1049,O
in,1050,1052,O
the,1053,1056,O
primary,1057,1064,O
sensorimotor,1065,1077,O
and,1078,1081,O
lateral,1082,1089,B-Multi-tissue_structure
premotor,1090,1098,I-Multi-tissue_structure
areas,1099,1104,I-Multi-tissue_structure
",",1104,1105,O
but,1106,1109,O
only,1110,1114,O
during,1115,1121,O
the,1122,1125,O
non,1126,1129,O
-,1129,1130,O
dominant,1130,1138,O
SM,1139,1141,O
task,1142,1146,O
and,1147,1150,O
the,1151,1154,O
dominant,1155,1163,O
hand,1164,1168,B-Organism_subdivision
RM,1169,1171,O
task,1172,1176,O
.,1176,1177,O
Non,1178,1181,O
-,1181,1182,O
dominant,1182,1190,O
hand,1191,1195,B-Organism_subdivision
movements,1196,1205,O
",",1205,1206,O
perhaps,1207,1214,O
because,1215,1222,O
they,1223,1227,O
are,1228,1231,O
less,1232,1236,O
',1237,1238,O
automatic,1238,1247,O
',1247,1248,O
",",1248,1249,O
appear,1250,1256,O
to,1257,1259,O
require,1260,1267,O
more,1268,1272,O
cortical,1273,1281,B-Multi-tissue_structure
activity,1282,1290,O
similar,1291,1298,O
to,1299,1301,O
complex,1302,1309,O
tasks,1310,1315,O
with,1316,1320,O
the,1321,1324,O
dominant,1325,1333,O
hand,1334,1338,B-Organism_subdivision
",",1338,1339,O
and,1340,1343,O
result,1344,1350,O
in,1351,1353,O
greater,1354,1361,O
recruitment,1362,1373,O
of,1374,1376,O
ipsilateral,1377,1388,B-Multi-tissue_structure
cortical,1389,1397,I-Multi-tissue_structure
motor,1398,1403,I-Multi-tissue_structure
areas,1404,1409,I-Multi-tissue_structure
and,1410,1413,O
striatum,1414,1422,B-Multi-tissue_structure
.,1422,1423,O
The,1424,1427,O
study,1428,1433,O
also,1434,1438,O
illustrates,1439,1450,O
how,1451,1454,O
potentially,1455,1466,O
meaningful,1467,1477,O
subtleties,1478,1488,O
seen,1489,1493,O
on,1494,1496,O
individual,1497,1507,O
maps,1508,1512,O
may,1513,1516,O
be,1517,1519,O
obscured,1520,1528,O
with,1529,1533,O
group,1534,1539,O
averaging,1540,1549,O
approaches,1550,1560,O
.,1560,1561,O
Selective,0,9,O
inhibition,10,20,O
of,21,23,O
the,24,27,O
renal,28,33,B-Organ
dopamine,34,42,O
subtype,43,50,O
D1A,51,54,O
receptor,55,63,O
induces,64,71,O
antinatriuresis,72,87,O
in,88,90,O
conscious,91,100,O
rats,101,105,O
.,105,106,O
Both,107,111,O
dopamine,112,120,O
D1,121,123,O
-,123,124,O
like,124,128,O
(,129,130,O
D1A,130,133,O
and,134,137,O
D1B,138,141,O
),141,142,O
and,143,146,O
D2,147,149,O
-,149,150,O
like,150,154,O
(,155,156,O
D2,156,158,O
",",158,159,O
D3,160,162,O
",",162,163,O
and,164,167,O
D4,168,170,O
),170,171,O
receptor,172,180,O
subfamilies,181,192,O
are,193,196,O
present,197,204,O
in,205,207,O
the,208,211,O
kidney,212,218,B-Organ
.,218,219,O
Blockade,220,228,O
of,229,231,O
the,232,235,O
intrarenal,236,246,O
D1,247,249,O
-,249,250,O
like,250,254,O
receptor,255,263,O
family,264,270,O
is,271,273,O
associated,274,284,O
with,285,289,O
natriuresis,290,301,O
and,302,305,O
diuresis,306,314,O
.,314,315,O
Because,316,323,O
the,324,327,O
D1A,328,331,O
and,332,335,O
D1B,336,339,O
receptor,340,348,O
subtypes,349,357,O
are,358,361,O
not,362,365,O
distinguishable,366,381,O
by,382,384,O
currently,385,394,O
available,395,404,O
dopaminergic,405,417,O
agents,418,424,O
",",424,425,O
their,426,431,O
functional,432,442,O
role,443,447,O
remains,448,455,O
undefined,456,465,O
.,465,466,O
In,467,469,O
the,470,473,O
present,474,481,O
study,482,487,O
",",487,488,O
the,489,492,O
effect,493,499,O
of,500,502,O
selective,503,512,O
inhibition,513,523,O
of,524,526,O
the,527,530,O
renal,531,536,B-Organ
D1A,537,540,O
receptor,541,549,O
with,550,554,O
phosphorothioated,555,572,O
antisense,573,582,O
oligodeoxynucleotide,583,603,O
(,604,605,O
AS,605,607,O
-,607,608,O
ODN,608,611,O
),611,612,O
was,613,616,O
investigated,617,629,O
in,630,632,O
conscious,633,642,O
uninephrectomized,643,660,O
rats,661,665,O
.,665,666,O
After,667,672,O
renal,673,678,B-Immaterial_anatomical_entity
interstitial,679,691,I-Immaterial_anatomical_entity
administration,692,706,O
of,707,709,O
Texas,710,715,O
red,716,719,O
-,719,720,O
labeled,720,727,O
D1A,728,731,O
receptor,732,740,O
AS,741,743,O
-,743,744,O
ODN,744,747,O
",",747,748,O
intense,749,756,O
fluorescent,757,768,O
signal,769,775,O
was,776,779,O
localized,780,789,O
in,790,792,O
the,793,796,O
renal,797,802,B-Tissue
tubular,803,810,I-Tissue
epithelium,811,821,I-Tissue
and,822,825,O
vasculature,826,837,B-Multi-tissue_structure
.,837,838,O
In,839,841,O
rats,842,846,O
on,847,849,O
normal,850,856,O
salt,857,861,O
intake,862,868,O
",",868,869,O
AS,870,872,O
-,872,873,O
ODN,873,876,O
injected,877,885,O
interstitially,886,900,O
into,901,905,O
the,906,909,O
kidney,910,916,B-Organ
reduced,917,924,O
daily,925,930,O
urinary,931,938,B-Organism_substance
sodium,939,945,O
excretion,946,955,O
(,956,957,O
1,957,958,O
.,958,959,O
4,959,960,O
+,960,961,O
/,961,962,O
-,962,963,O
0,963,964,O
.,964,965,O
04,965,967,O
versus,968,974,O
0,975,976,O
.,976,977,O
8,977,978,O
+,978,979,O
/,979,980,O
-,980,981,O
0,981,982,O
.,982,983,O
2,983,984,O
mEq,985,988,O
/,988,989,O
d,989,990,O
",",990,991,O
n,992,993,O
=,993,994,O
5,994,995,O
",",995,996,O
P,997,998,O
<,998,999,O
0,999,1000,O
.,1000,1001,O
05,1001,1003,O
),1003,1004,O
and,1005,1008,O
urine,1009,1014,B-Organism_substance
output,1015,1021,O
(,1022,1023,O
16,1023,1025,O
.,1025,1026,O
9,1026,1027,O
+,1027,1028,O
/,1028,1029,O
-,1029,1030,O
3,1030,1031,O
.,1031,1032,O
8,1032,1033,O
versus,1034,1040,O
12,1041,1043,O
.,1043,1044,O
5,1044,1045,O
+,1045,1046,O
/,1046,1047,O
-,1047,1048,O
3,1048,1049,O
.,1049,1050,O
6,1050,1051,O
mL,1052,1054,O
/,1054,1055,O
d,1055,1056,O
",",1056,1057,O
n,1058,1059,O
=,1059,1060,O
5,1060,1061,O
",",1061,1062,O
P,1063,1064,O
<,1064,1065,O
0,1065,1066,O
.,1066,1067,O
05,1067,1069,O
),1069,1070,O
.,1070,1071,O
In,1072,1074,O
rats,1075,1079,O
on,1080,1082,O
high,1083,1087,O
sodium,1088,1094,O
intake,1095,1101,O
",",1101,1102,O
continuous,1103,1113,O
renal,1114,1119,B-Immaterial_anatomical_entity
interstitial,1120,1132,I-Immaterial_anatomical_entity
administration,1133,1147,O
of,1148,1150,O
D1A,1151,1154,O
receptor,1155,1163,O
AS,1164,1166,O
-,1166,1167,O
ODN,1167,1170,O
transiently,1171,1182,O
decreased,1183,1192,O
daily,1193,1198,O
urinary,1199,1206,B-Organism_substance
sodium,1207,1213,O
excretion,1214,1223,O
(,1224,1225,O
5,1225,1226,O
.,1226,1227,O
4,1227,1228,O
+,1228,1229,O
/,1229,1230,O
-,1230,1231,O
0,1231,1232,O
.,1232,1233,O
5,1233,1234,O
versus,1235,1241,O
4,1242,1243,O
.,1243,1244,O
2,1244,1245,O
+,1245,1246,O
/,1246,1247,O
-,1247,1248,O
0,1248,1249,O
.,1249,1250,O
3,1250,1251,O
mEq,1252,1255,O
/,1255,1256,O
d,1256,1257,O
",",1257,1258,O
n,1259,1260,O
=,1260,1261,O
7,1261,1262,O
",",1262,1263,O
P,1264,1265,O
<,1265,1266,O
0,1266,1267,O
.,1267,1268,O
01,1268,1270,O
),1270,1271,O
and,1272,1275,O
urine,1276,1281,B-Organism_substance
output,1282,1288,O
(,1289,1290,O
27,1290,1292,O
.,1292,1293,O
6,1293,1294,O
+,1294,1295,O
/,1295,1296,O
-,1296,1297,O
4,1297,1298,O
.,1298,1299,O
5,1299,1300,O
versus,1301,1307,O
18,1308,1310,O
.,1310,1311,O
1,1311,1312,O
+,1312,1313,O
/,1313,1314,O
-,1314,1315,O
1,1315,1316,O
.,1316,1317,O
8,1317,1318,O
mL,1319,1321,O
/,1321,1322,O
d,1322,1323,O
",",1323,1324,O
n,1325,1326,O
=,1326,1327,O
7,1327,1328,O
",",1328,1329,O
P,1330,1331,O
<,1331,1332,O
0,1332,1333,O
.,1333,1334,O
01,1334,1336,O
),1336,1337,O
.,1337,1338,O
Neither,1339,1346,O
vehicle,1347,1354,O
nor,1355,1358,O
sense,1359,1364,O
oligodeoxynucleotide,1365,1385,O
had,1386,1389,O
significant,1390,1401,O
effects,1402,1409,O
.,1409,1410,O
Systolic,1411,1419,O
blood,1420,1425,B-Organism_substance
pressure,1426,1434,O
remained,1435,1443,O
unchanged,1444,1453,O
.,1453,1454,O
The,1455,1458,O
renal,1459,1464,B-Organ
D1A,1465,1468,O
receptor,1469,1477,O
protein,1478,1485,O
was,1486,1489,O
significantly,1490,1503,O
decreased,1504,1513,O
by,1514,1516,O
35,1517,1519,O
%,1519,1520,O
and,1521,1524,O
46,1525,1527,O
%,1527,1528,O
at,1529,1531,O
the,1532,1535,O
end,1536,1539,O
of,1540,1542,O
the,1543,1546,O
study,1547,1552,O
in,1553,1555,O
AS,1556,1558,O
-,1558,1559,O
ODN,1559,1562,O
-,1562,1563,O
treated,1563,1570,O
rats,1571,1575,O
on,1576,1578,O
normal,1579,1585,O
and,1586,1589,O
high,1590,1594,O
salt,1595,1599,O
intake,1600,1606,O
",",1606,1607,O
respectively,1608,1620,O
",",1620,1621,O
whereas,1622,1629,O
the,1630,1633,O
D1B,1634,1637,O
receptor,1638,1646,O
and,1647,1650,O
beta,1651,1655,O
-,1655,1656,O
actin,1656,1661,O
were,1662,1666,O
not,1667,1670,O
affected,1671,1679,O
.,1679,1680,O
These,1681,1686,O
results,1687,1694,O
provide,1695,1702,O
the,1703,1706,O
first,1707,1712,O
direct,1713,1719,O
evidence,1720,1728,O
that,1729,1733,O
the,1734,1737,O
renal,1738,1743,B-Organ
D1A,1744,1747,O
receptor,1748,1756,O
subtype,1757,1764,O
plays,1765,1770,O
an,1771,1773,O
important,1774,1783,O
role,1784,1788,O
in,1789,1791,O
the,1792,1795,O
control,1796,1803,O
of,1804,1806,O
sodium,1807,1813,O
excretion,1814,1823,O
.,1823,1824,O
[,0,1,O
Epidemiology,1,13,O
of,14,16,O
respiratory,17,28,B-Anatomical_system
allergy,29,36,O
in,37,39,O
children,40,48,O
],48,49,O
.,49,50,O
Epidemiology,51,63,O
of,64,66,O
paediatric,67,77,O
respiratory,78,89,B-Anatomical_system
allergic,90,98,O
disorders,99,108,O
allows,109,115,O
the,116,119,O
approach,120,128,O
to,129,131,O
causal,132,138,O
and,139,142,O
preventive,143,153,O
risk,154,158,O
factors,159,166,O
by,167,169,O
studying,170,178,O
groups,179,185,O
or,186,188,O
sub,189,192,O
groups,193,199,O
of,200,202,O
children,203,211,O
in,212,214,O
different,215,224,O
locations,225,234,O
and,235,238,O
under,239,244,O
different,245,254,O
conditions,255,265,O
.,265,266,O
This,267,271,O
is,272,274,O
",",274,275,O
however,276,283,O
",",283,284,O
complicated,285,296,O
by,297,299,O
the,300,303,O
lack,304,308,O
of,309,311,O
consensus,312,321,O
on,322,324,O
disease,325,332,O
definitions,333,344,O
",",344,345,O
which,346,351,O
renders,352,359,O
comparisons,360,371,O
between,372,379,O
studies,380,387,O
difficult,388,397,O
.,397,398,O
Atopy,399,404,O
is,405,407,O
usually,408,415,O
defined,416,423,O
by,424,426,O
the,427,430,O
presence,431,439,O
of,440,442,O
positive,443,451,O
skin,452,456,B-Organ
tests,457,462,O
(,463,464,O
wheal,464,469,O
size,470,474,O
of,475,477,O
at,478,480,O
least,481,486,O
a,487,488,O
mean,489,493,O
diameter,494,502,O
>,503,504,O
or,505,507,O
=,508,509,O
3,510,511,O
mm,512,514,O
),514,515,O
",",515,516,O
by,517,519,O
the,520,523,O
presence,524,532,O
of,533,535,O
specific,536,544,O
IgE,545,548,O
",",548,549,O
or,550,552,O
by,553,555,O
the,556,559,O
presence,560,568,O
of,569,571,O
increased,572,581,O
total,582,587,O
IgE,588,591,O
(,592,593,O
>,593,594,O
or,595,597,O
=,598,599,O
100,600,603,O
UI,604,606,O
/,606,607,O
mL,607,609,O
),609,610,O
.,610,611,O
Infantile,612,621,O
asthma,622,628,O
is,629,631,O
not,632,635,O
well,636,640,O
defined,641,648,O
",",648,649,O
complicated,650,661,O
by,662,664,O
the,665,668,O
high,669,673,O
prevalence,674,684,O
of,685,687,O
bronchiolitis,688,701,O
;,701,702,O
one,703,706,O
thus,707,711,O
questions,712,721,O
between,722,729,O
wheezing,730,738,O
or,739,741,O
wheezy,742,748,O
bronchitis,749,759,O
.,759,760,O
Prevalence,761,771,O
is,772,774,O
high,775,779,O
:,779,780,O
among,781,786,O
early,787,792,O
wheezers,793,801,O
",",801,802,O
two,803,806,O
populations,807,818,O
will,819,823,O
be,824,826,O
defined,827,834,O
by,835,837,O
the,838,841,O
medium,842,848,O
term,849,853,O
evolution,854,863,O
:,863,864,O
transient,865,874,O
wheezers,875,883,O
and,884,887,O
persistent,888,898,O
wheezers,899,907,O
.,907,908,O
Risk,909,913,O
factors,914,921,O
for,922,925,O
these,926,931,O
two,932,935,O
conditions,936,946,O
are,947,950,O
different,951,960,O
.,960,961,O
Childhood,962,971,O
asthma,972,978,O
may,979,982,O
be,983,985,O
defined,986,993,O
by,994,996,O
the,997,1000,O
diagnosis,1001,1010,O
of,1011,1013,O
asthma,1014,1020,O
(,1021,1022,O
specific,1022,1030,O
but,1031,1034,O
fairly,1035,1041,O
non,1042,1045,O
-,1045,1046,O
sensitive,1046,1055,O
),1055,1056,O
",",1056,1057,O
by,1058,1060,O
asthmatic,1061,1070,O
symptoms,1071,1079,O
(,1080,1081,O
wheezing,1081,1089,O
",",1089,1090,O
waking,1091,1097,O
by,1098,1100,O
an,1101,1103,O
attack,1104,1110,O
of,1111,1113,O
shortness,1114,1123,O
of,1124,1126,O
breath,1127,1133,O
),1133,1134,O
(,1135,1136,O
sensitive,1136,1145,O
but,1146,1149,O
not,1150,1153,O
very,1154,1158,O
specific,1159,1167,O
),1167,1168,O
",",1168,1169,O
or,1170,1172,O
by,1173,1175,O
the,1176,1179,O
combination,1180,1191,O
of,1192,1194,O
symptoms,1195,1203,O
and,1204,1207,O
airway,1208,1214,B-Multi-tissue_structure
hyperresponsiveness,1215,1234,O
.,1234,1235,O
The,1236,1239,O
ISAAC,1240,1245,O
study,1246,1251,O
has,1252,1255,O
standardised,1256,1268,O
a,1269,1270,O
questionnaire,1271,1284,O
to,1285,1287,O
assess,1288,1294,O
the,1295,1298,O
prevalence,1299,1309,O
of,1310,1312,O
asthma,1313,1319,O
.,1319,1320,O
The,1321,1324,O
preliminary,1325,1336,O
results,1337,1344,O
show,1345,1349,O
that,1350,1354,O
there,1355,1360,O
are,1361,1364,O
wide,1365,1369,O
variations,1370,1380,O
across,1381,1387,O
the,1388,1391,O
world,1392,1397,O
.,1397,1398,O
The,1399,1402,O
prevalence,1403,1413,O
is,1414,1416,O
low,1417,1420,O
in,1421,1423,O
Africa,1424,1430,O
and,1431,1434,O
Asia,1435,1439,O
",",1439,1440,O
intermediate,1441,1453,O
in,1454,1456,O
Europe,1457,1463,O
",",1463,1464,O
and,1465,1468,O
high,1469,1473,O
in,1474,1476,O
Anglo,1477,1482,O
-,1482,1483,O
Saxon,1483,1488,O
countries,1489,1498,O
.,1498,1499,O
The,1500,1503,O
prevalence,1504,1514,O
of,1515,1517,O
asthma,1518,1524,O
has,1525,1528,O
gradually,1529,1538,O
increased,1539,1548,O
over,1549,1553,O
the,1554,1557,O
past,1558,1562,O
20,1563,1565,O
years,1566,1571,O
in,1572,1574,O
developed,1575,1584,O
countries,1585,1594,O
.,1594,1595,O
Asthma,1596,1602,O
and,1603,1606,O
atopy,1607,1612,O
are,1613,1616,O
closely,1617,1624,O
associated,1625,1635,O
in,1636,1638,O
children,1639,1647,O
.,1647,1648,O
Risk,1649,1653,O
factors,1654,1661,O
are,1662,1665,O
genetic,1666,1673,O
",",1673,1674,O
associated,1675,1685,O
with,1686,1690,O
sex,1691,1694,O
and,1695,1698,O
environmental,1699,1712,O
factors,1713,1720,O
.,1720,1721,O
Among,1722,1727,O
these,1728,1733,O
",",1733,1734,O
allergic,1735,1743,O
sensitisation,1744,1757,O
is,1758,1760,O
associated,1761,1771,O
with,1772,1776,O
the,1777,1780,O
degree,1781,1787,O
of,1788,1790,O
exposure,1791,1799,O
to,1800,1802,O
allergens,1803,1812,O
.,1812,1813,O
Westernization,1814,1828,O
of,1829,1831,O
way,1832,1835,O
of,1836,1838,O
life,1839,1843,O
is,1844,1846,O
associated,1847,1857,O
with,1858,1862,O
increased,1863,1872,O
prevalence,1873,1883,O
of,1884,1886,O
atopy,1887,1892,O
",",1892,1893,O
allergic,1894,1902,O
rhinitis,1903,1911,O
and,1912,1915,O
asthma,1916,1922,O
.,1922,1923,O
Atopy,1924,1929,O
seems,1930,1935,O
inversely,1936,1945,O
correlated,1946,1956,O
to,1957,1959,O
certain,1960,1967,O
infections,1968,1978,O
.,1978,1979,O
Passive,1980,1987,O
smoking,1988,1995,O
is,1996,1998,O
clearly,1999,2006,O
associated,2007,2017,O
with,2018,2022,O
early,2023,2028,O
wheezing,2029,2037,O
.,2037,2038,O
This,2039,2043,O
and,2044,2047,O
atmospheric,2048,2059,O
pollution,2060,2069,O
aggravate,2070,2079,O
childhood,2080,2089,O
asthma,2090,2096,O
.,2096,2097,O
However,2098,2105,O
",",2105,2106,O
the,2107,2110,O
inducing,2111,2119,O
role,2120,2124,O
of,2125,2127,O
pollution,2128,2137,O
on,2138,2140,O
asthma,2141,2147,O
is,2148,2150,O
still,2151,2156,O
controversial,2157,2170,O
.,2170,2171,O
Novel,0,5,O
mechanism,6,15,O
for,16,19,O
the,20,23,O
impairment,24,34,O
of,35,37,O
cell,38,42,B-Cell
proliferation,43,56,O
in,57,59,O
HIV,60,63,O
-,63,64,O
1,64,65,O
infection,66,75,O
.,75,76,O
The,77,80,O
synthesis,81,90,O
of,91,93,O
ribonucleotides,94,109,O
is,110,112,O
essential,113,122,O
to,123,125,O
cell,126,130,B-Cell
proliferation,131,144,O
.,144,145,O
Defects,146,153,O
in,154,156,O
the,157,160,O
relevant,161,169,O
metabolic,170,179,O
pathways,180,188,O
have,189,193,O
been,194,198,O
demonstrated,199,211,O
in,212,214,O
stimulated,215,225,O
T,226,227,B-Cell
cells,228,233,I-Cell
from,234,238,O
AIDS,239,243,O
patients,244,252,O
and,253,256,O
are,257,260,O
associated,261,271,O
with,272,276,O
lymphocyte,277,287,B-Cell
necrotic,288,296,O
death,297,302,O
.,302,303,O
Here,304,308,O
",",308,309,O
Margarita,310,319,O
Bofill,320,326,O
and,327,330,O
colleagues,331,341,O
discuss,342,349,O
the,350,353,O
possibility,354,365,O
that,366,370,O
an,371,373,O
impaired,374,382,O
ribonucleotide,383,397,O
metabolism,398,408,O
might,409,414,O
be,415,417,O
common,418,424,O
to,425,427,O
all,428,431,O
rapidly,432,439,O
dividing,440,448,O
cells,449,454,B-Cell
and,455,458,O
thus,459,463,O
contribute,464,474,O
to,475,477,O
other,478,483,O
recognized,484,494,O
symptoms,495,503,O
of,504,506,O
HIV,507,510,O
-,510,511,O
1,511,512,O
infection,513,522,O
.,522,523,O
A,0,1,O
pancreatic,2,12,B-Cell
beta,13,17,I-Cell
-,18,19,I-Cell
cell,19,23,I-Cell
-,23,24,O
specific,24,32,O
enhancer,33,41,O
in,42,44,O
the,45,48,O
human,49,54,O
PDX,55,58,O
-,58,59,O
1,59,60,O
gene,61,65,O
is,66,68,O
regulated,69,78,O
by,79,81,O
hepatocyte,82,92,O
nuclear,93,100,O
factor,101,107,O
3beta,108,113,O
(,114,115,O
HNF,115,118,O
-,118,119,O
3beta,119,124,O
),125,126,O
",",126,127,O
HNF,128,131,O
-,131,132,O
1alpha,132,138,O
",",138,139,O
and,140,143,O
SPs,144,147,O
transcription,148,161,O
factors,162,169,O
.,169,170,O
The,171,174,O
PDX,175,178,O
-,178,179,O
1,179,180,O
transcription,181,194,O
factor,195,201,O
plays,202,207,O
a,208,209,O
key,210,213,O
role,214,218,O
in,219,221,O
pancreas,222,230,B-Organ
development,231,242,O
.,242,243,O
Although,244,252,O
expressed,253,262,O
in,263,265,O
all,266,269,O
cells,270,275,B-Cell
at,276,278,O
the,279,282,O
early,283,288,O
stages,289,295,O
",",295,296,O
in,297,299,O
the,300,303,O
adult,304,309,O
it,310,312,O
is,313,315,O
mainly,316,322,O
restricted,323,333,O
to,334,336,O
the,337,340,O
beta,341,345,B-Cell
-,345,346,I-Cell
cell,346,350,I-Cell
.,350,351,O
To,352,354,O
characterize,355,367,O
the,368,371,O
regulatory,372,382,O
elements,383,391,O
and,392,395,O
potential,396,405,O
transcription,406,419,O
factors,420,427,O
necessary,428,437,O
for,438,441,O
human,442,447,O
PDX,448,451,O
-,451,452,O
1,452,453,O
gene,454,458,O
expression,459,469,O
in,470,472,O
beta,473,477,B-Cell
-,477,478,I-Cell
cells,478,483,I-Cell
",",483,484,O
we,485,487,O
constructed,488,499,O
a,500,501,O
series,502,508,O
of,509,511,O
5,512,513,O
',513,514,O
and,515,518,O
3,519,520,O
',520,521,O
deletion,522,530,O
fragments,531,540,O
of,541,543,O
the,544,547,O
5,548,549,O
',549,550,O
-,550,551,O
flanking,551,559,O
region,560,566,O
of,567,569,O
the,570,573,O
gene,574,578,O
",",578,579,O
fused,580,585,O
to,586,588,O
the,589,592,O
luciferase,593,603,O
reporter,604,612,O
gene,613,617,O
.,617,618,O
In,619,621,O
this,622,626,O
report,627,633,O
",",633,634,O
we,635,637,O
identify,638,646,O
by,647,649,O
transient,650,659,O
transfections,660,673,O
in,674,676,O
beta,677,681,B-Cell
-,681,682,I-Cell
and,683,686,O
non,687,690,B-Cell
-,690,691,I-Cell
beta,691,695,I-Cell
-,695,696,I-Cell
cells,696,701,I-Cell
a,702,703,O
novel,704,709,O
beta,710,714,B-Cell
-,714,715,I-Cell
cell,715,719,I-Cell
-,719,720,O
specific,720,728,O
distal,729,735,O
enhancer,736,744,O
element,745,752,O
located,753,760,O
between,761,768,O
-,769,770,O
3,770,771,O
.,771,772,O
7,772,773,O
and,774,777,O
-,778,779,O
3,779,780,O
.,780,781,O
45,781,783,O
kilobases,784,793,O
.,793,794,O
DNase,795,800,O
I,801,802,O
footprinting,803,815,O
analysis,816,824,O
revealed,825,833,O
two,834,837,O
protected,838,847,O
regions,848,855,O
",",855,856,O
one,857,860,O
binding,861,868,O
the,869,872,O
transcription,873,886,O
factors,887,894,O
SP1,895,898,O
and,899,902,O
SP3,903,906,O
and,907,910,O
the,911,914,O
other,915,920,O
hepatocyte,921,931,O
nuclear,932,939,O
factor,940,946,O
3beta,947,952,O
(,953,954,O
HNF,954,957,O
-,957,958,O
3beta,958,963,O
),963,964,O
and,965,968,O
HNF,969,972,O
-,972,973,O
1alpha,973,979,O
.,979,980,O
Cotransfection,981,995,O
experiments,996,1007,O
suggest,1008,1015,O
that,1016,1020,O
HNF,1021,1024,O
-,1024,1025,O
3beta,1025,1030,O
",",1030,1031,O
HNF,1032,1035,O
-,1035,1036,O
1alpha,1036,1042,O
",",1042,1043,O
and,1044,1047,O
SP1,1048,1051,O
are,1052,1055,O
positive,1056,1064,O
regulators,1065,1075,O
of,1076,1078,O
the,1079,1082,O
herein,1083,1089,O
-,1089,1090,O
described,1090,1099,O
human,1100,1105,O
PDX,1106,1109,O
-,1109,1110,O
1,1110,1111,O
enhancer,1112,1120,O
element,1121,1128,O
.,1128,1129,O
Furthermore,1130,1141,O
",",1141,1142,O
mutations,1143,1152,O
within,1153,1159,O
each,1160,1164,O
motif,1165,1170,O
abolished,1171,1180,O
the,1181,1184,O
binding,1185,1192,O
of,1193,1195,O
the,1196,1199,O
corresponding,1200,1213,O
factor,1214,1220,O
(,1220,1221,O
s,1221,1222,O
),1222,1223,O
and,1224,1227,O
dramatically,1228,1240,O
impaired,1241,1249,O
the,1250,1253,O
enhancer,1254,1262,O
activity,1263,1271,O
",",1271,1272,O
therefore,1273,1282,O
suggesting,1283,1293,O
cooperativity,1294,1307,O
between,1308,1315,O
these,1316,1321,O
factors,1322,1329,O
.,1329,1330,O
[,0,1,O
A,1,2,O
decline,3,10,O
in,11,13,O
the,14,17,O
French,18,24,O
demographic,25,36,O
situation,37,46,O
in,47,49,O
the,50,53,O
context,54,61,O
of,62,64,O
a,65,66,O
Europe,67,73,O
also,74,78,O
in,79,81,O
demographic,82,93,O
decline,94,101,O
],101,102,O
.,102,103,O
The,104,107,O
author,108,114,O
analyzes,115,123,O
the,124,127,O
decline,128,135,O
in,136,138,O
French,139,145,O
fertility,146,155,O
which,156,161,O
has,162,165,O
occurred,166,174,O
over,175,179,O
the,180,183,O
past,184,188,O
two,189,192,O
years,193,198,O
using,199,204,O
data,205,209,O
from,210,214,O
official,215,223,O
sources,224,231,O
.,231,232,O
Some,234,238,O
comparisons,239,250,O
are,251,254,O
made,255,259,O
with,260,264,O
fertility,265,274,O
trends,275,281,O
in,282,284,O
other,285,290,O
European,291,299,O
countries,300,309,O
.,309,310,O
The,0,3,O
patterns,4,12,O
of,13,15,O
internal,16,24,O
migration,25,34,O
in,35,37,O
Maharashtra,38,49,O
:,49,50,O
an,52,54,O
analysis,55,63,O
of,64,66,O
1971,67,71,O
census,72,78,O
data,79,83,O
.,83,84,O
Patterns,85,93,O
of,94,96,O
internal,97,105,O
migration,106,115,O
in,116,118,O
the,119,122,O
state,123,128,O
of,129,131,O
Maharashtra,132,143,O
",",143,144,O
India,145,150,O
",",150,151,O
for,152,155,O
the,156,159,O
period,160,166,O
1961,167,171,O
-,171,172,O
1971,172,176,O
are,177,180,O
analyzed,181,189,O
using,190,195,O
1971,196,200,O
census,201,207,O
data,208,212,O
.,212,213,O
The,215,218,O
nature,219,225,O
",",225,226,O
volume,227,233,O
",",233,234,O
and,235,238,O
direction,239,248,O
of,249,251,O
migration,252,261,O
are,262,265,O
examined,266,274,O
.,274,275,O
Migrants,277,285,O
are,286,289,O
characterized,290,303,O
according,304,313,O
to,314,316,O
factors,317,324,O
including,325,334,O
age,335,338,O
",",338,339,O
sex,340,343,O
",",343,344,O
marital,345,352,O
status,353,359,O
",",359,360,O
occupation,361,371,O
",",371,372,O
and,373,376,O
areas,377,382,O
of,383,385,O
origin,386,392,O
and,393,396,O
destination,397,408,O
.,408,409,O
Deletion,0,8,O
of,9,11,O
guanine,12,19,O
nucleotide,20,30,O
binding,31,38,O
protein,39,46,O
alpha,47,52,O
z,53,54,O
subunit,55,62,O
in,63,65,O
mice,66,70,O
induces,71,78,O
a,79,80,O
gene,81,85,O
dose,86,90,O
dependent,91,100,O
tolerance,101,110,O
to,111,113,O
morphine,114,122,O
.,122,123,O
The,124,127,O
mechanism,128,137,O
underlying,138,148,O
the,149,152,O
development,153,164,O
of,165,167,O
tolerance,168,177,O
to,178,180,O
morphine,181,189,O
is,190,192,O
still,193,198,O
incompletely,199,211,O
understood,212,222,O
.,222,223,O
Morphine,224,232,O
binds,233,238,O
to,239,241,O
opioid,242,248,O
receptors,249,258,O
",",258,259,O
which,260,265,O
in,266,268,O
turn,269,273,O
activates,274,283,O
downstream,284,294,O
second,295,301,O
messenger,302,311,O
cascades,312,320,O
through,321,328,O
heterotrimeric,329,343,O
guanine,344,351,O
nucleotide,352,362,O
binding,363,370,O
proteins,371,379,O
(,380,381,O
G,381,382,O
proteins,383,391,O
),391,392,O
.,392,393,O
In,394,396,O
this,397,401,O
paper,402,407,O
",",407,408,O
we,409,411,O
show,412,416,O
that,417,421,O
G,422,423,O
(,423,424,O
z,424,425,O
),425,426,O
",",426,427,O
a,428,429,O
member,430,436,O
of,437,439,O
the,440,443,O
inhibitory,444,454,O
G,455,456,O
protein,457,464,O
family,465,471,O
",",471,472,O
plays,473,478,O
an,479,481,O
important,482,491,O
role,492,496,O
in,497,499,O
mediating,500,509,O
the,510,513,O
analgesic,514,523,O
and,524,527,O
lethality,528,537,O
effects,538,545,O
of,546,548,O
morphine,549,557,O
after,558,563,O
tolerance,564,573,O
development,574,585,O
.,585,586,O
We,587,589,O
blocked,590,597,O
signaling,598,607,O
through,608,615,O
the,616,619,O
G,620,621,O
(,621,622,O
z,622,623,O
),623,624,O
second,625,631,O
messenger,632,641,O
cascade,642,649,O
by,650,652,O
genetic,653,660,O
ablation,661,669,O
of,670,672,O
the,673,676,O
alpha,677,682,O
subunit,683,690,O
of,691,693,O
the,694,697,O
G,698,699,O
protein,700,707,O
in,708,710,O
mice,711,715,O
.,715,716,O
The,717,720,O
Galpha,721,727,O
(,727,728,O
z,728,729,O
),729,730,O
knockout,731,739,O
mouse,740,745,O
develops,746,754,O
significantly,755,768,O
increased,769,778,O
tolerance,779,788,O
to,789,791,O
morphine,792,800,O
",",800,801,O
which,802,807,O
depends,808,815,O
on,816,818,O
Galpha,819,825,O
(,825,826,O
z,826,827,O
),827,828,O
gene,829,833,O
dosage,834,840,O
.,840,841,O
Further,842,849,O
experiments,850,861,O
demonstrate,862,873,O
that,874,878,O
the,879,882,O
enhanced,883,891,O
morphine,892,900,O
tolerance,901,910,O
is,911,913,O
not,914,917,O
caused,918,924,O
by,925,927,O
pharmacokinetic,928,943,O
and,944,947,O
behavioural,948,959,O
learning,960,968,O
mechanisms,969,979,O
.,979,980,O
The,981,984,O
results,985,992,O
suggest,993,1000,O
that,1001,1005,O
G,1006,1007,O
(,1007,1008,O
z,1008,1009,O
),1009,1010,O
signaling,1011,1020,O
pathways,1021,1029,O
are,1030,1033,O
involved,1034,1042,O
in,1043,1045,O
transducing,1046,1057,O
the,1058,1061,O
analgesic,1062,1071,O
and,1072,1075,O
lethality,1076,1085,O
effects,1086,1093,O
of,1094,1096,O
morphine,1097,1105,O
following,1106,1115,O
chronic,1116,1123,O
morphine,1124,1132,O
treatment,1133,1142,O
.,1142,1143,O
Effects,0,7,O
of,8,10,O
buffer,11,17,O
properties,18,28,O
on,29,31,O
cyclodextrin,32,44,O
glucanotransferase,45,63,O
reactions,64,73,O
and,74,77,O
cyclodextrin,78,90,O
production,91,101,O
from,102,106,O
raw,107,110,O
sago,111,115,O
(,116,117,O
Cycas,117,122,O
revoluta,123,131,O
),131,132,O
starch,133,139,B-Organism_substance
.,139,140,O
Results,141,148,O
from,149,153,O
the,154,157,O
present,158,165,O
study,166,171,O
have,172,176,O
shown,177,182,O
that,183,187,O
the,188,191,O
ionic,192,197,O
species,198,205,O
of,206,208,O
buffers,209,216,O
",",216,217,O
pH,218,220,O
values,221,227,O
and,228,231,O
reaction,232,240,O
temperature,241,252,O
can,253,256,O
affect,257,263,O
the,264,267,O
enzyme,268,274,O
unit,275,279,O
activities,280,290,O
and,291,294,O
product,295,302,O
specificity,303,314,O
of,315,317,O
Toruzyme,318,326,O
(,327,328,O
Novo,328,332,O
Nordisk,333,340,O
A,341,342,O
/,342,343,O
S,343,344,O
Bagsvaerd,345,354,O
",",354,355,O
Denmark,356,363,O
),363,364,O
CGTase,365,371,O
(,372,373,O
cyclodextrin,373,385,O
glucanotransferase,386,404,O
),404,405,O
.,405,406,O
Applying,407,415,O
a,416,417,O
similar,418,425,O
reaction,426,434,O
environment,435,446,O
(,447,448,O
acetate,448,455,O
buffer,456,462,O
",",462,463,O
pH,464,466,O
6,467,468,O
.,468,469,O
0,469,470,O
;,470,471,O
temperature,472,483,O
",",483,484,O
60,485,487,O
degrees,488,495,O
C,496,497,O
),497,498,O
",",498,499,O
the,500,503,O
CGTase,504,510,O
was,511,514,O
found,515,520,O
to,521,523,O
be,524,526,O
capable,527,534,O
of,535,537,O
producing,538,547,O
pre,548,551,O
dominantly,552,562,O
beta,563,567,O
-,567,568,O
cyclodextrin,568,580,O
from,581,585,O
either,586,592,O
raw,593,596,O
or,597,599,O
gelatinized,600,611,O
sago,612,616,O
(,617,618,O
Cycas,618,623,O
revoluta,624,632,O
),632,633,O
starch,634,640,B-Organism_substance
.,640,641,O
Changing,642,650,O
the,651,654,O
buffer,655,661,O
from,662,666,O
acetate,667,674,O
to,675,677,O
phosphate,678,687,O
reduced,688,695,O
the,696,699,O
yield,700,705,O
of,706,708,O
beta,709,713,O
-,713,714,O
cyclodextrin,714,726,O
from,727,731,O
2,732,733,O
.,733,734,O
48,734,736,O
to,737,739,O
1,740,741,O
.,741,742,O
42,742,744,O
mg,745,747,O
/,747,748,O
ml,748,750,O
and,751,754,O
also,755,759,O
affected,760,768,O
the,769,772,O
product,773,780,O
specificity,781,792,O
",",792,793,O
where,794,799,O
production,800,810,O
of,811,813,O
both,814,818,O
alpha,819,824,O
-,824,825,O
and,826,829,O
beta,830,834,O
-,834,835,O
cyclodextrins,835,848,O
were,849,853,O
more,854,858,O
pronounced,859,869,O
.,869,870,O
The,871,874,O
decrease,875,883,O
in,884,886,O
the,887,890,O
production,891,901,O
of,902,904,O
cyclodextrins,905,918,O
in,919,921,O
phosphate,922,931,O
buffer,932,938,O
was,939,942,O
significant,943,954,O
at,955,957,O
both,958,962,O
pH,963,965,O
6,966,967,O
.,967,968,O
0,968,969,O
and,970,973,O
7,974,975,O
.,975,976,O
0,976,977,O
.,977,978,O
However,979,986,O
",",986,987,O
changing,988,996,O
the,997,1000,O
buffer,1001,1007,O
to,1008,1010,O
Tris,1011,1015,O
/,1015,1016,O
HCl,1016,1019,O
(,1020,1021,O
pH,1021,1023,O
7,1024,1025,O
.,1025,1026,O
0,1026,1027,O
),1027,1028,O
showed,1029,1035,O
a,1036,1037,O
significant,1038,1049,O
increase,1050,1058,O
in,1059,1061,O
beta,1062,1066,O
-,1066,1067,O
cyclodextrin,1067,1079,O
production,1080,1090,O
.,1090,1091,O
Increasing,1092,1102,O
the,1103,1106,O
ionic,1107,1112,O
strength,1113,1121,O
of,1122,1124,O
sodium,1125,1131,O
acetate,1132,1139,O
and,1140,1143,O
Tris,1144,1148,O
/,1148,1149,O
HCl,1149,1152,O
buffers,1153,1160,O
at,1161,1163,O
pH,1164,1166,O
6,1167,1168,O
.,1168,1169,O
0,1169,1170,O
and,1171,1174,O
7,1175,1176,O
.,1176,1177,O
0,1177,1178,O
to,1179,1181,O
equivalent,1182,1192,O
ionic,1193,1198,O
strength,1199,1207,O
of,1208,1210,O
phosphate,1211,1220,O
buffers,1221,1228,O
showed,1229,1235,O
no,1236,1238,O
significant,1239,1250,O
effects,1251,1258,O
on,1259,1261,O
cyclodextrin,1262,1274,O
production,1275,1285,O
.,1285,1286,O
Higher,1287,1293,O
yield,1294,1299,O
of,1300,1302,O
cyclodextrins,1303,1316,O
at,1317,1319,O
pH,1320,1322,O
7,1323,1324,O
.,1324,1325,O
0,1325,1326,O
when,1327,1331,O
Tris,1332,1336,O
/,1336,1337,O
HCl,1337,1340,O
was,1341,1344,O
used,1345,1349,O
might,1350,1355,O
be,1356,1358,O
due,1359,1362,O
to,1363,1365,O
the,1366,1369,O
binding,1370,1377,O
of,1378,1380,O
chloride,1381,1389,O
ions,1390,1394,O
at,1395,1397,O
the,1398,1401,O
calcium,1402,1409,O
-,1409,1410,O
binding,1410,1417,O
sites,1418,1423,O
of,1424,1426,O
the,1427,1430,O
CGTase,1431,1437,O
",",1437,1438,O
resulting,1439,1448,O
in,1449,1451,O
the,1452,1455,O
shift,1456,1461,O
of,1462,1464,O
the,1465,1468,O
optimum,1469,1476,O
pH,1477,1479,O
close,1480,1485,O
to,1486,1488,O
physiological,1489,1502,O
environment,1503,1514,O
",",1514,1515,O
leading,1516,1523,O
to,1524,1526,O
an,1527,1529,O
increase,1530,1538,O
in,1539,1541,O
the,1542,1545,O
activities,1546,1556,O
and,1557,1560,O
specificity,1561,1572,O
.,1572,1573,O
Rational,0,8,O
synthesis,9,18,O
of,19,21,O
multicyclic,22,33,O
bis,34,37,O
[,37,38,O
2,38,39,O
],39,40,O
catenanes,40,49,O
.,49,50,O
Bis,51,54,O
-,54,55,O
loop,55,59,O
tetraurea,60,69,O
calix,70,75,O
[,75,76,O
4,76,77,O
],77,78,O
arene,78,83,O
6,84,85,O
has,86,89,O
been,90,94,O
prepared,95,103,O
by,104,106,O
acylation,107,116,O
of,117,119,O
the,120,123,O
wide,124,128,O
-,128,129,O
rim,129,132,O
calix,133,138,O
[,138,139,O
4,139,140,O
],140,141,O
arene,141,146,O
tetraamine,147,157,O
1,158,159,O
with,160,164,O
the,165,168,O
activated,169,178,O
bis,179,182,O
(,182,183,O
urethane,183,191,O
),191,192,O
8,193,194,O
under,195,200,O
dilution,201,209,O
conditions,210,220,O
.,220,221,O
Similarly,222,231,O
the,232,235,O
bis,236,239,O
(,239,240,O
Boc,240,243,O
-,243,244,O
protected,244,253,O
),253,254,O
tetraamine,255,265,O
2,266,267,O
is,268,270,O
converted,271,280,O
into,281,285,O
the,286,289,O
mono,290,294,O
-,294,295,O
loop,295,299,O
derivative,300,310,O
3,311,312,O
which,313,318,O
after,319,324,O
deprotection,325,337,O
and,338,341,O
acylation,342,351,O
gives,352,357,O
the,358,361,O
bisalkenyl,362,372,O
derivative,373,383,O
5,384,385,O
.,385,386,O
In,387,389,O
apolar,390,396,O
solvents,397,405,O
this,406,410,O
tetraurea,411,420,O
calix,421,426,O
[,426,427,O
4,427,428,O
],428,429,O
arene,429,434,O
5,435,436,O
forms,437,442,O
regioselectively,443,459,O
a,460,461,O
single,462,468,O
hydrogen,469,477,O
-,477,478,O
bonded,478,484,O
homodimer,485,494,O
",",494,495,O
from,496,500,O
which,501,506,O
the,507,510,O
bis,511,514,O
[,514,515,O
2,515,516,O
],516,517,O
catenane,517,525,O
10a,526,529,O
is,530,532,O
formed,533,539,O
in,540,542,O
49,543,545,O
%,545,546,O
by,547,549,O
a,550,551,O
metathesis,552,562,O
reaction,563,571,O
followed,572,580,O
by,581,583,O
hydrogenation,584,597,O
.,597,598,O
Bis,599,602,O
-,602,603,O
loop,603,607,O
derivative,608,618,O
6,619,620,O
forms,621,626,O
no,627,629,O
homodimers,630,640,O
for,641,644,O
steric,645,651,O
reasons,652,659,O
",",659,660,O
but,661,664,O
a,665,666,O
stoichiometric,667,681,O
mixture,682,689,O
with,690,694,O
the,695,698,O
open,699,703,O
-,703,704,O
chain,704,709,O
tetraalkenyl,710,722,O
derivative,723,733,O
7a,734,736,O
contains,737,745,O
exclusively,746,757,O
the,758,761,O
heterodimer,762,773,O
.,773,774,O
Metathesis,775,785,O
and,786,789,O
subsequent,790,800,O
hydrogenation,801,814,O
now,815,818,O
yields,819,825,O
65,826,828,O
%,829,830,O
of,831,833,O
the,834,837,O
pure,838,842,O
bis,843,846,O
[,846,847,O
2,847,848,O
],848,849,O
catenane,849,857,O
10a,858,861,O
which,862,867,O
could,868,873,O
not,874,877,O
be,878,880,O
isolated,881,889,O
from,890,894,O
the,895,898,O
complex,899,906,O
reaction,907,915,O
mixture,916,923,O
obtained,924,932,O
from,933,937,O
the,938,941,O
homodimer,942,951,O
7a,952,954,O
.,954,955,O
7a,955,957,O
.,957,958,O
The,959,962,O
chirality,963,972,O
of,973,975,O
10a,976,979,O
(,980,981,O
D,981,982,O
(,982,983,O
2,983,984,O
),984,985,O
symmetry,986,994,O
),994,995,O
has,996,999,O
been,1000,1004,O
verified,1005,1013,O
by,1014,1016,O
optical,1017,1024,O
resolution,1025,1035,O
using,1036,1041,O
HPLC,1042,1046,O
on,1047,1049,O
a,1050,1051,O
chiral,1052,1058,O
stationary,1059,1069,O
phase,1070,1075,O
.,1075,1076,O
Sciatic,0,7,B-Multi-tissue_structure
nerve,8,13,I-Multi-tissue_structure
repair,14,20,O
by,21,23,O
microgrooved,24,36,O
nerve,37,42,B-Multi-tissue_structure
conduits,43,51,O
made,52,56,O
of,57,59,O
chitosan,60,68,O
-,68,69,O
gold,69,73,O
nanocomposites,74,88,O
.,88,89,O
BACKGROUND,90,100,O
:,100,101,O
To,102,104,O
better,105,111,O
direct,112,118,O
the,119,122,O
repair,123,129,O
of,130,132,O
peripheral,133,143,B-Multi-tissue_structure
nerve,144,149,I-Multi-tissue_structure
after,150,155,O
injury,156,162,O
",",162,163,O
an,164,166,O
implant,167,174,O
consisting,175,185,O
of,186,188,O
a,189,190,O
multicomponent,191,205,O
micropatterned,206,220,O
conduit,221,228,B-Multi-tissue_structure
seeded,229,235,O
with,236,240,O
NSC,241,244,B-Cell
was,245,248,O
designed,249,257,O
.,257,258,O
METHODS,259,266,O
:,266,267,O
The,268,271,O
mechanical,272,282,O
properties,283,293,O
of,294,296,O
the,297,300,O
chi,301,304,O
-,304,305,O
Au,305,307,O
nanocomposites,308,322,O
were,323,327,O
tested,328,334,O
.,334,335,O
In,336,338,O
vitro,339,344,O
",",344,345,O
the,346,349,O
effect,350,356,O
of,357,359,O
chi,360,363,O
-,363,364,O
Au,364,366,O
on,367,369,O
cell,370,374,B-Cell
behavior,375,383,O
(,384,385,O
NSC,385,388,B-Cell
and,389,392,O
glial,393,398,B-Cell
cell,399,403,I-Cell
line,404,408,I-Cell
C6,409,411,I-Cell
),411,412,O
and,413,416,O
the,417,420,O
influence,421,430,O
of,431,433,O
micropattern,434,446,O
on,447,449,O
cell,450,454,B-Cell
alignment,455,464,O
were,465,469,O
evaluated,470,479,O
.,479,480,O
In,481,483,O
vivo,484,488,O
",",488,489,O
the,490,493,O
micropatterned,494,508,O
conduits,509,517,O
with,518,522,O
/,522,523,O
without,523,530,O
the,531,534,O
preseeded,535,544,O
NSC,545,548,B-Cell
were,549,553,O
implanted,554,563,O
to,564,566,O
bridge,567,573,O
a,574,575,O
10,576,578,O
-,578,579,O
mm,579,581,O
-,581,582,O
long,582,586,O
defect,587,593,O
of,594,596,O
the,597,600,O
sciatic,601,608,B-Multi-tissue_structure
nerve,609,614,I-Multi-tissue_structure
in,615,617,O
9,618,619,O
male,620,624,O
Sprague,625,632,O
-,632,633,O
Dawley,633,639,O
rats,640,644,O
.,644,645,O
The,646,649,O
repair,650,656,O
outcome,657,664,O
was,665,668,O
investigated,669,681,O
6,682,683,O
weeks,684,689,O
after,690,695,O
the,696,699,O
surgery,700,707,O
.,707,708,O
RESULTS,709,716,O
:,716,717,O
Based,718,723,O
on,724,726,O
the,727,730,O
dynamic,731,738,O
modulus,739,746,O
",",746,747,O
chitosan,748,756,O
with,757,761,O
50,762,764,O
ppm,765,768,O
or,769,771,O
more,772,776,O
gold,777,781,O
was,782,785,O
a,786,787,O
stronger,788,796,O
material,797,805,O
than,806,810,O
others,811,817,O
.,817,818,O
In,819,821,O
vitro,822,827,O
",",827,828,O
gold,829,833,O
at,834,836,O
25,837,839,O
or,840,842,O
50,843,845,O
ppm,846,849,O
led,850,853,O
to,854,856,O
better,857,863,O
cell,864,868,B-Cell
performance,869,880,O
for,881,884,O
NSC,885,888,B-Cell
;,888,889,O
and,890,893,O
gold,894,898,O
at,899,901,O
50,902,904,O
ppm,905,908,O
gave,909,913,O
better,914,920,O
cell,921,925,B-Cell
performance,926,937,O
for,938,941,O
C6,942,944,B-Cell
.,944,945,O
On,946,948,O
the,949,952,O
microgrooved,953,965,O
substrate,966,975,O
",",975,976,O
the,977,980,O
NSC,981,984,B-Cell
had,985,988,O
elongated,989,998,O
processes,999,1008,O
oriented,1009,1017,O
parallel,1018,1026,O
to,1027,1029,O
the,1030,1033,O
grooves,1034,1041,O
",",1041,1042,O
whereas,1043,1050,O
the,1051,1054,O
NSC,1055,1058,B-Cell
on,1059,1061,O
the,1062,1065,O
nonpatterned,1066,1078,O
surfaces,1079,1087,O
did,1088,1091,O
not,1092,1095,O
exhibit,1096,1103,O
a,1104,1105,O
particular,1106,1116,O
bias,1117,1121,O
in,1122,1124,O
alignment,1125,1134,O
.,1134,1135,O
In,1136,1138,O
vivo,1139,1143,O
",",1143,1144,O
the,1145,1148,O
number,1149,1155,O
of,1156,1158,O
regenerated,1159,1170,O
axons,1171,1176,O
",",1176,1177,O
the,1178,1181,O
regenerated,1182,1193,O
area,1194,1198,O
",",1198,1199,O
and,1200,1203,O
the,1204,1207,O
number,1208,1214,O
of,1215,1217,O
blood,1218,1223,B-Multi-tissue_structure
vessels,1224,1231,I-Multi-tissue_structure
were,1232,1236,O
significantly,1237,1250,O
higher,1251,1257,O
in,1258,1260,O
the,1261,1264,O
NSC,1265,1268,B-Cell
-,1268,1269,O
preseeded,1269,1278,O
conduit,1279,1286,O
.,1286,1287,O
CONCLUSION,1288,1298,O
:,1298,1299,O
Modification,1300,1312,O
of,1313,1315,O
the,1316,1319,O
chitosan,1320,1328,O
matrix,1329,1335,O
by,1336,1338,O
gold,1339,1343,O
nanoparticles,1344,1357,O
not,1358,1361,O
only,1362,1366,O
provides,1367,1375,O
the,1376,1379,O
mechanical,1380,1390,O
strength,1391,1399,O
but,1400,1403,O
also,1404,1408,O
affects,1409,1416,O
the,1417,1420,O
cellular,1421,1429,B-Cell
response,1430,1438,O
.,1438,1439,O
The,1440,1443,O
preliminary,1444,1455,O
in,1456,1458,O
vivo,1459,1463,O
data,1464,1468,O
demonstrated,1469,1481,O
that,1482,1486,O
the,1487,1490,O
biodegradable,1491,1504,O
micropatterned,1505,1519,O
conduits,1520,1528,O
preseeded,1529,1538,O
with,1539,1543,O
NSC,1544,1547,B-Cell
provided,1548,1556,O
a,1557,1558,O
combination,1559,1570,O
of,1571,1573,O
physical,1574,1582,O
and,1583,1586,O
biological,1587,1597,O
guidance,1598,1606,O
cues,1607,1611,O
for,1612,1615,O
regenerating,1616,1628,O
axons,1629,1634,B-Cellular_component
at,1635,1637,O
the,1638,1641,O
cellular,1642,1650,B-Cell
level,1651,1656,O
and,1657,1660,O
offered,1661,1668,O
a,1669,1670,O
better,1671,1677,O
alternative,1678,1689,O
for,1690,1693,O
repairing,1694,1703,O
sciatic,1704,1711,B-Multi-tissue_structure
nerve,1712,1717,I-Multi-tissue_structure
transactions,1718,1730,O
.,1730,1731,O
[,0,1,O
The,1,4,O
clinical,5,13,O
and,14,17,O
laboratory,18,28,O
features,29,37,O
of,38,40,O
acute,41,46,O
promyelocytic,47,60,O
leukemia,61,69,O
:,69,70,O
an,71,73,O
analysis,74,82,O
of,83,85,O
513,86,89,O
cases,90,95,O
],95,96,O
.,96,97,O
OBJECTIVE,98,107,O
:,107,108,O
To,109,111,O
investigate,112,123,O
the,124,127,O
clinical,128,136,O
and,137,140,O
laboratory,141,151,O
features,152,160,O
of,161,163,O
acute,164,169,O
promyelocytic,170,183,O
leukemia,184,192,O
(,193,194,O
APL,194,197,O
),197,198,O
.,198,199,O
METHODS,200,207,O
:,207,208,O
513,209,212,O
APL,213,216,O
patients,217,225,O
in,226,228,O
the,229,232,O
last,233,237,O
two,238,241,O
decades,242,249,O
were,250,254,O
retrospectively,255,270,O
analyzed,271,279,O
in,280,282,O
this,283,287,O
research,288,296,O
.,296,297,O
We,298,300,O
investigated,301,313,O
the,314,317,O
clinical,318,326,O
features,327,335,O
including,336,345,O
age,346,349,O
",",349,350,O
sex,351,354,O
",",354,355,O
abnormality,356,367,O
of,368,370,O
peripheral,371,381,O
hemogram,382,390,O
before,391,397,O
treatment,398,407,O
",",407,408,O
therapeutic,409,420,O
effect,421,427,O
and,428,431,O
follow,432,438,O
-,438,439,O
up,439,441,O
and,442,445,O
laboratory,446,456,O
data,457,461,O
such,462,466,O
as,467,469,O
morphology,470,480,O
",",480,481,O
immunology,482,492,O
",",492,493,O
cytogenetics,494,506,O
and,507,510,O
molecular,511,520,O
biology,521,528,O
(,529,530,O
MICM,530,534,O
),534,535,O
.,535,536,O
RESULTS,537,544,O
:,544,545,O
The,546,549,O
median,550,556,O
age,557,560,O
of,561,563,O
the,564,567,O
APL,568,571,O
patients,572,580,O
was,581,584,O
33,585,587,O
years,588,593,O
old,594,597,O
and,598,601,O
the,602,605,O
ratio,606,611,O
of,612,614,O
male,615,619,O
and,620,623,O
female,624,630,O
was,631,634,O
1,635,636,O
.,636,637,O
21,637,639,O
:,639,640,O
1,640,641,O
.,641,642,O
Before,643,649,O
treatment,650,659,O
",",659,660,O
the,661,664,O
median,665,671,O
level,672,677,O
of,678,680,O
WBC,681,684,B-Cell
was,685,688,O
4,689,690,O
.,690,691,O
3,691,692,O
x,693,694,O
10,695,697,O
(,697,698,O
9,698,699,O
),699,700,O
/,700,701,O
L,701,702,O
and,703,706,O
the,707,710,O
detection,711,720,O
rate,721,725,O
of,726,728,O
abnormal,729,737,O
promyelocyte,738,750,B-Cell
on,751,753,O
blood,754,759,B-Organism_substance
film,760,764,O
was,765,768,O
85,769,771,O
.,771,772,O
8,772,773,O
%,773,774,O
;,774,775,O
with,776,780,O
immunophenotypic,781,797,O
detection,798,807,O
",",807,808,O
the,809,812,O
expression,813,823,O
levels,824,830,O
of,831,833,O
CD117,834,839,O
",",839,840,O
CD34,841,845,O
",",845,846,O
HLA,847,850,O
-,850,851,O
DR,851,853,O
",",853,854,O
CD7,855,858,O
",",858,859,O
CD14,860,864,O
and,865,868,O
CD19,869,873,O
in,874,876,O
APL,877,880,O
were,881,885,O
found,886,891,O
to,892,894,O
be,895,897,O
lower,898,903,O
and,904,907,O
the,908,911,O
expression,912,922,O
levels,923,929,O
of,930,932,O
CD2,933,936,O
",",936,937,O
CD33,938,942,O
and,943,946,O
MPO,947,950,O
higher,951,957,O
than,958,962,O
those,963,968,O
in,969,971,O
other,972,977,O
subtypes,978,986,O
of,987,989,O
acute,990,995,O
myelocytic,996,1006,O
leukemia,1007,1015,O
(,1016,1017,O
AML,1017,1020,O
),1020,1021,O
(,1022,1023,O
both,1023,1027,O
P,1028,1029,O
<,1030,1031,O
0,1032,1033,O
.,1033,1034,O
01,1034,1036,O
),1036,1037,O
.,1037,1038,O
Specific,1039,1047,O
abnormal,1048,1056,O
chromosome,1057,1067,B-Cellular_component
t,1068,1069,O
(,1070,1071,O
15,1071,1073,O
;,1073,1074,O
17,1074,1076,O
),1076,1077,O
was,1078,1081,O
detected,1082,1090,O
in,1091,1093,O
91,1094,1096,O
.,1096,1097,O
7,1097,1098,O
%,1098,1099,O
of,1100,1102,O
the,1103,1106,O
patients,1107,1115,O
",",1115,1116,O
of,1117,1119,O
whom,1120,1124,O
75,1125,1127,O
.,1127,1128,O
9,1128,1129,O
%,1129,1130,O
had,1131,1134,O
standard,1135,1143,O
translocation,1144,1157,O
of,1158,1160,O
t,1161,1162,O
(,1163,1164,O
15,1164,1166,O
;,1166,1167,O
17,1167,1169,O
),1169,1170,O
",",1170,1171,O
being,1172,1177,O
the,1178,1181,O
most,1182,1186,O
common,1187,1193,O
one,1194,1197,O
and,1198,1201,O
15,1202,1204,O
.,1204,1205,O
8,1205,1206,O
%,1206,1207,O
of,1208,1210,O
the,1211,1214,O
patients,1215,1223,O
had,1224,1227,O
t,1228,1229,O
(,1230,1231,O
15,1231,1233,O
;,1233,1234,O
17,1234,1236,O
),1236,1237,O
with,1238,1242,O
additional,1243,1253,O
abnormal,1254,1262,O
chromosome,1263,1273,B-Cellular_component
.,1273,1274,O
There,1275,1280,O
was,1281,1284,O
only,1285,1289,O
7,1290,1291,O
.,1291,1292,O
5,1292,1293,O
%,1293,1294,O
of,1295,1297,O
the,1298,1301,O
patients,1302,1310,O
with,1311,1315,O
normal,1316,1322,O
karyotype,1323,1332,O
.,1332,1333,O
However,1334,1341,O
",",1341,1342,O
the,1343,1346,O
presence,1347,1355,O
of,1356,1358,O
both,1359,1363,O
simple,1364,1370,O
translocation,1371,1384,O
and,1385,1388,O
complex,1389,1396,O
translocation,1397,1410,O
was,1411,1414,O
seldom,1415,1421,O
seen,1422,1426,O
.,1426,1427,O
With,1428,1432,O
molecular,1433,1442,O
biological,1443,1453,O
detection,1454,1463,O
",",1463,1464,O
PML,1465,1468,O
/,1468,1469,O
RARalpha,1469,1477,O
fusion,1478,1484,O
gene,1485,1489,O
positive,1490,1498,O
rate,1499,1503,O
was,1504,1507,O
99,1508,1510,O
.,1510,1511,O
6,1511,1512,O
%,1512,1513,O
.,1513,1514,O
In,1515,1517,O
a,1518,1519,O
relatively,1520,1530,O
long,1531,1535,O
clinical,1536,1544,O
follow,1545,1551,O
-,1551,1552,O
up,1552,1554,O
",",1554,1555,O
we,1556,1558,O
found,1559,1564,O
that,1565,1569,O
the,1570,1573,O
complete,1574,1582,O
remission,1583,1592,O
(,1593,1594,O
CR,1594,1596,O
),1596,1597,O
rate,1598,1602,O
in,1603,1605,O
APL,1606,1609,O
patients,1610,1618,O
was,1619,1622,O
84,1623,1625,O
.,1625,1626,O
7,1626,1627,O
%,1627,1628,O
",",1628,1629,O
incidence,1630,1639,O
of,1640,1642,O
DIC,1643,1646,O
was,1647,1650,O
13,1651,1653,O
.,1653,1654,O
4,1654,1655,O
%,1655,1656,O
and,1657,1660,O
five,1661,1665,O
-,1665,1666,O
year,1666,1670,O
survival,1671,1679,O
rate,1680,1684,O
was,1685,1688,O
30,1689,1691,O
.,1691,1692,O
7,1692,1693,O
%,1693,1694,O
.,1694,1695,O
The,1696,1699,O
median,1700,1706,O
count,1707,1712,O
of,1713,1715,O
WBC,1716,1719,B-Cell
in,1720,1722,O
CR,1723,1725,O
group,1726,1731,O
was,1732,1735,O
lower,1736,1741,O
than,1742,1746,O
that,1747,1751,O
non,1752,1755,O
-,1755,1756,O
remission,1756,1765,O
group,1766,1771,O
(,1772,1773,O
P,1773,1774,O
<,1775,1776,O
0,1777,1778,O
.,1778,1779,O
01,1779,1781,O
),1781,1782,O
.,1782,1783,O
There,1784,1789,O
were,1790,1794,O
no,1795,1797,O
significant,1798,1809,O
differences,1810,1821,O
on,1822,1824,O
expressions,1825,1836,O
of,1837,1839,O
CD34,1840,1844,O
and,1845,1848,O
CD2,1849,1852,O
and,1853,1856,O
changes,1857,1864,O
of,1865,1867,O
cytogenetics,1868,1880,O
between,1881,1888,O
the,1889,1892,O
two,1893,1896,O
groups,1897,1903,O
(,1904,1905,O
P,1905,1906,O
>,1907,1908,O
0,1909,1910,O
.,1910,1911,O
05,1911,1913,O
),1913,1914,O
.,1914,1915,O
CONCLUSIONS,1916,1927,O
:,1927,1928,O
Comprehensive,1929,1942,O
evaluation,1943,1953,O
of,1954,1956,O
MICM,1957,1961,O
could,1962,1967,O
be,1968,1970,O
of,1971,1973,O
important,1974,1983,O
significance,1984,1996,O
in,1997,1999,O
the,2000,2003,O
diagnosis,2004,2013,O
and,2014,2017,O
prognosis,2018,2027,O
judgment,2028,2036,O
for,2037,2040,O
APL,2041,2044,O
patients,2045,2053,O
.,2053,2054,O
The,2055,2058,O
CR,2059,2061,O
rate,2062,2066,O
in,2067,2069,O
these,2070,2075,O
patients,2076,2084,O
with,2085,2089,O
high,2090,2094,O
WBC,2095,2098,B-Cell
count,2099,2104,O
was,2105,2108,O
considerable,2109,2121,O
low,2122,2125,O
.,2125,2126,O
Cognitive,0,9,O
function,10,18,O
and,19,22,O
number,23,29,O
of,30,32,O
teeth,33,38,B-Organ
in,39,41,O
a,42,43,O
community,44,53,O
-,53,54,O
dwelling,54,62,O
elderly,63,70,O
population,71,81,O
without,82,89,O
dementia,90,98,O
.,98,99,O
Although,100,108,O
the,109,112,O
number,113,119,O
of,120,122,O
sound,123,128,O
or,129,131,O
decayed,132,139,O
teeth,140,145,B-Organ
has,146,149,O
been,150,154,O
reported,155,163,O
to,164,166,O
be,167,169,O
associated,170,180,O
with,181,185,O
cognitive,186,195,O
function,196,204,O
in,205,207,O
elderly,208,215,O
populations,216,227,O
with,228,232,O
dementia,233,241,O
",",241,242,O
little,243,249,O
is,250,252,O
known,253,258,O
about,259,264,O
this,265,269,O
association,270,281,O
in,282,284,O
elderly,285,292,O
populations,293,304,O
without,305,312,O
dementia,313,321,O
.,321,322,O
We,323,325,O
evaluated,326,335,O
this,336,340,O
relationship,341,353,O
",",353,354,O
with,355,359,O
adjustment,360,370,O
for,371,374,O
confounding,375,386,O
factors,387,394,O
",",394,395,O
in,396,398,O
Japanese,399,407,O
populations,408,419,O
of,420,422,O
60,423,425,O
-,425,426,O
year,426,430,O
-,430,431,O
old,431,434,O
(,435,436,O
n,436,437,O
=,438,439,O
270,440,443,O
;,443,444,O
120,445,448,O
males,449,454,O
and,455,458,O
150,459,462,O
females,463,470,O
),470,471,O
and,472,475,O
65,476,478,O
-,478,479,O
year,479,483,O
-,483,484,O
old,484,487,O
(,488,489,O
n,489,490,O
=,491,492,O
123,493,496,O
;,496,497,O
57,498,500,O
males,501,506,O
and,507,510,O
66,511,513,O
females,514,521,O
),521,522,O
individuals,523,534,O
residing,535,543,O
in,544,546,O
Fukuoka,547,554,O
Prefecture,555,565,O
of,566,568,O
Japan,569,574,O
.,574,575,O
Dental,576,582,O
examinations,583,595,O
were,596,600,O
performed,601,610,O
in,611,613,O
all,614,617,O
subjects,618,626,O
",",626,627,O
along,628,633,O
with,634,638,O
the,639,642,O
Mini,643,647,O
-,647,648,O
mental,648,654,O
state,655,660,O
examination,661,672,O
(,673,674,O
MMSE,674,678,O
),678,679,O
for,680,683,O
assessing,684,693,O
cognitive,694,703,O
function,704,712,O
.,712,713,O
Among,714,719,O
the,720,723,O
total,724,729,O
of,730,732,O
393,733,736,O
subjects,737,745,O
",",745,746,O
the,747,750,O
mean,751,755,O
MMSE,756,760,O
score,761,766,O
was,767,770,O
27,771,773,O
.,773,774,O
9,774,775,O
+,776,777,O
/,777,778,O
-,778,779,O
1,780,781,O
.,781,782,O
9,782,783,O
",",783,784,O
and,785,788,O
391,789,792,O
subjects,793,801,O
scored,802,808,O
24,809,811,O
or,812,814,O
higher,815,821,O
.,821,822,O
The,823,826,O
mean,827,831,O
numbers,832,839,O
of,840,842,O
sound,843,848,O
and,849,852,O
decayed,853,860,O
teeth,861,866,B-Organ
were,867,871,O
12,872,874,O
.,874,875,O
0,875,876,O
+,877,878,O
/,878,879,O
-,879,880,O
6,881,882,O
.,882,883,O
3,883,884,O
and,885,888,O
0,889,890,O
.,890,891,O
5,891,892,O
+,893,894,O
/,894,895,O
-,895,896,O
1,897,898,O
.,898,899,O
2,899,900,O
",",900,901,O
respectively,902,914,O
.,914,915,O
Associations,916,928,O
were,929,933,O
found,934,939,O
between,940,947,O
the,948,951,O
numbers,952,959,O
of,960,962,O
sound,963,968,O
and,969,972,O
decayed,973,980,O
teeth,981,986,B-Organ
and,987,990,O
MMSE,991,995,O
in,996,998,O
total,999,1004,O
subjects,1005,1013,O
and,1014,1017,O
males,1018,1023,O
",",1023,1024,O
but,1025,1028,O
not,1029,1032,O
in,1033,1035,O
females,1036,1043,O
",",1043,1044,O
by,1045,1047,O
multiple,1048,1056,O
regression,1057,1067,O
analysis,1068,1076,O
adjusted,1077,1085,O
for,1086,1089,O
gender,1090,1096,O
",",1096,1097,O
age,1098,1101,O
",",1101,1102,O
level,1103,1108,O
of,1109,1111,O
education,1112,1121,O
",",1121,1122,O
marital,1123,1130,O
status,1131,1137,O
",",1137,1138,O
smoking,1139,1146,O
",",1146,1147,O
alcohol,1148,1155,O
drinking,1156,1164,O
",",1164,1165,O
working,1166,1173,O
status,1174,1180,O
",",1180,1181,O
systolic,1182,1190,O
blood,1191,1196,B-Organism_substance
pressure,1197,1205,O
and,1206,1209,O
blood,1210,1215,B-Organism_substance
glucose,1216,1223,O
.,1223,1224,O
An,1225,1227,O
association,1228,1239,O
was,1240,1243,O
also,1244,1248,O
found,1249,1254,O
between,1255,1262,O
MMSE,1263,1267,O
and,1268,1271,O
the,1272,1275,O
number,1276,1282,O
of,1283,1285,O
sound,1286,1291,O
teeth,1292,1297,B-Organ
in,1298,1300,O
a,1301,1302,O
logistic,1303,1311,O
regression,1312,1322,O
analysis,1323,1331,O
.,1331,1332,O
In,1333,1335,O
conclusion,1336,1346,O
",",1346,1347,O
associations,1348,1360,O
were,1361,1365,O
found,1366,1371,O
between,1372,1379,O
normal,1380,1386,O
-,1386,1387,O
range,1387,1392,O
cognitive,1393,1402,O
function,1403,1411,O
and,1412,1415,O
the,1416,1419,O
numbers,1420,1427,O
of,1428,1430,O
sound,1431,1436,O
and,1437,1440,O
decayed,1441,1448,O
teeth,1449,1454,B-Organ
",",1454,1455,O
after,1456,1461,O
adjustment,1462,1472,O
for,1473,1476,O
various,1477,1484,O
confounding,1485,1496,O
factors,1497,1504,O
",",1504,1505,O
in,1506,1508,O
an,1509,1511,O
elderly,1512,1519,O
Japanese,1520,1528,O
population,1529,1539,O
.,1539,1540,O
Comment,0,7,O
on,8,10,O
"""",11,12,O
Why,12,15,O
reduced,16,23,O
-,23,24,O
form,24,28,O
regression,29,39,O
models,40,46,O
of,47,49,O
health,50,56,O
effects,57,64,O
versus,65,71,O
exposures,72,81,O
should,82,88,O
not,89,92,O
replace,93,100,O
QRA,101,104,O
:,104,105,O
livestock,106,115,O
production,116,126,O
and,127,130,O
infant,131,137,O
mortality,138,147,O
as,148,150,O
an,151,153,O
example,154,161,O
",",161,162,O
"""",162,163,O
by,164,166,O
Louis,167,172,O
Anthony,173,180,O
(,181,182,O
Tony,182,186,O
),186,187,O
Cox,188,191,O
",",191,192,O
Jr,193,195,O
.,195,196,O
",",196,197,O
Risk,198,202,O
Analysis,203,211,O
2009,212,216,O
",",216,217,O
Vol,218,221,O
.,221,222,O
29,223,225,O
",",225,226,O
No,227,229,O
.,229,230,O
12,231,233,O
.,233,234,O
While,235,240,O
a,241,242,O
recent,243,249,O
paper,250,255,O
by,256,258,O
Cox,259,262,O
in,263,265,O
this,266,270,O
journal,271,278,O
uses,279,283,O
as,284,286,O
its,287,290,O
motivating,291,301,O
factor,302,308,O
the,309,312,O
benefits,313,321,O
of,322,324,O
quantitative,325,337,O
risk,338,342,O
assessment,343,353,O
",",353,354,O
its,355,358,O
content,359,366,O
is,367,369,O
entirely,370,378,O
devoted,379,386,O
to,387,389,O
critiquing,390,400,O
Sneeringer,401,411,O
',411,412,O
s,412,413,O
article,414,421,O
in,422,424,O
the,425,428,O
American,429,437,O
Journal,438,445,O
of,446,448,O
Agricultural,449,461,O
Economics,462,471,O
.,471,472,O
Cox,473,476,O
',476,477,O
s,477,478,O
two,479,482,O
main,483,487,O
critiques,488,497,O
of,498,500,O
Sneeringer,501,511,O
are,512,515,O
fundamentally,516,529,O
flawed,530,536,O
and,537,540,O
misrepresent,541,553,O
the,554,557,O
original,558,566,O
article,567,574,O
.,574,575,O
Cox,576,579,O
posits,580,586,O
that,587,591,O
Sneeringer,592,602,O
did,603,606,O
A,607,608,O
and,609,612,O
B,613,614,O
",",614,615,O
and,616,619,O
then,620,624,O
argues,625,631,O
why,632,635,O
A,636,637,O
and,638,641,O
B,642,643,O
are,644,647,O
incorrect,648,657,O
.,657,658,O
However,659,666,O
",",666,667,O
Sneeringer,668,678,O
in,679,681,O
fact,682,686,O
did,687,690,O
C,691,692,O
and,693,696,O
D,697,698,O
;,698,699,O
thus,700,704,O
critiques,705,714,O
of,715,717,O
A,718,719,O
and,720,723,O
B,724,725,O
are,726,729,O
not,730,733,O
applicable,734,744,O
to,745,747,O
Sneeringer,748,758,O
',758,759,O
s,759,760,O
analysis,761,769,O
.,769,770,O
Prognostic,0,10,O
significance,11,23,O
of,24,26,O
TRAIL,27,32,O
signaling,33,42,O
molecules,43,52,O
in,53,55,O
stage,56,61,B-Pathological_formation
II,62,64,I-Pathological_formation
and,65,68,I-Pathological_formation
III,69,72,I-Pathological_formation
colorectal,73,83,I-Pathological_formation
cancer,84,90,I-Pathological_formation
.,90,91,O
PURPOSE,92,99,O
:,99,100,O
We,101,103,O
previously,104,114,O
found,115,120,O
that,121,125,O
cellular,126,134,O
FLICE,135,140,O
-,140,141,O
inhibitory,141,151,O
protein,152,159,O
(,160,161,O
c,161,162,O
-,162,163,O
FLIP,163,167,O
),167,168,O
",",168,169,O
caspase,170,177,O
8,178,179,O
",",179,180,O
and,181,184,O
tumor,185,190,O
necrosis,191,199,O
factor,200,206,O
-,206,207,O
related,207,214,O
apoptosis,215,224,O
-,224,225,O
inducing,225,233,O
ligand,234,240,O
(,241,242,O
TRAIL,242,247,O
),247,248,O
receptor,249,257,O
2,258,259,O
(,260,261,O
DR5,261,264,O
),264,265,O
are,266,269,O
major,270,275,O
regulators,276,286,O
of,287,289,O
cell,290,294,B-Cell
viability,295,304,O
and,305,308,O
chemotherapy,309,321,O
-,321,322,O
induced,322,329,O
apoptosis,330,339,O
in,340,342,O
colorectal,343,353,B-Pathological_formation
cancer,354,360,I-Pathological_formation
.,360,361,O
In,362,364,O
this,365,369,O
study,370,375,O
",",375,376,O
we,377,379,O
determined,380,390,O
the,391,394,O
prognostic,395,405,O
significance,406,418,O
of,419,421,O
c,422,423,O
-,423,424,O
FLIP,424,428,O
",",428,429,O
caspase,430,437,O
8,438,439,O
",",439,440,O
TRAIL,441,446,O
and,447,450,O
DR5,451,454,O
expression,455,465,O
in,466,468,O
tissues,469,476,B-Tissue
from,477,481,O
patients,482,490,O
with,491,495,O
stage,496,501,B-Pathological_formation
II,502,504,I-Pathological_formation
and,505,508,I-Pathological_formation
III,509,512,I-Pathological_formation
colorectal,513,523,I-Pathological_formation
cancer,524,530,I-Pathological_formation
.,530,531,O
EXPERIMENTAL,532,544,O
DESIGN,545,551,O
:,551,552,O
Tissue,553,559,B-Tissue
microarrays,560,571,O
were,572,576,O
constructed,577,588,O
from,589,593,O
matched,594,601,O
normal,602,608,B-Tissue
and,609,612,O
tumor,613,618,B-Tissue
tissue,619,625,I-Tissue
derived,626,633,O
from,634,638,O
patients,639,647,O
(,648,649,O
n,649,650,O
=,651,652,O
253,653,656,O
),656,657,O
enrolled,658,666,O
in,667,669,O
a,670,671,O
phase,672,677,O
III,678,681,O
trial,682,687,O
of,688,690,O
adjuvant,691,699,O
5,700,701,O
-,701,702,O
fluorouracil,702,714,O
-,714,715,O
based,715,720,O
chemotherapy,721,733,O
versus,734,740,O
postoperative,741,754,O
observation,755,766,O
alone,767,772,O
.,772,773,O
TRAIL,774,779,O
",",779,780,O
DR5,781,784,O
",",784,785,O
caspase,786,793,O
8,794,795,O
",",795,796,O
and,797,800,O
c,801,802,O
-,802,803,O
FLIP,803,807,O
expression,808,818,O
levels,819,825,O
were,826,830,O
determined,831,841,O
by,842,844,O
immunohistochemistry,845,865,O
.,865,866,O
RESULTS,867,874,O
:,874,875,O
Colorectal,876,886,B-Pathological_formation
tumors,887,893,I-Pathological_formation
displayed,894,903,O
significantly,904,917,O
higher,918,924,O
expression,925,935,O
levels,936,942,O
of,943,945,O
c,946,947,O
-,947,948,O
FLIP,948,952,O
(,953,954,O
P,954,955,O
<,956,957,O
0,958,959,O
.,959,960,O
001,960,963,O
),963,964,O
",",964,965,O
caspase,966,973,O
8,974,975,O
(,976,977,O
P,977,978,O
=,979,980,O
0,981,982,O
.,982,983,O
01,983,985,O
),985,986,O
",",986,987,O
and,988,991,O
DR5,992,995,O
(,996,997,O
P,997,998,O
<,999,1000,O
0,1001,1002,O
.,1002,1003,O
001,1003,1006,O
),1006,1007,O
",",1007,1008,O
but,1009,1012,O
lower,1013,1018,O
levels,1019,1025,O
of,1026,1028,O
TRAIL,1029,1034,O
(,1035,1036,O
P,1036,1037,O
<,1038,1039,O
0,1040,1041,O
.,1041,1042,O
001,1042,1045,O
),1045,1046,O
compared,1047,1055,O
with,1056,1060,O
matched,1061,1068,O
normal,1069,1075,B-Tissue
tissue,1076,1082,I-Tissue
.,1082,1083,O
In,1084,1086,O
univariate,1087,1097,O
analysis,1098,1106,O
",",1106,1107,O
higher,1108,1114,O
TRAIL,1115,1120,O
expression,1121,1131,O
in,1132,1134,O
the,1135,1138,O
tumor,1139,1144,B-Pathological_formation
was,1145,1148,O
associated,1149,1159,O
with,1160,1164,O
worse,1165,1170,O
overall,1171,1178,O
survival,1179,1187,O
(,1188,1189,O
P,1189,1190,O
=,1191,1192,O
0,1193,1194,O
.,1194,1195,O
026,1195,1198,O
),1198,1199,O
",",1199,1200,O
with,1201,1205,O
a,1206,1207,O
trend,1208,1213,O
to,1214,1216,O
decreased,1217,1226,O
relapse,1227,1234,O
-,1234,1235,O
free,1235,1239,O
survival,1240,1248,O
(,1249,1250,O
RFS,1250,1253,O
;,1253,1254,O
P,1255,1256,O
=,1257,1258,O
0,1259,1260,O
.,1260,1261,O
06,1261,1263,O
),1263,1264,O
",",1264,1265,O
and,1266,1269,O
higher,1270,1276,O
tumor,1277,1282,B-Pathological_formation
c,1283,1284,O
-,1284,1285,O
FLIP,1285,1289,O
expression,1290,1300,O
was,1301,1304,O
associated,1305,1315,O
with,1316,1320,O
a,1321,1322,O
significantly,1323,1336,O
decreased,1337,1346,O
RFS,1347,1350,O
(,1351,1352,O
P,1352,1353,O
=,1354,1355,O
0,1356,1357,O
.,1357,1358,O
015,1358,1361,O
),1361,1362,O
.,1362,1363,O
Using,1364,1369,O
multivariate,1370,1382,O
predictive,1383,1393,O
modeling,1394,1402,O
for,1403,1406,O
RFS,1407,1410,O
in,1411,1413,O
all,1414,1417,O
patients,1418,1426,O
and,1427,1430,O
including,1431,1440,O
all,1441,1444,O
biomarkers,1445,1455,O
",",1455,1456,O
age,1457,1460,O
",",1460,1461,O
treatment,1462,1471,O
",",1471,1472,O
and,1473,1476,O
stage,1477,1482,O
",",1482,1483,O
we,1484,1486,O
found,1487,1492,O
that,1493,1497,O
the,1498,1501,O
model,1502,1507,O
was,1508,1511,O
significant,1512,1523,O
when,1524,1528,O
the,1529,1532,O
mean,1533,1537,O
tumor,1538,1543,B-Pathological_formation
c,1544,1545,O
-,1545,1546,O
FLIP,1546,1550,O
expression,1551,1561,O
score,1562,1567,O
and,1568,1571,O
disease,1572,1579,O
stage,1580,1585,O
were,1586,1590,O
included,1591,1599,O
(,1600,1601,O
P,1601,1602,O
<,1603,1604,O
0,1605,1606,O
.,1606,1607,O
001,1607,1610,O
),1610,1611,O
.,1611,1612,O
As,1613,1615,O
regards,1616,1623,O
overall,1624,1631,O
survival,1632,1640,O
",",1640,1641,O
the,1642,1645,O
overall,1646,1653,O
model,1654,1659,O
was,1660,1663,O
predictive,1664,1674,O
when,1675,1679,O
both,1680,1684,O
TRAIL,1685,1690,O
expression,1691,1701,O
and,1702,1705,O
disease,1706,1713,O
stage,1714,1719,O
were,1720,1724,O
included,1725,1733,O
(,1734,1735,O
P,1735,1736,O
<,1737,1738,O
0,1739,1740,O
.,1740,1741,O
001,1741,1744,O
),1744,1745,O
.,1745,1746,O
CONCLUSIONS,1747,1758,O
:,1758,1759,O
High,1760,1764,O
c,1765,1766,O
-,1766,1767,O
FLIP,1767,1771,O
and,1772,1775,O
TRAIL,1776,1781,O
expression,1782,1792,O
may,1793,1796,O
be,1797,1799,O
independent,1800,1811,O
adverse,1812,1819,O
prognostic,1820,1830,O
markers,1831,1838,O
in,1839,1841,O
stage,1842,1847,B-Pathological_formation
II,1848,1850,I-Pathological_formation
and,1851,1854,I-Pathological_formation
III,1855,1858,I-Pathological_formation
colorectal,1859,1869,I-Pathological_formation
cancer,1870,1876,I-Pathological_formation
and,1877,1880,O
might,1881,1886,O
identify,1887,1895,O
patients,1896,1904,O
most,1905,1909,O
at,1910,1912,O
risk,1913,1917,O
of,1918,1920,O
relapse,1921,1928,O
.,1928,1929,O
Influences,0,10,O
on,11,13,O
the,14,17,O
pharmacokinetics,18,34,O
of,35,37,O
oxycodone,38,47,O
:,47,48,O
a,49,50,O
multicentre,51,62,O
cross,63,68,O
-,68,69,O
sectional,69,78,O
study,79,84,O
in,85,87,O
439,88,91,O
adult,92,97,O
cancer,98,104,B-Pathological_formation
patients,105,113,O
.,113,114,O
OBJECTIVE,115,124,O
:,124,125,O
Oxycodone,126,135,O
is,136,138,O
widely,139,145,O
used,146,150,O
for,151,154,O
the,155,158,O
treatment,159,168,O
of,169,171,O
cancer,172,178,B-Pathological_formation
pain,179,183,O
",",183,184,O
but,185,188,O
little,189,195,O
is,196,198,O
known,199,204,O
of,205,207,O
its,208,211,O
pharmacokinetics,212,228,O
in,229,231,O
cancer,232,238,B-Pathological_formation
pain,239,243,O
patients,244,252,O
.,252,253,O
The,254,257,O
aim,258,261,O
of,262,264,O
this,265,269,O
study,270,275,O
was,276,279,O
to,280,282,O
explore,283,290,O
the,291,294,O
relationships,295,308,O
between,309,316,O
ordinary,317,325,O
patient,326,333,O
characteristics,334,349,O
and,350,353,O
serum,354,359,B-Organism_substance
concentrations,360,374,O
of,375,377,O
oxycodone,378,387,O
and,388,391,O
the,392,395,O
ratios,396,402,O
noroxycodone,403,415,O
or,416,418,O
oxymorphone,419,430,O
/,430,431,O
oxycodone,431,440,O
in,441,443,O
cancer,444,450,B-Pathological_formation
patients,451,459,O
.,459,460,O
METHODS,461,468,O
:,468,469,O
Four,470,474,O
hundred,475,482,O
and,483,486,O
thirty,487,493,O
-,493,494,O
nine,494,498,O
patients,499,507,O
using,508,513,O
oral,514,518,O
oxycodone,519,528,O
for,529,532,O
cancer,533,539,B-Pathological_formation
pain,540,544,O
were,545,549,O
included,550,558,O
.,558,559,O
The,560,563,O
patients,564,572,O
',572,573,O
characteristics,574,589,O
(,590,591,O
sex,591,594,O
",",594,595,O
age,596,599,O
",",599,600,O
body,601,605,B-Organism_subdivision
mass,606,610,O
index,611,616,O
[,617,618,O
BMI,618,621,O
],621,622,O
",",622,623,O
Karnofsky,624,633,O
performance,634,645,O
status,646,652,O
",",652,653,O
"""",654,655,O
time,655,659,O
since,660,665,O
starting,666,674,O
opioids,675,682,O
"""",682,683,O
",",683,684,O
"""",685,686,O
oxycodone,686,695,O
total,696,701,O
daily,702,707,O
dose,708,712,O
"""",712,713,O
",",713,714,O
"""",715,716,O
time,716,720,O
from,721,725,O
last,726,730,O
oxycodone,731,740,O
dose,741,745,O
"""",745,746,O
",",746,747,O
use,748,751,O
of,752,754,O
CYP3A4,755,761,O
inducer,762,769,O
/,769,770,O
inhibitor,770,779,O
",",779,780,O
"""",781,782,O
use,782,785,O
of,786,788,O
systemic,789,797,O
steroids,798,806,O
"""",806,807,O
",",807,808,O
"""",809,810,O
number,810,816,O
of,817,819,O
medications,820,831,O
taken,832,837,O
in,838,840,O
the,841,844,O
last,845,849,O
24,850,852,O
h,853,854,O
"""",854,855,O
",",855,856,O
glomerular,857,867,B-Multi-tissue_structure
filtration,868,878,O
rate,879,883,O
(,884,885,O
GFR,885,888,O
),888,889,O
and,890,893,O
albumin,894,901,O
serum,902,907,B-Organism_substance
concentrations,908,922,O
),922,923,O
influence,924,933,O
on,934,936,O
oxycodone,937,946,O
serum,947,952,B-Organism_substance
concentrations,953,967,O
or,968,970,O
metabolite,971,981,O
/,981,982,O
oxycodone,982,991,O
ratios,992,998,O
were,999,1003,O
explored,1004,1012,O
by,1013,1015,O
multiple,1016,1024,O
regression,1025,1035,O
analyses,1036,1044,O
.,1044,1045,O
RESULTS,1046,1053,O
:,1053,1054,O
Sex,1055,1058,O
",",1058,1059,O
CYP3A4,1060,1066,O
inducers,1067,1075,O
/,1075,1076,O
inhibitors,1076,1086,O
",",1086,1087,O
total,1088,1093,O
daily,1094,1099,O
dose,1100,1104,O
",",1104,1105,O
and,1106,1109,O
"""",1110,1111,O
time,1111,1115,O
from,1116,1120,O
last,1121,1125,O
oxycodone,1126,1135,O
dose,1136,1140,O
"""",1140,1141,O
predicted,1142,1151,O
oxycodone,1152,1161,O
concentrations,1162,1176,O
.,1176,1177,O
CYP3A4,1178,1184,O
inducers,1185,1193,O
",",1193,1194,O
total,1195,1200,O
daily,1201,1206,O
dose,1207,1211,O
",",1211,1212,O
and,1213,1216,O
"""",1217,1218,O
number,1218,1224,O
of,1225,1227,O
medications,1228,1239,O
taken,1240,1245,O
in,1246,1248,O
the,1249,1252,O
last,1253,1257,O
24,1258,1260,O
h,1261,1262,O
"""",1262,1263,O
predicted,1264,1273,O
the,1274,1277,O
oxymorphone,1278,1289,O
/,1289,1290,O
oxycodone,1290,1299,O
ratio,1300,1305,O
.,1305,1306,O
Total,1307,1312,O
daily,1313,1318,O
dose,1319,1323,O
",",1323,1324,O
"""",1325,1326,O
time,1326,1330,O
from,1331,1335,O
last,1336,1340,O
dose,1341,1345,O
to,1346,1348,O
blood,1349,1354,B-Organism_substance
sample,1355,1361,I-Organism_substance
"""",1361,1362,O
",",1362,1363,O
albumin,1364,1371,O
",",1371,1372,O
sex,1373,1376,O
",",1376,1377,O
CYP3A4,1378,1384,O
inducers,1385,1393,O
/,1393,1394,O
inhibitors,1394,1404,O
",",1404,1405,O
steroids,1406,1414,O
",",1414,1415,O
BMI,1416,1419,O
and,1420,1423,O
GFR,1424,1427,O
predicted,1428,1437,O
the,1438,1441,O
noroxycodone,1442,1454,O
/,1454,1455,O
oxycodone,1455,1464,O
ratio,1465,1470,O
.,1470,1471,O
CONCLUSION,1472,1482,O
:,1482,1483,O
Women,1484,1489,O
had,1490,1493,O
lower,1494,1499,O
oxycodone,1500,1509,O
serum,1510,1515,B-Organism_substance
concentrations,1516,1530,O
than,1531,1535,O
men,1536,1539,O
.,1539,1540,O
CYP3A4,1541,1547,O
inducers,1548,1556,O
/,1556,1557,O
inhibitors,1557,1567,O
should,1568,1574,O
be,1575,1577,O
used,1578,1582,O
with,1583,1587,O
caution,1588,1595,O
as,1596,1598,O
these,1599,1604,O
are,1605,1608,O
predicted,1609,1618,O
to,1619,1621,O
have,1622,1626,O
a,1627,1628,O
significant,1629,1640,O
impact,1641,1647,O
on,1648,1650,O
oxycodone,1651,1660,O
pharmacokinetics,1661,1677,O
.,1677,1678,O
Other,1679,1684,O
characteristics,1685,1700,O
explained,1701,1710,O
only,1711,1715,O
minor,1716,1721,O
parts,1722,1727,O
of,1728,1730,O
the,1731,1734,O
variability,1735,1746,O
of,1747,1749,O
the,1750,1753,O
outcomes,1754,1762,O
.,1762,1763,O
Phase,0,5,O
II,6,8,O
trial,9,14,O
with,15,19,O
D,20,21,O
-,21,22,O
Trp,22,25,O
-,25,26,O
6,26,27,O
-,27,28,O
LH,28,30,O
-,30,31,O
RH,31,33,O
in,34,36,O
prostatic,37,46,B-Pathological_formation
carcinoma,47,56,I-Pathological_formation
:,56,57,O
comparison,58,68,O
with,69,73,O
other,74,79,O
hormonal,80,88,O
agents,89,95,O
.,95,96,O
Various,97,104,O
approaches,105,115,O
to,116,118,O
hormonal,119,127,O
treatment,128,137,O
of,138,140,O
prostate,141,149,B-Pathological_formation
carcinoma,150,159,I-Pathological_formation
are,160,163,O
discussed,164,173,O
.,173,174,O
Eighty,175,181,O
-,181,182,O
one,182,185,O
patients,186,194,O
with,195,199,O
prostatic,200,209,B-Pathological_formation
carcinoma,210,219,I-Pathological_formation
",",219,220,O
eight,221,226,O
with,227,231,O
stage,232,237,O
B,238,239,O
",",239,240,O
nine,241,245,O
with,246,250,O
stage,251,256,O
C,257,258,O
",",258,259,O
and,260,263,O
64,264,266,O
with,267,271,O
stage,272,277,O
D,278,279,O
disease,280,287,O
",",287,288,O
were,289,293,O
treated,294,301,O
subcutaneously,302,316,O
daily,317,322,O
for,323,326,O
3,327,328,O
months,329,335,O
with,336,340,O
the,341,344,O
LH,345,347,O
-,347,348,O
RH,348,350,O
agonist,351,358,O
D,359,360,O
-,360,361,O
Trp,361,364,O
-,364,365,O
6,365,366,O
-,366,367,O
LH,367,369,O
-,369,370,O
RH,370,372,O
(,373,374,O
Decapeptyl,374,384,O
),384,385,O
in,386,388,O
order,389,394,O
to,395,397,O
evaluate,398,406,O
the,407,410,O
incidence,411,420,O
of,421,423,O
remissions,424,434,O
according,435,444,O
to,445,447,O
WHO,448,451,O
recommendations,452,467,O
for,468,471,O
oncologic,472,481,O
trials,482,488,O
.,488,489,O
The,490,493,O
findings,494,502,O
were,503,507,O
compared,508,516,O
to,517,519,O
those,520,525,O
obtained,526,534,O
with,535,539,O
other,540,545,O
hormonal,546,554,O
therapies,555,564,O
of,565,567,O
prostatic,568,577,B-Pathological_formation
carcinoma,578,587,I-Pathological_formation
according,588,597,O
to,598,600,O
the,601,604,O
statistical,605,616,O
method,617,623,O
of,624,626,O
"""",627,628,O
expected,628,636,O
response,637,645,O
rate,646,650,O
"""",650,651,O
as,652,654,O
adapted,655,662,O
by,663,665,O
Lee,666,669,O
and,670,673,O
Wesley,674,680,O
for,681,684,O
phase,685,690,O
II,691,693,O
trials,694,700,O
.,700,701,O
Treatment,702,711,O
with,712,716,O
D,717,718,O
-,718,719,O
Trp,719,722,O
-,722,723,O
6,723,724,O
-,724,725,O
LH,725,727,O
-,727,728,O
RH,728,730,O
greatly,731,738,O
reduced,739,746,O
serum,747,752,B-Organism_substance
LH,753,755,O
and,756,759,O
testosterone,760,772,O
levels,773,779,O
without,780,787,O
raising,788,795,O
serum,796,801,B-Organism_substance
prolactin,802,811,O
.,811,812,O
After,813,818,O
1,819,820,O
-,820,821,O
2,821,822,O
weeks,823,828,O
of,829,831,O
therapy,832,839,O
",",839,840,O
there,841,846,O
was,847,850,O
relief,851,857,O
of,858,860,O
subjective,861,871,O
symptoms,872,880,O
and,881,884,O
a,885,886,O
reversal,887,895,O
of,896,898,O
the,899,902,O
signs,903,908,O
of,909,911,O
prostatism,912,922,O
as,923,925,O
well,926,930,O
as,931,933,O
a,934,935,O
marked,936,942,O
decrease,943,951,O
in,952,954,O
bone,955,959,B-Organ
pain,960,964,O
.,964,965,O
At,966,968,O
90,969,971,O
days,972,976,O
52,977,979,O
patients,980,988,O
had,989,992,O
complete,993,1001,O
relief,1002,1008,O
of,1009,1011,O
prostatism,1012,1022,O
and,1023,1026,O
21,1027,1029,O
had,1030,1033,O
only,1034,1038,O
mild,1039,1043,O
signs,1044,1049,O
and,1050,1053,O
symptoms,1054,1062,O
.,1062,1063,O
Seventy,1064,1071,O
patients,1072,1080,O
were,1081,1085,O
experiencing,1086,1098,O
no,1099,1101,O
bone,1102,1106,B-Organ
pain,1107,1111,O
and,1112,1115,O
an,1116,1118,O
additional,1119,1129,O
six,1130,1133,O
had,1134,1137,O
only,1138,1142,O
mild,1143,1147,O
pain,1148,1152,O
.,1152,1153,O
Prostatic,1154,1163,B-Organ
size,1164,1168,O
",",1168,1169,O
evaluated,1170,1179,O
by,1180,1182,O
rectal,1183,1189,O
examination,1190,1201,O
and,1202,1205,O
transabdominal,1206,1220,B-Organism_subdivision
ultrasonography,1221,1236,O
",",1236,1237,O
reverted,1238,1246,O
to,1247,1249,O
normal,1250,1256,O
in,1257,1259,O
26,1260,1262,O
.,1262,1263,O
4,1263,1264,O
%,1264,1265,O
of,1266,1268,O
patients,1269,1277,O
(,1278,1279,O
complete,1279,1287,O
remission,1288,1297,O
),1297,1298,O
and,1299,1302,O
was,1303,1306,O
reduced,1307,1314,O
by,1315,1317,O
more,1318,1322,O
than,1323,1327,O
50,1328,1330,O
%,1330,1331,O
in,1332,1334,O
an,1335,1337,O
additional,1338,1348,O
17,1349,1351,O
.,1351,1352,O
6,1352,1353,O
%,1353,1354,O
(,1355,1356,O
partial,1356,1363,O
remission,1364,1373,O
),1373,1374,O
",",1374,1375,O
the,1376,1379,O
overall,1380,1387,O
rate,1388,1392,O
of,1393,1395,O
complete,1396,1404,O
plus,1405,1409,O
partial,1410,1417,O
regression,1418,1428,O
of,1429,1431,O
prostatic,1432,1441,B-Organ
enlargement,1442,1453,O
being,1454,1459,O
44,1460,1462,O
%,1462,1463,O
.,1463,1464,O
Scans,1465,1470,O
showed,1471,1477,O
a,1478,1479,O
major,1480,1485,O
improvement,1486,1497,O
of,1498,1500,O
bone,1501,1505,B-Pathological_formation
lesions,1506,1513,I-Pathological_formation
in,1514,1516,O
14,1517,1519,O
.,1519,1520,O
8,1520,1521,O
%,1521,1522,O
of,1523,1525,O
cases,1526,1531,O
.,1531,1532,O
This,1533,1537,O
response,1538,1546,O
increased,1547,1556,O
to,1557,1559,O
37,1560,1562,O
%,1562,1563,O
after,1564,1569,O
more,1570,1574,O
than,1575,1579,O
6,1580,1581,O
months,1582,1588,O
of,1589,1591,O
follow,1592,1598,O
-,1598,1599,O
up,1599,1601,O
.,1601,1602,O
Prostatic,1603,1612,B-Organ
acid,1613,1617,O
phosphatase,1618,1629,O
levels,1630,1636,O
were,1637,1641,O
decreased,1642,1651,O
by,1652,1654,O
more,1655,1659,O
than,1660,1664,O
50,1665,1667,O
%,1667,1668,O
in,1669,1671,O
61,1672,1674,O
%,1674,1675,O
of,1676,1678,O
the,1679,1682,O
patients,1683,1691,O
",",1691,1692,O
but,1693,1696,O
this,1697,1701,O
test,1702,1706,O
appears,1707,1714,O
to,1715,1717,O
be,1718,1720,O
a,1721,1722,O
less,1723,1727,O
valid,1728,1733,O
marker,1734,1740,O
than,1741,1745,O
the,1746,1749,O
lipid,1750,1755,O
-,1755,1756,O
associated,1756,1766,O
sialic,1767,1773,O
acid,1774,1778,O
(,1779,1780,O
LASA,1780,1784,O
),1784,1785,O
.,1785,1786,O
The,1787,1790,O
increase,1791,1799,O
in,1800,1802,O
LASA,1803,1807,O
before,1808,1814,O
treatment,1815,1824,O
and,1825,1828,O
a,1829,1830,O
reduction,1831,1840,O
after,1841,1846,O
treatment,1847,1856,O
can,1857,1860,O
frequently,1861,1871,O
be,1872,1874,O
correlated,1875,1885,O
with,1886,1890,O
the,1891,1894,O
objective,1895,1904,O
volume,1905,1911,O
of,1912,1914,O
the,1915,1918,O
neoplasms,1919,1928,B-Pathological_formation
.,1928,1929,O
No,1930,1932,O
flare,1933,1938,O
-,1938,1939,O
up,1939,1941,O
of,1942,1944,O
the,1945,1948,O
disease,1949,1956,O
was,1957,1960,O
encountered,1961,1972,O
",",1972,1973,O
and,1974,1977,O
there,1978,1983,O
were,1984,1988,O
no,1989,1991,O
side,1992,1996,O
effects,1997,2004,O
except,2005,2011,O
for,2012,2015,O
impotence,2016,2025,O
.,2025,2026,O
Statistical,2027,2038,O
analyses,2039,2047,O
of,2048,2050,O
results,2051,2058,O
by,2059,2061,O
the,2062,2065,O
method,2066,2072,O
of,2073,2075,O
Lee,2076,2079,O
and,2080,2083,O
Wesley,2084,2090,O
indicated,2091,2100,O
that,2101,2105,O
the,2106,2109,O
incidence,2110,2119,O
of,2120,2122,O
complete,2123,2131,O
and,2132,2135,O
partial,2136,2143,O
regression,2144,2154,O
(,2155,2156,O
CR,2156,2158,O
and,2159,2162,O
PR,2163,2165,O
),2165,2166,O
observed,2167,2175,O
with,2176,2180,O
D,2181,2182,O
-,2182,2183,O
Trp,2183,2186,O
-,2186,2187,O
6,2187,2188,O
-,2188,2189,O
LH,2189,2191,O
-,2191,2192,O
RH,2192,2194,O
was,2195,2198,O
not,2199,2202,O
significantly,2203,2216,O
different,2217,2226,O
from,2227,2231,O
that,2232,2236,O
recorded,2237,2245,O
in,2246,2248,O
previous,2249,2257,O
studies,2258,2265,O
for,2266,2269,O
another,2270,2277,O
LH,2278,2280,O
-,2280,2281,O
RH,2281,2283,O
analog,2284,2290,O
",",2290,2291,O
Buserelin,2292,2301,O
.,2301,2302,O
However,2303,2310,O
",",2310,2311,O
CR,2312,2314,O
and,2315,2318,O
PR,2319,2321,O
obtained,2322,2330,O
with,2331,2335,O
D,2336,2337,O
-,2337,2338,O
Trp,2338,2341,O
-,2341,2342,O
6,2342,2343,O
-,2343,2344,O
LH,2344,2346,O
-,2346,2347,O
RH,2347,2349,O
(,2350,2351,O
44,2351,2353,O
%,2353,2354,O
),2354,2355,O
were,2356,2360,O
significantly,2361,2374,O
higher,2375,2381,O
than,2382,2386,O
with,2387,2391,O
subcapsular,2392,2403,O
orchiectomy,2404,2415,O
(,2416,2417,O
22,2417,2419,O
%,2419,2420,O
),2420,2421,O
.,2421,2422,O
Hormonal,2423,2431,O
effects,2432,2439,O
and,2440,2443,O
some,2444,2448,O
other,2449,2454,O
actions,2455,2462,O
of,2463,2465,O
D,2466,2467,O
-,2467,2468,O
Trp,2468,2471,O
-,2471,2472,O
6,2472,2473,O
-,2473,2474,O
LH,2474,2476,O
-,2476,2477,O
RH,2477,2479,O
were,2480,2484,O
compared,2485,2493,O
and,2494,2497,O
contrasted,2498,2508,O
with,2509,2513,O
those,2514,2519,O
produced,2520,2528,O
by,2529,2531,O
castration,2532,2542,O
",",2542,2543,O
estrogens,2544,2553,O
",",2553,2554,O
antiandrogens,2555,2568,O
",",2568,2569,O
and,2570,2573,O
progestogens,2574,2586,O
.,2586,2587,O
(,2587,2588,O
ABSTRACT,2588,2596,O
TRUNCATED,2597,2606,O
AT,2607,2609,O
400,2610,2613,O
WORDS,2614,2619,O
),2619,2620,O
[,0,1,O
Histophysiology,1,16,O
and,17,20,O
histopathology,21,35,O
of,36,38,O
the,39,42,O
adrenals,43,51,B-Organ
in,52,54,O
experimental,55,67,O
hypokinesia,68,79,O
],79,80,O
.,80,81,O
In,82,84,O
experiments,85,96,O
on,97,99,O
male,100,104,O
rats,105,109,O
in,110,112,O
the,113,116,O
course,117,123,O
of,124,126,O
3,127,128,O
-,128,129,O
month,129,134,O
hypokinesia,135,146,O
phasic,147,153,O
changes,154,161,O
were,162,166,O
observed,167,175,O
in,176,178,O
the,179,182,O
relative,183,191,O
adrenal,192,199,B-Organ
gland,200,205,I-Organ
weight,206,212,O
",",212,213,O
in,214,216,O
the,217,220,O
volume,221,227,O
of,228,230,O
the,231,234,O
cell,235,239,B-Cellular_component
nuclei,240,246,I-Cellular_component
of,247,249,O
the,250,253,O
glomerular,254,264,B-Multi-tissue_structure
",",264,265,O
fasicular,266,275,B-Multi-tissue_structure
zones,276,281,I-Multi-tissue_structure
and,282,285,O
the,286,289,O
medulla,290,297,B-Multi-tissue_structure
",",297,298,O
in,299,301,O
the,302,305,O
activity,306,314,O
of,315,317,O
the,318,321,O
succinic,322,330,O
dehydrogenase,331,344,O
",",344,345,O
alkaline,346,354,O
and,355,358,O
acid,359,363,O
phosphatases,364,376,O
",",376,377,O
in,378,380,O
the,381,384,O
RNA,385,388,O
and,389,392,O
catecholamine,393,406,O
content,407,414,O
.,414,415,O
These,416,421,O
changes,422,429,O
are,430,433,O
associated,434,444,O
with,445,449,O
variations,450,460,O
in,461,463,O
the,464,467,O
secretion,468,477,O
and,478,481,O
biosynthesis,482,494,O
of,495,497,O
the,498,501,O
hormones,502,510,O
of,511,513,O
the,514,517,O
cortical,518,526,B-Multi-tissue_structure
and,527,530,O
the,531,534,O
medullary,535,544,B-Multi-tissue_structure
layer,545,550,I-Multi-tissue_structure
of,551,553,O
the,554,557,O
adrenal,558,565,B-Organ
glands,566,572,I-Organ
during,573,579,O
the,580,583,O
hypokinetic,584,595,O
stress,596,602,O
development,603,614,O
.,614,615,O
Dynorphin,0,9,O
is,10,12,O
contained,13,22,O
within,23,29,O
hippocampal,30,41,B-Tissue
mossy,42,47,I-Tissue
fibers,48,54,I-Tissue
:,54,55,O
immunochemical,56,70,O
alterations,71,82,O
after,83,88,O
kainic,89,95,O
acid,96,100,O
administration,101,115,O
and,116,119,O
colchicine,120,130,O
-,130,131,O
induced,131,138,O
neurotoxicity,139,152,O
.,152,153,O
Antisera,154,162,B-Organism_substance
raised,163,169,O
against,170,177,O
synthetic,178,187,O
dynorphin,188,197,O
or,198,200,O
[,201,202,O
Leu5,202,206,O
],206,207,O
enkephalin,207,217,O
demonstrate,218,229,O
immunostaining,230,244,O
in,245,247,O
hippocampal,248,259,B-Tissue
mossy,260,265,I-Tissue
fibers,266,272,I-Tissue
and,273,276,O
in,277,279,O
dentate,280,287,B-Cell
granule,288,295,I-Cell
cells,296,301,I-Cell
.,301,302,O
However,303,310,O
",",310,311,O
dynorphin,312,321,O
immunoreactivity,322,338,O
(,339,340,O
ir,340,342,O
),342,343,O
appears,344,351,O
to,352,354,O
be,355,357,O
denser,358,364,O
in,365,367,O
immunocytochemical,368,386,O
preparations,387,399,O
and,400,403,O
is,404,406,O
quantitatively,407,421,O
greater,422,429,O
by,430,432,O
radioimmunoassay,433,449,O
than,450,454,O
enkephalin,455,465,O
-,465,466,O
ir,466,468,O
.,468,469,O
Immunostaining,470,484,O
with,485,489,O
dynorphin,490,499,O
antisera,500,508,O
is,509,511,O
eliminated,512,522,O
by,523,525,O
adsorption,526,536,O
with,537,541,O
1,542,543,O
-,543,544,O
100,544,547,O
microM,548,554,O
dynorphin,555,564,O
-,564,565,O
17,565,567,O
whereas,568,575,O
immunostaining,576,590,O
with,591,595,O
enkephalin,596,606,O
antisera,607,615,O
is,616,618,O
eliminated,619,629,O
by,630,632,O
adsorption,633,643,O
with,644,648,O
1,649,650,O
-,650,651,O
100,651,654,O
microM,655,661,O
[,662,663,O
Leu5,663,667,O
],667,668,O
enkephalin,668,678,O
",",678,679,O
dynorphin,680,689,O
-,689,690,O
17,690,692,O
",",692,693,O
dynorphin,694,703,O
-,703,704,O
(,704,705,O
1,705,706,O
-,706,707,O
13,707,709,O
),709,710,O
",",710,711,O
or,712,714,O
alpha,715,720,O
-,720,721,O
neo,721,724,O
-,724,725,O
endorphin,725,734,O
.,734,735,O
Intrahippocampal,736,752,B-Multi-tissue_structure
colchicine,753,763,O
injections,764,774,O
",",774,775,O
which,776,781,O
selectively,782,793,O
destroy,794,801,O
dentate,802,809,O
granule,810,817,O
cells,818,823,O
",",823,824,O
significantly,825,838,O
decrease,839,847,O
the,848,851,O
dynorphin,852,861,O
-,861,862,O
ir,862,864,O
and,865,868,O
enkephalin,869,879,O
-,879,880,O
ir,880,882,O
levels,883,889,O
in,890,892,O
rat,893,896,O
hippocampus,897,908,B-Multi-tissue_structure
.,908,909,O
Intraventricularly,910,928,B-Multi-tissue_structure
administered,929,941,O
kainic,942,948,O
acid,949,953,O
",",953,954,O
which,955,960,O
selectively,961,972,O
destroys,973,981,O
CA3,982,985,B-Cell
-,985,986,I-Cell
4,986,987,I-Cell
pyramidal,988,997,I-Cell
cells,998,1003,I-Cell
",",1003,1004,O
results,1005,1012,O
in,1013,1015,O
an,1016,1018,O
increase,1019,1027,O
of,1028,1030,O
enkephalin,1031,1041,O
immunostaining,1042,1056,O
in,1057,1059,O
mossy,1060,1065,B-Tissue
fibers,1066,1072,I-Tissue
and,1073,1076,O
a,1077,1078,O
significant,1079,1090,O
increase,1091,1099,O
in,1100,1102,O
enkephalin,1103,1113,O
-,1113,1114,O
ir,1114,1116,O
by,1117,1119,O
radioimmunoassay,1120,1136,O
in,1137,1139,O
whole,1140,1145,O
hippocampus,1146,1157,B-Multi-tissue_structure
.,1157,1158,O
The,1159,1162,O
enkephalin,1163,1173,B-Cell
-,1173,1174,I-Cell
ir,1174,1176,I-Cell
cells,1177,1182,I-Cell
and,1183,1186,O
fibers,1187,1193,B-Tissue
in,1194,1196,O
entorhinal,1197,1207,B-Multi-tissue_structure
/,1207,1208,O
perirhinal,1208,1218,B-Multi-tissue_structure
cortex,1219,1225,I-Multi-tissue_structure
",",1225,1226,O
which,1227,1232,O
innervate,1233,1242,O
rat,1243,1246,O
hippocampus,1247,1258,B-Multi-tissue_structure
and,1259,1262,O
dentate,1263,1270,B-Multi-tissue_structure
gyrus,1271,1276,I-Multi-tissue_structure
",",1276,1277,O
do,1278,1280,O
not,1281,1284,O
contain,1285,1292,O
dynorphin,1293,1302,O
-,1302,1303,O
ir,1303,1305,O
.,1305,1306,O
Differential,0,12,O
reactivity,13,23,O
of,24,26,O
the,27,30,O
functional,31,41,O
sulfhydryl,42,52,O
groups,53,59,O
of,60,62,O
cysteine,63,71,O
-,71,72,O
32,72,74,O
and,75,78,O
cysteine,79,87,O
-,87,88,O
35,88,90,O
present,91,98,O
in,99,101,O
the,102,105,O
reduced,106,113,O
form,114,118,O
of,119,121,O
thioredoxin,122,133,O
from,134,138,O
Escherichia,139,150,O
coli,151,155,O
.,155,156,O
Only,157,161,O
one,162,165,O
of,166,168,O
the,169,172,O
sulfhydryl,173,183,O
groups,184,190,O
from,191,195,O
Cys,196,199,O
-,199,200,O
32,200,202,O
and,203,206,O
Cys,207,210,O
-,210,211,O
35,211,213,O
in,214,216,O
the,217,220,O
active,221,227,O
center,228,234,O
of,235,237,O
native,238,244,O
Escherichia,245,256,O
coli,257,261,O
thioredoxin,262,273,O
-,273,274,O
(,274,275,O
SH,275,277,O
),277,278,O
2,278,279,O
was,280,283,O
alkylated,284,293,O
by,294,296,O
excess,297,303,O
iodoacetic,304,314,O
acid,315,319,O
at,320,322,O
pH,323,325,O
values,326,332,O
below,333,338,O
8,339,340,O
.,340,341,O
0,341,342,O
.,342,343,O
Both,344,348,O
groups,349,355,O
reacted,356,363,O
in,364,366,O
the,367,370,O
protein,371,378,O
denatured,379,388,O
with,389,393,O
4,394,395,O
.,395,396,O
5,396,397,O
M,398,399,O
guanidine,400,409,O
hydrochloride,410,423,O
.,423,424,O
The,425,428,O
second,429,435,O
order,436,441,O
rate,442,446,O
of,447,449,O
alkylation,450,460,O
of,461,463,O
thioredoxin,464,475,O
-,475,476,O
(,476,477,O
SH,477,479,O
),479,480,O
2,480,481,O
with,482,486,O
1,487,488,O
eq,489,491,O
of,492,494,O
iodoacetic,495,505,O
acid,506,510,O
was,511,514,O
pH,515,517,O
-,517,518,O
dependent,518,527,O
and,528,531,O
showed,532,538,O
independent,539,550,O
initial,551,558,O
reactions,559,568,O
of,569,571,O
one,572,575,O
thiolate,576,584,O
ion,585,588,O
with,589,593,O
a,594,595,O
pK,596,598,O
value,599,604,O
of,605,607,O
6,608,609,O
.,609,610,O
7,610,611,O
and,612,615,O
a,616,617,O
second,618,624,O
with,625,629,O
a,630,631,O
pK,632,634,O
value,635,640,O
close,641,646,O
to,647,649,O
9,650,651,O
.,651,652,O
0,652,653,O
.,653,654,O
The,655,658,O
same,659,663,O
pH,664,666,O
dependence,667,677,O
was,678,681,O
observed,682,690,O
for,691,694,O
alkylation,695,705,O
with,706,710,O
iodoacetamide,711,724,O
but,725,728,O
the,729,732,O
apparent,733,741,O
rate,742,746,O
constant,747,755,O
",",755,756,O
107,757,760,O
M,761,762,O
-,762,763,O
1,763,764,O
S,765,766,O
-,766,767,O
1,767,768,O
at,769,771,O
pH,772,774,O
7,775,776,O
.,776,777,O
2,777,778,O
",",778,779,O
was,780,783,O
about,784,789,O
20,790,792,O
-,792,793,O
fold,793,797,O
higher,798,804,O
than,805,809,O
the,810,813,O
corresponding,814,827,O
rate,828,832,O
with,833,837,O
iodoacetate,838,849,O
.,849,850,O
The,851,854,O
sulfhydryl,855,865,O
group,866,871,O
with,872,876,O
a,877,878,O
pK,879,881,O
value,882,887,O
of,888,890,O
6,891,892,O
.,892,893,O
7,893,894,O
was,895,898,O
shown,899,904,O
to,905,907,O
belong,908,914,O
to,915,917,O
Cys,918,921,O
-,921,922,O
32,922,924,O
by,925,927,O
labeling,928,936,O
thioredoxin,937,948,O
with,949,953,O
[,954,955,O
14C,955,958,O
],958,959,O
iodoacetic,959,969,O
acid,970,974,O
followed,975,983,O
by,984,986,O
complete,987,995,O
alkylation,996,1006,O
with,1007,1011,O
[,1012,1013,O
3H,1013,1015,O
],1015,1016,O
iodoacetate,1016,1027,O
and,1028,1031,O
amino,1032,1037,O
acid,1038,1042,O
sequence,1043,1051,O
analysis,1052,1060,O
of,1061,1063,O
peptides,1064,1072,O
from,1073,1077,O
the,1078,1081,O
active,1082,1088,O
center,1089,1095,O
.,1095,1096,O
The,1097,1100,O
abnormally,1101,1111,O
low,1112,1115,O
pK,1116,1118,O
value,1119,1124,O
of,1125,1127,O
Cys,1128,1131,O
-,1131,1132,O
32,1132,1134,O
is,1135,1137,O
suggested,1138,1147,O
to,1148,1150,O
arise,1151,1156,O
by,1157,1159,O
electrostatic,1160,1173,O
influence,1174,1183,O
from,1184,1188,O
a,1189,1190,O
positive,1191,1199,O
charge,1200,1206,O
on,1207,1209,O
the,1210,1213,O
amino,1214,1219,O
group,1220,1225,O
of,1226,1228,O
Lys,1229,1232,O
-,1232,1233,O
36,1233,1235,O
.,1235,1236,O
A,1237,1238,O
mechanism,1239,1248,O
of,1249,1251,O
action,1252,1258,O
for,1259,1262,O
thioredoxin,1263,1274,O
-,1274,1275,O
(,1275,1276,O
SH,1276,1278,O
),1278,1279,O
2,1279,1280,O
as,1281,1283,O
a,1284,1285,O
protein,1286,1293,O
disulfide,1294,1303,O
reductase,1304,1313,O
has,1314,1317,O
been,1318,1322,O
formulated,1323,1333,O
.,1333,1334,O
This,1335,1339,O
is,1340,1342,O
based,1343,1348,O
on,1349,1351,O
an,1352,1354,O
initial,1355,1362,O
nucleophilic,1363,1375,O
attack,1376,1382,O
by,1383,1385,O
the,1386,1389,O
thiolate,1390,1398,O
of,1399,1401,O
Cys,1402,1405,O
-,1405,1406,O
32,1406,1408,O
with,1409,1413,O
the,1414,1417,O
formation,1418,1427,O
of,1428,1430,O
an,1431,1433,O
unstable,1434,1442,O
transient,1443,1452,O
mixed,1453,1458,O
disulfide,1459,1468,O
involving,1469,1478,O
Cys,1479,1482,O
-,1482,1483,O
32,1483,1485,O
and,1486,1489,O
one,1490,1493,O
of,1494,1496,O
the,1497,1500,O
sulfurs,1501,1508,O
in,1509,1511,O
the,1512,1515,O
substrate,1516,1525,O
.,1525,1526,O
This,1527,1531,O
is,1532,1534,O
followed,1535,1543,O
by,1544,1546,O
a,1547,1548,O
conformational,1549,1563,O
change,1564,1570,O
and,1571,1574,O
a,1575,1576,O
nucleophilic,1577,1589,O
attack,1590,1596,O
of,1597,1599,O
Cys,1600,1603,O
-,1603,1604,O
35,1604,1606,O
to,1607,1609,O
give,1610,1614,O
the,1615,1618,O
14,1619,1621,O
-,1621,1622,O
membered,1622,1630,O
disulfide,1631,1640,O
ring,1641,1645,O
in,1646,1648,O
thioredoxin,1649,1660,O
-,1660,1661,O
S2,1661,1663,O
and,1664,1667,O
the,1668,1671,O
dithiol,1672,1679,O
of,1680,1682,O
the,1683,1686,O
substrate,1687,1696,O
.,1696,1697,O
Identification,0,14,O
of,15,17,O
NAB1,18,22,O
",",22,23,O
a,24,25,O
repressor,26,35,O
of,36,38,O
NGFI,39,43,O
-,43,44,O
A,44,45,O
-,45,46,O
and,47,50,O
Krox20,51,57,O
-,57,58,O
mediated,58,66,O
transcription,67,80,O
.,80,81,O
NGFI,82,86,O
-,86,87,O
A,87,88,O
(,89,90,O
also,90,94,O
called,95,101,O
Egr1,102,106,O
",",106,107,O
Zif268,108,114,O
",",114,115,O
or,116,118,O
Krox24,119,125,O
),125,126,O
and,127,130,O
the,131,134,O
closely,135,142,O
related,143,150,O
proteins,151,159,O
Krox20,160,166,O
",",166,167,O
NGFI,168,172,O
-,172,173,O
C,173,174,O
",",174,175,O
and,176,179,O
Egr3,180,184,O
are,185,188,O
zinc,189,193,O
-,193,194,O
finger,194,200,O
transcription,201,214,O
factors,215,222,O
encoded,223,230,O
by,231,233,O
immediate,234,243,O
-,243,244,O
early,244,249,O
genes,250,255,O
which,256,261,O
are,262,265,O
induced,266,273,O
by,274,276,O
a,277,278,O
wide,279,283,O
variety,284,291,O
of,292,294,O
extracellular,295,308,B-Immaterial_anatomical_entity
stimuli,309,316,O
.,316,317,O
NGFI,318,322,O
-,322,323,O
A,323,324,O
has,325,328,O
been,329,333,O
implicated,334,344,O
in,345,347,O
cell,348,352,B-Cell
proliferation,353,366,O
",",366,367,O
macrophage,368,378,B-Cell
differentiation,379,394,O
",",394,395,O
synaptic,396,404,B-Cellular_component
activation,405,415,O
",",415,416,O
and,417,420,O
long,421,425,O
-,425,426,O
term,426,430,O
potentiation,431,443,O
",",443,444,O
whereas,445,452,O
Krox20,453,459,O
is,460,462,O
critical,463,471,O
for,472,475,O
proper,476,482,O
hindbrain,483,492,O
segmentation,493,505,O
and,506,509,O
peripheral,510,520,B-Multi-tissue_structure
nerve,521,526,I-Multi-tissue_structure
myelination,527,538,O
.,538,539,O
In,540,542,O
previous,543,551,O
work,552,556,O
",",556,557,O
a,558,559,O
structure,560,569,O
/,569,570,O
function,570,578,O
analysis,579,587,O
of,588,590,O
NGFI,591,595,O
-,595,596,O
A,596,597,O
revealed,598,606,O
a,607,608,O
34,609,611,O
-,611,612,O
aa,612,614,O
inhibitory,615,625,O
domain,626,632,O
that,633,637,O
was,638,641,O
hypothesized,642,654,O
to,655,657,O
be,658,660,O
the,661,664,O
target,665,671,O
of,672,674,O
a,675,676,O
cellular,677,685,B-Cell
factor,686,692,O
that,693,697,O
represses,698,707,O
NGFI,708,712,O
-,712,713,O
A,713,714,O
transcriptional,715,730,O
activity,731,739,O
.,739,740,O
Using,741,746,O
the,747,750,O
yeast,751,756,O
two,757,760,O
-,760,761,O
hybrid,761,767,O
system,768,774,O
",",774,775,O
we,776,778,O
have,779,783,O
isolated,784,792,O
a,793,794,O
cDNA,795,799,O
clone,800,805,O
which,806,811,O
encodes,812,819,O
a,820,821,O
protein,822,829,O
that,830,834,O
interacts,835,844,O
with,845,849,O
this,850,854,O
inhibitory,855,865,O
domain,866,872,O
and,873,876,O
inhibits,877,885,O
the,886,889,O
ability,890,897,O
of,898,900,O
NGFI,901,905,O
-,905,906,O
A,906,907,O
to,908,910,O
activate,911,919,O
transcription,920,933,O
.,933,934,O
This,935,939,O
NGFI,940,944,O
-,944,945,O
A,945,946,O
-,946,947,O
binding,947,954,O
protein,955,962,O
",",962,963,O
NAB1,964,968,O
",",968,969,O
is,970,972,O
a,973,974,O
570,975,978,O
-,978,979,O
aa,979,981,O
nuclear,982,989,B-Cellular_component
protein,990,997,O
that,998,1002,O
bears,1003,1008,O
no,1009,1011,O
obvious,1012,1019,O
sequence,1020,1028,O
homology,1029,1037,O
to,1038,1040,O
known,1041,1046,O
proteins,1047,1055,O
.,1055,1056,O
NAB1,1057,1061,O
also,1062,1066,O
represses,1067,1076,O
Krox20,1077,1083,O
activity,1084,1092,O
",",1092,1093,O
but,1094,1097,O
it,1098,1100,O
does,1101,1105,O
not,1106,1109,O
influence,1110,1119,O
Egr3,1120,1124,O
or,1125,1127,O
NGFI,1128,1132,O
-,1132,1133,O
G,1133,1134,O
",",1134,1135,O
thus,1136,1140,O
providing,1141,1150,O
a,1151,1152,O
mechanism,1153,1162,O
for,1163,1166,O
the,1167,1170,O
differential,1171,1183,O
regulation,1184,1194,O
of,1195,1197,O
this,1198,1202,O
family,1203,1209,O
of,1210,1212,O
immediate,1213,1222,O
-,1222,1223,O
early,1223,1228,O
transcription,1229,1242,O
factors,1243,1250,O
.,1250,1251,O
Comparison,0,10,O
of,11,13,O
image,14,19,O
(,20,21,O
CAS,21,24,O
200,25,28,O
),28,29,O
and,30,33,O
flow,34,38,O
cytometry,39,48,O
determined,49,59,O
DNA,60,63,O
content,64,71,O
of,72,74,O
paraffin,75,83,O
-,83,84,O
embedded,84,92,O
Hodgkin,93,100,B-Tissue
',100,101,I-Tissue
s,101,102,I-Tissue
disease,103,110,I-Tissue
tissue,111,117,I-Tissue
.,117,118,O
To,119,121,O
assess,122,128,O
the,129,132,O
reliability,133,144,O
of,145,147,O
DNA,148,151,O
estimation,152,162,O
using,163,168,O
image,169,174,O
cytometry,175,184,O
",",184,185,O
deparaffinized,186,200,O
lymph,201,206,B-Multi-tissue_structure
nodes,207,212,I-Multi-tissue_structure
from,213,217,O
70,218,220,O
patients,221,229,O
with,230,234,O
Hodgkin,235,242,O
',242,243,O
s,243,244,O
disease,245,252,O
were,253,257,O
examined,258,266,O
and,267,270,O
the,271,274,O
results,275,282,O
obtained,283,291,O
were,292,296,O
compared,297,305,O
with,306,310,O
those,311,316,O
from,317,321,O
flow,322,326,O
cytometry,327,336,O
.,336,337,O
Image,338,343,O
analysis,344,352,O
without,353,360,O
discriminating,361,375,O
between,376,383,O
the,384,387,O
various,388,395,O
cell,396,400,B-Cell
types,401,406,O
",",406,407,O
as,408,410,O
found,411,416,O
in,417,419,O
Hodgkin,420,427,O
',427,428,O
s,428,429,O
disease,430,437,O
",",437,438,O
revealed,439,447,O
no,448,450,O
separate,451,459,O
aneuploid,460,469,O
peak,470,474,O
.,474,475,O
Selecting,476,485,O
on,486,488,O
morphologically,489,504,O
defined,505,512,O
nuclear,513,520,B-Cellular_component
types,521,526,O
DNA,527,530,O
aneuploidy,531,541,O
was,542,545,O
detected,546,554,O
in,555,557,O
20,558,560,O
%,560,561,O
of,562,564,O
the,565,568,O
cases,569,574,O
(,575,576,O
14,576,578,O
/,578,579,O
70,579,581,O
),581,582,O
.,582,583,O
The,584,587,O
aneuploid,588,597,O
populations,598,609,O
were,610,614,O
limited,615,622,O
to,623,625,O
the,626,629,O
population,630,640,O
of,641,643,O
nuclei,644,650,B-Cellular_component
defined,651,658,O
as,659,661,O
Reed,662,666,O
-,666,667,O
Sternberg,667,676,O
(,677,678,O
RS,678,680,O
),680,681,O
-,681,682,O
like,682,686,O
or,687,689,O
medium,690,696,O
-,696,697,O
sized,697,702,O
lymphocytes,703,714,B-Cell
.,714,715,O
Benign,716,722,B-Pathological_formation
lymph,723,728,I-Pathological_formation
nodes,729,734,I-Pathological_formation
DNA,735,738,O
aneuploidy,739,749,O
was,750,753,O
not,754,757,O
found,758,763,O
in,764,766,O
any,767,770,O
of,771,773,O
the,774,777,O
controls,778,786,O
.,786,787,O
Comparison,788,798,O
of,799,801,O
DNA,802,805,O
histograms,806,816,O
obtained,817,825,O
by,826,828,O
image,829,834,O
and,835,838,O
flow,839,843,O
cytometry,844,853,O
showed,854,860,O
aneuploid,861,870,O
peaks,871,876,O
using,877,882,O
image,883,888,O
cytometry,889,898,O
in,899,901,O
4,902,903,O
of,904,906,O
30,907,909,O
diploid,910,917,O
and,918,921,O
10,922,924,O
of,925,927,O
40,928,930,O
aneuploid,931,940,O
flow,941,945,O
histograms,946,956,O
.,956,957,O
In,958,960,O
conclusion,961,971,O
",",971,972,O
image,973,978,O
analysis,979,987,O
using,988,993,O
the,994,997,O
CAS,998,1001,O
200,1002,1005,O
system,1006,1012,O
as,1013,1015,O
compared,1016,1024,O
to,1025,1027,O
flow,1028,1032,O
cytometry,1033,1042,O
is,1043,1045,O
more,1046,1050,O
time,1051,1055,O
-,1055,1056,O
consuming,1056,1065,O
and,1066,1069,O
less,1070,1074,O
sensitive,1075,1084,O
to,1085,1087,O
assess,1088,1094,O
ploidy,1095,1101,O
status,1102,1108,O
",",1108,1109,O
although,1110,1118,O
it,1119,1121,O
may,1122,1125,O
provide,1126,1133,O
extra,1134,1139,O
information,1140,1151,O
in,1152,1154,O
some,1155,1159,O
selected,1160,1168,O
cases,1169,1174,O
.,1174,1175,O
Evidence,1176,1184,O
is,1185,1187,O
obtained,1188,1196,O
that,1197,1201,O
DNA,1202,1205,O
aneuploidy,1206,1216,O
in,1217,1219,O
Hodgkin,1220,1227,O
',1227,1228,O
s,1228,1229,O
disease,1230,1237,O
is,1238,1240,O
preferentially,1241,1255,O
expressed,1256,1265,O
by,1266,1268,O
cells,1269,1274,B-Cell
with,1275,1279,O
the,1280,1283,O
RS,1284,1286,O
/,1286,1287,O
H,1287,1288,O
-,1288,1289,O
like,1289,1293,O
and,1294,1297,O
medium,1298,1304,O
-,1304,1305,O
sized,1305,1310,O
lymphocyte,1311,1321,B-Cell
morphology,1322,1332,O
.,1332,1333,O
Imaging,0,7,O
techniques,8,18,O
for,19,22,O
the,23,26,O
assessment,27,37,O
of,38,40,O
body,41,45,B-Organism_subdivision
composition,46,57,O
.,57,58,O
Three,59,64,O
imaging,65,72,O
methods,73,80,O
",",80,81,O
ultrasound,82,92,O
imaging,93,100,O
(,101,102,O
UI,102,104,O
),104,105,O
",",105,106,O
computer,107,115,O
-,115,116,O
assisted,116,124,O
axial,125,130,O
tomography,131,141,O
(,142,143,O
CAT,143,146,O
),146,147,O
and,148,151,O
magnetic,152,160,O
resonance,161,170,O
imaging,171,178,O
(,179,180,O
MRI,180,183,O
),183,184,O
",",184,185,O
are,186,189,O
widely,190,196,O
used,197,201,O
in,202,204,O
medicine,205,213,O
.,213,214,O
Their,215,220,O
application,221,232,O
to,233,235,O
the,236,239,O
assessment,240,250,O
of,251,253,O
body,254,258,B-Organism_subdivision
composition,259,270,O
in,271,273,O
nutrition,274,283,O
research,284,292,O
is,293,295,O
still,296,301,O
being,302,307,O
explored,308,316,O
and,317,320,O
developed,321,330,O
.,330,331,O
Ultrasound,332,342,O
imaging,343,350,O
yields,351,357,O
poor,358,362,O
image,363,368,O
quality,369,376,O
but,377,380,O
",",380,381,O
because,382,389,O
it,390,392,O
is,393,395,O
cheap,396,401,O
and,402,405,O
safe,406,410,O
",",410,411,O
deserves,412,420,O
further,421,428,O
exploration,429,440,O
.,440,441,O
Both,442,446,O
CAT,447,450,O
and,451,454,O
MRI,455,458,O
can,459,462,O
produce,463,470,O
images,471,477,O
with,478,482,O
good,483,487,O
discrimination,488,502,O
among,503,508,O
bone,509,513,B-Organ
",",513,514,O
muscle,515,521,B-Organ
and,522,525,O
adipose,526,533,B-Tissue
tissue,534,540,I-Tissue
.,540,541,O
Movement,542,550,O
artifacts,551,560,O
tend,561,565,O
to,566,568,O
be,569,571,O
more,572,576,O
serious,577,584,O
in,585,587,O
MRI,588,591,O
than,592,596,O
in,597,599,O
CAT,600,603,O
due,604,607,O
to,608,610,O
the,611,614,O
longer,615,621,O
imaging,622,629,O
time,630,634,O
.,634,635,O
On,636,638,O
the,639,642,O
other,643,648,O
hand,649,653,O
",",653,654,O
the,655,658,O
X,659,660,O
-,660,661,O
ray,661,664,O
exposure,665,673,O
in,674,676,O
CAT,677,680,O
is,681,683,O
likely,684,690,O
to,691,693,O
limit,694,699,O
its,700,703,O
use,704,707,O
in,708,710,O
human,711,716,O
nutrition,717,726,O
research,727,735,O
.,735,736,O
Repeated,737,745,O
measurements,746,758,O
of,759,761,O
tissue,762,768,B-Tissue
volumes,769,776,O
by,777,779,O
CAT,780,783,O
and,784,787,O
MRI,788,791,O
give,792,796,O
similar,797,804,O
CV,805,807,O
.,807,808,O
In,809,811,O
both,812,816,O
CAT,817,820,O
and,821,824,O
MRI,825,828,O
",",828,829,O
intra,830,835,O
-,835,836,O
abdominal,836,845,B-Tissue
adipose,846,853,I-Tissue
tissue,854,860,I-Tissue
presents,861,869,O
greater,870,877,O
problems,878,886,O
of,887,889,O
measurement,890,901,O
than,902,906,O
subcutaneous,907,919,B-Tissue
adipose,920,927,I-Tissue
tissue,928,934,I-Tissue
.,934,935,O
Validation,936,946,O
studies,947,954,O
with,955,959,O
77,960,962,O
-,962,963,O
kg,963,965,O
pigs,966,970,O
of,971,973,O
MRI,974,977,O
",",977,978,O
using,979,984,O
13,985,987,O
slices,988,994,O
",",994,995,O
predicted,996,1005,O
total,1006,1011,O
body,1012,1016,B-Organism_subdivision
lipid,1017,1022,O
with,1023,1027,O
residual,1028,1036,O
standard,1037,1045,O
deviation,1046,1055,O
of,1056,1058,O
1,1059,1060,O
.,1060,1061,O
9,1061,1062,O
%,1062,1063,O
.,1063,1064,O
In,1065,1067,O
validating,1068,1078,O
any,1079,1082,O
of,1083,1085,O
these,1086,1091,O
methods,1092,1099,O
",",1099,1100,O
account,1101,1108,O
should,1109,1115,O
be,1116,1118,O
take,1119,1123,O
of,1124,1126,O
the,1127,1130,O
extent,1131,1137,O
to,1138,1140,O
which,1141,1146,O
the,1147,1150,O
information,1151,1162,O
they,1163,1167,O
give,1168,1172,O
can,1173,1176,O
augment,1177,1184,O
that,1185,1189,O
given,1190,1195,O
by,1196,1198,O
more,1199,1203,O
simple,1204,1210,O
measures,1211,1219,O
like,1220,1224,O
age,1225,1228,O
and,1229,1232,O
weight,1233,1239,O
.,1239,1240,O
Defective,0,9,O
biliary,10,17,O
copper,18,24,O
excretion,25,34,O
in,35,37,O
Wilson,38,44,O
',44,45,O
s,45,46,O
disease,47,54,O
:,54,55,O
the,56,59,O
role,60,64,O
of,65,67,O
caeruloplasmin,68,82,O
.,82,83,O
Previous,84,92,O
studies,93,100,O
have,101,105,O
failed,106,112,O
to,113,115,O
explain,116,123,O
the,124,127,O
link,128,132,O
between,133,140,O
copper,141,147,O
accumulation,148,160,O
and,161,164,O
abnormal,165,173,O
caeruloplasmin,174,188,O
expression,189,199,O
in,200,202,O
Wilson,203,209,O
',209,210,O
s,210,211,O
disease,212,219,O
.,219,220,O
Furthermore,221,232,O
",",232,233,O
despite,234,241,O
the,242,245,O
isolation,246,255,O
of,256,258,O
a,259,260,O
candidate,261,270,O
gene,271,275,O
for,276,279,O
Wilson,280,286,O
',286,287,O
s,287,288,O
disease,289,296,O
",",296,297,O
which,298,303,O
predicts,304,312,O
a,313,314,O
defective,315,324,O
copper,325,331,O
transport,332,341,O
protein,342,349,O
",",349,350,O
the,351,354,O
localization,355,367,O
of,368,370,O
this,371,375,O
putative,376,384,O
protein,385,392,O
and,393,396,O
its,397,400,O
relationship,401,413,O
to,414,416,O
the,417,420,O
pathway,421,428,O
involved,429,437,O
in,438,440,O
copper,441,447,O
excretion,448,457,O
and,458,461,O
to,462,464,O
caeruloplasmin,465,479,O
remain,480,486,O
unknown,487,494,O
.,494,495,O
We,496,498,O
now,499,502,O
present,503,510,O
evidence,511,519,O
that,520,524,O
caeruloplasmin,525,539,O
",",539,540,O
the,541,544,O
major,545,550,O
plasma,551,557,B-Organism_substance
copper,558,564,O
-,564,565,O
carrying,565,573,O
protein,574,581,O
",",581,582,O
is,583,585,O
present,586,593,O
in,594,596,O
the,597,600,O
liver,601,606,B-Organ
in,607,609,O
Wilson,610,616,O
',616,617,O
s,617,618,O
disease,619,626,O
",",626,627,O
and,628,631,O
thus,632,636,O
that,637,641,O
reduced,642,649,O
circulating,650,661,O
levels,662,668,O
of,669,671,O
the,672,675,O
protein,676,683,O
result,684,690,O
from,691,695,O
a,696,697,O
post,698,702,O
-,702,703,O
translational,703,716,O
defect,717,723,O
in,724,726,O
the,727,730,O
secretory,731,740,O
pathway,741,748,O
.,748,749,O
We,750,752,O
have,753,757,O
also,758,762,O
identified,763,773,O
a,774,775,O
novel,776,781,O
form,782,786,O
of,787,789,O
caeruloplasmin,790,804,O
",",804,805,O
molecular,806,815,O
weight,816,822,O
125,823,826,O
kD,827,829,O
",",829,830,O
which,831,836,O
we,837,839,O
propose,840,847,O
may,848,851,O
act,852,855,O
as,856,858,O
the,859,862,O
carrier,863,870,O
for,871,874,O
excretory,875,884,O
copper,885,891,O
into,892,896,O
bile,897,901,B-Organism_substance
",",901,902,O
since,903,908,O
it,909,911,O
is,912,914,O
normally,915,923,O
present,924,931,O
in,932,934,O
both,935,939,O
liver,940,945,B-Organ
and,946,949,O
bile,950,954,B-Organism_substance
",",954,955,O
although,956,964,O
largely,965,972,O
absent,973,979,O
from,980,984,O
serum,985,990,B-Organism_substance
",",990,991,O
and,992,995,O
undetectable,996,1008,O
in,1009,1011,O
bile,1012,1016,B-Organism_substance
from,1017,1021,O
Wilson,1022,1028,O
',1028,1029,O
s,1029,1030,O
disease,1031,1038,O
patients,1039,1047,O
.,1047,1048,O
The,1049,1052,O
presence,1053,1061,O
of,1062,1064,O
this,1065,1069,O
form,1070,1074,O
of,1075,1077,O
caeruloplasmin,1078,1092,O
in,1093,1095,O
Wilson,1096,1102,O
',1102,1103,O
s,1103,1104,O
disease,1105,1112,O
liver,1113,1118,B-Organ
suggests,1119,1127,O
that,1128,1132,O
a,1133,1134,O
related,1135,1142,O
post,1143,1147,O
-,1147,1148,O
translational,1148,1161,O
defect,1162,1168,O
may,1169,1172,O
also,1173,1177,O
be,1178,1180,O
responsible,1181,1192,O
for,1193,1196,O
its,1197,1200,O
absence,1201,1208,O
from,1209,1213,O
bile,1214,1218,B-Organism_substance
in,1219,1221,O
Wilson,1222,1228,O
',1228,1229,O
s,1229,1230,O
disease,1231,1238,O
.,1238,1239,O
This,1240,1244,O
study,1245,1250,O
thus,1251,1255,O
provides,1256,1264,O
the,1265,1268,O
first,1269,1274,O
plausible,1275,1284,O
explanation,1285,1296,O
of,1297,1299,O
a,1300,1301,O
link,1302,1306,O
between,1307,1314,O
the,1315,1318,O
defective,1319,1328,O
copper,1329,1335,O
excretion,1336,1345,O
and,1346,1349,O
the,1350,1353,O
reduced,1354,1361,O
plasma,1362,1368,B-Organism_substance
caeruloplasmin,1369,1383,O
",",1383,1384,O
which,1385,1390,O
characterize,1391,1403,O
Wilson,1404,1410,O
',1410,1411,O
s,1411,1412,O
disease,1413,1420,O
.,1420,1421,O
Conservative,0,12,O
treatment,13,22,O
of,23,25,O
endometriosis,26,39,O
:,39,40,O
the,41,44,O
effects,45,52,O
of,53,55,O
limited,56,63,O
surgery,64,71,O
and,72,75,O
hormonal,76,84,O
pseudopregnancy,85,100,O
.,100,101,O
This,102,106,O
study,107,112,O
compares,113,121,O
the,122,125,O
effects,126,133,O
of,134,136,O
limited,137,144,O
surgery,145,152,O
or,153,155,O
hormonal,156,164,O
pseudopregnancy,165,180,O
",",180,181,O
or,182,184,O
a,185,186,O
combination,187,198,O
of,199,201,O
these,202,207,O
two,208,211,O
",",211,212,O
upon,213,217,O
fertility,218,227,O
and,228,231,O
the,232,235,O
need,236,240,O
for,241,244,O
subsequent,245,255,O
surgery,256,263,O
with,264,268,O
respect,269,276,O
to,277,279,O
the,280,283,O
extent,284,290,O
of,291,293,O
the,294,297,O
disease,298,305,O
at,306,308,O
the,309,312,O
time,313,317,O
of,318,320,O
initial,321,328,O
diagnosis,329,338,O
in,339,341,O
patients,342,350,O
with,351,355,O
endometriosis,356,369,O
externa,370,377,O
.,377,378,O
Of,379,381,O
the,382,385,O
61,386,388,O
patients,389,397,O
who,398,401,O
desired,402,409,O
to,410,412,O
enhance,413,420,O
or,421,423,O
preserve,424,432,O
reproductive,433,445,O
capacity,446,454,O
",",454,455,O
20,456,458,O
patients,459,467,O
became,468,474,O
pregnant,475,483,O
",",483,484,O
for,485,488,O
a,489,490,O
pregnancy,491,500,O
rate,501,505,O
of,506,508,O
33,509,511,O
%,511,512,O
.,512,513,O
The,514,517,O
pregnancy,518,527,O
rate,528,532,O
in,533,535,O
all,536,539,O
categories,540,550,O
",",550,551,O
that,552,556,O
is,557,559,O
",",559,560,O
those,561,566,O
patients,567,575,O
treated,576,583,O
with,584,588,O
pseudopregnancy,589,604,O
",",604,605,O
conservative,606,618,O
surgery,619,626,O
",",626,627,O
and,628,631,O
combined,632,640,O
pseudopregnancy,641,656,O
and,657,660,O
surgery,661,668,O
",",668,669,O
was,670,673,O
found,674,679,O
to,680,682,O
be,683,685,O
in,686,688,O
direct,689,695,O
relationship,696,708,O
to,709,711,O
the,712,715,O
initial,716,723,O
extent,724,730,O
of,731,733,O
disease,734,741,O
.,741,742,O
In,743,745,O
such,746,750,O
patients,751,759,O
",",759,760,O
conservative,761,773,O
surgery,774,781,O
alone,782,787,O
seemed,788,794,O
to,795,797,O
give,798,802,O
the,803,806,O
best,807,811,O
results,812,819,O
in,820,822,O
the,823,826,O
achievement,827,838,O
of,839,841,O
pregnancy,842,851,O
.,851,852,O
There,853,858,O
seemed,859,865,O
to,866,868,O
be,869,871,O
little,872,878,O
difference,879,889,O
between,890,897,O
pseudopregnancy,898,913,O
alone,914,919,O
and,920,923,O
conservative,924,936,O
surgery,937,944,O
in,945,947,O
regard,948,954,O
to,955,957,O
the,958,961,O
need,962,966,O
for,967,970,O
subsequent,971,981,O
surgery,982,989,O
after,990,995,O
initial,996,1003,O
therapy,1004,1011,O
",",1011,1012,O
although,1013,1021,O
there,1022,1027,O
seemed,1028,1034,O
to,1035,1037,O
be,1038,1040,O
a,1041,1042,O
significantly,1043,1056,O
greater,1057,1064,O
chance,1065,1071,O
for,1072,1075,O
the,1076,1079,O
need,1080,1084,O
for,1085,1088,O
subsequent,1089,1099,O
surgery,1100,1107,O
in,1108,1110,O
patients,1111,1119,O
receiving,1120,1129,O
a,1130,1131,O
combination,1132,1143,O
of,1144,1146,O
the,1147,1150,O
two,1151,1154,O
forms,1155,1160,O
of,1161,1163,O
therapy,1164,1171,O
.,1171,1172,O
The,1173,1176,O
need,1177,1181,O
for,1182,1185,O
subsequent,1186,1196,O
surgery,1197,1204,O
after,1205,1210,O
initial,1211,1218,O
therapy,1219,1226,O
in,1227,1229,O
80,1230,1232,O
patients,1233,1241,O
increased,1242,1251,O
in,1252,1254,O
direct,1255,1261,O
relationship,1262,1274,O
to,1275,1277,O
the,1278,1281,O
initial,1282,1289,O
extent,1290,1296,O
of,1297,1299,O
disease,1300,1307,O
present,1308,1315,O
",",1315,1316,O
despite,1317,1324,O
the,1325,1328,O
form,1329,1333,O
of,1334,1336,O
therapy,1337,1344,O
used,1345,1349,O
.,1349,1350,O
Fifty,1351,1356,O
-,1356,1357,O
nine,1357,1361,O
other,1362,1367,O
patients,1368,1376,O
with,1377,1381,O
endometriosis,1382,1395,O
",",1395,1396,O
who,1397,1400,O
did,1401,1404,O
not,1405,1408,O
desire,1409,1415,O
to,1416,1418,O
preserve,1419,1427,O
fertility,1428,1437,O
and,1438,1441,O
presented,1442,1451,O
for,1452,1455,O
relief,1456,1462,O
of,1463,1465,O
other,1466,1471,O
symptoms,1472,1480,O
",",1480,1481,O
underwent,1482,1491,O
initial,1492,1499,O
"""",1500,1501,O
radical,1501,1508,O
"""",1508,1509,O
therapy,1510,1517,O
.,1517,1518,O
Forty,1519,1524,O
-,1524,1525,O
six,1525,1528,O
patients,1529,1537,O
underwent,1538,1547,O
complete,1548,1556,O
operation,1557,1566,O
",",1566,1567,O
including,1568,1577,O
removal,1578,1585,O
of,1586,1588,O
uterus,1589,1595,B-Organ
",",1595,1596,O
tubes,1597,1602,B-Multi-tissue_structure
and,1603,1606,O
ovaries,1607,1614,B-Organ
",",1614,1615,O
and,1616,1619,O
none,1620,1624,O
required,1625,1633,O
subsequent,1634,1644,O
reoperation,1645,1656,O
.,1656,1657,O
Of,1658,1660,O
the,1661,1664,O
13,1665,1667,O
remaining,1668,1677,O
patients,1678,1686,O
",",1686,1687,O
who,1688,1691,O
underwent,1692,1701,O
incomplete,1702,1712,O
surgical,1713,1721,O
removal,1722,1729,O
",",1729,1730,O
leaving,1731,1738,O
one,1739,1742,O
or,1743,1745,O
both,1746,1750,O
ovaries,1751,1758,B-Organ
in,1759,1761,O
situ,1762,1766,O
",",1766,1767,O
11,1768,1770,O
required,1771,1779,O
subsequent,1780,1790,O
reoperation,1791,1802,O
for,1803,1806,O
recurrent,1807,1816,O
pelvic,1817,1823,O
endometriosis,1824,1837,O
.,1837,1838,O
Lack,0,4,O
of,5,7,O
developmental,8,21,O
and,22,25,O
reproductive,26,38,O
toxicity,39,47,O
of,48,50,O
2,51,52,O
",",52,53,O
3,53,54,O
",",54,55,O
3,55,56,O
',56,57,O
",",57,58,O
4,58,59,O
",",59,60,O
4,61,62,O
',62,63,O
-,63,64,O
pentachlorobiphenyl,64,83,O
(,84,85,O
PCB,85,88,O
105,89,92,O
),92,93,O
in,94,96,O
ring,97,101,O
-,101,102,O
necked,102,108,O
pheasants,109,118,O
.,118,119,O
Mono,120,124,O
-,124,125,O
ortho,125,130,O
PCBs,131,135,O
are,136,139,O
global,140,146,O
contaminants,147,159,O
of,160,162,O
wildlife,163,171,O
with,172,176,O
the,177,180,O
potential,181,190,O
to,191,193,O
produce,194,201,O
toxicity,202,210,O
by,211,213,O
an,214,216,O
aryl,217,221,O
hydrocarbon,222,233,O
receptor,234,242,O
(,243,244,O
AhR,244,247,O
),247,248,O
-,248,249,O
mediated,249,257,O
mechanism,258,267,O
.,267,268,O
To,269,271,O
determine,272,281,O
the,282,285,O
potency,286,293,O
of,294,296,O
2,297,298,O
",",298,299,O
3,299,300,O
",",300,301,O
3,301,302,O
',302,303,O
",",303,304,O
4,304,305,O
",",305,306,O
4,307,308,O
',308,309,O
-,309,310,O
pentachlorobiphenyl,310,329,O
(,330,331,O
PCB,331,334,O
105,335,338,O
),338,339,O
for,340,343,O
producing,344,353,O
reproductive,354,366,O
and,367,370,O
developmental,371,384,O
toxicity,385,393,O
",",393,394,O
adult,395,400,O
ring,401,405,O
-,405,406,O
necked,406,412,O
pheasant,413,421,O
hens,422,426,O
(,427,428,O
Phasianus,428,437,O
colchicus,438,447,O
),447,448,O
were,449,453,O
orally,454,460,O
dosed,461,466,O
with,467,471,O
0,472,473,O
",",473,474,O
0,475,476,O
.,476,477,O
06,477,479,O
",",479,480,O
0,481,482,O
.,482,483,O
6,483,484,O
",",484,485,O
or,486,488,O
6,489,490,O
mg,491,493,O
PCB,494,497,O
105,498,501,O
/,501,502,O
kg,502,504,O
hen,505,508,O
/,508,509,O
week,509,513,O
for,514,517,O
10,518,520,O
weeks,521,526,O
to,527,529,O
achieve,530,537,O
cumulative,538,548,O
doses,549,554,O
of,555,557,O
0,558,559,O
",",559,560,O
0,561,562,O
.,562,563,O
6,563,564,O
",",564,565,O
6,566,567,O
",",567,568,O
or,569,571,O
60,572,574,O
mg,575,577,O
PCB,578,581,O
105,582,585,O
/,585,586,O
kg,586,588,O
hen,589,592,O
after,593,598,O
which,599,604,O
hens,605,609,O
were,610,614,O
bred,615,619,O
with,620,624,O
untreated,625,634,O
roosters,635,643,O
once,644,648,O
per,649,652,O
week,653,657,O
for,658,661,O
8,662,663,O
weeks,664,669,O
.,669,670,O
Except,671,677,O
at,678,680,O
week,681,685,O
6,686,687,O
of,688,690,O
the,691,694,O
egg,695,698,B-Developing_anatomical_structure
-,698,699,O
laying,699,705,O
period,706,712,O
when,713,717,O
cumulative,718,728,O
egg,729,732,B-Developing_anatomical_structure
production,733,743,O
in,744,746,O
the,747,750,O
6,751,752,O
mg,753,755,O
PCB,756,759,O
105,760,763,O
/,763,764,O
kg,764,766,O
hen,767,770,O
group,771,776,O
was,777,780,O
greater,781,788,O
than,789,793,O
controls,794,802,O
",",802,803,O
fertilized,804,814,O
egg,815,818,B-Developing_anatomical_structure
production,819,829,O
was,830,833,O
not,834,837,O
significantly,838,851,O
different,852,861,O
between,862,869,O
treatment,870,879,O
groups,880,886,O
.,886,887,O
Embryo,888,894,B-Developing_anatomical_structure
mortality,895,904,O
and,905,908,O
chick,909,914,O
mortality,915,924,O
were,925,929,O
not,930,933,O
significantly,934,947,O
different,948,957,O
between,958,965,O
treatment,966,975,O
groups,976,982,O
.,982,983,O
Total,984,989,O
body,990,994,B-Organism_subdivision
and,995,998,O
heart,999,1004,B-Organ
weights,1005,1012,O
of,1013,1015,O
all,1016,1019,O
chicks,1020,1026,O
1,1027,1028,O
day,1029,1032,O
posthatch,1033,1042,O
(,1043,1044,O
dph,1044,1047,O
),1047,1048,O
were,1049,1053,O
not,1054,1057,O
different,1058,1067,O
between,1068,1075,O
groups,1076,1082,O
",",1082,1083,O
however,1084,1091,O
",",1091,1092,O
liver,1093,1098,B-Organ
weights,1099,1106,O
of,1107,1109,O
chicks,1110,1116,O
from,1117,1121,O
the,1122,1125,O
60,1126,1128,O
mg,1129,1131,O
/,1131,1132,O
kg,1132,1134,O
treatment,1135,1144,O
group,1145,1150,O
were,1151,1155,O
greater,1156,1163,O
than,1164,1168,O
controls,1169,1177,O
at,1178,1180,O
1,1181,1182,O
dph,1183,1186,O
.,1186,1187,O
The,1188,1191,O
first,1192,1197,O
chick,1198,1203,O
to,1204,1206,O
hatch,1207,1212,O
from,1213,1217,O
each,1218,1222,O
hen,1223,1226,O
was,1227,1230,O
reared,1231,1237,O
to,1238,1240,O
21,1241,1243,O
dph,1244,1247,O
and,1248,1251,O
among,1252,1257,O
these,1258,1263,O
birds,1264,1269,O
",",1269,1270,O
the,1271,1274,O
total,1275,1280,O
body,1281,1285,B-Organism_subdivision
",",1285,1286,O
liver,1287,1292,B-Organ
",",1292,1293,O
and,1294,1297,O
heart,1298,1303,B-Organ
weights,1304,1311,O
were,1312,1316,O
not,1317,1320,O
different,1321,1330,O
between,1331,1338,O
groups,1339,1345,O
.,1345,1346,O
There,1347,1352,O
were,1353,1357,O
no,1358,1360,O
dose,1361,1365,O
-,1365,1366,O
related,1366,1373,O
malformations,1374,1387,O
of,1388,1390,O
the,1391,1394,O
beak,1395,1399,B-Organism_subdivision
or,1400,1402,O
limbs,1403,1408,B-Organism_subdivision
",",1408,1409,O
and,1410,1413,O
no,1414,1416,O
signs,1417,1422,O
of,1423,1425,O
subcutaneous,1426,1438,B-Pathological_formation
edema,1439,1444,I-Pathological_formation
",",1444,1445,O
ascites,1446,1453,B-Organism_substance
",",1453,1454,O
or,1455,1457,O
pericardial,1458,1469,B-Pathological_formation
edema,1470,1475,I-Pathological_formation
in,1476,1478,O
chicks,1479,1485,O
at,1486,1488,O
1,1489,1490,O
or,1491,1493,O
21,1494,1496,O
dph,1497,1500,O
.,1500,1501,O
Hepatic,1502,1509,O
microsomal,1510,1520,O
monooxygenase,1521,1534,O
activities,1535,1545,O
[,1546,1547,O
ethoxyresorufin,1547,1562,O
-,1562,1563,O
O,1563,1564,O
-,1564,1565,O
dealkylase,1565,1575,O
(,1576,1577,O
EROD,1577,1581,O
),1581,1582,O
",",1582,1583,O
benzyloxyresorufin,1584,1602,O
-,1602,1603,O
O,1603,1604,O
-,1604,1605,O
dealkylase,1605,1615,O
(,1616,1617,O
BROD,1617,1621,O
),1621,1622,O
",",1622,1623,O
and,1624,1627,O
methyloxyresorufin,1628,1646,O
-,1646,1647,O
O,1647,1648,O
-,1648,1649,O
dealkylase,1649,1659,O
(,1660,1661,O
MROD,1661,1665,O
),1665,1666,O
],1666,1667,O
were,1668,1672,O
significantly,1673,1686,O
elevated,1687,1695,O
in,1696,1698,O
chicks,1699,1705,O
at,1706,1708,O
1,1709,1710,O
dph,1711,1714,O
from,1715,1719,O
hens,1720,1724,O
given,1725,1730,O
a,1731,1732,O
cumulative,1733,1743,O
PCB,1744,1747,O
105,1748,1751,O
dose,1752,1756,O
of,1757,1759,O
6,1760,1761,O
mg,1762,1764,O
/,1764,1765,O
kg,1765,1767,O
and,1768,1771,O
in,1772,1774,O
chicks,1775,1781,O
at,1782,1784,O
21,1785,1787,O
dph,1788,1791,O
from,1792,1796,O
hens,1797,1801,O
given,1802,1807,O
a,1808,1809,O
cumulative,1810,1820,O
PCB,1821,1824,O
dose,1825,1829,O
of,1830,1832,O
60,1833,1835,O
mg,1836,1838,O
/,1838,1839,O
kg,1839,1841,O
.,1841,1842,O
These,1843,1848,O
results,1849,1856,O
indicate,1857,1865,O
that,1866,1870,O
a,1871,1872,O
cumulative,1873,1883,O
PCB,1884,1887,O
105,1888,1891,O
dose,1892,1896,O
up,1897,1899,O
to,1900,1902,O
60,1903,1905,O
mg,1906,1908,O
/,1908,1909,O
kg,1909,1911,O
hen,1912,1915,O
does,1916,1920,O
not,1921,1924,O
decrease,1925,1933,O
the,1934,1937,O
production,1938,1948,O
of,1949,1951,O
fertilized,1952,1962,O
eggs,1963,1967,B-Developing_anatomical_structure
or,1968,1970,O
increase,1971,1979,O
embryo,1980,1986,B-Developing_anatomical_structure
or,1987,1989,O
chick,1990,1995,O
mortality,1996,2005,O
in,2006,2008,O
ring,2009,2013,O
-,2013,2014,O
necked,2014,2020,O
pheasants,2021,2030,O
",",2030,2031,O
but,2032,2035,O
does,2036,2040,O
increase,2041,2049,O
chick,2050,2055,O
hepatic,2056,2063,B-Organ
monooxygenase,2064,2077,O
activity,2078,2086,O
.,2086,2087,O
Detection,0,9,O
of,10,12,O
total,13,18,O
assist,19,25,O
and,26,29,O
sucking,30,37,O
points,38,44,O
based,45,50,O
on,51,53,O
the,54,57,O
pulsatility,58,69,O
of,70,72,O
a,73,74,O
continuous,75,85,O
flow,86,90,O
artificial,91,101,O
heart,102,107,O
:,107,108,O
in,109,111,O
vivo,112,116,O
evaluation,117,127,O
.,127,128,O
Our,129,132,O
novel,133,138,O
control,139,146,O
strategy,147,155,O
for,156,159,O
a,160,161,O
continuous,162,172,O
flow,173,177,O
artificial,178,188,O
heart,189,194,O
by,195,197,O
detecting,198,207,O
the,208,211,O
total,212,217,O
assist,218,224,O
and,225,228,O
sucking,229,236,O
points,237,243,O
based,244,249,O
on,250,252,O
pump,253,257,O
pulsatility,258,269,O
was,270,273,O
evaluated,274,283,O
in,284,286,O
acute,287,292,O
animal,293,299,O
experiments,300,311,O
using,312,317,O
beagle,318,324,O
dogs,325,329,O
and,330,333,O
our,334,337,O
mixed,338,343,O
flow,344,348,O
pump,349,353,O
.,353,354,O
The,355,358,O
pump,359,363,O
was,364,367,O
installed,368,377,O
as,378,380,O
a,381,382,O
left,383,387,B-Multi-tissue_structure
ventricular,388,399,I-Multi-tissue_structure
(,400,401,O
LV,401,403,B-Multi-tissue_structure
),403,404,O
bypass,405,411,O
through,412,419,O
a,420,421,O
left,422,426,O
thoracotomy,427,438,O
.,438,439,O
To,440,442,O
change,443,449,O
LV,450,452,B-Multi-tissue_structure
contractility,453,466,O
",",466,467,O
the,468,471,O
left,472,476,O
coronary,477,485,B-Multi-tissue_structure
arteries,486,494,I-Multi-tissue_structure
were,495,499,O
occluded,500,508,O
for,509,512,O
30,513,515,O
min,516,519,O
",",519,520,O
followed,521,529,O
by,530,532,O
a,533,534,O
120,535,538,O
min,539,542,O
reperfusion,543,554,O
.,554,555,O
To,556,558,O
change,559,565,O
LV,566,568,B-Multi-tissue_structure
end,569,572,O
diastolic,573,582,O
pressure,583,591,O
(,592,593,O
LVEDP,593,598,O
),598,599,O
",",599,600,O
dextran,601,608,O
solution,609,617,O
was,618,621,O
rapidly,622,629,O
infused,630,637,O
.,637,638,O
To,639,641,O
estimate,642,650,O
the,651,654,O
pump,655,659,O
pulsatility,660,671,O
without,672,679,O
any,680,683,O
specific,684,692,O
sensor,693,699,O
",",699,700,O
we,701,703,O
calculated,704,714,O
the,715,718,O
index,719,724,O
of,725,727,O
current,728,735,O
amplitude,736,745,O
(,746,747,O
ICA,747,750,O
),750,751,O
",",751,752,O
which,753,758,O
was,759,762,O
obtained,763,771,O
from,772,776,O
the,777,780,O
amplitude,781,790,O
of,791,793,O
the,794,797,O
motor,798,803,O
current,804,811,O
waveform,812,820,O
divided,821,828,O
by,829,831,O
the,832,835,O
simultaneous,836,848,O
mean,849,853,O
value,854,859,O
.,859,860,O
To,861,863,O
investigate,864,875,O
the,876,879,O
basic,880,885,O
characteristics,886,901,O
of,902,904,O
the,905,908,O
ICA,909,912,O
",",912,913,O
the,914,917,O
pump,918,922,O
speed,923,928,O
was,929,932,O
changed,933,940,O
temporarily,941,952,O
from,953,957,O
2,958,959,O
",",959,960,O
300,960,963,O
rpm,964,967,O
to,968,970,O
5,971,972,O
",",972,973,O
000,973,976,O
rpm,977,980,O
.,980,981,O
In,982,984,O
92,985,987,O
%,987,988,O
of,989,991,O
all,992,995,O
measurements,996,1008,O
",",1008,1009,O
the,1010,1013,O
ICA,1014,1017,O
plotted,1018,1025,O
against,1026,1033,O
the,1034,1037,O
pump,1038,1042,O
speed,1043,1048,O
had,1049,1052,O
a,1053,1054,O
peak,1055,1059,O
point,1060,1065,O
(,1066,1067,O
t,1067,1068,O
-,1068,1069,O
point,1069,1074,O
),1074,1075,O
that,1076,1080,O
corresponded,1081,1093,O
highly,1094,1100,O
with,1101,1105,O
the,1106,1109,O
turning,1110,1117,O
point,1118,1123,O
from,1124,1128,O
partial,1129,1136,O
to,1137,1139,O
total,1140,1145,O
assistance,1146,1156,O
.,1156,1157,O
The,1158,1161,O
ICA,1162,1165,O
also,1166,1170,O
had,1171,1174,O
a,1175,1176,O
trough,1177,1183,O
(,1184,1185,O
s,1185,1186,O
-,1186,1187,O
point,1187,1192,O
),1192,1193,O
that,1194,1198,O
corresponded,1199,1211,O
with,1212,1216,O
the,1217,1220,O
beginning,1221,1230,O
of,1231,1233,O
severe,1234,1240,O
sucking,1241,1248,O
in,1249,1251,O
most,1252,1256,O
cases,1257,1262,O
.,1262,1263,O
Only,1264,1268,O
preload,1269,1276,O
significantly,1277,1290,O
influenced,1291,1301,O
pump,1302,1306,O
flow,1307,1311,O
rate,1312,1316,O
at,1317,1319,O
the,1320,1323,O
t,1324,1325,O
-,1325,1326,O
point,1326,1331,O
from,1332,1336,O
among,1337,1342,O
preload,1343,1350,O
(,1351,1352,O
LVEDP,1352,1357,O
),1357,1358,O
",",1358,1359,O
afterload,1360,1369,O
(,1370,1371,O
SAoP,1371,1375,O
),1375,1376,O
",",1376,1377,O
and,1378,1381,O
contractility,1382,1395,O
(,1396,1397,O
max,1397,1400,O
LV,1401,1403,B-Multi-tissue_structure
dP,1404,1406,O
/,1406,1407,O
dt,1407,1409,O
),1409,1410,O
",",1410,1411,O
by,1412,1414,O
which,1415,1420,O
we,1421,1423,O
can,1424,1427,O
simulate,1428,1436,O
Starling,1437,1445,O
',1445,1446,O
s,1446,1447,O
law,1448,1451,O
of,1452,1454,O
the,1455,1458,O
natural,1459,1466,O
heart,1467,1472,B-Organ
.,1472,1473,O
We,1474,1476,O
concluded,1477,1486,O
that,1487,1491,O
a,1492,1493,O
continuous,1494,1504,O
flow,1505,1509,O
artificial,1510,1520,O
heart,1521,1526,O
could,1527,1532,O
be,1533,1535,O
well,1536,1540,O
controlled,1541,1551,O
by,1552,1554,O
detecting,1555,1564,O
the,1565,1568,O
t,1569,1570,O
-,1570,1571,O
point,1571,1576,O
and,1577,1580,O
s,1581,1582,O
-,1582,1583,O
point,1583,1588,O
.,1588,1589,O
Immunostaining,0,14,O
and,15,18,O
confocal,19,27,O
analysis,28,36,O
DNA,37,40,O
labelling,41,50,O
and,51,54,O
staining,55,63,O
with,64,68,O
5,69,70,O
-,70,71,O
bromo,71,76,O
-,76,77,O
2,77,78,O
',78,79,O
-,79,80,O
deoxyuridine,80,92,O
(,93,94,O
BrdU,94,98,O
labelling,99,108,O
and,109,112,O
detection,113,122,O
kit,123,126,O
I,127,128,O
;,128,129,O
Boehringer,130,140,O
Mannheim,141,149,O
",",149,150,O
Germany,151,158,O
),158,159,O
was,160,163,O
performed,164,173,O
according,174,183,O
to,184,186,O
the,187,190,O
manufacturer,191,203,O
',203,204,O
s,204,205,O
instructions,206,218,O
.,218,219,O
The,220,223,O
nucleoli,224,232,B-Cellular_component
were,233,237,O
detected,238,246,O
with,247,251,O
an,252,254,O
anti,255,259,O
-,259,260,O
nucleolin,260,269,O
antibody,270,278,O
(,279,280,O
clone,280,285,O
3G4B2,286,291,O
;,291,292,O
Upstate,293,300,O
biotechnology,301,314,O
",",314,315,O
Lake,316,320,O
Placid,321,327,O
",",327,328,O
NY,329,331,O
),331,332,O
on,333,335,O
cells,336,341,B-Cell
fixed,342,347,O
in,348,350,O
2,351,352,O
%,352,353,O
formalin,354,362,O
for,363,366,O
10,367,369,O
min,370,373,O
followed,374,382,O
by,383,385,O
permeabilization,386,402,O
with,403,407,O
ice,408,411,O
-,411,412,O
cold,412,416,O
methanol,417,425,O
for,426,429,O
30,430,432,O
min,433,436,O
.,436,437,O
The,438,441,O
secondary,442,451,O
antibody,452,460,O
used,461,465,O
for,466,469,O
both,470,474,O
BrdU,475,479,O
and,480,483,O
nucleoli,484,492,B-Cellular_component
staining,493,501,O
was,502,505,O
a,506,507,O
rhodamine,508,517,O
(,518,519,O
tetra,519,524,O
-,524,525,O
methyl,525,531,O
),531,532,O
-,532,533,O
conjugated,533,543,O
goat,544,548,O
anti,549,553,O
-,553,554,O
mouse,554,559,O
antibody,560,568,O
(,569,570,O
T,570,571,O
-,571,572,O
2762,572,576,O
),576,577,O
from,578,582,O
Molecular,583,592,O
Probe,593,598,O
(,599,600,O
Eugene,600,606,O
",",606,607,O
OR,608,610,O
),610,611,O
.,611,612,O
The,613,616,O
cells,617,622,B-Cell
were,623,627,O
examined,628,636,O
in,637,639,O
a,640,641,O
Zeiss,642,647,O
LSM,648,651,O
510,652,655,O
laser,656,661,O
scanning,662,670,O
microscope,671,681,O
equipped,682,690,O
with,691,695,O
a,696,697,O
Plan,698,702,O
-,702,703,O
Apochromate,703,714,O
63x,715,718,O
/,718,719,O
1,719,720,O
.,720,721,O
4,721,722,O
oil,723,726,O
immersion,727,736,O
objective,737,746,O
.,746,747,O
We,748,750,O
used,751,755,O
the,756,759,O
488,760,763,O
nm,764,766,O
laser,767,772,O
line,773,777,O
for,778,781,O
excitation,782,792,O
of,793,795,O
EGFP,796,800,O
(,801,802,O
detected,802,810,O
at,811,813,O
505,814,817,O
nm,818,820,O
<,821,822,O
lambdaEGFP,823,833,O
<,834,835,O
530,836,839,O
nm,840,842,O
),842,843,O
and,844,847,O
the,848,851,O
543,852,855,O
nm,856,858,O
laser,859,864,O
line,865,869,O
for,870,873,O
rhodamine,874,883,O
(,884,885,O
tetra,885,890,O
-,890,891,O
methyl,891,897,O
),897,898,O
(,899,900,O
detected,900,908,O
at,909,911,O
lambdaRhodamine,912,927,O
>,928,929,O
560,930,933,O
nm,934,936,O
),936,937,O
.,937,938,O
ECFP,939,943,O
fusion,944,950,O
protein,951,958,O
was,959,962,O
excited,963,970,O
with,971,975,O
a,976,977,O
458,978,981,O
nm,982,984,O
laser,985,990,O
line,991,995,O
(,996,997,O
detected,997,1005,O
at,1006,1008,O
480,1009,1012,O
nm,1013,1015,O
<,1016,1017,O
lambdaECFP,1018,1028,O
<,1029,1030,O
520,1031,1034,O
nm,1035,1037,O
),1037,1038,O
",",1038,1039,O
EYFP,1040,1044,O
fusion,1045,1051,O
protein,1052,1059,O
was,1060,1063,O
excited,1064,1071,O
with,1072,1076,O
a,1077,1078,O
514,1079,1082,O
nm,1083,1085,O
laser,1086,1091,O
line,1092,1096,O
(,1097,1098,O
lambdaEGFP,1098,1108,O
>,1109,1110,O
560,1111,1114,O
nm,1115,1117,O
),1117,1118,O
and,1119,1122,O
HcRed,1123,1128,O
fusion,1129,1135,O
protein,1136,1143,O
was,1144,1147,O
excited,1148,1155,O
with,1156,1160,O
a,1161,1162,O
543,1163,1166,O
nm,1167,1169,O
laser,1170,1175,O
line,1176,1180,O
and,1181,1184,O
detected,1185,1193,O
at,1194,1196,O
>,1197,1198,O
585,1198,1201,O
or,1202,1204,O
650,1205,1208,O
nm,1209,1211,O
.,1211,1212,O
The,1213,1216,O
images,1217,1223,O
were,1224,1228,O
from,1229,1233,O
1,1234,1235,O
mum,1236,1239,O
thick,1240,1245,O
slices,1246,1252,B-Cell
of,1253,1255,O
the,1256,1259,O
cells,1260,1265,B-Cell
.,1265,1266,O
The,1267,1270,O
images,1271,1277,O
were,1278,1282,O
exported,1283,1291,O
into,1292,1296,O
Adobe,1297,1302,O
Photoshop,1303,1312,O
(,1313,1314,O
Adobe,1314,1319,O
Systems,1320,1327,O
Inc,1328,1331,O
.,1331,1332,O
",",1332,1333,O
San,1334,1337,O
Jose,1338,1342,O
",",1342,1343,O
CA,1344,1346,O
),1346,1347,O
.,1347,1348,O
Conclusions,0,11,O
Only,12,16,O
after,17,22,O
careful,23,30,O
consideration,31,44,O
of,45,47,O
the,48,51,O
biological,52,62,O
underpinnings,63,76,O
of,77,79,O
a,80,81,O
truly,82,87,O
beneficial,88,98,O
response,99,107,O
can,108,111,O
an,112,114,O
exposure,115,123,O
be,124,126,O
considered,127,137,O
for,138,141,O
the,142,145,O
general,146,153,O
population,154,164,O
",",164,165,O
such,166,170,O
as,171,173,O
the,174,177,O
addition,178,186,O
of,187,189,O
folic,190,195,O
acid,196,200,O
to,201,203,O
cereals,204,211,O
.,211,212,O
If,213,215,O
a,216,217,O
toxic,218,223,O
or,224,226,O
hazardous,227,236,O
pollutant,237,246,O
were,247,251,O
found,252,257,O
to,258,260,O
have,261,265,O
truly,266,271,O
beneficial,272,282,O
effects,283,290,O
at,291,293,O
low,294,297,O
dose,298,302,O
",",302,303,O
then,304,308,O
that,309,313,O
agent,314,319,O
should,320,326,O
be,327,329,O
tested,330,336,O
clinically,337,347,O
",",347,348,O
go,349,351,O
through,352,359,O
the,360,363,O
U,364,365,O
.,365,366,O
S,366,367,O
.,367,368,O
Food,369,373,O
and,374,377,O
Drug,378,382,O
Administration,383,397,O
(,398,399,O
FDA,399,402,O
),402,403,O
approval,404,412,O
process,413,420,O
",",420,421,O
and,422,425,O
be,426,428,O
regulated,429,438,O
as,439,441,O
a,442,443,O
pharmaceutical,444,458,O
for,459,462,O
those,463,468,O
who,469,472,O
might,473,478,O
benefit,479,486,O
from,487,491,O
its,492,495,O
use,496,499,O
.,499,500,O
Certainly,501,510,O
",",510,511,O
the,512,515,O
general,516,523,O
population,524,534,O
should,535,541,O
not,542,545,O
be,546,548,O
exposed,549,556,O
to,557,559,O
chemotherapeutic,560,576,O
agents,577,583,O
that,584,588,O
benefit,589,596,O
cancer,597,603,B-Pathological_formation
patients,604,612,O
.,612,613,O
For,614,617,O
pharmaceuticals,618,633,O
",",633,634,O
it,635,637,O
is,638,640,O
understood,641,651,O
that,652,656,O
there,657,662,O
are,663,666,O
trade,667,672,O
offs,673,677,O
between,678,685,O
benefits,686,694,O
and,695,698,O
risks,699,704,O
.,704,705,O
For,706,709,O
example,710,717,O
",",717,718,O
although,719,727,O
aspirin,728,735,O
is,736,738,O
a,739,740,O
generally,741,750,O
well,751,755,O
-,755,756,O
tolerated,756,765,O
pain,766,770,O
reliever,771,779,O
and,780,783,O
is,784,786,O
increasingly,787,799,O
advocated,800,809,O
as,810,812,O
a,813,814,O
preventative,815,827,O
tool,828,832,O
for,833,836,O
heart,837,842,B-Organ
attacks,843,850,O
and,851,854,O
colorectal,855,865,B-Pathological_formation
cancer,866,872,I-Pathological_formation
(,873,874,O
Vainio,874,880,O
and,881,884,O
Miller,885,891,O
2003,892,896,O
;,896,897,O
Werner,898,904,O
et,905,907,O
al,908,910,O
.,910,911,O
2004,912,916,O
),916,917,O
",",917,918,O
it,919,921,O
is,922,924,O
also,925,929,O
linked,930,936,O
to,937,939,O
increased,940,949,O
risk,950,954,O
of,955,957,O
gastrointestinal,958,974,B-Organism_subdivision
bleeding,975,983,O
",",983,984,O
cerebral,985,993,B-Organ
hemorrhage,994,1004,O
(,1005,1006,O
Werner,1006,1012,O
et,1013,1015,O
al,1016,1018,O
.,1018,1019,O
2004,1020,1024,O
),1024,1025,O
",",1025,1026,O
and,1027,1030,O
asthma,1031,1037,O
attacks,1038,1045,O
(,1046,1047,O
Jenkins,1047,1054,O
et,1055,1057,O
al,1058,1060,O
.,1060,1061,O
2004,1062,1066,O
),1066,1067,O
.,1067,1068,O
In,1069,1071,O
addition,1072,1080,O
",",1080,1081,O
aspirin,1082,1089,O
is,1090,1092,O
not,1093,1096,O
recommended,1097,1108,O
for,1109,1112,O
children,1113,1121,O
or,1122,1124,O
teenagers,1125,1134,O
who,1135,1138,O
have,1139,1143,O
or,1144,1146,O
are,1147,1150,O
recovering,1151,1161,O
from,1162,1166,O
chicken,1167,1174,O
pox,1175,1178,O
or,1179,1181,O
flulike,1182,1189,O
symptoms,1190,1198,O
because,1199,1206,O
it,1207,1209,O
can,1210,1213,O
cause,1214,1219,O
debilitating,1220,1232,O
and,1233,1236,O
sometimes,1237,1246,O
lethal,1247,1253,O
Reyes,1254,1259,O
syndrome,1260,1268,O
(,1269,1270,O
U,1270,1271,O
.,1271,1272,O
S,1272,1273,O
.,1273,1274,O
FDA,1275,1278,O
2003,1279,1283,O
),1283,1284,O
.,1284,1285,O
Individual,1286,1296,O
risks,1297,1302,O
to,1303,1305,O
pharmaceutical,1306,1320,O
agents,1321,1327,O
can,1328,1331,O
be,1332,1334,O
controlled,1335,1345,O
with,1346,1350,O
proper,1351,1357,O
usage,1358,1363,O
;,1363,1364,O
however,1365,1372,O
",",1372,1373,O
increased,1374,1383,O
exposure,1384,1392,O
to,1393,1395,O
environmental,1396,1409,O
toxins,1410,1416,O
presents,1417,1425,O
additional,1426,1436,O
involuntary,1437,1448,O
risks,1449,1454,O
for,1455,1458,O
the,1459,1462,O
general,1463,1470,O
population,1471,1481,O
.,1481,1482,O
Under,1483,1488,O
the,1489,1492,O
latter,1493,1499,O
condition,1500,1509,O
",",1509,1510,O
exposure,1511,1519,O
is,1520,1522,O
inadequately,1523,1535,O
controlled,1536,1546,O
",",1546,1547,O
and,1548,1551,O
there,1552,1557,O
is,1558,1560,O
no,1561,1563,O
mechanism,1564,1573,O
to,1574,1576,O
correct,1577,1584,O
for,1585,1588,O
individual,1589,1599,O
circumstances,1600,1613,O
(,1614,1615,O
e,1615,1616,O
.,1616,1617,O
g,1617,1618,O
.,1618,1619,O
",",1619,1620,O
medical,1621,1628,O
condition,1629,1638,O
or,1639,1641,O
age,1642,1645,O
),1645,1646,O
that,1647,1651,O
may,1652,1655,O
result,1656,1662,O
in,1663,1665,O
harm,1666,1670,O
.,1670,1671,O
Although,1672,1680,O
hormetic,1681,1689,O
effects,1690,1697,O
may,1698,1701,O
occur,1702,1707,O
in,1708,1710,O
some,1711,1715,O
instances,1716,1725,O
",",1725,1726,O
it,1727,1729,O
is,1730,1732,O
indeed,1733,1739,O
rare,1740,1744,O
that,1745,1749,O
exposures,1750,1759,O
to,1760,1762,O
toxic,1763,1768,O
",",1768,1769,O
mutagenic,1770,1779,O
",",1779,1780,O
teratogenic,1781,1792,O
",",1792,1793,O
and,1794,1797,O
carcinogenic,1798,1810,O
chemicals,1811,1820,O
",",1820,1821,O
even,1822,1826,O
at,1827,1829,O
low,1830,1833,O
exposure,1834,1842,O
levels,1843,1849,O
",",1849,1850,O
would,1851,1856,O
be,1857,1859,O
risk,1860,1864,O
free,1865,1869,O
and,1870,1873,O
provide,1874,1881,O
health,1882,1888,O
benefits,1889,1897,O
for,1898,1901,O
the,1902,1905,O
general,1906,1913,O
public,1914,1920,O
.,1920,1921,O
Portraying,1922,1932,O
chemicals,1933,1942,O
with,1943,1947,O
numerous,1948,1956,O
adverse,1957,1964,O
effects,1965,1972,O
as,1973,1975,O
having,1976,1982,O
benefits,1983,1991,O
while,1992,1997,O
ignoring,1998,2006,O
their,2007,2012,O
hazards,2013,2020,O
is,2021,2023,O
irresponsible,2024,2037,O
and,2038,2041,O
does,2042,2046,O
not,2047,2050,O
provide,2051,2058,O
full,2059,2063,O
and,2064,2067,O
objective,2068,2077,O
disclosure,2078,2088,O
.,2088,2089,O
In,2090,2092,O
the,2093,2096,O
1950s,2097,2102,O
doctors,2103,2110,O
prescribed,2111,2121,O
DES,2122,2125,O
to,2126,2128,O
pregnant,2129,2137,O
women,2138,2143,O
to,2144,2146,O
prevent,2147,2154,O
miscarriage,2155,2166,O
and,2167,2170,O
premature,2171,2180,O
births,2181,2187,O
and,2188,2191,O
to,2192,2194,O
produce,2195,2202,O
"""",2203,2204,O
bigger,2204,2210,O
and,2211,2214,O
stronger,2215,2223,O
babies,2224,2230,O
"""",2230,2231,O
even,2232,2236,O
though,2237,2243,O
DES,2244,2247,O
had,2248,2251,O
been,2252,2256,O
shown,2257,2262,O
to,2263,2265,O
cause,2266,2271,O
damage,2272,2278,O
to,2279,2281,O
reproductive,2282,2294,O
tissues,2295,2302,B-Tissue
in,2303,2305,O
animals,2306,2313,O
(,2314,2315,O
Dinusson,2315,2323,O
et,2324,2326,O
al,2327,2329,O
.,2329,2330,O
1948,2331,2335,O
;,2335,2336,O
Dunn,2337,2341,O
and,2342,2345,O
Green,2346,2351,O
1963,2352,2356,O
;,2356,2357,O
Takasugi,2358,2366,O
and,2367,2370,O
Bern,2371,2375,O
1964,2376,2380,O
),2380,2381,O
.,2381,2382,O
Human,2383,2388,O
use,2389,2392,O
of,2393,2395,O
DES,2396,2399,O
was,2400,2403,O
banned,2404,2410,O
in,2411,2413,O
the,2414,2417,O
United,2418,2424,O
States,2425,2431,O
in,2432,2434,O
1971,2435,2439,O
after,2440,2445,O
the,2446,2449,O
discovery,2450,2459,O
of,2460,2462,O
high,2463,2467,O
rates,2468,2473,O
of,2474,2476,O
rare,2477,2481,O
",",2481,2482,O
clear,2483,2488,O
-,2488,2489,O
cell,2489,2493,O
adenocarcinomas,2494,2509,B-Pathological_formation
of,2510,2512,O
the,2513,2516,O
vagina,2517,2523,B-Multi-tissue_structure
and,2524,2527,O
cervix,2528,2534,B-Multi-tissue_structure
in,2535,2537,O
DES,2538,2541,O
-,2541,2542,O
exposed,2542,2549,O
daughters,2550,2559,O
(,2560,2561,O
Herbst,2561,2567,O
1981,2568,2572,O
),2572,2573,O
",",2573,2574,O
and,2575,2578,O
later,2579,2584,O
studies,2585,2592,O
showed,2593,2599,O
elevated,2600,2608,O
breast,2609,2615,B-Pathological_formation
cancer,2616,2622,I-Pathological_formation
risk,2623,2627,O
in,2628,2630,O
women,2631,2636,O
who,2637,2640,O
took,2641,2645,O
DES,2646,2649,O
during,2650,2656,O
pregnancy,2657,2666,O
(,2667,2668,O
Titus,2668,2673,O
-,2673,2674,O
Ernstoff,2674,2682,O
et,2683,2685,O
al,2686,2688,O
.,2688,2689,O
2001,2690,2694,O
),2694,2695,O
.,2695,2696,O
Certainly,2697,2706,O
",",2706,2707,O
health,2708,2714,O
policy,2715,2721,O
decisions,2722,2731,O
should,2732,2738,O
be,2739,2741,O
based,2742,2747,O
on,2748,2750,O
scientific,2751,2761,O
evidence,2762,2770,O
and,2771,2774,O
not,2775,2778,O
on,2779,2781,O
speculation,2782,2793,O
of,2794,2796,O
health,2797,2803,O
benefits,2804,2812,O
in,2813,2815,O
order,2816,2821,O
for,2822,2825,O
the,2826,2829,O
general,2830,2837,O
population,2838,2848,O
to,2849,2851,O
avoid,2852,2857,O
repeating,2858,2867,O
the,2868,2871,O
mistakes,2872,2880,O
of,2881,2883,O
the,2884,2887,O
past,2888,2892,O
similar,2893,2900,O
to,2901,2903,O
that,2904,2908,O
of,2909,2911,O
the,2912,2915,O
DES,2916,2919,O
tragedy,2920,2927,O
.,2927,2928,O
The,2929,2932,O
claims,2933,2939,O
and,2940,2943,O
projections,2944,2955,O
of,2956,2958,O
health,2959,2965,O
benefits,2966,2974,O
from,2975,2979,O
exposures,2980,2989,O
to,2990,2992,O
environmental,2993,3006,O
toxicants,3007,3016,O
and,3017,3020,O
carcinogens,3021,3032,O
are,3033,3036,O
based,3037,3042,O
on,3043,3045,O
untested,3046,3054,O
assumptions,3055,3066,O
and,3067,3070,O
disregard,3071,3080,O
numerous,3081,3089,O
well,3090,3094,O
-,3094,3095,O
established,3095,3106,O
scientific,3107,3117,O
principles,3118,3128,O
that,3129,3133,O
underpin,3134,3142,O
a,3143,3144,O
public,3145,3151,O
health,3152,3158,O
-,3158,3159,O
protective,3159,3169,O
approach,3170,3178,O
to,3179,3181,O
regulating,3182,3192,O
exposure,3193,3201,O
to,3202,3204,O
toxic,3205,3210,O
substances,3211,3221,O
.,3221,3222,O
If,3223,3225,O
hormesis,3226,3234,O
were,3235,3239,O
used,3240,3244,O
in,3245,3247,O
the,3248,3251,O
decision,3252,3260,O
-,3260,3261,O
making,3261,3267,O
process,3268,3275,O
to,3276,3278,O
allow,3279,3284,O
higher,3285,3291,O
exposures,3292,3301,O
to,3302,3304,O
toxic,3305,3310,O
and,3311,3314,O
carcinogenic,3315,3327,O
agents,3328,3334,O
",",3334,3335,O
this,3336,3340,O
would,3341,3346,O
substantially,3347,3360,O
increase,3361,3369,O
health,3370,3376,O
risks,3377,3382,O
for,3383,3386,O
many,3387,3391,O
",",3391,3392,O
if,3393,3395,O
not,3396,3399,O
most,3400,3404,O
",",3404,3405,O
segments,3406,3414,O
of,3415,3417,O
the,3418,3421,O
general,3422,3429,O
population,3430,3440,O
.,3440,3441,O
Measured,0,8,O
analytes,9,17,O
in,18,20,O
five,21,25,O
biologic,26,34,O
sample,35,41,O
matrices,42,50,O
.,50,51,O
a,51,52,O
Competing,0,9,O
interests,10,19,O
None,20,24,O
declared,25,33,O
.,33,34,O
This,35,39,O
article,40,47,O
is,48,50,O
the,51,54,O
third,55,60,O
in,61,63,O
an,64,66,O
ongoing,67,74,O
",",74,75,O
educational,76,87,O
review,88,94,O
series,95,101,O
on,102,104,O
medical,105,112,O
statistics,113,123,O
in,124,126,O
critical,127,135,O
care,136,140,O
.,140,141,O
Previous,142,150,O
articles,151,159,O
have,160,164,O
covered,165,172,O
',173,174,O
presenting,174,184,O
and,185,188,O
summarising,189,200,O
data,201,205,O
',205,206,O
[,207,208,O
3,208,209,O
],209,210,O
and,211,214,O
',215,216,O
samples,216,223,O
and,224,227,O
populations,228,239,O
',239,240,O
[,241,242,O
4,242,243,O
],243,244,O
.,244,245,O
Future,246,252,O
topics,253,259,O
to,260,262,O
be,263,265,O
covered,266,273,O
include,274,281,O
power,282,287,O
calculations,288,300,O
",",300,301,O
comparison,302,312,O
of,313,315,O
means,316,321,O
",",321,322,O
comparison,323,333,O
of,334,336,O
proportions,337,348,O
",",348,349,O
and,350,353,O
analysis,354,362,O
of,363,365,O
survival,366,374,O
data,375,379,O
to,380,382,O
name,383,387,O
but,388,391,O
a,392,393,O
few,394,397,O
.,397,398,O
If,399,401,O
there,402,407,O
is,408,410,O
a,411,412,O
medical,413,420,O
statistics,421,431,O
topic,432,437,O
you,438,441,O
would,442,447,O
like,448,452,O
explained,453,462,O
contact,463,470,O
us,471,473,O
on,474,476,O
editorial,477,486,O
@,486,487,O
ccforum,487,494,O
.,494,495,O
com,495,498,O
.,499,500,O
Results,0,7,O
The,8,11,O
set,12,15,O
of,16,18,O
E,19,20,O
.,20,21,O
coli,22,26,O
expression,27,37,O
vectors,38,45,O
",",45,46,O
encode,47,53,O
for,54,57,O
either,58,64,O
a,65,66,O
hexa,67,71,O
-,71,72,O
histidine,72,81,O
tag,82,85,O
or,86,88,O
the,89,92,O
three,93,98,O
most,99,103,O
commonly,104,112,O
used,113,117,O
solubility,118,128,O
tags,129,133,O
(,134,135,O
GST,135,138,O
",",138,139,O
MBP,140,143,O
",",143,144,O
NusA,145,149,O
),149,150,O
and,151,154,O
all,155,158,O
with,159,163,O
an,164,166,O
N,167,168,O
-,168,169,O
terminal,169,177,O
hexa,178,182,O
-,182,183,O
histidine,183,192,O
sequence,193,201,O
.,201,202,O
The,203,206,O
result,207,213,O
is,214,216,O
two,217,220,O
-,220,221,O
fold,221,225,O
:,225,226,O
the,227,230,O
His,231,234,O
-,234,235,O
tag,235,238,O
facilitates,239,250,O
purification,251,263,O
by,264,266,O
immobilised,267,278,O
metal,279,284,O
affinity,285,293,O
chromatography,294,308,O
",",308,309,O
whilst,310,316,O
the,317,320,O
fusion,321,327,O
domains,328,335,O
act,336,339,O
primarily,340,349,O
as,350,352,O
solubility,353,363,O
aids,364,368,O
during,369,375,O
expression,376,386,O
",",386,387,O
in,388,390,O
addition,391,399,O
to,400,402,O
providing,403,412,O
an,413,415,O
optional,416,424,O
purification,425,437,O
step,438,442,O
.,442,443,O
We,444,446,O
have,447,451,O
also,452,456,O
incorporated,457,469,O
a,470,471,O
TEV,472,475,O
recognition,476,487,O
sequence,488,496,O
following,497,506,O
the,507,510,O
solubility,511,521,O
tag,522,525,O
domain,526,532,O
",",532,533,O
which,534,539,O
allows,540,546,O
for,547,550,O
highly,551,557,O
specific,558,566,O
cleavage,567,575,O
(,576,577,O
using,577,582,O
TEV,583,586,O
protease,587,595,O
),595,596,O
of,597,599,O
the,600,603,O
fusion,604,610,O
protein,611,618,O
to,619,621,O
yield,622,627,O
native,628,634,O
protein,635,642,O
.,642,643,O
These,644,649,O
vectors,650,657,O
are,658,661,O
also,662,666,O
designed,667,675,O
for,676,679,O
ligation,680,688,O
-,688,689,O
independent,689,700,O
cloning,701,708,O
and,709,712,O
they,713,717,O
possess,718,725,O
a,726,727,O
high,728,732,O
-,732,733,O
level,733,738,O
expressing,739,749,O
T7,750,752,O
promoter,753,761,O
",",761,762,O
which,763,768,O
is,769,771,O
suitable,772,780,O
for,781,784,O
auto,785,789,O
-,789,790,O
induction,790,799,O
.,799,800,O
To,801,803,O
validate,804,812,O
our,813,816,O
vector,817,823,O
system,824,830,O
",",830,831,O
we,832,834,O
have,835,839,O
cloned,840,846,O
four,847,851,O
different,852,861,O
genes,862,867,O
and,868,871,O
also,872,876,O
one,877,880,O
gene,881,885,O
into,886,890,O
all,891,894,O
four,895,899,O
vectors,900,907,O
and,908,911,O
used,912,916,O
small,917,922,O
-,922,923,O
scale,923,928,O
expression,929,939,O
and,940,943,O
purification,944,956,O
techniques,957,967,O
.,967,968,O
We,969,971,O
demonstrate,972,983,O
that,984,988,O
the,989,992,O
vectors,993,1000,O
are,1001,1004,O
capable,1005,1012,O
of,1013,1015,O
high,1016,1020,O
levels,1021,1027,O
of,1028,1030,O
expression,1031,1041,O
and,1042,1045,O
that,1046,1050,O
efficient,1051,1060,O
screening,1061,1070,O
of,1071,1073,O
new,1074,1077,O
proteins,1078,1086,O
can,1087,1090,O
be,1091,1093,O
readily,1094,1101,O
achieved,1102,1110,O
at,1111,1113,O
the,1114,1117,O
laboratory,1118,1128,O
level,1129,1134,O
.,1134,1135,O
Inflammation,0,12,O
-,12,13,O
modulating,13,23,O
effect,24,30,O
of,31,33,O
antithrombin,34,46,O
on,47,49,O
the,50,53,O
endothelium,54,65,B-Tissue
.,65,66,O
Ligation,67,75,O
of,76,78,O
heparan,79,86,O
sulfate,87,94,O
proteoglycans,95,108,O
(,109,110,O
HSPGs,110,115,O
),115,116,O
of,117,119,O
endothelium,120,131,B-Tissue
with,132,136,O
antithrombin,137,149,O
(,150,151,O
AT,151,153,O
),153,154,O
induces,155,162,O
cellular,163,171,B-Cell
signalling,172,182,O
events,183,189,O
that,190,194,O
alter,195,200,O
the,201,204,O
cell,205,209,B-Cell
',209,210,O
s,210,211,O
biochemical,212,223,O
and,224,227,O
functional,228,238,O
responses,239,248,O
to,249,251,O
inflammatory,252,264,O
stimuli,265,272,O
(,273,274,O
e,274,275,O
.,275,276,O
g,276,277,O
.,277,278,O
bacterial,279,288,O
lipopolysaccharide,289,307,O
[,308,309,O
LPS,309,312,O
],312,313,O
),313,314,O
.,314,315,O
Changes,316,323,O
include,324,331,O
reduced,332,339,O
release,340,347,O
of,348,350,O
inflammatory,351,363,O
and,364,367,O
procoagulatory,368,382,O
mediators,383,392,O
(,393,394,O
e,394,395,O
.,395,396,O
g,396,397,O
.,397,398,O
interleukin,399,410,O
[,411,412,O
IL,412,414,O
],414,415,O
-,415,416,O
1,416,417,O
",",417,418,O
IL,419,421,O
-,421,422,O
6,422,423,O
",",423,424,O
tumour,425,431,O
necrosis,432,440,O
factor,441,447,O
-,447,448,O
alpha,448,453,O
[,453,454,O
TNF,454,457,O
],457,458,O
),458,459,O
",",459,460,O
tissue,461,467,O
factor,468,474,O
(,475,476,O
TF,476,478,O
),478,479,O
",",479,480,O
adenosine,481,490,O
diphosphate,491,502,O
(,503,504,O
ADP,504,507,O
),507,508,O
and,509,512,O
cellular,513,521,B-Cell
adhesion,522,530,O
molecules,531,540,O
(,541,542,O
not,542,545,O
shown,546,551,O
),551,552,O
",",552,553,O
as,554,556,O
well,557,561,O
as,562,564,O
increased,565,574,O
release,575,582,O
of,583,585,O
anticoagulatory,586,601,O
prostacyclin,602,614,O
(,615,616,O
prostaglandin,616,629,O
[,630,631,O
PG,631,633,O
],633,634,O
I,634,635,O
),635,636,O
or,637,639,O
CD39,640,644,O
/,644,645,O
ATPDase,645,652,O
.,652,653,O
In,654,656,O
neuronal,657,665,B-Tissue
tissue,666,672,I-Tissue
",",672,673,O
protective,674,684,O
mechanisms,685,695,O
may,696,699,O
by,700,702,O
mediated,703,711,O
via,712,715,O
the,716,719,O
release,720,727,O
of,728,730,O
calcitonin,731,741,O
gene,742,746,O
-,746,747,O
related,747,754,O
peptide,755,762,O
and,763,766,O
nitric,767,773,O
oxide,774,779,O
with,780,784,O
the,785,788,O
potential,789,798,O
to,799,801,O
affect,802,808,O
prostacyclin,809,821,O
release,822,829,O
[,830,831,O
55,831,833,O
],833,834,O
.,834,835,O
Background,0,10,O
Hallucinations,11,25,O
may,26,29,O
occur,30,35,O
in,36,38,O
any,39,42,O
sensory,43,50,O
modalities,51,61,O
.,61,62,O
Formed,63,69,O
musical,70,77,O
hallucinations,78,92,O
(,93,94,O
i,94,95,O
.,95,96,O
e,96,97,O
.,97,98,O
Perception,99,109,O
of,110,112,O
either,113,119,O
vocal,120,125,O
or,126,128,O
instrumental,129,141,O
melodies,142,150,O
),150,151,O
reported,152,160,O
in,161,163,O
English,164,171,O
literature,172,182,O
to,183,185,O
date,186,190,O
have,191,195,O
typically,196,205,O
been,206,210,O
associated,211,221,O
with,222,226,O
marked,227,233,O
hearing,234,241,O
loss,242,246,O
",",246,247,O
advanced,248,256,O
age,257,260,O
",",260,261,O
female,262,268,O
sex,269,272,O
(,273,274,O
71,274,276,O
%,276,277,O
),277,278,O
",",278,279,O
lack,280,284,O
of,285,287,O
response,288,296,O
to,297,299,O
treatment,300,309,O
and,310,313,O
associated,314,324,O
psychopathology,325,340,O
[,341,342,O
1,342,343,O
],343,344,O
but,345,348,O
has,349,352,O
been,353,357,O
concluded,358,367,O
that,368,372,O
hearing,373,380,O
loss,381,385,O
is,386,388,O
neither,389,396,O
a,397,398,O
necessary,399,408,O
nor,409,412,O
sufficient,413,423,O
condition,424,433,O
for,434,437,O
the,438,441,O
occurrence,442,452,O
of,453,455,O
musical,456,463,O
hallucinations,464,478,O
[,479,480,O
1,480,481,O
],481,482,O
.,482,483,O
Tumor,484,489,B-Pathological_formation
like,490,494,O
Astrocytoma,495,506,B-Pathological_formation
",",506,507,O
Temporal,508,516,B-Multi-tissue_structure
lobe,517,521,I-Multi-tissue_structure
epilepsy,522,530,O
",",530,531,O
raised,532,538,O
intra,539,544,O
cranial,545,552,B-Organism_subdivision
tension,553,560,O
",",560,561,O
drug,562,566,O
induced,567,574,O
(,575,576,O
tricyclics,576,586,O
",",586,587,O
Propronolol,588,599,O
etc,600,603,O
;,604,605,O
),605,606,O
",",606,607,O
meningitis,608,618,O
and,619,622,O
psychotic,623,632,O
illness,633,640,O
were,641,645,O
shown,646,651,O
to,652,654,O
cause,655,660,O
palinacousis,661,673,O
and,674,677,O
musical,678,685,O
hallucinations,686,700,O
[,701,702,O
2,702,703,O
",",703,704,O
3,704,705,O
],705,706,O
.,706,707,O
Musical,708,715,O
hallucinations,716,730,O
are,731,734,O
pseudo,735,741,O
hallucinations,742,756,O
that,757,761,O
originate,762,771,O
in,772,774,O
memory,775,781,O
representations,782,797,O
and,798,801,O
they,802,806,O
may,807,810,O
undergo,811,818,O
a,819,820,O
transition,821,831,O
to,832,834,O
true,835,839,O
hallucination,840,853,O
.,853,854,O
In,855,857,O
musical,858,865,O
hallucination,866,879,O
spatial,880,887,O
projection,888,898,O
is,899,901,O
less,902,906,O
definite,907,915,O
.,915,916,O
Sometimes,917,926,O
they,927,931,O
are,932,935,O
perceived,936,945,O
like,946,950,O
the,951,954,O
tinnitus,955,963,O
in,964,966,O
patient,967,974,O
',974,975,O
s,975,976,O
own,977,980,O
head,981,985,B-Organism_subdivision
.,985,986,O
The,987,990,O
quality,991,998,O
is,999,1001,O
usually,1002,1009,O
very,1010,1014,O
intense,1015,1022,O
and,1023,1026,O
distinct,1027,1035,O
often,1036,1041,O
very,1042,1046,O
loud,1047,1051,O
.,1051,1052,O
They,1053,1057,O
vary,1058,1062,O
from,1063,1067,O
elementary,1068,1078,O
sounds,1079,1085,O
to,1086,1088,O
instrumental,1089,1101,O
music,1102,1107,O
",",1107,1108,O
vocal,1109,1114,O
music,1115,1120,O
",",1120,1121,O
bird,1122,1126,O
songs,1127,1132,O
",",1132,1133,O
bells,1134,1139,O
",",1139,1140,O
pieces,1141,1147,O
of,1148,1150,O
melodies,1151,1159,O
or,1160,1162,O
sentences,1163,1172,O
",",1172,1173,O
religious,1174,1183,O
music,1184,1189,O
etc,1190,1193,O
:,1193,1194,O
-,1194,1195,O
We,1196,1198,O
report,1199,1205,O
an,1206,1208,O
unusual,1209,1216,O
presentation,1217,1229,O
of,1230,1232,O
an,1233,1235,O
elderly,1236,1243,O
lady,1244,1248,O
who,1249,1252,O
had,1253,1256,O
experienced,1257,1268,O
musical,1269,1276,O
hallucinations,1277,1291,O
whilst,1292,1298,O
being,1299,1304,O
treated,1305,1312,O
with,1313,1317,O
Electro,1318,1325,O
Convulsive,1326,1336,O
Therapy,1337,1344,O
.,1344,1345,O
Though,1346,1352,O
this,1353,1357,O
has,1358,1361,O
never,1362,1367,O
been,1368,1372,O
reported,1373,1381,O
earlier,1382,1389,O
",",1389,1390,O
there,1391,1396,O
seemed,1397,1403,O
to,1404,1406,O
have,1407,1411,O
a,1412,1413,O
good,1414,1418,O
association,1419,1430,O
between,1431,1438,O
the,1439,1442,O
initiation,1443,1453,O
of,1454,1456,O
Electro,1457,1464,O
convulsive,1465,1475,O
therapy,1476,1483,O
and,1484,1487,O
musical,1488,1495,O
hallucination,1496,1509,O
in,1510,1512,O
our,1513,1516,O
patient,1517,1524,O
.,1524,1525,O
Correlation,0,11,O
between,12,19,O
sperm,20,25,B-Cell
morphology,26,36,O
and,37,40,O
seminal,41,48,B-Organism_substance
plasma,49,55,I-Organism_substance
NO,56,58,O
(,59,60,O
a,60,61,O
),61,62,O
and,63,66,O
TBARS,67,72,O
(,73,74,O
b,74,75,O
),75,76,O
levels,77,83,O
in,84,86,O
both,87,91,O
groups,92,98,O
.,98,99,O
Conclusion,0,10,O
The,11,14,O
survey,15,21,O
indicated,22,31,O
that,32,36,O
",",36,37,O
the,38,41,O
study,42,47,O
area,48,52,O
has,53,56,O
plenty,57,63,O
of,64,66,O
medicinal,67,76,O
plants,77,83,O
to,84,86,O
treat,87,92,O
a,93,94,O
wide,95,99,O
spectrum,100,108,O
of,109,111,O
human,112,117,O
ailments,118,126,O
.,126,127,O
Earlier,128,135,O
studies,136,143,O
on,144,146,O
traditional,147,158,O
medicinal,159,168,O
plants,169,175,O
also,176,180,O
revealed,181,189,O
that,190,194,O
the,195,198,O
economically,199,211,O
backward,212,220,O
local,221,226,O
and,227,230,O
tribal,231,237,O
people,238,244,O
of,245,247,O
Tamil,248,253,O
Nadu,254,258,O
prefer,259,265,O
folk,266,270,O
medicine,271,279,O
due,280,283,O
to,284,286,O
low,287,290,O
cost,291,295,O
and,296,299,O
sometimes,300,309,O
it,310,312,O
is,313,315,O
a,316,317,O
part,318,322,O
of,323,325,O
their,326,331,O
social,332,338,O
life,339,343,O
and,344,347,O
culture,348,355,O
[,356,357,O
40,357,359,O
-,359,360,O
45,360,362,O
],362,363,O
.,363,364,O
It,365,367,O
is,368,370,O
evident,371,378,O
from,379,383,O
the,384,387,O
interviews,388,398,O
conducted,399,408,O
in,409,411,O
different,412,421,O
villages,422,430,O
",",430,431,O
knowledge,432,441,O
of,442,444,O
medicinal,445,454,O
plants,455,461,O
is,462,464,O
limited,465,472,O
to,473,475,O
traditional,476,487,O
healers,488,495,O
",",495,496,O
herbalists,497,507,O
and,508,511,O
elderly,512,519,O
persons,520,527,O
who,528,531,O
are,532,535,O
living,536,542,O
in,543,545,O
rural,546,551,O
areas,552,557,O
.,557,558,O
This,559,563,O
study,564,569,O
also,570,574,O
points,575,581,O
out,582,585,O
that,586,590,O
certain,591,598,O
species,599,606,O
of,607,609,O
medicinal,610,619,O
plants,620,626,O
are,627,630,O
being,631,636,O
exploited,637,646,O
by,647,649,O
the,650,653,O
local,654,659,O
residents,660,669,O
who,670,673,O
are,674,677,O
unaware,678,685,O
of,686,688,O
the,689,692,O
importance,693,703,O
of,704,706,O
medicinal,707,716,O
plants,717,723,O
in,724,726,O
the,727,730,O
ecosystem,731,740,O
.,740,741,O
This,742,746,O
study,747,752,O
concluded,753,762,O
that,763,767,O
even,768,772,O
though,773,779,O
the,780,783,O
accessibility,784,797,O
of,798,800,O
Western,801,808,O
medicine,809,817,O
for,818,821,O
simple,822,828,O
and,829,832,O
complicated,833,844,O
diseases,845,853,O
is,854,856,O
available,857,866,O
",",866,867,O
many,868,872,O
people,873,879,O
in,880,882,O
the,883,886,O
studied,887,894,O
parts,895,900,O
of,901,903,O
Kancheepuram,904,916,O
district,917,925,O
is,926,928,O
still,929,934,O
continue,935,943,O
to,944,946,O
depend,947,953,O
on,954,956,O
medicinal,957,966,O
plants,967,973,O
",",973,974,O
at,975,977,O
least,978,983,O
for,984,987,O
the,988,991,O
treatment,992,1001,O
of,1002,1004,O
some,1005,1009,O
simple,1010,1016,O
diseases,1017,1025,O
such,1026,1030,O
as,1031,1033,O
",",1033,1034,O
cold,1035,1039,O
",",1039,1040,O
cough,1041,1046,O
",",1046,1047,O
fever,1048,1053,O
",",1053,1054,O
headache,1055,1063,O
",",1063,1064,O
poison,1065,1071,O
bites,1072,1077,O
",",1077,1078,O
skin,1079,1083,B-Organ
diseases,1084,1092,O
and,1093,1096,O
tooth,1097,1102,B-Organ
infections,1103,1113,O
.,1113,1114,O
Well,1115,1119,O
-,1119,1120,O
knowledged,1120,1130,O
healers,1131,1138,O
have,1139,1143,O
good,1144,1148,O
interactions,1149,1161,O
with,1162,1166,O
patients,1167,1175,O
and,1176,1179,O
this,1180,1184,O
would,1185,1190,O
improve,1191,1198,O
the,1199,1202,O
quality,1203,1210,O
of,1211,1213,O
healthcare,1214,1224,O
delivery,1225,1233,O
.,1233,1234,O
The,1235,1238,O
present,1239,1246,O
-,1246,1247,O
day,1247,1250,O
traditional,1251,1262,O
healers,1263,1270,O
are,1271,1274,O
very,1275,1279,O
old,1280,1283,O
.,1283,1284,O
Due,1285,1288,O
to,1289,1291,O
lack,1292,1296,O
of,1297,1299,O
interest,1300,1308,O
among,1309,1314,O
the,1315,1318,O
younger,1319,1326,O
generation,1327,1337,O
as,1338,1340,O
well,1341,1345,O
as,1346,1348,O
their,1349,1354,O
tendency,1355,1363,O
to,1364,1366,O
migrate,1367,1374,O
to,1375,1377,O
cities,1378,1384,O
for,1385,1388,O
lucrative,1389,1398,O
jobs,1399,1403,O
",",1403,1404,O
there,1405,1410,O
is,1411,1413,O
a,1414,1415,O
possibility,1416,1427,O
of,1428,1430,O
losing,1431,1437,O
this,1438,1442,O
wealth,1443,1449,O
of,1450,1452,O
knowledge,1453,1462,O
in,1463,1465,O
the,1466,1469,O
near,1470,1474,O
future,1475,1481,O
.,1481,1482,O
It,1483,1485,O
thus,1486,1490,O
becomes,1491,1498,O
necessary,1499,1508,O
to,1509,1511,O
acquire,1512,1519,O
and,1520,1523,O
preserve,1524,1532,O
this,1533,1537,O
traditional,1538,1549,O
system,1550,1556,O
of,1557,1559,O
medicine,1560,1568,O
by,1569,1571,O
proper,1572,1578,O
documentation,1579,1592,O
and,1593,1596,O
identification,1597,1611,O
of,1612,1614,O
specimens,1615,1624,O
.,1624,1625,O
Figures,0,7,O
and,8,11,O
Tables,12,18,O
Figure,19,25,O
1,26,27,O
Modular,28,35,O
crosstalking,36,48,O
in,49,51,O
synthetic,52,61,O
gene,62,66,O
networks,67,75,O
.,75,76,O
A,77,78,O
promoter,79,87,O
with,88,92,O
binding,93,100,O
sites,101,106,O
for,107,110,O
lambda,111,117,O
cI,118,120,O
dimers,121,127,O
(,128,129,O
OR1,129,132,O
and,133,136,O
OR2,137,140,O
),140,141,O
and,142,145,O
for,146,149,O
the,150,153,O
lac,154,157,O
repressor,158,167,O
(,168,169,O
Olac,169,173,O
),173,174,O
controls,175,183,O
the,184,187,O
production,188,198,O
of,199,201,O
the,202,205,O
lac,206,209,O
repressor,210,219,O
(,220,221,O
encoded,221,228,O
by,229,231,O
lacI,232,236,O
),236,237,O
in,238,240,O
module,241,247,O
1,248,249,O
and,250,253,O
lambda,254,260,O
cI,261,263,O
(,264,265,O
encoded,265,272,O
by,273,275,O
cI,276,278,O
),278,279,O
in,280,282,O
module,283,289,O
2,290,291,O
.,291,292,O
The,293,296,O
lac,297,300,O
repressor,301,310,O
and,311,314,O
lambda,315,321,O
cI,322,324,O
dimers,325,331,O
are,332,335,O
represented,336,347,O
by,348,350,O
blue,351,355,O
ellipsoids,356,366,O
and,367,370,O
red,371,374,O
circles,375,382,O
",",382,383,O
respectively,384,396,O
.,396,397,O
When,398,402,O
the,403,406,O
two,407,410,O
modules,411,418,O
are,419,422,O
put,423,426,O
together,427,435,O
",",435,436,O
two,437,440,O
pairs,441,446,O
of,447,449,O
lambda,450,456,O
cI,457,459,O
dimers,460,466,O
bound,467,472,O
at,473,475,O
different,476,485,O
operators,486,495,O
can,496,499,O
loop,500,504,O
DNA,505,508,O
and,509,512,O
octamerize,513,523,O
",",523,524,O
forming,525,532,O
a,533,534,O
tetramer,535,543,O
of,544,546,O
dimers,547,553,O
.,553,554,O
Comparison,0,10,O
of,11,13,O
the,14,17,O
Predicted,18,27,O
Irr,28,31,O
Regulon,32,39,O
and,40,43,O
ICE,44,47,O
Motifs,48,54,O
with,55,59,O
the,60,63,O
Published,64,73,O
Expression,74,84,O
Microarray,85,95,O
Data,96,100,O
for,101,104,O
Iron,105,109,O
-,109,110,O
and,111,114,O
Irr,115,118,O
-,118,119,O
Affected,119,127,O
Genes,128,133,O
in,134,136,O
Bradyrhizobium,137,151,O
japonicum,152,161,O
Mass,0,4,O
casualty,5,13,O
estimation,14,24,O
on,25,27,O
a,28,29,O
geographic,30,40,O
basis,41,46,O
The,47,50,O
Defense,51,58,O
Threat,59,65,O
Reduction,66,75,O
Agency,76,82,O
(,83,84,O
DTRA,84,88,O
),88,89,O
has,90,93,O
expended,94,102,O
considerable,103,115,O
effort,116,122,O
to,123,125,O
develop,126,133,O
models,134,140,O
for,141,144,O
calculating,145,156,O
mass,157,161,O
casualties,162,172,O
from,173,177,O
a,178,179,O
nuclear,180,187,O
detonation,188,198,O
.,198,199,O
In,200,202,O
order,203,208,O
to,209,211,O
specifically,212,224,O
evaluate,225,233,O
urban,234,239,O
medical,240,247,O
systems,248,255,O
vulnerability,256,269,O
we,270,272,O
are,273,276,O
employing,277,286,O
the,287,290,O
PC,291,293,O
based,294,299,O
Consequence,300,311,O
Assessment,312,322,O
Tool,323,327,O
Set,328,331,O
(,332,333,O
CATS,333,337,O
),337,338,O
v6,339,341,O
",",341,342,O
with,343,347,O
ESRI,348,352,O
',352,353,O
s,353,354,O
ArcGIS9,355,362,O
[,363,364,O
14,364,366,O
],366,367,O
",",367,368,O
CATS,369,373,O
/,373,374,O
JACE,374,378,O
(,379,380,O
Joint,380,385,O
Assessment,386,396,O
of,397,399,O
Catastrophic,400,412,O
Events,413,419,O
),419,420,O
v5,421,423,O
with,424,428,O
ESRI,429,433,O
',433,434,O
s,434,435,O
ArcView,436,443,O
3,444,445,O
.,445,446,O
3,446,447,O
",",447,448,O
Hazard,449,455,O
Prediction,456,466,O
and,467,470,O
Assessment,471,481,O
Capability,482,492,O
(,493,494,O
HPAC,494,498,O
),498,499,O
V4,500,502,O
.,502,503,O
04SP3,503,508,O
[,509,510,O
15,510,512,O
],512,513,O
",",513,514,O
as,515,517,O
well,518,522,O
as,523,525,O
custom,526,532,O
GIS,533,536,O
and,537,540,O
database,541,549,O
software,550,558,O
applications,559,571,O
.,571,572,O
HPAC,573,577,O
does,578,582,O
excellent,583,592,O
Chemical,593,601,O
Biological,602,612,O
and,613,616,O
Nuclear,617,624,O
(,625,626,O
CBN,626,629,O
),629,630,O
modeling,631,639,O
",",639,640,O
although,641,649,O
output,650,656,O
could,657,662,O
provide,663,670,O
more,671,675,O
flexibility,676,687,O
.,687,688,O
Additionally,689,701,O
",",701,702,O
results,703,710,O
can,711,714,O
be,715,717,O
exported,718,726,O
to,727,729,O
CATS,730,734,O
for,735,738,O
further,739,746,O
analysis,747,755,O
and,756,759,O
display,760,767,O
.,767,768,O
All,769,772,O
three,773,778,O
programs,779,787,O
can,788,791,O
access,792,798,O
the,799,802,O
current,803,810,O
weather,811,818,O
data,819,823,O
from,824,828,O
both,829,833,O
classified,834,844,O
and,845,848,O
unclassified,849,861,O
weather,862,869,O
servers,870,877,O
.,877,878,O
Examples,879,887,O
of,888,890,O
uses,891,895,O
of,896,898,O
CATS,899,903,O
/,903,904,O
HPAC,904,908,O
are,909,912,O
hurricane,913,922,O
",",922,923,O
tidal,924,929,O
surge,930,935,O
and,936,939,O
earthquake,940,950,O
damage,951,957,O
",",957,958,O
prediction,959,969,O
of,970,972,O
the,973,976,O
results,977,984,O
from,985,989,O
nuclear,990,997,O
",",997,998,O
biological,999,1009,O
and,1010,1013,O
chemical,1014,1022,O
releases,1023,1031,O
",",1031,1032,O
assessment,1033,1043,O
of,1044,1046,O
persons,1047,1054,O
and,1055,1058,O
infrastructure,1059,1073,O
affected,1074,1082,O
and,1083,1086,O
at,1087,1089,O
risk,1090,1094,O
(,1095,1096,O
e,1096,1097,O
.,1097,1098,O
g,1098,1099,O
.,1099,1100,O
which,1101,1106,O
hospitals,1107,1116,O
and,1117,1120,O
pharmacies,1121,1131,O
are,1132,1135,O
under,1136,1141,O
a,1142,1143,O
CBN,1144,1147,O
plume,1148,1153,O
and,1154,1157,O
are,1158,1161,O
thus,1162,1166,O
out,1167,1170,O
of,1171,1173,O
commission,1174,1184,O
),1184,1185,O
",",1185,1186,O
and,1187,1190,O
mobilization,1191,1203,O
of,1204,1206,O
surviving,1207,1216,O
and,1217,1220,O
nearby,1221,1227,O
infrastructure,1228,1242,O
outside,1243,1250,O
the,1251,1254,O
plume,1255,1260,O
that,1261,1265,O
would,1266,1271,O
be,1272,1274,O
needed,1275,1281,O
to,1282,1284,O
address,1285,1292,O
healthcare,1293,1303,O
and,1304,1307,O
other,1308,1313,O
emergency,1314,1323,O
response,1324,1332,O
needs,1333,1338,O
of,1339,1341,O
the,1342,1345,O
community,1346,1355,O
.,1355,1356,O
These,1357,1362,O
models,1363,1369,O
have,1370,1374,O
been,1375,1379,O
",",1379,1380,O
and,1381,1384,O
continue,1385,1393,O
to,1394,1396,O
be,1397,1399,O
",",1399,1400,O
developed,1401,1410,O
with,1411,1415,O
a,1416,1417,O
view,1418,1422,O
to,1423,1425,O
better,1426,1432,O
estimating,1433,1443,O
the,1444,1447,O
impact,1448,1454,O
of,1455,1457,O
WMD,1458,1461,O
weapons,1462,1469,O
in,1470,1472,O
an,1473,1475,O
offensive,1476,1485,O
setting,1486,1493,O
.,1493,1494,O
However,1495,1502,O
",",1502,1503,O
recent,1504,1510,O
DTRA,1511,1515,O
enhancements,1516,1528,O
and,1529,1532,O
our,1533,1536,O
modifications,1537,1550,O
have,1551,1555,O
facilitated,1556,1567,O
their,1568,1573,O
use,1574,1577,O
in,1578,1580,O
helping,1581,1588,O
estimate,1589,1597,O
potential,1598,1607,O
casualties,1608,1618,O
from,1619,1623,O
a,1624,1625,O
WMD,1626,1629,O
terrorist,1630,1639,O
incident,1640,1648,O
.,1648,1649,O
One,1650,1653,O
area,1654,1658,O
of,1659,1661,O
intense,1662,1669,O
interest,1670,1678,O
",",1678,1679,O
and,1680,1683,O
somewhat,1684,1692,O
of,1693,1695,O
a,1696,1697,O
vacuum,1698,1704,O
in,1705,1707,O
public,1708,1714,O
health,1715,1721,O
planning,1722,1730,O
",",1730,1731,O
has,1732,1735,O
been,1736,1740,O
the,1741,1744,O
utility,1745,1752,O
of,1753,1755,O
this,1756,1760,O
approach,1761,1769,O
in,1770,1772,O
estimating,1773,1783,O
medical,1784,1791,O
care,1792,1796,O
vulnerabilities,1797,1812,O
in,1813,1815,O
such,1816,1820,O
an,1821,1823,O
attack,1824,1830,O
",",1830,1831,O
and,1832,1835,O
for,1836,1839,O
the,1840,1843,O
calculation,1844,1855,O
of,1856,1858,O
the,1859,1862,O
distribution,1863,1875,O
of,1876,1878,O
surviving,1879,1888,O
medical,1889,1896,O
care,1897,1901,O
resources,1902,1911,O
.,1911,1912,O
While,1913,1918,O
much,1919,1923,O
work,1924,1928,O
has,1929,1932,O
already,1933,1940,O
occurred,1941,1949,O
in,1950,1952,O
estimating,1953,1963,O
the,1964,1967,O
impact,1968,1974,O
of,1975,1977,O
chemical,1978,1986,O
weapons,1987,1994,O
(,1995,1996,O
due,1996,1999,O
to,2000,2002,O
the,2003,2006,O
dual,2007,2011,O
use,2012,2015,O
in,2016,2018,O
chemical,2019,2027,O
spill,2028,2033,O
management,2034,2044,O
from,2045,2049,O
transportation,2050,2064,O
and,2065,2068,O
industrial,2069,2079,O
accidents,2080,2089,O
),2089,2090,O
",",2090,2091,O
or,2092,2094,O
in,2095,2097,O
nuclear,2098,2105,O
power,2106,2111,O
plant,2112,2117,O
accident,2118,2126,O
management,2127,2137,O
",",2137,2138,O
much,2139,2143,O
less,2144,2148,O
research,2149,2157,O
and,2158,2161,O
development,2162,2173,O
has,2174,2177,O
gone,2178,2182,O
into,2183,2187,O
estimating,2188,2198,O
the,2199,2202,O
impact,2203,2209,O
on,2210,2212,O
our,2213,2216,O
civilian,2217,2225,O
population,2226,2236,O
of,2237,2239,O
a,2240,2241,O
nuclear,2242,2249,O
weapon,2250,2256,O
detonation,2257,2267,O
from,2268,2272,O
a,2273,2274,O
terrorist,2275,2284,O
incident,2285,2293,O
in,2294,2296,O
a,2297,2298,O
large,2299,2304,O
urban,2305,2310,O
area,2311,2315,O
.,2315,2316,O
The,2317,2320,O
models,2321,2327,O
already,2328,2335,O
calculate,2336,2345,O
such,2346,2350,O
factors,2351,2358,O
as,2359,2361,O
the,2362,2365,O
impact,2366,2372,O
of,2373,2375,O
blast,2376,2381,O
",",2381,2382,O
thermal,2383,2390,O
effects,2391,2398,O
and,2399,2402,O
fallout,2403,2410,O
",",2410,2411,O
but,2412,2415,O
results,2416,2423,O
are,2424,2427,O
often,2428,2433,O
not,2434,2437,O
available,2438,2447,O
at,2448,2450,O
the,2451,2454,O
detail,2455,2461,O
level,2462,2467,O
needed,2468,2474,O
for,2475,2478,O
civil,2479,2484,O
defense,2485,2492,O
purposes,2493,2501,O
",",2501,2502,O
casualty,2503,2511,O
management,2512,2522,O
",",2522,2523,O
and,2524,2527,O
planning,2528,2536,O
the,2537,2540,O
use,2541,2544,O
of,2545,2547,O
scarce,2548,2554,O
health,2555,2561,O
resources,2562,2571,O
in,2572,2574,O
response,2575,2583,O
to,2584,2586,O
a,2587,2588,O
nuclear,2589,2596,O
weapon,2597,2603,O
detonation,2604,2614,O
.,2614,2615,O
Furthermore,2616,2627,O
",",2627,2628,O
the,2629,2632,O
models,2633,2639,O
do,2640,2642,O
not,2643,2646,O
readily,2647,2654,O
facilitate,2655,2665,O
the,2666,2669,O
calculation,2670,2681,O
of,2682,2684,O
injuries,2685,2693,O
from,2694,2698,O
multiple,2699,2707,O
effects,2708,2715,O
such,2716,2720,O
as,2721,2723,O
burns,2724,2729,O
and,2730,2733,O
blast,2734,2739,O
with,2740,2744,O
fallout,2745,2752,O
or,2753,2755,O
prompt,2756,2762,O
radiation,2763,2772,O
.,2772,2773,O
The,2774,2777,O
complexity,2778,2788,O
of,2789,2791,O
the,2792,2795,O
urban,2796,2801,O
three,2802,2807,O
-,2807,2808,O
dimensional,2808,2819,O
landscape,2820,2829,O
and,2830,2833,O
its,2834,2837,O
local,2838,2843,O
impact,2844,2850,O
on,2851,2853,O
thermal,2854,2861,O
",",2861,2862,O
blast,2863,2868,O
and,2869,2872,O
radiation,2873,2882,O
is,2883,2885,O
also,2886,2890,O
poorly,2891,2897,O
understood,2898,2908,O
.,2908,2909,O
Additionally,2910,2922,O
",",2922,2923,O
given,2924,2929,O
their,2930,2935,O
traditional,2936,2947,O
world,2948,2953,O
-,2953,2954,O
wide,2954,2958,O
focus,2959,2964,O
",",2964,2965,O
and,2966,2969,O
the,2970,2973,O
increased,2974,2983,O
sensitivity,2984,2995,O
to,2996,2998,O
providing,2999,3008,O
information,3009,3020,O
on,3021,3023,O
the,3024,3027,O
U,3028,3029,O
.,3029,3030,O
S,3030,3031,O
.,3031,3032,O
A,3032,3033,O
.,3033,3034,O
of,3035,3037,O
use,3038,3041,O
to,3042,3044,O
terrorists,3045,3055,O
",",3055,3056,O
the,3057,3060,O
models,3061,3067,O
do,3068,3070,O
not,3071,3074,O
provide,3075,3082,O
detailed,3083,3091,O
or,3092,3094,O
current,3095,3102,O
data,3103,3107,O
that,3108,3112,O
exists,3113,3119,O
for,3120,3123,O
the,3124,3127,O
United,3128,3134,O
States,3135,3141,O
that,3142,3146,O
would,3147,3152,O
help,3153,3157,O
provide,3158,3165,O
better,3166,3172,O
casualty,3173,3181,O
estimates,3182,3191,O
and,3192,3195,O
response,3196,3204,O
.,3204,3205,O
The,3206,3209,O
models,3210,3216,O
can,3217,3220,O
be,3221,3223,O
customized,3224,3234,O
locally,3235,3242,O
and,3243,3246,O
data,3247,3251,O
updated,3252,3259,O
if,3260,3262,O
the,3263,3266,O
user,3267,3271,O
has,3272,3275,O
sufficient,3276,3286,O
expertise,3287,3296,O
.,3296,3297,O
However,3298,3305,O
",",3305,3306,O
there,3307,3312,O
is,3313,3315,O
often,3316,3321,O
a,3322,3323,O
significant,3324,3335,O
duplication,3336,3347,O
of,3348,3350,O
effort,3351,3357,O
due,3358,3361,O
to,3362,3364,O
overlapping,3365,3376,O
jurisdictions,3377,3390,O
and,3391,3394,O
the,3395,3398,O
lack,3399,3403,O
of,3404,3406,O
data,3407,3411,O
sharing,3412,3419,O
due,3420,3423,O
to,3424,3426,O
security,3427,3435,O
and,3436,3439,O
other,3440,3445,O
considerations,3446,3460,O
.,3460,3461,O
CATS,3462,3466,O
and,3467,3470,O
HPAC,3471,3475,O
are,3476,3479,O
also,3480,3484,O
useful,3485,3491,O
for,3492,3495,O
creating,3496,3504,O
realistic,3505,3514,O
scenarios,3515,3524,O
for,3525,3528,O
training,3529,3537,O
and,3538,3541,O
planning,3542,3550,O
before,3551,3557,O
a,3558,3559,O
disaster,3560,3568,O
strikes,3569,3576,O
",",3576,3577,O
thus,3578,3582,O
enabling,3583,3591,O
responders,3592,3602,O
to,3603,3605,O
drill,3606,3611,O
and,3612,3615,O
exercise,3616,3624,O
so,3625,3627,O
they,3628,3632,O
know,3633,3637,O
roughly,3638,3645,O
what,3646,3650,O
to,3651,3653,O
expect,3654,3660,O
and,3661,3664,O
how,3665,3668,O
to,3669,3671,O
react,3672,3677,O
.,3677,3678,O
Contingency,3679,3690,O
plans,3691,3696,O
can,3697,3700,O
be,3701,3703,O
created,3704,3711,O
using,3712,3717,O
comprehensive,3718,3731,O
national,3732,3740,O
and,3741,3744,O
more,3745,3749,O
detailed,3750,3758,O
population,3759,3769,O
and,3770,3773,O
infrastructure,3774,3788,O
data,3789,3793,O
.,3793,3794,O
Should,3795,3801,O
disaster,3802,3810,O
strike,3811,3817,O
",",3817,3818,O
the,3819,3822,O
affected,3823,3831,O
population,3832,3842,O
and,3843,3846,O
the,3847,3850,O
impact,3851,3857,O
on,3858,3860,O
critical,3861,3869,O
facilities,3870,3880,O
can,3881,3884,O
be,3885,3887,O
quickly,3888,3895,O
assessed,3896,3904,O
",",3904,3905,O
although,3906,3914,O
efforts,3915,3922,O
frequently,3923,3933,O
need,3934,3938,O
to,3939,3941,O
be,3942,3944,O
expended,3945,3953,O
to,3954,3956,O
ensure,3957,3963,O
regional,3964,3972,O
and,3973,3976,O
local,3977,3982,O
databases,3983,3992,O
are,3993,3996,O
current,3997,4004,O
and,4005,4008,O
useful,4009,4015,O
.,4015,4016,O
Case,0,4,O
Presentation,5,17,O
The,18,21,O
patient,22,29,O
is,30,32,O
an,33,35,O
80,36,38,O
year,39,43,O
old,44,47,O
male,48,52,O
with,53,57,O
diabetes,58,66,O
mellitus,67,75,O
and,76,79,O
hypertension,80,92,O
",",92,93,O
who,94,97,O
at,98,100,O
age,101,104,O
74,105,107,O
(,108,109,O
March,109,114,O
2001,115,119,O
),119,120,O
had,121,124,O
received,125,133,O
a,134,135,O
living,136,142,O
non,143,146,O
-,146,147,O
related,147,154,O
donor,155,160,O
kidney,161,167,B-Organ
transplant,168,178,O
.,178,179,O
At,180,182,O
that,183,187,O
time,188,192,O
he,193,195,O
was,196,199,O
discharged,200,210,O
with,211,215,O
a,216,217,O
double,218,224,O
immunosuppressive,225,242,O
therapy,243,250,O
consisting,251,261,O
of,262,264,O
prednisone,265,275,O
20,276,278,O
mg,279,281,O
/,281,282,O
day,282,285,O
and,286,289,O
mophetil,290,298,O
mycophenolate,299,312,O
1,313,314,O
.,314,315,O
5,315,316,O
gr,317,319,O
/,319,320,O
day,320,323,O
.,323,324,O
No,325,327,O
calcineurin,328,339,O
inhibitor,340,349,O
was,350,353,O
administered,354,366,O
.,366,367,O
His,368,371,O
prednisone,372,382,O
dose,383,387,O
was,388,391,O
further,392,399,O
decreased,400,409,O
to,410,412,O
5,413,414,O
mg,415,417,O
/,417,418,O
day,418,421,O
and,422,425,O
mophetil,426,434,O
mycophenolate,435,448,O
doses,449,454,O
sustained,455,464,O
.,464,465,O
In,466,468,O
November,469,477,O
2001,478,482,O
he,483,485,O
developed,486,495,O
cutaneous,496,505,O
purple,506,512,O
elevated,513,521,O
lesions,522,529,B-Pathological_formation
in,530,532,O
his,533,536,O
lower,537,542,B-Organism_subdivision
limbs,543,548,I-Organism_subdivision
that,549,553,O
were,554,558,O
diagnosed,559,568,O
as,569,571,O
KS,572,574,B-Pathological_formation
by,575,577,O
skin,578,582,B-Organ
biopsy,583,589,O
.,589,590,O
He,591,593,O
received,594,602,O
19,603,605,O
administrations,606,621,O
of,622,624,O
vincristine,625,636,O
(,637,638,O
1,638,639,O
mg,640,642,O
),642,643,O
and,644,647,O
bleomycin,648,657,O
(,658,659,O
15,659,661,O
mg,662,664,O
),664,665,O
weekly,666,672,O
that,673,677,O
resulted,678,686,O
in,687,689,O
flattening,690,700,O
and,701,704,O
fading,705,711,O
of,712,714,O
the,715,718,O
lesions,719,726,B-Pathological_formation
.,726,727,O
Treatment,728,737,O
was,738,741,O
discontinued,742,754,O
for,755,758,O
two,759,762,O
months,763,769,O
",",769,770,O
and,771,774,O
KS,775,777,B-Pathological_formation
recurred,778,786,O
",",786,787,O
with,788,792,O
pain,793,797,O
and,798,801,O
edema,802,807,B-Pathological_formation
in,808,810,O
both,811,815,O
legs,816,820,B-Organism_subdivision
.,820,821,O
On,822,824,O
July,825,829,O
2002,830,834,O
",",834,835,O
with,836,840,O
an,841,843,O
almost,844,850,O
100,851,854,O
%,854,855,O
involvement,856,867,O
of,868,870,O
his,871,874,O
lower,875,880,B-Organ
limbs,881,886,I-Organ
skin,887,891,I-Organ
with,892,896,O
KS,897,899,B-Pathological_formation
but,900,903,O
no,904,906,O
visceral,907,915,O
involvement,916,927,O
he,928,930,O
received,931,939,O
50,940,942,O
mg,943,945,O
of,946,948,O
liposomal,949,958,O
-,958,959,O
adriamycin,959,969,O
.,969,970,O
In,971,973,O
addition,974,982,O
",",982,983,O
he,984,986,O
was,987,990,O
then,991,995,O
prescribed,996,1006,O
valganciclovir,1007,1021,O
450,1022,1025,O
mg,1026,1028,O
BID,1029,1032,O
(,1033,1034,O
corrected,1034,1043,O
for,1044,1047,O
creatinine,1048,1058,O
clearance,1059,1068,O
),1068,1069,O
[,1070,1071,O
7,1071,1072,O
],1072,1073,O
and,1074,1077,O
three,1078,1083,O
additional,1084,1094,O
administrations,1095,1110,O
of,1111,1113,O
liposomal,1114,1123,O
-,1123,1124,O
adriamycin,1124,1134,O
",",1134,1135,O
up,1136,1138,O
to,1139,1141,O
December,1142,1150,O
2002,1151,1155,O
.,1155,1156,O
He,1157,1159,O
showed,1160,1166,O
40,1167,1169,O
%,1169,1170,O
response,1171,1179,O
again,1180,1185,O
with,1186,1190,O
early,1191,1196,O
relapse,1197,1204,O
.,1204,1205,O
On,1206,1208,O
January,1209,1216,O
2003,1217,1221,O
the,1222,1225,O
patient,1226,1233,O
developed,1234,1243,O
disseminated,1244,1256,O
herpes,1257,1263,O
zoster,1264,1270,O
",",1270,1271,O
which,1272,1277,O
was,1278,1281,O
treated,1282,1289,O
with,1290,1294,O
IV,1295,1297,O
acyclovir,1298,1307,O
.,1307,1308,O
In,1309,1311,O
May,1312,1315,O
2003,1316,1320,O
KS,1321,1323,B-Pathological_formation
progression,1324,1335,O
was,1336,1339,O
observed,1340,1348,O
and,1349,1352,O
received,1353,1361,O
radiotherapy,1362,1374,O
with,1375,1379,O
no,1380,1382,O
benefit,1383,1390,O
Figure,1391,1397,O
1,1398,1399,O
.,1399,1400,O
In,1401,1403,O
August,1404,1410,O
2003,1411,1415,O
he,1416,1418,O
started,1419,1426,O
oral,1427,1431,O
etoposide,1432,1441,O
at,1442,1444,O
50,1445,1447,O
mg,1448,1450,O
QD,1451,1453,O
for,1454,1457,O
two,1458,1461,O
weeks,1462,1467,O
followed,1468,1476,O
by,1477,1479,O
two,1480,1483,O
weeks,1484,1489,O
off,1490,1493,O
until,1494,1499,O
May,1500,1503,O
2004,1504,1508,O
achieving,1509,1518,O
a,1519,1520,O
very,1521,1525,O
slow,1526,1530,O
50,1531,1533,O
%,1533,1534,O
response,1535,1543,O
.,1543,1544,O
Tolerance,1545,1554,O
was,1555,1558,O
good,1559,1563,O
and,1564,1567,O
serum,1568,1573,B-Organism_substance
creatinine,1574,1584,O
remain,1585,1591,O
stable,1592,1598,O
at,1599,1601,O
around,1602,1608,O
1,1609,1610,O
",",1610,1611,O
4,1611,1612,O
mg,1613,1615,O
/,1615,1616,O
dl,1616,1618,O
.,1618,1619,O
Mophetil,1620,1628,O
mycophenolate,1629,1642,O
dose,1643,1647,O
was,1648,1651,O
reduced,1652,1659,O
to,1660,1662,O
1,1663,1664,O
g,1665,1666,O
/,1666,1667,O
day,1667,1670,O
and,1671,1674,O
prednisone,1675,1685,O
to,1686,1688,O
2,1689,1690,O
.,1690,1691,O
5,1691,1692,O
mg,1693,1695,O
/,1695,1696,O
day,1696,1699,O
.,1699,1700,O
Figure,1701,1707,O
1,1708,1709,O
Kaposi,1710,1716,B-Pathological_formation
',1716,1717,I-Pathological_formation
s,1717,1718,I-Pathological_formation
sarcoma,1719,1726,I-Pathological_formation
progressions,1727,1739,O
after,1740,1745,O
chemotherapy,1746,1758,O
withdrawal,1759,1769,O
",",1769,1770,O
both,1771,1775,O
lower,1776,1781,B-Organism_subdivision
limbs,1782,1787,I-Organism_subdivision
were,1788,1792,O
completely,1793,1803,O
covered,1804,1811,O
with,1812,1816,O
Kaposi,1817,1823,B-Pathological_formation
',1823,1824,I-Pathological_formation
s,1824,1825,I-Pathological_formation
Sarcoma,1826,1833,I-Pathological_formation
(,1834,1835,O
June,1835,1839,O
2003,1840,1844,O
),1844,1845,O
.,1845,1846,O
On,1847,1849,O
May,1850,1853,O
2004,1854,1858,O
the,1859,1862,O
patient,1863,1870,O
requested,1871,1880,O
a,1881,1882,O
second,1883,1889,O
opinion,1890,1897,O
and,1898,1901,O
was,1902,1905,O
prescribed,1906,1916,O
Imatinib,1917,1925,O
200,1926,1929,O
mg,1930,1932,O
qd,1933,1935,O
for,1936,1939,O
two,1940,1943,O
weeks,1944,1949,O
followed,1950,1958,O
by,1959,1961,O
400,1962,1965,O
mg,1966,1968,O
qd,1969,1971,O
.,1971,1972,O
After,1973,1978,O
four,1979,1983,O
weeks,1984,1989,O
of,1990,1992,O
Imatinib,1993,2001,O
",",2001,2002,O
his,2003,2006,O
health,2007,2013,O
deteriorated,2014,2026,O
rapidly,2027,2034,O
",",2034,2035,O
he,2036,2038,O
developed,2039,2048,O
anasarca,2049,2057,B-Pathological_formation
",",2057,2058,O
worsening,2059,2068,O
of,2069,2071,O
KS,2072,2074,O
",",2074,2075,O
his,2076,2079,O
serum,2080,2085,B-Organism_substance
creatinine,2086,2096,O
increased,2097,2106,O
from,2107,2111,O
1,2112,2113,O
.,2113,2114,O
4,2114,2115,O
mg,2116,2118,O
/,2118,2119,O
dl,2119,2121,O
to,2122,2124,O
2,2125,2126,O
.,2126,2127,O
3,2127,2128,O
mg,2129,2131,O
/,2131,2132,O
dl,2132,2134,O
and,2135,2138,O
he,2139,2141,O
developed,2142,2151,O
grade,2152,2157,O
4,2158,2159,O
granulocytopenia,2160,2176,O
(,2177,2178,O
Figure,2178,2184,O
2,2185,2186,O
),2186,2187,O
.,2187,2188,O
The,2189,2192,O
patient,2193,2200,O
was,2201,2204,O
hospitalized,2205,2217,O
with,2218,2222,O
fever,2223,2228,O
and,2229,2232,O
was,2233,2236,O
started,2237,2244,O
on,2245,2247,O
IV,2248,2250,O
antibiotics,2251,2262,O
and,2263,2266,O
daily,2267,2272,O
G,2273,2274,O
-,2274,2275,O
CSF,2275,2278,O
for,2279,2282,O
four,2283,2287,O
days,2288,2292,O
after,2293,2298,O
which,2299,2304,O
his,2305,2308,O
WBC,2309,2312,B-Cell
count,2313,2318,O
normalized,2319,2329,O
.,2329,2330,O
Two,2331,2334,O
weeks,2335,2340,O
later,2341,2346,O
the,2347,2350,O
creatinine,2351,2361,O
level,2362,2367,O
returned,2368,2376,O
to,2377,2379,O
1,2380,2381,O
.,2381,2382,O
5,2382,2383,O
mg,2384,2386,O
/,2386,2387,O
dl,2387,2389,O
.,2389,2390,O
On,2391,2393,O
February,2394,2402,O
2005,2403,2407,O
he,2408,2410,O
was,2411,2414,O
started,2415,2422,O
on,2423,2425,O
30,2426,2428,O
mg,2429,2431,O
of,2432,2434,O
paclitaxel,2435,2445,O
IV,2446,2448,O
every,2449,2454,O
three,2455,2460,O
weeks,2461,2466,O
.,2466,2467,O
After,2468,2473,O
three,2474,2479,O
courses,2480,2487,O
with,2488,2492,O
no,2493,2495,O
clinical,2496,2504,O
benefit,2505,2512,O
he,2513,2515,O
developed,2516,2525,O
a,2526,2527,O
skin,2528,2532,B-Organ
rash,2533,2537,O
that,2538,2542,O
prompted,2543,2551,O
discontinuation,2552,2567,O
.,2567,2568,O
Figure,2569,2575,O
2,2576,2577,O
Patient,2578,2585,O
developed,2586,2595,O
anasarca,2596,2604,B-Pathological_formation
with,2605,2609,O
rapid,2610,2615,O
progression,2616,2627,O
of,2628,2630,O
Kaposi,2631,2637,B-Pathological_formation
',2637,2638,I-Pathological_formation
s,2638,2639,I-Pathological_formation
Sarcoma,2640,2647,I-Pathological_formation
after,2648,2653,O
four,2654,2658,O
weeks,2659,2664,O
of,2665,2667,O
taking,2668,2674,O
Imatinib,2675,2683,O
(,2684,2685,O
June,2685,2689,O
2004,2690,2694,O
),2694,2695,O
.,2695,2696,O
On,2697,2699,O
April,2700,2705,O
2005,2706,2710,O
",",2710,2711,O
he,2712,2714,O
was,2715,2718,O
started,2719,2726,O
on,2727,2729,O
Sirolimus,2730,2739,O
2,2740,2741,O
mg,2742,2744,O
a,2745,2746,O
day,2747,2750,O
",",2750,2751,O
and,2752,2755,O
after,2756,2761,O
8,2762,2763,O
weeks,2764,2769,O
escalated,2770,2779,O
to,2780,2782,O
4,2783,2784,O
mg,2785,2787,O
a,2788,2789,O
day,2790,2793,O
.,2793,2794,O
Three,2795,2800,O
weeks,2801,2806,O
later,2807,2812,O
mophetil,2813,2821,O
mycophenolate,2822,2835,O
and,2836,2839,O
prednisone,2840,2850,O
were,2851,2855,O
discontinued,2856,2868,O
.,2868,2869,O
Sustained,2870,2879,O
and,2880,2883,O
significant,2884,2895,O
KS,2896,2898,B-Pathological_formation
regression,2899,2909,O
was,2910,2913,O
evident,2914,2921,O
after,2922,2927,O
16,2928,2930,O
weeks,2931,2936,O
",",2936,2937,O
but,2938,2941,O
he,2942,2944,O
developed,2945,2954,O
a,2955,2956,O
basal,2957,2962,B-Pathological_formation
cell,2963,2967,I-Pathological_formation
carcinoma,2968,2977,I-Pathological_formation
and,2978,2981,O
pneumonia,2982,2991,O
that,2992,2996,O
required,2997,3005,O
hospital,3006,3014,O
admission,3015,3024,O
;,3024,3025,O
Sirolimus,3026,3035,O
dose,3036,3040,O
was,3041,3044,O
lowered,3045,3052,O
to,3053,3055,O
2,3056,3057,O
mg,3058,3060,O
a,3061,3062,O
day,3063,3066,O
.,3066,3067,O
Thereafter,3068,3078,O
his,3079,3082,O
clinical,3083,3091,O
course,3092,3098,O
has,3099,3102,O
been,3103,3107,O
satisfactory,3108,3120,O
with,3121,3125,O
continuous,3126,3136,O
and,3137,3140,O
progressive,3141,3152,O
regression,3153,3163,O
of,3164,3166,O
KS,3167,3169,B-Pathological_formation
lesions,3170,3177,I-Pathological_formation
(,3178,3179,O
Figure,3179,3185,O
3,3186,3187,O
),3187,3188,O
.,3188,3189,O
His,3190,3193,O
serum,3194,3199,B-Organism_substance
creatinine,3200,3210,O
has,3211,3214,O
remained,3215,3223,O
under,3224,3229,O
1,3230,3231,O
.,3231,3232,O
6,3232,3233,O
mg,3234,3236,O
/,3236,3237,O
dl,3237,3239,O
and,3240,3243,O
he,3244,3246,O
has,3247,3250,O
not,3251,3254,O
developed,3255,3264,O
new,3265,3268,O
infectious,3269,3279,O
episodes,3280,3288,O
.,3288,3289,O
Figure,3290,3296,O
3,3297,3298,O
Extensive,3299,3308,O
regression,3309,3319,O
of,3320,3322,O
Kaposi,3323,3329,B-Pathological_formation
Sarcoma,3330,3337,I-Pathological_formation
after,3338,3343,O
immune,3344,3350,O
-,3350,3351,O
suppression,3351,3362,O
was,3363,3366,O
changed,3367,3374,O
to,3375,3377,O
Sirolimus,3378,3387,O
",",3387,3388,O
(,3389,3390,O
14,3390,3392,O
months,3393,3399,O
later,3400,3405,O
),3405,3406,O
",",3406,3407,O
he,3408,3410,O
only,3411,3415,O
has,3416,3419,O
hyperpigmented,3420,3434,O
areas,3435,3440,O
at,3441,3443,O
knee,3444,3448,B-Organism_subdivision
levels,3449,3455,O
",",3455,3456,O
skin,3457,3461,B-Organ
looks,3462,3467,O
thin,3468,3472,O
and,3473,3476,O
delicate,3477,3485,O
and,3486,3489,O
easily,3490,3496,O
bruised,3497,3504,O
(,3505,3506,O
July,3506,3510,O
2006,3511,3515,O
),3515,3516,O
.,3516,3517,O
Hypothetical,0,12,O
distribution,13,25,O
patterns,26,34,O
of,35,37,O
the,38,41,O
meadow,42,48,O
brown,49,54,O
Maniola,55,62,O
jurtina,63,70,O
in,71,73,O
Europe,74,80,O
during,81,87,O
the,88,91,O
last,92,96,O
glacial,97,104,O
maximum,105,112,O
(,113,114,O
dark,114,118,O
hatched,119,126,O
areas,127,132,O
),132,133,O
.,133,134,O
Postglacial,135,146,O
expansions,147,157,O
are,158,161,O
indicated,162,171,O
by,172,174,O
solid,175,180,O
arrows,181,187,O
.,187,188,O
The,189,192,O
postulated,193,203,O
actual,204,210,O
hybrid,211,217,O
zone,218,222,O
is,223,225,O
shown,226,231,O
by,232,234,O
the,235,238,O
hatched,239,246,O
area,247,251,O
.,251,252,O
Question,253,261,O
marks,262,267,O
indicate,268,276,O
lack,277,281,O
of,282,284,O
information,285,296,O
concerning,297,307,O
ancient,308,315,O
distribution,316,328,O
patterns,329,337,O
in,338,340,O
the,341,344,O
South,345,350,O
and,351,354,O
present,355,362,O
distribution,363,375,O
of,376,378,O
hybrid,379,385,O
populations,386,397,O
in,398,400,O
the,401,404,O
North,405,410,O
.,410,411,O
Redrawn,412,419,O
from,420,424,O
Schmitt,425,432,O
et,433,435,O
.,435,436,O
al,437,439,O
.,439,440,O
[,441,442,O
36,442,444,O
],444,445,O
;,445,446,O
based,447,452,O
on,453,455,O
Thomson,456,463,O
[,464,465,O
37,465,467,O
],467,468,O
and,469,472,O
Schmitt,473,480,O
et,481,483,O
al,484,486,O
.,486,487,O
[,488,489,O
36,489,491,O
],491,492,O
.,492,493,O
Supporting,0,10,O
Information,11,22,O
Alternate,23,32,O
Language,33,41,O
Article,42,49,O
S1,50,52,O
Translation,53,64,O
of,65,67,O
the,68,71,O
manuscript,72,82,O
into,83,87,O
French,88,94,O
by,95,97,O
EL,98,100,O
(,101,102,O
201,102,105,O
KB,106,108,O
DOC,109,112,O
),112,113,O
.,113,114,O
Click,115,120,O
here,121,125,O
for,126,129,O
additional,130,140,O
data,141,145,O
file,146,150,O
.,150,151,O
Extrapyramidal,0,14,O
symptoms,15,23,O
based,24,29,O
on,30,32,O
Extrapyramidal,33,47,O
Symptoms,48,56,O
Rating,57,63,O
Scale,64,69,O
Etiology,0,8,O
Anorectal,9,18,B-Organism_subdivision
malformations,19,32,O
(,33,34,O
ARM,34,37,O
),37,38,O
represent,39,48,O
a,49,50,O
spectrum,51,59,O
of,60,62,O
abnormalities,63,76,O
ranging,77,84,O
from,85,89,O
mild,90,94,O
anal,95,99,B-Immaterial_anatomical_entity
anomalies,100,109,O
to,110,112,O
complex,113,120,O
cloacal,121,128,O
malformations,129,142,O
.,142,143,O
The,144,147,O
etiology,148,156,O
of,157,159,O
such,160,164,O
malformations,165,178,O
remains,179,186,O
unclear,187,194,O
and,195,198,O
is,199,201,O
likely,202,208,O
multifactorial,209,223,O
.,223,224,O
There,225,230,O
are,231,234,O
however,235,242,O
reasons,243,250,O
to,251,253,O
believe,254,261,O
there,262,267,O
is,268,270,O
a,271,272,O
genetic,273,280,O
componenet,281,291,O
.,291,292,O
As,293,295,O
early,296,301,O
as,302,304,O
the,305,308,O
1950s,309,314,O
",",314,315,O
it,316,318,O
was,319,322,O
recognized,323,333,O
that,334,338,O
there,339,344,O
was,345,348,O
an,349,351,O
increased,352,361,O
risk,362,366,O
for,367,370,O
a,371,372,O
sibling,373,380,O
of,381,383,O
a,384,385,O
patient,386,393,O
with,394,398,O
ARM,399,402,O
to,403,405,O
be,406,408,O
born,409,413,O
with,414,418,O
a,419,420,O
malformation,421,433,O
",",433,434,O
as,435,437,O
much,438,442,O
as,443,445,O
1,446,447,O
in,448,450,O
100,451,454,O
",",454,455,O
compared,456,464,O
with,465,469,O
the,470,473,O
incidence,474,483,O
of,484,486,O
about,487,492,O
1,493,494,O
in,495,497,O
5000,498,502,O
in,503,505,O
the,506,509,O
general,510,517,O
population,518,528,O
.,528,529,O
Since,530,535,O
that,536,540,O
time,541,545,O
there,546,551,O
have,552,556,O
been,557,561,O
reports,562,569,O
of,570,572,O
families,573,581,O
with,582,586,O
2,587,588,O
or,589,591,O
more,592,596,O
affected,597,605,O
members,606,613,O
and,614,617,O
associations,618,630,O
of,631,633,O
ARMs,634,638,O
with,639,643,O
multisystem,644,655,O
syndromes,656,665,O
.,665,666,O
In,667,669,O
particular,670,680,O
",",680,681,O
mutations,682,691,O
in,692,694,O
specific,695,703,O
genes,704,709,O
encoding,710,718,O
transcription,719,732,O
factors,733,740,O
have,741,745,O
been,746,750,O
described,751,760,O
in,761,763,O
patients,764,772,O
having,773,779,O
Townes,780,786,O
-,786,787,O
Broks,787,792,O
syndrome,793,801,O
",",801,802,O
Currarino,803,812,O
',812,813,O
s,813,814,O
syndrome,815,823,O
",",823,824,O
and,825,828,O
Pallister,829,838,O
-,838,839,O
Hall,839,843,O
syndrome,844,852,O
",",852,853,O
each,854,858,O
of,859,861,O
which,862,867,O
have,868,872,O
autosomal,873,882,O
dominant,883,891,O
modes,892,897,O
of,898,900,O
inheritance,901,912,O
.,912,913,O
In,914,916,O
addition,917,925,O
",",925,926,O
it,927,929,O
has,930,933,O
been,934,938,O
found,939,944,O
that,945,949,O
there,950,955,O
is,956,958,O
not,959,962,O
only,963,967,O
an,968,970,O
increased,971,980,O
incidence,981,990,O
of,991,993,O
ARM,994,997,O
in,998,1000,O
patient,1001,1008,O
with,1009,1013,O
trisomy,1014,1021,O
21,1022,1024,O
(,1025,1026,O
Down,1026,1030,O
',1030,1031,O
s,1031,1032,O
syndrome,1033,1041,O
),1041,1042,O
",",1042,1043,O
but,1044,1047,O
that,1048,1052,O
95,1053,1055,O
%,1055,1056,O
of,1057,1059,O
patients,1060,1068,O
with,1069,1073,O
trisomy,1074,1081,O
21,1082,1084,O
and,1085,1088,O
ARM,1089,1092,O
have,1093,1097,O
imperforate,1098,1109,O
anus,1110,1114,B-Immaterial_anatomical_entity
without,1115,1122,O
fistula,1123,1130,B-Pathological_formation
",",1130,1131,O
compared,1132,1140,O
with,1141,1145,O
only,1146,1150,O
5,1151,1152,O
%,1152,1153,O
of,1154,1156,O
all,1157,1160,O
patients,1161,1169,O
with,1170,1174,O
ARM,1175,1178,O
.,1178,1179,O
Based,1180,1185,O
on,1186,1188,O
this,1189,1193,O
evidence,1194,1202,O
",",1202,1203,O
it,1204,1206,O
is,1207,1209,O
likely,1210,1216,O
that,1217,1221,O
the,1222,1225,O
mutation,1226,1234,O
of,1235,1237,O
a,1238,1239,O
variety,1240,1247,O
of,1248,1250,O
different,1251,1260,O
genes,1261,1266,O
can,1267,1270,O
result,1271,1277,O
in,1278,1280,O
ARM,1281,1284,O
",",1284,1285,O
or,1286,1288,O
that,1289,1293,O
the,1294,1297,O
etiology,1298,1306,O
of,1307,1309,O
ARM,1310,1313,O
is,1314,1316,O
multigenic,1317,1327,O
[,1328,1329,O
13,1329,1331,O
],1331,1332,O
.,1332,1333,O
Images,0,6,O
Fig,7,10,O
.,10,11,O
1,12,13,O
Fig,14,17,O
.,17,18,O
2,19,20,O
Fig,21,24,O
.,24,25,O
3,26,27,O
Images,0,6,O
Figure,7,13,O
1,14,15,O
Results,0,7,O
The,8,11,O
observation,12,23,O
that,24,28,O
AP,29,31,O
-,31,32,O
3,32,33,O
is,34,36,O
found,37,42,O
in,43,45,O
both,46,50,O
cytosolic,51,60,B-Organism_substance
and,61,64,O
membrane,65,73,B-Organism_substance
subcellular,74,85,I-Organism_substance
fractions,86,95,I-Organism_substance
",",95,96,O
and,97,100,O
that,101,105,O
membrane,106,114,B-Cellular_component
-,114,115,O
associated,115,125,O
AP,126,128,O
-,128,129,O
3,129,130,O
can,131,134,O
be,135,137,O
extracted,138,147,O
with,148,152,O
salts,153,158,O
(,159,160,O
Dell,160,164,O
',164,165,O
Angelica,165,173,O
et,174,176,O
al,177,179,O
.,179,180,O
",",180,181,O
1997a,182,187,O
),187,188,O
is,189,191,O
consistent,192,202,O
with,203,207,O
its,208,211,O
role,212,216,O
as,217,219,O
a,220,221,O
membrane,222,230,B-Cellular_component
coat,231,235,O
that,236,240,O
can,241,244,O
be,245,247,O
recruited,248,257,O
from,258,262,O
a,263,264,O
cytosolic,265,274,B-Organism_substance
pool,275,279,I-Organism_substance
.,279,280,O
In,281,283,O
addition,284,292,O
",",292,293,O
the,294,297,O
punctate,298,306,O
staining,307,315,O
of,316,318,O
AP,319,321,O
-,321,322,O
3,322,323,O
by,324,326,O
immunofluorescence,327,345,O
microscopy,346,356,O
",",356,357,O
its,358,361,O
redistribution,362,376,O
to,377,379,O
the,380,383,O
cytosol,384,391,B-Organism_substance
by,392,394,O
BFA,395,398,O
",",398,399,O
and,400,403,O
the,404,407,O
reversibility,408,421,O
of,422,424,O
the,425,428,O
BFA,429,432,O
effect,433,439,O
(,440,441,O
Dell,441,445,O
',445,446,O
Angelica,446,454,O
et,455,457,O
al,458,460,O
.,460,461,O
",",461,462,O
1997a,463,468,O
;,468,469,O
Simpson,470,477,O
et,478,480,O
al,481,483,O
.,483,484,O
",",484,485,O
1997,486,490,O
),490,491,O
also,492,496,O
indicate,497,505,O
that,506,510,O
AP,511,513,O
-,513,514,O
3,514,515,O
can,516,519,O
cycle,520,525,O
between,526,533,O
the,534,537,O
cytosol,538,545,B-Organism_substance
and,546,549,O
membranes,550,559,B-Cellular_component
.,559,560,O
The,561,564,O
sensitivity,565,576,O
of,577,579,O
AP,580,582,O
-,582,583,O
3,583,584,O
to,585,587,O
BFA,588,591,O
in,592,594,O
cells,595,600,B-Cell
suggests,601,609,O
that,610,614,O
its,615,618,O
membrane,619,627,B-Cellular_component
association,628,639,O
may,640,643,O
be,644,646,O
regulated,647,656,O
by,657,659,O
ARF1,660,664,O
",",664,665,O
since,666,671,O
BFA,672,675,O
inhibits,676,684,O
ARF1,685,689,O
guanine,690,697,O
nucleotide,698,708,O
exchange,709,717,O
",",717,718,O
and,719,722,O
has,723,726,O
been,727,731,O
shown,732,737,O
to,738,740,O
prevent,741,748,O
ARF1,749,753,O
membrane,754,762,B-Cellular_component
binding,763,770,O
in,771,773,O
vitro,774,779,O
(,780,781,O
Donaldson,781,790,O
et,791,793,O
al,794,796,O
.,796,797,O
",",797,798,O
1992,799,803,O
;,803,804,O
Helms,805,810,O
and,811,814,O
Rothman,815,822,O
",",822,823,O
1992,824,828,O
;,828,829,O
Randazzo,830,838,O
et,839,841,O
al,842,844,O
.,844,845,O
",",845,846,O
1993,847,851,O
),851,852,O
.,852,853,O
Immunocytochemistry,0,19,O
C2C12,20,25,B-Cell
cells,26,31,I-Cell
grown,32,37,O
in,38,40,O
8,41,42,O
-,42,43,O
chamber,43,50,O
slides,51,57,O
(,58,59,O
Nunc,59,63,O
),63,64,O
were,65,69,O
fixed,70,75,O
in,76,78,O
4,79,80,O
%,80,81,O
PFA,82,85,O
/,85,86,O
PBS,86,89,O
for,90,93,O
10,94,96,O
min,97,100,O
and,101,104,O
permeabilized,105,118,O
in,119,121,O
0,122,123,O
.,123,124,O
1,124,125,O
%,125,126,O
Triton,127,133,O
X,134,135,O
-,135,136,O
100,136,139,O
for,140,143,O
20,144,146,O
min,147,150,O
.,150,151,O
In,152,154,O
some,155,159,O
cases,160,165,O
",",165,166,O
they,167,171,O
were,172,176,O
fixed,177,182,O
and,183,186,O
permeabilized,187,200,O
in,201,203,O
methanol,204,212,O
at,213,215,O
-,216,217,O
20degreesC,217,227,O
for,228,231,O
2,232,233,O
min,234,237,O
.,237,238,O
The,239,242,O
fixed,243,248,O
and,249,252,O
permeabilized,253,266,O
cells,267,272,B-Cell
were,273,277,O
blocked,278,285,O
in,286,288,O
PBS,289,292,O
containing,293,303,O
3,304,305,O
%,305,306,O
BSA,307,310,O
(,311,312,O
Jackson,312,319,O
ImmunoResearch,320,334,O
Laboratories,335,347,O
),347,348,O
and,349,352,O
incubated,353,362,O
overnight,363,372,O
at,373,375,O
4degreesC,376,385,O
with,386,390,O
primary,391,398,O
antibodies,399,409,O
in,410,412,O
blocking,413,421,O
solution,422,430,O
.,430,431,O
Immunoreactivity,432,448,O
was,449,452,O
detected,453,461,O
with,462,466,O
either,467,473,O
Alexa,474,479,O
-,479,480,O
conjugated,480,490,O
secondary,491,500,O
antibody,501,509,O
(,510,511,O
Molecular,511,520,O
Probes,521,527,O
),527,528,O
or,529,531,O
a,532,533,O
combination,534,545,O
of,546,548,O
biotin,549,555,O
-,555,556,O
conjugated,556,566,O
secondary,567,576,O
antibody,577,585,O
(,586,587,O
Vector,587,593,O
Laboratories,594,606,O
),606,607,O
and,608,611,O
Alexa,612,617,O
-,617,618,O
conjugated,618,628,O
streptavidin,629,641,O
(,642,643,O
Molecular,643,652,O
Probes,653,659,O
),659,660,O
.,660,661,O
Cytology,0,8,O
and,9,12,O
Histology,13,22,O
For,23,26,O
semithin,27,35,O
sections,36,44,O
",",44,45,O
embryoid,46,54,B-Developing_anatomical_structure
bodies,55,61,I-Developing_anatomical_structure
were,62,66,O
washed,67,73,O
twice,74,79,O
in,80,82,O
PBS,83,86,O
",",86,87,O
fixed,88,93,O
in,94,96,O
4,97,98,O
%,98,99,O
paraformaldehyde,100,116,O
at,117,119,O
4degreesC,120,129,O
overnight,130,139,O
",",139,140,O
and,141,144,O
after,145,150,O
dehydration,151,162,O
in,163,165,O
ethanol,166,173,O
were,174,178,O
embedded,179,187,O
in,188,190,O
JB,191,193,O
-,193,194,O
4,194,195,O
resin,196,201,O
(,202,203,O
Polysciences,203,215,O
",",215,216,O
Inc,217,220,O
.,220,221,O
),221,222,O
.,222,223,O
1,224,225,O
-,225,226,O
4,226,227,O
-,227,228,O
mum,228,231,O
sections,232,240,O
were,241,245,O
cut,246,249,O
with,250,254,O
a,255,256,O
glass,257,262,O
knife,263,268,O
.,268,269,O
For,270,273,O
cytology,274,282,O
",",282,283,O
the,284,287,O
sections,288,296,O
were,297,301,O
stained,302,309,O
with,310,314,O
toluidine,315,324,O
blue,325,329,O
.,329,330,O
In,331,333,O
cell,334,338,B-Cell
mixing,339,345,O
experiments,346,357,O
",",357,358,O
the,359,362,O
embryoid,363,371,B-Developing_anatomical_structure
bodies,372,378,I-Developing_anatomical_structure
were,379,383,O
prefixed,384,392,O
and,393,396,O
stained,397,404,O
for,405,408,O
beta,409,413,O
-,413,414,O
galactosidase,414,427,O
and,428,431,O
the,432,435,O
sections,436,444,O
were,445,449,O
counterstained,450,464,O
with,465,469,O
neutral,470,477,O
red,478,481,O
.,481,482,O
Teratocarcinomas,483,499,O
were,500,504,O
fixed,505,510,O
in,511,513,O
Bouin,514,519,O
fixative,520,528,O
",",528,529,O
embedded,530,538,O
in,539,541,O
Paraplast,542,551,O
",",551,552,O
and,553,556,O
the,557,560,O
sections,561,569,O
were,570,574,O
stained,575,582,O
with,583,587,O
hematoxylin,588,599,O
and,600,603,O
eosin,604,609,O
.,609,610,O
Microphotography,611,627,O
was,628,631,O
with,632,636,O
a,637,638,O
ZEISS,639,644,O
Axiomat,645,652,O
microscope,653,663,O
.,663,664,O
Films,665,670,O
were,671,675,O
scanned,676,683,O
and,684,687,O
figures,688,695,O
were,696,700,O
prepared,701,709,O
with,710,714,O
Photoshop,715,724,O
5,725,726,O
.,726,727,O
5,727,728,O
software,729,737,O
.,737,738,O
Stimulation,0,11,O
/,11,12,O
Inhibition,12,22,O
of,23,25,O
iDC,26,29,B-Cell
Functions,30,39,O
by,40,42,O
Activated,43,52,O
NK,53,55,B-Cell
Cells,56,61,I-Cell
.,61,62,O
Two,63,66,O
previous,67,75,O
studies,76,83,O
have,84,88,O
shown,89,94,O
that,95,99,O
both,100,104,O
resting,105,112,O
and,113,116,O
activated,117,126,O
NK,127,129,B-Cell
cells,130,135,I-Cell
partially,136,145,O
kill,146,150,O
autologous,151,161,O
DCs,162,165,B-Cell
",",165,166,O
as,167,169,O
measured,170,178,O
by,179,181,O
3,182,183,O
-,183,184,O
4,184,185,O
-,185,186,O
h,186,187,O
chromium,188,196,O
release,197,204,O
assays,205,211,O
using,212,217,O
high,218,222,O
NK,223,225,B-Cell
/,225,226,O
DC,226,228,B-Cell
ratios,229,235,O
(,236,237,O
11,237,239,O
",",239,240,O
12,241,243,O
),243,244,O
.,244,245,O
However,246,253,O
",",253,254,O
in,255,257,O
our,258,261,O
long,262,266,O
-,266,267,O
term,267,271,O
cultures,272,280,O
(,281,282,O
24,282,284,O
-,284,285,O
48,285,287,O
h,288,289,O
),289,290,O
the,291,294,O
NK,295,297,B-Cell
cells,298,303,I-Cell
stimulated,304,314,O
the,315,318,O
iDCs,319,323,B-Cell
rather,324,330,O
than,331,335,O
lysing,336,342,O
them,343,347,O
.,347,348,O
Based,349,354,O
on,355,357,O
these,358,363,O
conflicting,364,375,O
results,376,383,O
",",383,384,O
we,385,387,O
examined,388,396,O
in,397,399,O
more,400,404,O
detail,405,411,O
the,412,415,O
apparent,416,424,O
stimulation,425,436,O
of,437,439,O
iDCs,440,444,B-Cell
after,445,450,O
contact,451,458,O
with,459,463,O
NK,464,466,B-Cell
cells,467,472,I-Cell
.,472,473,O
We,474,476,O
reasoned,477,485,O
that,486,490,O
activated,491,500,O
NK,501,503,B-Cell
cells,504,509,I-Cell
would,510,515,O
be,516,518,O
more,519,523,O
useful,524,530,O
for,531,534,O
these,535,540,O
experiments,541,552,O
because,553,560,O
(,561,562,O
i,562,563,O
),563,564,O
an,565,567,O
encounter,568,577,O
in,578,580,O
vivo,581,585,O
between,586,593,O
NK,594,596,B-Cell
cells,597,602,I-Cell
that,603,607,O
normally,608,616,O
traffic,617,624,O
in,625,627,O
the,628,631,O
blood,632,637,B-Organism_substance
(,638,639,O
4,639,640,O
),640,641,O
and,642,645,O
iDCs,646,650,B-Cell
which,651,656,O
reside,657,663,O
in,664,666,O
the,667,670,O
tissues,671,678,B-Tissue
(,679,680,O
1,680,681,O
",",681,682,O
3,683,684,O
),684,685,O
",",685,686,O
should,687,693,O
only,694,698,O
occur,699,704,O
when,705,709,O
both,710,714,O
cells,715,720,B-Cell
are,721,724,O
activated,725,734,O
;,734,735,O
(,736,737,O
ii,737,739,O
),739,740,O
activated,741,750,O
NK,751,753,B-Cell
cells,754,759,I-Cell
mediate,760,767,O
more,768,772,O
potent,773,779,O
lysis,780,785,O
of,786,788,O
iDCs,789,793,B-Cell
(,794,795,O
11,795,797,O
-,797,798,O
13,798,800,O
),800,801,O
",",801,802,O
thereby,803,810,O
allowing,811,819,O
for,820,823,O
a,824,825,O
more,826,830,O
rigorous,831,839,O
examination,840,851,O
of,852,854,O
a,855,856,O
potential,857,866,O
cytotoxic,867,876,O
effect,877,883,O
;,883,884,O
and,885,888,O
(,889,890,O
iii,890,893,O
),893,894,O
the,895,898,O
number,899,905,O
of,906,908,O
NK,909,911,B-Cell
cells,912,917,I-Cell
obtained,918,926,O
after,927,932,O
short,933,938,O
-,938,939,O
term,939,943,O
in,944,946,O
vitro,947,952,O
culture,953,960,O
would,961,966,O
be,967,969,O
far,970,973,O
greater,974,981,O
providing,982,991,O
more,992,996,O
cells,997,1002,B-Cell
for,1003,1006,O
analysis,1007,1015,O
(,1016,1017,O
9,1017,1018,O
),1018,1019,O
.,1019,1020,O
The,1021,1024,O
DC,1025,1027,B-Cell
maturation,1028,1038,O
induced,1039,1046,O
by,1047,1049,O
resting,1050,1057,O
NK,1058,1060,B-Cell
cells,1061,1066,I-Cell
we,1067,1069,O
observed,1070,1078,O
was,1079,1082,O
dependent,1083,1092,O
on,1093,1095,O
endogenous,1096,1106,O
TNF,1107,1110,O
-,1110,1111,O
alpha,1111,1116,O
production,1117,1127,O
.,1127,1128,O
Furthermore,1129,1140,O
",",1140,1141,O
TNF,1142,1145,O
-,1145,1146,O
alpha,1146,1151,O
and,1152,1155,O
other,1156,1161,O
proinflammatory,1162,1177,O
cytokines,1178,1187,O
are,1188,1191,O
important,1192,1201,O
amplifiers,1202,1212,O
of,1213,1215,O
immune,1216,1222,O
responses,1223,1232,O
(,1233,1234,O
14,1234,1236,O
),1236,1237,O
.,1237,1238,O
Therefore,1239,1248,O
",",1248,1249,O
we,1250,1252,O
used,1253,1257,O
TNF,1258,1261,O
-,1261,1262,O
alpha,1262,1267,O
production,1268,1278,O
as,1279,1281,O
a,1282,1283,O
readout,1284,1291,O
for,1292,1295,O
DC,1296,1298,B-Cell
stimulation,1299,1310,O
in,1311,1313,O
our,1314,1317,O
culture,1318,1325,O
system,1326,1332,O
.,1332,1333,O
Culturing,1334,1343,O
activated,1344,1353,O
NK,1354,1356,B-Cell
cells,1357,1362,I-Cell
with,1363,1367,O
DCs,1368,1371,B-Cell
at,1372,1374,O
low,1375,1378,O
NK,1379,1381,B-Cell
/,1381,1382,O
DC,1382,1384,B-Cell
ratios,1385,1391,O
(,1392,1393,O
1,1393,1394,O
:,1394,1395,O
5,1395,1396,O
),1396,1397,O
led,1398,1401,O
to,1402,1404,O
increases,1405,1414,O
in,1415,1417,O
TNF,1418,1421,O
-,1421,1422,O
alpha,1422,1427,O
production,1428,1438,O
",",1438,1439,O
which,1440,1445,O
were,1446,1450,O
augmented,1451,1460,O
dramatically,1461,1473,O
by,1474,1476,O
the,1477,1480,O
addition,1481,1489,O
of,1490,1492,O
suboptimal,1493,1503,O
doses,1504,1509,O
(,1510,1511,O
10,1511,1513,O
ng,1514,1516,O
/,1516,1517,O
ml,1517,1519,O
),1519,1520,O
of,1521,1523,O
LPS,1524,1527,O
(,1528,1529,O
Fig,1529,1532,O
.,1532,1533,O
2,1534,1535,O
A,1536,1537,O
),1537,1538,O
.,1538,1539,O
The,1540,1543,O
increased,1544,1553,O
TNF,1554,1557,O
-,1557,1558,O
alpha,1558,1563,O
production,1564,1574,O
was,1575,1578,O
dependent,1579,1588,O
on,1589,1591,O
cell,1592,1596,B-Cell
-,1596,1597,O
to,1597,1599,O
-,1599,1600,O
cell,1600,1604,B-Cell
contact,1605,1612,O
because,1613,1620,O
when,1621,1625,O
the,1626,1629,O
two,1630,1633,O
cell,1634,1638,B-Cell
types,1639,1644,O
were,1645,1649,O
separated,1650,1659,O
in,1660,1662,O
trans,1663,1668,O
-,1668,1669,O
wells,1669,1674,O
",",1674,1675,O
no,1676,1678,O
stimulation,1679,1690,O
was,1691,1694,O
observed,1695,1703,O
(,1704,1705,O
Fig,1705,1708,O
.,1708,1709,O
2,1710,1711,O
B,1712,1713,O
),1713,1714,O
.,1714,1715,O
In,1716,1718,O
separate,1719,1727,O
experiments,1728,1739,O
we,1740,1742,O
observed,1743,1751,O
this,1752,1756,O
NK,1757,1759,B-Cell
-,1759,1760,O
stimulatory,1760,1771,O
effect,1772,1778,O
on,1779,1781,O
TNF,1782,1785,O
-,1785,1786,O
alpha,1786,1791,O
production,1792,1802,O
at,1803,1805,O
NK,1806,1808,B-Cell
/,1808,1809,O
DC,1809,1811,B-Cell
ratios,1812,1818,O
as,1819,1821,O
low,1822,1825,O
as,1826,1828,O
1,1829,1830,O
:,1830,1831,O
20,1831,1833,O
and,1834,1837,O
1,1838,1839,O
:,1839,1840,O
40,1840,1842,O
(,1843,1844,O
data,1844,1848,O
not,1849,1852,O
shown,1853,1858,O
),1858,1859,O
.,1859,1860,O
Raising,1861,1868,O
the,1869,1872,O
NK,1873,1875,B-Cell
/,1875,1876,O
DC,1876,1878,B-Cell
ratio,1879,1884,O
to,1885,1887,O
5,1888,1889,O
:,1889,1890,O
1,1890,1891,O
changes,1892,1899,O
the,1900,1903,O
interaction,1904,1915,O
from,1916,1920,O
one,1921,1924,O
of,1925,1927,O
potent,1928,1934,O
DC,1935,1937,B-Cell
stimulation,1938,1949,O
to,1950,1952,O
that,1953,1957,O
of,1958,1960,O
complete,1961,1969,O
inhibition,1970,1980,O
in,1981,1983,O
the,1984,1987,O
presence,1988,1996,O
or,1997,1999,O
absence,2000,2007,O
of,2008,2010,O
LPS,2011,2014,O
(,2015,2016,O
Fig,2016,2019,O
.,2019,2020,O
2,2021,2022,O
C,2023,2024,O
),2024,2025,O
.,2025,2026,O
An,2027,2029,O
identical,2030,2039,O
pattern,2040,2047,O
is,2048,2050,O
seen,2051,2055,O
for,2056,2059,O
IL,2060,2062,O
-,2062,2063,O
12,2063,2065,O
p40,2066,2069,O
production,2070,2080,O
(,2081,2082,O
Fig,2082,2085,O
.,2085,2086,O
2,2087,2088,O
D,2089,2090,O
),2090,2091,O
.,2091,2092,O
No,2093,2095,O
IL,2096,2098,O
-,2098,2099,O
10,2099,2101,O
production,2102,2112,O
in,2113,2115,O
the,2116,2119,O
cultures,2120,2128,O
was,2129,2132,O
detected,2133,2141,O
under,2142,2147,O
any,2148,2151,O
of,2152,2154,O
the,2155,2158,O
conditions,2159,2169,O
tested,2170,2176,O
(,2177,2178,O
data,2178,2182,O
not,2183,2186,O
shown,2187,2192,O
),2192,2193,O
.,2193,2194,O
The,2195,2198,O
massive,2199,2206,O
production,2207,2217,O
of,2218,2220,O
TNF,2221,2224,O
-,2224,2225,O
alpha,2225,2230,O
in,2231,2233,O
the,2234,2237,O
cultures,2238,2246,O
at,2247,2249,O
the,2250,2253,O
lowest,2254,2260,O
ratios,2261,2267,O
was,2268,2271,O
mediated,2272,2280,O
primarily,2281,2290,O
by,2291,2293,O
DCs,2294,2297,B-Cell
in,2298,2300,O
the,2301,2304,O
culture,2305,2312,O
due,2313,2316,O
to,2317,2319,O
the,2320,2323,O
low,2324,2327,O
number,2328,2334,O
of,2335,2337,O
NK,2338,2340,B-Cell
cells,2341,2346,I-Cell
(,2347,2348,O
2,2348,2349,O
x,2350,2351,O
104,2352,2355,O
cells,2356,2361,B-Cell
per,2362,2365,O
well,2366,2370,O
),2370,2371,O
used,2372,2376,O
in,2377,2379,O
these,2380,2385,O
experiments,2386,2397,O
.,2397,2398,O
In,2399,2401,O
addition,2402,2410,O
",",2410,2411,O
efforts,2412,2419,O
to,2420,2422,O
stimulate,2423,2432,O
NK,2433,2435,B-Cell
cells,2436,2441,I-Cell
directly,2442,2450,O
with,2451,2455,O
optimal,2456,2463,O
doses,2464,2469,O
of,2470,2472,O
anti,2473,2477,O
-,2477,2478,O
CD16,2478,2482,O
",",2482,2483,O
rIL,2484,2487,O
-,2487,2488,O
2,2488,2489,O
",",2489,2490,O
rIL,2491,2494,O
-,2494,2495,O
12,2495,2497,O
",",2497,2498,O
and,2499,2502,O
PMA,2503,2506,O
/,2506,2507,O
ionomycin,2507,2516,O
alone,2517,2522,O
or,2523,2525,O
in,2526,2528,O
combination,2529,2540,O
induced,2541,2548,O
only,2549,2553,O
moderate,2554,2562,O
(,2563,2564,O
<,2564,2565,O
500,2565,2568,O
pg,2569,2571,O
/,2571,2572,O
ml,2572,2574,O
),2574,2575,O
TNF,2576,2579,O
-,2579,2580,O
alpha,2580,2585,O
production,2586,2596,O
by,2597,2599,O
the,2600,2603,O
NK,2604,2606,B-Cell
cells,2607,2612,I-Cell
alone,2613,2618,O
which,2619,2624,O
were,2625,2629,O
present,2630,2637,O
at,2638,2640,O
2,2641,2642,O
x,2643,2644,O
105,2645,2648,O
cells,2649,2654,B-Cell
per,2655,2658,O
well,2659,2663,O
(,2664,2665,O
data,2665,2669,O
not,2670,2673,O
shown,2674,2679,O
),2679,2680,O
.,2680,2681,O
Figure,2682,2688,O
2,2689,2690,O
.,2690,2691,O
Activated,2692,2701,O
/,2701,2702,O
cultured,2702,2710,O
NK,2711,2713,B-Cell
cell,2714,2718,I-Cell
-,2718,2719,O
mediated,2719,2727,O
amplification,2728,2741,O
/,2741,2742,O
inhibition,2742,2752,O
of,2753,2755,O
DC,2756,2758,B-Cell
cytokine,2759,2767,O
production,2768,2778,O
.,2778,2779,O
Results,2780,2787,O
are,2788,2791,O
presented,2792,2801,O
on,2802,2804,O
log,2805,2808,O
scales,2809,2815,O
.,2815,2816,O
Cultured,2817,2825,O
iDCs,2826,2830,B-Cell
were,2831,2835,O
incubated,2836,2845,O
alone,2846,2851,O
or,2852,2854,O
with,2855,2859,O
cultured,2860,2868,O
/,2868,2869,O
purified,2869,2877,O
NK,2878,2880,B-Cell
cells,2881,2886,I-Cell
for,2887,2890,O
24,2891,2893,O
h,2894,2895,O
(,2896,2897,O
A,2897,2898,O
and,2899,2902,O
B,2903,2904,O
),2904,2905,O
or,2906,2908,O
48,2909,2911,O
h,2912,2913,O
(,2914,2915,O
C,2915,2916,O
-,2916,2917,O
E,2917,2918,O
),2918,2919,O
in,2920,2922,O
the,2923,2926,O
presence,2927,2935,O
or,2936,2938,O
absence,2939,2946,O
of,2947,2949,O
the,2950,2953,O
indicated,2954,2963,O
concentrations,2964,2978,O
of,2979,2981,O
LPS,2982,2985,O
.,2985,2986,O
After,2987,2992,O
culture,2993,3000,O
the,3001,3004,O
supernatants,3005,3017,O
were,3018,3022,O
removed,3023,3030,O
and,3031,3034,O
analyzed,3035,3043,O
by,3044,3046,O
ELISA,3047,3052,O
for,3053,3056,O
TNF,3057,3060,O
-,3060,3061,O
alpha,3061,3066,O
or,3067,3069,O
IL,3070,3072,O
-,3072,3073,O
12,3073,3075,O
p40,3076,3079,O
.,3079,3080,O
(,3081,3082,O
A,3082,3083,O
),3083,3084,O
TNF,3085,3088,O
-,3088,3089,O
alpha,3089,3094,O
production,3095,3105,O
was,3106,3109,O
measured,3110,3118,O
in,3119,3121,O
the,3122,3125,O
supernatants,3126,3138,O
from,3139,3143,O
cultures,3144,3152,O
of,3153,3155,O
:,3155,3156,O
DCs,3157,3160,B-Cell
alone,3161,3166,O
(,3167,3168,O
gray,3168,3172,O
bars,3173,3177,O
),3177,3178,O
;,3178,3179,O
NK,3180,3182,B-Cell
+,3182,3183,O
DC,3183,3185,B-Cell
(,3186,3187,O
1,3187,3188,O
:,3188,3189,O
5,3189,3190,O
),3190,3191,O
(,3192,3193,O
black,3193,3198,O
bars,3199,3203,O
),3203,3204,O
.,3204,3205,O
LPS,3206,3209,O
concentrations,3210,3224,O
used,3225,3229,O
were,3230,3234,O
:,3234,3235,O
0,3236,3237,O
",",3237,3238,O
10,3239,3241,O
",",3241,3242,O
and,3243,3246,O
1,3247,3248,O
",",3248,3249,O
000,3249,3252,O
ng,3253,3255,O
/,3255,3256,O
ml,3256,3258,O
(,3259,3260,O
DCs,3260,3263,B-Cell
alone,3264,3269,O
only,3270,3274,O
),3274,3275,O
.,3275,3276,O
(,3277,3278,O
B,3278,3279,O
),3279,3280,O
Contact,3281,3288,O
-,3288,3289,O
dependent,3289,3298,O
stimulation,3299,3310,O
of,3311,3313,O
iDC,3314,3317,B-Cell
TNF,3318,3321,O
-,3321,3322,O
alpha,3322,3327,O
production,3328,3338,O
by,3339,3341,O
NK,3342,3344,B-Cell
cells,3345,3350,I-Cell
was,3351,3354,O
tested,3355,3361,O
under,3362,3367,O
the,3368,3371,O
following,3372,3381,O
conditions,3382,3392,O
:,3392,3393,O
DCs,3394,3397,B-Cell
alone,3398,3403,O
(,3404,3405,O
gray,3405,3409,O
bars,3410,3414,O
),3414,3415,O
;,3415,3416,O
NK,3417,3419,B-Cell
+,3419,3420,O
DC,3420,3422,B-Cell
(,3423,3424,O
1,3424,3425,O
:,3425,3426,O
5,3426,3427,O
),3427,3428,O
(,3429,3430,O
black,3430,3435,O
bars,3436,3440,O
),3440,3441,O
;,3441,3442,O
NK,3443,3445,B-Cell
/,3445,3446,O
DC,3446,3448,B-Cell
(,3449,3450,O
1,3450,3451,O
:,3451,3452,O
5,3452,3453,O
),3453,3454,O
trans,3455,3460,O
-,3460,3461,O
wells,3461,3466,O
(,3467,3468,O
striped,3468,3475,O
bars,3476,3480,O
),3480,3481,O
.,3481,3482,O
LPS,3483,3486,O
concentrations,3487,3501,O
used,3502,3506,O
were,3507,3511,O
:,3511,3512,O
10,3513,3515,O
ng,3516,3518,O
/,3518,3519,O
ml,3519,3521,O
(,3522,3523,O
donor,3523,3528,O
1,3529,3530,O
),3530,3531,O
and,3532,3535,O
20,3536,3538,O
ng,3539,3541,O
/,3541,3542,O
ml,3542,3544,O
(,3545,3546,O
donor,3546,3551,O
2,3552,3553,O
),3553,3554,O
.,3554,3555,O
(,3556,3557,O
C,3557,3558,O
and,3559,3562,O
D,3563,3564,O
),3564,3565,O
Effect,3566,3572,O
of,3573,3575,O
increasing,3576,3586,O
the,3587,3590,O
NK,3591,3593,B-Cell
/,3593,3594,O
DC,3594,3596,B-Cell
ratio,3597,3602,O
(,3603,3604,O
DCs,3604,3607,B-Cell
alone,3608,3613,O
;,3613,3614,O
NK,3615,3617,B-Cell
:,3617,3618,O
DC,3618,3620,B-Cell
-,3620,3621,O
1,3621,3622,O
:,3622,3623,O
5,3623,3624,O
;,3624,3625,O
1,3626,3627,O
:,3627,3628,O
1,3628,3629,O
;,3629,3630,O
5,3631,3632,O
:,3632,3633,O
1,3633,3634,O
),3634,3635,O
on,3636,3638,O
(,3639,3640,O
C,3640,3641,O
),3641,3642,O
TNF,3643,3646,O
-,3646,3647,O
alpha,3647,3652,O
and,3653,3656,O
(,3657,3658,O
D,3658,3659,O
),3659,3660,O
IL,3661,3663,O
-,3663,3664,O
12,3664,3666,O
p40,3667,3670,O
production,3671,3681,O
.,3681,3682,O
LPS,3683,3686,O
concentrations,3687,3701,O
used,3702,3706,O
were,3707,3711,O
:,3711,3712,O
0,3713,3714,O
ng,3715,3717,O
/,3717,3718,O
ml,3718,3720,O
(,3721,3722,O
*,3722,3723,O
),3723,3724,O
;,3724,3725,O
20,3726,3728,O
ng,3729,3731,O
/,3731,3732,O
ml,3732,3734,O
(,3735,3736,O
*,3736,3737,O
),3737,3738,O
;,3738,3739,O
50,3740,3742,O
ng,3743,3745,O
/,3745,3746,O
ml,3746,3748,O
(,3749,3750,O
^,3750,3751,O
),3751,3752,O
;,3752,3753,O
and,3754,3757,O
1,3758,3759,O
",",3759,3760,O
000,3760,3763,O
ng,3764,3766,O
/,3766,3767,O
ml,3767,3769,O
-,3769,3770,O
LPS,3770,3773,O
(,3774,3775,O
*,3775,3776,O
),3776,3777,O
(,3778,3779,O
DCs,3779,3782,B-Cell
alone,3783,3788,O
only,3789,3793,O
),3793,3794,O
.,3794,3795,O
(,3796,3797,O
E,3797,3798,O
),3798,3799,O
The,3800,3803,O
effect,3804,3810,O
of,3811,3813,O
neutralizing,3814,3826,O
IFN,3827,3830,O
-,3830,3831,O
gamma,3831,3836,O
production,3837,3847,O
was,3848,3851,O
tested,3852,3858,O
under,3859,3864,O
the,3865,3868,O
following,3869,3878,O
conditions,3879,3889,O
:,3889,3890,O
DCs,3891,3894,B-Cell
alone,3895,3900,O
(,3901,3902,O
gray,3902,3906,O
bars,3907,3911,O
),3911,3912,O
;,3912,3913,O
NK,3914,3916,B-Cell
+,3916,3917,O
DC,3917,3919,B-Cell
(,3920,3921,O
1,3921,3922,O
:,3922,3923,O
5,3923,3924,O
),3924,3925,O
(,3926,3927,O
black,3927,3932,O
bars,3933,3937,O
),3937,3938,O
;,3938,3939,O
NK,3940,3942,B-Cell
+,3942,3943,O
DC,3943,3945,B-Cell
(,3946,3947,O
1,3947,3948,O
:,3948,3949,O
5,3949,3950,O
),3950,3951,O
and,3952,3955,O
10,3956,3958,O
mug,3959,3962,O
/,3962,3963,O
ml,3963,3965,O
of,3966,3968,O
blocking,3969,3977,O
anti,3978,3982,O
-,3982,3983,O
IFN,3983,3986,O
-,3986,3987,O
gamma,3987,3992,O
mAb,3993,3996,O
(,3997,3998,O
stippled,3998,4006,O
bars,4007,4011,O
),4011,4012,O
.,4012,4013,O
LPS,4014,4017,O
concentrations,4018,4032,O
used,4033,4037,O
were,4038,4042,O
:,4042,4043,O
0,4044,4045,O
ng,4046,4048,O
/,4048,4049,O
ml,4049,4051,O
(,4052,4053,O
NO,4053,4055,O
LPS,4056,4059,O
),4059,4060,O
and,4061,4064,O
20,4065,4067,O
ng,4068,4070,O
/,4070,4071,O
ml,4071,4073,O
(,4074,4075,O
LPS,4075,4078,O
20,4079,4081,O
),4081,4082,O
.,4082,4083,O
Blocking,4084,4092,O
reagents,4093,4101,O
for,4102,4105,O
CD80,4106,4110,O
",",4110,4111,O
CD86,4112,4116,O
",",4116,4117,O
CD154,4118,4123,O
",",4123,4124,O
CD95,4125,4129,O
",",4129,4130,O
CD11a,4131,4136,O
",",4136,4137,O
CD50,4138,4142,O
",",4142,4143,O
or,4144,4146,O
IL,4147,4149,O
-,4149,4150,O
12,4150,4152,O
",",4152,4153,O
had,4154,4157,O
no,4158,4160,O
effect,4161,4167,O
on,4168,4170,O
the,4171,4174,O
NK,4175,4177,B-Cell
cell,4178,4182,I-Cell
-,4182,4183,O
induced,4183,4190,O
TNF,4191,4194,O
-,4194,4195,O
alpha,4195,4200,O
or,4201,4203,O
IL,4204,4206,O
-,4206,4207,O
12,4207,4209,O
p40,4210,4213,O
production,4214,4224,O
",",4224,4225,O
whereas,4226,4233,O
a,4234,4235,O
neutralizing,4236,4248,O
antibody,4249,4257,O
for,4258,4261,O
IFN,4262,4265,O
-,4265,4266,O
gamma,4266,4271,O
while,4272,4277,O
not,4278,4281,O
affecting,4282,4291,O
TNF,4292,4295,O
-,4295,4296,O
alpha,4296,4301,O
production,4302,4312,O
partially,4313,4322,O
blocked,4323,4330,O
(,4331,4332,O
<,4332,4333,O
20,4333,4335,O
%,4335,4336,O
),4336,4337,O
IL,4338,4340,O
-,4340,4341,O
12,4341,4343,O
p40,4344,4347,O
production,4348,4358,O
induced,4359,4366,O
by,4367,4369,O
the,4370,4373,O
NK,4374,4376,B-Cell
cells,4377,4382,I-Cell
(,4383,4384,O
Fig,4384,4387,O
.,4387,4388,O
2,4389,4390,O
E,4391,4392,O
),4392,4393,O
.,4393,4394,O
This,4395,4399,O
partial,4400,4407,O
inhibition,4408,4418,O
is,4419,4421,O
consistent,4422,4432,O
with,4433,4437,O
numerous,4438,4446,O
previous,4447,4455,O
reports,4456,4463,O
demonstrating,4464,4477,O
a,4478,4479,O
central,4480,4487,O
role,4488,4492,O
for,4493,4496,O
an,4497,4499,O
IL,4500,4502,O
-,4502,4503,O
12,4503,4505,O
/,4505,4506,O
IFN,4506,4509,O
-,4509,4510,O
gamma,4510,4515,O
positive,4516,4524,O
feedback,4525,4533,O
loop,4534,4538,O
active,4539,4545,O
between,4546,4553,O
NK,4554,4556,B-Cell
cells,4557,4562,I-Cell
and,4563,4566,O
IL,4567,4569,B-Cell
-,4569,4570,I-Cell
12,4570,4572,I-Cell
-,4572,4573,I-Cell
producing,4573,4582,I-Cell
cells,4583,4588,I-Cell
(,4589,4590,O
15,4590,4592,O
-,4592,4593,O
17,4593,4595,O
),4595,4596,O
.,4596,4597,O
Clearly,4598,4605,O
",",4605,4606,O
however,4607,4614,O
",",4614,4615,O
this,4616,4620,O
well,4621,4625,O
-,4625,4626,O
described,4626,4635,O
cytokine,4636,4644,O
cross,4645,4650,O
-,4650,4651,O
talk,4651,4655,O
mechanism,4656,4665,O
is,4666,4668,O
secondary,4669,4678,O
to,4679,4681,O
the,4682,4685,O
contact,4686,4693,O
-,4693,4694,O
dependent,4694,4703,O
activation,4704,4714,O
of,4715,4717,O
DCs,4718,4721,B-Cell
by,4722,4724,O
NK,4725,4727,B-Cell
cells,4728,4733,I-Cell
described,4734,4743,O
here,4744,4748,O
.,4748,4749,O
Taken,4750,4755,O
together,4756,4764,O
these,4765,4770,O
results,4771,4778,O
indicate,4779,4787,O
that,4788,4792,O
novel,4793,4798,O
mechanisms,4799,4809,O
control,4810,4817,O
cognate,4818,4825,O
interactions,4826,4838,O
between,4839,4846,O
NK,4847,4849,B-Cell
cells,4850,4855,I-Cell
and,4856,4859,O
DCs,4860,4863,B-Cell
and,4864,4867,O
that,4868,4872,O
NK,4873,4875,B-Cell
-,4875,4876,O
DC,4876,4878,B-Cell
contact,4879,4886,O
has,4887,4890,O
the,4891,4894,O
potential,4895,4904,O
to,4905,4907,O
serve,4908,4913,O
as,4914,4916,O
an,4917,4919,O
important,4920,4929,O
control,4930,4937,O
switch,4938,4944,O
for,4945,4948,O
both,4949,4953,O
amplifying,4954,4964,O
and,4965,4968,O
attenuating,4969,4980,O
innate,4981,4987,O
immune,4988,4994,O
responses,4995,5004,O
in,5005,5007,O
vivo,5008,5012,O
.,5012,5013,O
We,5014,5016,O
next,5017,5021,O
tested,5022,5028,O
directly,5029,5037,O
whether,5038,5045,O
NK,5046,5048,B-Cell
cell,5049,5053,I-Cell
killing,5054,5061,O
was,5062,5065,O
active,5066,5072,O
in,5073,5075,O
our,5076,5079,O
system,5080,5086,O
using,5087,5092,O
both,5093,5097,O
short,5098,5103,O
-,5103,5104,O
term,5104,5108,O
(,5109,5110,O
4,5110,5111,O
-,5111,5112,O
h,5112,5113,O
),5113,5114,O
chromium,5115,5123,O
release,5124,5131,O
assays,5132,5138,O
(,5139,5140,O
data,5140,5144,O
not,5145,5148,O
shown,5149,5154,O
),5154,5155,O
and,5156,5159,O
a,5160,5161,O
flow,5162,5166,O
cytometric,5167,5177,O
assay,5178,5183,O
which,5184,5189,O
allowed,5190,5197,O
us,5198,5200,O
to,5201,5203,O
follow,5204,5210,O
the,5211,5214,O
survival,5215,5223,O
of,5224,5226,O
the,5227,5230,O
autologous,5231,5241,O
iDCs,5242,5246,B-Cell
in,5247,5249,O
the,5250,5253,O
presence,5254,5262,O
of,5263,5265,O
NK,5266,5268,B-Cell
cells,5269,5274,I-Cell
over,5275,5279,O
longer,5280,5286,O
periods,5287,5294,O
(,5295,5296,O
Fig,5296,5299,O
.,5299,5300,O
3,5301,5302,O
),5302,5303,O
.,5303,5304,O
The,5305,5308,O
results,5309,5316,O
demonstrate,5317,5328,O
that,5329,5333,O
NK,5334,5336,B-Cell
cells,5337,5342,I-Cell
kill,5343,5347,O
autologous,5348,5358,O
iDCs,5359,5363,B-Cell
(,5364,5365,O
Fig,5365,5368,O
.,5368,5369,O
3,5370,5371,O
A,5372,5373,O
),5373,5374,O
at,5375,5377,O
all,5378,5381,O
NK,5382,5384,B-Cell
/,5384,5385,O
DC,5385,5387,B-Cell
ratios,5388,5394,O
tested,5395,5401,O
after,5402,5407,O
4,5408,5409,O
h,5410,5411,O
and,5412,5415,O
the,5416,5419,O
level,5420,5425,O
of,5426,5428,O
killing,5429,5436,O
is,5437,5439,O
similar,5440,5447,O
to,5448,5450,O
the,5451,5454,O
lysis,5455,5460,O
of,5461,5463,O
K562,5464,5468,B-Cell
cells,5469,5474,I-Cell
over,5475,5479,O
the,5480,5483,O
same,5484,5488,O
time,5489,5493,O
(,5494,5495,O
Fig,5495,5498,O
.,5498,5499,O
3,5500,5501,O
B,5502,5503,O
),5503,5504,O
.,5504,5505,O
After,5506,5511,O
24,5512,5514,O
h,5515,5516,O
",",5516,5517,O
however,5518,5525,O
",",5525,5526,O
the,5527,5530,O
presence,5531,5539,O
of,5540,5542,O
NK,5543,5545,B-Cell
cells,5546,5551,I-Cell
led,5552,5555,O
to,5556,5558,O
completely,5559,5569,O
divergent,5570,5579,O
effects,5580,5587,O
on,5588,5590,O
the,5591,5594,O
DCs,5595,5598,B-Cell
.,5598,5599,O
At,5600,5602,O
the,5603,5606,O
5,5607,5608,O
:,5608,5609,O
1,5609,5610,O
(,5611,5612,O
NK,5612,5614,B-Cell
/,5614,5615,O
DC,5615,5617,B-Cell
),5617,5618,O
ratio,5619,5624,O
",",5624,5625,O
NK,5626,5628,B-Cell
cell,5629,5633,I-Cell
-,5633,5634,O
mediated,5634,5642,O
destruction,5643,5654,O
of,5655,5657,O
the,5658,5661,O
iDCs,5662,5666,B-Cell
was,5667,5670,O
the,5671,5674,O
dominant,5675,5683,O
feature,5684,5691,O
",",5691,5692,O
whereas,5693,5700,O
at,5701,5703,O
the,5704,5707,O
low,5708,5711,O
ratio,5712,5717,O
(,5718,5719,O
1,5719,5720,O
:,5720,5721,O
5,5721,5722,O
),5722,5723,O
the,5724,5727,O
same,5728,5732,O
NK,5733,5735,B-Cell
cells,5736,5741,I-Cell
promoted,5742,5750,O
iDCs,5751,5755,B-Cell
survival,5756,5764,O
compared,5765,5773,O
with,5774,5778,O
iDCs,5779,5783,B-Cell
alone,5784,5789,O
over,5790,5794,O
the,5795,5798,O
same,5799,5803,O
period,5804,5810,O
(,5811,5812,O
Fig,5812,5815,O
.,5815,5816,O
3,5817,5818,O
A,5819,5820,O
),5820,5821,O
.,5821,5822,O
The,5823,5826,O
equal,5827,5832,O
ratio,5833,5838,O
of,5839,5841,O
NK,5842,5844,B-Cell
/,5844,5845,O
DC,5845,5847,B-Cell
(,5848,5849,O
1,5849,5850,O
:,5850,5851,O
1,5851,5852,O
),5852,5853,O
fell,5854,5858,O
between,5859,5866,O
these,5867,5872,O
two,5873,5876,O
extremes,5877,5885,O
.,5885,5886,O
The,5887,5890,O
NK,5891,5893,B-Cell
cell,5894,5898,I-Cell
-,5898,5899,O
mediated,5899,5907,O
lysis,5908,5913,O
of,5914,5916,O
the,5917,5920,O
K562,5921,5925,B-Cell
targets,5926,5933,O
increased,5934,5943,O
at,5944,5946,O
all,5947,5950,O
ratios,5951,5957,O
tested,5958,5964,O
after,5965,5970,O
the,5971,5974,O
24,5975,5977,O
-,5977,5978,O
h,5978,5979,O
incubation,5980,5990,O
.,5990,5991,O
These,5992,5997,O
striking,5998,6006,O
differences,6007,6018,O
between,6019,6026,O
death,6027,6032,O
and,6033,6036,O
survival,6037,6045,O
of,6046,6048,O
DCs,6049,6052,B-Cell
upon,6053,6057,O
encountering,6058,6070,O
NK,6071,6073,B-Cell
cells,6074,6079,I-Cell
correlate,6080,6089,O
precisely,6090,6099,O
with,6100,6104,O
our,6105,6108,O
previous,6109,6117,O
results,6118,6125,O
on,6126,6128,O
TNF,6129,6132,O
-,6132,6133,O
alpha,6133,6138,O
and,6139,6142,O
IL,6143,6145,O
-,6145,6146,O
12,6146,6148,O
p40,6149,6152,O
production,6153,6163,O
where,6164,6169,O
increasing,6170,6180,O
numbers,6181,6188,O
of,6189,6191,O
NK,6192,6194,B-Cell
cells,6195,6200,I-Cell
in,6201,6203,O
the,6204,6207,O
culture,6208,6215,O
shifts,6216,6222,O
the,6223,6226,O
NK,6227,6229,B-Cell
effect,6230,6236,O
from,6237,6241,O
potent,6242,6248,O
stimulation,6249,6260,O
to,6261,6263,O
complete,6264,6272,O
inhibition,6273,6283,O
(,6284,6285,O
Fig,6285,6288,O
.,6288,6289,O
2,6290,6291,O
),6291,6292,O
.,6292,6293,O
Figure,6294,6300,O
3,6301,6302,O
.,6302,6303,O
Activated,6304,6313,O
/,6313,6314,O
cultured,6314,6322,O
NK,6323,6325,B-Cell
cell,6326,6330,I-Cell
-,6330,6331,O
mediated,6331,6339,O
death,6340,6345,O
/,6345,6346,O
survival,6346,6354,O
of,6355,6357,O
DCs,6358,6361,B-Cell
and,6362,6365,O
NK,6366,6368,B-Cell
-,6368,6369,O
DC,6369,6371,B-Cell
conjugate,6372,6381,O
formation,6382,6391,O
.,6391,6392,O
NK,6393,6395,B-Cell
cell,6396,6400,I-Cell
mediated,6401,6409,O
killing,6410,6417,O
/,6417,6418,O
survival,6418,6426,O
of,6427,6429,O
CFDA,6430,6434,O
.,6434,6435,O
SE,6435,6437,O
-,6437,6438,O
loaded,6438,6444,O
iDCs,6445,6449,B-Cell
(,6450,6451,O
A,6451,6452,O
),6452,6453,O
and,6454,6457,O
K562,6458,6462,B-Cell
cells,6463,6468,I-Cell
(,6469,6470,O
B,6470,6471,O
),6471,6472,O
was,6473,6476,O
measured,6477,6485,O
by,6486,6488,O
flow,6489,6493,O
cytometry,6494,6503,O
over,6504,6508,O
4,6509,6510,O
h,6511,6512,O
(,6513,6514,O
*,6514,6515,O
),6515,6516,O
or,6517,6519,O
24,6520,6522,O
h,6523,6524,O
(,6525,6526,O
*,6526,6527,O
),6527,6528,O
at,6529,6531,O
the,6532,6535,O
indicated,6536,6545,O
NK,6546,6548,B-Cell
/,6548,6549,O
DC,6549,6551,B-Cell
ratios,6552,6558,O
as,6559,6561,O
described,6562,6571,O
in,6572,6574,O
Materials,6575,6584,O
and,6585,6588,O
Methods,6589,6596,O
.,6596,6597,O
Results,6598,6605,O
are,6606,6609,O
presented,6610,6619,O
as,6620,6622,O
percentage,6623,6633,O
of,6634,6636,O
specific,6637,6645,O
lysis,6646,6651,O
+,6652,6653,O
/,6653,6654,O
-,6654,6655,O
SEM,6656,6659,O
(,6660,6661,O
n,6661,6662,O
=,6663,6664,O
3,6665,6666,O
independent,6667,6678,O
experiments,6679,6690,O
),6690,6691,O
.,6691,6692,O
NK,6693,6695,B-Cell
-,6695,6696,O
DC,6696,6698,B-Cell
(,6699,6700,O
C,6700,6701,O
-,6701,6702,O
E,6702,6703,O
),6703,6704,O
or,6705,6707,O
NK,6708,6710,B-Cell
-,6710,6711,O
K562,6711,6715,B-Cell
(,6716,6717,O
F,6717,6718,O
-,6718,6719,O
H,6719,6720,O
),6720,6721,O
conjugate,6722,6731,O
formation,6732,6741,O
was,6742,6745,O
measured,6746,6754,O
by,6755,6757,O
flow,6758,6762,O
cytometry,6763,6772,O
",",6772,6773,O
at,6774,6776,O
the,6777,6780,O
following,6781,6790,O
ratios,6791,6797,O
(,6798,6799,O
NK,6799,6801,B-Cell
/,6801,6802,O
DC,6802,6804,B-Cell
or,6805,6807,O
NK,6808,6810,B-Cell
/,6810,6811,O
K562,6811,6815,B-Cell
),6815,6816,O
:,6816,6817,O
1,6818,6819,O
:,6819,6820,O
5,6820,6821,O
(,6822,6823,O
C,6823,6824,O
and,6825,6828,O
F,6829,6830,O
),6830,6831,O
;,6831,6832,O
1,6833,6834,O
:,6834,6835,O
1,6835,6836,O
(,6837,6838,O
D,6838,6839,O
and,6840,6843,O
G,6844,6845,O
),6845,6846,O
;,6846,6847,O
and,6848,6851,O
5,6852,6853,O
:,6853,6854,O
1,6854,6855,O
(,6856,6857,O
E,6857,6858,O
and,6859,6862,O
H,6863,6864,O
),6864,6865,O
.,6865,6866,O
Snarf,6867,6872,O
-,6872,6873,O
1,6873,6874,O
(,6875,6876,O
FL3,6876,6879,O
),6879,6880,O
-,6880,6881,O
labeled,6881,6888,O
iDCs,6889,6893,B-Cell
or,6894,6896,O
K562,6897,6901,B-Cell
cells,6902,6907,I-Cell
were,6908,6912,O
incubated,6913,6922,O
(,6923,6924,O
30,6924,6926,O
min,6927,6930,O
),6930,6931,O
with,6932,6936,O
CFDA,6937,6941,O
.,6941,6942,O
SE,6942,6944,O
(,6945,6946,O
FL1,6946,6949,O
),6949,6950,O
-,6950,6951,O
labeled,6951,6958,O
NK,6959,6961,B-Cell
cells,6962,6967,I-Cell
at,6968,6970,O
the,6971,6974,O
different,6975,6984,O
ratios,6985,6991,O
.,6991,6992,O
The,6993,6996,O
percentage,6997,7007,O
of,7008,7010,O
conjugates,7011,7021,O
formed,7022,7028,O
(,7029,7030,O
top,7030,7033,O
right,7034,7039,O
quadrant,7040,7048,O
),7048,7049,O
was,7050,7053,O
calculated,7054,7064,O
by,7065,7067,O
determining,7068,7079,O
the,7080,7083,O
percentage,7084,7094,O
of,7095,7097,O
FL3,7098,7101,O
+,7101,7102,O
(,7103,7104,O
Snarf,7104,7109,O
-,7109,7110,O
1,7110,7111,O
),7111,7112,O
events,7113,7119,O
which,7120,7125,O
were,7126,7130,O
also,7131,7135,O
positive,7136,7144,O
for,7145,7148,O
FL1,7149,7152,O
(,7153,7154,O
CFDA,7154,7158,O
.,7158,7159,O
SE,7159,7161,O
),7161,7162,O
.,7162,7163,O
The,7164,7167,O
results,7168,7175,O
are,7176,7179,O
representative,7180,7194,O
of,7195,7197,O
four,7198,7202,O
experiments,7203,7214,O
performed,7215,7224,O
with,7225,7229,O
activated,7230,7239,O
NK,7240,7242,B-Cell
cells,7243,7248,I-Cell
.,7248,7249,O
Resting,7250,7257,O
NK,7258,7260,B-Cell
cells,7261,7266,I-Cell
also,7267,7271,O
readily,7272,7279,O
formed,7280,7286,O
conjugates,7287,7297,O
with,7298,7302,O
autologous,7303,7313,O
iDCs,7314,7318,B-Cell
(,7319,7320,O
data,7320,7324,O
not,7325,7328,O
shown,7329,7334,O
),7334,7335,O
.,7335,7336,O
NK,7337,7339,B-Cell
cells,7340,7345,I-Cell
can,7346,7349,O
both,7350,7354,O
efficiently,7355,7366,O
kill,7367,7371,O
and,7372,7375,O
potently,7376,7384,O
stimulate,7385,7394,O
DCs,7395,7398,B-Cell
in,7399,7401,O
our,7402,7405,O
model,7406,7411,O
system,7412,7418,O
and,7419,7422,O
each,7423,7427,O
of,7428,7430,O
these,7431,7436,O
opposing,7437,7445,O
effects,7446,7453,O
appear,7454,7460,O
dependent,7461,7470,O
on,7471,7473,O
cell,7474,7478,B-Cell
-,7478,7479,O
to,7479,7481,O
-,7481,7482,O
cell,7482,7486,B-Cell
contact,7487,7494,O
.,7494,7495,O
To,7496,7498,O
quantify,7499,7507,O
these,7508,7513,O
apparent,7514,7522,O
cognate,7523,7530,O
interactions,7531,7543,O
we,7544,7546,O
measured,7547,7555,O
the,7556,7559,O
formation,7560,7569,O
of,7570,7572,O
NK,7573,7575,B-Cell
-,7575,7576,O
DC,7576,7578,B-Cell
conjugates,7579,7589,O
and,7590,7593,O
compared,7594,7602,O
them,7603,7607,O
to,7608,7610,O
conjugates,7611,7621,O
formed,7622,7628,O
by,7629,7631,O
NK,7632,7634,B-Cell
cells,7635,7640,I-Cell
and,7641,7644,O
tumor,7645,7650,B-Pathological_formation
targets,7651,7658,O
.,7658,7659,O
Our,7660,7663,O
analysis,7664,7672,O
revealed,7673,7681,O
that,7682,7686,O
NK,7687,7689,B-Cell
cells,7690,7695,I-Cell
bound,7696,7701,O
DC,7702,7704,B-Cell
(,7705,7706,O
Fig,7706,7709,O
.,7709,7710,O
3,7711,7712,O
C,7713,7714,O
-,7714,7715,O
E,7715,7716,O
),7716,7717,O
with,7718,7722,O
an,7723,7725,O
efficiency,7726,7736,O
almost,7737,7743,O
equal,7744,7749,O
to,7750,7752,O
that,7753,7757,O
of,7758,7760,O
NK,7761,7763,B-Cell
cell,7764,7768,I-Cell
binding,7769,7776,O
to,7777,7779,O
the,7780,7783,O
classical,7784,7793,O
NK,7794,7796,B-Cell
-,7796,7797,O
target,7797,7803,O
",",7803,7804,O
K562,7805,7809,B-Cell
(,7810,7811,O
Fig,7811,7814,O
.,7814,7815,O
3,7816,7817,O
F,7818,7819,O
-,7819,7820,O
H,7820,7821,O
),7821,7822,O
.,7822,7823,O
Binding,7824,7831,O
was,7832,7835,O
detectable,7836,7846,O
even,7847,7851,O
at,7852,7854,O
the,7855,7858,O
lowest,7859,7865,O
NK,7866,7868,B-Cell
/,7868,7869,O
DC,7869,7871,B-Cell
ratio,7872,7877,O
tested,7878,7884,O
(,7885,7886,O
1,7886,7887,O
:,7887,7888,O
5,7888,7889,O
),7889,7890,O
indicating,7891,7901,O
that,7902,7906,O
NK,7907,7909,B-Cell
-,7909,7910,O
DC,7910,7912,B-Cell
conjugates,7913,7923,O
are,7924,7927,O
formed,7928,7934,O
in,7935,7937,O
our,7938,7941,O
other,7942,7947,O
experiments,7948,7959,O
measuring,7960,7969,O
cytokine,7970,7978,O
production,7979,7989,O
and,7990,7993,O
cell,7994,7998,B-Cell
killing,7999,8006,O
.,8006,8007,O
Our,8008,8011,O
initial,8012,8019,O
experiments,8020,8031,O
using,8032,8037,O
resting,8038,8045,O
NK,8046,8048,B-Cell
cells,8049,8054,I-Cell
(,8055,8056,O
Fig,8056,8059,O
.,8059,8060,O
1,8061,8062,O
),8062,8063,O
demonstrated,8064,8076,O
a,8077,8078,O
contact,8079,8086,O
-,8086,8087,O
dependent,8087,8096,O
NK,8097,8099,B-Cell
effect,8100,8106,O
driving,8107,8114,O
iDCs,8115,8119,B-Cell
to,8120,8122,O
mature,8123,8129,O
.,8129,8130,O
Therefore,8131,8140,O
",",8140,8141,O
we,8142,8144,O
tested,8145,8151,O
what,8152,8156,O
effects,8157,8164,O
activated,8165,8174,O
NK,8175,8177,B-Cell
cells,8178,8183,I-Cell
mediated,8184,8192,O
on,8193,8195,O
DC,8196,8198,B-Cell
maturation,8199,8209,O
(,8210,8211,O
Fig,8211,8214,O
.,8214,8215,O
4,8216,8217,O
),8217,8218,O
.,8218,8219,O
Similar,8220,8227,O
to,8228,8230,O
our,8231,8234,O
previous,8235,8243,O
results,8244,8251,O
with,8252,8256,O
activated,8257,8266,O
NK,8267,8269,B-Cell
cells,8270,8275,I-Cell
(,8276,8277,O
Figs,8277,8281,O
.,8281,8282,O
2,8283,8284,O
and,8285,8288,O
3,8289,8290,O
),8290,8291,O
",",8291,8292,O
addition,8293,8301,O
of,8302,8304,O
NK,8305,8307,B-Cell
cells,8308,8313,I-Cell
to,8314,8316,O
the,8317,8320,O
culture,8321,8328,O
leads,8329,8334,O
to,8335,8337,O
opposing,8338,8346,O
effects,8347,8354,O
on,8355,8357,O
the,8358,8361,O
iDC,8362,8365,B-Cell
population,8366,8376,O
depending,8377,8386,O
on,8387,8389,O
the,8390,8393,O
NK,8394,8396,B-Cell
/,8396,8397,O
DC,8397,8399,B-Cell
ratio,8400,8405,O
.,8405,8406,O
Compared,8407,8415,O
with,8416,8420,O
the,8421,8424,O
untreated,8425,8434,O
DCs,8435,8438,B-Cell
(,8439,8440,O
Fig,8440,8443,O
.,8443,8444,O
4,8445,8446,O
A,8447,8448,O
-,8448,8449,O
C,8449,8450,O
),8450,8451,O
",",8451,8452,O
low,8453,8456,O
NK,8457,8459,B-Cell
/,8459,8460,O
DC,8460,8462,B-Cell
ratios,8463,8469,O
(,8470,8471,O
1,8471,8472,O
:,8472,8473,O
5,8473,8474,O
or,8475,8477,O
1,8478,8479,O
:,8479,8480,O
1,8480,8481,O
),8481,8482,O
consistently,8483,8495,O
augmented,8496,8505,O
expression,8506,8516,O
of,8517,8519,O
the,8520,8523,O
maturation,8524,8534,O
markers,8535,8542,O
:,8542,8543,O
CD86,8544,8548,O
(,8549,8550,O
Fig,8550,8553,O
.,8553,8554,O
4,8555,8556,O
D,8557,8558,O
-,8558,8559,O
I,8559,8560,O
),8560,8561,O
",",8561,8562,O
CD83,8563,8567,O
",",8567,8568,O
and,8569,8572,O
HLA,8573,8576,O
-,8576,8577,O
DR,8577,8579,O
(,8580,8581,O
data,8581,8585,O
not,8586,8589,O
shown,8590,8595,O
),8595,8596,O
.,8596,8597,O
At,8598,8600,O
a,8601,8602,O
5,8603,8604,O
:,8604,8605,O
1,8605,8606,O
ratio,8607,8612,O
(,8613,8614,O
NK,8614,8616,B-Cell
/,8616,8617,O
DC,8617,8619,B-Cell
),8619,8620,O
most,8621,8625,O
of,8626,8628,O
the,8629,8632,O
DCs,8633,8636,B-Cell
are,8637,8640,O
nonviable,8641,8650,O
(,8651,8652,O
Fig,8652,8655,O
.,8655,8656,O
4,8657,8658,O
J,8659,8660,O
-,8660,8661,O
L,8661,8662,O
),8662,8663,O
.,8663,8664,O
Addition,8665,8673,O
of,8674,8676,O
suboptimal,8677,8687,O
doses,8688,8693,O
of,8694,8696,O
LPS,8697,8700,O
(,8701,8702,O
Fig,8702,8705,O
.,8705,8706,O
4,8707,8708,O
C,8709,8710,O
",",8710,8711,O
F,8712,8713,O
",",8713,8714,O
I,8715,8716,O
",",8716,8717,O
and,8718,8721,O
L,8722,8723,O
),8723,8724,O
augmented,8725,8734,O
the,8735,8738,O
NK,8739,8741,B-Cell
-,8741,8742,O
induced,8742,8749,O
maturation,8750,8760,O
at,8761,8763,O
NK,8764,8766,B-Cell
/,8766,8767,O
DC,8767,8769,B-Cell
ratios,8770,8776,O
of,8777,8779,O
1,8780,8781,O
:,8781,8782,O
5,8782,8783,O
and,8784,8787,O
1,8788,8789,O
:,8789,8790,O
1,8790,8791,O
",",8791,8792,O
but,8793,8796,O
had,8797,8800,O
no,8801,8803,O
effect,8804,8810,O
at,8811,8813,O
the,8814,8817,O
5,8818,8819,O
:,8819,8820,O
1,8820,8821,O
ratio,8822,8827,O
.,8827,8828,O
Again,8829,8834,O
",",8834,8835,O
DC,8836,8838,B-Cell
maturation,8839,8849,O
was,8850,8853,O
dependent,8854,8863,O
on,8864,8866,O
NK,8867,8869,B-Cell
cell,8870,8874,I-Cell
contact,8875,8882,O
and,8883,8886,O
endogenously,8887,8899,O
produced,8900,8908,O
TNF,8909,8912,O
-,8912,8913,O
alpha,8913,8918,O
",",8918,8919,O
because,8920,8927,O
it,8928,8930,O
did,8931,8934,O
not,8935,8938,O
occur,8939,8944,O
when,8945,8949,O
the,8950,8953,O
two,8954,8957,O
cell,8958,8962,B-Cell
types,8963,8968,O
were,8969,8973,O
separated,8974,8983,O
in,8984,8986,O
trans,8987,8992,O
-,8992,8993,O
wells,8993,8998,O
or,8999,9001,O
upon,9002,9006,O
the,9007,9010,O
addition,9011,9019,O
of,9020,9022,O
a,9023,9024,O
neutralizing,9025,9037,O
antibody,9038,9046,O
for,9047,9050,O
TNF,9051,9054,O
-,9054,9055,O
alpha,9055,9060,O
(,9061,9062,O
Fig,9062,9065,O
.,9065,9066,O
5,9067,9068,O
),9068,9069,O
.,9069,9070,O
Moreover,9071,9079,O
",",9079,9080,O
addition,9081,9089,O
of,9090,9092,O
blocking,9093,9101,O
reagents,9102,9110,O
for,9111,9114,O
CD80,9115,9119,O
",",9119,9120,O
CD86,9121,9125,O
",",9125,9126,O
CD154,9127,9132,O
",",9132,9133,O
CD95,9134,9138,O
",",9138,9139,O
CD11a,9140,9145,O
",",9145,9146,O
CD50,9147,9151,O
",",9151,9152,O
IL,9153,9155,O
-,9155,9156,O
12,9156,9158,O
",",9158,9159,O
IFN,9160,9163,O
-,9163,9164,O
gamma,9164,9169,O
",",9169,9170,O
IFN,9171,9174,O
-,9174,9175,O
alpha,9175,9180,O
",",9180,9181,O
or,9182,9184,O
IFN,9185,9188,O
-,9188,9189,O
beta,9189,9193,O
had,9194,9197,O
no,9198,9200,O
effect,9201,9207,O
on,9208,9210,O
the,9211,9214,O
NK,9215,9217,B-Cell
-,9217,9218,O
induced,9218,9225,O
maturation,9226,9236,O
(,9237,9238,O
data,9238,9242,O
not,9243,9246,O
shown,9247,9252,O
),9252,9253,O
.,9253,9254,O
Figure,9255,9261,O
4,9262,9263,O
.,9263,9264,O
Activated,9265,9274,O
/,9274,9275,O
cultured,9275,9283,O
NK,9284,9286,B-Cell
cell,9287,9291,I-Cell
-,9291,9292,O
mediated,9292,9300,O
maturation,9301,9311,O
/,9311,9312,O
death,9312,9317,O
of,9318,9320,O
DCs,9321,9324,B-Cell
.,9324,9325,O
Cultured,9326,9334,O
iDCs,9335,9339,B-Cell
were,9340,9344,O
incubated,9345,9354,O
for,9355,9358,O
48,9359,9361,O
h,9362,9363,O
",",9363,9364,O
alone,9365,9370,O
(,9371,9372,O
A,9372,9373,O
-,9373,9374,O
C,9374,9375,O
),9375,9376,O
",",9376,9377,O
or,9378,9380,O
with,9381,9385,O
NK,9386,9388,B-Cell
cells,9389,9394,I-Cell
at,9395,9397,O
the,9398,9401,O
following,9402,9411,O
ratios,9412,9418,O
(,9419,9420,O
NK,9420,9422,B-Cell
/,9422,9423,O
DC,9423,9425,B-Cell
),9425,9426,O
",",9426,9427,O
1,9428,9429,O
:,9429,9430,O
5,9430,9431,O
(,9432,9433,O
D,9433,9434,O
-,9434,9435,O
F,9435,9436,O
),9436,9437,O
",",9437,9438,O
1,9439,9440,O
:,9440,9441,O
1,9441,9442,O
(,9443,9444,O
G,9444,9445,O
-,9445,9446,O
I,9446,9447,O
),9447,9448,O
",",9448,9449,O
and,9450,9453,O
5,9454,9455,O
:,9455,9456,O
1,9456,9457,O
(,9458,9459,O
J,9459,9460,O
-,9460,9461,O
L,9461,9462,O
),9462,9463,O
.,9463,9464,O
Forward,9465,9472,O
versus,9473,9479,O
side,9480,9484,O
scatter,9485,9492,O
plots,9493,9498,O
(,9499,9500,O
A,9500,9501,O
",",9501,9502,O
D,9503,9504,O
",",9504,9505,O
G,9506,9507,O
",",9507,9508,O
and,9509,9512,O
J,9513,9514,O
),9514,9515,O
show,9516,9520,O
the,9521,9524,O
gating,9525,9531,O
on,9532,9534,O
the,9535,9538,O
DC,9539,9541,B-Cell
subset,9542,9548,O
and,9549,9552,O
demonstrate,9553,9564,O
its,9565,9568,O
disappearance,9569,9582,O
at,9583,9585,O
the,9586,9589,O
5,9590,9591,O
:,9591,9592,O
1,9592,9593,O
(,9594,9595,O
NK,9595,9597,B-Cell
/,9597,9598,O
DC,9598,9600,B-Cell
),9600,9601,O
ratio,9602,9607,O
(,9608,9609,O
J,9609,9610,O
),9610,9611,O
.,9611,9612,O
Propidium,9613,9622,O
iodide,9623,9629,O
staining,9630,9638,O
of,9639,9641,O
the,9642,9645,O
NK,9646,9648,B-Cell
/,9648,9649,O
DC,9649,9651,B-Cell
(,9652,9653,O
5,9653,9654,O
:,9654,9655,O
1,9655,9656,O
),9656,9657,O
cultures,9658,9666,O
confirmed,9667,9676,O
the,9677,9680,O
almost,9681,9687,O
complete,9688,9696,O
absence,9697,9704,O
of,9705,9707,O
viable,9708,9714,O
DCs,9715,9718,B-Cell
(,9719,9720,O
data,9720,9724,O
not,9725,9728,O
shown,9729,9734,O
),9734,9735,O
.,9735,9736,O
Staining,9737,9745,O
for,9746,9749,O
CD86,9750,9754,O
expression,9755,9765,O
was,9766,9769,O
performed,9770,9779,O
as,9780,9782,O
described,9783,9792,O
in,9793,9795,O
Fig,9796,9799,O
.,9799,9800,O
1,9801,9802,O
and,9803,9806,O
the,9807,9810,O
histograms,9811,9821,O
are,9822,9825,O
shown,9826,9831,O
for,9832,9835,O
DCs,9836,9839,B-Cell
cultured,9840,9848,O
in,9849,9851,O
the,9852,9855,O
presence,9856,9864,O
(,9865,9866,O
C,9866,9867,O
",",9867,9868,O
F,9869,9870,O
",",9870,9871,O
I,9872,9873,O
",",9873,9874,O
and,9875,9878,O
L,9879,9880,O
),9880,9881,O
or,9882,9884,O
absence,9885,9892,O
(,9893,9894,O
B,9894,9895,O
",",9895,9896,O
E,9897,9898,O
",",9898,9899,O
H,9900,9901,O
",",9901,9902,O
and,9903,9906,O
K,9907,9908,O
),9908,9909,O
of,9910,9912,O
1,9913,9914,O
ng,9915,9917,O
/,9917,9918,O
ml,9918,9920,O
of,9921,9923,O
LPS,9924,9927,O
.,9927,9928,O
Results,9929,9936,O
are,9937,9940,O
representative,9941,9955,O
of,9956,9958,O
six,9959,9962,O
experiments,9963,9974,O
performed,9975,9984,O
.,9984,9985,O
Figure,9986,9992,O
5,9993,9994,O
.,9994,9995,O
Activated,9996,10005,O
/,10005,10006,O
cultured,10006,10014,O
NK,10015,10017,B-Cell
cell,10018,10022,I-Cell
-,10022,10023,O
induced,10023,10030,O
DC,10031,10033,B-Cell
maturation,10034,10044,O
is,10045,10047,O
dependent,10048,10057,O
on,10058,10060,O
cell,10061,10065,B-Cell
-,10065,10066,O
to,10066,10068,O
-,10068,10069,O
cell,10069,10073,B-Cell
contact,10074,10081,O
and,10082,10085,O
endogenous,10086,10096,O
TNF,10097,10100,O
-,10100,10101,O
alpha,10101,10106,O
production,10107,10117,O
.,10117,10118,O
Cultured,10119,10127,O
iDCs,10128,10132,B-Cell
were,10133,10137,O
incubated,10138,10147,O
alone,10148,10153,O
(,10154,10155,O
A,10155,10156,O
",",10156,10157,O
D,10158,10159,O
",",10159,10160,O
and,10161,10164,O
G,10165,10166,O
),10166,10167,O
;,10167,10168,O
with,10169,10173,O
activated,10174,10183,O
NK,10184,10186,B-Cell
cells,10187,10192,I-Cell
at,10193,10195,O
an,10196,10198,O
NK,10199,10201,B-Cell
/,10201,10202,O
DC,10202,10204,B-Cell
ratio,10205,10210,O
of,10211,10213,O
1,10214,10215,O
:,10215,10216,O
5,10216,10217,O
(,10218,10219,O
B,10219,10220,O
",",10220,10221,O
E,10222,10223,O
",",10223,10224,O
and,10225,10228,O
H,10229,10230,O
),10230,10231,O
;,10231,10232,O
with,10233,10237,O
activated,10238,10247,O
NK,10248,10250,B-Cell
cells,10251,10256,I-Cell
(,10257,10258,O
NK,10258,10260,B-Cell
/,10260,10261,O
DC,10261,10263,B-Cell
;,10263,10264,O
1,10265,10266,O
:,10266,10267,O
5,10267,10268,O
),10268,10269,O
separated,10270,10279,O
in,10280,10282,O
trans,10283,10288,O
-,10288,10289,O
wells,10289,10294,O
(,10295,10296,O
C,10296,10297,O
and,10298,10301,O
F,10302,10303,O
),10303,10304,O
;,10304,10305,O
or,10306,10308,O
with,10309,10313,O
activated,10314,10323,O
NK,10324,10326,B-Cell
cells,10327,10332,I-Cell
and,10333,10336,O
10,10337,10339,O
mug,10340,10343,O
/,10343,10344,O
ml,10344,10346,O
of,10347,10349,O
a,10350,10351,O
neutralizing,10352,10364,O
antibody,10365,10373,O
for,10374,10377,O
TNF,10378,10381,O
-,10381,10382,O
alpha,10382,10387,O
(,10388,10389,O
I,10389,10390,O
),10390,10391,O
.,10391,10392,O
LPS,10393,10396,O
concentrations,10397,10411,O
used,10412,10416,O
were,10417,10421,O
:,10421,10422,O
0,10423,10424,O
ng,10425,10427,O
/,10427,10428,O
ml,10428,10430,O
(,10431,10432,O
A,10432,10433,O
-,10433,10434,O
C,10434,10435,O
),10435,10436,O
;,10436,10437,O
10,10438,10440,O
ng,10441,10443,O
/,10443,10444,O
ml,10444,10446,O
(,10447,10448,O
D,10448,10449,O
-,10449,10450,O
F,10450,10451,O
),10451,10452,O
and,10453,10456,O
50,10457,10459,O
ng,10460,10462,O
/,10462,10463,O
ml,10463,10465,O
(,10466,10467,O
G,10467,10468,O
-,10468,10469,O
I,10469,10470,O
),10470,10471,O
.,10471,10472,O
CD86,10473,10477,O
staining,10478,10486,O
of,10487,10489,O
the,10490,10493,O
DC,10494,10496,B-Cell
subset,10497,10503,O
was,10504,10507,O
performed,10508,10517,O
as,10518,10520,O
in,10521,10523,O
Figs,10524,10528,O
.,10528,10529,O
1,10530,10531,O
and,10532,10535,O
4,10536,10537,O
.,10537,10538,O
Results,10539,10546,O
are,10547,10550,O
representative,10551,10565,O
of,10566,10568,O
four,10569,10573,O
experiments,10574,10585,O
performed,10586,10595,O
.,10595,10596,O
Acknowledgements,0,16,O
We,17,19,O
would,20,25,O
like,26,30,O
to,31,33,O
thank,34,39,O
our,40,43,O
colleague,44,53,O
Dr,54,56,O
.,56,57,O
Nikolaos,58,66,O
Papathanasiou,67,80,O
for,81,84,O
his,85,88,O
assistance,89,99,O
in,100,102,O
performing,103,113,O
the,114,117,O
statistical,118,129,O
analysis,130,138,O
.,138,139,O
Anion,0,5,O
to,6,8,O
cation,9,15,O
selectivity,16,27,O
ratio,28,33,O
determined,34,44,O
from,45,49,O
the,50,53,O
relative,54,62,O
rates,63,68,O
of,69,71,O
reaction,72,80,O
of,81,83,O
MTSES,84,89,O
-,89,90,O
and,91,94,O
MTSET,95,100,O
+,100,101,O
with,102,106,O
the,107,110,O
water,111,116,O
exposed,117,124,O
residues,125,133,O
in,134,136,O
the,137,140,O
M6,141,143,O
segment,144,151,O
.,151,152,O
The,153,156,O
anion,157,162,O
selectivity,163,174,O
ratio,175,180,O
is,181,183,O
calculated,184,194,O
as,195,197,O
described,198,207,O
in,208,210,O
Table,211,216,O
II,217,219,O
",",219,220,O
column,221,227,O
5,228,229,O
.,229,230,O
Note,231,235,O
the,236,239,O
marked,240,246,O
increase,247,255,O
in,256,258,O
anion,259,264,O
selectivity,265,276,O
at,277,279,O
the,280,283,O
residues,284,292,O
T351C,293,298,O
and,299,302,O
Q353C,303,308,O
.,308,309,O
A,310,311,O
ratio,312,317,O
of,318,320,O
1,321,322,O
indicates,323,332,O
no,333,335,O
selectivity,336,347,O
between,348,355,O
anions,356,362,O
and,363,366,O
cations,367,374,O
.,374,375,O
The,376,379,O
larger,380,386,O
the,387,390,O
ratio,391,396,O
the,397,400,O
greater,401,408,O
the,409,412,O
anion,413,418,O
selectivity,419,430,O
.,430,431,O
Authors,0,7,O
',7,8,O
contributions,9,22,O
All,23,26,O
authors,27,34,O
contributed,35,46,O
to,47,49,O
the,50,53,O
development,54,65,O
of,66,68,O
the,69,72,O
methodology,73,84,O
.,84,85,O
CY,86,88,O
and,89,92,O
NZ,93,95,O
led,96,99,O
method,100,106,O
conceptualization,107,124,O
and,125,128,O
prepared,129,137,O
the,138,141,O
original,142,150,O
draft,151,156,O
",",156,157,O
which,158,163,O
was,164,167,O
revised,168,175,O
by,176,178,O
JR,179,181,O
.,181,182,O
CY,183,185,O
and,186,189,O
VD,190,192,O
performed,193,202,O
most,203,207,O
implementations,208,223,O
.,223,224,O
All,225,228,O
authors,229,236,O
read,237,241,O
and,242,245,O
approved,246,254,O
the,255,258,O
final,259,264,O
manuscript,265,275,O
.,275,276,O
Background,0,10,O
Potato,11,17,O
late,18,22,O
blight,23,29,O
",",29,30,O
a,31,32,O
disease,33,40,O
caused,41,47,O
by,48,50,O
the,51,54,O
oomycete,55,63,O
pathogen,64,72,O
Phytophthora,73,85,O
infestans,86,95,O
",",95,96,O
is,97,99,O
one,100,103,O
of,104,106,O
the,107,110,O
world,111,116,O
',116,117,O
s,117,118,O
most,119,123,O
devastating,124,135,O
crop,136,140,O
diseases,141,149,O
.,149,150,O
World,151,156,O
-,156,157,O
wide,157,161,O
losses,162,168,O
due,169,172,O
to,173,175,O
late,176,180,O
blight,181,187,O
exceed,188,194,O
several,195,202,O
billion,203,210,O
dollars,211,218,O
annually,219,227,O
[,228,229,O
1,229,230,O
],230,231,O
.,231,232,O
Most,233,237,O
of,238,240,O
the,241,244,O
potato,245,251,O
cultivars,252,261,O
currently,262,271,O
grown,272,277,O
in,278,280,O
the,281,284,O
United,285,291,O
States,292,298,O
are,299,302,O
highly,303,309,O
susceptible,310,321,O
to,322,324,O
late,325,329,O
blight,330,336,O
and,337,340,O
control,341,348,O
of,349,351,O
this,352,356,O
disease,357,364,O
relies,365,371,O
almost,372,378,O
exclusively,379,390,O
on,391,393,O
fungicide,394,403,O
applications,404,416,O
.,416,417,O
The,418,421,O
most,422,426,O
effective,427,436,O
and,437,440,O
environmentally,441,456,O
sound,457,462,O
way,463,466,O
for,467,470,O
controlling,471,482,O
late,483,487,O
blight,488,494,O
is,495,497,O
to,498,500,O
incorporate,501,512,O
natural,513,520,O
resistance,521,531,O
into,532,536,O
potato,537,543,O
cultivars,544,553,O
.,553,554,O
The,555,558,O
pedigrees,559,568,O
of,569,571,O
many,572,576,O
potato,577,583,O
cultivars,584,593,O
currently,594,603,O
used,604,608,O
in,609,611,O
different,612,621,O
countries,622,631,O
include,632,639,O
late,640,644,O
blight,645,651,O
resistant,652,661,O
germplasm,662,671,O
derived,672,679,O
from,680,684,O
Solanum,685,692,O
demissum,693,701,O
",",701,702,O
Solanum,703,710,O
andigena,711,719,O
",",719,720,O
and,721,724,O
other,725,730,O
wild,731,735,O
species,736,743,O
.,743,744,O
However,745,752,O
",",752,753,O
most,754,758,O
of,759,761,O
the,762,765,O
resistance,766,776,O
derived,777,784,O
from,785,789,O
these,790,795,O
wild,796,800,O
species,801,808,O
is,809,811,O
controlled,812,822,O
by,823,825,O
single,826,832,O
dominant,833,841,O
resistance,842,852,O
genes,853,858,O
(,859,860,O
R,860,861,O
genes,862,867,O
),867,868,O
.,868,869,O
These,870,875,O
R,876,877,O
genes,878,883,O
are,884,887,O
only,888,892,O
effective,893,902,O
in,903,905,O
preventing,906,916,O
the,917,920,O
development,921,932,O
of,933,935,O
late,936,940,O
blight,941,947,O
if,948,950,O
the,951,954,O
invading,955,963,O
P,964,965,O
.,965,966,O
infestans,967,976,O
race,977,981,O
contains,982,990,O
the,991,994,O
corresponding,995,1008,O
avirulence,1009,1019,O
genes,1020,1025,O
.,1025,1026,O
This,1027,1031,O
R,1032,1033,O
gene,1034,1038,O
-,1038,1039,O
mediated,1039,1047,O
resistance,1048,1058,O
is,1059,1061,O
often,1062,1067,O
short,1068,1073,O
-,1073,1074,O
lived,1074,1079,O
and,1080,1083,O
is,1084,1086,O
rapidly,1087,1094,O
overcome,1095,1103,O
by,1104,1106,O
new,1107,1110,O
races,1111,1116,O
of,1117,1119,O
the,1120,1123,O
late,1124,1128,O
blight,1129,1135,O
pathogen,1136,1144,O
.,1144,1145,O
Solanum,1146,1153,O
bulbocastanum,1154,1167,O
(,1168,1169,O
2n,1169,1171,O
=,1172,1173,O
2x,1174,1176,O
=,1177,1178,O
24,1179,1181,O
),1181,1182,O
is,1183,1185,O
a,1186,1187,O
diploid,1188,1195,O
species,1196,1203,O
that,1204,1208,O
has,1209,1212,O
adapted,1213,1220,O
in,1221,1223,O
the,1224,1227,O
same,1228,1232,O
environment,1233,1244,O
as,1245,1247,O
the,1248,1251,O
late,1252,1256,O
blight,1257,1263,O
pathogen,1264,1272,O
.,1272,1273,O
This,1274,1278,O
wild,1279,1283,O
species,1284,1291,O
was,1292,1295,O
characterized,1296,1309,O
as,1310,1312,O
possessing,1313,1323,O
durable,1324,1331,O
resistance,1332,1342,O
against,1343,1350,O
P,1351,1352,O
.,1352,1353,O
infestans,1354,1363,O
",",1363,1364,O
even,1365,1369,O
under,1370,1375,O
high,1376,1380,O
disease,1381,1388,O
pressure,1389,1397,O
[,1398,1399,O
2,1399,1400,O
",",1400,1401,O
3,1401,1402,O
],1402,1403,O
.,1403,1404,O
Two,1405,1408,O
resistance,1409,1419,O
genes,1420,1425,O
",",1425,1426,O
RB,1427,1429,O
(,1430,1431,O
Rpi,1431,1434,O
-,1434,1435,O
blb1,1435,1439,O
),1439,1440,O
and,1441,1444,O
Rpi,1445,1448,O
-,1448,1449,O
blb2,1449,1453,O
",",1453,1454,O
have,1455,1459,O
been,1460,1464,O
cloned,1465,1471,O
from,1472,1476,O
S,1477,1478,O
.,1478,1479,O
bulbocastanum,1480,1493,O
[,1494,1495,O
4,1495,1496,O
-,1496,1497,O
6,1497,1498,O
],1498,1499,O
.,1499,1500,O
Both,1501,1505,O
genes,1506,1511,O
confer,1512,1518,O
broad,1519,1524,O
-,1524,1525,O
spectrum,1525,1533,O
resistance,1534,1544,O
against,1545,1552,O
a,1553,1554,O
wide,1555,1559,O
range,1560,1565,O
of,1566,1568,O
known,1569,1574,O
P,1575,1576,O
.,1576,1577,O
infestans,1578,1587,O
races,1588,1593,O
.,1593,1594,O
Transgenic,1595,1605,O
potato,1606,1612,O
lines,1613,1618,O
containing,1619,1629,O
a,1630,1631,O
single,1632,1638,O
RB,1639,1641,O
gene,1642,1646,O
showed,1647,1653,O
a,1654,1655,O
high,1656,1660,O
-,1660,1661,O
level,1661,1666,O
resistance,1667,1677,O
in,1678,1680,O
the,1681,1684,O
Toluca,1685,1691,O
Valley,1692,1698,O
",",1698,1699,O
Mexico,1700,1706,O
",",1706,1707,O
where,1708,1713,O
the,1714,1717,O
potato,1718,1724,O
fields,1725,1731,O
are,1732,1735,O
naturally,1736,1745,O
intensively,1746,1757,O
infested,1758,1766,O
with,1767,1771,O
the,1772,1775,O
most,1776,1780,O
diversified,1781,1792,O
P,1793,1794,O
.,1794,1795,O
infestans,1796,1805,O
populations,1806,1817,O
[,1818,1819,O
7,1819,1820,O
],1820,1821,O
.,1821,1822,O
Most,1823,1827,O
interestingly,1828,1841,O
",",1841,1842,O
transgenic,1843,1853,O
RB,1854,1856,O
plants,1857,1863,O
did,1864,1867,O
not,1868,1871,O
show,1872,1876,O
total,1877,1882,O
immunity,1883,1891,O
to,1892,1894,O
late,1895,1899,O
blight,1900,1906,O
",",1906,1907,O
but,1908,1911,O
instead,1912,1919,O
showed,1920,1926,O
a,1927,1928,O
marked,1929,1935,O
delay,1936,1941,O
in,1942,1944,O
both,1945,1949,O
onset,1950,1955,O
of,1956,1958,O
symptoms,1959,1967,O
and,1968,1971,O
development,1972,1983,O
of,1984,1986,O
lesions,1987,1994,B-Pathological_formation
.,1994,1995,O
Such,1996,2000,O
rate,2001,2005,O
-,2005,2006,O
limiting,2006,2014,O
resistance,2015,2025,O
may,2026,2029,O
put,2030,2033,O
less,2034,2038,O
selection,2039,2048,O
pressure,2049,2057,O
on,2058,2060,O
the,2061,2064,O
P,2065,2066,O
.,2066,2067,O
infestans,2068,2077,O
populations,2078,2089,O
and,2090,2093,O
protect,2094,2101,O
the,2102,2105,O
durability,2106,2116,O
of,2117,2119,O
this,2120,2124,O
resistance,2125,2135,O
gene,2136,2140,O
.,2140,2141,O
The,2142,2145,O
RB,2146,2148,O
gene,2149,2153,O
therefore,2154,2163,O
provides,2164,2172,O
an,2173,2175,O
excellent,2176,2185,O
model,2186,2191,O
to,2192,2194,O
study,2195,2200,O
the,2201,2204,O
mechanism,2205,2214,O
of,2215,2217,O
broad,2218,2223,O
-,2223,2224,O
spectrum,2224,2232,O
and,2233,2236,O
rate,2237,2241,O
-,2241,2242,O
limiting,2242,2250,O
disease,2251,2258,O
resistances,2259,2270,O
.,2270,2271,O
An,2272,2274,O
understanding,2275,2288,O
of,2289,2291,O
the,2292,2295,O
underlying,2296,2306,O
mechanism,2307,2316,O
of,2317,2319,O
this,2320,2324,O
type,2325,2329,O
of,2330,2332,O
resistance,2333,2343,O
is,2344,2346,O
important,2347,2356,O
for,2357,2360,O
developing,2361,2371,O
strategies,2372,2382,O
to,2383,2385,O
breed,2386,2391,O
durable,2392,2399,O
and,2400,2403,O
sustainable,2404,2415,O
disease,2416,2423,O
resistance,2424,2434,O
.,2434,2435,O
Several,2436,2443,O
genes,2444,2449,O
have,2450,2454,O
been,2455,2459,O
implicated,2460,2470,O
in,2471,2473,O
the,2474,2477,O
regulation,2478,2488,O
of,2489,2491,O
R,2492,2493,O
gene,2494,2498,O
function,2499,2507,O
.,2507,2508,O
Of,2509,2511,O
these,2512,2517,O
genes,2518,2523,O
",",2523,2524,O
Rar1,2525,2529,O
and,2530,2533,O
Sgt1,2534,2538,O
are,2539,2542,O
among,2543,2548,O
the,2549,2552,O
most,2553,2557,O
extensively,2558,2569,O
studied,2570,2577,O
genes,2578,2583,O
.,2583,2584,O
The,2585,2588,O
Rar1,2589,2593,O
(,2594,2595,O
required,2595,2603,O
for,2604,2607,O
Mla12,2608,2613,O
resistance,2614,2624,O
),2624,2625,O
gene,2626,2630,O
was,2631,2634,O
first,2635,2640,O
identified,2641,2651,O
for,2652,2655,O
its,2656,2659,O
essential,2660,2669,O
role,2670,2674,O
in,2675,2677,O
the,2678,2681,O
function,2682,2690,O
of,2691,2693,O
a,2694,2695,O
subset,2696,2702,O
of,2703,2705,O
Mla,2706,2709,O
genes,2710,2715,O
that,2716,2720,O
confer,2721,2727,O
resistance,2728,2738,O
to,2739,2741,O
barley,2742,2748,O
powdery,2749,2756,O
mildew,2757,2763,O
[,2764,2765,O
8,2765,2766,O
],2766,2767,O
.,2767,2768,O
The,2769,2772,O
RAR1,2773,2777,O
protein,2778,2785,O
contains,2786,2794,O
two,2795,2798,O
highly,2799,2805,O
similar,2806,2813,O
but,2814,2817,O
distinct,2818,2826,O
cysteine,2827,2835,O
-,2835,2836,O
and,2837,2840,O
histidine,2841,2850,O
-,2850,2851,O
rich,2851,2855,O
(,2856,2857,O
CHORD,2857,2862,O
),2862,2863,O
Zn2,2864,2867,O
+,2867,2868,O
-,2868,2869,O
binding,2869,2876,O
domains,2877,2884,O
and,2885,2888,O
was,2889,2892,O
proposed,2893,2901,O
to,2902,2904,O
play,2905,2909,O
a,2910,2911,O
role,2912,2916,O
in,2917,2919,O
stabilizing,2920,2931,O
R,2932,2933,O
proteins,2934,2942,O
in,2943,2945,O
a,2946,2947,O
confirmation,2948,2960,O
that,2961,2965,O
is,2966,2968,O
implicated,2969,2979,O
in,2980,2982,O
receiving,2983,2992,O
pathogen,2993,3001,O
signals,3002,3009,O
[,3010,3011,O
9,3011,3012,O
],3012,3013,O
.,3013,3014,O
The,3015,3018,O
Sgt1,3019,3023,O
gene,3024,3028,O
(,3029,3030,O
suppressor,3030,3040,O
of,3041,3043,O
the,3044,3047,O
G2,3048,3050,O
allele,3051,3057,O
of,3058,3060,O
skp1,3061,3065,O
),3065,3066,O
is,3067,3069,O
an,3070,3072,O
essential,3073,3082,O
gene,3083,3087,O
with,3088,3092,O
multiple,3093,3101,O
functions,3102,3111,O
in,3112,3114,O
yeast,3115,3120,O
.,3120,3121,O
SGT1,3122,3126,O
protein,3127,3134,O
was,3135,3138,O
initially,3139,3148,O
identified,3149,3159,O
as,3160,3162,O
a,3163,3164,O
RAR1,3165,3169,O
-,3169,3170,O
interacting,3170,3181,O
partner,3182,3189,O
in,3190,3192,O
a,3193,3194,O
yeast,3195,3200,O
two,3201,3204,O
-,3204,3205,O
hybrid,3205,3211,O
screen,3212,3218,O
[,3219,3220,O
10,3220,3222,O
],3222,3223,O
.,3223,3224,O
SGT1,3225,3229,O
may,3230,3233,O
play,3234,3238,O
a,3239,3240,O
role,3241,3245,O
in,3246,3248,O
R,3249,3250,O
protein,3251,3258,O
accumulation,3259,3271,O
[,3272,3273,O
11,3273,3275,O
],3275,3276,O
.,3276,3277,O
Rar1,3278,3282,O
and,3283,3286,O
Sgt1,3287,3291,O
genes,3292,3297,O
are,3298,3301,O
required,3302,3310,O
in,3311,3313,O
various,3314,3321,O
R,3322,3323,O
-,3323,3324,O
gene,3324,3328,O
mediated,3329,3337,O
resistance,3338,3348,O
against,3349,3356,O
viral,3357,3362,O
",",3362,3363,O
bacterial,3364,3373,O
",",3373,3374,O
oomycete,3375,3383,O
or,3384,3386,O
fungal,3387,3393,O
pathogens,3394,3403,O
[,3404,3405,O
12,3405,3407,O
],3407,3408,O
.,3408,3409,O
However,3410,3417,O
",",3417,3418,O
none,3419,3423,O
of,3424,3426,O
the,3427,3430,O
previously,3431,3441,O
studied,3442,3449,O
R,3450,3451,O
genes,3452,3457,O
showed,3458,3464,O
a,3465,3466,O
race,3467,3471,O
-,3471,3472,O
non,3472,3475,O
-,3475,3476,O
specific,3476,3484,O
and,3485,3488,O
rate,3489,3493,O
-,3493,3494,O
limiting,3494,3502,O
resistance,3503,3513,O
phenotype,3514,3523,O
as,3524,3526,O
the,3527,3530,O
RB,3531,3533,O
gene,3534,3538,O
.,3538,3539,O
In,3540,3542,O
addition,3543,3551,O
",",3551,3552,O
the,3553,3556,O
role,3557,3561,O
the,3562,3565,O
Rar1,3566,3570,O
and,3571,3574,O
Sgt1,3575,3579,O
genes,3580,3585,O
are,3586,3589,O
not,3590,3593,O
universal,3594,3603,O
and,3604,3607,O
these,3608,3613,O
genes,3614,3619,O
are,3620,3623,O
not,3624,3627,O
essential,3628,3637,O
for,3638,3641,O
resistance,3642,3652,O
involving,3653,3662,O
some,3663,3667,O
R,3668,3669,O
genes,3670,3675,O
[,3676,3677,O
12,3677,3679,O
",",3679,3680,O
13,3680,3682,O
],3682,3683,O
.,3683,3684,O
Besides,3685,3692,O
the,3693,3696,O
two,3697,3700,O
broad,3701,3706,O
-,3706,3707,O
spectrum,3707,3715,O
resistance,3716,3726,O
genes,3727,3732,O
RB,3733,3735,O
and,3736,3739,O
Rpi,3740,3743,O
-,3743,3744,O
blb2,3744,3748,O
",",3748,3749,O
several,3750,3757,O
race,3758,3762,O
-,3762,3763,O
specific,3763,3771,O
late,3772,3776,O
blight,3777,3783,O
resistance,3784,3794,O
genes,3795,3800,O
have,3801,3805,O
also,3806,3810,O
been,3811,3815,O
cloned,3816,3822,O
[,3823,3824,O
14,3824,3826,O
-,3826,3827,O
16,3827,3829,O
],3829,3830,O
.,3830,3831,O
Numerous,3832,3840,O
late,3841,3845,O
blight,3846,3852,O
resistance,3853,3863,O
genes,3864,3869,O
have,3870,3874,O
recently,3875,3883,O
been,3884,3888,O
mapped,3889,3895,O
in,3896,3898,O
various,3899,3906,O
potato,3907,3913,O
species,3914,3921,O
or,3922,3924,O
populations,3925,3936,O
[,3937,3938,O
17,3938,3940,O
-,3940,3941,O
25,3941,3943,O
],3943,3944,O
.,3944,3945,O
However,3946,3953,O
",",3953,3954,O
there,3955,3960,O
is,3961,3963,O
almost,3964,3970,O
no,3971,3973,O
information,3974,3985,O
available,3986,3995,O
about,3996,4001,O
the,4002,4005,O
resistance,4006,4016,O
pathways,4017,4025,O
mediated,4026,4034,O
by,4035,4037,O
any,4038,4041,O
of,4042,4044,O
these,4045,4050,O
genes,4051,4056,O
.,4056,4057,O
As,4058,4060,O
an,4061,4063,O
initial,4064,4071,O
effort,4072,4078,O
to,4079,4081,O
understand,4082,4092,O
the,4093,4096,O
RB,4097,4099,O
-,4099,4100,O
mediated,4100,4108,O
late,4109,4113,O
blight,4114,4120,O
resistance,4121,4131,O
pathway,4132,4139,O
",",4139,4140,O
we,4141,4143,O
silenced,4144,4152,O
the,4153,4156,O
Rar1,4157,4161,O
and,4162,4165,O
Sgt1,4166,4170,O
genes,4171,4176,O
using,4177,4182,O
an,4183,4185,O
RNAi,4186,4190,O
-,4190,4191,O
based,4191,4196,O
approach,4197,4205,O
in,4206,4208,O
a,4209,4210,O
potato,4211,4217,O
line,4218,4222,O
containing,4223,4233,O
the,4234,4237,O
RB,4238,4240,O
gene,4241,4245,O
.,4245,4246,O
We,4247,4249,O
demonstrated,4250,4262,O
that,4263,4267,O
SGT1,4268,4272,O
",",4272,4273,O
but,4274,4277,O
not,4278,4281,O
RAR1,4282,4286,O
",",4286,4287,O
is,4288,4290,O
essential,4291,4300,O
for,4301,4304,O
the,4305,4308,O
RB,4309,4311,O
-,4311,4312,O
mediated,4312,4320,O
broad,4321,4326,O
-,4326,4327,O
spectrum,4327,4335,O
resistance,4336,4346,O
to,4347,4349,O
potato,4350,4356,O
late,4357,4361,O
blight,4362,4368,O
.,4368,4369,O
Ovariectomy,0,11,O
Based,12,17,O
on,18,20,O
the,21,24,O
uterine,25,32,B-Organ
weight,33,39,O
",",39,40,O
we,41,43,O
determined,44,54,O
seven,55,60,O
unsuccessful,61,73,O
OVXs,74,78,O
.,78,79,O
The,80,83,O
rats,84,88,O
concerned,89,98,O
were,99,103,O
removed,104,111,O
from,112,116,O
further,117,124,O
analyses,125,133,O
",",133,134,O
which,135,140,O
left,141,145,O
nine,146,150,O
rats,151,155,O
in,156,158,O
the,159,162,O
control,163,170,O
group,171,176,O
",",176,177,O
five,178,182,O
in,183,185,O
the,186,189,O
OVX,190,193,O
group,194,199,O
",",199,200,O
seven,201,206,O
in,207,209,O
the,210,213,O
OVX,214,217,O
and,218,221,O
late,222,226,O
ZOL,227,230,O
group,231,236,O
",",236,237,O
and,238,241,O
eight,242,247,O
in,248,250,O
the,251,254,O
OVX,255,258,O
and,259,262,O
early,263,268,O
ZOL,269,272,O
group,273,278,O
.,278,279,O
For,280,283,O
each,284,288,O
animal,289,295,O
",",295,296,O
we,297,299,O
determined,300,310,O
the,311,314,O
percentage,315,325,O
change,326,332,O
in,333,335,O
structural,336,346,O
parameters,347,357,O
compared,358,366,O
to,367,369,O
the,370,373,O
values,374,380,O
at,381,383,O
week,384,388,O
0,389,390,O
.,390,391,O
Figure,392,398,O
1,399,400,O
shows,401,406,O
the,407,410,O
average,411,418,O
percentage,419,429,O
change,430,436,O
and,437,440,O
upper,441,446,O
standard,447,455,O
deviation,456,465,O
for,466,469,O
all,470,473,O
groups,474,480,O
for,481,484,O
BV,485,487,O
/,487,488,O
TV,488,490,O
",",490,491,O
Conn,492,496,O
.,496,497,O
D,497,498,O
",",498,499,O
SMI,500,503,O
",",503,504,O
Tb,505,507,O
.,507,508,O
N,508,509,O
",",509,510,O
Tb,511,513,O
.,513,514,O
Th,514,516,O
",",516,517,O
and,518,521,O
Tb,522,524,O
.,524,525,O
Sp,525,527,O
.,527,528,O
The,529,532,O
OVX,533,536,O
group,537,542,O
without,543,550,O
treatment,551,560,O
showed,561,567,O
large,568,573,O
changes,574,581,O
in,582,584,O
structural,585,595,O
parameters,596,606,O
",",606,607,O
indicating,608,618,O
the,619,622,O
development,623,634,O
of,635,637,O
OVX,638,641,O
-,641,642,O
induced,642,649,O
bone,650,654,B-Tissue
loss,655,659,O
(,660,661,O
Figs,661,665,O
.,665,666,O
1,667,668,O
and,669,672,O
2,673,674,O
),674,675,O
.,675,676,O
Paired,677,683,O
Student,684,691,O
',691,692,O
s,692,693,O
t,694,695,O
-,695,696,O
test,696,700,O
indicated,701,710,O
significant,711,722,O
changes,723,730,O
within,731,737,O
2,738,739,O
weeks,740,745,O
after,746,751,O
OVX,752,755,O
for,756,759,O
all,760,763,O
structural,764,774,O
parameters,775,785,O
.,785,786,O
BV,787,789,O
/,789,790,O
TV,790,792,O
",",792,793,O
Conn,794,798,O
.,798,799,O
D,799,800,O
",",800,801,O
and,802,805,O
Tb,806,808,O
.,808,809,O
N,809,810,O
decreased,811,820,O
during,821,827,O
the,828,831,O
experiment,832,842,O
and,843,846,O
SMI,847,850,O
and,851,854,O
Tb,855,857,O
.,857,858,O
Sp,858,860,O
increased,861,870,O
.,870,871,O
Both,872,876,O
Tb,877,879,O
.,879,880,O
Th,880,882,O
and,883,886,O
Tb,887,889,O
.,889,890,O
N,890,891,O
decreased,892,901,O
within,902,908,O
2,909,910,O
weeks,911,916,O
",",916,917,O
indicating,918,928,O
that,929,933,O
both,934,938,O
thinning,939,947,O
and,948,951,O
complete,952,960,O
resorption,961,971,O
of,972,974,O
trabeculae,975,985,O
started,986,993,O
directly,994,1002,O
after,1003,1008,O
OVX,1009,1012,O
.,1012,1013,O
The,1014,1017,O
initial,1018,1025,O
rapid,1026,1031,O
loss,1032,1036,O
of,1037,1039,O
bone,1040,1044,B-Tissue
and,1045,1048,O
connectivity,1049,1061,O
was,1062,1065,O
largely,1066,1073,O
accompanied,1074,1085,O
by,1086,1088,O
trabecular,1089,1099,B-Organ
thinning,1100,1108,O
",",1108,1109,O
while,1110,1115,O
secondary,1116,1125,O
",",1125,1126,O
slower,1127,1133,O
loss,1134,1138,O
of,1139,1141,O
bone,1142,1146,B-Tissue
was,1147,1150,O
concomitant,1151,1162,O
with,1163,1167,O
a,1168,1169,O
decrease,1170,1178,O
in,1179,1181,O
Tb,1182,1184,O
.,1184,1185,O
N,1185,1186,O
.,1186,1187,O
While,1188,1193,O
BV,1194,1196,O
/,1196,1197,O
TV,1197,1199,O
",",1199,1200,O
Conn,1201,1205,O
.,1205,1206,O
D,1206,1207,O
",",1207,1208,O
SMI,1209,1212,O
",",1212,1213,O
Tb,1214,1216,O
.,1216,1217,O
N,1217,1218,O
",",1218,1219,O
and,1220,1223,O
Tb,1224,1226,O
.,1226,1227,O
Sp,1227,1229,O
showed,1230,1236,O
continuous,1237,1247,O
changes,1248,1255,O
in,1256,1258,O
the,1259,1262,O
same,1263,1267,O
direction,1268,1277,O
throughout,1278,1288,O
the,1289,1292,O
experiment,1293,1303,O
",",1303,1304,O
Tb,1305,1307,O
.,1307,1308,O
Th,1308,1310,O
initially,1311,1320,O
decreased,1321,1330,O
significantly,1331,1344,O
until,1345,1350,O
4,1351,1352,O
weeks,1353,1358,O
after,1359,1364,O
OVX,1365,1368,O
and,1369,1372,O
then,1373,1377,O
increased,1378,1387,O
again,1388,1393,O
until,1394,1399,O
after,1400,1405,O
16,1406,1408,O
weeks,1409,1414,O
Tb,1415,1417,O
.,1417,1418,O
Th,1418,1420,O
was,1421,1424,O
significantly,1425,1438,O
higher,1439,1445,O
than,1446,1450,O
in,1451,1453,O
the,1454,1457,O
control,1458,1465,O
group,1466,1471,O
.,1471,1472,O
Fig,1474,1477,O
.,1477,1478,O
1,1479,1480,O
Average,1481,1488,O
percentage,1489,1499,O
change,1500,1506,O
in,1507,1509,O
structural,1510,1520,O
parameters,1521,1531,O
in,1532,1534,O
the,1535,1538,O
metaphyseal,1539,1550,O
proximal,1551,1559,O
tibia,1560,1565,B-Organ
and,1566,1569,O
upper,1570,1575,O
standard,1576,1584,O
deviation,1585,1594,O
for,1595,1598,O
all,1599,1602,O
groups,1603,1609,O
at,1610,1612,O
all,1613,1616,O
time,1617,1621,O
points,1622,1628,O
.,1628,1629,O
Brackets,1630,1638,O
indicate,1639,1647,O
P,1648,1649,O
<,1650,1651,O
0,1652,1653,O
.,1653,1654,O
05,1654,1656,O
at,1657,1659,O
week,1660,1664,O
16,1665,1667,O
Fig,1668,1671,O
.,1671,1672,O
2,1673,1674,O
Same,1675,1679,O
slice,1680,1685,O
of,1686,1688,O
an,1689,1691,O
unprocessed,1692,1703,O
CT,1704,1706,O
scan,1707,1711,O
of,1712,1714,O
the,1715,1718,O
same,1719,1723,O
rat,1724,1727,O
in,1728,1730,O
the,1731,1734,O
OVX,1735,1738,O
group,1739,1744,O
taken,1745,1750,O
at,1751,1753,O
weeks,1754,1759,O
0,1760,1761,O
(,1762,1763,O
a,1763,1764,O
),1764,1765,O
",",1765,1766,O
2,1767,1768,O
(,1769,1770,O
b,1770,1771,O
),1771,1772,O
",",1772,1773,O
4,1774,1775,O
(,1776,1777,O
c,1777,1778,O
),1778,1779,O
",",1779,1780,O
8,1781,1782,O
(,1783,1784,O
d,1784,1785,O
),1785,1786,O
",",1786,1787,O
12,1788,1790,O
(,1791,1792,O
e,1792,1793,O
),1793,1794,O
",",1794,1795,O
and,1796,1799,O
16,1800,1802,O
(,1803,1804,O
f,1804,1805,O
),1805,1806,O
.,1806,1807,O
Images,1808,1814,O
show,1815,1819,O
typical,1820,1827,O
trabecular,1828,1838,B-Tissue
bone,1839,1843,I-Tissue
loss,1844,1848,O
due,1849,1852,O
to,1853,1855,O
OVX,1856,1859,O
in,1860,1862,O
the,1863,1866,O
metaphysis,1867,1877,O
.,1877,1878,O
Green,1879,1884,O
line,1885,1889,O
shows,1890,1895,O
the,1896,1899,O
analyzed,1900,1908,O
metaphyseal,1909,1920,O
bone,1921,1925,B-Tissue
The,1926,1929,O
absolute,1930,1938,O
average,1939,1946,O
values,1947,1953,O
and,1954,1957,O
standard,1958,1966,O
deviations,1967,1977,O
for,1978,1981,O
all,1982,1985,O
structural,1986,1996,O
parameters,1997,2007,O
of,2008,2010,O
all,2011,2014,O
measurements,2015,2027,O
are,2028,2031,O
shown,2032,2037,O
in,2038,2040,O
Table,2041,2046,O
1,2047,2048,O
.,2048,2049,O
At,2050,2052,O
the,2053,2056,O
starting,2057,2065,O
point,2066,2071,O
",",2071,2072,O
some,2073,2077,O
differences,2078,2089,O
in,2090,2092,O
the,2093,2096,O
values,2097,2103,O
between,2104,2111,O
the,2112,2115,O
groups,2116,2122,O
were,2123,2127,O
present,2128,2135,O
.,2135,2136,O
This,2137,2141,O
was,2142,2145,O
due,2146,2149,O
to,2150,2152,O
the,2153,2156,O
fact,2157,2161,O
that,2162,2166,O
some,2167,2171,O
animals,2172,2179,O
",",2179,2180,O
which,2181,2186,O
mostly,2187,2193,O
had,2194,2197,O
a,2198,2199,O
relatively,2200,2210,O
low,2211,2214,O
BV,2215,2217,O
/,2217,2218,O
TV,2218,2220,O
",",2220,2221,O
were,2222,2226,O
removed,2227,2234,O
from,2235,2239,O
the,2240,2243,O
study,2244,2249,O
because,2250,2257,O
they,2258,2262,O
did,2263,2266,O
not,2267,2270,O
respond,2271,2278,O
to,2279,2281,O
the,2282,2285,O
OVX,2286,2289,O
.,2289,2290,O
However,2291,2298,O
",",2298,2299,O
since,2300,2305,O
we,2306,2308,O
compared,2309,2317,O
the,2318,2321,O
relative,2322,2330,O
changes,2331,2338,O
in,2339,2341,O
each,2342,2346,O
animal,2347,2353,O
",",2353,2354,O
the,2355,2358,O
results,2359,2366,O
were,2367,2371,O
most,2372,2376,O
likely,2377,2383,O
not,2384,2387,O
affected,2388,2396,O
by,2397,2399,O
the,2400,2403,O
difference,2404,2414,O
in,2415,2417,O
absolute,2418,2426,O
values,2427,2433,O
.,2433,2434,O
Table,2436,2441,O
1,2442,2443,O
Mean,2444,2448,O
values,2449,2455,O
and,2456,2459,O
standard,2460,2468,O
deviation,2469,2478,O
of,2479,2481,O
all,2482,2485,O
structural,2486,2496,O
parameters,2497,2507,O
of,2508,2510,O
all,2511,2514,O
groups,2515,2521,O
at,2522,2524,O
the,2525,2528,O
start,2529,2534,O
of,2535,2537,O
the,2538,2541,O
experiment,2542,2552,O
Group,2553,2558,O
BV,2559,2561,O
/,2561,2562,O
TV,2562,2564,O
(,2565,2566,O
1,2566,2567,O
),2567,2568,O
Conn,2569,2573,O
.,2573,2574,O
D,2574,2575,O
(,2576,2577,O
1,2577,2578,O
/,2578,2579,O
mm,2579,2581,O
),2581,2582,O
SMI,2583,2586,O
(,2587,2588,O
1,2588,2589,O
),2589,2590,O
Tb,2591,2593,O
.,2593,2594,O
N,2594,2595,O
(,2596,2597,O
1,2597,2598,O
/,2598,2599,O
mm,2599,2601,O
),2601,2602,O
Tb,2603,2605,O
.,2605,2606,O
Th,2606,2608,O
(,2609,2610,O
mum,2610,2613,O
),2613,2614,O
Tb,2615,2617,O
.,2617,2618,O
Sp,2618,2620,O
(,2621,2622,O
mum,2622,2625,O
),2625,2626,O
Control,2627,2634,O
0,2635,2636,O
.,2636,2637,O
17,2637,2639,O
(,2640,2641,O
0,2641,2642,O
.,2642,2643,O
056,2643,2646,O
),2646,2647,O
41,2648,2650,O
(,2651,2652,O
47,2652,2654,O
),2654,2655,O
1,2656,2657,O
.,2657,2658,O
52,2658,2660,O
(,2661,2662,O
0,2662,2663,O
.,2663,2664,O
53,2664,2666,O
),2666,2667,O
1,2668,2669,O
.,2669,2670,O
89,2670,2672,O
(,2673,2674,O
1,2674,2675,O
.,2675,2676,O
38,2676,2678,O
),2678,2679,O
105,2680,2683,O
(,2684,2685,O
49,2685,2687,O
),2687,2688,O
613,2689,2692,O
(,2693,2694,O
368,2694,2697,O
),2697,2698,O
OVX,2699,2702,O
0,2703,2704,O
.,2704,2705,O
26,2705,2707,O
(,2708,2709,O
0,2709,2710,O
.,2710,2711,O
055,2711,2714,O
),2714,2715,O
141,2716,2719,O
(,2720,2721,O
76,2721,2723,O
),2723,2724,O
1,2725,2726,O
.,2726,2727,O
22,2727,2729,O
(,2730,2731,O
0,2731,2732,O
.,2732,2733,O
39,2733,2735,O
),2735,2736,O
3,2737,2738,O
.,2738,2739,O
77,2739,2741,O
(,2742,2743,O
1,2743,2744,O
.,2744,2745,O
66,2745,2747,O
),2747,2748,O
84,2749,2751,O
(,2752,2753,O
10,2753,2755,O
),2755,2756,O
335,2757,2760,O
(,2761,2762,O
174,2762,2765,O
),2765,2766,O
OVX,2767,2770,O
+,2771,2772,O
late,2773,2777,O
ZOL,2778,2781,O
0,2782,2783,O
.,2783,2784,O
23,2784,2786,O
(,2787,2788,O
0,2788,2789,O
.,2789,2790,O
062,2790,2793,O
),2793,2794,O
86,2795,2797,O
(,2798,2799,O
66,2799,2801,O
),2801,2802,O
1,2803,2804,O
.,2804,2805,O
23,2805,2807,O
(,2808,2809,O
0,2809,2810,O
.,2810,2811,O
34,2811,2813,O
),2813,2814,O
2,2815,2816,O
.,2816,2817,O
77,2817,2819,O
(,2820,2821,O
1,2821,2822,O
.,2822,2823,O
55,2823,2825,O
),2825,2826,O
89,2827,2829,O
(,2830,2831,O
13,2831,2833,O
),2833,2834,O
482,2835,2838,O
(,2839,2840,O
227,2840,2843,O
),2843,2844,O
OVX,2845,2848,O
+,2849,2850,O
early,2851,2856,O
ZOL,2857,2860,O
0,2861,2862,O
.,2862,2863,O
17,2863,2865,O
(,2866,2867,O
0,2867,2868,O
.,2868,2869,O
056,2869,2872,O
),2872,2873,O
38,2874,2876,O
(,2877,2878,O
21,2878,2880,O
),2880,2881,O
1,2882,2883,O
.,2883,2884,O
70,2884,2886,O
(,2887,2888,O
0,2888,2889,O
.,2889,2890,O
39,2890,2892,O
),2892,2893,O
1,2894,2895,O
.,2895,2896,O
86,2896,2898,O
(,2899,2900,O
0,2900,2901,O
.,2901,2902,O
80,2902,2904,O
),2904,2905,O
95,2906,2908,O
(,2909,2910,O
7,2910,2911,O
),2911,2912,O
647,2913,2916,O
(,2917,2918,O
207,2918,2921,O
),2921,2922,O
Click,0,5,O
here,6,10,O
for,11,14,O
file,15,19,O
Aim,0,3,O
This,4,8,O
study,9,14,O
reports,15,22,O
the,23,26,O
results,27,34,O
of,35,37,O
a,38,39,O
large,40,45,O
prospective,46,57,O
single,58,64,O
-,64,65,O
blinded,65,72,O
clinical,73,81,O
trial,82,87,O
of,88,90,O
3,91,92,O
SSRI,93,97,O
(,98,99,O
paroxetine,99,109,O
",",109,110,O
fluoxetine,111,121,O
and,122,125,O
escitalopram,126,138,O
),138,139,O
in,140,142,O
PE,143,145,O
using,146,151,O
a,152,153,O
validated,154,163,O
questionnaire,164,177,O
.,177,178,O
Summary,0,7,O
of,8,10,O
studies,11,18,O
reporting,19,28,O
comorbidities,29,42,O
with,43,47,O
diabetes,48,56,O
.,56,57,O
Click,0,5,O
here,6,10,O
for,11,14,O
additional,15,25,O
data,26,30,O
file,31,35,O
.,35,36,O
Images,0,6,O
Figure,7,13,O
1,14,15,O
Figure,16,22,O
5,23,24,O
Figure,25,31,O
6,32,33,O
Characteristics,0,15,O
of,16,18,O
cases,19,24,O
with,25,29,O
childhood,30,39,O
leukaemia,40,49,O
(,50,51,O
n,51,52,O
=,52,53,O
162,53,56,O
),56,57,O
and,58,61,O
matched,62,69,O
controls,70,78,O
(,79,80,O
n,80,81,O
=,81,82,O
2125,82,86,O
),86,87,O
",",87,88,O
all,89,92,O
registered,93,103,O
within,104,110,O
3,111,112,O
months,113,119,O
of,120,122,O
birth,123,128,O
Appendix,0,8,O
Table,9,14,O
Detection,15,24,O
of,25,27,O
Nipah,28,33,O
virus,34,39,O
antibody,40,48,O
among,49,54,O
bat,55,58,O
serum,59,64,B-Organism_substance
samples,65,72,I-Organism_substance
collected,73,82,O
from,83,87,O
10,88,90,O
provinces,91,100,O
in,101,103,O
China,104,109,O
",",109,110,O
2004,111,115,O
-,115,116,O
2007,116,120,O
*,120,121,O
Whole,0,5,O
-,5,6,O
Body,6,10,O
gamma,11,16,O
-,16,17,O
Irradiation,17,28,O
To,29,31,O
evaluate,32,40,O
differential,41,53,O
sensitivity,54,65,O
to,66,68,O
irradiation,69,80,O
",",80,81,O
mice,82,86,O
were,87,91,O
exposed,92,99,O
to,100,102,O
gamma,103,108,O
-,108,109,O
irradiation,109,120,O
(,121,122,O
4,122,123,O
-,123,124,O
10,124,126,O
Gy,127,129,O
",",129,130,O
single,131,137,O
dose,138,142,O
),142,143,O
and,144,147,O
closely,148,155,O
monitored,156,165,O
throughout,166,176,O
the,177,180,O
experimentation,181,196,O
period,197,203,O
.,203,204,O
Animals,205,212,O
were,213,217,O
killed,218,224,O
at,225,227,O
the,228,231,O
first,232,237,O
appearance,238,248,O
of,249,251,O
signs,252,257,O
of,258,260,O
poor,261,265,O
health,266,272,O
.,272,273,O
Recipients,274,284,O
of,285,287,O
bone,288,292,B-Multi-tissue_structure
marrow,293,299,I-Multi-tissue_structure
transplants,300,311,O
were,312,316,O
pre,317,320,O
-,320,321,O
irradiated,321,331,O
with,332,336,O
a,337,338,O
total,339,344,O
dose,345,349,O
of,350,352,O
10,353,355,O
.,355,356,O
2,356,357,O
Gy,358,360,O
(,361,362,O
two,362,365,O
doses,366,371,O
of,372,374,O
5,375,376,O
.,376,377,O
1,377,378,O
Gy,379,381,O
",",381,382,O
3,383,384,O
h,385,386,O
apart,387,392,O
),392,393,O
.,393,394,O
For,395,398,O
in,399,401,O
vivo,402,406,O
DNA,407,410,O
damage,411,417,O
experiments,418,429,O
",",429,430,O
mice,431,435,O
were,436,440,O
irradiated,441,451,O
with,452,456,O
a,457,458,O
single,459,465,O
dose,466,470,O
of,471,473,O
5Gy,474,477,O
and,478,481,O
killed,482,488,O
after,489,494,O
1,495,496,O
",",496,497,O
3,498,499,O
or,500,502,O
6,503,504,O
hours,505,510,O
.,510,511,O
All,512,515,O
irradiations,516,528,O
were,529,533,O
carried,534,541,O
out,542,545,O
in,546,548,O
a,549,550,O
Cesium,551,557,O
Mark1,558,563,O
irradiator,564,574,O
(,575,576,O
Shepherd,576,584,O
Associates,585,595,O
),595,596,O
.,596,597,O
Background,0,10,O
Sealant,0,7,O
application,8,19,O
criteria,20,28,O
for,29,32,O
molar,33,38,B-Organ
fissures,39,47,O
Power,0,5,O
(,6,7,O
Y,7,8,O
-,8,9,O
axis,9,13,O
),13,14,O
as,15,17,O
a,18,19,O
function,20,28,O
of,29,31,O
main,32,36,O
effects,37,44,O
(,45,46,O
x,46,47,O
-,47,48,O
axis,48,52,O
),52,53,O
.,53,54,O
For,55,58,O
a,59,60,O
pure,61,65,O
main,66,70,O
-,70,71,O
effects,71,78,O
model,79,84,O
(,85,86,O
x,86,87,O
-,87,88,O
axis,88,92,O
=,93,94,O
a1,95,97,O
>,98,99,O
0,100,101,O
;,101,102,O
interaction,103,114,O
effects,115,122,O
a2,123,125,O
=,126,127,O
a3,128,130,O
=,131,132,O
0,133,134,O
are,135,138,O
all,139,142,O
zero,143,147,O
),147,148,O
",",148,149,O
Figure,150,156,O
1,157,158,O
shows,159,164,O
that,165,169,O
pattern,170,177,O
(,178,179,O
solid,179,184,O
red,185,188,O
line,189,193,O
),193,194,O
and,195,198,O
single,199,205,O
-,205,206,O
locus,206,211,O
(,212,213,O
broken,213,219,O
blue,220,224,O
line,225,229,O
),229,230,O
approaches,231,241,O
have,242,246,O
virtually,247,256,O
the,257,260,O
same,261,265,O
power,266,271,O
.,271,272,O
Peptide,0,7,O
-,7,8,O
BSA,8,11,O
conjugates,12,22,O
as,23,25,O
diagnostic,26,36,O
antigens,37,45,O
To,46,48,O
analyse,49,56,O
the,57,60,O
potential,61,70,O
of,71,73,O
the,74,77,O
peptides,78,86,O
to,87,89,O
behave,90,96,O
as,97,99,O
antigen,100,107,O
mimics,108,114,O
",",114,115,O
their,116,121,O
ability,122,129,O
to,130,132,O
react,133,138,O
with,139,143,O
IgM,144,147,O
antibodies,148,158,O
from,159,163,O
individuals,164,175,O
infected,176,184,O
with,185,189,O
EBV,190,193,O
was,194,197,O
assessed,198,206,O
.,206,207,O
In,208,210,O
our,211,214,O
previous,215,223,O
study,224,229,O
",",229,230,O
we,231,233,O
demonstrated,234,246,O
that,247,251,O
the,252,255,O
sensitivity,256,267,O
of,268,270,O
detection,271,280,O
was,281,284,O
greatly,285,292,O
improved,293,301,O
when,302,306,O
the,307,310,O
peptides,311,319,O
were,320,324,O
coupled,325,332,O
to,333,335,O
a,336,337,O
carrier,338,345,O
molecule,346,354,O
such,355,359,O
as,360,362,O
BSA,363,366,O
prior,367,372,O
to,373,375,O
immobilisation,376,390,O
onto,391,395,O
a,396,397,O
solid,398,403,O
surface,404,411,O
(,412,413,O
Casey,413,418,O
et,419,421,O
al,422,424,O
.,424,425,O
",",425,426,O
2006,427,431,O
),431,432,O
.,432,433,O
This,434,438,O
strategy,439,447,O
was,448,451,O
adopted,452,459,O
to,460,462,O
test,463,467,O
peptides,468,476,O
Eb1,477,480,O
-,480,481,O
4,481,482,O
and,483,486,O
H1,487,489,O
.,489,490,O
A,491,492,O
set,493,496,O
of,497,499,O
40,500,502,O
clinical,503,511,O
samples,512,519,O
that,520,524,O
were,525,529,O
classified,530,540,O
as,541,543,O
EBV,544,547,O
seropositive,548,560,O
(,561,562,O
n,562,563,O
=,564,565,O
16,566,568,O
),568,569,O
",",569,570,O
seronegative,571,583,O
(,584,585,O
n,585,586,O
=,587,588,O
16,589,591,O
),591,592,O
or,593,595,O
potentially,596,607,O
cross,608,613,O
-,613,614,O
reactive,614,622,O
sera,623,627,B-Organism_substance
(,628,629,O
n,629,630,O
=,631,632,O
8,633,634,O
),634,635,O
were,636,640,O
assessed,641,649,O
for,650,653,O
reactivity,654,664,O
with,665,669,O
Eb1,670,673,O
-,673,674,O
4,674,675,O
and,676,679,O
H1,680,682,O
peptides,683,691,O
individually,692,704,O
.,704,705,O
The,706,709,O
cut,710,713,O
-,713,714,O
off,714,717,O
level,718,723,O
was,724,727,O
defined,728,735,O
as,736,738,O
the,739,742,O
mean,743,747,O
optical,748,755,O
density,756,763,O
of,764,766,O
the,767,770,O
seronegative,771,783,O
samples,784,791,O
plus,792,796,O
3,797,798,O
standard,799,807,O
deviations,808,818,O
shown,819,824,O
as,825,827,O
a,828,829,O
line,830,834,O
on,835,837,O
the,838,841,O
graphs,842,848,O
in,849,851,O
Fig,852,855,O
.,855,856,O
5,857,858,O
.,858,859,O
Readings,860,868,O
above,869,874,O
this,875,879,O
level,880,885,O
were,886,890,O
defined,891,898,O
as,899,901,O
positive,902,910,O
and,911,914,O
below,915,920,O
this,921,925,O
level,926,931,O
negative,932,940,O
.,940,941,O
The,942,945,O
same,946,950,O
set,951,954,O
of,955,957,O
samples,958,965,O
were,966,970,O
analysed,971,979,O
on,980,982,O
BSA,983,986,O
alone,987,992,O
and,993,996,O
these,997,1002,O
values,1003,1009,O
were,1010,1014,O
subtracted,1015,1025,O
from,1026,1030,O
the,1031,1034,O
peptide,1035,1042,O
-,1042,1043,O
BSA,1043,1046,O
conjugate,1047,1056,O
readings,1057,1065,O
and,1066,1069,O
the,1070,1073,O
corrected,1074,1083,O
absorbance,1084,1094,O
readings,1095,1103,O
were,1104,1108,O
plotted,1109,1116,O
individually,1117,1129,O
for,1130,1133,O
our,1134,1137,O
new,1138,1141,O
peptides,1142,1150,O
Eb1,1151,1154,O
-,1154,1155,O
4,1155,1156,O
and,1157,1160,O
H1,1161,1163,O
in,1164,1166,O
Fig,1167,1170,O
.,1170,1171,O
5,1172,1173,O
.,1173,1174,O
There,1175,1180,O
was,1181,1184,O
a,1185,1186,O
clear,1187,1192,O
difference,1193,1203,O
in,1204,1206,O
the,1207,1210,O
detection,1211,1220,O
of,1221,1223,O
seropositive,1224,1236,O
antibodies,1237,1247,O
by,1248,1250,O
all,1251,1254,O
the,1255,1258,O
peptides,1259,1267,O
(,1268,1269,O
Fig,1269,1272,O
.,1272,1273,O
5A,1274,1276,O
-,1276,1277,O
E,1277,1278,O
),1278,1279,O
compared,1280,1288,O
with,1289,1293,O
the,1294,1297,O
analysis,1298,1306,O
of,1307,1309,O
BSA,1310,1313,O
alone,1314,1319,O
(,1320,1321,O
Fig,1321,1324,O
.,1324,1325,O
5F,1326,1328,O
),1328,1329,O
",",1329,1330,O
with,1331,1335,O
the,1336,1339,O
majority,1340,1348,O
of,1349,1351,O
absorbance,1352,1362,O
readings,1363,1371,O
above,1372,1377,O
the,1378,1381,O
cut,1382,1385,O
-,1385,1386,O
off,1386,1389,O
level,1390,1395,O
.,1395,1396,O
We,1397,1399,O
compared,1400,1408,O
the,1409,1412,O
ability,1413,1420,O
of,1421,1423,O
our,1424,1427,O
panel,1428,1433,O
of,1434,1436,O
peptide,1437,1444,O
mimotopes,1445,1454,O
to,1455,1457,O
be,1458,1460,O
recognised,1461,1471,O
by,1472,1474,O
antibodies,1475,1485,O
in,1486,1488,O
the,1489,1492,O
same,1493,1497,O
set,1498,1501,O
of,1502,1504,O
seropositive,1505,1517,O
samples,1518,1525,O
in,1526,1528,O
Fig,1529,1532,O
.,1532,1533,O
6A,1534,1536,O
and,1537,1540,O
the,1541,1544,O
sensitivity,1545,1556,O
of,1557,1559,O
detection,1560,1569,O
is,1570,1572,O
shown,1573,1578,O
in,1579,1581,O
Fig,1582,1585,O
.,1585,1586,O
6B,1587,1589,O
.,1589,1590,O
We,1591,1593,O
also,1594,1598,O
included,1599,1607,O
F1,1608,1610,O
and,1611,1614,O
Gp125,1615,1620,O
mimotopes,1621,1630,O
specific,1631,1639,O
for,1640,1643,O
two,1644,1647,O
mAbs,1648,1652,O
in,1653,1655,O
our,1656,1659,O
previous,1660,1668,O
study,1669,1674,O
(,1675,1676,O
Casey,1676,1681,O
et,1682,1684,O
al,1685,1687,O
.,1687,1688,O
",",1688,1689,O
2006,1690,1694,O
),1694,1695,O
.,1695,1696,O
Of,1697,1699,O
the,1700,1703,O
peptides,1704,1712,O
identified,1713,1723,O
from,1724,1728,O
polyclonal,1729,1739,O
sera,1740,1744,B-Organism_substance
Eb1,1745,1748,O
",",1748,1749,O
Gp125,1750,1755,O
and,1756,1759,O
F1,1760,1762,O
had,1763,1766,O
the,1767,1770,O
highest,1771,1778,O
sensitivity,1779,1790,O
(,1791,1792,O
94,1792,1794,O
%,1794,1795,O
),1795,1796,O
.,1796,1797,O
Slightly,1798,1806,O
lower,1807,1812,O
sensitivity,1813,1824,O
was,1825,1828,O
observed,1829,1837,O
for,1838,1841,O
Eb2,1842,1845,O
",",1845,1846,O
3,1847,1848,O
and,1849,1852,O
4,1853,1854,O
(,1855,1856,O
88,1856,1858,O
%,1858,1859,O
),1859,1860,O
and,1861,1864,O
H1,1865,1867,O
peptide,1868,1875,O
had,1876,1879,O
the,1880,1883,O
lowest,1884,1890,O
sensitivity,1891,1902,O
(,1903,1904,O
81,1904,1906,O
%,1906,1907,O
),1907,1908,O
as,1909,1911,O
summarised,1912,1922,O
in,1923,1925,O
Fig,1926,1929,O
.,1929,1930,O
6B,1931,1933,O
.,1933,1934,O
The,1935,1938,O
sensitivity,1939,1950,O
of,1951,1953,O
F1,1954,1956,O
and,1957,1960,O
Gp125,1961,1966,O
was,1967,1970,O
similar,1971,1978,O
to,1979,1981,O
that,1982,1986,O
produced,1987,1995,O
by,1996,1998,O
the,1999,2002,O
mimotopes,2003,2012,O
selected,2013,2021,O
in,2022,2024,O
our,2025,2028,O
previous,2029,2037,O
study,2038,2043,O
",",2043,2044,O
95,2045,2047,O
%,2047,2048,O
for,2049,2052,O
F1,2053,2055,O
and,2056,2059,O
92,2060,2062,O
%,2062,2063,O
for,2064,2067,O
Gp125,2068,2073,O
.,2073,2074,O
Fig,2075,2078,O
.,2078,2079,O
5,2080,2081,O
Evaluation,2082,2092,O
of,2093,2095,O
peptides,2096,2104,O
Eb1,2105,2108,O
-,2108,2109,O
4,2109,2110,O
and,2111,2114,O
H1,2115,2117,O
coupled,2118,2125,O
to,2126,2128,O
BSA,2129,2132,O
as,2133,2135,O
EBV,2136,2139,O
diagnostic,2140,2150,O
reagents,2151,2159,O
.,2159,2160,O
Human,2161,2166,O
serum,2167,2172,B-Organism_substance
(,2173,2174,O
n,2174,2175,O
=,2176,2177,O
40,2178,2180,O
),2180,2181,O
previously,2182,2192,O
analysed,2193,2201,O
using,2202,2207,O
a,2208,2209,O
diagnostic,2210,2220,O
test,2221,2225,O
for,2226,2229,O
VCA,2230,2233,O
IgM,2234,2237,O
was,2238,2241,O
allowed,2242,2249,O
to,2250,2252,O
react,2253,2258,O
with,2259,2263,O
the,2264,2267,O
peptides,2268,2276,O
and,2277,2280,O
the,2281,2284,O
bound,2285,2290,O
IgM,2291,2294,O
antibodies,2295,2305,O
were,2306,2310,O
detected,2311,2319,O
using,2320,2325,O
anti,2326,2330,O
-,2330,2331,O
human,2331,2336,O
IgM,2337,2340,O
HRP,2341,2344,O
.,2344,2345,O
The,2346,2349,O
absorbance,2350,2360,O
readings,2361,2369,O
for,2370,2373,O
1,2374,2375,O
(,2376,2377,O
positive,2377,2385,O
),2385,2386,O
",",2386,2387,O
2,2388,2389,O
(,2390,2391,O
negative,2391,2399,O
),2399,2400,O
and,2401,2404,O
putative,2405,2413,O
cross,2414,2419,O
-,2419,2420,O
reactive,2420,2428,O
sera,2429,2433,B-Organism_substance
for,2434,2437,O
3,2438,2439,O
(,2440,2441,O
Parvo,2441,2446,O
),2446,2447,O
",",2447,2448,O
4,2449,2450,O
(,2451,2452,O
HSV,2452,2455,O
),2455,2456,O
",",2456,2457,O
5,2458,2459,O
(,2460,2461,O
CMV,2461,2464,O
),2464,2465,O
and,2466,2469,O
6,2470,2471,O
(,2472,2473,O
RF,2473,2475,O
),2475,2476,O
are,2477,2480,O
plotted,2481,2488,O
for,2489,2492,O
(,2493,2494,O
A,2494,2495,O
),2495,2496,O
Eb1,2497,2500,O
",",2500,2501,O
(,2502,2503,O
B,2503,2504,O
),2504,2505,O
Eb2,2506,2509,O
",",2509,2510,O
(,2511,2512,O
C,2512,2513,O
),2513,2514,O
Eb3,2515,2518,O
",",2518,2519,O
(,2520,2521,O
D,2521,2522,O
),2522,2523,O
Eb4,2524,2527,O
",",2527,2528,O
(,2529,2530,O
E,2530,2531,O
),2531,2532,O
H1,2533,2535,O
and,2536,2539,O
(,2540,2541,O
F,2541,2542,O
),2542,2543,O
BSA,2544,2547,O
",",2547,2548,O
respectively,2549,2561,O
.,2561,2562,O
The,2563,2566,O
cut,2567,2570,O
-,2570,2571,O
off,2571,2574,O
value,2575,2580,O
is,2581,2583,O
defined,2584,2591,O
as,2592,2594,O
the,2595,2598,O
mean,2599,2603,O
of,2604,2606,O
the,2607,2610,O
negative,2611,2619,O
population,2620,2630,O
+,2631,2632,O
3SD,2632,2635,O
indicated,2636,2645,O
by,2646,2648,O
a,2649,2650,O
solid,2651,2656,O
horizontal,2657,2667,O
line,2668,2672,O
;,2672,2673,O
since,2674,2679,O
there,2680,2685,O
were,2686,2690,O
no,2691,2693,O
false,2694,2699,O
positives,2700,2709,O
",",2709,2710,O
the,2711,2714,O
specificity,2715,2726,O
for,2727,2730,O
each,2731,2735,O
mimotope,2736,2744,O
was,2745,2748,O
100,2749,2752,O
%,2752,2753,O
.,2753,2754,O
Fig,2755,2758,O
.,2758,2759,O
6,2760,2761,O
Comparison,2762,2772,O
of,2773,2775,O
the,2776,2779,O
reactivities,2780,2792,O
of,2793,2795,O
our,2796,2799,O
panel,2800,2805,O
of,2806,2808,O
mimotopes,2809,2818,O
Eb1,2819,2822,O
-,2822,2823,O
4,2823,2824,O
",",2824,2825,O
H1,2826,2828,O
",",2828,2829,O
F1,2830,2832,O
and,2833,2836,O
Gp125,2837,2842,O
conjugated,2843,2853,O
to,2854,2856,O
BSA,2857,2860,O
with,2861,2865,O
EBV,2866,2869,O
IgM,2870,2873,O
-,2873,2874,O
positive,2874,2882,O
sera,2883,2887,B-Organism_substance
(,2888,2889,O
n,2889,2890,O
=,2891,2892,O
16,2893,2895,O
),2895,2896,O
absorbance,2897,2907,O
values,2908,2914,O
are,2915,2918,O
plotted,2919,2926,O
and,2927,2930,O
the,2931,2934,O
cut,2935,2938,O
-,2938,2939,O
off,2939,2942,O
levels,2943,2949,O
are,2950,2953,O
depicted,2954,2962,O
by,2963,2965,O
a,2966,2967,O
horizontal,2968,2978,O
line,2979,2983,O
in,2984,2986,O
(,2987,2988,O
A,2988,2989,O
),2989,2990,O
.,2990,2991,O
(,2992,2993,O
B,2993,2994,O
),2994,2995,O
Summary,2996,3003,O
of,3004,3006,O
the,3007,3010,O
false,3011,3016,O
-,3016,3017,O
negative,3017,3025,O
results,3026,3033,O
from,3034,3038,O
the,3039,3042,O
5,3043,3044,O
/,3044,3045,O
16,3045,3047,O
serum,3048,3053,B-Organism_substance
samples,3054,3061,I-Organism_substance
seropositive,3062,3074,O
for,3075,3078,O
IgM,3079,3082,O
EBV,3083,3086,O
and,3087,3090,O
the,3091,3094,O
overall,3095,3102,O
sensitivity,3103,3114,O
for,3115,3118,O
each,3119,3123,O
mimotope,3124,3132,O
for,3133,3136,O
diagnosis,3137,3146,O
of,3147,3149,O
EBV,3150,3153,O
IgM,3154,3157,O
antibodies,3158,3168,O
.,3168,3169,O
We,3170,3172,O
also,3173,3177,O
considered,3178,3188,O
which,3189,3194,O
seropositive,3195,3207,O
EBV,3208,3211,O
samples,3212,3219,B-Organism_substance
contained,3220,3229,O
antibodies,3230,3240,O
that,3241,3245,O
did,3246,3249,O
not,3250,3253,O
recognise,3254,3263,O
the,3264,3267,O
panel,3268,3273,O
of,3274,3276,O
peptides,3277,3285,O
",",3285,3286,O
i,3287,3288,O
.,3288,3289,O
e,3289,3290,O
.,3290,3291,O
false,3292,3297,O
-,3297,3298,O
negative,3298,3306,O
readings,3307,3315,O
",",3315,3316,O
listed,3317,3323,O
in,3324,3326,O
Fig,3327,3330,O
.,3330,3331,O
6B,3332,3334,O
.,3334,3335,O
The,3336,3339,O
antibodies,3340,3350,O
in,3351,3353,O
serum,3354,3359,B-Organism_substance
1,3360,3361,O
(,3362,3363,O
s1,3363,3365,O
),3365,3366,O
were,3367,3371,O
unreactive,3372,3382,O
with,3383,3387,O
all,3388,3391,O
of,3392,3394,O
the,3395,3398,O
peptides,3399,3407,O
identified,3408,3418,O
in,3419,3421,O
this,3422,3426,O
study,3427,3432,O
",",3432,3433,O
s2,3434,3436,O
was,3437,3440,O
not,3441,3444,O
reactive,3445,3453,O
with,3454,3458,O
Eb3,3459,3462,O
",",3462,3463,O
Eb4,3464,3467,O
and,3468,3471,O
H1,3472,3474,O
and,3475,3478,O
s3,3479,3481,O
was,3482,3485,O
unreactive,3486,3496,O
with,3497,3501,O
H1,3502,3504,O
.,3504,3505,O
Gp125,3506,3511,O
and,3512,3515,O
F1,3516,3518,O
that,3519,3523,O
were,3524,3528,O
selected,3529,3537,O
in,3538,3540,O
our,3541,3544,O
previous,3545,3553,O
study,3554,3559,O
were,3560,3564,O
recognised,3565,3575,O
by,3576,3578,O
s1,3579,3581,O
",",3581,3582,O
2,3583,3584,O
and,3585,3588,O
3,3589,3590,O
;,3590,3591,O
however,3592,3599,O
",",3599,3600,O
two,3601,3604,O
different,3605,3614,O
serum,3615,3620,B-Organism_substance
samples,3621,3628,I-Organism_substance
(,3629,3630,O
s4,3630,3632,O
and,3633,3636,O
5,3637,3638,O
),3638,3639,O
did,3640,3643,O
not,3644,3647,O
recognise,3648,3657,O
F1,3658,3660,O
or,3661,3663,O
Gp125,3664,3669,O
",",3669,3670,O
respectively,3671,3683,O
.,3683,3684,O
This,3685,3689,O
demonstrates,3690,3702,O
that,3703,3707,O
individual,3708,3718,O
peptides,3719,3727,O
are,3728,3731,O
not,3732,3735,O
recognised,3736,3746,O
by,3747,3749,O
all,3750,3753,O
EBV,3754,3757,O
antibodies,3758,3768,O
and,3769,3772,O
confirms,3773,3781,O
that,3782,3786,O
different,3787,3796,O
peptides,3797,3805,O
are,3806,3809,O
required,3810,3818,O
to,3819,3821,O
represent,3822,3831,O
different,3832,3841,O
epitopes,3842,3850,O
.,3850,3851,O
Therefore,3852,3861,O
",",3861,3862,O
a,3863,3864,O
combination,3865,3876,O
of,3877,3879,O
Eb1,3880,3883,O
peptide,3884,3891,O
F1,3892,3894,O
and,3895,3898,O
Gp125,3899,3904,O
peptides,3905,3913,O
could,3914,3919,O
be,3920,3922,O
recognised,3923,3933,O
by,3934,3936,O
antibodies,3937,3947,O
present,3948,3955,O
in,3956,3958,O
all,3959,3962,O
this,3963,3967,O
set,3968,3971,O
of,3972,3974,O
EBV,3975,3978,O
clinical,3979,3987,O
samples,3988,3995,O
resulting,3996,4005,O
in,4006,4008,O
100,4009,4012,O
%,4012,4013,O
sensitivity,4014,4025,O
.,4025,4026,O
For,4027,4030,O
the,4031,4034,O
samples,4035,4042,O
defined,4043,4050,O
as,4051,4053,O
EBV,4054,4057,O
-,4057,4058,O
seronegative,4058,4070,O
",",4070,4071,O
there,4072,4077,O
were,4078,4082,O
no,4083,4085,O
readings,4086,4094,O
above,4095,4100,O
the,4101,4104,O
cut,4105,4108,O
-,4108,4109,O
off,4109,4112,O
level,4113,4118,O
and,4119,4122,O
therefore,4123,4132,O
no,4133,4135,O
false,4136,4141,O
positives,4142,4151,O
",",4151,4152,O
resulting,4153,4162,O
in,4163,4165,O
100,4166,4169,O
%,4169,4170,O
specificity,4171,4182,O
.,4182,4183,O
In,4184,4186,O
addition,4187,4195,O
",",4195,4196,O
there,4197,4202,O
were,4203,4207,O
no,4208,4210,O
absorbance,4211,4221,O
readings,4222,4230,O
above,4231,4236,O
the,4237,4240,O
cut,4241,4244,O
-,4244,4245,O
off,4245,4248,O
levels,4249,4255,O
for,4256,4259,O
the,4260,4263,O
potentially,4264,4275,O
cross,4276,4281,O
-,4281,4282,O
reactive,4282,4290,O
serum,4291,4296,B-Organism_substance
samples,4297,4304,I-Organism_substance
",",4304,4305,O
inferring,4306,4315,O
that,4316,4320,O
the,4321,4324,O
peptides,4325,4333,O
identified,4334,4344,O
in,4345,4347,O
this,4348,4352,O
study,4353,4358,O
have,4359,4363,O
high,4364,4368,O
specificity,4369,4380,O
for,4381,4384,O
EBV,4385,4388,O
antibodies,4389,4399,O
.,4399,4400,O
Additional,0,10,O
File,11,15,O
2,16,17,O
Full,18,22,O
Model,23,28,O
Code,29,33,O
.,33,34,O
Full,35,39,O
model,40,45,O
code,46,50,O
plus,51,55,O
instructions,56,68,O
for,69,72,O
running,73,80,O
in,81,83,O
Berkeley,84,92,O
Madonna,93,100,O
(,100,101,O
TM,101,103,O
),103,104,O
.,104,105,O
Secchi,0,6,O
depth,7,12,O
in,13,15,O
the,16,19,O
Baltic,20,26,O
Proper,27,33,O
",",33,34,O
June,35,39,O
-,39,40,O
August,40,46,O
",",46,47,O
1957,48,52,O
-,52,53,O
1998,53,57,O
.,57,58,O
Number,59,65,O
of,66,68,O
data,69,73,O
:,73,74,O
3,75,76,O
",",76,77,O
452,77,80,O
.,80,81,O
Nucleotide,0,10,O
features,11,19,O
of,20,22,O
free,23,27,O
-,27,28,O
standing,28,36,O
homing,37,43,O
-,43,44,O
endonucleases,44,57,O
Gene,58,62,O
control,63,70,O
elements,71,79,O
were,80,84,O
identified,85,95,O
for,96,99,O
several,100,107,O
members,108,115,O
of,116,118,O
each,119,123,O
type,124,128,O
of,129,131,O
intervening,132,143,O
homing,144,150,O
endonuclease,151,163,O
genes,164,169,O
described,170,179,O
in,180,182,O
this,183,187,O
study,188,193,O
.,193,194,O
In,195,197,O
15,198,200,O
out,201,204,O
of,205,207,O
16,208,210,O
",",210,211,O
5,212,213,O
',213,214,O
untranslated,215,227,O
regions,228,235,O
of,236,238,O
the,239,242,O
endonucleases,243,256,O
we,257,259,O
identified,260,270,O
RNA,271,274,O
hairpin,275,282,O
structures,283,293,O
upstream,294,302,O
of,303,305,O
initiation,306,316,O
codons,317,323,O
(,324,325,O
Figures,325,332,O
1,333,334,O
and,335,338,O
4A,339,341,O
),341,342,O
.,342,343,O
This,344,348,O
may,349,352,O
be,353,355,O
a,356,357,O
translational,358,371,O
regulatory,372,382,O
hairpin,383,390,O
structure,391,400,O
known,401,406,O
from,407,411,O
various,412,419,O
phage,420,425,O
genes,426,431,O
",",431,432,O
including,433,442,O
homing,443,449,O
endonucleases,450,463,O
(,464,465,O
22,465,467,O
",",467,468,O
47,468,470,O
-,470,471,O
49,471,473,O
),473,474,O
.,474,475,O
The,476,479,O
hairpins,480,488,O
we,489,491,O
found,492,497,O
are,498,501,O
in,502,504,O
fractured,505,514,O
gene,515,519,O
loci,520,524,O
with,525,529,O
different,530,539,O
protein,540,547,O
host,548,552,O
types,553,558,O
",",558,559,O
including,560,569,O
gp41,570,574,O
",",574,575,O
IMPDH,576,581,O
",",581,582,O
DnaE,583,587,O
",",587,588,O
NrdJ,589,593,O
and,594,597,O
NrdA,598,602,O
.,602,603,O
Ten,604,607,O
of,608,610,O
these,611,616,O
hairpins,617,625,O
also,626,630,O
include,631,638,O
a,639,640,O
conserved,641,650,O
sequence,651,659,O
of,660,662,O
Aeh1,663,667,O
phage,668,673,O
late,674,678,O
promoter,679,687,O
element,688,695,O
(,696,697,O
TATAAATA,697,705,O
),705,706,O
",",706,707,O
which,708,713,O
was,714,717,O
recently,718,726,O
shown,727,732,O
to,733,735,O
inhibit,736,743,O
the,744,747,O
translation,748,759,O
of,760,762,O
a,763,764,O
gene,765,769,O
-,769,770,O
fracturing,770,780,O
endonuclease,781,793,O
gene,794,798,O
",",798,799,O
by,800,802,O
sequestering,803,815,O
its,816,819,O
ribosome,820,828,B-Cellular_component
binding,829,836,O
site,837,841,O
(,842,843,O
22,843,845,O
",",845,846,O
23,846,848,O
),848,849,O
.,849,850,O
Analysis,851,859,O
of,860,862,O
the,863,866,O
endonuclease,867,879,O
5,880,881,O
',881,882,O
untranslated,883,895,O
regions,896,903,O
revealed,904,912,O
two,913,916,O
conserved,917,926,O
motifs,927,933,O
(,934,935,O
Figures,935,942,O
4A,943,945,O
and,946,949,O
Supplementary,950,963,O
Figure,964,970,O
S4,971,973,O
),973,974,O
",",974,975,O
which,976,981,O
usually,982,989,O
complement,990,1000,O
each,1001,1005,O
other,1006,1011,O
on,1012,1014,O
the,1015,1018,O
stem,1019,1023,O
of,1024,1026,O
the,1027,1030,O
conserved,1031,1040,O
hairpin,1041,1048,O
structures,1049,1059,O
.,1059,1060,O
Figure,1062,1068,O
4,1069,1070,O
.,1070,1071,O
Nucleotide,1072,1082,O
features,1083,1091,O
of,1092,1094,O
endonuclease,1095,1107,O
genes,1108,1113,O
.,1113,1114,O
(,1115,1116,O
A,1116,1117,O
),1117,1118,O
RNA,1119,1122,O
hairpin,1123,1130,O
structures,1131,1141,O
at,1142,1144,O
the,1145,1148,O
5,1149,1150,O
',1150,1151,O
untranslated,1152,1164,O
region,1165,1171,O
of,1172,1174,O
endonuclease,1175,1187,O
ORFs,1188,1192,O
in,1193,1195,O
the,1196,1199,O
gp41,1200,1204,O
-,1204,1205,O
1,1205,1206,O
(,1207,1208,O
representing,1208,1220,O
the,1221,1224,O
very,1225,1229,O
similar,1230,1237,O
sequences,1238,1247,O
of,1248,1250,O
gp41,1251,1255,O
-,1255,1256,O
1,1256,1257,O
-,1257,1258,O
7,1258,1259,O
),1259,1260,O
",",1260,1261,O
nrdA,1262,1266,O
-,1266,1267,O
5,1267,1268,O
and,1269,1272,O
DnaE,1273,1277,O
-,1277,1278,O
1,1278,1279,O
gene,1280,1284,O
loci,1285,1289,O
.,1289,1290,O
Initiator,1291,1300,O
codons,1301,1307,O
are,1308,1311,O
marked,1312,1318,O
by,1319,1321,O
arrows,1322,1328,O
",",1328,1329,O
conserved,1330,1339,O
putative,1340,1348,O
T4,1349,1351,O
late,1352,1356,O
promoter,1357,1365,O
elements,1366,1374,O
are,1375,1378,O
boxed,1379,1384,O
",",1384,1385,O
and,1386,1389,O
conserved,1390,1399,O
sequence,1400,1408,O
motifs,1409,1415,O
(,1416,1417,O
Supplementary,1417,1430,O
Figure,1431,1437,O
S4,1438,1440,O
),1440,1441,O
are,1442,1445,O
highlighted,1446,1457,O
in,1458,1460,O
grey,1461,1465,O
.,1465,1466,O
The,1467,1470,O
expected,1471,1479,O
values,1480,1486,O
for,1487,1490,O
motifs,1491,1497,O
1,1498,1499,O
and,1500,1503,O
2,1504,1505,O
are,1506,1509,O
1,1510,1511,O
.,1511,1512,O
7,1512,1513,O
-,1513,1514,O
10,1514,1516,O
and,1517,1520,O
9,1521,1522,O
.,1522,1523,O
9,1523,1524,O
-,1524,1525,O
3,1525,1526,O
",",1526,1527,O
respectively,1528,1540,O
.,1540,1541,O
RNA,1542,1545,O
structures,1546,1556,O
were,1557,1561,O
calculated,1562,1572,O
using,1573,1578,O
the,1579,1582,O
Vienna,1583,1589,O
package,1590,1597,O
(,1598,1599,O
http,1599,1603,O
:,1603,1604,O
/,1604,1605,O
/,1605,1606,O
rna,1606,1609,O
.,1609,1610,O
tbi,1610,1613,O
.,1613,1614,O
univie,1614,1620,O
.,1620,1621,O
ac,1621,1623,O
.,1623,1624,O
at,1624,1626,O
/,1626,1627,O
cgi,1627,1630,O
-,1630,1631,O
bin,1631,1634,O
/,1634,1635,O
RNAfold,1635,1642,O
.,1642,1643,O
cgi,1643,1646,O
),1646,1647,O
",",1647,1648,O
and,1649,1652,O
sequence,1653,1661,O
motifs,1662,1668,O
were,1669,1673,O
identified,1674,1684,O
using,1685,1690,O
the,1691,1694,O
MEME,1695,1699,O
program,1700,1707,O
.,1707,1708,O
(,1709,1710,O
B,1710,1711,O
),1711,1712,O
Overlapping,1713,1724,O
#,1724,1725,O
protein,1725,1732,O
coding,1733,1739,O
regions,1740,1747,O
of,1748,1750,O
endonuclease,1751,1763,O
3,1764,1765,O
',1765,1766,O
termini,1767,1774,O
and,1775,1778,O
the,1779,1782,O
5,1783,1784,O
',1784,1785,O
termini,1786,1793,O
of,1794,1796,O
their,1797,1802,O
downstream,1803,1813,O
genes,1814,1819,O
.,1819,1820,O
Additionally,1821,1833,O
",",1833,1834,O
15,1835,1837,O
loci,1838,1842,O
included,1843,1851,O
an,1852,1854,O
overlapping,1855,1866,O
region,1867,1873,O
of,1874,1876,O
6,1877,1878,O
-,1878,1879,O
69,1879,1881,O
bp,1882,1884,O
between,1885,1892,O
the,1893,1896,O
coding,1897,1903,O
regions,1904,1911,O
of,1912,1914,O
the,1915,1918,O
probable,1919,1927,O
endonuclease,1928,1940,O
C,1941,1942,O
-,1942,1943,O
termini,1943,1950,O
and,1951,1954,O
the,1955,1958,O
downstream,1959,1969,O
N,1970,1971,O
-,1971,1972,O
termini,1972,1979,O
of,1980,1982,O
the,1983,1986,O
split,1987,1992,O
-,1992,1993,O
intein,1993,1999,O
part,2000,2004,O
(,2005,2006,O
Figures,2006,2013,O
1,2014,2015,O
and,2016,2019,O
4B,2020,2022,O
),2022,2023,O
.,2023,2024,O
This,2025,2029,O
overlap,2030,2037,O
is,2038,2040,O
present,2041,2048,O
in,2049,2051,O
both,2052,2056,O
types,2057,2062,O
of,2063,2065,O
endonucleases,2066,2079,O
",",2079,2080,O
and,2081,2084,O
is,2085,2087,O
independent,2088,2099,O
on,2100,2102,O
the,2103,2106,O
presence,2107,2115,O
of,2116,2118,O
a,2119,2120,O
split,2121,2126,O
-,2126,2127,O
intein,2127,2133,O
part,2134,2138,O
in,2139,2141,O
the,2142,2145,O
fractured,2146,2155,O
gene,2156,2160,O
",",2160,2161,O
also,2162,2166,O
occurring,2167,2176,O
in,2177,2179,O
the,2180,2183,O
putative,2184,2192,O
sbcD,2193,2197,O
DNA,2198,2201,O
-,2201,2202,O
repair,2202,2208,O
gene,2209,2213,O
that,2214,2218,O
we,2219,2221,O
found,2222,2227,O
",",2227,2228,O
as,2229,2231,O
well,2232,2236,O
as,2237,2239,O
in,2240,2242,O
the,2243,2246,O
Aeh1,2247,2251,O
fractured,2252,2261,O
nrdA,2262,2266,O
found,2267,2272,O
by,2273,2275,O
Gibb,2276,2280,O
and,2281,2284,O
Edgell,2285,2291,O
(,2292,2293,O
22,2293,2295,O
),2295,2296,O
.,2296,2297,O
Efficacy,0,8,O
of,9,11,O
MMF,12,15,O
in,16,18,O
current,19,26,O
immunosuppressive,27,44,O
regimens,45,53,O
after,54,59,O
kidney,60,66,B-Organ
transplantation,67,82,O
Current,83,90,O
established,91,102,O
immunosuppressive,103,120,O
strategies,121,131,O
in,132,134,O
kidney,135,141,B-Organ
transplantation,142,157,O
often,158,163,O
include,164,171,O
an,172,174,O
induction,175,184,O
agent,185,190,O
(,191,192,O
monoclonal,192,202,O
or,203,205,O
polyclonal,206,216,O
anti,217,221,O
-,221,222,O
T,222,223,B-Cell
-,223,224,I-Cell
cell,224,228,I-Cell
antibodies,229,239,O
),239,240,O
based,241,246,O
on,247,249,O
the,250,253,O
immunologic,254,265,O
risk,266,270,O
of,271,273,O
the,274,277,O
recipient,278,287,O
",",287,288,O
followed,289,297,O
by,298,300,O
a,301,302,O
maintenance,303,314,O
regimen,315,322,O
combining,323,332,O
a,333,334,O
CNI,335,338,O
and,339,342,O
an,343,345,O
anti,346,350,O
-,350,351,O
proliferative,351,364,O
agent,365,370,O
",",370,371,O
with,372,376,O
or,377,379,O
without,380,387,O
corticosteroids,388,403,O
.,403,404,O
2,404,405,O
-,405,406,O
4,406,407,O
As,408,410,O
MMF,411,414,O
was,415,418,O
the,419,422,O
first,423,428,O
MPA,429,432,O
formulation,433,444,O
approved,445,453,O
in,454,456,O
clinical,457,465,O
kidney,466,472,B-Organ
transplantation,473,488,O
",",488,489,O
more,490,494,O
extensive,495,504,O
clinical,505,513,O
data,514,518,O
are,519,522,O
available,523,532,O
with,533,537,O
this,538,542,O
drug,543,547,O
in,548,550,O
comparison,551,561,O
to,562,564,O
EC,565,567,O
-,567,568,O
MPS,568,571,O
.,571,572,O
Sex,0,3,O
and,4,7,O
age,8,11,O
distributions,12,25,O
of,26,28,O
confirmed,29,38,O
cases,39,44,O
Of,45,47,O
480,48,51,O
confirmed,52,61,O
cases,62,67,O
",",67,68,O
56,69,71,O
%,71,72,O
(,73,74,O
269,74,77,O
/,77,78,O
480,78,81,O
),81,82,O
were,83,87,O
male,88,92,O
patients,93,101,O
and,102,105,O
44,106,108,O
%,108,109,O
(,110,111,O
211,111,114,O
/,114,115,O
480,115,118,O
),118,119,O
were,120,124,O
female,125,131,O
",",131,132,O
respectively,133,145,O
.,145,146,O
The,147,150,O
percentage,151,161,O
of,162,164,O
male,165,169,O
cases,170,175,O
was,176,179,O
higher,180,186,O
than,187,191,O
that,192,196,O
of,197,199,O
females,200,207,O
in,208,210,O
all,211,214,O
groups,215,221,O
except,222,228,O
for,229,232,O
the,233,236,O
group,237,242,O
aged,243,247,O
31,248,250,O
-,250,251,O
40,251,253,O
(,254,255,O
chi2,255,259,O
=,260,261,O
42,262,264,O
.,264,265,O
4,265,266,O
",",266,267,O
P,268,269,O
<,270,271,O
0,272,273,O
.,273,274,O
001,274,277,O
),277,278,O
.,278,279,O
278,280,283,O
(,284,285,O
57,285,287,O
.,287,288,O
9,288,289,O
%,289,290,O
),290,291,O
cases,292,297,O
were,298,302,O
in,303,305,O
the,306,309,O
group,310,315,O
aged,316,320,O
21,321,323,O
-,323,324,O
50,324,326,O
",",326,327,O
followed,328,336,O
by,337,339,O
102,340,343,O
(,344,345,O
21,345,347,O
.,347,348,O
3,348,349,O
%,349,350,O
),350,351,O
",",351,352,O
79,353,355,O
(,356,357,O
16,357,359,O
.,359,360,O
5,360,361,O
%,361,362,O
),362,363,O
and,364,367,O
21,368,370,O
(,371,372,O
4,372,373,O
.,373,374,O
4,374,375,O
%,375,376,O
),376,377,O
cases,378,383,O
in,384,386,O
the,387,390,O
group,391,396,O
aged,397,401,O
51,402,404,O
-,404,405,O
70,405,407,O
",",407,408,O
0,409,410,O
-,410,411,O
20,411,413,O
",",413,414,O
and,415,418,O
>,419,420,O
=,420,421,O
71,422,424,O
",",424,425,O
respectively,426,438,O
.,438,439,O
The,440,443,O
youngest,444,452,O
and,453,456,O
oldest,457,463,O
cases,464,469,O
were,470,474,O
1,475,476,O
.,476,477,O
5,477,478,O
and,479,482,O
81,483,485,O
years,486,491,O
old,492,495,O
",",495,496,O
respectively,497,509,O
(,510,511,O
Table,511,516,O
2,517,518,O
),518,519,O
.,519,520,O
Table,521,526,O
2,527,528,O
Age,529,532,O
and,533,536,O
occupational,537,549,O
distributions,550,563,O
and,564,567,O
activities,568,578,O
(,579,580,O
1,580,581,O
-,581,582,O
3,582,583,O
weeks,584,589,O
prior,590,595,O
to,596,598,O
symptom,599,606,O
appearance,607,617,O
),617,618,O
of,619,621,O
confirmed,622,631,O
cases,632,637,O
Cases,638,643,O
(,644,645,O
%,645,646,O
),646,647,O
(,648,649,O
Male,649,653,O
:,653,654,O
Female,655,661,O
",",661,662,O
%,663,664,O
),664,665,O
Age,666,669,O
(,670,671,O
Years,671,676,O
),676,677,O
0,678,679,O
-,679,680,O
10,680,682,O
46,683,685,O
(,686,687,O
9,687,688,O
.,688,689,O
6,689,690,O
),690,691,O
(,692,693,O
76,693,695,O
:,695,696,O
24,696,698,O
),698,699,O
11,700,702,O
-,702,703,O
20,703,705,O
33,706,708,O
(,709,710,O
6,710,711,O
.,711,712,O
9,712,713,O
),713,714,O
(,715,716,O
79,716,718,O
:,718,719,O
21,719,721,O
),721,722,O
21,723,725,O
-,725,726,O
30,726,728,O
78,729,731,O
(,732,733,O
16,733,735,O
.,735,736,O
3,736,737,O
),737,738,O
(,739,740,O
51,740,742,O
:,742,743,O
49,743,745,O
),745,746,O
31,747,749,O
-,749,750,O
40,750,752,O
99,753,755,O
(,756,757,O
20,757,759,O
.,759,760,O
6,760,761,O
),761,762,O
(,763,764,O
46,764,766,O
:,766,767,O
54,767,769,O
),769,770,O
41,771,773,O
-,773,774,O
50,774,776,O
101,777,780,O
(,781,782,O
21,782,784,O
.,784,785,O
0,785,786,O
),786,787,O
(,788,789,O
56,789,791,O
:,791,792,O
44,792,794,O
),794,795,O
51,796,798,O
-,798,799,O
60,799,801,O
47,802,804,O
(,805,806,O
9,806,807,O
.,807,808,O
8,808,809,O
),809,810,O
(,811,812,O
55,812,814,O
:,814,815,O
45,815,817,O
),817,818,O
61,819,821,O
-,821,822,O
70,822,824,O
55,825,827,O
(,828,829,O
11,829,831,O
.,831,832,O
5,832,833,O
),833,834,O
(,835,836,O
53,836,838,O
:,838,839,O
47,839,841,O
),841,842,O
>,843,844,O
=,844,845,O
71,846,848,O
21,849,851,O
(,852,853,O
4,853,854,O
.,854,855,O
4,855,856,O
),856,857,O
(,858,859,O
52,859,861,O
:,861,862,O
48,862,864,O
),864,865,O
Occupation,866,876,O
Children,877,885,O
at,886,888,O
preschool,889,898,O
age,899,902,O
20,903,905,O
(,906,907,O
4,907,908,O
.,908,909,O
2,909,910,O
),910,911,O
(,912,913,O
75,913,915,O
:,915,916,O
25,916,918,O
),918,919,O
Pupils,920,926,O
50,927,929,O
(,930,931,O
10,931,933,O
.,933,934,O
4,934,935,O
),935,936,O
(,937,938,O
78,938,940,O
:,940,941,O
22,941,943,O
),943,944,O
Farmers,945,952,O
408,953,956,O
(,957,958,O
85,958,960,O
.,960,961,O
0,961,962,O
),962,963,O
(,964,965,O
52,965,967,O
:,967,968,O
48,968,970,O
),970,971,O
Others,972,978,O
2,979,980,O
(,981,982,O
0,982,983,O
.,983,984,O
4,984,985,O
),985,986,O
(,987,988,O
50,988,990,O
:,990,991,O
50,991,993,O
),993,994,O
Activities,995,1005,O
Farm,1006,1010,O
work,1011,1015,O
325,1016,1019,O
(,1020,1021,O
67,1021,1023,O
.,1023,1024,O
7,1024,1025,O
),1025,1026,O
(,1027,1028,O
53,1028,1030,O
:,1030,1031,O
47,1031,1033,O
),1033,1034,O
Play,1035,1039,O
on,1040,1042,O
grassland,1043,1052,O
65,1053,1055,O
(,1056,1057,O
13,1057,1059,O
.,1059,1060,O
5,1060,1061,O
),1061,1062,O
(,1063,1064,O
75,1064,1066,O
:,1066,1067,O
25,1067,1069,O
),1069,1070,O
Recreation,1071,1081,O
20,1082,1084,O
(,1085,1086,O
4,1086,1087,O
.,1087,1088,O
2,1088,1089,O
),1089,1090,O
(,1091,1092,O
65,1092,1094,O
:,1094,1095,O
35,1095,1097,O
),1097,1098,O
Housework,1099,1108,O
25,1109,1111,O
(,1112,1113,O
5,1113,1114,O
.,1114,1115,O
2,1115,1116,O
),1116,1117,O
(,1118,1119,O
8,1119,1120,O
:,1120,1121,O
92,1121,1123,O
),1123,1124,O
Unknown,1125,1132,O
45,1133,1135,O
(,1136,1137,O
9,1137,1138,O
.,1138,1139,O
4,1139,1140,O
),1140,1141,O
(,1142,1143,O
71,1143,1145,O
:,1145,1146,O
29,1146,1148,O
),1148,1149,O
Discussion,0,10,O
Because,11,18,O
Netherton,19,28,O
syndrome,29,37,O
exhibits,38,46,O
allergic,47,55,O
phenotype,56,65,O
",",65,66,O
it,67,69,O
is,70,72,O
reasonable,73,83,O
to,84,86,O
speculate,87,96,O
that,97,101,O
SPINK5,102,108,O
",",108,109,O
which,110,115,O
is,116,118,O
mutated,119,126,O
in,127,129,O
Netherton,130,139,O
syndrome,140,148,O
",",148,149,O
may,150,153,O
act,154,157,O
as,158,160,O
a,161,162,O
candidate,163,172,O
gene,173,177,O
for,178,181,O
asthma,182,188,O
and,189,192,O
other,193,198,O
allergic,199,207,O
diseases,208,216,O
[,217,218,O
9,218,219,O
],219,220,O
.,220,221,O
An,222,224,O
extensive,225,234,O
search,235,241,O
for,242,245,O
single,246,252,O
nucleotide,253,263,O
polymorphisms,264,277,O
in,278,280,O
the,281,284,O
SPINK5,285,291,O
led,292,295,O
to,296,298,O
the,299,302,O
identification,303,317,O
of,318,320,O
a,321,322,O
number,323,329,O
of,330,332,O
SNPs,333,337,O
",",337,338,O
including,339,348,O
six,349,352,O
nonsynonymous,353,366,O
SNPs,367,371,O
in,372,374,O
coding,375,381,O
region,382,388,O
that,389,393,O
might,394,399,O
perturb,400,407,O
its,408,411,O
immune,412,418,O
function,419,427,O
.,427,428,O
Subsequent,429,439,O
genotyping,440,450,O
of,451,453,O
three,454,459,O
nonsynonymous,460,473,O
SNPs,474,478,O
",",478,479,O
A1103G,480,486,O
",",486,487,O
G1156A,488,494,O
and,495,498,O
G1258A,499,505,O
in,506,508,O
two,509,512,O
independent,513,524,O
panels,525,531,O
of,532,534,O
British,535,542,O
families,543,551,O
showed,552,558,O
a,559,560,O
significant,561,572,O
association,573,584,O
between,585,592,O
SNP,593,596,O
G1258A,597,603,O
(,604,605,O
Glu420Lys,605,614,O
),614,615,O
and,616,619,O
atopy,620,625,O
",",625,626,O
atopic,627,633,O
dermatitis,634,644,O
",",644,645,O
elevated,646,654,O
serum,655,660,B-Organism_substance
IgE,661,664,O
levels,665,671,O
and,672,675,O
asthma,676,682,O
[,683,684,O
10,684,686,O
],686,687,O
.,687,688,O
This,689,693,O
association,694,705,O
was,706,709,O
confirmed,710,719,O
in,720,722,O
a,723,724,O
large,725,730,O
German,731,737,O
population,738,748,O
and,749,752,O
two,753,756,O
Japanese,757,765,O
populations,766,777,O
[,778,779,O
16,779,781,O
-,781,782,O
18,782,784,O
],784,785,O
.,785,786,O
Kato,787,791,O
et,792,794,O
al,795,797,O
analyzed,798,806,O
eight,807,812,O
SNPs,813,817,O
in,818,820,O
exon,821,825,O
13,826,828,O
and,829,832,O
14,833,835,O
of,836,838,O
the,839,842,O
SPINK5,843,849,O
including,850,859,O
G1258A,860,866,O
(,867,868,O
Glu420Lys,868,877,O
),877,878,O
",",878,879,O
and,880,883,O
found,884,889,O
a,890,891,O
positive,892,900,O
association,901,912,O
of,913,915,O
seven,916,921,O
SNPs,922,926,O
with,927,931,O
atopic,932,938,O
dermatitis,939,949,O
in,950,952,O
a,953,954,O
Japanese,955,963,O
study,964,969,O
sample,970,976,O
using,977,982,O
a,983,984,O
case,985,989,O
-,989,990,O
control,990,997,O
study,998,1003,O
design,1004,1010,O
[,1011,1012,O
16,1012,1014,O
],1014,1015,O
.,1015,1016,O
Nishio,1017,1023,O
et,1024,1026,O
al,1027,1029,O
surveyed,1030,1038,O
five,1039,1043,O
of,1044,1046,O
six,1047,1050,O
previously,1051,1061,O
reported,1062,1070,O
nonsynonymous,1071,1084,O
SPINK5,1085,1091,O
SNPs,1092,1096,O
in,1097,1099,O
Japanese,1100,1108,O
atopic,1109,1115,O
families,1116,1124,O
identified,1125,1135,O
through,1136,1143,O
asthmatic,1144,1153,O
children,1154,1162,O
or,1163,1165,O
subjects,1166,1174,O
with,1175,1179,O
atopic,1180,1186,O
dermatitis,1187,1197,O
and,1198,1201,O
found,1202,1207,O
that,1208,1212,O
SPINK5,1213,1219,O
was,1220,1223,O
associated,1224,1234,O
with,1235,1239,O
development,1240,1251,O
of,1252,1254,O
atopic,1255,1261,O
dermatitis,1262,1272,O
but,1273,1276,O
not,1277,1280,O
asthma,1281,1287,O
[,1288,1289,O
17,1289,1291,O
],1291,1292,O
.,1292,1293,O
Kabesch,1294,1301,O
M,1302,1303,O
et,1304,1306,O
al,1307,1309,O
.,1309,1310,O
analyzed,1311,1319,O
G1258A,1320,1326,O
(,1327,1328,O
Glu420Lys,1328,1337,O
),1337,1338,O
in,1339,1341,O
a,1342,1343,O
German,1344,1350,O
population,1351,1361,O
of,1362,1364,O
school,1365,1371,O
children,1372,1380,O
",",1380,1381,O
and,1382,1385,O
found,1386,1391,O
its,1392,1395,O
association,1396,1407,O
with,1408,1412,O
asthma,1413,1419,O
as,1420,1422,O
well,1423,1427,O
as,1428,1430,O
a,1431,1432,O
concomitant,1433,1444,O
occurrence,1445,1455,O
of,1456,1458,O
asthma,1459,1465,O
and,1466,1469,O
atopic,1470,1476,O
dermatitis,1477,1487,O
[,1488,1489,O
18,1489,1491,O
],1491,1492,O
.,1492,1493,O
However,1494,1501,O
",",1501,1502,O
two,1503,1506,O
subsequent,1507,1517,O
studies,1518,1525,O
failed,1526,1532,O
to,1533,1535,O
replicate,1536,1545,O
the,1546,1549,O
original,1550,1558,O
SPINK5,1559,1565,O
findings,1566,1574,O
for,1575,1578,O
allergic,1579,1587,O
diseases,1588,1596,O
[,1597,1598,O
19,1598,1600,O
",",1600,1601,O
20,1601,1603,O
],1603,1604,O
.,1604,1605,O
Folster,1606,1613,O
-,1613,1614,O
Holst,1614,1619,O
et,1620,1622,O
al,1623,1625,O
genotyped,1626,1635,O
four,1636,1640,O
nonsynonymous,1641,1654,O
SNPs,1655,1659,O
(,1660,1661,O
Asp106Asn,1661,1670,O
",",1670,1671,O
Asn368Ser,1672,1681,O
",",1681,1682,O
Asp386Asn,1683,1692,O
",",1692,1693,O
and,1694,1697,O
Glu420Lys,1698,1707,O
),1707,1708,O
",",1708,1709,O
and,1710,1713,O
detected,1714,1722,O
no,1723,1725,O
association,1726,1737,O
between,1738,1745,O
SPINK5,1746,1752,O
and,1753,1756,O
atopic,1757,1763,O
dermatitis,1764,1774,O
in,1775,1777,O
populations,1778,1789,O
of,1790,1792,O
Northern,1793,1801,O
German,1802,1808,O
origin,1809,1815,O
[,1816,1817,O
20,1817,1819,O
],1819,1820,O
.,1820,1821,O
Jongepier,1822,1831,O
H,1832,1833,O
et,1834,1836,O
al,1837,1839,O
.,1839,1840,O
failed,1841,1847,O
to,1848,1850,O
detect,1851,1857,O
any,1858,1861,O
association,1862,1873,O
between,1874,1881,O
SPINK5,1882,1888,O
and,1889,1892,O
asthma,1893,1899,O
",",1899,1900,O
atopic,1901,1907,O
phenotypes,1908,1918,O
and,1919,1922,O
atopic,1923,1929,O
dermatitis,1930,1940,O
in,1941,1943,O
a,1944,1945,O
Dutch,1946,1951,O
population,1952,1962,O
[,1963,1964,O
19,1964,1966,O
],1966,1967,O
.,1967,1968,O
These,1969,1974,O
discordant,1975,1985,O
findings,1986,1994,O
probably,1995,2003,O
reflect,2004,2011,O
different,2012,2021,O
genetic,2022,2029,O
and,2030,2033,O
environmental,2034,2047,O
backgrounds,2048,2059,O
in,2060,2062,O
various,2063,2070,O
populations,2071,2082,O
.,2082,2083,O
To,2084,2086,O
determine,2087,2096,O
whether,2097,2104,O
nonsynonymous,2105,2118,O
SNPs,2119,2123,O
of,2124,2126,O
the,2127,2130,O
SPINK5,2131,2137,O
are,2138,2141,O
involved,2142,2150,O
in,2151,2153,O
the,2154,2157,O
pathogenesis,2158,2170,O
of,2171,2173,O
asthma,2174,2180,O
in,2181,2183,O
the,2184,2187,O
Chinese,2188,2195,O
Han,2196,2199,O
population,2200,2210,O
",",2210,2211,O
we,2212,2214,O
performed,2215,2224,O
a,2225,2226,O
case,2227,2231,O
-,2231,2232,O
control,2232,2239,O
study,2240,2245,O
by,2246,2248,O
genotyping,2249,2259,O
four,2260,2264,O
nonsynonymous,2265,2278,O
SNPs,2279,2283,O
in,2284,2286,O
the,2287,2290,O
SPINK5,2291,2297,O
.,2297,2298,O
We,2299,2301,O
did,2302,2305,O
not,2306,2309,O
detect,2310,2316,O
any,2317,2320,O
significant,2321,2332,O
association,2333,2344,O
between,2345,2352,O
these,2353,2358,O
nonsynonymous,2359,2372,O
SNPs,2373,2377,O
and,2378,2381,O
asthma,2382,2388,O
in,2389,2391,O
our,2392,2395,O
Chinese,2396,2403,O
samples,2404,2411,O
.,2411,2412,O
With,2413,2417,O
our,2418,2421,O
sample,2422,2428,O
size,2429,2433,O
",",2433,2434,O
we,2435,2437,O
expected,2438,2446,O
a,2447,2448,O
power,2449,2454,O
of,2455,2457,O
at,2458,2460,O
least,2461,2466,O
80,2467,2469,O
%,2469,2470,O
in,2471,2473,O
detecting,2474,2483,O
an,2484,2486,O
effect,2487,2493,O
of,2494,2496,O
OR,2497,2499,O
>,2500,2501,O
=,2501,2502,O
1,2502,2503,O
.,2503,2504,O
3,2504,2505,O
for,2506,2509,O
each,2510,2514,O
of,2515,2517,O
these,2518,2523,O
SNPs,2524,2528,O
.,2528,2529,O
Therefore,2530,2539,O
",",2539,2540,O
our,2541,2544,O
failure,2545,2552,O
to,2553,2555,O
detect,2556,2562,O
an,2563,2565,O
association,2566,2577,O
for,2578,2581,O
these,2582,2587,O
4,2588,2589,O
SNPs,2590,2594,O
was,2595,2598,O
not,2599,2602,O
due,2603,2606,O
to,2607,2609,O
the,2610,2613,O
sample,2614,2620,O
size,2621,2625,O
.,2625,2626,O
These,2627,2632,O
results,2633,2640,O
suggest,2641,2648,O
that,2649,2653,O
the,2654,2657,O
polymorphisms,2658,2671,O
in,2672,2674,O
the,2675,2678,O
coding,2679,2685,O
region,2686,2692,O
of,2693,2695,O
the,2696,2699,O
SPINK5,2700,2706,O
are,2707,2710,O
unlikely,2711,2719,O
to,2720,2722,O
contribute,2723,2733,O
to,2734,2736,O
asthma,2737,2743,O
risk,2744,2748,O
in,2749,2751,O
the,2752,2755,O
Chinese,2756,2763,O
Han,2764,2767,O
population,2768,2778,O
.,2778,2779,O
However,2780,2787,O
",",2787,2788,O
because,2789,2796,O
our,2797,2800,O
patients,2801,2809,O
were,2810,2814,O
ascertained,2815,2826,O
for,2827,2830,O
asthma,2831,2837,O
",",2837,2838,O
we,2839,2841,O
could,2842,2847,O
not,2848,2851,O
exclude,2852,2859,O
a,2860,2861,O
role,2862,2866,O
of,2867,2869,O
the,2870,2873,O
coding,2874,2880,O
SNPs,2881,2885,O
of,2886,2888,O
the,2889,2892,O
SPINK5,2893,2899,O
in,2900,2902,O
atopic,2903,2909,O
dermatitis,2910,2920,O
in,2921,2923,O
our,2924,2927,O
population,2928,2938,O
.,2938,2939,O
The,2940,2943,O
variations,2944,2954,O
in,2955,2957,O
the,2958,2961,O
regulatory,2962,2972,O
sequences,2973,2982,O
of,2983,2985,O
genes,2986,2991,O
may,2992,2995,O
determine,2996,3005,O
risks,3006,3011,O
to,3012,3014,O
common,3015,3021,O
diseases,3022,3030,O
by,3031,3033,O
causing,3034,3041,O
different,3042,3051,O
levels,3052,3058,O
of,3059,3061,O
expression,3062,3072,O
.,3072,3073,O
Therefore,3074,3083,O
",",3083,3084,O
the,3085,3088,O
identification,3089,3103,O
and,3104,3107,O
functional,3108,3118,O
evaluation,3119,3129,O
of,3130,3132,O
polymorphisms,3133,3146,O
in,3147,3149,O
promoter,3150,3158,O
region,3159,3165,O
are,3166,3169,O
of,3170,3172,O
great,3173,3178,O
value,3179,3184,O
in,3185,3187,O
understanding,3188,3201,O
the,3202,3205,O
genetic,3206,3213,O
susceptibility,3214,3228,O
to,3229,3231,O
asthma,3232,3238,O
.,3238,3239,O
In,3240,3242,O
order,3243,3248,O
to,3249,3251,O
determine,3252,3261,O
the,3262,3265,O
role,3266,3270,O
of,3271,3273,O
the,3274,3277,O
SPINK5,3278,3284,O
promoter,3285,3293,O
polymorphism,3294,3306,O
in,3307,3309,O
the,3310,3313,O
pathogenesis,3314,3326,O
of,3327,3329,O
asthma,3330,3336,O
",",3336,3337,O
we,3338,3340,O
genotyped,3341,3350,O
a,3351,3352,O
promoter,3353,3361,O
polymorphism,3362,3374,O
",",3374,3375,O
-,3376,3377,O
206G,3377,3381,O
>,3381,3382,O
A,3382,3383,O
",",3383,3384,O
in,3385,3387,O
422,3388,3391,O
asthma,3392,3398,O
patients,3399,3407,O
and,3408,3411,O
410,3412,3415,O
controls,3416,3424,O
",",3424,3425,O
and,3426,3429,O
found,3430,3435,O
a,3436,3437,O
marginal,3438,3446,O
association,3447,3458,O
.,3458,3459,O
The,3460,3463,O
frequency,3464,3473,O
of,3474,3476,O
allele,3477,3483,O
G,3484,3485,O
was,3486,3489,O
significantly,3490,3503,O
higher,3504,3510,O
in,3511,3513,O
asthmatic,3514,3523,O
patients,3524,3532,O
than,3533,3537,O
that,3538,3542,O
in,3543,3545,O
controls,3546,3554,O
(,3555,3556,O
p,3556,3557,O
=,3558,3559,O
0,3560,3561,O
.,3561,3562,O
022,3562,3565,O
),3565,3566,O
.,3566,3567,O
To,3568,3570,O
confirm,3571,3578,O
the,3579,3582,O
association,3583,3594,O
",",3594,3595,O
additional,3596,3606,O
267,3607,3610,O
asthma,3611,3617,O
patients,3618,3626,O
and,3627,3630,O
301,3631,3634,O
controls,3635,3643,O
newly,3644,3649,O
recruited,3650,3659,O
from,3660,3664,O
the,3665,3668,O
same,3669,3673,O
hospital,3674,3682,O
were,3683,3687,O
genotyped,3688,3697,O
",",3697,3698,O
and,3699,3702,O
the,3703,3706,O
-,3707,3708,O
206G,3708,3712,O
>,3712,3713,O
A,3713,3714,O
polymorphism,3715,3727,O
remained,3728,3736,O
significantly,3737,3750,O
associated,3751,3761,O
with,3762,3766,O
asthma,3767,3773,O
(,3774,3775,O
P,3775,3776,O
=,3777,3778,O
0,3779,3780,O
.,3780,3781,O
001,3781,3784,O
),3784,3785,O
",",3785,3786,O
even,3787,3791,O
after,3792,3797,O
Bonferroni,3798,3808,O
correction,3809,3819,O
(,3819,3820,O
adjusted,3820,3828,O
P,3829,3830,O
=,3831,3832,O
0,3833,3834,O
.,3834,3835,O
01,3835,3837,O
),3837,3838,O
.,3838,3839,O
To,3840,3842,O
our,3843,3846,O
knowledge,3847,3856,O
",",3856,3857,O
this,3858,3862,O
is,3863,3865,O
the,3866,3869,O
first,3870,3875,O
report,3876,3882,O
of,3883,3885,O
an,3886,3888,O
association,3889,3900,O
of,3901,3903,O
-,3904,3905,O
206G,3905,3909,O
>,3909,3910,O
A,3910,3911,O
polymorphism,3912,3924,O
with,3925,3929,O
asthma,3930,3936,O
.,3936,3937,O
We,3938,3940,O
further,3941,3948,O
examined,3949,3957,O
the,3958,3961,O
potential,3962,3971,O
functional,3972,3982,O
role,3983,3987,O
of,3988,3990,O
this,3991,3995,O
promoter,3996,4004,O
polymorphism,4005,4017,O
",",4017,4018,O
and,4019,4022,O
found,4023,4028,O
that,4029,4033,O
the,4034,4037,O
G,4038,4039,O
to,4040,4042,O
A,4043,4044,O
substitution,4045,4057,O
at,4058,4060,O
-,4061,4062,O
206,4062,4065,O
generated,4066,4075,O
a,4076,4077,O
GATA,4078,4082,O
-,4082,4083,O
3,4083,4084,O
transcription,4085,4098,O
factor,4099,4105,O
binding,4106,4113,O
site,4114,4118,O
.,4118,4119,O
Major,4120,4125,O
transcription,4126,4139,O
factors,4140,4147,O
controlling,4148,4159,O
Th1,4160,4163,O
and,4164,4167,O
Th2,4168,4171,O
development,4172,4183,O
",",4183,4184,O
such,4185,4189,O
as,4190,4192,O
T,4193,4194,O
-,4194,4195,O
box,4195,4198,O
transcription,4199,4212,O
factor,4213,4219,O
and,4220,4223,O
GATA3,4224,4229,O
",",4229,4230,O
are,4231,4234,O
possibly,4235,4243,O
involved,4244,4252,O
in,4253,4255,O
asthma,4256,4262,O
and,4263,4266,O
atopic,4267,4273,O
diseases,4274,4282,O
.,4282,4283,O
GATA,4284,4288,O
-,4288,4289,O
3,4289,4290,O
",",4290,4291,O
a,4292,4293,O
transcription,4294,4307,O
factor,4308,4314,O
specifically,4315,4327,O
expressed,4328,4337,O
in,4338,4340,O
T,4341,4342,B-Cell
helper,4343,4349,I-Cell
2,4350,4351,I-Cell
(,4352,4353,I-Cell
Th2,4353,4356,I-Cell
),4356,4357,I-Cell
cells,4358,4363,I-Cell
",",4363,4364,O
plays,4365,4370,O
a,4371,4372,O
critical,4373,4381,O
role,4382,4386,O
in,4387,4389,O
the,4390,4393,O
differentiation,4394,4409,O
of,4410,4412,O
Th2,4413,4416,B-Cell
cells,4417,4422,I-Cell
from,4423,4427,O
uncommitted,4428,4439,O
CD4,4440,4443,B-Cell
+,4443,4444,I-Cell
lymphocytes,4445,4456,I-Cell
.,4456,4457,O
In,4458,4460,O
addition,4461,4469,O
",",4469,4470,O
GATA,4471,4475,O
-,4475,4476,O
3,4476,4477,O
is,4478,4480,O
essential,4481,4490,O
for,4491,4494,O
the,4495,4498,O
expression,4499,4509,O
of,4510,4512,O
the,4513,4516,O
cytokines,4517,4526,O
IL,4527,4529,O
-,4529,4530,O
4,4530,4531,O
",",4531,4532,O
IL,4533,4535,O
-,4535,4536,O
5,4536,4537,O
and,4538,4541,O
IL,4542,4544,O
-,4544,4545,O
13,4545,4547,O
that,4548,4552,O
mediate,4553,4560,O
allergic,4561,4569,O
inflammation,4570,4582,O
[,4583,4584,O
23,4584,4586,O
],4586,4587,O
.,4587,4588,O
Our,4589,4592,O
luciferase,4593,4603,O
reporter,4604,4612,O
assay,4613,4618,O
confirmed,4619,4628,O
that,4629,4633,O
SNP,4634,4637,O
-,4638,4639,O
206G,4639,4643,O
>,4643,4644,O
A,4644,4645,O
is,4646,4648,O
associated,4649,4659,O
with,4660,4664,O
the,4665,4668,O
transcriptional,4669,4684,O
activity,4685,4693,O
of,4694,4696,O
SPINK5,4697,4703,O
.,4703,4704,O
The,4705,4708,O
G,4709,4710,O
allele,4711,4717,O
was,4718,4721,O
associated,4722,4732,O
with,4733,4737,O
decreased,4738,4747,O
transcriptional,4748,4763,O
activity,4764,4772,O
of,4773,4775,O
the,4776,4779,O
SPINK5,4780,4786,O
.,4786,4787,O
The,4788,4791,O
mechanism,4792,4801,O
by,4802,4804,O
which,4805,4810,O
the,4811,4814,O
-,4815,4816,O
206G,4816,4820,O
>,4820,4821,O
A,4821,4822,O
SNP,4823,4826,O
affects,4827,4834,O
SPINK5,4835,4841,O
expression,4842,4852,O
may,4853,4856,O
be,4857,4859,O
explained,4860,4869,O
by,4870,4872,O
the,4873,4876,O
potential,4877,4886,O
differential,4887,4899,O
transcription,4900,4913,O
factor,4914,4920,O
binding,4921,4928,O
of,4929,4931,O
GATA,4932,4936,O
binding,4937,4944,O
factor,4945,4951,O
",",4951,4952,O
since,4953,4958,O
-,4959,4960,O
206G,4960,4964,O
>,4964,4965,O
A,4965,4966,O
is,4967,4969,O
located,4970,4977,O
at,4978,4980,O
the,4981,4984,O
core,4985,4989,O
sequence,4990,4998,O
of,4999,5001,O
GATA,5002,5006,O
binding,5007,5014,O
factor,5015,5021,O
binding,5022,5029,O
site,5030,5034,O
.,5034,5035,O
Electrophoretic,5036,5051,O
mobility,5052,5060,O
shift,5061,5066,O
assay,5067,5072,O
confirmed,5073,5082,O
that,5083,5087,O
the,5088,5091,O
A,5092,5093,O
to,5094,5096,O
G,5097,5098,O
substitution,5099,5111,O
at,5112,5114,O
-,5115,5116,O
206,5116,5119,O
significantly,5120,5133,O
reduced,5134,5141,O
the,5142,5145,O
binding,5146,5153,O
efficiency,5154,5164,O
of,5165,5167,O
nuclear,5168,5175,B-Cellular_component
proteins,5176,5184,O
to,5185,5187,O
this,5188,5192,O
element,5193,5200,O
.,5200,5201,O
Our,5202,5205,O
data,5206,5210,O
suggest,5211,5218,O
that,5219,5223,O
loss,5224,5228,O
of,5229,5231,O
GATA,5232,5236,O
transcription,5237,5250,O
factor,5251,5257,O
regulation,5258,5268,O
with,5269,5273,O
the,5274,5277,O
-,5278,5279,O
206G,5279,5283,O
may,5284,5287,O
decrease,5288,5296,O
the,5297,5300,O
SPINK5,5301,5307,O
expression,5308,5318,O
and,5319,5322,O
thereby,5323,5330,O
potentially,5331,5342,O
perturb,5343,5350,O
the,5351,5354,O
immunosuppressive,5355,5372,O
function,5373,5381,O
of,5382,5384,O
LEKTI,5385,5390,O
.,5390,5391,O
Statistical,0,11,O
Analysis,12,20,O
Mitochondrial,21,34,B-Cellular_component
DNA,35,38,O
haplogroup,39,49,O
frequencies,50,61,O
were,62,66,O
calculated,67,77,O
by,78,80,O
counting,81,89,O
from,90,94,O
the,95,98,O
observed,99,107,O
genotypes,108,117,O
.,117,118,O
The,119,122,O
Pearson,123,130,O
chi,131,134,O
-,134,135,O
square,135,141,O
test,142,146,O
and,147,150,O
the,151,154,O
chi,155,158,O
-,158,159,O
square,159,165,O
test,166,170,O
for,171,174,O
linear,175,181,O
-,181,182,O
by,182,184,O
-,184,185,O
linear,185,191,O
association,192,203,O
were,204,208,O
used,209,213,O
to,214,216,O
analyze,217,224,O
the,225,228,O
significances,229,242,O
between,243,250,O
the,251,254,O
prevalence,255,265,O
of,266,268,O
haplogroups,269,280,O
and,281,284,O
different,285,294,O
age,295,298,O
groups,299,305,O
.,305,306,O
SPSS,307,311,O
software,312,320,O
(,321,322,O
version,322,329,O
10,330,332,O
.,332,333,O
0,333,334,O
),334,335,O
was,336,339,O
used,340,344,O
.,344,345,O
Duplicated,0,10,O
HGT,11,14,O
candidates,15,25,O
in,26,28,O
K,29,30,O
.,30,31,O
thermotolerans,32,46,O
.,46,47,O
(,48,49,O
A,49,50,O
),50,51,O
Part,52,56,O
of,57,59,O
the,60,63,O
conserved,64,73,O
synteny,74,81,O
block,82,87,O
surrounding,88,99,O
KLTH0C07700g,100,112,O
and,113,116,O
KLTH0C07722g,117,129,O
tandem,130,136,O
genes,137,142,O
.,142,143,O
Same,144,148,O
legend,149,155,O
as,156,158,O
Figure,159,165,O
3A,166,168,O
.,168,169,O
(,170,171,O
B,171,172,O
),172,173,O
Part,174,178,O
of,179,181,O
the,182,185,O
conserved,186,195,O
synteny,196,203,O
block,204,209,O
surrounding,210,221,O
KLTH0F12276g,222,234,O
gene,235,239,O
.,239,240,O
Same,241,245,O
legend,246,252,O
as,253,255,O
Figure,256,262,O
3A,263,265,O
.,265,266,O
(,267,268,O
C,268,269,O
),269,270,O
Sequence,271,279,O
alignment,280,289,O
of,290,292,O
proteins,293,301,O
from,302,306,O
K,307,308,O
.,308,309,O
thermotolerans,310,324,O
and,325,328,O
K,329,330,O
.,330,331,O
waltii,332,338,O
.,338,339,O
(,340,341,O
D,341,342,O
),342,343,O
Phylogenetic,344,356,O
tree,357,361,O
reconstructed,362,375,O
from,376,380,O
sequence,381,389,O
alignment,390,399,O
of,400,402,O
100,403,406,O
sites,407,412,O
of,413,415,O
K,416,417,O
.,417,418,O
thermotolerans,419,433,O
protein,434,441,O
family,442,448,O
members,449,456,O
",",456,457,O
K,458,459,O
.,459,460,O
waltii,461,467,O
gene,468,472,O
",",472,473,O
bacterial,474,483,O
(,484,485,O
green,485,490,O
),490,491,O
and,492,495,O
amoebal,496,503,O
(,504,505,O
blue,505,509,O
),509,510,O
proteins,511,519,O
.,519,520,O
Bootstrap,521,530,O
values,531,537,O
are,538,541,O
indicated,542,551,O
next,552,556,O
to,557,559,O
the,560,563,O
nodes,564,569,O
and,570,573,O
branch,574,580,O
length,581,587,O
scale,588,593,O
is,594,596,O
shown,597,602,O
at,603,605,O
bottom,606,612,O
left,613,617,O
.,617,618,O
Quantitative,0,12,O
reverse,13,20,O
transcription,21,34,O
PCR,35,38,O
Reverse,39,46,O
transcription,47,60,O
was,61,64,O
performed,65,74,O
using,75,80,O
0,81,82,O
.,82,83,O
2,83,84,O
mug,85,88,O
of,89,91,O
total,92,97,O
RNA,98,101,O
from,102,106,O
muscle,107,113,B-Tissue
of,114,116,O
10,117,119,O
week,120,124,O
-,124,125,O
old,125,128,O
and,129,132,O
19,133,135,O
month,136,141,O
-,141,142,O
old,142,145,O
C57Bl6,146,152,O
mice,153,157,O
(,158,159,O
five,159,163,O
animals,164,171,O
per,172,175,O
group,176,181,O
),181,182,O
",",182,183,O
a,184,185,O
Core,186,190,O
kit,191,194,O
(,195,196,O
RT,196,198,O
-,198,199,O
RTCK,199,203,O
-,203,204,O
03,204,206,O
",",206,207,O
Eurogentec,208,218,O
),218,219,O
according,220,229,O
to,230,232,O
manufacturer,233,245,O
',245,246,O
s,246,247,O
instruction,248,259,O
and,260,263,O
a,264,265,O
mix,266,269,O
of,270,272,O
random,273,279,O
primers,280,287,O
(,288,289,O
9,289,290,O
mers,291,295,O
),295,296,O
and,297,300,O
oligodT,301,308,O
.,308,309,O
qPCR,310,314,O
was,315,318,O
performed,319,328,O
on,329,331,O
SDS7900HT,332,341,O
(,342,343,O
Applied,343,350,O
Biosystem,351,360,O
),360,361,O
using,362,367,O
Mesagreen,368,377,O
qPCR,378,382,O
kit,383,386,O
for,387,390,O
SYBR,391,395,O
(,396,397,O
Eurogentec,397,407,O
),407,408,O
and,409,412,O
the,413,416,O
following,417,426,O
primers,427,434,O
:,434,435,O
PPARbeta,437,445,O
:,445,446,O
5,447,448,O
',448,449,O
-,449,450,O
AGATGGTGGCAGAGCTATGACC,450,472,O
-,472,473,O
3,473,474,O
',474,475,O
;,475,476,O
5,477,478,O
',478,479,O
-,479,480,O
TCCTCCTGTGGCTGTTCC,480,498,O
-,498,499,O
3,499,500,O
',500,501,O
.,501,502,O
Catalase,503,511,O
:,511,512,O
5,513,514,O
',514,515,O
-,515,516,O
GGATCCTGACATGGTCTGGG,516,536,O
-,536,537,O
3,537,538,O
',538,539,O
;,539,540,O
5,541,542,O
',542,543,O
-,543,544,O
TGGAGAGACTCGGGACGAAG,544,564,O
-,564,565,O
3,565,566,O
',566,567,O
.,567,568,O
PDK4,569,573,O
:,573,574,O
5,575,576,O
',576,577,O
-,577,578,O
GCATTTCTACTCGGATGCTCAATG,578,602,O
-,602,603,O
3,603,604,O
',604,605,O
;,605,606,O
5,607,608,O
',608,609,O
-,609,610,O
CCAATGTGGCTTGGGTTTCC,610,630,O
-,630,631,O
3,631,632,O
',632,633,O
.,633,634,O
36B4,635,639,O
:,639,640,O
5,641,642,O
',642,643,O
-,643,644,O
TCCAGGCTTTGGGCATCA,644,662,O
-,662,663,O
3,663,664,O
',664,665,O
;,665,666,O
5,667,668,O
',668,669,O
-,669,670,O
CTTTATCAGCTGCACATCACTCAGA,670,695,O
-,695,696,O
3,696,697,O
',697,698,O
.,698,699,O
Data,700,704,O
were,705,709,O
all,710,713,O
normalised,714,724,O
using,725,730,O
36B4,731,735,O
as,736,738,O
housekeeping,739,751,O
gene,752,756,O
.,756,757,O
Chicken,0,7,O
CCN3,8,12,O
expression,13,23,O
in,24,26,O
embryonic,27,36,B-Tissue
and,37,40,O
extraembryonic,41,55,B-Tissue
tissues,56,63,I-Tissue
Expression,64,74,O
of,75,77,O
CCN3,78,82,O
in,83,85,O
axial,86,91,O
structure,92,101,O
becomes,102,109,O
visible,110,117,O
in,118,120,O
the,121,124,O
presegmentation,125,140,O
stage,141,146,O
and,147,150,O
reaches,151,158,O
to,159,161,O
the,162,165,O
highest,166,173,O
level,174,179,O
at,180,182,O
the,183,186,O
beginning,187,196,O
of,197,199,O
somitogenesis,200,213,O
(,214,215,O
HH,215,217,O
stage,218,223,O
7,224,225,O
",",225,226,O
Fig,227,230,O
.,230,231,O
1a,232,234,O
),234,235,O
.,235,236,O
Strong,237,243,O
similarity,244,254,O
between,255,262,O
CCN3,263,267,O
and,268,271,O
Sonic,272,277,O
Hedgehog,278,286,O
was,287,290,O
observed,291,299,O
for,300,303,O
the,304,307,O
expression,308,318,O
pattern,319,326,O
in,327,329,O
axial,330,335,O
structure,336,345,O
(,346,347,O
notochord,347,356,O
and,357,360,O
floor,361,366,O
plate,367,372,O
),372,373,O
",",373,374,O
in,375,377,O
which,378,383,O
the,384,387,O
left,388,392,O
-,392,393,O
right,393,398,O
asymmetrical,399,411,O
pattern,412,419,O
in,420,422,O
the,423,426,O
node,427,431,O
area,432,436,O
is,437,439,O
also,440,444,O
conserved,445,454,O
(,455,456,O
Fig,456,459,O
.,459,460,O
1b,461,463,O
),463,464,O
.,464,465,O
However,466,473,O
",",473,474,O
Sonic,475,480,O
Hedgehog,481,489,O
expression,490,500,O
is,501,503,O
slightly,504,512,O
broader,513,520,O
than,521,525,O
that,526,530,O
of,531,533,O
CCN3,534,538,O
.,538,539,O
Since,540,545,O
CCN3,546,550,O
stimulates,551,561,O
Notch,562,567,O
signaling,568,577,O
(,578,579,O
Sakamoto,579,587,O
et,588,590,O
al,591,593,O
.,593,594,O
2002,595,599,O
),599,600,O
",",600,601,O
we,602,604,O
investigated,605,617,O
the,618,621,O
expression,622,632,O
of,633,635,O
Notch,636,641,O
signal,642,648,O
genes,649,654,O
.,654,655,O
Among,656,661,O
them,662,666,O
",",666,667,O
Serrate1,668,676,O
",",676,677,O
a,678,679,O
ligand,680,686,O
of,687,689,O
Notch,690,695,O
is,696,698,O
unique,699,705,O
because,706,713,O
its,714,717,O
expression,718,728,O
is,729,731,O
apparently,732,742,O
a,743,744,O
right,745,750,O
deviated,751,759,O
pattern,760,767,O
in,768,770,O
the,771,774,O
node,775,779,O
area,780,784,O
(,785,786,O
Fig,786,789,O
.,789,790,O
1c,791,793,O
),793,794,O
.,794,795,O
Another,796,803,O
Notch,804,809,O
ligand,810,816,O
",",816,817,O
Delta1,818,824,O
shows,825,830,O
a,831,832,O
right,833,838,O
deviated,839,847,O
pattern,848,855,O
",",855,856,O
but,857,860,O
is,861,863,O
more,864,868,O
caudal,869,875,O
area,876,880,O
of,881,883,O
the,884,887,O
node,888,892,O
extending,893,902,O
to,903,905,O
the,906,909,O
primitive,910,919,O
streak,920,926,O
(,927,928,O
data,928,932,O
not,933,936,O
shown,937,942,O
),942,943,O
.,943,944,O
The,945,948,O
expression,949,959,O
of,960,962,O
CCN3,963,967,O
in,968,970,O
axial,971,976,O
structure,977,986,O
was,987,990,O
followed,991,999,O
by,1000,1002,O
the,1003,1006,O
presomitic,1007,1017,O
mesoderm,1018,1026,O
although,1027,1035,O
it,1036,1038,O
is,1039,1041,O
diminished,1042,1052,O
(,1053,1054,O
Sakamoto,1054,1062,O
et,1063,1065,O
al,1066,1068,O
.,1068,1069,O
2002,1070,1074,O
),1074,1075,O
.,1075,1076,O
Fig,1078,1081,O
.,1081,1082,O
1,1083,1084,O
Expression,1085,1095,O
of,1096,1098,O
mRNA,1099,1103,O
in,1104,1106,O
early,1107,1112,O
stage,1113,1118,O
chicken,1119,1126,O
embryo,1127,1133,B-Developing_anatomical_structure
;,1133,1134,O
CCN3,1135,1139,O
(,1140,1141,O
a,1141,1142,O
),1142,1143,O
",",1143,1144,O
Sonic,1145,1150,O
Hedgehog,1151,1159,O
(,1160,1161,O
b,1161,1162,O
),1162,1163,O
and,1164,1167,O
Serrate1,1168,1176,O
(,1177,1178,O
c,1178,1179,O
),1179,1180,O
at,1181,1183,O
the,1184,1187,O
beginning,1188,1197,O
stage,1198,1203,O
of,1204,1206,O
somitogenesis,1207,1220,O
(,1221,1222,O
Hamburger,1222,1231,O
and,1232,1235,O
Hamilton,1236,1244,O
(,1245,1246,O
HH,1246,1248,O
),1248,1249,O
Stage,1250,1255,O
7,1256,1257,O
),1257,1258,O
.,1258,1259,O
Arrowheads,1260,1270,O
indicate,1271,1279,O
Hensen,1280,1286,O
',1286,1287,O
s,1287,1288,O
node,1289,1293,O
.,1293,1294,O
Demonstrates,1295,1307,O
the,1308,1311,O
schematic,1312,1321,O
view,1322,1326,O
of,1327,1329,O
tissue,1330,1336,B-Tissue
organization,1337,1349,O
at,1350,1352,O
this,1353,1357,O
stage,1358,1363,O
(,1364,1365,O
d,1365,1366,O
),1366,1367,O
.,1367,1368,O
Expression,1369,1379,O
of,1380,1382,O
CCN3,1383,1387,O
mRNA,1388,1392,O
in,1393,1395,O
blood,1396,1401,B-Organism_substance
islands,1402,1409,I-Organism_substance
of,1410,1412,O
chicken,1413,1420,O
extraembryonic,1421,1435,B-Tissue
tissue,1436,1442,I-Tissue
(,1443,1444,O
HH,1444,1446,O
stage,1447,1452,O
10,1453,1455,O
),1455,1456,O
(,1457,1458,O
e,1458,1459,O
),1459,1460,O
.,1460,1461,O
Ventral,1462,1469,B-Multi-tissue_structure
part,1470,1474,O
of,1475,1477,O
the,1478,1481,O
endothelial,1482,1493,B-Cell
precursor,1494,1503,I-Cell
cells,1504,1509,I-Cell
in,1510,1512,O
blood,1513,1518,B-Organism_substance
islands,1519,1526,I-Organism_substance
is,1527,1529,O
positive,1530,1538,O
for,1539,1542,O
CCN3,1543,1547,O
expression,1548,1558,O
.,1558,1559,O
Coloration,1560,1570,O
was,1571,1574,O
stopped,1575,1582,O
before,1583,1589,O
the,1590,1593,O
background,1594,1604,O
staining,1605,1613,O
started,1614,1621,O
in,1622,1624,O
sense,1625,1630,O
probes,1631,1637,O
(,1638,1639,O
negative,1639,1647,O
control,1648,1655,O
),1655,1656,O
There,1657,1662,O
is,1663,1665,O
accumulating,1666,1678,O
evidence,1679,1687,O
of,1688,1690,O
CCN3,1691,1695,O
commitment,1696,1706,O
to,1707,1709,O
hematopoiesis,1710,1723,O
and,1724,1727,O
therefore,1728,1737,O
we,1738,1740,O
investigated,1741,1753,O
the,1754,1757,O
CCN3,1758,1762,O
expression,1763,1773,O
in,1774,1776,O
extraembryonic,1777,1791,B-Tissue
tissues,1792,1799,I-Tissue
.,1799,1800,O
Blood,1801,1806,B-Organism_substance
islands,1807,1814,I-Organism_substance
are,1815,1818,O
formed,1819,1825,O
in,1826,1828,O
the,1829,1832,O
yolk,1833,1837,B-Tissue
sac,1838,1841,I-Tissue
mesodermal,1842,1852,I-Tissue
area,1853,1857,O
just,1858,1862,O
between,1863,1870,O
the,1871,1874,O
visceral,1875,1883,B-Tissue
endodermal,1884,1894,I-Tissue
and,1895,1898,O
ectodermal,1899,1909,B-Tissue
layers,1910,1916,I-Tissue
",",1916,1917,O
which,1918,1923,O
supply,1924,1930,O
the,1931,1934,O
red,1935,1938,B-Cell
blood,1939,1944,I-Cell
cells,1945,1950,I-Cell
at,1951,1953,O
the,1954,1957,O
primary,1958,1965,O
stage,1966,1971,O
.,1971,1972,O
The,1973,1976,O
cells,1977,1982,B-Cell
in,1983,1985,O
blood,1986,1991,B-Organism_substance
islands,1992,1999,I-Organism_substance
are,2000,2003,O
called,2004,2010,O
hemangioblasts,2011,2025,B-Cell
since,2026,2031,O
they,2032,2036,O
also,2037,2041,O
differentiate,2042,2055,O
into,2056,2060,O
the,2061,2064,O
endothelial,2065,2076,B-Cell
cells,2077,2082,I-Cell
of,2083,2085,O
extraembryonic,2086,2100,B-Developing_anatomical_structure
blood,2101,2106,I-Developing_anatomical_structure
vessel,2107,2113,I-Developing_anatomical_structure
structure,2114,2123,I-Developing_anatomical_structure
.,2123,2124,O
In,2125,2127,O
chicken,2128,2135,O
embryo,2136,2142,B-Developing_anatomical_structure
",",2142,2143,O
differentiating,2144,2159,O
endothelial,2160,2171,B-Cell
cells,2172,2177,I-Cell
in,2178,2180,O
the,2181,2184,O
ventral,2185,2192,B-Multi-tissue_structure
part,2193,2197,O
of,2198,2200,O
blood,2201,2206,B-Organism_substance
islands,2207,2214,I-Organism_substance
express,2215,2222,O
CCN3,2223,2227,O
from,2228,2232,O
the,2233,2236,O
initial,2237,2244,O
stage,2245,2250,O
(,2251,2252,O
Fig,2252,2255,O
.,2255,2256,O
1e,2257,2259,O
),2259,2260,O
.,2260,2261,O
Erythroblasts,2262,2275,B-Cell
in,2276,2278,O
the,2279,2282,O
center,2283,2289,O
of,2290,2292,O
blood,2293,2298,B-Organism_substance
islands,2299,2306,I-Organism_substance
(,2307,2308,O
spherical,2308,2317,O
cells,2318,2323,B-Cell
in,2324,2326,O
Fig,2327,2330,O
.,2330,2331,O
1e,2332,2334,O
),2334,2335,O
weakly,2336,2342,O
express,2343,2350,O
CCN3,2351,2355,O
and,2356,2359,O
their,2360,2365,O
expression,2366,2376,O
is,2377,2379,O
mildly,2380,2386,O
enhanced,2387,2395,O
in,2396,2398,O
later,2399,2404,O
stage,2405,2410,O
(,2411,2412,O
data,2412,2416,O
not,2417,2420,O
shown,2421,2426,O
),2426,2427,O
.,2427,2428,O
Assessment,0,10,O
of,11,13,O
various,14,21,O
forms,22,27,O
of,28,30,O
bevavioural,31,42,O
addictions,43,53,O
A,54,55,O
first,56,61,O
approach,62,70,O
for,71,74,O
the,75,78,O
comprehensive,79,92,O
and,93,96,O
standardized,97,109,O
assessment,110,120,O
of,121,123,O
different,124,133,O
forms,134,139,O
of,140,142,O
behavioural,143,154,O
addictions,155,165,O
(,166,167,O
e,167,168,O
.,168,169,O
g,169,170,O
.,170,171,O
",",171,172,O
pathological,173,185,O
gambling,186,194,O
",",194,195,O
workaholism,196,207,O
",",207,208,O
compulsive,209,219,O
buying,220,226,O
),226,227,O
is,228,230,O
the,231,234,O
German,235,241,O
self,242,246,O
-,246,247,O
assessment,247,257,O
questionnaire,258,271,O
"""",272,273,O
Fragebogen,273,283,O
zur,284,287,O
Differenzierten,288,303,O
Anamnese,304,312,O
exzessiver,313,323,O
Verhaltensweisen,324,340,O
"""",340,341,O
(,342,343,O
FDAV,343,347,O
",",347,348,O
Questionnaire,349,362,O
on,363,365,O
Differentiated,366,380,O
Assessment,381,391,O
of,392,394,O
Excessive,395,404,O
Behaviours,405,415,O
),415,416,O
[,417,418,O
96,418,420,O
],420,421,O
.,421,422,O
The,423,426,O
FDAV,427,431,O
is,432,434,O
based,435,440,O
on,441,443,O
the,444,447,O
criteria,448,456,O
of,457,459,O
substance,460,469,O
-,469,470,O
related,470,477,O
addictions,478,488,O
",",488,489,O
pathological,490,502,O
gambling,503,511,O
and,512,515,O
impulse,516,523,O
control,524,531,O
disorders,532,541,O
of,542,544,O
the,545,548,O
ICD,549,552,O
-,552,553,O
10,553,555,O
[,556,557,O
3,557,558,O
],558,559,O
and,560,563,O
the,564,567,O
DSM,568,571,O
-,571,572,O
IV,572,574,O
-,574,575,O
TR,575,577,O
[,578,579,O
2,579,580,O
],580,581,O
.,581,582,O
The,583,586,O
FDAV,587,591,O
is,592,594,O
a,595,596,O
modified,597,605,O
version,606,613,O
of,614,616,O
the,617,620,O
"""",621,622,O
Fragebogen,622,632,O
zur,633,636,O
Differenzierten,637,652,O
Drogenanamnese,653,667,O
"""",667,668,O
(,669,670,O
FDDA,670,674,O
;,674,675,O
Questionnaire,676,689,O
on,690,692,O
Differentiated,693,707,O
Assessment,708,718,O
of,719,721,O
Addiction,722,731,O
",",731,732,O
QDAA,733,737,O
),737,738,O
[,739,740,O
97,740,742,O
],742,743,O
.,743,744,O
Its,745,748,O
seven,749,754,O
modules,755,762,O
obtain,763,769,O
"""",770,771,O
sociodemographic,771,787,O
information,788,799,O
"""",799,800,O
(,801,802,O
e,802,803,O
.,803,804,O
g,804,805,O
.,805,806,O
",",806,807,O
age,808,811,O
",",811,812,O
profession,813,823,O
",",823,824,O
marital,825,832,O
status,833,839,O
),839,840,O
",",840,841,O
"""",842,843,O
history,843,850,O
of,851,853,O
excessive,854,863,O
behaviour,864,873,O
"""",873,874,O
(,875,876,O
e,876,877,O
.,877,878,O
g,878,879,O
.,879,880,O
",",880,881,O
diagnostic,882,892,O
criteria,893,901,O
for,902,905,O
addictions,906,916,O
and,917,920,O
impulse,921,928,O
control,929,936,O
disorder,937,945,O
",",945,946,O
individual,947,957,O
patterns,958,966,O
of,967,969,O
behaviour,970,979,O
",",979,980,O
craving,981,988,O
symptoms,989,997,O
),997,998,O
",",998,999,O
"""",1000,1001,O
critical,1001,1009,O
life,1010,1014,O
events,1015,1021,O
"""",1021,1022,O
(,1023,1024,O
stress,1024,1030,O
caused,1031,1037,O
by,1038,1040,O
traumatic,1041,1050,O
events,1051,1057,O
),1057,1058,O
",",1058,1059,O
"""",1060,1061,O
legal,1061,1066,O
situation,1067,1076,O
"""",1076,1077,O
",",1077,1078,O
"""",1079,1080,O
medical,1080,1087,O
history,1088,1095,O
"""",1095,1096,O
",",1096,1097,O
"""",1098,1099,O
physical,1099,1107,O
and,1108,1111,O
psychological,1112,1125,O
complaints,1126,1136,O
"""",1136,1137,O
",",1137,1138,O
and,1139,1142,O
"""",1143,1144,O
emotional,1144,1153,O
state,1154,1159,O
"""",1159,1160,O
(,1161,1162,O
triggering,1162,1172,O
psychological,1173,1186,O
conditions,1187,1197,O
",",1197,1198,O
or,1199,1201,O
consequences,1202,1214,O
of,1215,1217,O
the,1218,1221,O
addictive,1222,1231,O
behaviour,1232,1241,O
",",1241,1242,O
respectively,1243,1255,O
),1255,1256,O
.,1256,1257,O
Every,1258,1263,O
module,1264,1270,O
can,1271,1274,O
be,1275,1277,O
administered,1278,1290,O
separately,1291,1301,O
according,1302,1311,O
to,1312,1314,O
the,1315,1318,O
suspected,1319,1328,O
behavioural,1329,1340,O
addiction,1341,1350,O
",",1350,1351,O
thereby,1352,1359,O
making,1360,1366,O
the,1367,1370,O
FDAV,1371,1375,O
an,1376,1378,O
economical,1379,1389,O
tool,1390,1394,O
in,1395,1397,O
assessing,1398,1407,O
behavioural,1408,1419,O
addictions,1420,1430,O
.,1430,1431,O
The,1432,1435,O
FDAV,1436,1440,O
is,1441,1443,O
suitable,1444,1452,O
for,1453,1456,O
diagnostics,1457,1468,O
",",1468,1469,O
evaluation,1470,1480,O
of,1481,1483,O
therapy,1484,1491,O
and,1492,1495,O
follow,1496,1502,O
-,1502,1503,O
up,1503,1505,O
in,1506,1508,O
clinical,1509,1517,O
practice,1518,1526,O
and,1527,1530,O
research,1531,1539,O
.,1539,1540,O
Currently,1541,1550,O
",",1550,1551,O
the,1552,1555,O
FDAV,1556,1560,O
is,1561,1563,O
being,1564,1569,O
validated,1570,1579,O
in,1580,1582,O
clinical,1583,1591,O
and,1592,1595,O
non,1596,1599,O
-,1599,1600,O
clinical,1600,1608,O
samples,1609,1616,O
.,1616,1617,O
Click,0,5,O
here,6,10,O
for,11,14,O
file,15,19,O
Method,0,6,O
Results,0,7,O
:,7,8,O
All,9,12,O
fractures,13,22,O
united,23,29,O
.,29,30,O
Individual,31,41,O
movement,42,50,O
of,51,53,O
dorsiflexion,54,66,O
",",66,67,O
palmar,68,74,B-Organism_subdivision
flexion,75,82,O
",",82,83,O
supination,84,94,O
",",94,95,O
pronation,96,105,O
and,106,109,O
radial,110,116,B-Organ
-,116,117,O
ulnar,117,122,B-Organ
deviation,123,132,O
were,133,137,O
all,138,141,O
significantly,142,155,O
better,156,162,O
in,163,165,O
the,166,169,O
dorsiflexed,170,181,O
-,181,182,O
immobilized,182,193,O
group,194,199,O
as,200,202,O
compared,203,211,O
with,212,216,O
the,217,220,O
palmar,221,227,B-Organism_subdivision
flexed,228,234,O
immobilized,235,246,O
group,247,252,O
.,252,253,O
Grip,254,258,O
strength,259,267,O
recovery,268,276,O
with,277,281,O
subjective,282,292,O
assessment,293,303,O
was,304,307,O
better,308,314,O
in,315,317,O
the,318,321,O
dorsiflexed,322,333,O
group,334,339,O
(,340,341,O
77,341,343,O
%,343,344,O
),344,345,O
as,346,348,O
compared,349,357,O
to,358,360,O
the,361,364,O
palmar,365,371,B-Organism_subdivision
flexed,372,378,O
group,379,384,O
(,385,386,O
23,386,388,O
%,388,389,O
),389,390,O
.,390,391,O
Radiological,392,404,O
parameters,405,415,O
were,416,420,O
markedly,421,429,O
better,430,436,O
in,437,439,O
the,440,443,O
dorsiflexed,444,455,O
group,456,461,O
.,461,462,O
Ninety,463,469,O
-,469,470,O
one,470,473,O
per,474,477,O
cent,478,482,O
of,483,485,O
patients,486,494,O
in,495,497,O
the,498,501,O
dorsiflexed,502,513,O
group,514,519,O
had,520,523,O
excellent,524,533,O
to,534,536,O
good,537,541,O
results,542,549,O
as,550,552,O
compared,553,561,O
to,562,564,O
66,565,567,O
%,567,568,O
in,569,571,O
the,572,575,O
palmar,576,582,B-Organism_subdivision
flexed,583,589,O
group,590,595,O
.,595,596,O
3,0,1,O
.,1,2,O
2,2,3,O
.,3,4,O
Cell,5,9,B-Cell
line,10,14,I-Cell
and,15,18,O
culture,19,26,O
DU145,27,32,B-Cell
(,33,34,I-Cell
prostate,34,42,I-Cell
cancer,43,49,I-Cell
),49,50,I-Cell
cell,51,55,I-Cell
line,56,60,I-Cell
was,61,64,O
used,65,69,O
in,70,72,O
this,73,77,O
assay,78,83,O
.,83,84,O
DU145,85,90,B-Cell
was,91,94,O
grown,95,100,O
in,101,103,O
DMEM,104,108,O
/,108,109,O
F,109,110,O
-,110,111,O
12,111,113,O
medium,114,120,O
(,121,122,O
Gibco,122,127,O
BRL,128,131,O
Life,132,136,O
Technologies,137,149,O
",",149,150,O
San,151,154,O
Diego,155,160,O
",",160,161,O
CA,162,164,O
.,164,165,O
",",165,166,O
USA,167,170,O
),170,171,O
supplemented,172,184,O
with,185,189,O
10,190,192,O
%,192,193,O
fetal,194,199,B-Developing_anatomical_structure
calf,200,204,O
serum,205,210,B-Organism_substance
and,211,214,O
kept,215,219,O
in,220,222,O
a,223,224,O
humidified,225,235,O
37,236,238,O
degreesC,239,247,O
",",247,248,O
5,249,250,O
%,250,251,O
CO2,252,255,O
incubator,256,265,O
.,265,266,O
Target,0,6,O
volumes,7,14,O
',14,15,O
coverage,16,24,O
The,25,28,O
mean,29,33,O
PTV1,34,38,O
and,39,42,O
PTV2,43,47,O
volumes,48,55,O
were,56,60,O
452,61,64,O
cm3,65,68,O
(,69,70,O
range,70,75,O
276,76,79,O
-,79,80,O
1074,80,84,O
cm3,85,88,O
),88,89,O
and,90,93,O
300,94,97,O
cm3,98,101,O
(,102,103,O
range,103,108,O
137,109,112,O
-,112,113,O
567,113,116,O
cm3,117,120,O
),120,121,O
respectively,122,134,O
.,134,135,O
A,136,137,O
mean,138,142,O
of,143,145,O
>,146,147,O
98,147,149,O
%,149,150,O
(,151,152,O
range,152,157,O
92,158,160,O
-,160,161,O
100,161,164,O
%,164,165,O
),165,166,O
of,167,169,O
the,170,173,O
PTV1,174,178,O
received,179,187,O
100,188,191,O
%,191,192,O
of,193,195,O
the,196,199,O
prescribed,200,210,O
dose,211,215,O
in,216,218,O
all,219,222,O
planning,223,231,O
methods,232,239,O
.,239,240,O
A,241,242,O
mean,243,247,O
of,248,250,O
95,251,253,O
.,253,254,O
5,254,255,O
%,255,256,O
and,257,260,O
95,261,263,O
.,263,264,O
7,264,265,O
%,265,266,O
of,267,269,O
the,270,273,O
PTV2,274,278,O
received,279,287,O
100,288,291,O
%,291,292,O
of,293,295,O
the,296,299,O
prescribed,300,310,O
dose,311,315,O
with,316,320,O
TOMO,321,325,O
and,326,329,O
IMRT,330,334,O
plans,335,340,O
respectively,341,353,O
.,353,354,O
A,355,356,O
mean,357,361,O
of,362,364,O
94,365,367,O
%,367,368,O
and,369,372,O
92,373,375,O
%,375,376,O
of,377,379,O
the,380,383,O
PTV2,384,388,O
received,389,397,O
100,398,401,O
%,401,402,O
of,403,405,O
the,406,409,O
prescribed,410,420,O
dose,421,425,O
with,426,430,O
IB,431,433,O
and,434,437,O
3D,438,440,O
treatment,441,450,O
plans,451,456,O
",",456,457,O
respectively,458,470,O
.,470,471,O
The,472,475,O
mean,476,480,O
IB,481,483,O
and,484,487,O
3D,488,490,O
plans,491,496,O
PTV2,497,501,O
coverage,502,510,O
was,511,514,O
significantly,515,528,O
inferior,529,537,O
then,538,542,O
the,543,546,O
IMRT,547,551,O
and,552,555,O
TOMO,556,560,O
plans,561,566,O
(,567,568,O
p,568,569,O
<,570,571,O
0,572,573,O
.,573,574,O
02,574,576,O
",",576,577,O
for,578,581,O
all,582,585,O
comparisons,586,597,O
),597,598,O
.,598,599,O
The,600,603,O
mean,604,608,O
Inhomogeneity,609,622,O
Coefficient,623,634,O
(,635,636,O
IC,636,638,O
),638,639,O
was,640,643,O
significantly,644,657,O
lower,658,663,O
(,664,665,O
better,665,671,O
),671,672,O
with,673,677,O
the,678,681,O
TOMO,682,686,O
plans,687,692,O
",",692,693,O
compared,694,702,O
to,703,705,O
all,706,709,O
other,710,715,O
plans,716,721,O
for,722,725,O
both,726,730,O
PTV1,731,735,O
and,736,739,O
PTV2,740,744,O
(,745,746,O
p,746,747,O
<,748,749,O
0,750,751,O
.,751,752,O
0003,752,756,O
for,757,760,O
all,761,764,O
comparisons,765,776,O
),776,777,O
(,778,779,O
figure,779,785,O
3,786,787,O
),787,788,O
.,788,789,O
The,790,793,O
mean,794,798,O
IC,799,801,O
of,802,804,O
the,805,808,O
IMRT,809,813,O
plans,814,819,O
was,820,823,O
significantly,824,837,O
higher,838,844,O
(,845,846,O
worse,846,851,O
),851,852,O
than,853,857,O
the,858,861,O
mean,862,866,O
IC,867,869,O
of,870,872,O
the,873,876,O
3D,877,879,O
plans,880,885,O
regarding,886,895,O
PTV,896,899,O
1,900,901,O
(,902,903,O
p,903,904,O
<,905,906,O
0,907,908,O
.,908,909,O
02,909,911,O
),911,912,O
and,913,916,O
higher,917,923,O
(,924,925,O
worse,925,930,O
),930,931,O
then,932,936,O
the,937,940,O
mean,941,945,O
IC,946,948,O
of,949,951,O
the,952,955,O
IB,956,958,O
plans,959,964,O
regarding,965,974,O
PTV2,975,979,O
(,980,981,O
p,981,982,O
<,983,984,O
0,985,986,O
.,986,987,O
03,987,989,O
),989,990,O
(,991,992,O
figure,992,998,O
3,999,1000,O
),1000,1001,O
.,1001,1002,O
No,1003,1005,O
significant,1006,1017,O
difference,1018,1028,O
was,1029,1032,O
found,1033,1038,O
between,1039,1046,O
the,1047,1050,O
means,1051,1056,O
of,1057,1059,O
the,1060,1063,O
IC,1064,1066,O
of,1067,1069,O
the,1070,1073,O
3D,1074,1076,O
and,1077,1080,O
IB,1081,1083,O
plans,1084,1089,O
.,1089,1090,O
Figure,1091,1097,O
3,1098,1099,O
The,1100,1103,O
mean,1104,1108,O
Inhomogeneity,1109,1122,O
Coefficient,1123,1134,O
(,1135,1136,O
IC,1136,1138,O
),1138,1139,O
achieved,1140,1148,O
by,1149,1151,O
the,1152,1155,O
different,1156,1165,O
planning,1166,1174,O
methods,1175,1182,O
.,1182,1183,O
The,1184,1187,O
mean,1188,1192,O
of,1193,1195,O
the,1196,1199,O
Inhomogeneity,1200,1213,O
Coefficient,1214,1225,O
is,1226,1228,O
a,1229,1230,O
measure,1231,1238,O
of,1239,1241,O
dose,1242,1246,O
inhomogeneity,1247,1260,O
in,1261,1263,O
the,1264,1267,O
target,1268,1274,O
volumes,1275,1282,O
.,1282,1283,O
The,1284,1287,O
closer,1288,1294,O
the,1295,1298,O
IC,1299,1301,O
to,1302,1304,O
zero,1305,1309,O
",",1309,1310,O
the,1311,1314,O
more,1315,1319,O
homogenous,1320,1330,O
the,1331,1334,O
dose,1335,1339,O
is,1340,1342,O
.,1342,1343,O
RESEARCH,0,8,O
DESIGN,9,15,O
AND,16,19,O
METHODS,20,27,O
For,28,31,O
this,32,36,O
study,37,42,O
",",42,43,O
20,44,46,O
individuals,47,58,O
(,59,60,O
mean,60,64,O
age,65,68,O
39,69,71,O
.,71,72,O
5,72,73,O
+,74,75,O
/,75,76,O
-,76,77,O
11,78,80,O
.,80,81,O
1,81,82,O
years,83,88,O
),88,89,O
with,90,94,O
long,95,99,O
-,99,100,O
standing,100,108,O
type,109,113,O
1,114,115,O
diabetes,116,124,O
(,125,126,O
21,126,128,O
.,128,129,O
3,129,130,O
+,131,132,O
/,132,133,O
-,133,134,O
10,135,137,O
.,137,138,O
7,138,139,O
years,140,145,O
),145,146,O
were,147,151,O
enrolled,152,160,O
in,161,163,O
this,164,168,O
prospective,169,180,O
open,181,185,O
-,185,186,O
label,186,191,O
crossover,192,201,O
trial,202,207,O
.,207,208,O
After,209,214,O
achieving,215,224,O
optimal,225,232,O
blood,233,238,B-Organism_substance
glucose,239,246,O
control,247,254,O
",",254,255,O
16,256,258,O
subjects,259,267,O
were,268,272,O
randomized,273,283,O
to,284,286,O
exenatide,287,296,O
with,297,301,O
or,302,304,O
without,305,312,O
daclizumab,313,323,O
.,323,324,O
Endogenous,325,335,O
insulin,336,343,O
production,344,354,O
was,355,358,O
determined,359,369,O
by,370,372,O
repeatedly,373,383,O
measuring,384,393,O
serum,394,399,B-Organism_substance
C,400,401,O
-,401,402,O
peptide,402,409,O
.,409,410,O
Subjects,0,8,O
and,9,12,O
Methods,13,20,O
ABPM,21,25,O
was,26,29,O
conducted,30,39,O
for,40,43,O
60,44,46,O
selected,47,55,O
patients,56,64,O
who,65,68,O
had,69,72,O
visited,73,80,O
Sunlin,81,87,O
Hospital,88,96,O
between,97,104,O
January,105,112,O
2008,113,117,O
and,118,121,O
August,122,128,O
2008,129,133,O
.,133,134,O
Patients,135,143,O
were,144,148,O
classified,149,159,O
into,160,164,O
3,165,166,O
groups,167,173,O
;,173,174,O
an,175,177,O
obese,178,183,O
group,184,189,O
whose,190,195,O
body,196,200,B-Organism_subdivision
mass,201,205,O
index,206,211,O
(,212,213,O
BMI,213,216,O
),216,217,O
was,218,221,O
>,222,223,O
the,224,227,O
95th,228,232,O
percentile,233,243,O
",",243,244,O
an,245,247,O
overweight,248,258,O
group,259,264,O
whose,265,270,O
BMI,271,274,O
was,275,278,O
>,279,280,O
the,281,284,O
85th,285,289,O
percentile,290,300,O
but,301,304,O
less,305,309,O
than,310,314,O
the,315,318,O
95th,319,323,O
percentile,324,334,O
",",334,335,O
and,336,339,O
a,340,341,O
normal,342,348,O
group,349,354,O
whose,355,360,O
BMI,361,364,O
was,365,368,O
below,369,374,O
the,375,378,O
85th,379,383,O
percentile,384,394,O
.,394,395,O
Overall,396,403,O
mean,404,408,O
BP,409,411,O
",",411,412,O
day,413,416,O
and,417,420,O
night,421,426,O
BP,427,429,O
and,430,433,O
BP,434,436,O
load,437,441,O
were,442,446,O
measured,447,455,O
by,456,458,O
ABPM,459,463,O
.,463,464,O
Surgery,0,7,O
Trabeculectomy,8,22,O
should,23,29,O
be,30,32,O
considered,33,43,O
in,44,46,O
all,47,50,O
patients,51,59,O
",",59,60,O
when,61,65,O
the,66,69,O
',70,71,O
target,71,77,O
IOP,78,81,O
',81,82,O
is,83,85,O
not,86,89,O
achieved,90,98,O
with,99,103,O
glaucoma,104,112,O
medications,113,124,O
and,125,128,O
if,129,131,O
the,132,135,O
expected,136,144,O
rate,145,149,O
of,150,152,O
visual,153,159,O
loss,160,164,O
could,165,170,O
affect,171,177,O
the,178,181,O
patient,182,189,O
during,190,196,O
their,197,202,O
lifetime,203,211,O
.,211,212,O
In,213,215,O
this,216,220,O
procedure,221,230,O
",",230,231,O
an,232,234,O
opening,235,242,O
is,243,245,O
made,246,250,O
in,251,253,O
the,254,257,O
trabecular,258,268,B-Organ
meshwork,269,277,O
",",277,278,O
so,279,281,O
that,282,286,O
aqueous,287,294,O
humor,295,300,B-Organism_substance
can,301,304,O
drain,305,310,O
into,311,315,O
the,316,319,O
sclera,320,326,B-Multi-tissue_structure
.,326,327,O
Many,328,332,O
patients,333,341,O
can,342,345,O
discontinue,346,357,O
glaucoma,358,366,O
medications,367,378,O
after,379,384,O
surgery,385,392,O
.,392,393,O
Approximately,394,407,O
one,408,411,O
-,411,412,O
third,412,417,O
of,418,420,O
the,421,424,O
trabeculectomy,425,439,O
patients,440,448,O
develop,449,456,O
cataract,457,465,O
within,466,472,O
five,473,477,O
years,478,483,O
.,483,484,O
If,485,487,O
trabeculectomy,488,502,O
fails,503,508,O
",",508,509,O
another,510,517,O
type,518,522,O
of,523,525,O
surgery,526,533,O
places,534,540,O
a,541,542,O
drainage,543,551,O
tube,552,556,O
(,557,558,O
Molteno,558,565,O
tube,566,570,O
),570,571,O
in,572,574,O
the,575,578,O
eye,579,582,B-Organ
",",582,583,O
between,584,591,O
the,592,595,O
cornea,596,602,B-Multi-tissue_structure
and,603,606,O
iris,607,611,B-Multi-tissue_structure
",",611,612,O
which,613,618,O
exits,619,624,O
at,625,627,O
the,628,631,O
junction,632,640,O
of,641,643,O
the,644,647,O
cornea,648,654,B-Multi-tissue_structure
and,655,658,O
sclera,659,665,B-Multi-tissue_structure
.,665,666,O
Cyclodestructive,667,683,O
procedures,684,694,O
",",694,695,O
which,696,701,O
lower,702,707,O
IOP,708,711,O
by,712,714,O
destroying,715,725,O
the,726,729,O
ciliary,730,737,B-Multi-tissue_structure
body,738,742,I-Multi-tissue_structure
",",742,743,O
are,744,747,O
typically,748,757,O
reserved,758,766,O
for,767,770,O
eyes,771,775,B-Organ
",",775,776,O
which,777,782,O
are,783,786,O
refractory,787,797,O
to,798,800,O
all,801,804,O
other,805,810,O
forms,811,816,O
of,817,819,O
therapy,820,827,O
.,827,828,O
These,829,834,O
procedures,835,845,O
include,846,853,O
cyclocryotherapy,854,870,O
",",870,871,O
cylcodiathermy,872,886,O
and,887,890,O
laser,891,896,O
cyclophotocoagulation,897,918,O
.,918,919,O
[,919,920,O
91,920,922,O
-,922,923,O
93,923,925,O
],925,926,O
Follow,0,6,O
-,6,7,O
up,7,9,O
Patients,10,18,O
were,19,23,O
followed,24,32,O
up,33,35,O
at,36,38,O
the,39,42,O
outpatient,43,53,O
clinic,54,60,O
at,61,63,O
1,64,65,O
",",65,66,O
4,67,68,O
",",68,69,O
and,70,73,O
7,74,75,O
months,76,82,O
after,83,88,O
the,89,92,O
ablation,93,101,O
procedure,102,111,O
and,112,115,O
every,116,121,O
6,122,123,O
months,124,130,O
thereafter,131,141,O
.,141,142,O
Routine,143,150,O
24,151,153,O
or,154,156,O
48,157,159,O
h,160,161,O
Holter,162,168,O
monitoring,169,179,O
was,180,183,O
performed,184,193,O
before,194,200,O
each,201,205,O
appointment,206,217,O
",",217,218,O
and,219,222,O
a,223,224,O
12,225,227,O
-,227,228,O
lead,228,232,O
electrocardiogram,233,250,O
was,251,254,O
obtained,255,263,O
at,264,266,O
each,267,271,O
visit,272,277,O
.,277,278,O
Patients,279,287,O
were,288,292,O
asked,293,298,O
to,299,301,O
report,302,308,O
to,309,311,O
the,312,315,O
emergency,316,325,O
room,326,330,O
or,331,333,O
our,334,337,O
arrhythmia,338,348,O
unit,349,353,O
for,354,357,O
an,358,360,O
ECG,361,364,O
if,365,367,O
any,368,371,O
symptom,372,379,O
suggestive,380,390,O
of,391,393,O
recurrence,394,404,O
occurred,405,413,O
between,414,421,O
scheduled,422,431,O
visits,432,438,O
.,438,439,O
After,440,445,O
the,446,449,O
ablation,450,458,O
procedure,459,468,O
",",468,469,O
all,470,473,O
patients,474,482,O
received,483,491,O
anti,492,496,O
-,496,497,O
arrhythmic,497,507,O
treatment,508,517,O
for,518,521,O
at,522,524,O
least,525,530,O
1,531,532,O
month,533,538,O
to,539,541,O
protect,542,549,O
against,550,557,O
early,558,563,O
recurrences,564,575,O
and,576,579,O
continued,580,589,O
oral,590,594,O
anticoagulation,595,610,O
for,611,614,O
a,615,616,O
minimum,617,624,O
of,625,627,O
2,628,629,O
months,630,636,O
to,637,639,O
maintain,640,648,O
an,649,651,O
international,652,665,O
normalized,666,676,O
ratio,677,682,O
between,683,690,O
2,691,692,O
.,692,693,O
0,693,694,O
and,695,698,O
3,699,700,O
.,700,701,O
0,701,702,O
.,702,703,O
Additionally,704,716,O
",",716,717,O
magnetic,718,726,O
resonance,727,736,O
angiography,737,748,O
was,749,752,O
repeated,753,761,O
at,762,764,O
3,765,766,O
-,766,767,O
6,767,768,O
months,769,775,O
after,776,781,O
the,782,785,O
procedure,786,795,O
to,796,798,O
evaluate,799,807,O
the,808,811,O
presence,812,820,O
of,821,823,O
PV,824,826,O
stenosis,827,835,O
.,835,836,O
Arrhythmia,837,847,O
recurrence,848,858,O
was,859,862,O
defined,863,870,O
as,871,873,O
a,874,875,O
documented,876,886,O
AF,887,889,O
or,890,892,O
atrial,893,899,B-Multi-tissue_structure
flutter,900,907,O
episode,908,915,O
of,916,918,O
>,919,920,O
30,920,922,O
s,923,924,O
.,924,925,O
Arrhythmic,926,936,O
episodes,937,945,O
within,946,952,O
the,953,956,O
first,957,962,O
3,963,964,O
months,965,971,O
after,972,977,O
the,978,981,O
CPVA,982,986,O
(,987,988,O
healing,988,995,O
period,996,1002,O
),1002,1003,O
were,1004,1008,O
not,1009,1012,O
considered,1013,1023,O
in,1024,1026,O
the,1027,1030,O
evaluation,1031,1041,O
of,1042,1044,O
final,1045,1050,O
success,1051,1058,O
rates,1059,1064,O
because,1065,1072,O
they,1073,1077,O
are,1078,1081,O
often,1082,1087,O
described,1088,1097,O
as,1098,1100,O
transient,1101,1110,O
recurrences,1111,1122,O
related,1123,1130,O
to,1131,1133,O
atrial,1134,1140,B-Multi-tissue_structure
inflammatory,1141,1153,O
processes,1154,1163,O
following,1164,1173,O
RF,1174,1176,O
lesions,1177,1184,O
.,1184,1185,O
26,1185,1187,O
The,1188,1191,O
endpoint,1192,1200,O
of,1201,1203,O
the,1204,1207,O
study,1208,1213,O
was,1214,1217,O
freedom,1218,1225,O
from,1226,1230,O
arrhythmia,1231,1241,O
recurrence,1242,1252,O
after,1253,1258,O
a,1259,1260,O
single,1261,1267,O
CPVA,1268,1272,O
procedure,1273,1282,O
",",1282,1283,O
without,1284,1291,O
anti,1292,1296,O
-,1296,1297,O
arrhythmic,1297,1307,O
medication,1308,1318,O
.,1318,1319,O
A,1320,1321,O
minimum,1322,1329,O
follow,1330,1336,O
-,1336,1337,O
up,1337,1339,O
of,1340,1342,O
3,1343,1344,O
months,1345,1351,O
was,1352,1355,O
required,1356,1364,O
.,1364,1365,O
Electrostatic,0,13,O
interaction,14,25,O
energies,26,34,O
between,35,42,O
the,43,46,O
SNARE,47,52,O
complex,53,60,O
and,61,64,O
fusing,65,71,O
membranes,72,81,B-Cellular_component
.,81,82,O
(,83,84,O
A,84,85,O
),85,86,O
Schematic,87,96,O
diagram,97,104,O
and,105,108,O
definitions,109,120,O
of,121,123,O
intermolecular,124,138,O
interaction,139,150,O
energies,151,159,O
presented,160,169,O
in,170,172,O
(,173,174,O
B,174,175,O
),175,176,O
and,177,180,O
(,181,182,O
C,182,183,O
),183,184,O
.,184,185,O
In,186,188,O
(,189,190,O
A,190,191,O
),191,192,O
through,193,200,O
(,201,202,O
C,202,203,O
),203,204,O
",",204,205,O
only,206,210,O
the,211,214,O
SNARE,215,220,O
core,221,225,O
complex,226,233,O
is,234,236,O
considered,237,247,O
.,247,248,O
Interaction,249,260,O
free,261,265,O
energies,266,274,O
are,275,278,O
calculated,279,289,O
for,290,293,O
(,294,295,O
B,295,296,O
),296,297,O
a,298,299,O
series,300,306,O
of,307,309,O
SNARE,310,315,O
/,315,316,O
membrane,316,324,B-Cellular_component
distances,325,334,O
and,335,338,O
(,339,340,O
C,340,341,O
),341,342,O
different,343,352,O
membrane,353,361,B-Cellular_component
lipid,362,367,O
compositions,368,380,O
.,380,381,O
Arrow,382,387,O
in,388,390,O
(,391,392,O
B,392,393,O
),393,394,O
indicates,395,404,O
the,405,408,O
most,409,413,O
physiologically,414,429,O
relevant,430,438,O
distance,439,447,O
when,448,452,O
the,453,456,O
closest,457,464,O
points,465,471,O
between,472,479,O
SNARE,480,485,O
and,486,489,O
membranes,490,499,B-Cellular_component
are,500,503,O
3,504,505,O
A,506,507,O
",",507,508,O
the,509,512,O
thickness,513,522,O
of,523,525,O
a,526,527,O
layer,528,533,O
of,534,536,O
water,537,542,O
.,542,543,O
[,543,544,O
19,544,546,O
],546,547,O
In,548,550,O
(,551,552,O
D,552,553,O
),553,554,O
through,555,562,O
(,563,564,O
F,564,565,O
),565,566,O
",",566,567,O
TMDs,568,572,O
of,573,575,O
VAMP,576,580,O
and,581,584,O
syntaxin,585,593,O
are,594,597,O
present,598,605,O
and,606,609,O
embedded,610,618,O
in,619,621,O
membranes,622,631,B-Cellular_component
.,631,632,O
Furthermore,633,644,O
",",644,645,O
the,646,649,O
C,650,651,O
-,651,652,O
terminus,652,660,O
of,661,663,O
the,664,667,O
SNARE,668,673,O
motif,674,679,O
is,680,682,O
partially,683,692,O
unraveled,693,702,O
into,703,707,O
individual,708,718,O
alpha,719,724,O
-,724,725,O
helices,725,732,O
by,733,735,O
molecular,736,745,O
dynamics,746,754,O
simulations,755,766,O
to,767,769,O
represent,770,779,O
trans,780,785,O
-,785,786,O
SNARE,786,791,O
complex,792,799,O
.,799,800,O
Interaction,801,812,O
free,813,817,O
energies,818,826,O
are,827,830,O
then,831,835,O
calculated,836,846,O
for,847,850,O
(,851,852,O
E,852,853,O
),853,854,O
a,855,856,O
series,857,863,O
of,864,866,O
SNARE,867,872,O
motif,873,878,O
C,879,880,O
-,880,881,O
terminus,881,889,O
separation,890,900,O
distances,901,910,O
and,911,914,O
(,915,916,O
F,916,917,O
),917,918,O
different,919,928,O
lipid,929,934,O
compositions,935,947,O
of,948,950,O
the,951,954,O
membranes,955,964,B-Cellular_component
.,964,965,O
Conclusions,966,977,O
drawn,978,983,O
from,984,988,O
both,989,993,O
groups,994,1000,O
of,1001,1003,O
studies,1004,1011,O
are,1012,1015,O
essentially,1016,1027,O
the,1028,1031,O
same,1032,1036,O
.,1036,1037,O
V,1038,1039,O
(,1040,1041,O
circles,1041,1048,O
),1048,1049,O
:,1049,1050,O
Interaction,1051,1062,O
energies,1063,1071,O
between,1072,1079,O
the,1080,1083,O
SNARE,1084,1089,O
complex,1090,1097,O
and,1098,1101,O
the,1102,1105,O
v,1106,1107,B-Cellular_component
-,1107,1108,I-Cellular_component
membrane,1108,1116,I-Cellular_component
.,1116,1117,O
T,1118,1119,O
(,1120,1121,O
squares,1121,1128,O
),1128,1129,O
:,1129,1130,O
Interaction,1131,1142,O
energies,1143,1151,O
between,1152,1159,O
SNARE,1160,1165,O
and,1166,1169,O
the,1170,1173,O
t,1174,1175,B-Cellular_component
-,1175,1176,I-Cellular_component
membrane,1176,1184,I-Cellular_component
.,1184,1185,O
VT,1186,1188,O
(,1189,1190,O
triangles,1190,1199,O
),1199,1200,O
:,1200,1201,O
Interaction,1202,1213,O
energies,1214,1222,O
between,1223,1230,O
the,1231,1234,O
v,1235,1236,B-Cellular_component
-,1236,1237,I-Cellular_component
and,1238,1241,O
the,1242,1245,O
t,1246,1247,B-Cellular_component
-,1247,1248,I-Cellular_component
membranes,1248,1257,I-Cellular_component
if,1258,1260,O
the,1261,1264,O
SNARE,1265,1270,O
complex,1271,1278,O
were,1279,1283,O
extracted,1284,1293,O
.,1293,1294,O
Demographic,0,11,O
data,12,16,O
of,17,19,O
subjects,20,28,O
1,0,1,O
.,1,2,O
Background,3,13,O
The,14,17,O
United,18,24,O
Republic,25,33,O
of,34,36,O
Tanzania,37,45,O
",",45,46,O
is,47,49,O
among,50,55,O
the,56,59,O
many,60,64,O
countries,65,74,O
in,75,77,O
sub,78,81,O
-,81,82,O
Saharan,82,89,O
Africa,90,96,O
facing,97,103,O
a,104,105,O
human,106,111,O
resources,112,121,O
crisis,122,128,O
in,129,131,O
its,132,135,O
health,136,142,O
sector,143,149,O
",",149,150,O
with,151,155,O
a,156,157,O
small,158,163,O
and,164,167,O
inequitably,168,179,O
distributed,180,191,O
health,192,198,O
workforce,199,208,O
[,209,210,O
1,210,211,O
],211,212,O
that,213,217,O
shoulders,218,227,O
a,228,229,O
disproportionately,230,248,O
high,249,253,O
burden,254,260,O
of,261,263,O
disease,264,271,O
[,271,272,O
2,272,273,O
],273,274,O
.,274,275,O
Although,276,284,O
all,285,288,O
poor,289,293,O
countries,294,303,O
in,304,306,O
the,307,310,O
world,311,316,O
face,317,321,O
a,322,323,O
severe,324,330,O
human,331,336,O
resource,337,345,O
crisis,346,352,O
in,353,355,O
their,356,361,O
health,362,368,O
sectors,369,376,O
[,377,378,O
3,378,379,O
",",379,380,O
4,380,381,O
],381,382,O
",",382,383,O
the,384,387,O
problem,388,395,O
is,396,398,O
most,399,403,O
acute,404,409,O
in,410,412,O
Sub,413,416,O
-,416,417,O
Saharan,417,424,O
Africa,425,431,O
",",431,432,O
in,433,435,O
which,436,441,O
an,442,444,O
estimated,445,454,O
workforce,455,464,O
of,465,467,O
750,468,471,O
000,472,475,O
health,476,482,O
workers,483,490,O
in,491,493,O
the,494,497,O
region,498,504,O
serves,505,511,O
682,512,515,O
million,516,523,O
people,524,530,O
[,531,532,O
2,532,533,O
],533,534,O
.,534,535,O
By,536,538,O
comparison,539,549,O
",",549,550,O
the,551,554,O
ratio,555,560,O
is,561,563,O
10,564,566,O
to,567,569,O
15,570,572,O
times,573,578,O
higher,579,585,O
in,586,588,O
developed,589,598,O
countries,599,608,O
.,608,609,O
Moreover,610,618,O
",",618,619,O
this,620,624,O
estimated,625,634,O
workforce,635,644,O
of,645,647,O
doctors,648,655,O
",",655,656,O
nurses,657,663,O
and,664,667,O
allied,668,674,O
health,675,681,O
workers,682,689,O
in,690,692,O
Sub,693,696,O
-,696,697,O
Saharan,697,704,O
Africa,705,711,O
constitutes,712,723,O
1,724,725,O
.,725,726,O
3,726,727,O
%,727,728,O
of,729,731,O
the,732,735,O
world,736,741,O
',741,742,O
s,742,743,O
health,744,750,O
workforce,751,760,O
",",760,761,O
while,762,767,O
Africa,768,774,O
suffers,775,782,O
from,783,787,O
25,788,790,O
%,790,791,O
of,792,794,O
the,795,798,O
world,799,804,O
',804,805,O
s,805,806,O
burden,807,813,O
of,814,816,O
disease,817,824,O
[,825,826,O
2,826,827,O
],827,828,O
.,828,829,O
A,830,831,O
minimum,832,839,O
level,840,845,O
of,846,848,O
a,849,850,O
health,851,857,O
workforce,858,867,O
of,868,870,O
2,871,872,O
.,872,873,O
5,873,874,O
health,875,881,O
workers,882,889,O
per,890,893,O
1000,894,898,O
people,899,905,O
is,906,908,O
required,909,917,O
to,918,920,O
achieve,921,928,O
the,929,932,O
Millennium,933,943,O
Development,944,955,O
Goals,956,961,O
[,962,963,O
5,963,964,O
],964,965,O
.,965,966,O
Africa,967,973,O
is,974,976,O
far,977,980,O
from,981,985,O
this,986,990,O
level,991,996,O
with,997,1001,O
a,1002,1003,O
health,1004,1010,O
workforce,1011,1020,O
density,1021,1028,O
that,1029,1033,O
only,1034,1038,O
averages,1039,1047,O
0,1048,1049,O
.,1049,1050,O
8,1050,1051,O
worker,1052,1058,O
per,1059,1062,O
1000,1063,1067,O
people,1068,1074,O
",",1074,1075,O
while,1076,1081,O
the,1082,1085,O
world,1086,1091,O
median,1092,1098,O
density,1099,1106,O
of,1107,1109,O
health,1110,1116,O
personnel,1117,1126,O
is,1127,1129,O
5,1130,1131,O
per,1132,1135,O
1000,1136,1140,O
people,1141,1147,O
[,1148,1149,O
5,1149,1150,O
],1150,1151,O
.,1151,1152,O
There,1153,1158,O
is,1159,1161,O
a,1162,1163,O
positive,1164,1172,O
correlation,1173,1184,O
between,1185,1192,O
health,1193,1199,O
worker,1200,1206,O
density,1207,1214,O
and,1215,1218,O
various,1219,1226,O
health,1227,1233,O
indices,1234,1241,O
",",1241,1242,O
most,1243,1247,O
notably,1248,1255,O
infant,1256,1262,O
mortality,1263,1272,O
rate,1273,1277,O
",",1277,1278,O
maternal,1279,1287,O
mortality,1288,1297,O
rates,1298,1303,O
",",1303,1304,O
and,1305,1308,O
various,1309,1316,O
disease,1317,1324,O
specific,1325,1333,O
mortality,1334,1343,O
and,1344,1347,O
morbidity,1348,1357,O
rates,1358,1363,O
[,1364,1365,O
6,1365,1366,O
",",1366,1367,O
7,1367,1368,O
],1368,1369,O
.,1369,1370,O
An,1371,1373,O
increase,1374,1382,O
in,1383,1385,O
the,1386,1389,O
number,1390,1396,O
of,1397,1399,O
health,1400,1406,O
workers,1407,1414,O
per,1415,1418,O
capita,1419,1425,O
is,1426,1428,O
associated,1429,1439,O
with,1440,1444,O
a,1445,1446,O
notable,1447,1454,O
decline,1455,1462,O
in,1463,1465,O
the,1466,1469,O
rates,1470,1475,O
mentioned,1476,1485,O
above,1486,1491,O
.,1491,1492,O
As,1493,1495,O
a,1496,1497,O
consequence,1498,1509,O
",",1509,1510,O
it,1511,1513,O
has,1514,1517,O
been,1518,1522,O
argued,1523,1529,O
that,1530,1534,O
health,1535,1541,O
worker,1542,1548,O
shortages,1549,1558,O
have,1559,1563,O
impeded,1564,1571,O
the,1572,1575,O
implementation,1576,1590,O
of,1591,1593,O
development,1594,1605,O
goals,1606,1611,O
in,1612,1614,O
many,1615,1619,O
poor,1620,1624,O
countries,1625,1634,O
[,1635,1636,O
8,1636,1637,O
],1637,1638,O
.,1638,1639,O
CASE,0,4,O
:,4,5,O
Here,6,10,O
for,11,14,O
the,15,18,O
first,19,24,O
time,25,29,O
a,30,31,O
case,32,36,O
of,37,39,O
CDLS,40,44,O
from,45,49,O
Iran,50,54,O
",",54,55,O
a,56,57,O
15,58,60,O
-,60,61,O
week,61,65,O
-,65,66,O
old,66,69,O
male,70,74,O
infant,75,81,O
who,82,85,O
was,86,89,O
refereed,90,98,O
as,99,101,O
a,102,103,O
case,104,108,O
of,109,111,O
multiple,112,120,O
congenital,121,131,O
anomalies,132,141,O
.,141,142,O
Clinical,143,151,O
investigation,152,165,O
showed,166,172,O
that,173,177,O
the,178,181,O
child,182,187,O
was,188,191,O
a,192,193,O
case,194,198,O
of,199,201,O
CDLS,202,206,O
.,206,207,O
Applying,0,8,O
A1C,9,12,O
cut,13,16,O
offs,17,21,O
to,22,24,O
the,25,28,O
AusDiab,29,36,O
population,37,47,O
(,48,49,O
4,49,50,O
.,50,51,O
6,51,52,O
%,52,53,O
undiagnosed,54,65,O
diabetes,66,74,O
),74,75,O
Applying,76,84,O
the,85,88,O
same,89,93,O
cut,94,97,O
offs,98,102,O
",",102,103,O
a,104,105,O
total,106,111,O
75,112,114,O
.,114,115,O
9,115,116,O
%,116,117,O
of,118,120,O
the,121,124,O
AusDiab,125,132,O
population,133,143,O
had,144,147,O
diabetes,148,156,O
ruled,157,162,O
in,163,165,O
or,166,168,O
ruled,169,174,O
out,175,178,O
(,179,180,O
Fig,180,183,O
.,183,184,O
1B,185,187,O
),187,188,O
",",188,189,O
while,190,195,O
the,196,199,O
remaining,200,209,O
24,210,212,O
.,212,213,O
1,213,214,O
%,214,215,O
had,216,219,O
impaired,220,228,O
A1C,229,232,O
.,232,233,O
From,234,238,O
those,239,244,O
with,245,249,O
impaired,250,258,O
A1C,259,262,O
",",262,263,O
69,264,266,O
.,266,267,O
3,267,268,O
%,268,269,O
had,270,273,O
abnormal,274,282,O
glucose,283,290,O
status,291,297,O
.,297,298,O
For,299,302,O
diabetes,303,311,O
",",311,312,O
A1C,313,316,O
at,317,319,O
5,320,321,O
.,321,322,O
5,322,323,O
%,323,324,O
provided,325,333,O
moderate,334,342,O
sensitivity,343,354,O
(,355,356,O
83,356,358,O
.,358,359,O
5,359,360,O
%,360,361,O
),361,362,O
but,363,366,O
high,367,371,O
NPV,372,375,O
(,376,377,O
99,377,379,O
.,379,380,O
0,380,381,O
%,381,382,O
),382,383,O
",",383,384,O
since,385,390,O
diabetes,391,399,O
prevalence,400,410,O
was,411,414,O
lower,415,420,O
in,421,423,O
the,424,427,O
AusDiab,428,435,O
than,436,440,O
in,441,443,O
the,444,447,O
MP,448,450,O
population,451,461,O
.,461,462,O
A1C,463,466,O
at,467,469,O
7,470,471,O
.,471,472,O
0,472,473,O
%,473,474,O
gave,475,479,O
100,480,483,O
%,483,484,O
specificity,485,496,O
and,497,500,O
100,501,504,O
%,504,505,O
PPV,506,509,O
.,509,510,O
By,511,513,O
dropping,514,522,O
the,523,526,O
cut,527,530,O
off,531,534,O
to,535,537,O
6,538,539,O
.,539,540,O
5,540,541,O
%,541,542,O
",",542,543,O
specificity,544,555,O
remained,556,564,O
99,565,567,O
.,567,568,O
9,568,569,O
%,569,570,O
",",570,571,O
with,572,576,O
PPV,577,580,O
near,581,585,O
100,586,589,O
%,589,590,O
.,590,591,O
Calcium,0,7,O
intake,8,14,O
and,15,18,O
effects,19,26,O
on,27,29,O
QUS,30,33,O
T,34,35,O
-,35,36,O
score,36,41,O
Figure,42,48,O
5,49,50,O
shows,51,56,O
the,57,60,O
amounts,61,68,O
of,69,71,O
dietary,72,79,O
calcium,80,87,O
intake,88,94,O
according,95,104,O
to,105,107,O
menopausal,108,118,O
status,119,125,O
.,125,126,O
Calcium,127,134,O
consumption,135,146,O
in,147,149,O
most,150,154,O
groups,155,161,O
",",161,162,O
like,163,167,O
that,168,172,O
in,173,175,O
the,176,179,O
study,180,185,O
population,186,196,O
as,197,199,O
a,200,201,O
whole,202,207,O
",",207,208,O
was,209,212,O
inadequate,213,223,O
.,223,224,O
Fewer,225,230,O
than,231,235,O
one,236,239,O
third,240,245,O
of,246,248,O
premenopausal,249,262,O
and,263,266,O
postmenopausal,267,281,O
women,282,287,O
received,288,296,O
more,297,301,O
than,302,306,O
800,307,310,O
mg,311,313,O
calcium,314,321,O
daily,322,327,O
",",327,328,O
and,329,332,O
fewer,333,338,O
than,339,343,O
16,344,346,O
%,346,347,O
of,348,350,O
premenopausal,351,364,O
women,365,370,O
in,371,373,O
the,374,377,O
50,378,380,O
-,380,381,O
59,381,383,O
age,384,387,O
decade,388,394,O
(,395,396,O
n,396,397,O
=,398,399,O
38,400,402,O
),402,403,O
consumed,404,412,O
more,413,417,O
than,418,422,O
800,423,426,O
mg,427,429,O
calcium,430,437,O
daily,438,443,O
.,443,444,O
Figure,445,451,O
5,452,453,O
Daily,454,459,O
calcium,460,467,O
intake,468,474,O
in,475,477,O
premenopausal,478,491,O
and,492,495,O
postmenopausal,496,510,O
women,511,516,O
.,516,517,O
This,518,522,O
figure,523,529,O
depicts,530,537,O
the,538,541,O
daily,542,547,O
amounts,548,555,O
of,556,558,O
dietary,559,566,O
calcium,567,574,O
intake,575,581,O
(,582,583,O
and,583,586,O
percent,587,594,O
),594,595,O
according,596,605,O
to,606,608,O
menopausal,609,619,O
status,620,626,O
using,627,632,O
800,633,636,O
mg,637,639,O
daily,640,645,O
as,646,648,O
cut,649,652,O
off,653,656,O
point,657,662,O
.,662,663,O
QUS,664,667,O
T,668,669,O
-,669,670,O
score,670,675,O
were,676,680,O
then,681,685,O
calculated,686,696,O
according,697,706,O
to,707,709,O
daily,710,715,O
calcium,716,723,O
intake,724,730,O
in,731,733,O
all,734,737,O
premenopausal,738,751,O
and,752,755,O
postmenopausal,756,770,O
activity,771,779,O
groups,780,786,O
using,787,792,O
800,793,796,O
mg,797,799,O
daily,800,805,O
calcium,806,813,O
as,814,816,O
cutoff,817,823,O
point,824,829,O
.,829,830,O
As,831,833,O
shown,834,839,O
in,840,842,O
Tables,843,849,O
3,850,851,O
and,852,855,O
4,856,857,O
and,858,861,O
Figure,862,868,O
6,869,870,O
",",870,871,O
premenopausal,872,885,O
women,886,891,O
who,892,895,O
were,896,900,O
systematically,901,915,O
active,916,922,O
and,923,926,O
consumed,927,935,O
more,936,940,O
than,941,945,O
800,946,949,O
mg,950,952,O
calcium,953,960,O
daily,961,966,O
had,967,970,O
significantly,971,984,O
higher,985,991,O
QUS,992,995,O
T,996,997,O
-,997,998,O
scores,998,1004,O
compared,1005,1013,O
with,1014,1018,O
all,1019,1022,O
other,1023,1028,O
activity,1029,1037,O
groups,1038,1044,O
(,1045,1046,O
p,1046,1047,O
<,1048,1049,O
0,1050,1051,O
.,1051,1052,O
05,1052,1054,O
),1054,1055,O
.,1055,1056,O
Among,1057,1062,O
systematically,1063,1077,O
active,1078,1084,O
premenopausal,1085,1098,O
women,1099,1104,O
who,1105,1108,O
received,1109,1117,O
more,1118,1122,O
than,1123,1127,O
800,1128,1131,O
mg,1132,1134,O
calcium,1135,1142,O
per,1143,1146,O
day,1147,1150,O
",",1150,1151,O
this,1152,1156,O
difference,1157,1167,O
was,1168,1171,O
separately,1172,1182,O
significant,1183,1194,O
verses,1195,1201,O
sedentary,1202,1211,O
(,1212,1213,O
p,1213,1214,O
=,1215,1216,O
0,1217,1218,O
.,1218,1219,O
028,1219,1222,O
),1222,1223,O
and,1224,1227,O
moderately,1228,1238,O
active,1239,1245,O
(,1246,1247,O
p,1247,1248,O
=,1249,1250,O
0,1251,1252,O
.,1252,1253,O
04,1253,1255,O
),1255,1256,O
women,1257,1262,O
.,1262,1263,O
In,1264,1266,O
contrast,1267,1275,O
",",1275,1276,O
postmenopausal,1277,1291,O
women,1292,1297,O
showed,1298,1304,O
no,1305,1307,O
difference,1308,1318,O
in,1319,1321,O
QUS,1322,1325,O
T,1326,1327,O
-,1327,1328,O
scores,1328,1334,O
regardless,1335,1345,O
of,1346,1348,O
the,1349,1352,O
amount,1353,1359,O
of,1360,1362,O
daily,1363,1368,O
calcium,1369,1376,O
intake,1377,1383,O
.,1383,1384,O
Figure,1385,1391,O
6,1392,1393,O
Synergy,1394,1401,O
between,1402,1409,O
physical,1410,1418,O
activity,1419,1427,O
and,1428,1431,O
dietary,1432,1439,O
calcium,1440,1447,O
intake,1448,1454,O
in,1455,1457,O
women,1458,1463,O
consuming,1464,1473,O
calcium,1474,1481,O
amounts,1482,1489,O
greater,1490,1497,O
than,1498,1502,O
800,1503,1506,O
mg,1507,1509,O
/,1509,1510,O
day,1510,1513,O
.,1513,1514,O
This,1515,1519,O
graphic,1520,1527,O
depicts,1528,1535,O
mean,1536,1540,O
QUS,1541,1544,O
T,1545,1546,O
-,1546,1547,O
score,1547,1552,O
values,1553,1559,O
calculated,1560,1570,O
according,1571,1580,O
to,1581,1583,O
daily,1584,1589,O
calcium,1590,1597,O
intake,1598,1604,O
in,1605,1607,O
all,1608,1611,O
premenopausal,1612,1625,O
and,1626,1629,O
postmenopausal,1630,1644,O
activity,1645,1653,O
groups,1654,1660,O
using,1661,1666,O
800,1667,1670,O
mg,1671,1673,O
daily,1674,1679,O
as,1680,1682,O
cut,1683,1686,O
off,1687,1690,O
point,1691,1696,O
(,1697,1698,O
for,1698,1701,O
statistical,1702,1713,O
significant,1714,1725,O
values,1726,1732,O
see,1733,1736,O
text,1737,1741,O
),1741,1742,O
.,1742,1743,O
CONCLUSIONS,0,11,O
The,12,15,O
lack,16,20,O
of,21,23,O
association,24,35,O
between,36,43,O
depression,44,54,O
and,55,58,O
glycemic,59,67,O
control,68,75,O
is,76,78,O
not,79,82,O
due,83,86,O
to,87,89,O
the,90,93,O
use,94,97,O
of,98,100,O
a,101,102,O
binary,103,109,O
measure,110,117,O
of,118,120,O
depression,121,131,O
.,131,132,O
Findings,133,141,O
further,142,149,O
clarify,150,157,O
the,158,161,O
significant,162,173,O
association,174,185,O
between,186,193,O
distress,194,202,O
and,203,206,O
A1C,207,210,O
.,210,211,O
Discussion,0,10,O
This,11,15,O
is,16,18,O
the,19,22,O
first,23,28,O
study,29,34,O
to,35,37,O
employ,38,44,O
such,45,49,O
a,50,51,O
large,52,57,O
number,58,64,O
of,65,67,O
replicated,68,78,O
samples,79,86,O
in,87,89,O
order,90,95,O
to,96,98,O
assess,99,105,O
the,106,109,O
bacterial,110,119,O
communities,120,131,O
of,132,134,O
healthy,135,142,O
and,143,146,O
diseased,147,155,O
corals,156,162,O
",",162,163,O
and,164,167,O
the,168,171,O
first,172,177,O
culture,178,185,O
-,185,186,O
independent,186,197,O
assessment,198,208,O
of,209,211,O
bacterial,212,221,O
communities,222,233,O
on,234,236,O
Acroporid,237,246,O
WS,247,249,O
corals,250,256,O
on,257,259,O
the,260,263,O
GBR,264,267,O
.,267,268,O
Despite,269,276,O
the,277,280,O
potential,281,290,O
of,291,293,O
not,294,297,O
capturing,298,307,O
rare,308,312,O
or,313,315,O
very,316,320,O
low,321,324,O
abundance,325,334,O
bacterial,335,344,O
ribotypes,345,354,O
",",354,355,O
the,356,359,O
DGGE,360,364,O
analysis,365,373,O
used,374,378,O
in,379,381,O
this,382,386,O
study,387,392,O
indicated,393,402,O
similar,403,410,O
results,411,418,O
of,419,421,O
captured,422,430,O
bacterial,431,440,O
ribotypes,441,450,O
and,451,454,O
tentative,455,464,O
bacterial,465,474,O
species,475,482,O
replacement,483,494,O
in,495,497,O
unhealthy,498,507,O
corals,508,514,O
to,515,517,O
that,518,522,O
of,523,525,O
less,526,530,O
replicated,531,541,O
studies,542,549,O
using,550,555,O
other,556,561,O
non,562,565,O
-,565,566,O
culture,566,573,O
based,574,579,O
techniques,580,590,O
(,591,592,O
e,592,593,O
.,593,594,O
g,594,595,O
.,595,596,O
[,597,598,O
3,598,599,O
],599,600,O
",",600,601,O
[,602,603,O
54,603,605,O
],605,606,O
",",606,607,O
[,608,609,O
69,609,611,O
],611,612,O
;,612,613,O
Figure,614,620,O
4,621,622,O
),622,623,O
.,623,624,O
The,625,628,O
results,629,636,O
from,637,641,O
this,642,646,O
research,647,655,O
reinforce,656,665,O
",",665,666,O
with,667,671,O
statistically,672,685,O
relevant,686,694,O
data,695,699,O
",",699,700,O
that,701,705,O
corals,706,712,O
harbour,713,720,O
bacterial,721,730,O
communities,731,742,O
different,743,752,O
to,753,755,O
the,756,759,O
water,760,765,O
column,766,772,O
[,773,774,O
7,774,775,O
],775,776,O
",",776,777,O
[,778,779,O
9,779,780,O
],780,781,O
",",781,782,O
[,783,784,O
42,784,786,O
],786,787,O
",",787,788,O
corroborate,789,800,O
findings,801,809,O
that,810,814,O
corals,815,821,O
associate,822,831,O
only,832,836,O
with,837,841,O
certain,842,849,O
specific,850,858,O
bacterial,859,868,O
groups,869,875,O
",",875,876,O
and,877,880,O
that,881,885,O
these,886,891,O
coral,892,897,O
-,897,898,O
associated,898,908,O
bacterial,909,918,O
communities,919,930,O
are,931,934,O
',935,936,O
host,936,940,O
',940,941,O
species,942,949,O
-,949,950,O
specific,950,958,O
[,959,960,O
2,960,961,O
],961,962,O
.,962,963,O
The,964,967,O
data,968,972,O
presented,973,982,O
here,983,987,O
highlight,988,997,O
a,998,999,O
cluster,1000,1007,O
of,1008,1010,O
bacterial,1011,1020,O
ribotypes,1021,1030,O
frequently,1031,1041,O
associated,1042,1052,O
with,1053,1057,O
corals,1058,1064,O
",",1064,1065,O
and,1066,1069,O
the,1070,1073,O
distribution,1074,1086,O
of,1087,1089,O
these,1090,1095,O
bacterial,1096,1105,O
ribotypes,1106,1115,O
on,1116,1118,O
healthy,1119,1126,O
and,1127,1130,O
diseased,1131,1139,O
corals,1140,1146,O
",",1146,1147,O
which,1148,1153,O
allows,1154,1160,O
for,1161,1164,O
further,1165,1172,O
targeted,1173,1181,O
research,1182,1190,O
into,1191,1195,O
a,1196,1197,O
tentative,1198,1207,O
link,1208,1212,O
between,1213,1220,O
these,1221,1226,O
common,1227,1233,O
coral,1234,1239,O
associates,1240,1250,O
and,1251,1254,O
coral,1255,1260,O
health,1261,1267,O
.,1267,1268,O
This,1269,1273,O
study,1274,1279,O
indicates,1280,1289,O
that,1290,1294,O
coral,1295,1300,O
bacterial,1301,1310,O
community,1311,1320,O
assessments,1321,1332,O
require,1333,1340,O
a,1341,1342,O
number,1343,1349,O
of,1350,1352,O
replicates,1353,1363,O
per,1364,1367,O
coral,1368,1373,O
species,1374,1381,O
and,1382,1385,O
site,1386,1390,O
to,1391,1393,O
accurately,1394,1404,O
describe,1405,1413,O
the,1414,1417,O
diversity,1418,1427,O
present,1428,1435,O
across,1436,1442,O
the,1443,1446,O
population,1447,1457,O
and,1458,1461,O
in,1462,1464,O
order,1465,1470,O
to,1471,1473,O
draw,1474,1478,O
inferences,1479,1489,O
on,1490,1492,O
health,1493,1499,O
-,1499,1500,O
related,1500,1507,O
changes,1508,1515,O
in,1516,1518,O
the,1519,1522,O
community,1523,1532,O
composition,1533,1544,O
.,1544,1545,O
In,1546,1548,O
addition,1549,1557,O
",",1557,1558,O
the,1559,1562,O
comparisons,1563,1574,O
of,1575,1577,O
healthy,1578,1585,O
and,1586,1589,O
diseased,1590,1598,O
Acropora,1599,1607,O
hyacinthus,1608,1618,O
samples,1619,1626,O
showed,1627,1633,O
that,1634,1638,O
bacterial,1639,1648,O
communities,1649,1660,O
can,1661,1664,O
change,1665,1671,O
dramatically,1672,1684,O
in,1685,1687,O
diseased,1688,1696,O
individuals,1697,1708,O
.,1708,1709,O
The,1710,1713,O
DGGE,1714,1718,O
profiles,1719,1727,O
observed,1728,1736,O
for,1737,1740,O
corals,1741,1747,O
displaying,1748,1758,O
signs,1759,1764,O
of,1765,1767,O
White,1768,1773,O
Syndrome,1774,1782,O
comprised,1783,1792,O
a,1793,1794,O
range,1795,1800,O
of,1801,1803,O
bacterial,1804,1813,O
ribotypes,1814,1823,O
not,1824,1827,O
generally,1828,1837,O
found,1838,1843,O
on,1844,1846,O
healthy,1847,1854,O
corals,1855,1861,O
",",1861,1862,O
including,1863,1872,O
close,1873,1878,O
relatives,1879,1888,O
of,1889,1891,O
bacteria,1892,1900,O
previously,1901,1911,O
found,1912,1917,O
on,1918,1920,O
Black,1921,1926,O
Band,1927,1931,O
Diseased,1932,1940,O
corals,1941,1947,O
.,1947,1948,O
However,1949,1956,O
the,1957,1960,O
community,1961,1970,O
profiles,1971,1979,O
across,1980,1986,O
the,1987,1990,O
samples,1991,1998,O
taken,1999,2004,O
from,2005,2009,O
diseased,2010,2018,O
coral,2019,2024,O
colonies,2025,2033,O
were,2034,2038,O
inconsistent,2039,2051,O
and,2052,2055,O
not,2056,2059,O
indicative,2060,2070,O
of,2071,2073,O
a,2074,2075,O
single,2076,2082,O
bacterial,2083,2092,O
causative,2093,2102,O
agent,2103,2108,O
.,2108,2109,O
The,0,3,O
eukaryotic,4,14,O
parasite,15,23,O
Trypanosoma,24,35,O
brucei,36,42,O
is,43,45,O
able,46,50,O
to,51,53,O
import,54,60,O
inositol,61,69,O
from,70,74,O
the,75,78,O
environment,79,90,O
or,91,93,O
synthesize,94,104,O
it,105,107,O
de,108,110,O
novo,111,115,O
.,115,116,O
However,117,124,O
",",124,125,O
according,126,135,O
to,136,138,O
the,139,142,O
current,143,150,O
model,151,156,O
",",156,157,O
inositol,158,166,O
imported,167,175,O
from,176,180,O
the,181,184,O
environment,185,196,O
is,197,199,O
utilized,200,208,O
primarily,209,218,O
in,219,221,O
bulk,222,226,O
phosphatidylinositol,227,247,O
(,248,249,O
red,249,252,O
and,253,256,O
yellow,257,263,O
phospholipid,264,276,O
),276,277,O
production,278,288,O
via,289,292,O
a,293,294,O
phosphatidylinositol,295,315,O
synthase,316,324,O
(,325,326,O
PIS,326,329,O
),329,330,O
localized,331,340,O
to,341,343,O
the,344,347,O
Golgi,348,353,B-Cellular_component
complex,354,361,I-Cellular_component
.,361,362,O
Inositol,363,371,O
synthesized,372,383,O
de,384,386,O
novo,387,391,O
is,392,394,O
primarily,395,404,O
used,405,409,O
to,410,412,O
generate,413,421,O
phosphatidylinositol,422,442,O
that,443,447,O
is,448,450,O
used,451,455,O
for,456,459,O
production,460,470,O
of,471,473,O
glycosylphosphatidylinositols,474,503,O
(,504,505,O
GPIs,505,509,O
),509,510,O
.,510,511,O
The,512,515,O
de,516,518,O
novo,519,523,O
-,523,524,O
synthesized,524,535,O
inositol,536,544,O
is,545,547,O
believed,548,556,O
to,557,559,O
be,560,562,O
utilized,563,571,O
mostly,572,578,O
for,579,582,O
GPI,583,586,O
production,587,597,O
because,598,605,O
the,606,609,O
IMPase,610,616,O
that,617,621,O
dephosphorylates,622,638,O
inositol,639,647,O
3,648,649,O
-,649,650,O
phosphate,650,659,O
to,660,662,O
inositol,663,671,O
is,672,674,O
localized,675,684,O
to,685,687,O
the,688,691,O
ER,692,694,O
",",694,695,O
where,696,701,O
GPI,702,705,O
synthesis,706,715,O
occurs,716,722,O
.,722,723,O
Mutants,724,731,O
lacking,732,739,O
TbINO1,740,746,O
are,747,750,O
inviable,751,759,O
because,760,767,O
of,768,770,O
diminished,771,781,O
GPI,782,785,O
production,786,796,O
.,796,797,O
Large,0,5,O
nodular,6,13,B-Pathological_formation
hepatic,14,21,I-Pathological_formation
flexure,22,29,I-Pathological_formation
lesions,30,37,I-Pathological_formation
as,38,40,O
seen,41,45,O
on,46,48,O
Colonoscopy,49,60,O
.,60,61,O
Water,0,5,O
emerging,6,14,O
from,15,19,O
the,20,23,O
yoke,24,28,O
adapter,29,36,O
of,37,39,O
the,40,43,O
nitrous,44,51,O
oxide,52,57,O
hose,58,62,O
The,0,3,O
pedigree,4,12,O
of,13,15,O
a,16,17,O
Korean,18,24,O
family,25,31,O
with,32,36,O
macular,37,44,B-Tissue
dystrophy,45,54,O
demonstrating,55,68,O
the,69,72,O
characteristics,73,88,O
of,89,91,O
an,92,94,O
autosomal,95,104,O
dominant,105,113,O
inheritance,114,125,O
trait,126,131,O
.,131,132,O
Histological,0,12,O
analysis,13,21,O
A,22,23,O
cross,24,29,O
-,29,30,O
section,30,37,O
of,38,40,O
the,41,44,O
distal,45,51,B-Multi-tissue_structure
colon,52,57,I-Multi-tissue_structure
(,58,59,O
2,59,60,O
cm,61,63,O
),63,64,O
was,65,68,O
fixed,69,74,O
in,75,77,O
10,78,80,O
%,80,81,O
paraformaldehyde,82,98,O
solution,99,107,O
.,107,108,O
Afterwards,109,119,O
",",119,120,O
it,121,123,O
was,124,127,O
cut,128,131,O
into,132,136,O
small,137,142,O
fragments,143,152,O
",",152,153,O
dehydrated,154,164,O
through,165,172,O
an,173,175,O
ethanol,176,183,O
series,184,190,O
(,191,192,O
70,192,194,O
%,194,195,O
-,195,196,O
100,196,199,O
%,199,200,O
),200,201,O
",",201,202,O
cleared,203,210,O
in,211,213,O
xylol,214,219,O
and,220,223,O
embedded,224,232,O
in,233,235,O
paraffin,236,244,O
.,244,245,O
The,246,249,O
fragments,250,259,B-Multi-tissue_structure
were,260,264,O
sliced,265,271,O
into,272,276,O
5,277,278,O
mum,279,282,O
thick,283,288,O
sections,289,297,O
and,298,301,O
stained,302,309,O
with,310,314,O
hematoxylin,315,326,O
-,326,327,O
eosin,327,332,O
.,332,333,O
Histological,334,346,O
evaluation,347,357,O
was,358,361,O
done,362,366,O
by,367,369,O
a,370,371,O
pathologist,372,383,O
who,384,387,O
was,388,391,O
blinded,392,399,O
to,400,402,O
the,403,406,O
experimental,407,419,O
groups,420,426,O
",",426,427,O
and,428,431,O
it,432,434,O
was,435,438,O
based,439,444,O
on,445,447,O
the,448,451,O
intensity,452,461,O
of,462,464,O
mononuclear,465,476,O
and,477,480,O
polymorphonuclear,481,498,O
infiltrates,499,510,O
in,511,513,O
the,514,517,O
lamina,518,524,B-Tissue
propria,525,532,I-Tissue
",",532,533,O
crypt,534,539,B-Immaterial_anatomical_entity
dilation,540,548,O
",",548,549,O
cellular,550,558,B-Cell
destruction,559,570,O
and,571,574,O
mucosal,575,582,B-Multi-tissue_structure
ulceration,583,593,O
.,593,594,O
Histopathological,595,612,O
changes,613,620,O
were,621,625,O
graded,626,632,O
according,633,642,O
to,643,645,O
the,646,649,O
degree,650,656,O
of,657,659,O
inflammation,660,672,O
using,673,678,O
the,679,682,O
following,683,692,O
scale,693,698,O
:,698,699,O
absent,700,706,O
(,707,708,O
0,708,709,O
),709,710,O
",",710,711,O
light,712,717,O
(,718,719,O
1,719,720,O
),720,721,O
",",721,722,O
moderate,723,731,O
(,732,733,O
2,733,734,O
),734,735,O
and,736,739,O
intense,740,747,O
(,748,749,O
3,749,750,O
),750,751,O
",",751,752,O
and,753,756,O
the,757,760,O
numbers,761,768,O
represented,769,780,O
the,781,784,O
inflammation,785,797,O
score,798,803,O
(,804,805,O
IS,805,807,O
),807,808,O
.,808,809,O
Results,810,817,O
were,818,822,O
expressed,823,832,O
as,833,835,O
mean,836,840,O
values,841,847,O
of,848,850,O
IS,851,853,O
+,854,855,O
/,855,856,O
-,856,857,O
standard,858,866,O
error,867,872,O
of,873,875,O
the,876,879,O
mean,880,884,O
(,885,886,O
SEM,886,889,O
),889,890,O
for,891,894,O
each,895,899,O
experimental,900,912,O
group,913,918,O
.,918,919,O
Pteris,0,6,O
vittata,7,14,O
Intervention,0,12,O
Patients,13,21,O
',21,22,O
initial,23,30,O
introduction,31,43,O
to,44,46,O
the,47,50,O
Wrist,51,56,B-Organism_subdivision
Extension,57,66,O
Dynasplint,67,77,O
(,78,79,O
WED,79,82,O
),82,83,O
system,84,90,O
",",90,91,O
[,92,93,O
Dynasplint,93,103,O
Systems,104,111,O
",",111,112,O
Inc,113,116,O
.,116,117,O
",",117,118,O
Severna,119,126,O
Park,127,131,O
",",131,132,O
MD,133,135,O
",",135,136,O
USA,137,140,O
],140,141,O
included,142,150,O
customized,151,161,O
fitting,162,169,O
(,170,171,O
wrist,171,176,B-Organism_subdivision
length,177,183,O
",",183,184,O
width,185,190,O
",",190,191,O
and,192,195,O
girth,196,201,O
so,202,204,O
that,205,209,O
the,210,213,O
force,214,219,O
and,220,223,O
counter,224,231,O
force,232,237,O
straps,238,244,O
could,245,250,O
be,251,253,O
properly,254,262,O
aligned,263,270,O
),270,271,O
and,272,275,O
training,276,284,O
on,285,287,O
donning,288,295,O
and,296,299,O
doffing,300,307,O
of,308,310,O
the,311,314,O
device,315,321,O
.,321,322,O
(,323,324,O
See,324,327,O
figure,328,334,O
1,335,336,O
.,336,337,O
),337,338,O
Verbal,339,345,O
and,346,349,O
written,350,357,O
instructions,358,370,O
were,371,375,O
provided,376,384,O
throughout,385,395,O
the,396,399,O
duration,400,408,O
of,409,411,O
treatment,412,421,O
for,422,425,O
safety,426,432,O
",",432,433,O
general,434,441,O
wear,442,446,O
and,447,450,O
care,451,455,O
",",455,456,O
and,457,460,O
tension,461,468,O
setting,469,476,O
goals,477,482,O
based,483,488,O
on,489,491,O
patient,492,499,O
tolerance,500,509,O
.,509,510,O
Figure,511,517,O
1,518,519,O
Wrist,520,525,B-Organism_subdivision
Extension,526,535,O
Dynasplint,536,546,O
.,546,547,O
Each,548,552,O
patient,553,560,O
initially,561,570,O
wore,571,575,O
the,576,579,O
WED,580,583,O
for,584,587,O
4,588,589,O
-,589,590,O
6,590,591,O
continuous,592,602,O
hours,603,608,O
at,609,611,O
an,612,614,O
initial,615,622,O
tension,623,630,O
setting,631,638,O
of,639,641,O
#,642,643,O
2,643,644,O
(,645,646,O
0,646,647,O
.,647,648,O
1,648,649,O
foot,650,654,O
pounds,655,661,O
of,662,664,O
torque,665,671,O
),671,672,O
.,672,673,O
This,674,678,O
duration,679,687,O
was,688,691,O
for,692,695,O
acclimatization,696,711,O
to,712,714,O
the,715,718,O
system,719,725,O
;,725,726,O
then,727,731,O
patients,732,740,O
were,741,745,O
instructed,746,756,O
to,757,759,O
wear,760,764,O
the,765,768,O
WED,769,772,O
system,773,779,O
at,780,782,O
night,783,788,O
while,789,794,O
sleeping,795,803,O
for,804,807,O
6,808,809,O
-,809,810,O
8,810,811,O
hours,812,817,O
of,818,820,O
continuous,821,831,O
wear,832,836,O
.,836,837,O
After,838,843,O
each,844,848,O
patient,849,856,O
was,857,860,O
comfortable,861,872,O
wearing,873,880,O
the,881,884,O
unit,885,889,O
for,890,893,O
one,894,897,O
week,898,902,O
at,903,905,O
tension,906,913,O
level,914,919,O
#,920,921,O
2,921,922,O
",",922,923,O
they,924,928,O
were,929,933,O
instructed,934,944,O
to,945,947,O
increase,948,956,O
the,957,960,O
tension,961,968,O
level,969,974,O
to,975,977,O
#,978,979,O
3,979,980,O
(,981,982,O
0,982,983,O
.,983,984,O
3,984,985,O
ft,986,988,O
lbs,989,992,O
.,992,993,O
),993,994,O
and,995,998,O
make,999,1003,O
continual,1004,1013,O
increases,1014,1023,O
every,1024,1029,O
two,1030,1033,O
weeks,1034,1039,O
.,1039,1040,O
If,1041,1043,O
prolonged,1044,1053,O
soreness,1054,1062,O
followed,1063,1071,O
a,1072,1073,O
session,1074,1081,O
(,1082,1083,O
soreness,1083,1091,O
for,1092,1095,O
more,1096,1100,O
than,1101,1105,O
15,1106,1108,O
minutes,1109,1116,O
),1116,1117,O
the,1118,1121,O
patient,1122,1129,O
was,1130,1133,O
instructed,1134,1144,O
to,1145,1147,O
decrease,1148,1156,O
the,1157,1160,O
tension,1161,1168,O
one,1169,1172,O
half,1173,1177,O
a,1178,1179,O
setting,1180,1187,O
for,1188,1191,O
two,1192,1195,O
days,1196,1200,O
until,1201,1206,O
they,1207,1211,O
were,1212,1216,O
comfortable,1217,1228,O
wearing,1229,1236,O
it,1237,1239,O
for,1240,1243,O
6,1244,1245,O
-,1245,1246,O
8,1246,1247,O
hours,1248,1253,O
at,1254,1256,O
the,1257,1260,O
new,1261,1264,O
tension,1265,1272,O
setting,1273,1280,O
.,1280,1281,O
The,1282,1285,O
majority,1286,1294,O
of,1295,1297,O
all,1298,1301,O
patients,1302,1310,O
reached,1311,1318,O
level,1319,1324,O
#,1325,1326,O
5,1326,1327,O
(,1328,1329,O
0,1329,1330,O
.,1330,1331,O
8,1331,1332,O
foot,1333,1337,O
pounds,1338,1344,O
of,1345,1347,O
torque,1348,1354,O
),1354,1355,O
by,1356,1358,O
the,1359,1362,O
end,1363,1366,O
of,1367,1369,O
two,1370,1373,O
months,1374,1380,O
.,1380,1381,O
All,1382,1385,O
range,1386,1391,O
of,1392,1394,O
motion,1395,1401,O
measurements,1402,1414,O
were,1415,1419,O
recorded,1420,1428,O
by,1429,1431,O
the,1432,1435,O
prescribing,1436,1447,O
clinician,1448,1457,O
.,1457,1458,O
Animals,0,7,O
STOP,8,12,O
null,13,17,O
mice,18,22,O
and,23,26,O
their,27,32,O
WT,33,35,O
littermates,36,47,O
were,48,52,O
generated,53,62,O
on,63,65,O
a,66,67,O
mixed,68,73,O
BALBc,74,79,O
/,79,80,O
129,80,83,O
SvPas,84,89,O
and,90,93,O
on,94,96,O
a,97,98,O
pure,99,103,O
129,104,107,O
SvPas,108,113,O
background,114,124,O
as,125,127,O
previously,128,138,O
reported,139,147,O
by,148,150,O
Andrieux,151,159,O
et,160,162,O
al,163,165,O
.,165,166,O
[,167,168,O
4,168,169,O
],169,170,O
.,170,171,O
All,172,175,O
animals,176,183,O
used,184,188,O
in,189,191,O
the,192,195,O
study,196,201,O
underwent,202,211,O
immunohistochemistry,212,232,O
for,233,236,O
the,237,240,O
detection,241,250,O
of,251,253,O
STOP,254,258,O
protein,259,266,O
",",266,267,O
resulting,268,277,O
in,278,280,O
no,281,283,O
staining,284,292,O
in,293,295,O
STOP,296,300,O
null,301,305,O
mice,306,310,O
",",310,311,O
and,312,315,O
genotyping,316,326,O
by,327,329,O
PCR,330,333,O
as,334,336,O
described,337,346,O
by,347,349,O
Andrieux,350,358,O
et,359,361,O
al,362,364,O
.,364,365,O
[,366,367,O
4,367,368,O
],368,369,O
.,369,370,O
All,371,374,O
mice,375,379,O
were,380,384,O
kept,385,389,O
under,390,395,O
standard,396,404,O
housing,405,412,O
conditions,413,423,O
with,424,428,O
a,429,430,O
12,431,433,O
-,433,434,O
hour,434,438,O
/,438,439,O
12,439,441,O
-,441,442,O
hour,442,446,O
dark,447,451,O
-,451,452,O
light,452,457,O
cycle,458,463,O
.,463,464,O
The,465,468,O
experiments,469,480,O
were,481,485,O
carried,486,493,O
out,494,497,O
in,498,500,O
accordance,501,511,O
with,512,516,O
the,517,520,O
European,521,529,O
Communities,530,541,O
Council,542,549,O
Directive,550,559,O
of,560,562,O
24,563,565,O
November,566,574,O
1986,575,579,O
(,580,581,O
86,581,583,O
/,583,584,O
609,584,587,O
/,587,588,O
EEC,588,591,O
),591,592,O
",",592,593,O
and,594,597,O
the,598,601,O
French,602,608,O
Department,609,619,O
of,620,622,O
Agriculture,623,634,O
(,635,636,O
License,636,643,O
Ndegrees,644,652,O
67,653,655,O
-,655,656,O
95,656,658,O
),658,659,O
.,659,660,O
The,661,664,O
protocol,665,673,O
was,674,677,O
approved,678,686,O
by,687,689,O
the,690,693,O
ethical,694,701,O
Animal,702,708,O
Research,709,717,O
Committee,718,727,O
of,728,730,O
Louis,731,736,O
Pasteur,737,744,O
University,745,755,O
(,756,757,O
CREMEAS,757,764,O
#,765,766,O
AL,766,768,O
/,768,769,O
01,769,771,O
/,771,772,O
19,772,774,O
/,774,775,O
10,775,777,O
/,777,778,O
07,778,780,O
),780,781,O
.,781,782,O
In,783,785,O
a,786,787,O
first,788,793,O
experiment,794,804,O
",",804,805,O
we,806,808,O
searched,809,817,O
for,818,821,O
differences,822,833,O
in,834,836,O
glomerular,837,847,B-Multi-tissue_structure
ultrastructure,848,862,O
and,863,866,O
peripheral,867,877,O
neurogenesis,878,890,O
between,891,898,O
WT,899,901,O
and,902,905,O
STOP,906,910,O
null,911,915,O
mice,916,920,O
:,920,921,O
a,922,923,O
first,924,929,O
group,930,935,O
of,936,938,O
24,939,941,O
mice,942,946,O
",",946,947,O
3,948,949,O
-,949,950,O
to,951,953,O
6,954,955,O
-,955,956,O
month,957,962,O
-,962,963,O
old,963,966,O
",",966,967,O
was,968,971,O
used,972,976,O
for,977,980,O
ultrastructural,981,996,O
study,997,1002,O
of,1003,1005,O
the,1006,1009,O
OBs,1010,1013,O
;,1013,1014,O
a,1015,1016,O
second,1017,1023,O
group,1024,1029,O
of,1030,1032,O
13,1033,1035,O
animals,1036,1043,O
was,1044,1047,O
used,1048,1052,O
to,1053,1055,O
analyse,1056,1063,O
proliferation,1064,1077,O
and,1078,1081,O
apoptosis,1082,1091,O
in,1092,1094,O
the,1095,1098,O
OE,1099,1101,B-Tissue
and,1102,1105,O
VNE,1106,1109,B-Tissue
on,1110,1112,O
paraffin,1113,1121,B-Tissue
sections,1122,1130,I-Tissue
in,1131,1133,O
3,1134,1135,O
-,1135,1136,O
month,1136,1141,O
-,1141,1142,O
old,1142,1145,O
mice,1146,1150,O
.,1150,1151,O
In,1152,1154,O
a,1155,1156,O
second,1157,1163,O
experiment,1164,1174,O
we,1175,1177,O
analysed,1178,1186,O
",",1186,1187,O
in,1188,1190,O
WT,1191,1193,O
and,1194,1197,O
STOP,1198,1202,O
null,1203,1207,O
mice,1208,1212,O
",",1212,1213,O
the,1214,1217,O
effect,1218,1224,O
of,1225,1227,O
OE,1228,1230,B-Tissue
regeneration,1231,1243,O
on,1244,1246,O
glomeruli,1247,1256,B-Multi-tissue_structure
structure,1257,1266,O
and,1267,1270,O
ultrastructure,1271,1285,O
and,1286,1289,O
on,1290,1292,O
peripheral,1293,1303,O
neurogenesis,1304,1316,O
at,1317,1319,O
two,1320,1323,O
age,1324,1327,O
times,1328,1333,O
(,1334,1335,O
3,1335,1336,O
and,1337,1340,O
10,1341,1343,O
months,1344,1350,O
),1350,1351,O
.,1351,1352,O
Effect,0,6,O
of,7,9,O
the,10,13,O
deletion,14,22,O
of,23,25,O
IRE1alpha,26,35,O
on,36,38,O
the,39,42,O
liver,43,48,B-Organ
.,48,49,O
(,50,51,O
A,51,52,O
),52,53,O
HE,54,56,O
-,56,57,O
stained,57,64,O
sections,65,73,B-Tissue
of,74,76,O
the,77,80,O
liver,81,86,B-Tissue
tissue,87,93,I-Tissue
(,94,95,O
scale,95,100,O
bar,101,104,O
:,104,105,O
50,106,108,O
mum,109,112,O
),112,113,O
.,113,114,O
(,115,116,O
B,116,117,O
),117,118,O
Comparison,119,129,O
of,130,132,O
the,133,136,O
serum,137,142,B-Organism_substance
AST,143,146,O
and,147,150,O
ALT,151,154,O
levels,155,161,O
between,162,169,O
the,170,173,O
IRE1alpha,174,183,O
CKO,184,187,O
mice,188,192,O
and,193,196,O
the,197,200,O
control,201,208,O
mice,209,213,O
.,213,214,O
Data,215,219,O
are,220,223,O
expressed,224,233,O
as,234,236,O
mean,237,241,O
+,242,243,O
/,243,244,O
-,244,245,O
S,246,247,O
.,247,248,O
E,248,249,O
.,249,250,O
M,250,251,O
(,252,253,O
n,253,254,O
=,255,256,O
5,257,258,O
),258,259,O
.,259,260,O
(,261,262,O
C,262,263,O
),263,264,O
Quantitative,265,277,O
PCR,278,281,O
analysis,282,290,O
of,291,293,O
lipid,294,299,O
synthesis,300,309,O
genes,310,315,O
in,316,318,O
the,319,322,O
liver,323,328,B-Organ
of,329,331,O
mice,332,336,O
fed,337,340,O
normal,341,347,O
or,348,350,O
high,351,355,O
-,355,356,O
fructose,356,364,O
feed,365,369,O
.,369,370,O
Columns,371,378,O
indicate,379,387,O
mean,388,392,O
and,393,396,O
error,397,402,O
bars,403,407,O
denote,408,414,O
S,415,416,O
.,416,417,O
E,417,418,O
.,418,419,O
M,419,420,O
(,421,422,O
n,422,423,O
=,424,425,O
3,426,427,O
),427,428,O
.,428,429,O
All,430,433,O
the,434,437,O
data,438,442,O
were,443,447,O
obtained,448,456,O
from,457,461,O
20,462,464,O
weeks,465,470,O
old,471,474,O
male,475,479,O
mice,480,484,O
.,484,485,O
2,0,1,O
.,1,2,O
Methods,3,10,O
Summary,0,7,O
of,8,10,O
instrument,11,21,O
characteristics,22,37,O
Histology,0,9,O
of,10,12,O
the,13,16,O
lung,17,21,B-Organ
The,22,25,O
left,26,30,O
lung,31,35,B-Organ
was,36,39,O
fixed,40,45,O
by,46,48,O
gentle,49,55,O
infusion,56,64,O
of,65,67,O
fixative,68,76,O
(,77,78,O
4,78,79,O
%,79,80,O
paraformaldehyde,81,97,O
),97,98,O
through,99,106,O
the,107,110,O
tracheal,111,119,B-Multi-tissue_structure
cannula,120,127,O
[,128,129,O
24,129,131,O
],131,132,O
.,132,133,O
After,134,139,O
excision,140,148,O
",",148,149,O
the,150,153,O
lung,154,158,B-Organ
was,159,162,O
immersed,163,171,O
in,172,174,O
a,175,176,O
fresh,177,182,O
fixative,183,191,O
for,192,195,O
2,196,197,O
h,198,199,O
.,199,200,O
The,201,204,O
lung,205,209,B-Multi-tissue_structure
lobe,210,214,I-Multi-tissue_structure
was,215,218,O
embedded,219,227,O
in,228,230,O
paraffin,231,239,O
and,240,243,O
cut,244,247,O
into,248,252,O
3,253,254,O
mum,255,258,O
transverse,259,269,O
sections,270,278,O
",",278,279,O
followed,280,288,O
by,289,291,O
immunohistochemical,292,311,O
and,312,315,O
chemical,316,324,O
staining,325,333,O
.,333,334,O
Photomicrographs,335,351,O
were,352,356,O
captured,357,365,O
using,366,371,O
KS400,372,377,O
image,378,383,O
analyze,384,391,O
platform,392,400,O
(,401,402,O
Zeiss,402,407,O
",",407,408,O
Oberkochen,409,419,O
",",419,420,O
Germany,421,428,O
),428,429,O
and,430,433,O
analyzed,434,442,O
quantitatively,443,457,O
.,457,458,O
Data,0,4,O
collection,5,15,O
:,15,16,O
CrystalClear,17,29,O
(,30,31,O
Rigaku,31,37,O
/,37,38,O
MSC,38,41,O
",",41,42,O
2005,43,47,O
>,48,49,O
),49,50,O
;,50,51,O
cell,52,56,B-Cell
refinement,57,67,O
:,67,68,O
CrystalClear,69,81,O
;,81,82,O
data,83,87,O
reduction,88,97,O
:,97,98,O
CrystalClear,99,111,O
;,111,112,O
program,113,120,O
(,120,121,O
s,121,122,O
),122,123,O
used,124,128,O
to,129,131,O
solve,132,137,O
structure,138,147,O
:,147,148,O
SHELXS97,149,157,O
(,158,159,O
Sheldrick,159,168,O
",",168,169,O
2008,170,174,O
>,175,176,O
),176,177,O
;,177,178,O
program,179,186,O
(,186,187,O
s,187,188,O
),188,189,O
used,190,194,O
to,195,197,O
refine,198,204,O
structure,205,214,O
:,214,215,O
SHELXL97,216,224,O
(,225,226,O
Sheldrick,226,235,O
",",235,236,O
2008,237,241,O
>,242,243,O
),243,244,O
;,244,245,O
molecular,246,255,O
graphics,256,264,O
:,264,265,O
ORTEPII,266,273,O
(,274,275,O
Johnson,275,282,O
",",282,283,O
1976,284,288,O
>,289,290,O
),290,291,O
;,291,292,O
software,293,301,O
used,302,306,O
to,307,309,O
prepare,310,317,O
material,318,326,O
for,327,330,O
publication,331,342,O
:,342,343,O
SHELXL97,344,352,O
.,352,353,O
Experimental,0,12,O
The,0,3,O
molecular,4,13,O
structure,14,23,O
of,24,26,O
(,27,28,O
I,28,29,O
),29,30,O
",",30,31,O
showing,32,39,O
displacement,40,52,O
ellipsoids,53,63,O
at,64,66,O
the,67,70,O
30,71,73,O
%,73,74,O
probability,75,86,O
level,87,92,O
for,93,96,O
non,97,100,O
-,100,101,O
H,101,102,O
atoms,103,108,O
.,108,109,O
Discussion,0,10,O
Our,11,14,O
results,15,22,O
indicate,23,31,O
beneficial,32,42,O
effects,43,50,O
of,51,53,O
motivational,54,66,O
incentives,67,77,O
on,78,80,O
cognitive,81,90,O
performance,91,102,O
and,103,106,O
alleviating,107,118,O
effects,119,126,O
on,127,129,O
cognitive,130,139,O
decline,140,147,O
.,147,148,O
These,149,154,O
beneficial,155,165,O
effects,166,173,O
were,174,178,O
evident,179,186,O
in,187,189,O
healthy,190,197,O
young,198,203,O
and,204,207,O
older,208,213,O
adults,214,220,O
and,221,224,O
in,225,227,O
patients,228,236,O
with,237,241,O
Parkinson,242,251,O
',251,252,O
s,252,253,O
disease,254,261,O
.,261,262,O
Young,263,268,O
adults,269,275,O
showed,276,282,O
improved,283,291,O
antisaccade,292,303,O
preparation,304,315,O
when,316,320,O
a,321,322,O
reward,323,329,O
was,330,333,O
at,334,336,O
stake,337,342,O
;,342,343,O
older,344,349,O
adults,350,356,O
and,357,360,O
PD,361,363,O
patients,364,372,O
could,373,378,O
utilize,379,386,O
reward,387,393,O
prospect,394,402,O
to,403,405,O
improve,406,413,O
their,414,419,O
impaired,420,428,O
antisaccade,429,440,O
preparation,441,452,O
.,452,453,O
Elderly,454,461,O
participants,462,474,O
and,475,478,O
PD,479,481,O
patients,482,490,O
were,491,495,O
not,496,499,O
only,500,504,O
better,505,511,O
prepared,512,520,O
by,521,523,O
means,524,529,O
of,530,532,O
commonly,533,541,O
used,542,546,O
preparatory,547,558,O
aids,559,563,O
(,564,565,O
i,565,566,O
.,566,567,O
e,567,568,O
.,568,569,O
",",569,570,O
more,571,575,O
preparation,576,587,O
time,588,592,O
and,593,596,O
advance,597,604,O
information,605,616,O
on,617,619,O
the,620,623,O
upcoming,624,632,O
response,633,641,O
),641,642,O
but,643,646,O
also,647,651,O
by,652,654,O
means,655,660,O
of,661,663,O
motivational,664,676,O
incentives,677,687,O
.,687,688,O
These,689,694,O
beneficial,695,705,O
effects,706,713,O
of,714,716,O
motivational,717,729,O
incentives,730,740,O
on,741,743,O
cognitive,744,753,O
action,754,760,O
preparation,761,772,O
in,773,775,O
healthy,776,783,O
and,784,787,O
pathological,788,800,O
aging,801,806,O
further,807,814,O
support,815,822,O
views,823,828,O
that,829,833,O
question,834,842,O
the,843,846,O
notion,847,853,O
of,854,856,O
monotonic,857,866,O
deterioration,867,880,O
of,881,883,O
cognitive,884,893,O
function,894,902,O
with,903,907,O
age,908,911,O
(,912,913,O
Allen,913,918,O
et,919,921,O
al,922,924,O
.,924,925,O
",",925,926,O
2001,927,931,O
),931,932,O
.,932,933,O
They,934,938,O
indicate,939,947,O
that,948,952,O
age,953,956,O
-,956,957,O
related,957,964,O
declines,965,973,O
can,974,977,O
be,978,980,O
modulated,981,990,O
by,991,993,O
emotion,994,1001,O
-,1001,1002,O
cognition,1002,1011,O
interactions,1012,1024,O
.,1024,1025,O
In,1026,1028,O
line,1029,1033,O
with,1034,1038,O
the,1039,1042,O
predominant,1043,1054,O
view,1055,1059,O
that,1060,1064,O
cognitive,1065,1074,O
control,1075,1082,O
deteriorates,1083,1095,O
in,1096,1098,O
aging,1099,1104,O
and,1105,1108,O
Parkinson,1109,1118,O
',1118,1119,O
s,1119,1120,O
disease,1121,1128,O
",",1128,1129,O
and,1130,1133,O
in,1134,1136,O
line,1137,1141,O
with,1142,1146,O
previous,1147,1155,O
findings,1156,1164,O
on,1165,1167,O
age,1168,1171,O
-,1171,1172,O
related,1172,1179,O
changes,1180,1187,O
in,1188,1190,O
antisaccade,1191,1202,O
control,1203,1210,O
specifically,1211,1223,O
(,1224,1225,O
Eenshuistra,1225,1236,O
et,1237,1239,O
al,1240,1242,O
.,1242,1243,O
",",1243,1244,O
2004,1245,1249,O
;,1249,1250,O
Chan,1251,1255,O
et,1256,1258,O
al,1259,1261,O
.,1261,1262,O
",",1262,1263,O
2005,1264,1268,O
;,1268,1269,O
Amador,1270,1276,O
et,1277,1279,O
al,1280,1282,O
.,1282,1283,O
",",1283,1284,O
2006,1285,1289,O
;,1289,1290,O
Abel,1291,1295,O
and,1296,1299,O
Douglas,1300,1307,O
",",1307,1308,O
2007,1309,1313,O
),1313,1314,O
",",1314,1315,O
the,1316,1319,O
current,1320,1327,O
results,1328,1335,O
showed,1336,1342,O
decline,1343,1350,O
in,1351,1353,O
antisaccade,1354,1365,O
preparation,1366,1377,O
in,1378,1380,O
PD,1381,1383,O
patients,1384,1392,O
with,1393,1397,O
severe,1398,1404,O
motor,1405,1410,O
symptoms,1411,1419,O
as,1420,1422,O
compared,1423,1431,O
to,1432,1434,O
healthy,1435,1442,O
seniors,1443,1450,O
.,1450,1451,O
Mild,1452,1456,O
-,1456,1457,O
symptom,1457,1464,O
patients,1465,1473,O
and,1474,1477,O
healthy,1478,1485,O
elderly,1486,1493,O
did,1494,1497,O
not,1498,1501,O
differ,1502,1508,O
in,1509,1511,O
antisaccade,1512,1523,O
preparation,1524,1535,O
.,1535,1536,O
Healthy,1537,1544,O
seniors,1545,1552,O
showed,1553,1559,O
declining,1560,1569,O
antisaccade,1570,1581,O
preparation,1582,1593,O
as,1594,1596,O
compared,1597,1605,O
to,1606,1608,O
young,1609,1614,O
adults,1615,1621,O
.,1621,1622,O
Decline,1623,1630,O
was,1631,1634,O
evident,1635,1642,O
on,1643,1645,O
several,1646,1653,O
oculomotor,1654,1664,B-Multi-tissue_structure
parameters,1665,1675,O
and,1676,1679,O
most,1680,1684,O
pronounced,1685,1695,O
on,1696,1698,O
antisaccade,1699,1710,O
onset,1711,1716,O
latencies,1717,1726,O
.,1726,1727,O
In,1728,1730,O
line,1731,1735,O
with,1736,1740,O
the,1741,1744,O
notion,1745,1751,O
that,1752,1756,O
in,1757,1759,O
general,1760,1767,O
",",1767,1768,O
elderly,1769,1776,O
tend,1777,1781,O
to,1782,1784,O
prefer,1785,1791,O
accuracy,1792,1800,O
over,1801,1805,O
speed,1806,1811,O
",",1811,1812,O
elderly,1813,1820,O
showed,1821,1827,O
no,1828,1830,O
decreased,1831,1840,O
antisaccade,1841,1852,O
accuracy,1853,1861,O
as,1862,1864,O
compared,1865,1873,O
to,1874,1876,O
young,1877,1882,O
adults,1883,1889,O
.,1889,1890,O
As,1891,1893,O
compared,1894,1902,O
to,1903,1905,O
the,1906,1909,O
young,1910,1915,O
group,1916,1921,O
",",1921,1922,O
elderly,1923,1930,O
and,1931,1934,O
PD,1935,1937,O
patients,1938,1946,O
exhibited,1947,1956,O
slightly,1957,1965,O
",",1965,1966,O
but,1967,1970,O
not,1971,1974,O
significantly,1975,1988,O
more,1989,1993,O
premature,1994,2003,O
eye,2004,2007,B-Organ
movements,2008,2017,O
.,2017,2018,O
Premature,2019,2028,O
eye,2029,2032,B-Organ
movements,2033,2042,O
",",2042,2043,O
however,2044,2051,O
significantly,2052,2065,O
increased,2066,2075,O
in,2076,2078,O
elderly,2079,2086,O
and,2087,2090,O
PD,2091,2093,O
patients,2094,2102,O
but,2103,2106,O
only,2107,2111,O
slightly,2112,2120,O
in,2121,2123,O
the,2124,2127,O
young,2128,2133,O
",",2133,2134,O
when,2135,2139,O
more,2140,2144,O
specific,2145,2153,O
information,2154,2165,O
on,2166,2168,O
the,2169,2172,O
upcoming,2173,2181,O
movement,2182,2190,O
was,2191,2194,O
available,2195,2204,O
in,2205,2207,O
advance,2208,2215,O
.,2215,2216,O
Presumably,2217,2227,O
",",2227,2228,O
this,2229,2233,O
increase,2234,2242,O
in,2243,2245,O
premature,2246,2255,O
eye,2256,2259,B-Organ
movements,2260,2269,O
reflects,2270,2278,O
difficulties,2279,2291,O
with,2292,2296,O
the,2297,2300,O
inhibition,2301,2311,O
of,2312,2314,O
externally,2315,2325,O
guided,2326,2332,O
movement,2333,2341,O
and,2342,2345,O
/,2345,2346,O
or,2346,2348,O
the,2349,2352,O
suppression,2353,2364,O
of,2365,2367,O
strongly,2368,2376,O
activated,2377,2386,O
prepotent,2387,2396,O
action,2397,2403,O
plans,2404,2409,O
.,2409,2410,O
On,2411,2413,O
the,2414,2417,O
one,2418,2421,O
hand,2422,2426,O
",",2426,2427,O
the,2428,2431,O
choice,2432,2438,O
for,2439,2442,O
medicated,2443,2452,O
PD,2453,2455,O
patients,2456,2464,O
represents,2465,2475,O
a,2476,2477,O
limitation,2478,2488,O
of,2489,2491,O
the,2492,2495,O
current,2496,2503,O
study,2504,2509,O
as,2510,2512,O
we,2513,2515,O
cannot,2516,2522,O
exclude,2523,2530,O
differential,2531,2543,O
effects,2544,2551,O
of,2552,2554,O
medication,2555,2565,O
on,2566,2568,O
behavior,2569,2577,O
.,2577,2578,O
On,2579,2581,O
the,2582,2585,O
other,2586,2591,O
hand,2592,2596,O
",",2596,2597,O
PD,2598,2600,O
patients,2601,2609,O
generally,2610,2619,O
take,2620,2624,O
medication,2625,2635,O
in,2636,2638,O
their,2639,2644,O
daily,2645,2650,O
routine,2651,2658,O
",",2658,2659,O
such,2660,2664,O
that,2665,2669,O
the,2670,2673,O
results,2674,2681,O
can,2682,2685,O
be,2686,2688,O
generalized,2689,2700,O
to,2701,2703,O
clinical,2704,2712,O
practice,2713,2721,O
.,2721,2722,O
Exploratory,2723,2734,O
analysis,2735,2743,O
within,2744,2750,O
the,2751,2754,O
PD,2755,2757,O
patient,2758,2765,O
group,2766,2771,O
revealed,2772,2780,O
that,2781,2785,O
patients,2786,2794,O
with,2795,2799,O
more,2800,2804,O
severe,2805,2811,O
motoric,2812,2819,O
symptoms,2820,2828,O
(,2829,2830,O
as,2830,2832,O
indexed,2833,2840,O
by,2841,2843,O
their,2844,2849,O
motoric,2850,2857,O
subscore,2858,2866,O
on,2867,2869,O
the,2870,2873,O
UPDRS,2874,2879,O
),2879,2880,O
displayed,2881,2890,O
more,2891,2895,O
signs,2896,2901,O
of,2902,2904,O
antisaccade,2905,2916,O
decline,2917,2924,O
",",2924,2925,O
such,2926,2930,O
as,2931,2933,O
longer,2934,2940,O
antisaccade,2941,2952,O
latencies,2953,2962,O
and,2963,2966,O
lower,2967,2972,O
accuracy,2973,2981,O
compared,2982,2990,O
to,2991,2993,O
mildly,2994,3000,O
affected,3001,3009,O
patients,3010,3018,O
",",3018,3019,O
who,3020,3023,O
initiated,3024,3033,O
saccades,3034,3042,O
equally,3043,3050,O
fast,3051,3055,O
as,3056,3058,O
healthy,3059,3066,O
adults,3067,3073,O
.,3073,3074,O
This,3075,3079,O
suggests,3080,3088,O
that,3089,3093,O
dopaminergic,3094,3106,O
medication,3107,3117,O
was,3118,3121,O
not,3122,3125,O
sufficient,3126,3136,O
to,3137,3139,O
raise,3140,3145,O
the,3146,3149,O
patient,3150,3157,O
',3157,3158,O
s,3158,3159,O
antisaccadic,3160,3172,O
preparation,3173,3184,O
up,3185,3187,O
to,3188,3190,O
the,3191,3194,O
level,3195,3200,O
of,3201,3203,O
the,3204,3207,O
healthy,3208,3215,O
older,3216,3221,O
adults,3222,3228,O
.,3228,3229,O
One,3230,3233,O
intriguing,3234,3244,O
observation,3245,3256,O
was,3257,3260,O
that,3261,3265,O
despite,3266,3273,O
the,3274,3277,O
different,3278,3287,O
extents,3288,3295,O
of,3296,3298,O
observed,3299,3307,O
antisaccade,3308,3319,O
performance,3320,3331,O
decline,3332,3339,O
in,3340,3342,O
elderly,3343,3350,O
and,3351,3354,O
PD,3355,3357,O
patients,3358,3366,O
",",3366,3367,O
reward,3368,3374,O
prospect,3375,3383,O
led,3384,3387,O
to,3388,3390,O
beneficial,3391,3401,O
effects,3402,3409,O
on,3410,3412,O
antisaccade,3413,3424,O
latency,3425,3432,O
and,3433,3436,O
accuracy,3437,3445,O
in,3446,3448,O
young,3449,3454,O
",",3454,3455,O
elderly,3456,3463,O
",",3463,3464,O
and,3465,3468,O
PD,3469,3471,O
patients,3472,3480,O
alike,3481,3486,O
.,3486,3487,O
Young,3488,3493,O
",",3493,3494,O
elderly,3495,3502,O
and,3503,3506,O
PD,3507,3509,O
patients,3510,3518,O
benefited,3519,3528,O
from,3529,3533,O
reward,3534,3540,O
prospect,3541,3549,O
to,3550,3552,O
the,3553,3556,O
same,3557,3561,O
extent,3562,3568,O
",",3568,3569,O
confirming,3570,3580,O
that,3581,3585,O
the,3586,3589,O
expectancy,3590,3600,O
of,3601,3603,O
reward,3604,3610,O
is,3611,3613,O
a,3614,3615,O
powerful,3616,3624,O
mediator,3625,3633,O
of,3634,3636,O
cognitive,3637,3646,O
control,3647,3654,O
",",3654,3655,O
even,3656,3660,O
if,3661,3663,O
cognitive,3664,3673,O
control,3674,3681,O
suffers,3682,3689,O
from,3690,3694,O
decline,3695,3702,O
.,3702,3703,O
The,3704,3707,O
expectation,3708,3719,O
of,3720,3722,O
rewarding,3723,3732,O
incentives,3733,3743,O
thus,3744,3748,O
seems,3749,3754,O
to,3755,3757,O
support,3758,3765,O
older,3766,3771,O
adults,3772,3778,O
',3778,3779,O
and,3780,3783,O
PD,3784,3786,O
patients,3787,3795,O
',3795,3796,O
ability,3797,3804,O
to,3805,3807,O
anticipate,3808,3818,O
",",3818,3819,O
prepare,3820,3827,O
and,3828,3831,O
initiate,3832,3840,O
goal,3841,3845,O
-,3845,3846,O
directed,3846,3854,O
behavior,3855,3863,O
.,3863,3864,O
These,3865,3870,O
findings,3871,3879,O
imply,3880,3885,O
that,3886,3890,O
despite,3891,3898,O
a,3899,3900,O
general,3901,3908,O
decline,3909,3916,O
in,3917,3919,O
the,3920,3923,O
action,3924,3930,O
preparation,3931,3942,O
system,3943,3949,O
as,3950,3952,O
indexed,3953,3960,O
by,3961,3963,O
increased,3964,3973,O
antisaccade,3974,3985,O
latency,3986,3993,O
",",3993,3994,O
action,3995,4001,O
preparation,4002,4013,O
processes,4014,4023,O
remain,4024,4030,O
susceptible,4031,4042,O
to,4043,4045,O
the,4046,4049,O
prospect,4050,4058,O
of,4059,4061,O
future,4062,4068,O
reward,4069,4075,O
.,4075,4076,O
It,4077,4079,O
could,4080,4085,O
thus,4086,4090,O
be,4091,4093,O
argued,4094,4100,O
that,4101,4105,O
the,4106,4109,O
neural,4110,4116,B-Multi-tissue_structure
representations,4117,4132,O
of,4133,4135,O
upcoming,4136,4144,O
rewards,4145,4152,O
influence,4153,4162,O
neural,4163,4169,B-Anatomical_system
systems,4170,4177,I-Anatomical_system
concerned,4178,4187,O
with,4188,4192,O
action,4193,4199,O
preparation,4200,4211,O
and,4212,4215,O
oculomotor,4216,4226,B-Multi-tissue_structure
control,4227,4234,O
.,4234,4235,O
Although,4236,4244,O
the,4245,4248,O
current,4249,4256,O
behavioral,4257,4267,O
results,4268,4275,O
cannot,4276,4282,O
exclude,4283,4290,O
or,4291,4293,O
confirm,4294,4301,O
neural,4302,4308,B-Multi-tissue_structure
links,4309,4314,O
between,4315,4322,O
reward,4323,4329,O
anticipation,4330,4342,O
and,4343,4346,O
action,4347,4353,O
preparation,4354,4365,O
systems,4366,4373,O
in,4374,4376,O
the,4377,4380,O
brain,4381,4386,B-Organ
",",4386,4387,O
they,4388,4392,O
suggest,4393,4400,O
intact,4401,4407,O
cross,4408,4413,O
-,4413,4414,O
talk,4414,4418,O
among,4419,4424,O
subcortical,4425,4436,B-Multi-tissue_structure
circuits,4437,4445,O
that,4446,4450,O
allow,4451,4456,O
goal,4457,4461,O
-,4461,4462,O
directed,4462,4470,O
action,4471,4477,O
to,4478,4480,O
be,4481,4483,O
modified,4484,4492,O
by,4493,4495,O
motivational,4496,4508,O
factors,4509,4516,O
.,4516,4517,O
The,4518,4521,O
motivational,4522,4534,O
neural,4535,4541,B-Multi-tissue_structure
reward,4542,4548,O
anticipation,4549,4561,O
signal,4562,4568,O
presumably,4569,4579,O
activates,4580,4589,O
the,4590,4593,O
reward,4594,4600,O
network,4601,4608,O
including,4609,4618,O
the,4619,4622,O
amygdala,4623,4631,O
",",4631,4632,O
orbitofrontal,4633,4646,B-Multi-tissue_structure
cortex,4647,4653,I-Multi-tissue_structure
",",4653,4654,O
the,4655,4658,O
more,4659,4663,O
ventral,4664,4671,B-Multi-tissue_structure
and,4672,4675,O
dorsal,4676,4682,B-Multi-tissue_structure
striatum,4683,4691,I-Multi-tissue_structure
(,4692,4693,O
nucleus,4693,4700,B-Multi-tissue_structure
accumbens,4701,4710,I-Multi-tissue_structure
",",4710,4711,O
putamen,4712,4719,B-Multi-tissue_structure
",",4719,4720,O
and,4721,4724,O
caudate,4725,4732,B-Multi-tissue_structure
),4732,4733,O
",",4733,4734,O
leading,4735,4742,O
to,4743,4745,O
an,4746,4748,O
release,4749,4756,O
of,4757,4759,O
caudate,4760,4767,O
/,4767,4768,O
SNr,4768,4771,O
inhibition,4772,4782,O
on,4783,4785,O
the,4786,4789,O
executive,4790,4799,O
oculomotor,4800,4810,B-Multi-tissue_structure
structure,4811,4820,I-Multi-tissue_structure
superior,4821,4829,I-Multi-tissue_structure
colliculus,4830,4840,I-Multi-tissue_structure
.,4840,4841,O
This,4842,4846,O
transiently,4847,4858,O
decreased,4859,4868,O
inhibitory,4869,4879,O
force,4880,4885,O
on,4886,4888,O
superior,4889,4897,B-Multi-tissue_structure
colliculus,4898,4908,I-Multi-tissue_structure
may,4909,4912,O
improve,4913,4920,O
goal,4921,4925,O
-,4925,4926,O
directed,4926,4934,O
oculomotor,4935,4945,B-Multi-tissue_structure
control,4946,4953,O
.,4953,4954,O
Thus,4955,4959,O
reward,4960,4966,O
anticipation,4967,4979,O
might,4980,4985,O
compensate,4986,4996,O
for,4997,5000,O
the,5001,5004,O
age,5005,5008,O
-,5008,5009,O
and,5010,5013,O
disease,5014,5021,O
-,5021,5022,O
related,5022,5029,O
dopaminergic,5030,5042,O
loss,5043,5047,O
in,5048,5050,O
the,5051,5054,O
SNc,5055,5058,O
projections,5059,5070,O
to,5071,5073,O
the,5074,5077,O
caudate,5078,5085,O
/,5085,5086,O
SNr,5086,5089,O
and,5090,5093,O
may,5094,5097,O
thus,5098,5102,O
play,5103,5107,O
a,5108,5109,O
compensatory,5110,5122,O
role,5123,5127,O
in,5128,5130,O
"""",5131,5132,O
boosting,5132,5140,O
"""",5140,5141,O
the,5142,5145,O
efficiency,5146,5156,O
of,5157,5159,O
interactions,5160,5172,O
between,5173,5180,O
motivational,5181,5193,O
and,5194,5197,O
impaired,5198,5206,O
cognitive,5207,5216,O
control,5217,5224,O
processes,5225,5234,O
.,5234,5235,O
However,5236,5243,O
the,5244,5247,O
reward,5248,5254,O
-,5254,5255,O
related,5255,5262,O
modulation,5263,5273,O
of,5274,5276,O
the,5277,5280,O
oculomotor,5281,5291,B-Multi-tissue_structure
control,5292,5299,I-Multi-tissue_structure
system,5300,5306,I-Multi-tissue_structure
may,5307,5310,O
not,5311,5314,O
only,5315,5319,O
apply,5320,5325,O
to,5326,5328,O
the,5329,5332,O
basal,5333,5338,B-Multi-tissue_structure
ganglia,5339,5346,I-Multi-tissue_structure
part,5347,5351,O
of,5352,5354,O
the,5355,5358,O
oculomotor,5359,5369,B-Multi-tissue_structure
network,5370,5377,I-Multi-tissue_structure
.,5377,5378,O
Although,5379,5387,O
speculative,5388,5399,O
",",5399,5400,O
it,5401,5403,O
could,5404,5409,O
extend,5410,5416,O
to,5417,5419,O
the,5420,5423,O
cortical,5424,5432,B-Multi-tissue_structure
eyefields,5433,5442,I-Multi-tissue_structure
(,5443,5444,O
frontal,5444,5451,B-Multi-tissue_structure
",",5451,5452,O
supplementary,5453,5466,B-Multi-tissue_structure
",",5466,5467,O
and,5468,5471,O
parietal,5472,5480,B-Multi-tissue_structure
eyefields,5481,5490,I-Multi-tissue_structure
),5490,5491,O
and,5492,5495,O
to,5496,5498,O
parts,5499,5504,O
of,5505,5507,O
the,5508,5511,O
visual,5512,5518,B-Multi-tissue_structure
cortex,5519,5525,I-Multi-tissue_structure
.,5525,5526,O
Human,5527,5532,O
research,5533,5541,O
shows,5542,5547,O
that,5548,5552,O
more,5553,5557,O
preparatory,5558,5569,O
activation,5570,5580,O
in,5581,5583,O
the,5584,5587,O
frontal,5588,5595,B-Multi-tissue_structure
eyefields,5596,5605,I-Multi-tissue_structure
leads,5606,5611,O
to,5612,5614,O
a,5615,5616,O
faster,5617,5623,O
antisaccade,5624,5635,O
latency,5636,5643,O
(,5644,5645,O
Connolly,5645,5653,O
et,5654,5656,O
al,5657,5659,O
.,5659,5660,O
",",5660,5661,O
2002,5662,5666,O
",",5666,5667,O
2005,5668,5672,O
),5672,5673,O
.,5673,5674,O
The,5675,5678,O
compensatory,5679,5691,O
effect,5692,5698,O
on,5699,5701,O
the,5702,5705,O
antisaccade,5706,5717,O
latency,5718,5725,O
",",5725,5726,O
therefore,5727,5736,O
",",5736,5737,O
could,5738,5743,O
theoretically,5744,5757,O
stem,5758,5762,O
from,5763,5767,O
a,5768,5769,O
propagation,5770,5781,O
of,5782,5784,O
reward,5785,5791,O
anticipation,5792,5804,O
signal,5805,5811,O
in,5812,5814,O
the,5815,5818,O
caudate,5819,5826,B-Multi-tissue_structure
to,5827,5829,O
the,5830,5833,O
frontal,5834,5841,B-Multi-tissue_structure
eyefields,5842,5851,I-Multi-tissue_structure
.,5851,5852,O
Complex,5853,5860,O
structural,5861,5871,O
connections,5872,5883,O
enable,5884,5890,O
the,5891,5894,O
striatum,5895,5903,B-Multi-tissue_structure
to,5904,5906,O
exert,5907,5912,O
a,5913,5914,O
controlling,5915,5926,O
influence,5927,5936,O
over,5937,5941,O
the,5942,5945,O
cerebral,5946,5954,B-Multi-tissue_structure
cortex,5955,5961,I-Multi-tissue_structure
via,5962,5965,O
a,5966,5967,O
series,5968,5974,O
of,5975,5977,O
reentrant,5978,5987,B-Multi-tissue_structure
corticobasal,5988,6000,I-Multi-tissue_structure
ganglia,6001,6008,I-Multi-tissue_structure
circuits,6009,6017,O
.,6017,6018,O
Thus,6019,6023,O
reward,6024,6030,O
anticipation,6031,6043,O
may,6044,6047,O
increase,6048,6056,O
the,6057,6060,O
level,6061,6066,O
of,6067,6069,O
preparation,6070,6081,O
in,6082,6084,O
the,6085,6088,O
intact,6089,6095,O
cortical,6096,6104,B-Multi-tissue_structure
eyefields,6105,6114,I-Multi-tissue_structure
and,6115,6118,O
thereby,6119,6126,O
compensate,6127,6137,O
for,6138,6141,O
age,6142,6145,O
-,6145,6146,O
and,6147,6150,O
disease,6151,6158,O
-,6158,6159,O
related,6159,6166,O
subcortical,6167,6178,B-Multi-tissue_structure
decrements,6179,6189,O
in,6190,6192,O
the,6193,6196,O
oculomotor,6197,6207,B-Multi-tissue_structure
network,6208,6215,I-Multi-tissue_structure
.,6215,6216,O
Taken,6217,6222,O
together,6223,6231,O
",",6231,6232,O
it,6233,6235,O
seems,6236,6241,O
plausible,6242,6251,O
that,6252,6256,O
motivational,6257,6269,O
reward,6270,6276,O
processes,6277,6286,O
in,6287,6289,O
the,6290,6293,O
caudate,6294,6301,B-Multi-tissue_structure
enhance,6302,6309,O
preparatory,6310,6321,O
activation,6322,6332,O
in,6333,6335,O
subcortical,6336,6347,B-Multi-tissue_structure
as,6348,6350,O
well,6351,6355,O
as,6356,6358,O
in,6359,6361,O
cortical,6362,6370,B-Multi-tissue_structure
nodes,6371,6376,I-Multi-tissue_structure
of,6377,6379,O
the,6380,6383,O
oculomotor,6384,6394,B-Multi-tissue_structure
network,6395,6402,I-Multi-tissue_structure
.,6402,6403,O
Several,6404,6411,O
neurotransmission,6412,6429,O
mechanisms,6430,6440,O
may,6441,6444,O
underlie,6445,6453,O
the,6454,6457,O
remedial,6458,6466,O
effect,6467,6473,O
of,6474,6476,O
positive,6477,6485,O
incentives,6486,6496,O
on,6497,6499,O
declining,6500,6509,O
antisaccadic,6510,6522,O
control,6523,6530,O
.,6530,6531,O
Given,6532,6537,O
the,6538,6541,O
convergence,6542,6553,O
of,6554,6556,O
dopamine,6557,6565,O
and,6566,6569,O
glutamate,6570,6579,O
inputs,6580,6586,O
at,6587,6589,O
the,6590,6593,O
spiny,6594,6599,B-Cell
projection,6600,6610,I-Cell
neurons,6611,6618,I-Cell
in,6619,6621,O
the,6622,6625,O
striatum,6626,6634,B-Multi-tissue_structure
(,6635,6636,O
Burns,6636,6641,O
et,6642,6644,O
al,6645,6647,O
.,6647,6648,O
",",6648,6649,O
1994,6650,6654,O
),6654,6655,O
",",6655,6656,O
an,6657,6659,O
interaction,6660,6671,O
between,6672,6679,O
dopamine,6680,6688,O
and,6689,6692,O
glutamate,6693,6702,O
might,6703,6708,O
underlie,6709,6717,O
striatal,6718,6726,B-Multi-tissue_structure
processes,6727,6736,O
of,6737,6739,O
reward,6740,6746,O
anticipation,6747,6759,O
and,6760,6763,O
action,6764,6770,O
preparation,6771,6782,O
.,6782,6783,O
However,6784,6791,O
",",6791,6792,O
it,6793,6795,O
cannot,6796,6802,O
be,6803,6805,O
fully,6806,6811,O
excluded,6812,6820,O
that,6821,6825,O
alterations,6826,6837,O
in,6838,6840,O
other,6841,6846,O
neurotransmitter,6847,6863,O
systems,6864,6871,O
may,6872,6875,O
also,6876,6880,O
have,6881,6885,O
an,6886,6888,O
effect,6889,6895,O
on,6896,6898,O
declining,6899,6908,O
oculomotor,6909,6919,B-Multi-tissue_structure
control,6920,6927,O
and,6928,6931,O
on,6932,6934,O
remediating,6935,6946,O
incentive,6947,6956,O
effects,6957,6964,O
.,6964,6965,O
Non,6966,6969,O
-,6969,6970,O
dopaminergic,6970,6982,O
changes,6983,6990,O
such,6991,6995,O
as,6996,6998,O
noradrenergic,6999,7012,O
",",7012,7013,O
serotonergic,7014,7026,O
",",7026,7027,O
and,7028,7031,O
cholinergic,7032,7043,O
deafferentation,7044,7059,O
of,7060,7062,O
the,7063,7066,O
cortex,7067,7073,B-Multi-tissue_structure
also,7074,7078,O
occur,7079,7084,O
in,7085,7087,O
PD,7088,7090,O
and,7091,7094,O
can,7095,7098,O
inflict,7099,7106,O
cognitive,7107,7116,O
deficits,7117,7125,O
(,7126,7127,O
Agid,7127,7131,O
et,7132,7134,O
al,7135,7137,O
.,7137,7138,O
",",7138,7139,O
1987,7140,7144,O
),7144,7145,O
.,7145,7146,O
Evidence,7147,7155,O
from,7156,7160,O
non,7161,7164,O
-,7164,7165,O
human,7165,7170,O
primates,7171,7179,O
suggests,7180,7188,O
that,7189,7193,O
basal,7194,7199,B-Multi-tissue_structure
ganglia,7200,7207,I-Multi-tissue_structure
dopamine,7208,7216,O
acts,7217,7221,O
to,7222,7224,O
speed,7225,7230,B-Multi-tissue_structure
motor,7231,7236,I-Multi-tissue_structure
responding,7237,7247,O
in,7248,7250,O
response,7251,7259,O
to,7260,7262,O
rewarding,7263,7272,O
cues,7273,7277,O
(,7278,7279,O
Niv,7279,7282,O
",",7282,7283,O
2007,7284,7288,O
;,7288,7289,O
Niv,7290,7293,O
et,7294,7296,O
al,7297,7299,O
.,7299,7300,O
",",7300,7301,O
2007,7302,7306,O
),7306,7307,O
.,7307,7308,O
Among,7309,7314,O
at,7315,7317,O
least,7318,7323,O
five,7324,7328,O
types,7329,7334,O
of,7335,7337,O
DA,7338,7340,O
receptors,7341,7350,O
",",7350,7351,O
mainly,7352,7358,O
D1,7359,7361,O
and,7362,7365,O
D2,7366,7368,O
receptors,7369,7378,O
are,7379,7382,O
expressed,7383,7392,O
in,7393,7395,O
caudate,7396,7403,B-Cell
projection,7404,7414,I-Cell
neurons,7415,7422,I-Cell
(,7423,7424,O
Nakamura,7424,7432,O
and,7433,7436,O
Hikosaka,7437,7445,O
",",7445,7446,O
2006,7447,7451,O
),7451,7452,O
.,7452,7453,O
Tendencies,7454,7464,O
to,7465,7467,O
speed,7468,7473,O
responses,7474,7483,O
to,7484,7486,O
obtain,7487,7493,O
large,7494,7499,O
rewards,7500,7507,O
have,7508,7512,O
been,7513,7517,O
found,7518,7523,O
to,7524,7526,O
be,7527,7529,O
dependent,7530,7539,O
on,7540,7542,O
striatal,7543,7551,B-Multi-tissue_structure
D1,7552,7554,O
receptors,7555,7564,O
(,7565,7566,O
Dalley,7566,7572,O
et,7573,7575,O
al,7576,7578,O
.,7578,7579,O
",",7579,7580,O
2005,7581,7585,O
;,7585,7586,O
Berridge,7587,7595,O
",",7595,7596,O
2007,7597,7601,O
),7601,7602,O
.,7602,7603,O
In,7604,7606,O
contrast,7607,7615,O
to,7616,7618,O
this,7619,7623,O
D1,7624,7626,O
modulated,7627,7636,O
speeding,7637,7645,O
in,7646,7648,O
reward,7649,7655,O
-,7655,7656,O
motor,7656,7661,O
tasks,7662,7667,O
",",7667,7668,O
evidence,7669,7677,O
from,7678,7682,O
saccade,7683,7690,O
tasks,7691,7696,O
in,7697,7699,O
non,7700,7703,O
-,7703,7704,O
human,7704,7709,O
primates,7710,7718,O
suggests,7719,7727,O
D2,7728,7730,O
receptor,7731,7739,O
modulation,7740,7750,O
of,7751,7753,O
reward,7754,7760,O
dependent,7761,7770,O
improvements,7771,7783,O
of,7784,7786,O
performance,7787,7798,O
(,7799,7800,O
Nakamura,7800,7808,O
and,7809,7812,O
Hikosaka,7813,7821,O
",",7821,7822,O
2006,7823,7827,O
),7827,7828,O
.,7828,7829,O
Injections,7830,7840,O
of,7841,7843,O
a,7844,7845,O
D1,7846,7848,O
antagonist,7849,7859,O
and,7860,7863,O
a,7864,7865,O
D2,7866,7868,O
antagonist,7869,7879,O
into,7880,7884,O
the,7885,7888,O
region,7889,7895,O
of,7896,7898,O
the,7899,7902,O
caudate,7903,7910,B-Multi-tissue_structure
where,7911,7916,O
saccade,7917,7924,O
-,7924,7925,O
related,7925,7932,O
neurons,7933,7940,B-Cell
are,7941,7944,O
clustered,7945,7954,O
while,7955,7960,O
the,7961,7964,O
monkey,7965,7971,O
performed,7972,7981,O
a,7982,7983,O
reward,7984,7990,O
-,7990,7991,O
biased,7991,7997,O
saccade,7998,8005,O
task,8006,8010,O
showed,8011,8017,O
that,8018,8022,O
D1,8023,8025,O
antagonists,8026,8037,O
attenuate,8038,8047,O
the,8048,8051,O
reward,8052,8058,O
modulation,8059,8069,O
of,8070,8072,O
saccade,8073,8080,O
behavior,8081,8089,O
whereas,8090,8097,O
D2,8098,8100,O
antagonists,8101,8112,O
into,8113,8117,O
the,8118,8121,O
same,8122,8126,O
region,8127,8133,O
enhanced,8134,8142,O
the,8143,8146,O
reward,8147,8153,O
-,8153,8154,O
dependent,8154,8163,O
changes,8164,8171,O
.,8171,8172,O
Future,8173,8179,O
studies,8180,8187,O
of,8188,8190,O
Parkinson,8191,8200,O
patients,8201,8209,O
on,8210,8212,O
versus,8213,8219,O
off,8220,8223,O
medication,8224,8234,O
",",8234,8235,O
could,8236,8241,O
provide,8242,8249,O
some,8250,8254,O
information,8255,8266,O
on,8267,8269,O
the,8270,8273,O
role,8274,8278,O
of,8279,8281,O
dopaminergic,8282,8294,O
mechanisms,8295,8305,O
in,8306,8308,O
the,8309,8312,O
remedial,8313,8321,O
effects,8322,8329,O
on,8330,8332,O
antisaccadic,8333,8345,O
performance,8346,8357,O
.,8357,8358,O
A,8359,8360,O
recent,8361,8367,O
study,8368,8373,O
of,8374,8376,O
reward,8377,8383,O
learning,8384,8392,O
in,8393,8395,O
Parkinson,8396,8405,O
patients,8406,8414,O
on,8415,8417,O
/,8417,8418,O
off,8418,8421,O
dopaminergic,8422,8434,O
medication,8435,8445,O
showed,8446,8452,O
that,8453,8457,O
patients,8458,8466,O
adapted,8467,8474,O
their,8475,8480,O
behavior,8481,8489,O
to,8490,8492,O
maximize,8493,8501,O
expected,8502,8510,O
reward,8511,8517,O
value,8518,8523,O
dependent,8524,8533,O
on,8534,8536,O
their,8537,8542,O
medication,8543,8553,O
status,8554,8560,O
(,8561,8562,O
Moustafa,8562,8570,O
et,8571,8573,O
al,8574,8576,O
.,8576,8577,O
",",8577,8578,O
2008,8579,8583,O
),8583,8584,O
.,8584,8585,O
Whilst,8586,8592,O
off,8593,8596,O
dopaminergic,8597,8609,O
medication,8610,8620,O
",",8620,8621,O
patients,8622,8630,O
slowed,8631,8637,O
their,8638,8643,O
responses,8644,8653,O
to,8654,8656,O
avoid,8657,8662,O
low,8663,8666,O
expected,8667,8675,O
values,8676,8682,O
",",8682,8683,O
but,8684,8687,O
succeeded,8688,8697,O
less,8698,8702,O
well,8703,8707,O
in,8708,8710,O
speeding,8711,8719,O
responses,8720,8729,O
when,8730,8734,O
a,8735,8736,O
reward,8737,8743,O
was,8744,8747,O
at,8748,8750,O
stake,8751,8756,O
.,8756,8757,O
The,8758,8761,O
opposite,8762,8770,O
pattern,8771,8778,O
emerged,8779,8786,O
when,8787,8791,O
the,8792,8795,O
same,8796,8800,O
patients,8801,8809,O
were,8810,8814,O
on,8815,8817,O
medication,8818,8828,O
;,8828,8829,O
patients,8830,8838,O
showed,8839,8845,O
better,8846,8852,O
response,8853,8861,O
speeding,8862,8870,O
",",8870,8871,O
and,8872,8875,O
worse,8876,8881,O
response,8882,8890,O
slowing,8891,8898,O
",",8898,8899,O
to,8900,8902,O
maximize,8903,8911,O
expected,8912,8920,O
value,8921,8926,O
.,8926,8927,O
The,8928,8931,O
current,8932,8939,O
behavioral,8940,8950,O
findings,8951,8959,O
are,8960,8963,O
in,8964,8966,O
line,8967,8971,O
with,8972,8976,O
neuroimaging,8977,8989,O
research,8990,8998,O
showing,8999,9006,O
intact,9007,9013,O
neural,9014,9020,B-Multi-tissue_structure
representations,9021,9036,O
of,9037,9039,O
future,9040,9046,O
reward,9047,9053,O
in,9054,9056,O
the,9057,9060,O
aging,9061,9066,O
striatum,9067,9075,B-Multi-tissue_structure
(,9076,9077,O
Samanez,9077,9084,O
-,9084,9085,O
Larkin,9085,9091,O
et,9092,9094,O
al,9095,9097,O
.,9097,9098,O
",",9098,9099,O
2007,9100,9104,O
),9104,9105,O
.,9105,9106,O
The,9107,9110,O
observation,9111,9122,O
however,9123,9130,O
that,9131,9135,O
older,9136,9141,O
adults,9142,9148,O
and,9149,9152,O
PD,9153,9155,O
patients,9156,9164,O
can,9165,9168,O
use,9169,9172,O
this,9173,9177,O
intact,9178,9184,O
neural,9185,9191,B-Multi-tissue_structure
representation,9192,9206,O
of,9207,9209,O
reward,9210,9216,O
anticipation,9217,9229,O
(,9230,9231,O
a,9231,9232,O
positive,9233,9241,O
motivational,9242,9254,O
incentive,9255,9264,O
),9264,9265,O
to,9266,9268,O
optimize,9269,9277,O
their,9278,9283,O
preparatory,9284,9295,O
processes,9296,9305,O
",",9305,9306,O
cannot,9307,9313,O
necessarily,9314,9325,O
be,9326,9328,O
generalized,9329,9340,O
to,9341,9343,O
cognitive,9344,9353,O
contexts,9354,9362,O
with,9363,9367,O
negative,9368,9376,O
motivational,9377,9389,O
incentives,9390,9400,O
.,9400,9401,O
Samanez,9402,9409,O
-,9409,9410,O
Larkin,9410,9416,O
et,9417,9419,O
al,9420,9422,O
.,9422,9423,O
(,9423,9424,O
2010,9424,9428,O
),9428,9429,O
recently,9430,9438,O
showed,9439,9445,O
that,9446,9450,O
older,9451,9456,O
adults,9457,9463,O
were,9464,9468,O
not,9469,9472,O
able,9473,9477,O
to,9478,9480,O
optimally,9481,9490,O
use,9491,9494,O
their,9495,9500,O
intact,9501,9507,O
neural,9508,9514,B-Multi-tissue_structure
reward,9515,9521,O
anticipation,9522,9534,O
system,9535,9541,O
in,9542,9544,O
risky,9545,9550,O
financial,9551,9560,O
decision,9561,9569,O
making,9570,9576,O
.,9576,9577,O
Elderly,9578,9585,O
made,9586,9590,O
more,9591,9595,O
suboptimal,9596,9606,O
choices,9607,9614,O
when,9615,9619,O
they,9620,9624,O
were,9625,9629,O
to,9630,9632,O
choose,9633,9639,O
risky,9640,9645,O
assets,9646,9652,O
.,9652,9653,O
The,9654,9657,O
authors,9658,9665,O
deemed,9666,9672,O
it,9673,9675,O
likely,9676,9682,O
that,9683,9687,O
these,9688,9693,O
decrements,9694,9704,O
in,9705,9707,O
value,9708,9713,O
-,9713,9714,O
based,9714,9719,O
decision,9720,9728,O
making,9729,9735,O
are,9736,9739,O
explained,9740,9749,O
by,9750,9752,O
the,9753,9756,O
fact,9757,9761,O
that,9762,9766,O
value,9767,9772,O
-,9772,9773,O
based,9773,9778,O
decision,9779,9787,O
making,9788,9794,O
requires,9795,9803,O
the,9804,9807,O
weighting,9808,9817,O
of,9818,9820,O
behavioral,9821,9831,O
alternatives,9832,9844,O
",",9844,9845,O
that,9846,9850,O
may,9851,9854,O
lead,9855,9859,O
to,9860,9862,O
either,9863,9869,O
gain,9870,9874,O
or,9875,9877,O
loss,9878,9882,O
.,9882,9883,O
During,9884,9890,O
anticipation,9891,9903,O
of,9904,9906,O
rewards,9907,9914,O
older,9915,9920,O
adults,9921,9927,O
show,9928,9932,O
similar,9933,9940,O
neural,9941,9947,B-Multi-tissue_structure
responses,9948,9957,O
as,9958,9960,O
young,9961,9966,O
adults,9967,9973,O
but,9974,9977,O
they,9978,9982,O
show,9983,9987,O
reduced,9988,9995,O
neural,9996,10002,B-Multi-tissue_structure
activation,10003,10013,O
during,10014,10020,O
the,10021,10024,O
anticipation,10025,10037,O
of,10038,10040,O
losses,10041,10047,O
(,10048,10049,O
Samanez,10049,10056,O
-,10056,10057,O
Larkin,10057,10063,O
et,10064,10066,O
al,10067,10069,O
.,10069,10070,O
",",10070,10071,O
2007,10072,10076,O
),10076,10077,O
.,10077,10078,O
The,10079,10082,O
latter,10083,10089,O
",",10089,10090,O
together,10091,10099,O
with,10100,10104,O
the,10105,10108,O
observation,10109,10120,O
that,10121,10125,O
older,10126,10131,O
adults,10132,10138,O
tend,10139,10143,O
to,10144,10146,O
shift,10147,10152,O
their,10153,10158,O
attention,10159,10168,O
away,10169,10173,O
from,10174,10178,O
negative,10179,10187,O
stimuli,10188,10195,O
and,10196,10199,O
attend,10200,10206,O
to,10207,10209,O
positive,10210,10218,O
information,10219,10230,O
instead,10231,10238,O
(,10239,10240,O
Mather,10240,10246,O
and,10247,10250,O
Carstensen,10251,10261,O
",",10261,10262,O
2003,10263,10267,O
",",10267,10268,O
2005,10269,10273,O
),10273,10274,O
",",10274,10275,O
may,10276,10279,O
have,10280,10284,O
led,10285,10288,O
to,10289,10291,O
the,10292,10295,O
underestimation,10296,10311,O
of,10312,10314,O
loss,10315,10319,O
and,10320,10323,O
therefore,10324,10333,O
to,10334,10336,O
more,10337,10341,O
risky,10342,10347,O
and,10348,10351,O
suboptimal,10352,10362,O
decisions,10363,10372,O
.,10372,10373,O
In,10374,10376,O
this,10377,10381,O
respect,10382,10389,O
",",10389,10390,O
one,10391,10394,O
limitation,10395,10405,O
of,10406,10408,O
the,10409,10412,O
current,10413,10420,O
task,10421,10425,O
is,10426,10428,O
that,10429,10433,O
it,10434,10436,O
built,10437,10442,O
solely,10443,10449,O
on,10450,10452,O
reward,10453,10459,O
prospect,10460,10468,O
and,10469,10472,O
not,10473,10476,O
on,10477,10479,O
the,10480,10483,O
prospect,10484,10492,O
of,10493,10495,O
loss,10496,10500,O
",",10500,10501,O
such,10502,10506,O
that,10507,10511,O
the,10512,10515,O
question,10516,10524,O
of,10525,10527,O
how,10528,10531,O
the,10532,10535,O
anticipation,10536,10548,O
of,10549,10551,O
loss,10552,10556,O
influences,10557,10567,O
action,10568,10574,O
preparation,10575,10586,O
was,10587,10590,O
not,10591,10594,O
tested,10595,10601,O
.,10601,10602,O
The,10603,10606,O
impact,10607,10613,O
of,10614,10616,O
negative,10617,10625,O
incentives,10626,10636,O
might,10637,10642,O
be,10643,10645,O
an,10646,10648,O
intriguing,10649,10659,O
question,10660,10668,O
for,10669,10672,O
future,10673,10679,O
research,10680,10688,O
",",10688,10689,O
as,10690,10692,O
due,10693,10696,O
to,10697,10699,O
the,10700,10703,O
decreased,10704,10713,O
activation,10714,10724,O
of,10725,10727,O
the,10728,10731,O
neural,10732,10738,B-Multi-tissue_structure
loss,10739,10743,O
anticipation,10744,10756,O
system,10757,10763,O
(,10764,10765,O
Samanez,10765,10772,O
-,10772,10773,O
Larkin,10773,10779,O
et,10780,10782,O
al,10783,10785,O
.,10785,10786,O
",",10786,10787,O
2007,10788,10792,O
),10792,10793,O
together,10794,10802,O
with,10803,10807,O
the,10808,10811,O
observed,10812,10820,O
differential,10821,10833,O
attentional,10834,10845,O
bias,10846,10850,O
for,10851,10854,O
negative,10855,10863,O
and,10864,10867,O
positive,10868,10876,O
information,10877,10888,O
(,10889,10890,O
Mather,10890,10896,O
and,10897,10900,O
Carstensen,10901,10911,O
",",10911,10912,O
2003,10913,10917,O
),10917,10918,O
",",10918,10919,O
it,10920,10922,O
seems,10923,10928,O
likely,10929,10935,O
that,10936,10940,O
negative,10941,10949,O
motivational,10950,10962,O
incentives,10963,10973,O
",",10973,10974,O
i,10975,10976,O
.,10976,10977,O
e,10977,10978,O
.,10978,10979,O
",",10979,10980,O
the,10981,10984,O
prospect,10985,10993,O
of,10994,10996,O
loss,10997,11001,O
",",11001,11002,O
might,11003,11008,O
have,11009,11013,O
a,11014,11015,O
different,11016,11025,O
impact,11026,11032,O
on,11033,11035,O
action,11036,11042,O
preparation,11043,11054,O
in,11055,11057,O
older,11058,11063,O
adults,11064,11070,O
than,11071,11075,O
in,11076,11078,O
the,11079,11082,O
young,11083,11088,O
.,11088,11089,O
Future,11090,11096,O
approaches,11097,11107,O
to,11108,11110,O
the,11111,11114,O
effect,11115,11121,O
of,11122,11124,O
loss,11125,11129,O
anticipation,11130,11142,O
on,11143,11145,O
declining,11146,11155,O
antisaccade,11156,11167,O
control,11168,11175,O
may,11176,11179,O
ideally,11180,11187,O
contain,11188,11195,O
a,11196,11197,O
sequence,11198,11206,O
of,11207,11209,O
experiments,11210,11221,O
",",11221,11222,O
starting,11223,11231,O
with,11232,11236,O
a,11237,11238,O
separate,11239,11247,O
(,11248,11249,O
punishment,11249,11259,O
only,11260,11264,O
),11264,11265,O
approach,11266,11274,O
before,11275,11281,O
moving,11282,11288,O
to,11289,11291,O
combined,11292,11300,O
reward,11301,11307,O
-,11307,11308,O
punishment,11308,11318,O
designs,11319,11326,O
.,11326,11327,O
This,11328,11332,O
might,11333,11338,O
be,11339,11341,O
necessary,11342,11351,O
as,11352,11354,O
previous,11355,11363,O
evidence,11364,11372,O
(,11373,11374,O
from,11374,11378,O
healthy,11379,11386,O
young,11387,11392,O
adults,11393,11399,O
),11399,11400,O
suggests,11401,11409,O
that,11410,11414,O
the,11415,11418,O
reward,11419,11425,O
effect,11426,11432,O
on,11433,11435,O
oculomotor,11436,11446,B-Multi-tissue_structure
control,11447,11454,O
disappears,11455,11465,O
in,11466,11468,O
the,11469,11472,O
presence,11473,11481,O
of,11482,11484,O
punishment,11485,11495,O
trials,11496,11502,O
.,11502,11503,O
The,11504,11507,O
authors,11508,11515,O
deemed,11516,11522,O
it,11523,11525,O
likely,11526,11532,O
that,11533,11537,O
the,11538,11541,O
participants,11542,11554,O
increased,11555,11564,O
caution,11565,11572,O
to,11573,11575,O
all,11576,11579,O
incentive,11580,11589,O
(,11590,11591,O
reward,11591,11597,O
and,11598,11601,O
punishment,11602,11612,O
),11612,11613,O
trials,11614,11620,O
(,11621,11622,O
Blaukopf,11622,11630,O
and,11631,11634,O
DiGirolamo,11635,11645,O
",",11645,11646,O
2006,11647,11651,O
),11651,11652,O
.,11652,11653,O
As,11654,11656,O
of,11657,11659,O
yet,11660,11663,O
",",11663,11664,O
age,11665,11668,O
-,11668,11669,O
related,11669,11676,O
changes,11677,11684,O
in,11685,11687,O
neural,11688,11694,B-Multi-tissue_structure
reward,11695,11701,O
anticipation,11702,11714,O
have,11715,11719,O
mainly,11720,11726,O
been,11727,11731,O
studied,11732,11739,O
in,11740,11742,O
isolation,11743,11752,O
.,11752,11753,O
Recently,11754,11762,O
however,11763,11770,O
",",11770,11771,O
the,11772,11775,O
interaction,11776,11787,O
of,11788,11790,O
neural,11791,11797,B-Multi-tissue_structure
reward,11798,11804,O
processing,11805,11815,O
with,11816,11820,O
other,11821,11826,O
cognitive,11827,11836,O
functions,11837,11846,O
and,11847,11850,O
their,11851,11856,O
underlying,11857,11867,O
neural,11868,11874,B-Anatomical_system
systems,11875,11882,I-Anatomical_system
",",11882,11883,O
such,11884,11888,O
as,11889,11891,O
the,11892,11895,O
action,11896,11902,B-Anatomical_system
control,11903,11910,I-Anatomical_system
system,11911,11917,I-Anatomical_system
",",11917,11918,O
has,11919,11922,O
gained,11923,11929,O
increasing,11930,11940,O
interest,11941,11949,O
(,11950,11951,O
Haber,11951,11956,O
and,11957,11960,O
Knutson,11961,11968,O
",",11968,11969,O
2010,11970,11974,O
),11974,11975,O
.,11975,11976,O
Initial,11977,11984,O
evidence,11985,11993,O
suggests,11994,12002,O
coordinated,12003,12014,O
activity,12015,12023,O
between,12024,12031,O
distant,12032,12039,O
brain,12040,12045,B-Organ
regions,12046,12053,O
responsible,12054,12065,O
for,12066,12069,O
reward,12070,12076,O
processing,12077,12087,O
(,12088,12089,O
Cohen,12089,12094,O
et,12095,12097,O
al,12098,12100,O
.,12100,12101,O
",",12101,12102,O
2009,12103,12107,O
),12107,12108,O
.,12108,12109,O
The,12110,12113,O
current,12114,12121,O
results,12122,12129,O
encourage,12130,12139,O
further,12140,12147,O
neural,12148,12154,B-Multi-tissue_structure
network,12155,12162,I-Multi-tissue_structure
investigations,12163,12177,O
on,12178,12180,O
the,12181,12184,O
role,12185,12189,O
of,12190,12192,O
coordinated,12193,12204,O
brain,12205,12210,B-Organ
network,12211,12218,O
activity,12219,12227,O
in,12228,12230,O
motivated,12231,12240,O
behavior,12241,12249,O
.,12249,12250,O
Behavioral,12251,12261,O
benefits,12262,12270,O
from,12271,12275,O
motivation,12276,12286,O
might,12287,12292,O
be,12293,12295,O
associated,12296,12306,O
with,12307,12311,O
changes,12312,12319,O
in,12320,12322,O
functional,12323,12333,O
brain,12334,12339,B-Organ
connectivity,12340,12352,O
on,12353,12355,O
a,12356,12357,O
larger,12358,12364,O
scale,12365,12370,O
",",12370,12371,O
e,12372,12373,O
.,12373,12374,O
g,12374,12375,O
.,12375,12376,O
",",12376,12377,O
between,12378,12385,O
frontostriatal,12386,12400,B-Multi-tissue_structure
reward,12401,12407,O
and,12408,12411,O
action,12412,12418,O
preparation,12419,12430,O
structures,12431,12441,O
.,12441,12442,O
Another,12443,12450,O
important,12451,12460,O
factor,12461,12467,O
that,12468,12472,O
emerges,12473,12480,O
from,12481,12485,O
the,12486,12489,O
present,12490,12497,O
and,12498,12501,O
previous,12502,12510,O
results,12511,12518,O
",",12518,12519,O
is,12520,12522,O
the,12523,12526,O
importance,12527,12537,O
of,12538,12540,O
the,12541,12544,O
training,12545,12553,O
of,12554,12556,O
the,12557,12560,O
motivational,12561,12573,O
aspects,12574,12581,O
of,12582,12584,O
the,12585,12588,O
instructions,12589,12601,O
that,12602,12606,O
need,12607,12611,O
to,12612,12614,O
be,12615,12617,O
kept,12618,12622,O
in,12623,12625,O
working,12626,12633,O
memory,12634,12640,O
when,12641,12645,O
performing,12646,12656,O
a,12657,12658,O
cognitive,12659,12668,O
task,12669,12673,O
.,12673,12674,O
Samanez,12675,12682,O
-,12682,12683,O
Larkin,12683,12689,O
et,12690,12692,O
al,12693,12695,O
.,12695,12696,O
(,12697,12698,O
2007,12698,12702,O
),12702,12703,O
found,12704,12709,O
intact,12710,12716,O
neural,12717,12723,B-Multi-tissue_structure
reward,12724,12730,O
anticipation,12731,12743,O
processes,12744,12753,O
specifically,12754,12766,O
in,12767,12769,O
the,12770,12773,O
absence,12774,12781,O
of,12782,12784,O
learning,12785,12793,O
(,12794,12795,O
after,12795,12800,O
the,12801,12804,O
learning,12805,12813,O
process,12814,12821,O
of,12822,12824,O
reward,12825,12831,O
cue,12832,12835,O
-,12835,12836,O
reward,12836,12842,O
associations,12843,12855,O
was,12856,12859,O
completed,12860,12869,O
),12869,12870,O
.,12870,12871,O
Therefore,12872,12881,O
it,12882,12884,O
might,12885,12890,O
be,12891,12893,O
important,12894,12903,O
for,12904,12907,O
researchers,12908,12919,O
doing,12920,12925,O
experiments,12926,12937,O
with,12938,12942,O
motivation,12943,12953,O
based,12954,12959,O
instructions,12960,12972,O
to,12973,12975,O
keep,12976,12980,O
in,12981,12983,O
mind,12984,12988,O
that,12989,12993,O
",",12993,12994,O
compared,12995,13003,O
to,13004,13006,O
young,13007,13012,O
adults,13013,13019,O
",",13019,13020,O
elderly,13021,13028,O
and,13029,13032,O
PD,13033,13035,O
patients,13036,13044,O
are,13045,13048,O
generally,13049,13058,O
hampered,13059,13067,O
on,13068,13070,O
stimulus,13071,13079,O
-,13079,13080,O
response,13080,13088,O
learning,13089,13097,O
(,13098,13099,O
Shohamy,13099,13106,O
et,13107,13109,O
al,13110,13112,O
.,13112,13113,O
",",13113,13114,O
2004,13115,13119,O
;,13119,13120,O
Marschner,13121,13130,O
et,13131,13133,O
al,13134,13136,O
.,13136,13137,O
",",13137,13138,O
2005,13139,13143,O
),13143,13144,O
.,13144,13145,O
Reward,13146,13152,O
instruction,13153,13164,O
cues,13165,13169,O
",",13169,13170,O
as,13171,13173,O
they,13174,13178,O
were,13179,13183,O
used,13184,13188,O
in,13189,13191,O
the,13192,13195,O
current,13196,13203,O
study,13204,13209,O
require,13210,13217,O
participants,13218,13230,O
to,13231,13233,O
form,13234,13238,O
reward,13239,13245,O
cue,13246,13249,O
-,13249,13250,O
reward,13250,13256,O
associations,13257,13269,O
.,13269,13270,O
Impairments,13271,13282,O
in,13283,13285,O
the,13286,13289,O
learning,13290,13298,O
of,13299,13301,O
associations,13302,13314,O
between,13315,13322,O
the,13323,13326,O
cue,13327,13330,O
signaling,13331,13340,O
reward,13341,13347,O
and,13348,13351,O
the,13352,13355,O
actual,13356,13362,O
reward,13363,13369,O
might,13370,13375,O
conceal,13376,13383,O
intact,13384,13390,O
reward,13391,13397,O
anticipation,13398,13410,O
processes,13411,13420,O
.,13420,13421,O
When,13422,13426,O
the,13427,13430,O
formation,13431,13440,O
of,13441,13443,O
associations,13444,13456,O
is,13457,13459,O
weakened,13460,13468,O
",",13468,13469,O
it,13470,13472,O
could,13473,13478,O
appear,13479,13485,O
as,13486,13488,O
a,13489,13490,O
failure,13491,13498,O
to,13499,13501,O
capitalize,13502,13512,O
on,13513,13515,O
the,13516,13519,O
neural,13520,13526,B-Multi-tissue_structure
reward,13527,13533,O
anticipation,13534,13546,O
system,13547,13553,O
",",13553,13554,O
whereas,13555,13562,O
it,13563,13565,O
represents,13566,13576,O
an,13577,13579,O
indirect,13580,13588,O
effect,13589,13595,O
of,13596,13598,O
non,13599,13602,O
-,13602,13603,O
available,13603,13612,O
reward,13613,13619,O
associations,13620,13632,O
in,13633,13635,O
working,13636,13643,O
memory,13644,13650,O
when,13651,13655,O
preparing,13656,13665,O
the,13666,13669,O
response,13670,13678,O
.,13678,13679,O
Hence,13680,13685,O
",",13685,13686,O
one,13687,13690,O
might,13691,13696,O
circumvent,13697,13707,O
the,13708,13711,O
effect,13712,13718,O
of,13719,13721,O
potential,13722,13731,O
learning,13732,13740,O
impairments,13741,13752,O
on,13753,13755,O
reward,13756,13762,O
anticipation,13763,13775,O
processes,13776,13785,O
by,13786,13788,O
the,13789,13792,O
training,13793,13801,O
of,13802,13804,O
abstract,13805,13813,O
reward,13814,13820,O
cues,13821,13825,O
(,13826,13827,O
as,13827,13829,O
in,13830,13832,O
the,13833,13836,O
current,13837,13844,O
and,13845,13848,O
in,13849,13851,O
Samanez,13852,13859,O
-,13859,13860,O
Larkin,13860,13866,O
',13866,13867,O
s,13867,13868,O
study,13869,13874,O
),13874,13875,O
or,13876,13878,O
by,13879,13881,O
using,13882,13887,O
explicit,13888,13896,O
and,13897,13900,O
concrete,13901,13909,O
rewards,13910,13917,O
.,13917,13918,O
Once,13919,13923,O
the,13924,13927,O
learning,13928,13936,O
of,13937,13939,O
reward,13940,13946,O
cues,13947,13951,O
is,13952,13954,O
accomplished,13955,13967,O
the,13968,13971,O
intact,13972,13978,O
reward,13979,13985,O
anticipation,13986,13998,O
processes,13999,14008,O
might,14009,14014,O
become,14015,14021,O
evident,14022,14029,O
.,14029,14030,O
In,14031,14033,O
sum,14034,14037,O
",",14037,14038,O
the,14039,14042,O
results,14043,14050,O
confirmed,14051,14060,O
that,14061,14065,O
the,14066,14069,O
preparation,14070,14081,O
of,14082,14084,O
goal,14085,14089,O
-,14089,14090,O
directed,14090,14098,O
actions,14099,14106,O
declined,14107,14115,O
in,14116,14118,O
PD,14119,14121,O
patients,14122,14130,O
compared,14131,14139,O
to,14140,14142,O
healthy,14143,14150,O
seniors,14151,14158,O
",",14158,14159,O
and,14160,14163,O
in,14164,14166,O
healthy,14167,14174,O
seniors,14175,14182,O
compared,14183,14191,O
to,14192,14194,O
young,14195,14200,O
adults,14201,14207,O
.,14207,14208,O
Due,14209,14212,O
perhaps,14213,14220,O
to,14221,14223,O
deterioration,14224,14237,O
in,14238,14240,O
dopaminergic,14241,14253,O
striatal,14254,14262,B-Multi-tissue_structure
circuitry,14263,14272,O
",",14272,14273,O
antisaccade,14274,14285,O
performance,14286,14297,O
is,14298,14300,O
subject,14301,14308,O
to,14309,14311,O
decline,14312,14319,O
in,14320,14322,O
healthy,14323,14330,O
seniors,14331,14338,O
",",14338,14339,O
and,14340,14343,O
even,14344,14348,O
more,14349,14353,O
in,14354,14356,O
individuals,14357,14368,O
with,14369,14373,O
Parkinson,14374,14383,O
',14383,14384,O
s,14384,14385,O
disease,14386,14393,O
.,14393,14394,O
The,14395,14398,O
prospect,14399,14407,O
of,14408,14410,O
future,14411,14417,O
reward,14418,14424,O
however,14425,14432,O
provided,14433,14441,O
a,14442,14443,O
motivational,14444,14456,O
incentive,14457,14466,O
for,14467,14470,O
optimizing,14471,14481,O
oculomotor,14482,14492,B-Multi-tissue_structure
preparation,14493,14504,O
in,14505,14507,O
all,14508,14511,O
groups,14512,14518,O
alike,14519,14524,O
.,14524,14525,O
These,14526,14531,O
results,14532,14539,O
suggest,14540,14547,O
that,14548,14552,O
reward,14553,14559,O
-,14559,14560,O
processing,14560,14570,O
networks,14571,14579,O
and,14580,14583,O
oculomotor,14584,14594,B-Multi-tissue_structure
-,14594,14595,I-Multi-tissue_structure
control,14595,14602,I-Multi-tissue_structure
networks,14603,14611,I-Multi-tissue_structure
in,14612,14614,O
the,14615,14618,O
brain,14619,14624,B-Organ
are,14625,14628,O
connected,14629,14638,O
in,14639,14641,O
such,14642,14646,O
a,14647,14648,O
way,14649,14652,O
(,14653,14654,O
presumably,14654,14664,O
with,14665,14669,O
the,14670,14673,O
dorsal,14674,14680,B-Multi-tissue_structure
striatum,14681,14689,I-Multi-tissue_structure
as,14690,14692,O
a,14693,14694,O
common,14695,14701,O
nexus,14702,14707,O
),14707,14708,O
that,14709,14713,O
reward,14714,14720,O
anticipation,14721,14733,O
can,14734,14737,O
facilitate,14738,14748,O
oculomotor,14749,14759,B-Multi-tissue_structure
control,14760,14767,O
and,14768,14771,O
alleviate,14772,14781,O
the,14782,14785,O
deficiencies,14786,14798,O
experienced,14799,14810,O
by,14811,14813,O
healthy,14814,14821,O
seniors,14822,14829,O
and,14830,14833,O
PD,14834,14836,O
patients,14837,14845,O
.,14845,14846,O
Future,14847,14853,O
investigations,14854,14868,O
should,14869,14875,O
examine,14876,14883,O
whether,14884,14891,O
the,14892,14895,O
observed,14896,14904,O
effects,14905,14912,O
are,14913,14916,O
specific,14917,14925,O
for,14926,14929,O
the,14930,14933,O
current,14934,14941,O
task,14942,14946,O
or,14947,14949,O
generalize,14950,14960,O
to,14961,14963,O
other,14964,14969,O
tasks,14970,14975,O
that,14976,14980,O
show,14981,14985,O
age,14986,14989,O
-,14989,14990,O
and,14991,14994,O
PD,14995,14997,O
-,14997,14998,O
related,14998,15005,O
cognitive,15006,15015,O
decrements,15016,15026,O
(,15027,15028,O
e,15028,15029,O
.,15029,15030,O
g,15030,15031,O
.,15031,15032,O
",",15032,15033,O
in,15034,15036,O
task,15037,15041,O
switching,15042,15051,O
),15051,15052,O
and,15053,15056,O
have,15057,15061,O
been,15062,15066,O
related,15067,15074,O
to,15075,15077,O
dopaminergic,15078,15090,O
denervation,15091,15102,O
in,15103,15105,O
the,15106,15109,O
caudate,15110,15117,B-Multi-tissue_structure
(,15118,15119,O
e,15119,15120,O
.,15120,15121,O
g,15121,15122,O
.,15122,15123,O
",",15123,15124,O
impaired,15125,15133,O
verbal,15134,15140,O
episodic,15141,15149,O
memory,15150,15156,O
",",15156,15157,O
attention,15158,15167,O
",",15167,15168,O
and,15169,15172,O
response,15173,15181,O
inhibition,15182,15192,O
;,15192,15193,O
Rinne,15194,15199,O
et,15200,15202,O
al,15203,15205,O
.,15205,15206,O
",",15206,15207,O
2000,15208,15212,O
;,15212,15213,O
Bruck,15214,15219,O
et,15220,15222,O
al,15223,15225,O
.,15225,15226,O
",",15226,15227,O
2005,15228,15232,O
),15232,15233,O
.,15233,15234,O
Future,15235,15241,O
studies,15242,15249,O
on,15250,15252,O
network,15253,15260,O
processes,15261,15270,O
may,15271,15274,O
help,15275,15279,O
to,15280,15282,O
localize,15283,15291,O
the,15292,15295,O
neural,15296,15302,B-Multi-tissue_structure
link,15303,15307,O
between,15308,15315,O
reward,15316,15322,O
prospect,15323,15331,O
and,15332,15335,O
action,15336,15342,O
preparation,15343,15354,O
that,15355,15359,O
enables,15360,15367,O
alleviating,15368,15379,O
effects,15380,15387,O
of,15388,15390,O
motivational,15391,15403,O
incentives,15404,15414,O
on,15415,15417,O
cognitive,15418,15427,O
decline,15428,15435,O
.,15435,15436,O
Crystal,0,7,O
data,8,12,O
C24H21ClN4O2S,13,26,O
M,27,28,O
r,29,30,O
=,31,32,O
464,33,36,O
.,36,37,O
96,37,39,O
Triclinic,40,49,O
",",49,50,O
a,52,53,O
=,54,55,O
8,56,57,O
.,57,58,O
6798,58,62,O
(,63,64,O
18,64,66,O
),66,67,O
A,68,69,O
b,70,71,O
=,72,73,O
11,74,76,O
.,76,77,O
078,77,80,O
(,81,82,O
2,82,83,O
),83,84,O
A,85,86,O
c,87,88,O
=,89,90,O
11,91,93,O
.,93,94,O
372,94,97,O
(,98,99,O
2,99,100,O
),100,101,O
A,102,103,O
alpha,104,109,O
=,110,111,O
78,112,114,O
.,114,115,O
984,115,118,O
(,119,120,O
7,120,121,O
),121,122,O
degrees,122,129,O
beta,130,134,O
=,135,136,O
81,137,139,O
.,139,140,O
867,140,143,O
(,144,145,O
10,145,147,O
),147,148,O
degrees,148,155,O
gamma,156,161,O
=,162,163,O
81,164,166,O
.,166,167,O
718,167,170,O
(,171,172,O
11,172,174,O
),174,175,O
degrees,175,182,O
V,183,184,O
=,185,186,O
1054,187,191,O
.,191,192,O
8,192,193,O
(,194,195,O
4,195,196,O
),196,197,O
A3,198,200,O
Z,201,202,O
=,203,204,O
2,205,206,O
Cu,207,209,O
Kalpha,210,216,O
radiation,217,226,O
mu,227,229,O
=,230,231,O
2,232,233,O
.,233,234,O
78,234,236,O
mm,237,239,O
-,239,240,O
1,240,241,O
T,242,243,O
=,244,245,O
113,246,249,O
K,250,251,O
0,252,253,O
.,253,254,O
28,254,256,O
x,257,258,O
0,259,260,O
.,260,261,O
24,261,263,O
x,264,265,O
0,266,267,O
.,267,268,O
20,268,270,O
mm,271,273,O
Characteristics,0,15,O
of,16,18,O
fistula,19,26,B-Pathological_formation
lesions,27,34,I-Pathological_formation
Selective,0,9,O
SMA,10,13,O
angiography,14,25,O
was,26,29,O
performed,30,39,O
5,40,41,O
h,42,43,O
from,44,48,O
onset,49,54,O
.,54,55,O
Before,56,62,O
therapy,63,70,O
",",70,71,O
the,72,75,O
SMA,76,79,O
was,80,83,O
completely,84,94,O
occluded,95,103,O
by,104,106,O
an,107,109,O
embolus,110,117,B-Organism_substance
at,118,120,O
the,121,124,O
proximal,125,133,O
portion,134,141,O
(,142,143,O
a,143,144,O
),144,145,O
",",145,146,O
and,147,150,O
after,151,156,O
the,157,160,O
bolus,161,166,B-Organism_substance
infusion,167,175,O
of,176,178,O
urokinase,179,188,O
(,189,190,O
600,190,193,O
",",193,194,O
000,194,197,O
IU,198,200,O
),200,201,O
into,202,206,O
the,207,210,O
SMA,211,214,O
",",214,215,O
peripheral,216,226,B-Organism_substance
blood,227,232,I-Organism_substance
flow,233,237,O
was,238,241,O
improved,242,250,O
.,250,251,O
However,252,259,O
",",259,260,O
the,261,264,O
thrombus,265,273,B-Organism_substance
decreased,274,283,O
in,284,286,O
size,287,291,O
",",291,292,O
but,293,296,O
remained,297,305,O
(,306,307,O
b,307,308,O
),308,309,O
.,309,310,O
Asterisks,311,320,O
indicate,321,329,O
thrombus,330,338,B-Organism_substance
.,338,339,O
Measurement,0,11,O
of,12,14,O
IgA1,15,19,O
content,20,27,O
IgA1,28,32,O
content,33,40,O
in,41,43,O
the,44,47,O
supernatant,48,59,B-Organism_substance
from,60,64,O
each,65,69,O
culture,70,77,O
well,78,82,O
was,83,86,O
measured,87,95,O
in,96,98,O
duplicate,99,108,O
using,109,114,O
enzyme,115,121,O
-,121,122,O
linked,122,128,O
immunosorbent,129,142,O
assay,143,148,O
(,149,150,O
ELISA,150,155,O
),155,156,O
.,156,157,O
All,158,161,O
incubations,162,173,O
were,174,178,O
performed,179,188,O
at,189,191,O
room,192,196,O
temperature,197,208,O
except,209,215,O
for,216,219,O
capture,220,227,O
antibody,228,236,O
coating,237,244,O
.,244,245,O
Briefly,246,253,O
",",253,254,O
96,255,257,O
-,257,258,O
well,258,262,O
immunoplates,263,275,O
(,276,277,O
Thermo,277,283,O
Fisher,284,290,O
Scientific,291,301,O
",",301,302,O
Waltham,303,310,O
",",310,311,O
MA,312,314,O
",",314,315,O
USA,316,319,O
),319,320,O
were,321,325,O
coated,326,332,O
with,333,337,O
5,338,339,O
microg,340,346,O
/,346,347,O
mL,347,349,O
of,350,352,O
F,353,354,O
(,354,355,O
ab,355,357,O
',357,358,O
),358,359,O
2,359,360,O
fragment,361,369,O
goat,370,374,O
anti,375,379,O
-,379,380,O
human,380,385,O
IgA,386,389,O
antibody,390,398,O
(,399,400,O
Jackson,400,407,O
ImmunoResearch,408,422,O
Laboratories,423,435,O
",",435,436,O
West,437,441,O
Grove,442,447,O
",",447,448,O
PA,449,451,O
",",451,452,O
USA,453,456,O
),456,457,O
",",457,458,O
in,459,461,O
phosphate,462,471,O
-,471,472,O
buffered,472,480,O
saline,481,487,O
(,488,489,O
PBS,489,492,O
),492,493,O
at,494,496,O
4degreesC,497,506,O
overnight,507,516,O
.,516,517,O
After,518,523,O
three,524,529,O
washes,530,536,O
with,537,541,O
PBS,542,545,O
containing,546,556,O
0,557,558,O
.,558,559,O
05,559,561,O
%,561,562,O
Tween,563,568,O
-,568,569,O
20,569,571,O
(,572,573,O
PBST,573,577,O
),577,578,O
",",578,579,O
plates,580,586,O
were,587,591,O
blocked,592,599,O
by,600,602,O
adding,603,609,O
PBS,610,613,O
containing,614,624,O
1,625,626,O
%,626,627,O
bovine,628,634,O
serum,635,640,B-Organism_substance
albumin,641,648,O
(,649,650,O
BSA,650,653,O
),653,654,O
to,655,657,O
the,658,661,O
wells,662,667,O
for,668,671,O
90,672,674,O
min,675,678,O
.,678,679,O
Next,680,684,O
",",684,685,O
50,686,688,O
microL,689,695,O
of,696,698,O
supernatant,699,710,B-Organism_substance
sample,711,717,I-Organism_substance
or,718,720,O
standard,721,729,O
human,730,735,O
IgA1,736,740,O
(,741,742,O
CALBIOCHEM,742,752,O
",",752,753,O
La,754,756,O
Jolla,757,762,O
",",762,763,O
CA,764,766,O
",",766,767,O
USA,768,771,O
),771,772,O
was,773,776,O
added,777,782,O
to,783,785,O
the,786,789,O
reaction,790,798,O
wells,799,804,O
and,805,808,O
then,809,813,O
incubated,814,823,O
for,824,827,O
90,828,830,O
min,831,834,O
.,834,835,O
After,836,841,O
three,842,847,O
washes,848,854,O
",",854,855,O
0,856,857,O
.,857,858,O
75,858,860,O
microg,861,867,O
/,867,868,O
mL,868,870,O
alkaline,871,879,O
phosphatase,880,891,O
conjugated,892,902,O
goat,903,907,O
anti,908,912,O
-,912,913,O
human,913,918,O
IgA,919,922,O
(,923,924,O
Southern,924,932,O
Biotechnology,933,946,O
Associates,947,957,O
",",957,958,O
Birmingham,959,969,O
",",969,970,O
AL,971,973,O
",",973,974,O
USA,975,978,O
),978,979,O
in,980,982,O
1,983,984,O
%,984,985,O
BSA,986,989,O
/,989,990,O
PBS,990,993,O
was,994,997,O
added,998,1003,O
to,1004,1006,O
the,1007,1010,O
reaction,1011,1019,O
wells,1020,1025,O
and,1026,1029,O
then,1030,1034,O
incubated,1035,1044,O
for,1045,1048,O
90,1049,1051,O
min,1052,1055,O
.,1055,1056,O
Plates,1057,1063,O
were,1064,1068,O
washed,1069,1075,O
three,1076,1081,O
times,1082,1087,O
and,1088,1091,O
developed,1092,1101,O
with,1102,1106,O
a,1107,1108,O
substrate,1109,1118,O
solution,1119,1127,O
of,1128,1130,O
1,1131,1132,O
mg,1133,1135,O
/,1135,1136,O
mL,1136,1138,O
p,1139,1140,O
-,1140,1141,O
nitrophenyl,1141,1152,O
phosphate,1153,1162,O
disodium,1163,1171,O
salt,1172,1176,O
(,1177,1178,O
SIGMA,1178,1183,O
",",1183,1184,O
St,1185,1187,O
.,1187,1188,O
Louis,1189,1194,O
",",1194,1195,O
MO,1196,1198,O
",",1198,1199,O
USA,1200,1203,O
),1203,1204,O
in,1205,1207,O
0,1208,1209,O
.,1209,1210,O
1,1210,1211,O
M,1212,1213,O
glycine,1214,1221,O
buffer,1222,1228,O
containing,1229,1239,O
1,1240,1241,O
mM,1242,1244,O
MgCl2,1245,1250,O
",",1250,1251,O
1,1252,1253,O
mM,1254,1256,O
ZnCl2,1257,1262,O
",",1262,1263,O
pH,1264,1266,O
10,1267,1269,O
.,1269,1270,O
4,1270,1271,O
.,1271,1272,O
The,1273,1276,O
optical,1277,1284,O
density,1285,1292,O
at,1293,1295,O
405,1296,1299,O
nm,1300,1302,O
was,1303,1306,O
determined,1307,1317,O
in,1318,1320,O
a,1321,1322,O
microplate,1323,1333,O
reader,1334,1340,O
(,1341,1342,O
Benchmark,1342,1351,O
PlusTM,1352,1358,O
Bio,1359,1362,O
-,1362,1363,O
Rad,1363,1366,O
Laboratories,1367,1379,O
",",1379,1380,O
Hercules,1381,1389,O
",",1389,1390,O
CA,1391,1393,O
",",1393,1394,O
USA,1395,1398,O
),1398,1399,O
.,1399,1400,O
IgA1,1401,1405,O
concentration,1406,1419,O
in,1420,1422,O
unknown,1423,1430,O
duplicate,1431,1440,O
samples,1441,1448,O
was,1449,1452,O
determined,1453,1463,O
by,1464,1466,O
interpolation,1467,1480,O
of,1481,1483,O
the,1484,1487,O
respective,1488,1498,O
optical,1499,1506,O
density,1507,1514,O
into,1515,1519,O
the,1520,1523,O
appropriate,1524,1535,O
standard,1536,1544,O
curve,1545,1550,O
.,1550,1551,O
IgG,1552,1555,O
and,1556,1559,O
IgM,1560,1563,O
contents,1564,1572,O
in,1573,1575,O
the,1576,1579,O
supernatant,1580,1591,B-Organism_substance
were,1592,1596,O
measured,1597,1605,O
using,1606,1611,O
sandwich,1612,1620,O
ELISA,1621,1626,O
(,1627,1628,O
IMMUNOtek,1628,1637,O
(,1637,1638,O
R,1638,1639,O
),1639,1640,O
",",1640,1641,O
ZeptoMetrix,1642,1653,O
Corporation,1654,1665,O
",",1665,1666,O
Buffalo,1667,1674,O
",",1674,1675,O
NY,1676,1678,O
",",1678,1679,O
USA,1680,1683,O
),1683,1684,O
according,1685,1694,O
to,1695,1697,O
the,1698,1701,O
manufacturer,1702,1714,O
',1714,1715,O
s,1715,1716,O
instructions,1717,1729,O
.,1729,1730,O
The,0,3,O
thickness,4,13,O
of,14,16,O
the,17,20,O
inner,21,26,B-Multi-tissue_structure
retina,27,33,I-Multi-tissue_structure
was,34,37,O
established,38,49,O
as,50,52,O
the,53,56,O
distance,57,65,O
between,66,73,O
retinal,74,81,B-Tissue
nerve,82,87,I-Tissue
fiber,88,93,I-Tissue
layer,94,99,I-Tissue
and,100,103,O
inner,104,109,B-Tissue
nuclear,110,117,I-Tissue
layer,118,123,I-Tissue
and,124,127,O
was,128,131,O
measured,132,140,O
using,141,146,O
the,147,150,O
1,151,152,O
",",152,153,O
000,153,156,O
mum,157,160,O
caliper,161,168,O
available,169,178,O
in,179,181,O
the,182,185,O
OCT,186,189,O
-,189,190,O
SLO,190,193,O
Spectralis,194,204,O
.,204,205,O
Ten,206,209,O
age,210,213,O
-,213,214,O
matched,214,221,O
normal,222,228,O
eyes,229,233,B-Organ
were,234,238,O
used,239,243,O
as,244,246,O
controls,247,255,O
.,255,256,O
Observe,257,264,O
the,265,268,O
decrease,269,277,O
in,278,280,O
the,281,284,O
nasal,285,290,B-Organism_subdivision
and,291,294,O
temporal,295,303,O
inner,304,309,B-Multi-tissue_structure
retinal,310,317,I-Multi-tissue_structure
thickness,318,327,O
in,328,330,O
the,331,334,O
right,335,340,O
eye,341,344,B-Organ
in,345,347,O
comparison,348,358,O
to,359,361,O
the,362,365,O
left,366,370,O
and,371,374,O
normal,375,381,O
control,382,389,O
eyes,390,394,B-Organ
.,394,395,O
Real,0,4,O
time,5,9,O
RT,10,12,O
-,12,13,O
PCR,13,16,O
RNA,17,20,O
extraction,21,31,O
and,32,35,O
real,36,40,O
-,40,41,O
time,41,45,O
RT,46,48,O
-,48,49,O
PCR,49,52,O
were,53,57,O
performed,58,67,O
as,68,70,O
we,71,73,O
described,74,83,O
previously,84,94,O
[,95,96,O
22,96,98,O
],98,99,O
.,99,100,O
The,101,104,O
sequences,105,114,O
of,115,117,O
ABCG2,118,123,O
primers,124,131,O
are,132,135,O
5,136,137,O
',137,138,O
-,138,139,O
GGCTTTCTACCTGCACGAAAACCAGTTGAG,139,169,O
-,169,170,O
3,170,171,O
',171,172,O
(,173,174,O
forward,174,181,O
),181,182,O
and,183,186,O
5,187,188,O
',188,189,O
-,189,190,O
ATGGCGTTGAGACCAG,190,206,O
-,206,207,O
3,207,208,O
',208,209,O
(,210,211,O
reverse,211,218,O
),218,219,O
.,219,220,O
The,221,224,O
sequences,225,234,O
of,235,237,O
GAPDH,238,243,O
primers,244,251,O
are,252,255,O
5,256,257,O
',257,258,O
-,258,259,O
AAGGACTCATGACCACAGTCCAT,259,282,O
-,282,283,O
3,283,284,O
',284,285,O
(,286,287,O
forward,287,294,O
),294,295,O
and,296,299,O
5,300,301,O
',301,302,O
-,302,303,O
CCATCACGCCACAGTTTCC,303,322,O
-,322,323,O
3,323,324,O
',324,325,O
(,326,327,O
reverse,327,334,O
),334,335,O
.,335,336,O
The,337,340,O
relative,341,349,O
ABCG2,350,355,O
RNA,356,359,O
level,360,365,O
(,366,367,O
2DeltaCT,367,375,O
),375,376,O
treated,377,384,O
with,385,389,O
inhibitors,390,400,O
was,401,404,O
expressed,405,414,O
as,415,417,O
percentage,418,428,O
of,429,431,O
the,432,435,O
control,436,443,O
(,444,445,O
in,445,447,O
the,448,451,O
presence,452,460,O
of,461,463,O
0,464,465,O
.,465,466,O
1,466,467,O
%,467,468,O
DMSO,469,473,O
),473,474,O
where,475,480,O
DeltaCT,481,488,O
(,489,490,O
threshold,490,499,O
cycle,500,505,O
),505,506,O
=,507,508,O
(,509,510,O
CTABCG2,510,517,O
-,517,518,O
CTGAPDH,518,525,O
),525,526,O
.,526,527,O
Introduction,0,12,O
Adipose,13,20,B-Tissue
tissue,21,27,I-Tissue
",",27,28,O
once,29,33,O
viewed,34,40,O
as,41,43,O
simply,44,50,O
a,51,52,O
storage,53,60,O
and,61,64,O
release,65,72,O
depot,73,78,O
for,79,82,O
lipids,83,89,O
",",89,90,O
is,91,93,O
now,94,97,O
considered,98,108,O
an,109,111,O
endocrine,112,121,B-Tissue
tissue,122,128,I-Tissue
[,129,130,O
1,130,131,O
",",131,132,O
2,132,133,O
],133,134,O
that,135,139,O
secretes,140,148,O
various,149,156,O
substances,157,167,O
(,168,169,O
adipokines,169,179,O
),179,180,O
",",180,181,O
including,182,191,O
tumor,192,197,O
necrosis,198,206,O
factor,207,213,O
-,213,214,O
alpha,214,219,O
(,220,221,O
TNF,221,224,O
-,224,225,O
alpha,225,230,O
),230,231,O
",",231,232,O
interleukin,233,244,O
(,245,246,O
IL,246,248,O
),248,249,O
-,249,250,O
6,250,251,O
",",251,252,O
leptin,253,259,O
",",259,260,O
adiponectin,261,272,O
",",272,273,O
resistin,274,282,O
",",282,283,O
visfatin,284,292,O
",",292,293,O
and,294,297,O
omenetin,298,306,O
[,307,308,O
3,308,309,O
",",309,310,O
4,310,311,O
],311,312,O
.,312,313,O
Among,314,319,O
these,320,325,O
adipokines,326,336,O
",",336,337,O
much,338,342,O
attention,343,352,O
has,353,356,O
been,357,361,O
paid,362,366,O
to,367,369,O
adiponectin,370,381,O
',381,382,O
s,382,383,O
relationship,384,396,O
with,397,401,O
insulin,402,409,O
sensitivity,410,421,O
and,422,425,O
glucose,426,433,O
and,434,437,O
lipid,438,443,O
metabolism,444,454,O
in,455,457,O
the,458,461,O
past,462,466,O
10,467,469,O
years,470,475,O
.,475,476,O
In,477,479,O
addition,480,488,O
",",488,489,O
adiponectin,490,501,O
is,502,504,O
known,505,510,O
to,511,513,O
exhibit,514,521,O
potent,522,528,O
anti,529,533,O
-,533,534,O
inflammatory,534,546,O
[,547,548,O
5,548,549,O
],549,550,O
",",550,551,O
atheroprotective,552,568,O
[,569,570,O
6,570,571,O
],571,572,O
",",572,573,O
and,574,577,O
antidiabetic,578,590,O
[,591,592,O
7,592,593,O
],593,594,O
effects,595,602,O
.,602,603,O
Recent,604,610,O
findings,611,619,O
suggest,620,627,O
that,628,632,O
adiponectin,633,644,O
may,645,648,O
be,649,651,O
involved,652,660,O
in,661,663,O
the,664,667,O
pathogenesis,668,680,O
of,681,683,O
rheumatoid,684,694,O
arthritis,695,704,O
(,705,706,O
RA,706,708,O
),708,709,O
.,709,710,O
Levels,711,717,O
of,718,720,O
adiponectin,721,732,O
in,733,735,O
synovial,736,744,B-Organism_substance
fluid,745,750,I-Organism_substance
and,751,754,O
sera,755,759,B-Organism_substance
were,760,764,O
elevated,765,773,O
in,774,776,O
patients,777,785,O
with,786,790,O
RA,791,793,O
[,794,795,O
8,795,796,O
",",796,797,O
9,797,798,O
],798,799,O
.,799,800,O
Adiponectin,801,812,O
also,813,817,O
induces,818,825,O
the,826,829,O
production,830,840,O
of,841,843,O
proinflammatory,844,859,O
cytokines,860,869,O
",",869,870,O
IL,871,873,O
-,873,874,O
6,874,875,O
",",875,876,O
matrix,877,883,O
metalloproteinase,884,901,O
(,902,903,O
MMP,903,906,O
),906,907,O
-,907,908,O
1,908,909,O
",",909,910,O
and,911,914,O
IL,915,917,O
-,917,918,O
8,918,919,O
from,920,924,O
RA,925,927,O
synovial,928,936,B-Cell
fibroblasts,937,948,I-Cell
in,949,951,O
vitro,952,957,O
[,958,959,O
10,959,961,O
",",961,962,O
11,962,964,O
],964,965,O
.,965,966,O
Thus,967,971,O
",",971,972,O
it,973,975,O
was,976,979,O
suggested,980,989,O
that,990,994,O
adiponectin,995,1006,O
can,1007,1010,O
also,1011,1015,O
exert,1016,1021,O
significant,1022,1033,O
proinflammatory,1034,1049,O
and,1050,1053,O
matrix,1054,1060,O
-,1060,1061,O
degrading,1061,1070,O
effects,1071,1078,O
.,1078,1079,O
However,1080,1087,O
",",1087,1088,O
the,1089,1092,O
role,1093,1097,O
of,1098,1100,O
adiponectin,1101,1112,O
in,1113,1115,O
the,1116,1119,O
pathogenesis,1120,1132,O
of,1133,1135,O
RA,1136,1138,O
is,1139,1141,O
still,1142,1147,O
controversial,1148,1161,O
because,1162,1169,O
of,1170,1172,O
conflicting,1173,1184,O
reports,1185,1192,O
about,1193,1198,O
its,1199,1202,O
function,1203,1211,O
[,1212,1213,O
10,1213,1215,O
",",1215,1216,O
12,1216,1218,O
-,1218,1219,O
15,1219,1221,O
],1221,1222,O
.,1222,1223,O
In,1224,1226,O
particular,1227,1237,O
",",1237,1238,O
adiponectin,1239,1250,O
seems,1251,1256,O
to,1257,1259,O
play,1260,1264,O
an,1265,1267,O
anti,1268,1272,O
-,1272,1273,O
inflammatory,1273,1285,O
role,1286,1290,O
because,1291,1298,O
it,1299,1301,O
significantly,1302,1315,O
inhibited,1316,1325,O
IL,1326,1328,O
-,1328,1329,O
1beta,1329,1334,O
-,1334,1335,O
stimulated,1335,1345,O
synovial,1346,1354,B-Cell
cell,1355,1359,I-Cell
proliferation,1360,1373,O
in,1374,1376,O
collagen,1377,1385,O
-,1385,1386,O
induced,1386,1393,O
arthritic,1394,1403,O
mice,1404,1408,O
",",1408,1409,O
despite,1410,1417,O
increased,1418,1427,O
IL,1428,1430,O
-,1430,1431,O
6,1431,1432,O
expression,1433,1443,O
[,1444,1445,O
16,1445,1447,O
],1447,1448,O
.,1448,1449,O
In,1450,1452,O
contrast,1453,1461,O
",",1461,1462,O
high,1463,1467,O
-,1467,1468,O
grade,1468,1473,O
inflammation,1474,1486,O
in,1487,1489,O
RA,1490,1492,O
patients,1493,1501,O
was,1502,1505,O
negatively,1506,1516,O
correlated,1517,1527,O
with,1528,1532,O
circulating,1533,1544,O
adiponectin,1545,1556,O
concentrations,1557,1571,O
[,1572,1573,O
17,1573,1575,O
],1575,1576,O
.,1576,1577,O
Rather,1578,1584,O
",",1584,1585,O
it,1586,1588,O
was,1589,1592,O
suggested,1593,1602,O
that,1603,1607,O
circulating,1608,1619,O
adiponectin,1620,1631,O
may,1632,1635,O
be,1636,1638,O
involved,1639,1647,O
in,1648,1650,O
cardiovascular,1651,1665,B-Multi-tissue_structure
disease,1666,1673,O
in,1674,1676,O
RA,1677,1679,O
patients,1680,1688,O
.,1688,1689,O
Although,1690,1698,O
this,1699,1703,O
contradiction,1704,1717,O
was,1718,1721,O
partly,1722,1728,O
explained,1729,1738,O
by,1739,1741,O
the,1742,1745,O
induction,1746,1755,O
of,1756,1758,O
tolerance,1759,1768,O
to,1769,1771,O
inflammatory,1772,1784,O
stimuli,1785,1792,O
by,1793,1795,O
adiponectin,1796,1807,O
[,1808,1809,O
18,1809,1811,O
],1811,1812,O
",",1812,1813,O
the,1814,1817,O
pro,1818,1821,O
-,1821,1822,O
or,1823,1825,O
anti,1826,1830,O
-,1830,1831,O
inflammatory,1831,1843,O
effects,1844,1851,O
of,1852,1854,O
adiponectin,1855,1866,O
on,1867,1869,O
the,1870,1873,O
pathogenesis,1874,1886,O
of,1887,1889,O
RA,1890,1892,O
remain,1893,1899,O
unknown,1900,1907,O
.,1907,1908,O
With,1909,1913,O
regard,1914,1920,O
to,1921,1923,O
adiponectin,1924,1935,O
',1935,1936,O
s,1936,1937,O
proinflammatory,1938,1953,O
effects,1954,1961,O
",",1961,1962,O
we,1963,1965,O
wondered,1966,1974,O
whether,1975,1982,O
adiponectin,1983,1994,O
might,1995,2000,O
stimulate,2001,2010,O
the,2011,2014,O
production,2015,2025,O
of,2026,2028,O
vascular,2029,2037,O
endothelial,2038,2049,O
growth,2050,2056,O
factor,2057,2063,O
(,2064,2065,O
VEGF,2065,2069,O
),2069,2070,O
and,2071,2074,O
MMPs,2075,2079,O
as,2080,2082,O
well,2083,2087,O
as,2088,2090,O
proinflammatory,2091,2106,O
mediators,2107,2116,O
like,2117,2121,O
IL,2122,2124,O
-,2124,2125,O
1beta,2125,2130,O
and,2131,2134,O
TNF,2135,2138,O
-,2138,2139,O
alpha,2139,2144,O
do,2145,2147,O
.,2147,2148,O
In,2149,2151,O
this,2152,2156,O
study,2157,2162,O
",",2162,2163,O
we,2164,2166,O
investigated,2167,2179,O
the,2180,2183,O
stimulatory,2184,2195,O
effect,2196,2202,O
of,2203,2205,O
adiponectin,2206,2217,O
on,2218,2220,O
the,2221,2224,O
production,2225,2235,O
of,2236,2238,O
IL,2239,2241,O
-,2241,2242,O
6,2242,2243,O
",",2243,2244,O
IL,2245,2247,O
-,2247,2248,O
8,2248,2249,O
",",2249,2250,O
prostaglandin,2251,2264,O
E2,2265,2267,O
(,2268,2269,O
PGE2,2269,2273,O
),2273,2274,O
",",2274,2275,O
VEGF,2276,2280,O
",",2280,2281,O
and,2282,2285,O
MMPs,2286,2290,O
.,2290,2291,O
In,2292,2294,O
addition,2295,2303,O
",",2303,2304,O
the,2305,2308,O
correlation,2309,2320,O
between,2321,2328,O
adiponectin,2329,2340,O
and,2341,2344,O
VEGF,2345,2349,O
or,2350,2352,O
MMPs,2353,2357,O
was,2358,2361,O
investigated,2362,2374,O
by,2375,2377,O
measuring,2378,2387,O
the,2388,2391,O
levels,2392,2398,O
of,2399,2401,O
these,2402,2407,O
three,2408,2413,O
proteins,2414,2422,O
in,2423,2425,O
the,2426,2429,O
joint,2430,2435,B-Organism_substance
fluid,2436,2441,I-Organism_substance
of,2442,2444,O
patients,2445,2453,O
with,2454,2458,O
RA,2459,2461,O
or,2462,2464,O
osteoarthritis,2465,2479,O
(,2480,2481,O
OA,2481,2483,O
),2483,2484,O
.,2484,2485,O
Refinement,0,10,O
The,11,14,O
H,15,16,O
-,16,17,O
atoms,17,22,O
were,23,27,O
positioned,28,38,O
geometrically,39,52,O
(,53,54,O
O,54,55,O
-,55,56,O
H,56,57,O
=,58,59,O
0,60,61,O
.,61,62,O
82,62,64,O
",",64,65,O
C,66,67,O
-,67,68,O
H,68,69,O
=,70,71,O
0,72,73,O
.,73,74,O
93,74,76,O
A,77,78,O
),78,79,O
and,80,83,O
were,84,88,O
included,89,97,O
in,98,100,O
the,101,104,O
refinement,105,115,O
in,116,118,O
the,119,122,O
riding,123,129,O
model,130,135,O
approximation,136,149,O
",",149,150,O
with,151,155,O
Uiso,156,160,O
(,160,161,O
H,161,162,O
),162,163,O
=,164,165,O
xUeq,166,170,O
(,170,171,O
C,171,172,O
",",172,173,O
O,174,175,O
),175,176,O
",",176,177,O
where,178,183,O
x,184,185,O
=,186,187,O
1,188,189,O
.,189,190,O
2,190,191,O
for,192,195,O
all,196,199,O
H,200,201,O
-,201,202,O
atoms,202,207,O
.,207,208,O
Reagents,0,8,O
and,9,12,O
antibodies,13,23,O
Maxisorp,24,32,O
strips,33,39,O
(,40,41,O
NunC,41,45,O
",",45,46,O
Roskilde,47,55,O
",",55,56,O
Denmark,57,64,O
),64,65,O
",",65,66,O
GST,67,70,O
-,70,71,O
PNMA2,71,76,O
recombinant,77,88,O
protein,89,96,O
(,97,98,O
Abnova,98,104,O
",",104,105,O
Taipei,106,112,O
",",112,113,O
Taiwan,114,120,O
),120,121,O
;,121,122,O
3,123,124,O
",",124,125,O
3,125,126,O
',126,127,O
",",127,128,O
5,128,129,O
",",129,130,O
5,130,131,O
-,131,132,O
tetramethylbenzidine,132,152,O
(,153,154,O
TMB,154,157,O
),157,158,O
+,159,160,O
substrate,161,170,O
(,171,172,O
Dako,172,176,O
",",176,177,O
Glostrup,178,186,O
",",186,187,O
Denmark,188,195,O
),195,196,O
",",196,197,O
Peroxidase,198,208,O
with,209,213,O
dakocytomation,214,228,O
peroxidase,229,239,O
block,240,245,O
(,246,247,O
Dako,247,251,O
),251,252,O
",",252,253,O
Dakocytomation,254,268,O
envision,269,277,O
(,277,278,O
R,278,279,O
),279,280,O
system,281,287,O
labeled,288,295,O
polymer,296,303,O
-,303,304,O
HRP,304,307,O
anti,308,312,O
-,312,313,O
rabbit,313,319,O
kit,320,323,O
and,324,327,O
3,328,329,O
-,329,330,O
3,330,331,O
',331,332,O
-,332,333,O
diaminobenzidine,333,349,O
(,350,351,O
Dako,351,355,O
),355,356,O
",",356,357,O
Mayer,358,363,O
',363,364,O
s,364,365,O
hematoxylin,366,377,O
(,378,379,O
Histolab,379,387,O
Product,388,395,O
AB,396,398,O
",",398,399,O
Gothenburg,400,410,O
",",410,411,O
Sweden,412,418,O
),418,419,O
",",419,420,O
Graded,421,427,O
alcohol,428,435,O
(,436,437,O
Kemetyl,437,444,O
",",444,445,O
Vestby,446,452,O
",",452,453,O
Norway,454,460,O
),460,461,O
",",461,462,O
Xylen,463,468,O
(,469,470,O
Solveco,470,477,O
",",477,478,O
Rosersberg,479,489,O
",",489,490,O
Sweden,491,497,O
),497,498,O
",",498,499,O
Pertex,500,506,O
(,506,507,O
R,507,508,O
),508,509,O
(,510,511,O
Histolab,511,519,O
",",519,520,O
Gothenburg,521,531,O
",",531,532,O
Sweden,533,539,O
),539,540,O
",",540,541,O
Tris,542,546,O
-,546,547,O
Glycine,547,554,O
blotting,555,563,O
buffer,564,570,O
(,571,572,O
Amresco,572,579,O
",",579,580,O
Solon,581,586,O
",",586,587,O
OH,588,590,O
),590,591,O
",",591,592,O
Western,593,600,O
blotting,601,609,O
(,610,611,O
WB,611,613,O
),613,614,O
reagent,615,622,O
and,623,626,O
Lumi,627,631,O
-,631,632,O
Light,632,637,O
WB,638,640,O
substrate,641,650,O
(,651,652,O
Roche,652,657,O
",",657,658,O
Basel,659,664,O
",",664,665,O
Switzerland,666,677,O
),677,678,O
",",678,679,O
EasyTag,680,687,O
Methionine,688,698,O
-,698,699,O
L,699,700,O
-,700,701,O
35S,701,704,O
",",704,705,O
NEG709A005MC,706,718,O
(,719,720,O
PerkinElmer,720,731,O
",",731,732,O
Waltham,733,740,O
",",740,741,O
MA,742,744,O
),744,745,O
",",745,746,O
Full,747,751,O
-,751,752,O
length,752,758,O
cDNA,759,763,O
clone,764,769,O
for,770,773,O
human,774,779,O
PNMA2,780,785,O
",",785,786,O
ID6580976,787,796,O
(,797,798,O
BioScience,798,808,O
Geneservice,809,820,O
",",820,821,O
Cambridge,822,831,O
",",831,832,O
UK,833,835,O
),835,836,O
",",836,837,O
TnT,838,841,O
(,841,842,O
R,842,843,O
),843,844,O
SP6,845,848,O
Quick,849,854,O
Coupled,855,862,O
Transcription,863,876,O
/,876,877,O
Translation,877,888,O
System,889,895,O
(,896,897,O
Promega,897,904,O
",",904,905,O
Madison,906,913,O
",",913,914,O
WI,915,917,O
),917,918,O
",",918,919,O
Protein,920,927,O
G,928,929,O
-,929,930,O
Sepharose,930,939,O
beads,940,945,O
(,946,947,O
GE,947,949,O
Healthcare,950,960,O
",",960,961,O
Little,962,968,O
Chalfont,969,977,O
",",977,978,O
Buckinghamshire,979,994,O
",",994,995,O
UK,996,998,O
),998,999,O
",",999,1000,O
Peroxidase,1001,1011,O
(,1012,1013,O
HRP,1013,1016,O
),1016,1017,O
-,1017,1018,O
conjugated,1018,1028,O
rabbit,1029,1035,O
anti,1036,1040,O
human,1041,1046,O
IgG,1047,1050,O
(,1051,1052,O
anti,1052,1056,O
-,1056,1057,O
IgG,1057,1060,O
),1060,1061,O
(,1062,1063,O
Dako,1063,1067,O
),1067,1068,O
",",1068,1069,O
rabbit,1070,1076,O
polyclonal,1077,1087,O
antibody,1088,1096,O
anti,1097,1101,O
-,1101,1102,O
PNMA2,1102,1107,O
(,1108,1109,O
Atlas,1109,1114,O
Antibodies,1115,1125,O
",",1125,1126,O
Stockholm,1127,1136,O
",",1136,1137,O
Sweden,1138,1144,O
),1144,1145,O
",",1145,1146,O
monoclonal,1147,1157,O
mouse,1158,1163,O
anti,1164,1168,O
-,1168,1169,O
GST,1169,1172,O
",",1172,1173,O
sc,1174,1176,O
-,1176,1177,O
138,1177,1180,O
",",1180,1181,O
polyclonal,1182,1192,O
goat,1193,1197,O
anti,1198,1202,O
-,1202,1203,O
human,1203,1208,O
Ma2,1209,1212,O
",",1212,1213,O
sc,1214,1216,O
-,1216,1217,O
68099,1217,1222,O
",",1222,1223,O
HRP,1224,1227,O
-,1227,1228,O
donkey,1228,1234,O
anti,1235,1239,O
-,1239,1240,O
goat,1240,1244,O
",",1244,1245,O
sc,1246,1248,O
-,1248,1249,O
2020,1249,1253,O
",",1253,1254,O
(,1255,1256,O
Santa,1256,1261,O
Cruz,1262,1266,O
Biotechnology,1267,1280,O
",",1280,1281,O
Santa,1282,1287,O
Cruz,1288,1292,O
",",1292,1293,O
CA,1294,1296,O
),1296,1297,O
",",1297,1298,O
HRP,1299,1302,O
-,1302,1303,O
goat,1303,1307,O
anti,1308,1312,O
-,1312,1313,O
rabbit,1313,1319,O
",",1319,1320,O
P0448,1321,1326,O
",",1326,1327,O
(,1328,1329,O
Dako,1329,1333,O
),1333,1334,O
and,1335,1338,O
Ravo,1339,1343,O
PNS,1344,1347,O
-,1347,1348,O
Blot,1348,1352,O
",",1352,1353,O
(,1354,1355,O
Ravo,1355,1359,O
Diagnostika,1360,1371,O
GmbH,1372,1376,O
",",1376,1377,O
Freiburg,1378,1386,O
",",1386,1387,O
Germany,1388,1395,O
),1395,1396,O
.,1396,1397,O
Statistical,0,11,O
analysis,12,20,O
All,21,24,O
statistical,25,36,O
analyses,37,45,O
were,46,50,O
performed,51,60,O
using,61,66,O
SPSS13,67,73,O
.,73,74,O
0,74,75,O
software,76,84,O
.,84,85,O
The,86,89,O
differences,90,101,O
between,102,109,O
groups,110,116,O
were,117,121,O
compared,122,130,O
using,131,136,O
Student,137,144,O
',144,145,O
s,145,146,O
t,147,148,O
-,148,149,O
test,149,153,O
",",153,154,O
and,155,158,O
data,159,163,O
were,164,168,O
expressed,169,178,O
as,179,181,O
mean,182,186,O
+,187,188,O
/,188,189,O
-,189,190,O
SD,191,193,O
.,193,194,O
Statistical,195,206,O
difference,207,217,O
was,218,221,O
accepted,222,230,O
at,231,233,O
P,234,235,O
<,235,236,O
0,236,237,O
.,237,238,O
05,238,240,O
.,240,241,O
The,0,3,O
importance,4,14,O
in,15,17,O
identifying,18,29,O
genes,30,35,O
involved,36,44,O
in,45,47,O
spinal,48,54,B-Organism_subdivision
curvature,55,64,O
Spinal,65,71,B-Organism_subdivision
curvature,72,81,O
is,82,84,O
a,85,86,O
prevalent,87,96,O
and,97,100,O
costly,101,107,O
deformity,108,117,O
among,118,123,O
humans,124,130,O
and,131,134,O
teleosts,135,143,O
.,143,144,O
The,145,148,O
estimated,149,158,O
annual,159,165,O
cost,166,170,O
of,171,173,O
treating,174,182,O
children,183,191,O
hospitalized,192,204,O
with,205,209,O
idiopathic,210,220,O
scoliosis,221,230,O
(,231,232,O
IS,232,234,O
),234,235,O
in,236,238,O
the,239,242,O
United,243,249,O
States,250,256,O
alone,257,262,O
is,263,265,O
over,266,270,O
$,271,272,O
3,272,273,O
billion,274,281,O
.,281,282,O
This,283,287,O
cost,288,292,O
estimate,293,301,O
does,302,306,O
not,307,310,O
consider,311,319,O
Scheuermann,320,331,O
kyphosis,332,340,O
",",340,341,O
or,342,344,O
adults,345,351,O
with,352,356,O
idiopathic,357,367,O
-,367,368,O
type,368,372,O
spinal,373,379,B-Organism_subdivision
curvature,380,389,O
who,390,393,O
suffer,394,400,O
from,401,405,O
chronic,406,413,O
back,414,418,B-Organism_subdivision
pain,419,423,O
",",423,424,O
contributing,425,437,O
to,438,440,O
the,441,444,O
estimated,445,454,O
$,455,456,O
849,456,459,O
billion,460,467,O
cost,468,472,O
of,473,475,O
treatment,476,485,O
and,486,489,O
lost,490,494,O
wages,495,500,O
associated,501,511,O
with,512,516,O
musculoskeletal,517,532,B-Anatomical_system
disease,533,540,O
[,541,542,O
24,542,544,O
],544,545,O
.,545,546,O
Among,547,552,O
teleosts,553,561,O
",",561,562,O
spinal,563,569,B-Organism_subdivision
column,570,576,I-Organism_subdivision
deformities,577,588,O
reduce,589,595,O
total,596,601,O
production,602,612,O
in,613,615,O
the,616,619,O
aquaculture,620,631,O
industry,632,640,O
substantially,641,654,O
[,655,656,O
12,656,658,O
],658,659,O
.,659,660,O
In,661,663,O
contrast,664,672,O
to,673,675,O
humans,676,682,O
",",682,683,O
teleost,684,691,O
curve,692,697,O
phenotypes,698,708,O
are,709,712,O
less,713,717,O
well,718,722,O
characterized,723,736,O
;,736,737,O
although,738,746,O
heritable,747,756,O
curves,757,763,O
are,764,767,O
acknowledged,768,780,O
to,781,783,O
account,784,791,O
for,792,795,O
many,796,800,O
cases,801,806,O
among,807,812,O
cultured,813,821,O
stocks,822,828,O
",",828,829,O
whether,830,837,O
these,838,843,O
cases,844,849,O
are,850,853,O
from,854,858,O
congenital,859,869,O
defects,870,877,O
or,878,880,O
are,881,884,O
idiopathic,885,895,O
-,895,896,O
type,896,900,O
is,901,903,O
often,904,909,O
not,910,913,O
known,914,919,O
.,919,920,O
Despite,921,928,O
the,929,932,O
prevalence,933,943,O
and,944,947,O
impact,948,954,O
of,955,957,O
this,958,962,O
type,963,967,O
of,968,970,O
deformity,971,980,O
",",980,981,O
the,982,985,O
genetic,986,993,O
architecture,994,1006,O
and,1007,1010,O
specific,1011,1019,O
genes,1020,1025,O
involved,1026,1034,O
are,1035,1038,O
unknown,1039,1046,O
.,1046,1047,O
The,1048,1051,O
current,1052,1059,O
view,1060,1064,O
is,1065,1067,O
that,1068,1072,O
human,1073,1078,O
idiopathic,1079,1089,O
-,1089,1090,O
type,1090,1094,O
scoliosis,1095,1104,O
is,1105,1107,O
a,1108,1109,O
complex,1110,1117,O
genetic,1118,1125,O
disorder,1126,1134,O
with,1135,1139,O
multiple,1140,1148,O
genes,1149,1154,O
segregating,1155,1166,O
in,1167,1169,O
the,1170,1173,O
population,1174,1184,O
exhibiting,1185,1195,O
complex,1196,1203,O
genotype,1204,1212,O
by,1213,1215,O
environment,1216,1227,O
interactions,1228,1240,O
[,1241,1242,O
25,1242,1244,O
-,1244,1245,O
30,1245,1247,O
],1247,1248,O
.,1248,1249,O
In,1250,1252,O
aquaculture,1253,1264,O
stocks,1265,1271,O
",",1271,1272,O
inheritance,1273,1284,O
for,1285,1288,O
spinal,1289,1295,B-Organism_subdivision
curvature,1296,1305,O
has,1306,1309,O
been,1310,1314,O
described,1315,1324,O
as,1325,1327,O
Mendelian,1328,1337,O
recessive,1338,1347,O
or,1348,1350,O
dominant,1351,1359,O
",",1359,1360,O
as,1361,1363,O
well,1364,1368,O
as,1369,1371,O
polygenic,1372,1381,O
",",1381,1382,O
depending,1383,1392,O
on,1393,1395,O
how,1396,1399,O
well,1400,1404,O
the,1405,1408,O
phenotype,1409,1418,O
is,1419,1421,O
characterized,1422,1435,O
and,1436,1439,O
what,1440,1444,O
stock,1445,1450,O
is,1451,1453,O
considered,1454,1464,O
(,1465,1466,O
reviewed,1466,1474,O
in,1475,1477,O
[,1478,1479,O
13,1479,1481,O
],1481,1482,O
",",1482,1483,O
[,1484,1485,O
16,1485,1487,O
],1487,1488,O
),1488,1489,O
.,1489,1490,O
The,1491,1494,O
guppy,1495,1500,O
curveback,1501,1510,O
phenotype,1511,1520,O
has,1521,1524,O
been,1525,1529,O
extensively,1530,1541,O
characterized,1542,1555,O
so,1556,1558,O
that,1559,1563,O
the,1564,1567,O
lineage,1568,1575,O
can,1576,1579,O
be,1580,1582,O
applied,1583,1590,O
as,1591,1593,O
a,1594,1595,O
model,1596,1601,O
for,1602,1605,O
understanding,1606,1619,O
the,1620,1623,O
biological,1624,1634,O
context,1635,1642,O
of,1643,1645,O
heritable,1646,1655,O
spinal,1656,1662,B-Organism_subdivision
curvature,1663,1672,O
[,1673,1674,O
1,1674,1675,O
",",1675,1676,O
7,1676,1677,O
-,1677,1678,O
9,1678,1679,O
],1679,1680,O
.,1680,1681,O
Future,1682,1688,O
studies,1689,1696,O
can,1697,1700,O
use,1701,1704,O
approaches,1705,1715,O
to,1716,1718,O
map,1719,1722,O
QTL,1723,1726,O
affecting,1727,1736,O
shape,1737,1742,O
based,1743,1748,O
on,1749,1751,O
digital,1752,1759,O
photos,1760,1766,O
[,1767,1768,O
31,1768,1770,O
",",1770,1771,O
32,1771,1773,O
],1773,1774,O
",",1774,1775,O
rather,1776,1782,O
than,1783,1787,O
the,1788,1791,O
qualitative,1792,1803,O
scale,1804,1809,O
used,1810,1814,O
in,1815,1817,O
the,1818,1821,O
present,1822,1829,O
study,1830,1835,O
.,1835,1836,O
The,1837,1840,O
identification,1841,1855,O
of,1856,1858,O
QTL,1859,1862,O
in,1863,1865,O
this,1866,1870,O
study,1871,1876,O
is,1877,1879,O
a,1880,1881,O
first,1882,1887,O
step,1888,1892,O
in,1893,1895,O
understanding,1896,1909,O
the,1910,1913,O
genetics,1914,1922,O
of,1923,1925,O
this,1926,1930,O
type,1931,1935,O
of,1936,1938,O
deformity,1939,1948,O
and,1949,1952,O
will,1953,1957,O
lead,1958,1962,O
to,1963,1965,O
the,1966,1969,O
identification,1970,1984,O
of,1985,1987,O
biological,1988,1998,O
pathways,1999,2007,O
associated,2008,2018,O
with,2019,2023,O
spinal,2024,2030,B-Organism_subdivision
integrity,2031,2040,O
.,2040,2041,O
Intact,0,6,O
mass,7,11,O
analysis,12,20,O
of,21,23,O
a,24,25,O
mixed,26,31,O
population,32,42,O
of,43,45,O
proteins,46,54,O
.,54,55,O
A,56,57,O
mixture,58,65,O
of,66,68,O
the,69,72,O
membrane,73,81,B-Cellular_component
protein,82,89,O
KCNJ12,90,96,O
",",96,97,O
the,98,101,O
soluble,102,109,O
TEV,110,113,O
protease,114,122,O
used,123,127,O
to,128,130,O
cleave,131,137,O
the,138,141,O
fusion,142,148,O
tag,149,152,O
",",152,153,O
and,154,157,O
the,158,161,O
membrane,162,170,B-Cellular_component
protein,171,178,O
HVCN1,179,184,O
",",184,185,O
which,186,191,O
occurred,192,200,O
as,201,203,O
a,204,205,O
contaminant,206,217,O
from,218,222,O
an,223,225,O
earlier,226,233,O
analysis,234,242,O
on,243,245,O
the,246,249,O
same,250,254,O
LC,255,257,O
column,258,264,O
.,264,265,O
The,0,3,O
asymmetric,4,14,O
unit,15,19,O
of,20,22,O
the,23,26,O
title,27,32,O
compound,33,41,O
with,42,46,O
the,47,50,O
atomic,51,57,O
labelling,58,67,O
scheme,68,74,O
.,74,75,O
Displacement,75,87,O
are,88,91,O
drawn,92,97,O
at,98,100,O
the,101,104,O
50,105,107,O
%,107,108,O
probability,109,120,O
level,121,126,O
.,126,127,O
H,128,129,O
atoms,130,135,O
are,136,139,O
represented,140,151,O
as,152,154,O
small,155,160,O
spheres,161,168,O
of,169,171,O
arbitrary,172,181,O
radii,182,187,O
.,187,188,O
Hydrogen,189,197,O
bonds,198,203,O
are,204,207,O
shown,208,213,O
as,214,216,O
dashed,217,223,O
lines,224,229,O
.,229,230,O
Modified,0,8,O
radiology,9,18,O
-,18,19,O
guided,19,25,O
percutaneous,26,38,O
gastrostomy,39,50,O
technique,51,60,O
.,60,61,O
A,62,63,O
.,63,64,O
21G,65,68,O
fine,69,73,O
needle,74,80,O
punctured,81,90,O
localized,91,100,O
collection,101,111,O
of,112,114,O
air,115,118,O
",",118,119,O
which,120,125,O
was,126,129,O
visible,130,137,O
in,138,140,O
collapsed,141,150,O
stomach,151,158,B-Organ
under,159,164,O
fluoroscopy,165,176,O
-,176,177,O
guided,177,183,O
gastrostomy,184,195,O
.,195,196,O
Needle,197,203,O
tip,204,207,O
is,208,210,O
then,211,215,O
gradually,216,225,O
withdrawn,226,235,O
while,236,241,O
injecting,242,251,O
small,252,257,O
amounts,258,265,O
of,266,268,O
water,269,274,O
-,274,275,O
soluble,275,282,O
contrast,283,291,O
medium,292,298,O
.,298,299,O
Location,300,308,O
of,309,311,O
stomach,312,319,B-Organ
is,320,322,O
confirmed,323,332,O
by,333,335,O
visualization,336,349,O
of,350,352,O
opacified,353,362,O
gastric,363,370,B-Organ
rugae,371,376,O
.,376,377,O
B,378,379,O
.,379,380,O
Stomach,381,388,B-Organ
was,389,392,O
inflated,393,401,O
with,402,406,O
approximately,407,420,O
600,421,424,O
-,424,425,O
800,425,428,O
mL,429,431,O
of,432,434,O
room,435,439,O
air,440,443,O
through,444,451,O
21G,452,455,O
fine,456,460,O
needle,461,467,O
.,467,468,O
C,469,470,O
.,470,471,O
100,472,475,O
-,475,476,O
cm,476,478,O
stainless,479,488,O
steel,489,494,O
guide,495,500,O
wire,501,505,O
is,506,508,O
inserted,509,517,O
through,518,525,O
needle,526,532,O
",",532,533,O
and,534,537,O
gastro,538,544,B-Organ
-,544,545,O
percutaneous,545,557,O
tract,558,563,O
is,564,566,O
gradually,567,576,O
dilated,577,584,O
.,584,585,O
D,586,587,O
.,587,588,O
Insertion,589,598,O
of,599,601,O
14,602,604,O
-,604,605,O
Fr,605,607,O
pigtail,608,615,O
gastrostomy,616,627,O
catheter,628,636,O
and,637,640,O
injection,641,650,O
of,651,653,O
small,654,659,O
amount,660,666,O
of,667,669,O
water,670,675,O
-,675,676,O
soluble,676,683,O
contrast,684,692,O
medium,693,699,O
via,700,703,O
pigtail,704,711,O
catheter,712,720,O
confirmed,721,730,O
that,731,735,O
gastrostomy,736,747,O
catheter,748,756,O
is,757,759,O
correctly,760,769,O
placed,770,776,O
within,777,783,O
stomach,784,791,B-Organ
.,791,792,O
Loss,0,4,O
of,5,7,O
body,8,12,B-Organism_subdivision
weight,13,19,O
after,20,25,O
challenge,26,35,O
-,35,36,O
infection,36,45,O
with,46,50,O
WNV,51,54,O
.,54,55,O
Mice,56,60,O
(,61,62,O
n,62,63,O
=,64,65,O
8,66,67,O
),67,68,O
were,69,73,O
vaccinated,74,84,O
intranasally,85,97,B-Immaterial_anatomical_entity
with,98,102,O
Flu,103,106,O
-,106,107,O
NA,107,109,O
-,109,110,O
DIII,110,114,O
(,115,116,O
*,116,117,O
),117,118,O
or,119,121,O
Flu,122,125,O
-,125,126,O
NA,126,128,O
-,128,129,O
GFP,129,132,O
(,133,134,O
o,134,135,O
),135,136,O
or,137,139,O
by,140,142,O
the,143,146,O
subcutaneous,147,159,O
route,160,165,O
(,166,167,O
^,167,168,O
and,169,172,O
^,173,174,O
",",174,175,O
respectively,176,188,O
),188,189,O
.,189,190,O
The,191,194,O
daily,195,200,O
weights,201,208,O
of,209,211,O
each,212,216,O
animal,217,223,O
were,224,228,O
calculated,229,239,O
compared,240,248,O
to,249,251,O
their,252,257,O
respective,258,268,O
weight,269,275,O
on,276,278,O
the,279,282,O
day,283,286,O
of,287,289,O
challenge,290,299,O
",",299,300,O
and,301,304,O
data,305,309,O
are,310,313,O
shown,314,319,O
as,320,322,O
the,323,326,O
average,327,334,O
percentage,335,345,O
of,346,348,O
initial,349,356,O
weight,357,363,O
for,364,367,O
each,368,372,O
group,373,378,O
.,378,379,O
Error,380,385,O
bars,386,390,O
represent,391,400,O
the,401,404,O
standard,405,413,O
error,414,419,O
for,420,423,O
all,424,427,O
samples,428,435,O
available,436,445,O
at,446,448,O
that,449,453,O
time,454,458,O
point,459,464,O
.,464,465,O
Subsequently,466,478,O
",",478,479,O
the,480,483,O
mice,484,488,O
were,489,493,O
challenged,494,504,O
subcutaneously,505,519,O
with,520,524,O
106,525,528,O
TCID50,529,535,O
WNV,536,539,O
-,539,540,O
NY99,540,544,O
and,545,548,O
weighed,549,556,O
daily,557,562,O
.,562,563,O
The,564,567,O
mean,568,572,O
body,573,577,B-Organism_subdivision
weight,578,584,O
is,585,587,O
expressed,588,597,O
as,598,600,O
the,601,604,O
percentage,605,615,O
of,616,618,O
the,619,622,O
body,623,627,B-Organism_subdivision
weight,628,634,O
before,635,641,O
challenge,642,651,O
infection,652,661,O
(,662,663,O
A,663,664,O
),664,665,O
.,665,666,O
The,667,670,O
survival,671,679,O
rates,680,685,O
of,686,688,O
mice,689,693,O
after,694,699,O
challenge,700,709,O
infection,710,719,O
with,720,724,O
WNV,725,728,O
-,728,729,O
NY99,729,733,O
are,734,737,O
depicted,738,746,O
as,747,749,O
Kaplan,750,756,O
-,756,757,O
Meier,757,762,O
survival,763,771,O
curves,772,778,O
(,779,780,O
B,780,781,O
),781,782,O
.,782,783,O
The,784,787,O
difference,788,798,O
in,799,801,O
survival,802,810,O
rate,811,815,O
between,816,823,O
Flu,824,827,O
-,827,828,O
NA,828,830,O
-,830,831,O
DIII,831,835,O
and,836,839,O
Flu,840,843,O
-,843,844,O
NA,844,846,O
-,846,847,O
GFP,847,850,O
vaccinated,851,861,O
mice,862,866,O
was,867,870,O
statistically,871,884,O
significant,885,896,O
as,897,899,O
determined,900,910,O
by,911,913,O
the,914,917,O
logrank,918,925,O
test,926,930,O
.,930,931,O
The,932,935,O
symbols,936,943,O
for,944,947,O
the,948,951,O
respective,952,962,O
groups,963,969,O
are,970,973,O
the,974,977,O
same,978,982,O
as,983,985,O
in,986,988,O
panel,989,994,O
A,995,996,O
.,996,997,O
Representative,0,14,O
time,15,19,O
histories,20,29,O
of,30,32,O
the,33,36,O
estimated,37,46,O
SatO2,47,52,O
levels,53,59,O
of,60,62,O
normal,63,69,O
cortex,70,76,B-Multi-tissue_structure
(,77,78,O
black,78,83,O
),83,84,O
and,85,88,O
tumor,89,94,B-Pathological_formation
(,95,96,O
grey,96,100,O
),100,101,O
from,102,106,O
all,107,110,O
six,111,114,O
patients,115,123,O
.,123,124,O
Etymology,0,9,O
.,9,10,O
Professor,11,20,O
Stephen,21,28,O
Lane,29,33,O
Wood,34,38,O
worked,39,45,O
extensively,46,57,O
on,58,60,O
collections,61,72,O
of,73,75,O
Scolytinae,76,86,O
preserved,87,96,O
in,97,99,O
Indian,100,106,O
museums,107,114,O
",",114,115,O
and,116,119,O
described,120,129,O
a,130,131,O
number,132,138,O
of,139,141,O
new,142,145,O
Scolytinae,146,156,O
species,157,164,O
from,165,169,O
India,170,175,O
.,175,176,O
In,177,179,O
this,180,184,O
paper,185,190,O
we,191,193,O
describe,194,202,O
one,203,206,O
more,207,211,O
new,212,215,O
bark,216,220,O
-,220,221,O
beetle,221,227,O
species,228,235,O
from,236,240,O
India,241,246,O
kept,247,251,O
in,252,254,O
the,255,258,O
Natural,259,266,O
History,267,274,O
Museum,275,281,O
in,282,284,O
Vienna,285,291,O
(,292,293,O
NHMW,293,297,O
),297,298,O
and,299,302,O
dedicate,303,311,O
this,312,316,O
species,317,324,O
to,325,327,O
the,328,331,O
late,332,336,O
Professor,337,346,O
Stephen,347,354,O
Lane,355,359,O
Wood,360,364,O
.,364,365,O
Statistics,0,10,O
The,11,14,O
survival,15,23,O
of,24,26,O
mice,27,31,O
was,32,35,O
analyzed,36,44,O
using,45,50,O
Kaplan,51,57,O
-,57,58,O
Meier,58,63,O
survival,64,72,O
analysis,73,81,O
.,81,82,O
All,83,86,O
other,87,92,O
data,93,97,O
were,98,102,O
analyzed,103,111,O
by,112,114,O
one,115,118,O
-,118,119,O
way,119,122,O
ANOVA,123,128,O
",",128,129,O
followed,130,138,O
by,139,141,O
the,142,145,O
Student,146,153,O
-,153,154,O
Newman,154,160,O
-,160,161,O
Keuls,161,166,O
test,167,171,O
for,172,175,O
all,176,179,O
pairwise,180,188,O
comparisons,189,200,O
.,200,201,O
Prior,202,207,O
to,208,210,O
ANOVA,211,216,O
",",216,217,O
Levene,218,224,O
',224,225,O
s,225,226,O
Test,227,231,O
for,232,235,O
Equality,236,244,O
of,245,247,O
Variances,248,257,O
was,258,261,O
performed,262,271,O
.,271,272,O
All,273,276,O
statistical,277,288,O
analyses,289,297,O
were,298,302,O
performed,303,312,O
using,313,318,O
MedCalc,319,326,O
software,327,335,O
",",335,336,O
version,337,344,O
11,345,347,O
.,347,348,O
2,348,349,O
.,349,350,O
1,350,351,O
.,351,352,O
0,352,353,O
.,353,354,O
Acknowledgements,0,16,O
The,17,20,O
authors,21,28,O
gratefully,29,39,O
acknowledge,40,51,O
the,52,55,O
support,56,63,O
of,64,66,O
DRUID,67,72,O
study,73,78,O
participants,79,91,O
",",91,92,O
study,93,98,O
staff,99,104,O
",",104,105,O
members,106,113,O
of,114,116,O
the,117,120,O
Indigenous,121,131,O
Steering,132,140,O
Group,141,146,O
",",146,147,O
and,148,151,O
partner,152,159,O
organisations,160,173,O
.,173,174,O
The,175,178,O
DRUID,179,184,O
Study,185,190,O
was,191,194,O
funded,195,201,O
by,202,204,O
the,205,208,O
National,209,217,O
Health,218,224,O
and,225,228,O
Medical,229,236,O
Research,237,245,O
Council,246,253,O
(,254,255,O
NHMRC,255,260,O
Project,261,268,O
Grant,269,274,O
#,275,276,O
236207,276,282,O
),282,283,O
",",283,284,O
with,285,289,O
additional,290,300,O
support,301,308,O
from,309,313,O
the,314,317,O
Australian,318,328,O
Government,329,339,O
Department,340,350,O
of,351,353,O
Employment,354,364,O
and,365,368,O
Workplace,369,378,O
Relations,379,388,O
",",388,389,O
the,390,393,O
Clive,394,399,O
and,400,403,O
Vera,404,408,O
Ramaciotti,409,419,O
Foundation,420,430,O
",",430,431,O
the,432,435,O
Vincent,436,443,O
Fairfax,444,451,O
Family,452,458,O
Foundation,459,469,O
",",469,470,O
the,471,474,O
International,475,488,O
Diabetes,489,497,O
Institute,498,507,O
(,508,509,O
AusDiab,509,516,O
Partnership,517,528,O
),528,529,O
",",529,530,O
and,531,534,O
Bayer,535,540,O
HealthCare,541,551,O
.,551,552,O
The,553,556,O
DRUID,557,562,O
Study,563,568,O
is,569,571,O
an,572,574,O
in,575,577,O
-,577,578,O
kind,578,582,O
project,583,590,O
of,591,593,O
the,594,597,O
Cooperative,598,609,O
Research,610,618,O
Centre,619,625,O
for,626,629,O
Aboriginal,630,640,O
Health,641,647,O
.,647,648,O
LMB,649,652,O
had,653,656,O
a,657,658,O
NHMRC,659,664,O
Scholarship,665,676,O
2003,677,681,O
-,681,682,O
5,682,683,O
and,684,687,O
is,688,690,O
supported,691,700,O
by,701,703,O
NHMRC,704,709,O
Training,710,718,O
Fellowship,719,729,O
(,730,731,O
#,731,732,O
605837,732,738,O
),738,739,O
",",739,740,O
NHMRC,741,746,O
#,747,748,O
320860,748,754,O
and,755,758,O
the,759,762,O
Centre,763,769,O
of,770,772,O
Clinical,773,781,O
Research,782,790,O
Excellence,791,801,O
in,802,804,O
Clinical,805,813,O
Science,814,821,O
in,822,824,O
Diabetes,825,833,O
",",833,834,O
University,835,845,O
of,846,848,O
Melbourne,849,858,O
.,858,859,O
JC,860,862,O
was,863,866,O
supported,867,876,O
by,877,879,O
a,880,881,O
NHMRC,882,887,O
Career,888,894,O
Development,895,906,O
Award,907,912,O
(,913,914,O
#,914,915,O
283310,915,921,O
),921,922,O
and,923,926,O
a,927,928,O
NHMRC,929,934,O
Research,935,943,O
Fellowship,944,954,O
(,955,956,O
#,956,957,O
545200,957,963,O
),963,964,O
.,964,965,O
AH,966,968,O
is,969,971,O
supported,972,981,O
by,982,984,O
NHMRC,985,990,O
Fellowship,991,1001,O
(,1002,1003,O
#,1003,1004,O
520316,1004,1010,O
),1010,1011,O
.,1011,1012,O
Thank,1013,1018,O
you,1019,1022,O
to,1023,1025,O
Dr,1026,1028,O
Jaquelyne,1029,1038,O
Hughes,1039,1045,O
for,1046,1049,O
comments,1050,1058,O
on,1059,1061,O
the,1062,1065,O
manuscript,1066,1076,O
.,1076,1077,O
Funding,1078,1085,O
sources,1086,1093,O
played,1094,1100,O
no,1101,1103,O
role,1104,1108,O
in,1109,1111,O
the,1112,1115,O
study,1116,1121,O
design,1122,1128,O
",",1128,1129,O
in,1130,1132,O
the,1133,1136,O
collection,1137,1147,O
",",1147,1148,O
analysis,1149,1157,O
and,1158,1161,O
interpretation,1162,1176,O
of,1177,1179,O
the,1180,1183,O
data,1184,1188,O
",",1188,1189,O
in,1190,1192,O
the,1193,1196,O
writing,1197,1204,O
of,1205,1207,O
the,1208,1211,O
manuscript,1212,1222,O
",",1222,1223,O
or,1224,1226,O
in,1227,1229,O
the,1230,1233,O
decision,1234,1242,O
to,1243,1245,O
submit,1246,1252,O
the,1253,1256,O
manuscript,1257,1267,O
for,1268,1271,O
publication,1272,1283,O
.,1283,1284,O
Concurrent,0,10,O
disease,11,18,O
in,19,21,O
33,22,24,O
cows,25,29,O
with,30,34,O
LDA,35,38,O
.,38,39,O
Parkin,0,6,O
regulates,7,16,O
the,17,20,O
proteasomal,21,32,B-Cellular_component
degradation,33,44,O
of,45,47,O
PARIS,48,53,O
and,54,57,O
PGC,58,61,O
-,61,62,O
1alpha,62,68,O
-,68,69,O
dependent,69,78,O
mitochondrial,79,92,B-Cellular_component
biogenesis,93,103,O
.,103,104,O
(,105,106,O
A,106,107,O
),107,108,O
Normal,109,115,O
physiological,116,129,O
conditions,130,140,O
that,141,145,O
maintain,146,154,O
mitochondrial,155,168,B-Cellular_component
homeostasis,169,180,O
:,180,181,O
PINK1,182,187,O
recruits,188,196,O
parkin,197,203,O
to,204,206,O
the,207,210,O
mitochondria,211,223,B-Cellular_component
",",223,224,O
where,225,230,O
these,231,236,O
two,237,240,O
proteins,241,249,O
interact,250,258,O
to,259,261,O
eliminate,262,271,O
abnormal,272,280,O
mitochondria,281,293,B-Cellular_component
through,294,301,O
mitophagy,302,311,O
.,311,312,O
Alterations,313,324,O
in,325,327,O
mitochondrial,328,341,B-Cellular_component
membrane,342,350,I-Cellular_component
potential,351,360,O
(,361,362,O
DeltaPsim,362,371,O
;,371,372,O
a,373,374,O
key,375,378,O
indicator,379,388,O
of,389,391,O
mitochondrial,392,405,B-Cellular_component
physiology,406,416,O
and,417,420,O
cell,421,425,B-Cell
viability,426,435,O
),435,436,O
initiate,437,445,O
the,446,449,O
PINK1,450,455,O
-,455,456,O
parkin,456,462,O
cascade,463,470,O
of,471,473,O
events,474,480,O
that,481,485,O
lead,486,490,O
to,491,493,O
mitophagy,494,503,O
.,503,504,O
Furthermore,505,516,O
",",516,517,O
parkin,518,524,O
ubiquitylates,525,538,O
and,539,542,O
thereby,543,550,O
promotes,551,559,O
proteasomal,560,571,B-Cellular_component
degradation,572,583,O
of,584,586,O
PARIS,587,592,O
.,592,593,O
Because,594,601,O
PARIS,602,607,O
represses,608,617,O
the,618,621,O
expression,622,632,O
of,633,635,O
PGC,636,639,O
-,639,640,O
1alpha,640,646,O
",",646,647,O
degradation,648,659,O
of,660,662,O
PARIS,663,668,O
by,669,671,O
parkin,672,678,O
allows,679,685,O
PGC,686,689,O
-,689,690,O
1alpha,690,696,O
-,696,697,O
dependent,697,706,O
gene,707,711,O
expression,712,722,O
and,723,726,O
enables,727,734,O
mitochondrial,735,748,B-Cellular_component
biogenesis,749,759,O
.,759,760,O
Parkin,761,767,O
seems,768,773,O
to,774,776,O
be,777,779,O
an,780,782,O
integral,783,791,O
regulator,792,801,O
of,802,804,O
mitochondrial,805,818,B-Cellular_component
homeostasis,819,830,O
",",830,831,O
controlling,832,843,O
both,844,848,O
degradation,849,860,O
and,861,864,O
biogenesis,865,875,O
.,875,876,O
(,877,878,O
B,878,879,O
),879,880,O
Loss,881,885,O
of,886,888,O
parkin,889,895,O
function,896,904,O
as,905,907,O
a,908,909,O
result,910,916,O
of,917,919,O
familial,920,928,O
mutations,929,938,O
(,939,940,O
in,940,942,O
the,943,946,O
case,947,951,O
of,952,954,O
AR,955,957,O
-,957,958,O
PD,958,960,O
),960,961,O
or,962,964,O
aging,965,970,O
",",970,971,O
environmental,972,985,O
or,986,988,O
cellular,989,997,B-Cell
stress,998,1004,O
(,1005,1006,O
in,1006,1008,O
the,1009,1012,O
case,1013,1017,O
of,1018,1020,O
sporadic,1021,1029,O
PD,1030,1032,O
),1032,1033,O
leads,1034,1039,O
to,1040,1042,O
the,1043,1046,O
accumulation,1047,1059,O
of,1060,1062,O
abnormal,1063,1071,O
mitochondria,1072,1084,B-Cellular_component
",",1084,1085,O
owing,1086,1091,O
to,1092,1094,O
faulty,1095,1101,O
mitophagy,1102,1111,O
.,1111,1112,O
In,1113,1115,O
addition,1116,1124,O
",",1124,1125,O
PARIS,1126,1131,O
accumulates,1132,1143,O
and,1144,1147,O
represses,1148,1157,O
PGC,1158,1161,O
-,1161,1162,O
1alpha,1162,1168,O
",",1168,1169,O
preventing,1170,1180,O
mitochondrial,1181,1194,B-Cellular_component
biogenesis,1195,1205,O
.,1205,1206,O
Loss,1207,1211,O
of,1212,1214,O
parkin,1215,1221,O
function,1222,1230,O
does,1231,1235,O
not,1236,1239,O
tip,1240,1243,O
the,1244,1247,O
balance,1248,1255,O
between,1256,1263,O
mitochondrial,1264,1277,B-Cellular_component
biogenesis,1278,1288,O
and,1289,1292,O
degradation,1293,1304,O
to,1305,1307,O
either,1308,1314,O
side,1315,1319,O
",",1319,1320,O
but,1321,1324,O
leads,1325,1330,O
to,1331,1333,O
a,1334,1335,O
general,1336,1343,O
breakdown,1344,1353,O
of,1354,1356,O
mitochondrial,1357,1370,B-Cellular_component
homeostasis,1371,1382,O
that,1383,1387,O
can,1388,1391,O
ultimately,1392,1402,O
lead,1403,1407,O
to,1408,1410,O
PD,1411,1413,O
.,1413,1414,O
4,0,1,O
.,1,2,O
2,2,3,O
.,3,4,O
Histological,5,17,O
Findings,18,26,O
Microscopy,27,37,O
revealed,38,46,O
features,47,55,O
of,56,58,O
a,59,60,O
diffusely,61,70,O
growing,71,78,O
discohesive,79,90,B-Pathological_formation
carcinoma,91,100,I-Pathological_formation
",",100,101,O
exclusively,102,113,O
growing,114,121,O
in,122,124,O
the,125,128,O
alveolar,129,137,B-Multi-tissue_structure
interstitium,138,150,I-Multi-tissue_structure
",",150,151,O
thus,152,156,O
expanding,157,166,O
it,167,169,O
",",169,170,O
while,171,176,O
leaving,177,184,O
the,185,188,O
original,189,197,O
alveolar,198,206,B-Multi-tissue_structure
architecture,207,219,O
intact,220,226,O
(,227,228,O
Figure,228,234,O
2,235,236,O
),236,237,O
.,237,238,O
There,239,244,O
was,245,248,O
local,249,254,O
ulceration,255,265,O
of,266,268,O
the,269,272,O
pleura,273,279,B-Multi-tissue_structure
",",279,280,O
while,281,286,O
",",286,287,O
beyond,288,294,O
this,295,299,O
ulcer,300,305,B-Pathological_formation
",",305,306,O
the,307,310,O
tumor,311,316,B-Pathological_formation
formed,317,323,O
a,324,325,O
thick,326,331,O
cake,332,336,O
of,337,339,O
discohesive,340,351,B-Cell
tumor,352,357,I-Cell
cells,358,363,I-Cell
lining,364,370,O
the,371,374,O
pleural,375,382,B-Multi-tissue_structure
membrane,383,391,I-Multi-tissue_structure
(,392,393,O
Figure,393,399,O
2,400,401,O
(,401,402,O
c,402,403,O
),403,404,O
),404,405,O
",",405,406,O
with,407,411,O
only,412,416,O
focal,417,422,O
",",422,423,O
microscopic,424,435,O
invasion,436,444,O
into,445,449,O
the,450,453,O
fatty,454,459,B-Tissue
tissue,460,466,I-Tissue
of,467,469,O
the,470,473,O
parietal,474,482,B-Multi-tissue_structure
pleura,483,489,I-Multi-tissue_structure
.,489,490,O
The,491,494,O
tumor,495,500,B-Pathological_formation
consisted,501,510,O
of,511,513,O
atypical,514,522,O
",",522,523,O
moderately,524,534,O
polymorphous,535,547,O
",",547,548,O
and,549,552,O
irregularly,553,564,O
shaped,565,571,O
tumor,572,577,B-Cell
cells,578,583,I-Cell
with,584,588,O
marked,589,595,O
discohesiveness,596,611,O
.,611,612,O
They,613,617,O
featured,618,626,O
scant,627,632,O
eosinophilic,633,645,B-Organism_substance
cytoplasm,646,655,I-Organism_substance
and,656,659,O
irregularly,660,671,O
contoured,672,681,O
and,682,685,O
hyperchromatic,686,700,O
nuclei,701,707,B-Cellular_component
",",707,708,O
often,709,714,O
containing,715,725,O
one,726,729,O
or,730,732,O
more,733,737,O
prominent,738,747,O
nucleoli,748,756,B-Cellular_component
(,757,758,O
Figure,758,764,O
2,765,766,O
(,766,767,O
b,767,768,O
),768,769,O
),769,770,O
.,770,771,O
There,772,777,O
were,778,782,O
many,783,787,O
mitoses,788,795,O
and,796,799,O
apoptoses,800,809,O
present,810,817,O
",",817,818,O
but,819,822,O
necrosis,823,831,O
was,832,835,O
not,836,839,O
observed,840,848,O
.,848,849,O
No,850,852,O
squamous,853,861,B-Cell
or,862,864,O
glandular,865,874,B-Cell
differentiation,875,890,O
was,891,894,O
observed,895,903,O
",",903,904,O
and,905,908,O
mucin,909,914,O
stains,915,921,O
(,922,923,O
PAS,923,926,O
-,926,927,O
D,927,928,O
and,929,932,O
alcian,933,939,O
blue,940,944,O
),944,945,O
were,946,950,O
negative,951,959,O
.,959,960,O
Within,961,967,O
the,968,971,O
tumor,972,977,B-Pathological_formation
",",977,978,O
there,979,984,O
were,985,989,O
multiple,990,998,O
small,999,1004,O
blood,1005,1010,B-Organism_substance
-,1010,1011,O
filled,1011,1017,O
clefts,1018,1024,O
and,1025,1028,O
blood,1029,1034,B-Organism_substance
lakes,1035,1040,O
.,1040,1041,O
Angioinvasion,1042,1055,O
in,1056,1058,O
medium,1059,1065,O
-,1065,1066,O
sized,1066,1071,O
vessels,1072,1079,B-Multi-tissue_structure
",",1079,1080,O
including,1081,1090,O
an,1091,1093,O
artery,1094,1100,B-Multi-tissue_structure
",",1100,1101,O
was,1102,1105,O
demonstrated,1106,1118,O
(,1119,1120,O
Figure,1120,1126,O
2,1127,1128,O
(,1128,1129,O
d,1129,1130,O
),1130,1131,O
),1131,1132,O
.,1132,1133,O
Of,1134,1136,O
note,1137,1141,O
",",1141,1142,O
the,1143,1146,O
broadened,1147,1156,O
alveolar,1157,1165,B-Multi-tissue_structure
septa,1166,1171,I-Multi-tissue_structure
were,1172,1176,O
lined,1177,1182,O
by,1183,1185,O
markedly,1186,1194,O
atypical,1195,1203,O
epithelial,1204,1214,B-Cell
cells,1215,1220,I-Cell
",",1220,1221,O
yet,1222,1225,O
less,1226,1230,O
atypical,1231,1239,O
than,1240,1244,O
the,1245,1248,O
interstitial,1249,1261,B-Pathological_formation
carcinoma,1262,1271,I-Pathological_formation
(,1272,1273,O
Figures,1273,1280,O
2,1281,1282,O
(,1282,1283,O
a,1283,1284,O
),1284,1285,O
and,1286,1289,O
2,1290,1291,O
(,1291,1292,O
b,1292,1293,O
),1293,1294,O
),1294,1295,O
.,1295,1296,O
The,1297,1300,O
atypia,1301,1307,O
of,1308,1310,O
the,1311,1314,O
lining,1315,1321,B-Cell
cells,1322,1327,I-Cell
extended,1328,1336,O
beyond,1337,1343,O
the,1344,1347,O
tumor,1348,1353,B-Pathological_formation
front,1354,1359,O
",",1359,1360,O
showing,1361,1368,O
a,1369,1370,O
sharp,1371,1376,O
demarcation,1377,1388,O
with,1389,1393,O
normal,1394,1400,O
type,1401,1405,B-Cell
I,1406,1407,I-Cell
pneumocytes,1408,1419,I-Cell
(,1420,1421,O
Figure,1421,1427,O
2,1428,1429,O
(,1429,1430,O
a,1430,1431,O
),1431,1432,O
),1432,1433,O
",",1433,1434,O
a,1435,1436,O
feature,1437,1444,O
characteristic,1445,1459,O
to,1460,1462,O
nonmucinous,1463,1474,B-Pathological_formation
adenocarcinoma,1475,1489,I-Pathological_formation
in,1490,1492,O
situ,1493,1497,O
with,1498,1502,O
lepidic,1503,1510,O
growth,1511,1517,O
pattern,1518,1525,O
(,1526,1527,O
former,1527,1533,O
bronchioloalveolar,1534,1552,B-Pathological_formation
carcinoma,1553,1562,I-Pathological_formation
",",1562,1563,O
BAC,1564,1567,B-Pathological_formation
),1567,1568,O
[,1569,1570,O
3,1570,1571,O
],1571,1572,O
.,1572,1573,O
Paederus,0,8,O
dermatitis,9,19,O
involving,20,29,O
the,30,33,O
neck,34,38,B-Organism_subdivision
Introduction,0,12,O
During,13,19,O
the,20,23,O
weaning,24,31,O
period,32,38,O
and,39,42,O
transition,43,53,O
to,54,56,O
solid,57,62,O
foods,63,68,O
in,69,71,O
the,72,75,O
first,76,81,O
year,82,86,O
of,87,89,O
life,90,94,O
",",94,95,O
infants,96,103,O
take,104,108,O
a,109,110,O
critical,111,119,O
step,120,124,O
in,125,127,O
their,128,133,O
eating,134,140,O
behavior,141,149,O
and,150,153,O
need,154,158,O
to,159,161,O
meet,162,166,O
high,167,171,O
nutrient,172,180,O
requirements,181,193,O
[,194,195,O
1,195,196,O
",",196,197,O
2,198,199,O
],199,200,O
.,200,201,O
They,202,206,O
are,207,210,O
exposed,211,218,O
to,219,221,O
new,222,225,O
foods,226,231,O
and,232,235,O
food,236,240,O
combinations,241,253,O
",",253,254,O
which,255,260,O
should,261,267,O
ensure,268,274,O
a,275,276,O
smooth,277,283,O
transition,284,294,O
to,295,297,O
the,298,301,O
family,302,308,O
diet,309,313,O
later,314,319,O
in,320,322,O
life,323,327,O
.,327,328,O
At,329,331,O
this,332,336,O
stage,337,342,O
",",342,343,O
either,344,350,O
homemade,351,359,O
or,360,362,O
commercially,363,375,O
prepared,376,384,O
foods,385,390,O
may,391,394,O
be,395,397,O
fed,398,401,O
.,401,402,O
It,403,405,O
is,406,408,O
worth,409,414,O
noting,415,421,O
that,422,426,O
in,427,429,O
prosperous,430,440,O
countries,441,450,O
the,451,454,O
modern,455,461,O
diet,462,466,O
differs,467,474,O
considerably,475,487,O
from,488,492,O
that,493,497,O
of,498,500,O
previous,501,509,O
generations,510,521,O
",",521,522,O
now,523,526,O
dominated,527,536,O
by,537,539,O
products,540,548,O
that,549,553,O
have,554,558,O
been,559,563,O
processed,564,573,O
",",573,574,O
stored,575,581,O
",",581,582,O
and,583,586,O
transported,587,598,O
over,599,603,O
great,604,609,O
distances,610,619,O
.,619,620,O
Traditional,621,632,O
",",632,633,O
cold,634,638,O
-,638,639,O
pressed,639,646,O
vegetable,647,656,B-Organism_substance
oils,657,661,I-Organism_substance
of,662,664,O
the,665,668,O
highest,669,676,O
nutritional,677,688,O
quality,689,696,O
",",696,697,O
e,698,699,O
.,699,700,O
g,700,701,O
.,701,702,O
extra,703,708,O
virgin,709,715,O
olive,716,721,O
oil,722,725,B-Organism_substance
",",725,726,O
may,727,730,O
therefore,731,740,O
constitute,741,751,O
an,752,754,O
important,755,764,O
part,765,769,O
of,770,772,O
the,773,776,O
modern,777,783,O
diet,784,788,O
[,789,790,O
3,790,791,O
",",791,792,O
4,793,794,O
],794,795,O
.,795,796,O
In,797,799,O
Poland,800,806,O
",",806,807,O
many,808,812,O
infants,813,820,O
do,821,823,O
not,824,827,O
receive,828,835,O
any,836,839,O
traditional,840,851,O
homemade,852,860,O
foods,861,866,O
and,867,870,O
even,871,875,O
fruits,876,882,B-Organism_subdivision
come,883,887,O
from,888,892,O
purchased,893,902,O
jars,903,907,O
.,907,908,O
Commercial,909,919,O
baby,920,924,O
foods,925,930,O
are,931,934,O
regarded,935,943,O
by,944,946,O
some,947,951,O
parents,952,959,O
and,960,963,O
medical,964,971,O
professionals,972,985,O
to,986,988,O
be,989,991,O
more,992,996,O
appropriate,997,1008,O
for,1009,1012,O
several,1013,1020,O
reasons,1021,1028,O
:,1028,1029,O
they,1030,1034,O
undergo,1035,1042,O
intense,1043,1050,O
screening,1051,1060,O
for,1061,1064,O
contaminants,1065,1077,O
in,1078,1080,O
comparison,1081,1091,O
to,1092,1094,O
foods,1095,1100,O
sold,1101,1105,O
for,1106,1109,O
the,1110,1113,O
general,1114,1121,O
population,1122,1132,O
",",1132,1133,O
contain,1134,1141,O
no,1142,1144,O
additives,1145,1154,O
of,1155,1157,O
certain,1158,1165,O
types,1166,1171,O
",",1171,1172,O
and,1173,1176,O
are,1177,1180,O
thought,1181,1188,O
to,1189,1191,O
be,1192,1194,O
designed,1195,1203,O
to,1204,1206,O
help,1207,1211,O
infants,1212,1219,O
meet,1220,1224,O
nutrient,1225,1233,O
requirements,1234,1246,O
[,1247,1248,O
5,1248,1249,O
],1249,1250,O
.,1250,1251,O
The,1252,1255,O
process,1256,1263,O
of,1264,1266,O
peeling,1267,1274,O
",",1274,1275,O
however,1276,1283,O
",",1283,1284,O
was,1285,1288,O
identified,1289,1299,O
as,1300,1302,O
the,1303,1306,O
most,1307,1311,O
effective,1312,1321,O
",",1321,1322,O
and,1323,1326,O
simple,1327,1333,O
",",1333,1334,O
procedure,1335,1344,O
in,1345,1347,O
reducing,1348,1356,O
residues,1357,1365,O
",",1365,1366,O
e,1367,1368,O
.,1368,1369,O
g,1369,1370,O
.,1370,1371,O
pesticides,1372,1382,O
",",1382,1383,O
in,1384,1386,O
fruits,1387,1393,B-Organism_subdivision
and,1394,1397,O
vegetables,1398,1408,B-Organism_subdivision
[,1409,1410,O
6,1410,1411,O
],1411,1412,O
.,1412,1413,O
Moreover,1414,1422,O
",",1422,1423,O
contrary,1424,1432,O
to,1433,1435,O
homemade,1436,1444,O
food,1445,1449,O
",",1449,1450,O
which,1451,1456,O
does,1457,1461,O
not,1462,1465,O
contain,1466,1473,O
furan,1474,1479,O
",",1479,1480,O
the,1481,1484,O
highest,1485,1492,O
average,1493,1500,O
content,1501,1508,O
of,1509,1511,O
this,1512,1516,O
chemical,1517,1525,O
was,1526,1529,O
found,1530,1535,O
in,1536,1538,O
ready,1539,1544,O
-,1544,1545,O
to,1545,1547,O
-,1547,1548,O
eat,1548,1551,O
baby,1552,1556,O
foods,1557,1562,O
with,1563,1567,O
pasta,1568,1573,O
meals,1574,1579,O
",",1579,1580,O
followed,1581,1589,O
by,1590,1592,O
vegetable,1593,1602,B-Organism_subdivision
meals,1603,1608,O
and,1609,1612,O
meals,1613,1618,O
with,1619,1623,O
meat,1624,1628,B-Organism_subdivision
[,1629,1630,O
7,1630,1631,O
],1631,1632,O
.,1632,1633,O
Furan,1634,1639,O
is,1640,1642,O
considered,1643,1653,O
to,1654,1656,O
be,1657,1659,O
potentially,1660,1671,O
hazardous,1672,1681,O
chemical,1682,1690,O
and,1691,1694,O
is,1695,1697,O
classified,1698,1708,O
as,1709,1711,O
a,1712,1713,O
possible,1714,1722,O
carcinogen,1723,1733,O
.,1733,1734,O
The,1735,1738,O
problem,1739,1746,O
of,1747,1749,O
this,1750,1754,O
chemical,1755,1763,O
in,1764,1766,O
homemade,1767,1775,O
food,1776,1780,O
may,1781,1784,O
only,1785,1789,O
arise,1790,1795,O
if,1796,1798,O
meals,1799,1804,O
with,1805,1809,O
potatoes,1810,1818,O
are,1819,1822,O
stored,1823,1829,O
and,1830,1833,O
then,1834,1838,O
hardly,1839,1845,O
re,1846,1848,O
-,1848,1849,O
heated,1849,1855,O
[,1856,1857,O
7,1857,1858,O
],1858,1859,O
.,1859,1860,O
There,1861,1866,O
is,1867,1869,O
a,1870,1871,O
growing,1872,1879,O
body,1880,1884,B-Organism_subdivision
of,1885,1887,O
evidence,1888,1896,O
that,1897,1901,O
flavor,1902,1908,O
experiences,1909,1920,O
and,1921,1924,O
dietary,1925,1932,O
patterns,1933,1941,O
in,1942,1944,O
childhood,1945,1954,O
influence,1955,1964,O
these,1965,1970,O
patterns,1971,1979,O
later,1980,1985,O
in,1986,1988,O
life,1989,1993,O
[,1994,1995,O
1,1995,1996,O
",",1996,1997,O
8,1998,1999,O
",",1999,2000,O
9,2001,2002,O
],2002,2003,O
.,2003,2004,O
It,2005,2007,O
is,2008,2010,O
most,2011,2015,O
likely,2016,2022,O
early,2023,2028,O
in,2029,2031,O
life,2032,2036,O
that,2037,2041,O
culture,2042,2049,O
-,2049,2050,O
specific,2050,2058,O
flavor,2059,2065,O
preferences,2066,2077,O
are,2078,2081,O
initiated,2082,2091,O
[,2092,2093,O
10,2093,2095,O
",",2095,2096,O
11,2097,2099,O
],2099,2100,O
.,2100,2101,O
Consequently,2102,2114,O
",",2114,2115,O
exposure,2116,2124,O
to,2125,2127,O
flavors,2128,2135,O
and,2136,2139,O
smells,2140,2146,O
of,2147,2149,O
transitory,2150,2160,O
foods,2161,2166,O
may,2167,2170,O
serve,2171,2176,O
to,2177,2179,O
heighten,2180,2188,O
preferences,2189,2200,O
for,2201,2204,O
"""",2205,2206,O
known,2206,2211,O
tastes,2212,2218,O
"""",2218,2219,O
in,2220,2222,O
the,2223,2226,O
family,2227,2233,O
diet,2234,2238,O
later,2239,2244,O
in,2245,2247,O
adulthood,2248,2257,O
.,2257,2258,O
Moreover,2259,2267,O
",",2267,2268,O
adopting,2269,2277,O
elements,2278,2286,O
of,2287,2289,O
childhood,2290,2299,O
dinner,2300,2306,O
patterns,2307,2315,O
was,2316,2319,O
recognized,2320,2330,O
to,2331,2333,O
be,2334,2336,O
an,2337,2339,O
important,2340,2349,O
part,2350,2354,O
of,2355,2357,O
the,2358,2361,O
social,2362,2368,O
reproduction,2369,2381,O
of,2382,2384,O
family,2385,2391,O
identities,2392,2402,O
across,2403,2409,O
generations,2410,2421,O
[,2422,2423,O
12,2423,2425,O
],2425,2426,O
.,2426,2427,O
Processing,2428,2438,O
industries,2439,2449,O
have,2450,2454,O
been,2455,2459,O
successful,2460,2470,O
in,2471,2473,O
manufacturing,2474,2487,O
and,2488,2491,O
marketing,2492,2501,O
jarred,2502,2508,O
baby,2509,2513,O
foods,2514,2519,O
on,2520,2522,O
a,2523,2524,O
commercial,2525,2535,O
scale,2536,2541,O
.,2541,2542,O
Available,2543,2552,O
products,2553,2561,O
contain,2562,2569,O
different,2570,2579,O
ingredients,2580,2591,O
and,2592,2595,O
depend,2596,2602,O
on,2603,2605,O
the,2606,2609,O
manufacturer,2610,2622,O
",",2622,2623,O
country,2624,2631,O
",",2631,2632,O
traditional,2633,2644,O
cuisine,2645,2652,O
",",2652,2653,O
income,2654,2660,O
rate,2661,2665,O
",",2665,2666,O
and,2667,2670,O
lastly,2671,2677,O
",",2677,2678,O
personal,2679,2687,O
beliefs,2688,2695,O
and,2696,2699,O
values,2700,2706,O
of,2707,2709,O
parents,2710,2717,O
[,2718,2719,O
9,2719,2720,O
",",2720,2721,O
11,2722,2724,O
],2724,2725,O
.,2725,2726,O
Jarred,2727,2733,O
foods,2734,2739,O
with,2740,2744,O
vegetables,2745,2755,B-Organism_subdivision
",",2755,2756,O
meats,2757,2762,B-Organism_subdivision
",",2762,2763,O
and,2764,2767,O
desserts,2768,2776,O
may,2777,2780,O
contain,2781,2788,O
added,2789,2794,O
fat,2795,2798,O
from,2799,2803,O
a,2804,2805,O
variety,2806,2813,O
of,2814,2816,O
sources,2817,2824,O
:,2824,2825,O
vegetable,2826,2835,B-Organism_substance
oils,2836,2840,I-Organism_substance
",",2840,2841,O
cow,2842,2845,O
milk,2846,2850,B-Organism_substance
butter,2851,2857,O
",",2857,2858,O
or,2859,2861,O
cream,2862,2867,O
.,2867,2868,O
Manufacturer,2869,2881,O
advertising,2882,2893,O
makes,2894,2899,O
the,2900,2903,O
majority,2904,2912,O
of,2913,2915,O
consumers,2916,2925,O
feel,2926,2930,O
safe,2931,2935,O
",",2935,2936,O
causing,2937,2944,O
them,2945,2949,O
to,2950,2952,O
believe,2953,2960,O
that,2961,2965,O
they,2966,2970,O
are,2971,2974,O
doing,2975,2980,O
the,2981,2984,O
best,2985,2989,O
possible,2990,2998,O
in,2999,3001,O
buying,3002,3008,O
given,3009,3014,O
products,3015,3023,O
[,3024,3025,O
11,3025,3027,O
],3027,3028,O
.,3028,3029,O
A,3030,3031,O
noteworthy,3032,3042,O
fact,3043,3047,O
is,3048,3050,O
that,3051,3055,O
many,3056,3060,O
types,3061,3066,O
of,3067,3069,O
baby,3070,3074,O
foods,3075,3080,O
produced,3081,3089,O
by,3090,3092,O
international,3093,3106,O
manufacturers,3107,3120,O
are,3121,3124,O
",",3124,3125,O
in,3126,3128,O
essence,3129,3136,O
",",3136,3137,O
the,3138,3141,O
same,3142,3146,O
mixtures,3147,3155,O
with,3156,3160,O
different,3161,3170,O
names,3171,3176,O
;,3176,3177,O
this,3178,3182,O
procedure,3183,3192,O
aims,3193,3197,O
to,3198,3200,O
exploit,3201,3208,O
the,3209,3212,O
specifics,3213,3222,O
of,3223,3225,O
local,3226,3231,O
markets,3232,3239,O
without,3240,3247,O
delivering,3248,3258,O
any,3259,3262,O
new,3263,3266,O
",",3266,3267,O
real,3268,3272,O
value,3273,3278,O
[,3279,3280,O
11,3280,3282,O
],3282,3283,O
.,3283,3284,O
In,3285,3287,O
the,3288,3291,O
book,3292,3296,O
",",3296,3297,O
How,3298,3301,O
to,3302,3304,O
Eat,3305,3308,O
Well,3309,3313,O
and,3314,3317,O
Stay,3318,3322,O
Well,3323,3327,O
the,3328,3331,O
Mediterranean,3332,3345,O
Way,3346,3349,O
by,3350,3352,O
Keys,3353,3357,O
[,3358,3359,O
13,3359,3361,O
],3361,3362,O
first,3363,3368,O
used,3369,3373,O
the,3374,3377,O
term,3378,3382,O
"""",3383,3384,O
good,3384,3388,O
Mediterranean,3389,3402,O
diet,3403,3407,O
"""",3407,3408,O
to,3409,3411,O
describe,3412,3420,O
the,3421,3424,O
eating,3425,3431,O
patterns,3432,3440,O
of,3441,3443,O
populations,3444,3455,O
dwelling,3456,3464,O
in,3465,3467,O
southern,3468,3476,O
Europe,3477,3483,O
",",3483,3484,O
where,3485,3490,O
the,3491,3494,O
olive,3495,3500,O
tree,3501,3505,O
(,3506,3507,O
Olea,3507,3511,O
europaea,3512,3520,O
),3520,3521,O
is,3522,3524,O
an,3525,3527,O
emblematic,3528,3538,O
species,3539,3546,O
[,3547,3548,O
4,3548,3549,O
",",3549,3550,O
14,3551,3553,O
],3553,3554,O
.,3554,3555,O
There,3556,3561,O
is,3562,3564,O
variation,3565,3574,O
between,3575,3582,O
the,3583,3586,O
exact,3587,3592,O
diet,3593,3597,O
in,3598,3600,O
different,3601,3610,O
parts,3611,3616,O
of,3617,3619,O
the,3620,3623,O
Mediterranean,3624,3637,O
region,3638,3644,O
.,3644,3645,O
However,3646,3653,O
",",3653,3654,O
generalized,3655,3666,O
and,3667,3670,O
distinctive,3671,3682,O
dietary,3683,3690,O
patterns,3691,3699,O
do,3700,3702,O
exist,3703,3708,O
",",3708,3709,O
including,3710,3719,O
olive,3720,3725,O
oil,3726,3729,B-Organism_substance
as,3730,3732,O
the,3733,3736,O
main,3737,3741,O
source,3742,3748,O
of,3749,3751,O
visible,3752,3759,O
fat,3760,3763,O
",",3763,3764,O
employed,3765,3773,O
both,3774,3778,O
in,3779,3781,O
cooking,3782,3789,O
and,3790,3793,O
as,3794,3796,O
a,3797,3798,O
dressing,3799,3807,O
",",3807,3808,O
moderate,3809,3817,O
fish,3818,3822,O
and,3823,3826,O
poultry,3827,3834,O
but,3835,3838,O
low,3839,3842,O
red,3843,3846,B-Organism_subdivision
meat,3847,3851,I-Organism_subdivision
consumption,3852,3863,O
",",3863,3864,O
high,3865,3869,O
intake,3870,3876,O
of,3877,3879,O
vegetables,3880,3890,B-Organism_subdivision
",",3890,3891,O
fruits,3892,3898,B-Organism_subdivision
",",3898,3899,O
legumes,3900,3907,O
",",3907,3908,O
nuts,3909,3913,B-Organism_subdivision
",",3913,3914,O
and,3915,3918,O
whole,3919,3924,O
-,3924,3925,O
grain,3925,3930,O
cereals,3931,3938,O
[,3939,3940,O
4,3940,3941,O
",",3941,3942,O
14,3943,3945,O
-,3945,3946,O
16,3946,3948,O
],3948,3949,O
.,3949,3950,O
When,3951,3955,O
dietary,3956,3963,B-Organism_substance
fats,3964,3968,I-Organism_substance
are,3969,3972,O
added,3973,3978,O
",",3978,3979,O
in,3980,3982,O
accordance,3983,3993,O
with,3994,3998,O
the,3999,4002,O
traditional,4003,4014,O
Mediterranean,4015,4028,O
diet,4029,4033,O
",",4033,4034,O
olive,4035,4040,O
oil,4041,4044,B-Organism_substance
is,4045,4047,O
the,4048,4051,O
choice,4052,4058,O
for,4059,4062,O
children,4063,4071,O
[,4072,4073,O
17,4073,4075,O
],4075,4076,O
.,4076,4077,O
It,4078,4080,O
has,4081,4084,O
been,4085,4089,O
repeatedly,4090,4100,O
observed,4101,4109,O
that,4110,4114,O
individuals,4115,4126,O
applying,4127,4135,O
the,4136,4139,O
Mediterranean,4140,4153,O
diet,4154,4158,O
have,4159,4163,O
reduced,4164,4171,O
risks,4172,4177,O
of,4178,4180,O
type,4181,4185,O
2,4186,4187,O
diabetes,4188,4196,O
and,4197,4200,O
other,4201,4206,O
diseases,4207,4215,O
associated,4216,4226,O
with,4227,4231,O
the,4232,4235,O
metabolic,4236,4245,O
syndrome,4246,4254,O
",",4254,4255,O
autoimmunological,4256,4273,O
diseases,4274,4282,O
",",4282,4283,O
and,4284,4287,O
certain,4288,4295,O
forms,4296,4301,O
of,4302,4304,O
cancer,4305,4311,B-Pathological_formation
[,4312,4313,O
18,4313,4315,O
],4315,4316,O
.,4316,4317,O
Moreover,4318,4326,O
",",4326,4327,O
considerable,4328,4340,O
evidence,4341,4349,O
exists,4350,4356,O
that,4357,4361,O
the,4362,4365,O
Mediterranean,4366,4379,O
diet,4380,4384,O
increases,4385,4394,O
quality,4395,4402,O
of,4403,4405,O
life,4406,4410,O
in,4411,4413,O
the,4414,4417,O
course,4418,4424,O
of,4425,4427,O
ageing,4428,4434,O
",",4434,4435,O
as,4436,4438,O
well,4439,4443,O
as,4444,4446,O
longevity,4447,4456,O
[,4457,4458,O
13,4458,4460,O
",",4460,4461,O
19,4462,4464,O
],4464,4465,O
.,4465,4466,O
The,4467,4470,O
health,4471,4477,O
benefits,4478,4486,O
of,4487,4489,O
olive,4490,4495,O
oil,4496,4499,B-Organism_substance
have,4500,4504,O
been,4505,4509,O
attributed,4510,4520,O
to,4521,4523,O
two,4524,4527,O
main,4528,4532,O
constituents,4533,4545,O
:,4545,4546,O
a,4547,4548,O
high,4549,4553,O
oleic,4554,4559,O
acid,4560,4564,O
(,4565,4566,O
monounsaturated,4566,4581,O
fatty,4582,4587,O
acid,4588,4592,O
",",4592,4593,O
18,4594,4596,O
:,4596,4597,O
1n,4597,4599,O
-,4599,4600,O
9,4600,4601,O
),4601,4602,O
content,4603,4610,O
(,4611,4612,O
70,4612,4614,O
-,4614,4615,O
85,4615,4617,O
%,4617,4618,O
),4618,4619,O
and,4620,4623,O
a,4624,4625,O
large,4626,4631,O
amount,4632,4638,O
of,4639,4641,O
antioxidant,4642,4653,O
compounds,4654,4663,O
",",4663,4664,O
which,4665,4670,O
also,4671,4675,O
possess,4676,4683,O
antiviral,4684,4693,O
",",4693,4694,O
antibacterial,4695,4708,O
",",4708,4709,O
and,4710,4713,O
immunomodulating,4714,4730,O
effects,4731,4738,O
[,4739,4740,O
3,4740,4741,O
",",4741,4742,O
4,4743,4744,O
",",4744,4745,O
14,4746,4748,O
",",4748,4749,O
16,4750,4752,O
],4752,4753,O
.,4753,4754,O
Polyphenols,4755,4766,O
found,4767,4772,O
in,4773,4775,O
virgin,4776,4782,O
olive,4783,4788,O
oil,4789,4792,B-Organism_substance
are,4793,4796,O
linked,4797,4803,O
to,4804,4806,O
both,4807,4811,O
its,4812,4815,O
flavor,4816,4822,O
and,4823,4826,O
its,4827,4830,O
remarkable,4831,4841,O
stability,4842,4851,O
[,4852,4853,O
3,4853,4854,O
],4854,4855,O
.,4855,4856,O
The,4857,4860,O
introduction,4861,4873,O
of,4874,4876,O
solid,4877,4882,O
foods,4883,4888,O
in,4889,4891,O
infancy,4892,4899,O
is,4900,4902,O
one,4903,4906,O
of,4907,4909,O
the,4910,4913,O
primary,4914,4921,O
matters,4922,4929,O
often,4930,4935,O
discussed,4936,4945,O
by,4946,4948,O
parents,4949,4956,O
with,4957,4961,O
their,4962,4967,O
child,4968,4973,O
',4973,4974,O
s,4974,4975,O
pediatrician,4976,4988,O
.,4988,4989,O
However,4990,4997,O
",",4997,4998,O
many,4999,5003,O
parents,5004,5011,O
do,5012,5014,O
not,5015,5018,O
feel,5019,5023,O
that,5024,5028,O
the,5029,5032,O
diet,5033,5037,O
of,5038,5040,O
their,5041,5046,O
child,5047,5052,O
may,5053,5056,O
be,5057,5059,O
linked,5060,5066,O
to,5067,5069,O
poor,5070,5074,O
health,5075,5081,O
outcomes,5082,5090,O
in,5091,5093,O
the,5094,5097,O
future,5098,5104,O
.,5104,5105,O
Parents,5106,5113,O
should,5114,5120,O
be,5121,5123,O
educated,5124,5132,O
about,5133,5138,O
the,5139,5142,O
interplay,5143,5152,O
of,5153,5155,O
environmental,5156,5169,O
and,5170,5173,O
genetic,5174,5181,O
influences,5182,5192,O
on,5193,5195,O
children,5196,5204,O
",",5204,5205,O
specifically,5206,5218,O
during,5219,5225,O
the,5226,5229,O
early,5230,5235,O
years,5236,5241,O
of,5242,5244,O
development,5245,5256,O
when,5257,5261,O
the,5262,5265,O
child,5266,5271,O
is,5272,5274,O
maturing,5275,5283,O
and,5284,5287,O
taking,5288,5294,O
control,5295,5302,O
of,5303,5305,O
its,5306,5309,O
own,5310,5313,O
diet,5314,5318,O
[,5319,5320,O
11,5320,5322,O
],5322,5323,O
.,5323,5324,O
Nutrition,5325,5334,O
educators,5335,5344,O
should,5345,5351,O
increase,5352,5360,O
the,5361,5364,O
critical,5365,5373,O
awareness,5374,5383,O
of,5384,5386,O
parents,5387,5394,O
in,5395,5397,O
relation,5398,5406,O
to,5407,5409,O
their,5410,5415,O
child,5416,5421,O
',5421,5422,O
s,5422,5423,O
solid,5424,5429,O
food,5430,5434,O
choices,5435,5442,O
.,5442,5443,O
It,5444,5446,O
is,5447,5449,O
important,5450,5459,O
to,5460,5462,O
emphasize,5463,5472,O
to,5473,5475,O
parents,5476,5483,O
the,5484,5487,O
fundamental,5488,5499,O
role,5500,5504,O
that,5505,5509,O
the,5510,5513,O
Mediterranean,5514,5527,O
diet,5528,5532,O
and,5533,5536,O
consumption,5537,5548,O
of,5549,5551,O
foods,5552,5557,O
with,5558,5562,O
olive,5563,5568,O
oil,5569,5572,B-Organism_substance
play,5573,5577,O
in,5578,5580,O
a,5581,5582,O
healthy,5583,5590,O
life,5591,5595,O
style,5596,5601,O
[,5602,5603,O
14,5603,5605,O
",",5605,5606,O
20,5607,5609,O
],5609,5610,O
.,5610,5611,O
Parental,5612,5620,O
management,5621,5631,O
of,5632,5634,O
the,5635,5638,O
family,5639,5645,O
food,5646,5650,O
environment,5651,5662,O
may,5663,5666,O
be,5667,5669,O
complicated,5670,5681,O
by,5682,5684,O
numerous,5685,5693,O
mitigating,5694,5704,O
factors,5705,5712,O
",",5712,5713,O
e,5714,5715,O
.,5715,5716,O
g,5716,5717,O
.,5717,5718,O
health,5719,5725,O
literacy,5726,5734,O
",",5734,5735,O
time,5736,5740,O
availability,5741,5753,O
",",5753,5754,O
and,5755,5758,O
financial,5759,5768,O
resources,5769,5778,O
.,5778,5779,O
Considering,5780,5791,O
the,5792,5795,O
role,5796,5800,O
baby,5801,5805,O
food,5806,5810,O
manufacturers,5811,5824,O
play,5825,5829,O
in,5830,5832,O
the,5833,5836,O
infant,5837,5843,O
',5843,5844,O
s,5844,5845,O
contextual,5846,5856,O
environment,5857,5868,O
",",5868,5869,O
their,5870,5875,O
products,5876,5884,O
",",5884,5885,O
as,5886,5888,O
well,5889,5893,O
as,5894,5896,O
the,5897,5900,O
manufacturers,5901,5914,O
themselves,5915,5925,O
",",5925,5926,O
should,5927,5933,O
also,5934,5938,O
be,5939,5941,O
viewed,5942,5948,O
as,5949,5951,O
key,5952,5955,O
players,5956,5963,O
and,5964,5967,O
central,5968,5975,O
agents,5976,5982,O
in,5983,5985,O
establishing,5986,5998,O
dietary,5999,6006,O
habits,6007,6013,O
.,6013,6014,O
Consequently,6015,6027,O
",",6027,6028,O
we,6029,6031,O
attempted,6032,6041,O
to,6042,6044,O
survey,6045,6051,O
manufacturer,6052,6064,O
claims,6065,6071,O
concerning,6072,6082,O
added,6083,6088,O
fat,6089,6092,O
in,6093,6095,O
jarred,6096,6102,O
infant,6103,6109,O
foods,6110,6115,O
supplied,6116,6124,O
to,6125,6127,O
the,6128,6131,O
Polish,6132,6138,O
market,6139,6145,O
.,6145,6146,O
2,0,1,O
.,1,2,O
1,2,3,O
.,3,4,O
3,4,5,O
Pixel,6,11,O
Classification,12,26,O
The,27,30,O
feature,31,38,O
vector,39,45,O
of,46,48,O
a,49,50,O
grid,51,55,O
",",55,56,O
which,57,62,O
consists,63,71,O
of,72,74,O
nine,75,79,O
features,80,88,O
",",88,89,O
is,90,92,O
normalized,93,103,O
to,104,106,O
[,107,108,O
0,108,109,O
",",109,110,O
1,111,112,O
],112,113,O
",",113,114,O
and,115,118,O
the,119,122,O
position,123,131,O
features,132,140,O
are,141,144,O
scaled,145,151,O
by,152,154,O
the,155,158,O
weighting,159,168,O
coefficient,169,180,O
wpos,181,185,O
.,185,186,O
Then,187,191,O
",",191,192,O
taking,193,199,O
the,200,203,O
nine,204,208,O
dimensional,209,220,O
vector,221,227,O
of,228,230,O
each,231,235,O
grid,236,240,O
as,241,243,O
the,244,247,O
input,248,253,O
of,254,256,O
the,257,260,O
classifier,261,271,O
",",271,272,O
the,273,276,O
ROI,277,280,O
and,281,284,O
non,285,288,O
-,288,289,O
ROI,289,292,O
background,293,303,O
in,304,306,O
ultrasonic,307,317,O
breast,318,324,B-Pathological_formation
tumor,325,330,I-Pathological_formation
images,331,337,O
can,338,341,O
be,342,344,O
distinguished,345,358,O
.,358,359,O
In,360,362,O
this,363,367,O
section,368,375,O
",",375,376,O
the,377,380,O
self,381,385,O
-,385,386,O
organizing,386,396,O
feature,397,404,O
map,405,408,O
neural,409,415,O
network,416,423,O
(,424,425,O
SOMNN,425,430,O
),430,431,O
[,432,433,O
25,433,435,O
],435,436,O
",",436,437,O
proposed,438,446,O
by,447,449,O
Kohonen,450,457,O
according,458,467,O
to,468,470,O
characteristics,471,486,O
of,487,489,O
the,490,493,O
nervous,494,501,B-Anatomical_system
system,502,508,I-Anatomical_system
",",508,509,O
is,510,512,O
used,513,517,O
for,518,521,O
the,522,525,O
classification,526,540,O
of,541,543,O
these,544,549,O
grids,550,555,O
to,556,558,O
detect,559,565,O
the,566,569,O
ROI,570,573,O
automatically,574,587,O
.,587,588,O
The,589,592,O
SOM,593,596,O
is,597,599,O
trained,600,607,O
by,608,610,O
the,611,614,O
unsupervised,615,627,O
learning,628,636,O
to,637,639,O
produce,640,647,O
a,648,649,O
low,650,653,O
-,653,654,O
dimensional,654,665,O
discretized,666,677,O
representation,678,692,O
of,693,695,O
the,696,699,O
input,700,705,O
space,706,711,O
of,712,714,O
the,715,718,O
training,719,727,O
samples,728,735,O
",",735,736,O
and,737,740,O
it,741,743,O
uses,744,748,O
a,749,750,O
neighborhood,751,763,O
function,764,772,O
to,773,775,O
preserve,776,784,O
the,785,788,O
topological,789,800,O
properties,801,811,O
of,812,814,O
the,815,818,O
input,819,824,O
space,825,830,O
",",830,831,O
which,832,837,O
makes,838,843,O
it,844,846,O
different,847,856,O
from,857,861,O
other,862,867,O
artificial,868,878,O
neural,879,885,O
networks,886,894,O
.,894,895,O
In,896,898,O
this,899,903,O
way,904,907,O
",",907,908,O
the,909,912,O
SOM,913,916,O
is,917,919,O
able,920,924,O
to,925,927,O
classify,928,936,O
the,937,940,O
sub,941,944,O
-,944,945,O
blocks,945,951,O
into,952,956,O
n,957,958,O
clusters,959,967,O
only,968,972,O
by,973,975,O
the,976,979,O
unsupervised,980,992,O
learning,993,1001,O
.,1001,1002,O
In,1003,1005,O
our,1006,1009,O
study,1010,1015,O
",",1015,1016,O
the,1017,1020,O
output,1021,1027,O
layer,1028,1033,O
number,1034,1040,O
n,1041,1042,O
is,1043,1045,O
set,1046,1049,O
to,1050,1052,O
2,1053,1054,O
(,1055,1056,O
ROI,1056,1059,O
and,1060,1063,O
non,1064,1067,O
-,1067,1068,O
ROI,1068,1071,O
output,1072,1078,O
),1078,1079,O
and,1080,1083,O
the,1084,1087,O
feature,1088,1095,O
vector,1096,1102,O
extracted,1103,1112,O
from,1113,1117,O
each,1118,1122,O
grid,1123,1127,O
is,1128,1130,O
taken,1131,1136,O
as,1137,1139,O
the,1140,1143,O
input,1144,1149,O
.,1149,1150,O
To,1151,1153,O
map,1154,1157,O
the,1158,1161,O
sorted,1162,1168,O
sub,1169,1172,O
-,1172,1173,O
blocks,1173,1179,O
back,1180,1184,O
to,1185,1187,O
the,1188,1191,O
size,1192,1196,O
of,1197,1199,O
the,1200,1203,O
original,1204,1212,O
ultrasonic,1213,1223,O
images,1224,1230,O
",",1230,1231,O
the,1232,1235,O
initial,1236,1243,O
result,1244,1250,O
of,1251,1253,O
ROI,1254,1257,O
detection,1258,1267,O
can,1268,1271,O
be,1272,1274,O
represented,1275,1286,O
by,1287,1289,O
a,1290,1291,O
binary,1292,1298,O
image,1299,1304,O
as,1305,1307,O
shown,1308,1313,O
in,1314,1316,O
Fig,1317,1320,O
.,1320,1321,O
(,1322,1323,O
2d,1323,1325,O
),1325,1326,O
",",1326,1327,O
where,1328,1333,O
white,1334,1339,O
areas,1340,1345,O
indicate,1346,1354,O
the,1355,1358,O
ROI,1359,1362,O
candidates,1363,1373,O
while,1374,1379,O
black,1380,1385,O
areas,1386,1391,O
the,1392,1395,O
non,1396,1399,O
-,1399,1400,O
ROIs,1400,1404,O
.,1404,1405,O
Materials,0,9,O
and,10,13,O
Methods,14,21,O
:,21,22,O
A,23,24,O
total,25,30,O
of,31,33,O
75,34,36,O
brain,37,42,B-Multi-tissue_structure
abscess,43,50,I-Multi-tissue_structure
pus,51,54,I-Multi-tissue_structure
specimens,55,64,I-Multi-tissue_structure
were,65,69,O
collected,70,79,O
during,80,86,O
neurosurgery,87,99,O
",",99,100,O
either,101,107,O
by,108,110,O
burr,111,115,O
hole,116,120,O
or,121,123,O
by,124,126,O
craniotomy,127,137,O
.,137,138,O
These,139,144,O
specimens,145,154,B-Multi-tissue_structure
were,155,159,O
further,160,167,O
subjected,168,177,O
to,178,180,O
Gram,181,185,O
stain,186,191,O
",",191,192,O
Ziehl,193,198,O
-,198,199,O
Neelsen,199,206,O
(,207,208,O
ZN,208,210,O
),210,211,O
stain,212,217,O
",",217,218,O
and,219,222,O
conventional,223,235,O
microbiological,236,251,O
culture,252,259,O
.,259,260,O
Only,261,265,O
those,266,271,O
cases,272,277,O
which,278,283,O
showed,284,290,O
presence,291,299,O
of,300,302,O
AFB,303,306,O
on,307,309,O
ZN,310,312,O
stain,313,318,O
along,319,324,O
with,325,329,O
the,330,333,O
growth,334,340,O
of,341,343,O
Mycobacterium,344,357,O
tuberculosis,358,370,O
were,371,375,O
considered,376,386,O
as,387,389,O
TBAs,390,394,O
.,394,395,O
Such,396,400,O
TBA,401,404,O
cases,405,410,O
were,411,415,O
further,416,423,O
presented,424,433,O
along,434,439,O
with,440,444,O
their,445,450,O
In,451,453,O
vitro,454,459,O
Proton,460,466,O
Magnetic,467,475,O
Resonance,476,485,O
(,486,487,O
MR,487,489,O
),489,490,O
Spectroscopic,491,504,O
findings,505,513,O
.,513,514,O
Challenges,0,10,O
to,11,13,O
creating,14,22,O
and,23,26,O
implementing,27,39,O
a,40,41,O
perioperative,42,55,O
glycemic,56,64,O
control,65,72,O
protocol,73,81,O
.,81,82,O
Parameters,0,10,O
derived,11,18,O
from,19,23,O
normalized,24,34,O
averaged,35,43,O
data,44,48,O
across,49,55,O
participants,56,68,O
Absolute,0,8,O
responder,9,18,O
rates,19,24,O
for,25,28,O
medical,29,36,O
management,37,47,O
recommendations,48,63,O
.,63,64,O
Conclusions,0,11,O
This,12,16,O
is,17,19,O
the,20,23,O
first,24,29,O
prospective,30,41,O
evaluation,42,52,O
of,53,55,O
parents,56,63,O
',63,64,O
preferences,65,76,O
in,77,79,O
newly,80,85,O
diagnosed,86,95,O
juvenile,96,104,O
idiopathic,105,115,O
arthritis,116,125,O
patients,126,134,O
participating,135,148,O
in,149,151,O
the,152,155,O
BeSt,156,160,O
for,161,164,O
Kids,165,169,O
trial,170,175,O
.,175,176,O
Within,177,183,O
the,184,187,O
limitations,188,199,O
of,200,202,O
the,203,206,O
small,207,212,O
amounts,213,220,O
",",220,221,O
patients,222,230,O
clearly,231,238,O
preferred,239,248,O
initial,249,256,O
combination,257,268,O
therapy,269,276,O
with,277,281,O
etanercept,282,292,O
and,293,296,O
disliked,297,305,O
taking,306,312,O
prednisone,313,323,O
.,323,324,O
After,325,330,O
actual,331,337,O
exposure,338,346,O
and,347,350,O
follow,351,357,O
up,358,360,O
",",360,361,O
this,362,366,O
questionnaire,367,380,O
will,381,385,O
be,386,388,O
repeated,389,397,O
to,398,400,O
see,401,404,O
if,405,407,O
preferences,408,419,O
remain,420,426,O
the,427,430,O
same,431,435,O
.,435,436,O
Patients,0,8,O
and,9,12,O
Study,13,18,O
Design,19,25,O
A,26,27,O
prospective,28,39,O
evaluation,40,50,O
of,51,53,O
the,54,57,O
different,58,67,O
CMR,68,71,O
parameters,72,82,O
for,83,86,O
predicting,87,97,O
LV,98,100,B-Multi-tissue_structure
segmental,101,110,O
and,111,114,O
global,115,121,O
functional,122,132,O
recovery,133,141,O
was,142,145,O
performed,146,155,O
in,156,158,O
46,159,161,O
patients,162,170,O
(,171,172,O
63,172,174,O
+,175,176,O
/,176,177,O
-,177,178,O
10,179,181,O
years,182,187,O
old,188,191,O
",",191,192,O
3,193,194,O
with,195,199,O
previous,200,208,O
CABG,209,213,O
",",213,214,O
35,215,217,O
with,218,222,O
three,223,228,O
-,228,229,O
vessel,229,235,O
disease,236,243,O
",",243,244,O
3,245,246,O
with,247,251,O
one,252,255,O
-,255,256,O
vessel,256,262,O
disease,263,270,O
),270,271,O
with,272,276,O
LV,277,279,B-Multi-tissue_structure
systolic,280,288,O
dysfunction,289,300,O
(,301,302,O
LVEF,302,306,O
35,307,309,O
+,310,311,O
/,311,312,O
-,312,313,O
8,314,315,O
%,315,316,O
),316,317,O
before,318,324,O
they,325,329,O
underwent,330,339,O
surgical,340,348,O
(,349,350,O
n,350,351,O
=,352,353,O
34,354,356,O
),356,357,O
or,358,360,O
percutaneous,361,373,O
(,374,375,O
n,375,376,O
=,377,378,O
12,379,381,O
),381,382,O
revascularisation,383,400,O
.,400,401,O
Sixty,402,407,O
patients,408,416,O
without,417,424,O
contraindications,425,442,O
for,443,446,O
CMR,447,450,O
were,451,455,O
screened,456,464,O
for,465,468,O
the,469,472,O
following,473,482,O
inclusion,483,492,O
criteria,493,501,O
:,501,502,O
(,503,504,O
1,504,505,O
),505,506,O
CAD,507,510,O
(,511,512,O
>,512,513,O
70,514,516,O
%,516,517,O
stenosis,518,526,O
in,527,529,O
one,530,533,O
or,534,536,O
more,537,541,O
major,542,547,O
epicardial,548,558,B-Multi-tissue_structure
vessels,559,566,I-Multi-tissue_structure
),566,567,O
",",567,568,O
scheduled,569,578,O
for,579,582,O
a,583,584,O
revascularisation,585,602,O
procedure,603,612,O
;,612,613,O
(,614,615,O
2,615,616,O
),616,617,O
LVEF,618,622,O
<,623,624,O
=,624,625,O
45,626,628,O
%,628,629,O
;,629,630,O
(,631,632,O
3,632,633,O
),633,634,O
at,635,637,O
least,638,643,O
two,644,647,O
adjacent,648,656,O
segments,657,665,O
with,666,670,O
wall,671,675,B-Multi-tissue_structure
motion,676,682,O
abnormalities,683,696,O
at,697,699,O
rest,700,704,O
;,704,705,O
and,706,709,O
(,710,711,O
4,711,712,O
),712,713,O
no,714,716,O
infarction,717,727,O
or,728,730,O
revascularisation,731,748,O
within,749,755,O
the,756,759,O
last,760,764,O
two,765,768,O
months,769,775,O
.,775,776,O
Patients,777,785,O
were,786,790,O
included,791,799,O
in,800,802,O
the,803,806,O
study,807,812,O
only,813,817,O
after,818,823,O
a,824,825,O
successful,826,836,O
and,837,840,O
complete,841,849,O
coronary,850,858,B-Multi-tissue_structure
revascularisation,859,876,O
.,876,877,O
Of,878,880,O
the,881,884,O
14,885,887,O
patients,888,896,O
who,897,900,O
did,901,904,O
not,905,908,O
complete,909,917,O
the,918,921,O
study,922,927,O
",",927,928,O
3,929,930,O
decided,931,938,O
not,939,942,O
to,943,945,O
undergo,946,953,O
the,954,957,O
repeated,958,966,O
CMR,967,970,O
scan,971,975,O
or,976,978,O
were,979,983,O
lost,984,988,O
during,989,995,O
follow,996,1002,O
-,1002,1003,O
up,1003,1005,O
;,1005,1006,O
7,1007,1008,O
had,1009,1012,O
significant,1013,1024,O
periprocedural,1025,1039,O
injury,1040,1046,O
(,1047,1048,O
new,1048,1051,O
LGE,1052,1055,B-Pathological_formation
zones,1056,1061,O
on,1062,1064,O
repeated,1065,1073,O
CMR,1074,1077,O
scans,1078,1083,O
and,1084,1087,O
clinically,1088,1098,O
proven,1099,1105,O
periprocedural,1106,1120,O
myocardial,1121,1131,B-Multi-tissue_structure
infarction,1132,1142,O
(,1143,1144,O
MI,1144,1146,O
),1146,1147,O
or,1148,1150,O
MI,1151,1153,O
between,1154,1161,O
both,1162,1166,O
scans,1167,1172,O
),1172,1173,O
;,1173,1174,O
3,1175,1176,O
had,1177,1180,O
pacemakers,1181,1191,O
or,1192,1194,O
defibrillators,1195,1209,O
implanted,1210,1219,O
in,1220,1222,O
the,1223,1226,O
period,1227,1233,O
between,1234,1241,O
the,1242,1245,O
MR,1246,1248,O
scans,1249,1254,O
;,1254,1255,O
and,1256,1259,O
1,1260,1261,O
was,1262,1265,O
excluded,1266,1274,O
because,1275,1282,O
of,1283,1285,O
dilated,1286,1293,O
cardiomyopathy,1294,1308,O
with,1309,1313,O
secondary,1314,1323,O
CAD,1324,1327,O
.,1327,1328,O
None,1329,1333,O
of,1334,1336,O
the,1337,1340,O
patients,1341,1349,O
were,1350,1354,O
excluded,1355,1363,O
from,1364,1368,O
the,1369,1372,O
study,1373,1378,O
for,1379,1382,O
technical,1383,1392,O
reasons,1393,1400,O
or,1401,1403,O
image,1404,1409,O
quality,1410,1417,O
.,1417,1418,O
The,1419,1422,O
mean,1423,1427,O
interval,1428,1436,O
between,1437,1444,O
CMR,1445,1448,O
and,1449,1452,O
revascularisation,1453,1470,O
was,1471,1474,O
12,1475,1477,O
+,1478,1479,O
/,1479,1480,O
-,1480,1481,O
13,1482,1484,O
days,1485,1489,O
",",1489,1490,O
and,1491,1494,O
none,1495,1499,O
of,1500,1502,O
the,1503,1506,O
patients,1507,1515,O
presented,1516,1525,O
clinical,1526,1534,O
evidence,1535,1543,O
of,1544,1546,O
infarction,1547,1557,O
during,1558,1564,O
this,1565,1569,O
period,1570,1576,O
.,1576,1577,O
The,1578,1581,O
mean,1582,1586,O
interval,1587,1595,O
between,1596,1603,O
MI,1604,1606,O
and,1607,1610,O
the,1611,1614,O
first,1615,1620,O
CMR,1621,1624,O
was,1625,1628,O
3,1629,1630,O
.,1630,1631,O
6,1631,1632,O
years,1633,1638,O
.,1638,1639,O
In,1640,1642,O
46,1643,1645,O
patients,1646,1654,O
",",1654,1655,O
the,1656,1659,O
extent,1660,1666,O
of,1667,1669,O
regional,1670,1678,O
contractility,1679,1692,O
and,1693,1696,O
LGE,1697,1700,B-Pathological_formation
were,1701,1705,O
determined,1706,1716,O
repeatedly,1717,1727,O
by,1728,1730,O
CMR,1731,1734,O
28,1735,1737,O
+,1738,1739,O
/,1739,1740,O
-,1740,1741,O
4,1742,1743,O
weeks,1744,1749,O
(,1750,1751,O
6,1751,1752,O
months,1753,1759,O
),1759,1760,O
after,1761,1766,O
revascularisation,1767,1784,O
.,1784,1785,O
The,1786,1789,O
study,1790,1795,O
was,1796,1799,O
approved,1800,1808,O
by,1809,1811,O
the,1812,1815,O
Lithuanian,1816,1826,O
Bioethics,1827,1836,O
Committee,1837,1846,O
(,1847,1848,O
Nr,1848,1850,O
.,1850,1851,O
17,1852,1854,O
),1854,1855,O
",",1855,1856,O
and,1857,1860,O
informed,1861,1869,O
written,1870,1877,O
consent,1878,1885,O
was,1886,1889,O
obtained,1890,1898,O
from,1899,1903,O
each,1904,1908,O
patient,1909,1916,O
prior,1917,1922,O
to,1923,1925,O
inclusion,1926,1935,O
in,1936,1938,O
the,1939,1942,O
study,1943,1948,O
.,1948,1949,O
Authors,0,7,O
',7,8,O
contributions,9,22,O
EEKN,23,27,O
was,28,31,O
responsible,32,43,O
for,44,47,O
data,48,52,O
collection,53,63,O
",",63,64,O
statistical,65,76,O
analysis,77,85,O
and,86,89,O
drafting,90,98,O
the,99,102,O
manuscript,103,113,O
.,113,114,O
SAGN,115,119,O
and,120,123,O
YW,124,126,O
involved,127,135,O
in,136,138,O
data,139,143,O
collection,144,154,O
and,155,158,O
helped,159,165,O
with,166,170,O
the,171,174,O
data,175,179,O
analysis,180,188,O
.,188,189,O
AS,190,192,O
helped,193,199,O
in,200,202,O
data,203,207,O
analysis,208,216,O
.,216,217,O
EST,218,221,O
and,222,225,O
JL,226,228,O
directed,229,237,O
the,238,241,O
study,242,247,O
and,248,251,O
helped,252,258,O
in,259,261,O
revising,262,270,O
the,271,274,O
manuscript,275,285,O
.,285,286,O
RMVD,287,291,O
helped,292,298,O
in,299,301,O
data,302,306,O
analysis,307,315,O
",",315,316,O
interpretation,317,331,O
of,332,334,O
the,335,338,O
results,339,346,O
and,347,350,O
led,351,354,O
writing,355,362,O
of,363,365,O
the,366,369,O
manuscript,370,380,O
.,380,381,O
All,382,385,O
authors,386,393,O
read,394,398,O
and,399,402,O
approved,403,411,O
the,412,415,O
final,416,421,O
manuscript,422,432,O
.,432,433,O
Figures,0,7,O
Fig,8,11,O
.,11,12,O
1,13,14,O
.,14,15,O
A,16,17,O
view,18,22,O
of,23,25,O
(,26,27,O
I,27,28,O
),28,29,O
with,30,34,O
displacement,35,47,O
ellipsoids,48,58,O
drawn,59,64,O
at,65,67,O
the,68,71,O
30,72,74,O
%,74,75,O
probability,76,87,O
level,88,93,O
.,93,94,O
Fig,95,98,O
.,98,99,O
2,100,101,O
.,101,102,O
Stereoview,103,113,O
of,114,116,O
the,117,120,O
sheet,121,126,O
formed,127,133,O
by,134,136,O
C,137,138,O
-,138,139,O
-,139,140,O
H,140,141,O
.,141,142,O
.,142,143,O
.,143,144,O
pi,144,146,O
interactions,147,159,O
.,159,160,O
Hydrogen,161,169,O
atoms,170,175,O
not,176,179,O
involved,180,188,O
in,189,191,O
the,192,195,O
motifs,196,202,O
are,203,206,O
not,207,210,O
included,211,219,O
.,219,220,O
The,0,3,O
growth,4,10,O
in,11,13,O
the,14,17,O
number,18,24,O
of,25,27,O
database,28,36,O
publications,37,49,O
per,50,53,O
year,54,58,O
.,58,59,O
Each,60,64,O
bar,65,68,O
shows,69,74,O
the,75,78,O
number,79,85,O
of,86,88,O
research,89,97,O
articles,98,106,O
with,107,111,O
the,112,115,O
keyword,116,123,O
',124,125,O
database,125,133,O
',133,134,O
appearing,135,144,O
in,145,147,O
the,148,151,O
article,152,159,O
title,160,165,O
in,166,168,O
the,169,172,O
given,173,178,O
year,179,183,O
.,183,184,O
The,185,188,O
count,189,194,O
only,195,199,O
covers,200,206,O
articles,207,215,O
indexed,216,223,O
in,224,226,O
PubMed,227,233,O
.,233,234,O
The,235,238,O
increase,239,247,O
shows,248,253,O
an,254,256,O
exponential,257,268,O
trend,269,274,O
that,275,279,O
will,280,284,O
produce,285,292,O
nearly,293,299,O
2000,300,304,O
database,305,313,O
publications,314,326,O
per,327,330,O
year,331,335,O
by,336,338,O
2015,339,343,O
.,343,344,O
Cation,0,6,O
binding,7,14,O
to,15,17,O
yolk,18,22,B-Cell
platelet,23,31,I-Cell
phosvitin,32,41,O
In,42,44,O
addition,45,53,O
to,54,56,O
non,57,60,O
-,60,61,O
heme,61,65,O
iron,66,70,O
[,71,72,O
23,72,74,O
],74,75,O
",",75,76,O
yolk,77,81,B-Developing_anatomical_structure
phosvitin,82,91,O
also,92,96,O
contains,97,105,O
Ca2,106,109,O
+,109,110,O
",",110,111,O
Mg2,112,115,O
+,115,116,O
",",116,117,O
Na,118,120,O
+,120,121,O
and,122,125,O
K,126,127,O
+,127,128,O
[,129,130,O
11,130,132,O
],132,133,O
.,133,134,O
Partially,135,144,O
relaxed,145,152,O
23Na,153,157,O
Fourier,158,165,O
transform,166,175,O
NMR,176,179,O
spectra,180,187,O
revealed,188,196,O
the,197,200,O
existence,201,210,O
of,211,213,O
at,214,216,O
least,217,222,O
two,223,226,O
major,227,232,O
intracellular,233,246,B-Cellular_component
compartments,247,259,I-Cellular_component
of,260,262,O
NMR,263,266,O
-,266,267,O
visible,267,274,O
Na,275,277,O
+,277,278,O
[,279,280,O
35,280,282,O
],282,283,O
.,283,284,O
A,285,286,O
large,287,292,O
fraction,293,301,O
of,302,304,O
the,305,308,O
Rana,309,313,O
oocyte,314,320,B-Cell
Na,321,323,O
+,323,324,O
was,325,328,O
NMR,329,332,O
-,332,333,O
invisible,333,342,O
and,343,346,O
could,347,352,O
be,353,355,O
recovered,356,365,O
in,366,368,O
the,369,372,O
yolk,373,377,B-Cell
platelets,378,387,I-Cell
[,388,389,O
35,389,391,O
],391,392,O
.,392,393,O
During,394,400,O
the,401,404,O
first,405,410,O
meiotic,411,418,O
division,419,427,O
there,428,433,O
is,434,436,O
a,437,438,O
net,439,442,O
increase,443,451,O
in,452,454,O
NMR,455,458,O
-,458,459,O
visible,459,466,O
Na,467,469,O
+,469,470,O
;,470,471,O
by,472,474,O
completion,475,485,O
of,486,488,O
the,489,492,O
second,493,499,O
meiotic,500,507,O
division,508,516,O
(,517,518,O
following,518,527,O
fertilization,528,541,O
),541,542,O
",",542,543,O
about,544,549,O
70,550,552,O
%,552,553,O
of,554,556,O
the,557,560,O
total,561,566,O
Na,567,569,O
+,569,570,O
becomes,571,578,O
NMR,579,582,O
-,582,583,O
visible,583,590,O
.,590,591,O
Thus,592,596,O
",",596,597,O
phosvitin,598,607,O
not,608,611,O
only,612,616,O
serves,617,623,O
as,624,626,O
a,627,628,O
site,629,633,O
for,634,637,O
energy,638,644,O
storage,645,652,O
",",652,653,O
but,654,657,O
also,658,662,O
as,663,665,O
a,666,667,O
storage,668,675,O
site,676,680,O
for,681,684,O
iron,685,689,O
and,690,693,O
other,694,699,O
ions,700,704,O
essential,705,714,O
for,715,718,O
embryonic,719,728,B-Developing_anatomical_structure
development,729,740,O
in,741,743,O
ponds,744,749,O
and,750,753,O
streams,754,761,O
that,762,766,O
contain,767,774,O
little,775,781,O
dissolved,782,791,O
salts,792,797,O
and,798,801,O
minerals,802,810,O
.,810,811,O
Predicted,0,9,O
methylation,10,21,O
level,22,27,O
of,28,30,O
C,31,32,O
.,32,33,O
gigas,34,39,O
genes,40,45,O
categorized,46,57,O
by,58,60,O
biological,61,71,O
processes,72,81,O
compared,82,90,O
to,91,93,O
measured,94,102,O
level,103,108,O
of,109,111,O
DNA,112,115,O
methylation,116,127,O
.,127,128,O
Mean,129,133,O
CpG,134,137,O
O,138,139,O
/,139,140,O
E,140,141,O
for,142,145,O
10,146,148,O
",",148,149,O
699,149,152,O
C,153,154,O
.,154,155,O
gigas,156,161,O
genes,162,167,O
categorized,168,179,O
according,180,189,O
to,190,192,O
Biological,193,203,O
Process,204,211,O
Gene,212,216,O
Ontology,217,225,O
(,226,227,O
GO,227,229,O
),229,230,O
Slim,231,235,O
terms,236,241,O
are,242,245,O
plotted,246,253,O
on,254,256,O
the,257,260,O
x,261,262,O
-,262,263,O
axis,263,267,O
(,268,269,O
modified,269,277,O
from,278,282,O
Gavery,283,289,O
and,290,293,O
Roberts,294,301,O
",",301,302,O
2010,303,307,O
),307,308,O
.,308,309,O
DNA,310,313,O
methylation,314,325,O
was,326,329,O
empirically,330,341,O
measured,342,350,O
by,351,353,O
performing,354,364,O
MBD,365,368,O
-,368,369,O
seq,369,372,O
on,373,375,O
the,376,379,O
SOLiD,380,385,O
4,386,387,O
platform,388,396,O
(,397,398,O
Applied,398,405,O
Biosystems,406,416,O
),416,417,O
.,417,418,O
Genes,419,424,O
identified,425,435,O
in,436,438,O
the,439,442,O
MBD,443,446,O
-,446,447,O
library,447,454,O
were,455,459,O
associated,460,470,O
with,471,475,O
respective,476,486,O
GO,487,489,O
terms,490,495,O
and,496,499,O
enrichment,500,510,O
analysis,511,519,O
was,520,523,O
performed,524,533,O
based,534,539,O
on,540,542,O
the,543,546,O
entire,547,553,O
transcriptome,554,567,O
(,568,569,O
Fleury,569,575,O
et,576,578,O
al,579,581,O
.,581,582,O
",",582,583,O
2009,584,588,O
),588,589,O
using,590,595,O
DAVID,596,601,O
(,602,603,O
Huang,603,608,O
et,609,611,O
al,612,614,O
.,614,615,O
",",615,616,O
2009a,617,622,O
",",622,623,O
b,623,624,O
),624,625,O
.,625,626,O
Results,627,634,O
indicate,635,643,O
the,644,647,O
most,648,652,O
underrepresented,653,669,O
genes,670,675,O
in,676,678,O
the,679,682,O
library,683,690,O
are,691,694,O
involved,695,703,O
in,704,706,O
cell,707,711,B-Cell
adhesion,712,720,O
and,721,724,O
genes,725,730,O
involved,731,739,O
in,740,742,O
DNA,743,746,O
and,747,750,O
protein,751,758,O
metabolism,759,769,O
were,770,774,O
most,775,779,O
prevalent,780,789,O
in,790,792,O
the,793,796,O
MBD,797,800,O
-,800,801,O
library,801,808,O
.,808,809,O
Discussion,0,10,O
We,11,13,O
estimated,14,23,O
the,24,27,O
future,28,34,O
acceptability,35,48,O
of,49,51,O
PrEP,52,56,O
",",56,57,O
examining,58,67,O
the,68,71,O
attitudes,72,81,O
and,82,85,O
preferences,86,97,O
of,98,100,O
potential,101,110,O
user,111,115,O
groups,116,122,O
from,123,127,O
different,128,137,O
countries,138,147,O
towards,148,155,O
hypothetical,156,168,O
and,169,172,O
known,173,178,O
PrEP,179,183,O
attributes,184,194,O
.,194,195,O
Our,196,199,O
results,200,207,O
show,208,212,O
that,213,217,O
participants,218,230,O
were,231,235,O
generally,236,245,O
willing,246,253,O
to,254,256,O
accept,257,263,O
PrEP,264,268,O
and,269,272,O
adopt,273,278,O
it,279,281,O
as,282,284,O
soon,285,289,O
as,290,292,O
it,293,295,O
becomes,296,303,O
available,304,313,O
.,313,314,O
Surprisingly,315,327,O
",",327,328,O
participants,329,341,O
were,342,346,O
also,347,351,O
willing,352,359,O
to,360,362,O
take,363,367,O
PrEP,368,372,O
even,373,377,O
when,378,382,O
reminded,383,391,O
of,392,394,O
potential,395,404,O
side,405,409,O
effects,410,417,O
",",417,418,O
cost,419,423,O
",",423,424,O
condom,425,431,O
use,432,435,O
",",435,436,O
and,437,440,O
frequent,441,449,O
HIV,450,453,O
testing,454,461,O
.,461,462,O
These,463,468,O
findings,469,477,O
indicate,478,486,O
participants,487,499,O
',499,500,O
motivation,501,511,O
to,512,514,O
overcome,515,523,O
barriers,524,532,O
which,533,538,O
can,539,542,O
have,543,547,O
a,548,549,O
considerable,550,562,O
impact,563,569,O
on,570,572,O
uptake,573,579,O
.,579,580,O
In,581,583,O
contrast,584,592,O
",",592,593,O
participants,594,606,O
mentioned,607,616,O
that,617,621,O
the,622,625,O
thought,626,633,O
of,634,636,O
taking,637,643,O
PrEP,644,648,O
made,649,653,O
them,654,658,O
feel,659,663,O
anxious,664,671,O
",",671,672,O
although,673,681,O
they,682,686,O
also,687,691,O
indicated,692,701,O
that,702,706,O
taking,707,713,O
PrEP,714,718,O
would,719,724,O
not,725,728,O
be,729,731,O
embarrassing,732,744,O
and,745,748,O
they,749,753,O
would,754,759,O
want,760,764,O
their,765,770,O
partner,771,778,O
or,779,781,O
partners,782,790,O
to,791,793,O
know,794,798,O
.,798,799,O
Participants,800,812,O
',812,813,O
anxiety,814,821,O
may,822,825,O
be,826,828,O
explained,829,838,O
by,839,841,O
the,842,845,O
hypothetical,846,858,O
nature,859,865,O
of,866,868,O
most,869,873,O
of,874,876,O
the,877,880,O
presented,881,890,O
PrEP,891,895,O
characteristics,896,911,O
",",911,912,O
the,913,916,O
stigma,917,923,O
associated,924,934,O
with,935,939,O
HIV,940,943,O
[,944,945,O
34,945,947,O
],947,948,O
",",948,949,O
and,950,953,O
in,954,956,O
some,957,961,O
settings,962,970,O
",",970,971,O
the,972,975,O
criminalization,976,991,O
of,992,994,O
sex,995,998,O
work,999,1003,O
",",1003,1004,O
injected,1005,1013,O
drug,1014,1018,O
use,1019,1022,O
and,1023,1026,O
homosexuality,1027,1040,O
[,1041,1042,O
35,1042,1044,O
],1044,1045,O
.,1045,1046,O
Most,1047,1051,O
participants,1052,1064,O
",",1064,1065,O
nonetheless,1066,1077,O
",",1077,1078,O
subsequently,1079,1091,O
indicated,1092,1101,O
that,1102,1106,O
PrEP,1107,1111,O
would,1112,1117,O
give,1118,1122,O
them,1123,1127,O
hope,1128,1132,O
",",1132,1133,O
which,1134,1139,O
suggests,1140,1148,O
that,1149,1153,O
their,1154,1159,O
initial,1160,1167,O
willingness,1168,1179,O
to,1180,1182,O
take,1183,1187,O
it,1188,1190,O
remained,1191,1199,O
largely,1200,1207,O
unscathed,1208,1217,O
.,1217,1218,O
Female,1219,1225,O
participants,1226,1238,O
indicated,1239,1248,O
a,1249,1250,O
higher,1251,1257,O
level,1258,1263,O
of,1264,1266,O
willingness,1267,1278,O
to,1279,1281,O
take,1282,1286,O
PrEP,1287,1291,O
than,1292,1296,O
male,1297,1301,O
participants,1302,1314,O
",",1314,1315,O
which,1316,1321,O
may,1322,1325,O
be,1326,1328,O
explained,1329,1338,O
by,1339,1341,O
women,1342,1347,O
',1347,1348,O
s,1348,1349,O
difficulty,1350,1360,O
negotiating,1361,1372,O
the,1373,1376,O
use,1377,1380,O
of,1381,1383,O
condoms,1384,1391,O
and,1392,1395,O
awareness,1396,1405,O
of,1406,1408,O
their,1409,1414,O
and,1415,1418,O
/,1418,1419,O
or,1419,1421,O
their,1422,1427,O
partners,1428,1436,O
',1436,1437,O
risk,1438,1442,O
of,1443,1445,O
becoming,1446,1454,O
infected,1455,1463,O
with,1464,1468,O
HIV,1469,1472,O
[,1473,1474,O
36,1474,1476,O
],1476,1477,O
.,1477,1478,O
We,1479,1481,O
also,1482,1486,O
found,1487,1492,O
that,1493,1497,O
younger,1498,1505,O
participants,1506,1518,O
and,1519,1522,O
those,1523,1528,O
with,1529,1533,O
fewer,1534,1539,O
children,1540,1548,O
",",1548,1549,O
those,1550,1555,O
who,1556,1559,O
reported,1560,1568,O
adherence,1569,1578,O
to,1579,1581,O
past,1582,1586,O
medication,1587,1597,O
",",1597,1598,O
more,1599,1603,O
frequent,1604,1612,O
condom,1613,1619,O
usage,1620,1625,O
",",1625,1626,O
having,1627,1633,O
been,1634,1638,O
tested,1639,1645,O
for,1646,1649,O
HIV,1650,1653,O
in,1654,1656,O
the,1657,1660,O
past,1661,1665,O
and,1666,1669,O
never,1670,1675,O
injecting,1676,1685,O
drugs,1686,1691,O
",",1691,1692,O
reported,1693,1701,O
greater,1702,1709,O
willingness,1710,1721,O
to,1722,1724,O
take,1725,1729,O
PrEP,1730,1734,O
.,1734,1735,O
These,1736,1741,O
promising,1742,1751,O
findings,1752,1760,O
suggest,1761,1768,O
that,1769,1773,O
those,1774,1779,O
who,1780,1783,O
are,1784,1787,O
currently,1788,1797,O
bearing,1798,1805,O
the,1806,1809,O
brunt,1810,1815,O
of,1816,1818,O
HIV,1819,1822,O
[,1823,1824,O
1,1824,1825,O
],1825,1826,O
",",1826,1827,O
have,1828,1832,O
higher,1833,1839,O
perceived,1840,1849,O
risk,1850,1854,O
",",1854,1855,O
and,1856,1859,O
are,1860,1863,O
most,1864,1868,O
likely,1869,1875,O
to,1876,1878,O
adhere,1879,1885,O
to,1886,1888,O
a,1889,1890,O
comprehensive,1891,1904,O
PrEP,1905,1909,O
program,1910,1917,O
",",1917,1918,O
are,1919,1922,O
also,1923,1927,O
the,1928,1931,O
most,1932,1936,O
motivated,1937,1946,O
to,1947,1949,O
enroll,1950,1956,O
.,1956,1957,O
Yet,1958,1961,O
",",1961,1962,O
while,1963,1968,O
participants,1969,1981,O
stated,1982,1988,O
not,1989,1992,O
being,1993,1998,O
interested,1999,2009,O
in,2010,2012,O
selling,2013,2020,O
PrEP,2021,2025,O
",",2025,2026,O
the,2027,2030,O
majority,2031,2039,O
reported,2040,2048,O
intentions,2049,2059,O
to,2060,2062,O
share,2063,2068,O
it,2069,2071,O
.,2071,2072,O
Therefore,2073,2082,O
",",2082,2083,O
information,2084,2095,O
and,2096,2099,O
counseling,2100,2110,O
about,2111,2116,O
the,2117,2120,O
risks,2121,2126,O
of,2127,2129,O
sharing,2130,2137,O
PrEP,2138,2142,O
should,2143,2149,O
be,2150,2152,O
readily,2153,2160,O
available,2161,2170,O
as,2171,2173,O
part,2174,2178,O
of,2179,2181,O
any,2182,2185,O
implementation,2186,2200,O
program,2201,2208,O
.,2208,2209,O
Results,2210,2217,O
from,2218,2222,O
the,2223,2226,O
conjoint,2227,2235,O
analysis,2236,2244,O
reveal,2245,2251,O
trends,2252,2258,O
in,2259,2261,O
participants,2262,2274,O
',2274,2275,O
preferences,2276,2287,O
which,2288,2293,O
deserve,2294,2301,O
consideration,2302,2315,O
.,2315,2316,O
PrEP,2317,2321,O
route,2322,2327,O
of,2328,2330,O
administration,2331,2345,O
was,2346,2349,O
the,2350,2353,O
most,2354,2358,O
important,2359,2368,O
attribute,2369,2378,O
",",2378,2379,O
and,2380,2383,O
bi,2384,2386,O
-,2386,2387,O
monthly,2387,2394,O
and,2395,2398,O
monthly,2399,2406,O
injections,2407,2417,O
were,2418,2422,O
the,2423,2426,O
preferred,2427,2436,O
alternatives,2437,2449,O
.,2449,2450,O
This,2451,2455,O
finding,2456,2463,O
is,2464,2466,O
encouraging,2467,2478,O
from,2479,2483,O
a,2484,2485,O
policy,2486,2492,O
perspective,2493,2504,O
if,2505,2507,O
such,2508,2512,O
modalities,2513,2523,O
become,2524,2530,O
available,2531,2540,O
;,2540,2541,O
since,2542,2547,O
it,2548,2550,O
may,2551,2554,O
reduce,2555,2561,O
users,2562,2567,O
',2567,2568,O
likelihood,2569,2579,O
of,2580,2582,O
sharing,2583,2590,O
",",2590,2591,O
selling,2592,2599,O
or,2600,2602,O
forgetting,2603,2613,O
to,2614,2616,O
take,2617,2621,O
PrEP,2622,2626,O
",",2626,2627,O
but,2628,2631,O
it,2632,2634,O
also,2635,2639,O
raises,2640,2646,O
questions,2647,2656,O
regarding,2657,2666,O
participants,2667,2679,O
',2679,2680,O
willingness,2681,2692,O
to,2693,2695,O
take,2696,2700,O
oral,2701,2705,O
PrEP,2706,2710,O
.,2710,2711,O
HIV,2712,2715,O
testing,2716,2723,O
was,2724,2727,O
the,2728,2731,O
second,2732,2738,O
most,2739,2743,O
important,2744,2753,O
attribute,2754,2763,O
",",2763,2764,O
and,2765,2768,O
a,2769,2770,O
test,2771,2775,O
every,2776,2781,O
six,2782,2785,O
months,2786,2792,O
was,2793,2796,O
",",2796,2797,O
as,2798,2800,O
expected,2801,2809,O
",",2809,2810,O
the,2811,2814,O
preferred,2815,2824,O
alternative,2825,2836,O
.,2836,2837,O
Interestingly,2838,2851,O
",",2851,2852,O
dispensing,2853,2863,O
sites,2864,2869,O
were,2870,2874,O
more,2875,2879,O
important,2880,2889,O
than,2890,2894,O
any,2895,2898,O
other,2899,2904,O
attribute,2905,2914,O
for,2915,2918,O
some,2919,2923,O
groups,2924,2930,O
",",2930,2931,O
particularly,2932,2944,O
in,2945,2947,O
Africa,2948,2954,O
.,2954,2955,O
This,2956,2960,O
may,2961,2964,O
indicate,2965,2973,O
concerns,2974,2982,O
about,2983,2988,O
social,2989,2995,O
stigma,2996,3002,O
and,3003,3006,O
access,3007,3013,O
[,3014,3015,O
37,3015,3017,O
],3017,3018,O
.,3018,3019,O
However,3020,3027,O
",",3027,3028,O
it,3029,3031,O
is,3032,3034,O
encouraging,3035,3046,O
that,3047,3051,O
most,3052,3056,O
participants,3057,3069,O
were,3070,3074,O
willing,3075,3082,O
to,3083,3085,O
receive,3086,3093,O
PrEP,3094,3098,O
at,3099,3101,O
a,3102,3103,O
healthcare,3104,3114,O
facility,3115,3123,O
",",3123,3124,O
which,3125,3130,O
can,3131,3134,O
facilitate,3135,3145,O
synergies,3146,3155,O
between,3156,3163,O
PrEP,3164,3168,O
and,3169,3172,O
other,3173,3178,O
existing,3179,3187,O
prevention,3188,3198,O
services,3199,3207,O
.,3207,3208,O
Time,3209,3213,O
spent,3214,3219,O
obtaining,3220,3229,O
PrEP,3230,3234,O
and,3235,3238,O
frequency,3239,3248,O
of,3249,3251,O
pick,3252,3256,O
up,3257,3259,O
",",3259,3260,O
which,3261,3266,O
we,3267,3269,O
used,3270,3274,O
as,3275,3277,O
a,3278,3279,O
proxy,3280,3285,O
measure,3286,3293,O
for,3294,3297,O
cost,3298,3302,O
-,3302,3303,O
opportunity,3303,3314,O
",",3314,3315,O
were,3316,3320,O
generally,3321,3330,O
less,3331,3335,O
important,3336,3345,O
",",3345,3346,O
consistent,3347,3357,O
with,3358,3362,O
participants,3363,3375,O
',3375,3376,O
willingness,3377,3388,O
to,3389,3391,O
pay,3392,3395,O
for,3396,3399,O
PrEP,3400,3404,O
.,3404,3405,O
Our,3406,3409,O
findings,3410,3418,O
are,3419,3422,O
broadly,3423,3430,O
consistent,3431,3441,O
with,3442,3446,O
the,3447,3450,O
work,3451,3455,O
of,3456,3458,O
Guest,3459,3464,O
et,3465,3467,O
al,3468,3470,O
.,3470,3471,O
and,3472,3475,O
Galea,3476,3481,O
et,3482,3484,O
al,3485,3487,O
[,3488,3489,O
18,3489,3491,O
],3491,3492,O
",",3492,3493,O
[,3494,3495,O
19,3495,3497,O
],3497,3498,O
.,3498,3499,O
However,3500,3507,O
",",3507,3508,O
specific,3509,3517,O
comparisons,3518,3529,O
are,3530,3533,O
not,3534,3537,O
advisable,3538,3547,O
as,3548,3550,O
the,3551,3554,O
composition,3555,3566,O
and,3567,3570,O
size,3571,3575,O
of,3576,3578,O
the,3579,3582,O
samples,3583,3590,O
",",3590,3591,O
recruitment,3592,3603,O
methods,3604,3611,O
",",3611,3612,O
measures,3613,3621,O
and,3622,3625,O
statistical,3626,3637,O
analyses,3638,3646,O
differ,3647,3653,O
greatly,3654,3661,O
.,3661,3662,O
Previous,3663,3671,O
work,3672,3676,O
on,3677,3679,O
PrEP,3680,3684,O
implementation,3685,3699,O
suggests,3700,3708,O
that,3709,3713,O
delivery,3714,3722,O
programs,3723,3731,O
will,3732,3736,O
need,3737,3741,O
to,3742,3744,O
meet,3745,3749,O
a,3750,3751,O
number,3752,3758,O
of,3759,3761,O
requirements,3762,3774,O
in,3775,3777,O
order,3778,3783,O
to,3784,3786,O
be,3787,3789,O
effective,3790,3799,O
",",3799,3800,O
including,3801,3810,O
:,3810,3811,O
prioritization,3812,3826,O
of,3827,3829,O
groups,3830,3836,O
at,3837,3839,O
higher,3840,3846,O
risk,3847,3851,O
of,3852,3854,O
infection,3855,3864,O
;,3864,3865,O
delivery,3866,3874,O
of,3875,3877,O
PrEP,3878,3882,O
in,3883,3885,O
combination,3886,3897,O
with,3898,3902,O
other,3903,3908,O
prevention,3909,3919,O
services,3920,3928,O
",",3928,3929,O
including,3930,3939,O
risk,3940,3944,O
reduction,3945,3954,O
and,3955,3958,O
medication,3959,3969,O
adherence,3970,3979,O
counseling,3980,3990,O
",",3990,3991,O
condoms,3992,3999,O
provision,4000,4009,O
",",4009,4010,O
diagnosis,4011,4020,O
and,4021,4024,O
treatment,4025,4034,O
of,4035,4037,O
other,4038,4043,O
sexually,4044,4052,O
transmitted,4053,4064,O
infections,4065,4075,O
",",4075,4076,O
and,4077,4080,O
frequent,4081,4089,O
HIV,4090,4093,O
testing,4094,4101,O
;,4101,4102,O
and,4103,4106,O
monitoring,4107,4117,O
of,4118,4120,O
side,4121,4125,O
effects,4126,4133,O
",",4133,4134,O
adherence,4135,4144,O
and,4145,4148,O
risk,4149,4153,O
behaviors,4154,4163,O
[,4164,4165,O
8,4165,4166,O
],4166,4167,O
",",4167,4168,O
[,4169,4170,O
38,4170,4172,O
],4172,4173,O
",",4173,4174,O
[,4175,4176,O
39,4176,4178,O
],4178,4179,O
",",4179,4180,O
[,4181,4182,O
40,4182,4184,O
],4184,4185,O
",",4185,4186,O
[,4187,4188,O
41,4188,4190,O
],4190,4191,O
",",4191,4192,O
[,4193,4194,O
42,4194,4196,O
],4196,4197,O
.,4197,4198,O
Our,4199,4202,O
results,4203,4210,O
provide,4211,4218,O
valuable,4219,4227,O
clues,4228,4233,O
that,4234,4238,O
can,4239,4242,O
help,4243,4247,O
countries,4248,4257,O
to,4258,4260,O
deliver,4261,4268,O
PrEP,4269,4273,O
more,4274,4278,O
effectively,4279,4290,O
",",4290,4291,O
should,4292,4298,O
they,4299,4303,O
decide,4304,4310,O
to,4311,4313,O
implement,4314,4323,O
it,4324,4326,O
",",4326,4327,O
by,4328,4330,O
focusing,4331,4339,O
their,4340,4345,O
efforts,4346,4353,O
on,4354,4356,O
the,4357,4360,O
aspects,4361,4368,O
that,4369,4373,O
need,4374,4378,O
more,4379,4383,O
attention,4384,4393,O
.,4393,4394,O
This,4395,4399,O
is,4400,4402,O
the,4403,4406,O
first,4407,4412,O
multinational,4413,4426,O
study,4427,4432,O
",",4432,4433,O
to,4434,4436,O
our,4437,4440,O
knowledge,4441,4450,O
",",4450,4451,O
that,4452,4456,O
integrates,4457,4467,O
different,4468,4477,O
disciplines,4478,4489,O
to,4490,4492,O
shed,4493,4497,O
light,4498,4503,O
on,4504,4506,O
a,4507,4508,O
question,4509,4517,O
that,4518,4522,O
we,4523,4525,O
believe,4526,4533,O
is,4534,4536,O
of,4537,4539,O
global,4540,4546,O
importance,4547,4557,O
.,4557,4558,O
Our,4559,4562,O
study,4563,4568,O
complements,4569,4580,O
previous,4581,4589,O
work,4590,4594,O
on,4595,4597,O
PrEP,4598,4602,O
by,4603,4605,O
examining,4606,4615,O
potential,4616,4625,O
users,4626,4631,O
',4631,4632,O
perspective,4633,4644,O
and,4645,4648,O
offering,4649,4657,O
insights,4658,4666,O
into,4667,4671,O
their,4672,4677,O
attitudes,4678,4687,O
and,4688,4691,O
preferences,4692,4703,O
.,4703,4704,O
We,4705,4707,O
note,4708,4712,O
that,4713,4717,O
it,4718,4720,O
may,4721,4724,O
not,4725,4728,O
be,4729,4731,O
possible,4732,4740,O
to,4741,4743,O
generalize,4744,4754,O
the,4755,4758,O
observed,4759,4767,O
PrEP,4768,4772,O
acceptability,4773,4786,O
to,4787,4789,O
other,4790,4795,O
settings,4796,4804,O
and,4805,4808,O
our,4809,4812,O
results,4813,4820,O
should,4821,4827,O
be,4828,4830,O
considered,4831,4841,O
within,4842,4848,O
the,4849,4852,O
context,4853,4860,O
of,4861,4863,O
this,4864,4868,O
study,4869,4874,O
',4874,4875,O
s,4875,4876,O
limitations,4877,4888,O
.,4888,4889,O
Given,4890,4895,O
the,4896,4899,O
sensitive,4900,4909,O
nature,4910,4916,O
of,4917,4919,O
the,4920,4923,O
addressed,4924,4933,O
questions,4934,4943,O
",",4943,4944,O
and,4945,4948,O
despite,4949,4956,O
all,4957,4960,O
our,4961,4964,O
efforts,4965,4972,O
to,4973,4975,O
reduce,4976,4982,O
social,4983,4989,O
desirability,4990,5002,O
bias,5003,5007,O
",",5007,5008,O
there,5009,5014,O
is,5015,5017,O
an,5018,5020,O
unavoidable,5021,5032,O
risk,5033,5037,O
that,5038,5042,O
participants,5043,5055,O
may,5056,5059,O
have,5060,5064,O
felt,5065,5069,O
at,5070,5072,O
times,5073,5078,O
compelled,5079,5088,O
to,5089,5091,O
provide,5092,5099,O
what,5100,5104,O
they,5105,5109,O
felt,5110,5114,O
was,5115,5118,O
the,5119,5122,O
"""",5123,5124,O
right,5124,5129,O
"""",5129,5130,O
answer,5131,5137,O
.,5137,5138,O
Additionally,5139,5151,O
",",5151,5152,O
our,5153,5156,O
data,5157,5161,O
collection,5162,5172,O
took,5173,5177,O
place,5178,5183,O
in,5184,5186,O
urban,5187,5192,O
areas,5193,5198,O
",",5198,5199,O
where,5200,5205,O
HIV,5206,5209,O
incidence,5210,5219,O
is,5220,5222,O
normally,5223,5231,O
higher,5232,5238,O
",",5238,5239,O
thus,5240,5244,O
current,5245,5252,O
findings,5253,5261,O
may,5262,5265,O
not,5266,5269,O
be,5270,5272,O
generalizable,5273,5286,O
to,5287,5289,O
rural,5290,5295,O
settings,5296,5304,O
.,5304,5305,O
Finally,5306,5313,O
",",5313,5314,O
examining,5315,5324,O
acceptability,5325,5338,O
among,5339,5344,O
users,5345,5350,O
enrolled,5351,5359,O
in,5360,5362,O
pilot,5363,5368,O
programs,5369,5377,O
is,5378,5380,O
much,5381,5385,O
deserving,5386,5395,O
",",5395,5396,O
as,5397,5399,O
actual,5400,5406,O
acceptability,5407,5420,O
may,5421,5424,O
differ,5425,5431,O
from,5432,5436,O
potential,5437,5446,O
willingness,5447,5458,O
to,5459,5461,O
take,5462,5466,O
PrEP,5467,5471,O
",",5471,5472,O
especially,5473,5483,O
if,5484,5486,O
relevant,5487,5495,O
attributes,5496,5506,O
of,5507,5509,O
a,5510,5511,O
product,5512,5519,O
or,5520,5522,O
program,5523,5530,O
are,5531,5534,O
modified,5535,5543,O
",",5543,5544,O
as,5545,5547,O
observed,5548,5556,O
in,5557,5559,O
other,5560,5565,O
comparable,5566,5576,O
interventions,5577,5590,O
[,5591,5592,O
43,5592,5594,O
],5594,5595,O
.,5595,5596,O
Origins,0,7,O
of,8,10,O
Acquired,11,19,O
Antibiotic,20,30,O
Resistance,31,41,O
Mechanisms,42,52,O
Recently,53,61,O
",",61,62,O
D,63,64,O
',64,65,O
Costa,65,70,O
et,71,73,O
al,74,76,O
.,76,77,O
(,78,79,O
2011,79,83,O
),83,84,O
have,85,89,O
reported,90,98,O
a,99,100,O
metagenomic,101,112,O
analysis,113,121,O
of,122,124,O
the,125,128,O
Beringian,129,138,O
permafrost,139,149,O
",",149,150,O
which,151,156,O
is,157,159,O
30,160,162,O
",",162,163,O
000,163,166,O
years,167,172,O
old,173,176,O
.,176,177,O
They,178,182,O
showed,183,189,O
molecular,190,199,O
evidences,200,209,O
of,210,212,O
the,213,216,O
ancient,217,224,O
origins,225,232,O
of,233,235,O
antibiotic,236,246,O
resistances,247,258,O
",",258,259,O
detecting,260,269,O
beta,270,274,O
-,274,275,O
lactamases,275,285,O
genes,286,291,O
",",291,292,O
vanX,293,297,O
-,297,298,O
like,298,302,O
",",302,303,O
component,304,313,O
of,314,316,O
the,317,320,O
vancomycin,321,331,O
resistance,332,342,O
operon,343,349,O
",",349,350,O
and,351,354,O
tetM,355,359,O
",",359,360,O
coding,361,367,O
for,368,371,O
a,372,373,O
protein,374,381,O
protecting,382,392,O
the,393,396,O
ribosomal,397,406,B-Cellular_component
target,407,413,O
from,414,418,O
tetracycline,419,431,O
.,431,432,O
Sequence,433,441,O
analysis,442,450,O
revealed,451,459,O
that,460,464,O
the,465,468,O
beta,469,473,O
-,473,474,O
lactamases,474,484,O
genes,485,490,O
recovered,491,500,O
from,501,505,O
the,506,509,O
permafrost,510,520,O
demonstrated,521,533,O
an,534,536,O
amino,537,542,O
-,542,543,O
acid,543,547,O
homology,548,556,O
(,557,558,O
53,558,560,O
-,560,561,O
84,561,563,O
%,563,564,O
),564,565,O
to,566,568,O
known,569,574,O
beta,575,579,O
-,579,580,O
lactamases,580,590,O
from,591,595,O
beta,596,600,O
-,600,601,O
lactams,601,608,O
producing,609,618,O
Streptomyces,619,631,O
.,631,632,O
The,633,636,O
tetM,637,641,O
sequences,642,651,O
revealed,652,660,O
a,661,662,O
high,663,667,O
similarity,668,678,O
to,679,681,O
the,682,685,O
genes,686,691,O
coding,692,698,O
for,699,702,O
the,703,706,O
ribosomal,707,716,B-Cellular_component
protection,717,727,O
protein,728,735,O
of,736,738,O
actinomycetes,739,752,O
.,752,753,O
The,754,757,O
vanX,758,762,O
sequence,763,771,O
showed,772,778,O
a,779,780,O
similarity,781,791,O
to,792,794,O
the,795,798,O
vanX,799,803,O
gene,804,808,O
recovered,809,818,O
in,819,821,O
pathogenic,822,832,O
vancomycin,833,843,O
resistant,844,853,O
enterococci,854,865,O
(,866,867,O
VRE,867,870,O
),870,871,O
and,872,875,O
to,876,878,O
the,879,882,O
vanX,883,887,O
gene,888,892,O
from,893,897,O
Amycolatopsis,898,911,O
orientalis,912,922,O
.,922,923,O
This,924,928,O
environmental,929,942,O
species,943,950,O
",",950,951,O
belonging,952,961,O
to,962,964,O
the,965,968,O
actinobacteria,969,983,O
phylum,984,990,O
",",990,991,O
is,992,994,O
a,995,996,O
natural,997,1004,O
producer,1005,1013,O
of,1014,1016,O
vancomycin,1017,1027,O
",",1027,1028,O
and,1029,1032,O
very,1033,1037,O
likely,1038,1044,O
the,1045,1048,O
progenitor,1049,1059,O
of,1060,1062,O
the,1063,1066,O
van,1067,1070,O
genes,1071,1076,O
operons,1077,1084,O
",",1084,1085,O
responsible,1086,1097,O
for,1098,1101,O
resistance,1102,1112,O
to,1113,1115,O
vancomycin,1116,1126,O
.,1126,1127,O
The,1128,1131,O
integration,1132,1143,O
of,1144,1146,O
the,1147,1150,O
van,1151,1154,O
operons,1155,1162,O
on,1163,1165,O
transposons,1166,1177,O
and,1178,1181,O
on,1182,1184,O
conjugative,1185,1196,B-Cellular_component
plasmids,1197,1205,I-Cellular_component
has,1206,1209,O
enhanced,1210,1218,O
their,1219,1224,O
spread,1225,1231,O
(,1232,1233,O
Courvalin,1233,1242,O
",",1242,1243,O
2006,1244,1248,O
),1248,1249,O
.,1249,1250,O
Reports,1251,1258,O
of,1259,1261,O
VRE,1262,1265,O
in,1266,1268,O
freshwater,1269,1279,O
have,1280,1284,O
been,1285,1289,O
provided,1290,1298,O
by,1299,1301,O
several,1302,1309,O
authors,1310,1317,O
(,1318,1319,O
Talebi,1319,1325,O
et,1326,1328,O
al,1329,1331,O
.,1331,1332,O
",",1332,1333,O
2008,1334,1338,O
;,1338,1339,O
Lata,1340,1344,O
et,1345,1347,O
al,1348,1350,O
.,1350,1351,O
",",1351,1352,O
2009,1353,1357,O
;,1357,1358,O
Luczkiewicz,1359,1370,O
et,1371,1373,O
al,1374,1376,O
.,1376,1377,O
",",1377,1378,O
2010,1379,1383,O
),1383,1384,O
.,1384,1385,O
Interestingly,1386,1399,O
",",1399,1400,O
Schwartz,1401,1409,O
et,1410,1412,O
al,1413,1415,O
.,1415,1416,O
(,1417,1418,O
2003,1418,1422,O
),1422,1423,O
detected,1424,1432,O
vanA,1433,1437,O
genes,1438,1443,O
in,1444,1446,O
the,1447,1450,O
biofilm,1451,1458,B-Cell
of,1459,1461,O
drinking,1462,1470,O
water,1471,1476,O
supplies,1477,1485,O
",",1485,1486,O
in,1487,1489,O
the,1490,1493,O
absence,1494,1501,O
of,1502,1504,O
enterococci,1505,1516,O
",",1516,1517,O
demonstrating,1518,1531,O
the,1532,1535,O
lateral,1536,1543,O
transfer,1544,1552,O
of,1553,1555,O
this,1556,1560,O
gene,1561,1565,O
.,1565,1566,O
Notably,1567,1574,O
",",1574,1575,O
the,1576,1579,O
progenitors,1580,1591,O
of,1592,1594,O
these,1595,1600,O
resistance,1601,1611,O
genes,1612,1617,O
are,1618,1621,O
soil,1622,1626,O
bacteria,1627,1635,O
thus,1636,1640,O
most,1641,1645,O
likely,1646,1652,O
",",1652,1653,O
a,1654,1655,O
shuttle,1656,1663,O
has,1664,1667,O
been,1668,1672,O
responsible,1673,1684,O
for,1685,1688,O
the,1689,1692,O
introduction,1693,1705,O
of,1706,1708,O
these,1709,1714,O
genes,1715,1720,O
into,1721,1725,O
the,1726,1729,O
commensal,1730,1739,O
bacterial,1740,1749,O
community,1750,1759,O
and,1760,1763,O
afterward,1764,1773,O
into,1774,1778,O
the,1779,1782,O
pathogenic,1783,1793,O
species,1794,1801,O
.,1801,1802,O
Results,0,7,O
Supplementary,0,13,O
Material,14,22,O
Crystal,23,30,O
structure,31,40,O
:,40,41,O
contains,42,50,O
datablock,51,60,O
(,60,61,O
s,61,62,O
),62,63,O
global,64,70,O
",",70,71,O
I,72,73,O
.,73,74,O
DOI,75,78,O
:,78,79,O
10,80,82,O
.,82,83,O
1107,83,87,O
/,87,88,O
S1600536812002796,88,105,O
/,105,106,O
hg5166sup1,106,116,O
.,116,117,O
cif,117,120,O
Structure,121,130,O
factors,131,138,O
:,138,139,O
contains,140,148,O
datablock,149,158,O
(,158,159,O
s,159,160,O
),160,161,O
I,162,163,O
.,163,164,O
DOI,165,168,O
:,168,169,O
10,170,172,O
.,172,173,O
1107,173,177,O
/,177,178,O
S1600536812002796,178,195,O
/,195,196,O
hg5166Isup2,196,207,O
.,207,208,O
hkl,208,211,O
Additional,212,222,O
supplementary,223,236,O
materials,237,246,O
:,246,247,O
crystallographic,248,264,O
information,265,276,O
;,276,277,O
3D,278,280,O
view,281,285,O
;,285,286,O
checkCIF,287,295,O
report,296,302,O
Results,0,7,O
Images,0,6,O
Figure,7,13,O
1,14,15,O
Figure,16,22,O
2,23,24,O
Figure,25,31,O
3,32,33,O
Figure,34,40,O
4,41,42,O
Results,0,7,O
Images,0,6,O
FIGURE,7,13,O
2,14,15,O
.,15,16,O
Nf,0,2,O
and,3,6,O
GA,7,9,O
-,9,10,O
1,10,11,O
DNA,12,15,O
polymerases,16,27,O
couple,28,34,O
polymerization,35,49,O
to,50,52,O
strand,53,59,O
displacement,60,72,O
processively,73,85,O
The,86,89,O
results,90,97,O
presented,98,107,O
in,108,110,O
this,111,115,O
paper,116,121,O
clearly,122,129,O
indicate,130,138,O
that,139,143,O
Nf,144,146,O
and,147,150,O
GA,151,153,O
-,153,154,O
1,154,155,O
DNA,156,159,O
polymerases,160,171,O
can,172,175,O
account,176,183,O
for,184,187,O
their,188,193,O
genome,194,200,O
replication,201,212,O
without,213,220,O
the,221,224,O
assistance,225,235,O
of,236,238,O
unwinding,239,248,O
and,249,252,O
processivity,253,265,O
factors,266,273,O
",",273,274,O
in,275,277,O
contrast,278,286,O
to,287,289,O
most,290,294,O
replicative,295,306,O
DNA,307,310,O
polymerases,311,322,O
which,323,328,O
require,329,336,O
their,337,342,O
physical,343,351,O
association,352,363,O
to,364,366,O
processivity,367,379,O
factors,380,387,O
and,388,391,O
DNA,392,395,O
unwinding,396,405,O
proteins,406,414,O
(,415,416,O
1,416,417,O
",",417,418,O
70,418,420,O
),420,421,O
.,421,422,O
Strand,423,429,O
displacement,430,442,O
capacity,443,451,O
has,452,455,O
also,456,460,O
been,461,465,O
shown,466,471,O
for,472,475,O
other,476,481,O
protein,482,489,O
-,489,490,O
primed,490,496,O
DNA,497,500,O
polymerases,501,512,O
as,513,515,O
those,516,521,O
of,522,524,O
bacteriophages,525,539,O
phi29,540,545,O
(,546,547,O
10,547,549,O
),549,550,O
",",550,551,O
Cp,552,554,O
-,554,555,O
1,555,556,O
(,557,558,O
71,558,560,O
),560,561,O
and,562,565,O
PRD1,566,570,O
(,571,572,O
72,572,574,O
",",574,575,O
73,575,577,O
),577,578,O
.,578,579,O
On,580,582,O
the,583,586,O
contrary,587,595,O
",",595,596,O
adenovirus,597,607,O
DNA,608,611,O
polymerase,612,622,O
",",622,623,O
although,624,632,O
processive,633,643,O
",",643,644,O
cannot,645,651,O
couple,652,658,O
polymerization,659,673,O
to,674,676,O
strand,677,683,O
displacement,684,696,O
",",696,697,O
requiring,698,707,O
the,708,711,O
DNA,712,715,O
unwinding,716,725,O
activity,726,734,O
of,735,737,O
the,738,741,O
adenovirus,742,752,O
DBP,753,756,O
to,757,759,O
perform,760,767,O
strand,768,774,O
displacement,775,787,O
(,788,789,O
74,789,791,O
",",791,792,O
75,792,794,O
),794,795,O
.,795,796,O
Whereas,797,804,O
it,805,807,O
was,808,811,O
possible,812,820,O
to,821,823,O
obtain,824,830,O
GA,831,833,O
-,833,834,O
1,834,835,O
DNA,836,839,O
replication,840,851,O
by,852,854,O
using,855,860,O
exclusively,861,872,O
the,873,876,O
GA,877,879,O
-,879,880,O
1,880,881,O
TP,882,884,O
and,885,888,O
DNA,889,892,O
polymerase,893,903,O
",",903,904,O
Nf,905,907,O
DNA,908,911,O
polymerase,912,922,O
",",922,923,O
although,924,932,O
provided,933,941,O
with,942,946,O
competent,947,956,O
strand,957,963,O
displacement,964,976,O
and,977,980,O
processivity,981,993,O
features,994,1002,O
",",1002,1003,O
required,1004,1012,O
the,1013,1016,O
presence,1017,1025,O
of,1026,1028,O
Nf,1029,1031,O
DBP,1032,1035,O
for,1036,1039,O
an,1040,1042,O
effective,1043,1052,O
in,1053,1055,O
vitro,1056,1061,O
replication,1062,1073,O
of,1074,1076,O
Nf,1077,1079,O
TP,1080,1082,O
-,1082,1083,O
DNA,1083,1086,O
.,1086,1087,O
Results,1088,1095,O
presented,1096,1105,O
here,1106,1110,O
show,1111,1115,O
that,1116,1120,O
Nf,1121,1123,O
DBP,1124,1127,O
strongly,1128,1136,O
stimulates,1137,1147,O
the,1148,1151,O
formation,1152,1161,O
of,1162,1164,O
the,1165,1168,O
TP,1169,1171,O
-,1171,1172,O
dAMP,1172,1176,O
initiation,1177,1187,O
complex,1188,1195,O
by,1196,1198,O
decreasing,1199,1209,O
the,1210,1213,O
Km,1214,1216,O
for,1217,1220,O
dATP,1221,1225,O
and,1226,1229,O
facilitates,1230,1241,O
the,1242,1245,O
transition,1246,1256,O
from,1257,1261,O
initiation,1262,1272,O
to,1273,1275,O
elongation,1276,1286,O
",",1286,1287,O
as,1288,1290,O
it,1291,1293,O
occurs,1294,1300,O
in,1301,1303,O
phi29,1304,1309,O
(,1310,1311,O
76,1311,1313,O
),1313,1314,O
.,1314,1315,O
These,1316,1321,O
results,1322,1329,O
point,1330,1335,O
to,1336,1338,O
either,1339,1345,O
a,1346,1347,O
specific,1348,1356,O
and,1357,1360,O
direct,1361,1367,O
contact,1368,1375,O
between,1376,1383,O
DBP,1384,1387,O
and,1388,1391,O
DNA,1392,1395,O
polymerase,1396,1406,O
that,1407,1411,O
promotes,1412,1420,O
conformational,1421,1435,O
changes,1436,1443,O
at,1444,1446,O
the,1447,1450,O
polymerization,1451,1465,O
active,1466,1472,O
site,1473,1477,O
or,1478,1480,O
to,1481,1483,O
an,1484,1486,O
effect,1487,1493,O
of,1494,1496,O
DBP,1497,1500,O
in,1501,1503,O
conferring,1504,1514,O
the,1515,1518,O
optimal,1519,1526,O
template,1527,1535,O
structure,1536,1545,O
to,1546,1548,O
direct,1549,1555,O
initiating,1556,1566,O
nucleotide,1567,1577,O
insertion,1578,1587,O
.,1587,1588,O
A,1589,1590,O
similar,1591,1598,O
role,1599,1603,O
has,1604,1607,O
been,1608,1612,O
proposed,1613,1621,O
for,1622,1625,O
adenovirus,1626,1636,O
DBP,1637,1640,O
",",1640,1641,O
a,1642,1643,O
DNA,1644,1647,O
unwinding,1648,1657,O
protein,1658,1665,O
(,1666,1667,O
77,1667,1669,O
),1669,1670,O
.,1670,1671,O
As,1672,1674,O
in,1675,1677,O
the,1678,1681,O
case,1682,1686,O
of,1687,1689,O
phi29,1690,1695,O
and,1696,1699,O
Nf,1700,1702,O
DBP,1703,1706,O
",",1706,1707,O
this,1708,1712,O
protein,1713,1720,O
stimulates,1721,1731,O
the,1732,1735,O
rate,1736,1740,O
of,1741,1743,O
initiation,1744,1754,O
also,1755,1759,O
by,1760,1762,O
decreasing,1763,1773,O
the,1774,1777,O
Km,1778,1780,O
for,1781,1784,O
the,1785,1788,O
initiating,1789,1799,O
nucleotide,1800,1810,O
(,1811,1812,O
74,1812,1814,O
),1814,1815,O
.,1815,1816,O
The,1817,1820,O
fact,1821,1825,O
that,1826,1830,O
an,1831,1833,O
adenovirus,1834,1844,O
DBP,1845,1848,O
mutant,1849,1855,O
defective,1856,1865,O
in,1866,1868,O
unwinding,1869,1878,O
can,1879,1882,O
still,1883,1888,O
stimulate,1889,1898,O
initiation,1899,1909,O
precludes,1910,1919,O
the,1920,1923,O
unwinding,1924,1933,O
role,1934,1938,O
as,1939,1941,O
the,1942,1945,O
one,1946,1949,O
responsible,1950,1961,O
for,1962,1965,O
such,1966,1970,O
an,1971,1973,O
activation,1974,1984,O
(,1985,1986,O
77,1986,1988,O
",",1988,1989,O
78,1989,1991,O
),1991,1992,O
.,1992,1993,O
In,1994,1996,O
this,1997,2001,O
case,2002,2006,O
",",2006,2007,O
contacts,2008,2016,O
between,2017,2024,O
DBP,2025,2028,O
and,2029,2032,O
pTP,2033,2036,O
/,2036,2037,O
DNA,2037,2040,O
polymerase,2041,2051,O
complex,2052,2059,O
have,2060,2064,O
been,2065,2069,O
reported,2070,2078,O
(,2079,2080,O
77,2080,2082,O
),2082,2083,O
.,2083,2084,O
The,2085,2088,O
effect,2089,2095,O
of,2096,2098,O
Nf,2099,2101,O
DBP,2102,2105,O
in,2106,2108,O
promoting,2109,2118,O
elongation,2119,2129,O
of,2130,2132,O
the,2133,2136,O
initiation,2137,2147,O
products,2148,2156,O
could,2157,2162,O
be,2163,2165,O
due,2166,2169,O
to,2170,2172,O
a,2173,2174,O
decrease,2175,2183,O
of,2184,2186,O
the,2187,2190,O
Km,2191,2193,O
also,2194,2198,O
for,2199,2202,O
the,2203,2206,O
incorporation,2207,2220,O
of,2221,2223,O
the,2224,2227,O
dNMPs,2228,2233,O
during,2234,2240,O
the,2241,2244,O
transition,2245,2255,O
stage,2256,2261,O
from,2262,2266,O
initiation,2267,2277,O
to,2278,2280,O
elongation,2281,2291,O
",",2291,2292,O
to,2293,2295,O
a,2296,2297,O
different,2298,2307,O
type,2308,2312,O
of,2313,2315,O
contact,2316,2323,O
with,2324,2328,O
the,2329,2332,O
DNA,2333,2336,O
polymerase,2337,2347,O
that,2348,2352,O
helps,2353,2358,O
transition,2359,2369,O
to,2370,2372,O
elongation,2373,2383,O
",",2383,2384,O
or,2385,2387,O
both,2388,2392,O
.,2392,2393,O
The,2394,2397,O
similarity,2398,2408,O
in,2409,2411,O
replication,2412,2423,O
rates,2424,2429,O
when,2430,2434,O
comparing,2435,2444,O
M13,2445,2448,O
DNA,2449,2452,O
replication,2453,2464,O
",",2464,2465,O
performed,2466,2475,O
in,2476,2478,O
the,2479,2482,O
absence,2483,2490,O
of,2491,2493,O
DBP,2494,2497,O
(,2498,2499,O
2400,2499,2503,O
nt,2504,2506,O
/,2506,2507,O
min,2507,2510,O
),2510,2511,O
",",2511,2512,O
with,2513,2517,O
Nf,2518,2520,O
TP,2521,2523,O
-,2523,2524,O
DNA,2524,2527,O
replication,2528,2539,O
in,2540,2542,O
the,2543,2546,O
presence,2547,2555,O
of,2556,2558,O
DBP,2559,2562,O
(,2563,2564,O
2260,2564,2568,O
nt,2569,2571,O
/,2571,2572,O
min,2572,2575,O
),2575,2576,O
",",2576,2577,O
suggests,2578,2586,O
that,2587,2591,O
the,2592,2595,O
DBP,2596,2599,O
stimulatory,2600,2611,O
role,2612,2616,O
is,2617,2619,O
restricted,2620,2630,O
to,2631,2633,O
the,2634,2637,O
first,2638,2643,O
phases,2644,2650,O
of,2651,2653,O
Nf,2654,2656,O
TP,2657,2659,O
-,2659,2660,O
DNA,2660,2663,O
replication,2664,2675,O
.,2675,2676,O
2,0,1,O
-,1,2,O
Theory,3,9,O
Scanning,10,18,O
holography,19,29,O
is,30,32,O
a,33,34,O
two,35,38,O
-,38,39,O
pupil,39,44,O
interaction,45,56,O
method,57,63,O
[,64,65,O
8,65,66,O
],66,67,O
by,68,70,O
which,71,76,O
incoherent,77,87,O
imaging,88,95,O
with,96,100,O
complex,101,108,O
point,109,114,O
-,114,115,O
spread,115,121,O
-,121,122,O
functions,122,131,O
(,132,133,O
PSF,133,136,O
),136,137,O
is,138,140,O
possible,141,149,O
.,149,150,O
The,151,154,O
method,155,161,O
has,162,165,O
recently,166,174,O
been,175,179,O
applied,180,187,O
to,188,190,O
the,191,194,O
recording,195,204,O
of,205,207,O
high,208,212,O
resolution,213,223,O
holographic,224,235,O
images,236,242,O
of,243,245,O
incoherent,246,256,O
objects,257,264,O
and,265,268,O
fluorescent,269,280,O
biological,281,291,O
specimens,292,301,O
[,302,303,O
6,303,304,O
",",304,305,O
7,305,306,O
],306,307,O
.,307,308,O
A,309,310,O
single,311,317,O
-,317,318,O
sideband,318,326,O
in,327,329,O
-,329,330,O
line,330,334,O
Fresnel,335,342,O
hologram,343,351,O
is,352,354,O
obtained,355,363,O
by,364,366,O
a,367,368,O
2D,369,371,O
raster,372,378,O
scan,379,383,O
of,384,386,O
the,387,390,O
object,391,397,O
with,398,402,O
the,403,406,O
superposed,407,417,O
3D,418,420,O
diffraction,421,432,O
distributions,433,446,O
of,447,449,O
two,450,453,O
pupils,454,460,O
",",460,461,O
as,462,464,O
sketched,465,473,O
in,474,476,O
fig,477,480,O
.,480,481,O
1,482,483,O
.,483,484,O
The,485,488,O
two,489,492,O
pupil,493,498,O
distributions,499,512,O
P,513,514,O
~,514,515,O
1,515,516,O
(,516,517,O
rho,517,520,O
-,520,521,O
-,521,522,O
>,522,523,O
),523,524,O
MathType,525,533,O
@,533,534,O
MTEF,534,538,O
@,538,539,O
5,539,540,O
@,540,541,O
5,541,542,O
@,542,543,O
+,543,544,O
=,544,545,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,545,630,O
=,630,631,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,631,662,O
=,662,663,O
OqFfea0dXdd9vqai,663,679,O
=,679,680,O
hGuQ8kuc9pgc9s8qqaq,680,699,O
=,699,700,O
dirpe0xb9q8qiLsFr0,700,718,O
=,718,719,O
vr0,719,722,O
=,722,723,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGqbaugaacamaaBaaaleaacqaIXaqmaeqaaOGaeiikaGccciGaf8xWdiNbaSaacqGGPaqkaaa,723,840,O
@,840,841,O
3295,841,845,O
@,845,846,O
and,847,850,O
P,851,852,O
~,852,853,O
2,853,854,O
(,854,855,O
rho,855,858,O
-,858,859,O
-,859,860,O
>,860,861,O
),861,862,O
MathType,863,871,O
@,871,872,O
MTEF,872,876,O
@,876,877,O
5,877,878,O
@,878,879,O
5,879,880,O
@,880,881,O
+,881,882,O
=,882,883,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,883,968,O
=,968,969,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,969,1000,O
=,1000,1001,O
OqFfea0dXdd9vqai,1001,1017,O
=,1017,1018,O
hGuQ8kuc9pgc9s8qqaq,1018,1037,O
=,1037,1038,O
dirpe0xb9q8qiLsFr0,1038,1056,O
=,1056,1057,O
vr0,1057,1060,O
=,1060,1061,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGqbaugaacamaaBaaaleaacqaIYaGmaeqaaOGaeiikaGccciGaf8xWdiNbaSaacqGGPaqkaaa,1061,1178,O
@,1178,1179,O
3297,1179,1183,O
@,1183,1184,O
from,1185,1189,O
the,1190,1193,O
same,1194,1198,O
source,1199,1205,O
(,1206,1207,O
for,1207,1210,O
example,1211,1218,O
",",1218,1219,O
but,1220,1223,O
not,1224,1227,O
necessarily,1228,1239,O
",",1239,1240,O
a,1241,1242,O
laser,1243,1248,O
),1248,1249,O
are,1250,1253,O
combined,1254,1262,O
by,1263,1265,O
a,1266,1267,O
beam,1268,1272,O
splitter,1273,1281,O
in,1282,1284,O
the,1285,1288,O
pupil,1289,1294,O
plane,1295,1300,O
of,1301,1303,O
the,1304,1307,O
objective,1308,1317,O
where,1318,1323,O
they,1324,1328,O
interfere,1329,1338,O
",",1338,1339,O
forming,1340,1347,O
a,1348,1349,O
Fresnel,1350,1357,O
pattern,1358,1365,O
with,1366,1370,O
a,1371,1372,O
depth,1373,1378,O
-,1378,1379,O
dependent,1379,1388,O
Fresnel,1389,1396,O
number,1397,1403,O
.,1403,1404,O
To,1405,1407,O
obtain,1408,1414,O
the,1415,1418,O
conventional,1419,1431,O
point,1432,1437,O
-,1437,1438,O
spread,1438,1444,O
function,1445,1453,O
of,1454,1456,O
wide,1457,1461,O
field,1462,1467,O
imaging,1468,1475,O
",",1475,1476,O
P1,1477,1479,O
is,1480,1482,O
chosen,1483,1489,O
as,1490,1492,O
a,1493,1494,O
point,1495,1500,O
source,1501,1507,O
",",1507,1508,O
and,1509,1512,O
P2,1513,1515,O
as,1516,1518,O
a,1519,1520,O
spherical,1521,1530,O
wave,1531,1535,O
with,1536,1540,O
appropriate,1541,1552,O
curvature,1553,1562,O
.,1562,1563,O
The,1564,1567,O
3D,1568,1570,O
specimen,1571,1579,O
is,1580,1582,O
placed,1583,1589,O
in,1590,1592,O
the,1593,1596,O
focal,1597,1602,O
region,1603,1609,O
of,1610,1612,O
the,1613,1616,O
objective,1617,1626,O
",",1626,1627,O
and,1628,1631,O
scattered,1632,1641,O
lights,1642,1648,O
(,1649,1650,O
transmitted,1650,1661,O
",",1661,1662,O
reflected,1663,1672,O
",",1672,1673,O
and,1674,1677,O
fluorescent,1678,1689,O
),1689,1690,O
are,1691,1694,O
collected,1695,1704,O
by,1705,1707,O
non,1708,1711,O
-,1711,1712,O
imaging,1712,1719,O
detectors,1720,1729,O
.,1729,1730,O
The,1731,1734,O
hologram,1735,1743,O
data,1744,1748,O
can,1749,1752,O
be,1753,1755,O
obtained,1756,1764,O
by,1765,1767,O
heterodyne,1768,1778,O
detection,1779,1788,O
with,1789,1793,O
one,1794,1797,O
of,1798,1800,O
the,1801,1804,O
pupils,1805,1811,O
shifted,1812,1819,O
in,1820,1822,O
frequency,1823,1832,O
(,1833,1834,O
as,1834,1836,O
done,1837,1841,O
in,1842,1844,O
this,1845,1849,O
work,1850,1854,O
),1854,1855,O
",",1855,1856,O
or,1857,1859,O
by,1860,1862,O
a,1863,1864,O
homodyne,1865,1873,O
method,1874,1880,O
requiring,1881,1890,O
the,1891,1894,O
capture,1895,1902,O
of,1903,1905,O
at,1906,1908,O
least,1909,1914,O
three,1915,1920,O
frames,1921,1927,O
with,1928,1932,O
different,1933,1942,O
relative,1943,1951,O
phases,1952,1958,O
between,1959,1966,O
the,1967,1970,O
two,1971,1974,O
pupils,1975,1981,O
[,1982,1983,O
9,1983,1984,O
],1984,1985,O
.,1985,1986,O
The,1987,1990,O
amplitude,1991,2000,O
distribution,2001,2013,O
of,2014,2016,O
the,2017,2020,O
illuminating,2021,2033,O
beam,2034,2038,O
",",2038,2039,O
in,2040,2042,O
a,2043,2044,O
transverse,2045,2055,O
plane,2056,2061,O
at,2062,2064,O
an,2065,2067,O
axial,2068,2073,O
distance,2074,2082,O
z,2083,2084,O
from,2085,2089,O
the,2090,2093,O
focal,2094,2099,O
plane,2100,2105,O
of,2106,2108,O
the,2109,2112,O
objective,2113,2122,O
",",2122,2123,O
is,2124,2126,O
the,2127,2130,O
Fourier,2131,2138,O
transform,2139,2148,O
of,2149,2151,O
the,2152,2155,O
combined,2156,2164,O
pupil,2165,2170,O
distributions,2171,2184,O
[,2185,2186,O
10,2186,2188,O
],2188,2189,O
.,2189,2190,O
Namely,2191,2197,O
:,2197,2198,O
Figure,2199,2205,O
1,2206,2207,O
Experimental,2208,2220,O
set,2221,2224,O
up,2225,2227,O
of,2228,2230,O
a,2231,2232,O
scanning,2233,2241,O
holographic,2242,2253,O
microscope,2254,2264,O
.,2264,2265,O
Sketch,2266,2272,O
of,2273,2275,O
the,2276,2279,O
experimental,2280,2292,O
setup,2293,2298,O
.,2298,2299,O
M,2300,2301,O
',2301,2302,O
s,2302,2303,O
are,2304,2307,O
mirrors,2308,2315,O
",",2315,2316,O
BS,2317,2319,O
',2319,2320,O
s,2320,2321,O
are,2322,2325,O
beam,2326,2330,O
splitters,2331,2340,O
",",2340,2341,O
EO,2342,2344,O
is,2345,2347,O
an,2348,2350,O
electro,2351,2358,O
-,2358,2359,O
optic,2359,2364,O
phase,2365,2370,O
modulator,2371,2380,O
.,2380,2381,O
Lens,2382,2386,O
L1,2387,2389,O
(,2390,2391,O
achromat,2391,2399,O
doublet,2400,2407,O
16,2408,2410,O
cm,2411,2413,O
focal,2414,2419,O
length,2420,2426,O
),2426,2427,O
produces,2428,2436,O
the,2437,2440,O
desired,2441,2448,O
Fresnel,2449,2456,O
pattern,2457,2464,O
in,2465,2467,O
the,2468,2471,O
focal,2472,2477,O
plane,2478,2483,O
of,2484,2486,O
L2,2487,2489,O
(,2490,2491,O
achromat,2491,2499,O
doublet,2500,2507,O
16,2508,2510,O
cm,2511,2513,O
focal,2514,2519,O
length,2520,2526,O
),2526,2527,O
.,2527,2528,O
L2,2529,2531,O
and,2532,2535,O
the,2536,2539,O
objective,2540,2549,O
form,2550,2554,O
a,2555,2556,O
4,2557,2558,O
-,2558,2559,O
f,2559,2560,O
system,2561,2567,O
projecting,2568,2578,O
a,2579,2580,O
reduced,2581,2588,O
image,2589,2594,O
of,2595,2597,O
the,2598,2601,O
Fresnel,2602,2609,O
pattern,2610,2617,O
onto,2618,2622,O
the,2623,2626,O
specimen,2627,2635,O
.,2635,2636,O
L3,2637,2639,O
(,2640,2641,O
achromat,2641,2649,O
doublet,2650,2657,O
12,2658,2660,O
cm,2661,2663,O
focal,2664,2669,O
length,2670,2676,O
),2676,2677,O
projects,2678,2686,O
the,2687,2690,O
images,2691,2697,O
of,2698,2700,O
the,2701,2704,O
pupils,2705,2711,O
on,2712,2714,O
the,2715,2718,O
pinhole,2719,2726,O
detector,2727,2735,O
.,2735,2736,O
(,2737,2738,O
Not,2738,2741,O
shown,2742,2747,O
are,2748,2751,O
the,2752,2755,O
beam,2756,2760,O
expanders,2761,2770,O
used,2771,2775,O
to,2776,2778,O
illuminate,2779,2789,O
the,2790,2793,O
pupils,2794,2800,O
),2800,2801,O
.,2801,2802,O
S,2803,2804,O
(,2804,2805,O
r,2805,2806,O
-,2806,2807,O
-,2807,2808,O
>,2808,2809,O
",",2809,2810,O
z,2810,2811,O
),2811,2812,O
=,2812,2813,O
F,2813,2814,O
-,2814,2815,O
1,2815,2816,O
{,2816,2817,O
[,2817,2818,O
P,2818,2819,O
~,2819,2820,O
1,2820,2821,O
(,2821,2822,O
rho,2822,2825,O
-,2825,2826,O
-,2826,2827,O
>,2827,2828,O
;,2828,2829,O
z,2829,2830,O
),2830,2831,O
+,2831,2832,O
P,2832,2833,O
~,2833,2834,O
2,2834,2835,O
(,2835,2836,O
rho,2836,2839,O
-,2839,2840,O
-,2840,2841,O
>,2841,2842,O
;,2842,2843,O
z,2843,2844,O
),2844,2845,O
exp,2845,2848,O
(,2849,2850,O
-,2850,2851,O
iOmegat,2851,2858,O
],2858,2859,O
},2859,2860,O
",",2860,2861,O
(,2862,2863,O
1a,2863,2865,O
),2865,2866,O
MathType,2867,2875,O
@,2875,2876,O
MTEF,2876,2880,O
@,2880,2881,O
5,2881,2882,O
@,2882,2883,O
5,2883,2884,O
@,2884,2885,O
+,2885,2886,O
=,2886,2887,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,2887,2972,O
=,2972,2973,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,2973,3004,O
=,3004,3005,O
OqFfea0dXdd9vqai,3005,3021,O
=,3021,3022,O
hGuQ8kuc9pgc9s8qqaq,3022,3041,O
=,3041,3042,O
dirpe0xb9q8qiLsFr0,3042,3060,O
=,3060,3061,O
vr0,3061,3064,O
=,3064,3065,O
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,3065,3570,O
@,3570,3571,O
5D95,3571,3575,O
@,3575,3576,O
where,3577,3582,O
P,3583,3584,O
~,3584,3585,O
1,3585,3586,O
",",3586,3587,O
2,3587,3588,O
(,3588,3589,O
rho,3589,3592,O
-,3592,3593,O
-,3593,3594,O
>,3594,3595,O
;,3595,3596,O
z,3596,3597,O
),3597,3598,O
=,3598,3599,O
P,3599,3600,O
~,3600,3601,O
1,3601,3602,O
",",3602,3603,O
2,3603,3604,O
(,3604,3605,O
rho,3605,3608,O
-,3608,3609,O
-,3609,3610,O
>,3610,3611,O
),3611,3612,O
exp,3612,3615,O
(,3616,3617,O
ipilambdazrho2,3617,3631,O
),3631,3632,O
(,3633,3634,O
1b,3634,3636,O
),3636,3637,O
MathType,3638,3646,O
@,3646,3647,O
MTEF,3647,3651,O
@,3651,3652,O
5,3652,3653,O
@,3653,3654,O
5,3654,3655,O
@,3655,3656,O
+,3656,3657,O
=,3657,3658,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,3658,3743,O
=,3743,3744,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,3744,3775,O
=,3775,3776,O
OqFfea0dXdd9vqai,3776,3792,O
=,3792,3793,O
hGuQ8kuc9pgc9s8qqaq,3793,3812,O
=,3812,3813,O
dirpe0xb9q8qiLsFr0,3813,3831,O
=,3831,3832,O
vr0,3832,3835,O
=,3835,3836,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGqbaugaacamaaBaaaleaacqaIXaqmcqGGSaalcqaIYaGmaeqaaOGaeiikaGccciGaf8xWdiNbaSaacqGG7aWocqWG6bGEcqGGPaqkcqGH9aqpcuWGqbaugaacamaaBaaaleaacqaIXaqmcqGGSaalcqaIYaGmaeqaaOGaeiikaGIaf8xWdiNbaSaacqGGPaqkcyGGLbqzcqGG4baEcqGGWbaCcqGGOaakcqWGPbqAcqWFapaCcqWF7oaBcqWG6bGEcqWFbpGCdaahaaWcbeqaaiabikdaYaaakiabcMcaPiaaxMaacaWLjaWaaeWaaeaacqaIXaqmcqqGIbGyaiaawIcacaGLPaaaaaa,3836,4237,O
@,4237,4238,O
53A8,4238,4242,O
@,4242,4243,O
are,4244,4247,O
the,4248,4251,O
generalized,4252,4263,O
defocused,4264,4273,O
pupils,4274,4280,O
[,4281,4282,O
11,4282,4284,O
],4284,4285,O
.,4285,4286,O
F,4287,4288,O
-,4288,4289,O
1,4289,4290,O
stands,4291,4297,O
for,4298,4301,O
inverse,4302,4309,O
Fourier,4310,4317,O
transform,4318,4327,O
",",4327,4328,O
and,4329,4332,O
Omega,4333,4338,O
is,4339,4341,O
the,4342,4345,O
frequency,4346,4355,O
shift,4356,4361,O
of,4362,4364,O
one,4365,4368,O
of,4369,4371,O
the,4372,4375,O
pupils,4376,4382,O
.,4382,4383,O
The,4384,4387,O
transverse,4388,4398,O
spatial,4399,4406,O
frequency,4407,4416,O
vector,4417,4423,O
rho,4424,4427,O
-,4427,4428,O
-,4428,4429,O
>,4429,4430,O
MathType,4431,4439,O
@,4439,4440,O
MTEF,4440,4444,O
@,4444,4445,O
5,4445,4446,O
@,4446,4447,O
5,4447,4448,O
@,4448,4449,O
+,4449,4450,O
=,4450,4451,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,4451,4536,O
=,4536,4537,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,4537,4568,O
=,4568,4569,O
OqFfea0dXdd9vqai,4569,4585,O
=,4585,4586,O
hGuQ8kuc9pgc9s8qqaq,4586,4605,O
=,4605,4606,O
dirpe0xb9q8qiLsFr0,4606,4624,O
=,4624,4625,O
vr0,4625,4628,O
=,4628,4629,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacuWFbpGCgaWcaaaa,4629,4691,O
@,4691,4692,O
2E85,4692,4696,O
@,4696,4697,O
=,4698,4699,O
r,4700,4701,O
-,4701,4702,O
-,4702,4703,O
>,4703,4704,O
MathType,4705,4713,O
@,4713,4714,O
MTEF,4714,4718,O
@,4718,4719,O
5,4719,4720,O
@,4720,4721,O
5,4721,4722,O
@,4722,4723,O
+,4723,4724,O
=,4724,4725,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,4725,4810,O
=,4810,4811,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,4811,4842,O
=,4842,4843,O
OqFfea0dXdd9vqai,4843,4859,O
=,4859,4860,O
hGuQ8kuc9pgc9s8qqaq,4860,4879,O
=,4879,4880,O
dirpe0xb9q8qiLsFr0,4880,4898,O
=,4898,4899,O
vr0,4899,4902,O
=,4902,4903,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa,4903,4961,O
@,4961,4962,O
2E2B,4962,4966,O
@,4966,4967,O
P,4967,4968,O
/,4968,4969,O
lambdaf0,4969,4977,O
is,4978,4980,O
proportional,4981,4993,O
to,4994,4996,O
the,4997,5000,O
real,5001,5005,O
space,5006,5011,O
coordinate,5012,5022,O
r,5023,5024,O
-,5024,5025,O
-,5025,5026,O
>,5026,5027,O
MathType,5028,5036,O
@,5036,5037,O
MTEF,5037,5041,O
@,5041,5042,O
5,5042,5043,O
@,5043,5044,O
5,5044,5045,O
@,5045,5046,O
+,5046,5047,O
=,5047,5048,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,5048,5133,O
=,5133,5134,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,5134,5165,O
=,5165,5166,O
OqFfea0dXdd9vqai,5166,5182,O
=,5182,5183,O
hGuQ8kuc9pgc9s8qqaq,5183,5202,O
=,5202,5203,O
dirpe0xb9q8qiLsFr0,5203,5221,O
=,5221,5222,O
vr0,5222,5225,O
=,5225,5226,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa,5226,5284,O
@,5284,5285,O
2E2B,5285,5289,O
@,5289,5290,O
P,5290,5291,O
in,5292,5294,O
the,5295,5298,O
pupil,5299,5304,O
plane,5305,5310,O
[,5311,5312,O
10,5312,5314,O
],5314,5315,O
.,5315,5316,O
lambda,5317,5323,O
is,5324,5326,O
the,5327,5330,O
wavelength,5331,5341,O
of,5342,5344,O
the,5345,5348,O
illumination,5349,5361,O
",",5361,5362,O
and,5363,5366,O
f0,5367,5369,O
is,5370,5372,O
the,5373,5376,O
focal,5377,5382,O
length,5383,5389,O
of,5390,5392,O
the,5393,5396,O
objective,5397,5406,O
.,5406,5407,O
The,5408,5411,O
two,5412,5415,O
pupils,5416,5422,O
used,5423,5427,O
to,5428,5430,O
obtain,5431,5437,O
an,5438,5440,O
in,5441,5443,O
-,5443,5444,O
line,5444,5448,O
Fresnel,5449,5456,O
hologram,5457,5465,O
are,5466,5469,O
",",5469,5470,O
respectively,5471,5483,O
",",5483,5484,O
a,5485,5486,O
spherical,5487,5496,O
wave,5497,5501,O
filling,5502,5509,O
the,5510,5513,O
pupil,5514,5519,O
of,5520,5522,O
the,5523,5526,O
objective,5527,5536,O
",",5536,5537,O
and,5538,5541,O
a,5542,5543,O
point,5544,5549,O
at,5550,5552,O
the,5553,5556,O
center,5557,5563,O
of,5564,5566,O
that,5567,5571,O
pupil,5572,5577,O
:,5577,5578,O
P,5579,5580,O
~,5580,5581,O
1,5581,5582,O
(,5582,5583,O
rho,5583,5586,O
-,5586,5587,O
-,5587,5588,O
>,5588,5589,O
),5589,5590,O
MathType,5591,5599,O
@,5599,5600,O
MTEF,5600,5604,O
@,5604,5605,O
5,5605,5606,O
@,5606,5607,O
5,5607,5608,O
@,5608,5609,O
+,5609,5610,O
=,5610,5611,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,5611,5696,O
=,5696,5697,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,5697,5728,O
=,5728,5729,O
OqFfea0dXdd9vqai,5729,5745,O
=,5745,5746,O
hGuQ8kuc9pgc9s8qqaq,5746,5765,O
=,5765,5766,O
dirpe0xb9q8qiLsFr0,5766,5784,O
=,5784,5785,O
vr0,5785,5788,O
=,5788,5789,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGqbaugaacamaaBaaaleaacqaIXaqmaeqaaOGaeiikaGccciGaf8xWdiNbaSaacqGGPaqkaaa,5789,5906,O
@,5906,5907,O
3295,5907,5911,O
@,5911,5912,O
=,5913,5914,O
exp,5915,5918,O
(,5918,5919,O
ipilambdaz0rho2,5919,5934,O
),5934,5935,O
circ,5935,5939,O
(,5939,5940,O
rho,5940,5943,O
/,5943,5944,O
rhoMAX,5944,5950,O
),5950,5951,O
P,5952,5953,O
~,5953,5954,O
2,5954,5955,O
(,5955,5956,O
rho,5956,5959,O
-,5959,5960,O
-,5960,5961,O
>,5961,5962,O
),5962,5963,O
=,5963,5964,O
delta,5964,5969,O
(,5969,5970,O
rho,5970,5973,O
-,5973,5974,O
-,5974,5975,O
>,5975,5976,O
),5976,5977,O
.,5977,5978,O
(,5979,5980,O
2,5980,5981,O
),5981,5982,O
MathType,5983,5991,O
@,5991,5992,O
MTEF,5992,5996,O
@,5996,5997,O
5,5997,5998,O
@,5998,5999,O
5,5999,6000,O
@,6000,6001,O
+,6001,6002,O
=,6002,6003,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,6003,6088,O
=,6088,6089,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,6089,6120,O
=,6120,6121,O
OqFfea0dXdd9vqai,6121,6137,O
=,6137,6138,O
hGuQ8kuc9pgc9s8qqaq,6138,6157,O
=,6157,6158,O
dirpe0xb9q8qiLsFr0,6158,6176,O
=,6176,6177,O
vr0,6177,6180,O
=,6180,6181,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGqbaugaacamaaBaaaleaacqaIYaGmaeqaaOGaeiikaGccciGaf8xWdiNbaSaacqGGPaqkcqGH9aqpcqWF0oazcqGGOaakcuWFbpGCgaWcaiabcMcaPiabc6caUiaaxMaacaWLjaWaaeWaaeaacqaIYaGmaiaawIcacaGLPaaaaaa,6181,6398,O
@,6398,6399,O
3D5F,6399,6403,O
@,6403,6404,O
circ,6405,6409,O
(,6409,6410,O
x,6410,6411,O
),6411,6412,O
is,6413,6415,O
a,6416,6417,O
disc,6418,6422,O
function,6423,6431,O
of,6432,6434,O
unit,6435,6439,O
radius,6440,6446,O
.,6446,6447,O
rhoMAX,6448,6454,O
=,6455,6456,O
sinalpha,6457,6465,O
/,6465,6466,O
lambda,6466,6472,O
is,6473,6475,O
the,6476,6479,O
cutoff,6480,6486,O
frequency,6487,6496,O
of,6497,6499,O
the,6500,6503,O
objective,6504,6513,O
",",6513,6514,O
where,6515,6520,O
sinalpha,6521,6529,O
=,6530,6531,O
NA,6532,6534,O
is,6535,6537,O
its,6538,6541,O
numerical,6542,6551,O
aperture,6552,6560,O
.,6560,6561,O
The,6562,6565,O
Fresnel,6566,6573,O
pattern,6574,6581,O
projected,6582,6591,O
on,6592,6594,O
the,6595,6598,O
object,6599,6605,O
is,6606,6608,O
the,6609,6612,O
interference,6613,6625,O
of,6626,6628,O
the,6629,6632,O
Fourier,6633,6640,O
transforms,6641,6651,O
of,6652,6654,O
the,6655,6658,O
two,6659,6662,O
pupils,6663,6669,O
",",6669,6670,O
namely,6671,6677,O
a,6678,6679,O
spherical,6680,6689,O
wave,6690,6694,O
and,6695,6698,O
a,6699,6700,O
plane,6701,6706,O
wave,6707,6711,O
in,6712,6714,O
the,6715,6718,O
paraxial,6719,6727,O
approximation,6728,6741,O
.,6741,6742,O
The,6743,6746,O
Fresnel,6747,6754,O
number,6755,6761,O
of,6762,6764,O
this,6765,6769,O
pattern,6770,6777,O
is,6778,6780,O
determined,6781,6791,O
by,6792,6794,O
the,6795,6798,O
free,6799,6803,O
parameter,6804,6813,O
z0,6814,6816,O
",",6816,6817,O
which,6818,6823,O
is,6824,6826,O
the,6827,6830,O
distance,6831,6839,O
from,6840,6844,O
the,6845,6848,O
objective,6849,6858,O
',6858,6859,O
s,6859,6860,O
focal,6861,6866,O
plane,6867,6872,O
to,6873,6875,O
the,6876,6879,O
point,6880,6885,O
where,6886,6891,O
the,6892,6895,O
spherical,6896,6905,O
wave,6906,6910,O
comes,6911,6916,O
to,6917,6919,O
a,6920,6921,O
focus,6922,6927,O
.,6927,6928,O
There,6929,6934,O
are,6935,6938,O
two,6939,6942,O
possible,6943,6951,O
modes,6952,6957,O
of,6958,6960,O
operation,6961,6970,O
",",6970,6971,O
depending,6972,6981,O
on,6982,6984,O
the,6985,6988,O
detector,6989,6997,O
geometry,6998,7006,O
[,7007,7008,O
5,7008,7009,O
],7009,7010,O
.,7010,7011,O
With,7012,7016,O
a,7017,7018,O
spatially,7019,7028,O
integrating,7029,7040,O
detector,7041,7049,O
",",7049,7050,O
the,7051,7054,O
resulting,7055,7064,O
data,7065,7069,O
is,7070,7072,O
a,7073,7074,O
convolution,7075,7086,O
of,7087,7089,O
the,7090,7093,O
object,7094,7100,O
',7100,7101,O
s,7101,7102,O
intensity,7103,7112,O
distribution,7113,7125,O
with,7126,7130,O
the,7131,7134,O
desired,7135,7142,O
complex,7143,7150,O
PSF,7151,7154,O
(,7155,7156,O
namely,7156,7162,O
",",7162,7163,O
a,7164,7165,O
spherical,7166,7175,O
wave,7176,7180,O
with,7181,7185,O
a,7186,7187,O
radius,7188,7194,O
of,7195,7197,O
curvature,7198,7207,O
z0,7208,7210,O
+,7211,7212,O
z,7213,7214,O
",",7214,7215,O
and,7216,7219,O
a,7220,7221,O
radius,7222,7228,O
a,7229,7230,O
=,7231,7232,O
z0sinalpha,7233,7243,O
",",7243,7244,O
in,7245,7247,O
this,7248,7252,O
case,7253,7257,O
),7257,7258,O
.,7258,7259,O
This,7260,7264,O
detection,7265,7274,O
mode,7275,7279,O
leads,7280,7285,O
to,7286,7288,O
a,7289,7290,O
hologram,7291,7299,O
from,7300,7304,O
which,7305,7310,O
the,7311,7314,O
three,7315,7320,O
-,7320,7321,O
dimensional,7321,7332,O
distribution,7333,7345,O
of,7346,7348,O
scattering,7349,7359,O
intensity,7360,7369,O
",",7369,7370,O
absorption,7371,7381,O
",",7381,7382,O
and,7383,7386,O
fluorescence,7387,7399,O
intensity,7400,7409,O
can,7410,7413,O
be,7414,7416,O
reconstructed,7417,7430,O
.,7430,7431,O
With,7432,7436,O
a,7437,7438,O
point,7439,7444,O
detector,7445,7453,O
at,7454,7456,O
the,7457,7460,O
center,7461,7467,O
of,7468,7470,O
a,7471,7472,O
conjugate,7473,7482,O
pupil,7483,7488,O
plane,7489,7494,O
",",7494,7495,O
the,7496,7499,O
resulting,7500,7509,O
data,7510,7514,O
is,7515,7517,O
a,7518,7519,O
convolution,7520,7531,O
of,7532,7534,O
the,7535,7538,O
object,7539,7545,O
',7545,7546,O
s,7546,7547,O
complex,7548,7555,O
amplitude,7556,7565,O
distribution,7566,7578,O
with,7579,7583,O
the,7584,7587,O
same,7588,7592,O
complex,7593,7600,O
PSF,7601,7604,O
.,7604,7605,O
The,7606,7609,O
reconstruction,7610,7624,O
of,7625,7627,O
this,7628,7632,O
hologram,7633,7641,O
gives,7642,7647,O
the,7648,7651,O
three,7652,7657,O
-,7657,7658,O
dimensional,7658,7669,O
distribution,7670,7682,O
of,7683,7685,O
the,7686,7689,O
specimen,7690,7698,O
',7698,7699,O
s,7699,7700,O
complex,7701,7708,O
amplitude,7709,7718,O
transmittance,7719,7732,O
.,7732,7733,O
In,7734,7736,O
particular,7737,7747,O
",",7747,7748,O
assuming,7749,7757,O
that,7758,7762,O
multiple,7763,7771,O
scattering,7772,7782,O
can,7783,7786,O
be,7787,7789,O
ignored,7790,7797,O
",",7797,7798,O
the,7799,7802,O
phase,7803,7808,O
of,7809,7811,O
the,7812,7815,O
reconstruction,7816,7830,O
is,7831,7833,O
a,7834,7835,O
quantitative,7836,7848,O
measure,7849,7856,O
of,7857,7859,O
the,7860,7863,O
integrated,7864,7874,O
optical,7875,7882,O
path,7883,7887,O
length,7888,7894,O
through,7895,7902,O
the,7903,7906,O
specimen,7907,7915,O
.,7915,7916,O
These,7917,7922,O
two,7923,7926,O
modes,7927,7932,O
of,7933,7935,O
operation,7936,7945,O
are,7946,7949,O
similar,7950,7957,O
to,7958,7960,O
the,7961,7964,O
usual,7965,7970,O
coherent,7971,7979,O
/,7979,7980,O
incoherent,7980,7990,O
imaging,7991,7998,O
modes,7999,8004,O
of,8005,8007,O
a,8008,8009,O
conventional,8010,8022,O
system,8023,8029,O
",",8029,8030,O
which,8031,8036,O
are,8037,8040,O
obtained,8041,8049,O
by,8050,8052,O
using,8053,8058,O
",",8058,8059,O
respectively,8060,8072,O
",",8072,8073,O
a,8074,8075,O
point,8076,8081,O
source,8082,8088,O
",",8088,8089,O
or,8090,8092,O
a,8093,8094,O
large,8095,8100,O
spatially,8101,8110,O
incoherent,8111,8121,O
source,8122,8128,O
.,8128,8129,O
In,8130,8132,O
scanning,8133,8141,O
holography,8142,8152,O
",",8152,8153,O
the,8154,8157,O
detector,8158,8166,O
size,8167,8171,O
plays,8172,8177,O
a,8178,8179,O
similar,8180,8187,O
role,8188,8192,O
to,8193,8195,O
that,8196,8200,O
of,8201,8203,O
the,8204,8207,O
source,8208,8214,O
size,8215,8219,O
in,8220,8222,O
conventional,8223,8235,O
imaging,8236,8243,O
.,8243,8244,O
For,8245,8248,O
simplicity,8249,8259,O
",",8259,8260,O
let,8261,8264,O
',8264,8265,O
s,8265,8266,O
assume,8267,8273,O
an,8274,8276,O
object,8277,8283,O
with,8284,8288,O
an,8289,8291,O
amplitude,8292,8301,O
transmittance,8302,8315,O
T,8316,8317,O
(,8317,8318,O
r,8318,8319,O
-,8319,8320,O
-,8320,8321,O
>,8321,8322,O
MathType,8323,8331,O
@,8331,8332,O
MTEF,8332,8336,O
@,8336,8337,O
5,8337,8338,O
@,8338,8339,O
5,8339,8340,O
@,8340,8341,O
+,8341,8342,O
=,8342,8343,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,8343,8428,O
=,8428,8429,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,8429,8460,O
=,8460,8461,O
OqFfea0dXdd9vqai,8461,8477,O
=,8477,8478,O
hGuQ8kuc9pgc9s8qqaq,8478,8497,O
=,8497,8498,O
dirpe0xb9q8qiLsFr0,8498,8516,O
=,8516,8517,O
vr0,8517,8520,O
=,8520,8521,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa,8521,8579,O
@,8579,8580,O
2E2B,8580,8584,O
@,8584,8585,O
",",8585,8586,O
z,8587,8588,O
),8588,8589,O
.,8589,8590,O
Note,8591,8595,O
that,8596,8600,O
for,8601,8604,O
an,8605,8607,O
incoherent,8608,8618,O
or,8619,8621,O
fluorescent,8622,8633,O
object,8634,8640,O
",",8640,8641,O
the,8642,8645,O
phase,8646,8651,O
of,8652,8654,O
the,8655,8658,O
transmitted,8659,8670,O
field,8671,8676,O
is,8677,8679,O
a,8680,8681,O
random,8682,8688,O
variable,8689,8697,O
",",8697,8698,O
and,8699,8702,O
only,8703,8707,O
the,8708,8711,O
intensity,8712,8721,O
I,8722,8723,O
(,8723,8724,O
r,8724,8725,O
-,8725,8726,O
-,8726,8727,O
>,8727,8728,O
MathType,8729,8737,O
@,8737,8738,O
MTEF,8738,8742,O
@,8742,8743,O
5,8743,8744,O
@,8744,8745,O
5,8745,8746,O
@,8746,8747,O
+,8747,8748,O
=,8748,8749,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,8749,8834,O
=,8834,8835,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,8835,8866,O
=,8866,8867,O
OqFfea0dXdd9vqai,8867,8883,O
=,8883,8884,O
hGuQ8kuc9pgc9s8qqaq,8884,8903,O
=,8903,8904,O
dirpe0xb9q8qiLsFr0,8904,8922,O
=,8922,8923,O
vr0,8923,8926,O
=,8926,8927,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa,8927,8985,O
@,8985,8986,O
2E2B,8986,8990,O
@,8990,8991,O
",",8991,8992,O
z,8993,8994,O
),8994,8995,O
=,8996,8997,O
|,8998,8999,O
T,8999,9000,O
(,9000,9001,O
r,9001,9002,O
-,9002,9003,O
-,9003,9004,O
>,9004,9005,O
MathType,9006,9014,O
@,9014,9015,O
MTEF,9015,9019,O
@,9019,9020,O
5,9020,9021,O
@,9021,9022,O
5,9022,9023,O
@,9023,9024,O
+,9024,9025,O
=,9025,9026,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,9026,9111,O
=,9111,9112,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,9112,9143,O
=,9143,9144,O
OqFfea0dXdd9vqai,9144,9160,O
=,9160,9161,O
hGuQ8kuc9pgc9s8qqaq,9161,9180,O
=,9180,9181,O
dirpe0xb9q8qiLsFr0,9181,9199,O
=,9199,9200,O
vr0,9200,9203,O
=,9203,9204,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa,9204,9262,O
@,9262,9263,O
2E2B,9263,9267,O
@,9267,9268,O
",",9268,9269,O
z,9270,9271,O
),9271,9272,O
|,9272,9273,O
2,9273,9274,O
is,9275,9277,O
measurable,9278,9288,O
.,9288,9289,O
For,9290,9293,O
a,9294,9295,O
quasi,9296,9301,O
transparent,9302,9313,O
object,9314,9320,O
",",9320,9321,O
the,9322,9325,O
phase,9326,9331,O
is,9332,9334,O
equal,9335,9340,O
to,9341,9343,O
the,9344,9347,O
integrated,9348,9358,O
optical,9359,9366,O
thickness,9367,9376,O
of,9377,9379,O
the,9380,9383,O
object,9384,9390,O
:,9390,9391,O
Phi,9392,9395,O
(,9395,9396,O
r,9396,9397,O
-,9397,9398,O
-,9398,9399,O
>,9399,9400,O
MathType,9401,9409,O
@,9409,9410,O
MTEF,9410,9414,O
@,9414,9415,O
5,9415,9416,O
@,9416,9417,O
5,9417,9418,O
@,9418,9419,O
+,9419,9420,O
=,9420,9421,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,9421,9506,O
=,9506,9507,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,9507,9538,O
=,9538,9539,O
OqFfea0dXdd9vqai,9539,9555,O
=,9555,9556,O
hGuQ8kuc9pgc9s8qqaq,9556,9575,O
=,9575,9576,O
dirpe0xb9q8qiLsFr0,9576,9594,O
=,9594,9595,O
vr0,9595,9598,O
=,9598,9599,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa,9599,9657,O
@,9657,9658,O
2E2B,9658,9662,O
@,9662,9663,O
),9663,9664,O
=,9665,9666,O
(,9667,9668,O
2pi,9668,9671,O
/,9671,9672,O
lambda,9672,9678,O
),9678,9679,O
integraldzn,9679,9690,O
(,9690,9691,O
r,9691,9692,O
-,9692,9693,O
-,9693,9694,O
>,9694,9695,O
MathType,9696,9704,O
@,9704,9705,O
MTEF,9705,9709,O
@,9709,9710,O
5,9710,9711,O
@,9711,9712,O
5,9712,9713,O
@,9713,9714,O
+,9714,9715,O
=,9715,9716,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,9716,9801,O
=,9801,9802,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,9802,9833,O
=,9833,9834,O
OqFfea0dXdd9vqai,9834,9850,O
=,9850,9851,O
hGuQ8kuc9pgc9s8qqaq,9851,9870,O
=,9870,9871,O
dirpe0xb9q8qiLsFr0,9871,9889,O
=,9889,9890,O
vr0,9890,9893,O
=,9893,9894,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa,9894,9952,O
@,9952,9953,O
2E2B,9953,9957,O
@,9957,9958,O
",",9958,9959,O
z,9960,9961,O
),9961,9962,O
",",9962,9963,O
where,9964,9969,O
n,9970,9971,O
(,9971,9972,O
r,9972,9973,O
-,9973,9974,O
-,9974,9975,O
>,9975,9976,O
MathType,9977,9985,O
@,9985,9986,O
MTEF,9986,9990,O
@,9990,9991,O
5,9991,9992,O
@,9992,9993,O
5,9993,9994,O
@,9994,9995,O
+,9995,9996,O
=,9996,9997,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,9997,10082,O
=,10082,10083,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,10083,10114,O
=,10114,10115,O
OqFfea0dXdd9vqai,10115,10131,O
=,10131,10132,O
hGuQ8kuc9pgc9s8qqaq,10132,10151,O
=,10151,10152,O
dirpe0xb9q8qiLsFr0,10152,10170,O
=,10170,10171,O
vr0,10171,10174,O
=,10174,10175,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa,10175,10233,O
@,10233,10234,O
2E2B,10234,10238,O
@,10238,10239,O
",",10239,10240,O
z,10241,10242,O
),10242,10243,O
is,10244,10246,O
the,10247,10250,O
3D,10251,10253,O
distribution,10254,10266,O
of,10267,10269,O
refractive,10270,10280,O
index,10281,10286,O
.,10286,10287,O
The,10288,10291,O
amplitude,10292,10301,O
distribution,10302,10314,O
after,10315,10320,O
the,10321,10324,O
object,10325,10331,O
is,10332,10334,O
written,10335,10342,O
as,10343,10345,O
A,10346,10347,O
(,10347,10348,O
r,10348,10349,O
-,10349,10350,O
-,10350,10351,O
>,10351,10352,O
MathType,10353,10361,O
@,10361,10362,O
MTEF,10362,10366,O
@,10366,10367,O
5,10367,10368,O
@,10368,10369,O
5,10369,10370,O
@,10370,10371,O
+,10371,10372,O
=,10372,10373,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,10373,10458,O
=,10458,10459,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,10459,10490,O
=,10490,10491,O
OqFfea0dXdd9vqai,10491,10507,O
=,10507,10508,O
hGuQ8kuc9pgc9s8qqaq,10508,10527,O
=,10527,10528,O
dirpe0xb9q8qiLsFr0,10528,10546,O
=,10546,10547,O
vr0,10547,10550,O
=,10550,10551,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa,10551,10609,O
@,10609,10610,O
2E2B,10610,10614,O
@,10614,10615,O
",",10615,10616,O
t,10617,10618,O
),10618,10619,O
=,10620,10621,O
integraldzS,10622,10633,O
(,10633,10634,O
r,10634,10635,O
-,10635,10636,O
-,10636,10637,O
>,10637,10638,O
MathType,10639,10647,O
@,10647,10648,O
MTEF,10648,10652,O
@,10652,10653,O
5,10653,10654,O
@,10654,10655,O
5,10655,10656,O
@,10656,10657,O
+,10657,10658,O
=,10658,10659,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,10659,10744,O
=,10744,10745,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,10745,10776,O
=,10776,10777,O
OqFfea0dXdd9vqai,10777,10793,O
=,10793,10794,O
hGuQ8kuc9pgc9s8qqaq,10794,10813,O
=,10813,10814,O
dirpe0xb9q8qiLsFr0,10814,10832,O
=,10832,10833,O
vr0,10833,10836,O
=,10836,10837,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa,10837,10895,O
@,10895,10896,O
2E2B,10896,10900,O
@,10900,10901,O
",",10901,10902,O
z,10903,10904,O
),10904,10905,O
T,10905,10906,O
[,10906,10907,O
r,10907,10908,O
-,10908,10909,O
-,10909,10910,O
>,10910,10911,O
MathType,10912,10920,O
@,10920,10921,O
MTEF,10921,10925,O
@,10925,10926,O
5,10926,10927,O
@,10927,10928,O
5,10928,10929,O
@,10929,10930,O
+,10930,10931,O
=,10931,10932,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,10932,11017,O
=,11017,11018,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,11018,11049,O
=,11049,11050,O
OqFfea0dXdd9vqai,11050,11066,O
=,11066,11067,O
hGuQ8kuc9pgc9s8qqaq,11067,11086,O
=,11086,11087,O
dirpe0xb9q8qiLsFr0,11087,11105,O
=,11105,11106,O
vr0,11106,11109,O
=,11109,11110,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa,11110,11168,O
@,11168,11169,O
2E2B,11169,11173,O
@,11173,11174,O
-,11174,11175,O
r,11175,11176,O
-,11176,11177,O
-,11177,11178,O
>,11178,11179,O
MathType,11180,11188,O
@,11188,11189,O
MTEF,11189,11193,O
@,11193,11194,O
5,11194,11195,O
@,11195,11196,O
5,11196,11197,O
@,11197,11198,O
+,11198,11199,O
=,11199,11200,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,11200,11285,O
=,11285,11286,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,11286,11317,O
=,11317,11318,O
OqFfea0dXdd9vqai,11318,11334,O
=,11334,11335,O
hGuQ8kuc9pgc9s8qqaq,11335,11354,O
=,11354,11355,O
dirpe0xb9q8qiLsFr0,11355,11373,O
=,11373,11374,O
vr0,11374,11377,O
=,11377,11378,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa,11378,11436,O
@,11436,11437,O
2E2B,11437,11441,O
@,11441,11442,O
S,11442,11443,O
(,11443,11444,O
t,11444,11445,O
),11445,11446,O
",",11446,11447,O
z,11448,11449,O
],11449,11450,O
",",11450,11451,O
(,11452,11453,O
3,11453,11454,O
),11454,11455,O
where,11456,11461,O
r,11462,11463,O
-,11463,11464,O
-,11464,11465,O
>,11465,11466,O
MathType,11467,11475,O
@,11475,11476,O
MTEF,11476,11480,O
@,11480,11481,O
5,11481,11482,O
@,11482,11483,O
5,11483,11484,O
@,11484,11485,O
+,11485,11486,O
=,11486,11487,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,11487,11572,O
=,11572,11573,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,11573,11604,O
=,11604,11605,O
OqFfea0dXdd9vqai,11605,11621,O
=,11621,11622,O
hGuQ8kuc9pgc9s8qqaq,11622,11641,O
=,11641,11642,O
dirpe0xb9q8qiLsFr0,11642,11660,O
=,11660,11661,O
vr0,11661,11664,O
=,11664,11665,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa,11665,11723,O
@,11723,11724,O
2E2B,11724,11728,O
@,11728,11729,O
S,11729,11730,O
(,11730,11731,O
t,11731,11732,O
),11732,11733,O
is,11734,11736,O
the,11737,11740,O
instantaneous,11741,11754,O
position,11755,11763,O
of,11764,11766,O
the,11767,11770,O
2D,11771,11773,O
raster,11774,11780,O
scan,11781,11785,O
.,11785,11786,O
The,11787,11790,O
incoherent,11791,11801,O
imaging,11802,11809,O
mode,11810,11814,O
is,11815,11817,O
obtained,11818,11826,O
with,11827,11831,O
a,11832,11833,O
spatially,11834,11843,O
integrating,11844,11855,O
detector,11856,11864,O
",",11864,11865,O
leading,11866,11873,O
to,11874,11876,O
a,11877,11878,O
temporal,11879,11887,O
signal,11888,11894,O
proportional,11895,11907,O
to,11908,11910,O
the,11911,11914,O
integrated,11915,11925,O
intensity,11926,11935,O
",",11935,11936,O
integrald2r,11937,11948,O
|,11948,11949,O
A,11949,11950,O
(,11950,11951,O
r,11951,11952,O
-,11952,11953,O
-,11953,11954,O
>,11954,11955,O
MathType,11956,11964,O
@,11964,11965,O
MTEF,11965,11969,O
@,11969,11970,O
5,11970,11971,O
@,11971,11972,O
5,11972,11973,O
@,11973,11974,O
+,11974,11975,O
=,11975,11976,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,11976,12061,O
=,12061,12062,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,12062,12093,O
=,12093,12094,O
OqFfea0dXdd9vqai,12094,12110,O
=,12110,12111,O
hGuQ8kuc9pgc9s8qqaq,12111,12130,O
=,12130,12131,O
dirpe0xb9q8qiLsFr0,12131,12149,O
=,12149,12150,O
vr0,12150,12153,O
=,12153,12154,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa,12154,12212,O
@,12212,12213,O
2E2B,12213,12217,O
@,12217,12218,O
",",12218,12219,O
t,12220,12221,O
),12221,12222,O
|,12222,12223,O
2,12223,12224,O
",",12224,12225,O
which,12226,12231,O
is,12232,12234,O
stored,12235,12241,O
in,12242,12244,O
the,12245,12248,O
computer,12249,12257,O
.,12257,12258,O
The,12259,12262,O
data,12263,12267,O
corresponding,12268,12281,O
to,12282,12284,O
each,12285,12289,O
hologram,12290,12298,O
line,12299,12303,O
is,12304,12306,O
cut,12307,12310,O
from,12311,12315,O
the,12316,12319,O
signal,12320,12326,O
",",12326,12327,O
and,12328,12331,O
band,12332,12336,O
pass,12337,12341,O
filtered,12342,12350,O
to,12351,12353,O
extract,12354,12361,O
the,12362,12365,O
term,12366,12370,O
oscillating,12371,12382,O
at,12383,12385,O
Omega,12386,12391,O
.,12391,12392,O
The,12393,12396,O
lines,12397,12402,O
are,12403,12406,O
then,12407,12411,O
rearranged,12412,12422,O
in,12423,12425,O
a,12426,12427,O
2D,12428,12430,O
format,12431,12437,O
.,12437,12438,O
The,12439,12442,O
resulting,12443,12452,O
hologram,12453,12461,O
amplitude,12462,12471,O
is,12472,12474,O
found,12475,12480,O
to,12481,12483,O
be,12484,12486,O
HI,12487,12489,O
(,12489,12490,O
r,12490,12491,O
-,12491,12492,O
-,12492,12493,O
>,12493,12494,O
MathType,12495,12503,O
@,12503,12504,O
MTEF,12504,12508,O
@,12508,12509,O
5,12509,12510,O
@,12510,12511,O
5,12511,12512,O
@,12512,12513,O
+,12513,12514,O
=,12514,12515,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,12515,12600,O
=,12600,12601,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,12601,12632,O
=,12632,12633,O
OqFfea0dXdd9vqai,12633,12649,O
=,12649,12650,O
hGuQ8kuc9pgc9s8qqaq,12650,12669,O
=,12669,12670,O
dirpe0xb9q8qiLsFr0,12670,12688,O
=,12688,12689,O
vr0,12689,12692,O
=,12692,12693,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa,12693,12751,O
@,12751,12752,O
2E2B,12752,12756,O
@,12756,12757,O
),12757,12758,O
=,12759,12760,O
integraldzI,12761,12772,O
(,12772,12773,O
r,12773,12774,O
-,12774,12775,O
-,12775,12776,O
>,12776,12777,O
MathType,12778,12786,O
@,12786,12787,O
MTEF,12787,12791,O
@,12791,12792,O
5,12792,12793,O
@,12793,12794,O
5,12794,12795,O
@,12795,12796,O
+,12796,12797,O
=,12797,12798,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,12798,12883,O
=,12883,12884,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,12884,12915,O
=,12915,12916,O
OqFfea0dXdd9vqai,12916,12932,O
=,12932,12933,O
hGuQ8kuc9pgc9s8qqaq,12933,12952,O
=,12952,12953,O
dirpe0xb9q8qiLsFr0,12953,12971,O
=,12971,12972,O
vr0,12972,12975,O
=,12975,12976,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa,12976,13034,O
@,13034,13035,O
2E2B,13035,13039,O
@,13039,13040,O
",",13040,13041,O
z,13042,13043,O
),13043,13044,O
(,13045,13046,O
+,13046,13047,O
),13047,13048,O
[,13049,13050,O
p1,13050,13052,O
(,13052,13053,O
r,13053,13054,O
-,13054,13055,O
-,13055,13056,O
>,13056,13057,O
MathType,13058,13066,O
@,13066,13067,O
MTEF,13067,13071,O
@,13071,13072,O
5,13072,13073,O
@,13073,13074,O
5,13074,13075,O
@,13075,13076,O
+,13076,13077,O
=,13077,13078,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,13078,13163,O
=,13163,13164,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,13164,13195,O
=,13195,13196,O
OqFfea0dXdd9vqai,13196,13212,O
=,13212,13213,O
hGuQ8kuc9pgc9s8qqaq,13213,13232,O
=,13232,13233,O
dirpe0xb9q8qiLsFr0,13233,13251,O
=,13251,13252,O
vr0,13252,13255,O
=,13255,13256,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa,13256,13314,O
@,13314,13315,O
2E2B,13315,13319,O
@,13319,13320,O
",",13320,13321,O
z,13322,13323,O
),13323,13324,O
p,13324,13325,O
*,13325,13326,O
2,13326,13327,O
(,13327,13328,O
r,13328,13329,O
-,13329,13330,O
-,13330,13331,O
>,13331,13332,O
MathType,13333,13341,O
@,13341,13342,O
MTEF,13342,13346,O
@,13346,13347,O
5,13347,13348,O
@,13348,13349,O
5,13349,13350,O
@,13350,13351,O
+,13351,13352,O
=,13352,13353,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,13353,13438,O
=,13438,13439,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,13439,13470,O
=,13470,13471,O
OqFfea0dXdd9vqai,13471,13487,O
=,13487,13488,O
hGuQ8kuc9pgc9s8qqaq,13488,13507,O
=,13507,13508,O
dirpe0xb9q8qiLsFr0,13508,13526,O
=,13526,13527,O
vr0,13527,13530,O
=,13530,13531,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa,13531,13589,O
@,13589,13590,O
2E2B,13590,13594,O
@,13594,13595,O
",",13595,13596,O
z,13597,13598,O
),13598,13599,O
],13599,13600,O
",",13600,13601,O
(,13602,13603,O
4,13603,13604,O
),13604,13605,O
where,13606,13611,O
(,13612,13613,O
+,13613,13614,O
),13614,13615,O
symbolizes,13616,13626,O
a,13627,13628,O
convolution,13629,13640,O
integral,13641,13649,O
",",13649,13650,O
I,13651,13652,O
(,13652,13653,O
r,13653,13654,O
-,13654,13655,O
-,13655,13656,O
>,13656,13657,O
MathType,13658,13666,O
@,13666,13667,O
MTEF,13667,13671,O
@,13671,13672,O
5,13672,13673,O
@,13673,13674,O
5,13674,13675,O
@,13675,13676,O
+,13676,13677,O
=,13677,13678,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,13678,13763,O
=,13763,13764,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,13764,13795,O
=,13795,13796,O
OqFfea0dXdd9vqai,13796,13812,O
=,13812,13813,O
hGuQ8kuc9pgc9s8qqaq,13813,13832,O
=,13832,13833,O
dirpe0xb9q8qiLsFr0,13833,13851,O
=,13851,13852,O
vr0,13852,13855,O
=,13855,13856,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa,13856,13914,O
@,13914,13915,O
2E2B,13915,13919,O
@,13919,13920,O
",",13920,13921,O
z,13922,13923,O
),13923,13924,O
=,13925,13926,O
|,13927,13928,O
T,13928,13929,O
(,13929,13930,O
r,13930,13931,O
-,13931,13932,O
-,13932,13933,O
>,13933,13934,O
MathType,13935,13943,O
@,13943,13944,O
MTEF,13944,13948,O
@,13948,13949,O
5,13949,13950,O
@,13950,13951,O
5,13951,13952,O
@,13952,13953,O
+,13953,13954,O
=,13954,13955,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,13955,14040,O
=,14040,14041,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,14041,14072,O
=,14072,14073,O
OqFfea0dXdd9vqai,14073,14089,O
=,14089,14090,O
hGuQ8kuc9pgc9s8qqaq,14090,14109,O
=,14109,14110,O
dirpe0xb9q8qiLsFr0,14110,14128,O
=,14128,14129,O
vr0,14129,14132,O
=,14132,14133,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa,14133,14191,O
@,14191,14192,O
2E2B,14192,14196,O
@,14196,14197,O
",",14197,14198,O
z,14199,14200,O
),14200,14201,O
|,14201,14202,O
2,14202,14203,O
",",14203,14204,O
and,14205,14208,O
p1,14209,14211,O
",",14211,14212,O
2,14212,14213,O
(,14213,14214,O
r,14214,14215,O
-,14215,14216,O
-,14216,14217,O
>,14217,14218,O
MathType,14219,14227,O
@,14227,14228,O
MTEF,14228,14232,O
@,14232,14233,O
5,14233,14234,O
@,14234,14235,O
5,14235,14236,O
@,14236,14237,O
+,14237,14238,O
=,14238,14239,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,14239,14324,O
=,14324,14325,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,14325,14356,O
=,14356,14357,O
OqFfea0dXdd9vqai,14357,14373,O
=,14373,14374,O
hGuQ8kuc9pgc9s8qqaq,14374,14393,O
=,14393,14394,O
dirpe0xb9q8qiLsFr0,14394,14412,O
=,14412,14413,O
vr0,14413,14416,O
=,14416,14417,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa,14417,14475,O
@,14475,14476,O
2E2B,14476,14480,O
@,14480,14481,O
",",14481,14482,O
z,14483,14484,O
),14484,14485,O
are,14486,14489,O
the,14490,14493,O
inverse,14494,14501,O
Fourier,14502,14509,O
transforms,14510,14520,O
of,14521,14523,O
the,14524,14527,O
defocused,14528,14537,O
pupil,14538,14543,O
distributions,14544,14557,O
(,14558,14559,O
eq,14559,14561,O
.,14561,14562,O
1b,14562,14564,O
),14564,14565,O
.,14565,14566,O
The,14567,14570,O
superscript,14571,14582,O
*,14583,14584,O
stands,14585,14591,O
for,14592,14595,O
complex,14596,14603,O
conjugate,14604,14613,O
.,14613,14614,O
The,14615,14618,O
hologram,14619,14627,O
is,14628,14630,O
thus,14631,14635,O
the,14636,14639,O
convolution,14640,14651,O
of,14652,14654,O
the,14655,14658,O
object,14659,14665,O
intensity,14666,14675,O
with,14676,14680,O
a,14681,14682,O
spherical,14683,14692,O
wave,14693,14697,O
",",14697,14698,O
i,14699,14700,O
.,14700,14701,O
e,14701,14702,O
.,14702,14703,O
an,14704,14706,O
in,14707,14709,O
-,14709,14710,O
line,14710,14714,O
single,14715,14721,O
-,14721,14722,O
sideband,14722,14730,O
Gabor,14731,14736,O
hologram,14737,14745,O
.,14745,14746,O
In,14747,14749,O
Fourier,14750,14757,O
space,14758,14763,O
",",14763,14764,O
the,14765,14768,O
hologram,14769,14777,O
can,14778,14781,O
be,14782,14784,O
written,14785,14792,O
as,14793,14795,O
H,14796,14797,O
~,14797,14798,O
I,14798,14799,O
(,14799,14800,O
rho,14800,14803,O
-,14803,14804,O
-,14804,14805,O
>,14805,14806,O
),14806,14807,O
=,14807,14808,O
integraldzI,14808,14819,O
~,14819,14820,O
(,14820,14821,O
rho,14821,14824,O
-,14824,14825,O
-,14825,14826,O
>,14826,14827,O
;,14827,14828,O
z,14828,14829,O
),14829,14830,O
[,14830,14831,O
P,14831,14832,O
~,14832,14833,O
1,14833,14834,O
(,14834,14835,O
rho,14835,14838,O
-,14838,14839,O
-,14839,14840,O
>,14840,14841,O
;,14841,14842,O
z,14842,14843,O
),14843,14844,O
(,14844,14845,O
*,14845,14846,O
),14846,14847,O
P,14847,14848,O
~,14848,14849,O
2,14849,14850,O
(,14850,14851,O
rho,14851,14854,O
-,14854,14855,O
-,14855,14856,O
>,14856,14857,O
;,14857,14858,O
z,14858,14859,O
),14859,14860,O
],14860,14861,O
",",14861,14862,O
(,14863,14864,O
5,14864,14865,O
),14865,14866,O
MathType,14867,14875,O
@,14875,14876,O
MTEF,14876,14880,O
@,14880,14881,O
5,14881,14882,O
@,14882,14883,O
5,14883,14884,O
@,14884,14885,O
+,14885,14886,O
=,14886,14887,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,14887,14972,O
=,14972,14973,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,14973,15004,O
=,15004,15005,O
OqFfea0dXdd9vqai,15005,15021,O
=,15021,15022,O
hGuQ8kuc9pgc9s8qqaq,15022,15041,O
=,15041,15042,O
dirpe0xb9q8qiLsFr0,15042,15060,O
=,15060,15061,O
vr0,15061,15064,O
=,15064,15065,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGibasgaacamaaBaaaleaacqWGjbqsaeqaaOGaeiikaGccciGaf8xWdiNbaSaacqGGPaqkcqGH9aqpdaWdbaqaaiabdsgaKjabdQha6jqbdMeajzaaiaaaleqabeqdcqGHRiI8aOGaeiikaGIaf8xWdiNbaSaacqGG7aWocqWG6bGEcqGGPaqkdaWadaqaaiqbdcfaqzaaiaWaaSbaaSqaaiabigdaXaqabaGccqGGOaakcuWFbpGCgaWcaiabcUda7iabdQha6jabcMcaPiabgEPielqbdcfaqzaaiaWaaSbaaSqaaiabikdaYaqabaGccqGGOaakcuWFbpGCgaWcaiabcUda7iabdQha6jabcMcaPaGaay5waiaaw2faaiabcYcaSiaaxMaacaWLjaWaaeWaaeaacqaI1aqnaiaawIcacaGLPaaaaaa,15065,15550,O
@,15550,15551,O
58FF,15551,15555,O
@,15555,15556,O
where,15557,15562,O
(,15563,15564,O
+,15564,15565,O
),15565,15566,O
symbolizes,15567,15577,O
a,15578,15579,O
correlation,15580,15591,O
integral,15592,15600,O
.,15600,15601,O
With,15602,15606,O
the,15607,15610,O
pupils,15611,15617,O
of,15618,15620,O
eq,15621,15623,O
.,15623,15624,O
2,15624,15625,O
",",15625,15626,O
we,15627,15629,O
find,15630,15634,O
",",15634,15635,O
in,15636,15638,O
the,15639,15642,O
paraxial,15643,15651,O
approximation,15652,15665,O
",",15665,15666,O
H,15667,15668,O
~,15668,15669,O
I,15669,15670,O
(,15670,15671,O
rho,15671,15674,O
-,15674,15675,O
-,15675,15676,O
>,15676,15677,O
),15677,15678,O
=,15678,15679,O
integraldzI,15679,15690,O
~,15690,15691,O
(,15691,15692,O
rho,15692,15695,O
-,15695,15696,O
-,15696,15697,O
>,15697,15698,O
;,15698,15699,O
z,15699,15700,O
),15700,15701,O
exp,15701,15704,O
[,15705,15706,O
ipilambda,15706,15715,O
(,15715,15716,O
z0,15716,15718,O
+,15718,15719,O
z,15719,15720,O
),15720,15721,O
rho2,15721,15725,O
],15725,15726,O
circ,15726,15730,O
(,15730,15731,O
rho,15731,15734,O
/,15734,15735,O
rhoMAX,15735,15741,O
),15741,15742,O
",",15742,15743,O
(,15744,15745,O
6,15745,15746,O
),15746,15747,O
MathType,15748,15756,O
@,15756,15757,O
MTEF,15757,15761,O
@,15761,15762,O
5,15762,15763,O
@,15763,15764,O
5,15764,15765,O
@,15765,15766,O
+,15766,15767,O
=,15767,15768,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,15768,15853,O
=,15853,15854,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,15854,15885,O
=,15885,15886,O
OqFfea0dXdd9vqai,15886,15902,O
=,15902,15903,O
hGuQ8kuc9pgc9s8qqaq,15903,15922,O
=,15922,15923,O
dirpe0xb9q8qiLsFr0,15923,15941,O
=,15941,15942,O
vr0,15942,15945,O
=,15945,15946,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGibasgaacamaaBaaaleaacqWGjbqsaeqaaOGaeiikaGccciGaf8xWdiNbaSaacqGGPaqkcqGH9aqpdaWdbaqaaiabdsgaKjabdQha6jqbdMeajzaaiaaaleqabeqdcqGHRiI8aOGaeiikaGIaf8xWdiNbaSaacqGG7aWocqWG6bGEcqGGPaqkcyGGLbqzcqGG4baEcqGGWbaCdaWadaqaaiabdMgaPjab,15946,16216,O
=,16216,16217,O
b8aWjab,16217,16224,O
=,16224,16225,O
T7aSjabcIcaOiabdQha6naaBaaaleaacqaIWaamaeqaaOGaey4kaSIaemOEaONaeiykaKIae8xWdi3aaWbaaSqabeaacqaIYaGmaaaakiaawUfacaGLDbaacqWGJbWycqWGPbqAcqWGYbGCcqWGJbWycqGGOaakcqWFbpGCcqGGVaWlcqWFbpGCdaWgaaWcbaGaemyta0KaemyqaeKaemiwaGfabeaakiabcMcaPiabcYcaSiaaxMaacaWLjaWaaeWaaeaacqaI2aGnaiaawIcacaGLPaaaaaa,16225,16515,O
@,16515,16516,O
67E3,16516,16520,O
@,16520,16521,O
which,16522,16527,O
is,16528,16530,O
the,16531,16534,O
Fourier,16535,16542,O
transform,16543,16552,O
of,16553,16555,O
the,16556,16559,O
Fresnel,16560,16567,O
hologram,16568,16576,O
of,16577,16579,O
the,16580,16583,O
object,16584,16590,O
',16590,16591,O
s,16591,16592,O
intensity,16593,16602,O
distribution,16603,16615,O
.,16615,16616,O
The,16617,16620,O
coherent,16621,16629,O
imaging,16630,16637,O
mode,16638,16642,O
is,16643,16645,O
obtained,16646,16654,O
by,16655,16657,O
using,16658,16663,O
a,16664,16665,O
pinhole,16666,16673,O
or,16674,16676,O
a,16677,16678,O
point,16679,16684,O
detector,16685,16693,O
at,16694,16696,O
the,16697,16700,O
center,16701,16707,O
of,16708,16710,O
a,16711,16712,O
conjugate,16713,16722,O
plane,16723,16728,O
of,16729,16731,O
the,16732,16735,O
pupil,16736,16741,O
of,16742,16744,O
the,16745,16748,O
objective,16749,16758,O
.,16758,16759,O
This,16760,16764,O
leads,16765,16770,O
to,16771,16773,O
the,16774,16777,O
hologram,16778,16786,O
amplitude,16787,16796,O
HC,16797,16799,O
(,16799,16800,O
r,16800,16801,O
-,16801,16802,O
-,16802,16803,O
>,16803,16804,O
MathType,16805,16813,O
@,16813,16814,O
MTEF,16814,16818,O
@,16818,16819,O
5,16819,16820,O
@,16820,16821,O
5,16821,16822,O
@,16822,16823,O
+,16823,16824,O
=,16824,16825,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,16825,16910,O
=,16910,16911,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,16911,16942,O
=,16942,16943,O
OqFfea0dXdd9vqai,16943,16959,O
=,16959,16960,O
hGuQ8kuc9pgc9s8qqaq,16960,16979,O
=,16979,16980,O
dirpe0xb9q8qiLsFr0,16980,16998,O
=,16998,16999,O
vr0,16999,17002,O
=,17002,17003,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa,17003,17061,O
@,17061,17062,O
2E2B,17062,17066,O
@,17066,17067,O
),17067,17068,O
=,17069,17070,O
integraldz,17071,17081,O
[,17081,17082,O
T,17082,17083,O
(,17083,17084,O
r,17084,17085,O
-,17085,17086,O
-,17086,17087,O
>,17087,17088,O
MathType,17089,17097,O
@,17097,17098,O
MTEF,17098,17102,O
@,17102,17103,O
5,17103,17104,O
@,17104,17105,O
5,17105,17106,O
@,17106,17107,O
+,17107,17108,O
=,17108,17109,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,17109,17194,O
=,17194,17195,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,17195,17226,O
=,17226,17227,O
OqFfea0dXdd9vqai,17227,17243,O
=,17243,17244,O
hGuQ8kuc9pgc9s8qqaq,17244,17263,O
=,17263,17264,O
dirpe0xb9q8qiLsFr0,17264,17282,O
=,17282,17283,O
vr0,17283,17286,O
=,17286,17287,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa,17287,17345,O
@,17345,17346,O
2E2B,17346,17350,O
@,17350,17351,O
",",17351,17352,O
z,17353,17354,O
),17354,17355,O
(,17356,17357,O
+,17357,17358,O
),17358,17359,O
p1,17360,17362,O
(,17362,17363,O
r,17363,17364,O
-,17364,17365,O
-,17365,17366,O
>,17366,17367,O
MathType,17368,17376,O
@,17376,17377,O
MTEF,17377,17381,O
@,17381,17382,O
5,17382,17383,O
@,17383,17384,O
5,17384,17385,O
@,17385,17386,O
+,17386,17387,O
=,17387,17388,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,17388,17473,O
=,17473,17474,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,17474,17505,O
=,17505,17506,O
OqFfea0dXdd9vqai,17506,17522,O
=,17522,17523,O
hGuQ8kuc9pgc9s8qqaq,17523,17542,O
=,17542,17543,O
dirpe0xb9q8qiLsFr0,17543,17561,O
=,17561,17562,O
vr0,17562,17565,O
=,17565,17566,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa,17566,17624,O
@,17624,17625,O
2E2B,17625,17629,O
@,17629,17630,O
",",17630,17631,O
z,17632,17633,O
),17633,17634,O
],17634,17635,O
[,17635,17636,O
T,17636,17637,O
(,17637,17638,O
r,17638,17639,O
-,17639,17640,O
-,17640,17641,O
>,17641,17642,O
MathType,17643,17651,O
@,17651,17652,O
MTEF,17652,17656,O
@,17656,17657,O
5,17657,17658,O
@,17658,17659,O
5,17659,17660,O
@,17660,17661,O
+,17661,17662,O
=,17662,17663,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,17663,17748,O
=,17748,17749,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,17749,17780,O
=,17780,17781,O
OqFfea0dXdd9vqai,17781,17797,O
=,17797,17798,O
hGuQ8kuc9pgc9s8qqaq,17798,17817,O
=,17817,17818,O
dirpe0xb9q8qiLsFr0,17818,17836,O
=,17836,17837,O
vr0,17837,17840,O
=,17840,17841,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa,17841,17899,O
@,17899,17900,O
2E2B,17900,17904,O
@,17904,17905,O
",",17905,17906,O
z,17907,17908,O
),17908,17909,O
(,17910,17911,O
+,17911,17912,O
),17912,17913,O
p2,17914,17916,O
(,17916,17917,O
r,17917,17918,O
-,17918,17919,O
-,17919,17920,O
>,17920,17921,O
MathType,17922,17930,O
@,17930,17931,O
MTEF,17931,17935,O
@,17935,17936,O
5,17936,17937,O
@,17937,17938,O
5,17938,17939,O
@,17939,17940,O
+,17940,17941,O
=,17941,17942,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,17942,18027,O
=,18027,18028,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,18028,18059,O
=,18059,18060,O
OqFfea0dXdd9vqai,18060,18076,O
=,18076,18077,O
hGuQ8kuc9pgc9s8qqaq,18077,18096,O
=,18096,18097,O
dirpe0xb9q8qiLsFr0,18097,18115,O
=,18115,18116,O
vr0,18116,18119,O
=,18119,18120,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGYbGCgaWcaaaa,18120,18178,O
@,18178,18179,O
2E2B,18179,18183,O
@,18183,18184,O
",",18184,18185,O
z,18186,18187,O
),18187,18188,O
],18188,18189,O
*,18189,18190,O
.,18190,18191,O
(,18192,18193,O
7,18193,18194,O
),18194,18195,O
Where,18196,18201,O
again,18202,18207,O
",",18207,18208,O
(,18209,18210,O
+,18210,18211,O
),18211,18212,O
symbolizes,18213,18223,O
a,18224,18225,O
convolution,18226,18237,O
product,18238,18245,O
",",18245,18246,O
and,18247,18250,O
the,18251,18254,O
superscript,18255,18266,O
*,18267,18268,O
stands,18269,18275,O
for,18276,18279,O
complex,18280,18287,O
conjugate,18288,18297,O
.,18297,18298,O
In,18299,18301,O
Fourier,18302,18309,O
space,18310,18315,O
",",18315,18316,O
H,18317,18318,O
~,18318,18319,O
C,18319,18320,O
(,18320,18321,O
rho,18321,18324,O
-,18324,18325,O
-,18325,18326,O
>,18326,18327,O
),18327,18328,O
=,18328,18329,O
integraldzT,18329,18340,O
~,18340,18341,O
(,18341,18342,O
rho,18342,18345,O
-,18345,18346,O
-,18346,18347,O
>,18347,18348,O
;,18348,18349,O
z,18349,18350,O
),18350,18351,O
P,18351,18352,O
~,18352,18353,O
1,18353,18354,O
(,18354,18355,O
rho,18355,18358,O
-,18358,18359,O
-,18359,18360,O
>,18360,18361,O
;,18361,18362,O
z,18362,18363,O
),18363,18364,O
(,18364,18365,O
*,18365,18366,O
),18366,18367,O
T,18367,18368,O
~,18368,18369,O
(,18369,18370,O
rho,18370,18373,O
-,18373,18374,O
-,18374,18375,O
>,18375,18376,O
;,18376,18377,O
z,18377,18378,O
),18378,18379,O
P,18379,18380,O
~,18380,18381,O
2,18381,18382,O
(,18382,18383,O
rho,18383,18386,O
-,18386,18387,O
-,18387,18388,O
>,18388,18389,O
;,18389,18390,O
z,18390,18391,O
),18391,18392,O
.,18392,18393,O
(,18394,18395,O
8,18395,18396,O
),18396,18397,O
MathType,18398,18406,O
@,18406,18407,O
MTEF,18407,18411,O
@,18411,18412,O
5,18412,18413,O
@,18413,18414,O
5,18414,18415,O
@,18415,18416,O
+,18416,18417,O
=,18417,18418,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,18418,18503,O
=,18503,18504,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,18504,18535,O
=,18535,18536,O
OqFfea0dXdd9vqai,18536,18552,O
=,18552,18553,O
hGuQ8kuc9pgc9s8qqaq,18553,18572,O
=,18572,18573,O
dirpe0xb9q8qiLsFr0,18573,18591,O
=,18591,18592,O
vr0,18592,18595,O
=,18595,18596,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGibasgaacamaaBaaaleaacqWGdbWqaeqaaOGaeiikaGccciGaf8xWdiNbaSaacqGGPaqkcqGH9aqpdaWdbaqaaiabdsgaKjabdQha6jqbdsfauzaaiaaaleqabeqdcqGHRiI8aOGaeiikaGIaf8xWdiNbaSaacqGG7aWocqWG6bGEcqGGPaqkcuWGqbaugaacamaaBaaaleaacqaIXaqmaeqaaOGaeiikaGIaf8xWdiNbaSaacqGG7aWocqWG6bGEcqGGPaqkcqGHxkcXcuWGubavgaacaiabcIcaOiqb,18596,18938,O
=,18938,18939,O
f8aYzaalaGaei4oaSJaemOEaONaeiykaKIafmiuaaLbaGaadaWgaaWcbaGaeGOmaidabeaakiabcIcaOiqb,18939,19022,O
=,19022,19023,O
f8aYzaalaGaei4oaSJaemOEaONaeiykaKIaeiOla4IaaCzcaiaaxMaadaqadaqaaiabiIda4aGaayjkaiaawMcaaaaa,19023,19114,O
@,19114,19115,O
5E5B,19115,19119,O
@,19119,19120,O
With,19121,19125,O
the,19126,19129,O
pupils,19130,19136,O
of,19137,19139,O
eq,19140,19142,O
.,19142,19143,O
2,19143,19144,O
",",19144,19145,O
we,19146,19148,O
find,19149,19153,O
H,19154,19155,O
~,19155,19156,O
C,19156,19157,O
(,19157,19158,O
rho,19158,19161,O
-,19161,19162,O
-,19162,19163,O
>,19163,19164,O
),19164,19165,O
=,19165,19166,O
integraldzT,19166,19177,O
~,19177,19178,O
*,19178,19179,O
(,19179,19180,O
0,19180,19181,O
;,19181,19182,O
z,19182,19183,O
),19183,19184,O
T,19184,19185,O
~,19185,19186,O
(,19186,19187,O
rho,19187,19190,O
-,19190,19191,O
-,19191,19192,O
>,19192,19193,O
;,19193,19194,O
z,19194,19195,O
),19195,19196,O
exp,19196,19199,O
[,19200,19201,O
ipilambda,19201,19210,O
(,19210,19211,O
z0,19211,19213,O
+,19213,19214,O
z,19214,19215,O
),19215,19216,O
rho2,19216,19220,O
],19220,19221,O
circ,19221,19225,O
(,19225,19226,O
rho,19226,19229,O
/,19229,19230,O
rhoMAX,19230,19236,O
),19236,19237,O
.,19237,19238,O
(,19239,19240,O
9,19240,19241,O
),19241,19242,O
MathType,19243,19251,O
@,19251,19252,O
MTEF,19252,19256,O
@,19256,19257,O
5,19257,19258,O
@,19258,19259,O
5,19259,19260,O
@,19260,19261,O
+,19261,19262,O
=,19262,19263,O
feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY,19263,19348,O
=,19348,19349,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,19349,19380,O
=,19380,19381,O
OqFfea0dXdd9vqai,19381,19397,O
=,19397,19398,O
hGuQ8kuc9pgc9s8qqaq,19398,19417,O
=,19417,19418,O
dirpe0xb9q8qiLsFr0,19418,19436,O
=,19436,19437,O
vr0,19437,19440,O
=,19440,19441,O
vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacuWGibasgaacamaaBaaaleaacqWGdbWqaeqaaOGaeiikaGccciGaf8xWdiNbaSaacqGGPaqkcqGH9aqpdaWdbaqaaiabdsgaKjabdQha6jqbdsfauzaaiaGaey4fIOIaeiikaGIaeGimaaJaei4oaSJaemOEaONaeiykaKIafmivaqLbaGaaaSqabeqaniabgUIiYdGccqGGOaakcuWFbpGCgaWcaiabcUda7iabdQha6jabcMcaPiGbcwgaLjabcIha4jabcchaWnaadmaabaGaemyAaKMae8hWdaNae83UdWMaeiikaGIaemOEaO3aaSbaaSqaaiabicdaWaqabaGccqGHRaWkcqWG6bGEcqGGPaqkcqWFbpGCdaahaaWcbeqaaiabikdaYaaaaOGaay5waiaaw2faaiabdogaJjabdMgaPjabdkhaYjabdogaJjabcIcaOiab,19441,19943,O
=,19943,19944,O
f8aYjabc,19944,19952,O
+,19952,19953,O
caViab,19953,19959,O
=,19959,19960,O
f8aYnaaBaaaleaacqWGnbqtcqWGbbqqcqWGybawaeqaaOGaeiykaKIaeiOla4IaaCzcaiaaxMaadaqadaqaaiabiMda5aGaayjkaiaawMcaaaaa,19960,20071,O
@,20071,20072,O
6F41,20072,20076,O
@,20076,20077,O
Aside,20078,20083,O
from,20084,20088,O
an,20089,20091,O
inconsequential,20092,20107,O
complex,20108,20115,O
constant,20116,20124,O
(,20125,20126,O
the,20126,20129,O
first,20130,20135,O
term,20136,20140,O
under,20141,20146,O
the,20147,20150,O
integral,20151,20159,O
),20159,20160,O
",",20160,20161,O
eq,20162,20164,O
.,20164,20165,O
9,20165,20166,O
is,20167,20169,O
the,20170,20173,O
Fourier,20174,20181,O
transform,20182,20191,O
of,20192,20194,O
the,20195,20198,O
Fresnel,20199,20206,O
hologram,20207,20215,O
of,20216,20218,O
the,20219,20222,O
object,20223,20229,O
',20229,20230,O
s,20230,20231,O
complex,20232,20239,O
amplitude,20240,20249,O
distribution,20250,20262,O
.,20262,20263,O
Thus,20264,20268,O
",",20268,20269,O
the,20270,20273,O
reconstruction,20274,20288,O
of,20289,20291,O
the,20292,20295,O
hologram,20296,20304,O
recorded,20305,20313,O
in,20314,20316,O
the,20317,20320,O
coherent,20321,20329,O
mode,20330,20334,O
carries,20335,20342,O
a,20343,20344,O
quantitative,20345,20357,O
measure,20358,20365,O
of,20366,20368,O
the,20369,20372,O
object,20373,20379,O
',20379,20380,O
s,20380,20381,O
phase,20382,20387,O
distribution,20388,20400,O
.,20400,20401,O
Results,0,7,O
Here,8,12,O
we,13,15,O
include,16,23,O
data,24,28,O
obtained,29,37,O
from,38,42,O
active,43,49,O
",",49,50,O
oscillatory,51,62,O
brain,63,68,B-Multi-tissue_structure
slices,69,75,I-Multi-tissue_structure
as,76,78,O
well,79,83,O
as,84,86,O
from,87,91,O
recordings,92,102,O
during,103,109,O
cortical,110,118,B-Multi-tissue_structure
slow,119,123,O
oscillations,124,136,O
in,137,139,O
anesthetized,140,152,O
animals,153,160,O
.,160,161,O
All,162,165,O
recordings,166,176,O
included,177,185,O
in,186,188,O
this,189,193,O
study,194,199,O
were,200,204,O
obtained,205,213,O
from,214,218,O
the,219,222,O
visual,223,229,B-Multi-tissue_structure
cortex,230,236,I-Multi-tissue_structure
of,237,239,O
the,240,243,O
ferret,244,250,O
(,251,252,O
in,252,254,O
vitro,255,260,O
),260,261,O
",",261,262,O
cat,263,266,O
(,267,268,O
in,268,270,O
vivo,271,275,O
),275,276,O
and,277,280,O
from,281,285,O
barrel,286,292,B-Multi-tissue_structure
cortex,293,299,I-Multi-tissue_structure
of,300,302,O
the,303,306,O
rat,307,310,O
(,311,312,O
in,312,314,O
vivo,315,319,O
),319,320,O
.,320,321,O
Twenty,322,328,O
-,328,329,O
nine,329,333,O
neurons,334,341,B-Cell
recorded,342,350,O
from,351,355,O
ferret,356,362,O
cortical,363,371,B-Multi-tissue_structure
slices,372,378,I-Multi-tissue_structure
are,379,382,O
included,383,391,O
in,392,394,O
this,395,399,O
study,400,405,O
(,406,407,O
22,407,409,O
regular,410,417,O
spiking,418,425,O
(,426,427,O
RS,427,429,O
),429,430,O
;,430,431,O
5,432,433,O
chattering,434,444,O
(,445,446,O
CH,446,448,O
),448,449,O
and,450,453,O
2,454,455,O
intrinsic,456,465,O
bursting,466,474,O
(,475,476,O
IB,476,478,O
),478,479,O
),479,480,O
",",480,481,O
27,482,484,O
neurons,485,492,B-Cell
from,493,497,O
cat,498,501,O
visual,502,508,B-Multi-tissue_structure
cortex,509,515,I-Multi-tissue_structure
in,516,518,O
vivo,519,523,O
(,524,525,O
14,525,527,O
RS,528,530,O
;,530,531,O
5,532,533,O
CH,534,536,O
;,536,537,O
2,538,539,O
IB,540,542,O
;,542,543,O
3,544,545,O
fast,546,550,O
spiking,551,558,O
(,559,560,O
FS,560,562,O
),562,563,O
;,563,564,O
plus,565,569,O
3,570,571,O
non,572,575,O
classified,576,586,O
),586,587,O
and,588,591,O
14,592,594,O
neurons,595,602,B-Cell
from,603,607,O
rat,608,611,O
barrel,612,618,B-Multi-tissue_structure
cortex,619,625,I-Multi-tissue_structure
in,626,628,O
vivo,629,633,O
(,634,635,O
12,635,637,O
RS,638,640,O
;,640,641,O
1,642,643,O
CH,644,646,O
;,646,647,O
1,648,649,O
IB,650,652,O
),652,653,O
.,653,654,O
Synaptic,655,663,B-Cellular_component
potentials,664,674,O
were,675,679,O
evoked,680,686,O
by,687,689,O
electric,690,698,O
shocks,699,705,O
(,706,707,O
intracortical,707,720,O
or,721,723,O
thalamocortical,724,739,O
connections,740,751,O
),751,752,O
or,753,755,O
by,756,758,O
means,759,764,O
of,765,767,O
sensory,768,775,O
(,776,777,O
visual,777,783,O
or,784,786,O
whisker,787,794,O
),794,795,O
stimulation,796,807,O
.,807,808,O
The,809,812,O
main,813,817,O
results,818,825,O
are,826,829,O
:,829,830,O
1,831,832,O
),832,833,O
Synaptic,834,842,B-Cellular_component
potentials,843,853,O
show,854,858,O
more,859,863,O
paired,864,870,O
pulsed,871,877,O
facilitation,878,890,O
and,891,894,O
synaptic,895,903,B-Cellular_component
augmentation,904,916,O
in,917,919,O
active,920,926,O
than,927,931,O
in,932,934,O
silent,935,941,O
cortical,942,950,B-Multi-tissue_structure
networks,951,959,O
and,960,963,O
2,964,965,O
),965,966,O
Synaptic,967,975,B-Cellular_component
potentials,976,986,O
occurring,987,996,O
during,997,1003,O
up,1004,1006,O
or,1007,1009,O
activated,1010,1019,O
states,1020,1026,O
of,1027,1029,O
the,1030,1033,O
cortex,1034,1040,B-Multi-tissue_structure
increased,1041,1050,O
their,1051,1056,O
amplitude,1057,1066,O
with,1067,1071,O
respect,1072,1079,O
to,1080,1082,O
those,1083,1088,O
occurring,1089,1098,O
during,1099,1105,O
down,1106,1110,O
states,1111,1117,O
.,1117,1118,O
Ca2,0,3,O
+,3,4,O
Dependence,5,15,O
of,16,18,O
Slob57,19,25,O
Modulation,26,36,O
of,37,39,O
the,40,43,O
Voltage,44,51,O
Dependence,52,62,O
of,63,65,O
Activation,66,76,O
of,77,79,O
dSlo,80,84,O
Ca2,85,88,O
+,88,89,O
plays,90,95,O
a,96,97,O
fundamental,98,109,O
role,110,114,O
in,115,117,O
regulating,118,128,O
the,129,132,O
dSlo,133,137,O
response,138,146,O
to,147,149,O
membrane,150,158,B-Cellular_component
depolarization,159,173,O
.,173,174,O
One,175,178,O
of,179,181,O
the,182,185,O
three,186,191,O
known,192,197,O
Ca2,198,201,O
+,201,202,O
binding,203,210,O
sites,211,216,O
(,217,218,O
Xia,218,221,O
et,222,224,O
al,225,227,O
.,227,228,O
",",228,229,O
2002,230,234,O
;,234,235,O
Bao,236,239,O
et,240,242,O
al,243,245,O
.,245,246,O
",",246,247,O
2002,248,252,O
;,252,253,O
Zeng,254,258,O
et,259,261,O
al,262,264,O
.,264,265,O
",",265,266,O
2005b,267,272,O
),272,273,O
",",273,274,O
known,275,280,O
as,281,283,O
the,284,287,O
calcium,288,295,O
bowl,296,300,O
(,301,302,O
Schreiber,302,311,O
and,312,315,O
Salkoff,316,323,O
",",323,324,O
1997,325,329,O
),329,330,O
",",330,331,O
contributes,332,343,O
to,344,346,O
the,347,350,O
high,351,355,O
-,355,356,O
affinity,356,364,O
Ca2,365,368,O
+,368,369,O
sensitivity,370,381,O
of,382,384,O
the,385,388,O
channel,389,396,O
(,397,398,O
Schreiber,398,407,O
and,408,411,O
Salkoff,412,419,O
",",419,420,O
1997,421,425,O
;,425,426,O
Schreiber,427,436,O
et,437,439,O
al,440,442,O
.,442,443,O
",",443,444,O
1999,445,449,O
;,449,450,O
Braun,451,456,O
and,457,460,O
Sy,461,463,O
",",463,464,O
2001,465,469,O
;,469,470,O
Bao,471,474,O
et,475,477,O
al,478,480,O
.,480,481,O
",",481,482,O
2002,483,487,O
;,487,488,O
Niu,489,492,O
and,493,496,O
Magleby,497,504,O
",",504,505,O
2002,506,510,O
;,510,511,O
Xia,512,515,O
et,516,518,O
al,519,521,O
.,521,522,O
",",522,523,O
2002,524,528,O
;,528,529,O
Bao,530,533,O
et,534,536,O
al,537,539,O
.,539,540,O
",",540,541,O
2004,542,546,O
;,546,547,O
Zeng,548,552,O
et,553,555,O
al,556,558,O
.,558,559,O
",",559,560,O
2005b,561,566,O
),566,567,O
.,567,568,O
We,569,571,O
used,572,576,O
a,577,578,O
mutated,579,586,O
dSlo,587,591,O
channel,592,599,O
with,600,604,O
substitution,605,617,O
of,618,620,O
Asp966,621,627,O
-,627,628,O
Asp970,628,634,O
by,635,637,O
Asn966,638,644,O
-,644,645,O
Asn970,645,651,O
within,652,658,O
its,659,662,O
calcium,663,670,O
bowl,671,675,O
",",675,676,O
which,677,682,O
greatly,683,690,O
reduces,691,698,O
the,699,702,O
channel,703,710,O
',710,711,O
s,711,712,O
calcium,713,720,O
sensitivity,721,732,O
(,733,734,O
Bian,734,738,O
et,739,741,O
al,742,744,O
.,744,745,O
",",745,746,O
2001,747,751,O
),751,752,O
",",752,753,O
to,754,756,O
determine,757,766,O
whether,767,774,O
Ca2,775,778,O
+,778,779,O
participates,780,792,O
in,793,795,O
Slob57,796,802,O
modulation,803,813,O
of,814,816,O
dSlo,817,821,O
.,821,822,O
This,823,827,O
mutated,828,835,O
channel,836,843,O
",",843,844,O
dSloD5N5,845,853,O
",",853,854,O
still,855,860,O
binds,861,866,O
to,867,869,O
full,870,874,O
-,874,875,O
length,875,881,O
and,882,885,O
truncated,886,895,O
Slobs,896,901,O
(,902,903,O
Fig,903,906,O
.,906,907,O
1,908,909,O
B,910,911,O
",",911,912,O
lanes,913,918,O
4,919,920,O
-,920,921,O
6,921,922,O
),922,923,O
.,923,924,O
During,925,931,O
a,932,933,O
350,934,937,O
-,937,938,O
ms,938,940,O
test,941,945,O
pulse,946,951,O
(,952,953,O
Fig,953,956,O
.,956,957,O
7,958,959,O
E,960,961,O
),961,962,O
",",962,963,O
Slob57,964,970,O
causes,971,977,O
dSloD5N5,978,986,O
inactivation,987,999,O
(,1000,1001,O
Fig,1001,1004,O
.,1004,1005,O
7,1006,1007,O
B,1008,1009,O
),1009,1010,O
",",1010,1011,O
consistent,1012,1022,O
with,1023,1027,O
our,1028,1031,O
previous,1032,1040,O
finding,1041,1048,O
that,1049,1053,O
the,1054,1057,O
inactivation,1058,1070,O
caused,1071,1077,O
by,1078,1080,O
Slob57,1081,1087,O
is,1088,1090,O
Ca2,1091,1094,O
+,1094,1095,O
independent,1096,1107,O
(,1108,1109,O
Zeng,1109,1113,O
et,1114,1116,O
al,1117,1119,O
.,1119,1120,O
",",1120,1121,O
2005a,1122,1127,O
),1127,1128,O
.,1128,1129,O
After,1130,1135,O
deletion,1136,1144,O
of,1145,1147,O
the,1148,1151,O
amino,1152,1157,O
-,1157,1158,O
terminal,1158,1166,O
residues,1167,1175,O
2,1176,1177,O
-,1177,1178,O
6,1178,1179,O
of,1180,1182,O
Slob57,1183,1189,O
",",1189,1190,O
the,1191,1194,O
inactivation,1195,1207,O
of,1208,1210,O
dSloD5N5,1211,1219,O
is,1220,1222,O
eliminated,1223,1233,O
(,1234,1235,O
Fig,1235,1238,O
.,1238,1239,O
7,1240,1241,O
C,1242,1243,O
),1243,1244,O
",",1244,1245,O
and,1246,1249,O
further,1250,1257,O
truncation,1258,1268,O
of,1269,1271,O
Slob57,1272,1278,O
to,1279,1281,O
Arg16,1282,1287,O
also,1288,1292,O
eliminates,1293,1303,O
the,1304,1307,O
inactivation,1308,1320,O
(,1321,1322,O
Fig,1322,1325,O
.,1325,1326,O
7,1327,1328,O
D,1329,1330,O
),1330,1331,O
",",1331,1332,O
just,1333,1337,O
as,1338,1340,O
observed,1341,1349,O
with,1350,1354,O
wild,1355,1359,O
-,1359,1360,O
type,1360,1364,O
dSlo,1365,1369,O
(,1370,1371,O
Fig,1371,1374,O
.,1374,1375,O
2,1376,1377,O
",",1377,1378,O
C,1379,1380,O
and,1381,1384,O
D,1385,1386,O
),1386,1387,O
.,1387,1388,O
Figure,1389,1395,O
7,1396,1397,O
.,1397,1398,O
Slob57,1399,1405,O
causes,1406,1412,O
inactivation,1413,1425,O
of,1426,1428,O
dSloD5N5,1429,1437,O
.,1437,1438,O
Same,1439,1443,O
as,1444,1446,O
Fig,1447,1450,O
.,1450,1451,O
2,1452,1453,O
",",1453,1454,O
except,1455,1461,O
that,1462,1466,O
the,1467,1470,O
mutated,1471,1478,O
channel,1479,1486,O
dSloD5N5,1487,1495,O
was,1496,1499,O
used,1500,1504,O
instead,1505,1512,O
of,1513,1515,O
wild,1516,1520,O
-,1520,1521,O
type,1521,1525,O
dSlo,1526,1530,O
.,1530,1531,O
(,1532,1533,O
A,1533,1534,O
),1534,1535,O
dSloD5N5,1536,1544,O
alone,1545,1550,O
",",1550,1551,O
(,1552,1553,O
B,1553,1554,O
),1554,1555,O
dSloD5N5,1556,1564,O
together,1565,1573,O
with,1574,1578,O
Slob57,1579,1585,O
",",1585,1586,O
(,1587,1588,O
C,1588,1589,O
),1589,1590,O
dSloD5N5,1591,1599,O
together,1600,1608,O
with,1609,1613,O
Slob57DeltaN5,1614,1627,O
",",1627,1628,O
(,1629,1630,O
D,1630,1631,O
),1631,1632,O
dSloD5N5,1633,1641,O
together,1642,1650,O
with,1651,1655,O
Slob57DeltaN15,1656,1670,O
",",1670,1671,O
(,1672,1673,O
E,1673,1674,O
),1674,1675,O
pulse,1676,1681,O
protocol,1682,1690,O
.,1690,1691,O
We,1692,1694,O
next,1695,1699,O
used,1700,1704,O
a,1705,1706,O
100,1707,1710,O
-,1710,1711,O
ms,1711,1713,O
test,1714,1718,O
pulse,1719,1724,O
(,1725,1726,O
during,1726,1732,O
which,1733,1738,O
no,1739,1741,O
inactivation,1742,1754,O
occurs,1755,1761,O
),1761,1762,O
to,1763,1765,O
measure,1766,1773,O
the,1774,1777,O
voltage,1778,1785,O
dependence,1786,1796,O
of,1797,1799,O
activation,1800,1810,O
of,1811,1813,O
dSloD5N5,1814,1822,O
in,1823,1825,O
the,1826,1829,O
presence,1830,1838,O
of,1839,1841,O
110,1842,1845,O
muM,1846,1849,O
free,1850,1854,O
Ca2,1855,1858,O
+,1858,1859,O
",",1859,1860,O
as,1861,1863,O
only,1864,1868,O
at,1869,1871,O
high,1872,1876,O
concentrations,1877,1891,O
of,1892,1894,O
free,1895,1899,O
Ca2,1900,1903,O
+,1903,1904,O
can,1905,1908,O
tail,1909,1913,O
current,1914,1921,O
saturation,1922,1932,O
be,1933,1935,O
achieved,1936,1944,O
with,1945,1949,O
the,1950,1953,O
mutant,1954,1960,O
channel,1961,1968,O
(,1969,1970,O
Fig,1970,1973,O
.,1973,1974,O
8,1975,1976,O
),1976,1977,O
.,1977,1978,O
As,1979,1981,O
shown,1982,1987,O
in,1988,1990,O
Fig,1991,1994,O
.,1994,1995,O
8,1996,1997,O
",",1997,1998,O
Slob57,1999,2005,O
does,2006,2010,O
not,2011,2014,O
rightward,2015,2024,O
shift,2025,2030,O
the,2031,2034,O
conductance,2035,2046,O
-,2046,2047,O
voltage,2047,2054,O
relationship,2055,2067,O
of,2068,2070,O
dSloD5N5,2071,2079,O
.,2079,2080,O
Because,2081,2088,O
dSloD5N5,2089,2097,O
can,2098,2101,O
still,2102,2107,O
respond,2108,2115,O
to,2116,2118,O
an,2119,2121,O
increment,2122,2131,O
of,2132,2134,O
free,2135,2139,O
Ca2,2140,2143,O
+,2143,2144,O
at,2145,2147,O
high,2148,2152,O
concentration,2153,2166,O
(,2167,2168,O
Bian,2168,2172,O
et,2173,2175,O
al,2176,2178,O
.,2178,2179,O
",",2179,2180,O
2001,2181,2185,O
),2185,2186,O
",",2186,2187,O
we,2188,2190,O
then,2191,2195,O
increased,2196,2205,O
the,2206,2209,O
concentration,2210,2223,O
of,2224,2226,O
free,2227,2231,O
Ca2,2232,2235,O
+,2235,2236,O
to,2237,2239,O
300,2240,2243,O
muM,2244,2247,O
.,2247,2248,O
As,2249,2251,O
shown,2252,2257,O
in,2258,2260,O
Fig,2261,2264,O
.,2264,2265,O
8,2266,2267,O
",",2267,2268,O
the,2269,2272,O
conductance,2273,2284,O
-,2284,2285,O
voltage,2285,2292,O
relationship,2293,2305,O
of,2306,2308,O
dSloD5N5,2309,2317,O
shifts,2318,2324,O
to,2325,2327,O
less,2328,2332,O
depolarized,2333,2344,O
voltages,2345,2353,O
when,2354,2358,O
the,2359,2362,O
concentration,2363,2376,O
of,2377,2379,O
free,2380,2384,O
Ca2,2385,2388,O
+,2388,2389,O
is,2390,2392,O
increased,2393,2402,O
from,2403,2407,O
110,2408,2411,O
to,2412,2414,O
300,2415,2418,O
muM,2419,2422,O
",",2422,2423,O
but,2424,2427,O
again,2428,2433,O
the,2434,2437,O
V1,2438,2440,O
/,2440,2441,O
2,2441,2442,O
is,2443,2445,O
not,2446,2449,O
modulated,2450,2459,O
by,2460,2462,O
Slob57,2463,2469,O
.,2469,2470,O
Figure,2471,2477,O
8,2478,2479,O
.,2479,2480,O
Conductance,2481,2492,O
-,2492,2493,O
voltage,2493,2500,O
relationships,2501,2514,O
for,2515,2518,O
dSloD5N5,2519,2527,O
.,2527,2528,O
Same,2529,2533,O
protocol,2534,2542,O
as,2543,2545,O
Fig,2546,2549,O
.,2549,2550,O
6,2551,2552,O
",",2552,2553,O
except,2554,2560,O
that,2561,2565,O
the,2566,2569,O
mutated,2570,2577,O
channel,2578,2585,O
dSloD5N5,2586,2594,O
was,2595,2598,O
used,2599,2603,O
in,2604,2606,O
the,2607,2610,O
presence,2611,2619,O
(,2620,2621,O
circles,2621,2628,O
),2628,2629,O
or,2630,2632,O
absence,2633,2640,O
(,2641,2642,O
squares,2642,2649,O
),2649,2650,O
of,2651,2653,O
Slob57,2654,2660,O
",",2660,2661,O
and,2662,2665,O
the,2666,2669,O
concentration,2670,2683,O
of,2684,2686,O
free,2687,2691,O
Ca2,2692,2695,O
+,2695,2696,O
was,2697,2700,O
either,2701,2707,O
110,2708,2711,O
muM,2712,2715,O
(,2716,2717,O
filled,2717,2723,O
symbols,2724,2731,O
),2731,2732,O
or,2733,2735,O
300,2736,2739,O
muM,2740,2743,O
(,2744,2745,O
open,2745,2749,O
symbols,2750,2757,O
),2757,2758,O
.,2758,2759,O
We,2760,2762,O
next,2763,2767,O
measured,2768,2776,O
the,2777,2780,O
voltage,2781,2788,O
dependence,2789,2799,O
of,2800,2802,O
activation,2803,2813,O
of,2814,2816,O
wild,2817,2821,O
-,2821,2822,O
type,2822,2826,O
dSlo,2827,2831,O
",",2831,2832,O
in,2833,2835,O
the,2836,2839,O
presence,2840,2848,O
or,2849,2851,O
absence,2852,2859,O
of,2860,2862,O
Slob57,2863,2869,O
",",2869,2870,O
at,2871,2873,O
free,2874,2878,O
Ca2,2879,2882,O
+,2882,2883,O
concentrations,2884,2898,O
ranging,2899,2906,O
from,2907,2911,O
20,2912,2914,O
to,2915,2917,O
300,2918,2921,O
muM,2922,2925,O
.,2925,2926,O
As,2927,2929,O
shown,2930,2935,O
in,2936,2938,O
Fig,2939,2942,O
.,2942,2943,O
9,2944,2945,O
A,2946,2947,O
(,2948,2949,O
and,2949,2952,O
by,2953,2955,O
many,2956,2960,O
previous,2961,2969,O
investigators,2970,2983,O
),2983,2984,O
",",2984,2985,O
in,2986,2988,O
the,2989,2992,O
absence,2993,3000,O
of,3001,3003,O
Slob57,3004,3010,O
",",3010,3011,O
the,3012,3015,O
voltage,3016,3023,O
-,3023,3024,O
conductance,3024,3035,O
relationship,3036,3048,O
of,3049,3051,O
dSlo,3052,3056,O
shifts,3057,3063,O
to,3064,3066,O
less,3067,3071,O
depolarized,3072,3083,O
voltages,3084,3092,O
as,3093,3095,O
the,3096,3099,O
free,3100,3104,O
Ca2,3105,3108,O
+,3108,3109,O
concentration,3110,3123,O
is,3124,3126,O
increased,3127,3136,O
in,3137,3139,O
this,3140,3144,O
range,3145,3150,O
.,3150,3151,O
The,3152,3155,O
V1,3156,3158,O
/,3158,3159,O
2,3159,3160,O
decreases,3161,3170,O
from,3171,3175,O
85,3176,3178,O
to,3179,3181,O
-,3182,3183,O
22,3183,3185,O
mV,3186,3188,O
",",3188,3189,O
a,3190,3191,O
change,3192,3198,O
of,3199,3201,O
107,3202,3205,O
mV,3206,3208,O
",",3208,3209,O
when,3210,3214,O
the,3215,3218,O
concentration,3219,3232,O
of,3233,3235,O
free,3236,3240,O
Ca2,3241,3244,O
+,3244,3245,O
is,3246,3248,O
increased,3249,3258,O
from,3259,3263,O
20,3264,3266,O
to,3267,3269,O
300,3270,3273,O
muM,3274,3277,O
.,3277,3278,O
In,3279,3281,O
contrast,3282,3290,O
",",3290,3291,O
when,3292,3296,O
dSlo,3297,3301,O
is,3302,3304,O
coexpressed,3305,3316,O
with,3317,3321,O
Slob57,3322,3328,O
",",3328,3329,O
this,3330,3334,O
increment,3335,3344,O
of,3345,3347,O
free,3348,3352,O
Ca2,3353,3356,O
+,3356,3357,O
concentration,3358,3371,O
shifts,3372,3378,O
the,3379,3382,O
V1,3383,3385,O
/,3385,3386,O
2,3386,3387,O
to,3388,3390,O
a,3391,3392,O
much,3393,3397,O
lesser,3398,3404,O
extent,3405,3411,O
(,3412,3413,O
Fig,3413,3416,O
.,3416,3417,O
9,3418,3419,O
B,3420,3421,O
and,3422,3425,O
Fig,3426,3429,O
.,3429,3430,O
10,3431,3433,O
A,3434,3435,O
),3435,3436,O
.,3436,3437,O
Note,3438,3442,O
also,3443,3447,O
that,3448,3452,O
the,3453,3456,O
effect,3457,3463,O
of,3464,3466,O
Slob57,3467,3473,O
on,3474,3476,O
the,3477,3480,O
V1,3481,3483,O
/,3483,3484,O
2,3484,3485,O
is,3486,3488,O
more,3489,3493,O
apparent,3494,3502,O
at,3503,3505,O
higher,3506,3512,O
free,3513,3517,O
Ca2,3518,3521,O
+,3521,3522,O
concentrations,3523,3537,O
(,3538,3539,O
Fig,3539,3542,O
.,3542,3543,O
10,3544,3546,O
A,3547,3548,O
),3548,3549,O
.,3549,3550,O
To,3551,3553,O
illustrate,3554,3564,O
this,3565,3569,O
better,3570,3576,O
",",3576,3577,O
we,3578,3580,O
plotted,3581,3588,O
the,3589,3592,O
V1,3593,3595,O
/,3595,3596,O
2,3596,3597,O
change,3598,3604,O
evoked,3605,3611,O
by,3612,3614,O
Slob57,3615,3621,O
(,3622,3623,O
DeltaV1,3623,3630,O
/,3630,3631,O
2,3631,3632,O
),3632,3633,O
as,3634,3636,O
a,3637,3638,O
function,3639,3647,O
of,3648,3650,O
the,3651,3654,O
free,3655,3659,O
Ca2,3660,3663,O
+,3663,3664,O
concentration,3665,3678,O
(,3679,3680,O
Fig,3680,3683,O
.,3683,3684,O
10,3685,3687,O
B,3688,3689,O
),3689,3690,O
to,3691,3693,O
demonstrate,3694,3705,O
that,3706,3710,O
the,3711,3714,O
magnitude,3715,3724,O
of,3725,3727,O
the,3728,3731,O
modulatory,3732,3742,O
shift,3743,3748,O
in,3749,3751,O
V1,3752,3754,O
/,3754,3755,O
2,3755,3756,O
evoked,3757,3763,O
by,3764,3766,O
Slob57,3767,3773,O
itself,3774,3780,O
is,3781,3783,O
calcium,3784,3791,O
dependent,3792,3801,O
.,3801,3802,O
Figure,3803,3809,O
9,3810,3811,O
.,3811,3812,O
Effect,3813,3819,O
of,3820,3822,O
calcium,3823,3830,O
on,3831,3833,O
dSlo,3834,3838,O
voltage,3839,3846,O
dependence,3847,3857,O
of,3858,3860,O
activation,3861,3871,O
in,3872,3874,O
the,3875,3878,O
absence,3879,3886,O
or,3887,3889,O
presence,3890,3898,O
of,3899,3901,O
Slob57,3902,3908,O
.,3908,3909,O
Same,3910,3914,O
as,3915,3917,O
Fig,3918,3921,O
.,3921,3922,O
6,3923,3924,O
",",3924,3925,O
except,3926,3932,O
that,3933,3937,O
the,3938,3941,O
measurements,3942,3954,O
of,3955,3957,O
dSlo,3958,3962,O
expressed,3963,3972,O
alone,3973,3978,O
(,3979,3980,O
A,3980,3981,O
),3981,3982,O
or,3983,3985,O
together,3986,3994,O
with,3995,3999,O
Slob57,4000,4006,O
(,4007,4008,O
B,4008,4009,O
),4009,4010,O
were,4011,4015,O
performed,4016,4025,O
in,4026,4028,O
the,4029,4032,O
presence,4033,4041,O
of,4042,4044,O
different,4045,4054,O
concentrations,4055,4069,O
of,4070,4072,O
free,4073,4077,O
Ca2,4078,4081,O
+,4081,4082,O
:,4082,4083,O
20,4084,4086,O
muM,4087,4090,O
(,4091,4092,O
diamonds,4092,4100,O
),4100,4101,O
",",4101,4102,O
40,4103,4105,O
muM,4106,4109,O
(,4110,4111,O
inverted,4111,4119,O
triangles,4120,4129,O
),4129,4130,O
",",4130,4131,O
80,4132,4134,O
muM,4135,4138,O
(,4139,4140,O
triangles,4140,4149,O
),4149,4150,O
",",4150,4151,O
110,4152,4155,O
muM,4156,4159,O
(,4160,4161,O
squares,4161,4168,O
),4168,4169,O
",",4169,4170,O
and,4171,4174,O
300,4175,4178,O
muM,4179,4182,O
(,4183,4184,O
circles,4184,4191,O
),4191,4192,O
.,4192,4193,O
Figure,4194,4200,O
10,4201,4203,O
.,4203,4204,O
Interaction,4205,4216,O
between,4217,4224,O
Slob57,4225,4231,O
and,4232,4235,O
calcium,4236,4243,O
.,4243,4244,O
The,4245,4248,O
V1,4249,4251,O
/,4251,4252,O
2,4252,4253,O
(,4254,4255,O
A,4255,4256,O
),4256,4257,O
of,4258,4260,O
the,4261,4264,O
conductance,4265,4276,O
-,4276,4277,O
voltage,4277,4284,O
relationship,4285,4297,O
for,4298,4301,O
dSlo,4302,4306,O
expressed,4307,4316,O
alone,4317,4322,O
(,4323,4324,O
O,4324,4325,O
),4325,4326,O
or,4327,4329,O
together,4330,4338,O
with,4339,4343,O
Slob57,4344,4350,O
(,4351,4352,O
*,4352,4353,O
),4353,4354,O
",",4354,4355,O
taken,4356,4361,O
from,4362,4366,O
Fig,4367,4370,O
.,4370,4371,O
9,4372,4373,O
",",4373,4374,O
and,4375,4378,O
the,4379,4382,O
difference,4383,4393,O
in,4394,4396,O
V1,4397,4399,O
/,4399,4400,O
2,4400,4401,O
(,4402,4403,O
DeltaV1,4403,4410,O
/,4410,4411,O
2,4411,4412,O
),4412,4413,O
evoked,4414,4420,O
by,4421,4423,O
Slob57,4424,4430,O
(,4431,4432,O
B,4432,4433,O
),4433,4434,O
are,4435,4438,O
plotted,4439,4446,O
as,4447,4449,O
a,4450,4451,O
function,4452,4460,O
of,4461,4463,O
the,4464,4467,O
concentration,4468,4481,O
of,4482,4484,O
free,4485,4489,O
Ca2,4490,4493,O
+,4493,4494,O
.,4494,4495,O
Authors,0,7,O
',7,8,O
contributions,9,22,O
OK,23,25,O
and,26,29,O
MG,30,32,O
analyzed,33,41,O
and,42,45,O
interpreted,46,57,O
the,58,61,O
patient,62,69,O
data,70,74,O
regarding,75,84,O
his,85,88,O
hospitalization,89,104,O
.,104,105,O
SP,106,108,O
and,109,112,O
PK,113,115,O
performed,116,125,O
the,126,129,O
coronary,130,138,B-Multi-tissue_structure
angiography,139,150,O
",",150,151,O
and,152,155,O
were,156,160,O
the,161,164,O
major,165,170,O
contributors,171,183,O
in,184,186,O
writing,187,194,O
the,195,198,O
manuscript,199,209,O
.,209,210,O
All,211,214,O
authors,215,222,O
read,223,227,O
and,228,231,O
approved,232,240,O
the,241,244,O
final,245,250,O
manuscript,251,261,O
.,261,262,O
Authors,0,7,O
',7,8,O
contributions,9,22,O
CM,23,25,O
",",25,26,O
JRH,27,30,O
",",30,31,O
HJP,32,35,O
",",35,36,O
and,37,40,O
JH,41,43,O
carried,44,51,O
animal,52,58,O
studies,59,66,O
.,66,67,O
CM,68,70,O
performed,71,80,O
the,81,84,O
statistical,85,96,O
analysis,97,105,O
.,105,106,O
JLK,107,110,O
conceived,111,120,O
of,121,123,O
the,124,127,O
study,128,133,O
",",133,134,O
participated,135,147,O
in,148,150,O
its,151,154,O
design,155,161,O
and,162,165,O
coordination,166,178,O
",",178,179,O
and,180,183,O
drafted,184,191,O
and,192,195,O
edited,196,202,O
the,203,206,O
manuscript,207,217,O
.,217,218,O
All,219,222,O
authors,223,230,O
read,231,235,O
and,236,239,O
approved,240,248,O
the,249,252,O
final,253,258,O
manuscript,259,269,O
.,269,270,O
Disk,0,4,O
preparation,5,16,O
phase,17,22,O
o,23,24,O
Adoption,25,33,O
of,34,36,O
a,37,38,O
two,39,42,O
-,42,43,O
stage,43,48,O
sampling,49,57,O
scheme,58,64,O
.,64,65,O
o,66,67,O
Careful,68,75,O
planning,76,84,O
and,85,88,O
choice,89,95,O
of,96,98,O
representative,99,113,O
sampling,114,122,O
groups,123,129,O
and,130,133,O
sites,134,139,O
according,140,149,O
to,150,152,O
the,153,156,O
adopted,157,164,O
network,165,172,O
sampling,173,181,O
technique,182,191,O
",",191,192,O
and,193,196,O
determining,197,208,O
certain,209,216,O
criteria,217,225,O
such,226,230,O
as,231,233,O
control,234,241,O
sites,242,247,O
where,248,253,O
major,254,259,O
sampling,260,268,O
groups,269,275,O
exist,276,281,O
(,282,283,O
i,283,284,O
.,284,285,O
e,285,286,O
.,286,287,O
surface,288,295,O
water,296,301,O
points,302,308,O
",",308,309,O
valleys,310,317,O
",",317,318,O
and,319,322,O
wells,323,328,O
),328,329,O
",",329,330,O
impact,331,337,O
sites,338,343,O
where,344,349,O
contamination,350,363,O
is,364,366,O
expected,367,375,O
",",375,376,O
such,377,381,O
as,382,384,O
polygons,385,393,O
",",393,394,O
and,395,398,O
outlets,399,406,O
(,407,408,O
e,408,409,O
.,409,410,O
g,410,411,O
.,411,412,O
treated,413,420,O
water,421,426,O
discharges,427,437,O
site,438,442,O
),442,443,O
to,444,446,O
maximise,447,455,O
understanding,456,469,O
the,470,473,O
quality,474,481,O
of,482,484,O
urban,485,490,O
water,491,496,O
sources,497,504,O
",",504,505,O
and,506,509,O
with,510,514,O
the,515,518,O
least,519,524,O
risk,525,529,O
of,530,532,O
missing,533,540,O
the,541,544,O
correct,545,552,O
representative,553,567,O
sampling,568,576,O
groups,577,583,O
and,584,587,O
sites,588,593,O
.,593,594,O
o,595,596,O
Attention,597,606,O
paid,607,611,O
to,612,614,O
ensure,615,621,O
inclusion,622,631,O
in,632,634,O
the,635,638,O
sampling,639,647,O
frame,648,653,O
of,654,656,O
all,657,660,O
groups,661,667,O
and,668,671,O
locations,672,681,O
(,682,683,O
sites,683,688,O
",",688,689,O
roads,690,695,O
",",695,696,O
venues,697,703,O
",",703,704,O
and,705,708,O
so,709,711,O
on,712,714,O
),714,715,O
via,716,719,O
screening,720,729,O
",",729,730,O
browsing,731,739,O
",",739,740,O
and,741,744,O
delineation,745,756,O
from,757,761,O
a,762,763,O
satellite,764,773,O
digital,774,781,O
map,782,785,O
of,786,788,O
the,789,792,O
Khamis,793,799,O
Mushait,800,807,O
Governorate,808,819,O
zone,820,824,O
",",824,825,O
because,826,833,O
local,834,839,O
pre,840,843,O
-,843,844,O
knowledge,844,853,O
was,854,857,O
preferred,858,867,O
with,868,872,O
regard,873,879,O
to,880,882,O
accessibility,883,896,O
",",896,897,O
safety,898,904,O
",",904,905,O
and,906,909,O
permission,910,920,O
.,920,921,O
o,922,923,O
Approximation,924,937,O
of,938,940,O
the,941,944,O
number,945,951,O
of,952,954,O
the,955,958,O
target,959,965,O
study,966,971,O
population,972,982,O
in,983,985,O
each,986,990,O
group,991,996,O
and,997,1000,O
sampling,1001,1009,O
location,1010,1018,O
.,1018,1019,O
o,1020,1021,O
Determination,1022,1035,O
of,1036,1038,O
the,1039,1042,O
proportional,1043,1055,O
allocation,1056,1066,O
of,1067,1069,O
samples,1070,1077,O
between,1078,1085,O
different,1086,1095,O
groups,1096,1102,O
and,1103,1106,O
locations,1107,1116,O
.,1116,1117,O
o,1118,1119,O
Training,1120,1128,O
of,1129,1131,O
interviewers,1132,1144,O
\,1144,1145,O
sample,1145,1151,O
collectors,1152,1162,O
to,1163,1165,O
follow,1166,1172,O
and,1173,1176,O
to,1177,1179,O
use,1180,1183,O
the,1184,1187,O
sampling,1188,1196,O
strategy,1197,1205,O
and,1206,1209,O
procedures,1210,1220,O
.,1220,1221,O
o,1222,1223,O
Implementation,1224,1238,O
of,1239,1241,O
ways,1242,1246,O
to,1247,1249,O
boost,1250,1255,O
participation,1256,1269,O
rates,1270,1275,O
in,1276,1278,O
the,1279,1282,O
screening,1283,1292,O
and,1293,1296,O
core,1297,1301,O
interviews,1302,1312,O
and,1313,1316,O
sample,1317,1323,O
collection,1324,1334,O
.,1334,1335,O
o,1336,1337,O
Planning,1338,1346,O
of,1347,1349,O
logistic,1350,1358,O
needs,1359,1364,O
of,1365,1367,O
timing,1368,1374,O
",",1374,1375,O
gathering,1376,1385,O
",",1385,1386,O
handling,1387,1395,O
samples,1396,1403,O
",",1403,1404,O
and,1405,1408,O
laboratory,1409,1419,O
.,1419,1420,O
o,1421,1422,O
Producing,1423,1432,O
sampling,1433,1441,O
cards,1442,1447,O
to,1448,1450,O
be,1451,1453,O
completed,1454,1463,O
to,1464,1466,O
record,1467,1473,O
observations,1474,1486,O
at,1487,1489,O
scene,1490,1495,O
(,1496,1497,O
sample,1497,1503,O
ID,1504,1506,O
and,1507,1510,O
data,1511,1515,O
/,1515,1516,O
information,1516,1527,O
:,1527,1528,O
date,1529,1533,O
",",1533,1534,O
time,1535,1539,O
",",1539,1540,O
temperature,1541,1552,O
",",1552,1553,O
group,1554,1559,O
",",1559,1560,O
locality,1561,1569,O
",",1569,1570,O
problems,1571,1579,O
in,1580,1582,O
the,1583,1586,O
area,1587,1591,O
",",1591,1592,O
sketch,1593,1599,O
map,1600,1603,O
),1603,1604,O
.,1604,1605,O
o,1606,1607,O
Selection,1608,1617,O
of,1618,1620,O
an,1621,1623,O
appropriate,1624,1635,O
major,1636,1641,O
sampling,1642,1650,O
method,1651,1657,O
[,1658,1659,O
52,1659,1661,O
],1661,1662,O
(,1663,1664,O
i,1664,1665,O
.,1665,1666,O
e,1666,1667,O
.,1667,1668,O
simple,1669,1675,O
random,1676,1682,O
sample,1683,1689,O
;,1689,1690,O
network,1691,1698,O
sampling,1699,1707,O
),1707,1708,O
.,1708,1709,O
o,1710,1711,O
Planning,1712,1720,O
of,1721,1723,O
pilot,1724,1729,O
visits,1730,1736,O
to,1737,1739,O
samples,1740,1747,O
of,1748,1750,O
each,1751,1755,O
group,1756,1761,O
in,1762,1764,O
the,1765,1768,O
field,1769,1774,O
to,1775,1777,O
review,1778,1784,O
strategy,1785,1793,O
.,1793,1794,O
Results,0,7,O
In,8,10,O
the,11,14,O
established,15,26,O
adult,27,32,O
rat,33,36,O
NSC,37,40,B-Cell
culture,41,48,O
",",48,49,O
FGF,50,53,O
-,53,54,O
2,54,55,O
promotes,56,64,O
self,65,69,O
-,69,70,O
renewal,70,77,O
by,78,80,O
increasing,81,91,O
proliferation,92,105,O
and,106,109,O
inhibiting,110,120,O
spontaneous,121,132,O
differentiation,133,148,O
of,149,151,O
adult,152,157,O
NSCs,158,162,B-Cell
",",162,163,O
accompanied,164,175,O
with,176,180,O
activation,181,191,O
of,192,194,O
MAPK,195,199,O
and,200,203,O
PLC,204,207,O
pathways,208,216,O
.,216,217,O
Using,218,223,O
a,224,225,O
molecular,226,235,O
genetic,236,243,O
approach,244,252,O
",",252,253,O
we,254,256,O
demonstrate,257,268,O
that,269,273,O
activation,274,284,O
of,285,287,O
FGF,288,291,O
receptor,292,300,O
1,301,302,O
(,303,304,O
FGFR1,304,309,O
),309,310,O
",",310,311,O
largely,312,319,O
through,320,327,O
two,328,331,O
key,332,335,O
cytoplasmic,336,347,B-Organism_substance
amino,348,353,O
acid,354,358,O
residues,359,367,O
that,368,372,O
are,373,376,O
linked,377,383,O
to,384,386,O
MAPK,387,391,O
and,392,395,O
PLC,396,399,O
activation,400,410,O
",",410,411,O
suffices,412,420,O
to,421,423,O
promote,424,431,O
adult,432,437,O
NSC,438,441,B-Cell
self,442,446,O
-,446,447,O
renewal,447,454,O
.,454,455,O
The,456,459,O
canonical,460,469,O
MAPK,470,474,O
",",474,475,O
Erk1,476,480,O
/,480,481,O
2,481,482,O
activation,483,493,O
",",493,494,O
is,495,497,O
both,498,502,O
required,503,511,O
and,512,515,O
sufficient,516,526,O
for,527,530,O
the,531,534,O
NSC,535,538,B-Cell
expansion,539,548,O
and,549,552,O
anti,553,557,O
-,557,558,O
differentiation,558,573,O
effects,574,581,O
of,582,584,O
FGF,585,588,O
-,588,589,O
2,589,590,O
.,590,591,O
In,592,594,O
contrast,595,603,O
",",603,604,O
PLC,605,608,O
activation,609,619,O
is,620,622,O
integral,623,631,O
to,632,634,O
the,635,638,O
maintenance,639,650,O
of,651,653,O
adult,654,659,O
NSC,660,663,B-Cell
characteristics,664,679,O
",",679,680,O
including,681,690,O
the,691,694,O
full,695,699,O
capacity,700,708,O
for,709,712,O
neuronal,713,721,B-Cell
and,722,725,O
oligodendroglial,726,742,B-Cell
differentiation,743,758,O
.,758,759,O
Stochastic,0,10,O
models,11,17,O
Stochasticity,18,31,O
inevitably,32,42,O
emerges,43,50,O
when,51,55,O
molecular,56,65,O
components,66,76,O
are,77,80,O
present,81,88,O
at,89,91,O
low,92,95,O
cellular,96,104,B-Cell
concentrations,105,119,O
(,120,121,O
McAdams,121,128,O
&,129,130,O
Arkin,131,136,O
",",136,137,O
1997,138,142,O
;,142,143,O
Kierzek,144,151,O
et,152,154,O
al,155,157,O
.,157,158,O
",",158,159,O
2001,160,164,O
),164,165,O
.,165,166,O
This,167,171,O
physical,172,180,O
phenomenon,181,191,O
generates,192,201,O
noise,202,207,O
in,208,210,O
synthetic,211,220,O
and,221,224,O
natural,225,232,O
circuits,233,241,O
(,242,243,O
Paulsson,243,251,O
",",251,252,O
2004,253,257,O
;,257,258,O
Mettetal,259,267,O
et,268,270,O
al,271,273,O
.,273,274,O
",",274,275,O
2006,276,280,O
),280,281,O
",",281,282,O
and,283,286,O
its,287,290,O
consequences,291,303,O
over,304,308,O
the,309,312,O
phenotype,313,322,O
are,323,326,O
starting,327,335,O
to,336,338,O
be,339,341,O
explored,342,350,O
(,351,352,O
Suel,352,356,O
et,357,359,O
al,360,362,O
.,362,363,O
",",363,364,O
2006,365,369,O
),369,370,O
.,370,371,O
For,372,375,O
example,376,383,O
",",383,384,O
noise,385,390,O
constitutes,391,402,O
the,403,406,O
driving,407,414,O
force,415,420,O
behind,421,427,O
differentiation,428,443,O
in,444,446,O
isogenetic,447,457,O
colonies,458,466,O
(,467,468,O
Colman,468,474,O
-,474,475,O
Lerner,475,481,O
et,482,484,O
al,485,487,O
.,487,488,O
",",488,489,O
2005,490,494,O
),494,495,O
.,495,496,O
Biological,497,507,O
and,508,511,O
theoretical,512,523,O
studies,524,531,O
have,532,536,O
aided,537,542,O
to,543,545,O
delineate,546,555,O
the,556,559,O
regulatory,560,570,O
mechanism,571,580,O
by,581,583,O
which,584,589,O
the,590,593,O
cell,594,598,B-Cell
handles,599,606,O
noise,607,612,O
efficiently,613,624,O
and,625,628,O
effectively,629,640,O
to,641,643,O
carry,644,649,O
out,650,653,O
its,654,657,O
biological,658,668,O
functions,669,678,O
(,679,680,O
Gardner,680,687,O
&,688,689,O
Collins,690,697,O
",",697,698,O
2000,699,703,O
;,703,704,O
Orrell,705,711,O
&,712,713,O
Bolouri,714,721,O
",",721,722,O
2004,723,727,O
;,727,728,O
Raser,729,734,O
&,735,736,O
O,737,738,O
',738,739,O
Shea,739,743,O
",",743,744,O
2005,745,749,O
),749,750,O
.,750,751,O
From,752,756,O
a,757,758,O
theoretical,759,770,O
point,771,776,O
of,777,779,O
view,780,784,O
",",784,785,O
stochastic,786,796,O
models,797,803,O
are,804,807,O
the,808,811,O
most,812,816,O
challenging,817,828,O
but,829,832,O
also,833,837,O
the,838,841,O
most,842,846,O
realistic,847,856,O
ones,857,861,O
:,861,862,O
there,863,868,O
is,869,871,O
a,872,873,O
precise,874,881,O
counting,882,890,O
of,891,893,O
how,894,897,O
",",897,898,O
through,899,906,O
individual,907,917,O
chemical,918,926,O
reactions,927,936,O
",",936,937,O
the,938,941,O
populations,942,953,O
of,954,956,O
every,957,962,O
chemical,963,971,O
species,972,979,O
change,980,986,O
.,986,987,O
The,988,991,O
milestone,992,1001,O
to,1002,1004,O
simulate,1005,1013,O
stochastic,1014,1024,O
processes,1025,1034,O
is,1035,1037,O
the,1038,1041,O
Gillespie,1042,1051,O
algorithm,1052,1061,O
(,1062,1063,O
Gillespie,1063,1072,O
",",1072,1073,O
1992,1074,1078,O
),1078,1079,O
.,1079,1080,O
Because,1081,1088,O
of,1089,1091,O
their,1092,1097,O
analytical,1098,1108,O
and,1109,1112,O
computational,1113,1126,O
complexity,1127,1137,O
",",1137,1138,O
the,1139,1142,O
present,1143,1150,O
models,1151,1157,O
do,1158,1160,O
not,1161,1164,O
surpass,1165,1172,O
a,1173,1174,O
handful,1175,1182,O
of,1183,1185,O
chemical,1186,1194,O
species,1195,1202,O
.,1202,1203,O
Two,1204,1207,O
immediate,1208,1217,O
problems,1218,1226,O
must,1227,1231,O
be,1232,1234,O
solved,1235,1241,O
to,1242,1244,O
model,1245,1250,O
systems,1251,1258,O
with,1259,1263,O
several,1264,1271,O
dozens,1272,1278,O
of,1279,1281,O
genetic,1282,1289,O
components,1290,1300,O
:,1300,1301,O
the,1302,1305,O
systematic,1306,1316,O
determination,1317,1330,O
of,1331,1333,O
kinetic,1334,1341,O
constants,1342,1351,O
and,1352,1355,O
the,1356,1359,O
efficient,1360,1369,O
computation,1370,1381,O
of,1382,1384,O
thousands,1385,1394,O
of,1395,1397,O
chemical,1398,1406,O
stochastic,1407,1417,O
equations,1418,1427,O
(,1428,1429,O
Kuwahara,1429,1437,O
et,1438,1440,O
al,1441,1443,O
.,1443,1444,O
",",1444,1445,O
2006,1446,1450,O
;,1450,1451,O
Sanchez,1452,1459,O
&,1460,1461,O
Kondev,1462,1468,O
",",1468,1469,O
2008,1470,1474,O
),1474,1475,O
.,1475,1476,O
Model,0,5,O
of,6,8,O
how,9,12,O
estrogen,13,21,O
induces,22,29,O
DNA,30,33,O
damage,34,40,O
.,40,41,O
Estrogen,42,50,O
enters,51,57,O
the,58,61,O
cell,62,66,B-Cell
and,67,70,O
is,71,73,O
bound,74,79,O
by,80,82,O
the,83,86,O
ER,87,89,O
.,89,90,O
The,91,94,O
dimeric,95,102,O
ER,103,105,O
-,105,106,O
estrogen,106,114,O
complex,115,122,O
enters,123,129,O
the,130,133,O
nucleus,134,141,B-Cellular_component
and,142,145,O
induces,146,153,O
AID,154,157,O
expression,158,168,O
.,168,169,O
This,170,174,O
leads,175,180,O
to,181,183,O
an,184,186,O
increase,187,195,O
in,196,198,O
mutations,199,208,O
and,209,212,O
translocations,213,227,O
",",227,228,O
and,229,232,O
potentially,233,244,O
cancer,245,251,B-Pathological_formation
Results,0,7,O
:,7,8,O
In,9,11,O
the,12,15,O
total,16,21,O
population,22,32,O
(,33,34,O
N,34,35,O
=,35,36,O
95,36,38,O
),38,39,O
",",39,40,O
median,41,47,O
OS,48,50,O
was,51,54,O
significantly,55,68,O
longer,69,75,O
in,76,78,O
patients,79,87,O
with,88,92,O
baseline,93,101,O
CA,102,104,O
19,105,107,O
-,107,108,O
9,108,109,O
values,110,116,O
at,117,119,O
or,120,122,O
below,123,128,O
the,129,132,O
median,133,139,O
than,140,144,O
in,145,147,O
those,148,153,O
with,154,158,O
values,159,165,O
above,166,171,O
it,172,174,O
(,175,176,O
12,176,178,O
.,178,179,O
2,179,180,O
months,181,187,O
[,188,189,O
95,189,191,O
%,191,192,O
confidence,193,203,O
interval,204,212,O
(,213,214,O
CI,214,216,O
),216,217,O
",",217,218,O
8,219,220,O
.,220,221,O
6,221,222,O
-,222,223,O
16,223,225,O
.,225,226,O
6,226,227,O
%,227,228,O
],228,229,O
vs,230,232,O
5,233,234,O
.,234,235,O
0,235,236,O
months,237,243,O
[,244,245,O
95,245,247,O
%,247,248,O
CI,249,251,O
",",251,252,O
3,253,254,O
.,254,255,O
9,255,256,O
-,256,257,O
5,257,258,O
.,258,259,O
7,259,260,O
%,260,261,O
],261,262,O
;,262,263,O
P,264,265,O
<,265,266,O
0,266,267,O
.,267,268,O
0001,268,272,O
),272,273,O
.,273,274,O
This,275,279,O
also,280,284,O
reached,285,292,O
significance,293,305,O
in,306,308,O
the,309,312,O
Gem,313,316,O
+,316,317,O
A,317,318,O
arm,319,322,O
(,323,324,O
median,324,330,O
OS,331,333,O
",",333,334,O
12,335,337,O
.,337,338,O
5,338,339,O
months,340,346,O
[,347,348,O
95,348,350,O
%,350,351,O
CI,352,354,O
",",354,355,O
8,356,357,O
.,357,358,O
6,358,359,O
-,359,360,O
16,360,362,O
.,362,363,O
6,363,364,O
%,364,365,O
],365,366,O
vs,367,369,O
4,370,371,O
.,371,372,O
9,372,373,O
months,374,380,O
[,381,382,O
95,382,384,O
%,384,385,O
CI,386,388,O
",",388,389,O
3,390,391,O
.,391,392,O
6,392,393,O
-,393,394,O
5,394,395,O
.,395,396,O
6,396,397,O
%,397,398,O
],398,399,O
;,399,400,O
P,401,402,O
<,402,403,O
0,403,404,O
.,404,405,O
0001,405,409,O
),409,410,O
.,410,411,O
Patients,412,420,O
with,421,425,O
any,426,429,O
dBP,430,433,O
>,433,434,O
90,434,436,O
mmHg,437,441,O
had,442,445,O
significantly,446,459,O
longer,460,466,O
OS,467,469,O
than,470,474,O
those,475,480,O
who,481,484,O
did,485,488,O
not,489,492,O
.,492,493,O
However,494,501,O
",",501,502,O
there,503,508,O
was,509,512,O
no,513,515,O
predictive,516,526,O
significance,527,539,O
of,540,542,O
CA,543,545,O
19,546,548,O
-,548,549,O
9,549,550,O
.,550,551,O
Percentage,0,10,O
reported,11,19,O
purchasing,20,30,O
intentions,31,41,O
",",41,42,O
comparing,43,52,O
ITN,53,56,O
-,56,57,O
owning,57,63,O
to,64,66,O
non,67,70,O
-,70,71,O
owning,71,77,O
households,78,88,O
School,0,6,O
environment,7,18,O
At,19,21,O
the,22,25,O
majority,26,34,O
of,35,37,O
the,38,41,O
schools,42,49,O
a,50,51,O
soft,52,56,O
drink,57,62,O
vending,63,70,O
machine,71,78,O
(,79,80,O
91,80,82,O
%,82,83,O
",",83,84,O
n,85,86,O
=,87,88,O
446,89,92,O
),92,93,O
and,94,97,O
/,97,98,O
or,98,100,O
a,101,102,O
vending,103,110,O
machine,111,118,O
containing,119,129,O
sweets,130,136,O
and,137,140,O
candy,141,146,O
bars,147,151,O
(,152,153,O
81,153,155,O
%,155,156,O
",",156,157,O
n,158,159,O
=,160,161,O
413,162,165,O
),165,166,O
is,167,169,O
present,170,177,O
(,178,179,O
Table,179,184,O
2,185,186,O
),186,187,O
.,187,188,O
At,189,191,O
78,192,194,O
%,194,195,O
(,196,197,O
n,197,198,O
=,199,200,O
393,201,204,O
),204,205,O
of,206,208,O
the,209,212,O
schools,213,220,O
there,221,226,O
is,227,229,O
a,230,231,O
supermarket,232,243,O
",",243,244,O
gas,245,248,O
station,249,256,O
or,257,259,O
a,260,261,O
fast,262,266,O
food,267,271,O
restaurant,272,282,O
in,283,285,O
the,286,289,O
neighbourhood,290,303,O
(,304,305,O
within,305,311,O
1,312,313,O
km,314,316,O
of,317,319,O
the,320,323,O
school,324,330,O
),330,331,O
.,331,332,O
At,333,335,O
68,336,338,O
%,338,339,O
(,340,341,O
n,341,342,O
=,343,344,O
345,345,348,O
),348,349,O
of,350,352,O
the,353,356,O
schools,357,364,O
there,365,370,O
are,371,374,O
facilities,375,385,O
at,386,388,O
or,389,391,O
around,392,398,O
the,399,402,O
school,403,409,O
property,410,418,O
where,419,424,O
the,425,428,O
students,429,437,O
can,438,441,O
be,442,444,O
physically,445,455,O
active,456,462,O
",",462,463,O
for,464,467,O
example,468,475,O
a,476,477,O
soccer,478,484,O
field,485,490,O
or,491,493,O
a,494,495,O
basketball,496,506,O
field,507,512,O
.,512,513,O
Table,514,519,O
2,520,521,O
The,522,525,O
school,526,532,O
environment,533,544,O
Total,545,550,O
School,551,557,O
level,558,563,O
Vocational,564,574,O
education,575,584,O
schools,585,592,O
Mixed,593,598,O
schools,599,606,O
Higher,607,613,O
education,614,623,O
schools,624,631,O
Vocational,632,642,O
education,643,652,O
schools,653,660,O
versus,661,667,O
higher,668,674,O
education,675,684,O
schools,685,692,O
#,692,693,O
Mixed,694,699,O
schools,700,707,O
versus,708,714,O
higher,715,721,O
education,722,731,O
schools,732,739,O
#,739,740,O
n,741,742,O
=,743,744,O
515,745,748,O
n,749,750,O
=,751,752,O
216,753,756,O
n,757,758,O
=,759,760,O
232,761,764,O
n,765,766,O
=,767,768,O
67,769,771,O
%,772,773,O
(,774,775,O
n,775,776,O
),776,777,O
%,778,779,O
(,780,781,O
n,781,782,O
),782,783,O
%,784,785,O
(,786,787,O
n,787,788,O
),788,789,O
%,790,791,O
(,792,793,O
n,793,794,O
),794,795,O
OR,796,798,O
(,799,800,O
95,800,802,O
%,802,803,O
CI,803,805,O
),805,806,O
OR,807,809,O
(,810,811,O
95,811,813,O
%,813,814,O
CI,814,816,O
),816,817,O
Soft,818,822,O
drink,823,828,O
vending,829,836,O
machine,837,844,O
present,845,852,O
at,853,855,O
school,856,862,O
91,863,865,O
.,865,866,O
4,866,867,O
(,868,869,O
466,869,872,O
),872,873,O
90,874,876,O
.,876,877,O
2,877,878,O
(,879,880,O
194,880,883,O
),883,884,O
91,885,887,O
.,887,888,O
3,888,889,O
(,890,891,O
209,891,894,O
),894,895,O
95,896,898,O
.,898,899,O
5,899,900,O
(,901,902,O
63,902,904,O
),904,905,O
1,906,907,O
.,907,908,O
0,908,909,O
(,910,911,O
0,911,912,O
.,912,913,O
9,913,914,O
;,914,915,O
1,915,916,O
.,916,917,O
1,917,918,O
),918,919,O
1,920,921,O
.,921,922,O
0,922,923,O
(,924,925,O
0,925,926,O
.,926,927,O
9,927,928,O
;,928,929,O
1,929,930,O
.,930,931,O
0,931,932,O
),932,933,O
Percentage,934,944,O
of,945,947,O
soft,948,952,O
drink,953,958,O
vending,959,966,O
machines,967,975,O
present,976,983,O
at,984,986,O
school,987,993,O
that,994,998,O
contain,999,1006,O
light,1007,1012,O
soft,1013,1017,O
drinks,1018,1024,O
79,1025,1027,O
.,1027,1028,O
8,1028,1029,O
(,1030,1031,O
372,1031,1034,O
),1034,1035,O
75,1036,1038,O
.,1038,1039,O
4,1039,1040,O
(,1041,1042,O
147,1042,1045,O
),1045,1046,O
82,1047,1049,O
.,1049,1050,O
2,1050,1051,O
(,1052,1053,O
171,1053,1056,O
),1056,1057,O
85,1058,1060,O
.,1060,1061,O
7,1061,1062,O
(,1063,1064,O
54,1064,1066,O
),1066,1067,O
0,1068,1069,O
.,1069,1070,O
9,1070,1071,O
(,1072,1073,O
0,1073,1074,O
.,1074,1075,O
8,1075,1076,O
;,1076,1077,O
1,1077,1078,O
.,1078,1079,O
0,1079,1080,O
),1080,1081,O
1,1082,1083,O
.,1083,1084,O
0,1084,1085,O
(,1086,1087,O
0,1087,1088,O
.,1088,1089,O
9,1089,1090,O
;,1090,1091,O
1,1091,1092,O
.,1092,1093,O
1,1093,1094,O
),1094,1095,O
Soft,1096,1100,O
drink,1101,1106,O
vending,1107,1114,O
machines,1115,1123,O
contain,1124,1131,O
more,1132,1136,O
unhealthy,1137,1146,O
drinks,1147,1153,O
than,1154,1158,O
healthy,1159,1166,O
drinks,1167,1173,O
57,1174,1176,O
.,1176,1177,O
9,1177,1178,O
(,1179,1180,O
268,1180,1183,O
),1183,1184,O
61,1185,1187,O
.,1187,1188,O
9,1188,1189,O
(,1190,1191,O
120,1191,1194,O
),1194,1195,O
58,1196,1198,O
.,1198,1199,O
5,1199,1200,O
(,1201,1202,O
121,1202,1205,O
),1205,1206,O
43,1207,1209,O
.,1209,1210,O
6,1210,1211,O
(,1212,1213,O
27,1213,1215,O
),1215,1216,O
1,1217,1218,O
.,1218,1219,O
4,1219,1220,O
(,1221,1222,O
1,1222,1223,O
.,1223,1224,O
0,1224,1225,O
;,1225,1226,O
1,1226,1227,O
.,1227,1228,O
9,1228,1229,O
),1229,1230,O
1,1231,1232,O
.,1232,1233,O
4,1233,1234,O
(,1235,1236,O
1,1236,1237,O
.,1237,1238,O
0,1238,1239,O
;,1239,1240,O
1,1240,1241,O
.,1241,1242,O
9,1242,1243,O
),1243,1244,O
*,1244,1245,O
Vending,1246,1253,O
machine,1254,1261,O
present,1262,1269,O
at,1270,1272,O
school,1273,1279,O
that,1280,1284,O
contains,1285,1293,O
sweets,1294,1300,O
/,1300,1301,O
candy,1301,1306,O
bars,1307,1311,O
80,1312,1314,O
.,1314,1315,O
7,1315,1316,O
(,1317,1318,O
413,1318,1321,O
),1321,1322,O
75,1323,1325,O
.,1325,1326,O
6,1326,1327,O
(,1328,1329,O
161,1329,1332,O
),1332,1333,O
84,1334,1336,O
.,1336,1337,O
9,1337,1338,O
(,1339,1340,O
197,1340,1343,O
),1343,1344,O
82,1345,1347,O
.,1347,1348,O
1,1348,1349,O
(,1350,1351,O
55,1351,1353,O
),1353,1354,O
1,1355,1356,O
.,1356,1357,O
1,1357,1358,O
(,1359,1360,O
0,1360,1361,O
.,1361,1362,O
9,1362,1363,O
;,1363,1364,O
1,1364,1365,O
.,1365,1366,O
2,1366,1367,O
),1367,1368,O
1,1369,1370,O
.,1370,1371,O
1,1371,1372,O
(,1373,1374,O
1,1374,1375,O
.,1375,1376,O
0,1376,1377,O
;,1377,1378,O
1,1378,1379,O
.,1379,1380,O
2,1380,1381,O
),1381,1382,O
Sweets,1383,1389,O
/,1389,1390,O
candy,1390,1395,O
bars,1396,1400,O
vending,1401,1408,O
machines,1409,1417,O
contain,1418,1425,O
more,1426,1430,O
unhealthy,1431,1440,O
than,1441,1445,O
healthy,1446,1453,O
foods,1454,1459,O
63,1460,1462,O
.,1462,1463,O
7,1463,1464,O
(,1465,1466,O
260,1466,1469,O
),1469,1470,O
70,1471,1473,O
.,1473,1474,O
6,1474,1475,O
(,1476,1477,O
113,1477,1480,O
),1480,1481,O
64,1482,1484,O
.,1484,1485,O
4,1485,1486,O
(,1487,1488,O
125,1488,1491,O
),1491,1492,O
40,1493,1495,O
.,1495,1496,O
7,1496,1497,O
(,1498,1499,O
22,1499,1501,O
),1501,1502,O
1,1503,1504,O
.,1504,1505,O
7,1505,1506,O
(,1507,1508,O
1,1508,1509,O
.,1509,1510,O
2,1510,1511,O
;,1511,1512,O
2,1512,1513,O
.,1513,1514,O
4,1514,1515,O
),1515,1516,O
*,1516,1517,O
1,1518,1519,O
.,1519,1520,O
6,1520,1521,O
(,1522,1523,O
1,1523,1524,O
.,1524,1525,O
1,1525,1526,O
;,1526,1527,O
2,1527,1528,O
.,1528,1529,O
3,1529,1530,O
),1530,1531,O
*,1531,1532,O
There,1533,1538,O
is,1539,1541,O
a,1542,1543,O
supermarket,1544,1555,O
",",1555,1556,O
gas,1557,1560,O
station,1561,1568,O
",",1568,1569,O
or,1570,1572,O
fast,1573,1577,O
food,1578,1582,O
restaurant,1583,1593,O
in,1594,1596,O
the,1597,1600,O
neighbourhood,1601,1614,O
of,1615,1617,O
the,1618,1621,O
school,1622,1628,O
78,1629,1631,O
.,1631,1632,O
3,1632,1633,O
(,1634,1635,O
393,1635,1638,O
),1638,1639,O
76,1640,1642,O
.,1642,1643,O
7,1643,1644,O
(,1645,1646,O
161,1646,1649,O
),1649,1650,O
79,1651,1653,O
.,1653,1654,O
7,1654,1655,O
(,1656,1657,O
181,1657,1660,O
),1660,1661,O
78,1662,1664,O
.,1664,1665,O
5,1665,1666,O
(,1667,1668,O
51,1668,1670,O
),1670,1671,O
1,1672,1673,O
.,1673,1674,O
1,1674,1675,O
(,1676,1677,O
0,1677,1678,O
.,1678,1679,O
9,1679,1680,O
;,1680,1681,O
1,1681,1682,O
.,1682,1683,O
2,1683,1684,O
),1684,1685,O
1,1686,1687,O
.,1687,1688,O
1,1688,1689,O
(,1690,1691,O
0,1691,1692,O
.,1692,1693,O
9,1693,1694,O
;,1694,1695,O
1,1695,1696,O
.,1696,1697,O
2,1697,1698,O
),1698,1699,O
The,1700,1703,O
students,1704,1712,O
are,1713,1716,O
allowed,1717,1724,O
to,1725,1727,O
leave,1728,1733,O
the,1734,1737,O
school,1738,1744,O
property,1745,1753,O
during,1754,1760,O
school,1761,1767,O
hours,1768,1773,O
57,1774,1776,O
.,1776,1777,O
4,1777,1778,O
(,1779,1780,O
295,1780,1783,O
),1783,1784,O
42,1785,1787,O
.,1787,1788,O
6,1788,1789,O
(,1790,1791,O
92,1791,1793,O
),1793,1794,O
65,1795,1797,O
.,1797,1798,O
8,1798,1799,O
(,1800,1801,O
152,1801,1804,O
),1804,1805,O
76,1806,1808,O
.,1808,1809,O
1,1809,1810,O
(,1811,1812,O
51,1812,1814,O
),1814,1815,O
0,1816,1817,O
.,1817,1818,O
6,1818,1819,O
(,1820,1821,O
0,1821,1822,O
.,1822,1823,O
5,1823,1824,O
;,1824,1825,O
0,1825,1826,O
.,1826,1827,O
8,1827,1828,O
),1828,1829,O
*,1829,1830,O
0,1831,1832,O
.,1832,1833,O
9,1833,1834,O
(,1835,1836,O
0,1836,1837,O
.,1837,1838,O
8,1838,1839,O
;,1839,1840,O
1,1840,1841,O
.,1841,1842,O
0,1842,1843,O
),1843,1844,O
There,1845,1850,O
are,1851,1854,O
facilities,1855,1865,O
at,1866,1868,O
and,1869,1872,O
around,1873,1879,O
the,1880,1883,O
school,1884,1890,O
property,1891,1899,O
where,1900,1905,O
the,1906,1909,O
students,1910,1918,O
can,1919,1922,O
be,1923,1925,O
physically,1926,1936,O
active,1937,1943,O
68,1944,1946,O
.,1946,1947,O
1,1947,1948,O
(,1949,1950,O
345,1950,1953,O
),1953,1954,O
63,1955,1957,O
.,1957,1958,O
1,1958,1959,O
(,1960,1961,O
135,1961,1964,O
),1964,1965,O
70,1966,1968,O
.,1968,1969,O
3,1969,1970,O
(,1971,1972,O
161,1972,1975,O
),1975,1976,O
76,1977,1979,O
.,1979,1980,O
6,1980,1981,O
(,1982,1983,O
49,1983,1985,O
),1985,1986,O
0,1987,1988,O
.,1988,1989,O
8,1989,1990,O
(,1991,1992,O
0,1992,1993,O
.,1993,1994,O
7,1994,1995,O
;,1995,1996,O
1,1996,1997,O
.,1997,1998,O
0,1998,1999,O
),1999,2000,O
0,2001,2002,O
.,2002,2003,O
9,2003,2004,O
(,2005,2006,O
0,2006,2007,O
.,2007,2008,O
8,2008,2009,O
;,2009,2010,O
1,2010,2011,O
.,2011,2012,O
1,2012,2013,O
),2013,2014,O
#,2015,2016,O
Associations,2017,2029,O
are,2030,2033,O
adjusted,2034,2042,O
for,2043,2046,O
school,2047,2053,O
size,2054,2058,O
*,2059,2060,O
p,2061,2062,O
<,2063,2064,O
0,2065,2066,O
.,2066,2067,O
05,2067,2069,O
The,2070,2073,O
vocational,2074,2084,O
education,2085,2094,O
schools,2095,2102,O
did,2103,2106,O
not,2107,2110,O
differ,2111,2117,O
from,2118,2122,O
the,2123,2126,O
higher,2127,2133,O
education,2134,2143,O
schools,2144,2151,O
with,2152,2156,O
regard,2157,2163,O
to,2164,2166,O
the,2167,2170,O
presence,2171,2179,O
of,2180,2182,O
vending,2183,2190,O
machines,2191,2199,O
and,2200,2203,O
a,2204,2205,O
canteen,2206,2213,O
",",2213,2214,O
but,2215,2218,O
the,2219,2222,O
vending,2223,2230,O
machines,2231,2239,O
and,2240,2243,O
the,2244,2247,O
canteen,2248,2255,O
contained,2256,2265,O
a,2266,2267,O
less,2268,2272,O
favourable,2273,2283,O
selection,2284,2293,O
of,2294,2296,O
foods,2297,2302,O
and,2303,2306,O
drinks,2307,2313,O
.,2313,2314,O
The,2315,2318,O
vocational,2319,2329,O
education,2330,2339,O
schools,2340,2347,O
indicated,2348,2357,O
more,2358,2362,O
often,2363,2368,O
that,2369,2373,O
the,2374,2377,O
vending,2378,2385,O
machines,2386,2394,O
and,2395,2398,O
the,2399,2402,O
canteen,2403,2410,O
contained,2411,2420,O
more,2421,2425,O
unhealthy,2426,2435,O
foods,2436,2441,O
and,2442,2445,O
drinks,2446,2452,O
than,2453,2457,O
healthy,2458,2465,O
foods,2466,2471,O
and,2472,2475,O
drinks,2476,2482,O
.,2482,2483,O
Vocational,2484,2494,O
education,2495,2504,O
schools,2505,2512,O
had,2513,2516,O
fewer,2517,2522,O
facilities,2523,2533,O
at,2534,2536,O
and,2537,2540,O
around,2541,2547,O
the,2548,2551,O
school,2552,2558,O
property,2559,2567,O
to,2568,2570,O
be,2571,2573,O
physical,2574,2582,O
than,2583,2587,O
the,2588,2591,O
higher,2592,2598,O
education,2599,2608,O
schools,2609,2616,O
.,2616,2617,O
Most,2618,2622,O
associations,2623,2635,O
were,2636,2640,O
attenuated,2641,2651,O
after,2652,2657,O
adjustment,2658,2668,O
for,2669,2672,O
school,2673,2679,O
size,2680,2684,O
.,2684,2685,O
For,2686,2689,O
example,2690,2697,O
",",2697,2698,O
the,2699,2702,O
association,2703,2714,O
between,2715,2722,O
school,2723,2729,O
level,2730,2735,O
and,2736,2739,O
content,2740,2747,O
of,2748,2750,O
the,2751,2754,O
soft,2755,2759,O
drink,2760,2765,O
vending,2766,2773,O
machines,2774,2782,O
was,2783,2786,O
OR,2787,2789,O
=,2790,2791,O
1,2792,2793,O
.,2793,2794,O
42,2794,2796,O
",",2796,2797,O
95,2798,2800,O
%,2800,2801,O
CI,2801,2803,O
:,2803,2804,O
1,2805,2806,O
.,2806,2807,O
05,2807,2809,O
-,2809,2810,O
1,2810,2811,O
.,2811,2812,O
93,2812,2814,O
in,2815,2817,O
the,2818,2821,O
crude,2822,2827,O
analysis,2828,2836,O
and,2837,2840,O
OR,2841,2843,O
=,2844,2845,O
1,2846,2847,O
.,2847,2848,O
35,2848,2850,O
",",2850,2851,O
95,2852,2854,O
%,2854,2855,O
CI,2855,2857,O
:,2857,2858,O
0,2859,2860,O
.,2860,2861,O
99,2861,2863,O
-,2863,2864,O
1,2864,2865,O
.,2865,2866,O
85,2866,2868,O
in,2869,2871,O
the,2872,2875,O
adjusted,2876,2884,O
analysis,2885,2893,O
.,2893,2894,O
Background,0,10,O
Over,11,15,O
the,16,19,O
past,20,24,O
decades,25,32,O
",",32,33,O
extensive,34,43,O
comparative,44,55,O
mapping,56,63,O
research,64,72,O
has,73,76,O
been,77,81,O
performed,82,91,O
in,92,94,O
the,95,98,O
plant,99,104,O
family,105,111,O
Solanaceae,112,122,O
.,122,123,O
The,124,127,O
recent,128,134,O
identification,135,149,O
of,150,152,O
a,153,154,O
large,155,160,O
set,161,164,O
of,165,167,O
single,168,174,O
-,174,175,O
copy,175,179,O
conserved,180,189,O
orthologous,190,201,O
(,202,203,O
COSII,203,208,O
),208,209,O
markers,210,217,O
has,218,221,O
greatly,222,229,O
accelerated,230,241,O
comparative,242,253,O
mapping,254,261,O
studies,262,269,O
among,270,275,O
major,276,281,O
solanaceous,282,293,O
species,294,301,O
including,302,311,O
tomato,312,318,O
",",318,319,O
potato,320,326,O
",",326,327,O
eggplant,328,336,O
",",336,337,O
pepper,338,344,O
and,345,348,O
diploid,349,356,O
Nicotiana,357,366,O
species,367,374,O
(,375,376,O
as,376,378,O
well,379,383,O
as,384,386,O
tetraploid,387,397,O
tobacco,398,405,O
),405,406,O
.,406,407,O
The,408,411,O
large,412,417,O
amount,418,424,O
of,425,427,O
comparative,428,439,O
data,440,444,O
now,445,448,O
available,449,458,O
for,459,462,O
these,463,468,O
species,469,476,O
provides,477,485,O
the,486,489,O
opportunity,490,501,O
to,502,504,O
describe,505,513,O
the,514,517,O
overall,518,525,O
patterns,526,534,O
of,535,537,O
chromosomal,538,549,B-Cellular_component
evolution,550,559,O
in,560,562,O
this,563,567,O
important,568,577,O
plant,578,583,O
family,584,590,O
.,590,591,O
The,592,595,O
results,596,603,O
of,604,606,O
this,607,611,O
investigation,612,625,O
are,626,629,O
described,630,639,O
herein,640,646,O
.,646,647,O
Introduction,0,12,O
Tea,13,16,O
(,17,18,O
Camellia,18,26,O
sinensis,27,35,O
L,36,37,O
.,37,38,O
),38,39,O
is,40,42,O
one,43,46,O
of,47,49,O
the,50,53,O
most,54,58,O
widely,59,65,O
consumed,66,74,O
beverages,75,84,O
in,85,87,O
the,88,91,O
world,92,97,O
.,97,98,O
(,99,100,O
-,100,101,O
),101,102,O
-,102,103,O
Epigallocatechin,103,119,O
-,119,120,O
3,120,121,O
-,121,122,O
O,122,123,O
-,123,124,O
gallate,124,131,O
(,132,133,O
EGCG,133,137,O
),137,138,O
",",138,139,O
which,140,145,O
is,146,148,O
the,149,152,O
major,153,158,O
green,159,164,O
tea,165,168,O
catechin,169,177,O
present,178,185,O
in,186,188,O
the,189,192,O
leaves,193,199,B-Organ
",",199,200,O
is,201,203,O
believed,204,212,O
to,213,215,O
the,216,219,O
compound,220,228,O
most,229,233,O
responsible,234,245,O
for,246,249,O
the,250,253,O
health,254,260,O
benefits,261,269,O
attributed,270,280,O
to,281,283,O
tea,284,287,O
.,287,288,O
EGCG,289,293,O
was,294,297,O
reported,298,306,O
to,307,309,O
have,310,314,O
antioxidative,315,328,O
[,329,330,O
1,330,331,O
],331,332,O
",",332,333,O
[,334,335,O
2,335,336,O
],336,337,O
",",337,338,O
antimutagenic,339,352,O
[,353,354,O
3,354,355,O
],355,356,O
",",356,357,O
anti,358,362,O
-,362,363,O
inflammatory,363,375,O
[,376,377,O
4,377,378,O
],378,379,O
",",379,380,O
and,381,384,O
anticarcinogenic,385,401,O
activities,402,412,O
[,413,414,O
5,414,415,O
],415,416,O
.,416,417,O
Although,418,426,O
the,427,430,O
EGCG,431,435,O
concentrations,436,450,O
required,451,459,O
to,460,462,O
elicit,463,469,O
the,470,473,O
anticancer,474,484,B-Pathological_formation
activity,485,493,O
have,494,498,O
been,499,503,O
shown,504,509,O
to,510,512,O
be,513,515,O
more,516,520,O
than,521,525,O
1,526,527,O
microM,528,534,O
",",534,535,O
the,536,539,O
blood,540,545,B-Organism_substance
level,546,551,O
of,552,554,O
EGCG,555,559,O
after,560,565,O
consuming,566,575,O
the,576,579,O
equivalent,580,590,O
of,591,593,O
2,594,595,O
-,595,596,O
3,596,597,O
cups,598,602,O
of,603,605,O
green,606,611,O
tea,612,615,O
was,616,619,O
0,620,621,O
.,621,622,O
1,622,623,O
-,623,624,O
0,624,625,O
.,625,626,O
6,626,627,O
microM,628,634,O
and,635,638,O
for,639,642,O
an,643,645,O
equivalent,646,656,O
of,657,659,O
7,660,661,O
-,661,662,O
9,662,663,O
cups,664,668,O
was,669,672,O
still,673,678,O
lower,679,684,O
than,685,689,O
1,690,691,O
microM,692,698,O
[,699,700,O
6,700,701,O
],701,702,O
",",702,703,O
[,704,705,O
7,705,706,O
],706,707,O
.,707,708,O
In,709,711,O
a,712,713,O
cohort,714,720,O
study,721,726,O
",",726,727,O
daily,728,733,O
consumption,734,745,O
of,746,748,O
ten,749,752,O
cups,753,757,O
of,758,760,O
green,761,766,O
tea,767,770,O
was,771,774,O
required,775,783,O
for,784,787,O
the,788,791,O
cancer,792,798,B-Pathological_formation
preventive,799,809,O
effect,810,816,O
[,817,818,O
8,818,819,O
],819,820,O
.,820,821,O
Moreover,822,830,O
",",830,831,O
adverse,832,839,O
effects,840,847,O
of,848,850,O
green,851,856,O
tea,857,860,O
",",860,861,O
mainly,862,868,O
hepatitis,869,878,O
",",878,879,O
by,880,882,O
consumption,883,894,O
of,895,897,O
high,898,902,O
doses,903,908,O
of,909,911,O
green,912,917,O
tea,918,921,O
have,922,926,O
been,927,931,O
reported,932,940,O
[,941,942,O
9,942,943,O
],943,944,O
.,944,945,O
Therefore,946,955,O
",",955,956,O
it,957,959,O
is,960,962,O
important,963,972,O
to,973,975,O
enhance,976,983,O
the,984,987,O
pharmacologic,988,1001,O
effect,1002,1008,O
of,1009,1011,O
EGCG,1012,1016,O
to,1017,1019,O
obtain,1020,1026,O
the,1027,1030,O
health,1031,1037,O
benefit,1038,1045,O
in,1046,1048,O
reasonable,1049,1059,O
concentration,1060,1073,O
in,1074,1076,O
daily,1077,1082,O
life,1083,1087,O
.,1087,1088,O
We,1089,1091,O
have,1092,1096,O
reported,1097,1105,O
that,1106,1110,O
the,1111,1114,O
cell,1115,1119,B-Cellular_component
-,1119,1120,I-Cellular_component
surface,1120,1127,I-Cellular_component
binding,1128,1135,O
of,1136,1138,O
EGCG,1139,1143,O
and,1144,1147,O
its,1148,1151,O
derivatives,1152,1163,O
is,1164,1166,O
involved,1167,1175,O
in,1176,1178,O
their,1179,1184,O
biological,1185,1195,O
activities,1196,1206,O
[,1207,1208,O
10,1208,1210,O
],1210,1211,O
-,1211,1212,O
[,1212,1213,O
15,1213,1215,O
],1215,1216,O
.,1216,1217,O
We,1218,1220,O
have,1221,1225,O
identified,1226,1236,O
the,1237,1240,O
67,1241,1243,O
-,1243,1244,O
kDa,1244,1247,O
laminin,1248,1255,O
receptor,1256,1264,O
(,1265,1266,O
67LR,1266,1270,O
),1270,1271,O
as,1272,1274,O
a,1275,1276,O
cell,1277,1281,B-Cellular_component
surface,1282,1289,I-Cellular_component
receptor,1290,1298,O
for,1299,1302,O
EGCG,1303,1307,O
that,1308,1312,O
mediates,1313,1321,O
the,1322,1325,O
anticancer,1326,1336,O
activity,1337,1345,O
of,1346,1348,O
EGCG,1349,1353,O
[,1354,1355,O
16,1355,1357,O
],1357,1358,O
.,1358,1359,O
67LR,1360,1364,O
has,1365,1368,O
been,1369,1373,O
shown,1374,1379,O
to,1380,1382,O
be,1383,1385,O
overexpressed,1386,1399,O
on,1400,1402,O
the,1403,1406,O
cell,1407,1411,B-Cellular_component
surface,1412,1419,I-Cellular_component
of,1420,1422,O
various,1423,1430,O
tumor,1431,1436,B-Cell
cells,1437,1442,I-Cell
[,1443,1444,O
17,1444,1446,O
],1446,1447,O
.,1447,1448,O
It,1449,1451,O
was,1452,1455,O
postulated,1456,1466,O
that,1467,1471,O
67LR,1472,1476,O
plays,1477,1482,O
a,1483,1484,O
significant,1485,1496,O
role,1497,1501,O
in,1502,1504,O
the,1505,1508,O
tumor,1509,1514,B-Pathological_formation
progression,1515,1526,O
and,1527,1530,O
speculated,1531,1541,O
that,1542,1546,O
studies,1547,1554,O
conducted,1555,1564,O
to,1565,1567,O
define,1568,1574,O
the,1575,1578,O
function,1579,1587,O
of,1588,1590,O
67LR,1591,1595,O
could,1596,1601,O
provide,1602,1609,O
a,1610,1611,O
new,1612,1615,O
approach,1616,1624,O
to,1625,1627,O
cancer,1628,1634,B-Pathological_formation
prevention,1635,1645,O
.,1645,1646,O
Indeed,1647,1653,O
",",1653,1654,O
expression,1655,1665,O
of,1666,1668,O
67,1669,1671,O
LR,1672,1674,O
confers,1675,1682,O
EGCG,1683,1687,O
responsiveness,1688,1702,O
to,1703,1705,O
tumor,1706,1711,B-Cell
cells,1712,1717,I-Cell
in,1718,1720,O
vivo,1721,1725,O
[,1726,1727,O
18,1727,1729,O
],1729,1730,O
.,1730,1731,O
Vitamin,1732,1739,O
A,1740,1741,O
",",1741,1742,O
also,1743,1747,O
known,1748,1753,O
as,1754,1756,O
retinol,1757,1764,O
",",1764,1765,O
participates,1766,1778,O
in,1779,1781,O
physiological,1782,1795,O
activities,1796,1806,O
related,1807,1814,O
to,1815,1817,O
the,1818,1821,O
immune,1822,1828,O
system,1829,1835,O
",",1835,1836,O
maintenance,1837,1848,O
of,1849,1851,O
epithelial,1852,1862,B-Tissue
and,1863,1866,O
mucosa,1867,1873,B-Tissue
tissues,1874,1881,I-Tissue
",",1881,1882,O
growth,1883,1889,O
",",1889,1890,O
reproduction,1891,1903,O
",",1903,1904,O
and,1905,1908,O
bone,1909,1913,B-Organ
development,1914,1925,O
.,1925,1926,O
It,1927,1929,O
comes,1930,1935,O
from,1936,1940,O
animal,1941,1947,O
sources,1948,1955,O
",",1955,1956,O
such,1957,1961,O
as,1962,1964,O
eggs,1965,1969,B-Organism_substance
",",1969,1970,O
meat,1971,1975,B-Organism_subdivision
",",1975,1976,O
milk,1977,1981,B-Organism_substance
",",1981,1982,O
cheese,1983,1989,O
",",1989,1990,O
cream,1991,1996,O
",",1996,1997,O
liver,1998,2003,B-Organ
",",2003,2004,O
kidney,2005,2011,B-Organ
",",2011,2012,O
cod,2013,2016,O
and,2017,2020,O
halibut,2021,2028,O
fish,2029,2033,O
oil,2034,2037,B-Organism_substance
.,2037,2038,O
In,2039,2041,O
vitro,2042,2047,O
and,2048,2051,O
in,2052,2054,O
animal,2055,2061,O
models,2062,2068,O
",",2068,2069,O
it,2070,2072,O
has,2073,2076,O
been,2077,2081,O
demonstrated,2082,2094,O
that,2095,2099,O
vitamin,2100,2107,O
A,2108,2109,O
is,2110,2112,O
involved,2113,2121,O
in,2122,2124,O
the,2125,2128,O
regulation,2129,2139,O
and,2140,2143,O
promotion,2144,2153,O
of,2154,2156,O
growth,2157,2163,O
and,2164,2167,O
differentiation,2168,2183,O
of,2184,2186,O
many,2187,2191,O
cells,2192,2197,B-Cell
[,2198,2199,O
19,2199,2201,O
],2201,2202,O
.,2202,2203,O
The,2204,2207,O
visual,2208,2214,O
function,2215,2223,O
of,2224,2226,O
vitamin,2227,2234,O
A,2235,2236,O
depends,2237,2244,O
on,2245,2247,O
its,2248,2251,O
natural,2252,2259,O
and,2260,2263,O
synthetic,2264,2273,O
derivatives,2274,2285,O
",",2285,2286,O
retinoids,2287,2296,O
[,2297,2298,O
20,2298,2300,O
],2300,2301,O
.,2301,2302,O
All,2303,2306,O
-,2306,2307,O
trans,2307,2312,O
-,2312,2313,O
retinoic,2313,2321,O
acid,2322,2326,O
(,2327,2328,O
ATRA,2328,2332,O
),2332,2333,O
",",2333,2334,O
the,2335,2338,O
active,2339,2345,O
derivative,2346,2356,O
of,2357,2359,O
vitamin,2360,2367,O
A,2368,2369,O
",",2369,2370,O
has,2371,2374,O
been,2375,2379,O
well,2380,2384,O
documented,2385,2395,O
as,2396,2398,O
a,2399,2400,O
growth,2401,2407,O
and,2408,2411,O
differentiation,2412,2427,O
factor,2428,2434,O
in,2435,2437,O
many,2438,2442,O
tissues,2443,2450,B-Tissue
and,2451,2454,O
cells,2455,2460,B-Cell
",",2460,2461,O
and,2462,2465,O
proved,2466,2472,O
to,2473,2475,O
be,2476,2478,O
an,2479,2481,O
effective,2482,2491,O
treatment,2492,2501,O
to,2502,2504,O
many,2505,2509,O
diseases,2510,2518,O
including,2519,2528,O
cancers,2529,2536,B-Pathological_formation
[,2537,2538,O
21,2538,2540,O
],2540,2541,O
",",2541,2542,O
[,2543,2544,O
22,2544,2546,O
],2546,2547,O
.,2547,2548,O
Retinoids,2549,2558,O
exert,2559,2564,O
their,2565,2570,O
physiological,2571,2584,O
activities,2585,2595,O
through,2596,2603,O
retinoid,2604,2612,O
receptor,2613,2621,O
nuclear,2622,2629,B-Cellular_component
proteins,2630,2638,O
that,2639,2643,O
belong,2644,2650,O
to,2651,2653,O
the,2654,2657,O
superfamily,2658,2669,O
of,2670,2672,O
steroid,2673,2680,O
/,2680,2681,O
thyroid,2681,2688,O
hormone,2689,2696,O
receptors,2697,2706,O
",",2706,2707,O
of,2708,2710,O
which,2711,2716,O
there,2717,2722,O
are,2723,2726,O
two,2727,2730,O
classes,2731,2738,O
",",2738,2739,O
retinoic,2740,2748,O
acid,2749,2753,O
receptors,2754,2763,O
(,2764,2765,O
RARs,2765,2769,O
),2769,2770,O
and,2771,2774,O
the,2775,2778,O
retinoic,2779,2787,O
-,2787,2788,O
X,2788,2789,O
receptors,2790,2799,O
(,2800,2801,O
RXRs,2801,2805,O
),2805,2806,O
",",2806,2807,O
each,2808,2812,O
of,2813,2815,O
which,2816,2821,O
has,2822,2825,O
three,2826,2831,O
subtypes,2832,2840,O
",",2840,2841,O
alpha,2842,2847,O
",",2847,2848,O
beta,2849,2853,O
",",2853,2854,O
and,2855,2858,O
gamma,2859,2864,O
[,2865,2866,O
23,2866,2868,O
],2868,2869,O
",",2869,2870,O
[,2871,2872,O
24,2872,2874,O
],2874,2875,O
.,2875,2876,O
The,2877,2880,O
natural,2881,2888,O
ligands,2889,2896,O
for,2897,2900,O
the,2901,2904,O
RARs,2905,2909,O
are,2910,2913,O
ATRA,2914,2918,O
and,2919,2922,O
its,2923,2926,O
stereoisomers,2927,2940,O
9,2941,2942,O
-,2942,2943,O
cis,2943,2946,O
-,2946,2947,O
RA,2947,2949,O
and,2950,2953,O
13,2954,2956,O
-,2956,2957,O
cis,2957,2960,O
-,2960,2961,O
RA,2961,2963,O
",",2963,2964,O
whereas,2965,2972,O
RXRs,2973,2977,O
are,2978,2981,O
activated,2982,2991,O
by,2992,2994,O
9,2995,2996,O
-,2996,2997,O
cis,2997,3000,O
-,3000,3001,O
RA,3001,3003,O
only,3004,3008,O
.,3008,3009,O
ATRA,3010,3014,O
acts,3015,3019,O
through,3020,3027,O
RAR,3028,3031,O
to,3032,3034,O
transcriptionally,3035,3052,O
activate,3053,3061,O
target,3062,3068,O
genes,3069,3074,O
",",3074,3075,O
such,3076,3080,O
as,3081,3083,O
cytochrome,3084,3094,O
P450,3095,3099,O
and,3100,3103,O
CRABI,3104,3109,O
[,3110,3111,O
24,3111,3113,O
],3113,3114,O
.,3114,3115,O
This,3116,3120,O
study,3121,3126,O
was,3127,3130,O
designed,3131,3139,O
to,3140,3142,O
identify,3143,3151,O
a,3152,3153,O
food,3154,3158,O
component,3159,3168,O
that,3169,3173,O
could,3174,3179,O
be,3180,3182,O
effectively,3183,3194,O
used,3195,3199,O
in,3200,3202,O
combination,3203,3214,O
with,3215,3219,O
EGCG,3220,3224,O
and,3225,3228,O
to,3229,3231,O
investigate,3232,3243,O
the,3244,3247,O
mechanism,3248,3257,O
of,3258,3260,O
action,3261,3267,O
of,3268,3270,O
this,3271,3275,O
combination,3276,3287,O
.,3287,3288,O
By,3289,3291,O
using,3292,3297,O
in,3298,3300,O
vitro,3301,3306,O
and,3307,3310,O
in,3311,3313,O
vivo,3314,3318,O
systems,3319,3326,O
involving,3327,3336,O
a,3337,3338,O
highly,3339,3345,O
metastatic,3346,3356,O
mouse,3357,3362,O
B16,3363,3366,B-Cell
melanoma,3367,3375,I-Cell
cell,3376,3380,I-Cell
line,3381,3385,I-Cell
[,3386,3387,O
25,3387,3389,O
],3389,3390,O
",",3390,3391,O
we,3392,3394,O
found,3395,3400,O
that,3401,3405,O
ATRA,3406,3410,O
enhances,3411,3419,O
the,3420,3423,O
antitumor,3424,3433,B-Pathological_formation
activity,3434,3442,O
of,3443,3445,O
EGCG,3446,3450,O
by,3451,3453,O
upregulating,3454,3466,O
the,3467,3470,O
67,3471,3473,O
LR,3474,3476,O
expression,3477,3487,O
through,3488,3495,O
RAR,3496,3499,O
.,3499,3500,O
Titration,0,9,O
of,10,12,O
Ab,13,15,O
-,15,16,O
01,16,18,O
inhibition,19,29,O
of,30,32,O
ex,33,35,O
vivo,36,40,O
response,41,49,O
to,50,52,O
rhIL21,53,59,O
Samples,60,67,O
from,68,72,O
4,73,74,O
individual,75,85,O
healthy,86,93,O
human,94,99,O
donors,100,106,O
were,107,111,O
pre,112,115,O
-,115,116,O
incubated,116,125,O
for,126,129,O
2,130,131,O
hours,132,137,O
at,138,140,O
the,141,144,O
indicated,145,154,O
concentration,155,168,O
of,169,171,O
Ab,172,174,O
-,174,175,O
01,175,177,O
or,178,180,O
the,181,184,O
control,185,192,O
IgG1TM,193,199,O
prior,200,205,O
to,206,208,O
addition,209,217,O
of,218,220,O
10,221,223,O
ng,224,226,O
/,226,227,O
mL,227,229,O
rhIL21,230,236,O
and,237,240,O
2,241,242,O
hr,243,245,O
incubation,246,256,O
",",256,257,O
and,258,261,O
the,262,265,O
effect,266,272,O
on,273,275,O
the,276,279,O
6,280,281,O
biomarkers,282,292,O
was,293,296,O
then,297,301,O
assessed,302,310,O
(,311,312,O
Figures,312,319,O
4,320,321,O
and,322,325,O
5,326,327,O
),327,328,O
.,328,329,O
For,330,333,O
the,334,337,O
first,338,343,O
2,344,345,O
donors,346,352,O
tested,353,359,O
",",359,360,O
even,361,365,O
the,366,369,O
lowest,370,376,O
concentration,377,390,O
of,391,393,O
Ab,394,396,O
-,396,397,O
01,397,399,O
(,400,401,O
0,401,402,O
.,402,403,O
1,403,404,O
mug,405,408,O
/,408,409,O
mL,409,411,O
",",411,412,O
0,413,414,O
.,414,415,O
66,415,417,O
nM,418,420,O
),420,421,O
resulted,422,430,O
in,431,433,O
complete,434,442,O
inhibition,443,453,O
of,454,456,O
the,457,460,O
rhIL21,461,467,O
response,468,476,O
",",476,477,O
therefore,478,487,O
the,488,491,O
two,492,495,O
subsequent,496,506,O
donors,507,513,O
were,514,518,O
tested,519,525,O
at,526,528,O
increasing,529,539,O
concentrations,540,554,O
of,555,557,O
Ab,558,560,O
-,560,561,O
01,561,563,O
starting,564,572,O
at,573,575,O
0,576,577,O
.,577,578,O
003,578,581,O
mug,582,585,O
/,585,586,O
mL,586,588,O
.,588,589,O
Ab,590,592,O
-,592,593,O
01,593,595,O
inhibited,596,605,O
the,606,609,O
response,610,618,O
of,619,621,O
all,622,625,O
6,626,627,O
genes,628,633,O
in,634,636,O
all,637,640,O
4,641,642,O
donors,643,649,O
.,649,650,O
IC50,651,655,O
values,656,662,O
ranged,663,669,O
between,670,677,O
0,678,679,O
.,679,680,O
003,680,683,O
and,684,687,O
0,688,689,O
.,689,690,O
015,690,693,O
mug,694,697,O
/,697,698,O
mL,698,700,O
Ab,701,703,O
-,703,704,O
01,704,706,O
(,706,707,O
Figure,707,713,O
5,714,715,O
),715,716,O
.,716,717,O
Control,718,725,O
IgG1TM,726,732,O
had,733,736,O
no,737,739,O
significant,740,751,O
effect,752,758,O
on,759,761,O
rhIL21,762,768,O
response,769,777,O
(,778,779,O
Figure4B,779,787,O
),787,788,O
.,788,789,O
Figure,790,796,O
4,797,798,O
Average,799,806,O
percent,807,814,O
inhibition,815,825,O
of,826,828,O
the,829,832,O
expression,833,843,O
level,844,849,O
of,850,852,O
6,853,854,O
IL21,855,859,O
-,859,860,O
responsive,860,870,O
genes,871,876,O
.,876,877,O
Percent,878,885,O
inhibition,886,896,O
values,897,903,O
were,904,908,O
calculated,909,919,O
based,920,925,O
on,926,928,O
RQ,929,931,O
(,932,933,O
relative,933,941,O
quantification,942,956,O
),956,957,O
values,958,964,O
of,965,967,O
untreated,968,977,O
control,978,985,O
and,986,989,O
rhIL21,990,996,O
-,996,997,O
treated,997,1004,O
samples,1005,1012,O
for,1013,1016,O
each,1017,1021,O
of,1022,1024,O
the,1025,1028,O
4,1029,1030,O
donors,1031,1037,O
",",1037,1038,O
and,1039,1042,O
subsequently,1043,1055,O
the,1056,1059,O
mean,1060,1064,O
and,1065,1068,O
standard,1069,1077,O
deviation,1078,1087,O
were,1088,1092,O
determined,1093,1103,O
for,1104,1107,O
each,1108,1112,O
gene,1113,1117,O
shown,1118,1123,O
.,1123,1124,O
A,1125,1126,O
:,1126,1127,O
Percent,1128,1135,O
inhibition,1136,1146,O
in,1147,1149,O
presence,1150,1158,O
of,1159,1161,O
Ab,1162,1164,O
-,1164,1165,O
01,1165,1167,O
.,1167,1168,O
B,1169,1170,O
:,1170,1171,O
Percent,1172,1179,O
inhibition,1180,1190,O
in,1191,1193,O
presence,1194,1202,O
of,1203,1205,O
control,1206,1213,O
IgG1TM,1214,1220,O
.,1220,1221,O
Data,1222,1226,O
for,1227,1230,O
the,1231,1234,O
0,1235,1236,O
.,1236,1237,O
1,1237,1238,O
mug,1239,1242,O
/,1242,1243,O
mL,1243,1245,O
",",1246,1247,O
0,1248,1249,O
.,1249,1250,O
3,1250,1251,O
mug,1252,1255,O
/,1255,1256,O
mL,1256,1258,O
and,1259,1262,O
1,1263,1264,O
mug,1265,1268,O
/,1268,1269,O
mL,1269,1271,O
concentrations,1272,1286,O
were,1287,1291,O
generated,1292,1301,O
using,1302,1307,O
4,1308,1309,O
donors,1310,1316,O
.,1316,1317,O
Data,1318,1322,O
for,1323,1326,O
the,1327,1330,O
higher,1331,1337,O
and,1338,1341,O
the,1342,1345,O
lower,1346,1351,O
concentrations,1352,1366,O
were,1367,1371,O
generated,1372,1381,O
using,1382,1387,O
2,1388,1389,O
donors,1390,1396,O
.,1396,1397,O
Figure,1398,1404,O
5,1405,1406,O
Inhibition,1407,1417,O
by,1418,1420,O
Ab,1421,1423,O
-,1423,1424,O
01,1424,1426,O
at,1427,1429,O
the,1430,1433,O
indicated,1434,1443,O
concentration,1444,1457,O
is,1458,1460,O
shown,1461,1466,O
for,1467,1470,O
6,1471,1472,O
IL21,1473,1477,O
-,1477,1478,O
responsive,1478,1488,O
genes,1489,1494,O
.,1494,1495,O
IC50,1496,1500,O
values,1501,1507,O
of,1508,1510,O
inhibition,1511,1521,O
curves,1522,1528,O
shown,1529,1534,O
in,1535,1537,O
Figure,1538,1544,O
4A,1545,1547,O
were,1548,1552,O
calculated,1553,1563,O
using,1564,1569,O
curve,1570,1575,O
fit,1576,1579,O
(,1580,1581,O
XLfit,1581,1586,O
),1586,1587,O
program,1588,1595,O
for,1596,1599,O
each,1600,1604,O
of,1605,1607,O
the,1608,1611,O
referred,1612,1620,O
biomarker,1621,1630,O
genes,1631,1636,O
.,1636,1637,O
Values,1638,1644,O
for,1645,1648,O
the,1649,1652,O
0,1653,1654,O
.,1654,1655,O
1,1655,1656,O
mug,1657,1660,O
/,1660,1661,O
mL,1661,1663,O
",",1663,1664,O
0,1665,1666,O
.,1666,1667,O
3,1667,1668,O
mug,1669,1672,O
/,1672,1673,O
mL,1673,1675,O
and,1676,1679,O
1,1680,1681,O
mug,1682,1685,O
/,1685,1686,O
mL,1686,1688,O
concentrations,1689,1703,O
were,1704,1708,O
generated,1709,1718,O
using,1719,1724,O
4,1725,1726,O
donors,1727,1733,O
.,1733,1734,O
Data,1735,1739,O
for,1740,1743,O
the,1744,1747,O
higher,1748,1754,O
and,1755,1758,O
the,1759,1762,O
lower,1763,1768,O
concentrations,1769,1783,O
were,1784,1788,O
generated,1789,1798,O
using,1799,1804,O
2,1805,1806,O
donors,1807,1813,O
each,1814,1818,O
.,1818,1819,O
INTRODUCTION,0,12,O
For,13,16,O
several,17,24,O
years,25,30,O
now,31,34,O
",",34,35,O
virtual,36,43,O
microscopy,44,54,O
has,55,58,O
been,59,63,O
utilized,64,72,O
in,73,75,O
medical,76,83,O
teaching,84,92,O
",",92,93,O
research,94,102,O
",",102,103,O
proficiency,104,115,O
testing,116,123,O
",",123,124,O
American,125,133,O
Board,134,139,O
of,140,142,O
Pathology,143,152,O
examinations,153,165,O
",",165,166,O
pathology,167,176,O
meetings,177,185,O
and,186,189,O
conferences,190,201,O
",",201,202,O
and,203,206,O
quality,207,214,O
assurance,215,224,O
programs,225,233,O
.,233,234,O
In,235,237,O
diagnostic,238,248,O
practice,249,257,O
",",257,258,O
it,259,261,O
is,262,264,O
most,265,269,O
widely,270,276,O
and,277,280,O
routinely,281,290,O
used,291,295,O
in,296,298,O
image,299,304,O
analysis,305,313,O
.,313,314,O
Some,315,319,O
practices,320,329,O
are,330,333,O
beginning,334,343,O
to,344,346,O
use,347,350,O
it,351,353,O
internally,354,364,O
(,365,366,O
within,366,372,O
their,373,378,O
group,379,384,O
),384,385,O
for,386,389,O
frozen,390,396,O
section,397,404,O
intraoperative,405,419,O
consultations,420,433,O
and,434,437,O
subspecialty,438,450,O
consultations,451,464,O
due,465,468,O
to,469,471,O
geographic,472,482,O
and,483,486,O
time,487,491,O
constrains,492,502,O
.,502,503,O
Although,504,512,O
diagnostic,513,523,O
consultation,524,536,O
for,537,540,O
expert,541,547,O
second,548,554,O
opinion,555,562,O
is,563,565,O
a,566,567,O
well,568,572,O
-,572,573,O
established,573,584,O
practice,585,593,O
in,594,596,O
pathology,597,606,O
for,607,610,O
glass,611,616,O
slides,617,623,O
",",623,624,O
similar,625,632,O
consultation,633,645,O
via,646,649,O
virtual,650,657,O
microscopy,658,668,O
poses,669,674,O
multiple,675,683,O
controversial,684,697,O
issues,698,704,O
such,705,709,O
as,710,712,O
licensing,713,722,O
",",722,723,O
liability,724,733,O
",",733,734,O
security,735,743,O
",",743,744,O
reimbursement,745,758,O
",",758,759,O
and,760,763,O
scanning,764,772,O
quality,773,780,O
and,781,784,O
its,785,788,O
validation,789,799,O
.,799,800,O
Regulations,801,812,O
and,813,816,O
standardization,817,832,O
are,833,836,O
not,837,840,O
yet,841,844,O
in,845,847,O
place,848,853,O
that,854,858,O
pathologists,859,871,O
can,872,875,O
use,876,879,O
to,880,882,O
allay,883,888,O
these,889,894,O
fears,895,900,O
.,900,901,O
Nevertheless,902,914,O
",",914,915,O
if,916,918,O
the,919,922,O
virtual,923,930,O
microscopy,931,941,O
scans,942,947,O
are,948,951,O
of,952,954,O
optimal,955,962,O
quality,963,970,O
",",970,971,O
these,972,977,O
can,978,981,O
be,982,984,O
simply,985,991,O
substituted,992,1003,O
for,1004,1007,O
glass,1008,1013,O
slides,1014,1020,O
and,1021,1024,O
a,1025,1026,O
microscope,1027,1037,O
while,1038,1043,O
maintaining,1044,1055,O
all,1056,1059,O
other,1060,1065,O
practice,1066,1074,O
guidelines,1075,1085,O
for,1086,1089,O
second,1090,1096,O
opinion,1097,1104,O
consultation,1105,1117,O
.,1117,1118,O
Additionally,1119,1131,O
",",1131,1132,O
the,1133,1136,O
cost,1137,1141,O
and,1142,1145,O
maintenance,1146,1157,O
of,1158,1160,O
scanning,1161,1169,O
equipment,1170,1179,O
is,1180,1182,O
not,1183,1186,O
currently,1187,1196,O
affordable,1197,1207,O
to,1208,1210,O
most,1211,1215,O
practitioners,1216,1229,O
and,1230,1233,O
consultants,1234,1245,O
.,1245,1246,O
A,1247,1248,O
practice,1249,1257,O
model,1258,1263,O
that,1264,1268,O
offers,1269,1275,O
tertiary,1276,1284,O
consultation,1285,1297,O
in,1298,1300,O
gastrointestinal,1301,1317,B-Organism_subdivision
(,1318,1319,O
GI,1319,1321,B-Organism_subdivision
),1321,1322,O
and,1323,1326,O
liver,1327,1332,B-Organ
pathology,1333,1342,O
is,1343,1345,O
presented,1346,1355,O
that,1356,1360,O
eliminates,1361,1371,O
the,1372,1375,O
cost,1376,1380,O
and,1381,1384,O
maintenance,1385,1396,O
of,1397,1399,O
scanners,1400,1408,O
by,1409,1411,O
the,1412,1415,O
consultants,1416,1427,O
and,1428,1431,O
clients,1432,1439,O
",",1439,1440,O
minimizes,1441,1450,O
the,1451,1454,O
need,1455,1459,O
for,1460,1463,O
review,1464,1470,O
of,1471,1473,O
glass,1474,1479,O
slides,1480,1486,O
",",1486,1487,O
facilitates,1488,1499,O
clinicopathological,1500,1519,O
and,1520,1523,O
radiological,1524,1536,O
correlation,1537,1548,O
and,1549,1552,O
serves,1553,1559,O
the,1560,1563,O
need,1564,1568,O
of,1569,1571,O
clients,1572,1579,O
who,1580,1583,O
need,1584,1588,O
timely,1589,1595,O
help,1596,1600,O
with,1601,1605,O
challenging,1606,1617,O
liver,1618,1623,B-Organ
and,1624,1627,O
GI,1628,1630,B-Organism_subdivision
cases,1631,1636,O
and,1637,1640,O
to,1641,1643,O
obtain,1644,1650,O
expert,1651,1657,O
opinion,1658,1665,O
for,1666,1669,O
dysplasia,1670,1679,O
in,1680,1682,O
Barrett,1683,1690,O
',1690,1691,O
s,1691,1692,O
and,1693,1696,O
ulcerative,1697,1707,O
colitis,1708,1715,O
surveillance,1716,1728,O
biopsies,1729,1737,O
required,1738,1746,O
by,1747,1749,O
the,1750,1753,O
American,1754,1762,O
Gastroenterology,1763,1779,O
Association,1780,1791,O
(,1792,1793,O
AGA,1793,1796,O
),1796,1797,O
.,1797,1798,O
This,1799,1803,O
model,1804,1809,O
has,1810,1813,O
been,1814,1818,O
practiced,1819,1828,O
for,1829,1832,O
3,1833,1834,O
years,1835,1840,O
and,1841,1844,O
applied,1845,1852,O
to,1853,1855,O
over,1856,1860,O
2000,1861,1865,O
cases,1866,1871,O
by,1872,1874,O
small,1875,1880,O
pathology,1881,1890,O
practices,1891,1900,O
in,1901,1903,O
the,1904,1907,O
50,1908,1910,O
United,1911,1917,O
States,1918,1924,O
and,1925,1928,O
a,1929,1930,O
single,1931,1937,O
consultant,1938,1948,O
GI,1949,1951,B-Organism_subdivision
and,1952,1955,O
liver,1956,1961,B-Organ
pathologist,1962,1973,O
.,1973,1974,O
Click,0,5,O
here,6,10,O
for,11,14,O
file,15,19,O
The,0,3,O
right,4,9,O
eye,10,13,B-Organ
of,14,16,O
a,17,18,O
50,19,21,O
-,21,22,O
year,22,26,O
-,26,27,O
old,27,30,O
patient,31,38,O
with,39,43,O
severe,44,50,O
hypertension,51,63,O
at,64,66,O
the,67,70,O
first,71,76,O
visit,77,82,O
.,82,83,O
(,84,85,O
a,85,86,O
),86,87,O
Fundus,88,94,O
photograph,95,105,O
shows,106,111,O
serous,112,118,O
retinal,119,126,B-Multi-tissue_structure
detachment,127,137,O
.,137,138,O
The,139,142,O
optic,143,148,O
disc,149,153,O
is,154,156,O
pale,157,161,O
at,162,164,O
the,165,168,O
temporal,169,177,O
side,178,182,O
.,182,183,O
(,184,185,O
b,185,186,O
),186,187,O
Optical,188,195,O
coherence,196,205,O
tomography,206,216,O
(,217,218,O
OCT,218,221,O
),221,222,O
shows,223,228,O
retinal,229,236,B-Multi-tissue_structure
detachment,237,247,O
involving,248,257,O
the,258,261,O
fovea,262,267,O
and,268,271,O
cystic,272,278,O
change,279,285,O
of,286,288,O
inner,289,294,B-Multi-tissue_structure
retina,295,301,I-Multi-tissue_structure
.,301,302,O
(,303,304,O
c,304,305,O
),305,306,O
Early,307,312,O
phase,313,318,O
images,319,325,O
of,326,328,O
fluorescein,329,340,O
angiography,341,352,O
(,353,354,O
FA,354,356,O
),356,357,O
(,358,359,O
left,359,363,O
),363,364,O
and,365,368,O
indocyanine,369,380,O
green,381,386,O
angiography,387,398,O
(,399,400,O
IA,400,402,O
),402,403,O
(,404,405,O
right,405,410,O
),410,411,O
.,411,412,O
(,413,414,O
d,414,415,O
),415,416,O
Late,417,421,O
phase,422,427,O
images,428,434,O
of,435,437,O
FA,438,440,O
(,441,442,O
left,442,446,O
),446,447,O
and,448,451,O
IA,452,454,O
(,455,456,O
right,456,461,O
),461,462,O
.,462,463,O
FA,464,466,O
shows,467,472,O
window,473,479,O
defect,480,486,O
associated,487,497,O
with,498,502,O
macular,503,510,B-Tissue
cystic,511,517,O
change,518,524,O
.,524,525,O
Note,526,530,O
that,531,535,O
no,536,538,O
active,539,545,O
leakage,546,553,O
is,554,556,O
observed,557,565,O
in,566,568,O
the,569,572,O
area,573,577,O
with,578,582,O
serous,583,589,O
retinal,590,597,B-Multi-tissue_structure
detachment,598,608,O
or,609,611,O
cystoid,612,619,B-Pathological_formation
edema,620,625,I-Pathological_formation
.,625,626,O
IA,627,629,O
shows,630,635,O
decreased,636,645,O
perfusion,646,655,O
of,656,658,O
the,659,662,O
choroid,663,670,O
at,671,673,O
the,674,677,O
macula,678,684,B-Tissue
and,685,688,O
window,689,695,O
defect,696,702,O
with,703,707,O
the,708,711,O
damaged,712,719,O
RPE,720,723,O
.,723,724,O
Hypofluorescence,725,741,O
(,742,743,O
arrow,743,748,O
),748,749,O
along,750,755,O
the,756,759,O
retinal,760,767,B-Tissue
artery,768,774,I-Tissue
are,775,778,O
observed,779,787,O
.,787,788,O
These,789,794,O
are,795,798,O
unique,799,805,O
findings,806,814,O
.,814,815,O
5,0,1,O
.,1,2,O
Conclusion,3,13,O
RLs,14,17,O
are,18,21,O
new,22,25,O
actors,26,32,O
in,33,35,O
animal,36,42,O
and,43,46,O
plant,47,52,O
defense,53,60,O
and,61,64,O
their,65,70,O
low,71,74,O
toxicity,75,83,O
and,84,87,O
biodegradability,88,104,O
make,105,109,O
them,110,114,O
promising,115,124,O
molecules,125,134,O
to,135,137,O
be,138,140,O
used,141,145,O
against,146,153,O
pathogens,154,163,O
.,163,164,O
In,165,167,O
this,168,172,O
respect,173,180,O
",",180,181,O
there,182,187,O
are,188,191,O
some,192,196,O
clues,197,202,O
now,203,206,O
available,207,216,O
for,217,220,O
the,221,224,O
success,225,232,O
of,233,235,O
RL,236,238,O
applications,239,251,O
in,252,254,O
greenhouses,255,266,O
to,267,269,O
fight,270,275,O
phytopathogens,276,290,O
.,290,291,O
A,292,293,O
better,294,300,O
understanding,301,314,O
of,315,317,O
RL,318,320,O
mode,321,325,O
of,326,328,O
action,329,335,O
",",335,336,O
especially,337,347,O
their,348,353,O
perception,354,364,O
and,365,368,O
the,369,372,O
signaling,373,382,O
pathways,383,391,O
activated,392,401,O
",",401,402,O
will,403,407,O
be,408,410,O
very,411,415,O
important,416,425,O
to,426,428,O
potentiate,429,439,O
their,440,445,O
beneficial,446,456,O
effects,457,464,O
in,465,467,O
plants,468,474,O
.,474,475,O
RLs,476,479,O
have,480,484,O
a,485,486,O
dual,487,491,O
mode,492,496,O
of,497,499,O
action,500,506,O
:,506,507,O
they,508,512,O
are,513,516,O
antimicrobial,517,530,O
and,531,534,O
also,535,539,O
stimulate,540,549,O
plant,550,555,O
defense,556,563,O
responses,564,573,O
.,573,574,O
This,575,579,O
dual,580,584,O
property,585,593,O
is,594,596,O
probably,597,605,O
very,606,610,O
important,611,620,O
for,621,624,O
the,625,628,O
efficiency,629,639,O
of,640,642,O
new,643,646,O
biopesticides,647,660,O
.,660,661,O
In,662,664,O
animals,665,672,O
",",672,673,O
the,674,677,O
use,678,681,O
of,682,684,O
RLs,685,688,O
is,689,691,O
also,692,696,O
at,697,699,O
an,700,702,O
advanced,703,711,O
stage,712,717,O
.,717,718,O
RLs,719,722,O
are,723,726,O
successfully,727,739,O
used,740,744,O
as,745,747,O
antimicrobial,748,761,O
agents,762,768,O
",",768,769,O
especially,770,780,O
for,781,784,O
skin,785,789,B-Organ
disease,790,797,O
treatment,798,807,O
.,807,808,O
Deep,809,813,O
insight,814,821,O
into,822,826,O
the,827,830,O
physiochemical,831,845,O
effects,846,853,O
of,854,856,O
RLs,857,860,O
and,861,864,O
their,865,870,O
biological,871,881,O
importance,882,892,O
would,893,898,O
reveal,899,905,O
new,906,909,O
dimensions,910,920,O
in,921,923,O
the,924,927,O
fields,928,934,O
of,935,937,O
research,938,946,O
like,947,951,O
agriculture,952,963,O
and,964,967,O
medicine,968,976,O
",",976,977,O
precisely,978,987,O
in,988,990,O
plant,991,996,O
defense,997,1004,O
",",1004,1005,O
disease,1006,1013,O
control,1014,1021,O
and,1022,1025,O
pathogenesis,1026,1038,O
.,1038,1039,O
An,1040,1042,O
understanding,1043,1056,O
of,1057,1059,O
bacterial,1060,1069,O
genera,1070,1076,O
producing,1077,1086,O
RLs,1087,1090,O
that,1091,1095,O
are,1096,1099,O
not,1100,1103,O
yet,1104,1107,O
well,1108,1112,O
studied,1113,1120,O
would,1121,1126,O
provide,1127,1134,O
light,1135,1140,O
on,1141,1143,O
these,1144,1149,O
fascinating,1150,1161,O
aspects,1162,1169,O
.,1169,1170,O
Objectives,0,10,O
Evaluate,11,19,O
relationships,20,33,O
between,34,41,O
MRI,42,45,O
and,46,49,O
clinical,50,58,O
/,58,59,O
laboratory,59,69,O
/,69,70,O
radiographic,70,82,O
findings,83,91,O
in,92,94,O
rheumatoid,95,105,O
arthritis,106,115,O
(,116,117,O
RA,117,119,O
),119,120,O
.,120,121,O
Assessment,0,10,O
instruments,11,22,O
The,23,26,O
SCID,27,31,O
-,31,32,O
I,32,33,O
/,33,34,O
P,34,35,O
was,36,39,O
administered,40,52,O
by,53,55,O
psychiatrists,56,69,O
trained,70,77,O
and,78,81,O
certified,82,91,O
in,92,94,O
the,95,98,O
use,99,102,O
of,103,105,O
all,106,109,O
instruments,110,121,O
in,122,124,O
this,125,129,O
study,130,135,O
.,135,136,O
The,137,140,O
ICG,141,144,O
is,145,147,O
a,148,149,O
self,150,154,O
-,154,155,O
report,155,161,O
instrument,162,172,O
that,173,177,O
can,178,181,O
be,182,184,O
used,185,189,O
to,190,192,O
identify,193,201,O
CG,202,204,O
when,205,209,O
the,210,213,O
total,214,219,O
score,220,225,O
is,226,228,O
>,229,230,O
25,231,233,O
",",233,234,O
that,235,239,O
demonstrated,240,252,O
high,253,257,O
internal,258,266,O
consistency,267,278,O
(,279,280,O
Cronbach,280,288,O
',288,289,O
s,289,290,O
alpha,291,296,O
=,297,298,O
0,299,300,O
.,300,301,O
94,301,303,O
),303,304,O
",",304,305,O
and,306,309,O
convergent,310,320,O
and,321,324,O
criterion,325,334,O
validity,335,343,O
[,344,345,O
27,345,347,O
],347,348,O
.,348,349,O
The,350,353,O
ICG,354,357,O
total,358,363,O
score,364,369,O
also,370,374,O
showed,375,381,O
a,382,383,O
fairly,384,390,O
high,391,395,O
association,396,407,O
with,408,412,O
the,413,416,O
Beck,417,421,O
Depression,422,432,O
Inventory,433,442,O
(,443,444,O
BDI,444,447,O
),447,448,O
[,449,450,O
32,450,452,O
],452,453,O
total,454,459,O
score,460,465,O
(,466,467,O
r,467,468,O
=,469,470,O
0,471,472,O
.,472,473,O
67,473,475,O
",",475,476,O
P,477,478,O
<,479,480,O
0,481,482,O
.,482,483,O
001,483,486,O
),486,487,O
",",487,488,O
the,489,492,O
Texas,493,498,O
Revised,499,506,O
Inventory,507,516,O
of,517,519,O
Grief,520,525,O
(,526,527,O
TRIG,527,531,O
),531,532,O
[,533,534,O
33,534,536,O
],536,537,O
score,538,543,O
(,544,545,O
r,545,546,O
=,547,548,O
0,549,550,O
.,550,551,O
87,551,553,O
",",553,554,O
P,555,556,O
<,557,558,O
0,559,560,O
.,560,561,O
001,561,564,O
),564,565,O
",",565,566,O
and,567,570,O
the,571,574,O
Grief,575,580,O
Measurement,581,592,O
Scale,593,598,O
(,599,600,O
GMS,600,603,O
),603,604,O
[,605,606,O
34,606,608,O
],608,609,O
score,610,615,O
(,616,617,O
r,617,618,O
=,619,620,O
0,621,622,O
.,622,623,O
70,623,625,O
",",625,626,O
P,627,628,O
<,629,630,O
0,631,632,O
.,632,633,O
001,633,636,O
),636,637,O
.,637,638,O
The,639,642,O
ASA,643,646,O
-,646,647,O
27,647,649,O
is,650,652,O
a,653,654,O
self,655,659,O
-,659,660,O
report,660,666,O
measure,667,674,O
developed,675,684,O
to,685,687,O
rate,688,692,O
separation,693,703,O
anxiety,704,711,O
symptoms,712,720,O
in,721,723,O
adult,724,729,O
life,730,734,O
(,735,736,O
from,736,740,O
18,741,743,O
years,744,749,O
of,750,752,O
age,753,756,O
),756,757,O
.,757,758,O
Principal,759,768,O
components,769,779,O
analysis,780,788,O
revealed,789,797,O
a,798,799,O
coherent,800,808,O
construct,809,818,O
of,819,821,O
adult,822,827,O
separation,828,838,O
anxiety,839,846,O
with,847,851,O
high,852,856,O
internal,857,865,O
consistency,866,877,O
(,878,879,O
Cronbach,879,887,O
',887,888,O
s,888,889,O
alpha,890,895,O
=,896,897,O
0,898,899,O
.,899,900,O
95,900,902,O
),902,903,O
and,904,907,O
sound,908,913,O
test,914,918,O
-,918,919,O
retest,919,925,O
reliability,926,937,O
(,938,939,O
r,939,940,O
=,941,942,O
0,943,944,O
.,944,945,O
86,945,947,O
;,947,948,O
P,949,950,O
<,951,952,O
0,953,954,O
.,954,955,O
001,955,958,O
),958,959,O
.,959,960,O
Further,961,968,O
",",968,969,O
a,970,971,O
receiver,972,980,O
operation,981,990,O
characteristic,991,1005,O
(,1006,1007,O
ROC,1007,1010,O
),1010,1011,O
analysis,1012,1020,O
against,1021,1028,O
the,1029,1032,O
semistructured,1033,1047,O
interview,1048,1057,O
yielded,1058,1065,O
a,1066,1067,O
high,1068,1072,O
area,1073,1077,O
under,1078,1083,O
the,1084,1087,O
curve,1088,1093,O
(,1094,1095,O
AUC,1095,1098,O
),1098,1099,O
index,1100,1105,O
of,1106,1108,O
0,1109,1110,O
.,1110,1111,O
9,1111,1112,O
",",1112,1113,O
suggesting,1114,1124,O
that,1125,1129,O
the,1130,1133,O
questionnaire,1134,1147,O
is,1148,1150,O
an,1151,1153,O
adequate,1154,1162,O
alternative,1163,1174,O
measure,1175,1182,O
of,1183,1185,O
adult,1186,1191,O
separation,1192,1202,O
anxiety,1203,1210,O
[,1211,1212,O
29,1212,1214,O
],1214,1215,O
.,1215,1216,O
The,1217,1220,O
WSAS,1221,1225,O
is,1226,1228,O
a,1229,1230,O
self,1231,1235,O
-,1235,1236,O
report,1236,1242,O
scale,1243,1248,O
of,1249,1251,O
functional,1252,1262,O
impairment,1263,1273,O
that,1274,1278,O
includes,1279,1287,O
five,1288,1292,O
questions,1293,1302,O
rating,1303,1309,O
interference,1310,1322,O
of,1323,1325,O
psychiatric,1326,1337,O
symptoms,1338,1346,O
in,1347,1349,O
work,1350,1354,O
",",1354,1355,O
home,1356,1360,O
management,1361,1371,O
",",1371,1372,O
social,1373,1379,O
or,1380,1382,O
private,1383,1390,O
leisure,1391,1398,O
activities,1399,1409,O
",",1409,1410,O
and,1411,1414,O
ability,1415,1422,O
to,1423,1425,O
form,1426,1430,O
and,1431,1434,O
maintain,1435,1443,O
close,1444,1449,O
relationships,1450,1463,O
with,1464,1468,O
others,1469,1475,O
.,1475,1476,O
Each,1477,1481,O
question,1482,1490,O
is,1491,1493,O
rated,1494,1499,O
on,1500,1502,O
a,1503,1504,O
0,1505,1506,O
to,1507,1509,O
8,1510,1511,O
scale,1512,1517,O
with,1518,1522,O
0,1523,1524,O
indicating,1525,1535,O
no,1536,1538,O
impairment,1539,1549,O
at,1550,1552,O
all,1553,1556,O
and,1557,1560,O
8,1561,1562,O
indicating,1563,1573,O
very,1574,1578,O
severe,1579,1585,O
impairment,1586,1596,O
.,1596,1597,O
The,1598,1601,O
Cronbach,1602,1610,O
',1610,1611,O
s,1611,1612,O
alpha,1613,1618,O
measure,1619,1626,O
of,1627,1629,O
internal,1630,1638,O
scale,1639,1644,O
consistency,1645,1656,O
ranged,1657,1663,O
from,1664,1668,O
0,1669,1670,O
.,1670,1671,O
70,1671,1673,O
to,1674,1676,O
0,1677,1678,O
.,1678,1679,O
94,1679,1681,O
",",1681,1682,O
the,1683,1686,O
test,1687,1691,O
-,1691,1692,O
retest,1692,1698,O
correlation,1699,1710,O
was,1711,1714,O
0,1715,1716,O
.,1716,1717,O
73,1717,1719,O
",",1719,1720,O
and,1721,1724,O
the,1725,1728,O
WSAS,1729,1733,O
interactive,1734,1745,O
voice,1746,1751,O
response,1752,1760,O
administrations,1761,1776,O
gave,1777,1781,O
correlations,1782,1794,O
of,1795,1797,O
0,1798,1799,O
.,1799,1800,O
81,1800,1802,O
and,1803,1806,O
0,1807,1808,O
.,1808,1809,O
86,1809,1811,O
with,1812,1816,O
clinician,1817,1826,O
interviews,1827,1837,O
[,1838,1839,O
30,1839,1841,O
],1841,1842,O
.,1842,1843,O
Correlations,1844,1856,O
of,1857,1859,O
WSAS,1860,1864,O
with,1865,1869,O
severity,1870,1878,O
of,1879,1881,O
depression,1882,1892,O
and,1893,1896,O
obsessive,1897,1906,O
-,1906,1907,O
compulsive,1907,1917,O
disorder,1918,1926,O
symptoms,1927,1935,O
were,1936,1940,O
0,1941,1942,O
.,1942,1943,O
76,1943,1945,O
and,1946,1949,O
0,1950,1951,O
.,1951,1952,O
61,1952,1954,O
",",1954,1955,O
respectively,1956,1968,O
",",1968,1969,O
and,1970,1973,O
the,1974,1977,O
scores,1978,1984,O
were,1985,1989,O
sensitive,1990,1999,O
to,2000,2002,O
patient,2003,2010,O
differences,2011,2022,O
in,2023,2025,O
disorder,2026,2034,O
severity,2035,2043,O
and,2044,2047,O
treatment,2048,2057,O
-,2057,2058,O
related,2058,2065,O
change,2066,2072,O
[,2073,2074,O
30,2074,2076,O
],2076,2077,O
.,2077,2078,O
The,2079,2082,O
MOODS,2083,2088,O
-,2088,2089,O
SR,2089,2091,O
is,2092,2094,O
an,2095,2097,O
instrument,2098,2108,O
developed,2109,2118,O
and,2119,2122,O
validated,2123,2132,O
to,2133,2135,O
assess,2136,2142,O
lifetime,2143,2151,O
mood,2152,2156,O
spectrum,2157,2165,O
symptoms,2166,2174,O
[,2175,2176,O
35,2176,2178,O
],2178,2179,O
",",2179,2180,O
including,2181,2190,O
manic,2191,2196,O
and,2197,2200,O
depressive,2201,2211,O
features,2212,2220,O
",",2220,2221,O
rhythmicity,2222,2233,O
and,2234,2237,O
vegetative,2238,2248,O
functions,2249,2258,O
.,2258,2259,O
The,2260,2263,O
manic,2264,2269,O
and,2270,2273,O
depressive,2274,2284,O
components,2285,2295,O
are,2296,2299,O
subtyped,2300,2308,O
into,2309,2313,O
mood,2314,2318,O
",",2318,2319,O
energy,2320,2326,O
and,2327,2330,O
cognition,2331,2340,O
domains,2341,2348,O
",",2348,2349,O
focusing,2350,2358,O
on,2359,2361,O
manic,2362,2367,O
or,2368,2370,O
depressive,2371,2381,O
symptoms,2382,2390,O
",",2390,2391,O
respectively,2392,2404,O
.,2404,2405,O
The,2406,2409,O
rhythmicity,2410,2421,O
and,2422,2425,O
vegetative,2426,2436,O
functions,2437,2446,O
domain,2447,2453,O
include,2454,2461,O
changes,2462,2469,O
in,2470,2472,O
energy,2473,2479,O
",",2479,2480,O
physical,2481,2489,O
wellbeing,2490,2499,O
",",2499,2500,O
mental,2501,2507,O
and,2508,2511,O
physical,2512,2520,O
efficiency,2521,2531,O
",",2531,2532,O
related,2533,2540,O
to,2541,2543,O
the,2544,2547,O
weather,2548,2555,O
and,2556,2559,O
season,2560,2566,O
",",2566,2567,O
and,2568,2571,O
changes,2572,2579,O
in,2580,2582,O
appetite,2583,2591,O
",",2591,2592,O
sleep,2593,2598,O
and,2599,2602,O
sexual,2603,2609,O
activities,2610,2620,O
.,2620,2621,O
The,2622,2625,O
sum,2626,2629,O
of,2630,2632,O
the,2633,2636,O
scores,2637,2643,O
on,2644,2646,O
the,2647,2650,O
3,2651,2652,O
manic,2653,2658,O
domains,2659,2666,O
(,2667,2668,O
mood,2668,2672,O
",",2672,2673,O
energy,2674,2680,O
",",2680,2681,O
cognition,2682,2691,O
),2691,2692,O
constitutes,2693,2704,O
the,2705,2708,O
',2709,2710,O
manic,2710,2715,O
component,2716,2725,O
',2725,2726,O
(,2727,2728,O
62,2728,2730,O
items,2731,2736,O
),2736,2737,O
and,2738,2741,O
that,2742,2746,O
of,2747,2749,O
the,2750,2753,O
3,2754,2755,O
depressive,2756,2766,O
domains,2767,2774,O
the,2775,2778,O
',2779,2780,O
depressive,2780,2790,O
component,2791,2800,O
',2800,2801,O
(,2802,2803,O
63,2803,2805,O
items,2806,2811,O
),2811,2812,O
.,2812,2813,O
The,2814,2817,O
rhythmicity,2818,2829,O
and,2830,2833,O
vegetative,2834,2844,O
functions,2845,2854,O
domain,2855,2861,O
includes,2862,2870,O
29,2871,2873,O
items,2874,2879,O
.,2879,2880,O
The,2881,2884,O
instrument,2885,2895,O
can,2896,2899,O
be,2900,2902,O
downloaded,2903,2913,O
from,2914,2918,O
http,2919,2923,O
:,2923,2924,O
/,2924,2925,O
/,2925,2926,O
www,2926,2929,O
.,2929,2930,O
spectrum,2930,2938,O
-,2938,2939,O
project,2939,2946,O
.,2946,2947,O
org,2947,2950,O
.,2950,2951,O
[,0,1,O
Histopathologic,1,16,O
examination,17,28,O
of,29,31,O
rectal,32,38,B-Pathological_formation
carcinoma,39,48,I-Pathological_formation
],48,49,O
.,49,50,O
In,51,53,O
patients,54,62,O
with,63,67,O
rectal,68,74,B-Pathological_formation
carcinoma,75,84,I-Pathological_formation
",",84,85,O
the,86,89,O
histopathological,90,107,O
evaluation,108,118,O
of,119,121,O
the,122,125,O
surgical,126,134,B-Pathological_formation
specimen,135,143,I-Pathological_formation
provides,144,152,O
pivotal,153,160,O
prognostic,161,171,O
and,172,175,O
therapeutic,176,187,O
information,188,199,O
.,199,200,O
Important,201,210,O
parameters,211,221,O
are,222,225,O
tumor,226,231,B-Pathological_formation
site,232,236,O
",",236,237,O
depth,238,243,O
of,244,246,O
invasion,247,255,O
",",255,256,O
histological,257,269,O
type,270,274,O
and,275,278,O
grade,279,284,O
",",284,285,O
pattern,286,293,O
of,294,296,O
invasion,297,305,O
(,306,307,O
diffusely,307,316,O
infiltrating,317,329,O
versus,330,336,O
expanding,337,346,O
margin,347,353,O
),353,354,O
",",354,355,O
degree,356,362,O
of,363,365,O
peritumoral,366,377,B-Cell
lymphocytic,378,389,I-Cell
infiltration,390,402,O
",",402,403,O
and,404,407,O
tumor,408,413,B-Pathological_formation
involvement,414,425,O
of,426,428,O
surgical,429,437,B-Tissue
margins,438,445,I-Tissue
and,446,449,O
lymph,450,455,B-Multi-tissue_structure
nodes,456,461,I-Multi-tissue_structure
.,461,462,O
Evaluation,463,473,O
of,474,476,O
the,477,480,O
circumferential,481,496,B-Tissue
(,497,498,I-Tissue
deep,498,502,I-Tissue
",",502,503,I-Tissue
lateral,504,511,I-Tissue
),511,512,I-Tissue
margin,513,519,I-Tissue
is,520,522,O
of,523,525,O
utmost,526,532,O
importance,533,543,O
.,543,544,O
It,545,547,O
should,548,554,O
be,555,557,O
labeled,558,565,O
with,566,570,O
ink,571,574,O
in,575,577,O
the,578,581,O
gross,582,587,O
specimen,588,596,B-Pathological_formation
and,597,600,O
should,601,607,O
be,608,610,O
examined,611,619,O
histologically,620,634,O
using,635,640,O
several,641,648,O
tissue,649,655,B-Tissue
blocks,656,662,O
.,662,663,O
The,664,667,O
number,668,674,O
of,675,677,O
lymph,678,683,B-Pathological_formation
node,684,688,I-Pathological_formation
metastases,689,699,I-Pathological_formation
and,700,703,O
the,704,707,O
total,708,713,O
number,714,720,O
of,721,723,O
lymph,724,729,B-Multi-tissue_structure
nodes,730,735,I-Multi-tissue_structure
examined,736,744,O
should,745,751,O
be,752,754,O
reported,755,763,O
.,763,764,O
A,765,766,O
histological,767,779,O
evaluation,780,790,O
of,791,793,O
the,794,797,O
distal,798,804,B-Multi-tissue_structure
mesorectum,805,815,I-Multi-tissue_structure
in,816,818,O
its,819,822,O
entirety,823,831,O
is,832,834,O
recommended,835,846,O
to,847,849,O
detect,850,856,O
discontinuous,857,870,O
distal,871,877,B-Pathological_formation
mesorectal,878,888,I-Pathological_formation
tumor,889,894,I-Pathological_formation
spread,895,901,O
.,901,902,O
The,903,906,O
histopathological,907,924,O
findings,925,933,O
should,934,940,O
be,941,943,O
summarized,944,954,O
using,955,960,O
the,961,964,O
TNM,965,968,O
-,968,969,O
classification,969,983,O
.,983,984,O
Antisense,0,9,O
technologies,10,22,O
have,23,27,O
a,28,29,O
future,30,36,O
fighting,37,45,O
neurodegenerative,46,63,O
diseases,64,72,O
.,72,73,O
Our,74,77,O
growing,78,85,O
understanding,86,99,O
of,100,102,O
the,103,106,O
role,107,111,O
that,112,116,O
unfavorable,117,128,O
patterns,129,137,O
of,138,140,O
gene,141,145,O
expression,146,156,O
play,157,161,O
in,162,164,O
the,165,168,O
etiology,169,177,O
of,178,180,O
neurodegenerative,181,198,O
disease,199,206,O
emphasizes,207,217,O
the,218,221,O
need,222,226,O
for,227,230,O
strategies,231,241,O
to,242,244,O
selectively,245,256,O
block,257,262,O
the,263,266,O
biosynthesis,267,279,O
of,280,282,O
harmful,283,290,O
proteins,291,299,O
in,300,302,O
the,303,306,O
brain,307,312,B-Organ
.,312,313,O
Antisense,314,323,O
technologies,324,336,O
are,337,340,O
ideally,341,348,O
suited,349,355,O
to,356,358,O
this,359,363,O
purpose,364,371,O
.,371,372,O
Tailor,373,379,O
-,379,380,O
designed,380,388,O
to,389,391,O
target,392,398,O
specific,399,407,O
RNA,408,411,O
",",411,412,O
antisense,413,422,O
oligonucleotides,423,439,O
and,440,443,O
ribozymes,444,453,O
offer,454,459,O
tools,460,465,O
to,466,468,O
suppress,469,477,O
the,478,481,O
production,482,492,O
of,493,495,O
proteins,496,504,O
mediating,505,514,O
neurodegeneration,515,532,O
.,532,533,O
Although,534,542,O
technical,543,552,O
limitations,553,564,O
must,565,569,O
still,570,575,O
be,576,578,O
overcome,579,587,O
",",587,588,O
the,589,592,O
antisense,593,602,O
approach,603,611,O
represents,612,622,O
a,623,624,O
novel,625,630,O
and,631,634,O
exciting,635,643,O
strategy,644,652,O
for,653,656,O
intervention,657,669,O
in,670,672,O
diseases,673,681,O
of,682,684,O
the,685,688,O
central,689,696,B-Anatomical_system
nervous,697,704,I-Anatomical_system
system,705,711,I-Anatomical_system
.,711,712,O
Spacing,0,7,O
effects,8,15,O
on,16,18,O
the,19,22,O
memory,23,29,O
for,30,33,O
faces,34,39,B-Organism_subdivision
.,39,40,O
25,41,43,O
undergraduate,44,57,O
women,58,63,O
studied,64,71,O
12,72,74,O
stimulus,75,83,O
pictures,84,92,O
of,93,95,O
female,96,102,O
faces,103,108,B-Organism_subdivision
successively,109,121,O
presented,122,131,O
in,132,134,O
spaced,135,141,O
or,142,144,O
massed,145,151,O
conditions,152,162,O
and,163,166,O
made,167,171,O
affective,172,181,O
judgments,182,191,O
for,192,195,O
the,196,199,O
pictures,200,208,O
along,209,214,O
a,215,216,O
dimension,217,226,O
of,227,229,O
like,230,234,O
to,235,237,O
dislike,238,245,O
.,245,246,O
One,247,250,O
week,251,255,O
after,256,261,O
the,262,265,O
exposure,266,274,O
(,275,276,O
study,276,281,O
),281,282,O
period,283,289,O
",",289,290,O
subjects,291,299,O
were,300,304,O
given,305,310,O
an,311,313,O
identification,314,328,O
test,329,333,O
comprised,334,343,O
of,344,346,O
photographs,347,358,O
of,359,361,O
the,362,365,O
same,366,370,O
female,371,377,O
faces,378,383,B-Organism_subdivision
with,384,388,O
different,389,398,O
expressions,399,410,O
.,410,411,O
Analysis,412,420,O
showed,421,427,O
that,428,432,O
the,433,436,O
pictures,437,445,O
presented,446,455,O
in,456,458,O
the,459,462,O
spaced,463,469,O
condition,470,479,O
were,480,484,O
more,485,489,O
frequently,490,500,O
and,501,504,O
accurately,505,515,O
identified,516,526,O
than,527,531,O
those,532,537,O
presented,538,547,O
under,548,553,O
the,554,557,O
massed,558,564,O
condition,565,574,O
and,575,578,O
that,579,583,O
affective,584,593,O
judgment,594,602,O
was,603,606,O
unrelated,607,616,O
to,617,619,O
conditions,620,630,O
of,631,633,O
presentation,634,646,O
.,646,647,O
Abdominal,0,9,B-Organism_subdivision
approach,10,18,O
for,19,22,O
the,23,26,O
ligation,27,35,O
of,36,38,O
bleeding,39,47,O
oesophageal,48,59,B-Multi-tissue_structure
varices,60,67,I-Multi-tissue_structure
.,67,68,O
The,69,72,O
conventional,73,85,O
surgical,86,94,O
treatment,95,104,O
of,105,107,O
bleeding,108,116,O
oesophageal,117,128,B-Multi-tissue_structure
varices,129,136,I-Multi-tissue_structure
in,137,139,O
the,140,143,O
emergency,144,153,O
situation,154,163,O
is,164,166,O
based,167,172,O
upon,173,177,O
the,178,181,O
Boerema,182,189,O
-,189,190,O
Crile,190,195,O
operation,196,205,O
of,206,208,O
transthoracic,209,222,B-Organism_subdivision
oesophagotomy,223,236,O
and,237,240,O
ligation,241,249,O
of,250,252,O
the,253,256,O
varices,257,264,B-Multi-tissue_structure
.,264,265,O
This,266,270,O
and,271,274,O
the,275,278,O
other,279,284,O
methods,285,292,O
of,293,295,O
treatment,296,305,O
of,306,308,O
this,309,313,O
condition,314,323,O
in,324,326,O
current,327,334,O
practice,335,343,O
are,344,347,O
discussed,348,357,O
.,357,358,O
Two,359,362,O
cases,363,368,O
are,369,372,O
reported,373,381,O
in,382,384,O
which,385,390,O
a,391,392,O
transabdominal,393,407,B-Organism_subdivision
oesophagogastrotomy,408,427,O
was,428,431,O
used,432,436,O
to,437,439,O
approach,440,448,O
the,449,452,O
site,453,457,O
of,458,460,O
bleeding,461,469,O
.,469,470,O
This,471,475,O
operation,476,485,O
is,486,488,O
described,489,498,O
and,499,502,O
the,503,506,O
theoretical,507,518,O
and,519,522,O
practical,523,532,O
advantages,533,543,O
it,544,546,O
appears,547,554,O
to,555,557,O
offer,558,563,O
over,564,568,O
the,569,572,O
standard,573,581,O
approach,582,590,O
are,591,594,O
considered,595,605,O
.,605,606,O
Stimulation,0,11,O
of,12,14,O
the,15,18,O
sodium,19,25,O
pump,26,30,O
by,31,33,O
azide,34,39,O
and,40,43,O
high,44,48,O
internal,49,57,O
sodium,58,64,O
:,64,65,O
changes,66,73,O
in,74,76,O
the,77,80,O
number,81,87,O
of,88,90,O
pumping,91,98,O
sites,99,104,O
and,105,108,O
turnover,109,117,O
rate,118,122,O
.,122,123,O
1,124,125,O
.,125,126,O
The,127,130,O
effects,131,138,O
of,139,141,O
5,142,143,O
mM,144,146,O
azide,147,152,O
on,153,155,O
[,156,157,O
3H,157,159,O
],159,160,O
ouabain,160,167,O
uptake,168,174,O
and,175,178,O
22Na,179,183,O
efflux,184,190,O
were,191,195,O
determined,196,206,O
.,206,207,O
Both,208,212,O
glycoside,213,222,O
uptake,223,229,O
and,230,233,O
22Na,234,238,O
efflux,239,245,O
were,246,250,O
enhanced,251,259,O
by,260,262,O
azide,263,268,O
.,268,269,O
2,270,271,O
.,271,272,O
Azide,273,278,O
stimulated,279,289,O
the,290,293,O
Na,294,296,O
pump,297,301,O
in,302,304,O
muscles,305,312,B-Tissue
whose,313,318,O
pumping,319,326,O
sites,327,332,O
had,333,336,O
been,337,341,O
inhibited,342,351,O
by,352,354,O
ouabain,355,362,O
and,363,366,O
then,367,371,O
transferred,372,383,O
to,384,386,O
a,387,388,O
glycoside,389,398,O
-,398,399,O
free,399,403,O
solution,404,412,O
.,412,413,O
This,414,418,O
stimulation,419,430,O
was,431,434,O
observed,435,443,O
before,444,450,O
detecting,451,460,O
any,461,464,O
recovery,465,473,O
of,474,476,O
the,477,480,O
initial,481,488,O
pumping,489,496,O
activity,497,505,O
.,505,506,O
3,507,508,O
.,508,509,O
When,510,514,O
both,515,519,O
the,520,523,O
resting,524,531,O
and,532,535,O
the,536,539,O
azide,540,545,O
-,545,546,O
stimulated,546,556,O
22Na,557,561,O
efflux,562,568,O
had,569,572,O
been,573,577,O
blocked,578,585,O
by,586,588,O
ouabain,589,596,O
",",596,597,O
an,598,600,O
additional,601,611,O
exposure,612,620,O
to,621,623,O
azide,624,629,O
",",629,630,O
in,631,633,O
a,634,635,O
ouabain,636,643,O
-,643,644,O
free,644,648,O
solution,649,657,O
",",657,658,O
had,659,662,O
no,663,665,O
further,666,673,O
effects,674,681,O
on,682,684,O
22Na,685,689,O
efflux,690,696,O
.,696,697,O
4,698,699,O
.,699,700,O
It,701,703,O
is,704,706,O
concluded,707,716,O
that,717,721,O
the,722,725,O
increase,726,734,O
in,735,737,O
Na,738,740,O
pumping,741,748,O
caused,749,755,O
by,756,758,O
azide,759,764,O
is,765,767,O
due,768,771,O
in,772,774,O
part,775,779,O
to,780,782,O
an,783,785,O
increase,786,794,O
in,795,797,O
the,798,801,O
number,802,808,O
of,809,811,O
pumping,812,819,O
sites,820,825,O
.,825,826,O
5,827,828,O
.,828,829,O
[,830,831,O
3H,831,833,O
],833,834,O
ouabain,834,841,O
binding,842,849,O
was,850,853,O
measured,854,862,O
in,863,865,O
muscles,866,873,B-Tissue
with,874,878,O
different,879,888,O
intracellular,889,902,B-Immaterial_anatomical_entity
alkali,903,909,O
cation,910,916,O
concentrations,917,931,O
.,931,932,O
Variations,933,943,O
in,944,946,O
[,947,948,O
Na,948,950,O
],950,951,O
i,951,952,O
from,953,957,O
15,958,960,O
up,961,963,O
to,964,966,O
50,967,969,O
mM,970,972,O
did,973,976,O
not,977,980,O
significantly,981,994,O
affect,995,1001,O
the,1002,1005,O
amount,1006,1012,O
of,1013,1015,O
glycoside,1016,1025,O
bound,1026,1031,O
.,1031,1032,O
A,1033,1034,O
substantial,1035,1046,O
increase,1047,1055,O
in,1056,1058,O
binding,1059,1066,O
occurred,1067,1075,O
when,1076,1080,O
[,1081,1082,O
Na,1082,1084,O
],1084,1085,O
i,1085,1086,O
reached,1087,1094,O
70,1095,1097,O
mM,1098,1100,O
.,1100,1101,O
6,1102,1103,O
.,1103,1104,O
It,1105,1107,O
is,1108,1110,O
proposed,1111,1119,O
that,1120,1124,O
the,1125,1128,O
increase,1129,1137,O
in,1138,1140,O
Na,1141,1143,O
extrusion,1144,1153,O
that,1154,1158,O
occurs,1159,1165,O
during,1166,1172,O
the,1173,1176,O
recovery,1177,1185,O
of,1186,1188,O
Na,1189,1191,O
loaded,1192,1198,O
muscles,1199,1206,B-Tissue
mostly,1207,1213,O
results,1214,1221,O
from,1222,1226,O
an,1227,1229,O
increased,1230,1239,O
turnover,1240,1248,O
rate,1249,1253,O
of,1254,1256,O
the,1257,1260,O
pump,1261,1265,O
rather,1266,1272,O
than,1273,1277,O
from,1278,1282,O
an,1283,1285,O
increase,1286,1294,O
in,1295,1297,O
number,1298,1304,O
of,1305,1307,O
pumping,1308,1315,O
sites,1316,1321,O
.,1321,1322,O
Focal,0,5,O
congenital,6,16,O
alveolar,17,25,B-Multi-tissue_structure
proteinosis,26,37,O
associated,38,48,O
with,49,53,O
abnormal,54,62,O
surfactant,63,73,O
protein,74,81,O
B,82,83,O
messenger,84,93,O
RNA,94,97,O
.,97,98,O
Two,99,102,O
siblings,103,111,O
presented,112,121,O
with,122,126,O
typical,127,134,O
clinical,135,143,O
features,144,152,O
of,153,155,O
congenital,156,166,O
pulmonary,167,176,B-Multi-tissue_structure
alveolar,177,185,I-Multi-tissue_structure
proteinosis,186,197,O
(,198,199,O
PAP,199,202,O
),202,203,O
.,203,204,O
Necropsy,205,213,O
of,214,216,O
one,217,220,O
sibling,221,228,O
revealed,229,237,O
scattered,238,247,O
foci,248,252,B-Pathological_formation
of,253,255,O
the,256,259,O
diagnostic,260,270,O
histologic,271,281,O
changes,282,289,O
in,290,292,O
the,293,296,O
lung,297,301,B-Tissue
tissue,302,308,I-Tissue
.,308,309,O
In,310,312,O
contrast,313,321,O
to,322,324,O
infantile,325,334,O
and,335,338,O
adult,339,344,O
PAP,345,348,O
",",348,349,O
focal,350,355,B-Pathological_formation
distribution,356,368,O
is,369,371,O
uncommon,372,380,O
in,381,383,O
congenital,384,394,O
PAP,395,398,O
.,398,399,O
Defective,400,409,O
expression,410,420,O
of,421,423,O
the,424,427,O
granulocyte,428,439,O
-,439,440,O
macrophage,440,450,O
colony,451,457,O
-,457,458,O
stimulating,458,469,O
factor,470,476,O
receptor,477,485,O
was,486,489,O
ruled,490,495,O
out,496,499,O
.,499,500,O
The,501,504,O
surfactant,505,515,O
protein,516,523,O
B,524,525,O
(,526,527,O
SP,527,529,O
-,529,530,O
B,530,531,O
),531,532,O
content,533,540,O
in,541,543,O
the,544,547,O
lung,548,552,B-Tissue
tissue,553,559,I-Tissue
of,560,562,O
the,563,566,O
autopsied,567,576,O
patient,577,584,O
was,585,588,O
low,589,592,O
",",592,593,O
and,594,597,O
a,598,599,O
deletion,600,608,O
in,609,611,O
the,612,615,O
SP,616,618,O
-,618,619,O
B,619,620,O
messenger,621,630,O
RNA,631,634,O
was,635,638,O
detected,639,647,O
.,647,648,O
We,649,651,O
speculate,652,661,O
that,662,666,O
the,667,670,O
PAP,671,674,O
in,675,677,O
our,678,681,O
patients,682,690,O
was,691,694,O
related,695,702,O
to,703,705,O
the,706,709,O
reduced,710,717,O
quantity,718,726,O
and,727,730,O
/,730,731,O
or,731,733,O
to,734,736,O
the,737,740,O
altered,741,748,O
quality,749,756,O
of,757,759,O
SP,760,762,O
-,762,763,O
B,763,764,O
.,764,765,O
Tonometry,0,9,O
in,10,12,O
normal,13,19,O
and,20,23,O
scarred,24,31,O
corneas,32,39,B-Multi-tissue_structure
",",39,40,O
and,41,44,O
in,45,47,O
postkeratoplasty,48,64,O
eyes,65,69,B-Organ
:,69,70,O
a,71,72,O
comparative,73,84,O
study,85,90,O
of,91,93,O
the,94,97,O
Goldmann,98,106,O
",",106,107,O
the,108,111,O
ProTon,112,118,O
and,119,122,O
the,123,126,O
Schiotz,127,134,O
tonometers,135,145,O
.,145,146,O
PURPOSE,147,154,O
:,154,155,O
Clinical,156,164,O
comparison,165,175,O
of,176,178,O
intraocular,179,190,B-Immaterial_anatomical_entity
pressure,191,199,O
(,200,201,O
IOP,201,204,O
),204,205,O
measured,206,214,O
with,215,219,O
the,220,223,O
Goldmann,224,232,O
applanation,233,244,O
tonometer,245,254,O
(,255,256,O
GAT,256,259,O
),259,260,O
",",260,261,O
the,262,265,O
ProTon,266,272,O
tonometer,273,282,O
(,283,284,O
PT,284,286,O
),286,287,O
",",287,288,O
and,289,292,O
the,293,296,O
Schiotz,297,304,O
tonometer,305,314,O
(,315,316,O
ST,316,318,O
),318,319,O
",",319,320,O
in,321,323,O
normal,324,330,O
eyes,331,335,B-Organ
",",335,336,O
eyes,337,341,B-Organ
with,342,346,O
scarred,347,354,O
corneas,355,362,B-Multi-tissue_structure
and,363,366,O
postkeratoplasty,367,383,O
eyes,384,388,B-Organ
.,388,389,O
MATERIAL,390,398,O
AND,399,402,O
METHODS,403,410,O
:,410,411,O
The,412,415,O
IOP,416,419,O
readings,420,428,O
with,429,433,O
GAT,434,437,O
",",437,438,O
PT,439,441,O
",",441,442,O
and,443,446,O
ST,447,449,O
were,450,454,O
compared,455,463,O
in,464,466,O
125,467,470,O
eyes,471,475,B-Organ
with,476,480,O
normal,481,487,O
corneas,488,495,B-Multi-tissue_structure
(,496,497,O
Group,497,502,O
A,503,504,O
),504,505,O
",",505,506,O
17,507,509,O
eyes,510,514,B-Organ
with,515,519,O
scarred,520,527,O
corneas,528,535,B-Multi-tissue_structure
(,536,537,O
Group,537,542,O
B,543,544,O
),544,545,O
",",545,546,O
and,547,550,O
in,551,553,O
21,554,556,O
postkeratoplasty,557,573,O
eyes,574,578,B-Organ
(,579,580,O
Group,580,585,O
C,586,587,O
),587,588,O
.,588,589,O
The,590,593,O
data,594,598,O
were,599,603,O
statistically,604,617,O
analysed,618,626,O
at,627,629,O
95,630,632,O
%,632,633,O
confidence,634,644,O
interval,645,653,O
;,653,654,O
linear,655,661,O
regression,662,672,O
analysis,673,681,O
and,682,685,O
paired,686,692,O
t,693,694,O
-,694,695,O
test,695,699,O
were,700,704,O
done,705,709,O
.,709,710,O
RESULTS,711,718,O
:,718,719,O
The,720,723,O
mean,724,728,O
differences,729,740,O
and,741,744,O
their,745,750,O
standard,751,759,O
deviation,760,769,O
[,770,771,O
SD,771,773,O
],773,774,O
between,775,782,O
GAT,783,786,O
and,787,790,O
PT,791,793,O
readings,794,802,O
",",802,803,O
and,804,807,O
GAT,808,811,O
and,812,815,O
ST,816,818,O
readings,819,827,O
respectively,828,840,O
were,841,845,O
:,845,846,O
[,847,848,O
1,848,849,O
],849,850,O
in,851,853,O
Group,854,859,O
A,860,861,O
:,861,862,O
-,863,864,O
0,864,865,O
.,865,866,O
23,866,868,O
[,869,870,O
SD,870,872,O
2,873,874,O
.,874,875,O
75,875,877,O
],877,878,O
mmHg,879,883,O
and,884,887,O
+,888,889,O
0,889,890,O
.,890,891,O
24,891,893,O
[,894,895,O
SD,895,897,O
3,898,899,O
.,899,900,O
18,900,902,O
],902,903,O
mmHg,904,908,O
respectively,909,921,O
;,921,922,O
[,923,924,O
2,924,925,O
],925,926,O
in,927,929,O
Group,930,935,O
B,936,937,O
:,937,938,O
-,939,940,O
1,940,941,O
.,941,942,O
8,942,943,O
[,944,945,O
SD,945,947,O
12,948,950,O
.,950,951,O
67,951,953,O
],953,954,O
mmHg,955,959,O
and,960,963,O
-,964,965,O
4,965,966,O
.,966,967,O
5,967,968,O
[,969,970,O
SD,970,972,O
9,973,974,O
.,974,975,O
95,975,977,O
mmHg,978,982,O
;,982,983,O
and,984,987,O
[,988,989,O
3,989,990,O
],990,991,O
in,992,994,O
Group,995,1000,O
C,1001,1002,O
:,1002,1003,O
+,1004,1005,O
0,1005,1006,O
.,1006,1007,O
24,1007,1009,O
[,1010,1011,O
SD,1011,1013,O
8,1014,1015,O
.,1015,1016,O
72,1016,1018,O
],1018,1019,O
mmHg,1020,1024,O
and,1025,1028,O
-,1029,1030,O
0,1030,1031,O
.,1031,1032,O
12,1032,1034,O
[,1035,1036,O
SD,1036,1038,O
8,1039,1040,O
.,1040,1041,O
7,1041,1042,O
],1042,1043,O
mmHg,1044,1048,O
.,1048,1049,O
They,1050,1054,O
were,1055,1059,O
not,1060,1063,O
statistically,1064,1077,O
significant,1078,1089,O
.,1089,1090,O
In,1091,1093,O
Group,1094,1099,O
A,1100,1101,O
the,1102,1105,O
95,1106,1108,O
%,1108,1109,O
confidence,1110,1120,O
interval,1121,1129,O
between,1130,1137,O
GAT,1138,1141,O
and,1142,1145,O
PT,1146,1148,O
readings,1149,1157,O
was,1158,1161,O
-,1162,1163,O
5,1163,1164,O
.,1164,1165,O
27,1165,1167,O
mmHg,1168,1172,O
to,1173,1175,O
5,1176,1177,O
.,1177,1178,O
73,1178,1180,O
mmHg,1181,1185,O
",",1185,1186,O
and,1187,1190,O
between,1191,1198,O
GAT,1199,1202,O
and,1203,1206,O
ST,1207,1209,O
readings,1210,1218,O
",",1218,1219,O
-,1220,1221,O
6,1221,1222,O
.,1222,1223,O
12,1223,1225,O
mmHg,1226,1230,O
to,1231,1233,O
6,1234,1235,O
.,1235,1236,O
59,1236,1238,O
mmHg,1239,1243,O
.,1243,1244,O
Ninety,1245,1251,O
six,1252,1255,O
[,1256,1257,O
77,1257,1259,O
%,1259,1260,O
],1260,1261,O
eyes,1262,1266,B-Organ
with,1267,1271,O
the,1272,1275,O
PT,1276,1278,O
and,1279,1282,O
84,1283,1285,O
[,1286,1287,O
69,1287,1289,O
%,1289,1290,O
],1290,1291,O
eyes,1292,1296,B-Organ
with,1297,1301,O
ST,1302,1304,O
measurements,1305,1317,O
were,1318,1322,O
within,1323,1329,O
3,1330,1331,O
mmHg,1332,1336,O
of,1337,1339,O
GAT,1340,1343,O
pressure,1344,1352,O
.,1352,1353,O
The,1354,1357,O
correlation,1358,1369,O
coefficients,1370,1382,O
[,1383,1384,O
r,1384,1385,O
],1385,1386,O
for,1387,1390,O
PT,1391,1393,O
and,1394,1397,O
ST,1398,1400,O
were,1401,1405,O
0,1406,1407,O
.,1407,1408,O
93,1408,1410,O
[,1411,1412,O
P,1412,1413,O
=,1414,1415,O
0,1416,1417,O
.,1417,1418,O
0000,1418,1422,O
],1422,1423,O
and,1424,1427,O
0,1428,1429,O
.,1429,1430,O
88,1430,1432,O
[,1433,1434,O
P,1434,1435,O
=,1436,1437,O
0,1438,1439,O
.,1439,1440,O
0000,1440,1444,O
],1444,1445,O
respectively,1446,1458,O
.,1458,1459,O
In,1460,1462,O
Group,1463,1468,O
B,1469,1470,O
95,1471,1473,O
%,1473,1474,O
confidence,1475,1485,O
interval,1486,1494,O
between,1495,1502,O
GAT,1503,1506,O
and,1507,1510,O
PT,1511,1513,O
readings,1514,1522,O
was,1523,1526,O
-,1527,1528,O
27,1528,1530,O
.,1530,1531,O
17,1531,1533,O
mmHg,1534,1538,O
to,1539,1541,O
23,1542,1544,O
.,1544,1545,O
51,1545,1547,O
mmHg,1548,1552,O
",",1552,1553,O
and,1554,1557,O
between,1558,1565,O
GAT,1566,1569,O
and,1570,1573,O
ST,1574,1576,O
measurement,1577,1588,O
",",1588,1589,O
-,1590,1591,O
24,1591,1593,O
.,1593,1594,O
37,1594,1596,O
mmHg,1597,1601,O
to,1602,1604,O
15,1605,1607,O
.,1607,1608,O
44,1608,1610,O
mmHg,1611,1615,O
.,1615,1616,O
The,1617,1620,O
correlation,1621,1632,O
coefficients,1633,1645,O
[,1646,1647,O
r,1647,1648,O
],1648,1649,O
for,1650,1653,O
the,1654,1657,O
PT,1658,1660,O
and,1661,1664,O
ST,1665,1667,O
were,1668,1672,O
0,1673,1674,O
.,1674,1675,O
112,1675,1678,O
[,1679,1680,O
P,1680,1681,O
=,1682,1683,O
0,1684,1685,O
.,1685,1686,O
660,1686,1689,O
],1689,1690,O
and,1691,1694,O
0,1695,1696,O
.,1696,1697,O
630,1697,1700,O
[,1701,1702,O
P,1702,1703,O
=,1704,1705,O
0,1706,1707,O
.,1707,1708,O
006,1708,1711,O
],1711,1712,O
respectively,1713,1725,O
.,1725,1726,O
In,1727,1729,O
group,1730,1735,O
C,1736,1737,O
",",1737,1738,O
the,1739,1742,O
95,1743,1745,O
%,1745,1746,O
confidence,1747,1757,O
interval,1758,1766,O
between,1767,1774,O
GAT,1775,1778,O
and,1779,1782,O
PT,1783,1785,O
measurements,1786,1798,O
was,1799,1802,O
-,1803,1804,O
17,1804,1806,O
.,1806,1807,O
20,1807,1809,O
mmHg,1810,1814,O
to,1815,1817,O
17,1818,1820,O
.,1820,1821,O
67,1821,1823,O
mmHg,1824,1828,O
",",1828,1829,O
and,1830,1833,O
between,1834,1841,O
GAT,1842,1845,O
and,1846,1849,O
ST,1850,1852,O
measurements,1853,1865,O
",",1865,1866,O
-,1867,1868,O
17,1868,1870,O
.,1870,1871,O
51,1871,1873,O
mmHg,1874,1878,O
to,1879,1881,O
17,1882,1884,O
.,1884,1885,O
27,1885,1887,O
mmHg,1888,1892,O
.,1892,1893,O
The,1894,1897,O
correlation,1898,1909,O
coefficients,1910,1922,O
[,1923,1924,O
r,1924,1925,O
],1925,1926,O
for,1927,1930,O
the,1931,1934,O
PT,1935,1937,O
and,1938,1941,O
the,1942,1945,O
ST,1946,1948,O
were,1949,1953,O
0,1954,1955,O
.,1955,1956,O
780,1956,1959,O
[,1960,1961,O
P,1961,1962,O
=,1963,1964,O
0,1965,1966,O
.,1966,1967,O
0000,1967,1971,O
],1971,1972,O
and,1973,1976,O
0,1977,1978,O
.,1978,1979,O
740,1979,1982,O
[,1983,1984,O
P,1984,1985,O
=,1986,1987,O
0,1988,1989,O
.,1989,1990,O
0001,1990,1994,O
],1994,1995,O
respectively,1996,2008,O
.,2008,2009,O
CONCLUSIONS,2010,2021,O
:,2021,2022,O
In,2023,2025,O
clinical,2026,2034,O
practice,2035,2043,O
PT,2044,2046,O
appears,2047,2054,O
to,2055,2057,O
have,2058,2062,O
a,2063,2064,O
higher,2065,2071,O
level,2072,2077,O
of,2078,2080,O
accuracy,2081,2089,O
than,2090,2094,O
ST,2095,2097,O
in,2098,2100,O
normal,2101,2107,O
corneas,2108,2115,B-Multi-tissue_structure
.,2115,2116,O
In,2117,2119,O
scarred,2120,2127,O
corneas,2128,2135,B-Multi-tissue_structure
and,2136,2139,O
post,2140,2144,O
-,2144,2145,O
penetrating,2145,2156,O
keratoplasty,2157,2169,O
eyes,2170,2174,B-Organ
",",2174,2175,O
because,2176,2183,O
of,2184,2186,O
high,2187,2191,O
SD,2192,2194,O
for,2195,2198,O
mean,2199,2203,O
differences,2204,2215,O
and,2216,2219,O
wide,2220,2224,O
confidence,2225,2235,O
interval,2236,2244,O
of,2245,2247,O
95,2248,2250,O
%,2250,2251,O
",",2251,2252,O
both,2253,2257,O
PT,2258,2260,O
and,2261,2264,O
ST,2265,2267,O
are,2268,2271,O
inaccurate,2272,2282,O
in,2283,2285,O
measuring,2286,2295,O
IOP,2296,2299,O
as,2300,2302,O
compared,2303,2311,O
to,2312,2314,O
GAT,2315,2318,O
in,2319,2321,O
such,2322,2326,O
eyes,2327,2331,B-Organ
.,2331,2332,O
[,0,1,O
H,1,2,O
.,2,3,O
pylori,4,10,O
infection,11,20,O
.,20,21,O
Our,22,25,O
experience,26,36,O
with,37,41,O
the,42,45,O
quadruple,46,55,O
and,56,59,O
triple,60,66,O
therapy,67,74,O
as,75,77,O
first,78,83,O
pharmacologic,84,97,O
approach,98,106,O
],106,107,O
.,107,108,O
For,109,112,O
now,113,116,O
the,117,120,O
most,121,125,O
used,126,130,O
pharmacological,131,146,O
treatment,147,156,O
of,157,159,O
first,160,165,O
instance,166,174,O
to,175,177,O
eradication,178,189,O
of,190,192,O
Hp,193,195,O
foresees,196,204,O
utilization,205,216,O
of,217,219,O
triple,220,226,O
therapy,227,234,O
(,235,236,O
PPI,236,239,O
+,240,241,O
two,242,245,O
antibiotics,246,257,O
),257,258,O
.,258,259,O
In,260,262,O
our,263,266,O
study,267,272,O
we,273,275,O
have,276,280,O
compared,281,289,O
this,290,294,O
kind,295,299,O
of,300,302,O
treatment,303,312,O
with,313,317,O
the,318,321,O
quadruple,322,331,O
therapy,332,339,O
(,340,341,O
PPI,341,344,O
+,345,346,O
three,347,352,O
antibiotics,353,364,O
),364,365,O
",",365,366,O
that,367,371,O
have,372,376,O
showed,377,383,O
a,384,385,O
taller,386,392,O
percentage,393,403,O
of,404,406,O
eradication,407,418,O
at,419,421,O
the,422,425,O
end,426,429,O
of,430,432,O
first,433,438,O
therapeutical,439,452,O
cycle,453,458,O
with,459,463,O
a,464,465,O
shorter,466,473,O
time,474,478,O
and,479,482,O
lower,483,488,O
price,489,494,O
of,495,497,O
treatment,498,507,O
.,507,508,O
Renormalization,0,15,O
group,16,21,O
analysis,22,30,O
of,31,33,O
autoregressive,34,48,O
processes,49,58,O
and,59,62,O
fractional,63,73,O
noise,74,79,O
.,79,80,O
A,81,82,O
renormalization,83,98,O
group,99,104,O
analysis,105,113,O
is,114,116,O
applied,117,124,O
to,125,127,O
autoregressive,128,142,O
processes,143,152,O
with,153,157,O
an,158,160,O
infinite,161,169,O
series,170,176,O
of,177,179,O
coefficients,180,192,O
.,192,193,O
A,194,195,O
simple,196,202,O
fixed,203,208,O
point,209,214,O
is,215,217,O
given,218,223,O
by,224,226,O
a,227,228,O
random,229,235,O
walk,236,240,O
",",240,241,O
and,242,245,O
a,246,247,O
second,248,254,O
class,255,260,O
is,261,263,O
found,264,269,O
that,270,274,O
is,275,277,O
proportional,278,290,O
to,291,293,O
the,294,297,O
high,298,302,O
order,303,308,O
coefficients,309,321,O
of,322,324,O
fractional,325,335,O
autoregressive,336,350,O
integrated,351,361,O
moving,362,368,O
average,369,376,O
(,377,378,O
ARIMA,378,383,O
),383,384,O
processes,385,394,O
.,394,395,O
The,396,399,O
approach,400,408,O
might,409,414,O
be,415,417,O
useful,418,424,O
to,425,427,O
detect,428,434,O
nonstationarity,435,450,O
in,451,453,O
autoregressive,454,468,O
processes,469,478,O
.,478,479,O
In,0,2,O
vitro,3,8,O
cytotoxic,9,18,O
potential,19,28,O
and,29,32,O
mechanism,33,42,O
of,43,45,O
action,46,52,O
of,53,55,O
selected,56,64,O
coumarins,65,74,O
",",74,75,O
using,76,81,O
human,82,87,O
renal,88,93,B-Cell
cell,94,98,I-Cell
lines,99,104,I-Cell
.,104,105,O
This,106,110,O
study,111,116,O
determined,117,127,O
the,128,131,O
selective,132,141,O
cytotoxicity,142,154,O
of,155,157,O
eight,158,163,O
coumarin,164,172,O
compounds,173,182,O
to,183,185,O
human,186,191,O
renal,192,197,B-Cell
carcinoma,198,207,I-Cell
cells,208,213,I-Cell
",",213,214,O
relative,215,223,O
to,224,226,O
non,227,230,B-Cell
-,230,231,I-Cell
carcinoma,231,240,I-Cell
proximal,241,249,I-Cell
tubular,250,257,I-Cell
cells,258,263,I-Cell
.,263,264,O
Selectivity,265,276,O
cytotoxicity,277,289,O
was,290,293,O
observed,294,302,O
following,303,312,O
exposure,313,321,O
to,322,324,O
6,325,326,O
-,326,327,O
nitro,327,332,O
-,332,333,O
7,333,334,O
-,334,335,O
hydroxycoumarin,335,350,O
(,351,352,O
6,352,353,O
-,353,354,O
NO,354,356,O
(,356,357,O
2,357,358,O
),358,359,O
-,359,360,O
7,360,361,O
-,361,362,O
OHC,362,365,O
),365,366,O
and,367,370,O
7,371,372,O
",",372,373,O
8,373,374,O
-,374,375,O
dihydroxycoumarin,375,392,O
(,393,394,O
7,394,395,O
",",395,396,O
8,396,397,O
-,397,398,O
OHC,398,401,O
),401,402,O
.,402,403,O
6,404,405,O
-,405,406,O
NO,406,408,O
(,408,409,O
2,409,410,O
),410,411,O
-,411,412,O
7,412,413,O
-,413,414,O
OHC,414,417,O
induced,418,425,O
cytotoxicity,426,438,O
was,439,442,O
irreversible,443,455,O
in,456,458,O
both,459,463,O
cell,464,468,B-Cell
lines,469,474,I-Cell
",",474,475,O
unlike,476,482,O
7,483,484,O
",",484,485,O
8,485,486,O
-,486,487,O
OHC,487,490,O
",",490,491,O
which,492,497,O
was,498,501,O
reversible,502,512,O
in,513,515,O
the,516,519,O
carcinoma,520,529,B-Cell
cells,530,535,I-Cell
only,536,540,O
.,540,541,O
Mobility,542,550,O
shift,551,556,O
and,557,560,O
BrdU,561,565,O
incorporation,566,579,O
assays,580,586,O
showed,587,593,O
that,594,598,O
both,599,603,O
compounds,604,613,O
did,614,617,O
not,618,621,O
intercalate,622,633,O
DNA,634,637,O
but,638,641,O
had,642,645,O
a,646,647,O
concentration,648,661,O
-,661,662,O
dependent,662,671,O
inhibitory,672,682,O
effect,683,689,O
on,690,692,O
its,693,696,O
synthesis,697,706,O
.,706,707,O
All,708,711,O
coumarins,712,721,O
studied,722,729,O
were,730,734,O
found,735,740,O
to,741,743,O
be,744,746,O
non,747,750,O
-,750,751,O
mutagenic,751,760,O
using,761,766,O
the,767,770,O
standard,771,779,O
Ames,780,784,O
test,785,789,O
.,789,790,O
These,791,796,O
results,797,804,O
would,805,810,O
suggest,811,818,O
that,819,823,O
6,824,825,O
-,825,826,O
NO,826,828,O
(,828,829,O
2,829,830,O
),830,831,O
-,831,832,O
7,832,833,O
-,833,834,O
OHC,834,837,O
and,838,841,O
7,842,843,O
",",843,844,O
8,844,845,O
-,845,846,O
OHC,846,849,O
might,850,855,O
have,856,860,O
a,861,862,O
therapeutic,863,874,O
role,875,879,O
to,880,882,O
play,883,887,O
in,888,890,O
the,891,894,O
treatment,895,904,O
of,905,907,O
renal,908,913,B-Pathological_formation
cell,914,918,I-Pathological_formation
carcinoma,919,928,I-Pathological_formation
.,928,929,O
On,0,2,O
the,3,6,O
relationship,7,19,O
between,20,27,O
the,28,31,O
population,32,42,O
structure,43,52,O
and,53,56,O
national,57,65,O
economic,66,74,O
development,75,86,O
in,87,89,O
China,90,95,O
.,95,96,O
The,97,100,O
authors,101,108,O
examine,109,116,O
the,117,120,O
relationship,121,133,O
between,134,141,O
population,142,152,O
reproduction,153,165,O
and,166,169,O
the,170,173,O
production,174,184,O
of,185,187,O
material,188,196,O
goods,197,202,O
",",202,203,O
with,204,208,O
particular,209,219,O
reference,220,229,O
to,230,232,O
the,233,236,O
effect,237,243,O
of,244,246,O
changes,247,254,O
in,255,257,O
the,258,261,O
age,262,265,O
composition,266,277,O
of,278,280,O
the,281,284,O
population,285,295,O
on,296,298,O
the,299,302,O
national,303,311,O
economy,312,319,O
and,320,323,O
national,324,332,O
income,333,339,O
.,339,340,O
An,342,344,O
analysis,345,353,O
of,354,356,O
the,357,360,O
population,361,371,O
structure,372,381,O
of,382,384,O
China,385,390,O
is,391,393,O
presented,394,403,O
",",403,404,O
with,405,409,O
consideration,410,423,O
given,424,429,O
to,430,432,O
age,433,436,O
characteristics,437,452,O
",",452,453,O
occupation,454,464,O
",",464,465,O
and,466,469,O
urban,470,475,O
and,476,479,O
rural,480,485,O
population,486,496,O
.,496,497,O
Suggestions,499,510,O
for,511,514,O
improving,515,524,O
the,525,528,O
population,529,539,O
structure,540,549,O
to,550,552,O
achieve,553,560,O
maximum,561,568,O
rates,569,574,O
of,575,577,O
economic,578,586,O
development,587,598,O
are,599,602,O
presented,603,612,O
.,612,613,O
Regional,615,623,O
differences,624,635,O
in,636,638,O
population,639,649,O
structure,650,659,O
are,660,663,O
also,664,668,O
discussed,669,678,O
.,678,679,O
No,0,2,O
evidence,3,11,O
for,12,15,O
an,16,18,O
influence,19,28,O
of,29,31,O
the,32,35,O
human,36,41,O
platelet,42,50,O
antigen,51,58,O
-,58,59,O
1,59,60,O
polymorphism,61,73,O
on,74,76,O
the,77,80,O
antiplatelet,81,93,O
effects,94,101,O
of,102,104,O
glycoprotein,105,117,O
IIb,118,121,O
/,121,122,O
IIIa,122,126,O
inhibitors,127,137,O
.,137,138,O
This,139,143,O
study,144,149,O
investigated,150,162,O
the,163,166,O
hypothesis,167,177,O
that,178,182,O
the,183,186,O
human,187,192,O
platelet,193,201,O
antigen,202,209,O
-,209,210,O
1,210,211,O
(,212,213,O
HPA,213,216,O
-,216,217,O
1,217,218,O
),218,219,O
polymorphism,220,232,O
may,233,236,O
influence,237,246,O
the,247,250,O
antiplatelet,251,263,O
effects,264,271,O
of,272,274,O
glycoprotein,275,287,O
(,288,289,O
GP,289,291,O
),291,292,O
IIb,292,295,O
/,295,296,O
IIIa,296,300,O
inhibitors,301,311,O
.,311,312,O
Adenosine,313,322,O
diphosphate,323,334,O
(,335,336,O
30,336,338,O
micro,339,344,O
mol,345,348,O
),348,349,O
-,349,350,O
induced,350,357,O
fibrinogen,358,368,O
binding,369,376,O
was,377,380,O
measured,381,389,O
by,390,392,O
flow,393,397,O
cytometry,398,407,O
.,407,408,O
Abciximab,409,418,O
(,419,420,O
0,420,421,O
.,421,422,O
03,422,424,O
-,424,425,O
3,425,426,O
micro,427,432,O
g,433,434,O
/,434,435,O
ml,435,437,O
),437,438,O
",",438,439,O
tirofiban,440,449,O
(,450,451,O
0,451,452,O
.,452,453,O
3,453,454,O
-,454,455,O
30,455,457,O
nmol,458,462,O
/,462,463,O
l,463,464,O
),464,465,O
or,466,468,O
eptifibatide,469,481,O
(,482,483,O
0,483,484,O
.,484,485,O
01,485,487,O
-,487,488,O
1,488,489,O
micro,490,495,O
g,496,497,O
/,497,498,O
ml,498,500,O
),500,501,O
were,502,506,O
incubated,507,516,O
for,517,520,O
15,521,523,O
min,524,527,O
with,528,532,O
the,533,536,O
samples,537,544,O
prior,545,550,O
to,551,553,O
stimulation,554,565,O
.,565,566,O
IC,567,569,O
(,569,570,O
50,570,572,O
),572,573,O
values,574,580,O
for,581,584,O
the,585,588,O
inhibition,589,599,O
of,600,602,O
fibrinogen,603,613,O
binding,614,621,O
were,622,626,O
determined,627,637,O
from,638,642,O
each,643,647,O
experiment,648,658,O
.,658,659,O
All,660,663,O
subjects,664,672,O
were,673,677,O
genotyped,678,687,O
by,688,690,O
GALIOS,691,697,O
and,698,701,O
automated,702,711,O
fluorescence,712,724,O
correlation,725,736,O
spectroscopy,737,749,O
.,749,750,O
Although,751,759,O
a,760,761,O
marked,762,768,O
variability,769,780,O
in,781,783,O
the,784,787,O
inhibitory,788,798,O
effects,799,806,O
of,807,809,O
all,810,813,O
three,814,819,O
GPIIb,820,825,O
/,825,826,O
IIIa,826,830,O
inhibitors,831,841,O
was,842,845,O
confirmed,846,855,O
",",855,856,O
there,857,862,O
were,863,867,O
no,868,870,O
significant,871,882,O
differences,883,894,O
between,895,902,O
the,903,906,O
genotypes,907,916,O
with,917,921,O
respect,922,929,O
to,930,932,O
the,933,936,O
inhibition,937,947,O
of,948,950,O
fibrinogen,951,961,O
binding,962,969,O
.,969,970,O
Thus,971,975,O
",",975,976,O
the,977,980,O
present,981,988,O
study,989,994,O
does,995,999,O
not,1000,1003,O
provide,1004,1011,O
evidence,1012,1020,O
for,1021,1024,O
an,1025,1027,O
effect,1028,1034,O
of,1035,1037,O
HPA,1038,1041,O
-,1041,1042,O
1,1042,1043,O
polymorphism,1044,1056,O
on,1057,1059,O
the,1060,1063,O
inter,1064,1069,O
-,1069,1070,O
individual,1070,1080,O
variability,1081,1092,O
in,1093,1095,O
the,1096,1099,O
platelet,1100,1108,B-Cell
inhibitory,1109,1119,O
effects,1120,1127,O
of,1128,1130,O
the,1131,1134,O
three,1135,1140,O
GPIIb,1141,1146,O
/,1146,1147,O
IIIa,1147,1151,O
inhibitors,1152,1162,O
approved,1163,1171,O
for,1172,1175,O
clinical,1176,1184,O
use,1185,1188,O
.,1188,1189,O
The,0,3,O
Acute,4,9,O
Dialysis,10,18,O
Quality,19,26,O
Initiative,27,37,O
-,37,38,O
-,38,39,O
part,39,43,O
IV,44,46,O
:,46,47,O
membranes,48,57,B-Multi-tissue_structure
for,58,61,O
CRRT,62,66,O
.,66,67,O
The,68,71,O
extracorporeal,72,86,B-Multi-tissue_structure
membrane,87,95,I-Multi-tissue_structure
used,96,100,O
in,101,103,O
a,104,105,O
continuous,106,116,O
renal,117,122,B-Organ
replacement,123,134,O
therapy,135,142,O
(,143,144,O
CRRT,144,148,O
),148,149,O
for,150,153,O
the,154,157,O
treatment,158,167,O
of,168,170,O
a,171,172,O
critically,173,183,O
ill,184,187,O
patient,188,195,O
with,196,200,O
acute,201,206,O
renal,207,212,B-Organ
failure,213,220,O
(,221,222,O
ARF,222,225,O
),225,226,O
is,227,229,O
vitally,230,237,O
important,238,247,O
for,248,251,O
several,252,259,O
reasons,260,267,O
",",267,268,O
including,269,278,O
its,279,282,O
influence,283,292,O
on,293,295,O
biocompatibility,296,312,O
and,313,316,O
filter,317,323,O
performance,324,335,O
.,335,336,O
The,337,340,O
clinical,341,349,O
relevance,350,359,O
of,360,362,O
membrane,363,371,B-Multi-tissue_structure
-,371,372,O
related,372,379,O
biocompatibility,380,396,O
markers,397,404,O
traditionally,405,418,O
used,419,423,O
in,424,426,O
chronic,427,434,O
hemodialysis,435,447,O
remains,448,455,O
unclear,456,463,O
in,464,466,O
CRRT,467,471,O
.,471,472,O
Numerous,473,481,O
approaches,482,492,O
may,493,496,O
be,497,499,O
used,500,504,O
to,505,507,O
assess,508,514,O
membrane,515,523,B-Multi-tissue_structure
and,524,527,O
filter,528,534,O
performance,535,546,O
in,547,549,O
CRRT,550,554,O
",",554,555,O
but,556,559,O
no,560,562,O
specific,563,571,O
methodology,572,583,O
is,584,586,O
accepted,587,595,O
widely,596,602,O
at,603,605,O
present,606,613,O
.,613,614,O
Although,615,623,O
a,624,625,O
potential,626,635,O
benefit,636,643,O
of,644,646,O
certain,647,654,O
membranes,655,664,B-Multi-tissue_structure
used,665,669,O
for,670,673,O
CRRT,674,678,O
is,679,681,O
adsorptive,682,692,O
removal,693,700,O
of,701,703,O
inflammatory,704,716,O
mediators,717,726,O
",",726,727,O
this,728,732,O
issue,733,738,O
has,739,742,O
not,743,746,O
been,747,751,O
assessed,752,760,O
carefully,761,770,O
in,771,773,O
well,774,778,O
-,778,779,O
designed,779,787,O
clinical,788,796,O
trials,797,803,O
.,803,804,O
These,805,810,O
and,811,814,O
other,815,820,O
issues,821,827,O
should,828,834,O
be,835,837,O
the,838,841,O
subject,842,849,O
of,850,852,O
future,853,859,O
clinical,860,868,O
research,869,877,O
efforts,878,885,O
.,885,886,O
Sickle,0,6,B-Cell
cell,7,11,I-Cell
disease,12,19,O
:,19,20,O
continuous,21,31,O
arterial,32,40,B-Multi-tissue_structure
spin,41,45,O
-,45,46,O
labeling,46,54,O
perfusion,55,64,O
MR,65,67,O
imaging,68,75,O
in,76,78,O
children,79,87,O
.,87,88,O
Cerebral,89,97,B-Organ
blood,98,103,B-Organism_substance
flow,104,108,O
(,109,110,O
CBF,110,113,O
),113,114,O
was,115,118,O
measured,119,127,O
with,128,132,O
continuous,133,143,O
arterial,144,152,B-Multi-tissue_structure
spin,153,157,O
-,157,158,O
labeling,158,166,O
perfusion,167,176,O
magnetic,177,185,O
resonance,186,195,O
(,196,197,O
MR,197,199,O
),199,200,O
imaging,201,208,O
in,209,211,O
14,212,214,O
children,215,223,O
with,224,228,O
sickle,229,235,B-Cell
cell,236,240,I-Cell
disease,241,248,O
and,249,252,O
seven,253,258,O
control,259,266,O
subjects,267,275,O
.,275,276,O
Mean,277,281,O
CBF,282,285,O
values,286,292,O
were,293,297,O
higher,298,304,O
in,305,307,O
patients,308,316,O
(,317,318,O
P,318,319,O
<,320,321,O
.,321,322,O
005,322,325,O
),325,326,O
than,327,331,O
in,332,334,O
control,335,342,O
subjects,343,351,O
in,352,354,O
all,355,358,O
cerebral,359,367,B-Multi-tissue_structure
artery,368,374,I-Multi-tissue_structure
territories,375,386,O
.,386,387,O
Three,388,393,O
patients,394,402,O
had,403,406,O
decreased,407,416,O
CBF,417,420,O
in,421,423,O
right,424,429,B-Multi-tissue_structure
anterior,430,438,I-Multi-tissue_structure
and,439,442,O
middle,443,449,O
cerebral,450,458,B-Multi-tissue_structure
artery,459,465,I-Multi-tissue_structure
territories,466,477,O
compared,478,486,O
with,487,491,O
CBF,492,495,O
on,496,498,O
the,499,502,O
left,503,507,O
",",507,508,O
and,509,512,O
one,513,516,O
patient,517,524,O
had,525,528,O
a,529,530,O
profound,531,539,O
decrease,540,548,O
in,549,551,O
CBF,552,555,O
in,556,558,O
all,559,562,O
three,563,568,O
territories,569,580,O
in,581,583,O
the,584,587,O
right,588,593,B-Organism_subdivision
hemisphere,594,604,I-Organism_subdivision
.,604,605,O
Baseline,606,614,O
CBF,615,618,O
was,619,622,O
significantly,623,636,O
decreased,637,646,O
in,647,649,O
territories,650,661,O
seen,662,666,O
as,667,669,O
unaffected,670,680,O
on,681,683,O
conventional,684,696,O
MR,697,699,O
images,700,706,O
and,707,710,O
MR,711,713,O
angiograms,714,724,O
in,725,727,O
four,728,732,O
children,733,741,O
with,742,746,O
sickle,747,753,B-Cell
cell,754,758,I-Cell
disease,759,766,O
.,766,767,O
The,0,3,O
septic,4,10,B-Multi-tissue_structure
abscess,11,18,I-Multi-tissue_structure
wall,19,23,I-Multi-tissue_structure
:,23,24,O
a,25,26,O
cytokine,27,35,O
-,35,36,O
generating,36,46,O
organ,47,52,B-Organ
associated,53,63,O
with,64,68,O
portal,69,75,B-Multi-tissue_structure
venous,76,82,I-Multi-tissue_structure
cytokinemia,83,94,O
",",94,95,O
hepatic,96,103,B-Organ
outflow,104,111,O
fibrosis,112,120,O
",",120,121,O
sinusoidal,122,132,B-Tissue
congestion,133,143,O
",",143,144,O
inflammatory,145,157,B-Cell
cell,158,162,I-Cell
sequestration,163,176,O
",",176,177,O
hepatocellular,178,192,B-Cell
lipid,193,198,O
deposition,199,209,O
",",209,210,O
and,211,214,O
focal,215,220,O
cell,221,225,B-Cell
death,226,231,O
.,231,232,O
An,233,235,O
acute,236,241,O
septic,242,248,O
inflammatory,249,261,O
response,262,270,O
with,271,275,O
access,276,282,O
to,283,285,O
the,286,289,O
portal,290,296,O
circulation,297,308,O
was,309,312,O
created,313,320,O
in,321,323,O
a,324,325,O
rat,326,329,O
model,330,335,O
using,336,341,O
an,342,344,O
intra,345,350,O
-,350,351,O
abdominal,351,360,B-Pathological_formation
abscess,361,368,I-Pathological_formation
composed,369,377,O
of,378,380,O
a,381,382,O
sterile,383,390,O
agar,391,395,O
pellet,396,402,O
",",402,403,O
or,404,406,O
one,407,410,O
contaminated,411,423,O
with,424,428,O
102,429,432,O
Escherichia,433,444,O
coli,445,449,O
(,450,451,O
E,451,452,O
.,452,453,O
coli,454,458,O
),458,459,O
and,460,463,O
109,464,467,O
Bacteriodes,468,479,O
fragilis,480,488,O
(,489,490,O
B,490,491,O
.,491,492,O
fragilis,493,501,O
),501,502,O
.,502,503,O
After,504,509,O
3,510,511,O
days,512,516,O
postimplantation,517,533,O
",",533,534,O
a,535,536,O
well,537,541,O
-,541,542,O
formed,542,548,O
intra,549,554,O
-,554,555,O
abdominal,555,564,B-Pathological_formation
abscess,565,572,I-Pathological_formation
occurred,573,581,O
whose,582,587,O
wall,588,592,B-Tissue
showed,593,599,O
IL,600,602,O
-,602,603,O
6,603,604,O
DNA,605,608,O
by,609,611,O
PCR,612,615,O
and,616,619,O
IL,620,622,O
-,622,623,O
6,623,624,O
mRNA,625,629,O
by,630,632,O
in,633,635,O
situ,636,640,O
hybridization,641,654,O
.,654,655,O
Portal,656,662,B-Organism_substance
venous,663,669,I-Organism_substance
blood,670,675,I-Organism_substance
draining,676,684,O
into,685,689,O
the,690,693,O
liver,694,699,B-Organ
from,700,704,O
the,705,708,O
intra,709,714,O
-,714,715,O
abdominal,715,724,B-Pathological_formation
abscess,725,732,I-Pathological_formation
had,733,736,O
increased,737,746,O
levels,747,753,O
of,754,756,O
TNF,757,760,O
-,760,761,O
alpha,761,766,O
",",766,767,O
IL,768,770,O
-,770,771,O
1beta,771,776,O
",",776,777,O
and,778,781,O
IL,782,784,O
-,784,785,O
6,785,786,O
in,787,789,O
both,790,794,O
sterile,795,802,O
and,803,806,O
septic,807,813,O
groups,814,820,O
compared,821,829,O
with,830,834,O
a,835,836,O
control,837,844,O
normal,845,851,O
animal,852,858,O
group,859,864,O
.,864,865,O
Increased,866,875,O
levels,876,882,O
of,883,885,O
these,886,891,O
cytokines,892,901,O
were,902,906,O
also,907,911,O
found,912,917,O
in,918,920,O
suprahepatic,921,933,B-Organism_substance
inferior,934,942,I-Organism_substance
vena,943,947,I-Organism_substance
caval,948,953,I-Organism_substance
blood,954,959,I-Organism_substance
",",959,960,O
but,961,964,O
were,965,969,O
correlated,970,980,O
with,981,985,O
the,986,989,O
higher,990,996,O
portal,997,1003,B-Multi-tissue_structure
vein,1004,1008,I-Multi-tissue_structure
levels,1009,1015,O
",",1015,1016,O
suggesting,1017,1027,O
a,1028,1029,O
gradient,1030,1038,O
from,1039,1043,O
abscess,1044,1051,B-Multi-tissue_structure
wall,1052,1056,I-Multi-tissue_structure
to,1057,1059,O
portal,1060,1066,B-Multi-tissue_structure
vein,1067,1071,I-Multi-tissue_structure
into,1072,1076,O
the,1077,1080,O
systemic,1081,1089,O
circulation,1090,1101,O
via,1102,1105,O
the,1106,1109,O
liver,1110,1115,B-Organ
.,1115,1116,O
Liver,1117,1122,B-Organ
histology,1123,1132,O
demonstrated,1133,1145,O
sinusoidal,1146,1156,B-Tissue
congestion,1157,1167,O
centering,1168,1177,O
on,1178,1180,O
the,1181,1184,O
central,1185,1192,B-Multi-tissue_structure
vein,1193,1197,I-Multi-tissue_structure
",",1197,1198,O
growing,1199,1206,O
worse,1207,1212,O
with,1213,1217,O
progression,1218,1229,O
from,1230,1234,O
normal,1235,1241,O
in,1242,1244,O
control,1245,1252,O
",",1252,1253,O
to,1254,1256,O
sterile,1257,1264,O
",",1264,1265,O
to,1266,1268,O
septic,1269,1275,O
.,1275,1276,O
Similarly,1277,1286,O
",",1286,1287,O
the,1288,1291,O
degree,1292,1298,O
of,1299,1301,O
intrahepatic,1302,1314,O
myeloperoxidase,1315,1330,O
-,1330,1331,O
positive,1331,1339,O
inflammatory,1340,1352,B-Cell
cell,1353,1357,I-Cell
infiltration,1358,1370,O
and,1371,1374,O
hepatocellular,1375,1389,B-Cell
lipid,1390,1395,O
deposition,1396,1406,O
and,1407,1410,O
apoptosis,1411,1420,O
also,1421,1425,O
increased,1426,1435,O
from,1436,1440,O
control,1441,1448,O
",",1448,1449,O
to,1450,1452,O
sterile,1453,1460,O
",",1460,1461,O
to,1462,1464,O
septic,1465,1471,O
.,1471,1472,O
Gene,1473,1477,O
expression,1478,1488,O
by,1489,1491,O
in,1492,1494,O
situ,1495,1499,O
hybridization,1500,1513,O
demonstrated,1514,1526,O
a,1527,1528,O
significant,1529,1540,O
increase,1541,1549,O
in,1550,1552,O
IL,1553,1555,O
-,1555,1556,O
6,1556,1557,O
and,1558,1561,O
fibrinogen,1562,1572,O
mRNAs,1573,1578,O
in,1579,1581,O
cells,1582,1587,B-Cell
surrounding,1588,1599,O
the,1600,1603,O
central,1604,1611,B-Multi-tissue_structure
vein,1612,1616,I-Multi-tissue_structure
in,1617,1619,O
sterile,1620,1627,O
and,1628,1631,O
septic,1632,1638,O
animals,1639,1646,O
",",1646,1647,O
being,1648,1653,O
greatest,1654,1662,O
in,1663,1665,O
animals,1666,1673,O
with,1674,1678,O
sepsis,1679,1685,O
",",1685,1686,O
associated,1687,1697,O
with,1698,1702,O
an,1703,1705,O
increased,1706,1715,O
deposition,1716,1726,O
of,1727,1729,O
collagen,1730,1738,O
in,1739,1741,O
the,1742,1745,O
central,1746,1753,B-Multi-tissue_structure
vein,1754,1758,I-Multi-tissue_structure
area,1759,1763,O
",",1763,1764,O
most,1765,1769,O
prominent,1770,1779,O
in,1780,1782,O
the,1783,1786,O
septic,1787,1793,B-Organ
liver,1794,1799,I-Organ
.,1799,1800,O
The,1801,1804,O
pericentral,1805,1816,B-Cell
vein,1817,1821,I-Cell
cells,1822,1827,I-Cell
with,1828,1832,O
IL,1833,1835,O
-,1835,1836,O
6,1836,1837,O
and,1838,1841,O
fibrinogen,1842,1852,O
mRNA,1853,1857,O
increases,1858,1867,O
paralleled,1868,1878,O
the,1879,1882,O
increases,1883,1892,O
in,1893,1895,O
cells,1896,1901,B-Cell
containing,1902,1912,O
IL,1913,1915,O
-,1915,1916,O
6,1916,1917,O
and,1918,1921,O
fibrinogen,1922,1932,O
mRNAs,1933,1938,O
in,1939,1941,O
the,1942,1945,O
abscess,1946,1953,B-Multi-tissue_structure
walls,1954,1959,I-Multi-tissue_structure
of,1960,1962,O
sterile,1963,1970,O
and,1971,1974,O
septic,1975,1981,O
animals,1982,1989,O
",",1989,1990,O
respectively,1991,2003,O
.,2003,2004,O
The,2005,2008,O
data,2009,2013,O
suggest,2014,2021,O
that,2022,2026,O
an,2027,2029,O
intra,2030,2035,O
-,2035,2036,O
abdominal,2036,2045,B-Pathological_formation
abscess,2046,2053,I-Pathological_formation
",",2053,2054,O
especially,2055,2065,O
when,2066,2070,O
contaminated,2071,2083,O
with,2084,2088,O
gram,2089,2093,O
-,2093,2094,O
negative,2094,2102,O
bacteria,2103,2111,O
",",2111,2112,O
induces,2113,2120,O
mRNA,2121,2125,O
-,2125,2126,O
generated,2126,2135,O
cytokine,2136,2144,O
responses,2145,2154,O
in,2155,2157,O
the,2158,2161,O
abscess,2162,2169,B-Multi-tissue_structure
wall,2170,2174,I-Multi-tissue_structure
that,2175,2179,O
are,2180,2183,O
related,2184,2191,O
to,2192,2194,O
increased,2195,2204,O
portal,2205,2211,B-Multi-tissue_structure
venous,2212,2218,I-Multi-tissue_structure
levels,2219,2225,O
of,2226,2228,O
the,2229,2232,O
inflammatory,2233,2245,O
cytokines,2246,2255,O
TNF,2256,2259,O
-,2259,2260,O
alpha,2260,2265,O
",",2265,2266,O
IL,2267,2269,O
-,2269,2270,O
1beta,2270,2275,O
",",2275,2276,O
and,2277,2280,O
IL,2281,2283,O
-,2283,2284,O
6,2284,2285,O
perfusing,2286,2295,O
the,2296,2299,O
liver,2300,2305,B-Organ
.,2305,2306,O
These,2307,2312,O
",",2312,2313,O
in,2314,2316,O
turn,2317,2321,O
",",2321,2322,O
induce,2323,2329,O
localized,2330,2339,O
production,2340,2350,O
of,2351,2353,O
IL,2354,2356,O
-,2356,2357,O
6,2357,2358,O
and,2359,2362,O
fibrinogen,2363,2373,O
mRNAs,2374,2379,O
in,2380,2382,O
cells,2383,2388,B-Cell
at,2389,2391,O
the,2392,2395,O
central,2396,2403,B-Multi-tissue_structure
vein,2404,2408,I-Multi-tissue_structure
area,2409,2413,O
with,2414,2418,O
resultant,2419,2428,O
outflow,2429,2436,O
fibrosis,2437,2445,O
and,2446,2449,O
increased,2450,2459,O
inflammatory,2460,2472,B-Cell
cell,2473,2477,I-Cell
sequestration,2478,2491,O
within,2492,2498,O
the,2499,2502,O
liver,2503,2508,B-Multi-tissue_structure
lobular,2509,2516,I-Multi-tissue_structure
sinuses,2517,2524,I-Multi-tissue_structure
.,2524,2525,O
This,2526,2530,O
is,2531,2533,O
associated,2534,2544,O
with,2545,2549,O
a,2550,2551,O
generalized,2552,2563,O
inflammatory,2564,2576,O
response,2577,2585,O
and,2586,2589,O
intrahepatic,2590,2602,O
portal,2603,2609,O
sinusoid,2610,2618,O
congestion,2619,2629,O
.,2629,2630,O
There,2631,2636,O
is,2637,2639,O
also,2640,2644,O
increased,2645,2654,O
hepatocellular,2655,2669,B-Cell
lipid,2670,2675,O
deposition,2676,2686,O
and,2687,2690,O
apoptosis,2691,2700,O
.,2700,2701,O
Thus,2702,2706,O
",",2706,2707,O
the,2708,2711,O
cytokine,2712,2720,O
production,2721,2731,O
of,2732,2734,O
the,2735,2738,O
abscess,2739,2746,B-Multi-tissue_structure
wall,2747,2751,I-Multi-tissue_structure
itself,2752,2758,O
appears,2759,2766,O
to,2767,2769,O
be,2770,2772,O
a,2773,2774,O
major,2775,2780,O
mediator,2781,2789,O
of,2790,2792,O
the,2793,2796,O
septic,2797,2803,B-Organ
hepatic,2804,2811,I-Organ
response,2812,2820,O
.,2820,2821,O
Treatment,0,9,O
effects,10,17,O
on,18,20,O
nigrostriatal,21,34,B-Multi-tissue_structure
projection,35,45,O
integrity,46,55,O
in,56,58,O
partial,59,66,O
6,67,68,O
-,68,69,O
OHDA,69,73,O
lesions,74,81,B-Pathological_formation
:,81,82,O
comparison,83,93,O
of,94,96,O
L,97,98,O
-,98,99,O
DOPA,99,103,O
and,104,107,O
pramipexole,108,119,O
.,119,120,O
There,121,126,O
is,127,129,O
controversy,130,141,O
over,142,146,O
potential,147,156,O
effects,157,164,O
of,165,167,O
dopaminergic,168,180,O
replacement,181,192,O
therapies,193,202,O
on,203,205,O
the,206,209,O
partially,210,219,O
lesioned,220,228,B-Multi-tissue_structure
nigrostriatal,229,242,I-Multi-tissue_structure
dopaminergic,243,255,O
projection,256,266,O
.,266,267,O
We,268,270,O
evaluated,271,280,O
indirect,281,289,O
(,290,291,O
levodopa,291,299,O
",",299,300,O
L,301,302,O
-,302,303,O
DOPA,303,307,O
),307,308,O
versus,309,315,O
direct,316,322,O
(,323,324,O
pramipexole,324,335,O
",",335,336,O
PRA,337,340,O
),340,341,O
dopaminergic,342,354,O
treatment,355,364,O
effects,365,372,O
on,373,375,O
nigrostriatal,376,389,B-Pathological_formation
lesion,390,396,I-Pathological_formation
severity,397,405,O
as,406,408,O
measured,409,417,O
with,418,422,O
vesicular,423,432,O
monoamine,433,442,O
transporter,443,454,O
type,455,459,O
-,459,460,O
2,460,461,O
(,462,463,O
VMAT2,463,468,O
),468,469,O
binding,470,477,O
.,477,478,O
Prior,479,484,O
studies,485,492,O
have,493,497,O
shown,498,503,O
that,504,508,O
striatal,509,517,B-Multi-tissue_structure
VMAT2,518,523,O
density,524,531,O
provides,532,540,O
an,541,543,O
objective,544,553,O
estimate,554,562,O
of,563,565,O
dopaminergic,566,578,O
neuronal,579,587,B-Cell
integrity,588,597,O
",",597,598,O
without,599,606,O
confounding,607,618,O
effects,619,626,O
of,627,629,O
compensatory,630,642,O
regulation,643,653,O
.,653,654,O
Partial,655,662,O
unilateral,663,673,B-Multi-tissue_structure
median,674,680,I-Multi-tissue_structure
forebrain,681,690,I-Multi-tissue_structure
bundle,691,697,I-Multi-tissue_structure
lesions,698,705,I-Multi-tissue_structure
were,706,710,O
made,711,715,O
by,716,718,O
injection,719,728,O
of,729,731,O
6,732,733,O
-,733,734,O
hydroxydopamine,734,749,O
in,750,752,O
adult,753,758,O
male,759,763,O
Sprague,764,771,O
-,771,772,O
Dawley,772,778,O
rats,779,783,O
.,783,784,O
Lesion,785,791,B-Pathological_formation
severity,792,800,O
was,801,804,O
estimated,805,814,O
using,815,820,O
rotational,821,831,O
behavior,832,840,O
after,841,846,O
injections,847,857,O
of,858,860,O
apomorphine,861,872,O
and,873,876,O
amphetamine,877,888,O
.,888,889,O
Rats,890,894,O
were,895,899,O
ranked,900,906,O
and,907,910,O
matched,911,918,O
in,919,921,O
pairs,922,927,O
by,928,930,O
rotation,931,939,O
and,940,943,O
assigned,944,952,O
to,953,955,O
receive,956,963,O
either,964,970,O
PRA,971,974,O
(,975,976,O
1,976,977,O
mg,978,980,O
/,980,981,O
kg,981,983,O
/,983,984,O
day,984,987,O
),987,988,O
or,989,991,O
L,992,993,O
-,993,994,O
DOPA,994,998,O
/,998,999,O
benserazide,999,1010,O
(,1011,1012,O
100,1012,1015,O
/,1015,1016,O
25,1016,1018,O
mg,1019,1021,O
/,1021,1022,O
kg,1022,1024,O
/,1024,1025,O
day,1025,1028,O
),1028,1029,O
ip,1030,1032,O
via,1033,1036,O
osmotic,1037,1044,O
pump,1045,1049,O
.,1049,1050,O
After,1051,1056,O
4,1057,1058,O
weeks,1059,1064,O
of,1065,1067,O
drug,1068,1072,O
treatment,1073,1082,O
",",1082,1083,O
in,1084,1086,O
vitro,1087,1092,O
autoradiography,1093,1108,O
was,1109,1112,O
performed,1113,1122,O
with,1123,1127,O
[,1128,1129,O
(,1129,1130,O
3,1130,1131,O
),1131,1132,O
H,1132,1133,O
],1133,1134,O
methoxytetrabenazine,1134,1154,O
to,1155,1157,O
measure,1158,1165,O
striatal,1166,1174,B-Multi-tissue_structure
VMAT2,1175,1180,O
binding,1181,1188,O
density,1189,1196,O
.,1196,1197,O
Lesion,1198,1204,B-Pathological_formation
-,1204,1205,O
to,1205,1207,O
-,1207,1208,O
intact,1208,1214,O
VMAT2,1215,1220,O
density,1221,1228,O
correlated,1229,1239,O
with,1240,1244,O
rotation,1245,1253,O
in,1254,1256,O
both,1257,1261,O
treatment,1262,1271,O
groups,1272,1278,O
.,1278,1279,O
There,1280,1285,O
was,1286,1289,O
no,1290,1292,O
treatment,1293,1302,O
effect,1303,1309,O
on,1310,1312,O
VMAT2,1313,1318,O
expression,1319,1329,O
in,1330,1332,O
the,1333,1336,O
partially,1337,1346,O
lesioned,1347,1355,B-Multi-tissue_structure
striatum,1356,1364,I-Multi-tissue_structure
and,1365,1368,O
thus,1369,1373,O
no,1374,1376,O
differential,1377,1389,O
effect,1390,1396,O
of,1397,1399,O
indirect,1400,1408,O
versus,1409,1415,O
direct,1416,1422,O
dopamimetic,1423,1434,O
treatment,1435,1444,O
on,1445,1447,O
nigrostriatal,1448,1461,B-Multi-tissue_structure
integrity,1462,1471,O
.,1471,1472,O
Neutrophil,0,10,B-Cell
function,11,19,O
in,20,22,O
chronic,23,30,O
neutrophilic,31,43,B-Cell
leukemia,44,52,O
:,52,53,O
defective,54,63,O
respiratory,64,75,B-Anatomical_system
burst,76,81,O
in,82,84,O
response,85,93,O
to,94,96,O
phorbol,97,104,O
esters,105,111,O
.,111,112,O
Functional,113,123,O
analyses,124,132,O
were,133,137,O
performed,138,147,O
on,148,150,O
neutrophils,151,162,B-Cell
isolated,163,171,O
from,172,176,O
6,177,178,O
patients,179,187,O
from,188,192,O
two,193,196,O
institutions,197,209,O
who,210,213,O
displayed,214,223,O
features,224,232,O
of,233,235,O
chronic,236,243,O
neutrophilic,244,256,B-Cell
leukemia,257,265,O
(,266,267,O
CNL,267,270,O
),270,271,O
.,271,272,O
These,273,278,O
neutrophils,279,290,B-Cell
demonstrated,291,303,O
a,304,305,O
consistent,306,316,O
deficiency,317,327,O
(,328,329,O
44,329,331,O
+,332,333,O
/,333,334,O
-,334,335,O
8,336,337,O
%,337,338,O
of,339,341,O
control,342,349,O
values,350,356,O
),356,357,O
in,358,360,O
superoxide,361,371,O
anion,372,377,O
(,378,379,O
O2,379,381,O
-,381,382,O
),382,383,O
production,384,394,O
in,395,397,O
response,398,406,O
to,407,409,O
the,410,413,O
phorbol,414,421,O
ester,422,427,O
",",427,428,O
phorbol,429,436,O
myristate,437,446,O
acetate,447,454,O
(,455,456,O
PMA,456,459,O
),459,460,O
.,460,461,O
O2,462,464,O
-,464,465,O
production,466,476,O
in,477,479,O
response,480,488,O
to,489,491,O
chemotactic,492,503,O
peptides,504,512,O
was,513,516,O
near,517,521,O
normal,522,528,O
(,529,530,O
82,530,532,O
.,532,533,O
3,533,534,O
+,535,536,O
/,536,537,O
-,537,538,O
10,539,541,O
.,541,542,O
7,542,543,O
%,543,544,O
of,545,547,O
control,548,555,O
values,556,562,O
),562,563,O
.,563,564,O
Bacterial,565,574,O
killing,575,582,O
was,583,586,O
normal,587,593,O
in,594,596,O
the,597,600,O
two,601,604,O
patients,605,613,O
studied,614,621,O
",",621,622,O
and,623,626,O
chemotaxis,627,637,O
was,638,641,O
diminished,642,652,O
in,653,655,O
response,656,664,O
to,665,667,O
zymosan,668,675,O
-,675,676,O
activated,676,685,O
plasma,686,692,B-Organism_substance
and,693,696,O
to,697,699,O
high,700,704,O
concentrations,705,719,O
of,720,722,O
chemotactic,723,734,O
peptides,735,743,O
in,744,746,O
the,747,750,O
patients,751,759,O
studied,760,767,O
.,767,768,O
Cytosolic,769,778,O
C,779,780,O
kinase,781,787,O
activity,788,796,O
was,797,800,O
decreased,801,810,O
in,811,813,O
one,814,817,O
of,818,820,O
the,821,824,O
two,825,828,O
patients,829,837,O
studied,838,845,O
.,845,846,O
These,847,852,O
results,853,860,O
suggest,861,868,O
that,869,873,O
a,874,875,O
deficient,876,885,O
O2,886,888,O
-,888,889,O
release,890,897,O
in,898,900,O
response,901,909,O
to,910,912,O
PMA,913,916,O
is,917,919,O
a,920,921,O
hallmark,922,930,O
of,931,933,O
neutrophils,934,945,B-Cell
in,946,948,O
CNL,949,952,O
and,953,956,O
may,957,960,O
provide,961,968,O
a,969,970,O
diagnostic,971,981,O
indicator,982,991,O
of,992,994,O
this,995,999,O
condition,1000,1009,O
.,1009,1010,O
In,0,2,O
situ,3,7,O
alkylation,8,18,O
of,19,21,O
cysteine,22,30,O
residues,31,39,O
in,40,42,O
a,43,44,O
hydrophobic,45,56,O
membrane,57,65,B-Cellular_component
protein,66,73,O
immobilized,74,85,O
on,86,88,O
polyvinylidene,89,103,O
difluoride,104,114,O
membranes,115,124,O
by,125,127,O
electroblotting,128,143,O
prior,144,149,O
to,150,152,O
microsequence,153,166,O
and,167,170,O
amino,171,176,O
acid,177,181,O
analysis,182,190,O
.,190,191,O
For,192,195,O
identification,196,210,O
of,211,213,O
cysteine,214,222,O
residues,223,231,O
on,232,234,O
microsequence,235,248,O
analysis,249,257,O
it,258,260,O
is,261,263,O
crucial,264,271,O
to,272,274,O
derivatize,275,285,O
the,286,289,O
sulfhydryl,290,300,O
groups,301,307,O
.,307,308,O
This,309,313,O
reaction,314,322,O
requires,323,331,O
a,332,333,O
desalting,334,343,O
step,344,348,O
which,349,354,O
often,355,360,O
represents,361,371,O
a,372,373,O
major,374,379,O
obstacle,380,388,O
",",388,389,O
especially,390,400,O
if,401,403,O
the,404,407,O
sample,408,414,O
consists,415,423,O
of,424,426,O
limited,427,434,O
amounts,435,442,O
of,443,445,O
a,446,447,O
hydrophobic,448,459,O
membrane,460,468,B-Cellular_component
protein,469,476,O
.,476,477,O
An,478,480,O
alkylation,481,491,O
procedure,492,501,O
is,502,504,O
described,505,514,O
",",514,515,O
allowing,516,524,O
efficient,525,534,O
derivatization,535,549,O
(,550,551,O
greater,551,558,O
than,559,563,O
90,564,566,O
%,566,567,O
),567,568,O
of,569,571,O
cysteines,572,581,O
and,582,585,O
cystines,586,594,O
even,595,599,O
in,600,602,O
low,603,606,O
microgram,607,616,O
quantities,617,627,O
",",627,628,O
as,629,631,O
revealed,632,640,O
by,641,643,O
test,644,648,O
analyses,649,657,O
with,658,662,O
lysozyme,663,671,O
and,672,675,O
a,676,677,O
hydrophobic,678,689,O
membrane,690,698,B-Cellular_component
protein,699,706,O
.,706,707,O
The,708,711,O
modified,712,720,O
protein,721,728,O
is,729,731,O
recovered,732,741,O
in,742,744,O
high,745,749,O
yields,750,756,O
in,757,759,O
a,760,761,O
form,762,766,O
suitable,767,775,O
for,776,779,O
both,780,784,O
microsequence,785,798,O
analysis,799,807,O
and,808,811,O
amino,812,817,O
acid,818,822,O
analysis,823,831,O
.,831,832,O
The,833,836,O
method,837,843,O
involves,844,852,O
electrophoretic,853,868,O
desalting,869,878,O
by,879,881,O
miniaturized,882,894,O
Tricine,895,902,O
-,902,903,O
sodium,903,909,O
dodecyl,910,917,O
sulfate,918,925,O
-,925,926,O
polyacrylamide,926,940,O
gel,941,944,O
electrophoresis,945,960,O
and,961,964,O
in,965,967,O
situ,968,972,O
alkylation,973,983,O
after,984,989,O
electro,990,997,O
-,997,998,O
transfer,998,1006,O
onto,1007,1011,O
polyvinylidene,1012,1026,O
difluoride,1027,1037,O
membranes,1038,1047,O
.,1047,1048,O
Precautions,1049,1060,O
against,1061,1068,O
NH2,1069,1072,O
-,1072,1073,O
terminal,1073,1081,O
blocking,1082,1090,O
during,1091,1097,O
sample,1098,1104,O
preparations,1105,1117,O
are,1118,1121,O
provided,1122,1130,O
.,1130,1131,O
The,1132,1135,O
general,1136,1143,O
applicability,1144,1157,O
of,1158,1160,O
the,1161,1164,O
method,1165,1171,O
is,1172,1174,O
illustrated,1175,1186,O
by,1187,1189,O
the,1190,1193,O
structural,1194,1204,O
characterization,1205,1221,O
of,1222,1224,O
the,1225,1228,O
low,1229,1232,O
abundance,1233,1242,O
membrane,1243,1251,B-Cellular_component
receptor,1252,1260,O
for,1261,1264,O
human,1265,1270,O
urokinase,1271,1280,O
plasminogen,1281,1292,O
activator,1293,1302,O
.,1302,1303,O
The,0,3,O
effect,4,10,O
of,11,13,O
p,14,15,O
-,15,16,O
chlorophenylalanine,16,35,O
on,36,38,O
the,39,42,O
pethidine,43,52,O
-,52,53,O
or,54,56,O
methadone,57,66,O
-,66,67,O
induced,67,74,O
decrease,75,83,O
in,84,86,O
locomotor,87,96,O
activity,97,105,O
of,106,108,O
rats,109,113,O
.,113,114,O
Either,115,121,O
pethidine,122,131,O
HCl,132,135,O
(,136,137,O
50,137,139,O
mg,140,142,O
/,142,143,O
kg,143,145,O
s,146,147,O
.,147,148,O
c,148,149,O
.,149,150,O
),150,151,O
or,152,154,O
methadone,155,164,O
HCl,165,168,O
(,169,170,O
8,170,171,O
mg,172,174,O
/,174,175,O
kg,175,177,O
s,178,179,O
.,179,180,O
c,180,181,O
.,181,182,O
),182,183,O
produced,184,192,O
a,193,194,O
prominent,195,204,O
decrease,205,213,O
in,214,216,O
locomotor,217,226,O
activity,227,235,O
of,236,238,O
rats,239,243,O
.,243,244,O
Pretreatment,245,257,O
of,258,260,O
rats,261,265,O
with,266,270,O
p,271,272,O
-,272,273,O
chlorophenylalanine,273,292,O
(,293,294,O
p,294,295,O
-,295,296,O
CPA,296,299,O
",",299,300,O
320,301,304,O
mg,305,307,O
/,307,308,O
kg,308,310,O
i,311,312,O
.,312,313,O
p,313,314,O
.,314,315,O
),315,316,O
48,317,319,O
h,320,321,O
before,322,328,O
the,329,332,O
narcotic,333,341,O
injection,342,351,O
significantly,352,365,O
antagonized,366,377,O
the,378,381,O
activity,382,390,O
-,390,391,O
decreasing,391,401,O
effects,402,409,O
of,410,412,O
narcotics,413,422,O
.,422,423,O
When,424,428,O
rats,429,433,O
pretreated,434,444,O
with,445,449,O
p,450,451,O
-,451,452,O
CPA,452,455,O
were,456,460,O
given,461,466,O
5,467,468,O
-,468,469,O
hydroxytryptophan,469,486,O
(,487,488,O
75,488,490,O
mg,491,493,O
/,493,494,O
kg,494,496,O
s,497,498,O
.,498,499,O
c,499,500,O
.,500,501,O
),501,502,O
30,503,505,O
min,506,509,O
before,510,516,O
narcotic,517,525,O
administration,526,540,O
",",540,541,O
the,542,545,O
activity,546,554,O
-,554,555,O
decreasing,555,565,O
response,566,574,O
to,575,577,O
narcotics,578,587,O
was,588,591,O
restored,592,600,O
.,600,601,O
Thus,602,606,O
",",606,607,O
a,608,609,O
decrease,610,618,O
in,619,621,O
locomotor,622,631,O
activity,632,640,O
induced,641,648,O
in,649,651,O
rats,652,656,O
by,657,659,O
either,660,666,O
pethidine,667,676,O
or,677,679,O
methadone,680,689,O
is,690,692,O
probably,693,701,O
mediated,702,710,O
by,711,713,O
serotonergic,714,726,O
mechanisms,727,737,O
.,737,738,O
The,0,3,O
presence,4,12,O
of,13,15,O
nitrite,16,23,O
during,24,30,O
UVA,31,34,O
irradiation,35,46,O
protects,47,55,O
from,56,60,O
apoptosis,61,70,O
.,70,71,O
Nitrite,72,79,O
occurs,80,86,O
ubiquitously,87,99,O
in,100,102,O
biological,103,113,B-Organism_substance
fluids,114,120,I-Organism_substance
such,121,125,O
as,126,128,O
blood,129,134,B-Organism_substance
and,135,138,O
sweat,139,144,B-Organism_substance
",",144,145,O
representing,146,158,O
an,159,161,O
oxidation,162,171,O
product,172,179,O
of,180,182,O
nitric,183,189,O
oxide,190,195,O
.,195,196,O
Nitrite,197,204,O
has,205,208,O
been,209,213,O
associated,214,224,O
with,225,229,O
a,230,231,O
variety,232,239,O
of,240,242,O
adverse,243,250,O
effects,251,258,O
such,259,263,O
as,264,266,O
mutagenicity,267,279,O
",",279,280,O
carcinogenesis,281,295,O
",",295,296,O
and,297,300,O
toxicity,301,309,O
.,309,310,O
In,311,313,O
contrast,314,322,O
",",322,323,O
here,324,328,O
we,329,331,O
demonstrate,332,343,O
that,344,348,O
the,349,352,O
presence,353,361,O
of,362,364,O
nitrite,365,372,O
",",372,373,O
but,374,377,O
not,378,381,O
nitrate,382,389,O
",",389,390,O
during,391,397,O
irradiation,398,409,O
of,410,412,O
endothelial,413,424,B-Cell
cells,425,430,I-Cell
in,431,433,O
culture,434,441,O
exerts,442,448,O
a,449,450,O
potent,451,457,O
and,458,461,O
concentration,462,475,O
-,475,476,O
dependent,476,485,O
protection,486,496,O
against,497,504,O
UVA,505,508,O
-,508,509,O
induced,509,516,O
apoptotic,517,526,O
cell,527,531,B-Cell
death,532,537,O
.,537,538,O
Protection,539,549,O
is,550,552,O
half,553,557,O
-,557,558,O
maximal,558,565,O
at,566,568,O
a,569,570,O
concentration,571,584,O
of,585,587,O
3,588,589,O
mM,590,592,O
",",592,593,O
and,594,597,O
complete,598,606,O
rescue,607,613,O
is,614,616,O
observed,617,625,O
at,626,628,O
10,629,631,O
mM,632,634,O
.,634,635,O
Nitrite,636,643,O
-,643,644,O
mediated,644,652,O
protection,653,663,O
is,664,666,O
mediated,667,675,O
via,676,679,O
inhibition,680,690,O
of,691,693,O
lipid,694,699,O
peroxidation,700,712,O
in,713,715,O
a,716,717,O
similar,718,725,O
manner,726,732,O
as,733,735,O
seen,736,740,O
with,741,745,O
butylated,746,755,O
hydroxytoluene,756,770,O
",",770,771,O
a,772,773,O
known,774,779,O
inhibitor,780,789,O
of,790,792,O
lipid,793,798,O
peroxidation,799,811,O
.,811,812,O
Interestingly,813,826,O
",",826,827,O
nitrite,828,835,O
-,835,836,O
mediated,836,844,O
protection,845,855,O
is,856,858,O
completely,859,869,O
abolished,870,879,O
by,880,882,O
coincubation,883,895,O
with,896,900,O
the,901,904,O
NO,905,907,O
scavenger,908,917,O
cPTIO,918,923,O
.,923,924,O
Using,925,930,O
electron,931,939,O
paramagnetic,940,952,O
resonance,953,962,O
(,963,964,O
EPR,964,967,O
),967,968,O
spectroscopy,969,981,O
or,982,984,O
Faraday,985,992,O
modulation,993,1003,O
spectroscopy,1004,1016,O
",",1016,1017,O
we,1018,1020,O
directly,1021,1029,O
prove,1030,1035,O
UVA,1036,1039,O
-,1039,1040,O
induced,1040,1047,O
NO,1048,1050,O
formation,1051,1060,O
in,1061,1063,O
solutions,1064,1073,O
containing,1074,1084,O
nitrite,1085,1092,O
.,1092,1093,O
In,1094,1096,O
conclusion,1097,1107,O
",",1107,1108,O
evidence,1109,1117,O
is,1118,1120,O
presented,1121,1130,O
that,1131,1135,O
nitrite,1136,1143,O
represents,1144,1154,O
a,1155,1156,O
protective,1157,1167,O
agent,1168,1173,O
against,1174,1181,O
UVA,1182,1185,O
-,1185,1186,O
induced,1186,1193,O
apoptosis,1194,1203,O
due,1204,1207,O
to,1208,1210,O
photodecomposition,1211,1229,O
of,1230,1232,O
nitrite,1233,1240,O
and,1241,1244,O
subsequent,1245,1255,O
formation,1256,1265,O
of,1266,1268,O
NO,1269,1271,O
.,1271,1272,O
Induction,0,9,O
of,10,12,O
apoptosis,13,22,O
in,23,25,O
skeletal,26,34,B-Tissue
tissues,35,42,I-Tissue
:,42,43,O
phosphate,44,53,O
-,53,54,O
mediated,54,62,O
chick,63,68,O
chondrocyte,69,80,B-Cell
apoptosis,81,90,O
is,91,93,O
calcium,94,101,O
dependent,102,111,O
.,111,112,O
In,113,115,O
an,116,118,O
earlier,119,126,O
study,127,132,O
",",132,133,O
we,134,136,O
have,137,141,O
shown,142,147,O
that,148,152,O
Pi,153,155,O
induced,156,163,O
apoptosis,164,173,O
of,174,176,O
terminally,177,187,O
differentiated,188,202,O
hypertrophic,203,215,O
chondrocytes,216,228,B-Cell
.,228,229,O
To,230,232,O
ascertain,233,242,O
whether,243,250,O
Ca2,251,254,O
+,254,255,O
modulates,256,265,O
Pi,266,268,O
-,268,269,O
induced,269,276,O
cell,277,281,B-Cell
death,282,287,O
",",287,288,O
we,289,291,O
asked,292,297,O
the,298,301,O
following,302,311,O
two,312,315,O
questions,316,325,O
:,325,326,O
First,327,332,O
",",332,333,O
can,334,337,O
we,338,340,O
prevent,341,348,O
Pi,349,351,O
-,351,352,O
induced,352,359,O
apoptosis,360,369,O
by,370,372,O
removing,373,381,O
Ca2,382,385,O
+,385,386,O
from,387,391,O
the,392,395,O
culture,396,403,O
medium,404,410,O
;,410,411,O
alternatively,412,425,O
",",425,426,O
can,427,430,O
we,431,433,O
potentiate,434,444,O
cell,445,449,B-Cell
death,450,455,O
by,456,458,O
increasing,459,469,O
the,470,473,O
Ca2,474,477,O
+,477,478,O
concentration,479,492,O
?,492,493,O
Second,494,500,O
",",500,501,O
can,502,505,O
we,506,508,O
inhibit,509,516,O
chondrocyte,517,528,B-Cell
apoptosis,529,538,O
by,539,541,O
blocking,542,550,O
Pi,551,553,O
transport,554,563,O
?,563,564,O
We,565,567,O
also,568,572,O
explored,573,581,O
the,582,585,O
mechanism,586,595,O
of,596,598,O
apoptosis,599,608,O
by,609,611,O
evaluating,612,622,O
mitochondrial,623,636,B-Cellular_component
activity,637,645,O
and,646,649,O
reactive,650,658,O
oxygen,659,665,O
species,666,673,O
(,674,675,O
ROS,675,678,O
),678,679,O
generation,680,690,O
in,691,693,O
cells,694,699,B-Cell
treated,700,707,O
with,708,712,O
the,713,716,O
ion,717,720,O
pair,721,725,O
.,725,726,O
We,727,729,O
noted,730,735,O
that,736,740,O
EDTA,741,745,O
and,746,749,O
EGTA,750,754,O
blocked,755,762,O
Pi,763,765,O
-,765,766,O
induced,766,773,O
apoptosis,774,783,O
in,784,786,O
a,787,788,O
dose,789,793,O
-,793,794,O
dependent,794,803,O
manner,804,810,O
.,810,811,O
While,812,817,O
high,818,822,O
levels,823,829,O
of,830,832,O
Ca2,833,836,O
+,836,837,O
alone,838,843,O
had,844,847,O
little,848,854,O
effect,855,861,O
on,862,864,O
chondrocyte,865,876,B-Cell
viability,877,886,O
",",886,887,O
the,888,891,O
cation,892,898,O
enhanced,899,907,O
Pi,908,910,O
-,910,911,O
dependent,911,920,O
cell,921,925,B-Cell
death,926,931,O
and,932,935,O
greatly,936,943,O
increased,944,953,O
Pi,954,956,O
uptake,957,963,O
.,963,964,O
When,965,969,O
Pi,970,972,O
transport,973,982,O
was,983,986,O
blocked,987,994,O
",",994,995,O
there,996,1001,O
was,1002,1005,O
complete,1006,1014,O
inhibition,1015,1025,O
of,1026,1028,O
cell,1029,1033,B-Cell
killing,1034,1041,O
.,1041,1042,O
The,1043,1046,O
process,1047,1054,O
of,1055,1057,O
cell,1058,1062,B-Cell
death,1063,1068,O
was,1069,1072,O
characterized,1073,1086,O
by,1087,1089,O
mitochondrial,1090,1103,B-Cellular_component
hyperpolarization,1104,1121,O
;,1121,1122,O
two,1123,1126,O
hours,1127,1132,O
following,1133,1142,O
apoptogen,1143,1152,O
treatment,1153,1162,O
",",1162,1163,O
there,1164,1169,O
was,1170,1173,O
a,1174,1175,O
significant,1176,1187,O
decrease,1188,1196,O
in,1197,1199,O
the,1200,1203,O
mitochondrial,1204,1217,B-Cellular_component
membrane,1218,1226,I-Cellular_component
potential,1227,1236,O
.,1236,1237,O
Coincident,1238,1248,O
with,1249,1253,O
the,1254,1257,O
changes,1258,1265,O
in,1266,1268,O
mitochondrial,1269,1282,B-Cellular_component
function,1283,1291,O
",",1291,1292,O
there,1293,1298,O
was,1299,1302,O
an,1303,1305,O
increase,1306,1314,O
in,1315,1317,O
intracellular,1318,1331,B-Immaterial_anatomical_entity
Ca2,1332,1335,O
+,1335,1336,O
that,1337,1341,O
was,1342,1345,O
maintained,1346,1356,O
throughout,1357,1367,O
the,1368,1371,O
experimental,1372,1384,O
period,1385,1391,O
.,1391,1392,O
A,1393,1394,O
raised,1395,1401,O
Ca2,1402,1405,O
+,1405,1406,O
signal,1407,1413,O
was,1414,1417,O
observed,1418,1426,O
in,1427,1429,O
blebs,1430,1435,O
at,1436,1438,O
the,1439,1442,O
cell,1443,1447,B-Cellular_component
membrane,1448,1456,I-Cellular_component
.,1456,1457,O
Finally,1458,1465,O
",",1465,1466,O
we,1467,1469,O
noted,1470,1475,O
that,1476,1480,O
",",1480,1481,O
75,1482,1484,O
minutes,1485,1492,O
after,1493,1498,O
treatment,1499,1508,O
with,1509,1513,O
the,1514,1517,O
ion,1518,1521,O
pair,1522,1526,O
",",1526,1527,O
there,1528,1533,O
was,1534,1537,O
a,1538,1539,O
six,1540,1543,O
-,1543,1544,O
fold,1544,1548,O
elevation,1549,1558,O
in,1559,1561,O
ROS,1562,1565,O
levels,1566,1572,O
.,1572,1573,O
This,1574,1578,O
increase,1579,1587,O
declined,1588,1596,O
to,1597,1599,O
baseline,1600,1608,O
values,1609,1615,O
after,1616,1621,O
three,1622,1627,O
hours,1628,1633,O
.,1633,1634,O
Based,1635,1640,O
on,1641,1643,O
these,1644,1649,O
observations,1650,1662,O
",",1662,1663,O
we,1664,1666,O
suggest,1667,1674,O
that,1675,1679,O
",",1679,1680,O
at,1681,1683,O
the,1684,1687,O
cartilage,1688,1697,B-Tissue
mineralization,1698,1712,O
front,1713,1718,O
",",1718,1719,O
an,1720,1722,O
elevation,1723,1732,O
in,1733,1735,O
local,1736,1741,O
environmental,1742,1755,O
Ca2,1756,1759,O
+,1759,1760,O
and,1761,1764,O
Pi,1765,1767,O
concentrations,1768,1782,O
modulates,1783,1792,O
oxidative,1793,1802,O
metabolism,1803,1813,O
",",1813,1814,O
and,1815,1818,O
triggers,1819,1827,O
apoptosis,1828,1837,O
of,1838,1840,O
terminally,1841,1851,O
differentiated,1852,1866,O
chondrocytes,1867,1879,B-Cell
.,1879,1880,O
Outcomes,0,8,O
of,9,11,O
cefazolin,12,21,O
versus,22,28,O
ceftriaxone,29,40,O
therapy,41,48,O
in,49,51,O
treating,52,60,O
lower,61,66,B-Multi-tissue_structure
respiratory,67,78,I-Multi-tissue_structure
tract,79,84,I-Multi-tissue_structure
infections,85,95,O
in,96,98,O
adults,99,105,O
.,105,106,O
OBJECTIVE,107,116,O
:,116,117,O
To,118,120,O
determine,121,130,O
whether,131,138,O
choice,139,145,O
of,146,148,O
a,149,150,O
first,151,156,O
-,156,157,O
versus,158,164,O
third,165,170,O
-,170,171,O
generation,171,181,O
cephalosporin,182,195,O
as,196,198,O
initial,199,206,O
therapy,207,214,O
for,215,218,O
lower,219,224,B-Multi-tissue_structure
respiratory,225,236,I-Multi-tissue_structure
tract,237,242,I-Multi-tissue_structure
infections,243,253,O
in,254,256,O
hospitalized,257,269,O
adults,270,276,O
affects,277,284,O
the,285,288,O
course,289,295,O
and,296,299,O
duration,300,308,O
of,309,311,O
care,312,316,O
",",316,317,O
both,318,322,O
of,323,325,O
which,326,331,O
may,332,335,O
influence,336,345,O
antimicrobial,346,359,O
treatment,360,369,O
cost,370,374,O
.,374,375,O
DESIGN,376,382,O
:,382,383,O
Retrospective,384,397,O
analysis,398,406,O
of,407,409,O
discharge,410,419,O
abstracts,420,429,O
and,430,433,O
hospital,434,442,O
pharmacy,443,451,O
records,452,459,O
.,459,460,O
SETTING,461,468,O
:,468,469,O
Forty,470,475,O
-,475,476,O
eight,476,481,O
US,482,484,O
acute,485,490,O
-,490,491,O
care,491,495,O
hospitals,496,505,O
.,505,506,O
PATIENTS,507,515,O
:,515,516,O
One,517,520,O
thousand,521,529,O
ninety,530,536,O
-,536,537,O
two,537,540,O
hospitalized,541,553,O
adults,554,560,O
(,561,562,O
aged,562,566,O
>,567,568,O
17,569,571,O
y,572,573,O
),573,574,O
with,575,579,O
principal,580,589,O
diagnoses,590,599,O
of,600,602,O
lower,603,608,B-Multi-tissue_structure
respiratory,609,620,I-Multi-tissue_structure
tract,621,626,I-Multi-tissue_structure
infections,627,637,O
(,638,639,O
DRGs,639,643,O
79,644,646,O
-,646,647,O
80,647,649,O
",",649,650,O
89,651,653,O
-,653,654,O
90,654,656,O
),656,657,O
.,657,658,O
INTERVENTIONS,659,672,O
:,672,673,O
Cefazolin,674,683,O
or,684,686,O
ceftriaxone,687,698,O
",",698,699,O
given,700,705,O
as,706,708,O
sole,709,713,O
antimicrobial,714,727,O
therapy,728,735,O
for,736,739,O
at,740,742,O
least,743,748,O
one,749,752,O
day,753,756,O
.,756,757,O
MAIN,758,762,O
OUTCOME,763,770,O
MEASURES,771,779,O
:,779,780,O
(,781,782,O
1,782,783,O
),783,784,O
The,785,788,O
number,789,795,O
of,796,798,O
patients,799,807,O
who,808,811,O
received,812,820,O
another,821,828,O
parenteral,829,839,O
antibiotic,840,850,O
anytime,851,858,O
prior,859,864,O
to,865,867,O
hospital,868,876,O
discharge,877,886,O
;,886,887,O
(,888,889,O
2,889,890,O
),890,891,O
the,892,895,O
number,896,902,O
of,903,905,O
days,906,910,O
during,911,917,O
which,918,923,O
patients,924,932,O
received,933,941,O
any,942,945,O
parenteral,946,956,O
antibiotic,957,967,O
while,968,973,O
in,974,976,O
the,977,980,O
hospital,981,989,O
;,989,990,O
and,991,994,O
(,995,996,O
3,996,997,O
),997,998,O
the,999,1002,O
number,1003,1009,O
of,1010,1012,O
days,1013,1017,O
patients,1018,1026,O
remained,1027,1035,O
hospitalized,1036,1048,O
following,1049,1058,O
the,1059,1062,O
start,1063,1068,O
of,1069,1071,O
antibiotic,1072,1082,O
therapy,1083,1090,O
.,1090,1091,O
RESULTS,1092,1099,O
:,1099,1100,O
Patients,1101,1109,O
treated,1110,1117,O
with,1118,1122,O
cefazolin,1123,1132,O
(,1133,1134,O
n,1134,1135,O
=,1136,1137,O
763,1138,1141,O
),1141,1142,O
were,1143,1147,O
more,1148,1152,O
likely,1153,1159,O
to,1160,1162,O
receive,1163,1170,O
another,1171,1178,O
parenteral,1179,1189,O
antibiotic,1190,1200,O
while,1201,1206,O
in,1207,1209,O
the,1210,1213,O
hospital,1214,1222,O
(,1223,1224,O
30,1224,1226,O
.,1226,1227,O
3,1227,1228,O
vs,1229,1231,O
.,1231,1232,O
20,1233,1235,O
.,1235,1236,O
7,1236,1237,O
percent,1238,1245,O
;,1245,1246,O
p,1247,1248,O
<,1249,1250,O
0,1251,1252,O
.,1252,1253,O
001,1253,1256,O
),1256,1257,O
and,1258,1261,O
received,1262,1270,O
more,1271,1275,O
total,1276,1281,O
days,1282,1286,O
of,1287,1289,O
therapy,1290,1297,O
(,1298,1299,O
7,1299,1300,O
.,1300,1301,O
2,1301,1302,O
vs,1303,1305,O
.,1305,1306,O
6,1307,1308,O
.,1308,1309,O
7,1309,1310,O
d,1311,1312,O
;,1312,1313,O
p,1314,1315,O
<,1316,1317,O
0,1318,1319,O
.,1319,1320,O
05,1320,1322,O
),1322,1323,O
than,1324,1328,O
those,1329,1334,O
treated,1335,1342,O
with,1343,1347,O
ceftriaxone,1348,1359,O
(,1360,1361,O
n,1361,1362,O
=,1363,1364,O
329,1365,1368,O
),1368,1369,O
.,1369,1370,O
Although,1371,1379,O
the,1380,1383,O
time,1384,1388,O
to,1389,1391,O
hospital,1392,1400,O
discharge,1401,1410,O
did,1411,1414,O
not,1415,1418,O
differ,1419,1425,O
in,1426,1428,O
the,1429,1432,O
full,1433,1437,O
sample,1438,1444,O
(,1445,1446,O
9,1446,1447,O
.,1447,1448,O
2,1448,1449,O
d,1450,1451,O
for,1452,1455,O
both,1456,1460,O
groups,1461,1467,O
),1467,1468,O
",",1468,1469,O
it,1470,1472,O
was,1473,1476,O
greater,1477,1484,O
among,1485,1490,O
those,1491,1496,O
receiving,1497,1506,O
cefazolin,1507,1516,O
(,1517,1518,O
8,1518,1519,O
.,1519,1520,O
6,1520,1521,O
vs,1522,1524,O
.,1524,1525,O
8,1526,1527,O
.,1527,1528,O
0,1528,1529,O
d,1530,1531,O
;,1531,1532,O
p,1533,1534,O
<,1535,1536,O
0,1537,1538,O
.,1538,1539,O
05,1539,1541,O
),1541,1542,O
when,1543,1547,O
patients,1548,1556,O
with,1557,1561,O
lengths,1562,1569,O
of,1570,1572,O
stay,1573,1577,O
exceeding,1578,1587,O
24,1588,1590,O
days,1591,1595,O
were,1596,1600,O
excluded,1601,1609,O
from,1610,1614,O
both,1615,1619,O
groups,1620,1626,O
.,1626,1627,O
CONCLUSIONS,1628,1639,O
:,1639,1640,O
In,1641,1643,O
addition,1644,1652,O
to,1653,1655,O
acquisition,1656,1667,O
cost,1668,1672,O
",",1672,1673,O
differences,1674,1685,O
in,1686,1688,O
course,1689,1695,O
and,1696,1699,O
duration,1700,1708,O
of,1709,1711,O
care,1712,1716,O
should,1717,1723,O
be,1724,1726,O
considered,1727,1737,O
when,1738,1742,O
determining,1743,1754,O
the,1755,1758,O
most,1759,1763,O
cost,1764,1768,O
-,1768,1769,O
effective,1769,1778,O
choice,1779,1785,O
for,1786,1789,O
antimicrobial,1790,1803,O
therapy,1804,1811,O
.,1811,1812,O
Is,0,2,O
there,3,8,O
an,9,11,O
upper,12,17,O
limit,18,23,O
of,24,26,O
intracranial,27,39,B-Immaterial_anatomical_entity
pressure,40,48,O
in,49,51,O
patients,52,60,O
with,61,65,O
severe,66,72,O
head,73,77,B-Organism_subdivision
injury,78,84,O
if,85,87,O
cerebral,88,96,B-Organ
perfusion,97,106,O
pressure,107,115,O
is,116,118,O
maintained,119,129,O
?,129,130,O
Authors,131,138,O
of,139,141,O
recent,142,148,O
studies,149,156,O
have,157,161,O
championed,162,172,O
the,173,176,O
importance,177,187,O
of,188,190,O
maintaining,191,202,O
cerebral,203,211,B-Organ
perfusion,212,221,O
pressure,222,230,O
(,231,232,O
CPP,232,235,O
),235,236,O
to,237,239,O
prevent,240,247,O
secondary,248,257,O
brain,258,263,B-Organ
injury,264,270,O
following,271,280,O
traumatic,281,290,O
head,291,295,B-Organism_subdivision
injury,296,302,O
.,302,303,O
Data,304,308,O
from,309,313,O
these,314,319,O
studies,320,327,O
have,328,332,O
provided,333,341,O
little,342,348,O
information,349,360,O
regarding,361,370,O
outcome,371,378,O
following,379,388,O
severe,389,395,O
head,396,400,B-Organism_subdivision
injury,401,407,O
in,408,410,O
patients,411,419,O
with,420,424,O
an,425,427,O
intracranial,428,440,B-Immaterial_anatomical_entity
pressure,441,449,O
(,450,451,O
ICP,451,454,O
),454,455,O
greater,456,463,O
than,464,468,O
40,469,471,O
mm,472,474,O
Hg,475,477,O
",",477,478,O
however,479,486,O
",",486,487,O
in,488,490,O
July,491,495,O
1997,496,500,O
the,501,504,O
authors,505,512,O
instituted,513,523,O
a,524,525,O
protocol,526,534,O
for,535,538,O
the,539,542,O
management,543,553,O
of,554,556,O
severe,557,563,O
head,564,568,B-Organism_subdivision
injury,569,575,O
in,576,578,O
patients,579,587,O
with,588,592,O
a,593,594,O
Glasgow,595,602,O
Coma,603,607,O
Scale,608,613,O
score,614,619,O
lower,620,625,O
than,626,630,O
9,631,632,O
.,632,633,O
The,634,637,O
protocol,638,646,O
was,647,650,O
focused,651,658,O
on,659,661,O
resuscitation,662,675,O
from,676,680,O
acidosis,681,689,O
",",689,690,O
maintenance,691,702,O
of,703,705,O
a,706,707,O
CPP,708,711,O
greater,712,719,O
than,720,724,O
60,725,727,O
mm,728,730,O
Hg,731,733,O
through,734,741,O
whatever,742,750,O
means,751,756,O
necessary,757,766,O
as,767,769,O
well,770,774,O
as,775,777,O
elevation,778,787,O
of,788,790,O
the,791,794,O
head,795,799,O
of,800,802,O
the,803,806,O
bed,807,810,O
",",810,811,O
mannitol,812,820,O
infusion,821,829,O
",",829,830,O
and,831,834,O
ventriculostomy,835,850,O
with,851,855,O
cerebrospinal,856,869,B-Organism_substance
fluid,870,875,I-Organism_substance
drainage,876,884,O
for,885,888,O
control,889,896,O
of,897,899,O
ICP,900,903,O
.,903,904,O
Since,905,910,O
the,911,914,O
institution,915,926,O
of,927,929,O
this,930,934,O
protocol,935,943,O
",",943,944,O
nine,945,949,O
patients,950,958,O
had,959,962,O
a,963,964,O
sustained,965,974,O
ICP,975,978,O
greater,979,986,O
than,987,991,O
40,992,994,O
mm,995,997,O
Hg,998,1000,O
for,1001,1004,O
2,1005,1006,O
or,1007,1009,O
more,1010,1014,O
hours,1015,1020,O
",",1020,1021,O
and,1022,1025,O
five,1026,1030,O
of,1031,1033,O
these,1034,1039,O
had,1040,1043,O
an,1044,1046,O
ICP,1047,1050,O
greater,1051,1058,O
than,1059,1063,O
75,1064,1066,O
mm,1067,1069,O
Hg,1070,1072,O
on,1073,1075,O
insertion,1076,1085,O
of,1086,1088,O
the,1089,1092,O
ICP,1093,1096,O
monitor,1097,1104,O
and,1105,1108,O
later,1109,1114,O
experienced,1115,1126,O
herniation,1127,1137,O
and,1138,1141,O
expired,1142,1149,O
within,1150,1156,O
24,1157,1159,O
hours,1160,1165,O
.,1165,1166,O
Because,1167,1174,O
of,1175,1177,O
the,1178,1181,O
severe,1182,1188,O
nature,1189,1195,O
of,1196,1198,O
the,1199,1202,O
injuries,1203,1211,O
demonstrated,1212,1224,O
on,1225,1227,O
computerized,1228,1240,O
tomography,1241,1251,O
scans,1252,1257,O
and,1258,1261,O
their,1262,1267,O
physical,1268,1276,O
examinations,1277,1289,O
",",1289,1290,O
these,1291,1296,O
patients,1297,1305,O
were,1306,1310,O
not,1311,1314,O
aggressively,1315,1327,O
treated,1328,1335,O
under,1336,1341,O
this,1342,1346,O
protocol,1347,1355,O
.,1355,1356,O
The,1357,1360,O
authors,1361,1368,O
vigorously,1369,1379,O
attempted,1380,1389,O
to,1390,1392,O
maintain,1393,1401,O
a,1402,1403,O
CPP,1404,1407,O
greater,1408,1415,O
than,1416,1420,O
60,1421,1423,O
mm,1424,1426,O
Hg,1427,1429,O
with,1430,1434,O
intensive,1435,1444,O
fluid,1445,1450,B-Organism_substance
resuscitation,1451,1464,O
and,1465,1468,O
the,1469,1472,O
administration,1473,1487,O
of,1488,1490,O
pressor,1491,1498,O
agents,1499,1505,O
in,1506,1508,O
the,1509,1512,O
four,1513,1517,O
remaining,1518,1527,O
patients,1528,1536,O
who,1537,1540,O
had,1541,1544,O
developed,1545,1554,O
an,1555,1557,O
ICP,1558,1561,O
higher,1562,1568,O
than,1569,1573,O
40,1574,1576,O
mm,1577,1579,O
Hg,1580,1582,O
after,1583,1588,O
placement,1589,1598,O
of,1599,1601,O
the,1602,1605,O
ICP,1606,1609,O
monitor,1610,1617,O
.,1617,1618,O
Two,1619,1622,O
patients,1623,1631,O
had,1632,1635,O
an,1636,1638,O
episodic,1639,1647,O
ICP,1648,1651,O
greater,1652,1659,O
than,1660,1664,O
40,1665,1667,O
mm,1668,1670,O
Hg,1671,1673,O
for,1674,1677,O
more,1678,1682,O
than,1683,1687,O
36,1688,1690,O
hours,1691,1696,O
",",1696,1697,O
the,1698,1701,O
third,1702,1707,O
patient,1708,1715,O
had,1716,1719,O
an,1720,1722,O
episodic,1723,1731,O
ICP,1732,1735,O
greater,1736,1743,O
than,1744,1748,O
of,1749,1751,O
50,1752,1754,O
mm,1755,1757,O
Hg,1758,1760,O
for,1761,1764,O
more,1765,1769,O
than,1770,1774,O
36,1775,1777,O
hours,1778,1783,O
",",1783,1784,O
and,1785,1788,O
the,1789,1792,O
fourth,1793,1799,O
patient,1800,1807,O
had,1808,1811,O
an,1812,1814,O
episodic,1815,1823,O
ICP,1824,1827,O
greater,1828,1835,O
than,1836,1840,O
50,1841,1843,O
mm,1844,1846,O
Hg,1847,1849,O
for,1850,1853,O
more,1854,1858,O
than,1859,1863,O
48,1864,1866,O
hours,1867,1872,O
.,1872,1873,O
On,1874,1876,O
discharge,1877,1886,O
",",1886,1887,O
all,1888,1891,O
four,1892,1896,O
patients,1897,1905,O
were,1906,1910,O
able,1911,1915,O
to,1916,1918,O
perform,1919,1926,O
normal,1927,1933,O
activities,1934,1944,O
of,1945,1947,O
daily,1948,1953,O
living,1954,1960,O
with,1961,1965,O
minimal,1966,1973,O
assistance,1974,1984,O
and,1985,1988,O
experience,1989,1999,O
ongoing,2000,2007,O
improvement,2008,2019,O
.,2019,2020,O
Data,2021,2025,O
from,2026,2030,O
this,2031,2035,O
preliminary,2036,2047,O
study,2048,2053,O
indicate,2054,2062,O
that,2063,2067,O
intense,2068,2075,O
",",2075,2076,O
aggressive,2077,2087,O
management,2088,2098,O
of,2099,2101,O
CPP,2102,2105,O
can,2106,2109,O
lead,2110,2114,O
to,2115,2117,O
good,2118,2122,O
neurological,2123,2135,B-Anatomical_system
outcomes,2136,2144,O
despite,2145,2152,O
extremely,2153,2162,O
high,2163,2167,O
ICP,2168,2171,O
.,2171,2172,O
Aggressive,2173,2183,O
CPP,2184,2187,O
therapy,2188,2195,O
should,2196,2202,O
be,2203,2205,O
performed,2206,2215,O
and,2216,2219,O
maintained,2220,2230,O
even,2231,2235,O
though,2236,2242,O
apparently,2243,2253,O
lethal,2254,2260,O
ICP,2261,2264,O
levels,2265,2271,O
may,2272,2275,O
be,2276,2278,O
present,2279,2286,O
.,2286,2287,O
Further,2288,2295,O
study,2296,2301,O
is,2302,2304,O
needed,2305,2311,O
to,2312,2314,O
support,2315,2322,O
these,2323,2328,O
encouraging,2329,2340,O
results,2341,2348,O
.,2348,2349,O
Newly,0,5,O
recognized,6,16,O
syndrome,17,25,O
with,26,30,O
heminasal,31,40,O
aplasia,41,48,O
and,49,52,O
ocular,53,59,B-Organ
anomalies,60,69,O
or,70,72,O
wider,73,78,O
spectrum,79,87,O
of,88,90,O
heminasal,91,100,O
aplasia,101,108,O
/,108,109,O
atypical,109,117,O
clefting,118,126,O
syndrome,127,135,O
?,135,136,O
We,137,139,O
report,140,146,O
on,147,149,O
five,150,154,O
unrelated,155,164,O
Brazilian,165,174,O
patients,175,183,O
with,184,188,O
heminasal,189,198,O
aplasia,199,206,O
associated,207,217,O
with,218,222,O
diverses,223,231,O
anomalies,232,241,O
",",241,242,O
including,243,252,O
lateral,253,260,O
proboscis,261,270,O
",",270,271,O
and,272,275,O
anomalies,276,285,O
of,286,288,O
the,289,292,O
eye,293,296,B-Organ
and,297,300,O
first,301,306,O
branchial,307,316,B-Multi-tissue_structure
arch,317,321,I-Multi-tissue_structure
.,321,322,O
We,323,325,O
suggest,326,333,O
that,334,338,O
these,339,344,O
patients,345,353,O
represent,354,363,O
different,364,373,O
conditions,374,384,O
within,385,391,O
the,392,395,O
spectrum,396,404,O
of,405,407,O
the,408,411,O
heminasal,412,421,O
aplasia,422,429,O
malformation,430,442,O
.,442,443,O
Clinical,444,452,O
",",452,453,O
genetic,454,461,O
",",461,462,O
and,463,466,O
differential,467,479,O
diagnosis,480,489,O
are,490,493,O
discussed,494,503,O
.,503,504,O
Neurologic,0,10,O
diagnosis,11,20,O
and,21,24,O
treatment,25,34,O
in,35,37,O
patients,38,46,O
with,47,51,O
computed,52,60,O
tomography,61,71,O
and,72,75,O
nasal,76,81,B-Organism_subdivision
endoscopy,82,91,O
negative,92,100,O
facial,101,107,B-Organism_subdivision
pain,108,112,O
.,112,113,O
OBJECTIVE,114,123,O
:,123,124,O
To,125,127,O
determine,128,137,O
the,138,141,O
helpfulness,142,153,O
of,154,156,O
specialist,157,167,O
neurology,168,177,O
referral,178,186,O
for,187,190,O
patients,191,199,O
with,200,204,O
facial,205,211,B-Organism_subdivision
pain,212,216,O
",",216,217,O
a,218,219,O
normal,220,226,O
sinus,227,232,B-Immaterial_anatomical_entity
computed,233,241,O
tomography,242,252,O
(,253,254,O
CT,254,256,O
),256,257,O
scan,258,262,O
",",262,263,O
and,264,267,O
normal,268,274,O
nasal,275,280,B-Organism_subdivision
endoscopy,281,290,O
findings,291,299,O
.,299,300,O
STUDY,301,306,O
DESIGN,307,313,O
:,313,314,O
Prospective,315,326,O
identification,327,341,O
of,342,344,O
patients,345,353,O
and,354,357,O
analysis,358,366,O
of,367,369,O
data,370,374,O
approved,375,383,O
by,384,386,O
the,387,390,O
Institutional,391,404,O
Review,405,411,O
Board,412,417,O
.,417,418,O
METHODS,419,426,O
:,426,427,O
The,428,431,O
data,432,436,O
of,437,439,O
104,440,443,O
consecutive,444,455,O
patients,456,464,O
presenting,465,475,O
with,476,480,O
facial,481,487,B-Organism_subdivision
pain,488,492,O
",",492,493,O
a,494,495,O
normal,496,502,O
sinus,503,508,B-Immaterial_anatomical_entity
CT,509,511,O
scan,512,516,O
",",516,517,O
and,518,521,O
normal,522,528,O
nasal,529,534,B-Organism_subdivision
endoscopy,535,544,O
findings,545,553,O
were,554,558,O
reviewed,559,567,O
.,567,568,O
The,569,572,O
patients,573,581,O
presented,582,591,O
to,592,594,O
a,595,596,O
single,597,603,O
rhinologist,604,615,O
in,616,618,O
a,619,620,O
tertiary,621,629,O
care,630,634,O
institution,635,646,O
.,646,647,O
All,648,651,O
patients,652,660,O
were,661,665,O
referred,666,674,O
for,675,678,O
specialist,679,689,O
neurologic,690,700,O
evaluation,701,711,O
and,712,715,O
potential,716,725,O
treatment,726,735,O
.,735,736,O
Further,737,744,O
information,745,756,O
was,757,760,O
obtained,761,769,O
from,770,774,O
a,775,776,O
patient,777,784,O
survey,785,791,O
.,791,792,O
RESULTS,793,800,O
:,800,801,O
Of,802,804,O
the,805,808,O
104,809,812,O
patients,813,821,O
",",821,822,O
81,823,825,O
were,826,830,O
women,831,836,O
and,837,840,O
23,841,843,O
were,844,848,O
men,849,852,O
.,852,853,O
The,854,857,O
average,858,865,O
age,866,869,O
was,870,873,O
46,874,876,O
years,877,882,O
(,883,884,O
range,884,889,O
",",889,890,O
22,891,893,O
-,893,894,O
85,894,896,O
),896,897,O
.,897,898,O
Fifty,899,904,O
-,904,905,O
six,905,908,O
had,909,912,O
clear,913,918,O
CT,919,921,O
scans,922,927,O
",",927,928,O
48,929,931,O
had,932,935,O
minimal,936,943,O
change,944,950,O
",",950,951,O
and,952,955,O
all,956,959,O
had,960,963,O
negative,964,972,O
endoscopies,973,984,O
.,984,985,O
Twenty,986,992,O
-,992,993,O
nine,993,997,O
had,998,1001,O
previous,1002,1010,O
unsuccessful,1011,1023,O
sinus,1024,1029,B-Immaterial_anatomical_entity
surgery,1030,1037,O
.,1037,1038,O
The,1039,1042,O
average,1043,1050,O
follow,1051,1057,O
-,1057,1058,O
up,1058,1060,O
period,1061,1067,O
was,1068,1071,O
10,1072,1074,O
.,1074,1075,O
5,1075,1076,O
months,1077,1083,O
.,1083,1084,O
Forty,1085,1090,O
of,1091,1093,O
75,1094,1096,O
patients,1097,1105,O
seeing,1106,1112,O
a,1113,1114,O
neurologist,1115,1126,O
were,1127,1131,O
seen,1132,1136,O
on,1137,1139,O
multiple,1140,1148,O
occasions,1149,1158,O
.,1158,1159,O
Four,1160,1164,O
percent,1165,1172,O
of,1173,1175,O
patients,1176,1184,O
seen,1185,1189,O
by,1190,1192,O
a,1193,1194,O
neurologist,1195,1206,O
had,1207,1210,O
an,1211,1213,O
unsuspected,1214,1225,O
serious,1226,1233,O
intracranial,1234,1246,B-Immaterial_anatomical_entity
diagnosis,1247,1256,O
.,1256,1257,O
The,1258,1261,O
most,1262,1266,O
common,1267,1273,O
diagnoses,1274,1283,O
were,1284,1288,O
migraine,1289,1297,O
(,1298,1299,O
37,1299,1301,O
%,1301,1302,O
),1302,1303,O
",",1303,1304,O
rebound,1305,1312,O
headache,1313,1321,O
(,1322,1323,O
17,1323,1325,O
%,1325,1326,O
),1326,1327,O
",",1327,1328,O
chronic,1329,1336,O
daily,1337,1342,O
headache,1343,1351,O
(,1352,1353,O
17,1353,1355,O
%,1355,1356,O
),1356,1357,O
",",1357,1358,O
and,1359,1362,O
obstructive,1363,1374,O
sleep,1375,1380,O
apnea,1381,1386,O
(,1387,1388,O
16,1388,1390,O
%,1390,1391,O
),1391,1392,O
.,1392,1393,O
Overall,1394,1401,O
",",1401,1402,O
58,1403,1405,O
%,1405,1406,O
improved,1407,1415,O
on,1416,1418,O
medical,1419,1426,O
therapy,1427,1434,O
;,1434,1435,O
60,1436,1438,O
%,1438,1439,O
of,1440,1442,O
those,1443,1448,O
with,1449,1453,O
a,1454,1455,O
clear,1456,1461,O
CT,1462,1464,O
scan,1465,1469,O
improved,1470,1478,O
",",1478,1479,O
and,1480,1483,O
53,1484,1486,O
%,1486,1487,O
of,1488,1490,O
those,1491,1496,O
with,1497,1501,O
minimal,1502,1509,O
change,1510,1516,O
on,1517,1519,O
CT,1520,1522,O
scan,1523,1527,O
improved,1528,1536,O
(,1537,1538,O
P,1538,1539,O
=,1540,1541,O
.,1542,1543,O
749,1543,1546,O
),1546,1547,O
.,1547,1548,O
CONCLUSIONS,1549,1560,O
:,1560,1561,O
Facial,1562,1568,B-Organism_subdivision
pain,1569,1573,O
remains,1574,1581,O
a,1582,1583,O
difficult,1584,1593,O
symptom,1594,1601,O
to,1602,1604,O
diagnose,1605,1613,O
and,1614,1617,O
treat,1618,1623,O
in,1624,1626,O
rhinologic,1627,1637,O
practice,1638,1646,O
.,1646,1647,O
Patients,1648,1656,O
often,1657,1662,O
undergo,1663,1670,O
surgery,1671,1678,O
without,1679,1686,O
help,1687,1691,O
.,1691,1692,O
Most,1693,1697,O
patients,1698,1706,O
with,1707,1711,O
facial,1712,1718,B-Organism_subdivision
pain,1719,1723,O
",",1723,1724,O
a,1725,1726,O
normal,1727,1733,O
sinus,1734,1739,B-Immaterial_anatomical_entity
CT,1740,1742,O
scan,1743,1747,O
",",1747,1748,O
and,1749,1752,O
normal,1753,1759,O
endoscopy,1760,1769,O
findings,1770,1778,O
benefit,1779,1786,O
from,1787,1791,O
neurologic,1792,1802,O
consultation,1803,1815,O
.,1815,1816,O
Serious,1817,1824,O
intracranial,1825,1837,B-Immaterial_anatomical_entity
pathologic,1838,1848,O
conditions,1849,1859,O
can,1860,1863,O
be,1864,1866,O
excluded,1867,1875,O
and,1876,1879,O
diagnosis,1880,1889,O
-,1889,1890,O
specific,1890,1898,O
pharmacogenetic,1899,1914,O
therapy,1915,1922,O
instituted,1923,1933,O
with,1934,1938,O
improvement,1939,1950,O
in,1951,1953,O
more,1954,1958,O
than,1959,1963,O
50,1964,1966,O
%,1966,1967,O
.,1967,1968,O
TBX21,0,5,O
:,5,6,O
a,7,8,O
functional,9,19,O
variant,20,27,O
predicts,28,36,O
improvement,37,48,O
in,49,51,O
asthma,52,58,O
with,59,63,O
the,64,67,O
use,68,71,O
of,72,74,O
inhaled,75,82,O
corticosteroids,83,98,O
.,98,99,O
TBX21,100,105,O
encodes,106,113,O
for,114,117,O
the,118,121,O
transcription,122,135,O
factor,136,142,O
T,143,144,O
-,144,145,O
bet,145,148,O
(,149,150,O
T,150,151,O
-,151,152,O
box,152,155,O
expressed,156,165,O
in,166,168,O
T,169,170,B-Cell
cells,171,176,I-Cell
),176,177,O
",",177,178,O
which,179,184,O
influences,185,195,O
naive,196,201,O
T,202,203,B-Cell
lymphocyte,204,214,I-Cell
development,215,226,O
and,227,230,O
has,231,234,O
been,235,239,O
implicated,240,250,O
in,251,253,O
asthma,254,260,O
pathogenesis,261,273,O
.,273,274,O
Specifically,275,287,O
",",287,288,O
the,289,292,O
T,293,294,O
-,294,295,O
bet,295,298,O
knockout,299,307,O
mouse,308,313,O
spontaneously,314,327,O
develops,328,336,O
airway,337,343,B-Multi-tissue_structure
hyperresponsiveness,344,363,O
and,364,367,O
other,368,373,O
changes,374,381,O
consistent,382,392,O
with,393,397,O
asthma,398,404,O
.,404,405,O
Because,406,413,O
airway,414,420,B-Multi-tissue_structure
responsiveness,421,435,O
is,436,438,O
moderated,439,448,O
by,449,451,O
the,452,455,O
use,456,459,O
of,460,462,O
inhaled,463,470,O
corticosteroids,471,486,O
in,487,489,O
asthma,490,496,O
",",496,497,O
it,498,500,O
is,501,503,O
conceivable,504,515,O
that,516,520,O
genetic,521,528,O
variation,529,538,O
in,539,541,O
TBX21,542,547,O
may,548,551,O
alter,552,557,O
asthma,558,564,O
phenotypes,565,575,O
in,576,578,O
a,579,580,O
treatment,581,590,O
-,590,591,O
specific,591,599,O
fashion,600,607,O
.,607,608,O
Here,609,613,O
we,614,616,O
demonstrate,617,628,O
that,629,633,O
the,634,637,O
nonsynonymous,638,651,O
variation,652,661,O
in,662,664,O
TBX21,665,670,O
coding,671,677,O
for,678,681,O
replacement,682,693,O
of,694,696,O
histidine,697,706,O
33,707,709,O
with,710,714,O
glutamine,715,724,O
is,725,727,O
associated,728,738,O
with,739,743,O
significant,744,755,O
improvement,756,767,O
in,768,770,O
the,771,774,O
PC,775,777,O
(,777,778,O
20,778,780,O
),780,781,O
(,782,783,O
a,783,784,O
measure,785,792,O
of,793,795,O
airway,796,802,B-Multi-tissue_structure
responsiveness,803,817,O
),817,818,O
of,819,821,O
asthmatic,822,831,O
children,832,840,O
in,841,843,O
a,844,845,O
large,846,851,O
clinical,852,860,O
trial,861,866,O
spanning,867,875,O
4,876,877,O
years,878,883,O
.,883,884,O
We,885,887,O
note,888,892,O
that,893,897,O
this,898,902,O
increase,903,911,O
occurs,912,918,O
only,919,923,O
in,924,926,O
the,927,930,O
children,931,939,O
randomized,940,950,O
to,951,953,O
inhaled,954,961,O
corticosteroids,962,977,O
and,978,981,O
that,982,986,O
it,987,989,O
dramatically,990,1002,O
enhances,1003,1011,O
the,1012,1015,O
overall,1016,1023,O
improvement,1024,1035,O
in,1036,1038,O
PC,1039,1041,O
(,1041,1042,O
20,1042,1044,O
),1044,1045,O
associated,1046,1056,O
with,1057,1061,O
inhaled,1062,1069,O
corticosteroid,1070,1084,O
usage,1085,1090,O
.,1090,1091,O
The,1092,1095,O
average,1096,1103,O
PC,1104,1106,O
(,1106,1107,O
20,1107,1109,O
),1109,1110,O
at,1111,1113,O
trial,1114,1119,O
end,1120,1123,O
for,1124,1127,O
subjects,1128,1136,O
on,1137,1139,O
inhaled,1140,1147,O
corticosteroids,1148,1163,O
possessing,1164,1174,O
a,1175,1176,O
variant,1177,1184,O
allele,1185,1191,O
was,1192,1195,O
in,1196,1198,O
the,1199,1202,O
normal,1203,1209,O
range,1210,1215,O
for,1216,1219,O
nonasthmatics,1220,1233,O
.,1233,1234,O
In,1235,1237,O
cellular,1238,1246,O
models,1247,1253,O
",",1253,1254,O
we,1255,1257,O
show,1258,1262,O
that,1263,1267,O
the,1268,1271,O
TBX21,1272,1277,O
variant,1278,1285,O
increases,1286,1295,O
T,1296,1297,B-Cell
helper,1298,1304,I-Cell
1,1305,1306,I-Cell
and,1307,1310,O
decreases,1311,1320,O
T,1321,1322,B-Cell
helper,1323,1329,I-Cell
2,1330,1331,I-Cell
cytokine,1332,1340,O
expression,1341,1351,O
comparably,1352,1362,O
with,1363,1367,O
wild,1368,1372,O
type,1373,1377,O
.,1377,1378,O
TBX21,1379,1384,O
may,1385,1388,O
thus,1389,1393,O
be,1394,1396,O
an,1397,1399,O
important,1400,1409,O
determinant,1410,1421,O
pharmacogenetic,1422,1437,O
response,1438,1446,O
to,1447,1449,O
the,1450,1453,O
therapy,1454,1461,O
of,1462,1464,O
asthma,1465,1471,O
with,1472,1476,O
inhaled,1477,1484,O
corticosteroids,1485,1500,O
.,1500,1501,O
Sox9,0,4,O
neural,5,11,B-Tissue
crest,12,17,I-Tissue
determinant,18,29,O
gene,30,34,O
controls,35,43,O
patterning,44,54,O
and,55,58,O
closure,59,66,O
of,67,69,O
the,70,73,O
posterior,74,83,B-Multi-tissue_structure
frontal,84,91,I-Multi-tissue_structure
cranial,92,99,I-Multi-tissue_structure
suture,100,106,I-Multi-tissue_structure
.,106,107,O
Cranial,108,115,B-Multi-tissue_structure
suture,116,122,I-Multi-tissue_structure
development,123,134,O
involves,135,143,O
a,144,145,O
complex,146,153,O
interaction,154,165,O
of,166,168,O
genes,169,174,O
and,175,178,O
tissues,179,186,B-Tissue
derived,187,194,O
from,195,199,O
neural,200,206,B-Cell
crest,207,212,I-Cell
cells,213,218,I-Cell
(,219,220,O
NCC,220,223,B-Cell
),223,224,O
and,225,228,O
paraxial,229,237,B-Multi-tissue_structure
mesoderm,238,246,I-Multi-tissue_structure
.,246,247,O
In,248,250,O
mice,251,255,O
",",255,256,O
the,257,260,O
posterior,261,270,B-Multi-tissue_structure
frontal,271,278,I-Multi-tissue_structure
(,279,280,I-Multi-tissue_structure
PF,280,282,I-Multi-tissue_structure
),282,283,I-Multi-tissue_structure
suture,284,290,I-Multi-tissue_structure
closes,291,297,O
during,298,304,O
the,305,308,O
first,309,314,O
month,315,320,O
of,321,323,O
life,324,328,O
while,329,334,O
other,335,340,O
sutures,341,348,B-Multi-tissue_structure
remain,349,355,O
patent,356,362,O
throughout,363,373,O
the,374,377,O
life,378,382,O
of,383,385,O
the,386,389,O
animal,390,396,O
.,396,397,O
Given,398,403,O
the,404,407,O
unique,408,414,O
NCC,415,418,B-Cell
origin,419,425,O
of,426,428,O
PF,429,431,B-Multi-tissue_structure
suture,432,438,I-Multi-tissue_structure
complex,439,446,O
(,447,448,O
analogous,448,457,O
to,458,460,O
metopic,461,468,B-Multi-tissue_structure
suture,469,475,I-Multi-tissue_structure
in,476,478,O
humans,479,485,O
),485,486,O
",",486,487,O
we,488,490,O
performed,491,500,O
quantitative,501,513,O
real,514,518,O
-,518,519,O
time,519,523,O
PCR,524,527,O
and,528,531,O
immunohistochemistry,532,552,O
to,553,555,O
study,556,561,O
the,562,565,O
expression,566,576,O
pattern,577,584,O
of,585,587,O
the,588,591,O
NCC,592,595,B-Cell
determinant,596,607,O
gene,608,612,O
Sox9,613,617,O
and,618,621,O
select,622,628,O
markers,629,636,O
of,637,639,O
extracellular,640,653,B-Cellular_component
matrix,654,660,I-Cellular_component
.,660,661,O
Our,662,665,O
results,666,673,O
indicated,674,683,O
a,684,685,O
unique,686,692,O
up,693,695,O
-,695,696,O
regulated,696,705,O
expression,706,716,O
of,717,719,O
Sox9,720,724,O
",",724,725,O
a,726,727,O
regulator,728,737,O
of,738,740,O
chondrogenesis,741,755,O
",",755,756,O
during,757,763,O
initiation,764,774,O
of,775,777,O
PF,778,780,B-Multi-tissue_structure
suture,781,787,I-Multi-tissue_structure
closure,788,795,O
",",795,796,O
along,797,802,O
with,803,807,O
the,808,811,O
expression,812,822,O
of,823,825,O
specific,826,834,O
cartilage,835,844,B-Tissue
markers,845,852,O
(,853,854,O
Type,854,858,O
II,859,861,O
Collagen,862,870,O
and,871,874,O
Type,875,879,O
X,880,881,O
Collagen,882,890,O
),890,891,O
",",891,892,O
as,893,895,O
well,896,900,O
as,901,903,O
cartilage,904,913,B-Tissue
tissue,914,920,I-Tissue
formation,921,930,O
in,931,933,O
the,934,937,O
PF,938,940,B-Multi-tissue_structure
suture,941,947,I-Multi-tissue_structure
.,947,948,O
This,949,953,O
process,954,961,O
was,962,965,O
followed,966,974,O
by,975,977,O
expression,978,988,O
of,989,991,O
bone,992,996,B-Tissue
markers,997,1004,O
(,1005,1006,O
Type,1006,1010,O
I,1011,1012,O
Collagen,1013,1021,O
and,1022,1025,O
Osteocalcin,1026,1037,O
),1037,1038,O
",",1038,1039,O
suggesting,1040,1050,O
endochondral,1051,1063,O
ossification,1064,1076,O
.,1076,1077,O
Moreover,1078,1086,O
",",1086,1087,O
we,1088,1090,O
studied,1091,1098,O
the,1099,1102,O
effect,1103,1109,O
of,1110,1112,O
haploinsufficiency,1113,1131,O
of,1132,1134,O
the,1135,1138,O
NCC,1139,1142,B-Cell
determinant,1143,1154,O
gene,1155,1159,O
Sox9,1160,1164,O
in,1165,1167,O
the,1168,1171,O
NCC,1172,1175,B-Cell
derived,1176,1183,O
PF,1184,1186,B-Multi-tissue_structure
suture,1187,1193,I-Multi-tissue_structure
complex,1194,1201,O
.,1201,1202,O
A,1203,1204,O
decrease,1205,1213,O
in,1214,1216,O
dosage,1217,1223,O
of,1224,1226,O
Sox9,1227,1231,O
by,1232,1234,O
haploinsufficiency,1235,1253,O
in,1254,1256,O
NCC,1257,1260,B-Tissue
-,1260,1261,I-Tissue
derived,1261,1268,I-Tissue
tissues,1269,1276,I-Tissue
resulted,1277,1285,O
in,1286,1288,O
delayed,1289,1296,O
PF,1297,1299,B-Multi-tissue_structure
suture,1300,1306,I-Multi-tissue_structure
closure,1307,1314,O
.,1314,1315,O
These,1316,1321,O
results,1322,1329,O
demonstrate,1330,1341,O
a,1342,1343,O
unique,1344,1350,O
development,1351,1362,O
of,1363,1365,O
the,1366,1369,O
PF,1370,1372,B-Multi-tissue_structure
suture,1373,1379,I-Multi-tissue_structure
complex,1380,1387,O
and,1388,1391,O
the,1392,1395,O
role,1396,1400,O
of,1401,1403,O
Sox9,1404,1408,O
as,1409,1411,O
an,1412,1414,O
important,1415,1424,O
contributor,1425,1436,O
to,1437,1439,O
timely,1440,1446,O
and,1447,1450,O
proper,1451,1457,O
closure,1458,1465,O
of,1466,1468,O
the,1469,1472,O
PF,1473,1475,B-Multi-tissue_structure
suture,1476,1482,I-Multi-tissue_structure
through,1483,1490,O
endochondral,1491,1503,O
ossification,1504,1516,O
.,1516,1517,O
Experimental,0,12,O
investigation,13,26,O
of,27,29,O
equibiaxial,30,41,O
extension,42,51,O
and,52,55,O
breakup,56,63,O
of,64,66,O
drops,67,72,O
in,73,75,O
a,76,77,O
molten,78,84,O
two,85,88,O
-,88,89,O
phase,89,94,O
polymer,95,102,O
blend,103,108,O
.,108,109,O
We,110,112,O
experimentally,113,127,O
investigate,128,139,O
the,140,143,O
breakup,144,151,O
of,152,154,O
an,155,157,O
equibiaxially,158,171,O
elongated,172,181,O
polystyrene,182,193,O
(,194,195,O
PS,195,197,O
),197,198,O
drop,199,203,O
in,204,206,O
a,207,208,O
poly,209,213,O
(,213,214,O
methyl,214,220,O
methacrylate,221,233,O
),233,234,O
(,235,236,O
PMMA,236,240,O
),240,241,O
matrix,242,248,O
during,249,255,O
relaxation,256,266,O
after,267,272,O
melt,273,277,O
elongation,278,288,O
.,288,289,O
In,290,292,O
equibiaxial,293,304,O
elongation,305,315,O
",",315,316,O
the,317,320,O
initially,321,330,O
spherical,331,340,O
PS,341,343,O
drop,344,348,O
is,349,351,O
deformed,352,360,O
into,361,365,O
an,366,368,O
ellipsoidal,369,380,O
disclike,381,389,O
shape,390,395,O
for,396,399,O
our,400,403,O
test,404,408,O
parameters,409,419,O
.,419,420,O
Using,421,426,O
a,427,428,O
hotstage,429,437,O
in,438,440,O
combination,441,452,O
with,453,457,O
a,458,459,O
light,460,465,O
microscope,466,476,O
",",476,477,O
we,478,480,O
observe,481,488,O
the,489,492,O
evolution,493,502,O
of,503,505,O
the,506,509,O
drop,510,514,O
shape,515,520,O
during,521,527,O
relaxation,528,538,O
.,538,539,O
In,540,542,O
the,543,546,O
initial,547,554,O
stage,555,560,O
of,561,563,O
relaxation,564,574,O
",",574,575,O
fingers,576,583,O
and,584,587,O
holes,588,593,O
are,594,597,O
formed,598,604,O
.,604,605,O
The,606,609,O
holes,610,615,O
are,616,619,O
located,620,627,O
preferentially,628,642,O
near,643,647,O
the,648,651,O
rim,652,655,O
of,656,658,O
the,659,662,O
drop,663,667,O
.,667,668,O
The,669,672,O
number,673,679,O
and,680,683,O
the,684,687,O
size,688,692,O
of,693,695,O
the,696,699,O
holes,700,705,O
increase,706,714,O
with,715,719,O
time,720,724,O
such,725,729,O
that,730,734,O
the,735,738,O
elongated,739,748,O
PS,749,751,O
drop,752,756,O
attains,757,764,O
a,765,766,O
complex,767,774,O
shape,775,780,O
during,781,787,O
relaxation,788,798,O
.,798,799,O
The,800,803,O
fingers,804,811,O
form,812,816,O
bulbous,817,824,O
ends,825,829,O
which,830,835,O
separate,836,844,O
from,845,849,O
the,850,853,O
fingers,854,861,O
.,861,862,O
We,863,865,O
discuss,866,873,O
the,874,877,O
dynamics,878,886,O
of,887,889,O
this,890,894,O
breakup,895,902,O
process,903,910,O
by,911,913,O
taking,914,920,O
into,921,925,O
account,926,933,O
the,934,937,O
interfacial,938,949,O
energy,950,956,O
between,957,964,O
PS,965,967,O
and,968,971,O
PMMA,972,976,O
.,976,977,O
Our,978,981,O
analysis,982,990,O
shows,991,996,O
that,997,1001,O
a,1002,1003,O
very,1004,1008,O
large,1009,1014,O
number,1015,1021,O
of,1022,1024,O
small,1025,1030,O
PS,1031,1033,O
droplets,1034,1042,O
can,1043,1046,O
be,1047,1049,O
generated,1050,1059,O
by,1060,1062,O
the,1063,1066,O
sequential,1067,1077,O
breakup,1078,1085,O
of,1086,1088,O
the,1089,1092,O
elongated,1093,1102,O
PS,1103,1105,O
drop,1106,1110,O
.,1110,1111,O
Management,0,10,O
of,11,13,O
extremity,14,23,O
trauma,24,30,O
and,31,34,O
related,35,42,O
infections,43,53,O
occurring,54,63,O
in,64,66,O
the,67,70,O
aquatic,71,78,O
environment,79,90,O
.,90,91,O
Wounds,92,98,B-Pathological_formation
sustained,99,108,O
in,109,111,O
oceans,112,118,O
",",118,119,O
lakes,120,125,O
",",125,126,O
and,127,130,O
streams,131,138,O
are,139,142,O
exposed,143,150,O
to,151,153,O
a,154,155,O
milieu,156,162,O
of,163,165,O
bacteria,166,174,O
rarely,175,181,O
encountered,182,193,O
in,194,196,O
typical,197,204,O
land,205,209,O
-,209,210,O
based,210,215,O
injuries,216,224,O
.,224,225,O
These,226,231,O
include,232,239,O
Vibrio,240,246,O
species,247,254,O
",",254,255,O
Aeromonas,256,265,O
hydrophila,266,276,O
",",276,277,O
Pseudomonas,278,289,O
and,290,293,O
Plesiomonas,294,305,O
species,306,313,O
",",313,314,O
Erysipelothrix,315,329,O
rhusiopathiae,330,343,O
",",343,344,O
Mycobacterium,345,358,O
marinum,359,366,O
",",366,367,O
and,368,371,O
other,372,377,O
microbes,378,386,O
.,386,387,O
Failure,388,395,O
to,396,398,O
recognize,399,408,O
and,409,412,O
treat,413,418,O
these,419,424,O
less,425,429,O
common,430,436,O
pathogens,437,446,O
in,447,449,O
a,450,451,O
timely,452,458,O
manner,459,465,O
may,466,469,O
result,470,476,O
in,477,479,O
significant,480,491,O
morbidity,492,501,O
or,502,504,O
death,505,510,O
.,510,511,O
Initial,512,519,O
antibiotic,520,530,O
therapy,531,538,O
should,539,545,O
address,546,553,O
common,554,560,O
gram,561,565,O
-,565,566,O
positive,566,574,O
and,575,578,O
gram,579,583,O
-,583,584,O
negative,584,592,O
aquatic,593,600,O
bacteria,601,609,O
",",609,610,O
depending,611,620,O
on,621,623,O
the,624,627,O
environment,628,639,O
.,639,640,O
Trauma,641,647,O
occurring,648,657,O
in,658,660,O
brackish,661,669,O
or,670,672,O
salt,673,677,O
water,678,683,O
should,684,690,O
be,691,693,O
treated,694,701,O
with,702,706,O
doxycycline,707,718,O
and,719,722,O
ceftazidime,723,734,O
",",734,735,O
or,736,738,O
a,739,740,O
fluoroquinolone,741,756,O
(,757,758,O
eg,758,760,O
",",760,761,O
ciprofloxacin,762,775,O
or,776,778,O
levofloxacin,779,791,O
),791,792,O
.,792,793,O
Freshwater,794,804,O
wounds,805,811,B-Pathological_formation
should,812,818,O
be,819,821,O
managed,822,829,O
with,830,834,O
ciprofloxacin,835,848,O
",",848,849,O
levofloxacin,850,862,O
",",862,863,O
or,864,866,O
a,867,868,O
third,869,874,O
-,874,875,O
or,876,878,O
fourth,879,885,O
-,885,886,O
generation,886,896,O
cephalosporin,897,910,O
(,911,912,O
eg,912,914,O
",",914,915,O
ceftazidime,916,927,O
),927,928,O
.,928,929,O
Injuries,930,938,O
sustained,939,948,O
in,949,951,O
a,952,953,O
marine,954,960,O
or,961,963,O
freshwater,964,974,O
environment,975,986,O
may,987,990,O
result,991,997,O
from,998,1002,O
bites,1003,1008,O
or,1009,1011,O
venomous,1012,1020,O
stings,1021,1027,O
of,1028,1030,O
aquatic,1031,1038,O
organisms,1039,1048,O
as,1049,1051,O
well,1052,1056,O
as,1057,1059,O
from,1060,1064,O
accidental,1065,1075,O
trauma,1076,1082,O
.,1082,1083,O
Musculoskeletal,1084,1099,B-Pathological_formation
trauma,1100,1106,I-Pathological_formation
caused,1107,1113,O
by,1114,1116,O
venomous,1117,1125,O
underwater,1126,1136,O
species,1137,1144,O
(,1145,1146,O
eg,1146,1148,O
",",1148,1149,O
stingrays,1150,1159,O
",",1159,1160,O
stinging,1161,1169,O
fish,1170,1174,O
",",1174,1175,O
sea,1176,1179,O
urchins,1180,1187,O
",",1187,1188,O
and,1189,1192,O
coral,1193,1198,O
),1198,1199,O
requires,1200,1208,O
immediate,1209,1218,O
neutralization,1219,1233,O
of,1234,1236,O
the,1237,1240,O
heat,1241,1245,O
-,1245,1246,O
labile,1246,1252,O
toxin,1253,1258,O
with,1259,1263,O
immersion,1264,1273,O
in,1274,1276,O
nonscalding,1277,1288,O
water,1289,1294,O
for,1295,1298,O
30,1299,1301,O
to,1302,1304,O
90,1305,1307,O
minutes,1308,1315,O
.,1315,1316,O
Appropriate,1317,1328,O
management,1329,1339,O
of,1340,1342,O
aquatic,1343,1350,O
wounds,1351,1357,B-Pathological_formation
requires,1358,1366,O
recognition,1367,1378,O
of,1379,1381,O
the,1382,1385,O
mechanism,1386,1395,O
of,1396,1398,O
injury,1399,1405,O
",",1405,1406,O
neutralization,1407,1421,O
of,1422,1424,O
venom,1425,1430,O
",",1430,1431,O
antibiotic,1432,1442,O
administration,1443,1457,O
",",1457,1458,O
radiographic,1459,1471,O
assessment,1472,1482,O
",",1482,1483,O
surgical,1484,1492,O
debridement,1493,1504,O
with,1505,1509,O
irrigation,1510,1520,O
",",1520,1521,O
wound,1522,1527,B-Pathological_formation
cultures,1528,1536,O
",",1536,1537,O
and,1538,1541,O
structural,1542,1552,O
repair,1553,1559,O
or,1560,1562,O
amputation,1563,1573,O
as,1574,1576,O
indicated,1577,1586,O
by,1587,1589,O
the,1590,1593,O
severity,1594,1602,O
of,1603,1605,O
the,1606,1609,O
injury,1610,1616,O
.,1616,1617,O
Involvement,0,11,O
of,12,14,O
de,15,17,O
novo,18,22,O
ceramide,23,31,O
synthesis,32,41,O
in,42,44,O
radiocontrast,45,58,O
-,58,59,O
induced,59,66,O
renal,67,72,B-Cell
tubular,73,80,I-Cell
cell,81,85,I-Cell
injury,86,92,O
.,92,93,O
We,94,96,O
reported,97,105,O
previously,106,116,O
that,117,121,O
various,122,129,O
radiocontrast,130,143,O
media,144,149,O
cause,150,155,O
apoptosis,156,165,O
in,166,168,O
porcine,169,176,O
proximal,177,185,B-Cell
tubular,186,193,I-Cell
(,194,195,I-Cell
LLC,195,198,I-Cell
-,198,199,I-Cell
PK,199,201,I-Cell
(,201,202,I-Cell
1,202,203,I-Cell
),203,204,I-Cell
),204,205,I-Cell
cells,206,211,I-Cell
",",211,212,O
in,213,215,O
which,216,221,O
reduction,222,231,O
in,232,234,O
B,235,236,O
-,236,237,O
cell,237,241,O
lymphoma,242,250,O
(,251,252,O
Bcl,252,255,O
),255,256,O
-,256,257,O
2,257,258,O
expression,259,269,O
and,270,273,O
caspase,274,281,O
-,281,282,O
3,282,283,O
activation,284,294,O
are,295,298,O
implicated,299,309,O
.,309,310,O
In,311,313,O
the,314,317,O
present,318,325,O
study,326,331,O
",",331,332,O
we,333,335,O
investigated,336,348,O
a,349,350,O
role,351,355,O
for,356,359,O
ceramide,360,368,O
in,369,371,O
radiocontrast,372,385,O
media,386,391,O
-,391,392,O
induced,392,399,O
apoptosis,400,409,O
in,410,412,O
renal,413,418,B-Cell
tubular,419,426,I-Cell
cells,427,432,I-Cell
.,432,433,O
LLC,434,437,B-Cell
-,437,438,I-Cell
PK,438,440,I-Cell
(,440,441,I-Cell
1,441,442,I-Cell
),442,443,I-Cell
cells,444,449,I-Cell
were,450,454,O
exposed,455,462,O
to,463,465,O
radiocontrast,466,479,O
media,480,485,O
for,486,489,O
30,490,492,O
min,493,496,O
",",496,497,O
followed,498,506,O
by,507,509,O
incubation,510,520,O
for,521,524,O
24,525,527,O
h,528,529,O
in,530,532,O
normal,533,539,O
medium,540,546,O
.,546,547,O
Cell,548,552,B-Cell
viability,553,562,O
was,563,566,O
assessed,567,575,O
by,576,578,O
2,579,580,O
-,580,581,O
(,581,582,O
2,582,583,O
-,583,584,O
methoxy,584,591,O
-,591,592,O
4,592,593,O
-,593,594,O
nitrophenyl,594,605,O
),605,606,O
-,606,607,O
3,607,608,O
-,608,609,O
(,609,610,O
4,610,611,O
-,611,612,O
nitrophenyl,612,623,O
),623,624,O
-,624,625,O
5,625,626,O
-,626,627,O
(,627,628,O
2,628,629,O
",",629,630,O
4,630,631,O
-,631,632,O
disulfophenyl,632,645,O
),645,646,O
-,646,647,O
2H,647,649,O
-,649,650,O
tetrazolium,650,661,O
monosodium,662,672,O
salt,673,677,O
assay,678,683,O
",",683,684,O
while,685,690,O
apoptosis,691,700,O
was,701,704,O
determined,705,715,O
by,716,718,O
terminal,719,727,O
deoxynucleotidyl,728,744,O
transferase,745,756,O
-,756,757,O
mediated,757,765,O
dUTP,766,770,O
nick,771,775,O
end,776,779,O
labeling,780,788,O
stain,789,794,O
.,794,795,O
Immunofluorescent,796,813,O
stains,814,820,O
were,821,825,O
performed,826,835,O
using,836,841,O
antibodies,842,852,O
against,853,860,O
phosphorylated,861,875,O
Akt,876,879,O
(,880,881,O
pAkt,881,885,O
),885,886,O
and,887,890,O
cAMP,891,895,O
response,896,904,O
element,905,912,O
binding,913,920,O
protein,921,928,O
(,929,930,O
CREB,930,934,O
),934,935,O
(,936,937,O
pCREB,937,942,O
),942,943,O
",",943,944,O
and,945,948,O
ceramide,949,957,O
.,957,958,O
The,959,962,O
mRNA,963,967,O
expression,968,978,O
and,979,982,O
protein,983,990,O
content,991,998,O
of,999,1001,O
Bcl,1002,1005,O
-,1005,1006,O
2,1006,1007,O
were,1008,1012,O
determined,1013,1023,O
by,1024,1026,O
reverse,1027,1034,O
transcriptase,1035,1048,O
-,1048,1049,O
polymerase,1049,1059,O
chain,1060,1065,O
reaction,1066,1074,O
and,1075,1078,O
enzyme,1079,1085,O
immunoassay,1086,1097,O
",",1097,1098,O
respectively,1099,1111,O
.,1111,1112,O
In,1113,1115,O
vivo,1116,1120,O
model,1121,1126,O
of,1127,1129,O
contrast,1130,1138,O
-,1138,1139,O
induced,1139,1146,O
renal,1147,1152,B-Organ
injury,1153,1159,O
was,1160,1163,O
induced,1164,1171,O
in,1172,1174,O
mice,1175,1179,O
with,1180,1184,O
unilateral,1185,1195,O
renal,1196,1201,B-Organ
occlusion,1202,1211,O
.,1211,1212,O
The,1213,1216,O
cell,1217,1221,B-Cell
injury,1222,1228,O
induced,1229,1236,O
by,1237,1239,O
the,1240,1243,O
nonionic,1244,1252,O
radiocontrast,1253,1266,O
medium,1267,1273,O
ioversol,1274,1282,O
was,1283,1286,O
reversed,1287,1295,O
by,1296,1298,O
inhibiting,1299,1309,O
de,1310,1312,O
novo,1313,1317,O
ceramide,1318,1326,O
synthesis,1327,1336,O
with,1337,1341,O
fumonisin,1342,1351,O
B,1352,1353,O
(,1353,1354,O
1,1354,1355,O
),1355,1356,O
(,1357,1358,O
FB,1358,1360,O
(,1360,1361,O
1,1361,1362,O
),1362,1363,O
),1363,1364,O
and,1365,1368,O
L,1369,1370,O
-,1370,1371,O
cycloserine,1371,1382,O
",",1382,1383,O
but,1384,1387,O
not,1388,1391,O
by,1392,1394,O
suppressing,1395,1406,O
sphingomyelin,1407,1420,O
breakdown,1421,1430,O
with,1431,1435,O
D609,1436,1440,O
.,1440,1441,O
FB,1442,1444,O
(,1444,1445,O
1,1445,1446,O
),1446,1447,O
reversed,1448,1456,O
ioversol,1457,1465,O
-,1465,1466,O
induced,1466,1473,O
decrease,1474,1482,O
in,1483,1485,O
the,1486,1489,O
immunoreactivities,1490,1508,O
of,1509,1511,O
pAkt,1512,1516,O
and,1517,1520,O
pCREB,1521,1526,O
",",1526,1527,O
reduction,1528,1537,O
in,1538,1540,O
Bcl,1541,1544,O
-,1544,1545,O
2,1545,1546,O
expression,1547,1557,O
and,1558,1561,O
caspase,1562,1569,O
-,1569,1570,O
3,1570,1571,O
activation,1572,1582,O
.,1582,1583,O
Like,1584,1588,O
ioversol,1589,1597,O
",",1597,1598,O
C2,1599,1601,O
ceramide,1602,1610,O
and,1611,1614,O
the,1615,1618,O
Akt,1619,1622,O
inhibitor,1623,1632,O
Src,1633,1636,O
homology,1637,1645,O
-,1645,1646,O
6,1646,1647,O
induced,1648,1655,O
apoptosis,1656,1665,O
by,1666,1668,O
reducing,1669,1677,O
pAkt,1678,1682,O
and,1683,1686,O
pCREB,1687,1692,O
-,1692,1693,O
like,1693,1697,O
immunoreactivities,1698,1716,O
",",1716,1717,O
lowering,1718,1726,O
Bcl,1727,1730,O
-,1730,1731,O
2,1731,1732,O
expression,1733,1743,O
and,1744,1747,O
enhancing,1748,1757,O
caspase,1758,1765,O
-,1765,1766,O
3,1766,1767,O
activity,1768,1776,O
.,1776,1777,O
Indeed,1778,1784,O
",",1784,1785,O
various,1786,1793,O
radiocontrast,1794,1807,O
media,1808,1813,O
",",1813,1814,O
excluding,1815,1824,O
iodixanol,1825,1834,O
which,1835,1840,O
showed,1841,1847,O
the,1848,1851,O
least,1852,1857,O
nephrotoxicity,1858,1872,O
",",1872,1873,O
enhanced,1874,1882,O
ceramide,1883,1891,O
-,1891,1892,O
like,1892,1896,O
immunoreactivity,1897,1913,O
.,1913,1914,O
The,1915,1918,O
role,1919,1923,O
for,1924,1927,O
de,1928,1930,O
novo,1931,1935,O
ceramide,1936,1944,O
synthesis,1945,1954,O
was,1955,1958,O
also,1959,1963,O
shown,1964,1969,O
in,1970,1972,O
the,1973,1976,O
in,1977,1979,O
vivo,1980,1984,O
model,1985,1990,O
of,1991,1993,O
radiocontrast,1994,2007,O
nephropathy,2008,2019,O
.,2019,2020,O
We,2021,2023,O
demonstrated,2024,2036,O
here,2037,2041,O
for,2042,2045,O
the,2046,2049,O
first,2050,2055,O
time,2056,2060,O
that,2061,2065,O
the,2066,2069,O
enhancement,2070,2081,O
of,2082,2084,O
de,2085,2087,O
novo,2088,2092,O
ceramide,2093,2101,O
synthesis,2102,2111,O
contributes,2112,2123,O
to,2124,2126,O
radiocontrast,2127,2140,O
nephropathy,2141,2152,O
.,2152,2153,O
A,0,1,O
potential,2,11,O
role,12,16,O
for,17,20,O
the,21,24,O
Src,25,28,O
-,28,29,O
like,29,33,O
adapter,34,41,O
protein,42,49,O
SLAP,50,54,O
-,54,55,O
2,55,56,O
in,57,59,O
signaling,60,69,O
by,70,72,O
the,73,76,O
colony,77,83,O
stimulating,84,95,O
factor,96,102,O
-,102,103,O
1,103,104,O
receptor,105,113,O
.,113,114,O
The,115,118,O
development,119,130,O
of,131,133,O
macrophages,134,145,B-Cell
from,146,150,O
myeloid,151,158,B-Cell
progenitor,159,169,I-Cell
cells,170,175,I-Cell
is,176,178,O
primarily,179,188,O
controlled,189,199,O
by,200,202,O
the,203,206,O
growth,207,213,O
factor,214,220,O
colony,221,227,O
stimulating,228,239,O
factor,240,246,O
-,246,247,O
1,247,248,O
(,249,250,O
CSF,250,253,O
-,253,254,O
1,254,255,O
),255,256,O
and,257,260,O
its,261,264,O
cognate,265,272,O
receptor,273,281,O
",",281,282,O
a,283,284,O
transmembrane,285,298,B-Cellular_component
tyrosine,299,307,O
kinase,308,314,O
encoded,315,322,O
by,323,325,O
the,326,329,O
c,330,331,O
-,331,332,O
Fms,332,335,O
proto,336,341,O
-,341,342,O
oncogene,342,350,O
.,350,351,O
The,352,355,O
CSF,356,359,O
-,359,360,O
1,360,361,O
receptor,362,370,O
exerts,371,377,O
its,378,381,O
biological,382,392,O
effects,393,400,O
on,401,403,O
cells,404,409,B-Cell
via,410,413,O
a,414,415,O
range,416,421,O
of,422,424,O
signaling,425,434,O
proteins,435,443,O
including,444,453,O
Erk1,454,458,O
/,458,459,O
2,459,460,O
and,461,464,O
Akt,465,468,O
.,468,469,O
Here,470,474,O
we,475,477,O
have,478,482,O
investigated,483,495,O
the,496,499,O
potential,500,509,O
involvement,510,521,O
of,522,524,O
the,525,528,O
Src,529,532,O
-,532,533,O
like,533,537,O
adapter,538,545,O
protein,546,553,O
(,554,555,O
SLAP,555,559,O
-,559,560,O
2,560,561,O
),561,562,O
in,563,565,O
signaling,566,575,O
by,576,578,O
the,579,582,O
CSF,583,586,O
-,586,587,O
1,587,588,O
receptor,589,597,O
in,598,600,O
mouse,601,606,O
bone,607,611,B-Multi-tissue_structure
marrow,612,618,I-Multi-tissue_structure
-,618,619,O
derived,619,626,O
macrophages,627,638,B-Cell
.,638,639,O
RT,640,642,O
-,642,643,O
PCR,643,646,O
analysis,647,655,O
revealed,656,664,O
constitutive,665,677,O
expression,678,688,O
of,689,691,O
the,692,695,O
SLAP,696,700,O
-,700,701,O
2,701,702,O
gene,703,707,O
in,708,710,O
bone,711,715,B-Cell
marrow,716,722,I-Cell
macrophages,723,734,I-Cell
.,734,735,O
Surprisingly,736,748,O
",",748,749,O
co,750,752,O
-,752,753,O
immunoprecipitation,753,772,O
and,773,776,O
GST,777,780,O
binding,781,788,O
experiments,789,800,O
demonstrated,801,813,O
that,814,818,O
the,819,822,O
CSF,823,826,O
-,826,827,O
1,827,828,O
receptor,829,837,O
could,838,843,O
bind,844,848,O
to,849,851,O
SLAP,852,856,O
-,856,857,O
2,857,858,O
in,859,861,O
a,862,863,O
ligand,864,870,O
-,870,871,O
independent,871,882,O
manner,883,889,O
.,889,890,O
Furthermore,891,902,O
",",902,903,O
the,904,907,O
binding,908,915,O
of,916,918,O
SLAP,919,923,O
-,923,924,O
2,924,925,O
to,926,928,O
the,929,932,O
CSF,933,936,O
-,936,937,O
1,937,938,O
receptor,939,947,O
involved,948,956,O
multiple,957,965,O
domains,966,973,O
of,974,976,O
SLAP,977,981,O
-,981,982,O
2,982,983,O
.,983,984,O
SLAP,985,989,O
-,989,990,O
2,990,991,O
also,992,996,O
bound,997,1002,O
c,1003,1004,O
-,1004,1005,O
Cbl,1005,1008,O
",",1008,1009,O
with,1010,1014,O
the,1015,1018,O
interaction,1019,1030,O
being,1031,1036,O
mediated,1037,1045,O
",",1045,1046,O
at,1047,1049,O
least,1050,1055,O
in,1056,1058,O
part,1059,1063,O
",",1063,1064,O
by,1065,1067,O
the,1068,1071,O
unique,1072,1078,O
C,1079,1080,O
-,1080,1081,O
terminal,1081,1089,O
domain,1090,1096,O
of,1097,1099,O
SLAP,1100,1104,O
-,1104,1105,O
2,1105,1106,O
.,1106,1107,O
Overexpression,1108,1122,O
of,1123,1125,O
SLAP,1126,1130,O
-,1130,1131,O
2,1131,1132,O
in,1133,1135,O
bone,1136,1140,B-Cell
marrow,1141,1147,I-Cell
macrophages,1148,1159,I-Cell
partially,1160,1169,O
suppressed,1170,1180,O
the,1181,1184,O
CSF,1185,1188,O
-,1188,1189,O
1,1189,1190,O
-,1190,1191,O
induced,1191,1198,O
tyrosine,1199,1207,O
phosphorylation,1208,1223,O
and,1224,1227,O
/,1227,1228,O
or,1228,1230,O
expression,1231,1241,O
level,1242,1247,O
of,1248,1250,O
a,1251,1252,O
approximately,1253,1266,O
80,1267,1269,O
kDa,1270,1273,O
protein,1274,1281,O
without,1282,1289,O
affecting,1290,1299,O
CSF,1300,1303,O
-,1303,1304,O
1,1304,1305,O
-,1305,1306,O
induced,1306,1313,O
global,1314,1320,O
tyrosine,1321,1329,O
phosphorylation,1330,1345,O
",",1345,1346,O
or,1347,1349,O
activation,1350,1360,O
of,1361,1363,O
Akt,1364,1367,O
or,1368,1370,O
Erk1,1371,1375,O
/,1375,1376,O
2,1376,1377,O
.,1377,1378,O
Significantly,1379,1392,O
",",1392,1393,O
CSF,1394,1397,O
-,1397,1398,O
1,1398,1399,O
stimulation,1400,1411,O
induced,1412,1419,O
serine,1420,1426,O
phosphorylation,1427,1442,O
of,1443,1445,O
SLAP,1446,1450,O
-,1450,1451,O
2,1451,1452,O
.,1452,1453,O
Pharmacologic,1454,1467,O
inhibition,1468,1478,O
of,1479,1481,O
specific,1482,1490,O
protein,1491,1498,O
kinases,1499,1506,O
revealed,1507,1515,O
that,1516,1520,O
CSF,1521,1524,O
-,1524,1525,O
1,1525,1526,O
-,1526,1527,O
induced,1527,1534,O
phosphorylation,1535,1550,O
of,1551,1553,O
SLAP,1554,1558,O
-,1558,1559,O
2,1559,1560,O
was,1561,1564,O
dependent,1565,1574,O
on,1575,1577,O
JNK,1578,1581,O
activity,1582,1590,O
.,1590,1591,O
Taken,1592,1597,O
together,1598,1606,O
",",1606,1607,O
our,1608,1611,O
results,1612,1619,O
suggest,1620,1627,O
that,1628,1632,O
SLAP,1633,1637,O
-,1637,1638,O
2,1638,1639,O
could,1640,1645,O
potentially,1646,1657,O
be,1658,1660,O
involved,1661,1669,O
in,1670,1672,O
signaling,1673,1682,O
by,1683,1685,O
the,1686,1689,O
CSF,1690,1693,O
-,1693,1694,O
1,1694,1695,O
receptor,1696,1704,O
.,1704,1705,O
Structure,0,9,O
of,10,12,O
the,13,16,O
genetic,17,24,O
code,25,29,O
suggested,30,39,O
by,40,42,O
the,43,46,O
hydropathy,47,57,O
correlation,58,69,O
between,70,77,O
anticodons,78,88,O
and,89,92,O
amino,93,98,O
acid,99,103,O
residues,104,112,O
.,112,113,O
The,114,117,O
correlation,118,129,O
between,130,137,O
hydropathies,138,150,O
of,151,153,O
anticodons,154,164,O
and,165,168,O
amino,169,174,O
acids,175,180,O
",",180,181,O
detected,182,190,O
by,191,193,O
other,194,199,O
authors,200,207,O
utilizing,208,217,O
scales,218,224,O
of,225,227,O
amino,228,233,O
acid,234,238,O
molecules,239,248,O
in,249,251,O
solution,252,260,O
",",260,261,O
was,262,265,O
improved,266,274,O
with,275,279,O
the,280,283,O
utilization,284,295,O
of,296,298,O
scales,299,305,O
of,306,308,O
amino,309,314,O
acid,315,319,O
residues,320,328,O
in,329,331,O
proteins,332,340,O
.,340,341,O
Three,342,347,O
partitions,348,358,O
were,359,363,O
discerned,364,373,O
in,374,376,O
the,377,380,O
correlation,381,392,O
plot,393,397,O
with,398,402,O
the,403,406,O
principal,407,416,O
dinucleotides,417,430,O
of,431,433,O
anticodons,434,444,O
(,445,446,O
pDiN,446,450,O
",",450,451,O
excluding,452,461,O
the,462,465,O
wobble,466,472,O
position,473,481,O
),481,482,O
.,482,483,O
(,484,485,O
a,485,486,O
),486,487,O
The,488,491,O
set,492,495,O
of,496,498,O
outliers,499,507,O
of,508,510,O
the,511,514,O
correlation,515,526,O
:,526,527,O
Gly,528,531,O
-,531,532,O
CC,532,534,O
",",534,535,O
Pro,536,539,O
-,539,540,O
GG,540,542,O
",",542,543,O
Ser,544,547,O
-,547,548,O
GA,548,550,O
and,551,554,O
Ser,555,558,O
-,558,559,O
CU,559,561,O
.,561,562,O
The,563,566,O
amino,567,572,O
acids,573,578,O
are,579,582,O
consistently,583,595,O
small,596,601,O
",",601,602,O
hydro,603,608,O
-,608,609,O
apathetic,609,618,O
",",618,619,O
stabilizers,620,631,O
of,632,634,O
protein,635,642,O
N,643,644,O
-,644,645,O
ends,645,649,O
",",649,650,O
preferred,651,660,O
in,661,663,O
aperiodic,664,673,O
protein,674,681,O
conformations,682,695,O
and,696,699,O
belong,700,706,O
to,707,709,O
synthetases,710,721,O
class,722,727,O
II,728,730,O
.,730,731,O
The,732,735,O
pDiN,736,740,O
sequences,741,750,O
are,751,754,O
representative,755,769,O
of,770,772,O
the,773,776,O
homogeneous,777,788,O
sector,789,795,O
(,796,797,O
triplets,797,805,O
NRR,806,809,O
and,810,813,O
NYY,814,817,O
),817,818,O
",",818,819,O
distinguished,820,833,O
from,834,838,O
the,839,842,O
mixed,843,848,O
sector,849,855,O
(,856,857,O
triplets,857,865,O
NRY,866,869,O
and,870,873,O
NYR,874,877,O
),877,878,O
",",878,879,O
that,880,884,O
depict,885,891,O
a,892,893,O
70,894,896,O
%,896,897,O
correspondence,898,912,O
to,913,915,O
the,916,919,O
synthetases,920,931,O
class,932,937,O
II,938,940,O
and,941,944,O
I,945,946,O
",",946,947,O
respectively,948,960,O
.,960,961,O
The,962,965,O
triplet,966,973,O
pairs,974,979,O
proposed,980,988,O
to,989,991,O
be,992,994,O
responsible,995,1006,O
for,1007,1010,O
the,1011,1014,O
coherence,1015,1024,O
in,1025,1027,O
the,1028,1031,O
set,1032,1035,O
of,1036,1038,O
outliers,1039,1047,O
are,1048,1051,O
of,1052,1054,O
the,1055,1058,O
palindromic,1059,1070,O
kind,1071,1075,O
",",1075,1076,O
where,1077,1082,O
the,1083,1086,O
lateral,1087,1094,O
bases,1095,1100,O
are,1101,1104,O
the,1105,1108,O
same,1109,1113,O
",",1113,1114,O
CCC,1115,1118,O
:,1118,1119,O
GGG,1120,1123,O
and,1124,1127,O
AGA,1128,1131,O
:,1131,1132,O
UCU,1133,1136,O
.,1136,1137,O
This,1138,1142,O
suggests,1143,1151,O
that,1152,1156,O
UCU,1157,1160,O
previously,1161,1171,O
belonged,1172,1180,O
to,1181,1183,O
Ser,1184,1187,O
",",1187,1188,O
adding,1189,1195,O
to,1196,1198,O
other,1199,1204,O
indications,1205,1216,O
that,1217,1221,O
the,1222,1225,O
attribution,1226,1237,O
of,1238,1240,O
Arg,1241,1244,O
to,1245,1247,O
YCU,1248,1251,O
was,1252,1255,O
due,1256,1259,O
to,1260,1262,O
an,1263,1265,O
expansion,1266,1275,O
of,1276,1278,O
the,1279,1282,O
Arg,1283,1286,O
-,1286,1287,O
tRNA,1287,1291,O
synthetase,1292,1302,O
specificity,1303,1314,O
.,1314,1315,O
The,1316,1319,O
other,1320,1325,O
attributions,1326,1338,O
produced,1339,1347,O
two,1348,1351,O
correlation,1352,1363,O
sets,1364,1368,O
.,1368,1369,O
(,1370,1371,O
b,1371,1372,O
),1372,1373,O
One,1374,1377,O
corresponds,1378,1389,O
to,1390,1392,O
the,1393,1396,O
remaining,1397,1406,O
pDiN,1407,1411,O
of,1412,1414,O
the,1415,1418,O
homogeneous,1419,1430,O
sector,1431,1437,O
",",1437,1438,O
containing,1439,1449,O
both,1450,1454,O
synthetase,1455,1465,O
classes,1466,1473,O
;,1473,1474,O
its,1475,1478,O
regression,1479,1489,O
line,1490,1494,O
overlapped,1495,1505,O
the,1506,1509,O
one,1510,1513,O
formed,1514,1520,O
by,1521,1523,O
the,1524,1527,O
remaining,1528,1537,O
attributions,1538,1550,O
to,1551,1553,O
class,1554,1559,O
II,1560,1562,O
.,1562,1563,O
(,1564,1565,O
c,1565,1566,O
),1566,1567,O
The,1568,1571,O
other,1572,1577,O
contains,1578,1586,O
the,1587,1590,O
pDiN,1591,1595,O
of,1596,1598,O
the,1599,1602,O
mixed,1603,1608,O
sector,1609,1615,O
and,1616,1619,O
produced,1620,1628,O
steeper,1629,1636,O
slopes,1637,1643,O
",",1643,1644,O
especially,1645,1655,O
with,1656,1660,O
the,1661,1664,O
class,1665,1670,O
I,1671,1672,O
attributions,1673,1685,O
.,1685,1686,O
It,1687,1689,O
is,1690,1692,O
suggested,1693,1702,O
that,1703,1707,O
the,1708,1711,O
correlation,1712,1723,O
was,1724,1727,O
established,1728,1739,O
when,1740,1744,O
the,1745,1748,O
amino,1749,1754,O
acid,1755,1759,O
composition,1760,1771,O
of,1772,1774,O
the,1775,1778,O
protein,1779,1786,O
synthetases,1787,1798,O
became,1799,1805,O
progressively,1806,1819,O
enriched,1820,1828,O
and,1829,1832,O
that,1833,1837,O
the,1838,1841,O
set,1842,1845,O
of,1846,1848,O
outliers,1849,1857,O
were,1858,1862,O
the,1863,1866,O
earliest,1867,1875,O
to,1876,1878,O
have,1879,1883,O
been,1884,1888,O
fixed,1889,1894,O
.,1894,1895,O
Hypocholesterolaemic,0,20,O
and,21,24,O
antioxidant,25,36,O
effects,37,44,O
of,45,47,O
Glycyrrhiza,48,59,O
glabra,60,66,O
(,67,68,O
Linn,68,72,O
),72,73,O
in,74,76,O
rats,77,81,O
.,81,82,O
The,83,86,O
hypocholesterolaemic,87,107,O
and,108,111,O
antioxidant,112,123,O
effects,124,131,O
of,132,134,O
Glycyrrhiza,135,146,O
glabra,147,153,O
(,154,155,O
GG,155,157,O
),157,158,O
root,159,163,B-Organ
powder,164,170,O
were,171,175,O
examined,176,184,O
in,185,187,O
hypercholesterolaemic,188,209,O
male,210,214,O
albino,215,221,O
rats,222,226,O
.,226,227,O
A,228,229,O
4,230,231,O
-,231,232,O
week,232,236,O
administration,237,251,O
of,252,254,O
GG,255,257,O
root,258,262,B-Organ
powder,263,269,O
(,270,271,O
5,271,272,O
and,273,276,O
10,277,279,O
gm,280,282,O
%,282,283,O
in,284,286,O
diet,287,291,O
),291,292,O
to,293,295,O
hypercholesterolaemic,296,317,O
rats,318,322,O
resulted,323,331,O
in,332,334,O
significant,335,346,O
reduction,347,356,O
in,357,359,O
plasma,360,366,B-Organism_substance
",",366,367,O
hepatic,368,375,B-Organ
total,376,381,O
lipids,382,388,O
",",388,389,O
cholesterol,390,401,O
",",401,402,O
triglycerides,403,416,O
and,417,420,O
plasma,421,427,B-Organism_substance
low,428,431,O
-,431,432,O
density,432,439,O
lipoprotein,440,451,O
and,452,455,O
VLDL,456,460,O
-,460,461,O
cholesterol,461,472,O
accompanied,473,484,O
by,485,487,O
significant,488,499,O
increases,500,509,O
in,510,512,O
HDL,513,516,O
-,516,517,O
cholesterol,517,528,O
levels,529,535,O
.,535,536,O
Furthermore,537,548,O
",",548,549,O
significant,550,561,O
increases,562,571,O
in,572,574,O
fecal,575,580,B-Organism_substance
cholesterol,581,592,O
",",592,593,O
neutral,594,601,O
sterols,602,609,O
and,610,613,O
bile,614,618,O
acid,619,623,O
excretion,624,633,O
along,634,639,O
with,640,644,O
an,645,647,O
increase,648,656,O
in,657,659,O
hepatic,660,667,B-Organ
HMG,668,671,O
-,671,672,O
CoA,672,675,O
reductase,676,685,O
activity,686,694,O
and,695,698,O
bile,699,703,O
acid,704,708,O
production,709,719,O
were,720,724,O
observed,725,733,O
in,734,736,O
these,737,742,O
animals,743,750,O
.,750,751,O
The,752,755,O
root,756,760,B-Organ
powder,761,767,O
administration,768,782,O
to,783,785,O
hypercholesterolaemic,786,807,O
rats,808,812,O
also,813,817,O
decreased,818,827,O
hepatic,828,835,B-Organ
lipid,836,841,O
peroxidation,842,854,O
with,855,859,O
a,860,861,O
concomitant,862,873,O
increase,874,882,O
in,883,885,O
superoxide,886,896,O
dismutase,897,906,O
(,907,908,O
SOD,908,911,O
),911,912,O
and,913,916,O
catalase,917,925,O
activities,926,936,O
and,937,940,O
total,941,946,O
ascorbic,947,955,O
acid,956,960,O
content,961,968,O
.,968,969,O
Thus,970,974,O
",",974,975,O
the,976,979,O
hypocholesterolaemic,980,1000,O
and,1001,1004,O
antioxidant,1005,1016,O
effects,1017,1024,O
of,1025,1027,O
GG,1028,1030,O
root,1031,1035,B-Organ
appeared,1036,1044,O
to,1045,1047,O
be,1048,1050,O
mediated,1051,1059,O
via,1060,1063,O
(,1064,1065,O
i,1065,1066,O
),1066,1067,O
accelerated,1068,1079,O
cholesterol,1080,1091,O
",",1091,1092,O
neutral,1093,1100,O
sterol,1101,1107,O
and,1108,1111,O
bile,1112,1116,O
acid,1117,1121,O
elimination,1122,1133,O
through,1134,1141,O
fecal,1142,1147,B-Organism_substance
matter,1148,1154,I-Organism_substance
with,1155,1159,O
an,1160,1162,O
increased,1163,1172,O
hepatic,1173,1180,B-Organ
bile,1181,1185,O
acid,1186,1190,O
production,1191,1201,O
and,1202,1205,O
(,1206,1207,O
ii,1207,1209,O
),1209,1210,O
improving,1211,1220,O
the,1221,1224,O
activities,1225,1235,O
of,1236,1238,O
hepatic,1239,1246,B-Organ
SOD,1247,1250,O
",",1250,1251,O
catalase,1252,1260,O
and,1261,1264,O
increasing,1265,1275,O
the,1276,1279,O
ascorbic,1280,1288,O
acid,1289,1293,O
content,1294,1301,O
.,1301,1302,O
The,1303,1306,O
normo,1307,1312,O
-,1312,1313,O
cholesterolaemic,1313,1329,O
animals,1330,1337,O
when,1338,1342,O
fed,1343,1346,O
with,1347,1351,O
GG,1352,1354,O
root,1355,1359,B-Organ
powder,1360,1366,O
at,1367,1369,O
10,1370,1372,O
gm,1373,1375,O
%,1375,1376,O
level,1377,1382,O
",",1382,1383,O
registered,1384,1394,O
a,1395,1396,O
significant,1397,1408,O
decline,1409,1416,O
in,1417,1419,O
plasma,1420,1426,B-Organism_substance
lipid,1427,1432,O
profiles,1433,1441,O
and,1442,1445,O
an,1446,1448,O
increase,1449,1457,O
in,1458,1460,O
HDL,1461,1464,O
-,1464,1465,O
cholesterol,1465,1476,O
content,1477,1484,O
.,1484,1485,O
The,1486,1489,O
antioxidant,1490,1501,O
status,1502,1508,O
of,1509,1511,O
these,1512,1517,O
animals,1518,1525,O
also,1526,1530,O
was,1531,1534,O
improved,1535,1543,O
upon,1544,1548,O
treatment,1549,1558,O
.,1558,1559,O
Multicentre,0,11,O
study,12,17,O
on,18,20,O
peri,21,25,O
-,25,26,O
and,27,30,O
postoperative,31,44,O
central,45,52,B-Multi-tissue_structure
venous,53,59,I-Multi-tissue_structure
oxygen,60,66,O
saturation,67,77,O
in,78,80,O
high,81,85,O
-,85,86,O
risk,86,90,O
surgical,91,99,O
patients,100,108,O
.,108,109,O
INTRODUCTION,110,122,O
:,122,123,O
Low,124,127,O
central,128,135,B-Multi-tissue_structure
venous,136,142,I-Multi-tissue_structure
oxygen,143,149,O
saturation,150,160,O
(,161,162,O
ScvO2,162,167,O
),167,168,O
has,169,172,O
been,173,177,O
associated,178,188,O
with,189,193,O
increased,194,203,O
risk,204,208,O
of,209,211,O
postoperative,212,225,O
complications,226,239,O
in,240,242,O
high,243,247,O
-,247,248,O
risk,248,252,O
surgery,253,260,O
.,260,261,O
Whether,262,269,O
this,270,274,O
association,275,286,O
is,287,289,O
centre,290,296,O
-,296,297,O
specific,297,305,O
or,306,308,O
more,309,313,O
generalisable,314,327,O
is,328,330,O
not,331,334,O
known,335,340,O
.,340,341,O
The,342,345,O
aim,346,349,O
of,350,352,O
this,353,357,O
study,358,363,O
was,364,367,O
to,368,370,O
assess,371,377,O
the,378,381,O
association,382,393,O
between,394,401,O
peri,402,406,O
-,406,407,O
and,408,411,O
postoperative,412,425,O
ScvO2,426,431,O
and,432,435,O
outcome,436,443,O
in,444,446,O
high,447,451,O
-,451,452,O
risk,452,456,O
surgical,457,465,O
patients,466,474,O
in,475,477,O
a,478,479,O
multicentre,480,491,O
setting,492,499,O
.,499,500,O
METHODS,501,508,O
:,508,509,O
Three,510,515,O
large,516,521,O
European,522,530,O
university,531,541,O
hospitals,542,551,O
(,552,553,O
two,553,556,O
in,557,559,O
Finland,560,567,O
",",567,568,O
one,569,572,O
in,573,575,O
Switzerland,576,587,O
),587,588,O
participated,589,601,O
.,601,602,O
In,603,605,O
60,606,608,O
patients,609,617,O
with,618,622,O
intra,623,628,O
-,628,629,O
abdominal,629,638,B-Organism_subdivision
surgery,639,646,O
lasting,647,654,O
more,655,659,O
than,660,664,O
90,665,667,O
minutes,668,675,O
",",675,676,O
the,677,680,O
presence,681,689,O
of,690,692,O
at,693,695,O
least,696,701,O
two,702,705,O
of,706,708,O
Shoemaker,709,718,O
',718,719,O
s,719,720,O
criteria,721,729,O
",",729,730,O
and,731,734,O
ASA,735,738,O
(,739,740,O
American,740,748,O
Society,749,756,O
of,757,759,O
Anesthesiologists,760,777,O
),777,778,O
class,779,784,O
greater,785,792,O
than,793,797,O
2,798,799,O
",",799,800,O
ScvO2,801,806,O
was,807,810,O
determined,811,821,O
preoperatively,822,836,O
and,837,840,O
at,841,843,O
two,844,847,O
hour,848,852,O
intervals,853,862,O
during,863,869,O
the,870,873,O
operation,874,883,O
until,884,889,O
12,890,892,O
hours,893,898,O
postoperatively,899,914,O
.,914,915,O
Hospital,916,924,O
length,925,931,O
of,932,934,O
stay,935,939,O
(,940,941,O
LOS,941,944,O
),944,945,O
mortality,946,955,O
",",955,956,O
and,957,960,O
predefined,961,971,O
postoperative,972,985,O
complications,986,999,O
were,1000,1004,O
recorded,1005,1013,O
.,1013,1014,O
RESULTS,1015,1022,O
:,1022,1023,O
The,1024,1027,O
age,1028,1031,O
of,1032,1034,O
the,1035,1038,O
patients,1039,1047,O
was,1048,1051,O
72,1052,1054,O
+,1055,1056,O
/,1056,1057,O
-,1057,1058,O
10,1059,1061,O
years,1062,1067,O
(,1068,1069,O
mean,1069,1073,O
+,1074,1075,O
/,1075,1076,O
-,1076,1077,O
standard,1078,1086,O
deviation,1087,1096,O
),1096,1097,O
",",1097,1098,O
and,1099,1102,O
simplified,1103,1113,O
acute,1114,1119,O
physiology,1120,1130,O
score,1131,1136,O
(,1137,1138,O
SAPS,1138,1142,O
II,1143,1145,O
),1145,1146,O
was,1147,1150,O
32,1151,1153,O
+,1154,1155,O
/,1155,1156,O
-,1156,1157,O
12,1158,1160,O
.,1160,1161,O
Hospital,1162,1170,O
LOS,1171,1174,O
was,1175,1178,O
10,1179,1181,O
.,1181,1182,O
5,1182,1183,O
(,1184,1185,O
8,1185,1186,O
to,1187,1189,O
14,1190,1192,O
),1192,1193,O
days,1194,1198,O
",",1198,1199,O
and,1200,1203,O
28,1204,1206,O
-,1206,1207,O
day,1207,1210,O
hospital,1211,1219,O
mortality,1220,1229,O
was,1230,1233,O
10,1234,1236,O
.,1236,1237,O
0,1237,1238,O
%,1238,1239,O
.,1239,1240,O
Preoperative,1241,1253,O
ScvO2,1254,1259,O
decreased,1260,1269,O
from,1270,1274,O
77,1275,1277,O
%,1277,1278,O
+,1279,1280,O
/,1280,1281,O
-,1281,1282,O
10,1283,1285,O
%,1285,1286,O
to,1287,1289,O
70,1290,1292,O
%,1292,1293,O
+,1294,1295,O
/,1295,1296,O
-,1296,1297,O
11,1298,1300,O
%,1300,1301,O
(,1302,1303,O
p,1303,1304,O
<,1305,1306,O
0,1307,1308,O
.,1308,1309,O
001,1309,1312,O
),1312,1313,O
immediately,1314,1325,O
after,1326,1331,O
surgery,1332,1339,O
and,1340,1343,O
remained,1344,1352,O
unchanged,1353,1362,O
12,1363,1365,O
hours,1366,1371,O
later,1372,1377,O
.,1377,1378,O
A,1379,1380,O
total,1381,1386,O
of,1387,1389,O
67,1390,1392,O
postoperative,1393,1406,O
complications,1407,1420,O
were,1421,1425,O
recorded,1426,1434,O
in,1435,1437,O
32,1438,1440,O
patients,1441,1449,O
.,1449,1450,O
After,1451,1456,O
multivariate,1457,1469,O
analysis,1470,1478,O
",",1478,1479,O
mean,1480,1484,O
ScvO2,1485,1490,O
value,1491,1496,O
(,1497,1498,O
odds,1498,1502,O
ratio,1503,1508,O
[,1509,1510,O
OR,1510,1512,O
],1512,1513,O
1,1514,1515,O
.,1515,1516,O
23,1516,1518,O
[,1519,1520,O
95,1520,1522,O
%,1522,1523,O
confidence,1524,1534,O
interval,1535,1543,O
(,1544,1545,O
CI,1545,1547,O
),1547,1548,O
1,1549,1550,O
.,1550,1551,O
01,1551,1553,O
to,1554,1556,O
1,1557,1558,O
.,1558,1559,O
50,1559,1561,O
],1561,1562,O
",",1562,1563,O
p,1564,1565,O
=,1566,1567,O
0,1568,1569,O
.,1569,1570,O
037,1570,1573,O
),1573,1574,O
",",1574,1575,O
hospital,1576,1584,O
LOS,1585,1588,O
(,1589,1590,O
OR,1590,1592,O
0,1593,1594,O
.,1594,1595,O
75,1595,1597,O
[,1598,1599,O
95,1599,1601,O
%,1601,1602,O
CI,1603,1605,O
0,1606,1607,O
.,1607,1608,O
59,1608,1610,O
to,1611,1613,O
0,1614,1615,O
.,1615,1616,O
94,1616,1618,O
],1618,1619,O
",",1619,1620,O
p,1621,1622,O
=,1623,1624,O
0,1625,1626,O
.,1626,1627,O
012,1627,1630,O
),1630,1631,O
",",1631,1632,O
and,1633,1636,O
SAPS,1637,1641,O
II,1642,1644,O
(,1645,1646,O
OR,1646,1648,O
0,1649,1650,O
.,1650,1651,O
90,1651,1653,O
[,1654,1655,O
95,1655,1657,O
%,1657,1658,O
CI,1659,1661,O
0,1662,1663,O
.,1663,1664,O
82,1664,1666,O
to,1667,1669,O
0,1670,1671,O
.,1671,1672,O
99,1672,1674,O
],1674,1675,O
",",1675,1676,O
p,1677,1678,O
=,1679,1680,O
0,1681,1682,O
.,1682,1683,O
029,1683,1686,O
),1686,1687,O
were,1688,1692,O
independently,1693,1706,O
associated,1707,1717,O
with,1718,1722,O
postoperative,1723,1736,O
complications,1737,1750,O
.,1750,1751,O
The,1752,1755,O
optimal,1756,1763,O
value,1764,1769,O
of,1770,1772,O
mean,1773,1777,O
ScvO2,1778,1783,O
to,1784,1786,O
discriminate,1787,1799,O
between,1800,1807,O
patients,1808,1816,O
who,1817,1820,O
did,1821,1824,O
or,1825,1827,O
did,1828,1831,O
not,1832,1835,O
develop,1836,1843,O
complications,1844,1857,O
was,1858,1861,O
73,1862,1864,O
%,1864,1865,O
(,1866,1867,O
sensitivity,1867,1878,O
72,1879,1881,O
%,1881,1882,O
",",1882,1883,O
specificity,1884,1895,O
61,1896,1898,O
%,1898,1899,O
),1899,1900,O
.,1900,1901,O
CONCLUSION,1902,1912,O
:,1912,1913,O
Low,1914,1917,O
ScvO2,1918,1923,O
perioperatively,1924,1939,O
is,1940,1942,O
related,1943,1950,O
to,1951,1953,O
increased,1954,1963,O
risk,1964,1968,O
of,1969,1971,O
postoperative,1972,1985,O
complications,1986,1999,O
in,2000,2002,O
high,2003,2007,O
-,2007,2008,O
risk,2008,2012,O
surgery,2013,2020,O
.,2020,2021,O
This,2022,2026,O
warrants,2027,2035,O
trials,2036,2042,O
with,2043,2047,O
goal,2048,2052,O
-,2052,2053,O
directed,2053,2061,O
therapy,2062,2069,O
using,2070,2075,O
ScvO2,2076,2081,O
as,2082,2084,O
a,2085,2086,O
target,2087,2093,O
in,2094,2096,O
high,2097,2101,O
-,2101,2102,O
risk,2102,2106,O
surgery,2107,2114,O
patients,2115,2123,O
.,2123,2124,O
[,0,1,O
Treatment,1,10,O
of,11,13,O
squamous,14,22,B-Pathological_formation
intraepithelial,23,38,I-Pathological_formation
lesion,39,45,I-Pathological_formation
of,46,48,O
type,49,53,O
CIN2,54,58,O
et,59,61,O
CIN3,62,66,O
with,67,71,O
laser,72,77,O
CO2,78,81,O
vaporization,82,94,O
:,94,95,O
retrospective,96,109,O
study,110,115,O
of,116,118,O
52,119,121,O
cases,122,127,O
],127,128,O
.,128,129,O
OBJECTIVES,130,140,O
:,140,141,O
This,142,146,O
study,147,152,O
was,153,156,O
carried,157,164,O
out,165,168,O
over,169,173,O
an,174,176,O
8,177,178,O
-,178,179,O
year,179,183,O
period,184,190,O
in,191,193,O
order,194,199,O
to,200,202,O
evaluate,203,211,O
the,212,215,O
long,216,220,O
-,220,221,O
term,221,225,O
effectiveness,226,239,O
of,240,242,O
laser,243,248,O
CO2,249,252,O
vaporization,253,265,O
in,266,268,O
the,269,272,O
treatment,273,282,O
of,283,285,O
squamous,286,294,B-Pathological_formation
intraepithelial,295,310,I-Pathological_formation
lesion,311,317,I-Pathological_formation
of,318,320,O
type,321,325,O
CIN2,326,330,O
and,331,334,O
CIN3,335,339,O
.,339,340,O
MATERIALS,341,350,O
AND,351,354,O
METHODS,355,362,O
:,362,363,O
A,364,365,O
retrospective,366,379,O
study,380,385,O
of,386,388,O
52,389,391,O
cases,392,397,O
of,398,400,O
cervical,401,409,B-Pathological_formation
lesions,410,417,I-Pathological_formation
of,418,420,O
type,421,425,O
CIN2,426,430,O
and,431,434,O
CIN3,435,439,O
treated,440,447,O
in,448,450,O
first,451,456,O
intention,457,466,O
by,467,469,O
laser,470,475,O
CO2,476,479,O
vaporization,480,492,O
was,493,496,O
carried,497,504,O
out,505,508,O
at,509,511,O
the,512,515,O
hospital,516,524,O
Jeanne,525,531,O
-,531,532,O
de,532,534,O
-,534,535,O
Flandre,535,542,O
in,543,545,O
CHRU,546,550,O
of,551,553,O
Lille,554,559,O
from,560,564,O
1996,565,569,O
to,570,572,O
2003,573,577,O
.,577,578,O
This,579,583,O
treatment,584,593,O
was,594,597,O
performed,598,607,O
on,608,610,O
only,611,615,O
high,616,620,O
-,620,621,O
grade,621,626,O
exo,627,630,B-Pathological_formation
-,630,631,I-Pathological_formation
cervical,631,639,I-Pathological_formation
lesions,640,647,I-Pathological_formation
",",647,648,O
of,649,651,O
small,652,657,O
size,658,662,O
(,663,664,O
<,664,665,O
2cm2,665,669,O
),669,670,O
",",670,671,O
after,672,677,O
a,678,679,O
complete,680,688,O
colposcopic,689,700,O
examination,701,712,O
.,712,713,O
RESULTS,714,721,O
:,721,722,O
Fifty,723,728,O
-,728,729,O
two,729,732,O
patients,733,741,O
were,742,746,O
treated,747,754,O
by,755,757,O
first,758,763,O
-,763,764,O
intention,764,773,O
laser,774,779,O
vaporization,780,792,O
only,793,797,O
.,797,798,O
Mean,799,803,O
age,804,807,O
was,808,811,O
29,812,814,O
.,814,815,O
4,815,816,O
years,817,822,O
and,823,826,O
51,827,829,O
.,829,830,O
9,830,831,O
%,831,832,O
were,833,837,O
nulliparous,838,849,O
.,849,850,O
At,851,853,O
the,854,857,O
first,858,863,O
cyto,864,868,O
-,868,869,O
colposcopic,869,880,O
control,881,888,O
",",888,889,O
there,890,895,O
were,896,900,O
17,901,903,O
persistent,904,914,O
lesions,915,922,B-Pathological_formation
(,923,924,O
32,924,926,O
.,926,927,O
7,927,928,O
%,928,929,O
),929,930,O
.,930,931,O
Among,932,937,O
the,938,941,O
35,942,944,O
patients,945,953,O
without,954,961,O
persistent,962,972,O
lesion,973,979,B-Pathological_formation
",",979,980,O
29,981,983,O
achieved,984,992,O
cure,993,997,O
(,998,999,O
absence,999,1006,O
of,1007,1009,O
recurrence,1010,1020,O
),1020,1021,O
",",1021,1022,O
4,1023,1024,O
presented,1025,1034,O
a,1035,1036,O
recurrence,1037,1047,O
and,1048,1051,O
2,1052,1053,O
were,1054,1058,O
lost,1059,1063,O
to,1064,1066,O
follow,1067,1073,O
-,1073,1074,O
up,1074,1076,O
.,1076,1077,O
CONCLUSION,1078,1088,O
:,1088,1089,O
The,1090,1093,O
current,1094,1101,O
data,1102,1106,O
of,1107,1109,O
the,1110,1113,O
literature,1114,1124,O
concerning,1125,1135,O
the,1136,1139,O
treatment,1140,1149,O
by,1150,1152,O
laser,1153,1158,O
CO2,1159,1162,O
vaporization,1163,1175,O
authorize,1176,1185,O
application,1186,1197,O
of,1198,1200,O
this,1201,1205,O
method,1206,1212,O
for,1213,1216,O
certain,1217,1224,O
high,1225,1229,O
-,1229,1230,O
grade,1230,1235,O
exocervical,1236,1247,B-Pathological_formation
lesions,1248,1255,I-Pathological_formation
after,1256,1261,O
a,1262,1263,O
complete,1264,1272,O
colposcopic,1273,1284,O
examination,1285,1296,O
.,1296,1297,O
This,1298,1302,O
type,1303,1307,O
of,1308,1310,O
treatment,1311,1320,O
remains,1321,1328,O
less,1329,1333,O
aggressive,1334,1344,O
than,1345,1349,O
a,1350,1351,O
surgical,1352,1360,O
treatment,1361,1370,O
.,1370,1371,O
The,1372,1375,O
high,1376,1380,O
rate,1381,1385,O
of,1386,1388,O
residual,1389,1397,O
lesions,1398,1405,B-Pathological_formation
in,1406,1408,O
particular,1409,1419,O
in,1420,1422,O
the,1423,1426,O
event,1427,1432,O
of,1433,1435,O
CIN3,1436,1440,O
can,1441,1444,O
be,1445,1447,O
due,1448,1451,O
to,1452,1454,O
an,1455,1457,O
incomplete,1458,1468,O
destruction,1469,1480,O
of,1481,1483,O
the,1484,1487,O
lesion,1488,1494,B-Pathological_formation
.,1494,1495,O
Patients,1496,1504,O
should,1505,1511,O
thus,1512,1516,O
be,1517,1519,O
advised,1520,1527,O
that,1528,1532,O
monitoring,1533,1543,O
is,1544,1546,O
an,1547,1549,O
integral,1550,1558,O
part,1559,1563,O
of,1564,1566,O
the,1567,1570,O
treatment,1571,1580,O
.,1580,1581,O
Laser,1582,1587,O
vaporization,1588,1600,O
could,1601,1606,O
be,1607,1609,O
limited,1610,1617,O
to,1618,1620,O
CIN1,1621,1625,O
and,1626,1629,O
CIN2,1630,1634,O
lesions,1635,1642,B-Pathological_formation
.,1642,1643,O
Segmental,0,9,O
atrial,10,16,B-Multi-tissue_structure
contraction,17,28,O
in,29,31,O
patients,32,40,O
restored,41,49,O
to,50,52,O
sinus,53,58,B-Immaterial_anatomical_entity
rhythm,59,65,O
after,66,71,O
cardioversion,72,85,O
for,86,89,O
chronic,90,97,O
atrial,98,104,B-Multi-tissue_structure
fibrillation,105,117,O
:,117,118,O
a,119,120,O
colour,121,127,O
Doppler,128,135,O
tissue,136,142,B-Tissue
imaging,143,150,O
study,151,156,O
.,156,157,O
AIMS,158,162,O
:,162,163,O
There,164,169,O
is,170,172,O
little,173,179,O
known,180,185,O
about,186,191,O
segmental,192,201,O
atrial,202,208,B-Multi-tissue_structure
function,209,217,O
in,218,220,O
patients,221,229,O
with,230,234,O
atrial,235,241,B-Multi-tissue_structure
arrhythmias,242,253,O
.,253,254,O
We,255,257,O
evaluated,258,267,O
segmental,268,277,O
atrial,278,284,B-Multi-tissue_structure
contractility,285,298,O
using,299,304,O
colour,305,311,O
Doppler,312,319,O
tissue,320,326,B-Tissue
imaging,327,334,O
(,335,336,O
CDTI,336,340,O
),340,341,O
in,342,344,O
patients,345,353,O
with,354,358,O
chronic,359,366,O
atrial,367,373,B-Multi-tissue_structure
fibrillation,374,386,O
(,387,388,O
CAF,388,391,O
),391,392,O
who,393,396,O
were,397,401,O
successfully,402,414,O
restored,415,423,O
and,424,427,O
maintained,428,438,O
in,439,441,O
sinus,442,447,B-Immaterial_anatomical_entity
rhythm,448,454,O
(,455,456,O
SR,456,458,O
),458,459,O
.,459,460,O
METHODS,461,468,O
AND,469,472,O
RESULTS,473,480,O
:,480,481,O
We,482,484,O
compared,485,493,O
the,494,497,O
segmental,498,507,O
atrial,508,514,B-Multi-tissue_structure
contractility,515,528,O
in,529,531,O
39,532,534,O
CAF,535,538,O
patients,539,547,O
who,548,551,O
were,552,556,O
successfully,557,569,O
cardioverted,570,582,O
and,583,586,O
maintained,587,597,O
in,598,600,O
SR,601,603,O
for,604,607,O
6,608,609,O
months,610,616,O
.,616,617,O
Follow,618,624,O
up,625,627,O
echocardiograms,628,643,O
were,644,648,O
performed,649,658,O
at,659,661,O
baseline,662,670,O
",",670,671,O
1,672,673,O
week,674,678,O
",",678,679,O
1,680,681,O
month,682,687,O
and,688,691,O
6,692,693,O
months,694,700,O
and,701,704,O
compared,705,713,O
to,714,716,O
a,717,718,O
normal,719,725,O
age,726,729,O
matched,730,737,O
cohort,738,744,O
(,745,746,O
n,746,747,O
=,748,749,O
34,750,752,O
),752,753,O
.,753,754,O
Using,755,760,O
CDTI,761,765,O
",",765,766,O
mean,767,771,O
peak,772,776,O
velocities,777,787,O
of,788,790,O
atrial,791,797,B-Multi-tissue_structure
contraction,798,809,O
were,810,814,O
measured,815,823,O
from,824,828,O
annular,829,836,O
",",836,837,O
mid,838,841,O
and,842,845,O
superior,846,854,O
segments,855,863,O
of,864,866,O
lateral,867,874,B-Multi-tissue_structure
and,875,878,O
septal,879,885,B-Multi-tissue_structure
walls,886,891,I-Multi-tissue_structure
of,892,894,O
the,895,898,O
left,899,903,B-Multi-tissue_structure
atrium,904,910,I-Multi-tissue_structure
and,911,914,O
right,915,920,B-Multi-tissue_structure
atrium,921,927,I-Multi-tissue_structure
in,928,930,O
the,931,934,O
apical,935,941,O
four,942,946,O
-,946,947,O
chamber,947,954,O
view,955,959,O
.,959,960,O
Segmental,961,970,O
velocities,971,981,O
from,982,986,O
the,987,990,O
posterior,991,1000,O
and,1001,1004,O
anterior,1005,1013,O
walls,1014,1019,O
of,1020,1022,O
the,1023,1026,O
left,1027,1031,B-Multi-tissue_structure
atrium,1032,1038,I-Multi-tissue_structure
were,1039,1043,O
measured,1044,1052,O
from,1053,1057,O
the,1058,1061,O
apical,1062,1068,O
two,1069,1072,O
-,1072,1073,O
chamber,1073,1080,O
view,1081,1085,O
.,1085,1086,O
Segmental,1087,1096,O
left,1097,1101,B-Multi-tissue_structure
atrial,1102,1108,I-Multi-tissue_structure
velocities,1109,1119,O
improved,1120,1128,O
over,1129,1133,O
time,1134,1138,O
in,1139,1141,O
the,1142,1145,O
CAF,1146,1149,O
group,1150,1155,O
",",1155,1156,O
with,1157,1161,O
the,1162,1165,O
majority,1166,1174,O
of,1175,1177,O
the,1178,1181,O
recovery,1182,1190,O
occurring,1191,1200,O
in,1201,1203,O
the,1204,1207,O
first,1208,1213,O
month,1214,1219,O
",",1219,1220,O
but,1221,1224,O
failed,1225,1231,O
to,1232,1234,O
normalise,1235,1244,O
even,1245,1249,O
at,1250,1252,O
6,1253,1254,O
months,1255,1261,O
.,1261,1262,O
In,1263,1265,O
comparison,1266,1276,O
",",1276,1277,O
the,1278,1281,O
right,1282,1287,B-Multi-tissue_structure
atrial,1288,1294,I-Multi-tissue_structure
velocities,1295,1305,O
in,1306,1308,O
the,1309,1312,O
AF,1313,1315,O
group,1316,1321,O
had,1322,1325,O
normalised,1326,1336,O
at,1337,1339,O
1,1340,1341,O
month,1342,1347,O
.,1347,1348,O
CONCLUSION,1349,1359,O
:,1359,1360,O
Patients,1361,1369,O
with,1370,1374,O
CAF,1375,1378,O
have,1379,1383,O
persistent,1384,1394,O
segmental,1395,1404,O
left,1405,1409,B-Multi-tissue_structure
atrial,1410,1416,I-Multi-tissue_structure
dysfunction,1417,1428,O
even,1429,1433,O
6,1434,1435,O
months,1436,1442,O
after,1443,1448,O
restoration,1449,1460,O
and,1461,1464,O
maintenance,1465,1476,O
of,1477,1479,O
SR,1480,1482,O
",",1482,1483,O
though,1484,1490,O
right,1491,1496,B-Multi-tissue_structure
atrial,1497,1503,I-Multi-tissue_structure
velocities,1504,1514,O
appear,1515,1521,O
to,1522,1524,O
normalise,1525,1534,O
.,1534,1535,O
This,1536,1540,O
differential,1541,1553,O
recovery,1554,1562,O
indicates,1563,1572,O
that,1573,1577,O
left,1578,1582,B-Multi-tissue_structure
atrial,1583,1589,I-Multi-tissue_structure
function,1590,1598,O
remains,1599,1606,O
subnormal,1607,1616,O
in,1617,1619,O
patients,1620,1628,O
with,1629,1633,O
CAF,1634,1637,O
despite,1638,1645,O
maintenance,1646,1657,O
of,1658,1660,O
SR,1661,1663,O
",",1663,1664,O
suggesting,1665,1675,O
underlying,1676,1686,O
atrial,1687,1693,B-Multi-tissue_structure
myopathy,1694,1702,O
or,1703,1705,O
fibrosis,1706,1714,O
as,1715,1717,O
a,1718,1719,O
consequence,1720,1731,O
of,1732,1734,O
CAF,1735,1738,O
.,1738,1739,O
[,0,1,O
Anomalous,1,10,O
origin,11,17,O
of,18,20,O
the,21,24,O
right,25,30,B-Multi-tissue_structure
coronary,31,39,I-Multi-tissue_structure
artery,40,46,I-Multi-tissue_structure
from,47,51,O
the,52,55,O
left,56,60,O
sinus,61,66,B-Immaterial_anatomical_entity
of,67,69,O
Valsalva,70,78,O
:,78,79,O
case,80,84,O
report,85,91,O
and,92,95,O
literature,96,106,O
review,107,113,O
],113,114,O
.,114,115,O
We,116,118,O
describe,119,127,O
the,128,131,O
case,132,136,O
of,137,139,O
a,140,141,O
patient,142,149,O
in,150,152,O
whom,153,157,O
evaluation,158,168,O
of,169,171,O
effort,172,178,O
angina,179,185,O
revealed,186,194,O
a,195,196,O
tight,197,202,O
stenosis,203,211,O
of,212,214,O
a,215,216,O
right,217,222,B-Multi-tissue_structure
coronary,223,231,I-Multi-tissue_structure
artery,232,238,I-Multi-tissue_structure
anomalously,239,250,O
arising,251,258,O
from,259,263,O
the,264,267,O
left,268,272,O
sinus,273,278,B-Immaterial_anatomical_entity
of,279,281,O
Valsalva,282,290,O
",",290,291,O
which,292,297,O
was,298,301,O
successfully,302,314,O
treated,315,322,O
by,323,325,O
stent,326,331,O
implantation,332,344,O
.,344,345,O
The,346,349,O
abnormal,350,358,O
origin,359,365,O
of,366,368,O
the,369,372,O
right,373,378,B-Multi-tissue_structure
coronary,379,387,I-Multi-tissue_structure
artery,388,394,I-Multi-tissue_structure
from,395,399,O
the,400,403,O
left,404,408,O
aortic,409,415,B-Immaterial_anatomical_entity
sinus,416,421,I-Immaterial_anatomical_entity
coursing,422,430,O
between,431,438,O
the,439,442,O
aorta,443,448,B-Multi-tissue_structure
and,449,452,O
the,453,456,O
pulmonary,457,466,B-Multi-tissue_structure
trunk,467,472,I-Multi-tissue_structure
is,473,475,O
a,476,477,O
rare,478,482,O
congenital,483,493,O
anomaly,494,501,O
.,501,502,O
It,503,505,O
may,506,509,O
remain,510,516,O
asymptomatic,517,529,O
",",529,530,O
but,531,534,O
can,535,538,O
also,539,543,O
cause,544,549,O
major,550,555,O
cardiac,556,563,B-Organ
events,564,570,O
",",570,571,O
even,572,576,O
in,577,579,O
the,580,583,O
absence,584,591,O
of,592,594,O
coronary,595,603,B-Multi-tissue_structure
atherosclerosis,604,619,O
.,619,620,O
We,621,623,O
discuss,624,631,O
the,632,635,O
clinical,636,644,O
importance,645,655,O
of,656,658,O
this,659,663,O
anomaly,664,671,O
and,672,675,O
review,676,682,O
the,683,686,O
literature,687,697,O
concerning,698,708,O
current,709,716,O
views,717,722,O
and,723,726,O
therapy,727,734,O
.,734,735,O
Determination,0,13,O
of,14,16,O
eprosartan,17,27,O
in,28,30,O
human,31,36,O
plasma,37,43,B-Organism_substance
and,44,47,O
urine,48,53,B-Organism_substance
by,54,56,O
LC,57,59,O
/,59,60,O
MS,60,62,O
/,62,63,O
MS,63,65,O
.,65,66,O
A,67,68,O
protein,69,76,O
precipitation,77,90,O
",",90,91,O
liquid,92,98,O
chromatography,99,113,O
/,113,114,O
tandem,114,120,O
mass,121,125,O
spectrometry,126,138,O
(,139,140,O
LC,140,142,O
/,142,143,O
MS,143,145,O
/,145,146,O
MS,146,148,O
),148,149,O
method,150,156,O
has,157,160,O
been,161,165,O
developed,166,175,O
and,176,179,O
validated,180,189,O
for,190,193,O
the,194,197,O
determination,198,211,O
of,212,214,O
eprosartan,215,225,O
in,226,228,O
human,229,234,O
plasma,235,241,B-Organism_substance
and,242,245,O
urine,246,251,B-Organism_substance
.,251,252,O
The,253,256,O
solvent,257,264,O
system,265,271,O
also,272,276,O
served,277,283,O
as,284,286,O
a,287,288,O
protein,289,296,O
precipitation,297,310,O
reagent,311,318,O
.,318,319,O
The,320,323,O
chromatographic,324,339,O
separation,340,350,O
was,351,354,O
achieved,355,363,O
on,364,366,O
a,367,368,O
CAPCELL,369,376,O
PAK,377,380,O
C18,381,384,O
column,385,391,O
(,392,393,O
50,393,395,O
mmx2,396,400,O
.,400,401,O
0,401,402,O
mm,403,405,O
",",405,406,O
5,407,408,O
microm,409,415,O
",",415,416,O
Shiseido,417,425,O
),425,426,O
.,426,427,O
A,428,429,O
mobile,430,436,O
phase,437,442,O
was,443,446,O
consisted,447,456,O
of,457,459,O
0,460,461,O
.,461,462,O
5,462,463,O
%,463,464,O
formic,465,471,O
acid,472,476,O
in,477,479,O
water,480,485,O
and,486,489,O
0,490,491,O
.,491,492,O
5,492,493,O
%,493,494,O
formic,495,501,O
acid,502,506,O
in,507,509,O
acetonitrile,510,522,O
(,523,524,O
72,524,526,O
:,526,527,O
28,527,529,O
),529,530,O
.,530,531,O
Detection,532,541,O
was,542,545,O
by,546,548,O
positive,549,557,O
ion,558,561,O
electrospray,562,574,O
tandem,575,581,O
mass,582,586,O
spectrometry,587,599,O
on,600,602,O
a,603,604,O
Sciex,605,610,O
API3000,611,618,O
.,618,619,O
The,620,623,O
standard,624,632,O
curves,633,639,O
",",639,640,O
which,641,646,O
ranged,647,653,O
from,654,658,O
5,659,660,O
to,661,663,O
2000,664,668,O
ng,669,671,O
/,671,672,O
mL,672,674,O
in,675,677,O
human,678,683,O
plasma,684,690,B-Organism_substance
and,691,694,O
from,695,699,O
0,700,701,O
.,701,702,O
25,702,704,O
to,705,707,O
50,708,710,O
microg,711,717,O
/,717,718,O
mL,718,720,O
in,721,723,O
urine,724,729,B-Organism_substance
",",729,730,O
were,731,735,O
fitted,736,742,O
to,743,745,O
a,746,747,O
1,748,749,O
/,749,750,O
x,750,751,O
weighted,752,760,O
quadratic,761,770,O
regression,771,781,O
model,782,787,O
.,787,788,O
The,789,792,O
method,793,799,O
proved,800,806,O
to,807,809,O
be,810,812,O
accurate,813,821,O
",",821,822,O
specific,823,831,O
and,832,835,O
sensitive,836,845,O
enough,846,852,O
to,853,855,O
be,856,858,O
successfully,859,871,O
applied,872,879,O
to,880,882,O
a,883,884,O
pharmacokinetic,885,900,O
study,901,906,O
.,906,907,O
[,0,1,O
Synthetic,1,10,O
fragments,11,20,O
of,21,23,O
the,24,27,O
NS1,28,31,O
protein,32,39,O
of,40,42,O
the,43,46,O
tick,47,51,O
-,51,52,O
borne,52,57,O
encephalitis,58,70,O
virus,71,76,O
exhibiting,77,87,O
a,88,89,O
protective,90,100,O
effect,101,107,O
],107,108,O
.,108,109,O
Potentially,110,121,O
immunoactive,122,134,O
regions,135,142,O
of,143,145,O
the,146,149,O
NS1,150,153,O
nonstructural,154,167,O
protein,168,175,O
of,176,178,O
the,179,182,O
tick,183,187,O
-,187,188,O
borne,188,193,O
encephalitis,194,206,O
virus,207,212,O
that,213,217,O
can,218,221,O
stimulate,222,231,O
the,232,235,O
antibody,236,244,O
formation,245,254,O
in,255,257,O
vivo,258,262,O
and,263,266,O
protect,267,274,O
animals,275,282,O
from,283,287,O
this,288,292,O
disease,293,300,O
were,301,305,O
chosen,306,312,O
on,313,315,O
the,316,319,O
basis,320,325,O
of,326,328,O
theoretical,329,340,O
calculations,341,353,O
.,353,354,O
Eleven,355,361,O
16,362,364,O
-,364,365,O
to,366,368,O
27,369,371,O
-,371,372,O
aa,372,374,O
peptides,375,383,O
containing,384,394,O
the,395,398,O
chosen,399,405,O
regions,406,413,O
were,414,418,O
synthesized,419,430,O
.,430,431,O
The,432,435,O
ability,436,443,O
of,444,446,O
the,447,450,O
free,451,455,O
peptides,456,464,O
(,465,466,O
without,466,473,O
any,474,477,O
high,478,482,O
-,482,483,O
molecular,483,492,O
-,492,493,O
mass,493,497,O
carrier,498,505,O
),505,506,O
to,507,509,O
stimulate,510,519,O
the,520,523,O
production,524,534,O
of,535,537,O
antipeptide,538,549,O
antibodies,550,560,O
in,561,563,O
mice,564,568,O
of,569,571,O
three,572,577,O
lines,578,583,O
and,584,587,O
ensure,588,594,O
the,595,598,O
formation,599,608,O
of,609,611,O
protective,612,622,O
immunity,623,631,O
was,632,635,O
studied,636,643,O
.,643,644,O
Most,645,649,O
of,650,652,O
these,653,658,O
peptides,659,667,O
were,668,672,O
shown,673,678,O
to,679,681,O
exhibit,682,689,O
the,690,693,O
immunogenic,694,705,O
activity,706,714,O
in,715,717,O
a,718,719,O
free,720,724,O
state,725,730,O
.,730,731,O
Five,732,736,O
fragments,737,746,O
that,747,751,O
can,752,755,O
protect,756,763,O
mice,764,768,O
from,769,773,O
the,774,777,O
infection,778,787,O
by,788,790,O
a,791,792,O
lethal,793,799,O
dose,800,804,O
of,805,807,O
tick,808,812,O
-,812,813,O
borne,813,818,O
encephalitis,819,831,O
virus,832,837,O
were,838,842,O
found,843,848,O
.,848,849,O
Long,0,4,O
-,4,5,O
term,5,9,O
immunosuppression,10,27,O
in,28,30,O
burned,31,37,O
patients,38,46,O
assessed,47,55,O
by,56,58,O
in,59,61,O
vitro,62,67,O
neutrophil,68,78,B-Cell
oxidative,79,88,O
burst,89,94,O
(,95,96,O
Phagoburst,96,106,O
),106,107,O
.,107,108,O
OBJECTIVE,109,118,O
:,118,119,O
To,120,122,O
assess,123,129,O
the,130,133,O
duration,134,142,O
and,143,146,O
magnitude,147,156,O
of,157,159,O
immunosuppression,160,177,O
induced,178,185,O
by,186,188,O
burns,189,194,O
as,195,197,O
measured,198,206,O
by,207,209,O
the,210,213,O
neutrophil,214,224,B-Cell
oxidative,225,234,O
burst,235,240,O
in,241,243,O
vitro,244,249,O
.,249,250,O
DESIGN,251,257,O
:,257,258,O
Prospective,259,270,O
exploratory,271,282,O
cohort,283,289,O
study,290,295,O
.,295,296,O
SETTING,297,304,O
:,304,305,O
Tertiary,306,314,O
referral,315,323,O
unit,324,328,O
",",328,329,O
University,330,340,O
Hospital,341,349,O
",",349,350,O
Linkoping,351,360,O
",",360,361,O
Sweden,362,368,O
(,369,370,O
National,370,378,O
Burn,379,383,O
Unit,384,388,O
),388,389,O
.,389,390,O
PATIENTS,391,399,O
AND,400,403,O
HEALTHY,404,411,O
VOLUNTEERS,412,422,O
(,423,424,O
CONTROLS,424,432,O
),432,433,O
:,433,434,O
Twenty,435,441,O
-,441,442,O
eight,442,447,O
subjects,448,456,O
consecutively,457,470,O
admitted,471,479,O
to,480,482,O
the,483,486,O
Burn,487,491,O
Unit,492,496,O
.,496,497,O
The,498,501,O
mean,502,506,O
total,507,512,O
burn,513,517,O
surface,518,525,O
area,526,530,O
(,531,532,O
TBSA,532,536,O
%,536,537,O
),537,538,O
was,539,542,O
36,543,545,O
(,546,547,O
range,547,552,O
13,553,555,O
-,555,556,O
87,556,558,O
),558,559,O
and,560,563,O
mean,564,568,O
age,569,572,O
44,573,575,O
years,576,581,O
(,582,583,O
range,583,588,O
14,589,591,O
-,591,592,O
89,592,594,O
),594,595,O
.,595,596,O
Patients,597,605,O
',605,606,O
data,607,611,O
were,612,616,O
collected,617,626,O
prospectively,627,640,O
in,641,643,O
the,644,647,O
burn,648,652,O
unit,653,657,O
",",657,658,O
which,659,664,O
also,665,669,O
included,670,678,O
sequential,679,689,O
organ,690,695,B-Organ
failure,696,703,O
assessment,704,714,O
(,715,716,O
SOFA,716,720,O
),720,721,O
score,722,727,O
.,727,728,O
INTERVENTIONS,729,742,O
:,742,743,O
None,744,748,O
.,748,749,O
MEASUREMENTS,750,762,O
AND,763,766,O
RESULTS,767,774,O
:,774,775,O
To,776,778,O
assess,779,785,O
the,786,789,O
changes,790,797,O
in,798,800,O
the,801,804,O
oxidative,805,814,O
capacity,815,823,O
of,824,826,O
neutrophils,827,838,B-Cell
after,839,844,O
the,845,848,O
burn,849,853,O
",",853,854,O
blood,855,860,B-Organism_substance
samples,861,868,I-Organism_substance
for,869,872,O
the,873,876,O
Phagoburst,877,887,O
analysis,888,896,O
were,897,901,O
taken,902,907,O
on,908,910,O
admission,911,920,O
and,921,924,O
at,925,927,O
least,928,933,O
once,934,938,O
every,939,944,O
second,945,951,O
week,952,956,O
for,957,960,O
the,961,964,O
duration,965,973,O
of,974,976,O
stay,977,981,O
in,982,984,O
hospital,985,993,O
and,994,997,O
thereafter,998,1008,O
monthly,1009,1016,O
up,1017,1019,O
to,1020,1022,O
12,1023,1025,O
months,1026,1032,O
after,1033,1038,O
the,1039,1042,O
burn,1043,1047,O
.,1047,1048,O
Neutrophils,1049,1060,B-Cell
were,1061,1065,O
stimulated,1066,1076,O
in,1077,1079,O
vitro,1080,1085,O
by,1086,1088,O
Escherichia,1089,1100,O
coli,1101,1105,O
",",1105,1106,O
phorbol,1107,1114,O
12,1115,1117,O
-,1117,1118,O
phorbol,1118,1125,O
myristate,1126,1135,O
13,1136,1138,O
-,1138,1139,O
acetate,1139,1146,O
(,1147,1148,O
PMA,1148,1151,O
),1151,1152,O
",",1152,1153,O
and,1154,1157,O
peptide,1158,1165,O
N,1166,1167,O
-,1167,1168,O
formyl,1168,1174,O
-,1174,1175,O
Met,1175,1178,O
-,1178,1179,O
Leu,1179,1182,O
-,1182,1183,O
Phe,1183,1186,O
(,1187,1188,O
fMLP,1188,1192,O
),1192,1193,O
.,1193,1194,O
Oxidative,1195,1204,O
burst,1205,1210,O
was,1211,1214,O
measured,1215,1223,O
by,1224,1226,O
flow,1227,1231,O
cytometry,1232,1241,O
.,1241,1242,O
Oxidative,1243,1252,O
capacity,1253,1261,O
of,1262,1264,O
the,1265,1268,O
neutrophils,1269,1280,B-Cell
decreased,1281,1290,O
similarly,1291,1300,O
for,1301,1304,O
all,1305,1308,O
three,1309,1314,O
stimulants,1315,1325,O
:,1325,1326,O
there,1327,1332,O
was,1333,1336,O
a,1337,1338,O
pathological,1339,1351,O
decrease,1352,1360,O
shortly,1361,1368,O
after,1369,1374,O
admission,1375,1384,O
",",1384,1385,O
with,1386,1390,O
the,1391,1394,O
lowest,1395,1401,O
value,1402,1407,O
occurring,1408,1417,O
between,1418,1425,O
days,1426,1430,O
7,1431,1432,O
and,1433,1436,O
10,1437,1439,O
",",1439,1440,O
followed,1441,1449,O
by,1450,1452,O
a,1453,1454,O
gradual,1455,1462,O
recovery,1463,1471,O
during,1472,1478,O
the,1479,1482,O
ensuing,1483,1490,O
months,1491,1497,O
.,1497,1498,O
Full,1499,1503,O
recovery,1504,1512,O
(,1513,1514,O
to,1514,1516,O
the,1517,1520,O
values,1521,1527,O
of,1528,1530,O
the,1531,1534,O
controls,1535,1543,O
),1543,1544,O
was,1545,1548,O
seen,1549,1553,O
first,1554,1559,O
3,1560,1561,O
.,1561,1562,O
5,1562,1563,O
months,1564,1570,O
after,1571,1576,O
the,1577,1580,O
burn,1581,1585,O
.,1585,1586,O
Using,1587,1592,O
multiple,1593,1601,O
regression,1602,1612,O
",",1612,1613,O
we,1614,1616,O
found,1617,1622,O
that,1623,1627,O
only,1628,1632,O
age,1633,1636,O
and,1637,1640,O
time,1641,1645,O
since,1646,1651,O
the,1652,1655,O
burn,1656,1660,O
significantly,1661,1674,O
(,1675,1676,O
p,1676,1677,O
<,1677,1678,O
0,1678,1679,O
.,1679,1680,O
05,1680,1682,O
),1682,1683,O
affected,1684,1692,O
the,1693,1696,O
oxidative,1697,1706,O
burst,1707,1712,O
.,1712,1713,O
White,1714,1719,B-Cell
cell,1720,1724,I-Cell
count,1725,1730,O
(,1731,1732,O
WCC,1732,1735,O
),1735,1736,O
and,1737,1740,O
C,1741,1742,O
-,1742,1743,O
reactive,1743,1751,O
protein,1752,1759,O
(,1760,1761,O
CRP,1761,1764,O
),1764,1765,O
values,1766,1772,O
returned,1773,1781,O
to,1782,1784,O
reference,1785,1794,O
ranges,1795,1801,O
long,1802,1806,O
before,1807,1813,O
the,1814,1817,O
oxidative,1818,1827,O
burst,1828,1833,O
.,1833,1834,O
CONCLUSIONS,1835,1846,O
:,1846,1847,O
This,1848,1852,O
study,1853,1858,O
provides,1859,1867,O
evidence,1868,1876,O
that,1877,1881,O
immunosuppression,1882,1899,O
in,1900,1902,O
those,1903,1908,O
injured,1909,1916,O
by,1917,1919,O
burns,1920,1925,O
",",1925,1926,O
as,1927,1929,O
assessed,1930,1938,O
by,1939,1941,O
the,1942,1945,O
in,1946,1948,O
vitro,1949,1954,O
oxidative,1955,1964,O
burst,1965,1970,O
of,1971,1973,O
neutrophils,1974,1985,B-Cell
",",1985,1986,O
remains,1987,1994,O
long,1995,1999,O
after,2000,2005,O
the,2006,2009,O
event,2010,2015,O
of,2016,2018,O
the,2019,2022,O
burn,2023,2027,O
(,2028,2029,O
up,2029,2031,O
to,2032,2034,O
3,2035,2036,O
.,2036,2037,O
5,2037,2038,O
months,2039,2045,O
after,2046,2051,O
burn,2052,2056,O
),2056,2057,O
.,2057,2058,O
Absence,2059,2066,O
of,2067,2069,O
correlations,2070,2082,O
to,2083,2085,O
TBSA,2086,2090,O
%,2090,2091,O
",",2091,2092,O
FTB,2093,2096,O
%,2096,2097,O
",",2097,2098,O
blood,2099,2104,B-Organism_substance
transfusion,2105,2116,O
",",2116,2117,O
opiates,2118,2125,O
provided,2126,2134,O
",",2134,2135,O
and,2136,2139,O
multiple,2140,2148,O
organ,2149,2154,B-Organ
failure,2155,2162,O
score,2163,2168,O
and,2169,2172,O
laboratory,2173,2183,O
infection,2184,2193,O
variables,2194,2203,O
together,2204,2212,O
with,2213,2217,O
the,2218,2221,O
finding,2222,2229,O
that,2230,2234,O
decreased,2235,2244,O
oxidative,2245,2254,O
burst,2255,2260,O
was,2261,2264,O
uniform,2265,2272,O
after,2273,2278,O
the,2279,2282,O
injury,2283,2289,O
",",2289,2290,O
suggesting,2291,2301,O
that,2302,2306,O
this,2307,2311,O
immunosuppression,2312,2329,O
is,2330,2332,O
primarily,2333,2342,O
due,2343,2346,O
to,2347,2349,O
the,2350,2353,O
general,2354,2361,O
metabolic,2362,2371,O
response,2372,2380,O
rather,2381,2387,O
than,2388,2392,O
recurring,2393,2402,O
infections,2403,2413,O
.,2413,2414,O
Neurohypophyseal,0,16,B-Pathological_formation
granulomatous,17,30,I-Pathological_formation
germinoma,31,40,I-Pathological_formation
invading,41,49,O
the,50,53,O
right,54,59,B-Immaterial_anatomical_entity
cavernous,60,69,I-Immaterial_anatomical_entity
sinus,70,75,I-Immaterial_anatomical_entity
:,75,76,O
case,77,81,O
report,82,88,O
and,89,92,O
review,93,99,O
of,100,102,O
the,103,106,O
literature,107,117,O
.,117,118,O
We,119,121,O
encountered,122,133,O
a,134,135,O
rare,136,140,O
case,141,145,O
of,146,148,O
neurohypophyseal,149,165,B-Pathological_formation
germinoma,166,175,I-Pathological_formation
with,176,180,O
a,181,182,O
prominent,183,192,O
granulomatous,193,206,O
reaction,207,215,O
",",215,216,O
which,217,222,O
invaded,223,230,O
the,231,234,O
right,235,240,B-Immaterial_anatomical_entity
cavernous,241,250,I-Immaterial_anatomical_entity
sinus,251,256,I-Immaterial_anatomical_entity
.,256,257,O
The,258,261,O
neuroimaging,262,274,O
and,275,278,O
histopathology,279,293,O
features,294,302,O
in,303,305,O
this,306,310,O
case,311,315,O
were,316,320,O
unique,321,327,O
",",327,328,O
distinguishing,329,343,O
it,344,346,O
from,347,351,O
other,352,357,O
types,358,363,O
of,364,366,O
suprasellar,367,378,B-Pathological_formation
lesions,379,386,I-Pathological_formation
.,386,387,O
A,388,389,O
13,390,392,O
-,392,393,O
year,393,397,O
-,397,398,O
old,398,401,O
boy,402,405,O
presented,406,415,O
with,416,420,O
loss,421,425,O
of,426,428,O
appetite,429,437,O
and,438,441,O
polyuria,442,450,O
;,450,451,O
both,452,456,O
symptoms,457,465,O
were,466,470,O
present,471,478,O
for,479,482,O
1,483,484,O
year,485,489,O
",",489,490,O
and,491,494,O
headache,495,503,O
",",503,504,O
general,505,512,O
fatigue,513,520,O
and,521,524,O
blurred,525,532,O
vision,533,539,O
present,540,547,O
for,548,551,O
the,552,555,O
prior,556,561,O
2,562,563,O
months,564,570,O
.,570,571,O
On,572,574,O
admission,575,584,O
",",584,585,O
neurological,586,598,O
examination,599,610,O
indicated,611,620,O
bitemporal,621,631,O
hemianopsia,632,643,O
and,644,647,O
optic,648,653,O
atrophy,654,661,O
.,661,662,O
Endocrinological,663,679,O
exam,680,684,O
showed,685,691,O
panhypopituitarism,692,710,O
.,710,711,O
Tumor,712,717,B-Pathological_formation
markers,718,725,O
such,726,730,O
as,731,733,O
alpha,734,739,O
-,739,740,O
fetoprotein,740,751,O
",",751,752,O
human,753,758,O
growth,759,765,O
hormone,766,773,O
",",773,774,O
carcinoembryonic,775,791,O
antigen,792,799,O
",",799,800,O
and,801,804,O
placental,805,814,B-Organ
alkaline,815,823,O
phosphatase,824,835,O
were,836,840,O
negative,841,849,O
.,849,850,O
Brain,851,856,B-Organ
CT,857,859,O
revealed,860,868,O
a,869,870,O
suprasellar,871,882,B-Pathological_formation
tumor,883,888,I-Pathological_formation
with,889,893,O
calcification,894,907,O
.,907,908,O
MR,909,911,O
T,912,913,O
(,913,914,O
1,914,915,O
),915,916,O
-,916,917,O
weighted,917,925,O
and,926,929,O
T,930,931,O
(,931,932,O
2,932,933,O
),933,934,O
-,934,935,O
weighted,935,943,O
images,944,950,O
showed,951,957,O
the,958,961,O
tumor,962,967,B-Pathological_formation
to,968,970,O
be,971,973,O
isointense,974,984,O
to,985,987,O
normal,988,994,O
brain,995,1000,B-Organ
parenchyma,1001,1011,O
and,1012,1015,O
to,1016,1018,O
be,1019,1021,O
enhanced,1022,1030,O
densely,1031,1038,O
.,1038,1039,O
The,1040,1043,O
tumor,1044,1049,B-Pathological_formation
also,1050,1054,O
involved,1055,1063,O
the,1064,1067,O
right,1068,1073,B-Immaterial_anatomical_entity
cavernous,1074,1083,I-Immaterial_anatomical_entity
sinus,1084,1089,I-Immaterial_anatomical_entity
",",1089,1090,O
so,1091,1093,O
that,1094,1098,O
a,1099,1100,O
biopsy,1101,1107,O
was,1108,1111,O
performed,1112,1121,O
by,1122,1124,O
the,1125,1128,O
transsphenoidal,1129,1144,B-Multi-tissue_structure
approach,1145,1153,O
.,1153,1154,O
On,1155,1157,O
pathologic,1158,1168,O
examination,1169,1180,O
of,1181,1183,O
the,1184,1187,O
specimen,1188,1196,O
",",1196,1197,O
typical,1198,1205,O
large,1206,1211,O
tumor,1212,1217,B-Cell
cells,1218,1223,I-Cell
with,1224,1228,O
lymphocytic,1229,1240,B-Cell
cell,1241,1245,I-Cell
infiltration,1246,1258,O
and,1259,1262,O
prominent,1263,1272,O
granulomatous,1273,1286,O
reaction,1287,1295,O
were,1296,1300,O
observed,1301,1309,O
.,1309,1310,O
Neurohypophyseal,1311,1327,B-Pathological_formation
granulomatous,1328,1341,I-Pathological_formation
germinoma,1342,1351,I-Pathological_formation
was,1352,1355,O
diagnosed,1356,1365,O
.,1365,1366,O
Radiotherapy,1367,1379,O
was,1380,1383,O
performed,1384,1393,O
with,1394,1398,O
a,1399,1400,O
total,1401,1406,O
dose,1407,1411,O
of,1412,1414,O
51,1415,1417,O
Gy,1418,1420,O
and,1421,1424,O
the,1425,1428,O
tumor,1429,1434,B-Pathological_formation
shrank,1435,1441,O
remarkably,1442,1452,O
.,1452,1453,O
The,1454,1457,O
patient,1458,1465,O
returned,1466,1474,O
to,1475,1477,O
school,1478,1484,O
under,1485,1490,O
hormone,1491,1498,O
replacement,1499,1510,O
therapy,1511,1518,O
.,1518,1519,O
Melanoma,0,8,B-Pathological_formation
/,8,9,O
skin,9,13,B-Pathological_formation
cancer,14,20,I-Pathological_formation
screening,21,30,O
clinics,31,38,O
:,38,39,O
experiences,40,51,O
in,52,54,O
The,55,58,O
Netherlands,59,70,O
.,70,71,O
In,72,74,O
1989,75,79,O
and,80,83,O
1990,84,88,O
we,89,91,O
conducted,92,101,O
two,102,105,O
free,106,110,O
melanoma,111,119,B-Pathological_formation
/,119,120,O
skin,120,124,B-Organ
screening,125,134,O
clinics,135,142,O
in,143,145,O
Oss,146,149,O
and,150,153,O
Arnhem,154,160,O
in,161,163,O
the,164,167,O
Netherlands,168,179,O
.,179,180,O
The,181,184,O
study,185,190,O
was,191,194,O
carried,195,202,O
out,203,206,O
along,207,212,O
the,213,216,O
lines,217,222,O
of,223,225,O
the,226,229,O
recent,230,236,O
campaigns,237,246,O
supported,247,256,O
by,257,259,O
the,260,263,O
American,264,272,O
Academy,273,280,O
of,281,283,O
Dermatology,284,295,O
.,295,296,O
Of,297,299,O
2564,300,304,O
persons,305,312,O
screened,313,321,O
",",321,322,O
53,323,325,O
had,326,329,O
melanoma,330,338,B-Pathological_formation
or,339,341,O
nonmelanoma,342,353,B-Pathological_formation
skin,354,358,I-Pathological_formation
cancer,359,365,I-Pathological_formation
(,366,367,O
2,367,368,O
.,368,369,O
1,369,370,O
%,370,371,O
),371,372,O
.,372,373,O
Compliance,374,384,O
with,385,389,O
follow,390,396,O
-,396,397,O
up,397,399,O
for,400,403,O
persons,404,411,O
with,412,416,O
suspected,417,426,O
melanoma,427,435,B-Pathological_formation
/,435,436,O
skin,436,440,B-Pathological_formation
cancer,441,447,I-Pathological_formation
was,448,451,O
adequate,452,460,O
(,461,462,O
93,462,464,O
of,465,467,O
103,468,471,O
;,471,472,O
90,473,475,O
.,475,476,O
3,476,477,O
%,477,478,O
),478,479,O
.,479,480,O
Impact,0,6,O
of,7,9,O
dexamethasone,10,23,O
-,23,24,O
induced,24,31,O
immunosuppression,32,49,O
on,50,52,O
the,53,56,O
duration,57,65,O
and,66,69,O
level,70,75,O
of,76,78,O
shedding,79,87,O
of,88,90,O
Escherichia,91,102,O
coli,103,107,O
O157,108,112,O
:,112,113,O
H7,113,115,O
in,116,118,O
calves,119,125,O
.,125,126,O
The,127,130,O
goal,131,135,O
of,136,138,O
this,139,143,O
study,144,149,O
was,150,153,O
to,154,156,O
determine,157,166,O
whether,167,174,O
immunosuppression,175,192,O
plays,193,198,O
a,199,200,O
role,201,205,O
in,206,208,O
the,209,212,O
level,213,218,O
and,219,222,O
duration,223,231,O
of,232,234,O
fecal,235,240,B-Organism_substance
shedding,241,249,O
of,250,252,O
Escherichia,253,264,O
coli,265,269,O
O157,270,274,O
.,274,275,O
Immunosuppression,276,293,O
was,294,297,O
induced,298,305,O
in,306,308,O
calves,309,315,O
by,316,318,O
administering,319,332,O
dexamethasone,333,346,O
.,346,347,O
Six,348,351,O
1,352,353,O
-,353,354,O
week,354,358,O
-,358,359,O
old,359,362,O
Holstein,363,371,O
bull,372,376,O
calves,377,383,O
were,384,388,O
injected,389,397,O
intramuscularly,398,413,B-Tissue
with,414,418,O
dexamethasone,419,432,O
and,433,436,O
orally,437,443,O
inoculated,444,454,O
with,455,459,O
10,460,462,O
(,462,463,O
9,463,464,O
),464,465,O
CFU,466,469,O
of,470,472,O
a,473,474,O
mixture,475,482,O
of,483,485,O
three,486,491,O
nalidixic,492,501,O
-,501,502,O
acid,502,506,O
resistant,507,516,O
strains,517,524,O
of,525,527,O
E,528,529,O
.,529,530,O
coli,531,535,O
O157,536,540,O
:,540,541,O
H7,541,543,O
.,543,544,O
Five,545,549,O
1,550,551,O
-,551,552,O
week,552,556,O
-,556,557,O
old,557,560,O
Holstein,561,569,O
bull,570,574,O
calves,575,581,O
that,582,586,O
were,587,591,O
given,592,597,O
the,598,601,O
same,602,606,O
oral,607,611,O
inoculation,612,623,O
of,624,626,O
E,627,628,O
.,628,629,O
coli,630,634,O
O157,635,639,O
:,639,640,O
H7,640,642,O
",",642,643,O
but,644,647,O
not,648,651,O
the,652,655,O
dexamethasone,656,669,O
injections,670,680,O
",",680,681,O
served,682,688,O
as,689,691,O
controls,692,700,O
.,700,701,O
All,702,705,O
calves,706,712,O
were,713,717,O
examined,718,726,O
daily,727,732,O
and,733,736,O
fecal,737,742,B-Organism_substance
samples,743,750,O
were,751,755,O
collected,756,765,O
three,766,771,O
times,772,777,O
a,778,779,O
week,780,784,O
for,785,788,O
detection,789,798,O
and,799,802,O
enumeration,803,814,O
of,815,817,O
the,818,821,O
nalidixic,822,831,O
-,831,832,O
acid,832,836,O
resistant,837,846,O
E,847,848,O
.,848,849,O
coli,850,854,O
O157,855,859,O
.,859,860,O
Four,861,865,O
weeks,866,871,O
after,872,877,O
the,878,881,O
last,882,886,O
calf,887,891,O
stopped,892,899,O
shedding,900,908,O
",",908,909,O
all,910,913,O
calves,914,920,O
were,921,925,O
necropsied,926,936,O
and,937,940,O
samples,941,948,O
from,949,953,O
the,954,957,O
gastrointestinal,958,974,B-Organism_subdivision
tract,975,980,I-Organism_subdivision
were,981,985,O
taken,986,991,O
for,992,995,O
the,996,999,O
detection,1000,1009,O
of,1010,1012,O
the,1013,1016,O
nalidixic,1017,1026,O
-,1026,1027,O
acid,1027,1031,O
resistant,1032,1041,O
E,1042,1043,O
.,1043,1044,O
coli,1045,1049,O
O157,1050,1054,O
.,1054,1055,O
Dexamethasone,1056,1069,O
-,1069,1070,O
injected,1070,1078,O
calves,1079,1085,O
shed,1086,1090,O
at,1091,1093,O
higher,1094,1100,O
levels,1101,1107,O
(,1108,1109,O
P,1109,1110,O
=,1111,1112,O
0,1113,1114,O
.,1114,1115,O
04,1115,1117,O
),1117,1118,O
on,1119,1121,O
days,1122,1126,O
4,1127,1128,O
and,1129,1132,O
7,1133,1134,O
postinoculation,1135,1150,O
",",1150,1151,O
but,1152,1155,O
not,1156,1159,O
thereafter,1160,1170,O
.,1170,1171,O
None,1172,1176,O
of,1177,1179,O
the,1180,1183,O
samples,1184,1191,O
collected,1192,1201,O
at,1202,1204,O
necropsy,1205,1213,O
were,1214,1218,O
positive,1219,1227,O
for,1228,1231,O
E,1232,1233,O
.,1233,1234,O
coli,1235,1239,O
O157,1240,1244,O
.,1244,1245,O
Data,1246,1250,O
from,1251,1255,O
this,1256,1260,O
study,1261,1266,O
suggest,1267,1274,O
that,1275,1279,O
there,1280,1285,O
may,1286,1289,O
be,1290,1292,O
a,1293,1294,O
time,1295,1299,O
-,1299,1300,O
dependent,1300,1309,O
relationship,1310,1322,O
between,1323,1330,O
dexamethasone,1331,1344,O
immunosuppression,1345,1362,O
and,1363,1366,O
the,1367,1370,O
fecal,1371,1376,B-Organism_substance
concentration,1377,1390,O
of,1391,1393,O
E,1394,1395,O
.,1395,1396,O
coli,1397,1401,O
O157,1402,1406,O
but,1407,1410,O
that,1411,1415,O
transient,1416,1425,O
immunosuppression,1426,1443,O
does,1444,1448,O
not,1449,1452,O
appear,1453,1459,O
to,1460,1462,O
prolong,1463,1470,O
shedding,1471,1479,O
of,1480,1482,O
E,1483,1484,O
.,1484,1485,O
coli,1486,1490,O
O157,1491,1495,O
.,1495,1496,O
Analysis,0,8,O
of,9,11,O
processivity,12,24,O
of,25,27,O
mungbean,28,36,O
dideoxynucleotide,37,54,O
-,54,55,O
sensitive,55,64,O
DNA,65,68,O
polymerase,69,79,O
and,80,83,O
detection,84,93,O
of,94,96,O
the,97,100,O
activity,101,109,O
and,110,113,O
expression,114,124,O
of,125,127,O
the,128,131,O
enzyme,132,138,O
in,139,141,O
the,142,145,O
meristematic,146,158,B-Tissue
and,159,162,O
meiotic,163,170,B-Tissue
tissues,171,178,I-Tissue
and,179,182,O
following,183,192,O
DNA,193,196,O
damaging,197,205,O
agent,206,211,O
.,211,212,O
Analysis,213,221,O
of,222,224,O
the,225,228,O
processivity,229,241,O
of,242,244,O
mungbean,245,253,O
ddNTP,254,259,O
-,259,260,O
sensitive,260,269,O
DNA,270,273,O
polymerase,274,284,O
showed,285,291,O
the,292,295,O
incorporation,296,309,O
of,310,312,O
approximately,313,326,O
35,327,329,O
-,329,330,O
40,330,332,O
nucleotides,333,344,O
per,345,348,O
binding,349,356,O
event,357,362,O
in,363,365,O
the,366,369,O
replication,370,381,O
assays,382,388,O
involving,389,398,O
M13,399,402,O
ss,403,405,O
DNA,406,409,O
template,410,418,O
with,419,423,O
5,424,425,O
',425,426,O
-,426,427,O
labeled,427,434,O
17,435,437,O
-,437,438,O
mer,438,441,O
primer,442,448,O
.,448,449,O
Optimal,450,457,O
processivity,458,470,O
was,471,474,O
obtained,475,483,O
with,484,488,O
100,489,492,O
-,492,493,O
150,493,496,O
mM,497,499,O
KCl,500,503,O
and,504,507,O
6,508,509,O
-,509,510,O
8,510,511,O
mM,512,514,O
Mg2,515,518,O
+,518,519,O
at,520,522,O
pH,523,525,O
7,526,527,O
.,527,528,O
5,528,529,O
.,529,530,O
The,531,534,O
enzyme,535,541,O
showed,542,548,O
preference,549,559,O
for,560,563,O
Mg2,564,567,O
+,567,568,O
over,569,573,O
Mn2,574,577,O
+,577,578,O
as,579,581,O
the,582,585,O
metal,586,591,O
activator,592,601,O
for,602,605,O
processivity,606,618,O
.,618,619,O
2,620,621,O
',621,622,O
",",622,623,O
3,624,625,O
',625,626,O
dideoxythymidine,627,643,O
5,644,645,O
',645,646,O
triphosphate,647,659,O
(,660,661,O
ddTTP,661,666,O
),666,667,O
and,668,671,O
rat,672,675,O
DNA,676,679,O
pol,680,683,O
beta,684,688,O
antibody,689,697,O
strongly,698,706,O
influenced,707,717,O
distributive,718,730,O
synthesis,731,740,O
.,740,741,O
Considerable,742,754,O
enhancement,755,766,O
in,767,769,O
processivity,770,782,O
was,783,786,O
noticed,787,794,O
at,795,797,O
1mM,798,801,O
ATP,802,805,O
and,806,809,O
2,810,811,O
-,811,812,O
4,812,813,O
mM,814,816,O
spermidine,817,827,O
while,828,833,O
higher,834,840,O
concentrations,841,855,O
of,856,858,O
spermidine,859,869,O
caused,870,876,O
distributive,877,889,O
synthesis,890,899,O
.,899,900,O
The,901,904,O
enzyme,905,911,O
was,912,915,O
found,916,921,O
to,922,924,O
be,925,927,O
active,928,934,O
in,935,937,O
both,938,942,O
meristematic,943,955,B-Tissue
and,956,959,O
meiotic,960,967,B-Tissue
tissues,968,975,I-Tissue
and,976,979,O
distinctly,980,990,O
induced,991,998,O
by,999,1001,O
EMS,1002,1005,O
treatment,1006,1015,O
.,1015,1016,O
DNA,1017,1020,O
-,1020,1021,O
binding,1021,1028,O
assays,1029,1035,O
revealed,1036,1044,O
distinct,1045,1053,O
binding,1054,1061,O
ability,1062,1069,O
of,1070,1072,O
the,1073,1076,O
enzyme,1077,1083,O
to,1084,1086,O
template,1087,1095,O
/,1095,1096,O
primer,1096,1102,O
and,1103,1106,O
damaged,1107,1114,O
DNA,1115,1118,O
substrate,1119,1128,O
.,1128,1129,O
Together,1130,1138,O
these,1139,1144,O
observations,1145,1157,O
illustrate,1158,1168,O
the,1169,1172,O
probable,1173,1181,O
involvement,1182,1193,O
of,1194,1196,O
the,1197,1200,O
enzyme,1201,1207,O
in,1208,1210,O
replication,1211,1222,O
and,1223,1226,O
repair,1227,1233,O
machinery,1234,1243,O
in,1244,1246,O
higher,1247,1253,O
plants,1254,1260,O
.,1260,1261,O
The,0,3,O
detection,4,13,O
of,14,16,O
macrosomia,17,27,O
at,28,30,O
a,31,32,O
teaching,33,41,O
hospital,42,50,O
.,50,51,O
We,52,54,O
sought,55,61,O
to,62,64,O
determine,65,74,O
the,75,78,O
detection,79,88,O
(,89,90,O
clinical,90,98,O
or,99,101,O
sonographic,102,113,O
),113,114,O
rate,115,119,O
of,120,122,O
macrosomic,123,133,O
newborns,134,142,O
(,143,144,O
at,144,146,O
least,147,152,O
4000,153,157,O
g,158,159,O
),159,160,O
and,161,164,O
the,165,168,O
peripartum,169,179,O
factors,180,187,O
among,188,193,O
those,194,199,O
who,200,203,O
were,204,208,O
or,209,211,O
were,212,216,O
not,217,220,O
identified,221,231,O
accurately,232,242,O
.,242,243,O
We,244,246,O
retrospectively,247,262,O
reviewed,263,271,O
all,272,275,O
deliveries,276,286,O
over,287,291,O
1,292,293,O
year,294,298,O
and,299,302,O
all,303,306,O
maternal,307,315,O
and,316,319,O
neonatal,320,328,O
charts,329,335,O
of,336,338,O
macrosomic,339,349,O
newborns,350,358,O
delivered,359,368,O
during,369,375,O
that,376,380,O
year,381,385,O
.,385,386,O
Odds,387,391,O
ratio,392,397,O
(,398,399,O
ORs,399,402,O
),402,403,O
and,404,407,O
95,408,410,O
%,410,411,O
confidence,412,422,O
intervals,423,432,O
(,433,434,O
CIs,434,437,O
),437,438,O
were,439,443,O
calculated,444,454,O
.,454,455,O
Over,456,460,O
a,461,462,O
12,463,465,O
-,465,466,O
month,466,471,O
period,472,478,O
",",478,479,O
the,480,483,O
rate,484,488,O
of,489,491,O
macrosomia,492,502,O
was,503,506,O
10,507,509,O
%,509,510,O
(,511,512,O
421,512,515,O
/,515,516,O
4194,516,520,O
),520,521,O
and,522,525,O
of,526,528,O
those,529,534,O
",",534,535,O
only,536,540,O
11,541,543,O
%,543,544,O
(,545,546,O
95,546,548,O
%,548,549,O
CI,550,552,O
8,553,554,O
to,555,557,O
14,558,560,O
%,560,561,O
),561,562,O
were,563,567,O
suspected,568,577,O
clinically,578,588,O
or,589,591,O
sonographically,592,607,O
.,607,608,O
None,609,613,O
of,614,616,O
the,617,620,O
newborns,621,629,O
weighing,630,638,O
4500,639,643,O
g,644,645,O
or,646,648,O
more,649,653,O
were,654,658,O
recognized,659,669,O
before,670,676,O
birth,677,682,O
(,683,684,O
0,684,685,O
/,685,686,O
57,686,688,O
;,688,689,O
95,690,692,O
%,692,693,O
CI,694,696,O
0,697,698,O
to,699,701,O
6,702,703,O
%,703,704,O
),704,705,O
.,705,706,O
The,707,710,O
rate,711,715,O
of,716,718,O
cesarean,719,727,O
delivery,728,736,O
was,737,740,O
significantly,741,754,O
higher,755,761,O
among,762,767,O
newborns,768,776,O
correctly,777,786,O
identified,787,797,O
as,798,800,O
macrosomic,801,811,O
(,812,813,O
58,813,815,O
%,815,816,O
),816,817,O
versus,818,824,O
those,825,830,O
missed,831,837,O
(,838,839,O
36,839,841,O
%,841,842,O
;,842,843,O
OR,844,846,O
2,847,848,O
.,848,849,O
76,849,851,O
",",851,852,O
95,853,855,O
%,855,856,O
CI,857,859,O
1,860,861,O
.,861,862,O
46,862,864,O
",",864,865,O
5,866,867,O
.,867,868,O
16,868,870,O
),870,871,O
.,871,872,O
The,873,876,O
incidence,877,886,O
of,887,889,O
newborns,890,898,O
weighing,899,907,O
in,908,910,O
excess,911,917,O
of,918,920,O
4000,921,925,O
g,926,927,O
is,928,930,O
10,931,933,O
%,933,934,O
",",934,935,O
and,936,939,O
approximately,940,953,O
90,954,956,O
%,956,957,O
of,958,960,O
these,961,966,O
macrosomic,967,977,O
newborns,978,986,O
were,987,991,O
unsuspected,992,1003,O
before,1004,1010,O
birth,1011,1016,O
.,1016,1017,O
Heart,0,5,B-Organ
sound,6,11,O
and,12,15,O
electrocardiogram,16,33,O
recording,34,43,O
devices,44,51,O
for,52,55,O
telemedicine,56,68,O
environments,69,81,O
.,81,82,O
There,83,88,O
is,89,91,O
currently,92,101,O
a,102,103,O
worldwide,104,113,O
trend,114,119,O
to,120,122,O
bring,123,128,O
healthcare,129,139,O
services,140,148,O
as,149,151,O
close,152,157,O
as,158,160,O
possible,161,169,O
to,170,172,O
the,173,176,O
patient,177,184,O
",",184,185,O
either,186,192,O
through,193,200,O
home,201,205,O
healthcare,206,216,O
systems,217,224,O
",",224,225,O
or,226,228,O
telemedicine,229,241,O
.,241,242,O
There,243,248,O
is,249,251,O
thus,252,256,O
a,257,258,O
general,259,266,O
need,267,271,O
for,272,275,O
equipment,276,285,O
that,286,290,O
can,291,294,O
capture,295,302,O
patient,303,310,O
data,311,315,O
electronically,316,330,O
for,331,334,O
automated,335,344,O
review,345,351,O
or,352,354,O
analysis,355,363,O
by,364,366,O
a,367,368,O
medical,369,376,O
practitioner,377,389,O
.,389,390,O
This,391,395,O
paper,396,401,O
presents,402,410,O
prototype,411,420,O
systems,421,428,O
that,429,433,O
were,434,438,O
developed,439,448,O
with,449,453,O
the,454,457,O
ultimate,458,466,O
aim,467,470,O
for,471,474,O
use,475,478,O
in,479,481,O
telemedicine,482,494,O
settings,495,503,O
in,504,506,O
rural,507,512,O
Africa,513,519,O
.,519,520,O
These,521,526,O
devices,527,534,O
can,535,538,O
be,539,541,O
used,542,546,O
to,547,549,O
electronically,550,564,O
capture,565,572,O
data,573,577,O
on,578,580,O
patients,581,589,O
from,590,594,O
several,595,602,O
sensors,603,610,O
in,611,613,O
a,614,615,O
quick,616,621,O
an,622,624,O
easy,625,629,O
manner,630,636,O
.,636,637,O
In,638,640,O
our,641,644,O
presented,645,654,O
cases,655,660,O
we,661,663,O
focus,664,669,O
on,670,672,O
cardiovascular,673,687,B-Anatomical_system
information,688,699,O
.,699,700,O
One,701,704,O
of,705,707,O
the,708,711,O
main,712,716,O
advantages,717,727,O
of,728,730,O
the,731,734,O
proposed,735,743,O
systems,744,751,O
is,752,754,O
that,755,759,O
the,760,763,O
data,764,768,O
are,769,772,O
captured,773,781,O
simultaneously,782,796,O
from,797,801,O
multiple,802,810,O
sensors,811,818,O
.,818,819,O
The,820,823,O
data,824,828,O
can,829,832,O
be,833,835,O
stored,836,842,O
and,843,846,O
sent,847,851,O
electronically,852,866,O
for,867,870,O
review,871,877,O
and,878,881,O
analysis,882,890,O
",",890,891,O
and,892,895,O
knowledge,896,905,O
-,905,906,O
based,906,911,O
systems,912,919,O
or,920,922,O
neural,923,929,O
network,930,937,O
type,938,942,O
models,943,949,O
can,950,953,O
be,954,956,O
used,957,961,O
in,962,964,O
the,965,968,O
future,969,975,O
for,976,979,O
semi,980,984,O
-,984,985,O
autonomous,985,995,O
screening,996,1005,O
of,1006,1008,O
the,1009,1012,O
recordings,1013,1023,O
",",1023,1024,O
before,1025,1031,O
a,1032,1033,O
patient,1034,1041,O
is,1042,1044,O
referred,1045,1053,O
to,1054,1056,O
a,1057,1058,O
specialist,1059,1069,O
.,1069,1070,O
An,0,2,O
introduction,3,15,O
to,16,18,O
evidence,19,27,O
-,27,28,O
based,28,33,O
practice,34,42,O
for,43,46,O
hand,47,51,B-Organism_subdivision
surgeons,52,60,O
and,61,64,O
therapists,65,75,O
.,75,76,O
Evidence,77,85,O
-,85,86,O
based,86,91,O
practice,92,100,O
is,101,103,O
a,104,105,O
methodical,106,116,O
approach,117,125,O
to,126,128,O
clinical,129,137,O
practice,138,146,O
where,147,152,O
experience,153,163,O
",",163,164,O
best,165,169,O
research,170,178,O
evidence,179,187,O
",",187,188,O
and,189,192,O
patient,193,200,O
goals,201,206,O
and,207,210,O
values,211,217,O
are,218,221,O
integrated,222,232,O
to,233,235,O
make,236,240,O
optimal,241,248,O
decisions,249,258,O
when,259,263,O
making,264,270,O
a,271,272,O
diagnosis,273,282,O
",",282,283,O
selecting,284,293,O
a,294,295,O
diagnostic,296,306,O
test,307,311,O
",",311,312,O
picking,313,320,O
an,321,323,O
intervention,324,336,O
or,337,339,O
determining,340,351,O
prognosis,352,361,O
.,361,362,O
There,363,368,O
are,369,372,O
five,373,377,O
steps,378,383,O
in,384,386,O
this,387,391,O
process,392,399,O
.,399,400,O
Hand,401,405,B-Organism_subdivision
surgeons,406,414,O
and,415,418,O
therapists,419,429,O
can,430,433,O
use,434,437,O
the,438,441,O
evidence,442,450,O
-,450,451,O
based,451,456,O
process,457,464,O
to,465,467,O
attain,468,474,O
optimal,475,482,O
management,483,493,O
of,494,496,O
individual,497,507,O
patients,508,516,O
",",516,517,O
manage,518,524,O
their,525,530,O
overall,531,538,O
practice,539,547,O
",",547,548,O
guide,549,554,O
the,555,558,O
ongoing,559,566,O
professional,567,579,O
development,580,591,O
",",591,592,O
and,593,596,O
deal,597,601,O
with,602,606,O
funding,607,614,O
and,615,618,O
policy,619,625,O
makers,626,632,O
.,632,633,O
Prolonged,0,9,O
control,10,17,O
of,18,20,O
patterned,21,30,O
biofilm,31,38,B-Cell
formation,39,48,O
by,49,51,O
bio,52,55,O
-,55,56,O
inert,56,61,O
surface,62,69,O
chemistry,70,79,O
.,79,80,O
A,81,82,O
bio,83,86,O
-,86,87,O
inert,87,92,O
surface,93,100,O
chemistry,101,110,O
was,111,114,O
developed,115,124,O
that,125,129,O
can,130,133,O
confine,134,141,O
biofilm,142,149,B-Cell
formation,150,159,O
in,160,162,O
designed,163,171,O
patterns,172,180,O
for,181,184,O
at,185,187,O
least,188,193,O
26,194,196,O
days,197,201,O
.,201,202,O
Women,0,5,O
',5,6,O
s,6,7,O
attitudes,8,17,O
",",17,18,O
preferences,19,30,O
",",30,31,O
and,32,35,O
perceived,36,45,O
barriers,46,54,O
to,55,57,O
treatment,58,67,O
for,68,71,O
perinatal,72,81,O
depression,82,92,O
.,92,93,O
BACKGROUND,94,104,O
:,104,105,O
Perinatal,106,115,O
depression,116,126,O
is,127,129,O
associated,130,140,O
with,141,145,O
potential,146,155,O
negative,156,164,O
consequences,165,177,O
for,178,181,O
the,182,185,O
mother,186,192,O
and,193,196,O
infant,197,203,O
",",203,204,O
and,205,208,O
therefore,209,218,O
efforts,219,226,O
to,227,229,O
improve,230,237,O
treatment,238,247,O
access,248,254,O
and,255,258,O
efficacy,259,267,O
are,268,271,O
warranted,272,281,O
.,281,282,O
The,283,286,O
purpose,287,294,O
of,295,297,O
this,298,302,O
study,303,308,O
was,309,312,O
to,313,315,O
examine,316,323,O
pregnant,324,332,O
women,333,338,O
',338,339,O
s,339,340,O
preferences,341,352,O
and,353,356,O
attitudes,357,366,O
about,367,372,O
treatment,373,382,O
for,383,386,O
depression,387,397,O
",",397,398,O
and,399,402,O
perceived,403,412,O
potential,413,422,O
barriers,423,431,O
to,432,434,O
accessing,435,444,O
treatment,445,454,O
.,454,455,O
METHODS,456,463,O
:,463,464,O
Data,465,469,O
were,470,474,O
collected,475,484,O
by,485,487,O
means,488,493,O
of,494,496,O
a,497,498,O
questionnaire,499,512,O
from,513,517,O
a,518,519,O
convenience,520,531,O
sample,532,538,O
of,539,541,O
509,542,545,O
predominantly,546,559,O
well,560,564,O
-,564,565,O
educated,565,573,O
",",573,574,O
high,575,579,O
-,579,580,O
income,580,586,O
",",586,587,O
married,588,595,O
women,596,601,O
in,602,604,O
the,605,608,O
northeastern,609,621,O
United,622,628,O
States,629,635,O
during,636,642,O
the,643,646,O
last,647,651,O
trimester,652,661,O
of,662,664,O
pregnancy,665,674,O
.,674,675,O
Participants,676,688,O
were,689,693,O
queried,694,701,O
as,702,704,O
to,705,707,O
treatment,708,717,O
modalities,718,728,O
in,729,731,O
which,732,737,O
they,738,742,O
would,743,748,O
most,749,753,O
likely,754,760,O
participate,761,772,O
if,773,775,O
they,776,780,O
wanted,781,787,O
help,788,792,O
for,793,796,O
depression,797,807,O
",",807,808,O
their,809,814,O
attitudes,815,824,O
toward,825,831,O
psychotherapeutic,832,849,O
and,850,853,O
pharmacological,854,869,O
treatments,870,880,O
",",880,881,O
and,882,885,O
perceived,886,895,O
barriers,896,904,O
to,905,907,O
receiving,908,917,O
help,918,922,O
.,922,923,O
RESULTS,924,931,O
:,931,932,O
Most,933,937,O
women,938,943,O
(,944,945,O
92,945,947,O
%,947,948,O
),948,949,O
indicated,950,959,O
that,960,964,O
would,965,970,O
likely,971,977,O
participate,978,989,O
in,990,992,O
individual,993,1003,O
therapy,1004,1011,O
if,1012,1014,O
help,1015,1019,O
was,1020,1023,O
needed,1024,1030,O
.,1030,1031,O
Only,1032,1036,O
35,1037,1039,O
percent,1040,1047,O
stated,1048,1054,O
that,1055,1059,O
they,1060,1064,O
would,1065,1070,O
likely,1071,1077,O
take,1078,1082,O
medication,1083,1093,O
if,1094,1096,O
recommended,1097,1108,O
",",1108,1109,O
and,1110,1113,O
14,1114,1116,O
percent,1117,1124,O
indicated,1125,1134,O
that,1135,1139,O
they,1140,1144,O
would,1145,1150,O
participate,1151,1162,O
in,1163,1165,O
group,1166,1171,O
therapy,1172,1179,O
.,1179,1180,O
The,1181,1184,O
greatest,1185,1193,O
perceived,1194,1203,O
potential,1204,1213,O
barriers,1214,1222,O
to,1223,1225,O
treatment,1226,1235,O
were,1236,1240,O
lack,1241,1245,O
of,1246,1248,O
time,1249,1253,O
(,1254,1255,O
65,1255,1257,O
%,1257,1258,O
),1258,1259,O
",",1259,1260,O
stigma,1261,1267,O
(,1268,1269,O
43,1269,1271,O
%,1271,1272,O
),1272,1273,O
",",1273,1274,O
and,1275,1278,O
childcare,1279,1288,O
issues,1289,1295,O
(,1296,1297,O
33,1297,1299,O
%,1299,1300,O
),1300,1301,O
.,1301,1302,O
Most,1303,1307,O
women,1308,1313,O
indicated,1314,1323,O
a,1324,1325,O
preference,1326,1336,O
to,1337,1339,O
receive,1340,1347,O
mental,1348,1354,O
health,1355,1361,O
care,1362,1366,O
at,1367,1369,O
the,1370,1373,O
obstetrics,1374,1384,O
clinic,1385,1391,O
",",1391,1392,O
either,1393,1399,O
from,1400,1404,O
their,1405,1410,O
obstetrics,1411,1421,O
practitioner,1422,1434,O
or,1435,1437,O
from,1438,1442,O
a,1443,1444,O
mental,1445,1451,O
health,1452,1458,O
practitioner,1459,1471,O
located,1472,1479,O
at,1480,1482,O
the,1483,1486,O
clinic,1487,1493,O
.,1493,1494,O
Factors,1495,1502,O
associated,1503,1513,O
with,1514,1518,O
acceptability,1519,1532,O
of,1533,1535,O
various,1536,1543,O
depression,1544,1554,O
treatments,1555,1565,O
are,1566,1569,O
presented,1570,1579,O
.,1579,1580,O
CONCLUSIONS,1581,1592,O
:,1592,1593,O
Understanding,1594,1607,O
what,1608,1612,O
prevents,1613,1621,O
women,1622,1627,O
from,1628,1632,O
seeking,1633,1640,O
or,1641,1643,O
obtaining,1644,1653,O
help,1654,1658,O
for,1659,1662,O
depression,1663,1673,O
and,1674,1677,O
determining,1678,1689,O
what,1690,1694,O
they,1695,1699,O
prefer,1700,1706,O
in,1707,1709,O
the,1710,1713,O
way,1714,1717,O
of,1718,1720,O
treatment,1721,1730,O
may,1731,1734,O
lead,1735,1739,O
to,1740,1742,O
improved,1743,1751,O
depression,1752,1762,O
treatment,1763,1772,O
rates,1773,1778,O
and,1779,1782,O
hold,1783,1787,O
promise,1788,1795,O
for,1796,1799,O
improving,1800,1809,O
the,1810,1813,O
overall,1814,1821,O
health,1822,1828,O
of,1829,1831,O
childbearing,1832,1844,O
women,1845,1850,O
.,1850,1851,O
The,0,3,O
impact,4,10,O
of,11,13,O
tracheal,14,22,B-Multi-tissue_structure
intubation,23,33,O
on,34,36,O
host,37,41,O
defenses,42,50,O
and,51,54,O
risks,55,60,O
for,61,64,O
nosocomial,65,75,O
pneumonia,76,85,O
.,85,86,O
Nosocomial,87,97,O
pneumonia,98,107,O
remains,108,115,O
a,116,117,O
common,118,124,O
complication,125,137,O
in,138,140,O
patients,141,149,O
treated,150,157,O
with,158,162,O
endotracheal,163,175,O
intubation,176,186,O
and,187,190,O
mechanical,191,201,O
ventilation,202,213,O
and,214,217,O
continues,218,227,O
to,228,230,O
have,231,235,O
a,236,237,O
significant,238,249,O
impact,250,256,O
on,257,259,O
the,260,263,O
mortality,264,273,O
rate,274,278,O
of,279,281,O
these,282,287,O
patients,288,296,O
.,296,297,O
Epidemiologic,298,311,O
studies,312,319,O
have,320,324,O
shown,325,330,O
that,331,335,O
the,336,339,O
risk,340,344,O
of,345,347,O
pneumonia,348,357,O
increases,358,367,O
with,368,372,O
the,373,376,O
duration,377,385,O
of,386,388,O
intubation,389,399,O
but,400,403,O
that,404,408,O
the,409,412,O
period,413,419,O
of,420,422,O
highest,423,430,O
risk,431,435,O
is,436,438,O
the,439,442,O
first,443,448,O
2,449,450,O
weeks,451,456,O
of,457,459,O
therapy,460,467,O
.,467,468,O
Gram,469,473,O
-,473,474,O
negative,474,482,O
bacteria,483,491,O
account,492,499,O
for,500,503,O
most,504,508,O
nosocomial,509,519,O
pneumonias,520,530,O
in,531,533,O
intubated,534,543,O
patients,544,552,O
",",552,553,O
but,554,557,O
Staphylococcus,558,572,O
aureus,573,579,O
may,580,583,O
also,584,588,O
play,589,593,O
a,594,595,O
role,596,600,O
in,601,603,O
what,604,608,O
may,609,612,O
be,613,615,O
a,616,617,O
polymicrobial,618,631,O
infection,632,641,O
.,641,642,O
In,643,645,O
the,646,649,O
most,650,654,O
seriously,655,664,O
ill,665,668,O
individuals,669,680,O
",",680,681,O
and,682,685,O
in,686,688,O
those,689,694,O
treated,695,702,O
with,703,707,O
long,708,712,O
-,712,713,O
term,713,717,O
mechanical,718,728,O
ventilation,729,740,O
",",740,741,O
Pseudomonas,742,753,O
aeruginosa,754,764,O
is,765,767,O
a,768,769,O
common,770,776,O
pathogen,777,785,O
.,785,786,O
Endotracheal,787,799,O
intubation,800,810,O
and,811,814,O
mechanical,815,825,O
ventilation,826,837,O
predispose,838,848,O
to,849,851,O
pneumonia,852,861,O
for,862,865,O
a,866,867,O
variety,868,875,O
of,876,878,O
reasons,879,886,O
(,887,888,O
see,888,891,O
Fig,892,895,O
.,895,896,O
1,897,898,O
),898,899,O
.,899,900,O
The,901,904,O
endotracheal,905,917,B-Multi-tissue_structure
tube,918,922,I-Multi-tissue_structure
can,923,926,O
have,927,931,O
direct,932,938,O
effects,939,946,O
on,947,949,O
the,950,953,O
airway,954,960,B-Multi-tissue_structure
that,961,965,O
result,966,972,O
in,973,975,O
a,976,977,O
reduction,978,987,O
in,988,990,O
local,991,996,O
host,997,1001,O
defenses,1002,1010,O
.,1010,1011,O
Thus,1012,1016,O
",",1016,1017,O
mucosal,1018,1025,B-Multi-tissue_structure
injury,1026,1032,O
can,1033,1036,O
reduce,1037,1043,O
mucociliary,1044,1055,B-Tissue
function,1056,1064,O
",",1064,1065,O
while,1066,1071,O
upper,1072,1077,O
airway,1078,1084,B-Multi-tissue_structure
defenses,1085,1093,O
are,1094,1097,O
bypassed,1098,1106,O
and,1107,1110,O
the,1111,1114,O
effectiveness,1115,1128,O
of,1129,1131,O
cough,1132,1137,O
is,1138,1140,O
reduced,1141,1148,O
.,1148,1149,O
Indirectly,1150,1160,O
",",1160,1161,O
intubation,1162,1172,O
can,1173,1176,O
result,1177,1183,O
in,1184,1186,O
an,1187,1189,O
enhanced,1190,1198,O
capacity,1199,1207,O
of,1208,1210,O
tracheobronchial,1211,1227,B-Cell
cells,1228,1233,I-Cell
to,1234,1236,O
bind,1237,1241,O
gram,1242,1246,O
-,1246,1247,O
negative,1247,1255,O
bacteria,1256,1264,O
",",1264,1265,O
an,1266,1268,O
effect,1269,1275,O
that,1276,1280,O
favors,1281,1287,O
airway,1288,1294,B-Multi-tissue_structure
colonization,1295,1307,O
and,1308,1311,O
pneumonia,1312,1321,O
.,1321,1322,O
The,1323,1326,O
injury,1327,1333,O
to,1334,1336,O
the,1337,1340,O
airway,1341,1347,B-Multi-tissue_structure
can,1348,1351,O
create,1352,1358,O
binding,1359,1366,O
sites,1367,1372,O
for,1373,1376,O
bacteria,1377,1385,O
in,1386,1388,O
the,1389,1392,O
basement,1393,1401,B-Multi-tissue_structure
membrane,1402,1410,I-Multi-tissue_structure
of,1411,1413,O
the,1414,1417,O
bronchial,1418,1427,B-Multi-tissue_structure
tree,1428,1432,I-Multi-tissue_structure
and,1433,1436,O
the,1437,1440,O
stimulation,1441,1452,O
of,1453,1455,O
the,1456,1459,O
secretion,1460,1469,O
of,1470,1472,O
mucus,1473,1478,B-Organism_substance
",",1478,1479,O
which,1480,1485,O
then,1486,1490,O
stagnates,1491,1500,O
and,1501,1504,O
can,1505,1508,O
create,1509,1515,O
potential,1516,1525,O
sites,1526,1531,O
for,1532,1535,O
bacterial,1536,1545,O
adherence,1546,1555,O
.,1555,1556,O
The,1557,1560,O
endotracheal,1561,1573,B-Multi-tissue_structure
tube,1574,1578,I-Multi-tissue_structure
also,1579,1583,O
enhances,1584,1592,O
bacterial,1593,1602,O
entry,1603,1608,O
to,1609,1611,O
the,1612,1615,O
lung,1616,1620,B-Organ
by,1621,1623,O
serving,1624,1631,O
as,1632,1634,O
a,1635,1636,O
reservoir,1637,1646,O
for,1647,1650,O
bacteria,1651,1659,O
to,1660,1662,O
remain,1663,1669,O
sequestered,1670,1681,O
",",1681,1682,O
safe,1683,1687,O
from,1688,1692,O
host,1693,1697,O
defenses,1698,1706,O
.,1706,1707,O
Respiratory,1708,1719,O
therapy,1720,1727,O
devices,1728,1735,O
can,1736,1739,O
allow,1740,1745,O
bacteria,1746,1754,O
to,1755,1757,O
proliferate,1758,1769,O
and,1770,1773,O
can,1774,1777,O
then,1778,1782,O
introduce,1783,1792,O
them,1793,1797,O
into,1798,1802,O
the,1803,1806,O
patient,1807,1814,O
if,1815,1817,O
not,1818,1821,O
handled,1822,1829,O
properly,1830,1838,O
.,1838,1839,O
Finally,1840,1847,O
",",1847,1848,O
patients,1849,1857,O
who,1858,1861,O
are,1862,1865,O
ill,1866,1869,O
enough,1870,1876,O
to,1877,1879,O
require,1880,1887,O
intubation,1888,1898,O
also,1899,1903,O
have,1904,1908,O
disease,1909,1916,O
-,1916,1917,O
associated,1917,1927,O
impairments,1928,1939,O
in,1940,1942,O
systemic,1943,1951,O
host,1952,1956,O
defense,1957,1964,O
",",1964,1965,O
which,1966,1971,O
add,1972,1975,O
to,1976,1978,O
the,1979,1982,O
impairments,1983,1994,O
caused,1995,2001,O
by,2002,2004,O
the,2005,2008,O
use,2009,2012,O
of,2013,2015,O
an,2016,2018,O
artificial,2019,2029,O
airway,2030,2036,B-Multi-tissue_structure
.,2036,2037,O
The,2038,2041,O
host,2042,2046,O
defense,2047,2054,O
impairments,2055,2066,O
that,2067,2071,O
occur,2072,2077,O
in,2078,2080,O
mechanically,2081,2093,O
ventilated,2094,2104,O
patients,2105,2113,O
can,2114,2117,O
lead,2118,2122,O
to,2123,2125,O
respiratory,2126,2137,B-Multi-tissue_structure
tract,2138,2143,I-Multi-tissue_structure
infection,2144,2153,O
in,2154,2156,O
the,2157,2160,O
form,2161,2165,O
of,2166,2168,O
either,2169,2175,O
febrile,2176,2183,O
tracheobronchitis,2184,2201,O
or,2202,2204,O
pneumonia,2205,2214,O
.,2214,2215,O
The,2216,2219,O
diagnosis,2220,2229,O
of,2230,2232,O
pneumonia,2233,2242,O
in,2243,2245,O
intubated,2246,2255,O
patients,2256,2264,O
is,2265,2267,O
difficult,2268,2277,O
and,2278,2281,O
controversial,2282,2295,O
.,2295,2296,O
It,2297,2299,O
can,2300,2303,O
be,2304,2306,O
made,2307,2311,O
by,2312,2314,O
either,2315,2321,O
clinical,2322,2330,O
criteria,2331,2339,O
or,2340,2342,O
microbiologic,2343,2356,O
criteria,2357,2365,O
",",2365,2366,O
the,2367,2370,O
latter,2371,2377,O
by,2378,2380,O
using,2381,2386,O
a,2387,2388,O
bronchoscopically,2389,2406,O
directed,2407,2415,O
protected,2416,2425,O
specimen,2426,2434,O
brush,2435,2440,O
.,2440,2441,O
Therapy,2442,2449,O
of,2450,2452,O
pneumonia,2453,2462,O
in,2463,2465,O
mechanically,2466,2478,O
ventilated,2479,2489,O
patients,2490,2498,O
is,2499,2501,O
not,2502,2505,O
always,2506,2512,O
successful,2513,2523,O
",",2523,2524,O
and,2525,2528,O
systemic,2529,2537,O
antibiotics,2538,2549,O
may,2550,2553,O
need,2554,2558,O
to,2559,2561,O
be,2562,2564,O
supplemented,2565,2577,O
by,2578,2580,O
topical,2581,2588,O
antimicrobials,2589,2603,O
.,2603,2604,O
No,2605,2607,O
clearly,2608,2615,O
effective,2616,2625,O
prophylactic,2626,2638,O
strategy,2639,2647,O
currently,2648,2657,O
exists,2658,2664,O
",",2664,2665,O
but,2666,2669,O
our,2670,2673,O
understanding,2674,2687,O
of,2688,2690,O
pneumonia,2691,2700,O
pathogenesis,2701,2713,O
has,2714,2717,O
led,2718,2721,O
to,2722,2724,O
some,2725,2729,O
promising,2730,2739,O
directions,2740,2750,O
.,2750,2751,O
As,2752,2754,O
more,2755,2759,O
data,2760,2764,O
are,2765,2768,O
collected,2769,2778,O
",",2778,2779,O
inhaled,2780,2787,O
antibiotics,2788,2799,O
",",2799,2800,O
selective,2801,2810,O
digestive,2811,2820,O
decontamination,2821,2836,O
",",2836,2837,O
and,2838,2841,O
enhancement,2842,2853,O
of,2854,2856,O
host,2857,2861,O
defenses,2862,2870,O
by,2871,2873,O
cytokines,2874,2883,O
and,2884,2887,O
pre,2888,2891,O
-,2891,2892,O
formed,2892,2898,O
antibodies,2899,2909,O
may,2910,2913,O
emerge,2914,2920,O
as,2921,2923,O
useful,2924,2930,O
approaches,2931,2941,O
.,2941,2942,O
Mapping,0,7,O
of,8,10,O
the,11,14,O
L,15,16,O
-,16,17,O
methylmalonyl,17,30,O
-,30,31,O
CoA,31,34,O
mutase,35,41,O
gene,42,46,O
to,47,49,O
mouse,50,55,O
chromosome,56,66,B-Cellular_component
17,67,69,I-Cellular_component
.,69,70,O
In,71,73,O
humans,74,80,O
",",80,81,O
methylmalonyl,82,95,O
acidemia,96,104,O
is,105,107,O
caused,108,114,O
by,115,117,O
a,118,119,O
deficiency,120,130,O
of,131,133,O
L,134,135,O
-,135,136,O
methylmalonyl,136,149,O
-,149,150,O
CoA,150,153,O
mutase,154,160,O
(,161,162,O
MUT,162,165,O
),165,166,O
controlled,167,177,O
by,178,180,O
a,181,182,O
gene,183,187,O
that,188,192,O
has,193,196,O
been,197,201,O
mapped,202,208,O
to,209,211,O
chromosome,212,222,B-Cellular_component
6,223,224,I-Cellular_component
.,224,225,O
The,226,229,O
mouse,230,235,O
homolog,236,243,O
of,244,246,O
this,247,251,O
gene,252,256,O
has,257,260,O
now,261,264,O
been,265,269,O
mapped,270,276,O
to,277,279,O
mouse,280,285,O
chromosome,286,296,B-Cellular_component
17,297,299,I-Cellular_component
.,299,300,O
Recombinant,301,312,O
inbred,313,319,O
and,320,323,O
congenic,324,332,O
strains,333,340,O
place,341,346,O
the,347,350,O
mouse,351,356,O
Mut,357,360,O
locus,361,366,O
1,367,368,O
.,368,369,O
06,369,371,O
cM,372,374,O
distal,375,381,O
to,382,384,O
H,385,386,O
-,386,387,O
2,387,388,O
",",388,389,O
between,390,397,O
Pgk,398,401,O
-,401,402,O
2,402,403,O
and,404,407,O
Ce,408,410,O
-,410,411,O
2,411,412,O
.,412,413,O
The,414,417,O
relative,418,426,O
order,427,432,O
of,433,435,O
syntenic,436,444,O
probes,445,451,O
flanking,452,460,O
H,461,462,O
-,462,463,O
2,463,464,O
on,465,467,O
mouse,468,473,O
chromosome,474,484,B-Cellular_component
17,485,487,I-Cellular_component
and,488,491,O
HLA,492,495,O
on,496,498,O
human,499,504,O
chromosome,505,515,B-Cellular_component
6,516,517,I-Cellular_component
is,518,520,O
shown,521,526,O
to,527,529,O
be,530,532,O
different,533,542,O
.,542,543,O
Range,0,5,O
of,6,8,O
motion,9,15,O
limitation,16,26,O
after,27,32,O
rotator,33,40,B-Organ
cuff,41,45,I-Organ
repair,46,52,O
.,52,53,O
HYPOTHESIS,54,64,O
:,64,65,O
This,66,70,O
study,71,76,O
was,77,80,O
conducted,81,90,O
to,91,93,O
identify,94,102,O
preoperative,103,115,O
factors,116,123,O
correlating,124,135,O
with,136,140,O
limited,141,148,O
motion,149,155,O
after,156,161,O
rotator,162,169,B-Organ
cuff,170,174,I-Organ
repair,175,181,O
(,182,183,O
RCR,183,186,O
),186,187,O
and,188,191,O
to,192,194,O
evaluate,195,203,O
the,204,207,O
affect,208,214,O
of,215,217,O
loss,218,222,O
of,223,225,O
motion,226,232,O
on,233,235,O
outcome,236,243,O
.,243,244,O
We,245,247,O
hypothesized,248,260,O
that,261,265,O
patients,266,274,O
with,275,279,O
preoperative,280,292,O
ROM,293,296,O
loss,297,301,O
",",301,302,O
diabetes,303,311,O
",",311,312,O
and,313,316,O
workman,317,324,O
',324,325,O
s,325,326,O
compensation,327,339,O
claims,340,346,O
would,347,352,O
exhibit,353,360,O
postoperative,361,374,O
ROM,375,378,O
loss,379,383,O
at,384,386,O
3,387,388,O
months,389,395,O
.,395,396,O
MATERIAL,397,405,O
AND,406,409,O
METHODS,410,417,O
:,417,418,O
Preoperative,419,431,O
and,432,435,O
postoperative,436,449,O
evaluations,450,461,O
",",461,462,O
including,463,472,O
outcomes,473,481,O
assessment,482,492,O
and,493,496,O
physical,497,505,O
examination,506,517,O
parameters,518,528,O
",",528,529,O
were,530,534,O
reviewed,535,543,O
for,544,547,O
345,548,551,O
patients,552,560,O
who,561,564,O
underwent,565,574,O
RCR,575,578,O
.,578,579,O
Correlations,580,592,O
between,593,600,O
demographic,601,612,O
",",612,613,O
physical,614,622,O
examination,623,634,O
",",634,635,O
and,636,639,O
surgical,640,648,O
variables,649,658,O
and,659,662,O
postoperative,663,676,O
limitation,677,687,O
of,688,690,O
motion,691,697,O
and,698,701,O
need,702,706,O
for,707,710,O
capsular,711,719,O
release,720,727,O
were,728,732,O
determined,733,743,O
.,743,744,O
RESULTS,745,752,O
:,752,753,O
At,754,756,O
3,757,758,O
-,758,759,O
month,759,764,O
follow,765,771,O
-,771,772,O
up,772,774,O
",",774,775,O
mean,776,780,O
active,781,787,O
forward,788,795,O
elevation,796,805,O
(,806,807,O
AFE,807,810,O
),810,811,O
",",811,812,O
active,813,819,O
external,820,828,O
rotation,829,837,O
(,838,839,O
AER,839,842,O
),842,843,O
",",843,844,O
and,845,848,O
passive,849,856,O
internal,857,865,O
rotation,866,874,O
(,875,876,O
PIR,876,879,O
),879,880,O
were,881,885,O
90,886,888,O
%,888,889,O
",",889,890,O
78,891,893,O
%,893,894,O
",",894,895,O
and,896,899,O
80,900,902,O
%,902,903,O
of,904,906,O
the,907,910,O
contralateral,911,924,O
side,925,929,O
.,929,930,O
Limitation,931,941,O
of,942,944,O
preoperative,945,957,O
motion,958,964,O
correlated,965,975,O
with,976,980,O
limitation,981,991,O
of,992,994,O
postoperative,995,1008,O
AFE,1009,1012,O
",",1012,1013,O
AER,1014,1017,O
",",1017,1018,O
and,1019,1022,O
PIR,1023,1026,O
(,1027,1028,O
P,1028,1029,O
<,1030,1031,O
.,1032,1033,O
001,1033,1036,O
),1036,1037,O
.,1037,1038,O
Forty,1039,1044,O
-,1044,1045,O
seven,1045,1050,O
patients,1051,1059,O
considered,1060,1070,O
clinically,1071,1081,O
stiff,1082,1087,O
were,1088,1092,O
followed,1093,1101,O
at,1102,1104,O
1,1105,1106,O
year,1107,1111,O
postoperatively,1112,1127,O
.,1127,1128,O
Three,1129,1134,O
patients,1135,1143,O
required,1144,1152,O
arthroscopic,1153,1165,O
capsular,1166,1174,O
release,1175,1182,O
for,1183,1186,O
persistent,1187,1197,O
range,1198,1203,O
of,1204,1206,O
motion,1207,1213,O
loss,1214,1218,O
.,1218,1219,O
CONCLUSION,1220,1230,O
:,1230,1231,O
Early,1232,1237,O
postoperative,1238,1251,O
limitation,1252,1262,O
of,1263,1265,O
motion,1266,1272,O
after,1273,1278,O
RCR,1279,1282,O
is,1283,1285,O
associated,1286,1296,O
with,1297,1301,O
restricted,1302,1312,O
preoperative,1313,1325,O
motion,1326,1332,O
.,1332,1333,O
Other,1334,1339,O
factors,1340,1347,O
",",1347,1348,O
including,1349,1358,O
diabetes,1359,1367,O
mellitus,1368,1376,O
and,1377,1380,O
worker,1381,1387,O
',1387,1388,O
s,1388,1389,O
compensation,1390,1402,O
claim,1403,1408,O
",",1408,1409,O
are,1410,1413,O
also,1414,1418,O
associated,1419,1429,O
with,1430,1434,O
range,1435,1440,O
of,1441,1443,O
motion,1444,1450,O
loss,1451,1455,O
.,1455,1456,O
Most,1457,1461,O
shoulders,1462,1471,B-Organism_subdivision
with,1472,1476,O
early,1477,1482,O
motion,1483,1489,O
loss,1490,1494,O
recover,1495,1502,O
motion,1503,1509,O
and,1510,1513,O
rarely,1514,1520,O
require,1521,1528,O
capsular,1529,1537,O
release,1538,1545,O
.,1545,1546,O
Neural,0,6,O
network,7,14,O
analysis,15,23,O
of,24,26,O
spectroscopic,27,40,O
data,41,45,O
of,46,48,O
lycopene,49,57,O
and,58,61,O
beta,62,66,O
-,66,67,O
carotene,67,75,O
content,76,83,O
in,84,86,O
food,87,91,O
samples,92,99,O
compared,100,108,O
to,109,111,O
HPLC,112,116,O
-,116,117,O
UV,117,119,O
-,119,120,O
vis,120,123,O
.,123,124,O
In,125,127,O
this,128,132,O
study,133,138,O
a,139,140,O
neural,141,147,O
network,148,155,O
(,156,157,O
NN,157,159,O
),159,160,O
model,161,166,O
was,167,170,O
designed,171,179,O
to,180,182,O
predict,183,190,O
lycopene,191,199,O
and,200,203,O
beta,204,208,O
-,208,209,O
carotene,209,217,O
concentrations,218,232,O
in,233,235,O
food,236,240,O
samples,241,248,O
",",248,249,O
combined,250,258,O
with,259,263,O
a,264,265,O
simple,266,272,O
and,273,276,O
fast,277,281,O
technique,282,291,O
",",291,292,O
such,293,297,O
as,298,300,O
UV,301,303,O
-,303,304,O
vis,304,307,O
spectroscopy,308,320,O
.,320,321,O
The,322,325,O
measurement,326,337,O
of,338,340,O
the,341,344,O
absorbance,345,355,O
at,356,358,O
446,359,362,O
and,363,366,O
502,367,370,O
nm,371,373,O
of,374,376,O
different,377,386,O
beta,387,391,O
-,391,392,O
carotene,392,400,O
and,401,404,O
lycopene,405,413,O
standard,414,422,O
mixtures,423,431,O
was,432,435,O
used,436,440,O
to,441,443,O
optimize,444,452,O
a,453,454,O
neural,455,461,O
network,462,469,O
based,470,475,O
on,476,478,O
a,479,480,O
multilayer,481,491,O
perceptron,492,502,O
(,503,504,O
MLP,504,507,O
),507,508,O
(,509,510,O
learning,510,518,O
and,519,522,O
verification,523,535,O
process,536,543,O
),543,544,O
.,544,545,O
Then,546,550,O
",",550,551,O
for,552,555,O
validation,556,566,O
purposes,567,575,O
",",575,576,O
the,577,580,O
optimized,581,590,O
NN,591,593,O
has,594,597,O
been,598,602,O
applied,603,610,O
to,611,613,O
determine,614,623,O
the,624,627,O
concentration,628,641,O
of,642,644,O
both,645,649,O
compounds,650,659,O
in,660,662,O
food,663,667,O
samples,668,675,O
(,676,677,O
fresh,677,682,O
tomato,683,689,O
",",689,690,O
tomato,691,697,O
concentrate,698,709,B-Organism_substance
",",709,710,O
tomato,711,717,O
sauce,718,723,O
",",723,724,O
ketchup,725,732,O
",",732,733,O
tomato,734,740,O
juice,741,746,B-Organism_substance
",",746,747,O
watermelon,748,758,O
",",758,759,O
medlar,760,766,O
",",766,767,O
green,768,773,O
pepper,774,780,O
",",780,781,O
and,782,785,O
carrots,786,793,O
),793,794,O
",",794,795,O
comparing,796,805,O
the,806,809,O
NN,810,812,O
results,813,820,O
with,821,825,O
the,826,829,O
known,830,835,O
values,836,842,O
of,843,845,O
these,846,851,O
compounds,852,861,O
obtained,862,870,O
by,871,873,O
analytical,874,884,O
techniques,885,895,O
(,896,897,O
UV,897,899,O
-,899,900,O
vis,900,903,O
and,904,907,O
HPLC,908,912,O
),912,913,O
.,913,914,O
It,915,917,O
was,918,921,O
concluded,922,931,O
that,932,936,O
when,937,941,O
the,942,945,O
MLP,946,949,O
-,949,950,O
NN,950,952,O
is,953,955,O
used,956,960,O
within,961,967,O
the,968,971,O
range,972,977,O
studied,978,985,O
",",985,986,O
the,987,990,O
optimized,991,1000,O
NN,1001,1003,O
is,1004,1006,O
able,1007,1011,O
to,1012,1014,O
estimate,1015,1023,O
the,1024,1027,O
beta,1028,1032,O
-,1032,1033,O
carotene,1033,1041,O
and,1042,1045,O
lycopene,1046,1054,O
concentrations,1055,1069,O
in,1070,1072,O
food,1073,1077,O
samples,1078,1085,O
with,1086,1090,O
an,1091,1093,O
adequate,1094,1102,O
accuracy,1103,1111,O
",",1111,1112,O
solving,1113,1120,O
the,1121,1124,O
UV,1125,1127,O
-,1127,1128,O
vis,1128,1131,O
interference,1132,1144,O
of,1145,1147,O
beta,1148,1152,O
-,1152,1153,O
carotene,1153,1161,O
and,1162,1165,O
lycopene,1166,1174,O
.,1174,1175,O
Costs,0,5,O
of,6,8,O
hip,9,12,B-Organism_subdivision
fracture,13,21,O
.,21,22,O
Rehabilitation,23,37,O
of,38,40,O
180,41,44,O
patients,45,53,O
in,54,56,O
primary,57,64,O
health,65,71,O
care,72,76,O
.,76,77,O
Costs,78,83,O
related,84,91,O
to,92,94,O
functional,95,105,O
status,106,112,O
were,113,117,O
calculated,118,128,O
for,129,132,O
180,133,136,O
consecutive,137,148,O
hip,149,152,B-Organism_subdivision
fracture,153,161,O
patients,162,170,O
(,171,172,O
mean,172,176,O
age,177,180,O
78,181,183,O
years,184,189,O
),189,190,O
who,191,194,O
were,195,199,O
admitted,200,208,O
from,209,213,O
their,214,219,O
own,220,223,O
home,224,228,O
and,229,232,O
rehabilitated,233,246,O
in,247,249,O
primary,250,257,O
health,258,264,O
care,265,269,O
.,269,270,O
Within,271,277,O
4,278,279,O
months,280,286,O
after,287,292,O
the,293,296,O
fracture,297,305,O
",",305,306,O
75,307,309,O
percent,310,317,O
of,318,320,O
the,321,324,O
patients,325,333,O
had,334,337,O
been,338,342,O
discharged,343,353,O
to,354,356,O
their,357,362,O
own,363,366,O
home,367,371,O
",",371,372,O
9,373,374,O
percent,375,382,O
were,383,387,O
dead,388,392,O
",",392,393,O
and,394,397,O
the,398,401,O
short,402,407,O
-,407,408,O
term,408,412,O
medical,413,420,O
treatment,421,430,O
costs,431,436,O
per,437,440,O
patient,441,448,O
were,449,453,O
SEK,454,457,O
43,458,460,O
",",460,461,O
000,461,464,O
",",464,465,O
whereas,466,473,O
the,474,477,O
total,478,483,O
costs,484,489,O
including,490,499,O
communal,500,508,O
help,509,513,O
and,514,517,O
costs,518,523,O
for,524,527,O
living,528,534,O
accommodations,535,549,O
after,550,555,O
discharge,556,565,O
were,566,570,O
twice,571,576,O
as,577,579,O
high,580,584,O
.,584,585,O
The,586,589,O
total,590,595,O
costs,596,601,O
per,602,605,O
patient,606,613,O
for,614,617,O
long,618,622,O
-,622,623,O
term,623,627,O
medical,628,635,O
treatment,636,645,O
(,646,647,O
from,647,651,O
4,652,653,O
months,654,660,O
up,661,663,O
to,664,666,O
3,667,668,O
years,669,674,O
after,675,680,O
fracture,681,689,O
),689,690,O
were,691,695,O
7,696,697,O
percent,698,705,O
of,706,708,O
the,709,712,O
short,713,718,O
-,718,719,O
term,719,723,O
medical,724,731,O
treatment,732,741,O
costs,742,747,O
.,747,748,O
Patients,749,757,O
with,758,762,O
a,763,764,O
cervical,765,773,B-Organism_subdivision
fracture,774,782,O
discharged,783,793,O
to,794,796,O
their,797,802,O
own,803,806,O
home,807,811,O
and,812,815,O
with,816,820,O
good,821,825,O
functional,826,836,O
status,837,843,O
consumed,844,852,O
only,853,857,O
one,858,861,O
fifth,862,867,O
of,868,870,O
the,871,874,O
resources,875,884,O
that,885,889,O
patients,890,898,O
with,899,903,O
a,904,905,O
trochanteric,906,918,B-Multi-tissue_structure
fracture,919,927,O
discharged,928,938,O
to,939,941,O
institutional,942,955,O
care,956,960,O
and,961,964,O
who,965,968,O
had,969,972,O
reduced,973,980,O
functional,981,991,O
status,992,998,O
consumed,999,1007,O
.,1007,1008,O
A,1009,1010,O
substantial,1011,1022,O
part,1023,1027,O
of,1028,1030,O
the,1031,1034,O
costs,1035,1040,O
can,1041,1044,O
be,1045,1047,O
saved,1048,1053,O
by,1054,1056,O
improved,1057,1065,O
organization,1066,1078,O
of,1079,1081,O
rehabilitation,1082,1096,O
after,1097,1102,O
discharge,1103,1112,O
from,1113,1117,O
the,1118,1121,O
hospital,1122,1130,O
.,1130,1131,O
A,1132,1133,O
further,1134,1141,O
cost,1142,1146,O
reduction,1147,1156,O
would,1157,1162,O
require,1163,1170,O
a,1171,1172,O
combination,1173,1184,O
of,1185,1187,O
technologic,1188,1199,O
",",1199,1200,O
social,1201,1207,O
",",1207,1208,O
and,1209,1212,O
organizational,1213,1227,O
changes,1228,1235,O
aimed,1236,1241,O
at,1242,1244,O
early,1245,1250,O
discharge,1251,1260,O
and,1261,1264,O
continued,1265,1274,O
follow,1275,1281,O
-,1281,1282,O
up,1282,1284,O
in,1285,1287,O
primary,1288,1295,O
health,1296,1302,O
care,1303,1307,O
.,1307,1308,O
A,0,1,O
randomized,2,12,O
pilot,13,18,O
study,19,24,O
of,25,27,O
the,28,31,O
Engaging,32,40,O
Moms,41,45,O
Program,46,53,O
for,54,57,O
family,58,64,O
drug,65,69,O
court,70,75,O
.,75,76,O
In,77,79,O
response,80,88,O
to,89,91,O
the,92,95,O
need,96,100,O
for,101,104,O
effective,105,114,O
drug,115,119,O
court,120,125,O
interventions,126,139,O
",",139,140,O
the,141,144,O
effectiveness,145,158,O
of,159,161,O
the,162,165,O
Engaging,166,174,O
Moms,175,179,O
Program,180,187,O
(,188,189,O
EMP,189,192,O
),192,193,O
versus,194,200,O
Intensive,201,210,O
Case,211,215,O
Management,216,226,O
Services,227,235,O
(,236,237,O
ICMS,237,241,O
),241,242,O
on,243,245,O
multiple,246,254,O
outcomes,255,263,O
for,264,267,O
mothers,268,275,O
enrolled,276,284,O
in,285,287,O
family,288,294,O
drug,295,299,O
court,300,305,O
was,306,309,O
investigated,310,322,O
.,322,323,O
In,324,326,O
this,327,331,O
intent,332,338,O
-,338,339,O
to,339,341,O
-,341,342,O
treat,342,347,O
study,348,353,O
",",353,354,O
mothers,355,362,O
(,363,364,O
N,364,365,O
=,366,367,O
62,368,370,O
),370,371,O
were,372,376,O
randomly,377,385,O
assigned,386,394,O
to,395,397,O
either,398,404,O
usual,405,410,O
drug,411,415,O
court,416,421,O
care,422,426,O
or,427,429,O
the,430,433,O
Engaging,434,442,O
Moms,443,447,O
drug,448,452,O
court,453,458,O
program,459,466,O
.,466,467,O
Mothers,468,475,O
were,476,480,O
assessed,481,489,O
at,490,492,O
intake,493,499,O
and,500,503,O
3,504,505,O
",",505,506,O
6,507,508,O
",",508,509,O
12,510,512,O
",",512,513,O
and,514,517,O
18,518,520,O
months,521,527,O
following,528,537,O
intake,538,544,O
.,544,545,O
Results,546,553,O
indicated,554,563,O
that,564,568,O
at,569,571,O
18,572,574,O
months,575,581,O
post,582,586,O
drug,587,591,O
court,592,597,O
enrollment,598,608,O
",",608,609,O
77,610,612,O
%,612,613,O
of,614,616,O
mothers,617,624,O
assigned,625,633,O
to,634,636,O
EMP,637,640,O
versus,641,647,O
55,648,650,O
%,650,651,O
of,652,654,O
mothers,655,662,O
assigned,663,671,O
to,672,674,O
ICMS,675,679,O
had,680,683,O
positive,684,692,O
child,693,698,O
welfare,699,706,O
dispositions,707,719,O
.,719,720,O
There,721,726,O
were,727,731,O
statistically,732,745,O
significant,746,757,O
time,758,762,O
effects,763,770,O
for,771,774,O
both,775,779,O
intervention,780,792,O
groups,793,799,O
on,800,802,O
multiple,803,811,O
outcomes,812,820,O
including,821,830,O
substance,831,840,O
use,841,844,O
",",844,845,O
mental,846,852,O
health,853,859,O
",",859,860,O
parenting,861,870,O
practices,871,880,O
",",880,881,O
and,882,885,O
family,886,892,O
functioning,893,904,O
.,904,905,O
EMP,906,909,O
showed,910,916,O
equal,917,922,O
or,923,925,O
better,926,932,O
improvement,933,944,O
than,945,949,O
ICMS,950,954,O
on,955,957,O
all,958,961,O
outcomes,962,970,O
.,970,971,O
The,972,975,O
results,976,983,O
suggest,984,991,O
that,992,996,O
EMP,997,1000,O
in,1001,1003,O
family,1004,1010,O
drug,1011,1015,O
court,1016,1021,O
is,1022,1024,O
a,1025,1026,O
viable,1027,1033,O
and,1034,1037,O
promising,1038,1047,O
intervention,1048,1060,O
approach,1061,1069,O
to,1070,1072,O
reduce,1073,1079,O
maternal,1080,1088,O
addiction,1089,1098,O
and,1099,1102,O
child,1103,1108,O
maltreatment,1109,1121,O
.,1121,1122,O
Absence,0,7,O
of,8,10,O
microbiota,11,21,O
(,22,23,O
germ,23,27,O
-,27,28,O
free,28,32,O
conditions,33,43,O
),43,44,O
accelerates,45,56,O
the,57,60,O
atherosclerosis,61,76,O
in,77,79,O
ApoE,80,84,O
-,84,85,O
deficient,85,94,O
mice,95,99,O
fed,100,103,O
standard,104,112,O
low,113,116,O
cholesterol,117,128,O
diet,129,133,O
.,133,134,O
AIM,135,138,O
:,138,139,O
The,140,143,O
aim,144,147,O
of,148,150,O
our,151,154,O
work,155,159,O
was,160,163,O
to,164,166,O
determine,167,176,O
the,177,180,O
influence,181,190,O
of,191,193,O
intestinal,194,204,B-Multi-tissue_structure
bacteria,205,213,O
on,214,216,O
the,217,220,O
development,221,232,O
of,233,235,O
atherosclerotic,236,251,B-Pathological_formation
lesions,252,259,I-Pathological_formation
using,260,265,O
apolipoprotein,266,280,O
E,281,282,O
(,283,284,O
ApoE,284,288,O
),288,289,O
-,289,290,O
deficient,290,299,O
knockout,300,308,O
mice,309,313,O
.,313,314,O
METHODS,315,322,O
:,322,323,O
The,324,327,O
experiments,328,339,O
were,340,344,O
performed,345,354,O
on,355,357,O
ApoE,358,362,O
-,362,363,O
/,363,364,O
-,364,365,O
-,365,366,O
deficient,366,375,O
mouse,376,381,O
strain,382,388,O
C57BL,389,394,O
/,394,395,O
6,395,396,O
",",396,397,O
bred,398,402,O
under,403,408,O
germ,409,413,O
-,413,414,O
free,414,418,O
(,419,420,O
GF,420,422,O
),422,423,O
conditions,424,434,O
for,435,438,O
two,439,442,O
generations,443,454,O
or,455,457,O
under,458,463,O
conventional,464,476,O
conditions,477,487,O
with,488,492,O
defined,493,500,O
microflora,501,511,O
(,512,513,O
CV,513,515,O
),515,516,O
.,516,517,O
The,518,521,O
mice,522,526,O
were,527,531,O
fed,532,535,O
a,536,537,O
standard,538,546,O
low,547,550,O
cholesterol,551,562,O
diet,563,567,O
or,568,570,O
cholesterol,571,582,O
-,582,583,O
rich,583,587,O
diet,588,592,O
for,593,596,O
3,597,598,O
-,598,599,O
4,599,600,O
months,601,607,O
.,607,608,O
We,609,611,O
studied,612,619,O
the,620,623,O
development,624,635,O
of,636,638,O
advanced,639,647,O
lesions,648,655,B-Pathological_formation
in,656,658,O
the,659,662,O
thoracic,663,671,B-Multi-tissue_structure
and,672,675,O
abdominal,676,685,B-Multi-tissue_structure
aorta,686,691,I-Multi-tissue_structure
by,692,694,O
histological,695,707,O
",",707,708,O
morphometric,709,721,O
and,722,725,O
immunohistological,726,744,O
methods,745,752,O
.,752,753,O
RESULTS,754,761,O
:,761,762,O
Conventionally,763,777,O
reared,778,784,O
ApoE,785,789,O
-,789,790,O
/,790,791,O
-,791,792,O
mice,793,797,O
(,798,799,O
containing,799,809,O
no,810,812,O
pathogenic,813,823,O
intestinal,824,834,B-Multi-tissue_structure
microbiota,835,845,O
),845,846,O
and,847,850,O
fed,851,854,O
a,855,856,O
standard,857,865,O
low,866,869,O
cholesterol,870,881,O
diet,882,886,O
in,887,889,O
contrast,890,898,O
to,899,901,O
a,902,903,O
high,904,908,O
cholesterol,909,920,O
diet,921,925,O
did,926,929,O
not,930,933,O
develop,934,941,O
atherosclerotic,942,957,B-Pathological_formation
aortic,958,964,I-Pathological_formation
plaques,965,972,I-Pathological_formation
.,972,973,O
In,974,976,O
contrast,977,985,O
",",985,986,O
ApoE,987,991,O
-,991,992,O
/,992,993,O
-,993,994,O
mice,995,999,O
reared,1000,1006,O
under,1007,1012,O
germfree,1013,1021,O
conditions,1022,1032,O
for,1033,1036,O
2,1037,1038,O
generations,1039,1050,O
and,1051,1054,O
fed,1055,1058,O
a,1059,1060,O
low,1061,1064,O
cholesterol,1065,1076,O
diet,1077,1081,O
exhibited,1082,1091,O
atherosclerotic,1092,1107,B-Pathological_formation
plaques,1108,1115,I-Pathological_formation
in,1116,1118,O
the,1119,1122,O
aorta,1123,1128,B-Multi-tissue_structure
.,1128,1129,O
Characteristic,1130,1144,O
lipid,1145,1150,O
deposition,1151,1161,O
with,1162,1166,O
foam,1167,1171,O
cells,1172,1177,B-Cell
and,1178,1181,O
macrophages,1182,1193,B-Cell
was,1194,1197,O
found,1198,1203,O
in,1204,1206,O
their,1207,1212,O
arterial,1213,1221,B-Multi-tissue_structure
walls,1222,1227,I-Multi-tissue_structure
.,1227,1228,O
CONCLUSION,1229,1239,O
:,1239,1240,O
In,1241,1243,O
contrast,1244,1252,O
to,1253,1255,O
the,1256,1259,O
absence,1260,1267,O
of,1268,1270,O
atherosclerotic,1271,1286,B-Pathological_formation
plaques,1287,1294,I-Pathological_formation
in,1295,1297,O
conventionally,1298,1312,O
reared,1313,1319,O
ApoE,1320,1324,O
-,1324,1325,O
deficient,1325,1334,O
mice,1335,1339,O
",",1339,1340,O
germ,1341,1345,O
-,1345,1346,O
free,1346,1350,O
ApoE,1351,1355,O
-,1355,1356,O
/,1356,1357,O
-,1357,1358,O
mice,1359,1363,O
consuming,1364,1373,O
the,1374,1377,O
same,1378,1382,O
low,1383,1386,O
cholesterol,1387,1398,O
standard,1399,1407,O
diet,1408,1412,O
developed,1413,1422,O
atherosclerotic,1423,1438,B-Pathological_formation
plaques,1439,1446,I-Pathological_formation
in,1447,1449,O
the,1450,1453,O
aorta,1454,1459,B-Multi-tissue_structure
.,1459,1460,O
Differences,1461,1472,O
in,1473,1475,O
atherosclerotic,1476,1491,B-Pathological_formation
plaques,1492,1499,I-Pathological_formation
between,1500,1507,O
GF,1508,1510,O
and,1511,1514,O
CV,1515,1517,O
ApoE,1518,1522,O
-,1522,1523,O
/,1523,1524,O
-,1524,1525,O
mice,1526,1530,O
are,1531,1534,O
not,1535,1538,O
so,1539,1541,O
apparent,1542,1550,O
when,1551,1555,O
mice,1556,1560,O
are,1561,1564,O
fed,1565,1568,O
a,1569,1570,O
high,1571,1575,O
cholesterol,1576,1587,O
diet,1588,1592,O
.,1592,1593,O
Our,1594,1597,O
findings,1598,1606,O
thus,1607,1611,O
document,1612,1620,O
the,1621,1624,O
protective,1625,1635,O
effect,1636,1642,O
of,1643,1645,O
microbiota,1646,1656,O
(,1657,1658,O
commensal,1658,1667,O
bacteria,1668,1676,O
),1676,1677,O
on,1678,1680,O
atherosclerosis,1681,1696,O
development,1697,1708,O
.,1708,1709,O
A,0,1,O
generative,2,12,O
model,13,18,O
for,19,22,O
image,23,28,O
segmentation,29,41,O
based,42,47,O
on,48,50,O
label,51,56,O
fusion,57,63,O
.,63,64,O
We,65,67,O
propose,68,75,O
a,76,77,O
nonparametric,78,91,O
",",91,92,O
probabilistic,93,106,O
model,107,112,O
for,113,116,O
the,117,120,O
automatic,121,130,O
segmentation,131,143,O
of,144,146,O
medical,147,154,O
images,155,161,O
",",161,162,O
given,163,168,O
a,169,170,O
training,171,179,O
set,180,183,O
of,184,186,O
images,187,193,O
and,194,197,O
corresponding,198,211,O
label,212,217,O
maps,218,222,O
.,222,223,O
The,224,227,O
resulting,228,237,O
inference,238,247,O
algorithms,248,258,O
rely,259,263,O
on,264,266,O
pairwise,267,275,O
registrations,276,289,O
between,290,297,O
the,298,301,O
test,302,306,O
image,307,312,O
and,313,316,O
individual,317,327,O
training,328,336,O
images,337,343,O
.,343,344,O
The,345,348,O
training,349,357,O
labels,358,364,O
are,365,368,O
then,369,373,O
transferred,374,385,O
to,386,388,O
the,389,392,O
test,393,397,O
image,398,403,O
and,404,407,O
fused,408,413,O
to,414,416,O
compute,417,424,O
the,425,428,O
final,429,434,O
segmentation,435,447,O
of,448,450,O
the,451,454,O
test,455,459,O
subject,460,467,O
.,467,468,O
Such,469,473,O
label,474,479,O
fusion,480,486,O
methods,487,494,O
have,495,499,O
been,500,504,O
shown,505,510,O
to,511,513,O
yield,514,519,O
accurate,520,528,O
segmentation,529,541,O
",",541,542,O
since,543,548,O
the,549,552,O
use,553,556,O
of,557,559,O
multiple,560,568,O
registrations,569,582,O
captures,583,591,O
greater,592,599,O
inter,600,605,O
-,605,606,O
subject,606,613,O
anatomical,614,624,O
variability,625,636,O
and,637,640,O
improves,641,649,O
robustness,650,660,O
against,661,668,O
occasional,669,679,O
registration,680,692,O
failures,693,701,O
.,701,702,O
To,703,705,O
the,706,709,O
best,710,714,O
of,715,717,O
our,718,721,O
knowledge,722,731,O
",",731,732,O
this,733,737,O
manuscript,738,748,O
presents,749,757,O
the,758,761,O
first,762,767,O
comprehensive,768,781,O
probabilistic,782,795,O
framework,796,805,O
that,806,810,O
rigorously,811,821,O
motivates,822,831,O
label,832,837,O
fusion,838,844,O
as,845,847,O
a,848,849,O
segmentation,850,862,O
approach,863,871,O
.,871,872,O
The,873,876,O
proposed,877,885,O
framework,886,895,O
allows,896,902,O
us,903,905,O
to,906,908,O
compare,909,916,O
different,917,926,O
label,927,932,O
fusion,933,939,O
algorithms,940,950,O
theoretically,951,964,O
and,965,968,O
practically,969,980,O
.,980,981,O
In,982,984,O
particular,985,995,O
",",995,996,O
recent,997,1003,O
label,1004,1009,O
fusion,1010,1016,O
or,1017,1019,O
multiatlas,1020,1030,O
segmentation,1031,1043,O
algorithms,1044,1054,O
are,1055,1058,O
interpreted,1059,1070,O
as,1071,1073,O
special,1074,1081,O
cases,1082,1087,O
of,1088,1090,O
our,1091,1094,O
framework,1095,1104,O
.,1104,1105,O
We,1106,1108,O
conduct,1109,1116,O
two,1117,1120,O
sets,1121,1125,O
of,1126,1128,O
experiments,1129,1140,O
to,1141,1143,O
validate,1144,1152,O
the,1153,1156,O
proposed,1157,1165,O
methods,1166,1173,O
.,1173,1174,O
In,1175,1177,O
the,1178,1181,O
first,1182,1187,O
set,1188,1191,O
of,1192,1194,O
experiments,1195,1206,O
",",1206,1207,O
we,1208,1210,O
use,1211,1214,O
39,1215,1217,O
brain,1218,1223,B-Organ
MRI,1224,1227,O
scans,1228,1233,O
-,1233,1234,O
with,1234,1238,O
manually,1239,1247,O
segmented,1248,1257,O
white,1258,1263,B-Multi-tissue_structure
matter,1264,1270,I-Multi-tissue_structure
",",1270,1271,O
cerebral,1272,1280,B-Multi-tissue_structure
cortex,1281,1287,I-Multi-tissue_structure
",",1287,1288,O
ventricles,1289,1299,B-Multi-tissue_structure
and,1300,1303,O
subcortical,1304,1315,B-Multi-tissue_structure
structures,1316,1326,I-Multi-tissue_structure
-,1326,1327,O
to,1327,1329,O
compare,1330,1337,O
different,1338,1347,O
label,1348,1353,O
fusion,1354,1360,O
algorithms,1361,1371,O
and,1372,1375,O
the,1376,1379,O
widely,1380,1386,O
-,1386,1387,O
used,1387,1391,O
FreeSurfer,1392,1402,O
whole,1403,1408,O
-,1408,1409,O
brain,1409,1414,B-Organ
segmentation,1415,1427,O
tool,1428,1432,O
.,1432,1433,O
Our,1434,1437,O
results,1438,1445,O
indicate,1446,1454,O
that,1455,1459,O
the,1460,1463,O
proposed,1464,1472,O
framework,1473,1482,O
yields,1483,1489,O
more,1490,1494,O
accurate,1495,1503,O
segmentation,1504,1516,O
than,1517,1521,O
FreeSurfer,1522,1532,O
and,1533,1536,O
previous,1537,1545,O
label,1546,1551,O
fusion,1552,1558,O
algorithms,1559,1569,O
.,1569,1570,O
In,1571,1573,O
a,1574,1575,O
second,1576,1582,O
experiment,1583,1593,O
",",1593,1594,O
we,1595,1597,O
use,1598,1601,O
brain,1602,1607,B-Organ
MRI,1608,1611,O
scans,1612,1617,O
of,1618,1620,O
282,1621,1624,O
subjects,1625,1633,O
to,1634,1636,O
demonstrate,1637,1648,O
that,1649,1653,O
the,1654,1657,O
proposed,1658,1666,O
segmentation,1667,1679,O
tool,1680,1684,O
is,1685,1687,O
sufficiently,1688,1700,O
sensitive,1701,1710,O
to,1711,1713,O
robustly,1714,1722,O
detect,1723,1729,O
hippocampal,1730,1741,B-Multi-tissue_structure
volume,1742,1748,O
changes,1749,1756,O
in,1757,1759,O
a,1760,1761,O
study,1762,1767,O
of,1768,1770,O
aging,1771,1776,O
and,1777,1780,O
Alzheimer,1781,1790,O
',1790,1791,O
s,1791,1792,O
Disease,1793,1800,O
.,1800,1801,O
Listerine,0,9,O
:,9,10,O
past,11,15,O
",",15,16,O
present,17,24,O
and,25,28,O
future,29,35,O
-,35,36,O
-,36,37,O
a,37,38,O
test,39,43,O
of,44,46,O
thyme,47,52,O
.,52,53,O
Listerine,54,63,O
",",63,64,O
a,65,66,O
mouthrinse,67,77,O
composed,78,86,O
of,87,89,O
a,90,91,O
mixture,92,99,O
of,100,102,O
essential,103,112,O
oils,113,117,O
",",117,118,O
was,119,122,O
created,123,130,O
in,131,133,O
1879,134,138,O
and,139,142,O
was,143,146,O
originally,147,157,O
formulated,158,168,O
as,169,171,O
a,172,173,O
surgical,174,182,O
antiseptic,183,193,O
.,193,194,O
In,195,197,O
spite,198,203,O
of,204,206,O
its,207,210,O
known,211,216,O
antimicrobial,217,230,O
properties,231,241,O
it,242,244,O
was,245,248,O
thought,249,256,O
of,257,259,O
as,260,262,O
a,263,264,O
product,265,272,O
in,273,275,O
search,276,282,O
of,283,285,O
a,286,287,O
use,288,291,O
and,292,295,O
promoted,296,304,O
as,305,307,O
a,308,309,O
deterrent,310,319,O
for,320,323,O
halitosis,324,333,O
and,334,337,O
as,338,340,O
a,341,342,O
floor,343,348,O
cleaner,349,356,O
.,356,357,O
In,358,360,O
the,361,364,O
last,365,369,O
several,370,377,O
years,378,383,O
Listerine,384,393,O
has,394,397,O
emerged,398,405,O
as,406,408,O
a,409,410,O
bona,411,415,O
fide,416,420,O
therapeutic,421,432,O
agent,433,438,O
for,439,442,O
reduction,443,452,O
of,453,455,O
plaque,456,462,B-Organism_substance
induced,463,470,O
oral,471,475,B-Organism_subdivision
diseases,476,484,O
.,484,485,O
In,486,488,O
contrast,489,497,O
to,498,500,O
the,501,504,O
inconsistent,505,517,O
history,518,525,O
of,526,528,O
Listerine,529,538,O
",",538,539,O
systemic,540,548,O
antibiotics,549,560,O
discovered,561,571,O
in,572,574,O
the,575,578,O
1940,579,583,O
',583,584,O
s,584,585,O
were,586,590,O
heralded,591,599,O
as,600,602,O
miracle,603,610,O
drugs,611,616,O
.,616,617,O
However,618,625,O
",",625,626,O
the,627,630,O
value,631,636,O
of,637,639,O
prophylactic,640,652,O
usage,653,658,O
of,659,661,O
antibiotics,662,673,O
has,674,677,O
come,678,682,O
under,683,688,O
scrutiny,689,697,O
as,698,700,O
a,701,702,O
result,703,709,O
of,710,712,O
increasing,713,723,O
resistance,724,734,O
and,735,738,O
adverse,739,746,O
reactions,747,756,O
.,756,757,O
Moreover,758,766,O
",",766,767,O
reports,768,775,O
by,776,778,O
both,779,783,O
American,784,792,O
and,793,796,O
British,797,804,O
professional,805,817,O
societies,818,827,O
have,828,832,O
led,833,836,O
to,837,839,O
a,840,841,O
re,842,844,O
-,844,845,O
evaluation,845,855,O
of,856,858,O
the,859,862,O
relative,863,871,O
risks,872,877,O
associated,878,888,O
with,889,893,O
plaque,894,900,B-Organism_substance
induced,901,908,O
bacteremia,909,919,O
when,920,924,O
twice,925,930,O
-,930,931,O
yearly,931,937,O
visits,938,944,O
to,945,947,O
dental,948,954,O
professionals,955,968,O
are,969,972,O
compared,973,981,O
to,982,984,O
daily,985,990,O
activities,991,1001,O
.,1001,1002,O
These,1003,1008,O
new,1009,1012,O
recommendations,1013,1028,O
and,1029,1032,O
revelations,1033,1044,O
open,1045,1049,O
the,1050,1053,O
door,1054,1058,O
for,1059,1062,O
local,1063,1068,O
antimicrobial,1069,1082,O
approaches,1083,1093,O
to,1094,1096,O
reduce,1097,1103,O
the,1104,1107,O
challenge,1108,1117,O
of,1118,1120,O
plaque,1121,1127,B-Organism_substance
-,1127,1128,O
induced,1128,1135,O
bacteremias,1136,1147,O
.,1147,1148,O
These,1149,1154,O
issues,1155,1161,O
will,1162,1166,O
be,1167,1169,O
discussed,1170,1179,O
in,1180,1182,O
the,1183,1186,O
context,1187,1194,O
of,1195,1197,O
Listerine,1198,1207,O
",",1207,1208,O
its,1209,1212,O
intricate,1213,1222,O
and,1223,1226,O
complicated,1227,1238,O
past,1239,1243,O
",",1243,1244,O
and,1245,1248,O
its,1249,1252,O
connection,1253,1263,O
to,1264,1266,O
current,1267,1274,O
uses,1275,1279,O
in,1280,1282,O
oral,1283,1287,B-Organism_subdivision
health,1288,1294,O
and,1295,1298,O
beyond,1299,1305,O
.,1305,1306,O
Acute,0,5,O
ablation,6,14,O
of,15,17,O
Langerhans,18,28,B-Cell
cells,29,34,I-Cell
enhances,35,43,O
skin,44,48,B-Organ
immune,49,55,O
responses,56,65,O
.,65,66,O
Understanding,67,80,O
the,81,84,O
function,85,93,O
of,94,96,O
Langerhans,97,107,B-Cell
cells,108,113,I-Cell
(,114,115,O
LCs,115,118,B-Cell
),118,119,O
in,120,122,O
vivo,123,127,O
has,128,131,O
been,132,136,O
complicated,137,148,O
by,149,151,O
conflicting,152,163,O
results,164,171,O
from,172,176,O
LC,177,179,B-Cell
-,179,180,O
deficient,180,189,O
mice,190,194,O
.,194,195,O
Human,196,201,O
Langerin,202,210,O
-,210,211,O
DTA,211,214,O
mice,215,219,O
constitutively,220,234,O
lack,235,239,O
LCs,240,243,B-Cell
and,244,247,O
develop,248,255,O
exaggerated,256,267,O
contact,268,275,O
hypersensitivity,276,292,O
(,293,294,O
CHS,294,297,O
),297,298,O
responses,299,308,O
.,308,309,O
Murine,310,316,O
Langerin,317,325,O
-,325,326,O
diphtheria,326,336,O
toxin,337,342,O
receptor,343,351,O
(,352,353,O
DTR,353,356,O
),356,357,O
mice,358,362,O
allow,363,368,O
for,369,372,O
the,373,376,O
inducible,377,386,O
elimination,387,398,O
of,399,401,O
LCs,402,405,B-Cell
and,406,409,O
Langerin,410,418,B-Cell
(,418,419,I-Cell
+,419,420,I-Cell
),420,421,I-Cell
dermal,422,428,I-Cell
dendritic,429,438,I-Cell
cells,439,444,I-Cell
(,445,446,O
dDCs,446,450,B-Cell
),450,451,O
after,452,457,O
administration,458,472,O
of,473,475,O
diphtheria,476,486,O
toxin,487,492,O
",",492,493,O
which,494,499,O
results,500,507,O
in,508,510,O
reduced,511,518,O
CHS,519,522,O
.,522,523,O
When,524,528,O
Langerin,529,537,B-Cell
(,537,538,I-Cell
+,538,539,I-Cell
),539,540,I-Cell
dDCs,541,545,I-Cell
have,546,550,O
partially,551,560,O
repopulated,561,572,O
the,573,576,O
skin,577,581,B-Organ
but,582,585,O
LCs,586,589,B-Cell
are,590,593,O
still,594,599,O
absent,600,606,O
",",606,607,O
CHS,608,611,O
returns,612,619,O
to,620,622,O
normal,623,629,O
.,629,630,O
Thus,631,635,O
",",635,636,O
LCs,637,640,B-Cell
appear,641,647,O
to,648,650,O
be,651,653,O
suppressive,654,665,O
in,666,668,O
human,669,674,O
Langerin,675,683,O
-,683,684,O
DTA,684,687,O
mice,688,692,O
and,693,696,O
redundant,697,706,O
in,707,709,O
murine,710,716,O
Langerin,717,725,O
-,725,726,O
DTR,726,729,O
mice,730,734,O
.,734,735,O
To,736,738,O
determine,739,748,O
whether,749,756,O
inducible,757,766,O
versus,767,773,O
constitutive,774,786,O
LC,787,789,B-Cell
ablation,790,798,O
explains,799,807,O
these,808,813,O
results,814,821,O
",",821,822,O
we,823,825,O
engineered,826,836,O
human,837,842,O
Langerin,843,851,O
-,851,852,O
DTR,852,855,O
mice,856,860,O
in,861,863,O
which,864,869,O
diphtheria,870,880,O
toxin,881,886,O
ablates,887,894,O
LCs,895,898,B-Cell
without,899,906,O
affecting,907,916,O
Langerin,917,925,B-Cell
(,925,926,I-Cell
+,926,927,I-Cell
),927,928,I-Cell
dDCs,929,933,I-Cell
.,933,934,O
The,935,938,O
inducible,939,948,O
ablation,949,957,O
of,958,960,O
LCs,961,964,B-Cell
in,965,967,O
human,968,973,O
Langerin,974,982,O
-,982,983,O
DTR,983,986,O
mice,987,991,O
resulted,992,1000,O
in,1001,1003,O
increased,1004,1013,O
CHS,1014,1017,O
.,1017,1018,O
Thus,1019,1023,O
",",1023,1024,O
LC,1025,1027,B-Cell
-,1027,1028,O
mediated,1028,1036,O
suppression,1037,1048,O
does,1049,1053,O
not,1054,1057,O
require,1058,1065,O
their,1066,1071,O
absence,1072,1079,O
during,1080,1086,O
ontogeny,1087,1095,O
or,1096,1098,O
during,1099,1105,O
the,1106,1109,O
steady,1110,1116,O
-,1116,1117,O
state,1117,1122,O
and,1123,1126,O
is,1127,1129,O
consistent,1130,1140,O
with,1141,1145,O
a,1146,1147,O
model,1148,1153,O
in,1154,1156,O
which,1157,1162,O
LCs,1163,1166,B-Cell
actively,1167,1175,O
suppress,1176,1184,O
Ag,1185,1187,O
-,1187,1188,O
specific,1188,1196,O
CHS,1197,1200,O
responses,1201,1210,O
.,1210,1211,O
The,0,3,O
proenkephalin,4,17,O
-,17,18,O
A,18,19,O
-,19,20,O
derivative,20,30,O
Met,31,34,O
-,34,35,O
enkephalin,35,45,O
-,45,46,O
Arg,46,49,O
-,49,50,O
Gly,50,53,O
-,53,54,O
Leu,54,57,O
is,58,60,O
not,61,64,O
present,65,72,O
in,73,75,O
the,76,79,O
feline,80,86,O
species,87,94,O
.,94,95,O
No,96,98,O
opioid,99,105,O
octapeptide,106,117,O
Met,118,121,O
-,121,122,O
enkephalin,122,132,O
-,132,133,O
Arg,133,136,O
-,136,137,O
Gly,137,140,O
-,140,141,O
Leu,141,144,O
was,145,148,O
detected,149,157,O
either,158,164,O
in,165,167,O
the,168,171,O
brain,172,177,B-Organ
or,178,180,O
in,181,183,O
the,184,187,O
adrenal,188,195,B-Organ
gland,196,201,I-Organ
of,202,204,O
the,205,208,O
cat,209,212,O
using,213,218,O
a,219,220,O
specific,221,229,O
radioimmunoassay,230,246,O
.,246,247,O
Whereas,248,255,O
it,256,258,O
was,259,262,O
possible,263,271,O
to,272,274,O
determine,275,284,O
the,285,288,O
Met,289,292,O
-,292,293,O
enkephalin,293,303,O
and,304,307,O
Leu,308,311,O
-,311,312,O
enkephalin,312,322,O
contents,323,331,O
.,331,332,O
The,333,336,O
Met,337,340,O
-,340,341,O
enkephalin,341,351,O
versus,352,358,O
Leu,359,362,O
-,362,363,O
enkephalin,363,373,O
concentration,374,387,O
ratio,388,393,O
was,394,397,O
around,398,404,O
five,405,409,O
in,410,412,O
each,413,417,O
area,418,422,O
of,423,425,O
the,426,429,O
brain,430,435,B-Organ
assayed,436,443,O
.,443,444,O
The,445,448,O
presence,449,457,O
of,458,460,O
authentic,461,470,O
Met,471,474,O
-,474,475,O
enkephalin,475,485,O
and,486,489,O
Leu,490,493,O
-,493,494,O
enkephalin,494,504,O
was,505,508,O
confirmed,509,518,O
by,519,521,O
high,522,526,O
performance,527,538,O
liquid,539,545,O
chromatography,546,560,O
analysis,561,569,O
.,569,570,O
All,571,574,O
in,575,577,O
all,578,581,O
",",581,582,O
these,583,588,O
data,589,593,O
seem,594,598,O
to,599,601,O
indicate,602,610,O
that,611,615,O
the,616,619,O
cat,620,623,O
proenkephalin,624,637,O
is,638,640,O
partly,641,647,O
different,648,657,O
from,658,662,O
that,663,667,O
previously,668,678,O
analysed,679,687,O
in,688,690,O
mammalian,691,700,O
species,701,708,O
including,709,718,O
humans,719,725,O
",",725,726,O
rats,727,731,O
and,732,735,O
cows,736,740,O
.,740,741,O
Dissecting,0,10,O
genetic,11,18,O
networks,19,27,O
underlying,28,38,O
complex,39,46,O
phenotypes,47,57,O
:,57,58,O
the,59,62,O
theoretical,63,74,O
framework,75,84,O
.,84,85,O
Great,86,91,O
progress,92,100,O
has,101,104,O
been,105,109,O
made,110,114,O
in,115,117,O
genetic,118,125,O
dissection,126,136,O
of,137,139,O
quantitative,140,152,O
trait,153,158,O
variation,159,168,O
during,169,175,O
the,176,179,O
past,180,184,O
two,185,188,O
decades,189,196,O
",",196,197,O
but,198,201,O
many,202,206,O
studies,207,214,O
still,215,220,O
reveal,221,227,O
only,228,232,O
a,233,234,O
small,235,240,O
fraction,241,249,O
of,250,252,O
quantitative,253,265,O
trait,266,271,O
loci,272,276,O
(,277,278,O
QTLs,278,282,O
),282,283,O
",",283,284,O
and,285,288,O
epistasis,289,298,O
remains,299,306,O
elusive,307,314,O
.,314,315,O
We,316,318,O
integrate,319,328,O
contemporary,329,341,O
knowledge,342,351,O
of,352,354,O
signal,355,361,O
transduction,362,374,O
pathways,375,383,O
with,384,388,O
principles,389,399,O
of,400,402,O
quantitative,403,415,O
and,416,419,O
population,420,430,O
genetics,431,439,O
to,440,442,O
characterize,443,455,O
genetic,456,463,O
networks,464,472,O
underlying,473,483,O
complex,484,491,O
traits,492,498,O
",",498,499,O
using,500,505,O
a,506,507,O
model,508,513,O
founded,514,521,O
upon,522,526,O
one,527,530,O
-,530,531,O
way,531,534,O
functional,535,545,O
dependency,546,556,O
of,557,559,O
downstream,560,570,O
genes,571,576,O
on,577,579,O
upstream,580,588,O
regulators,589,599,O
(,600,601,O
the,601,604,O
principle,605,614,O
of,615,617,O
hierarchy,618,627,O
),627,628,O
and,629,632,O
mutual,633,639,O
functional,640,650,O
dependency,651,661,O
among,662,667,O
related,668,675,O
genes,676,681,O
(,682,683,O
functional,683,693,O
genetic,694,701,O
units,702,707,O
",",707,708,O
FGU,709,712,O
),712,713,O
.,713,714,O
Both,715,719,O
simulated,720,729,O
and,730,733,O
real,734,738,O
data,739,743,O
suggest,744,751,O
that,752,756,O
complementary,757,770,O
epistasis,771,780,O
contributes,781,792,O
greatly,793,800,O
to,801,803,O
quantitative,804,816,O
trait,817,822,O
variation,823,832,O
",",832,833,O
and,834,837,O
obscures,838,846,O
the,847,850,O
phenotypic,851,861,O
effects,862,869,O
of,870,872,O
many,873,877,O
',878,879,O
downstream,879,889,O
',889,890,O
loci,891,895,O
in,896,898,O
pathways,899,907,O
.,907,908,O
The,909,912,O
mathematical,913,925,O
relationships,926,939,O
between,940,947,O
the,948,951,O
main,952,956,O
effects,957,964,O
and,965,968,O
epistatic,969,978,O
effects,979,986,O
of,987,989,O
genes,990,995,O
acting,996,1002,O
at,1003,1005,O
different,1006,1015,O
levels,1016,1022,O
of,1023,1025,O
signaling,1026,1035,O
pathways,1036,1044,O
were,1045,1049,O
established,1050,1061,O
using,1062,1067,O
the,1068,1071,O
quantitative,1072,1084,O
and,1085,1088,O
population,1089,1099,O
genetic,1100,1107,O
parameters,1108,1118,O
.,1118,1119,O
Both,1120,1124,O
loss,1125,1129,O
of,1130,1132,O
function,1133,1141,O
and,1142,1145,O
"""",1146,1147,O
co,1147,1149,O
-,1149,1150,O
adapted,1150,1157,O
"""",1157,1158,O
gene,1159,1163,O
complexes,1164,1173,O
formed,1174,1180,O
by,1181,1183,O
multiple,1184,1192,O
alleles,1193,1200,O
with,1201,1205,O
differentiated,1206,1220,O
functions,1221,1230,O
(,1231,1232,O
effects,1232,1239,O
),1239,1240,O
are,1241,1244,O
predicted,1245,1254,O
to,1255,1257,O
be,1258,1260,O
frequent,1261,1269,O
types,1270,1275,O
of,1276,1278,O
allelic,1279,1286,O
diversity,1287,1296,O
at,1297,1299,O
loci,1300,1304,O
that,1305,1309,O
contribute,1310,1320,O
to,1321,1323,O
the,1324,1327,O
genetic,1328,1335,O
variation,1336,1345,O
of,1346,1348,O
complex,1349,1356,O
traits,1357,1363,O
in,1364,1366,O
populations,1367,1378,O
.,1378,1379,O
Downstream,1380,1390,O
FGUs,1391,1395,O
appear,1396,1402,O
to,1403,1405,O
be,1406,1408,O
more,1409,1413,O
vulnerable,1414,1424,O
to,1425,1427,O
loss,1428,1432,O
of,1433,1435,O
function,1436,1444,O
than,1445,1449,O
their,1450,1455,O
upstream,1456,1464,O
regulators,1465,1475,O
",",1475,1476,O
but,1477,1480,O
this,1481,1485,O
vulnerability,1486,1499,O
is,1500,1502,O
apparently,1503,1513,O
compensated,1514,1525,O
by,1526,1528,O
different,1529,1538,O
FGUs,1539,1543,O
of,1544,1546,O
similar,1547,1554,O
functions,1555,1564,O
.,1564,1565,O
Other,1566,1571,O
predictions,1572,1583,O
from,1584,1588,O
the,1589,1592,O
model,1593,1598,O
may,1599,1602,O
account,1603,1610,O
for,1611,1614,O
puzzling,1615,1623,O
results,1624,1631,O
regarding,1632,1641,O
responses,1642,1651,O
to,1652,1654,O
selection,1655,1664,O
",",1664,1665,O
genotype,1666,1674,O
by,1675,1677,O
environment,1678,1689,O
interaction,1690,1701,O
",",1701,1702,O
and,1703,1706,O
the,1707,1710,O
genetic,1711,1718,O
basis,1719,1724,O
of,1725,1727,O
heterosis,1728,1737,O
.,1737,1738,O
3,0,1,O
-,1,2,O
[,2,3,O
(,3,4,O
Methyl,4,10,O
-,10,11,O
carbamo,11,18,O
-,18,19,O
yl,19,21,O
),21,22,O
amino,22,27,O
],27,28,O
-,28,29,O
1H,29,31,O
-,31,32,O
isoindolium,32,43,O
chloride,44,52,O
.,52,53,O
The,54,57,O
title,58,63,O
compound,64,72,O
",",72,73,O
C,74,75,O
(,75,76,O
10,76,78,O
),78,79,O
H,79,80,O
(,80,81,O
12,81,83,O
),83,84,O
N,84,85,O
(,85,86,O
3,86,87,O
),87,88,O
O,88,89,O
(,89,90,O
+,90,91,O
),91,92,O
.,92,93,O
Cl,93,95,O
(,95,96,O
-,96,97,O
),97,98,O
",",98,99,O
is,100,102,O
a,103,104,O
derivative,105,115,O
of,116,118,O
o,119,120,O
-,120,121,O
phthaldehyde,121,133,O
and,134,137,O
methyl,138,144,O
-,144,145,O
thio,145,149,O
-,149,150,O
urea,150,154,O
.,154,155,O
The,156,159,O
mol,160,163,O
-,163,164,O
ecules,164,170,O
form,171,175,O
dimers,176,182,O
through,183,190,O
intra,191,196,O
-,196,197,O
and,198,201,O
inter,202,207,O
-,207,208,O
molecular,208,217,O
N,218,219,O
-,219,220,O
H,220,221,O
.,221,222,O
.,222,223,O
.,223,224,O
O,224,225,O
hydrogen,226,234,O
bonds,235,240,O
.,240,241,O
The,242,245,O
dimers,246,252,O
are,253,256,O
further,257,264,O
linked,265,271,O
into,272,276,O
chains,277,283,O
through,284,291,O
one,292,295,O
C,296,297,O
-,297,298,O
H,298,299,O
.,299,300,O
.,300,301,O
.,301,302,O
Cl,302,304,O
and,305,308,O
two,309,312,O
N,313,314,O
-,314,315,O
H,315,316,O
.,316,317,O
.,317,318,O
.,318,319,O
Cl,319,321,O
hydrogen,322,330,O
bonds,331,336,O
.,336,337,O
Oscillatory,0,11,O
alpha,12,17,O
-,17,18,O
band,18,22,O
mechanisms,23,33,O
and,34,37,O
the,38,41,O
deployment,42,52,O
of,53,55,O
spatial,56,63,O
attention,64,73,O
to,74,76,O
anticipated,77,88,O
auditory,89,97,O
and,98,101,O
visual,102,108,O
target,109,115,O
locations,116,125,O
:,125,126,O
supramodal,127,137,O
or,138,140,O
sensory,141,148,O
-,148,149,O
specific,149,157,O
control,158,165,O
mechanisms,166,176,O
?,176,177,O
Oscillatory,178,189,O
alpha,190,195,O
-,195,196,O
band,196,200,O
activity,201,209,O
(,210,211,O
8,211,212,O
-,212,213,O
15,213,215,O
Hz,216,218,O
),218,219,O
over,220,224,O
parieto,225,232,B-Multi-tissue_structure
-,232,233,I-Multi-tissue_structure
occipital,233,242,I-Multi-tissue_structure
cortex,243,249,I-Multi-tissue_structure
in,250,252,O
humans,253,259,O
plays,260,265,O
an,266,268,O
important,269,278,O
role,279,283,O
in,284,286,O
suppression,287,298,O
of,299,301,O
processing,302,312,O
for,313,316,O
inputs,317,323,O
at,324,326,O
to,327,329,O
-,329,330,O
be,330,332,O
-,332,333,O
ignored,333,340,O
regions,341,348,O
of,349,351,O
space,352,357,O
",",357,358,O
with,359,363,O
increased,364,373,O
alpha,374,379,O
-,379,380,O
band,380,384,O
power,385,390,O
observed,391,399,O
over,400,404,O
cortex,405,411,B-Multi-tissue_structure
contralateral,412,425,O
to,426,428,O
locations,429,438,O
expected,439,447,O
to,448,450,O
contain,451,458,O
distractors,459,470,O
.,470,471,O
It,472,474,O
is,475,477,O
unclear,478,485,O
whether,486,493,O
similar,494,501,O
processes,502,511,O
operate,512,519,O
during,520,526,O
deployment,527,537,O
of,538,540,O
spatial,541,548,O
attention,549,558,O
in,559,561,O
other,562,567,O
sensory,568,575,O
modalities,576,586,O
.,586,587,O
Evidence,588,596,O
from,597,601,O
lesion,602,608,B-Pathological_formation
patients,609,617,O
suggests,618,626,O
that,627,631,O
parietal,632,640,B-Organism_subdivision
regions,641,648,I-Organism_subdivision
house,649,654,O
supramodal,655,665,O
representations,666,681,O
of,682,684,O
space,685,690,O
.,690,691,O
The,692,695,O
parietal,696,704,B-Multi-tissue_structure
lobes,705,710,I-Multi-tissue_structure
are,711,714,O
prominent,715,724,O
generators,725,735,O
of,736,738,O
alpha,739,744,O
oscillations,745,757,O
",",757,758,O
raising,759,766,O
the,767,770,O
possibility,771,782,O
that,783,787,O
alpha,788,793,O
is,794,796,O
a,797,798,O
neural,799,805,B-Multi-tissue_structure
signature,806,815,O
of,816,818,O
supramodal,819,829,O
spatial,830,837,O
attention,838,847,O
.,847,848,O
Furthermore,849,860,O
",",860,861,O
when,862,866,O
spatial,867,874,O
attention,875,884,O
is,885,887,O
deployed,888,896,O
within,897,903,O
vision,904,910,O
",",910,911,O
processing,912,922,O
of,923,925,O
task,926,930,O
-,930,931,O
irrelevant,931,941,O
auditory,942,950,O
inputs,951,957,O
at,958,960,O
attended,961,969,O
locations,970,979,O
is,980,982,O
also,983,987,O
enhanced,988,996,O
",",996,997,O
pointing,998,1006,O
to,1007,1009,O
automatic,1010,1019,O
links,1020,1025,O
between,1026,1033,O
spatial,1034,1041,O
deployments,1042,1053,O
across,1054,1060,O
senses,1061,1067,O
.,1067,1068,O
Here,1069,1073,O
",",1073,1074,O
we,1075,1077,O
asked,1078,1083,O
whether,1084,1091,O
lateralized,1092,1103,O
alpha,1104,1109,O
-,1109,1110,O
band,1110,1114,O
activity,1115,1123,O
is,1124,1126,O
also,1127,1131,O
evident,1132,1139,O
in,1140,1142,O
a,1143,1144,O
purely,1145,1151,O
auditory,1152,1160,O
spatial,1161,1168,O
-,1168,1169,O
cueing,1169,1175,O
task,1176,1180,O
and,1181,1184,O
whether,1185,1192,O
it,1193,1195,O
had,1196,1199,O
the,1200,1203,O
same,1204,1208,O
underlying,1209,1219,O
generator,1220,1229,O
configuration,1230,1243,O
as,1244,1246,O
in,1247,1249,O
a,1250,1251,O
purely,1252,1258,O
visuospatial,1259,1271,O
task,1272,1276,O
.,1276,1277,O
If,1278,1280,O
common,1281,1287,O
to,1288,1290,O
both,1291,1295,O
sensory,1296,1303,O
systems,1304,1311,O
",",1311,1312,O
this,1313,1317,O
would,1318,1323,O
provide,1324,1331,O
strong,1332,1338,O
support,1339,1346,O
for,1347,1350,O
"""",1351,1352,O
supramodal,1352,1362,O
"""",1362,1363,O
attention,1364,1373,O
theory,1374,1380,O
.,1380,1381,O
Alternately,1382,1393,O
",",1393,1394,O
alpha,1395,1400,O
-,1400,1401,O
band,1401,1405,O
differences,1406,1417,O
between,1418,1425,O
auditory,1426,1434,O
and,1435,1438,O
visual,1439,1445,O
tasks,1446,1451,O
would,1452,1457,O
support,1458,1465,O
a,1466,1467,O
sensory,1468,1475,O
-,1475,1476,O
specific,1476,1484,O
account,1485,1492,O
.,1492,1493,O
Lateralized,1494,1505,O
shifts,1506,1512,O
in,1513,1515,O
alpha,1516,1521,O
-,1521,1522,O
band,1522,1526,O
activity,1527,1535,O
were,1536,1540,O
indeed,1541,1547,O
observed,1548,1556,O
during,1557,1563,O
a,1564,1565,O
purely,1566,1572,O
auditory,1573,1581,O
spatial,1582,1589,O
task,1590,1594,O
.,1594,1595,O
Crucially,1596,1605,O
",",1605,1606,O
there,1607,1612,O
were,1613,1617,O
clear,1618,1623,O
differences,1624,1635,O
in,1636,1638,O
scalp,1639,1644,B-Multi-tissue_structure
topographies,1645,1657,O
of,1658,1660,O
this,1661,1665,O
alpha,1666,1671,O
activity,1672,1680,O
depending,1681,1690,O
on,1691,1693,O
the,1694,1697,O
sensory,1698,1705,O
system,1706,1712,O
within,1713,1719,O
which,1720,1725,O
spatial,1726,1733,O
attention,1734,1743,O
was,1744,1747,O
deployed,1748,1756,O
.,1756,1757,O
Findings,1758,1766,O
suggest,1767,1774,O
that,1775,1779,O
parietally,1780,1790,O
generated,1791,1800,O
alpha,1801,1806,O
-,1806,1807,O
band,1807,1811,O
mechanisms,1812,1822,O
are,1823,1826,O
central,1827,1834,O
to,1835,1837,O
attentional,1838,1849,O
deployments,1850,1861,O
across,1862,1868,O
modalities,1869,1879,O
but,1880,1883,O
that,1884,1888,O
they,1889,1893,O
are,1894,1897,O
invoked,1898,1905,O
in,1906,1908,O
a,1909,1910,O
sensory,1911,1918,O
-,1918,1919,O
specific,1919,1927,O
manner,1928,1934,O
.,1934,1935,O
The,1936,1939,O
data,1940,1944,O
support,1945,1952,O
an,1953,1955,O
"""",1956,1957,O
interactivity,1957,1970,O
account,1971,1978,O
",",1978,1979,O
"""",1979,1980,O
whereby,1981,1988,O
a,1989,1990,O
supramodal,1991,2001,O
system,2002,2008,O
interacts,2009,2018,O
with,2019,2023,O
sensory,2024,2031,O
-,2031,2032,O
specific,2032,2040,O
control,2041,2048,O
systems,2049,2056,O
during,2057,2063,O
deployment,2064,2074,O
of,2075,2077,O
spatial,2078,2085,O
attention,2086,2095,O
.,2095,2096,O
Absence,0,7,O
of,8,10,O
antisperm,11,20,O
antibodies,21,31,O
in,32,34,O
anejaculatory,35,48,O
men,49,52,O
.,52,53,O
Antisperm,54,63,O
antibodies,64,74,O
were,75,79,O
assessed,80,88,O
in,89,91,O
the,92,95,O
serum,96,101,B-Organism_substance
samples,102,109,I-Organism_substance
of,110,112,O
73,113,115,O
men,116,119,O
unable,120,126,O
to,127,129,O
ejaculate,130,139,O
naturally,140,149,O
and,150,153,O
on,154,156,O
the,157,160,O
sperm,161,166,B-Cell
cells,167,172,I-Cell
of,173,175,O
13,176,178,O
of,179,181,O
these,182,187,O
men,188,191,O
.,191,192,O
None,193,197,O
of,198,200,O
the,201,204,O
serum,205,210,B-Organism_substance
samples,211,218,I-Organism_substance
were,219,223,O
found,224,229,O
to,230,232,O
be,233,235,O
positive,236,244,O
by,245,247,O
sperm,248,253,B-Cell
agglutination,254,267,O
or,268,270,O
sperm,271,276,B-Cell
immobilization,277,291,O
methods,292,299,O
and,300,303,O
antibodies,304,314,O
were,315,319,O
detected,320,328,O
by,329,331,O
an,332,334,O
immunobead,335,345,O
assay,346,351,O
on,352,354,O
the,355,358,O
sperm,359,364,B-Cell
cells,365,370,I-Cell
of,371,373,O
one,374,377,O
of,378,380,O
the,381,384,O
13,385,387,O
men,388,391,O
examined,392,400,O
.,400,401,O
[,0,1,O
Biotechnological,1,17,O
and,18,21,O
biomedical,22,32,O
aspects,33,40,O
of,41,43,O
production,44,54,O
and,55,58,O
study,59,64,O
of,65,67,O
metal,68,73,O
cation,74,80,O
-,80,81,O
phospholipid,81,93,O
complexes,94,103,O
],103,104,O
.,104,105,O
Problems,106,114,O
relating,115,123,O
to,124,126,O
the,127,130,O
technology,131,141,O
of,142,144,O
a,145,146,O
phospholipid,147,159,O
preparation,160,171,O
from,172,176,O
natural,177,184,O
materials,185,194,O
",",194,195,O
liposome,196,204,O
production,205,215,O
",",215,216,O
and,217,220,O
studies,221,228,O
into,229,233,O
the,234,237,O
mechanisms,238,248,O
of,249,251,O
interaction,252,263,O
between,264,271,O
metal,272,277,O
(,278,279,O
trace,279,284,O
elements,285,293,O
),293,294,O
cations,295,302,O
and,303,306,O
model,307,312,O
bilayer,313,320,B-Cellular_component
lipid,321,326,I-Cellular_component
membranes,327,336,I-Cellular_component
are,337,340,O
discussed,341,350,O
.,350,351,O
The,352,355,O
proposed,356,364,O
technology,365,375,O
of,376,378,O
extraction,379,389,O
allows,390,396,O
for,397,400,O
preparation,401,412,O
of,413,415,O
phospholipids,416,429,O
utilizable,430,440,O
for,441,444,O
liposome,445,453,O
formation,454,463,O
.,463,464,O
The,465,468,O
cation,469,475,O
specificity,476,487,O
of,488,490,O
lipid,491,496,O
bilayers,497,505,O
is,506,508,O
found,509,514,O
to,515,517,O
be,518,520,O
determined,521,531,O
by,532,534,O
the,535,538,O
presence,539,547,O
of,548,550,O
anionic,551,558,O
phosphate,559,568,O
adsorption,569,579,O
sites,580,585,O
on,586,588,O
their,589,594,O
surface,595,602,O
.,602,603,O
Endoscopic,0,10,O
injection,11,20,O
therapy,21,28,O
for,29,32,O
acute,33,38,O
upper,39,44,B-Organism_subdivision
GI,45,47,I-Organism_subdivision
bleeding,48,56,O
.,56,57,O
In,58,60,O
summary,61,68,O
",",68,69,O
we,70,72,O
have,73,77,O
found,78,83,O
this,84,88,O
technique,89,98,O
to,99,101,O
be,102,104,O
useful,105,111,O
in,112,114,O
patients,115,123,O
in,124,126,O
whom,127,131,O
coagulation,132,143,O
therapy,144,151,O
is,152,154,O
not,155,158,O
possible,159,167,O
or,168,170,O
effective,171,180,O
.,180,181,O
It,182,184,O
must,185,189,O
still,190,195,O
be,196,198,O
considered,199,209,O
a,210,211,O
technique,212,221,O
which,222,227,O
is,228,230,O
undergoing,231,241,O
evaluation,242,252,O
.,252,253,O
Prospective,254,265,O
randomized,266,276,O
trials,277,283,O
comparing,284,293,O
this,294,298,O
therapy,299,306,O
with,307,311,O
other,312,317,O
currently,318,327,O
available,328,337,O
therapies,338,347,O
such,348,352,O
a,353,354,O
electrocoagulation,355,373,O
",",373,374,O
laser,375,380,O
and,381,384,O
conservative,385,397,O
management,398,408,O
must,409,413,O
be,414,416,O
completed,417,426,O
to,427,429,O
firmly,430,436,O
define,437,443,O
its,444,447,O
place,448,453,O
in,454,456,O
treatment,457,466,O
strategy,467,475,O
for,476,479,O
acute,480,485,O
upper,486,491,B-Organism_subdivision
GI,492,494,I-Organism_subdivision
bleeding,495,503,O
.,503,504,O
Effects,0,7,O
of,8,10,O
hypertension,11,23,O
and,24,27,O
sympathetic,28,39,O
denervation,40,51,O
on,52,54,O
cerebral,55,63,B-Organ
blood,64,69,B-Organism_substance
flow,70,74,O
in,75,77,O
newborn,78,85,O
pigs,86,90,O
.,90,91,O
To,92,94,O
investigate,95,106,O
the,107,110,O
potential,111,120,O
role,121,125,O
of,126,128,O
sympathetic,129,140,O
nerves,141,147,B-Multi-tissue_structure
in,148,150,O
preventing,151,161,O
pronounced,162,172,O
increases,173,182,O
in,183,185,O
cerebral,186,194,B-Organ
blood,195,200,B-Organism_substance
flow,201,205,O
",",205,206,O
we,207,209,O
evaluated,210,219,O
the,220,223,O
effects,224,231,O
of,232,234,O
abrupt,235,241,O
hypertension,242,254,O
on,255,257,O
the,258,261,O
cerebral,262,270,B-Organ
circulation,271,282,O
of,283,285,O
newborn,286,293,O
pigs,294,298,O
with,299,303,O
intact,304,310,O
cerebral,311,319,B-Organ
sympathetic,320,331,O
innervation,332,343,O
and,344,347,O
after,348,353,O
cerebral,354,362,B-Organ
sympathetic,363,374,O
denervation,375,386,O
.,386,387,O
Epinephrine,388,399,O
infusion,400,408,O
was,409,412,O
used,413,417,O
to,418,420,O
induce,421,427,O
abrupt,428,434,O
increases,435,444,O
in,445,447,O
mean,448,452,O
(,453,454,O
+,454,455,O
/,455,456,O
-,456,457,O
SEM,458,461,O
),461,462,O
arterial,463,471,B-Multi-tissue_structure
pressure,472,480,O
(,481,482,O
innervated,482,492,O
pigs,493,497,O
",",497,498,O
62,499,501,O
+,502,503,O
/,503,504,O
-,504,505,O
3,506,507,O
mm,508,510,O
of,511,513,O
Hg,514,516,O
to,517,519,O
115,520,523,O
+,524,525,O
/,525,526,O
-,526,527,O
3,528,529,O
mm,530,532,O
of,533,535,O
Hg,536,538,O
;,538,539,O
denervated,540,550,O
pigs,551,555,O
",",555,556,O
71,557,559,O
+,560,561,O
/,561,562,O
-,562,563,O
4,564,565,O
mm,566,568,O
of,569,571,O
Hg,572,574,O
to,575,577,O
132,578,581,O
+,582,583,O
/,583,584,O
-,584,585,O
4,586,587,O
mm,588,590,O
of,591,593,O
Hg,594,596,O
),596,597,O
that,598,602,O
remained,603,611,O
increased,612,621,O
for,622,625,O
the,626,629,O
3,630,631,O
minutes,632,639,O
of,640,642,O
the,643,646,O
study,647,652,O
.,652,653,O
Abrupt,654,660,O
hypertension,661,673,O
increased,674,683,O
blood,684,689,B-Organism_substance
flow,690,694,O
to,695,697,O
all,698,701,O
brain,702,707,B-Organ
regions,708,715,O
.,715,716,O
In,717,719,O
denervated,720,730,O
pigs,731,735,O
",",735,736,O
the,737,740,O
increased,741,750,O
flow,751,755,O
to,756,758,O
the,759,762,O
cerebrum,763,771,B-Multi-tissue_structure
was,772,775,O
prolonged,776,785,O
",",785,786,O
compared,787,795,O
with,796,800,O
that,801,805,O
in,806,808,O
pigs,809,813,O
with,814,818,O
intact,819,825,O
sympathetic,826,837,O
innervation,838,849,O
.,849,850,O
Differences,851,862,O
between,863,870,O
pigs,871,875,O
of,876,878,O
the,879,882,O
innervated,883,893,O
and,894,897,O
denervated,898,908,O
groups,909,915,O
were,916,920,O
not,921,924,O
apparent,925,933,O
",",933,934,O
with,935,939,O
respect,940,947,O
to,948,950,O
blood,951,956,B-Organism_substance
flow,957,961,O
to,962,964,O
any,965,968,O
other,969,974,O
region,975,981,O
(,982,983,O
caudate,983,990,O
region,991,997,O
",",997,998,O
brain,999,1004,B-Multi-tissue_structure
stem,1005,1009,I-Multi-tissue_structure
",",1009,1010,O
cerebellum,1011,1021,B-Multi-tissue_structure
),1021,1022,O
.,1022,1023,O
In,1024,1026,O
newborn,1027,1034,O
pigs,1035,1039,O
",",1039,1040,O
sympathetic,1041,1052,O
nerves,1053,1059,B-Multi-tissue_structure
may,1060,1063,O
attenuate,1064,1073,O
hypertension,1074,1086,O
-,1086,1087,O
induced,1087,1094,O
increases,1095,1104,O
in,1105,1107,O
blood,1108,1113,B-Organism_substance
flow,1114,1118,O
to,1119,1121,O
the,1122,1125,O
cerebrum,1126,1134,B-Multi-tissue_structure
",",1134,1135,O
but,1136,1139,O
do,1140,1142,O
not,1143,1146,O
appear,1147,1153,O
to,1154,1156,O
affect,1157,1163,O
flow,1164,1168,O
to,1169,1171,O
the,1172,1175,O
rest,1176,1180,O
of,1181,1183,O
the,1184,1187,O
brain,1188,1193,B-Organ
.,1193,1194,O
Sensitivity,0,11,O
analysis,12,20,O
of,21,23,O
the,24,27,O
influence,28,37,O
of,38,40,O
source,41,47,O
-,47,48,O
term,48,52,O
and,53,56,O
environmental,57,70,O
parameters,71,81,O
on,82,84,O
the,85,88,O
radiological,89,101,O
risk,102,106,O
of,107,109,O
coal,110,114,O
-,114,115,O
fired,115,120,O
plants,121,127,O
.,127,128,O
A,129,130,O
sensitivity,131,142,O
analysis,143,151,O
was,152,155,O
undertaken,156,166,O
to,167,169,O
determine,170,179,O
the,180,183,O
influence,184,193,O
of,194,196,O
different,197,206,O
source,207,213,O
-,213,214,O
term,214,218,O
and,219,222,O
environmental,223,236,O
parameters,237,247,O
on,248,250,O
the,251,254,O
radiological,255,267,O
risks,268,273,O
from,274,278,O
a,279,280,O
coal,281,285,O
-,285,286,O
fired,286,291,O
plant,292,297,O
(,298,299,O
CFP,299,302,O
),302,303,O
.,303,304,O
It,305,307,O
was,308,311,O
found,312,317,O
that,318,322,O
the,323,326,O
release,327,334,O
rate,335,339,O
of,340,342,O
radionuclides,343,356,O
and,357,360,O
the,361,364,O
effective,365,374,O
release,375,382,O
height,383,389,O
most,390,394,O
significantly,395,408,O
influence,409,418,O
radiological,419,431,O
risk,432,436,O
.,436,437,O
Site,438,442,O
characteristics,443,458,O
",",458,459,O
such,460,464,O
as,465,467,O
rain,468,472,O
scavenging,473,483,O
coefficients,484,496,O
and,497,500,O
food,501,505,O
acquirement,506,517,O
habits,518,524,O
",",524,525,O
have,526,530,O
a,531,532,O
lesser,533,539,O
influence,540,549,O
",",549,550,O
and,551,554,O
some,555,559,O
parameters,560,570,O
",",570,571,O
such,572,576,O
as,577,579,O
time,580,584,O
delay,585,590,O
before,591,597,O
ingestion,598,607,O
of,608,610,O
contaminated,611,623,O
food,624,628,O
",",628,629,O
have,630,634,O
practically,635,646,O
no,647,649,O
influence,650,659,O
on,660,662,O
the,663,666,O
radiological,667,679,O
impact,680,686,O
of,687,689,O
a,690,691,O
CFP,692,695,O
.,695,696,O
The,697,700,O
contribution,701,713,O
to,714,716,O
radiation,717,726,O
risks,727,732,O
of,733,735,O
different,736,745,O
exposure,746,754,O
modes,755,760,O
(,761,762,O
i,762,763,O
.,763,764,O
e,764,765,O
.,765,766,O
inhalation,767,777,O
",",777,778,O
ingestion,779,788,O
and,789,792,O
contact,793,800,O
with,801,805,O
ground,806,812,O
surface,813,820,O
),820,821,O
were,822,826,O
also,827,831,O
analyzed,832,840,O
",",840,841,O
as,842,844,O
well,845,849,O
as,850,852,O
of,853,855,O
specific,856,864,O
radionuclides,865,878,O
and,879,882,O
human,883,888,O
body,889,893,B-Organ
organs,894,900,I-Organ
.,900,901,O
Results,902,909,O
of,910,912,O
the,913,916,O
sensitivity,917,928,O
analysis,929,937,O
were,938,942,O
interpreted,943,954,O
in,955,957,O
terms,958,963,O
of,964,966,O
the,967,970,O
characteristics,971,986,O
of,987,989,O
the,990,993,O
fuel,994,998,O
",",998,999,O
facilities,1000,1010,O
and,1011,1014,O
site,1015,1019,O
of,1020,1022,O
a,1023,1024,O
CFP,1025,1028,O
.,1028,1029,O
It,1030,1032,O
is,1033,1035,O
concluded,1036,1045,O
that,1046,1050,O
by,1051,1053,O
proper,1054,1060,O
choice,1061,1067,O
of,1068,1070,O
coal,1071,1075,O
",",1075,1076,O
furnace,1077,1084,O
",",1084,1085,O
ash,1086,1089,O
filtration,1090,1100,O
and,1101,1104,O
stack,1105,1110,O
height,1111,1117,O
",",1117,1118,O
as,1119,1121,O
well,1122,1126,O
as,1127,1129,O
by,1130,1132,O
proper,1133,1139,O
siting,1140,1146,O
",",1146,1147,O
the,1148,1151,O
radiological,1152,1164,O
impact,1165,1171,O
of,1172,1174,O
a,1175,1176,O
CFP,1177,1180,O
can,1181,1184,O
be,1185,1187,O
drastically,1188,1199,O
reduced,1200,1207,O
.,1207,1208,O
Antishock,0,9,O
trousers,10,18,O
:,18,19,O
a,20,21,O
collective,22,32,O
review,33,39,O
.,39,40,O
Antishock,41,50,O
trousers,51,59,O
have,60,64,O
become,65,71,O
an,72,74,O
integral,75,83,O
part,84,88,O
of,89,91,O
emergency,92,101,O
medical,102,109,O
care,110,114,O
for,115,118,O
many,119,123,O
traumatic,124,133,O
and,134,137,O
life,138,142,O
-,142,143,O
threatening,143,154,O
emergencies,155,166,O
.,166,167,O
This,168,172,O
article,173,180,O
represents,181,191,O
a,192,193,O
summary,194,201,O
of,202,204,O
the,205,208,O
current,209,216,O
state,217,222,O
of,223,225,O
knowledge,226,235,O
concerning,236,246,O
the,247,250,O
use,251,254,O
of,255,257,O
this,258,262,O
device,263,269,O
.,269,270,O
A,271,272,O
brief,273,278,O
history,279,286,O
of,287,289,O
the,290,293,O
development,294,305,O
of,306,308,O
antishock,309,318,O
garments,319,327,O
is,328,330,O
discussed,331,340,O
.,340,341,O
This,342,346,O
is,347,349,O
followed,350,358,O
by,359,361,O
a,362,363,O
discussion,364,374,O
of,375,377,O
human,378,383,O
clinical,384,392,O
studies,393,400,O
and,401,404,O
results,405,412,O
of,413,415,O
clinical,416,424,O
research,425,433,O
on,434,436,O
hemodynamics,437,449,O
",",449,450,O
respiration,451,462,O
",",462,463,O
use,464,467,O
in,468,470,O
head,471,475,B-Organism_subdivision
injury,476,482,O
",",482,483,O
and,484,487,O
effects,488,495,O
on,496,498,O
vascular,499,507,B-Multi-tissue_structure
hemostasis,508,518,O
.,518,519,O
Indications,520,531,O
",",531,532,O
contraindications,533,550,O
",",550,551,O
complications,552,565,O
",",565,566,O
and,567,570,O
recommended,571,582,O
procedure,583,592,O
for,593,596,O
use,597,600,O
are,601,604,O
discussed,605,614,O
.,614,615,O
Based,616,621,O
on,622,624,O
randomized,625,635,O
prospective,636,647,O
studies,648,655,O
",",655,656,O
antishock,657,666,O
garments,667,675,O
have,676,680,O
not,681,684,O
",",684,685,O
as,686,688,O
yet,689,692,O
",",692,693,O
been,694,698,O
shown,699,704,O
to,705,707,O
improve,708,715,O
patient,716,723,O
morbidity,724,733,O
or,734,736,O
mortality,737,746,O
.,746,747,O
Proper,748,754,O
use,755,758,O
of,759,761,O
antishock,762,771,O
garments,772,780,O
requires,781,789,O
an,790,792,O
understanding,793,806,O
of,807,809,O
both,810,814,O
their,815,820,O
function,821,829,O
and,830,833,O
their,834,839,O
limitations,840,851,O
.,851,852,O
Measurement,0,11,O
of,12,14,O
serum,15,20,B-Organism_substance
glycosylated,21,33,O
proteins,34,42,O
and,43,46,O
glycosylated,47,59,O
low,60,63,O
density,64,71,O
lipoprotein,72,83,O
fraction,84,92,O
in,93,95,O
diabetes,96,104,O
mellitus,105,113,O
.,113,114,O
A,115,116,O
simple,117,123,O
method,124,130,O
was,131,134,O
developed,135,144,O
for,145,148,O
estimating,149,159,O
serum,160,165,B-Organism_substance
glycosylated,166,178,O
protein,179,186,O
levels,187,193,O
using,194,199,O
gel,200,203,O
filtration,204,214,O
with,215,219,O
Bio,220,223,O
-,223,224,O
Gel,224,227,O
P6,228,230,O
by,231,233,O
determining,234,245,O
the,246,249,O
protein,250,257,O
and,258,261,O
sugar,262,267,O
content,268,275,O
in,276,278,O
the,279,282,O
void,283,287,O
volume,288,294,O
fraction,295,303,O
.,303,304,O
The,305,308,O
glycosylated,309,321,O
protein,322,329,O
levels,330,336,O
(,337,338,O
GSP,338,341,O
),341,342,O
correlated,343,353,O
well,354,358,O
with,359,363,O
fasting,364,371,O
blood,372,377,B-Organism_substance
sugar,378,383,O
levels,384,390,O
and,391,394,O
glycosylated,395,407,O
albumin,408,415,O
level,416,421,O
(,422,423,O
G,423,424,O
-,424,425,O
ALB,425,428,O
),428,429,O
determined,430,440,O
by,441,443,O
affinity,444,452,O
chromatography,453,467,O
with,468,472,O
Blue,473,477,O
Sepharose,478,487,O
CL6B,488,492,O
.,492,493,O
The,494,497,O
glycosylation,498,511,O
level,512,517,O
of,518,520,O
heparin,521,528,O
-,528,529,O
citrate,529,536,O
precipitable,537,549,O
fraction,550,558,O
of,559,561,O
serum,562,567,B-Organism_substance
which,568,573,O
predominantly,574,587,O
contained,588,597,O
low,598,601,O
density,602,609,O
lipoprotein,610,621,O
(,622,623,O
G,623,624,O
-,624,625,O
LDL,625,628,O
),628,629,O
also,630,634,O
correlated,635,645,O
well,646,650,O
with,651,655,O
GSP,656,659,O
and,660,663,O
LDL,664,667,O
-,667,668,O
cholesterol,668,679,O
levels,680,686,O
.,686,687,O
Significantly,688,701,O
different,702,711,O
values,712,718,O
were,719,723,O
obtained,724,732,O
for,733,736,O
GSP,737,740,O
",",740,741,O
G,742,743,O
-,743,744,O
ALB,744,747,O
",",747,748,O
and,749,752,O
G,753,754,O
-,754,755,O
LDL,755,758,O
between,759,766,O
normals,767,774,O
and,775,778,O
diabetics,779,788,O
.,788,789,O
The,0,3,O
origin,4,10,O
of,11,13,O
yolk,14,18,B-Developing_anatomical_structure
-,18,19,O
DNA,19,22,O
in,23,25,O
Xenopus,26,33,O
laevis,34,40,O
.,40,41,O
Xenopus,42,49,O
laevis,50,56,O
serum,57,62,B-Organism_substance
and,63,66,O
plasma,67,73,B-Organism_substance
was,74,77,O
found,78,83,O
to,84,86,O
contain,87,94,O
an,95,97,O
average,98,105,O
of,106,108,O
25,109,111,O
microgram,112,121,O
DNA,122,125,O
/,125,126,O
ml,126,128,O
.,128,129,O
Isolated,130,138,O
X,139,140,O
.,140,141,O
laevis,142,148,O
oocytes,149,156,B-Cell
incubated,157,166,O
in,167,169,O
medium,170,176,O
containing,177,187,O
25,188,190,O
microgram,191,200,O
DNA,201,204,O
/,204,205,O
ml,205,207,O
labeled,208,215,O
with,216,220,O
either,221,227,O
125I,228,232,O
",",232,233,O
32P,234,237,O
or,238,240,O
14C,241,244,O
and,245,248,O
from,249,253,O
three,254,259,O
different,260,269,O
sources,270,277,O
(,278,279,O
bovine,279,285,O
",",285,286,O
E,287,288,O
.,288,289,O
coli,290,294,O
and,295,298,O
X,299,300,O
.,300,301,O
laevis,302,308,O
),308,309,O
",",309,310,O
incorporated,311,323,O
the,324,327,O
label,328,333,O
at,334,336,O
an,337,339,O
average,340,347,O
rate,348,352,O
of,353,355,O
0,356,357,O
.,357,358,O
11,358,360,O
ng,361,363,O
.,363,364,O
mm,364,366,O
-,366,367,O
2,367,368,O
.,368,369,O
hr,369,371,O
-,371,372,O
1,372,373,O
.,373,374,O
Sucrose,375,382,O
gradient,383,391,O
fractionation,392,405,O
of,406,408,O
oocytes,409,416,B-Cell
revealed,417,425,O
that,426,430,O
40,431,433,O
-,433,434,O
75,434,436,O
%,436,437,O
of,438,440,O
the,441,444,O
acid,445,449,O
-,449,450,O
precipitable,450,462,O
label,463,468,O
incorporated,469,481,O
was,482,485,O
associated,486,496,O
with,497,501,O
the,502,505,O
yolk,506,510,B-Cell
platelets,511,520,I-Cell
.,520,521,O
Additional,522,532,O
incubations,533,544,O
of,545,547,O
oocytes,548,555,B-Cell
in,556,558,O
unlabeled,559,568,O
medium,569,575,O
demonstrated,576,588,O
that,589,593,O
the,594,597,O
DNA,598,601,O
incorporated,602,614,O
into,615,619,O
the,620,623,O
yolk,624,628,B-Cell
platelets,629,638,I-Cell
was,639,642,O
undergoing,643,653,O
turnover,654,662,O
;,662,663,O
only,664,668,O
20,669,671,O
%,671,672,O
of,673,675,O
the,676,679,O
yolk,680,684,B-Developing_anatomical_structure
-,684,685,O
associated,685,695,O
DNA,696,699,O
was,700,703,O
still,704,709,O
present,710,717,O
after,718,723,O
a,724,725,O
one,726,729,O
-,729,730,O
week,730,734,O
incubation,735,745,O
.,745,746,O
Our,747,750,O
data,751,755,O
suggest,756,763,O
that,764,768,O
yolk,769,773,B-Developing_anatomical_structure
-,773,774,O
DNA,774,777,O
arises,778,784,O
by,785,787,O
the,788,791,O
adventitious,792,804,O
uptake,805,811,O
of,812,814,O
DNA,815,818,O
present,819,826,O
in,827,829,O
the,830,833,O
maternal,834,842,O
serum,843,848,B-Organism_substance
by,849,851,O
vitellogenic,852,864,O
oocytes,865,872,B-Cell
.,872,873,O
Immunoglobulins,0,15,O
associated,16,26,O
with,27,31,O
elevated,32,40,O
riboflavin,41,51,O
binding,52,59,O
by,60,62,O
plasma,63,69,B-Organism_substance
from,70,74,O
cancer,75,81,B-Pathological_formation
patients,82,90,O
.,90,91,O
Plasma,92,98,B-Organism_substance
from,99,103,O
182,104,107,O
patients,108,116,O
with,117,121,O
different,122,131,O
malignant,132,141,O
diseases,142,150,O
was,151,154,O
tested,155,161,O
for,162,165,O
riboflavin,166,176,O
binding,177,184,O
by,185,187,O
immunoglobulins,188,203,O
",",203,204,O
which,205,210,O
have,211,215,O
been,216,220,O
recently,221,229,O
identified,230,240,O
as,241,243,O
major,244,249,O
carriers,250,258,O
of,259,261,O
this,262,266,O
micronutrient,267,280,O
.,280,281,O
A,282,283,O
wide,284,288,O
range,289,294,O
of,295,297,O
binding,298,305,O
(,306,307,O
5,307,308,O
.,308,309,O
9,309,310,O
to,311,313,O
130,314,317,O
pmole,318,323,O
/,323,324,O
ml,324,326,O
plasma,327,333,O
),333,334,O
was,335,338,O
observed,339,347,O
",",347,348,O
and,349,352,O
significant,353,364,O
elevations,365,375,O
were,376,380,O
found,381,386,O
for,387,390,O
patients,391,399,O
having,400,406,O
breast,407,413,B-Pathological_formation
cancer,414,420,I-Pathological_formation
(,421,422,O
21,422,424,O
.,424,425,O
2,425,426,O
+,427,428,O
/,428,429,O
-,429,430,O
1,431,432,O
.,432,433,O
9,433,434,O
",",434,435,O
P,436,437,O
less,438,442,O
than,443,447,O
0,448,449,O
.,449,450,O
05,450,452,O
),452,453,O
and,454,457,O
melanoma,458,466,B-Pathological_formation
(,467,468,O
25,468,470,O
.,470,471,O
7,471,472,O
+,473,474,O
/,474,475,O
-,475,476,O
1,477,478,O
.,478,479,O
9,479,480,O
",",480,481,O
P,482,483,O
less,484,488,O
than,489,493,O
0,494,495,O
.,495,496,O
001,496,499,O
),499,500,O
compared,501,509,O
to,510,512,O
controls,513,521,O
(,522,523,O
15,523,525,O
.,525,526,O
5,526,527,O
+,528,529,O
/,529,530,O
-,530,531,O
1,532,533,O
.,533,534,O
9,534,535,O
),535,536,O
.,536,537,O
The,538,541,O
proteins,542,550,O
responsible,551,562,O
for,563,566,O
a,567,568,O
majority,569,577,O
of,578,580,O
the,581,584,O
higher,585,591,O
binding,592,599,O
were,600,604,O
identified,605,615,O
as,616,618,O
immunoglobulins,619,634,O
",",634,635,O
based,636,641,O
on,642,644,O
their,645,650,O
elution,651,658,O
from,659,663,O
gel,664,667,O
filtration,668,678,O
columns,679,686,O
and,687,690,O
the,691,694,O
removal,695,702,O
of,703,705,O
57,706,708,O
-,708,709,O
88,709,711,O
%,711,712,O
of,713,715,O
the,716,719,O
non,720,723,O
-,723,724,O
albumin,724,731,O
binding,732,739,O
by,740,742,O
treating,743,751,O
of,752,754,O
plasma,755,761,B-Organism_substance
with,762,766,O
Protein,767,774,O
A,775,776,O
-,776,777,O
agarose,777,784,O
.,784,785,O
The,786,789,O
binding,790,797,O
was,798,801,O
only,802,806,O
weakly,807,813,O
related,814,821,O
to,822,824,O
the,825,828,O
total,829,834,O
concentration,835,848,O
of,849,851,O
immunoglobulins,852,867,O
(,868,869,O
r,869,870,O
=,871,872,O
0,873,874,O
.,874,875,O
11,875,877,O
by,878,880,O
linear,881,887,O
regression,888,898,O
analysis,899,907,O
),907,908,O
",",908,909,O
however,910,917,O
",",917,918,O
and,919,922,O
is,923,925,O
apparently,926,936,O
due,937,940,O
to,941,943,O
a,944,945,O
subclass,946,954,O
that,955,959,O
is,960,962,O
elevated,963,971,O
in,972,974,O
some,975,979,O
types,980,985,O
of,986,988,O
cancer,989,995,O
.,995,996,O
Elevated,997,1005,O
levels,1006,1012,O
of,1013,1015,O
these,1016,1021,O
immunoglobulins,1022,1037,O
may,1038,1041,O
contribute,1042,1052,O
to,1053,1055,O
the,1056,1059,O
lower,1060,1065,O
urinary,1066,1073,B-Organism_substance
levels,1074,1080,O
and,1081,1084,O
clearance,1085,1094,O
of,1095,1097,O
riboflavin,1098,1108,O
in,1109,1111,O
cancer,1112,1118,B-Pathological_formation
.,1118,1119,O
Postpartum,0,10,O
rubella,11,18,O
immunization,19,31,O
:,31,32,O
association,33,44,O
with,45,49,O
development,50,61,O
of,62,64,O
prolonged,65,74,O
arthritis,75,84,O
",",84,85,O
neurological,86,98,B-Anatomical_system
sequelae,99,107,O
",",107,108,O
and,109,112,O
chronic,113,120,O
rubella,121,128,O
viremia,129,136,O
.,136,137,O
Six,138,141,O
women,142,147,O
developed,148,157,O
chronic,158,165,O
long,166,170,O
-,170,171,O
term,171,175,O
arthropathy,176,187,O
after,188,193,O
postpartum,194,204,O
immunization,205,217,O
against,218,225,O
rubella,226,233,O
.,233,234,O
All,235,238,O
individuals,239,250,O
developed,251,260,O
acute,261,266,O
polyarticular,267,280,O
arthritis,281,290,O
within,291,297,O
12,298,300,O
days,301,305,O
to,306,308,O
three,309,314,O
weeks,315,320,O
postimmunization,321,337,O
and,338,341,O
have,342,346,O
had,347,350,O
continuing,351,361,O
chronic,362,369,O
or,370,372,O
recurrent,373,382,O
arthralgia,383,393,O
or,394,396,O
arthritis,397,406,O
for,407,410,O
two,411,414,O
to,415,417,O
seven,418,423,O
years,424,429,O
after,430,435,O
vaccination,436,447,O
.,447,448,O
Acute,449,454,O
neurological,455,467,B-Anatomical_system
manifestations,468,482,O
",",482,483,O
consisting,484,494,O
of,495,497,O
carpal,498,504,O
tunnel,505,511,O
syndrome,512,520,O
or,521,523,O
multiple,524,532,O
paresthesiae,533,545,O
",",545,546,O
developed,547,556,O
postvaccination,557,572,O
in,573,575,O
three,576,581,O
women,582,587,O
.,587,588,O
Two,589,592,O
have,593,597,O
developed,598,607,O
continuing,608,618,O
active,619,625,O
or,626,628,O
chronic,629,636,O
recurrent,637,646,O
episodes,647,655,O
of,656,658,O
blurred,659,666,O
vision,667,673,O
",",673,674,O
paresthesiae,675,687,O
",",687,688,O
and,689,692,O
painful,693,700,O
limb,701,705,B-Organism_subdivision
syndromes,706,715,O
together,716,724,O
with,725,729,O
recurrent,730,739,O
joint,740,745,O
symptoms,746,754,O
.,754,755,O
Chronic,756,763,O
rubella,764,771,O
viremia,772,779,O
has,780,783,O
been,784,788,O
detected,789,797,O
in,798,800,O
peripheral,801,811,B-Cell
blood,812,817,I-Cell
mononuclear,818,829,I-Cell
cell,830,834,I-Cell
(,835,836,O
MNC,836,839,B-Cell
),839,840,O
populations,841,852,O
in,853,855,O
five,856,860,O
of,861,863,O
the,864,867,O
six,868,871,O
women,872,877,O
up,878,880,O
to,881,883,O
six,884,887,O
years,888,893,O
after,894,899,O
vaccination,900,911,O
.,911,912,O
In,913,915,O
addition,916,924,O
rubella,925,932,O
virus,933,938,O
was,939,942,O
isolated,943,951,O
from,952,956,O
breast,957,963,B-Cell
milk,964,968,I-Cell
MNCs,969,973,I-Cell
in,974,976,O
one,977,980,O
individual,981,991,O
at,992,994,O
nine,995,999,O
months,1000,1006,O
postvaccination,1007,1022,O
and,1023,1026,O
from,1027,1031,O
peripheral,1032,1042,B-Cell
blood,1043,1048,I-Cell
MNCs,1049,1053,I-Cell
in,1054,1056,O
two,1057,1060,O
of,1061,1063,O
four,1064,1068,O
breast,1069,1075,B-Organism_subdivision
-,1075,1076,O
fed,1076,1079,O
infants,1080,1087,O
studied,1088,1095,O
at,1096,1098,O
12,1099,1101,O
-,1101,1102,O
18,1102,1104,O
months,1105,1111,O
of,1112,1114,O
age,1115,1118,O
.,1118,1119,O
Immune,1120,1126,O
responses,1127,1136,O
to,1137,1139,O
rubella,1140,1147,O
virus,1148,1153,O
studied,1154,1161,O
at,1162,1164,O
sequential,1165,1175,O
intervals,1176,1185,O
after,1186,1191,O
vaccination,1192,1203,O
correlated,1204,1214,O
with,1215,1219,O
development,1220,1231,O
of,1232,1234,O
rheumatologic,1235,1248,O
and,1249,1252,O
neurological,1253,1265,B-Anatomical_system
manifestations,1266,1280,O
.,1280,1281,O
Cardiac,0,7,B-Organ
gap,8,11,O
junction,12,20,O
configuration,21,34,O
after,35,40,O
an,41,43,O
uncoupling,44,54,O
treatment,55,64,O
as,65,67,O
a,68,69,O
function,70,78,O
of,79,81,O
time,82,86,O
.,86,87,O
Rabbit,88,94,O
ventricle,95,104,B-Multi-tissue_structure
either,105,111,O
was,112,115,O
fixed,116,121,O
in,122,124,O
glutaraldehyde,125,139,O
without,140,147,O
injury,148,154,O
(,155,156,O
control,156,163,O
),163,164,O
or,165,167,O
was,168,171,O
injured,172,179,O
before,180,186,O
fixation,187,195,O
",",195,196,O
presumably,197,207,O
causing,208,215,O
electrical,216,226,O
uncoupling,227,237,O
of,238,240,O
the,241,244,O
gap,245,248,O
junctions,249,258,O
.,258,259,O
All,260,263,O
tissue,264,270,B-Tissue
was,271,274,O
then,275,279,O
processed,280,289,O
for,290,293,O
freeze,294,300,O
-,300,301,O
fracture,301,309,O
.,309,310,O
Replicas,311,319,O
of,320,322,O
control,323,330,O
gap,331,334,O
junctions,335,344,O
exhibited,345,354,O
irregular,355,364,O
packing,365,372,O
of,373,375,O
the,376,379,O
P,380,381,O
-,381,382,O
face,382,386,O
particles,387,396,O
and,397,400,O
E,401,402,O
-,402,403,O
face,403,407,O
pits,408,412,O
.,412,413,O
Average,414,421,O
center,422,428,O
-,428,429,O
to,429,431,O
-,431,432,O
center,432,438,O
spacing,439,446,O
of,447,449,O
the,450,453,O
particles,454,463,O
was,464,467,O
10,468,470,O
.,470,471,O
5,471,472,O
nm,473,475,O
.,475,476,O
Tissue,477,483,B-Tissue
fixed,484,489,O
1,490,491,O
-,491,492,O
5,492,493,O
min,494,497,O
after,498,503,O
injury,504,510,O
showed,511,517,O
clumping,518,526,O
of,527,529,O
gap,530,533,O
junctional,534,544,O
particles,545,554,O
and,555,558,O
pits,559,563,O
.,563,564,O
Within,565,571,O
the,572,575,O
clumps,576,582,O
",",582,583,O
the,584,587,O
particles,588,597,O
and,598,601,O
pits,602,606,O
were,607,611,O
hexagonally,612,623,O
packed,624,630,O
and,631,634,O
the,635,638,O
center,639,645,O
-,645,646,O
to,646,648,O
-,648,649,O
center,649,655,O
spacing,656,663,O
of,664,666,O
the,667,670,O
particles,671,680,O
averaged,681,689,O
9,690,691,O
.,691,692,O
5,692,693,O
nm,694,696,O
.,696,697,O
In,698,700,O
tissue,701,707,B-Tissue
fixed,708,713,O
15,714,716,O
-,716,717,O
30,717,719,O
min,720,723,O
after,724,729,O
injury,730,736,O
",",736,737,O
the,738,741,O
clumps,742,748,O
of,749,751,O
gap,752,755,O
junctional,756,766,O
particles,767,776,O
had,777,780,O
coalesced,781,790,O
into,791,795,O
a,796,797,O
homogeneous,798,809,O
structure,810,819,O
in,820,822,O
most,823,827,O
junctions,828,837,O
.,837,838,O
The,839,842,O
packing,843,850,O
of,851,853,O
the,854,857,O
particles,858,867,O
and,868,871,O
pits,872,876,O
was,877,880,O
hexagonal,881,890,O
and,891,894,O
the,895,898,O
spacing,899,906,O
of,907,909,O
the,910,913,O
particles,914,923,O
averaged,924,932,O
9,933,934,O
.,934,935,O
5,935,936,O
nm,937,939,O
.,939,940,O
A,941,942,O
few,943,946,O
pieces,947,953,O
of,954,956,O
rabbit,957,963,O
atrium,964,970,B-Multi-tissue_structure
were,971,975,O
frozen,976,982,O
without,983,990,O
prior,991,996,O
fixation,997,1005,O
or,1006,1008,O
cryoprotection,1009,1023,O
to,1024,1026,O
try,1027,1030,O
to,1031,1033,O
assess,1034,1040,O
the,1041,1044,O
effect,1045,1051,O
of,1052,1054,O
glutarldehyde,1055,1068,O
fixation,1069,1077,O
on,1078,1080,O
gap,1081,1084,O
junction,1085,1093,O
structure,1094,1103,O
.,1103,1104,O
In,1105,1107,O
this,1108,1112,O
tissue,1113,1119,B-Tissue
the,1120,1123,O
gap,1124,1127,O
junctional,1128,1138,O
particles,1139,1148,O
were,1149,1153,O
irregularly,1154,1165,O
packed,1166,1172,O
and,1173,1176,O
their,1177,1182,O
spacing,1183,1190,O
averaged,1191,1199,O
10,1200,1202,O
.,1202,1203,O
0,1203,1204,O
nm,1205,1207,O
.,1207,1208,O
Absence,0,7,O
of,8,10,O
effect,11,17,O
of,18,20,O
prenatal,21,29,O
ethanol,30,37,O
on,38,40,O
adult,41,46,O
emotionality,47,59,O
and,60,63,O
ethanol,64,71,O
consumption,72,83,O
in,84,86,O
rats,87,91,O
.,91,92,O
Lower,93,98,O
peak,99,103,O
blood,104,109,B-Organism_substance
ethanol,110,117,O
concentrations,118,132,O
after,133,138,O
1,139,140,O
and,141,144,O
2,145,146,O
g,147,148,O
of,149,151,O
ethanol,152,159,O
per,160,163,O
kg,164,166,O
were,167,171,O
found,172,177,O
in,178,180,O
pregnant,181,189,O
rats,190,194,O
than,195,199,O
in,200,202,O
virgin,203,209,O
females,210,217,O
.,217,218,O
No,219,221,O
significant,222,233,O
differences,234,245,O
in,246,248,O
adult,249,254,O
"""",255,256,O
emotionality,256,268,O
"""",268,269,O
or,270,272,O
ethanol,273,280,O
consumption,281,292,O
were,293,297,O
found,298,303,O
in,304,306,O
rats,307,311,O
exposed,312,319,O
to,320,322,O
prenatal,323,331,O
alcohol,332,339,O
and,340,343,O
in,344,346,O
pair,347,351,O
-,351,352,O
fed,352,355,O
and,356,359,O
untreated,360,369,O
controls,370,378,O
.,378,379,O
Tropical,0,8,O
splenomegaly,9,21,O
syndrome,22,30,O
in,31,33,O
Zambia,34,40,O
:,40,41,O
further,42,49,O
observations,50,62,O
and,63,66,O
effects,67,74,O
of,75,77,O
cycloguanil,78,89,O
and,90,93,O
proguanil,94,103,O
.,103,104,O
Nineteen,105,113,O
Zambian,114,121,O
patients,122,130,O
with,131,135,O
the,136,139,O
tropical,140,148,O
splenomegaly,149,161,O
syndrome,162,170,O
and,171,174,O
sinusoidal,175,185,B-Tissue
lymphocytosis,186,199,O
on,200,202,O
liver,203,208,B-Organ
biopsy,209,215,O
were,216,220,O
studied,221,228,O
.,228,229,O
The,230,233,O
association,234,245,O
of,246,248,O
macrobulinaemia,249,264,O
with,265,269,O
the,270,273,O
tropical,274,282,O
splenomegaly,283,295,O
syndrome,296,304,O
has,305,308,O
again,309,314,O
been,315,319,O
confirmed,320,329,O
.,329,330,O
Sixteen,331,338,O
patients,339,347,O
were,348,352,O
treated,353,360,O
with,361,365,O
antimalarials,366,379,O
-,379,380,O
12,380,382,O
with,383,387,O
cycloguanil,388,399,O
pamoate,400,407,O
alone,408,413,O
",",413,414,O
3,415,416,O
with,417,421,O
cycloguanil,422,433,O
and,434,437,O
proguanil,438,447,O
",",447,448,O
and,449,452,O
1,453,454,O
with,455,459,O
proguanil,460,469,O
alone,470,475,O
.,475,476,O
Twelve,477,483,O
patients,484,492,O
were,493,497,O
observed,498,506,O
for,507,510,O
periods,511,518,O
of,519,521,O
sufficient,522,532,O
length,533,539,O
for,540,543,O
the,544,547,O
drug,548,552,O
effect,553,559,O
to,560,562,O
be,563,565,O
assessed,566,574,O
",",574,575,O
and,576,579,O
in,580,582,O
11,583,585,O
there,586,591,O
was,592,595,O
a,596,597,O
good,598,602,O
response,603,611,O
in,612,614,O
terms,615,620,O
of,621,623,O
decrease,624,632,O
in,633,635,O
spleen,636,642,B-Organ
size,643,647,O
.,647,648,O
Cycloguanil,648,659,O
pamoate,660,667,O
may,668,671,O
be,672,674,O
of,675,677,O
value,678,683,O
both,684,688,O
for,689,692,O
prophylaxis,693,704,O
and,705,708,O
treatment,709,718,O
in,719,721,O
areas,722,727,O
where,728,733,O
tropical,734,742,O
splenomegaly,743,755,O
syndrome,756,764,O
is,765,767,O
endemic,768,775,O
.,775,776,O
Regulation,0,10,O
of,11,13,O
glucosyl,14,22,O
-,22,23,O
and,24,27,O
fructosyltransferase,28,48,O
synthesis,49,58,O
by,59,61,O
continuous,62,72,O
cultures,73,81,O
of,82,84,O
Streptococcus,85,98,O
mutans,99,105,O
.,105,106,O
Streptococcus,107,120,O
mutans,121,127,O
strains,128,135,O
Ingbritt,136,144,O
",",144,145,O
and,146,149,O
its,150,153,O
derivative,154,164,O
B7,165,167,O
which,168,173,O
had,174,177,O
been,178,182,O
passaged,183,191,O
through,192,199,O
monkeys,200,207,O
",",207,208,O
have,209,213,O
been,214,218,O
used,219,223,O
to,224,226,O
investigate,227,238,O
how,239,242,O
the,243,246,O
synthesis,247,256,O
of,257,259,O
extracellular,260,273,B-Immaterial_anatomical_entity
glucosyl,274,282,O
-,282,283,O
and,284,287,O
fructosyltransferases,288,309,O
is,310,312,O
regulated,313,322,O
.,322,323,O
The,324,327,O
most,328,332,O
active,333,339,O
enzyme,340,346,O
from,347,351,O
carbon,352,358,O
-,358,359,O
limited,359,366,O
continuous,367,377,O
cultures,378,386,O
was,387,390,O
a,391,392,O
fructosyltransferase,393,413,O
;,413,414,O
enzymes,415,422,O
catalysing,423,433,O
the,434,437,O
formation,438,447,O
of,448,450,O
water,451,456,O
-,456,457,O
insoluble,457,466,O
glucans,467,474,O
from,475,479,O
sucrose,480,487,O
were,488,492,O
relatively,493,503,O
inactive,504,512,O
.,512,513,O
Dextransucrase,514,528,O
(,529,530,O
EC,530,532,O
2,533,534,O
.,534,535,O
4,535,536,O
.,536,537,O
1,537,538,O
.,538,539,O
5,539,540,O
),540,541,O
",",541,542,O
which,543,548,O
catalyses,549,558,O
soluble,559,566,O
glucan,567,573,O
synthesis,574,583,O
",",583,584,O
was,585,588,O
most,589,593,O
active,594,600,O
in,601,603,O
the,604,607,O
supernatant,608,619,O
fluid,620,625,O
from,626,630,O
cultures,631,639,O
grown,640,645,O
with,646,650,O
excess,651,657,O
glucose,658,665,O
",",665,666,O
fructose,667,675,O
or,676,678,O
sucrose,679,686,O
",",686,687,O
but,688,691,O
full,692,696,O
activity,697,705,O
was,706,709,O
detected,710,718,O
only,719,723,O
when,724,728,O
the,729,732,O
enzyme,733,739,O
was,740,743,O
incubated,744,753,O
with,754,758,O
both,759,763,O
sucrose,764,771,O
and,772,775,O
dextran,776,783,O
.,783,784,O
Little,785,791,O
dextransucrase,792,806,O
activity,807,815,O
was,816,819,O
detected,820,828,O
in,829,831,O
carbon,832,838,O
-,838,839,O
limited,839,846,O
cultures,847,855,O
.,855,856,O
It,857,859,O
is,860,862,O
concluded,863,872,O
that,873,877,O
glucosyl,878,886,O
-,886,887,O
and,888,891,O
fructosyltransferases,892,913,O
are,914,917,O
constitutive,918,930,O
enzymes,931,938,O
in,939,941,O
that,942,946,O
they,947,951,O
are,952,955,O
synthesized,956,967,O
at,968,970,O
similar,971,978,O
rates,979,984,O
during,985,991,O
growth,992,998,O
with,999,1003,O
an,1004,1006,O
excess,1007,1013,O
of,1014,1016,O
the,1017,1020,O
substrate,1021,1030,O
or,1031,1033,O
of,1034,1036,O
the,1037,1040,O
products,1041,1049,O
of,1050,1052,O
the,1053,1056,O
reactions,1057,1066,O
which,1067,1072,O
they,1073,1077,O
catalyse,1078,1086,O
.,1086,1087,O
Although,1088,1096,O
the,1097,1100,O
Ingbritt,1101,1109,O
strain,1110,1116,O
was,1117,1120,O
originally,1121,1131,O
isolated,1132,1140,O
from,1141,1145,O
a,1146,1147,O
carious,1148,1155,B-Pathological_formation
lesion,1156,1162,I-Pathological_formation
",",1162,1163,O
it,1164,1166,O
is,1167,1169,O
now,1170,1173,O
a,1174,1175,O
poor,1176,1180,O
source,1181,1187,O
of,1188,1190,O
glucosyltransferase,1191,1210,O
activity,1211,1219,O
.,1219,1220,O
Glucosyltransferases,1221,1241,O
were,1242,1246,O
extremely,1247,1256,O
active,1257,1263,O
in,1264,1266,O
cultures,1267,1275,O
of,1276,1278,O
a,1279,1280,O
recent,1281,1287,O
clinical,1288,1296,O
isolate,1297,1304,O
",",1304,1305,O
strain,1306,1312,O
3209,1313,1317,O
",",1317,1318,O
and,1319,1322,O
were,1323,1327,O
apparently,1328,1338,O
induced,1339,1346,O
during,1347,1353,O
growth,1354,1360,O
with,1361,1365,O
excess,1366,1372,O
glucose,1373,1380,O
.,1380,1381,O
Role,0,4,O
of,5,7,O
interleukin,8,19,O
1,20,21,O
in,22,24,O
antigen,25,32,O
-,32,33,O
specific,33,41,O
T,42,43,B-Cell
cell,44,48,I-Cell
proliferation,49,62,O
.,62,63,O
The,64,67,O
role,68,72,O
of,73,75,O
interleukin,76,87,O
1,88,89,O
(,90,91,O
IL,91,93,O
1,94,95,O
),95,96,O
in,97,99,O
human,100,105,O
antigen,106,113,O
-,113,114,O
specific,114,122,O
T,123,124,B-Cell
cell,125,129,I-Cell
proliferation,130,143,O
was,144,147,O
examined,148,156,O
.,156,157,O
Nylon,158,163,O
wool,164,168,O
-,168,169,O
purified,169,177,O
T,178,179,B-Cell
cells,180,185,I-Cell
proliferated,186,198,O
in,199,201,O
the,202,205,O
presence,206,214,O
of,215,217,O
autologous,218,228,B-Cell
monocytes,229,238,I-Cell
(,239,240,O
Mo,240,242,B-Cell
.,242,243,O
),243,244,O
pulsed,245,251,O
for,252,255,O
18,256,258,O
h,259,260,O
with,261,265,O
tetanus,266,273,O
toxoid,274,280,O
(,281,282,O
TT,282,284,O
),284,285,O
antigen,286,293,O
(,294,295,O
Mo,295,297,B-Cell
.,297,298,O
TT,298,300,O
),300,301,O
.,301,302,O
Irradiation,303,314,O
of,315,317,O
Mo,318,320,B-Cell
.,320,321,O
TT,321,323,O
with,324,328,O
ultraviolet,329,340,O
(,341,342,O
UV,342,344,O
),344,345,O
light,346,351,O
(,352,353,O
72,353,355,O
J,356,357,O
/,357,358,O
m2,358,360,O
),360,361,O
abolished,362,371,O
their,372,377,O
capacity,378,386,O
to,387,389,O
support,390,397,O
T,398,399,B-Cell
cell,400,404,I-Cell
proliferation,405,418,O
and,419,422,O
drastically,423,434,O
reduced,435,442,O
their,443,448,O
capacity,449,457,O
to,458,460,O
secrete,461,468,O
IL,469,471,O
1,472,473,O
after,474,479,O
stimulation,480,491,O
with,492,496,O
Staphylococcus,497,511,O
albus,512,517,O
.,517,518,O
The,519,522,O
defect,523,529,O
in,530,532,O
antigen,533,540,O
presentation,541,553,O
induced,554,561,O
by,562,564,O
UV,565,567,O
irradiation,568,579,O
of,580,582,O
Mo,583,585,B-Cell
.,585,586,O
TT,586,588,O
was,589,592,O
reversed,593,601,O
in,602,604,O
a,605,606,O
dose,607,611,O
-,611,612,O
dependent,612,621,O
manner,622,628,O
by,629,631,O
the,632,635,O
addition,636,644,O
of,645,647,O
two,648,651,O
different,652,661,O
preparations,662,674,O
containing,675,685,O
human,686,691,O
interleukin,692,703,O
1,704,705,O
(,706,707,O
IL,707,709,O
1,710,711,O
),711,712,O
.,712,713,O
The,714,717,O
first,718,723,O
preparation,724,735,O
consisted,736,745,O
of,746,748,O
supernatants,749,761,O
of,762,764,O
Mo,765,767,B-Cell
.,767,768,O
stimulated,769,779,O
with,780,784,O
Con,785,788,O
A,789,790,O
for,791,794,O
18,795,797,O
hr,798,800,O
and,801,804,O
in,805,807,O
which,808,813,O
Con,814,817,O
A,818,819,O
activity,820,828,O
was,829,832,O
blocked,833,840,O
by,841,843,O
alpha,844,849,O
-,849,850,O
D,850,851,O
-,851,852,O
methyl,852,858,O
-,858,859,O
mannoside,859,868,O
(,869,870,O
Mo,870,872,B-Cell
.,872,873,O
-,873,874,O
Con,874,877,O
A,878,879,O
-,879,880,O
Sup,880,883,O
),883,884,O
.,884,885,O
The,886,889,O
second,890,896,O
preparation,897,908,O
consisted,909,918,O
of,919,921,O
human,922,927,O
IL,928,930,O
1,931,932,O
partially,933,942,O
purified,943,951,O
from,952,956,O
supernatants,957,969,O
of,970,972,O
human,973,978,O
peripheral,979,989,B-Cell
blood,990,995,I-Cell
mononuclear,996,1007,I-Cell
cells,1008,1013,I-Cell
stimulated,1014,1024,O
with,1025,1029,O
S,1030,1031,O
.,1031,1032,O
albus,1033,1038,O
.,1038,1039,O
This,1040,1044,O
IL,1045,1047,O
1,1048,1049,O
copurified,1050,1060,O
with,1061,1065,O
human,1066,1071,O
leukocyte,1072,1081,B-Cell
pyrogen,1082,1089,O
(,1090,1091,O
LP,1091,1093,O
),1093,1094,O
and,1095,1098,O
was,1099,1102,O
termed,1103,1109,O
IL,1110,1112,O
1,1113,1114,O
/,1114,1115,O
LP,1115,1117,O
.,1117,1118,O
Both,1119,1123,O
IL,1124,1126,O
1,1127,1128,O
-,1128,1129,O
containing,1129,1139,O
preparations,1140,1152,O
enhanced,1153,1161,O
the,1162,1165,O
response,1166,1174,O
of,1175,1177,O
C57BL,1178,1183,O
/,1183,1184,O
6,1184,1185,O
mouse,1186,1191,O
thymocytes,1192,1202,B-Cell
to,1203,1205,O
phytohemagglutinin,1206,1224,O
.,1224,1225,O
A,1226,1227,O
rabbit,1228,1234,O
antibody,1235,1243,O
to,1244,1246,O
human,1247,1252,O
IL,1253,1255,O
1,1256,1257,O
/,1257,1258,O
LP,1258,1260,O
inhibited,1261,1270,O
the,1271,1274,O
capacity,1275,1283,O
of,1284,1286,O
T,1287,1288,B-Cell
cells,1289,1294,I-Cell
to,1295,1297,O
proliferate,1298,1309,O
in,1310,1312,O
response,1313,1321,O
to,1322,1324,O
Mo,1325,1327,B-Cell
.,1327,1328,O
TT,1328,1330,O
and,1331,1334,O
inhibited,1335,1344,O
the,1345,1348,O
capacity,1349,1357,O
of,1358,1360,O
Mo,1361,1363,B-Cell
.,1363,1364,O
-,1364,1365,O
Con,1365,1368,O
A,1369,1370,O
-,1370,1371,O
Sup,1371,1374,O
to,1375,1377,O
reconstitute,1378,1390,O
the,1391,1394,O
T,1395,1396,B-Cell
cell,1397,1401,I-Cell
response,1402,1410,O
to,1411,1413,O
UV,1414,1416,O
-,1416,1417,O
irradiated,1417,1427,O
Mo,1428,1430,B-Cell
.,1430,1431,O
TT,1431,1433,O
.,1433,1434,O
IL,1435,1437,O
1,1438,1439,O
/,1439,1440,O
LP,1440,1442,O
was,1443,1446,O
not,1447,1450,O
necessary,1451,1460,O
for,1461,1464,O
T,1465,1466,B-Cell
cells,1467,1472,I-Cell
to,1473,1475,O
recognize,1476,1485,O
the,1486,1489,O
immunogenic,1490,1501,O
moiety,1502,1508,O
presented,1509,1518,O
by,1519,1521,O
Mo,1522,1524,B-Cell
.,1524,1525,O
",",1525,1526,O
because,1527,1534,O
monolayers,1535,1545,O
of,1546,1548,O
UV,1549,1551,O
-,1551,1552,O
irradiated,1552,1562,O
Mo,1563,1565,B-Cell
.,1565,1566,O
TT,1566,1568,O
were,1569,1573,O
equivalent,1574,1584,O
to,1585,1587,O
monolayers,1588,1598,O
of,1599,1601,O
unirradiated,1602,1614,O
MO,1615,1617,B-Cell
.,1617,1618,O
TT,1618,1620,O
in,1621,1623,O
their,1624,1629,O
capacity,1630,1638,O
to,1639,1641,O
adsorb,1642,1648,O
TT,1649,1651,O
-,1651,1652,O
reactive,1652,1660,O
T,1661,1662,B-Cell
cells,1663,1668,I-Cell
specifically,1669,1681,O
.,1681,1682,O
Furthermore,1683,1694,O
",",1694,1695,O
the,1696,1699,O
addition,1700,1708,O
of,1709,1711,O
rabbit,1712,1718,O
antibody,1719,1727,O
to,1728,1730,O
IL,1731,1733,O
1,1734,1735,O
/,1735,1736,O
LP,1736,1738,O
did,1739,1742,O
not,1743,1746,O
interfere,1747,1756,O
with,1757,1761,O
the,1762,1765,O
capacity,1766,1774,O
of,1775,1777,O
UV,1778,1780,O
-,1780,1781,O
irradiated,1781,1791,O
Mo,1792,1794,B-Cell
.,1794,1795,O
TT,1795,1797,O
to,1798,1800,O
adsorb,1801,1807,O
TT,1808,1810,O
-,1810,1811,O
reactive,1811,1819,O
T,1820,1821,B-Cell
cells,1822,1827,I-Cell
.,1827,1828,O
The,1829,1832,O
results,1833,1840,O
obtained,1841,1849,O
in,1850,1852,O
this,1853,1857,O
study,1858,1863,O
indicate,1864,1872,O
that,1873,1877,O
IL,1878,1880,O
1,1881,1882,O
is,1883,1885,O
involved,1886,1894,O
in,1895,1897,O
optimal,1898,1905,O
antigen,1906,1913,O
-,1913,1914,O
driven,1914,1920,O
proliferation,1921,1934,O
of,1935,1937,O
human,1938,1943,O
T,1944,1945,B-Cell
lymphocytes,1946,1957,I-Cell
.,1957,1958,O
Ca,0,2,O
+,2,3,O
+,3,4,O
distribution,5,17,O
after,18,23,O
Na,24,26,O
+,26,27,O
pump,28,32,O
inhibition,33,43,O
in,44,46,O
cultured,47,55,O
neonatal,56,64,O
rat,65,68,O
myocardial,69,79,B-Cell
cells,80,85,I-Cell
.,85,86,O
The,87,90,O
influence,91,100,O
of,101,103,O
inhibition,104,114,O
of,115,117,O
the,118,121,O
Na,122,124,O
+,124,125,O
pump,126,130,O
",",130,131,O
with,132,136,O
secondary,137,146,O
stimulation,147,158,O
of,159,161,O
Na,162,164,O
+,164,165,O
-,165,166,O
Ca,166,168,O
+,168,169,O
+,169,170,O
exchange,171,179,O
",",179,180,O
on,181,183,O
cellular,184,192,B-Cell
Ca,193,195,O
+,195,196,O
+,196,197,O
distribution,198,210,O
is,211,213,O
examined,214,222,O
using,223,228,O
the,229,232,O
on,233,235,O
-,235,236,O
line,236,240,O
scintillation,241,254,O
disk,255,259,O
technique,260,269,O
and,270,273,O
cultured,274,282,O
neonatal,283,291,O
rat,292,295,O
myocardial,296,306,B-Cell
cells,307,312,I-Cell
.,312,313,O
Under,314,319,O
control,320,327,O
conditions,328,338,O
",",338,339,O
La,340,342,O
+,342,343,O
+,343,344,O
+,344,345,O
displaced,346,355,O
78,356,358,O
.,358,359,O
1,359,360,O
+,361,362,O
/,362,363,O
-,363,364,O
1,365,366,O
.,366,367,O
13,367,369,O
%,369,370,O
(,371,372,O
SEM,372,375,O
),375,376,O
of,377,379,O
the,380,383,O
total,384,389,O
cell,390,394,B-Cell
associated,395,405,O
45Ca,406,410,O
.,410,411,O
Application,412,423,O
of,424,426,O
1,427,428,O
mm,429,431,O
ouabain,432,439,O
or,440,442,O
reduction,443,452,O
of,453,455,O
[,456,457,O
K,457,458,O
+,458,459,O
],459,460,O
o,460,461,O
to,462,464,O
0,465,466,O
.,466,467,O
5,467,468,O
mM,469,471,O
resulted,472,480,O
in,481,483,O
a,484,485,O
net,486,489,O
increase,490,498,O
of,499,501,O
10,502,504,O
.,504,505,O
6,505,506,O
+,507,508,O
/,508,509,O
-,509,510,O
1,511,512,O
.,512,513,O
3,513,514,O
%,514,515,O
and,516,519,O
13,520,522,O
.,522,523,O
8,523,524,O
+,525,526,O
/,526,527,O
-,527,528,O
2,529,530,O
%,530,531,O
",",531,532,O
respectively,533,545,O
",",545,546,O
in,547,549,O
total,550,555,O
cell,556,560,B-Cell
-,560,561,O
associated,561,571,O
Ca,572,574,O
+,574,575,O
+,575,576,O
.,576,577,O
Of,578,580,O
this,581,585,O
added,586,591,O
45Ca,592,596,O
",",596,597,O
75,598,600,O
.,600,601,O
9,601,602,O
+,603,604,O
/,604,605,O
-,605,606,O
2,607,608,O
.,608,609,O
7,609,610,O
%,610,611,O
and,612,615,O
78,616,618,O
.,618,619,O
4,619,620,O
+,621,622,O
/,622,623,O
-,623,624,O
2,625,626,O
.,626,627,O
1,627,628,O
%,628,629,O
",",629,630,O
respectively,631,643,O
remained,644,652,O
La,653,655,O
+,655,656,O
+,656,657,O
+,657,658,O
-,658,659,O
displaceable,659,671,O
.,671,672,O
The,673,676,O
45Ca,677,681,O
-,681,682,O
binding,682,689,O
characteristics,690,705,O
of,706,708,O
isolated,709,717,O
sarcolemma,718,728,B-Cellular_component
",",728,729,O
prepared,730,738,O
from,739,743,O
the,744,747,O
cultured,748,756,O
neonatal,757,765,O
rat,766,769,O
myocardial,770,780,B-Cell
cells,781,786,I-Cell
using,787,792,O
the,793,796,O
gas,797,800,O
dissection,801,811,O
technique,812,821,O
",",821,822,O
were,823,827,O
examined,828,836,O
.,836,837,O
When,838,842,O
treated,843,850,O
with,851,855,O
either,856,862,O
ouabain,863,870,O
or,871,873,O
low,874,877,O
[,878,879,O
K,879,880,O
+,880,881,O
],881,882,O
o,882,883,O
solutions,884,893,O
",",893,894,O
sarcolemmal,895,906,B-Cellular_component
45Ca,907,911,O
binding,912,919,O
did,920,923,O
not,924,927,O
change,928,934,O
.,934,935,O
This,936,940,O
result,941,947,O
indicates,948,957,O
that,958,962,O
functional,963,973,O
",",973,974,O
intact,975,981,O
tissue,982,988,B-Tissue
is,989,991,O
necessary,992,1001,O
to,1002,1004,O
observe,1005,1012,O
the,1013,1016,O
Ca,1017,1019,O
+,1019,1020,O
+,1020,1021,O
increase,1022,1030,O
.,1030,1031,O
Treatment,1032,1041,O
of,1042,1044,O
the,1045,1048,O
cells,1049,1054,B-Cell
with,1055,1059,O
verapamil,1060,1069,O
before,1070,1076,O
and,1077,1080,O
during,1081,1087,O
ouabain,1088,1095,O
exposure,1096,1104,O
failed,1105,1111,O
to,1112,1114,O
inhibit,1115,1122,O
the,1123,1126,O
ouabain,1127,1134,O
-,1134,1135,O
induced,1135,1142,O
increase,1143,1151,O
in,1152,1154,O
cell,1155,1159,B-Cell
-,1159,1160,O
associated,1160,1170,O
45Ca,1171,1175,O
.,1175,1176,O
The,1177,1180,O
evidence,1181,1189,O
indicates,1190,1199,O
that,1200,1204,O
inhibition,1205,1215,O
of,1216,1218,O
the,1219,1222,O
Na,1223,1225,O
+,1225,1226,O
-,1226,1227,O
pump,1227,1231,O
",",1231,1232,O
and,1233,1236,O
secondary,1237,1246,O
stimulation,1247,1258,O
of,1259,1261,O
Na,1262,1264,O
+,1264,1265,O
-,1265,1266,O
Ca,1266,1268,O
+,1268,1269,O
+,1269,1270,O
exchange,1271,1279,O
",",1279,1280,O
result,1281,1287,O
in,1288,1290,O
a,1291,1292,O
net,1293,1296,O
increase,1297,1305,O
of,1306,1308,O
11,1309,1311,O
-,1311,1312,O
15,1312,1314,O
%,1314,1315,O
in,1316,1318,O
cell,1319,1323,O
-,1323,1324,O
associated,1324,1334,O
Ca,1335,1337,O
+,1337,1338,O
+,1338,1339,O
",",1339,1340,O
78,1341,1343,O
%,1343,1344,O
of,1345,1347,O
which,1348,1353,O
remains,1354,1361,O
La,1362,1364,O
+,1364,1365,O
+,1365,1366,O
+,1366,1367,O
-,1367,1368,O
displaceable,1368,1380,O
and,1381,1384,O
is,1385,1387,O
",",1387,1388,O
therefore,1389,1398,O
",",1398,1399,O
localized,1400,1409,O
to,1410,1412,O
the,1413,1416,O
sarcolemma,1417,1427,B-Cellular_component
-,1427,1428,O
glycocalyx,1428,1438,B-Cellular_component
complex,1439,1446,O
.,1446,1447,O
Oesophageal,0,11,B-Organ
candidiasis,12,23,O
and,24,27,O
croup,28,33,O
in,34,36,O
a,37,38,O
child,39,44,O
with,45,49,O
defective,50,59,O
neutrophil,60,70,B-Cell
motility,71,79,O
.,79,80,O
Severe,81,87,O
oesophageal,88,99,B-Organ
candidiasis,100,111,O
and,112,115,O
croup,116,121,O
due,122,125,O
to,126,128,O
involvement,129,140,O
of,141,143,O
the,144,147,O
larynx,148,154,B-Multi-tissue_structure
developed,155,164,O
insidiously,165,176,O
in,177,179,O
a,180,181,O
girl,182,186,O
aged,187,191,O
20,192,194,O
months,195,201,O
.,201,202,O
There,203,208,O
had,209,212,O
been,213,217,O
delayed,218,225,O
separation,226,236,O
of,237,239,O
the,240,243,O
umbilical,244,253,O
cord,254,258,O
and,259,262,O
repeated,263,271,O
infections,272,282,O
associated,283,293,O
with,294,298,O
a,299,300,O
defect,301,307,O
of,308,310,O
neutrophil,311,321,B-Cell
motility,322,330,O
.,330,331,O
The,332,335,O
significance,336,348,O
of,349,351,O
the,352,355,O
early,356,361,O
clinical,362,370,O
features,371,379,O
was,380,383,O
not,384,387,O
fully,388,393,O
appreciated,394,405,O
and,406,409,O
the,410,413,O
diagnosis,414,423,O
considered,424,434,O
only,435,439,O
when,440,444,O
stricture,445,454,O
of,455,457,O
the,458,461,O
oesophagus,462,472,B-Organ
became,473,479,O
evident,480,487,O
.,487,488,O
She,489,492,O
was,493,496,O
treated,497,504,O
with,505,509,O
oral,510,514,O
ketoconazole,515,527,O
100,528,531,O
mg,532,534,O
daily,535,540,O
.,540,541,O
After,542,547,O
one,548,551,O
month,552,557,O
',557,558,O
s,558,559,O
treatment,560,569,O
there,570,575,O
was,576,579,O
striking,580,588,O
radiological,589,601,O
improvement,602,613,O
apart,614,619,O
from,620,624,O
the,625,628,O
persistence,629,640,O
of,641,643,O
the,644,647,O
oesophageal,648,659,B-Organ
stricture,660,669,O
.,669,670,O
The,671,674,O
croup,675,680,O
resolved,681,689,O
completely,690,700,O
but,701,704,O
there,705,710,O
was,711,714,O
only,715,719,O
partial,720,727,O
relief,728,734,O
of,735,737,O
dysphagia,738,747,O
because,748,755,O
of,756,758,O
the,759,762,O
residual,763,771,O
stricture,772,781,O
.,781,782,O
We,783,785,O
would,786,791,O
emphasis,792,800,O
that,801,805,O
candidiasis,806,817,O
should,818,824,O
be,825,827,O
anticipated,828,839,O
and,840,843,O
treated,844,851,O
vigorously,852,862,O
in,863,865,O
children,866,874,O
with,875,879,O
such,880,884,O
a,885,886,O
defect,887,893,O
of,894,896,O
neutrophil,897,907,B-Cell
motility,908,916,O
.,916,917,O
[,0,1,O
Suppurated,1,11,O
acute,12,17,O
obstructive,18,29,O
cholangitis,30,41,O
.,41,42,O
Anatomoclinical,43,58,O
and,59,62,O
therapeutic,63,74,O
aspects,75,82,O
],82,83,O
.,83,84,O
A,85,86,O
total,87,92,O
of,93,95,O
134,96,99,O
cases,100,105,O
are,106,109,O
discussed,110,119,O
",",119,120,O
with,121,125,O
suppurated,126,136,O
acute,137,142,O
obstructive,143,154,O
angiocholitis,155,168,O
",",168,169,O
that,170,174,O
underwent,175,184,O
surgical,185,193,O
treatment,194,203,O
over,204,208,O
a,209,210,O
period,211,217,O
of,218,220,O
10,221,223,O
years,224,229,O
",",229,230,O
representing,231,243,O
12,244,246,O
",",246,247,O
8,247,248,O
%,248,249,O
of,250,252,O
the,253,256,O
total,257,262,O
number,263,269,O
of,270,272,O
organic,273,280,O
obstructions,281,293,O
of,294,296,O
the,297,300,O
hepato,301,307,B-Multi-tissue_structure
-,307,308,I-Multi-tissue_structure
choledocus,308,318,I-Multi-tissue_structure
.,318,319,O
From,320,324,O
the,325,328,O
standpoint,329,339,O
of,340,342,O
the,343,346,O
etiopathogenic,347,361,O
mechanisms,362,372,O
the,373,376,O
angiocholitis,377,390,O
was,391,394,O
determined,395,405,O
by,406,408,O
biliary,409,416,O
lithiasis,417,426,O
in,427,429,O
59,430,432,O
cases,433,438,O
",",438,439,O
by,440,442,O
sclerosis,443,452,O
of,453,455,O
the,456,459,O
Oddi,460,464,B-Tissue
sphincter,465,474,I-Tissue
in,475,477,O
5,478,479,O
cases,480,485,O
",",485,486,O
by,487,489,O
postoperative,490,503,O
cicatriceal,504,515,O
stenosis,516,524,O
of,525,527,O
the,528,531,O
main,532,536,O
biliary,537,544,O
pathway,545,552,O
in,553,555,O
2,556,557,O
cases,558,563,O
",",563,564,O
by,565,567,O
hepatic,568,575,B-Organ
hydatitosis,576,587,O
in,588,590,O
16,591,593,O
cases,594,599,O
",",599,600,O
by,601,603,O
Vater,604,609,O
ampuloma,610,618,O
in,619,621,O
10,622,624,O
cases,625,630,O
by,631,633,O
cancers,634,641,B-Pathological_formation
of,642,644,O
the,645,648,O
main,649,653,O
biliary,654,661,O
pathway,662,669,O
in,670,672,O
40,673,675,O
cases,676,681,O
and,682,685,O
by,686,688,O
the,689,692,O
congenital,693,703,O
cyst,704,708,B-Pathological_formation
of,709,711,O
the,712,715,O
choledocus,716,726,B-Multi-tissue_structure
in,727,729,O
one,730,733,O
case,734,738,O
.,738,739,O
The,740,743,O
high,744,748,O
frequency,749,758,O
was,759,762,O
noted,763,768,O
",",768,769,O
of,770,772,O
the,773,776,O
severe,777,783,O
forms,784,789,O
of,790,792,O
ictero,793,799,O
-,799,800,O
uremigenic,800,810,O
angiocholitis,811,824,O
(,825,826,O
representing,826,838,O
68,839,841,O
cases,842,847,O
",",847,848,O
or,849,851,O
50,852,854,O
",",854,855,O
7,855,856,O
%,856,857,O
of,858,860,O
the,861,864,O
total,865,870,O
",",870,871,O
with,872,876,O
a,877,878,O
death,879,884,O
rate,885,889,O
of,890,892,O
34,893,895,O
%,895,896,O
),896,897,O
.,897,898,O
Medico,899,905,O
-,905,906,O
surgical,906,914,O
treatment,915,924,O
should,925,931,O
be,932,934,O
performed,935,944,O
as,945,947,O
early,948,953,O
as,954,956,O
possible,957,965,O
",",965,966,O
and,967,970,O
it,971,973,O
must,974,978,O
be,979,981,O
intensive,982,991,O
",",991,992,O
complex,993,1000,O
",",1000,1001,O
and,1002,1005,O
adapted,1006,1013,O
to,1014,1016,O
the,1017,1020,O
anatomo,1021,1028,O
-,1028,1029,O
clinical,1029,1037,O
forms,1038,1043,O
.,1043,1044,O
The,1045,1048,O
authors,1049,1056,O
performed,1057,1066,O
evacuation,1067,1077,O
choledocotomy,1078,1091,O
with,1092,1096,O
external,1097,1105,O
draining,1106,1114,O
in,1115,1117,O
22,1118,1120,O
cases,1121,1126,O
(,1127,1128,O
3,1128,1129,O
deaths,1130,1136,O
),1136,1137,O
",",1137,1138,O
and,1139,1142,O
choledoco,1143,1152,O
-,1152,1153,O
duodenal,1153,1161,O
anastomosis,1162,1173,O
in,1174,1176,O
46,1177,1179,O
cases,1180,1185,O
(,1186,1187,O
10,1187,1189,O
deaths,1190,1196,O
),1196,1197,O
",",1197,1198,O
choledoco,1199,1208,O
-,1208,1209,O
jejunostomia,1209,1221,O
in,1222,1224,O
3,1225,1226,O
cases,1227,1232,O
",",1232,1233,O
Oddi,1234,1238,O
sphincterotomia,1239,1254,O
in,1255,1257,O
12,1258,1260,O
cases,1261,1266,O
(,1267,1268,O
2,1268,1269,O
deaths,1270,1276,O
),1276,1277,O
ampulectomia,1278,1290,O
in,1291,1293,O
5,1294,1295,O
cases,1296,1301,O
(,1302,1303,O
2,1303,1304,O
deaths,1305,1311,O
),1311,1312,O
.,1312,1313,O
Peripheral,1314,1324,O
bilio,1325,1330,O
-,1330,1331,O
hepatodigestive,1331,1346,O
anastomoses,1347,1358,O
were,1359,1363,O
performed,1364,1373,O
in,1374,1376,O
40,1377,1379,O
cases,1380,1385,O
with,1386,1390,O
5,1391,1392,O
deaths,1393,1399,O
.,1399,1400,O
[,0,1,O
Reactive,1,9,O
states,10,16,O
among,17,22,O
psychopathic,23,35,O
personalities,36,49,O
of,50,52,O
different,53,62,O
clinical,63,71,O
groups,72,78,O
],78,79,O
.,79,80,O
On,81,83,O
the,84,87,O
basis,88,93,O
of,94,96,O
a,97,98,O
clinical,99,107,O
follow,108,114,O
-,114,115,O
up,115,117,O
of,118,120,O
71,121,123,O
psychopaths,124,135,O
with,136,140,O
manifestations,141,155,O
of,156,158,O
reactive,159,167,O
psychosis,168,177,O
",",177,178,O
the,179,182,O
authors,183,190,O
established,191,202,O
the,203,206,O
clinico,207,214,O
-,214,215,O
typological,215,226,O
characteristics,227,242,O
of,243,245,O
both,246,250,O
groups,251,257,O
of,258,260,O
pathology,261,270,O
and,271,274,O
the,275,278,O
system,279,285,O
of,286,288,O
correlations,289,301,O
between,302,309,O
them,310,314,O
.,314,315,O
They,316,320,O
also,321,325,O
described,326,335,O
the,336,339,O
structure,340,349,O
of,350,352,O
the,353,356,O
psychopathic,357,369,O
and,370,373,O
psychogenic,374,385,O
syndromes,386,395,O
",",395,396,O
the,397,400,O
type,401,405,O
of,406,408,O
psychopathic,409,421,O
personality,422,433,O
reaction,434,442,O
and,443,446,O
the,447,450,O
form,451,455,O
of,456,458,O
psychogenic,459,470,O
responses,471,480,O
and,481,484,O
proved,485,491,O
statistically,492,505,O
their,506,511,O
close,512,517,O
interrelationship,518,535,O
.,535,536,O
Data,537,541,O
were,542,546,O
obtained,547,555,O
on,556,558,O
some,559,563,O
general,564,571,O
regularities,572,584,O
of,585,587,O
interrelations,588,602,O
of,603,605,O
reactive,606,614,O
psychoses,615,624,O
with,625,629,O
a,630,631,O
psychopathic,632,644,O
background,645,655,O
which,656,661,O
are,662,665,O
important,666,675,O
for,676,679,O
the,680,683,O
prognosis,684,693,O
",",693,694,O
prophylaxis,695,706,O
and,707,710,O
therapy,711,718,O
of,719,721,O
reactive,722,730,O
states,731,737,O
.,737,738,O
An,0,2,O
unusual,3,10,O
case,11,15,O
of,16,18,O
benign,19,25,O
mucous,26,32,B-Multi-tissue_structure
membrane,33,41,I-Multi-tissue_structure
pemphigoid,42,52,O
.,52,53,O
This,54,58,O
case,59,63,O
of,64,66,O
benign,67,73,O
mucous,74,80,B-Multi-tissue_structure
membrane,81,89,I-Multi-tissue_structure
pemphigoid,90,100,O
(,101,102,O
BMMP,102,106,O
),106,107,O
is,108,110,O
unusual,111,118,O
in,119,121,O
that,122,126,O
blistering,127,137,O
",",137,138,O
scarring,139,147,O
lesions,148,155,B-Pathological_formation
were,156,160,O
confined,161,169,O
to,170,172,O
the,173,176,O
skin,177,181,B-Organ
for,182,185,O
15,186,188,O
years,189,194,O
before,195,201,O
mucous,202,208,B-Multi-tissue_structure
membranes,209,218,I-Multi-tissue_structure
were,219,223,O
involved,224,232,O
.,232,233,O
The,234,237,O
onset,238,243,O
of,244,246,O
this,247,251,O
disorder,252,260,O
at,261,263,O
the,264,267,O
age,268,271,O
of,272,274,O
38,275,277,O
is,278,280,O
also,281,285,O
unusual,286,293,O
.,293,294,O
Detailed,295,303,O
immunological,304,317,O
investigation,318,331,O
was,332,335,O
performed,336,345,O
on,346,348,O
this,349,353,O
patient,354,361,O
but,362,365,O
the,366,369,O
results,370,377,O
in,378,380,O
no,381,383,O
way,384,387,O
clarify,388,395,O
the,396,399,O
present,400,407,O
confusion,408,417,O
regarding,418,427,O
the,428,431,O
immunopathological,432,450,O
processes,451,460,O
in,461,463,O
BMMP,464,468,O
related,469,476,O
to,477,479,O
those,480,485,O
operative,486,495,O
in,496,498,O
bullous,499,506,O
pemphigoid,507,517,O
.,517,518,O
The,0,3,O
LHRH,4,8,O
pulse,9,14,O
generator,15,24,O
:,24,25,O
a,26,27,O
mediobasal,28,38,B-Multi-tissue_structure
hypothalamic,39,51,I-Multi-tissue_structure
location,52,60,O
.,60,61,O
The,62,65,O
location,66,74,O
and,75,78,O
mechanism,79,88,O
of,89,91,O
LHRH,92,96,O
pulse,97,102,O
generator,103,112,O
are,113,116,O
discussed,117,126,O
based,127,132,O
on,133,135,O
our,136,139,O
series,140,146,O
of,147,149,O
experiments,150,161,O
.,161,162,O
Suckling,163,171,O
stimulus,172,180,O
is,181,183,O
a,184,185,O
novel,186,191,O
stimulus,192,200,O
that,201,205,O
inhibits,206,214,O
LH,215,217,O
pulses,218,224,O
without,225,232,O
any,233,236,O
cooperation,237,248,O
from,249,253,O
ovarian,254,261,B-Organ
steroids,262,270,O
",",270,271,O
unlike,272,278,O
other,279,284,O
stimuli,285,292,O
such,293,297,O
as,298,300,O
stress,301,307,O
",",307,308,O
photoperiod,309,320,O
etc,321,324,O
.,324,325,O
It,326,328,O
is,329,331,O
directly,332,340,O
involved,341,349,O
in,350,352,O
suppressing,353,364,O
the,365,368,O
activity,369,377,O
of,378,380,O
the,381,384,O
LHRH,385,389,O
pulse,390,395,O
generator,396,405,O
.,405,406,O
The,407,410,O
information,411,422,O
from,423,427,O
teats,428,433,O
suckled,434,441,O
by,442,444,O
pups,445,449,O
or,450,452,O
babies,453,459,O
is,460,462,O
conveyed,463,471,O
dorsally,472,480,O
to,481,483,O
the,484,487,O
mediobasal,488,498,B-Multi-tissue_structure
hypothalamus,499,511,I-Multi-tissue_structure
(,512,513,O
MBH,513,516,O
),516,517,O
",",517,518,O
where,519,524,O
the,525,528,O
LHRH,529,533,O
pulse,534,539,O
generator,540,549,O
may,550,553,O
be,554,556,O
located,557,564,O
.,564,565,O
Experiments,566,577,O
using,578,583,O
various,584,591,O
types,592,597,O
of,598,600,O
deafferentation,601,616,O
and,617,620,O
fetal,621,626,B-Tissue
brain,627,632,I-Tissue
tissue,633,639,I-Tissue
transplantation,640,655,O
confirmed,656,665,O
that,666,670,O
the,671,674,O
LHRH,675,679,O
pulse,680,685,O
generator,686,695,O
is,696,698,O
located,699,706,O
in,707,709,O
the,710,713,O
MBH,714,717,O
and,718,721,O
suggested,722,731,O
that,732,736,O
LHRH,737,741,O
pulse,742,747,O
generator,748,757,O
consists,758,766,O
of,767,769,O
nonLHRH,770,777,O
neurons,778,785,O
.,785,786,O
Endogenous,787,797,O
excitatory,798,808,O
amino,809,814,O
acid,815,819,O
is,820,822,O
one,823,826,O
of,827,829,O
the,830,833,O
possible,834,842,O
neurotransmitters,843,860,O
that,861,865,O
regulate,866,874,O
LHRH,875,879,O
release,880,887,O
at,888,890,O
the,891,894,O
nerve,895,900,B-Multi-tissue_structure
terminal,901,909,I-Multi-tissue_structure
in,910,912,O
ME,913,915,O
.,915,916,O
Colorimetrical,0,14,O
rate,15,19,O
assay,20,25,O
for,26,29,O
urinary,30,37,B-Organism_substance
dipeptidyl,38,48,O
peptidase,49,58,O
IV,59,61,O
(,62,63,O
DPPIV,63,68,O
),68,69,O
activity,70,78,O
using,79,84,O
a,85,86,O
new,87,90,O
substrate,91,100,O
.,100,101,O
We,102,104,O
synthesized,105,116,O
a,117,118,O
new,119,122,O
substrate,123,132,O
glycyl,133,139,O
-,139,140,O
L,140,141,O
-,141,142,O
proline,142,149,O
3,150,151,O
",",151,152,O
5,152,153,O
-,153,154,O
dibromo,154,161,O
-,161,162,O
4,162,163,O
-,163,164,O
hydroxyanilide,164,178,O
(,179,180,O
Gly,180,183,O
-,183,184,O
Pro,184,187,O
-,187,188,O
DBAP,188,192,O
),192,193,O
",",193,194,O
for,195,198,O
dipeptidyl,199,209,O
peptidase,210,219,O
IV,220,222,O
(,223,224,O
DPPIV,224,229,O
),229,230,O
.,230,231,O
Its,232,235,O
hydrolysis,236,246,O
by,247,249,O
DPPIV,250,255,O
resulted,256,264,O
in,265,267,O
the,268,271,O
formation,272,281,O
of,282,284,O
a,285,286,O
chromophore,287,298,O
",",298,299,O
2,300,301,O
",",301,302,O
6,302,303,O
-,303,304,O
dibromophenol,304,317,O
-,317,318,O
indo,318,322,O
-,322,323,O
p,323,324,O
-,324,325,O
xylenol,325,332,O
",",332,333,O
and,334,337,O
its,338,341,O
maximal,342,349,O
absorption,350,360,O
wavelength,361,371,O
(,372,373,O
600,373,376,O
nm,377,379,O
),379,380,O
was,381,384,O
longer,385,391,O
than,392,396,O
that,397,401,O
of,402,404,O
p,405,406,O
-,406,407,O
nitroaniline,407,419,O
(,420,421,O
415,421,424,O
nm,425,427,O
),427,428,O
released,429,437,O
from,438,442,O
conventional,443,455,O
substrate,456,465,O
",",465,466,O
glycyl,467,473,O
-,473,474,O
L,474,475,O
-,475,476,O
proline,476,483,O
p,484,485,O
-,485,486,O
nitroanilide,486,498,O
(,499,500,O
Gly,500,503,O
-,503,504,O
Pro,504,507,O
-,507,508,O
pNA,508,511,O
),511,512,O
.,512,513,O
We,514,516,O
also,517,521,O
established,522,533,O
the,534,537,O
rate,538,542,O
assay,543,548,O
for,549,552,O
urinary,553,560,B-Organism_substance
DPPIV,561,566,O
activity,567,575,O
using,576,581,O
Gly,582,585,O
-,585,586,O
Pro,586,589,O
-,589,590,O
DBAP,590,594,O
.,594,595,O
The,596,599,O
optimum,600,607,O
pH,608,610,O
was,611,614,O
between,615,622,O
8,623,624,O
.,624,625,O
5,625,626,O
and,627,630,O
9,631,632,O
.,632,633,O
0,633,634,O
.,634,635,O
The,636,639,O
apparent,640,648,O
Km,649,651,O
was,652,655,O
1,656,657,O
.,657,658,O
1,658,659,O
mmol,660,664,O
/,664,665,O
1,665,666,O
.,666,667,O
The,668,671,O
detectable,672,682,O
range,683,688,O
was,689,692,O
2,693,694,O
.,694,695,O
5,695,696,O
-,696,697,O
350,697,700,O
U,701,702,O
/,702,703,O
l,703,704,O
.,704,705,O
No,706,708,O
changes,709,716,O
in,717,719,O
blank,720,725,O
values,726,732,O
occurred,733,741,O
throughout,742,752,O
the,753,756,O
enzyme,757,763,O
reaction,764,772,O
in,773,775,O
the,776,779,O
optimum,780,787,O
pH,788,790,O
.,790,791,O
Its,792,795,O
value,796,801,O
was,802,805,O
also,806,810,O
much,811,815,O
lower,816,821,O
than,822,826,O
Gly,827,830,O
-,830,831,O
Pro,831,834,O
-,834,835,O
pNA,835,838,O
.,838,839,O
CVs,840,843,O
for,844,847,O
within,848,854,O
-,854,855,O
run,855,858,O
and,859,862,O
between,863,870,O
-,870,871,O
run,871,874,O
were,875,879,O
1,880,881,O
.,881,882,O
1,882,883,O
%,883,884,O
(,885,886,O
n,886,887,O
=,888,889,O
10,890,892,O
),892,893,O
and,894,897,O
3,898,899,O
.,899,900,O
0,900,901,O
%,901,902,O
(,903,904,O
n,904,905,O
=,906,907,O
10,908,910,O
),910,911,O
",",911,912,O
respectively,913,925,O
.,925,926,O
Among,927,932,O
tested,933,939,O
peptidases,940,950,O
",",950,951,O
only,952,956,O
DPPIV,957,962,O
could,963,968,O
hydrolyze,969,978,O
Gly,979,982,O
-,982,983,O
Pro,983,986,O
-,986,987,O
DBAP,987,991,O
.,991,992,O
Among,993,998,O
the,999,1002,O
protease,1003,1011,O
inhibitors,1012,1022,O
",",1022,1023,O
only,1024,1028,O
two,1029,1032,O
",",1032,1033,O
diprotin,1034,1042,O
-,1042,1043,O
A,1043,1044,O
and,1045,1048,O
phenylmethylsulfonyl,1049,1069,O
fluoride,1070,1078,O
(,1079,1080,O
PMSA,1080,1084,O
),1084,1085,O
",",1085,1086,O
could,1087,1092,O
inhibit,1093,1100,O
DPPIV,1101,1106,O
activity,1107,1115,O
.,1115,1116,O
The,1117,1120,O
present,1121,1128,O
method,1129,1135,O
did,1136,1139,O
not,1140,1143,O
interfere,1144,1153,O
with,1154,1158,O
urinary,1159,1166,B-Organism_substance
ingredients,1167,1178,O
such,1179,1183,O
as,1184,1186,O
hemoglobin,1187,1197,O
.,1197,1198,O
The,1199,1202,O
correlation,1203,1214,O
between,1215,1222,O
the,1223,1226,O
present,1227,1234,O
(,1235,1236,O
y,1236,1237,O
),1237,1238,O
and,1239,1242,O
conventional,1243,1255,O
(,1256,1257,O
x,1257,1258,O
),1258,1259,O
methods,1260,1267,O
is,1268,1270,O
presented,1271,1280,O
by,1281,1283,O
the,1284,1287,O
equation,1288,1296,O
y,1297,1298,O
=,1299,1300,O
1,1301,1302,O
.,1302,1303,O
121x,1303,1307,O
+,1308,1309,O
0,1310,1311,O
.,1311,1312,O
096,1312,1315,O
(,1316,1317,O
r,1317,1318,O
=,1319,1320,O
0,1321,1322,O
.,1322,1323,O
993,1323,1326,O
),1326,1327,O
.,1327,1328,O
Thus,1329,1333,O
the,1334,1337,O
present,1338,1345,O
method,1346,1352,O
provides,1353,1361,O
practical,1362,1371,O
advantages,1372,1382,O
over,1383,1387,O
the,1388,1391,O
conventional,1392,1404,O
method,1405,1411,O
for,1412,1415,O
routine,1416,1423,O
laboratory,1424,1434,O
use,1435,1438,O
.,1438,1439,O
Primary,0,7,O
hyperparathyroidism,8,27,O
and,28,31,O
the,32,35,O
heart,36,41,B-Organ
:,41,42,O
cardiac,43,50,B-Organ
abnormalities,51,64,O
correlated,65,75,O
to,76,78,O
clinical,79,87,O
and,88,91,O
biochemical,92,103,O
data,104,108,O
.,108,109,O
Comparing,110,119,O
patients,120,128,O
with,129,133,O
primary,134,141,O
hyperparathyroidism,142,161,O
(,162,163,O
PHP,163,166,O
),166,167,O
to,168,170,O
a,171,172,O
normocalcemic,173,186,O
control,187,194,O
population,195,205,O
",",205,206,O
those,207,212,O
with,213,217,O
PHP,218,221,O
have,222,226,O
a,227,228,O
higher,229,235,O
incidence,236,245,O
of,246,248,O
cardiovascular,249,263,B-Multi-tissue_structure
disease,264,271,O
and,272,275,O
cardiac,276,283,B-Organ
abnormalities,284,297,O
.,297,298,O
This,299,303,O
study,304,309,O
aimed,310,315,O
at,316,318,O
correlating,319,330,O
cardiac,331,338,B-Organ
findings,339,347,O
(,348,349,O
valvular,349,357,B-Multi-tissue_structure
and,358,361,O
myocardial,362,372,B-Multi-tissue_structure
calcification,373,386,O
",",386,387,O
myocardial,388,398,B-Multi-tissue_structure
hypertrophy,399,410,O
),410,411,O
with,412,416,O
clinical,417,425,O
data,426,430,O
(,431,432,O
age,432,435,O
",",435,436,O
sex,437,440,O
",",440,441,O
clinical,442,450,O
manifestation,451,464,O
",",464,465,O
nephrolithiasis,466,481,O
",",481,482,O
nephrocalcinosis,483,499,O
",",499,500,O
hypertension,501,513,O
",",513,514,O
skeletal,515,523,B-Anatomical_system
abnormalities,524,537,O
",",537,538,O
hypercalcemic,539,552,O
syndrome,553,561,O
),561,562,O
and,563,566,O
biochemical,567,578,O
data,579,583,O
(,584,585,O
serum,585,590,B-Organism_substance
calcium,591,598,O
",",598,599,O
serum,600,605,B-Organism_substance
phosphate,606,615,O
",",615,616,O
serum,617,622,B-Organism_substance
iPTH,623,627,O
level,628,633,O
",",633,634,O
serum,635,640,B-Organism_substance
creatinine,641,651,O
),651,652,O
.,652,653,O
A,654,655,O
group,656,661,O
of,662,664,O
132,665,668,O
consecutive,669,680,O
patients,681,689,O
with,690,694,O
surgically,695,705,O
verified,706,714,O
PHP,715,718,O
(,719,720,O
94,720,722,O
women,723,728,O
",",728,729,O
38,730,732,O
men,733,736,O
;,736,737,O
ages,738,742,O
15,743,745,O
-,745,746,O
86,746,748,O
",",748,749,O
mean,750,754,O
age,755,758,O
57,759,761,O
+,762,763,O
/,763,764,O
-,764,765,O
16,766,768,O
years,769,774,O
),774,775,O
were,776,780,O
included,781,789,O
in,790,792,O
this,793,797,O
study,798,803,O
.,803,804,O
Blood,805,810,B-Organism_substance
chemistry,811,820,O
",",820,821,O
clinical,822,830,O
presentation,831,843,O
",",843,844,O
radiography,845,856,O
",",856,857,O
and,858,861,O
echocardiography,862,878,O
were,879,883,O
carried,884,891,O
out,892,895,O
in,896,898,O
all,899,902,O
patients,903,911,O
for,912,915,O
univariate,916,926,O
and,927,930,O
multivariate,931,943,O
analyses,944,952,O
of,953,955,O
all,956,959,O
parameters,960,970,O
.,970,971,O
There,972,977,O
was,978,981,O
no,982,984,O
statistical,985,996,O
correlation,997,1008,O
between,1009,1016,O
clinical,1017,1025,O
symptoms,1026,1034,O
",",1034,1035,O
biochemical,1036,1047,O
data,1048,1052,O
",",1052,1053,O
and,1054,1057,O
cardiac,1058,1065,B-Organ
calcific,1066,1074,O
alterations,1075,1086,O
.,1086,1087,O
Typical,1088,1095,O
skeletal,1096,1104,B-Anatomical_system
manifestations,1105,1119,O
(,1120,1121,O
osteolysis,1121,1131,O
/,1131,1132,O
subperiostal,1132,1144,O
resorption,1145,1155,O
),1155,1156,O
and,1157,1160,O
valvular,1161,1169,B-Multi-tissue_structure
calcifications,1170,1184,O
were,1185,1189,O
significantly,1190,1203,O
correlated,1204,1214,O
to,1215,1217,O
left,1218,1222,B-Multi-tissue_structure
ventricular,1223,1234,I-Multi-tissue_structure
hypertrophy,1235,1246,O
(,1247,1248,O
p,1248,1249,O
=,1250,1251,O
0,1252,1253,O
.,1253,1254,O
005,1254,1257,O
),1257,1258,O
.,1258,1259,O
Cardiac,1260,1267,B-Organ
abnormalities,1268,1281,O
such,1282,1286,O
as,1287,1289,O
calcific,1290,1298,O
myocardial,1299,1309,B-Multi-tissue_structure
deposits,1310,1318,O
or,1319,1321,O
mitral,1322,1328,B-Multi-tissue_structure
and,1329,1332,O
aortic,1333,1339,B-Multi-tissue_structure
valvular,1340,1348,I-Multi-tissue_structure
calcifications,1349,1363,O
do,1364,1366,O
not,1367,1370,O
correlate,1371,1380,O
with,1381,1385,O
laboratory,1386,1396,O
findings,1397,1405,O
and,1406,1409,O
clinical,1410,1418,O
presentation,1419,1431,O
at,1432,1434,O
the,1435,1438,O
time,1439,1443,O
of,1444,1446,O
diagnosis,1447,1456,O
.,1456,1457,O
There,1458,1463,O
was,1464,1467,O
no,1468,1470,O
biochemical,1471,1482,O
or,1483,1485,O
clinical,1486,1494,O
variable,1495,1503,O
that,1504,1508,O
could,1509,1514,O
predict,1515,1522,O
the,1523,1526,O
frequency,1527,1536,O
or,1537,1539,O
severity,1540,1548,O
of,1549,1551,O
valvular,1552,1560,B-Multi-tissue_structure
sclerosis,1561,1570,O
or,1571,1573,O
calcific,1574,1582,O
deposits,1583,1591,O
in,1592,1594,O
the,1595,1598,O
myocardium,1599,1609,B-Multi-tissue_structure
.,1609,1610,O
However,1611,1618,O
",",1618,1619,O
PHP,1620,1623,O
-,1623,1624,O
related,1624,1631,O
skeletal,1632,1640,B-Anatomical_system
abnormalities,1641,1654,O
and,1655,1658,O
valvular,1659,1667,B-Multi-tissue_structure
calcification,1668,1681,O
were,1682,1686,O
predicting,1687,1697,O
factors,1698,1705,O
for,1706,1709,O
left,1710,1714,B-Multi-tissue_structure
ventricular,1715,1726,I-Multi-tissue_structure
hypertrophy,1727,1738,O
",",1738,1739,O
a,1740,1741,O
reversible,1742,1752,O
cardiac,1753,1760,B-Organ
manifestation,1761,1774,O
of,1775,1777,O
PHP,1778,1781,O
.,1781,1782,O
Myocardial,1783,1793,B-Multi-tissue_structure
hypertrophy,1794,1805,O
is,1806,1808,O
more,1809,1813,O
often,1814,1819,O
found,1820,1825,O
with,1826,1830,O
classic,1831,1838,O
symptomatic,1839,1850,O
PHP,1851,1854,O
with,1855,1859,O
osseous,1860,1867,B-Organ
abnormalities,1868,1881,O
.,1881,1882,O
Image,0,5,O
-,5,6,O
directed,6,14,O
and,15,18,O
color,19,24,O
Doppler,25,32,O
studies,33,40,O
of,41,43,O
gallbladder,44,55,B-Pathological_formation
tumors,56,62,I-Pathological_formation
.,62,63,O
Thirteen,64,72,O
cases,73,78,O
of,79,81,O
primary,82,89,O
adenocarcinoma,90,104,B-Pathological_formation
of,105,107,O
the,108,111,O
gallbladder,112,123,B-Organ
(,124,125,O
GB,125,127,B-Organ
),127,128,O
",",128,129,O
1,130,131,O
of,132,134,O
malignant,135,144,B-Pathological_formation
fibrous,145,152,I-Pathological_formation
histocytoma,153,164,I-Pathological_formation
",",164,165,O
3,166,167,O
of,168,170,O
metastatic,171,181,B-Pathological_formation
adenocarcinoma,182,196,I-Pathological_formation
",",196,197,O
5,198,199,O
of,200,202,O
adenoma,203,210,B-Pathological_formation
",",210,211,O
5,212,213,O
of,214,216,O
polypus,217,224,B-Pathological_formation
",",224,225,O
2,226,227,O
of,228,230,O
xanthogranuloma,231,246,B-Pathological_formation
",",246,247,O
6,248,249,O
of,250,252,O
chronic,253,260,O
cholecystitis,261,274,O
",",274,275,O
4,276,277,O
of,278,280,O
acute,281,286,O
cholecystitis,287,300,O
",",300,301,O
and,302,305,O
8,306,307,O
of,308,310,O
subacute,311,319,O
cholecystitis,320,333,O
were,334,338,O
studied,339,346,O
by,347,349,O
image,350,355,O
-,355,356,O
directed,356,364,O
and,365,368,O
color,369,374,O
Doppler,375,382,O
ultrasonography,383,398,O
(,399,400,O
CDUS,400,404,O
),404,405,O
.,405,406,O
All,407,410,O
of,411,413,O
the,414,417,O
14,418,420,O
cases,421,426,O
of,427,429,O
primary,430,437,O
GB,438,440,B-Pathological_formation
cancer,441,447,I-Pathological_formation
(,448,449,O
10,449,451,O
masses,452,458,O
",",458,459,O
4,460,461,O
thickening,462,472,O
wall,473,477,B-Multi-tissue_structure
),477,478,O
were,479,483,O
found,484,489,O
to,490,492,O
have,493,497,O
a,498,499,O
high,500,504,O
velocity,505,513,O
arterial,514,522,B-Organism_substance
blood,523,528,I-Organism_substance
flow,529,533,O
signal,534,540,O
in,541,543,O
the,544,547,O
wall,548,552,B-Multi-tissue_structure
of,553,555,O
the,556,559,O
GB,560,562,B-Organ
.,562,563,O
In,564,566,O
contrast,567,575,O
",",575,576,O
the,577,580,O
3,581,582,O
cases,583,588,O
of,589,591,O
metastatic,592,602,B-Pathological_formation
cancer,603,609,I-Pathological_formation
of,610,612,O
the,613,616,O
GB,617,619,B-Organ
had,620,623,O
no,624,626,O
blood,627,632,B-Organism_substance
flow,633,637,O
signal,638,644,O
in,645,647,O
the,648,651,O
wall,652,656,B-Multi-tissue_structure
of,657,659,O
the,660,663,O
GB,664,666,B-Organ
.,666,667,O
For,668,671,O
the,672,675,O
30,676,678,O
cases,679,684,O
of,685,687,O
benign,688,694,B-Pathological_formation
lesions,695,702,I-Pathological_formation
of,703,705,O
the,706,709,O
GB,710,712,B-Organ
",",712,713,O
only,714,718,O
in,719,721,O
12,722,724,O
cases,725,730,O
was,731,734,O
a,735,736,O
low,737,740,O
velocity,741,749,O
blood,750,755,B-Organism_substance
flow,756,760,O
signal,761,767,O
found,768,773,O
.,773,774,O
Nine,775,779,O
of,780,782,O
10,783,785,O
cases,786,791,O
of,792,794,O
primary,795,802,O
GB,803,805,B-Pathological_formation
malignancy,806,816,I-Pathological_formation
were,817,821,O
found,822,827,O
to,828,830,O
have,831,835,O
high,836,840,O
velocity,841,849,O
arterial,850,858,B-Organism_substance
blood,859,864,I-Organism_substance
flow,865,869,O
signals,870,877,O
in,878,880,O
the,881,884,O
tumor,885,890,B-Pathological_formation
masses,891,897,O
.,897,898,O
No,899,901,O
blood,902,907,B-Organism_substance
flow,908,912,O
signal,913,919,O
was,920,923,O
observed,924,932,O
in,933,935,O
the,936,939,O
masses,940,946,O
of,947,949,O
13,950,952,O
cases,953,958,O
(,959,960,O
3,960,961,O
of,962,964,O
metastatic,965,975,B-Pathological_formation
adenocarcinoma,976,990,I-Pathological_formation
",",990,991,O
5,992,993,O
of,994,996,O
adenoma,997,1004,B-Pathological_formation
",",1004,1005,O
5,1006,1007,O
of,1008,1010,O
polypus,1011,1018,B-Pathological_formation
),1018,1019,O
.,1019,1020,O
An,1021,1023,O
abnormal,1024,1032,O
high,1033,1037,O
velocity,1038,1046,O
arterial,1047,1055,B-Organism_substance
blood,1056,1061,I-Organism_substance
flow,1062,1066,O
signal,1067,1073,O
observed,1074,1082,O
within,1083,1089,O
masses,1090,1096,O
in,1097,1099,O
the,1100,1103,O
GB,1104,1106,B-Organ
or,1107,1109,O
in,1110,1112,O
the,1113,1116,O
GB,1117,1119,B-Multi-tissue_structure
wall,1120,1124,I-Multi-tissue_structure
is,1125,1127,O
a,1128,1129,O
significant,1130,1141,O
feature,1142,1149,O
of,1150,1152,O
primary,1153,1160,O
GB,1161,1163,B-Pathological_formation
cancer,1164,1170,I-Pathological_formation
and,1171,1174,O
thus,1175,1179,O
helps,1180,1185,O
to,1186,1188,O
differentiate,1189,1202,O
primary,1203,1210,O
GB,1211,1213,B-Pathological_formation
cancer,1214,1220,I-Pathological_formation
from,1221,1225,O
metastatic,1226,1236,B-Pathological_formation
and,1237,1240,O
benign,1241,1247,B-Pathological_formation
lesions,1248,1255,I-Pathological_formation
of,1256,1258,O
the,1259,1262,O
GB,1263,1265,B-Organ
.,1265,1266,O
Inhibition,0,10,O
of,11,13,O
calmodulin,14,24,O
-,24,25,O
dependent,25,34,O
myosin,35,41,O
light,42,47,O
-,47,48,O
chain,48,53,O
kinase,54,60,O
by,61,63,O
growth,64,70,O
-,70,71,O
hormone,71,78,O
-,78,79,O
releasing,79,88,O
factor,89,95,O
and,96,99,O
vasoactive,100,110,O
intestinal,111,121,B-Multi-tissue_structure
peptide,122,129,O
.,129,130,O
In,131,133,O
view,134,138,O
of,139,141,O
the,142,145,O
ability,146,153,O
of,154,156,O
calmodulin,157,167,O
to,168,170,O
bind,171,175,O
vasoactive,176,186,O
intestinal,187,197,B-Multi-tissue_structure
peptide,198,205,O
(,206,207,O
VIP,207,210,O
),210,211,O
and,212,215,O
growth,216,222,O
-,222,223,O
hormone,223,230,O
-,230,231,O
releasing,231,240,O
factor,241,247,O
(,248,249,O
GRF,249,252,O
),252,253,O
with,254,258,O
high,259,263,O
affinity,264,272,O
[,273,274,O
Stallwood,274,283,O
",",283,284,O
Brugger,285,292,O
",",292,293,O
Baggenstoss,294,305,O
",",305,306,O
Stemmer,307,314,O
",",314,315,O
Shiraga,316,323,O
",",323,324,O
Landers,325,332,O
and,333,336,O
Paul,337,341,O
(,342,343,O
1992,343,347,O
),347,348,O
J,349,350,O
.,350,351,O
Biol,352,356,O
.,356,357,O
Chem,358,362,O
.,362,363,O
267,364,367,O
",",367,368,O
19617,369,374,O
-,374,375,O
19621,375,380,O
],380,381,O
",",381,382,O
the,383,386,O
effects,387,394,O
of,395,397,O
these,398,403,O
neuropeptides,404,417,O
on,418,420,O
a,421,422,O
model,423,428,O
calmodulin,429,439,O
-,439,440,O
dependent,440,449,O
enzyme,450,456,O
",",456,457,O
myosin,458,464,O
light,465,470,O
-,470,471,O
chain,471,476,O
kinase,477,483,O
(,484,485,O
MLCK,485,489,O
),489,490,O
",",490,491,O
were,492,496,O
studied,497,504,O
.,504,505,O
Both,506,510,O
peptides,511,519,O
were,520,524,O
potent,525,531,O
inhibitors,532,542,O
of,543,545,O
MLCK,546,550,O
activity,551,559,O
.,559,560,O
The,561,564,O
inhibition,565,575,O
of,576,578,O
enzyme,579,585,O
activity,586,594,O
by,595,597,O
VIP,598,601,O
and,602,605,O
GRF,606,609,O
was,610,613,O
progressively,614,627,O
overcome,628,636,O
with,637,641,O
increasing,642,652,O
calmodulin,653,663,O
concentrations,664,678,O
",",678,679,O
with,680,684,O
no,685,687,O
inhibition,688,698,O
observed,699,707,O
at,708,710,O
a,711,712,O
saturating,713,723,O
calmodulin,724,734,O
concentration,735,748,O
.,748,749,O
Nanomolar,750,759,O
concentrations,760,774,O
of,775,777,O
MLCK,778,782,O
blocked,783,790,O
the,791,794,O
formation,795,804,O
of,805,807,O
calmodulin,808,818,O
-,818,819,O
[,819,820,O
125I,820,824,O
-,824,825,O
Tyr10,825,830,O
],830,831,O
VIP,831,834,O
complexes,835,844,O
.,844,845,O
These,846,851,O
data,852,856,O
provide,857,864,O
support,865,872,O
for,873,876,O
a,877,878,O
functional,879,889,O
role,890,894,O
of,895,897,O
VIP,898,901,O
and,902,905,O
GRF,906,909,O
binding,910,917,O
by,918,920,O
calmodulin,921,931,O
.,931,932,O
Methotrexate,0,12,O
osteopathy,13,23,O
in,24,26,O
rheumatic,27,36,O
disease,37,44,O
.,44,45,O
OBJECTIVE,46,55,O
:,55,56,O
To,57,59,O
determine,60,69,O
whether,70,77,O
two,78,81,O
adults,82,88,O
with,89,93,O
stress,94,100,O
fractures,101,110,O
receiving,111,120,O
low,121,124,O
weekly,125,131,O
doses,132,137,O
of,138,140,O
methotrexate,141,153,O
had,154,157,O
methotrexate,158,170,O
osteopathy,171,181,O
.,181,182,O
CASE,183,187,O
REPORTS,188,195,O
:,195,196,O
Two,197,200,O
adult,201,206,O
patients,207,215,O
developed,216,225,O
features,226,234,O
consistent,235,245,O
with,246,250,O
methotrexate,251,263,O
osteopathy,264,274,O
while,275,280,O
receiving,281,290,O
low,291,294,O
weekly,295,301,O
doses,302,307,O
of,308,310,O
methotrexate,311,323,O
.,323,324,O
METHODS,325,332,O
:,332,333,O
Iliac,334,339,B-Multi-tissue_structure
crest,340,345,I-Multi-tissue_structure
biopsy,346,352,I-Multi-tissue_structure
samples,353,360,I-Multi-tissue_structure
were,361,365,O
taken,366,371,O
and,372,375,O
bone,376,380,B-Tissue
histomorphometry,381,397,O
carried,398,405,O
out,406,409,O
.,409,410,O
RESULTS,411,418,O
:,418,419,O
Symptoms,420,428,O
resolved,429,437,O
when,438,442,O
the,443,446,O
methotrexate,447,459,O
was,460,463,O
discontinued,464,476,O
.,476,477,O
Bone,478,482,B-Tissue
histology,483,492,O
showed,493,499,O
changes,500,507,O
consistent,508,518,O
with,519,523,O
osteoblast,524,534,B-Cell
inhibition,535,545,O
by,546,548,O
methotrexate,549,561,O
.,561,562,O
CONCLUSIONS,563,574,O
:,574,575,O
When,576,580,O
given,581,586,O
in,587,589,O
low,590,593,O
doses,594,599,O
for,600,603,O
prolonged,604,613,O
periods,614,621,O
",",621,622,O
methotrexate,623,635,O
may,636,639,O
have,640,644,O
adverse,645,652,O
effects,653,660,O
on,661,663,O
bone,664,668,B-Organ
",",668,669,O
particularly,670,682,O
in,683,685,O
post,686,690,O
-,690,691,O
menopausal,691,701,O
women,702,707,O
.,707,708,O
Methodologies,0,13,O
for,14,17,O
measuring,18,27,O
carcinogen,28,38,O
adducts,39,46,O
in,47,49,O
humans,50,56,O
.,56,57,O
In,58,60,O
summary,61,68,O
",",68,69,O
although,70,78,O
some,79,83,O
of,84,86,O
the,87,90,O
more,91,95,O
optimistic,96,106,O
aspirations,107,118,O
for,119,122,O
human,123,128,O
biomonitoring,129,142,O
studies,143,150,O
envisaged,151,160,O
a,161,162,O
decade,163,169,O
ago,170,173,O
have,174,178,O
not,179,182,O
been,183,187,O
realized,188,196,O
thus,197,201,O
far,202,205,O
",",205,206,O
some,207,211,O
considerable,212,224,O
advances,225,233,O
have,234,238,O
been,239,243,O
made,244,248,O
.,248,249,O
The,250,253,O
examples,254,262,O
cited,263,268,O
above,269,274,O
indicate,275,283,O
that,284,288,O
the,289,292,O
feasibility,293,304,O
of,305,307,O
biomonitoring,308,321,O
has,322,325,O
been,326,330,O
clearly,331,338,O
established,339,350,O
.,350,351,O
In,352,354,O
addition,355,363,O
",",363,364,O
they,365,369,O
demonstrate,370,381,O
the,382,385,O
need,386,390,O
for,391,394,O
preliminary,395,406,O
biomarker,407,416,O
testing,417,424,O
and,425,428,O
validation,429,439,O
through,440,447,O
transitional,448,460,O
studies,461,468,O
prior,469,474,O
to,475,477,O
their,478,483,O
field,484,489,O
application,490,501,O
.,501,502,O
In,503,505,O
the,506,509,O
next,510,514,O
decade,515,521,O
of,522,524,O
research,525,533,O
into,534,538,O
carcinogen,539,549,O
adducts,550,557,O
in,558,560,O
humans,561,567,O
",",567,568,O
continued,569,578,O
improvements,579,591,O
in,592,594,O
the,595,598,O
reproducibility,599,614,O
and,615,618,O
specificity,619,630,O
of,631,633,O
assays,634,640,O
for,641,644,O
DNA,645,648,O
adducts,649,656,O
will,657,661,O
be,662,664,O
needed,665,671,O
.,671,672,O
Perhaps,673,680,O
the,681,684,O
increasing,685,695,O
use,696,699,O
of,700,702,O
hybrid,703,709,O
methodologies,710,723,O
to,724,726,O
concentrate,727,738,O
adducts,739,746,O
followed,747,755,O
by,756,758,O
specific,759,767,O
chemical,768,776,O
analyses,777,785,O
will,786,790,O
allow,791,796,O
such,797,801,O
adducts,802,809,O
to,810,812,O
be,813,815,O
monitored,816,825,O
more,826,830,O
precisely,831,840,O
.,840,841,O
Of,842,844,O
course,845,851,O
",",851,852,O
further,853,860,O
basic,861,866,O
research,867,875,O
into,876,880,O
the,881,884,O
mechanisms,885,895,O
of,896,898,O
carcinogenesis,899,913,O
will,914,918,O
allow,919,924,O
the,925,928,O
measurement,929,940,O
of,941,943,O
specific,944,952,O
novel,953,958,O
markers,959,966,O
which,967,972,O
are,973,976,O
more,977,981,O
closely,982,989,O
tied,990,994,O
to,995,997,O
the,998,1001,O
disease,1002,1009,O
endpoint,1010,1018,O
than,1019,1023,O
adducts,1024,1031,O
.,1031,1032,O
The,1033,1036,O
development,1037,1048,O
of,1049,1051,O
new,1052,1055,O
assays,1056,1062,O
for,1063,1066,O
determining,1067,1078,O
metabolic,1079,1088,O
phenotypes,1089,1099,O
and,1100,1103,O
genotypes,1104,1113,O
relevant,1114,1122,O
to,1123,1125,O
carcinogenesis,1126,1140,O
should,1141,1147,O
improve,1148,1155,O
our,1156,1159,O
estimates,1160,1169,O
of,1170,1172,O
susceptibility,1173,1187,O
(,1188,1189,O
46,1189,1191,O
-,1191,1192,O
48,1192,1194,O
),1194,1195,O
.,1195,1196,O
Such,1197,1201,O
new,1202,1205,O
approaches,1206,1216,O
along,1217,1222,O
with,1223,1227,O
the,1228,1231,O
sustained,1232,1241,O
improvement,1242,1253,O
of,1254,1256,O
current,1257,1264,O
assays,1265,1271,O
will,1272,1276,O
allow,1277,1282,O
molecular,1283,1292,O
approaches,1293,1303,O
to,1304,1306,O
continue,1307,1315,O
to,1316,1318,O
enrich,1319,1325,O
cancer,1326,1332,B-Pathological_formation
epidemiology,1333,1345,O
in,1346,1348,O
the,1349,1352,O
future,1353,1359,O
.,1359,1360,O
Lactotransferrin,0,16,O
binding,17,24,O
to,25,27,O
its,28,31,O
platelet,32,40,B-Cell
receptor,41,49,O
inhibits,50,58,O
platelet,59,67,B-Cell
aggregation,68,79,O
.,79,80,O
A,81,82,O
fluorescent,83,94,O
lactotransferrin,95,111,O
probe,112,117,O
was,118,121,O
prepared,122,130,O
by,131,133,O
coupling,134,142,O
5,143,144,O
-,144,145,O
(,145,146,O
(,146,147,O
[,147,148,O
2,148,149,O
-,149,150,O
(,150,151,O
carbhydrazino,151,164,O
),164,165,O
methyl,165,171,O
],171,172,O
-,172,173,O
thio,173,177,O
),177,178,O
acetyl,178,184,O
),184,185,O
amino,185,190,O
fluorescein,191,202,O
to,203,205,O
aldehyde,206,214,O
groups,215,221,O
that,222,226,O
were,227,231,O
produced,232,240,O
by,241,243,O
a,244,245,O
mild,246,250,O
periodic,251,259,O
-,259,260,O
acid,260,264,O
oxidation,265,274,O
of,275,277,O
the,278,281,O
glycan,282,288,O
moieties,289,297,O
of,298,300,O
lactotransferrin,301,317,O
.,317,318,O
In,319,321,O
this,322,326,O
manner,327,333,O
",",333,334,O
the,335,338,O
receptor,339,347,O
-,347,348,O
binding,348,355,O
site,356,360,O
of,361,363,O
the,364,367,O
lactotransferrin,368,384,O
remains,385,392,O
active,393,399,O
in,400,402,O
contrast,403,411,O
to,412,414,O
the,415,418,O
binding,419,426,O
site,427,431,O
of,432,434,O
the,435,438,O
lactotransferrin,439,455,O
derivatized,456,467,O
with,468,472,O
fluorescein,473,484,O
isothiocyanate,485,499,O
.,499,500,O
The,501,504,O
fluorescent,505,516,O
probe,517,522,O
allowed,523,530,O
us,531,533,O
to,534,536,O
characterize,537,549,O
",",549,550,O
by,551,553,O
flow,554,558,O
cytometry,559,568,O
",",568,569,O
the,570,573,O
binding,574,581,O
of,582,584,O
lactotransferrin,585,601,O
to,602,604,O
non,605,608,O
-,608,609,O
activated,609,618,O
human,619,624,O
platelets,625,634,B-Cell
.,634,635,O
The,636,639,O
putative,640,648,O
lactotransferrin,649,665,O
platelet,666,674,B-Cell
receptor,675,683,O
was,684,687,O
purified,688,696,O
and,697,700,O
its,701,704,O
immunological,705,718,O
and,719,722,O
physico,723,730,O
-,730,731,O
chemical,731,739,O
properties,740,750,O
were,751,755,O
found,756,761,O
to,762,764,O
be,765,767,O
very,768,772,O
similar,773,780,O
to,781,783,O
those,784,789,O
of,790,792,O
the,793,796,O
receptor,797,805,O
previously,806,816,O
isolated,817,825,O
from,826,830,O
activated,831,840,O
human,841,846,O
lymphocytes,847,858,B-Cell
.,858,859,O
Lactotransferrin,860,876,O
inhibits,877,885,O
ADP,886,889,O
-,889,890,O
induced,890,897,O
platelet,898,906,B-Cell
aggregation,907,918,O
at,919,921,O
concentrations,922,936,O
down,937,941,O
to,942,944,O
5,945,946,O
nM,947,949,O
",",949,950,O
which,951,956,O
can,957,960,O
be,961,963,O
reached,964,971,O
in,972,974,O
the,975,978,O
plasma,979,985,B-Organism_substance
after,986,991,O
leukocyte,992,1001,B-Cell
degranulation,1002,1015,O
.,1015,1016,O
Inhibition,1017,1027,O
of,1028,1030,O
platelet,1031,1039,B-Cell
aggregation,1040,1051,O
was,1052,1055,O
also,1056,1060,O
observed,1061,1069,O
with,1070,1074,O
the,1075,1078,O
N,1079,1080,O
-,1080,1081,O
terminal,1081,1089,O
fragment,1090,1098,O
of,1099,1101,O
lactotransferrin,1102,1118,O
(,1119,1120,O
residues,1120,1128,O
3,1129,1130,O
-,1130,1131,O
281,1131,1134,O
;,1134,1135,O
50,1136,1138,O
%,1138,1139,O
inhibition,1140,1150,O
=,1151,1152,O
2,1153,1154,O
microM,1155,1161,O
),1161,1162,O
and,1163,1166,O
with,1167,1171,O
CFQWQRNMRKVRGPPVSC,1172,1190,O
synthetic,1191,1200,O
octodecapeptide,1201,1216,O
(,1217,1218,O
residues,1218,1226,O
20,1227,1229,O
-,1229,1230,O
37,1230,1232,O
;,1232,1233,O
50,1234,1236,O
%,1236,1237,O
inhibition,1238,1248,O
=,1249,1250,O
20,1251,1253,O
microM,1254,1260,O
),1260,1261,O
corresponding,1262,1275,O
to,1276,1278,O
one,1279,1282,O
of,1283,1285,O
the,1286,1289,O
two,1290,1293,O
external,1294,1302,O
loops,1303,1308,O
(,1309,1310,O
residues,1310,1318,O
28,1319,1321,O
-,1321,1322,O
34,1322,1324,O
and,1325,1328,O
39,1329,1331,O
-,1331,1332,O
42,1332,1334,O
),1334,1335,O
where,1336,1341,O
we,1342,1344,O
recently,1345,1353,O
located,1354,1361,O
the,1362,1365,O
receptor,1366,1374,O
-,1374,1375,O
binding,1375,1382,O
site,1383,1387,O
.,1387,1388,O
The,1389,1392,O
activity,1393,1401,O
(,1402,1403,O
50,1403,1405,O
%,1405,1406,O
inhibition,1407,1417,O
=,1418,1419,O
500,1420,1423,O
microM,1424,1430,O
),1430,1431,O
of,1432,1434,O
the,1435,1438,O
tetrapeptide,1439,1451,O
KRDS,1452,1456,O
(,1457,1458,O
residues,1458,1466,O
39,1467,1469,O
-,1469,1470,O
42,1470,1472,O
),1472,1473,O
",",1473,1474,O
which,1475,1480,O
has,1481,1484,O
already,1485,1492,O
been,1493,1497,O
described,1498,1507,O
",",1507,1508,O
was,1509,1512,O
at,1513,1515,O
least,1516,1521,O
25,1522,1524,O
-,1524,1525,O
times,1525,1530,O
and,1531,1534,O
16000,1535,1540,O
-,1540,1541,O
times,1541,1546,O
lower,1547,1552,O
than,1553,1557,O
the,1558,1561,O
activity,1562,1570,O
of,1571,1573,O
the,1574,1577,O
octodecapeptide,1578,1593,O
and,1594,1597,O
of,1598,1600,O
the,1601,1604,O
lactotransferrin,1605,1621,O
molecules,1622,1631,O
",",1631,1632,O
respectively,1633,1645,O
.,1645,1646,O
Finally,1647,1654,O
",",1654,1655,O
the,1656,1659,O
inhibition,1660,1670,O
was,1671,1674,O
demonstrated,1675,1687,O
to,1688,1690,O
be,1691,1693,O
mediated,1694,1702,O
by,1703,1705,O
a,1706,1707,O
mechanism,1708,1717,O
which,1718,1723,O
requires,1724,1732,O
the,1733,1736,O
binding,1737,1744,O
of,1745,1747,O
lactotransferrin,1748,1764,O
to,1765,1767,O
its,1768,1771,O
putative,1772,1780,O
receptor,1781,1789,O
and,1790,1793,O
not,1794,1797,O
to,1798,1800,O
platelet,1801,1809,B-Cell
glycoprotein,1810,1822,O
IIb,1823,1826,O
-,1826,1827,O
IIIa,1827,1831,O
.,1831,1832,O
Do,0,2,O
we,3,5,O
know,6,10,O
how,11,14,O
much,15,19,O
people,20,26,O
like,27,31,O
one,32,35,O
another,36,43,O
?,43,44,O
Metaperception,45,59,O
is,60,62,O
a,63,64,O
person,65,71,O
',71,72,O
s,72,73,O
perception,74,84,O
about,85,90,O
a,91,92,O
second,93,99,O
person,100,106,O
',106,107,O
s,107,108,O
perception,109,119,O
of,120,122,O
a,123,124,O
third,125,130,O
person,131,137,O
.,137,138,O
The,139,142,O
purpose,143,150,O
of,151,153,O
this,154,158,O
article,159,166,O
is,167,169,O
to,170,172,O
examine,173,180,O
the,181,184,O
accuracy,185,193,O
of,194,196,O
metaperceptions,197,212,O
of,213,215,O
liking,216,222,O
.,222,223,O
A,224,225,O
related,226,233,O
question,234,242,O
concerns,243,251,O
whether,252,259,O
the,260,263,O
heuristics,264,274,O
of,275,277,O
balance,278,285,O
",",285,286,O
reciprocity,287,298,O
",",298,299,O
and,300,303,O
agreement,304,313,O
are,314,317,O
used,318,322,O
by,323,325,O
perceivers,326,336,O
when,337,341,O
forming,342,349,O
such,350,354,O
judgments,355,364,O
.,364,365,O
The,366,369,O
authors,370,377,O
present,378,385,O
analyses,386,394,O
from,395,399,O
5,400,401,O
diverse,402,409,O
research,410,418,O
studies,419,426,O
that,427,431,O
used,432,436,O
an,437,439,O
adaptation,440,450,O
of,451,453,O
the,454,457,O
social,458,464,O
relations,465,474,O
model,475,480,O
for,481,484,O
triads,485,491,O
(,492,493,O
C,493,494,O
.,494,495,O
F,495,496,O
.,496,497,O
Bond,498,502,O
",",502,503,O
E,504,505,O
.,505,506,O
M,506,507,O
.,507,508,O
Horn,509,513,O
",",513,514,O
&,515,516,O
D,517,518,O
.,518,519,O
A,519,520,O
.,520,521,O
Kenny,522,527,O
",",527,528,O
in,529,531,O
press,532,537,O
),537,538,O
.,538,539,O
The,540,543,O
results,544,551,O
indicate,552,560,O
that,561,565,O
people,566,572,O
know,573,577,O
how,578,581,O
much,582,586,O
people,587,593,O
like,594,598,O
one,599,602,O
another,603,610,O
",",610,611,O
even,612,616,O
with,617,621,O
small,622,627,O
amounts,628,635,O
of,636,638,O
information,639,650,O
.,650,651,O
Although,652,660,O
there,661,666,O
is,667,669,O
evidence,670,678,O
for,679,682,O
the,683,686,O
use,687,690,O
of,691,693,O
heuristics,694,704,O
",",704,705,O
particularly,706,718,O
reciprocity,719,730,O
and,731,734,O
agreement,735,744,O
",",744,745,O
accuracy,746,754,O
is,755,757,O
sometimes,758,767,O
enhanced,768,776,O
by,777,779,O
using,780,785,O
these,786,791,O
heuristics,792,802,O
.,802,803,O
Genetic,0,7,O
heterogeneity,8,21,O
evidenced,22,31,O
by,32,34,O
low,35,38,O
incidence,39,48,O
of,49,51,O
KAL,52,55,O
-,55,56,O
1,56,57,O
gene,58,62,O
mutations,63,72,O
in,73,75,O
sporadic,76,84,O
cases,85,90,O
of,91,93,O
gonadotropin,94,106,O
-,106,107,O
releasing,107,116,O
hormone,117,124,O
deficiency,125,135,O
.,135,136,O
Isolated,137,145,O
GnRH,146,150,O
deficiency,151,161,O
is,162,164,O
a,165,166,O
heritable,167,176,O
condition,177,186,O
characterized,187,200,O
by,201,203,O
a,204,205,O
functional,206,216,O
deficit,217,224,O
in,225,227,O
GnRH,228,232,O
secretion,233,242,O
.,242,243,O
Familial,244,252,O
cases,253,258,O
with,259,263,O
different,264,273,O
modes,274,279,O
of,280,282,O
inheritance,283,294,O
have,295,299,O
been,300,304,O
described,305,314,O
",",314,315,O
and,316,319,O
the,320,323,O
gene,324,328,O
responsible,329,340,O
for,341,344,O
the,345,348,O
X,349,350,O
-,350,351,O
linked,351,357,O
form,358,362,O
(,363,364,O
KAL,364,367,O
-,367,368,O
1,368,369,O
),369,370,O
has,371,374,O
been,375,379,O
identified,380,390,O
.,390,391,O
However,392,399,O
",",399,400,O
sporadic,401,409,O
cases,410,415,O
with,416,420,O
no,421,423,O
documented,424,434,O
family,435,441,O
history,442,449,O
of,450,452,O
GnRH,453,457,O
deficiency,458,468,O
account,469,476,O
for,477,480,O
the,481,484,O
majority,485,493,O
of,494,496,O
the,497,500,O
affected,501,509,O
patients,510,518,O
.,518,519,O
For,520,523,O
this,524,528,O
reason,529,535,O
",",535,536,O
we,537,539,O
sought,540,546,O
to,547,549,O
determine,550,559,O
the,560,563,O
frequency,564,573,O
with,574,578,O
which,579,584,O
KAL,585,588,O
-,588,589,O
1,589,590,O
gene,591,595,O
mutations,596,605,O
occur,606,611,O
in,612,614,O
patients,615,623,O
with,624,628,O
sporadic,629,637,O
GnRH,638,642,O
deficiency,643,653,O
.,653,654,O
Only,655,659,O
1,660,661,O
of,662,664,O
21,665,667,O
patients,668,676,O
with,677,681,O
sporadic,682,690,O
GnRH,691,695,O
deficiency,696,706,O
was,707,710,O
found,711,716,O
to,717,719,O
bear,720,724,O
a,725,726,O
defect,727,733,O
in,734,736,O
the,737,740,O
KAL,741,744,O
-,744,745,O
1,745,746,O
gene,747,751,O
(,752,753,O
a,753,754,O
deletion,755,763,O
of,764,766,O
14,767,769,O
bases,770,775,O
starting,776,784,O
at,785,787,O
codon,788,793,O
464,794,797,O
),797,798,O
.,798,799,O
Three,800,805,O
types,806,811,O
of,812,814,O
polymorphic,815,826,O
single,827,833,O
base,834,838,O
substitutions,839,852,O
with,853,857,O
no,858,860,O
apparent,861,869,O
correlation,870,881,O
with,882,886,O
GnRH,887,891,O
deficiency,892,902,O
were,903,907,O
also,908,912,O
detected,913,921,O
in,922,924,O
several,925,932,O
patients,933,941,O
.,941,942,O
In,943,945,O
each,946,950,O
of,951,953,O
3,954,955,O
different,956,965,O
patients,966,974,O
with,975,979,O
an,980,982,O
X,983,984,O
-,984,985,O
linked,985,991,O
mode,992,996,O
of,997,999,O
inheritance,1000,1011,O
",",1011,1012,O
3,1013,1014,O
genetic,1015,1022,O
defects,1023,1030,O
",",1030,1031,O
2,1032,1033,O
point,1034,1039,O
mutations,1040,1049,O
and,1050,1053,O
a,1054,1055,O
small,1056,1061,O
intragenic,1062,1072,O
deletion,1073,1081,O
",",1081,1082,O
were,1083,1087,O
detected,1088,1096,O
.,1096,1097,O
These,1098,1103,O
defects,1104,1111,O
consist,1112,1119,O
of,1120,1122,O
a,1123,1124,O
single,1125,1131,O
base,1132,1136,O
mutation,1137,1145,O
introducing,1146,1157,O
a,1158,1159,O
stop,1160,1164,O
codon,1165,1170,O
at,1171,1173,O
position,1174,1182,O
328,1183,1186,O
",",1186,1187,O
a,1188,1189,O
single,1190,1196,O
base,1197,1201,O
mutation,1202,1210,O
resulting,1211,1220,O
in,1221,1223,O
a,1224,1225,O
phenylalanine,1226,1239,O
to,1240,1242,O
leucine,1243,1250,O
substitution,1251,1263,O
at,1264,1266,O
position,1267,1275,O
517,1276,1279,O
",",1279,1280,O
and,1281,1284,O
a,1285,1286,O
9,1287,1288,O
-,1288,1289,O
base,1289,1293,O
deletion,1294,1302,O
at,1303,1305,O
the,1306,1309,O
3,1310,1311,O
',1311,1312,O
-,1312,1313,O
exon,1313,1317,O
-,1317,1318,O
intron,1318,1324,O
splice,1325,1331,O
site,1332,1336,O
of,1337,1339,O
exon,1340,1344,O
8,1345,1346,O
",",1346,1347,O
respectively,1348,1360,O
.,1360,1361,O
All,1362,1365,O
identified,1366,1376,O
genetic,1377,1384,O
defects,1385,1392,O
occur,1393,1398,O
within,1399,1405,O
the,1406,1409,O
fibronectin,1410,1421,O
type,1422,1426,O
III,1427,1430,O
repeats,1431,1438,O
of,1439,1441,O
the,1442,1445,O
predicted,1446,1455,O
protein,1456,1463,O
encoded,1464,1471,O
by,1472,1474,O
the,1475,1478,O
KAL,1479,1482,O
-,1482,1483,O
1,1483,1484,O
gene,1485,1489,O
.,1489,1490,O
In,1491,1493,O
conclusion,1494,1504,O
",",1504,1505,O
our,1506,1509,O
study,1510,1515,O
indicates,1516,1525,O
that,1526,1530,O
the,1531,1534,O
incidence,1535,1544,O
of,1545,1547,O
genetic,1548,1555,O
defects,1556,1563,O
within,1564,1570,O
the,1571,1574,O
coding,1575,1581,O
region,1582,1588,O
of,1589,1591,O
the,1592,1595,O
KAL,1596,1599,O
-,1599,1600,O
1,1600,1601,O
gene,1602,1606,O
in,1607,1609,O
patients,1610,1618,O
with,1619,1623,O
sporadic,1624,1632,O
GnRH,1633,1637,O
deficiency,1638,1648,O
is,1649,1651,O
low,1652,1655,O
(,1656,1657,O
5,1657,1658,O
-,1658,1659,O
8,1659,1660,O
%,1660,1661,O
),1661,1662,O
",",1662,1663,O
thus,1664,1668,O
supporting,1669,1679,O
the,1680,1683,O
idea,1684,1688,O
that,1689,1693,O
the,1694,1697,O
X,1698,1699,O
-,1699,1700,O
linked,1700,1706,O
form,1707,1711,O
of,1712,1714,O
inheritance,1715,1726,O
represents,1727,1737,O
the,1738,1741,O
least,1742,1747,O
common,1748,1754,O
form,1755,1759,O
of,1760,1762,O
the,1763,1766,O
disease,1767,1774,O
.,1774,1775,O
The,0,3,O
effect,4,10,O
of,11,13,O
early,14,19,O
diagnosis,20,29,O
and,30,33,O
treatment,34,43,O
in,44,46,O
cystic,47,53,O
fibrosis,54,62,O
:,62,63,O
a,64,65,O
seven,66,71,O
-,71,72,O
year,72,76,O
study,77,82,O
of,83,85,O
16,86,88,O
sibling,89,96,O
pairs,97,102,O
.,102,103,O
Data,104,108,O
on,109,111,O
16,112,114,O
sibling,115,122,O
pairs,123,128,O
with,129,133,O
cystic,134,140,O
fibrosis,141,149,O
were,150,154,O
analyzed,155,163,O
to,164,166,O
test,167,171,O
the,172,175,O
hypothesis,176,186,O
that,187,191,O
early,192,197,O
treatment,198,207,O
of,208,210,O
this,211,215,O
condition,216,225,O
improves,226,234,O
prognosis,235,244,O
.,244,245,O
Younger,246,253,O
siblings,254,262,O
',262,263,O
conditions,264,274,O
were,275,279,O
diagnosed,280,289,O
before,290,296,O
1,297,298,O
year,299,303,O
of,304,306,O
age,307,310,O
",",310,311,O
usually,312,319,O
before,320,326,O
the,327,330,O
onset,331,336,O
of,337,339,O
pulmonary,340,349,B-Organ
disease,350,357,O
.,357,358,O
Older,359,364,O
siblings,365,373,O
',373,374,O
conditions,375,385,O
were,386,390,O
diagnosed,391,400,O
after,401,406,O
1,407,408,O
year,409,413,O
of,414,416,O
age,417,420,O
and,421,424,O
after,425,430,O
the,431,434,O
onset,435,440,O
of,441,443,O
pulmonary,444,453,B-Organ
disease,454,461,O
.,461,462,O
Although,463,471,O
the,472,475,O
sibling,476,483,O
pairs,484,489,O
received,490,498,O
similar,499,506,O
treatment,507,516,O
",",516,517,O
comparison,518,528,O
at,529,531,O
7,532,533,O
years,534,539,O
of,540,542,O
age,543,546,O
showed,547,553,O
that,554,558,O
the,559,562,O
younger,563,570,O
siblings,571,579,O
had,580,583,O
significantly,584,597,O
better,598,604,O
chest,605,610,B-Organism_subdivision
roentgenogram,611,624,O
scores,625,631,O
",",631,632,O
total,633,638,O
clinical,639,647,O
scores,648,654,O
",",654,655,O
residual,656,664,O
lung,665,669,B-Organ
volumes,670,677,O
",",677,678,O
and,679,682,O
ratios,683,689,O
of,690,692,O
residual,693,701,O
volume,702,708,O
to,709,711,O
total,712,717,O
lung,718,722,B-Organ
volume,723,729,O
.,729,730,O
Younger,731,738,O
siblings,739,747,O
also,748,752,O
required,753,761,O
fewer,762,767,O
hospital,768,776,O
admissions,777,787,O
to,788,790,O
control,791,798,O
their,799,804,O
lung,805,809,B-Organ
disease,810,817,O
.,817,818,O
The,819,822,O
results,823,830,O
suggest,831,838,O
that,839,843,O
",",843,844,O
in,845,847,O
general,848,855,O
",",855,856,O
early,857,862,O
initiation,863,873,O
of,874,876,O
therapy,877,884,O
is,885,887,O
beneficial,888,898,O
for,899,902,O
patients,903,911,O
with,912,916,O
cystic,917,923,O
fibrosis,924,932,O
.,932,933,O
The,0,3,O
effects,4,11,O
of,12,14,O
oxidative,15,24,O
stress,25,31,O
on,32,34,O
in,35,37,O
vivo,38,42,O
brain,43,48,B-Organ
GSH,49,52,O
turnover,53,61,O
in,62,64,O
young,65,70,O
and,71,74,O
mature,75,81,O
mice,82,86,O
.,86,87,O
Glutathione,88,99,O
(,100,101,O
GSH,101,104,O
),104,105,O
synthetase,106,116,O
activities,117,127,O
and,128,131,O
GSH,132,135,O
turnover,136,144,O
rates,145,150,O
were,151,155,O
examined,156,164,O
during,165,171,O
severe,172,178,O
oxidative,179,188,O
stress,189,195,O
in,196,198,O
the,199,202,O
mouse,203,208,O
brain,209,214,B-Organ
as,215,217,O
induced,218,225,O
by,226,228,O
t,229,230,O
-,230,231,O
butylhydroperoxide,231,249,O
(,250,251,O
t,251,252,O
-,252,253,O
BuOOH,253,258,O
),258,259,O
.,259,260,O
Brain,261,266,B-Organ
GSH,267,270,O
synthetase,271,281,O
activities,282,292,O
in,293,295,O
8,296,297,O
-,297,298,O
mo,298,300,O
-,300,301,O
old,301,304,O
mice,305,309,O
in,310,312,O
the,313,316,O
cortex,317,323,B-Multi-tissue_structure
",",323,324,O
striatum,325,333,B-Multi-tissue_structure
",",333,334,O
thalamus,335,343,B-Multi-tissue_structure
",",343,344,O
hippocampus,345,356,B-Multi-tissue_structure
",",356,357,O
midbrain,358,366,B-Multi-tissue_structure
",",366,367,O
and,368,371,O
cerebellum,372,382,B-Multi-tissue_structure
were,383,387,O
found,388,393,O
to,394,396,O
increase,397,405,O
following,406,415,O
t,416,417,O
-,417,418,O
BuOOH,418,423,O
treatment,424,433,O
.,433,434,O
The,435,438,O
effect,439,445,O
of,446,448,O
GSH,449,452,O
synthesis,453,462,O
on,463,465,O
brain,466,471,B-Organ
GSH,472,475,O
turnover,476,484,O
rates,485,490,O
for,491,494,O
2,495,496,O
-,496,497,O
and,498,501,O
8,502,503,O
-,503,504,O
mo,504,506,O
-,506,507,O
old,507,510,O
mice,511,515,O
were,516,520,O
determined,521,531,O
after,532,537,O
intracerebroventricular,538,561,O
(,562,563,O
icv,563,566,O
),566,567,O
injection,568,577,O
of,578,580,O
[,581,582,O
35S,582,585,O
],585,586,O
cysteine,586,594,O
.,594,595,O
Rate,596,600,O
constants,601,610,O
for,611,614,O
GSH,615,618,O
turnover,619,627,O
were,628,632,O
determined,633,643,O
by,644,646,O
least,647,652,O
-,652,653,O
squares,653,660,O
iterative,661,670,O
minimization,671,683,O
from,684,688,O
the,689,692,O
specific,693,701,O
activity,702,710,O
data,711,715,O
from,716,720,O
20,721,723,O
min,724,727,O
to,728,730,O
108,731,734,O
h,735,736,O
after,737,742,O
[,743,744,O
35S,744,747,O
],747,748,O
cysteine,748,756,O
administration,757,771,O
.,771,772,O
GSH,773,776,O
and,777,780,O
glutathione,781,792,O
disulfide,793,802,O
(,803,804,O
GSSG,804,808,O
),808,809,O
specific,810,818,O
activities,819,829,O
were,830,834,O
determined,835,845,O
after,846,851,O
separation,852,862,O
by,863,865,O
high,866,870,O
-,870,871,O
pressure,871,879,O
liquid,880,886,O
chromatography,887,901,O
(,902,903,O
HPLC,903,907,O
),907,908,O
.,908,909,O
The,910,913,O
half,914,918,O
-,918,919,O
life,919,923,O
of,924,926,O
GSH,927,930,O
in,931,933,O
the,934,937,O
2,938,939,O
-,939,940,O
mo,940,942,O
-,942,943,O
old,943,946,O
mouse,947,952,O
was,953,956,O
59,957,959,O
.,959,960,O
5,960,961,O
h,962,963,O
and,964,967,O
in,968,970,O
the,971,974,O
8,975,976,O
-,976,977,O
mo,977,979,O
-,979,980,O
old,980,983,O
mouse,984,989,O
was,990,993,O
79,994,996,O
.,996,997,O
1,997,998,O
h,999,1000,O
.,1000,1001,O
In,1002,1004,O
summary,1005,1012,O
",",1012,1013,O
defense,1014,1021,O
mechanisms,1022,1032,O
against,1033,1040,O
oxidative,1041,1050,O
stress,1051,1057,O
in,1058,1060,O
the,1061,1064,O
brain,1065,1070,B-Organ
differ,1071,1077,O
with,1078,1082,O
age,1083,1086,O
.,1086,1087,O
Young,1088,1093,O
mice,1094,1098,O
can,1099,1102,O
increase,1103,1111,O
the,1112,1115,O
cellular,1116,1124,B-Cell
availability,1125,1137,O
of,1138,1140,O
GSH,1141,1144,O
",",1144,1145,O
whereas,1146,1153,O
mature,1154,1160,O
mice,1161,1165,O
can,1166,1169,O
increase,1170,1178,O
GSH,1179,1182,O
synthetase,1183,1193,O
activity,1194,1202,O
during,1203,1209,O
oxidative,1210,1219,O
stress,1220,1226,O
.,1226,1227,O
These,1228,1233,O
differences,1234,1245,O
make,1246,1250,O
mature,1251,1257,O
mice,1258,1262,O
more,1263,1267,O
susceptible,1268,1279,O
to,1280,1282,O
brain,1283,1288,B-Organ
oxidative,1289,1298,O
damage,1299,1305,O
.,1305,1306,O
Multiple,0,8,O
phosphotyrosine,9,24,O
phosphatase,25,36,O
mRNAs,37,42,O
are,43,46,O
expressed,47,56,O
in,57,59,O
the,60,63,O
human,64,69,O
lung,70,74,B-Cell
fibroblast,75,85,I-Cell
cell,86,90,I-Cell
line,91,95,I-Cell
WI,96,98,I-Cell
-,98,99,I-Cell
38,99,101,I-Cell
.,101,102,O
Protein,103,110,O
tyrosine,111,119,O
phosphatases,120,132,O
are,133,136,O
important,137,146,O
components,147,157,O
of,158,160,O
signal,161,167,O
transduction,168,180,O
pathways,181,189,O
.,189,190,O
The,191,194,O
authors,195,202,O
have,203,207,O
used,208,212,O
reverse,213,220,O
transcription,221,234,O
/,234,235,O
polymerase,235,245,O
chain,246,251,O
reactions,252,261,O
to,262,264,O
accomplish,265,275,O
a,276,277,O
comprehensive,278,291,O
examination,292,303,O
of,304,306,O
the,307,310,O
RNA,311,314,O
expression,315,325,O
for,326,329,O
58,330,332,O
distinct,333,341,O
mammalian,342,351,O
protein,352,359,O
tyrosine,360,368,O
and,369,372,O
dual,373,377,O
specificity,378,389,O
phosphatase,390,401,O
(,402,403,O
PTPase,403,409,O
),409,410,O
and,411,414,O
PTPase,415,421,O
-,421,422,O
like,422,426,O
genes,427,432,O
in,433,435,O
the,436,439,O
normal,440,446,O
human,447,452,O
diploid,453,460,B-Cell
fibroblast,461,471,I-Cell
cell,472,476,I-Cell
line,477,481,I-Cell
WI,482,484,I-Cell
-,484,485,I-Cell
38,485,487,I-Cell
.,487,488,O
Thirty,489,495,O
-,495,496,O
seven,496,501,O
of,502,504,O
these,505,510,O
PTPase,511,517,O
genes,518,523,O
express,524,531,O
easily,532,538,O
measurable,539,549,O
RNA,550,553,O
",",553,554,O
and,555,558,O
four,559,563,O
simultaneously,564,578,O
express,579,586,O
the,587,590,O
RNA,591,594,O
for,595,598,O
two,599,602,O
or,603,605,O
more,606,610,O
isoforms,611,619,O
.,619,620,O
Messages,621,629,O
for,630,633,O
an,634,636,O
additional,637,647,O
eight,648,653,O
PTPase,654,660,O
genes,661,666,O
are,667,670,O
detectable,671,681,O
at,682,684,O
low,685,688,O
levels,689,695,O
.,695,696,O
Only,697,701,O
14,702,704,O
known,705,710,O
PTPase,711,717,O
genes,718,723,O
do,724,726,O
not,727,730,O
express,731,738,O
measurable,739,749,O
RNA,750,753,O
under,754,759,O
our,760,763,O
conditions,764,774,O
.,774,775,O
For,776,779,O
purposes,780,788,O
of,789,791,O
comparison,792,802,O
",",802,803,O
the,804,807,O
authors,808,815,O
also,816,820,O
assessed,821,829,O
the,830,833,O
PTPases,834,841,O
expressed,842,851,O
in,852,854,O
the,855,858,O
WI,859,861,B-Cell
-,861,862,I-Cell
38,862,864,I-Cell
cell,865,869,I-Cell
line,870,874,I-Cell
using,875,880,O
highly,881,887,O
degenerate,888,898,O
primers,899,906,O
to,907,909,O
conserved,910,919,O
motifs,920,926,O
found,927,932,O
in,933,935,O
the,936,939,O
classical,940,949,O
tyrosine,950,958,O
-,958,959,O
specific,959,967,O
PTPases,968,975,O
.,975,976,O
Only,977,981,O
eight,982,987,O
of,988,990,O
the,991,994,O
22,995,997,O
classic,998,1005,O
tyrosine,1006,1014,O
-,1014,1015,O
specific,1015,1023,O
PTPases,1024,1031,O
detected,1032,1040,O
using,1041,1046,O
the,1047,1050,O
specific,1051,1059,O
primers,1060,1067,O
were,1068,1072,O
detected,1073,1081,O
using,1082,1087,O
these,1088,1093,O
degenerate,1094,1104,O
primers,1105,1112,O
.,1112,1113,O
Our,1114,1117,O
panel,1118,1123,O
of,1124,1126,O
specific,1127,1135,O
PTPase,1136,1142,O
primers,1143,1150,O
should,1151,1157,O
be,1158,1160,O
very,1161,1165,O
useful,1166,1172,O
for,1173,1176,O
semiquantitatively,1177,1195,O
assessing,1196,1205,O
the,1206,1209,O
repertoire,1210,1220,O
of,1221,1223,O
PTPases,1224,1231,O
expressed,1232,1241,O
by,1242,1244,O
cells,1245,1250,B-Cell
.,1250,1251,O
Epstein,0,7,O
-,7,8,O
Barr,8,12,O
virus,13,18,O
-,18,19,O
associated,19,29,O
nonsmall,30,38,B-Pathological_formation
cell,39,43,I-Pathological_formation
lung,44,48,I-Pathological_formation
carcinoma,49,58,I-Pathological_formation
:,58,59,O
undifferentiated,60,76,O
"""",77,78,B-Pathological_formation
lymphoepithelioma,78,95,I-Pathological_formation
-,95,96,I-Pathological_formation
like,96,100,I-Pathological_formation
"""",100,101,I-Pathological_formation
carcinoma,102,111,I-Pathological_formation
as,112,114,O
a,115,116,O
distinct,117,125,O
entity,126,132,O
with,133,137,O
better,138,144,O
prognosis,145,154,O
.,154,155,O
BACKGROUND,156,166,O
:,166,167,O
Epstein,168,175,O
-,175,176,O
Barr,176,180,O
virus,181,186,O
(,187,188,O
EBV,188,191,O
),191,192,O
infection,193,202,O
in,203,205,O
nonsmall,206,214,B-Pathological_formation
cell,215,219,I-Pathological_formation
lung,220,224,I-Pathological_formation
carcinoma,225,234,I-Pathological_formation
(,235,236,O
NSCLC,236,241,B-Pathological_formation
),241,242,O
has,243,246,O
been,247,251,O
demonstrated,252,264,O
in,265,267,O
some,268,272,O
ethnic,273,279,O
groups,280,286,O
.,286,287,O
The,288,291,O
pathobiology,292,304,O
and,305,308,O
the,309,312,O
role,313,317,O
of,318,320,O
EBV,321,324,O
and,325,328,O
oncoprotein,329,340,O
expression,341,351,O
in,352,354,O
these,355,360,O
tumors,361,367,B-Pathological_formation
have,368,372,O
not,373,376,O
been,377,381,O
studied,382,389,O
extensively,390,401,O
.,401,402,O
In,403,405,O
this,406,410,O
study,411,416,O
",",416,417,O
the,418,421,O
authors,422,429,O
investigated,430,442,O
EBV,443,446,O
-,446,447,O
encoded,447,454,O
RNA,455,458,O
-,458,459,O
1,459,460,O
(,461,462,O
EBER1,462,467,O
),467,468,O
transcripts,469,480,O
by,481,483,O
in,484,486,O
situ,487,491,O
hybridization,492,505,O
and,506,509,O
the,510,513,O
expression,514,524,O
of,525,527,O
latent,528,534,O
membrane,535,543,O
protein,544,551,O
-,551,552,O
1,552,553,O
(,554,555,O
LMP,555,558,O
-,558,559,O
1,559,560,O
),560,561,O
and,562,565,O
bcl,566,569,O
-,569,570,O
2,570,571,O
protein,572,579,O
by,580,582,O
immunohistochemistry,583,603,O
in,604,606,O
NSCLC,607,612,B-Pathological_formation
patients,613,621,O
from,622,626,O
Taiwan,627,633,O
",",633,634,O
where,635,640,O
nasopharyngeal,641,655,B-Pathological_formation
carcinoma,656,665,I-Pathological_formation
is,666,668,O
endemic,669,676,O
.,676,677,O
METHODS,678,685,O
:,685,686,O
A,687,688,O
total,689,694,O
of,695,697,O
127,698,701,O
cases,702,707,O
of,708,710,O
NSCLC,711,716,B-Pathological_formation
(,717,718,O
43,718,720,O
cases,721,726,O
of,727,729,O
squamous,730,738,B-Pathological_formation
cell,739,743,I-Pathological_formation
carcinoma,744,753,I-Pathological_formation
[,754,755,O
SCC,755,758,B-Pathological_formation
],758,759,O
",",759,760,O
67,761,763,O
cases,764,769,O
of,770,772,O
adenocarcinoma,773,787,B-Pathological_formation
[,788,789,O
AD,789,791,B-Pathological_formation
],791,792,O
",",792,793,O
12,794,796,O
cases,797,802,O
of,803,805,O
large,806,811,B-Pathological_formation
cell,812,816,I-Pathological_formation
carcinoma,817,826,I-Pathological_formation
[,827,828,O
LCC,828,831,B-Pathological_formation
],831,832,O
",",832,833,O
and,834,837,O
5,838,839,O
cases,840,845,O
of,846,848,O
lymphoepithelioma,849,866,B-Pathological_formation
-,866,867,I-Pathological_formation
like,867,871,I-Pathological_formation
carcinoma,872,881,I-Pathological_formation
[,882,883,O
LE,883,885,B-Pathological_formation
],885,886,O
),886,887,O
were,888,892,O
included,893,901,O
.,901,902,O
A,903,904,O
sensitive,905,914,O
polymerase,915,925,O
chain,926,931,O
reaction,932,940,O
-,940,941,O
derived,941,948,O
",",948,949,O
digoxigenin,950,961,O
-,961,962,O
labeled,962,969,O
DNA,970,973,O
probe,974,979,O
for,980,983,O
in,984,986,O
situ,987,991,O
detection,992,1001,O
of,1002,1004,O
EBER1,1005,1010,O
transcripts,1011,1022,O
was,1023,1026,O
performed,1027,1036,O
for,1037,1040,O
the,1041,1044,O
detection,1045,1054,O
of,1055,1057,O
EBV,1058,1061,O
.,1061,1062,O
Immunohistochemistry,1063,1083,O
using,1084,1089,O
the,1090,1093,O
avidin,1094,1100,O
-,1100,1101,O
biotin,1101,1107,O
-,1107,1108,O
immunoperoxidase,1108,1124,O
method,1125,1131,O
was,1132,1135,O
also,1136,1140,O
performed,1141,1150,O
to,1151,1153,O
evaluate,1154,1162,O
the,1163,1166,O
expression,1167,1177,O
of,1178,1180,O
bcl,1181,1184,O
-,1184,1185,O
2,1185,1186,O
and,1187,1190,O
LMP,1191,1194,O
-,1194,1195,O
1,1195,1196,O
.,1196,1197,O
RESULTS,1198,1205,O
:,1205,1206,O
EBER1,1207,1212,O
was,1213,1216,O
detected,1217,1225,O
in,1226,1228,O
11,1229,1231,O
of,1232,1234,O
the,1235,1238,O
127,1239,1242,O
NSCLC,1243,1248,B-Pathological_formation
cases,1249,1254,O
(,1255,1256,O
8,1256,1257,O
.,1257,1258,O
7,1258,1259,O
%,1259,1260,O
;,1260,1261,O
6,1262,1263,O
SCC,1264,1267,B-Pathological_formation
cases,1268,1273,O
and,1274,1277,O
5,1278,1279,O
LE,1280,1282,B-Pathological_formation
cases,1283,1288,O
),1288,1289,O
.,1289,1290,O
All,1291,1294,O
5,1295,1296,O
LE,1297,1299,B-Pathological_formation
cases,1300,1305,O
were,1306,1310,O
EBV,1311,1314,O
-,1314,1315,O
positive,1315,1323,O
",",1323,1324,O
whereas,1325,1332,O
only,1333,1337,O
6,1338,1339,O
of,1340,1342,O
the,1343,1346,O
43,1347,1349,O
SCC,1350,1353,B-Pathological_formation
cases,1354,1359,O
(,1360,1361,O
14,1361,1363,O
%,1363,1364,O
),1364,1365,O
",",1365,1366,O
0,1367,1368,O
of,1369,1371,O
67,1372,1374,O
AD,1375,1377,B-Pathological_formation
cases,1378,1383,O
",",1383,1384,O
and,1385,1388,O
12,1389,1391,O
LCC,1392,1395,B-Pathological_formation
cases,1396,1401,O
were,1402,1406,O
EBV,1407,1410,O
-,1410,1411,O
positive,1411,1419,O
(,1420,1421,O
P,1421,1422,O
<,1423,1424,O
0,1425,1426,O
.,1426,1427,O
05,1427,1429,O
),1429,1430,O
.,1430,1431,O
All,1432,1435,O
five,1436,1440,O
LE,1441,1443,B-Pathological_formation
cases,1444,1449,O
showed,1450,1456,O
diffuse,1457,1464,O
",",1464,1465,O
strong,1466,1472,O
",",1472,1473,O
positive,1474,1482,O
staining,1483,1491,O
of,1492,1494,O
tumor,1495,1500,B-Cell
cells,1501,1506,I-Cell
;,1506,1507,O
five,1508,1512,O
of,1513,1515,O
the,1516,1519,O
six,1520,1523,O
SCC,1524,1527,B-Pathological_formation
cases,1528,1533,O
showed,1534,1540,O
diffuse,1541,1548,O
but,1549,1552,O
weak,1553,1557,O
staining,1558,1566,O
.,1566,1567,O
Among,1568,1573,O
the,1574,1577,O
nontumor,1578,1586,B-Cell
epithelial,1587,1597,I-Cell
cells,1598,1603,I-Cell
",",1603,1604,O
there,1605,1610,O
was,1611,1614,O
no,1615,1617,O
EBER1,1618,1623,O
staining,1624,1632,O
of,1633,1635,O
any,1636,1639,O
of,1640,1642,O
the,1643,1646,O
11,1647,1649,O
EBER1,1650,1655,O
-,1655,1656,O
positive,1656,1664,O
cases,1665,1670,O
.,1670,1671,O
The,1672,1675,O
mean,1676,1680,O
age,1681,1684,O
of,1685,1687,O
the,1688,1691,O
LE,1692,1694,B-Pathological_formation
patients,1695,1703,O
was,1704,1707,O
10,1708,1710,O
years,1711,1716,O
younger,1717,1724,O
than,1725,1729,O
that,1730,1734,O
of,1735,1737,O
the,1738,1741,O
patients,1742,1750,O
with,1751,1755,O
other,1756,1761,O
histological,1762,1774,O
types,1775,1780,O
.,1780,1781,O
All,1782,1785,O
5,1786,1787,O
LE,1788,1790,B-Pathological_formation
patients,1791,1799,O
were,1800,1804,O
nonsmokers,1805,1815,O
",",1815,1816,O
whereas,1817,1824,O
3,1825,1826,O
of,1827,1829,O
the,1830,1833,O
6,1834,1835,O
patients,1836,1844,O
with,1845,1849,O
EBER1,1850,1855,O
-,1855,1856,O
positive,1856,1864,O
SCC,1865,1868,B-Pathological_formation
(,1869,1870,O
50,1870,1872,O
%,1872,1873,O
),1873,1874,O
were,1875,1879,O
smokers,1880,1887,O
.,1887,1888,O
EBER1,1889,1894,O
expression,1895,1905,O
did,1906,1909,O
not,1910,1913,O
correlate,1914,1923,O
with,1924,1928,O
the,1929,1932,O
2,1933,1934,O
-,1934,1935,O
year,1935,1939,O
survival,1940,1948,O
rate,1949,1953,O
of,1954,1956,O
overall,1957,1964,O
cases,1965,1970,O
",",1970,1971,O
but,1972,1975,O
all,1976,1979,O
5,1980,1981,O
LE,1982,1984,B-Pathological_formation
patients,1985,1993,O
were,1994,1998,O
alive,1999,2004,O
without,2005,2012,O
clinical,2013,2021,O
evidence,2022,2030,O
of,2031,2033,O
disease,2034,2041,O
at,2042,2044,O
last,2045,2049,O
follow,2050,2056,O
-,2056,2057,O
up,2057,2059,O
.,2059,2060,O
Gender,2061,2067,O
",",2067,2068,O
lymph,2069,2074,B-Multi-tissue_structure
node,2075,2079,I-Multi-tissue_structure
or,2080,2082,O
distant,2083,2090,O
metastasis,2091,2101,O
",",2101,2102,O
and,2103,2106,O
clinical,2107,2115,O
stage,2116,2121,O
were,2122,2126,O
not,2127,2130,O
found,2131,2136,O
to,2137,2139,O
have,2140,2144,O
any,2145,2148,O
correlation,2149,2160,O
with,2161,2165,O
EBER1,2166,2171,O
expression,2172,2182,O
(,2183,2184,O
P,2184,2185,O
>,2186,2187,O
0,2188,2189,O
.,2189,2190,O
05,2190,2192,O
),2192,2193,O
.,2193,2194,O
All,2195,2198,O
LE,2199,2201,B-Pathological_formation
cases,2202,2207,O
had,2208,2211,O
bcl,2212,2215,O
-,2215,2216,O
2,2216,2217,O
oncoprotein,2218,2229,O
expression,2230,2240,O
(,2241,2242,O
100,2242,2245,O
%,2245,2246,O
),2246,2247,O
.,2247,2248,O
This,2249,2253,O
frequency,2254,2263,O
was,2264,2267,O
significantly,2268,2281,O
different,2282,2291,O
from,2292,2296,O
other,2297,2302,O
histologic,2303,2313,O
types,2314,2319,O
(,2320,2321,O
P,2321,2322,O
<,2323,2324,O
0,2325,2326,O
.,2326,2327,O
05,2327,2329,O
),2329,2330,O
.,2330,2331,O
The,2332,2335,O
LMP,2336,2339,O
-,2339,2340,O
1,2340,2341,O
detection,2342,2351,O
rate,2352,2356,O
was,2357,2360,O
low,2361,2364,O
and,2365,2368,O
demonstrated,2369,2381,O
no,2382,2384,O
correlation,2385,2396,O
with,2397,2401,O
bcl,2402,2405,O
-,2405,2406,O
2,2406,2407,O
expression,2408,2418,O
.,2418,2419,O
CONCLUSIONS,2420,2431,O
:,2431,2432,O
In,2433,2435,O
this,2436,2440,O
study,2441,2446,O
",",2446,2447,O
the,2448,2451,O
authors,2452,2459,O
found,2460,2465,O
that,2466,2470,O
the,2471,2474,O
primary,2475,2482,O
LE,2483,2485,B-Pathological_formation
of,2486,2488,O
the,2489,2492,O
lung,2493,2497,B-Organ
is,2498,2500,O
associated,2501,2511,O
with,2512,2516,O
young,2517,2522,O
age,2523,2526,O
",",2526,2527,O
a,2528,2529,O
history,2530,2537,O
of,2538,2540,O
not,2541,2544,O
smoking,2545,2552,O
",",2552,2553,O
high,2554,2558,O
bcl,2559,2562,O
-,2562,2563,O
2,2563,2564,O
immunoreactivity,2565,2581,O
",",2581,2582,O
and,2583,2586,O
better,2587,2593,O
survival,2594,2602,O
rate,2603,2607,O
.,2607,2608,O
These,2609,2614,O
characteristics,2615,2630,O
demonstrate,2631,2642,O
that,2643,2647,O
EBV,2648,2651,O
-,2651,2652,O
associated,2652,2662,O
LE,2663,2665,B-Pathological_formation
of,2666,2668,O
the,2669,2672,O
lung,2673,2677,B-Organ
is,2678,2680,O
a,2681,2682,O
unique,2683,2689,O
entity,2690,2696,O
.,2696,2697,O
The,2698,2701,O
findings,2702,2710,O
of,2711,2713,O
the,2714,2717,O
current,2718,2725,O
study,2726,2731,O
suggest,2732,2739,O
that,2740,2744,O
EBV,2745,2748,O
infection,2749,2758,O
may,2759,2762,O
play,2763,2767,O
a,2768,2769,O
different,2770,2779,O
role,2780,2784,O
in,2785,2787,O
the,2788,2791,O
tumorigenesis,2792,2805,O
of,2806,2808,O
primary,2809,2816,O
LE,2817,2819,B-Pathological_formation
of,2820,2822,O
the,2823,2826,O
lung,2827,2831,B-Organ
than,2832,2836,O
it,2837,2839,O
does,2840,2844,O
in,2845,2847,O
other,2848,2853,O
EBER1,2854,2859,B-Pathological_formation
-,2859,2860,I-Pathological_formation
positive,2860,2868,I-Pathological_formation
NSCLCs,2869,2875,I-Pathological_formation
.,2875,2876,O
Antisocial,0,10,O
patients,11,19,O
:,19,20,O
a,21,22,O
comparison,23,33,O
of,34,36,O
those,37,42,O
with,43,47,O
and,48,51,O
those,52,57,O
without,58,65,O
childhood,66,75,O
conduct,76,83,O
disorder,84,92,O
.,92,93,O
The,94,97,O
purpose,98,105,O
of,106,108,O
this,109,113,O
study,114,119,O
was,120,123,O
to,124,126,O
compare,127,134,O
persons,135,142,O
with,143,147,O
antisocial,148,158,O
personality,159,170,O
disorder,171,179,O
(,180,181,O
ASP,181,184,O
),184,185,O
with,186,190,O
those,191,196,O
who,197,200,O
meet,201,205,O
the,206,209,O
adult,210,215,O
criteria,216,224,O
for,225,228,O
ASP,229,232,O
but,233,236,O
fail,237,241,O
to,242,244,O
meet,245,249,O
the,250,253,O
criteria,254,262,O
for,263,266,O
childhood,267,276,O
conduct,277,284,O
disorder,285,293,O
.,293,294,O
Sociodemographic,295,311,O
data,312,316,O
",",316,317,O
medical,318,325,O
history,326,333,O
",",333,334,O
and,335,338,O
psychiatric,339,350,O
symptoms,351,359,O
exhibited,360,369,O
during,370,376,O
a,377,378,O
recent,379,385,O
hospital,386,394,O
admission,395,404,O
were,405,409,O
compared,410,418,O
in,419,421,O
the,422,425,O
two,426,429,O
groups,430,436,O
by,437,439,O
chart,440,445,O
review,446,452,O
.,452,453,O
The,454,457,O
two,458,461,O
groups,462,468,O
were,469,473,O
virtually,474,483,O
indistinguishable,484,501,O
",",501,502,O
except,503,509,O
that,510,514,O
patients,515,523,O
without,524,531,O
childhood,532,541,O
conduct,542,549,O
disorder,550,558,O
were,559,563,O
less,564,568,O
likely,569,575,O
to,576,578,O
smoke,579,584,O
or,585,587,O
consume,588,595,O
alcohol,596,603,O
",",603,604,O
were,605,609,O
less,610,614,O
likely,615,621,O
to,622,624,O
have,625,629,O
spent,630,635,O
time,636,640,O
in,641,643,O
a,644,645,O
training,646,654,O
school,655,661,O
/,661,662,O
boot,662,666,O
camp,667,671,O
as,672,674,O
a,675,676,O
child,677,682,O
or,683,685,O
adolescent,686,696,O
",",696,697,O
were,698,702,O
less,703,707,O
likely,708,714,O
to,715,717,O
have,718,722,O
been,723,727,O
admitted,728,736,O
for,737,740,O
a,741,742,O
recent,743,749,O
suicide,750,757,O
attempt,758,765,O
",",765,766,O
and,767,770,O
were,771,775,O
less,776,780,O
likely,781,787,O
to,788,790,O
have,791,795,O
conned,796,802,O
others,803,809,O
.,809,810,O
We,811,813,O
conclude,814,822,O
that,823,827,O
persons,828,835,O
meeting,836,843,O
the,844,847,O
adult,848,853,O
criteria,854,862,O
for,863,866,O
ASP,867,870,O
but,871,874,O
not,875,878,O
the,879,882,O
childhood,883,892,O
conduct,893,900,O
disorder,901,909,O
criteria,910,918,O
essentially,919,930,O
suffer,931,937,O
the,938,941,O
same,942,946,O
disorder,947,955,O
as,956,958,O
those,959,964,O
who,965,968,O
meet,969,973,O
full,974,978,O
ASP,979,982,O
criteria,983,991,O
but,992,995,O
are,996,999,O
less,1000,1004,O
severely,1005,1013,O
affected,1014,1022,O
.,1022,1023,O
Brainstem,0,9,B-Multi-tissue_structure
auditory,10,18,O
-,18,19,O
evoked,19,25,O
potential,26,35,O
evaluation,36,46,O
in,47,49,O
children,50,58,O
with,59,63,O
meningitis,64,74,O
.,74,75,O
Brainstem,76,85,B-Multi-tissue_structure
auditory,86,94,O
-,94,95,O
evoked,95,101,O
potential,102,111,O
(,112,113,O
BAEP,113,117,O
),117,118,O
was,119,122,O
performed,123,132,O
on,133,135,O
101,136,139,O
children,140,148,O
with,149,153,O
meningitis,154,164,O
to,165,167,O
assess,168,174,O
the,175,178,O
incidence,179,188,O
of,189,191,O
hearing,192,199,O
impairment,200,210,O
.,210,211,O
Fifty,212,217,O
-,217,218,O
two,218,221,O
(,222,223,O
51,223,225,O
.,225,226,O
5,226,227,O
%,227,228,O
),228,229,O
children,230,238,O
had,239,242,O
bacterial,243,252,O
meningitis,253,263,O
",",263,264,O
six,265,268,O
(,269,270,O
5,270,271,O
.,271,272,O
9,272,273,O
%,273,274,O
),274,275,O
had,276,279,O
viral,280,285,O
meningitis,286,296,O
",",296,297,O
and,298,301,O
43,302,304,O
(,305,306,O
42,306,308,O
.,308,309,O
6,309,310,O
%,310,311,O
),311,312,O
had,313,316,O
aseptic,317,324,O
meningitis,325,335,O
.,335,336,O
Fifty,337,342,O
-,342,343,O
one,343,346,O
(,347,348,O
50,348,350,O
.,350,351,O
5,351,352,O
%,352,353,O
),353,354,O
patients,355,363,O
were,364,368,O
assessed,369,377,O
before,378,384,O
discharge,385,394,O
and,395,398,O
50,399,401,O
(,402,403,O
49,403,405,O
.,405,406,O
5,406,407,O
%,407,408,O
),408,409,O
9,410,411,O
days,412,416,O
to,417,419,O
17,420,422,O
months,423,429,O
later,430,435,O
(,436,437,O
mean,437,441,O
=,442,443,O
4,444,445,O
months,446,452,O
),452,453,O
.,453,454,O
BAEP,455,459,O
impairment,460,470,O
was,471,474,O
found,475,480,O
in,481,483,O
28,484,486,O
(,487,488,O
27,488,490,O
.,490,491,O
7,491,492,O
%,492,493,O
),493,494,O
of,495,497,O
101,498,501,O
patients,502,510,O
;,510,511,O
24,512,514,O
had,515,518,O
sensorineural,519,532,O
and,533,536,O
four,537,541,O
had,542,545,O
conductive,546,556,O
type,557,561,O
of,562,564,O
hearing,565,572,O
loss,573,577,O
",",577,578,O
and,579,582,O
17,583,585,O
(,586,587,O
60,587,589,O
.,589,590,O
7,590,591,O
%,591,592,O
),592,593,O
had,594,597,O
unilateral,598,608,O
and,609,612,O
11,613,615,O
(,616,617,O
39,617,619,O
.,619,620,O
3,620,621,O
%,621,622,O
),622,623,O
had,624,627,O
bilateral,628,637,O
impairment,638,648,O
.,648,649,O
Hearing,650,657,O
threshold,658,667,O
was,668,671,O
elevated,672,680,O
in,681,683,O
22,684,686,O
(,687,688,O
21,688,690,O
.,690,691,O
8,691,692,O
%,692,693,O
),693,694,O
patients,695,703,O
",",703,704,O
and,705,708,O
the,709,712,O
other,713,718,O
six,719,722,O
had,723,726,O
increased,727,736,O
latency,737,744,O
and,745,748,O
interpeak,749,758,O
latencies,759,768,O
with,769,773,O
normal,774,780,O
threshold,781,790,O
.,790,791,O
Frequency,792,801,O
of,802,804,O
BAEP,805,809,O
impairment,810,820,O
or,821,823,O
hearing,824,831,O
loss,832,836,O
associated,837,847,O
with,848,852,O
bacterial,853,862,O
meningitis,863,873,O
was,874,877,O
34,878,880,O
.,880,881,O
6,881,882,O
%,882,883,O
and,884,887,O
30,888,890,O
.,890,891,O
8,891,892,O
%,892,893,O
",",893,894,O
respectively,895,907,O
;,907,908,O
frequency,909,918,O
associated,919,929,O
with,930,934,O
aseptic,935,942,O
meningitis,943,953,O
was,954,957,O
20,958,960,O
.,960,961,O
9,961,962,O
%,962,963,O
and,964,967,O
13,968,970,O
.,970,971,O
9,971,972,O
%,972,973,O
",",973,974,O
respectively,975,987,O
.,987,988,O
One,989,992,O
child,993,998,O
with,999,1003,O
viral,1004,1009,O
meningitis,1010,1020,O
(,1021,1022,O
coxsackie,1022,1031,O
virus,1032,1037,O
),1037,1038,O
had,1039,1042,O
mild,1043,1047,O
BAEP,1048,1052,O
impairment,1053,1063,O
.,1063,1064,O
Most,1065,1069,O
of,1070,1072,O
the,1073,1076,O
BAEP,1077,1081,O
impairment,1082,1092,O
in,1093,1095,O
the,1096,1099,O
bacterial,1100,1109,O
meningitis,1110,1120,O
group,1121,1126,O
was,1127,1130,O
associated,1131,1141,O
with,1142,1146,O
H,1147,1148,O
.,1148,1149,O
influenzae,1150,1160,O
.,1160,1161,O
Prospective,1162,1173,O
BAEP,1174,1178,O
study,1179,1184,O
was,1185,1188,O
performed,1189,1198,O
in,1199,1201,O
20,1202,1204,O
patients,1205,1213,O
randomly,1214,1222,O
at,1223,1225,O
0,1226,1227,O
.,1227,1228,O
3,1228,1229,O
to,1230,1232,O
18,1233,1235,O
months,1236,1242,O
to,1243,1245,O
assess,1246,1252,O
hearing,1253,1260,O
status,1261,1267,O
after,1268,1273,O
antibiotic,1274,1284,O
treatment,1285,1294,O
",",1294,1295,O
10,1296,1298,O
with,1299,1303,O
normal,1304,1310,O
and,1311,1314,O
10,1315,1317,O
with,1318,1322,O
abnormal,1323,1331,O
BAEP,1332,1336,O
.,1336,1337,O
All,1338,1341,O
the,1342,1345,O
initially,1346,1355,O
normal,1356,1362,O
BAEP,1363,1367,O
patients,1368,1376,O
remained,1377,1385,O
normal,1386,1392,O
.,1392,1393,O
Of,1394,1396,O
the,1397,1400,O
10,1401,1403,O
patients,1404,1412,O
with,1413,1417,O
abnormal,1418,1426,O
BAEP,1427,1431,O
results,1432,1439,O
initially,1440,1449,O
",",1449,1450,O
four,1451,1455,O
returned,1456,1464,O
to,1465,1467,O
normal,1468,1474,O
",",1474,1475,O
two,1476,1479,O
improved,1480,1488,O
",",1488,1489,O
three,1490,1495,O
remained,1496,1504,O
unchanged,1505,1514,O
",",1514,1515,O
and,1516,1519,O
one,1520,1523,O
deteriorated,1524,1536,O
.,1536,1537,O
The,1538,1541,O
incidence,1542,1551,O
of,1552,1554,O
hearing,1555,1562,O
loss,1563,1567,O
after,1568,1573,O
bacterial,1574,1583,O
and,1584,1587,O
aseptic,1588,1595,O
meningitis,1596,1606,O
is,1607,1609,O
high,1610,1614,O
.,1614,1615,O
BAEP,1616,1620,O
is,1621,1623,O
useful,1624,1630,O
to,1631,1633,O
screen,1634,1640,O
for,1641,1644,O
possible,1645,1653,O
hearing,1654,1661,O
loss,1662,1666,O
in,1667,1669,O
children,1670,1678,O
with,1679,1683,O
meningitis,1684,1694,O
",",1694,1695,O
and,1696,1699,O
follow,1700,1706,O
-,1706,1707,O
up,1707,1709,O
BAEP,1710,1714,O
is,1715,1717,O
necessary,1718,1727,O
for,1728,1731,O
those,1732,1737,O
patients,1738,1746,O
with,1747,1751,O
initially,1752,1761,O
abnormal,1762,1770,O
BAEP,1771,1775,O
.,1775,1776,O
[,0,1,O
The,1,4,O
assessment,5,15,O
of,16,18,O
flow,19,23,O
velocity,24,32,O
in,33,35,O
carotid,36,43,B-Multi-tissue_structure
and,44,47,O
intracranial,48,60,B-Multi-tissue_structure
arteries,61,69,I-Multi-tissue_structure
in,70,72,O
three,73,78,O
different,79,88,O
age,89,92,O
groups,93,99,O
],99,100,O
.,100,101,O
In,102,104,O
this,105,109,O
report,110,116,O
we,117,119,O
assess,120,126,O
the,127,130,O
systolic,131,139,O
maximal,140,147,O
flow,148,152,O
velocity,153,161,O
in,162,164,O
carotid,165,172,B-Multi-tissue_structure
and,173,176,O
intracranial,177,189,B-Multi-tissue_structure
arteries,190,198,I-Multi-tissue_structure
in,199,201,O
191,202,205,O
subjects,206,214,O
with,215,219,O
no,220,222,O
history,223,230,O
of,231,233,O
cerebral,234,242,B-Multi-tissue_structure
vascular,243,251,I-Multi-tissue_structure
disease,252,259,O
in,260,262,O
3,263,264,O
age,265,268,O
groups,269,275,O
:,275,276,O
20,277,279,O
-,279,280,O
40,280,282,O
years,283,288,O
(,289,290,O
1,290,291,O
group,292,297,O
),297,298,O
",",298,299,O
41,300,302,O
-,302,303,O
60,303,305,O
years,306,311,O
(,312,313,O
2,313,314,O
group,315,320,O
),320,321,O
",",321,322,O
and,323,326,O
above,327,332,O
60,333,335,O
years,336,341,O
(,342,343,O
3,343,344,O
group,345,350,O
),350,351,O
.,351,352,O
The,353,356,O
subjects,357,365,O
were,366,370,O
assessed,371,379,O
using,380,385,O
Sonomed,386,393,O
Transcranial,394,406,O
Doppler,407,414,O
Spectrograph,415,427,O
according,428,437,O
to,438,440,O
generally,441,450,O
accepted,451,459,O
principles,460,470,O
.,470,471,O
The,472,475,O
purpose,476,483,O
of,484,486,O
the,487,490,O
study,491,496,O
was,497,500,O
to,501,503,O
establish,504,513,O
the,514,517,O
mean,518,522,O
value,523,528,O
of,529,531,O
maximal,532,539,O
flow,540,544,O
velocity,545,553,O
in,554,556,O
each,557,561,O
particular,562,572,O
artery,573,579,B-Multi-tissue_structure
in,580,582,O
three,583,588,O
age,589,592,O
groups,593,599,O
",",599,600,O
and,601,604,O
to,605,607,O
observe,608,615,O
the,616,619,O
changes,620,627,O
in,628,630,O
this,631,635,O
parameter,636,645,O
with,646,650,O
age,651,654,O
.,654,655,O
The,656,659,O
results,660,667,O
were,668,672,O
analyzed,673,681,O
using,682,687,O
statistical,688,699,O
methods,700,707,O
and,708,711,O
a,712,713,O
significant,714,725,O
decrease,726,734,O
in,735,737,O
blood,738,743,B-Organism_substance
flow,744,748,O
",",748,749,O
Vmax,750,754,O
",",754,755,O
was,756,759,O
found,760,765,O
in,766,768,O
all,769,772,O
investigated,773,785,O
arteries,786,794,B-Multi-tissue_structure
.,794,795,O
A,796,797,O
mean,798,802,O
decrease,803,811,O
of,812,814,O
8,815,816,O
.,816,817,O
02,817,819,O
%,819,820,O
in,821,823,O
flow,824,828,O
velocity,829,837,O
Vmax,838,842,O
was,843,846,O
found,847,852,O
",",852,853,O
when,854,858,O
comparing,859,868,O
groups,869,875,O
2,876,877,O
and,878,881,O
1,882,883,O
",",883,884,O
and,885,888,O
difference,889,899,O
15,900,902,O
.,902,903,O
99,903,905,O
%,905,906,O
comparing,907,916,O
3,917,918,O
and,919,922,O
1,923,924,O
.,924,925,O
(,0,1,O
a,1,2,O
),2,3,O
Schematic,4,13,O
drawing,14,21,O
of,22,24,O
the,25,28,O
magnetic,29,37,O
tweezers,38,46,O
.,46,47,O
A,48,49,O
DNA,50,53,O
molecule,54,62,O
is,63,65,O
attached,66,74,O
at,75,77,O
one,78,81,O
end,82,85,O
to,86,88,O
the,89,92,O
bottom,93,99,O
of,100,102,O
the,103,106,O
flow,107,111,O
cell,112,116,B-Cell
and,117,120,O
at,121,123,O
the,124,127,O
other,128,133,O
end,134,137,O
to,138,140,O
a,141,142,O
magnetic,143,151,O
bead,152,156,O
.,156,157,O
This,158,162,O
molecule,163,171,O
can,172,175,O
be,176,178,O
pulled,179,185,O
and,186,189,O
twisted,190,197,O
using,198,203,O
small,204,209,O
magnets,210,217,O
placed,218,224,O
above,225,230,O
the,231,234,O
flow,235,239,O
cell,240,244,B-Cell
.,244,245,O
The,246,249,O
position,250,258,O
of,259,261,O
the,262,265,O
magnetic,266,274,O
bead,275,279,O
is,280,282,O
measured,283,291,O
using,292,297,O
an,298,300,O
inverted,301,309,O
microscope,310,320,O
placed,321,327,O
beneath,328,335,O
the,336,339,O
flow,340,344,O
cell,345,349,B-Cell
.,349,350,O
The,351,354,O
bead,355,359,O
position,360,368,O
and,369,372,O
thus,373,377,O
the,378,381,O
end,382,385,O
-,385,386,O
to,386,388,O
-,388,389,O
end,389,392,O
distance,393,401,O
of,402,404,O
the,405,408,O
DNA,409,412,O
molecule,413,421,O
is,422,424,O
determined,425,435,O
using,436,441,O
video,442,447,O
microscopy,448,458,O
and,459,462,O
image,463,468,O
analysis,469,477,O
.,477,478,O
(,479,480,O
b,480,481,O
),481,482,O
Extension,483,492,O
of,493,495,O
a,496,497,O
DNA,498,501,O
molecule,502,510,O
versus,511,517,O
the,518,521,O
number,522,528,O
of,529,531,O
turns,532,537,O
applied,538,545,O
by,546,548,O
the,549,552,O
magnets,553,560,O
for,561,564,O
various,565,572,O
stretching,573,583,O
forces,584,590,O
.,590,591,O
At,592,594,O
low,595,598,O
force,599,604,O
",",604,605,O
contraction,606,617,O
of,618,620,O
the,621,624,O
molecule,625,633,O
is,634,636,O
symmetrical,637,648,O
under,649,654,O
positive,655,663,O
and,664,667,O
negative,668,676,O
applied,677,684,O
turns,685,690,O
.,690,691,O
At,692,694,O
higher,695,701,O
force,702,707,O
",",707,708,O
the,709,712,O
molecule,713,721,O
',721,722,O
s,722,723,O
extension,724,733,O
initially,734,743,O
remains,744,751,O
constant,752,760,O
for,761,764,O
positive,765,773,O
applied,774,781,O
turns,782,787,O
.,787,788,O
The,789,792,O
induced,793,800,O
torque,801,807,O
increases,808,817,O
linearly,818,826,O
with,827,831,O
the,832,835,O
number,836,842,O
of,843,845,O
applied,846,853,O
turns,854,859,O
",",859,860,O
as,861,863,O
depicted,864,872,O
in,873,875,O
the,876,879,O
top,880,883,O
graph,884,889,O
until,890,895,O
a,896,897,O
buckling,898,906,O
transition,907,917,O
allows,918,924,O
the,925,928,O
system,929,935,O
to,936,938,O
saturate,939,947,O
its,948,951,O
torsional,952,961,O
constraint,962,972,O
through,973,980,O
the,981,984,O
formation,985,994,O
of,995,997,O
plectonemes,998,1009,B-Cellular_component
.,1009,1010,O
Effect,0,6,O
of,7,9,O
Trail,10,15,O
on,16,18,O
the,19,22,O
expression,23,33,O
of,34,36,O
endogenous,37,47,O
M2,48,50,O
.,50,51,O
(,52,53,O
A,53,54,O
),54,55,O
Effect,56,62,O
of,63,65,O
Trail,66,71,O
on,72,74,O
the,75,78,O
level,79,84,O
of,85,87,O
endogenous,88,98,O
M2,99,101,O
protein,102,109,O
.,109,110,O
The,111,114,O
expression,115,125,O
level,126,131,O
of,132,134,O
endogenous,135,145,O
M2,146,148,O
protein,149,156,O
in,157,159,O
HeLa,160,164,B-Cell
cells,165,170,I-Cell
was,171,174,O
determined,175,185,O
using,186,191,O
western,192,199,O
blot,200,204,O
4,205,206,O
h,207,208,O
following,209,218,O
Trail,219,224,O
(,225,226,O
250,226,229,O
mug,230,233,O
/,233,234,O
ml,234,236,O
),236,237,O
treatment,238,247,O
.,247,248,O
(,249,250,O
B,250,251,O
),251,252,O
Effect,253,259,O
of,260,262,O
Trail,263,268,O
on,269,271,O
the,272,275,O
endogenous,276,286,O
M2,287,289,O
mRNA,290,294,O
.,294,295,O
The,296,299,O
expression,300,310,O
level,311,316,O
of,317,319,O
endogenous,320,330,O
M2,331,333,O
mRNA,334,338,O
in,339,341,O
HeLa,342,346,B-Cell
cells,347,352,I-Cell
was,353,356,O
detected,357,365,O
using,366,371,O
RNase,372,377,O
protection,378,388,O
assay,389,394,O
4,395,396,O
h,397,398,O
following,399,408,O
Trail,409,414,O
(,415,416,O
250,416,419,O
mug,420,423,O
/,423,424,O
ml,424,426,O
),426,427,O
treatment,428,437,O
.,437,438,O
(,439,440,O
C,440,441,O
),441,442,O
Effect,443,449,O
of,450,452,O
Trail,453,458,O
on,459,461,O
the,462,465,O
synthesis,466,475,O
of,476,478,O
endogenous,479,489,O
M2,490,492,O
protein,493,500,O
.,500,501,O
HeLa,502,506,B-Cell
cells,507,512,I-Cell
were,513,517,O
first,518,523,O
treated,524,531,O
with,532,536,O
250,537,540,O
mug,541,544,O
/,544,545,O
ml,545,547,O
Trail,548,553,O
followed,554,562,O
by,563,565,O
pulse,566,571,O
labeling,572,580,O
of,581,583,O
newly,584,589,O
synthesized,590,601,O
proteins,602,610,O
with,611,615,O
[,616,617,O
35S,617,620,O
],620,621,O
methionine,621,631,O
.,631,632,O
M2,633,635,O
protein,636,643,O
was,644,647,O
then,648,652,O
immunoprecipitated,653,671,O
and,672,675,O
separated,676,685,O
by,686,688,O
SDS,689,692,O
-,692,693,O
PAGE,693,697,O
for,698,701,O
autoradiography,702,717,O
as,718,720,O
described,721,730,O
in,731,733,O
Materials,734,743,O
and,744,747,O
Methods,748,755,O
.,755,756,O
The,0,3,O
most,4,8,O
highly,9,15,O
represented,16,27,O
gene,28,32,O
ontology,33,41,O
themes,42,48,O
in,49,51,O
the,52,55,O
neurosphere,56,67,B-Cell
vs,68,70,O
.,70,71,O
differentiated,72,86,B-Cell
cells,87,92,I-Cell
comparison,93,103,O
(,104,105,O
F,105,106,O
-,106,107,O
G,107,108,O
),108,109,O
.,109,110,O
Planning,0,8,O
for,9,12,O
the,13,16,O
Future,17,23,O
:,23,24,O
Disaster,25,33,O
Preparedness,34,46,O
and,47,50,O
Mitigation,51,61,O
It,62,64,O
is,65,67,O
often,68,73,O
believed,74,82,O
that,83,87,O
casualties,88,98,O
from,99,103,O
natural,104,111,O
disasters,112,121,O
are,122,125,O
unavoidable,126,137,O
",",137,138,O
but,139,142,O
this,143,147,O
belief,148,154,O
is,155,157,O
false,158,163,O
[,164,165,O
8,165,166,O
],166,167,O
.,167,168,O
There,169,174,O
are,175,178,O
many,179,183,O
measures,184,192,O
that,193,197,O
can,198,201,O
reduce,202,208,O
morbidity,209,218,O
and,219,222,O
mortality,223,232,O
following,233,242,O
large,243,248,O
and,249,252,O
potentially,253,264,O
catastrophic,265,277,O
flooding,278,286,O
events,287,293,O
[,294,295,O
19,295,297,O
],297,298,O
.,298,299,O
Early,300,305,O
warning,306,313,O
of,314,316,O
impending,317,326,O
floods,327,333,O
and,334,337,O
natural,338,345,O
events,346,352,O
such,353,357,O
as,358,360,O
hurricanes,361,371,O
allows,372,378,O
sufficient,379,389,O
time,390,394,O
for,395,398,O
communities,399,410,O
to,411,413,O
be,414,416,O
evacuated,417,426,O
to,427,429,O
safe,430,434,O
areas,435,440,O
.,440,441,O
Although,442,450,O
Florida,451,458,O
experienced,459,470,O
one,471,474,O
of,475,477,O
the,478,481,O
worst,482,487,O
hurricane,488,497,O
seasons,498,505,O
on,506,508,O
record,509,515,O
in,516,518,O
2004,519,523,O
",",523,524,O
the,525,528,O
number,529,535,O
of,536,538,O
fatalities,539,549,O
was,550,553,O
lower,554,559,O
than,560,564,O
expected,565,573,O
because,574,581,O
of,582,584,O
early,585,590,O
warning,591,598,O
and,599,602,O
evacuation,603,613,O
.,613,614,O
Early,615,620,O
warning,621,628,O
also,629,633,O
provides,634,642,O
sufficient,643,653,O
time,654,658,O
to,659,661,O
prepare,662,669,O
when,670,674,O
evacuation,675,685,O
is,686,688,O
not,689,692,O
possible,693,701,O
.,701,702,O
Hurricane,703,712,O
George,713,719,O
in,720,722,O
1998,723,727,O
caused,728,734,O
widespread,735,745,O
damage,746,752,O
and,753,756,O
several,757,764,O
fatalities,765,775,O
in,776,778,O
the,779,782,O
Dominican,783,792,O
Republic,793,801,O
",",801,802,O
where,803,808,O
residents,809,818,O
were,819,823,O
not,824,827,O
warned,828,834,O
.,834,835,O
In,836,838,O
contrast,839,847,O
",",847,848,O
Cuba,849,853,O
and,854,857,O
Puerto,858,864,O
Rico,865,869,O
experienced,870,881,O
relatively,882,892,O
limited,893,900,O
damage,901,907,O
and,908,911,O
loss,912,916,O
of,917,919,O
life,920,924,O
",",924,925,O
because,926,933,O
preparations,934,946,O
were,947,951,O
made,952,956,O
in,957,959,O
the,960,963,O
hours,964,969,O
before,970,976,O
the,977,980,O
storm,981,986,O
.,986,987,O
Disaster,988,996,O
preparedness,997,1009,O
can,1010,1013,O
also,1014,1018,O
be,1019,1021,O
developed,1022,1031,O
for,1032,1035,O
communities,1036,1047,O
that,1048,1052,O
are,1053,1056,O
regularly,1057,1066,O
exposed,1067,1074,O
to,1075,1077,O
flooding,1078,1086,O
disasters,1087,1096,O
.,1096,1097,O
Cyclone,1098,1105,O
shelters,1106,1114,O
built,1115,1120,O
by,1121,1123,O
the,1124,1127,O
Red,1128,1131,O
Cross,1132,1137,O
in,1138,1140,O
Orissa,1141,1147,O
",",1147,1148,O
India,1149,1154,O
",",1154,1155,O
saved,1156,1161,O
many,1162,1166,O
thousands,1167,1176,O
of,1177,1179,O
lives,1180,1185,O
in,1186,1188,O
1999,1189,1193,O
when,1194,1198,O
two,1199,1202,O
cyclones,1203,1211,O
struck,1212,1218,O
.,1218,1219,O
In,1220,1222,O
the,1223,1226,O
region,1227,1233,O
of,1234,1236,O
the,1237,1240,O
Americas,1241,1249,O
",",1249,1250,O
the,1251,1254,O
Pan,1255,1258,O
American,1259,1267,O
Health,1268,1274,O
Organization,1275,1287,O
has,1288,1291,O
spent,1292,1297,O
many,1298,1302,O
years,1303,1308,O
promoting,1309,1318,O
and,1319,1322,O
integrating,1323,1334,O
disaster,1335,1343,O
preparedness,1344,1356,O
into,1357,1361,O
building,1362,1370,O
health,1371,1377,O
facilities,1378,1388,O
to,1389,1391,O
ensure,1392,1398,O
that,1399,1403,O
medical,1404,1411,O
services,1412,1420,O
needed,1421,1427,O
to,1428,1430,O
treat,1431,1436,O
victims,1437,1444,O
and,1445,1448,O
maintain,1449,1457,O
ongoing,1458,1465,O
care,1466,1470,O
for,1471,1474,O
patients,1475,1483,O
with,1484,1488,O
chronic,1489,1496,O
conditions,1497,1507,O
will,1508,1512,O
not,1513,1516,O
be,1517,1519,O
disrupted,1520,1529,O
by,1530,1532,O
disasters,1533,1542,O
.,1542,1543,O
A,1544,1545,O
recent,1546,1552,O
global,1553,1559,O
-,1559,1560,O
scale,1560,1565,O
review,1566,1572,O
of,1573,1575,O
health,1576,1582,O
risks,1583,1588,O
from,1589,1593,O
flooding,1594,1602,O
highlights,1603,1613,O
that,1614,1618,O
in,1619,1621,O
flood,1622,1627,O
-,1627,1628,O
prone,1628,1633,O
areas,1634,1639,O
",",1639,1640,O
disaster,1641,1649,O
preparedness,1650,1662,O
within,1663,1669,O
the,1670,1673,O
health,1674,1680,O
system,1681,1687,O
as,1688,1690,O
a,1691,1692,O
whole,1693,1698,O
is,1699,1701,O
particularly,1702,1714,O
important,1715,1724,O
[,1725,1726,O
20,1726,1728,O
],1728,1729,O
.,1729,1730,O
In,1731,1733,O
addition,1734,1742,O
to,1743,1745,O
infrastructure,1746,1760,O
and,1761,1764,O
early,1765,1770,O
-,1770,1771,O
warning,1771,1778,O
systems,1779,1786,O
",",1786,1787,O
another,1788,1795,O
key,1796,1799,O
element,1800,1807,O
in,1808,1810,O
disaster,1811,1819,O
preparedness,1820,1832,O
is,1833,1835,O
education,1836,1845,O
and,1846,1849,O
raising,1850,1857,O
awareness,1858,1867,O
about,1868,1873,O
disaster,1874,1882,O
risks,1883,1888,O
and,1889,1892,O
response,1893,1901,O
plans,1902,1907,O
.,1907,1908,O
Had,1909,1912,O
there,1913,1918,O
been,1919,1923,O
greater,1924,1931,O
awareness,1932,1941,O
about,1942,1947,O
the,1948,1951,O
risk,1952,1956,O
of,1957,1959,O
tsunamis,1960,1968,O
",",1968,1969,O
perhaps,1970,1977,O
many,1978,1982,O
lives,1983,1988,O
could,1989,1994,O
have,1995,1999,O
been,2000,2004,O
saved,2005,2010,O
in,2011,2013,O
the,2014,2017,O
South,2018,2023,O
Asian,2024,2029,O
disaster,2030,2038,O
in,2039,2041,O
December,2042,2050,O
2004,2051,2055,O
.,2055,2056,O
Discussion,0,10,O
Among,11,16,O
adolescent,17,27,O
boys,28,32,O
in,33,35,O
Chapaevsk,36,45,O
",",45,46,O
Russia,47,53,O
",",53,54,O
higher,55,61,O
serum,62,67,B-Organism_substance
levels,68,74,O
of,75,77,O
sum,78,81,O
of,82,84,O
dioxin,85,91,O
-,91,92,O
like,92,96,O
compounds,97,106,O
and,107,110,O
sum,111,114,O
of,115,117,O
dioxin,118,124,O
TEQs,125,129,O
were,130,134,O
positively,135,145,O
associated,146,156,O
with,157,161,O
increased,162,171,O
age,172,175,O
",",175,176,O
consumption,177,188,O
of,189,191,O
fish,192,196,O
",",196,197,O
local,198,203,O
meats,204,209,B-Organism_subdivision
other,210,215,O
than,216,220,O
chicken,221,228,O
",",228,229,O
and,230,233,O
inversely,234,243,O
with,244,248,O
weeks,249,254,O
of,255,257,O
gestation,258,267,O
.,267,268,O
The,269,272,O
age,273,276,O
association,277,288,O
was,289,292,O
found,293,298,O
despite,299,306,O
a,307,308,O
narrow,309,315,O
age,316,319,O
range,320,325,O
of,326,328,O
slightly,329,337,O
over,338,342,O
two,343,346,O
years,347,352,O
in,353,355,O
our,356,359,O
study,360,365,O
.,365,366,O
Although,367,375,O
not,376,379,O
statistically,380,393,O
significant,394,405,O
",",405,406,O
the,407,410,O
distance,411,419,O
the,420,423,O
boy,424,427,O
lived,428,433,O
from,434,438,O
the,439,442,O
Khimprom,443,451,O
factory,452,459,O
at,460,462,O
the,463,466,O
time,467,471,O
of,472,474,O
blood,475,480,B-Organism_substance
draw,481,485,O
was,486,489,O
inversely,490,499,O
associated,500,510,O
with,511,515,O
serum,516,521,B-Organism_substance
levels,522,528,O
of,529,531,O
sum,532,535,O
of,536,538,O
dioxin,539,545,O
-,545,546,O
like,546,550,O
compounds,551,560,O
and,561,564,O
sum,565,568,O
of,569,571,O
dioxin,572,578,O
TEQs,579,583,O
.,583,584,O
As,585,587,O
expected,588,596,O
",",596,597,O
serum,598,603,B-Organism_substance
PCBs,604,608,O
",",608,609,O
specifically,610,622,O
PCB,623,626,O
118,627,630,O
",",630,631,O
were,632,636,O
strongly,637,645,O
associated,646,656,O
with,657,661,O
both,662,666,O
sum,667,670,O
of,671,673,O
dioxin,674,680,O
-,680,681,O
like,681,685,O
compounds,686,695,O
and,696,699,O
sum,700,703,O
of,704,706,O
dioxin,707,713,O
TEQs,714,718,O
.,718,719,O
There,720,725,O
was,726,729,O
no,730,732,O
association,733,744,O
between,745,752,O
the,753,756,O
distance,757,765,O
of,766,768,O
the,769,772,O
residence,773,782,O
from,783,787,O
the,788,791,O
Khimprom,792,800,O
plant,801,806,O
during,807,813,O
the,814,817,O
pregnancy,818,827,O
and,828,831,O
subsequent,832,842,O
serum,843,848,B-Organism_substance
dioxin,849,855,O
levels,856,862,O
.,862,863,O
One,864,867,O
potential,868,877,O
explanation,878,889,O
for,890,893,O
the,894,897,O
lack,898,902,O
of,903,905,O
association,906,917,O
may,918,921,O
include,922,929,O
misclassification,930,947,O
of,948,950,O
distance,951,959,O
since,960,965,O
the,966,969,O
mother,970,976,O
was,977,980,O
asked,981,986,O
to,987,989,O
recall,990,996,O
a,997,998,O
time,999,1003,O
period,1004,1010,O
more,1011,1015,O
than,1016,1020,O
14,1021,1023,O
years,1024,1029,O
prior,1030,1035,O
to,1036,1038,O
the,1039,1042,O
study,1043,1048,O
.,1048,1049,O
However,1050,1057,O
",",1057,1058,O
we,1059,1061,O
would,1062,1067,O
expect,1068,1074,O
that,1075,1079,O
the,1080,1083,O
mother,1084,1090,O
would,1091,1096,O
be,1097,1099,O
able,1100,1104,O
to,1105,1107,O
recall,1108,1114,O
residential,1115,1126,O
history,1127,1134,O
at,1135,1137,O
the,1138,1141,O
time,1142,1146,O
of,1147,1149,O
the,1150,1153,O
birth,1154,1159,O
of,1160,1162,O
their,1163,1168,O
son,1169,1172,O
.,1172,1173,O
Mother,1174,1180,O
',1180,1181,O
s,1181,1182,O
self,1183,1187,O
-,1187,1188,O
reported,1188,1196,O
estimates,1197,1206,O
of,1207,1209,O
current,1210,1217,O
residential,1218,1229,O
distance,1230,1238,O
from,1239,1243,O
Khimprom,1244,1252,O
was,1253,1256,O
generally,1257,1266,O
accurate,1267,1275,O
;,1275,1276,O
twenty,1277,1283,O
-,1283,1284,O
one,1284,1287,O
of,1288,1290,O
twenty,1291,1297,O
-,1297,1298,O
nine,1298,1302,O
mothers,1303,1310,O
correctly,1311,1320,O
categorized,1321,1332,O
their,1333,1338,O
current,1339,1346,O
residential,1347,1358,O
distance,1359,1367,O
from,1368,1372,O
the,1373,1376,O
Khimprom,1377,1385,O
plants,1386,1392,O
based,1393,1398,O
on,1399,1401,O
cross,1402,1407,O
-,1407,1408,O
referencing,1408,1419,O
using,1420,1425,O
GIS,1426,1429,O
mapping,1430,1437,O
.,1437,1438,O
Other,1439,1444,O
explanations,1445,1457,O
include,1458,1465,O
that,1466,1470,O
prenatal,1471,1479,O
exposure,1480,1488,O
14,1489,1491,O
or,1492,1494,O
more,1495,1499,O
years,1500,1505,O
prior,1506,1511,O
to,1512,1514,O
the,1515,1518,O
current,1519,1526,O
serum,1527,1532,B-Organism_substance
sample,1533,1539,I-Organism_substance
is,1540,1542,O
not,1543,1546,O
as,1547,1549,O
strong,1550,1556,O
a,1557,1558,O
predictor,1559,1568,O
as,1569,1571,O
are,1572,1575,O
exposures,1576,1585,O
resulting,1586,1595,O
from,1596,1600,O
present,1601,1608,O
residential,1609,1620,O
location,1621,1629,O
.,1629,1630,O
Although,1631,1639,O
there,1640,1645,O
was,1646,1649,O
no,1650,1652,O
association,1653,1664,O
of,1665,1667,O
case,1668,1672,O
status,1673,1679,O
(,1680,1681,O
cryptorchidism,1681,1695,O
or,1696,1698,O
hypospadias,1699,1710,O
),1710,1711,O
with,1712,1716,O
dioxin,1717,1723,O
levels,1724,1730,O
",",1730,1731,O
we,1732,1734,O
did,1735,1738,O
not,1739,1742,O
have,1743,1747,O
sufficient,1748,1758,O
power,1759,1764,O
to,1765,1767,O
definitively,1768,1780,O
assess,1781,1787,O
this,1788,1792,O
relationship,1793,1805,O
.,1805,1806,O
Perinatal,1807,1816,O
history,1817,1824,O
(,1825,1826,O
e,1826,1827,O
.,1827,1828,O
g,1828,1829,O
.,1829,1830,O
weeks,1831,1836,O
of,1837,1839,O
breastfeeding,1840,1853,O
),1853,1854,O
was,1855,1858,O
generally,1859,1868,O
not,1869,1872,O
associated,1873,1883,O
with,1884,1888,O
exposure,1889,1897,O
measures,1898,1906,O
in,1907,1909,O
this,1910,1914,O
population,1915,1925,O
;,1925,1926,O
this,1927,1931,O
may,1932,1935,O
be,1936,1938,O
a,1939,1940,O
function,1941,1949,O
of,1950,1952,O
older,1953,1958,O
age,1959,1962,O
of,1963,1965,O
the,1966,1969,O
children,1970,1978,O
.,1978,1979,O
However,1980,1987,O
",",1987,1988,O
there,1989,1994,O
are,1995,1998,O
limited,1999,2006,O
data,2007,2011,O
on,2012,2014,O
the,2015,2018,O
relationship,2019,2031,O
of,2032,2034,O
perinatal,2035,2044,O
factors,2045,2052,O
with,2053,2057,O
organochlorine,2058,2072,O
exposures,2073,2082,O
in,2083,2085,O
this,2086,2090,O
age,2091,2094,O
group,2095,2100,O
so,2101,2103,O
a,2104,2105,O
null,2106,2110,O
finding,2111,2118,O
is,2119,2121,O
of,2122,2124,O
interest,2125,2133,O
given,2134,2139,O
reports,2140,2147,O
that,2148,2152,O
differences,2153,2164,O
in,2165,2167,O
organochlorine,2168,2182,O
levels,2183,2189,O
among,2190,2195,O
breastfed,2196,2205,O
and,2206,2209,O
non,2210,2213,O
-,2213,2214,O
breastfed,2214,2223,O
are,2224,2227,O
generally,2228,2237,O
no,2238,2240,O
longer,2241,2247,O
discernable,2248,2259,O
by,2260,2262,O
early,2263,2268,O
school,2269,2275,O
age,2276,2279,O
[,2280,2281,O
24,2281,2283,O
",",2283,2284,O
25,2284,2286,O
],2286,2287,O
and,2288,2291,O
",",2291,2292,O
furthermore,2293,2304,O
",",2304,2305,O
that,2306,2310,O
dietary,2311,2318,O
intake,2319,2325,O
after,2326,2331,O
this,2332,2336,O
age,2337,2340,O
contributes,2341,2352,O
significantly,2353,2366,O
to,2367,2369,O
total,2370,2375,O
dioxin,2376,2382,O
intake,2383,2389,O
[,2390,2391,O
26,2391,2393,O
],2393,2394,O
.,2394,2395,O
In,2396,2398,O
prior,2399,2404,O
studies,2405,2412,O
",",2412,2413,O
substantial,2414,2425,O
emphasis,2426,2434,O
has,2435,2438,O
been,2439,2443,O
placed,2444,2450,O
on,2451,2453,O
pre,2454,2457,O
-,2457,2458,O
and,2459,2462,O
early,2463,2468,O
postnatal,2469,2478,O
(,2479,2480,O
via,2480,2483,O
breastfeeding,2484,2497,O
),2497,2498,O
exposures,2499,2508,O
because,2509,2516,O
of,2517,2519,O
particular,2520,2530,O
vulnerability,2531,2544,O
during,2545,2551,O
fetal,2552,2557,B-Developing_anatomical_structure
and,2558,2561,O
early,2562,2567,O
infant,2568,2574,O
development,2575,2586,O
.,2586,2587,O
The,2588,2591,O
exposure,2592,2600,O
risk,2601,2605,O
factors,2606,2613,O
during,2614,2620,O
peri,2621,2625,O
-,2625,2626,O
adolescence,2626,2637,O
",",2637,2638,O
another,2639,2646,O
period,2647,2653,O
of,2654,2656,O
potential,2657,2666,O
developmental,2667,2680,O
vulnerability,2681,2694,O
",",2694,2695,O
has,2696,2699,O
not,2700,2703,O
been,2704,2708,O
studied,2709,2716,O
in,2717,2719,O
-,2719,2720,O
detail,2720,2726,O
",",2726,2727,O
therefore,2728,2737,O
",",2737,2738,O
the,2739,2742,O
identification,2743,2757,O
of,2758,2760,O
exposure,2761,2769,O
risk,2770,2774,O
factors,2775,2782,O
specific,2783,2791,O
to,2792,2794,O
this,2795,2799,O
period,2800,2806,O
will,2807,2811,O
enhance,2812,2819,O
our,2820,2823,O
understanding,2824,2837,O
of,2838,2840,O
this,2841,2845,O
critical,2846,2854,O
period,2855,2861,O
.,2861,2862,O
Although,2863,2871,O
data,2872,2876,O
on,2877,2879,O
levels,2880,2886,O
of,2887,2889,O
PCDD,2890,2894,O
/,2894,2895,O
PCDFs,2895,2900,O
in,2901,2903,O
children,2904,2912,O
is,2913,2915,O
limited,2916,2923,O
",",2923,2924,O
our,2925,2928,O
results,2929,2936,O
suggest,2937,2944,O
that,2945,2949,O
the,2950,2953,O
mean,2954,2958,O
total,2959,2964,O
TEQs,2965,2969,O
among,2970,2975,O
Chapaevsk,2976,2985,O
adolescents,2986,2997,O
were,2998,3002,O
higher,3003,3009,O
than,3010,3014,O
most,3015,3019,O
values,3020,3026,O
previously,3027,3037,O
reported,3038,3046,O
in,3047,3049,O
non,3050,3053,O
-,3053,3054,O
occupationally,3054,3068,O
exposed,3069,3076,O
populations,3077,3088,O
of,3089,3091,O
comparable,3092,3102,O
or,3103,3105,O
even,3106,3110,O
older,3111,3116,O
ages,3117,3121,O
.,3121,3122,O
Figure,3123,3129,O
2,3130,3131,O
shows,3132,3137,O
a,3138,3139,O
comparison,3140,3150,O
of,3151,3153,O
the,3154,3157,O
mean,3158,3162,O
PCDD,3163,3167,O
/,3167,3168,O
PCDFs,3168,3173,O
TEQ,3174,3177,O
levels,3178,3184,O
in,3185,3187,O
Chapaevsk,3188,3197,O
boys,3198,3202,O
with,3203,3207,O
other,3208,3213,O
populations,3214,3225,O
(,3226,3227,O
TEQ,3227,3230,O
from,3231,3235,O
dioxin,3236,3242,O
-,3242,3243,O
like,3243,3247,O
PCBs,3248,3252,O
was,3253,3256,O
not,3257,3260,O
included,3261,3269,O
",",3269,3270,O
since,3271,3276,O
some,3277,3281,O
of,3282,3284,O
these,3285,3290,O
studies,3291,3298,O
did,3299,3302,O
not,3303,3306,O
report,3307,3313,O
them,3314,3318,O
),3318,3319,O
.,3319,3320,O
The,3321,3324,O
mean,3325,3329,O
TEQs,3330,3334,O
of,3335,3337,O
pooled,3338,3344,O
blood,3345,3350,B-Organism_substance
samples,3351,3358,I-Organism_substance
from,3359,3363,O
10,3364,3366,O
year,3367,3371,O
-,3371,3372,O
old,3372,3375,O
German,3376,3382,O
boys,3383,3387,O
in,3388,3390,O
rural,3391,3396,O
and,3397,3400,O
urban,3401,3406,O
settings,3407,3415,O
was,3416,3419,O
8,3420,3421,O
.,3421,3422,O
2,3422,3423,O
pg,3424,3426,O
TEQ,3427,3430,O
/,3430,3431,O
g,3431,3432,O
lipid,3433,3438,O
for,3439,3442,O
an,3443,3445,O
urban,3446,3451,O
industrial,3452,3462,O
area,3463,3467,O
",",3467,3468,O
9,3469,3470,O
.,3470,3471,O
0,3471,3472,O
pg,3473,3475,O
TEQ,3476,3479,O
/,3479,3480,O
g,3480,3481,O
lipid,3482,3487,O
for,3488,3491,O
an,3492,3494,O
industrial,3495,3505,O
area,3506,3510,O
within,3511,3517,O
a,3518,3519,O
rural,3520,3525,O
setting,3526,3533,O
",",3533,3534,O
and,3535,3538,O
10,3539,3541,O
.,3541,3542,O
1,3542,3543,O
pg,3544,3546,O
TEQ,3547,3550,O
/,3550,3551,O
g,3551,3552,O
lipid,3553,3558,O
for,3559,3562,O
a,3563,3564,O
rural,3565,3570,O
area,3571,3575,O
[,3576,3577,O
27,3577,3579,O
],3579,3580,O
.,3580,3581,O
In,3582,3584,O
comparison,3585,3595,O
",",3595,3596,O
the,3597,3600,O
mean,3601,3605,O
TEQ,3606,3609,O
in,3610,3612,O
the,3613,3616,O
Chapevsk,3617,3625,O
boys,3626,3630,O
was,3631,3634,O
19,3635,3637,O
.,3637,3638,O
3,3638,3639,O
pg,3640,3642,O
TEQ,3643,3646,O
/,3646,3647,O
g,3647,3648,O
lipid,3649,3654,O
.,3654,3655,O
With,3656,3660,O
the,3661,3664,O
exception,3665,3674,O
of,3675,3677,O
children,3678,3686,O
described,3687,3696,O
by,3697,3699,O
Wuthe,3700,3705,O
et,3706,3708,O
al,3709,3711,O
.,3711,3712,O
[,3713,3714,O
27,3714,3716,O
],3716,3717,O
",",3717,3718,O
subjects,3719,3727,O
in,3728,3730,O
the,3731,3734,O
other,3735,3740,O
studies,3741,3748,O
in,3749,3751,O
Figure,3752,3758,O
2,3759,3760,O
were,3761,3765,O
significantly,3766,3779,O
older,3780,3785,O
than,3786,3790,O
the,3791,3794,O
Chapaevsk,3795,3804,O
boys,3805,3809,O
.,3809,3810,O
Despite,3811,3818,O
age,3819,3822,O
differences,3823,3834,O
",",3834,3835,O
the,3836,3839,O
mean,3840,3844,O
TEQ,3845,3848,O
in,3849,3851,O
Chapaevsk,3852,3861,O
boys,3862,3866,O
was,3867,3870,O
comparable,3871,3881,O
to,3882,3884,O
or,3885,3887,O
even,3888,3892,O
higher,3893,3899,O
than,3900,3904,O
the,3905,3908,O
mean,3909,3913,O
TEQ,3914,3917,O
in,3918,3920,O
older,3921,3926,O
populations,3927,3938,O
from,3939,3943,O
other,3944,3949,O
countries,3950,3959,O
.,3959,3960,O
For,3961,3964,O
example,3965,3972,O
",",3972,3973,O
they,3974,3978,O
were,3979,3983,O
higher,3984,3990,O
than,3991,3995,O
mean,3996,4000,O
TEQs,4001,4005,O
of,4006,4008,O
18,4009,4011,O
.,4011,4012,O
4,4012,4013,O
pg,4014,4016,O
TEQ,4017,4020,O
/,4020,4021,O
g,4021,4022,O
lipid,4023,4028,O
in,4029,4031,O
adults,4032,4038,O
(,4039,4040,O
40,4040,4042,O
.,4042,4043,O
6,4043,4044,O
years,4045,4050,O
old,4051,4054,O
average,4055,4062,O
),4062,4063,O
from,4064,4068,O
South,4069,4074,O
Germany,4075,4082,O
[,4083,4084,O
27,4084,4086,O
],4086,4087,O
or,4088,4090,O
16,4091,4093,O
.,4093,4094,O
4,4094,4095,O
pg,4096,4098,O
TEQ,4099,4102,O
/,4102,4103,O
g,4103,4104,O
lipid,4105,4110,O
from,4111,4115,O
20,4116,4118,O
year,4119,4123,O
old,4124,4127,O
Japanese,4128,4136,O
women,4137,4142,O
[,4143,4144,O
28,4144,4146,O
],4146,4147,O
or,4148,4150,O
pooled,4151,4157,O
samples,4158,4165,B-Organism_substance
from,4166,4170,O
randomly,4171,4179,O
selected,4180,4188,O
males,4189,4194,O
and,4195,4198,O
females,4199,4206,O
18,4207,4209,O
-,4209,4210,O
69,4210,4212,O
years,4213,4218,O
of,4219,4221,O
age,4222,4225,O
from,4226,4230,O
the,4231,4234,O
Spanish,4235,4242,O
city,4243,4247,O
of,4248,4250,O
Mataro,4251,4257,O
[,4258,4259,O
29,4259,4261,O
],4261,4262,O
",",4262,4263,O
which,4264,4269,O
were,4270,4274,O
12,4275,4277,O
.,4277,4278,O
5,4278,4279,O
and,4280,4283,O
14,4284,4286,O
.,4286,4287,O
7,4287,4288,O
pg,4289,4291,O
TEQ,4292,4295,O
/,4295,4296,O
g,4296,4297,O
lipid,4298,4303,O
respectively,4304,4316,O
.,4316,4317,O
The,4318,4321,O
mean,4322,4326,O
levels,4327,4333,O
in,4334,4336,O
adult,4337,4342,O
female,4343,4349,O
(,4350,4351,O
mean,4351,4355,O
age,4356,4359,O
41,4360,4362,O
years,4363,4368,O
),4368,4369,O
non,4370,4373,O
-,4373,4374,O
factory,4374,4381,O
workers,4382,4389,O
in,4390,4392,O
the,4393,4396,O
Russian,4397,4404,O
city,4405,4409,O
of,4410,4412,O
Shelekhovo,4413,4423,O
were,4424,4428,O
also,4429,4433,O
lower,4434,4439,O
at,4440,4442,O
14,4443,4445,O
.,4445,4446,O
5,4446,4447,O
pg,4448,4450,O
TEQ,4451,4454,O
/,4454,4455,O
g,4455,4456,O
lipid,4457,4462,O
[,4463,4464,O
30,4464,4466,O
],4466,4467,O
.,4467,4468,O
Mean,4469,4473,O
TEQs,4474,4478,O
for,4479,4482,O
the,4483,4486,O
general,4487,4494,O
population,4495,4505,O
(,4506,4507,O
mean,4507,4511,O
age,4512,4515,O
44,4516,4518,O
.,4518,4519,O
2,4519,4520,O
years,4521,4526,O
),4526,4527,O
in,4528,4530,O
Germany,4531,4538,O
",",4538,4539,O
collected,4540,4549,O
in,4550,4552,O
1997,4553,4557,O
-,4557,4558,O
98,4558,4560,O
[,4561,4562,O
31,4562,4564,O
],4564,4565,O
",",4565,4566,O
and,4567,4570,O
median,4571,4577,O
TEQs,4578,4582,O
for,4583,4586,O
long,4587,4591,O
-,4591,4592,O
term,4592,4596,O
workers,4597,4604,O
of,4605,4607,O
pulp,4608,4612,O
and,4613,4616,O
paper,4617,4622,O
mill,4623,4627,O
and,4628,4631,O
non,4632,4635,O
-,4635,4636,O
workers,4636,4643,O
in,4644,4646,O
the,4647,4650,O
U,4651,4652,O
.,4652,4653,O
S,4653,4654,O
.,4654,4655,O
in,4656,4658,O
1996,4659,4663,O
[,4664,4665,O
32,4665,4667,O
],4667,4668,O
were,4669,4673,O
similar,4674,4681,O
to,4682,4684,O
levels,4685,4691,O
found,4692,4697,O
in,4698,4700,O
the,4701,4704,O
Chapaevsk,4705,4714,O
boys,4715,4719,O
.,4719,4720,O
The,4721,4724,O
mean,4725,4729,O
levels,4730,4736,O
in,4737,4739,O
the,4740,4743,O
study,4744,4749,O
in,4750,4752,O
Germany,4753,4760,O
were,4761,4765,O
20,4766,4768,O
.,4768,4769,O
71,4769,4771,O
pg,4772,4774,O
TEQ,4775,4778,O
/,4778,4779,O
g,4779,4780,O
lipid,4781,4786,O
and,4787,4790,O
in,4791,4793,O
the,4794,4797,O
U,4798,4799,O
.,4799,4800,O
S,4800,4801,O
.,4801,4802,O
the,4803,4806,O
median,4807,4813,O
levels,4814,4820,O
were,4821,4825,O
19,4826,4828,O
.,4828,4829,O
1,4829,4830,O
pg,4831,4833,O
TEQ,4834,4837,O
/,4837,4838,O
g,4838,4839,O
lipid,4840,4845,O
for,4846,4849,O
community,4850,4859,O
residents,4860,4869,O
and,4870,4873,O
21,4874,4876,O
.,4876,4877,O
2,4877,4878,O
pg,4879,4881,O
TEQ,4882,4885,O
/,4885,4886,O
g,4886,4887,O
lipid,4888,4893,O
for,4894,4897,O
low,4898,4901,O
exposure,4902,4910,O
workers,4911,4918,O
.,4918,4919,O
Figure,4920,4926,O
2,4927,4928,O
Mean,4929,4933,O
PCDD,4934,4938,O
/,4938,4939,O
PCDFs,4939,4944,O
TEQ,4945,4948,O
levels,4949,4955,O
in,4956,4958,O
Chapaevsk,4959,4968,O
boys,4969,4973,O
in,4974,4976,O
comparison,4977,4987,O
with,4988,4992,O
other,4993,4998,O
populations,4999,5010,O
.,5010,5011,O
Although,5012,5020,O
TCDD,5021,5025,O
was,5026,5029,O
largely,5030,5037,O
below,5038,5043,O
the,5044,5047,O
detection,5048,5057,O
limits,5058,5064,O
in,5065,5067,O
this,5068,5072,O
small,5073,5078,O
pilot,5079,5084,O
sample,5085,5091,B-Organism_substance
",",5091,5092,O
the,5093,5096,O
two,5097,5100,O
boys,5101,5105,O
with,5106,5110,O
detectable,5111,5121,O
values,5122,5128,O
had,5129,5132,O
high,5133,5137,O
TCDD,5138,5142,O
levels,5143,5149,O
(,5150,5151,O
17,5151,5153,O
.,5153,5154,O
9,5154,5155,O
and,5156,5159,O
21,5160,5162,O
.,5162,5163,O
7,5163,5164,O
pg,5165,5167,O
/,5167,5168,O
g,5168,5169,O
lipid,5170,5175,O
),5175,5176,O
",",5176,5177,O
suggesting,5178,5188,O
that,5189,5193,O
exposure,5194,5202,O
for,5203,5206,O
at,5207,5209,O
least,5210,5215,O
some,5216,5220,O
portion,5221,5228,O
of,5229,5231,O
this,5232,5236,O
population,5237,5247,O
is,5248,5250,O
substantially,5251,5264,O
higher,5265,5271,O
than,5272,5276,O
typical,5277,5284,O
of,5285,5287,O
this,5288,5292,O
age,5293,5296,O
group,5297,5302,O
.,5302,5303,O
In,5304,5306,O
comparison,5307,5317,O
",",5317,5318,O
in,5319,5321,O
a,5322,5323,O
cohort,5324,5330,O
of,5331,5333,O
adult,5334,5339,O
(,5340,5341,O
mean,5341,5345,O
age,5346,5349,O
of,5350,5352,O
58,5353,5355,O
years,5356,5361,O
),5361,5362,O
fishermen,5363,5372,O
from,5373,5377,O
a,5378,5379,O
polluted,5380,5388,O
region,5389,5395,O
of,5396,5398,O
Finland,5399,5406,O
",",5406,5407,O
the,5408,5411,O
mean,5412,5416,O
TCDD,5417,5421,O
concentration,5422,5435,O
was,5436,5439,O
19,5440,5442,O
pg,5443,5445,O
/,5445,5446,O
g,5446,5447,O
lipid,5448,5453,O
[,5454,5455,O
33,5455,5457,O
],5457,5458,O
.,5458,5459,O
In,5460,5462,O
adult,5463,5468,O
(,5469,5470,O
mean,5470,5474,O
age,5475,5478,O
of,5479,5481,O
53,5482,5484,O
years,5485,5490,O
),5490,5491,O
residents,5492,5501,O
from,5502,5506,O
Calcasieu,5507,5516,O
Parish,5517,5523,O
",",5523,5524,O
Louisiana,5525,5534,O
",",5534,5535,O
which,5536,5541,O
is,5542,5544,O
near,5545,5549,O
a,5550,5551,O
chemical,5552,5560,O
industrial,5561,5571,O
complex,5572,5579,O
",",5579,5580,O
the,5581,5584,O
mean,5585,5589,O
TCDD,5590,5594,O
level,5595,5600,O
was,5601,5604,O
7,5605,5606,O
.,5606,5607,O
6,5607,5608,O
pg,5609,5611,O
/,5611,5612,O
g,5612,5613,O
lipid,5614,5619,O
[,5620,5621,O
34,5621,5623,O
],5623,5624,O
.,5624,5625,O
Not,5626,5629,O
only,5630,5634,O
were,5635,5639,O
the,5640,5643,O
dioxin,5644,5650,O
levels,5651,5657,O
in,5658,5660,O
these,5661,5666,O
two,5667,5670,O
children,5671,5679,O
higher,5680,5686,O
than,5687,5691,O
those,5692,5697,O
found,5698,5703,O
in,5704,5706,O
these,5707,5712,O
studies,5713,5720,O
",",5720,5721,O
but,5722,5725,O
the,5726,5729,O
adults,5730,5736,O
in,5737,5739,O
the,5740,5743,O
previous,5744,5752,O
studies,5753,5760,O
were,5761,5765,O
several,5766,5773,O
decades,5774,5781,O
older,5782,5787,O
and,5788,5791,O
therefore,5792,5801,O
would,5802,5807,O
be,5808,5810,O
expected,5811,5819,O
to,5820,5822,O
have,5823,5827,O
higher,5828,5834,O
dioxin,5835,5841,O
body,5842,5846,B-Organism_subdivision
burdens,5847,5854,O
than,5855,5859,O
younger,5860,5867,O
children,5868,5876,O
[,5877,5878,O
35,5878,5880,O
],5880,5881,O
.,5881,5882,O
Potential,5883,5892,O
explanations,5893,5905,O
for,5906,5909,O
the,5910,5913,O
large,5914,5919,O
number,5920,5926,O
of,5927,5929,O
non,5930,5933,O
-,5933,5934,O
detectable,5934,5944,O
samples,5945,5952,B-Organism_substance
for,5953,5956,O
TCDD,5957,5961,O
include,5962,5969,O
the,5970,5973,O
small,5974,5979,O
sample,5980,5986,B-Organism_substance
volume,5987,5993,O
and,5994,5997,O
young,5998,6003,O
age,6004,6007,O
of,6008,6010,O
the,6011,6014,O
subjects,6015,6023,O
.,6023,6024,O
In,6025,6027,O
our,6028,6031,O
future,6032,6038,O
studies,6039,6046,O
in,6047,6049,O
this,6050,6054,O
population,6055,6065,O
",",6065,6066,O
we,6067,6069,O
will,6070,6074,O
collect,6075,6082,O
larger,6083,6089,O
volumes,6090,6097,O
of,6098,6100,O
serum,6101,6106,B-Organism_substance
for,6107,6110,O
dioxin,6111,6117,O
analysis,6118,6126,O
.,6126,6127,O
In,6128,6130,O
one,6131,6134,O
of,6135,6137,O
the,6138,6141,O
few,6142,6145,O
studies,6146,6153,O
on,6154,6156,O
dioxin,6157,6163,O
-,6163,6164,O
like,6164,6168,O
compounds,6169,6178,O
in,6179,6181,O
which,6182,6187,O
children,6188,6196,O
were,6197,6201,O
included,6202,6210,O
",",6210,6211,O
Eskenazi,6212,6220,O
and,6221,6224,O
coworkers,6225,6234,O
[,6235,6236,O
36,6236,6238,O
],6238,6239,O
evaluated,6240,6249,O
the,6250,6253,O
relationship,6254,6266,O
between,6267,6274,O
serum,6275,6280,B-Organism_substance
TCDD,6281,6285,O
concentrations,6286,6300,O
and,6301,6304,O
age,6305,6308,O
at,6309,6311,O
exposure,6312,6320,O
of,6321,6323,O
female,6324,6330,O
residents,6331,6340,O
of,6341,6343,O
Seveso,6344,6350,O
",",6350,6351,O
Italy,6352,6357,O
.,6357,6358,O
Residents,6359,6368,O
near,6369,6373,O
the,6374,6377,O
ICMESA,6378,6384,O
chemical,6385,6393,O
plant,6394,6399,O
in,6400,6402,O
Seveso,6403,6409,O
were,6410,6414,O
exposed,6415,6422,O
to,6423,6425,O
some,6426,6430,O
of,6431,6433,O
the,6434,6437,O
highest,6438,6445,O
known,6446,6451,O
residential,6452,6463,O
levels,6464,6470,O
of,6471,6473,O
2,6474,6475,O
",",6475,6476,O
3,6476,6477,O
",",6477,6478,O
7,6478,6479,O
",",6479,6480,O
8,6480,6481,O
-,6481,6482,O
TCDD,6482,6486,O
as,6487,6489,O
a,6490,6491,O
result,6492,6498,O
of,6499,6501,O
an,6502,6504,O
explosion,6505,6514,O
at,6515,6517,O
the,6518,6521,O
plant,6522,6527,O
.,6527,6528,O
Archived,6529,6537,O
serum,6538,6543,B-Organism_substance
collected,6544,6553,O
near,6554,6558,O
the,6559,6562,O
time,6563,6567,O
of,6568,6570,O
the,6571,6574,O
accident,6575,6583,O
was,6584,6587,O
used,6588,6592,O
to,6593,6595,O
measure,6596,6603,O
exposures,6604,6613,O
.,6613,6614,O
Residents,6615,6624,O
closest,6625,6632,O
to,6633,6635,O
the,6636,6639,O
plant,6640,6645,O
had,6646,6649,O
a,6650,6651,O
median,6652,6658,O
2,6659,6660,O
",",6660,6661,O
3,6661,6662,O
",",6662,6663,O
7,6663,6664,O
",",6664,6665,O
8,6665,6666,O
-,6666,6667,O
TCDD,6667,6671,O
level,6672,6677,O
of,6678,6680,O
272,6681,6684,O
ppt,6685,6688,O
(,6689,6690,O
IQR,6690,6693,O
92,6694,6696,O
-,6697,6698,O
883,6699,6702,O
ppt,6703,6706,O
),6706,6707,O
.,6707,6708,O
Residential,6709,6720,O
proximity,6721,6730,O
to,6731,6733,O
the,6734,6737,O
plant,6738,6743,O
and,6744,6747,O
younger,6748,6755,O
age,6756,6759,O
(,6760,6761,O
up,6761,6763,O
to,6764,6766,O
13,6767,6769,O
years,6770,6775,O
old,6776,6779,O
),6779,6780,O
were,6781,6785,O
the,6786,6789,O
strongest,6790,6799,O
predictors,6800,6810,O
of,6811,6813,O
an,6814,6816,O
individual,6817,6827,O
',6827,6828,O
s,6828,6829,O
serum,6830,6835,B-Organism_substance
2,6836,6837,O
",",6837,6838,O
3,6838,6839,O
",",6839,6840,O
7,6840,6841,O
",",6841,6842,O
8,6842,6843,O
-,6843,6844,O
TCDD,6844,6848,O
level,6849,6854,O
.,6854,6855,O
Other,6856,6861,O
predictors,6862,6872,O
included,6873,6881,O
being,6882,6887,O
outdoors,6888,6896,O
at,6897,6899,O
the,6900,6903,O
time,6904,6908,O
of,6909,6911,O
explosion,6912,6921,O
and,6922,6925,O
consumption,6926,6937,O
of,6938,6940,O
homegrown,6941,6950,O
food,6951,6955,O
.,6955,6956,O
The,6957,6960,O
higher,6961,6967,O
levels,6968,6974,O
found,6975,6980,O
in,6981,6983,O
children,6984,6992,O
were,6993,6997,O
most,6998,7002,O
likely,7003,7009,O
a,7010,7011,O
result,7012,7018,O
of,7019,7021,O
increased,7022,7031,O
exposure,7032,7040,O
as,7041,7043,O
a,7044,7045,O
result,7046,7052,O
of,7053,7055,O
activity,7056,7064,O
patterns,7065,7073,O
and,7074,7077,O
a,7078,7079,O
greater,7080,7087,O
proportionate,7088,7101,O
consumption,7102,7113,O
of,7114,7116,O
food,7117,7121,O
",",7121,7122,O
water,7123,7128,O
and,7129,7132,O
air,7133,7136,O
than,7137,7141,O
adults,7142,7148,O
[,7149,7150,O
37,7150,7152,O
],7152,7153,O
.,7153,7154,O
Although,7155,7163,O
the,7164,7167,O
exposure,7168,7176,O
scenario,7177,7185,O
(,7186,7187,O
an,7187,7189,O
acute,7190,7195,O
high,7196,7200,O
exposure,7201,7209,O
event,7210,7215,O
),7215,7216,O
is,7217,7219,O
different,7220,7229,O
than,7230,7234,O
the,7235,7238,O
chronic,7239,7246,O
low,7247,7250,O
/,7250,7251,O
moderate,7251,7259,O
exposure,7260,7268,O
occurring,7269,7278,O
in,7279,7281,O
Chapaevsk,7282,7291,O
",",7291,7292,O
the,7293,7296,O
results,7297,7304,O
from,7305,7309,O
Seveso,7310,7316,O
suggest,7317,7324,O
that,7325,7329,O
children,7330,7338,O
may,7339,7342,O
be,7343,7345,O
at,7346,7348,O
increased,7349,7358,O
risk,7359,7363,O
for,7364,7367,O
high,7368,7372,O
dioxin,7373,7379,O
exposure,7380,7388,O
from,7389,7393,O
environmental,7394,7407,O
contamination,7408,7421,O
.,7421,7422,O
In,7423,7425,O
our,7426,7429,O
study,7430,7435,O
",",7435,7436,O
although,7437,7445,O
distance,7446,7454,O
from,7455,7459,O
the,7460,7463,O
Khimprom,7464,7472,O
plants,7473,7479,O
was,7480,7483,O
a,7484,7485,O
weak,7486,7490,O
predictor,7491,7500,O
of,7501,7503,O
serum,7504,7509,B-Organism_substance
dioxin,7510,7516,O
-,7516,7517,O
like,7517,7521,O
compounds,7522,7531,O
",",7531,7532,O
consumption,7533,7544,O
of,7545,7547,O
local,7548,7553,O
foods,7554,7559,O
(,7560,7561,O
specifically,7561,7573,O
meat,7574,7578,B-Organism_subdivision
and,7579,7582,O
fish,7583,7587,O
),7587,7588,O
",",7588,7589,O
as,7590,7592,O
in,7593,7595,O
the,7596,7599,O
Seveso,7600,7606,O
study,7607,7612,O
",",7612,7613,O
was,7614,7617,O
a,7618,7619,O
strong,7620,7626,O
predictor,7627,7636,O
of,7637,7639,O
sum,7640,7643,O
of,7644,7646,O
dioxin,7647,7653,O
-,7653,7654,O
like,7654,7658,O
compounds,7659,7668,O
and,7669,7672,O
dioxin,7673,7679,O
TEQs,7680,7684,O
.,7684,7685,O
This,7686,7690,O
finding,7691,7698,O
is,7699,7701,O
notable,7702,7709,O
given,7710,7715,O
concerns,7716,7724,O
regarding,7725,7734,O
environmental,7735,7748,O
dioxin,7749,7755,O
contamination,7756,7769,O
in,7770,7772,O
the,7773,7776,O
community,7777,7786,O
and,7787,7790,O
suggests,7791,7799,O
that,7800,7804,O
food,7805,7809,O
may,7810,7813,O
be,7814,7816,O
one,7817,7820,O
of,7821,7823,O
the,7824,7827,O
more,7828,7832,O
",",7832,7833,O
if,7834,7836,O
not,7837,7840,O
most,7841,7845,O
",",7845,7846,O
important,7847,7856,O
routes,7857,7863,O
of,7864,7866,O
environmental,7867,7880,O
contaminant,7881,7892,O
exposure,7893,7901,O
for,7902,7905,O
residents,7906,7915,O
in,7916,7918,O
this,7919,7923,O
setting,7924,7931,O
.,7931,7932,O
In,7933,7935,O
other,7936,7941,O
settings,7942,7950,O
",",7950,7951,O
contaminated,7952,7964,O
food,7965,7969,O
generally,7970,7979,O
contributes,7980,7991,O
much,7992,7996,O
more,7997,8001,O
substantially,8002,8015,O
to,8016,8018,O
human,8019,8024,O
organochlorine,8025,8039,O
burden,8040,8046,O
than,8047,8051,O
air,8052,8055,O
or,8056,8058,O
soil,8059,8063,O
(,8064,8065,O
which,8065,8070,O
may,8071,8074,O
be,8075,8077,O
related,8078,8085,O
to,8086,8088,O
residential,8089,8100,O
proximity,8101,8110,O
to,8111,8113,O
pollutant,8114,8123,O
sources,8124,8131,O
),8131,8132,O
[,8133,8134,O
6,8134,8135,O
],8135,8136,O
.,8136,8137,O
We,8138,8140,O
will,8141,8145,O
investigate,8146,8157,O
this,8158,8162,O
issue,8163,8168,O
in,8169,8171,O
more,8172,8176,O
detail,8177,8183,O
in,8184,8186,O
our,8187,8190,O
ongoing,8191,8198,O
study,8199,8204,O
.,8204,8205,O
Figures,0,7,O
and,8,11,O
Tables,12,18,O
Figure,19,25,O
1,26,27,O
Allergen,28,36,O
and,37,40,O
particle,41,49,O
dose,50,54,O
-,54,55,O
response,55,63,O
experiments,64,75,O
in,76,78,O
BALB,79,83,O
/,83,84,O
cA,84,86,O
and,87,90,O
NIH,91,94,O
mice,95,99,O
Levels,100,106,O
of,107,109,O
serum,110,115,B-Organism_substance
OVA,116,119,O
-,119,120,O
specific,120,128,O
IgE,129,132,O
(,133,134,O
A,134,135,O
",",135,136,O
D,137,138,O
),138,139,O
",",139,140,O
IgG1,141,145,O
(,146,147,O
B,147,148,O
",",148,149,O
E,150,151,O
),151,152,O
and,153,156,O
IgG2a,157,162,O
(,163,164,O
C,164,165,O
",",165,166,O
F,167,168,O
),168,169,O
on,170,172,O
day,173,176,O
26,177,179,O
after,180,185,O
injection,186,195,O
into,196,200,O
one,201,204,O
hind,205,209,B-Organism_subdivision
footpad,210,217,I-Organism_subdivision
of,218,220,O
100,221,224,O
(,225,226,O
open,226,230,O
columns,231,238,O
),238,239,O
",",239,240,O
50,241,243,O
(,244,245,O
gray,245,249,O
),249,250,O
or,251,253,O
10,254,256,O
(,257,258,O
black,258,263,O
),263,264,O
mug,265,268,O
OVA,269,272,O
combined,273,281,O
with,282,286,O
100,287,290,O
",",290,291,O
40,292,294,O
",",294,295,O
10,296,298,O
or,299,301,O
0,302,303,O
mug,304,307,O
PSP,308,311,O
",",311,312,O
or,313,315,O
buffer,316,322,O
(,323,324,O
HBSS,324,328,O
(,329,330,O
hatched,330,337,O
),337,338,O
),338,339,O
",",339,340,O
in,341,343,O
BALB,344,348,O
/,348,349,O
cA,349,351,O
(,352,353,O
A,353,354,O
",",354,355,O
B,356,357,O
",",357,358,O
C,359,360,O
),360,361,O
and,362,365,O
NIH,366,369,O
(,370,371,O
D,371,372,O
",",372,373,O
E,374,375,O
",",375,376,O
F,377,378,O
),378,379,O
mice,380,384,O
.,384,385,O
On,386,388,O
day,389,392,O
21,393,395,O
the,396,399,O
mice,400,404,O
were,405,409,O
boostered,410,419,O
with,420,424,O
the,425,428,O
same,429,433,O
OVA,434,437,O
dose,438,442,O
in,443,445,O
the,446,449,O
footpad,450,457,B-Organism_subdivision
.,457,458,O
The,459,462,O
PSP,463,466,O
-,466,467,O
control,467,474,O
(,475,476,O
"""",476,477,O
PSP,477,480,O
ctr,481,484,O
"""",484,485,O
),485,486,O
group,487,492,O
was,493,496,O
given,497,502,O
100,503,506,O
mug,507,510,O
PSP,511,514,O
on,515,517,O
day,518,521,O
0,522,523,O
",",523,524,O
followed,525,533,O
by,534,536,O
HBSS,537,541,O
injection,542,551,O
on,552,554,O
day,555,558,O
21,559,561,O
(,562,563,O
diamonds,563,571,O
),571,572,O
.,572,573,O
Values,574,580,O
(,581,582,O
arbitrary,582,591,O
units,592,597,O
",",597,598,O
AU,599,601,O
),601,602,O
for,603,606,O
individual,607,617,O
mice,618,622,O
(,623,624,O
circles,624,631,O
),631,632,O
and,633,636,O
median,637,643,O
values,644,650,O
(,651,652,O
columns,652,659,O
),659,660,O
for,661,664,O
groups,665,671,O
of,672,674,O
eight,675,680,O
mice,681,685,O
are,686,689,O
shown,690,695,O
.,695,696,O
Dotted,697,703,O
lines,704,709,O
indicate,710,718,O
the,719,722,O
lower,723,728,O
or,729,731,O
higher,732,738,O
detection,739,748,O
limits,749,755,O
for,756,759,O
the,760,763,O
ELISA,764,769,O
assays,770,776,O
.,776,777,O
Note,778,782,O
different,783,792,O
scales,793,799,O
for,800,803,O
the,804,807,O
two,808,811,O
strains,812,819,O
of,820,822,O
mice,823,827,O
.,827,828,O
Figure,829,835,O
2,836,837,O
The,838,841,O
adjuvant,842,850,O
effect,851,857,O
of,858,860,O
PSP,861,864,O
on,865,867,O
OVA,868,871,O
-,871,872,O
specific,872,880,O
IgE,881,884,O
and,885,888,O
IgG2a,889,894,O
responses,895,904,O
in,905,907,O
different,908,917,O
strains,918,925,O
of,926,928,O
mice,929,933,O
Levels,934,940,O
of,941,943,O
serum,944,949,B-Organism_substance
OVA,950,953,O
-,953,954,O
specific,954,962,O
IgE,963,966,O
(,967,968,O
A,968,969,O
),969,970,O
and,971,974,O
IgG2a,975,980,O
(,981,982,O
B,982,983,O
),983,984,O
on,985,987,O
day,988,991,O
26,992,994,O
after,995,1000,O
injection,1001,1010,O
into,1011,1015,O
one,1016,1019,O
hind,1020,1024,B-Organism_subdivision
footpad,1025,1032,I-Organism_subdivision
of,1033,1035,O
HBSS,1036,1040,O
(,1041,1042,O
open,1042,1046,O
columns,1047,1054,O
),1054,1055,O
",",1055,1056,O
10,1057,1059,O
mug,1060,1063,O
OVA,1064,1067,O
(,1068,1069,O
gray,1069,1073,O
),1073,1074,O
",",1074,1075,O
40,1076,1078,O
mug,1079,1082,O
PSP,1083,1086,O
(,1087,1088,O
hatched,1088,1095,O
),1095,1096,O
or,1097,1099,O
10,1100,1102,O
mug,1103,1106,O
OVA,1107,1110,O
+,1111,1112,O
40,1113,1115,O
mug,1116,1119,O
PSP,1120,1123,O
(,1124,1125,O
black,1125,1130,O
),1130,1131,O
in,1132,1134,O
different,1135,1144,O
mouse,1145,1150,O
strains,1151,1158,O
.,1158,1159,O
On,1160,1162,O
day,1163,1166,O
21,1167,1169,O
all,1170,1173,O
mice,1174,1178,O
were,1179,1183,O
boostered,1184,1193,O
with,1194,1198,O
10,1199,1201,O
mug,1202,1205,O
OVA,1206,1209,O
in,1210,1212,O
the,1213,1216,O
footpad,1217,1224,B-Organism_subdivision
.,1224,1225,O
Vertical,1226,1234,O
straight,1235,1243,O
lines,1244,1249,O
indicate,1250,1258,O
separate,1259,1267,O
experiments,1268,1279,O
.,1279,1280,O
Values,1281,1287,O
(,1288,1289,O
arbitrary,1289,1298,O
units,1299,1304,O
",",1304,1305,O
AU,1306,1308,O
),1308,1309,O
for,1310,1313,O
individual,1314,1324,O
mice,1325,1329,O
(,1330,1331,O
circles,1331,1338,O
),1338,1339,O
and,1340,1343,O
median,1344,1350,O
values,1351,1357,O
(,1358,1359,O
columns,1359,1366,O
),1366,1367,O
for,1368,1371,O
groups,1372,1378,O
of,1379,1381,O
mice,1382,1386,O
are,1387,1390,O
shown,1391,1396,O
.,1396,1397,O
Dotted,1398,1404,O
lines,1405,1410,O
indicate,1411,1419,O
the,1420,1423,O
lower,1424,1429,O
detection,1430,1439,O
limits,1440,1446,O
for,1447,1450,O
the,1451,1454,O
ELISA,1455,1460,O
assays,1461,1467,O
.,1467,1468,O
Brackets,1469,1477,O
indicate,1478,1486,O
statistically,1487,1500,O
significant,1501,1512,O
differences,1513,1524,O
between,1525,1532,O
groups,1533,1539,O
(,1540,1541,O
p,1541,1542,O
<,1543,1544,O
0,1545,1546,O
.,1546,1547,O
05,1547,1549,O
),1549,1550,O
.,1550,1551,O
All,1552,1555,O
experiments,1556,1567,O
were,1568,1572,O
performed,1573,1582,O
twice,1583,1588,O
with,1589,1593,O
similar,1594,1601,O
results,1602,1609,O
",",1609,1610,O
with,1611,1615,O
eight,1616,1621,O
mice,1622,1626,O
per,1627,1630,O
group,1631,1636,O
.,1636,1637,O
Figure,1638,1644,O
3,1645,1646,O
The,1647,1650,O
primary,1651,1658,O
cellular,1659,1667,B-Cell
response,1668,1676,O
in,1677,1679,O
the,1680,1683,O
draining,1684,1692,O
lymph,1693,1698,B-Multi-tissue_structure
node,1699,1703,I-Multi-tissue_structure
The,1704,1707,O
primary,1708,1715,O
cellular,1716,1724,B-Cell
response,1725,1733,O
in,1734,1736,O
the,1737,1740,O
draining,1741,1749,O
PLN,1750,1753,B-Multi-tissue_structure
was,1754,1757,O
determined,1758,1768,O
five,1769,1773,O
days,1774,1778,O
after,1779,1784,O
a,1785,1786,O
single,1787,1793,O
injection,1794,1803,O
of,1804,1806,O
HBSS,1807,1811,O
(,1812,1813,O
open,1813,1817,O
columns,1818,1825,O
),1825,1826,O
",",1826,1827,O
10,1828,1830,O
mug,1831,1834,O
OVA,1835,1838,O
(,1839,1840,O
gray,1840,1844,O
),1844,1845,O
",",1845,1846,O
40,1847,1849,O
mug,1850,1853,O
PSP,1854,1857,O
(,1858,1859,O
hatched,1859,1866,O
),1866,1867,O
or,1868,1870,O
10,1871,1873,O
mug,1874,1877,O
OVA,1878,1881,O
+,1882,1883,O
40,1884,1886,O
mug,1887,1890,O
PSP,1891,1894,O
(,1895,1896,O
black,1896,1901,O
),1901,1902,O
into,1903,1907,O
both,1908,1912,O
hind,1913,1917,O
footpads,1918,1926,O
of,1927,1929,O
BALB,1930,1934,O
/,1934,1935,O
cA,1935,1937,O
",",1937,1938,O
NIH,1939,1942,O
and,1943,1946,O
C3H,1947,1950,O
/,1950,1951,O
HeN,1951,1954,O
mice,1955,1959,O
.,1959,1960,O
The,1961,1964,O
total,1965,1970,O
lymph,1971,1976,B-Cell
node,1977,1981,I-Cell
cell,1982,1986,I-Cell
numbers,1987,1994,O
(,1995,1996,O
A,1996,1997,O
),1997,1998,O
and,1999,2002,O
IL,2003,2005,O
-,2005,2006,O
4,2006,2007,O
(,2008,2009,O
B,2009,2010,O
),2010,2011,O
",",2011,2012,O
IFN,2013,2016,O
-,2016,2017,O
gamma,2017,2022,O
(,2023,2024,O
C,2024,2025,O
),2025,2026,O
and,2027,2030,O
IL,2031,2033,O
-,2033,2034,O
10,2034,2036,O
(,2037,2038,O
D,2038,2039,O
),2039,2040,O
secreted,2041,2049,O
from,2050,2054,O
the,2055,2058,O
PLN,2059,2062,B-Cell
cells,2063,2068,I-Cell
after,2069,2074,O
ex,2075,2077,O
vivo,2078,2082,O
stimulation,2083,2094,O
with,2095,2099,O
Con,2100,2103,O
A,2104,2105,O
were,2106,2110,O
determined,2111,2121,O
.,2121,2122,O
Values,2123,2129,O
for,2130,2133,O
individual,2134,2144,O
samples,2145,2152,B-Cell
(,2153,2154,O
circles,2154,2161,O
),2161,2162,O
and,2163,2166,O
group,2167,2172,O
median,2173,2179,O
values,2180,2186,O
(,2187,2188,O
columns,2188,2195,O
),2195,2196,O
are,2197,2200,O
shown,2201,2206,O
.,2206,2207,O
Dotted,2208,2214,O
lines,2215,2220,O
indicate,2221,2229,O
the,2230,2233,O
lower,2234,2239,O
detection,2240,2249,O
limits,2250,2256,O
for,2257,2260,O
the,2261,2264,O
cytokine,2265,2273,O
ELISA,2274,2279,O
assays,2280,2286,O
",",2286,2287,O
and,2288,2291,O
brackets,2292,2300,O
indicate,2301,2309,O
statistically,2310,2323,O
significant,2324,2335,O
differences,2336,2347,O
between,2348,2355,O
groups,2356,2362,O
(,2363,2364,O
p,2364,2365,O
<,2366,2367,O
0,2368,2369,O
.,2369,2370,O
05,2370,2372,O
),2372,2373,O
.,2373,2374,O
Figures,0,7,O
and,8,11,O
Tables,12,18,O
Stages,19,25,O
in,26,28,O
the,29,32,O
life,33,37,O
cycle,38,43,O
of,44,46,O
Plasmodium,47,57,O
falciparum,58,68,O
(,69,70,O
Illustration,70,82,O
:,82,83,O
Coatney,84,91,O
GR,92,94,O
",",94,95,O
Collins,96,103,O
WE,104,106,O
",",106,107,O
Warren,108,114,O
M,115,116,O
",",116,117,O
Contacos,118,126,O
PG,127,129,O
(,130,131,O
1971,131,135,O
),135,136,O
The,137,140,O
primate,141,148,O
malarias,149,157,O
.,157,158,O
(,159,160,O
Bethesda,160,168,O
),168,169,O
:,169,170,O
U,171,172,O
.,172,173,O
S,173,174,O
.,174,175,O
Department,176,186,O
of,187,189,O
Health,190,196,O
",",196,197,O
Education,198,207,O
and,208,211,O
Welfare,212,219,O
.,219,220,O
),220,221,O
Images,0,6,O
FIGURE,7,13,O
2,14,15,O
.,15,16,O
A,17,18,O
FIGURE,19,25,O
2,26,27,O
.,27,28,O
B,29,30,O
FIGURE,31,37,O
3,38,39,O
.,39,40,O
Supporting,0,10,O
Information,11,22,O
Table,23,28,O
S1,29,31,O
Supplementary,32,45,O
Information,46,57,O
on,58,60,O
Genes,61,66,O
in,67,69,O
the,70,73,O
Three,74,79,O
Gene,80,84,O
Sets,85,89,O
(,90,91,O
219,91,94,O
KB,95,97,O
PDF,98,101,O
),101,102,O
Click,103,108,O
here,109,113,O
for,114,117,O
additional,118,128,O
data,129,133,O
file,134,138,O
.,138,139,O
Table,140,145,O
S2,146,148,O
UFW,149,152,O
Primers,153,160,O
for,161,164,O
Gene,165,169,O
Set,170,173,O
I,174,175,O
(,176,177,O
36,177,179,O
KB,180,182,O
PDF,183,186,O
),186,187,O
Click,188,193,O
here,194,198,O
for,199,202,O
additional,203,213,O
data,214,218,O
file,219,223,O
.,223,224,O
Table,225,230,O
S3,231,233,O
UFW,234,237,O
Primers,238,245,O
for,246,249,O
Gene,250,254,O
Set,255,258,O
II,259,261,O
(,262,263,O
44,263,265,O
KB,266,268,O
PDF,269,272,O
),272,273,O
Click,274,279,O
here,280,284,O
for,285,288,O
additional,289,299,O
data,300,304,O
file,305,309,O
.,309,310,O
Table,311,316,O
S4,317,319,O
UFW,320,323,O
Primers,324,331,O
for,332,335,O
Gene,336,340,O
Set,341,344,O
III,345,348,O
(,349,350,O
31,350,352,O
KB,353,355,O
PDF,356,359,O
),359,360,O
Click,361,366,O
here,367,371,O
for,372,375,O
additional,376,386,O
data,387,391,O
file,392,396,O
.,396,397,O
Table,398,403,O
S5,404,406,O
Transposable,407,419,O
Element,420,427,O
-,427,428,O
Specific,428,436,O
Primers,437,444,O
for,445,448,O
Additional,449,459,O
Screens,460,467,O
(,468,469,O
80,469,471,O
KB,472,474,O
PDF,475,478,O
),478,479,O
Click,480,485,O
here,486,490,O
for,491,494,O
additional,495,505,O
data,506,510,O
file,511,515,O
.,515,516,O
Table,517,522,O
S6,523,525,O
Primers,526,533,O
for,534,537,O
Intergenic,538,548,O
Regions,549,556,O
(,557,558,O
58,558,560,O
KB,561,563,O
PDF,564,567,O
),567,568,O
Click,569,574,O
here,575,579,O
for,580,583,O
additional,584,594,O
data,595,599,O
file,600,604,O
.,604,605,O
Table,606,611,O
S7,612,614,O
P,615,616,O
Element,617,624,O
-,624,625,O
Specific,625,633,O
Primers,634,641,O
for,642,645,O
Orientation,646,657,O
and,658,661,O
Length,662,668,O
Determination,669,682,O
(,683,684,O
299,684,687,O
KB,688,690,O
PDF,691,694,O
),694,695,O
Click,696,701,O
here,702,706,O
for,707,710,O
additional,711,721,O
data,722,726,O
file,727,731,O
.,731,732,O
Background,0,10,O
HIV,11,14,O
-,14,15,O
1,15,16,O
infectivity,17,28,O
depends,29,36,O
on,37,39,O
free,40,44,O
cholesterol,45,56,O
incorporated,57,69,O
into,70,74,O
the,75,78,O
viral,79,84,O
envelope,85,93,B-Cellular_component
.,93,94,O
Here,95,99,O
",",99,100,O
we,101,103,O
analyze,104,111,O
HIV,112,115,O
infectivity,116,127,O
in,128,130,O
the,131,134,O
presence,135,143,O
of,144,146,O
drugs,147,152,O
that,153,157,O
stimulate,158,167,O
cholesterol,168,179,O
efflux,180,186,O
.,186,187,O
Additional,0,10,O
File,11,15,O
1,16,17,O
Appendix,18,26,O
1,27,28,O
.,28,29,O
Indications,30,41,O
for,42,45,O
liver,46,51,B-Organ
function,52,60,O
tests,61,66,O
with,67,71,O
no,72,74,O
obvious,75,82,O
liver,83,88,B-Organ
disease,89,96,O
",",96,97,O
and,98,101,O
consequent,102,112,O
investigations,113,127,O
Representative,0,14,O
PCR,15,18,O
/,18,19,O
LDR,19,22,O
results,23,30,O
for,31,34,O
HPTs,35,39,O
in,40,42,O
fimX,43,47,O
",",47,48,O
BP0059,49,55,O
",",55,56,O
BP0880,57,63,O
",",63,64,O
sphB2,65,70,O
",",70,71,O
ptxA,72,76,O
",",76,77,O
and,78,81,O
bhuR,82,86,O
.,86,87,O
Raw,88,91,O
capillary,92,101,O
electrophoresis,102,117,O
data,118,122,O
for,123,126,O
ligation,127,135,O
products,136,144,O
(,145,146,O
green,146,151,O
),151,152,O
and,153,156,O
molecular,157,166,O
weight,167,173,O
standards,174,183,O
(,184,185,O
red,185,188,O
),188,189,O
displayed,190,199,O
as,200,202,O
if,203,205,O
an,206,208,O
electrophoretic,209,224,O
gel,225,228,O
image,229,234,O
.,234,235,O
Assayed,236,243,O
locus,244,249,O
is,250,252,O
indicated,253,262,O
at,263,265,O
the,266,269,O
top,270,273,O
of,274,276,O
each,277,281,O
panel,282,287,O
;,287,288,O
strain,289,295,O
and,296,299,O
length,300,306,O
of,307,309,O
its,310,313,O
HPT,314,317,O
allele,318,324,O
are,325,328,O
noted,329,334,O
above,335,340,O
each,341,345,O
lane,346,350,O
.,350,351,O
Representative,352,366,O
LDR,367,370,O
results,371,378,O
are,379,382,O
depicted,383,391,O
here,392,396,O
;,396,397,O
for,398,401,O
complete,402,410,O
data,411,415,O
from,416,420,O
all,421,424,O
strains,425,432,O
see,433,436,O
Additional,437,447,O
files,448,453,O
8,454,455,O
",",455,456,O
9,457,458,O
",",458,459,O
10,460,462,O
",",462,463,O
11,464,466,O
",",466,467,O
12,468,470,O
",",470,471,O
and,472,475,O
13,476,478,O
.,478,479,O
BP0880,480,486,O
",",486,487,O
BP0059,488,494,O
",",494,495,O
fimX,496,500,O
",",500,501,O
and,502,505,O
sphB2,506,511,O
HPTs,512,516,O
were,517,521,O
screened,522,530,O
by,531,533,O
uniplex,534,541,O
LDR,542,545,O
reactions,546,555,O
containing,556,566,O
only,567,571,O
the,572,575,O
discriminating,576,590,O
oligonucleotide,591,606,O
that,607,611,O
targets,612,619,O
the,620,623,O
Tohama,624,630,O
I,631,632,O
sequence,633,641,O
.,641,642,O
The,643,646,O
ptxA,647,651,O
and,652,655,O
bhuR,656,660,O
HPTs,661,665,O
were,666,670,O
screened,671,679,O
by,680,682,O
multiplex,683,692,O
reactions,693,702,O
that,703,707,O
contain,708,715,O
all,716,719,O
three,720,725,O
discriminating,726,740,O
oligonucleotides,741,757,O
.,757,758,O
Letters,759,766,O
in,767,769,O
teal,770,774,O
indicate,775,783,O
molecular,784,793,O
weight,794,800,O
standards,801,810,O
as,811,813,O
labeled,814,821,O
in,822,824,O
the,825,828,O
corresponding,829,842,O
supplementary,843,856,O
figures,857,864,O
.,864,865,O
Ligation,866,874,O
products,875,883,O
(,884,885,O
arrows,885,891,O
),891,892,O
are,893,896,O
labeled,897,904,O
using,905,910,O
the,911,914,O
notation,915,923,O
described,924,933,O
in,934,936,O
the,937,940,O
legend,941,947,O
to,948,950,O
Figure,951,957,O
1,958,959,O
.,959,960,O
The,961,964,O
open,965,969,O
arrowhead,970,979,O
indicates,980,989,O
a,990,991,O
synthesis,992,1001,O
artifact,1002,1010,O
in,1011,1013,O
the,1014,1017,O
BP0059,1018,1024,O
common,1025,1031,O
oligonucleotide,1032,1047,O
preparation,1048,1059,O
.,1059,1060,O
INTRODUCTION,0,12,O
Comparing,13,22,O
genomic,23,30,O
sequences,31,40,O
across,41,47,O
related,48,55,O
species,56,63,O
is,64,66,O
a,67,68,O
fruitful,69,77,O
source,78,84,O
of,85,87,O
biological,88,98,O
insight,99,106,O
.,106,107,O
Functional,108,118,O
elements,119,127,O
such,128,132,O
as,133,135,O
exons,136,141,O
tend,142,146,O
to,147,149,O
exhibit,150,157,O
significant,158,169,O
sequence,170,178,O
similarity,179,189,O
due,190,193,O
to,194,196,O
purifying,197,206,O
selection,207,216,O
",",216,217,O
whereas,218,225,O
regions,226,233,O
that,234,238,O
are,239,242,O
not,243,246,O
functional,247,257,O
tend,258,262,O
to,263,265,O
be,266,268,O
neutrally,269,278,O
evolving,279,287,O
and,288,291,O
thus,292,296,O
less,297,301,O
conserved,302,311,O
.,311,312,O
The,313,316,O
first,317,322,O
step,323,327,O
in,328,330,O
comparing,331,340,O
genomic,341,348,O
sequences,349,358,O
is,359,361,O
to,362,364,O
align,365,370,O
them,371,375,O
-,375,376,O
-,376,377,O
to,377,379,O
map,380,383,O
the,384,387,O
letters,388,395,O
of,396,398,O
the,399,402,O
sequences,403,412,O
to,413,415,O
each,416,420,O
other,421,426,O
.,426,427,O
After,428,433,O
an,434,436,O
alignment,437,446,O
is,447,449,O
computed,450,458,O
",",458,459,O
visualization,460,473,O
frameworks,474,484,O
become,485,491,O
essential,492,501,O
to,502,504,O
enable,505,511,O
users,512,517,O
to,518,520,O
interact,521,529,O
with,530,534,O
the,535,538,O
sequence,539,547,O
and,548,551,O
conservation,552,564,O
data,565,569,O
",",569,570,O
especially,571,581,O
in,582,584,O
the,585,588,O
context,589,596,O
of,597,599,O
longer,600,606,O
DNA,607,610,O
sequences,611,620,O
or,621,623,O
whole,624,629,O
genomes,630,637,O
.,637,638,O
Visualization,639,652,O
frameworks,653,663,O
should,664,670,O
be,671,673,O
easy,674,678,O
to,679,681,O
understand,682,692,O
by,693,695,O
a,696,697,O
biologist,698,707,O
and,708,711,O
provide,712,719,O
insight,720,727,O
into,728,732,O
the,733,736,O
mutations,737,746,O
that,747,751,O
a,752,753,O
particular,754,764,O
genomic,765,772,O
locus,773,778,O
has,779,782,O
undergone,783,792,O
.,792,793,O
The,794,797,O
VISTA,798,803,O
portal,804,810,O
is,811,813,O
a,814,815,O
comprehensive,816,829,O
comparative,830,841,O
genomics,842,850,O
resource,851,859,O
that,860,864,O
provides,865,873,O
biomedical,874,884,O
scientists,885,895,O
with,896,900,O
a,901,902,O
single,903,909,O
unified,910,917,O
framework,918,927,O
to,928,930,O
generate,931,939,O
and,940,943,O
download,944,952,O
multiple,953,961,O
sequence,962,970,O
alignments,971,981,O
",",981,982,O
visualize,983,992,O
the,993,996,O
results,997,1004,O
in,1005,1007,O
the,1008,1011,O
context,1012,1019,O
of,1020,1022,O
existing,1023,1031,O
annotations,1032,1043,O
and,1044,1047,O
analyze,1048,1055,O
comparative,1056,1067,O
results,1068,1075,O
in,1076,1078,O
search,1079,1085,O
for,1086,1089,O
important,1090,1099,O
sequence,1100,1108,O
signals,1109,1116,O
in,1117,1119,O
alignments,1120,1130,O
.,1130,1131,O
The,1132,1135,O
VISTA,1136,1141,O
suite,1142,1147,O
of,1148,1150,O
programs,1151,1159,O
has,1160,1163,O
been,1164,1168,O
in,1169,1171,O
development,1172,1183,O
and,1184,1187,O
continued,1188,1197,O
use,1198,1201,O
since,1202,1207,O
2000,1208,1212,O
(,1213,1214,O
1,1214,1215,O
-,1215,1216,O
4,1216,1217,O
),1217,1218,O
.,1218,1219,O
It,1220,1222,O
was,1223,1226,O
originally,1227,1237,O
developed,1238,1247,O
for,1248,1251,O
the,1252,1255,O
alignment,1256,1265,O
and,1266,1269,O
comparative,1270,1281,O
analysis,1282,1290,O
of,1291,1293,O
long,1294,1298,O
genomic,1299,1306,O
sequences,1307,1316,O
and,1317,1320,O
later,1321,1326,O
was,1327,1330,O
expanded,1331,1339,O
to,1340,1342,O
pair,1343,1347,O
-,1347,1348,O
wise,1348,1352,O
and,1353,1356,O
multiple,1357,1365,O
alignment,1366,1375,O
of,1376,1378,O
vertebrate,1379,1389,O
genomes,1390,1397,O
.,1397,1398,O
VISTA,1399,1404,O
has,1405,1408,O
popularized,1409,1420,O
the,1421,1424,O
visualization,1425,1438,O
of,1439,1441,O
the,1442,1445,O
level,1446,1451,O
of,1452,1454,O
conservation,1455,1467,O
in,1468,1470,O
the,1471,1474,O
format,1475,1481,O
of,1482,1484,O
a,1485,1486,O
continuous,1487,1497,O
curve,1498,1503,O
based,1504,1509,O
on,1510,1512,O
the,1513,1516,O
conservation,1517,1529,O
in,1530,1532,O
a,1533,1534,O
sliding,1535,1542,O
window,1543,1549,O
.,1549,1550,O
This,1551,1555,O
concept,1556,1563,O
proved,1564,1570,O
to,1571,1573,O
be,1574,1576,O
extremely,1577,1586,O
successful,1587,1597,O
due,1598,1601,O
to,1602,1604,O
the,1605,1608,O
easy,1609,1613,O
interpretation,1614,1628,O
of,1629,1631,O
the,1632,1635,O
resulting,1636,1645,O
plots,1646,1651,O
.,1651,1652,O
VISTA,1653,1658,O
was,1659,1662,O
built,1663,1668,O
through,1669,1676,O
a,1677,1678,O
close,1679,1684,O
collaboration,1685,1698,O
between,1699,1706,O
computational,1707,1720,O
and,1721,1724,O
biological,1725,1735,O
scientists,1736,1746,O
",",1746,1747,O
resulting,1748,1757,O
in,1758,1760,O
a,1761,1762,O
product,1763,1770,O
that,1771,1775,O
is,1776,1778,O
robust,1779,1785,O
",",1785,1786,O
efficient,1787,1796,O
and,1797,1800,O
powerful,1801,1809,O
",",1809,1810,O
yet,1811,1814,O
simple,1815,1821,O
to,1822,1824,O
use,1825,1828,O
for,1829,1832,O
a,1833,1834,O
person,1835,1841,O
without,1842,1849,O
extensive,1850,1859,O
computer,1860,1868,O
experience,1869,1879,O
",",1879,1880,O
as,1881,1883,O
is,1884,1886,O
illustrated,1887,1898,O
by,1899,1901,O
more,1902,1906,O
than,1907,1911,O
1000,1912,1916,O
citations,1917,1926,O
to,1927,1929,O
the,1930,1933,O
various,1934,1941,O
VISTA,1942,1947,O
-,1947,1948,O
associated,1948,1958,O
tools,1959,1964,O
(,1965,1966,O
according,1966,1975,O
to,1976,1978,O
http,1979,1983,O
:,1983,1984,O
/,1984,1985,O
/,1985,1986,O
scholar,1986,1993,O
.,1993,1994,O
google,1994,2000,O
.,2000,2001,O
com,2001,2004,O
),2004,2005,O
.,2005,2006,O
In,2007,2009,O
the,2010,2013,O
last,2014,2018,O
2,2019,2020,O
years,2021,2026,O
the,2027,2030,O
VISTA,2031,2036,O
portal,2037,2043,O
has,2044,2047,O
seen,2048,2052,O
many,2053,2057,O
significant,2058,2069,O
improvements,2070,2082,O
.,2082,2083,O
In,2084,2086,O
addition,2087,2095,O
to,2096,2098,O
updating,2099,2107,O
the,2108,2111,O
whole,2112,2117,O
genome,2118,2124,O
alignments,2125,2135,O
",",2135,2136,O
computed,2137,2145,O
using,2146,2151,O
recent,2152,2158,O
assemblies,2159,2169,O
of,2170,2172,O
vertebrate,2173,2183,O
",",2183,2184,O
insect,2185,2191,O
",",2191,2192,O
plant,2193,2198,O
and,2199,2202,O
microbial,2203,2212,O
genomes,2213,2220,O
",",2220,2221,O
we,2222,2224,O
have,2225,2229,O
added,2230,2235,O
significant,2236,2247,O
new,2248,2251,O
functionality,2252,2265,O
and,2266,2269,O
resources,2270,2279,O
to,2280,2282,O
the,2283,2286,O
Genome,2287,2293,O
Browser,2294,2301,O
and,2302,2305,O
other,2306,2311,O
tools,2312,2317,O
",",2317,2318,O
including,2319,2328,O
:,2328,2329,O
A,2331,2332,O
novel,2333,2338,O
multiple,2339,2347,O
whole,2348,2353,O
genome,2354,2360,O
alignment,2361,2370,O
algorithm,2371,2380,O
.,2380,2381,O
A,2382,2383,O
new,2384,2387,O
server,2388,2394,O
for,2395,2398,O
whole,2399,2404,O
-,2404,2405,O
genome,2405,2411,O
alignment,2412,2421,O
of,2422,2424,O
bacterial,2425,2434,O
genomes,2435,2442,O
.,2442,2443,O
Base,2444,2448,O
-,2448,2449,O
pair,2449,2453,O
level,2454,2459,O
visualization,2460,2473,O
ability,2474,2481,O
within,2482,2488,O
the,2489,2492,O
VISTA,2493,2498,O
browser,2499,2506,O
.,2506,2507,O
Visual,2508,2514,O
access,2515,2521,O
to,2522,2524,O
the,2525,2528,O
results,2529,2536,O
of,2537,2539,O
the,2540,2543,O
prediction,2544,2554,O
of,2555,2557,O
potential,2558,2567,O
deleteriousness,2568,2583,O
of,2584,2586,O
non,2587,2590,O
-,2590,2591,O
synonymous,2591,2601,O
Single,2602,2608,O
Nucleotide,2609,2619,O
Polymorphisms,2620,2633,O
(,2634,2635,O
SNPs,2635,2639,O
),2639,2640,O
by,2641,2643,O
the,2644,2647,O
algorithm,2648,2657,O
PolyPhen,2658,2666,O
(,2667,2668,O
5,2668,2669,O
),2669,2670,O
.,2670,2671,O
A,2672,2673,O
novel,2674,2679,O
conservation,2680,2692,O
track,2693,2698,O
",",2698,2699,O
Rank,2700,2704,O
-,2704,2705,O
VISTA,2705,2710,O
",",2710,2711,O
to,2712,2714,O
show,2715,2719,O
the,2720,2723,O
statistical,2724,2735,O
significance,2736,2748,O
of,2749,2751,O
conserved,2752,2761,O
regions,2762,2769,O
computed,2770,2778,O
by,2779,2781,O
the,2782,2785,O
Gumby,2786,2791,O
algorithm,2792,2801,O
(,2802,2803,O
6,2803,2804,O
),2804,2805,O
.,2805,2806,O
Whole,2807,2812,O
-,2812,2813,O
genome,2813,2819,O
rVISTA,2820,2826,O
",",2826,2827,O
that,2828,2832,O
allows,2833,2839,O
for,2840,2843,O
evaluation,2844,2854,O
of,2855,2857,O
which,2858,2863,O
conserved,2864,2873,O
transcription,2874,2887,O
factor,2888,2894,O
binding,2895,2902,O
sites,2903,2908,O
(,2909,2910,O
TFBS,2910,2914,O
),2914,2915,O
are,2916,2919,O
over,2920,2924,O
-,2924,2925,O
represented,2925,2936,O
in,2937,2939,O
a,2940,2941,O
group,2942,2947,O
of,2948,2950,O
genes,2951,2956,O
.,2956,2957,O
Images,0,6,O
Figure,7,13,O
5,14,15,O
Miscellaneous,0,13,O
Proteins,14,22,O
Apart,23,28,O
from,29,33,O
the,34,37,O
above,38,43,O
-,43,44,O
described,44,53,O
proteins,54,62,O
",",62,63,O
several,64,71,O
other,72,77,O
molecules,78,87,O
are,88,91,O
also,92,96,O
associated,97,107,O
with,108,112,O
the,113,116,O
pathological,117,129,B-Pathological_formation
lesions,130,137,I-Pathological_formation
of,138,140,O
AD,141,143,O
",",143,144,O
and,145,148,O
some,149,153,O
of,154,156,O
these,157,162,O
can,163,166,O
be,167,169,O
regarded,170,178,O
as,179,181,O
amateur,182,189,O
chaperones,190,200,O
.,200,201,O
Acute,202,207,O
phase,208,213,O
proteins,214,222,O
",",222,223,O
such,224,228,O
as,229,231,O
alpha1,232,238,O
-,238,239,O
antichymotrypsin,239,255,O
(,256,257,O
ACT,257,260,O
),260,261,O
",",261,262,O
alpha2,263,269,O
-,269,270,O
macroglobulin,270,283,O
(,284,285,O
alpha2M,285,292,O
),292,293,O
",",293,294,O
and,295,298,O
SAP,299,302,O
",",302,303,O
are,304,307,O
all,308,311,O
associated,312,322,O
with,323,327,O
Abeta,328,333,O
deposition,334,344,O
[,345,346,O
129,346,349,O
-,349,350,O
132,350,353,O
],353,354,O
.,354,355,O
ACT,356,359,O
is,360,362,O
a,363,364,O
serine,365,371,O
protease,372,380,O
inhibitor,381,390,O
of,391,393,O
the,394,397,O
serpin,398,404,O
family,405,411,O
",",411,412,O
and,413,416,O
in,417,419,O
AD,420,422,O
",",422,423,O
ACT,424,427,O
levels,428,434,O
are,435,438,O
upregulated,439,450,O
",",450,451,O
and,452,455,O
binding,456,463,O
of,464,466,O
ACT,467,470,O
with,471,475,O
Abeta,476,481,O
induces,482,489,O
Abeta,490,495,O
fibrillogenesis,496,511,O
[,512,513,O
133,513,516,O
-,516,517,O
135,517,520,O
],520,521,O
.,521,522,O
Furthermore,523,534,O
",",534,535,O
when,536,540,O
ACT,541,544,O
is,545,547,O
overexpressed,548,561,O
in,562,564,O
transgenic,565,575,O
mice,576,580,O
",",580,581,O
an,582,584,O
increased,585,594,O
plaque,595,601,B-Cell
load,602,606,O
in,607,609,O
the,610,613,O
brains,614,620,B-Organ
of,621,623,O
these,624,629,O
mice,630,634,O
and,635,638,O
impaired,639,647,O
spatial,648,655,O
learning,656,664,O
is,665,667,O
observed,668,676,O
[,677,678,O
134,678,681,O
",",681,682,O
135,683,686,O
],686,687,O
.,687,688,O
alpha2M,689,696,O
also,697,701,O
binds,702,707,O
Abeta,708,713,O
",",713,714,O
although,715,723,O
in,724,726,O
contrast,727,735,O
to,736,738,O
ACT,739,742,O
",",742,743,O
this,744,748,O
binding,749,756,O
prevents,757,765,O
Abeta,766,771,O
fibril,772,778,B-Pathological_formation
formation,779,788,O
and,789,792,O
fibril,793,799,O
-,799,800,O
associated,800,810,O
neurotoxicity,811,824,O
[,825,826,O
136,826,829,O
",",829,830,O
137,831,834,O
],834,835,O
.,835,836,O
alpha2M,837,844,O
promotes,845,853,O
the,854,857,O
protease,858,866,O
-,866,867,O
mediated,867,875,O
degradation,876,887,O
of,888,890,O
alpha2M,891,898,O
/,898,899,O
Abeta,899,904,O
complexes,905,914,O
and,915,918,O
contributes,919,930,O
to,931,933,O
clearance,934,943,O
of,944,946,O
Abeta,947,952,O
from,953,957,O
the,958,961,O
brain,962,967,B-Organ
(,968,969,O
discussed,969,978,O
in,979,981,O
paragraph,982,991,O
4,992,993,O
),993,994,O
[,995,996,O
138,996,999,O
",",999,1000,O
139,1001,1004,O
],1004,1005,O
.,1005,1006,O
The,1007,1010,O
glycoprotein,1011,1023,O
SAP,1024,1027,O
belongs,1028,1035,O
to,1036,1038,O
the,1039,1042,O
pentraxin,1043,1052,O
family,1053,1059,O
and,1060,1063,O
is,1064,1066,O
a,1067,1068,O
common,1069,1075,O
component,1076,1085,O
of,1086,1088,O
all,1089,1092,O
known,1093,1098,O
types,1099,1104,O
of,1105,1107,O
amyloid,1108,1115,B-Pathological_formation
fibrils,1116,1123,I-Pathological_formation
.,1123,1124,O
SAP,1125,1128,O
is,1129,1131,O
upregulated,1132,1143,O
in,1144,1146,O
AD,1147,1149,O
and,1150,1153,O
protects,1154,1162,O
amyloid,1163,1170,B-Pathological_formation
fibrils,1171,1178,I-Pathological_formation
from,1179,1183,O
proteolysis,1184,1195,O
in,1196,1198,O
vitro,1199,1204,O
[,1205,1206,O
140,1206,1209,O
",",1209,1210,O
141,1211,1214,O
],1214,1215,O
.,1215,1216,O
SAP,1217,1220,O
not,1221,1224,O
only,1225,1229,O
colocalizes,1230,1241,O
with,1242,1246,O
SPs,1247,1250,O
and,1251,1254,O
interacts,1255,1264,O
with,1265,1269,O
aggregated,1270,1280,O
Abeta,1281,1286,O
;,1286,1287,O
SAP,1288,1291,O
oligomers,1292,1301,O
also,1302,1306,O
bind,1307,1311,O
and,1312,1315,O
activate,1316,1324,O
C1,1325,1327,O
[,1328,1329,O
142,1329,1332,O
],1332,1333,O
.,1333,1334,O
Both,1335,1339,O
C1,1340,1342,O
and,1343,1346,O
SAP,1347,1350,O
may,1351,1354,O
bind,1355,1359,O
to,1360,1362,O
fibrillar,1363,1372,B-Pathological_formation
Abeta,1373,1378,O
deposits,1379,1387,O
in,1388,1390,O
vivo,1391,1395,O
and,1396,1399,O
induce,1400,1406,O
microglial,1407,1417,B-Cell
activation,1418,1428,O
",",1428,1429,O
as,1430,1432,O
cultured,1433,1441,O
human,1442,1447,O
microglial,1448,1458,B-Cell
cells,1459,1464,I-Cell
show,1465,1469,O
an,1470,1472,O
increase,1473,1481,O
in,1482,1484,O
cytokine,1485,1493,O
production,1494,1504,O
after,1505,1510,O
co,1511,1513,O
-,1513,1514,O
stimulation,1514,1525,O
of,1526,1528,O
Abeta,1529,1534,O
with,1535,1539,O
C1q,1540,1543,O
and,1544,1547,O
SAP,1548,1551,O
[,1552,1553,O
104,1553,1556,O
],1556,1557,O
.,1557,1558,O
These,1559,1564,O
observations,1565,1577,O
further,1578,1585,O
strengthen,1586,1596,O
the,1597,1600,O
above,1601,1606,O
-,1606,1607,O
noted,1607,1612,O
suggestion,1613,1623,O
that,1624,1628,O
not,1629,1632,O
only,1633,1637,O
Abeta,1638,1643,O
",",1643,1644,O
but,1645,1648,O
also,1649,1653,O
several,1654,1661,O
Abeta,1662,1667,O
-,1667,1668,O
binding,1668,1675,O
proteins,1676,1684,O
",",1684,1685,O
are,1686,1689,O
capable,1690,1697,O
of,1698,1700,O
activating,1701,1711,O
the,1712,1715,O
complement,1716,1726,O
system,1727,1733,O
",",1733,1734,O
and,1735,1738,O
thus,1739,1743,O
",",1743,1744,O
contribute,1745,1755,O
to,1756,1758,O
neuroinflammation,1759,1776,O
in,1777,1779,O
AD,1780,1782,O
.,1782,1783,O
In,1784,1786,O
addition,1787,1795,O
",",1795,1796,O
both,1797,1801,O
alpha2M,1802,1809,O
and,1810,1813,O
ACT,1814,1817,O
",",1817,1818,O
in,1819,1821,O
contrast,1822,1830,O
to,1831,1833,O
SAP,1834,1837,O
",",1837,1838,O
can,1839,1842,O
be,1843,1845,O
regarded,1846,1854,O
as,1855,1857,O
amateur,1858,1865,O
chaperones,1866,1876,O
",",1876,1877,O
as,1878,1880,O
they,1881,1885,O
regulate,1886,1894,O
conformational,1895,1909,O
changes,1910,1917,O
of,1918,1920,O
Abeta,1921,1926,O
.,1926,1927,O
Tissue,1928,1934,O
-,1934,1935,O
type,1935,1939,O
plasminogen,1940,1951,O
activator,1952,1961,O
(,1962,1963,O
tPA,1963,1966,O
),1966,1967,O
regulates,1968,1977,O
activation,1978,1988,O
of,1989,1991,O
plasminogen,1992,2003,O
into,2004,2008,O
plasmin,2009,2016,O
and,2017,2020,O
is,2021,2023,O
expressed,2024,2033,O
in,2034,2036,O
various,2037,2044,O
regions,2045,2052,O
of,2053,2055,O
the,2056,2059,O
brain,2060,2065,B-Organ
especially,2066,2076,O
in,2077,2079,O
the,2080,2083,O
hippocampus,2084,2095,B-Multi-tissue_structure
[,2096,2097,O
143,2097,2100,O
],2100,2101,O
.,2101,2102,O
Several,2103,2110,O
reports,2111,2118,O
suggested,2119,2128,O
an,2129,2131,O
important,2132,2141,O
role,2142,2146,O
for,2147,2150,O
tPA,2151,2154,O
in,2155,2157,O
AD,2158,2160,O
",",2160,2161,O
as,2162,2164,O
the,2165,2168,O
tPA,2169,2172,O
system,2173,2179,O
is,2180,2182,O
involved,2183,2191,O
in,2192,2194,O
Abeta,2195,2200,O
turnover,2201,2209,O
[,2210,2211,O
144,2211,2214,O
",",2214,2215,O
145,2216,2219,O
],2219,2220,O
.,2220,2221,O
Fibrillar,2222,2231,B-Pathological_formation
forms,2232,2237,O
of,2238,2240,O
Abeta,2241,2246,O
stimulate,2247,2256,O
tPA,2257,2260,O
activity,2261,2269,O
in,2270,2272,O
vitro,2273,2278,O
",",2278,2279,O
whereas,2280,2287,O
in,2288,2290,O
AD,2291,2293,O
patients,2294,2302,O
",",2302,2303,O
a,2304,2305,O
reduction,2306,2315,O
of,2316,2318,O
tPA,2319,2322,O
activity,2323,2331,O
is,2332,2334,O
observed,2335,2343,O
in,2344,2346,O
the,2347,2350,O
affected,2351,2359,O
areas,2360,2365,O
[,2366,2367,O
144,2367,2370,O
",",2370,2371,O
146,2372,2375,O
],2375,2376,O
.,2376,2377,O
Although,2378,2386,O
tPA,2387,2390,O
has,2391,2394,O
no,2395,2397,O
effect,2398,2404,O
on,2405,2407,O
conformational,2408,2422,O
changes,2423,2430,O
of,2431,2433,O
Abeta,2434,2439,O
",",2439,2440,O
it,2441,2443,O
might,2444,2449,O
play,2450,2454,O
a,2455,2456,O
role,2457,2461,O
in,2462,2464,O
the,2465,2468,O
clearance,2469,2478,O
of,2479,2481,O
Abeta,2482,2487,O
from,2488,2492,O
the,2493,2496,O
brain,2497,2502,B-Organ
(,2503,2504,O
paragraph,2504,2513,O
4,2514,2515,O
],2515,2516,O
.,2516,2517,O
The,2518,2521,O
actin,2522,2527,O
-,2527,2528,O
regulatory,2528,2538,O
protein,2539,2546,O
gelsolin,2547,2555,O
is,2556,2558,O
found,2559,2564,O
both,2565,2569,O
intracellularly,2570,2585,B-Cell
and,2586,2589,O
in,2590,2592,O
plasma,2593,2599,B-Organism_substance
[,2600,2601,O
147,2601,2604,O
",",2604,2605,O
148,2606,2609,O
],2609,2610,O
.,2610,2611,O
Plasma,2612,2618,B-Organism_substance
gelsolin,2619,2627,O
can,2628,2631,O
be,2632,2634,O
considered,2635,2645,O
an,2646,2648,O
amateur,2649,2656,O
chaperone,2657,2666,O
",",2666,2667,O
as,2668,2670,O
it,2671,2673,O
binds,2674,2679,O
Abeta,2680,2685,O
and,2686,2689,O
not,2690,2693,O
only,2694,2698,O
inhibits,2699,2707,O
its,2708,2711,O
Abeta,2712,2717,O
fibrillization,2718,2732,O
but,2733,2736,O
is,2737,2739,O
also,2740,2744,O
capable,2745,2752,O
of,2753,2755,O
degrading,2756,2765,O
preformed,2766,2775,O
Abeta,2776,2781,O
fibrils,2782,2789,B-Pathological_formation
[,2790,2791,O
149,2791,2794,O
",",2794,2795,O
150,2796,2799,O
],2799,2800,O
.,2800,2801,O
Furthermore,2802,2813,O
",",2813,2814,O
gelsolin,2815,2823,O
inhibits,2824,2832,O
Abeta,2833,2838,O
-,2838,2839,O
mediated,2839,2847,O
neurotoxicity,2848,2861,O
[,2862,2863,O
151,2863,2866,O
],2866,2867,O
.,2867,2868,O
One,2869,2872,O
of,2873,2875,O
the,2876,2879,O
major,2880,2885,O
gangliosides,2886,2898,O
in,2899,2901,O
the,2902,2905,O
brain,2906,2911,B-Organ
is,2912,2914,O
GM1,2915,2918,O
.,2918,2919,O
Soluble,2920,2927,O
Abeta,2928,2933,O
binds,2934,2939,O
GM1,2940,2943,O
and,2944,2947,O
the,2948,2951,O
formed,2952,2958,O
complexes,2959,2968,O
accelerate,2969,2979,O
Abeta,2980,2985,O
fibrillogenesis,2986,3001,O
by,3002,3004,O
acting,3005,3011,O
as,3012,3014,O
a,3015,3016,O
seed,3017,3021,O
for,3022,3025,O
Abeta,3026,3031,O
[,3032,3033,O
152,3033,3036,O
],3036,3037,O
.,3037,3038,O
In,3039,3041,O
the,3042,3045,O
presence,3046,3054,O
of,3055,3057,O
GM1,3058,3061,O
",",3061,3062,O
Abeta,3063,3068,O
is,3069,3071,O
more,3072,3076,O
neurotoxic,3077,3087,O
than,3088,3092,O
Abeta,3093,3098,O
alone,3099,3104,O
",",3104,3105,O
and,3106,3109,O
cholesterol,3110,3121,O
-,3121,3122,O
rich,3122,3126,O
membranes,3127,3136,B-Cellular_component
demonstrate,3137,3148,O
accelerated,3149,3160,O
Abeta,3161,3166,O
binding,3167,3174,O
due,3175,3178,O
to,3179,3181,O
the,3182,3185,O
formation,3186,3195,O
of,3196,3198,O
GM1,3199,3202,O
clusters,3203,3211,O
[,3212,3213,O
153,3213,3216,O
",",3216,3217,O
154,3218,3221,O
],3221,3222,O
.,3222,3223,O
As,3224,3226,O
GM1,3227,3230,O
is,3231,3233,O
a,3234,3235,O
major,3236,3241,O
component,3242,3251,O
of,3252,3254,O
lipid,3255,3260,B-Organism_substance
rafts,3261,3266,I-Organism_substance
and,3267,3270,O
recent,3271,3277,O
studies,3278,3285,O
suggest,3286,3293,O
that,3294,3298,O
Abeta,3299,3304,O
accumulation,3305,3317,O
in,3318,3320,O
these,3321,3326,O
lipid,3327,3332,B-Organism_substance
rafts,3333,3338,I-Organism_substance
is,3339,3341,O
an,3342,3344,O
early,3345,3350,O
event,3351,3356,O
in,3357,3359,O
AD,3360,3362,O
development,3363,3374,O
",",3374,3375,O
GM1,3376,3379,O
might,3380,3385,O
play,3386,3390,O
an,3391,3393,O
important,3394,3403,O
role,3404,3408,O
in,3409,3411,O
the,3412,3415,O
early,3416,3421,O
steps,3422,3427,O
in,3428,3430,O
AD,3431,3433,O
pathogenesis,3434,3446,O
[,3447,3448,O
155,3448,3451,O
",",3451,3452,O
156,3453,3456,O
],3456,3457,O
.,3457,3458,O
In,3459,3461,O
summary,3462,3469,O
",",3469,3470,O
several,3471,3478,O
proteins,3479,3487,O
are,3488,3491,O
associated,3492,3502,O
with,3503,3507,O
Abeta,3508,3513,O
aggregates,3514,3524,O
in,3525,3527,O
the,3528,3531,O
AD,3532,3534,B-Organ
brain,3535,3540,I-Organ
and,3541,3544,O
contribute,3545,3555,O
to,3556,3558,O
the,3559,3562,O
aggregation,3563,3574,O
of,3575,3577,O
Abeta,3578,3583,O
and,3584,3587,O
should,3588,3594,O
",",3594,3595,O
therefore,3596,3605,O
",",3605,3606,O
be,3607,3609,O
considered,3610,3620,O
as,3621,3623,O
amateur,3624,3631,O
chaperones,3632,3642,O
.,3642,3643,O
In,3644,3646,O
addition,3647,3655,O
",",3655,3656,O
they,3657,3661,O
might,3662,3667,O
play,3668,3672,O
a,3673,3674,O
role,3675,3679,O
in,3680,3682,O
triggering,3683,3693,O
inflammation,3694,3706,O
.,3706,3707,O
Mineralization,0,14,O
(,15,16,O
red,16,19,O
),19,20,O
of,21,23,O
the,24,27,O
aorta,28,33,B-Multi-tissue_structure
is,34,36,O
prevented,37,46,O
by,47,49,O
local,50,55,O
(,56,57,O
left,57,61,O
),61,62,O
",",62,63,O
but,64,67,O
not,68,71,O
global,72,78,O
(,79,80,O
right,80,85,O
),85,86,O
",",86,87,O
Mgp,88,91,O
expression,92,102,O
.,102,103,O
Basilar,0,7,B-Multi-tissue_structure
papilla,8,15,I-Multi-tissue_structure
The,16,19,O
basilar,20,27,B-Multi-tissue_structure
papilla,28,35,I-Multi-tissue_structure
is,36,38,O
found,39,44,O
in,45,47,O
a,48,49,O
recess,50,56,O
that,57,61,O
opens,62,67,O
into,68,72,O
the,73,76,O
saccular,77,85,B-Immaterial_anatomical_entity
space,86,91,I-Immaterial_anatomical_entity
at,92,94,O
one,95,98,O
end,99,102,O
",",102,103,O
and,104,107,O
is,108,110,O
limited,111,118,O
by,119,121,O
a,122,123,O
thin,124,128,O
contact,129,136,B-Multi-tissue_structure
membrane,137,145,I-Multi-tissue_structure
at,146,148,O
the,149,152,O
other,153,158,O
.,158,159,O
The,160,163,O
contact,164,171,B-Multi-tissue_structure
membrane,172,180,I-Multi-tissue_structure
separates,181,190,O
the,191,194,O
endolymphatic,195,208,B-Organism_substance
fluid,209,214,I-Organism_substance
in,215,217,O
the,218,221,O
papillar,222,230,B-Multi-tissue_structure
recess,231,237,O
from,238,242,O
the,243,246,O
perilymphatic,247,260,B-Organism_substance
fluid,261,266,I-Organism_substance
at,267,269,O
the,270,273,O
round,274,279,O
window,280,286,O
(,287,288,O
Lewis,288,293,O
and,294,297,O
Narins,298,304,O
1999,305,309,O
;,309,310,O
Wever,311,316,O
1985,317,321,O
),321,322,O
.,322,323,O
The,324,327,O
recess,328,334,O
perimeter,335,344,O
is,345,347,O
roughly,348,355,O
oval,356,360,O
in,361,363,O
shape,364,369,O
;,369,370,O
in,371,373,O
the,374,377,O
bullfrog,378,386,O
",",386,387,O
Rana,388,392,O
catesbeiana,393,404,O
",",404,405,O
its,406,409,O
major,410,415,O
axis,416,420,O
is,421,423,O
approximately,424,437,O
200,438,441,O
mum,442,445,O
long,446,450,O
",",450,451,O
while,452,457,O
the,458,461,O
minor,462,467,O
axis,468,472,O
measures,473,481,O
approximately,482,495,O
150,496,499,O
mum,500,503,O
(,504,505,O
Van,505,508,O
Bergeijk,509,517,O
1957,518,522,O
),522,523,O
.,523,524,O
In,525,527,O
the,528,531,O
leopard,532,539,O
frog,540,544,O
",",544,545,O
Rana,546,550,O
pipiens,551,558,O
pipiens,559,566,O
",",566,567,O
it,568,570,O
is,571,573,O
of,574,576,O
similar,577,584,O
size,585,589,O
(,590,591,O
personal,591,599,O
observation,600,611,O
",",611,612,O
RLMS,613,617,O
&,618,619,O
JMS,620,623,O
),623,624,O
.,624,625,O
The,626,629,O
oval,630,634,O
perimeter,635,644,O
of,645,647,O
the,648,651,O
lumen,652,657,B-Immaterial_anatomical_entity
is,658,660,O
formed,661,667,O
from,668,672,O
limbic,673,679,B-Tissue
tissue,680,686,I-Tissue
;,686,687,O
a,688,689,O
substance,690,699,O
unique,700,706,O
to,707,709,O
the,710,713,O
inner,714,719,B-Multi-tissue_structure
ear,720,723,I-Multi-tissue_structure
",",723,724,O
and,725,728,O
similar,729,736,O
to,737,739,O
cartilage,740,749,B-Tissue
(,750,751,O
Wever,751,756,O
1985,757,761,O
),761,762,O
.,762,763,O
The,764,767,O
sensory,768,775,B-Tissue
epithelium,776,786,I-Tissue
is,787,789,O
approximately,790,803,O
100,804,807,O
mum,808,811,O
long,812,816,O
.,816,817,O
It,818,820,O
occupies,821,829,O
a,830,831,O
curved,832,838,O
area,839,843,O
that,844,848,O
is,849,851,O
symmetrical,852,863,O
in,864,866,O
the,867,870,O
major,871,876,O
axis,877,881,O
of,882,884,O
the,885,888,O
elliptical,889,899,B-Immaterial_anatomical_entity
lumen,900,905,I-Immaterial_anatomical_entity
.,905,906,O
It,907,909,O
contains,910,918,O
approximately,919,932,O
60,933,935,O
hair,936,940,B-Cell
cells,941,946,I-Cell
(,947,948,O
measured,948,956,O
in,957,959,O
Rana,960,964,O
catesbeiana,965,976,O
),976,977,O
",",977,978,O
from,979,983,O
which,984,989,O
the,990,993,O
stereovilli,994,1005,B-Cellular_component
protrude,1006,1014,O
into,1015,1019,O
the,1020,1023,O
lumen,1024,1029,B-Immaterial_anatomical_entity
and,1030,1033,O
connect,1034,1041,O
to,1042,1044,O
the,1045,1048,O
tectorial,1049,1058,B-Multi-tissue_structure
membrane,1059,1067,I-Multi-tissue_structure
(,1068,1069,O
Frishkopf,1069,1078,O
and,1079,1082,O
Flock,1083,1088,O
1974,1089,1093,O
),1093,1094,O
.,1094,1095,O
Typically,1096,1105,O
the,1106,1109,O
orientation,1110,1121,O
of,1122,1124,O
the,1125,1128,O
hair,1129,1133,B-Cell
cells,1134,1139,I-Cell
",",1139,1140,O
as,1141,1143,O
defined,1144,1151,O
by,1152,1154,O
the,1155,1158,O
direction,1159,1168,O
to,1169,1171,O
which,1172,1177,O
the,1178,1181,O
v,1182,1183,O
-,1183,1184,O
shape,1184,1189,O
of,1190,1192,O
the,1193,1196,O
stereovilli,1197,1208,B-Cellular_component
bundle,1209,1215,O
points,1216,1222,O
(,1223,1224,O
Lewis,1224,1229,O
et,1230,1232,O
al,1233,1235,O
.,1235,1236,O
1985,1237,1241,O
),1241,1242,O
",",1242,1243,O
is,1244,1246,O
away,1247,1251,O
from,1252,1256,O
the,1257,1260,O
sacculus,1261,1269,B-Multi-tissue_structure
in,1270,1272,O
Ranidae,1273,1280,O
.,1280,1281,O
The,1282,1285,O
tectorial,1286,1295,B-Multi-tissue_structure
membrane,1296,1304,I-Multi-tissue_structure
spans,1305,1310,O
the,1311,1314,O
lumen,1315,1320,B-Immaterial_anatomical_entity
of,1321,1323,O
the,1324,1327,O
papillar,1328,1336,B-Multi-tissue_structure
recess,1337,1343,O
.,1343,1344,O
It,1345,1347,O
occludes,1348,1356,O
about,1357,1362,O
half,1363,1367,O
the,1368,1371,O
lumen,1372,1377,B-Immaterial_anatomical_entity
",",1377,1378,O
and,1379,1382,O
consequently,1383,1395,O
takes,1396,1401,O
an,1402,1404,O
approximately,1405,1418,O
semi,1419,1423,O
-,1423,1424,O
circular,1424,1432,O
shape,1433,1438,O
when,1439,1443,O
viewed,1444,1450,O
from,1451,1455,O
the,1456,1459,O
saccular,1460,1468,B-Multi-tissue_structure
side,1469,1473,O
(,1474,1475,O
Frishkopf,1475,1484,O
and,1485,1488,O
Flock,1489,1494,O
1974,1495,1499,O
;,1499,1500,O
Wever,1501,1506,O
1985,1507,1511,O
),1511,1512,O
.,1512,1513,O
The,1514,1517,O
membrane,1518,1526,B-Multi-tissue_structure
has,1527,1530,O
pores,1531,1536,O
at,1537,1539,O
the,1540,1543,O
surface,1544,1551,O
closest,1552,1559,O
to,1560,1562,O
the,1563,1566,O
epithelium,1567,1577,B-Tissue
",",1577,1578,O
into,1579,1583,O
which,1584,1589,O
the,1590,1593,O
tips,1594,1598,O
of,1599,1601,O
the,1602,1605,O
hair,1606,1610,B-Multi-tissue_structure
bundles,1611,1618,O
project,1619,1626,O
(,1627,1628,O
Lewis,1628,1633,O
and,1634,1637,O
Narins,1638,1644,O
1999,1645,1649,O
),1649,1650,O
.,1650,1651,O
4,1651,1652,O
Haplotype,0,9,O
block,10,15,O
structure,16,25,O
from,26,30,O
one,31,34,O
replicate,35,44,O
generated,45,54,O
by,55,57,O
the,58,61,O
block,62,67,O
method,68,74,O
(,75,76,O
ALS,76,79,O
),79,80,O
.,80,81,O
Competing,0,9,O
interests,10,19,O
The,20,23,O
authors,24,31,O
declare,32,39,O
that,40,44,O
they,45,49,O
have,50,54,O
no,55,57,O
competing,58,67,O
interests,68,77,O
.,77,78,O
Background,0,10,O
Previous,11,19,O
publications,20,32,O
indicate,33,41,O
that,42,46,O
acupuncture,47,58,O
is,59,61,O
efficient,62,71,O
for,72,75,O
the,76,79,O
treatment,80,89,O
of,90,92,O
pelvic,93,99,B-Multi-tissue_structure
girdle,100,106,I-Multi-tissue_structure
pain,107,111,O
",",111,112,O
PGP,113,116,O
",",116,117,O
in,118,120,O
pregnant,121,129,O
women,130,135,O
.,135,136,O
However,137,144,O
",",144,145,O
the,146,149,O
use,150,153,O
of,154,156,O
acupuncture,157,168,O
for,169,172,O
PGP,173,176,O
is,177,179,O
rare,180,184,O
due,185,188,O
to,189,191,O
insufficient,192,204,O
documentation,205,218,O
of,219,221,O
adverse,222,229,O
effects,230,237,O
of,238,240,O
this,241,245,O
treatment,246,255,O
in,256,258,O
this,259,263,O
specific,264,272,O
condition,273,282,O
.,282,283,O
The,284,287,O
aim,288,291,O
of,292,294,O
the,295,298,O
present,299,306,O
work,307,311,O
was,312,315,O
to,316,318,O
assess,319,325,O
adverse,326,333,O
effects,334,341,O
of,342,344,O
acupuncture,345,356,O
on,357,359,O
the,360,363,O
pregnancy,364,373,O
",",373,374,O
mother,375,381,O
",",381,382,O
delivery,383,391,O
and,392,395,O
the,396,399,O
fetus,400,405,B-Developing_anatomical_structure
/,405,406,O
neonate,406,413,O
in,414,416,O
comparison,417,427,O
with,428,432,O
women,433,438,O
that,439,443,O
received,444,452,O
stabilising,453,464,O
exercises,465,474,O
as,475,477,O
adjunct,478,485,O
to,486,488,O
standard,489,497,O
treatment,498,507,O
or,508,510,O
standard,511,519,O
treatment,520,529,O
alone,530,535,O
.,535,536,O
Authors,0,7,O
',7,8,O
contributions,9,22,O
MP,23,25,O
prepared,26,34,O
the,35,38,O
first,39,44,O
draft,45,50,O
with,51,55,O
the,56,59,O
assistance,60,70,O
of,71,73,O
JLdR,74,78,O
.,78,79,O
Other,80,85,O
authors,86,93,O
reviewed,94,102,O
the,103,106,O
manuscript,107,117,O
",",117,118,O
provided,119,127,O
further,128,135,O
contributions,136,149,O
and,150,153,O
suggestions,154,165,O
.,165,166,O
All,167,170,O
of,171,173,O
the,174,177,O
authors,178,185,O
worked,186,192,O
collectively,193,205,O
to,206,208,O
develop,209,216,O
the,217,220,O
algorithms,221,231,O
and,232,235,O
methods,236,243,O
described,244,253,O
in,254,256,O
this,257,261,O
paper,262,267,O
.,267,268,O
Study,0,5,O
of,6,8,O
freeze,9,15,O
-,15,16,O
thaw,16,20,O
effects,21,28,O
and,29,32,O
CSF,33,36,O
pH,37,39,O
on,40,42,O
tissue,43,49,B-Tissue
RNA,50,53,O
integrity,54,63,O
We,64,66,O
have,67,71,O
long,72,76,O
suspected,77,86,O
",",86,87,O
on,88,90,O
the,91,94,O
basis,95,100,O
of,101,103,O
our,104,107,O
tissue,108,114,B-Tissue
banking,115,122,O
experience,123,133,O
",",133,134,O
that,135,139,O
most,140,144,O
of,145,147,O
the,148,151,O
molecular,152,161,O
degradation,162,173,O
that,174,178,O
occurs,179,185,O
in,186,188,O
banked,189,195,O
tissue,196,202,B-Tissue
is,203,205,O
due,206,209,O
to,210,212,O
repeated,213,221,O
freeze,222,228,O
-,228,229,O
thaw,229,233,O
cycles,234,240,O
",",240,241,O
which,242,247,O
occur,248,253,O
due,254,257,O
to,258,260,O
improper,261,269,O
handling,270,278,O
during,279,285,O
dissection,286,296,O
for,297,300,O
tissue,301,307,B-Tissue
retrieval,308,317,O
or,318,320,O
due,321,324,O
to,325,327,O
freezer,328,335,O
malfunctions,336,348,O
.,348,349,O
Our,350,353,O
freezers,354,362,O
are,363,366,O
currently,367,376,O
protected,377,386,O
by,387,389,O
temperature,390,401,O
-,401,402,O
sensitive,402,411,O
alarms,412,418,O
that,419,423,O
automatically,424,437,O
telephone,438,447,O
maintenance,448,459,O
and,460,463,O
tissue,464,470,B-Tissue
banking,471,478,O
personnel,479,488,O
when,489,493,O
the,494,497,O
temperature,498,509,O
reaches,510,517,O
a,518,519,O
certain,520,527,O
level,528,533,O
.,533,534,O
More,535,539,O
protection,540,550,O
is,551,553,O
preferable,554,564,O
",",564,565,O
with,566,570,O
CO2,571,574,O
tanks,575,580,O
for,581,584,O
backup,585,591,O
cooling,592,599,O
the,600,603,O
optimum,604,611,O
(,612,613,O
but,613,616,O
expensive,617,626,O
),626,627,O
approach,628,636,O
.,636,637,O
We,638,640,O
plan,641,645,O
to,646,648,O
systematically,649,663,O
investigate,664,675,O
the,676,679,O
effects,680,687,O
of,688,690,O
thawing,691,698,O
and,699,702,O
refreezing,703,713,O
on,714,716,O
RNA,717,720,O
integrity,721,730,O
",",730,731,O
by,732,734,O
deliberately,735,747,O
thawing,748,755,O
and,756,759,O
freezing,760,768,O
small,769,774,O
samples,775,782,B-Tissue
of,783,785,O
brain,786,791,B-Tissue
tissue,792,798,I-Tissue
over,799,803,O
varying,804,811,O
time,812,816,O
intervals,817,826,O
and,827,830,O
temperatures,831,843,O
.,843,844,O
Printing,0,8,O
solution,9,17,O
Several,18,25,O
transfection,26,38,O
reagents,39,47,O
were,48,52,O
tested,53,59,O
(,60,61,O
data,61,65,O
not,66,69,O
shown,70,75,O
),75,76,O
",",76,77,O
and,78,81,O
we,82,84,O
found,85,90,O
that,91,95,O
the,96,99,O
X,100,101,O
-,101,102,O
tremeGENE,102,111,O
siRNA,112,117,O
transfection,118,130,O
reagent,131,138,O
(,139,140,O
Roche,140,145,O
),145,146,O
gave,147,151,O
good,152,156,O
transfection,157,169,O
efficiencies,170,182,O
both,183,187,O
for,188,191,O
plasmids,192,200,B-Cellular_component
and,201,204,O
siRNAs,205,211,O
",",211,212,O
and,213,216,O
chose,217,222,O
to,223,225,O
use,226,229,O
this,230,234,O
reagent,235,242,O
for,243,246,O
all,247,250,O
transfected,251,262,O
cell,263,267,B-Cell
microarray,268,278,O
experiments,279,290,O
in,291,293,O
the,294,297,O
present,298,305,O
study,306,311,O
.,311,312,O
For,313,316,O
printing,317,325,O
the,326,329,O
arrays,330,336,O
",",336,337,O
one,338,341,O
major,342,347,O
challenge,348,357,O
is,358,360,O
to,361,363,O
find,364,368,O
a,369,370,O
good,371,375,O
balance,376,383,O
between,384,391,O
high,392,396,O
transfection,397,409,O
efficiency,410,420,O
and,421,424,O
spatially,425,434,O
confined,435,443,O
spots,444,449,O
to,450,452,O
avoid,453,458,O
cross,459,464,O
-,464,465,O
contamination,465,478,O
between,479,486,O
the,487,490,O
spots,491,496,O
.,496,497,O
In,498,500,O
order,501,506,O
to,507,509,O
optimize,510,518,O
the,519,522,O
reverse,523,530,O
transfection,531,543,O
protocol,544,552,O
for,553,556,O
HEK,557,560,B-Cell
293ind,561,567,I-Cell
-,567,568,I-Cell
ICER,568,572,I-Cell
IIgamma,573,580,I-Cell
cells,581,586,I-Cell
(,587,588,O
see,588,591,O
below,592,597,O
),597,598,O
and,599,602,O
X,603,604,O
-,604,605,O
tremeGENE,605,614,O
transfection,615,627,O
reagent,628,635,O
",",635,636,O
we,637,639,O
investigated,640,652,O
the,653,656,O
effect,657,663,O
of,664,666,O
varying,667,674,O
the,675,678,O
concentrations,679,693,O
of,694,696,O
gelatine,697,705,O
and,706,709,O
sucrose,710,717,O
in,718,720,O
the,721,724,O
printing,725,733,O
solution,734,742,O
.,742,743,O
These,744,749,O
reagents,750,758,O
have,759,763,O
been,764,768,O
reported,769,777,O
to,778,780,O
influence,781,790,O
both,791,795,O
the,796,799,O
transfection,800,812,O
efficiency,813,823,O
and,824,827,O
spot,828,832,O
integrity,833,842,O
(,843,844,O
6,844,845,O
",",845,846,O
27,846,848,O
),848,849,O
.,849,850,O
Sucrose,851,858,O
was,859,862,O
observed,863,871,O
to,872,874,O
be,875,877,O
specifically,878,890,O
beneficial,891,901,O
for,902,905,O
obtaining,906,915,O
high,916,920,O
transfection,921,933,O
efficiency,934,944,O
when,945,949,O
storing,950,957,O
the,958,961,O
arrays,962,968,O
for,969,972,O
several,973,980,O
weeks,981,986,O
before,987,993,O
use,994,997,O
(,998,999,O
data,999,1003,O
not,1004,1007,O
shown,1008,1013,O
),1013,1014,O
.,1014,1015,O
Figure,1016,1022,O
1A,1023,1025,O
and,1026,1029,O
B,1030,1031,O
show,1032,1036,O
representative,1037,1051,O
images,1052,1058,O
of,1059,1061,O
the,1062,1065,O
observed,1066,1074,O
effects,1075,1082,O
of,1083,1085,O
varying,1086,1093,O
the,1094,1097,O
concentrations,1098,1112,O
of,1113,1115,O
gelatine,1116,1124,O
and,1125,1128,O
sucrose,1129,1136,O
.,1136,1137,O
We,1138,1140,O
observed,1141,1149,O
that,1150,1154,O
the,1155,1158,O
transfection,1159,1171,O
efficiency,1172,1182,O
increased,1183,1192,O
with,1193,1197,O
increasing,1198,1208,O
gelatine,1209,1217,O
concentration,1218,1231,O
(,1232,1233,O
tested,1233,1239,O
in,1240,1242,O
the,1243,1246,O
range,1247,1252,O
0,1253,1254,O
.,1254,1255,O
01,1255,1257,O
-,1257,1258,O
0,1258,1259,O
.,1259,1260,O
40,1260,1262,O
%,1262,1263,O
),1263,1264,O
.,1264,1265,O
However,1266,1273,O
",",1273,1274,O
an,1275,1277,O
increased,1278,1287,O
disturbance,1288,1299,O
of,1300,1302,O
the,1303,1306,O
spatial,1307,1314,O
definition,1315,1325,O
of,1326,1328,O
the,1329,1332,O
spots,1333,1338,O
was,1339,1342,O
observed,1343,1351,O
with,1352,1356,O
increasing,1357,1367,O
concentrations,1368,1382,O
of,1383,1385,O
gelatine,1386,1394,O
or,1395,1397,O
sucrose,1398,1405,O
(,1406,1407,O
tested,1407,1413,O
in,1414,1416,O
the,1417,1420,O
range,1421,1426,O
0,1427,1428,O
-,1428,1429,O
100,1429,1432,O
mM,1433,1435,O
),1435,1436,O
.,1436,1437,O
A,1438,1439,O
combined,1440,1448,O
effect,1449,1455,O
of,1456,1458,O
the,1459,1462,O
concentrations,1463,1477,O
of,1478,1480,O
gelatine,1481,1489,O
and,1490,1493,O
sucrose,1494,1501,O
was,1502,1505,O
also,1506,1510,O
observed,1511,1519,O
",",1519,1520,O
as,1521,1523,O
low,1524,1527,O
concentrations,1528,1542,O
of,1543,1545,O
gelatine,1546,1554,O
allowed,1555,1562,O
us,1563,1565,O
to,1566,1568,O
use,1569,1572,O
higher,1573,1579,O
concentrations,1580,1594,O
of,1595,1597,O
sucrose,1598,1605,O
than,1606,1610,O
with,1611,1615,O
higher,1616,1622,O
concentrations,1623,1637,O
of,1638,1640,O
gelatine,1641,1649,O
before,1650,1656,O
cells,1657,1662,B-Cell
spread,1663,1669,O
outside,1670,1677,O
the,1678,1681,O
spots,1682,1687,O
.,1687,1688,O
Based,1689,1694,O
on,1695,1697,O
several,1698,1705,O
optimizing,1706,1716,O
experiments,1717,1728,O
",",1728,1729,O
we,1730,1732,O
found,1733,1738,O
that,1739,1743,O
3,1744,1745,O
microl,1746,1752,O
X,1753,1754,O
-,1754,1755,O
tremeGENE,1755,1764,O
solution,1765,1773,O
per,1774,1777,O
microgram,1778,1787,O
nucleic,1788,1795,O
acid,1796,1800,O
",",1800,1801,O
25,1802,1804,O
mM,1805,1807,O
sucrose,1808,1815,O
and,1816,1819,O
0,1820,1821,O
.,1821,1822,O
1,1822,1823,O
%,1823,1824,O
gelatine,1825,1833,O
in,1834,1836,O
the,1837,1840,O
final,1841,1846,O
printing,1847,1855,O
solution,1856,1864,O
reproducibly,1865,1877,O
gave,1878,1882,O
spatial,1883,1890,O
restricted,1891,1901,O
transfection,1902,1914,O
with,1915,1919,O
high,1920,1924,O
transfection,1925,1937,O
efficiency,1938,1948,O
printing,1949,1957,O
the,1958,1961,O
arrays,1962,1968,O
with,1969,1973,O
both,1974,1978,O
a,1979,1980,O
pipette,1981,1988,O
tip,1989,1992,O
and,1993,1996,O
a,1997,1998,O
hand,1999,2003,O
-,2003,2004,O
held,2004,2008,O
arrayer,2009,2016,O
(,2017,2018,O
see,2018,2021,O
below,2022,2027,O
),2027,2028,O
.,2028,2029,O
Figure,2031,2037,O
1,2038,2039,O
.,2039,2040,O
Effects,2041,2048,O
of,2049,2051,O
sucrose,2052,2059,O
and,2060,2063,O
gelatine,2064,2072,O
concentrations,2073,2087,O
on,2088,2090,O
spot,2091,2095,O
integrity,2096,2105,O
and,2106,2109,O
transfection,2110,2122,O
efficiency,2123,2133,O
.,2133,2134,O
(,2135,2136,O
A,2136,2137,O
),2137,2138,O
Array,2139,2144,O
printed,2145,2152,O
with,2153,2157,O
pDsRed,2158,2164,O
(,2165,2166,O
50,2166,2168,O
ng,2169,2171,O
/,2171,2172,O
microl,2172,2178,O
),2178,2179,O
in,2180,2182,O
a,2183,2184,O
printing,2185,2193,O
solution,2194,2202,O
with,2203,2207,O
different,2208,2217,O
gelatine,2218,2226,O
and,2227,2230,O
sucrose,2231,2238,O
concentrations,2239,2253,O
.,2253,2254,O
Scanning,2255,2263,O
image,2264,2269,O
of,2270,2272,O
the,2273,2276,O
whole,2277,2282,O
array,2283,2288,O
and,2289,2292,O
magnifications,2293,2307,O
of,2308,2310,O
specific,2311,2319,O
spots,2320,2325,O
.,2325,2326,O
(,2327,2328,O
B,2328,2329,O
),2329,2330,O
Array,2331,2336,O
printed,2337,2344,O
with,2345,2349,O
pEGFP,2350,2355,O
(,2356,2357,O
50,2357,2359,O
ng,2360,2362,O
/,2362,2363,O
microl,2363,2369,O
),2369,2370,O
in,2371,2373,O
a,2374,2375,O
printing,2376,2384,O
solution,2385,2393,O
with,2394,2398,O
25,2399,2401,O
mM,2402,2404,O
sucrose,2405,2412,O
and,2413,2416,O
four,2417,2421,O
different,2422,2431,O
concentrations,2432,2446,O
of,2447,2449,O
gelatine,2450,2458,O
.,2458,2459,O
Top,2460,2463,O
:,2463,2464,O
Box,2465,2468,O
plot,2469,2473,O
of,2474,2476,O
the,2477,2480,O
fluorescence,2481,2493,O
intensities,2494,2505,O
in,2506,2508,O
each,2509,2513,O
spot,2514,2518,O
(,2519,2520,O
n,2520,2521,O
=,2522,2523,O
32,2524,2526,O
-,2526,2527,O
34,2527,2529,O
),2529,2530,O
.,2530,2531,O
Bottom,2532,2538,O
:,2538,2539,O
Scanning,2540,2548,O
image,2549,2554,O
showing,2555,2562,O
squares,2563,2570,O
of,2571,2573,O
seven,2574,2579,O
times,2580,2585,O
five,2586,2590,O
spots,2591,2596,O
for,2597,2600,O
the,2601,2604,O
four,2605,2609,O
gelatine,2610,2618,O
concentrations,2619,2633,O
.,2633,2634,O
From,2635,2639,O
left,2640,2644,O
to,2645,2647,O
right,2648,2653,O
:,2653,2654,O
0,2655,2656,O
.,2656,2657,O
01,2657,2659,O
",",2659,2660,O
0,2661,2662,O
.,2662,2663,O
05,2663,2665,O
",",2665,2666,O
0,2667,2668,O
.,2668,2669,O
1,2669,2670,O
and,2671,2674,O
0,2675,2676,O
.,2676,2677,O
2,2677,2678,O
%,2678,2679,O
gelatine,2680,2688,O
.,2688,2689,O
The,2690,2693,O
DNA,2694,2697,O
-,2697,2698,O
lipid,2698,2703,O
-,2703,2704,O
gelatine,2704,2712,O
-,2712,2713,O
sucrose,2713,2720,O
solutions,2721,2730,O
were,2731,2735,O
printed,2736,2743,O
manually,2744,2752,O
with,2753,2757,O
a,2758,2759,O
10,2760,2762,O
microl,2763,2769,O
pipette,2770,2777,O
tip,2778,2781,O
(,2782,2783,O
A,2783,2784,O
),2784,2785,O
or,2786,2788,O
by,2789,2791,O
MicroCasterTM,2792,2805,O
manual,2806,2812,O
arrayer,2813,2820,O
system,2821,2827,O
(,2828,2829,O
B,2829,2830,O
),2830,2831,O
.,2831,2832,O
In,2833,2835,O
a,2836,2837,O
1,2838,2839,O
.,2839,2840,O
5,2840,2841,O
ml,2842,2844,O
microcentrifuge,2845,2860,O
tube,2861,2865,O
",",2865,2866,O
plasmid,2867,2874,O
(,2875,2876,O
1,2876,2877,O
microg,2878,2884,O
/,2884,2885,O
microl,2885,2891,O
),2891,2892,O
and,2893,2896,O
siRNA,2897,2902,O
were,2903,2907,O
mixed,2908,2913,O
with,2914,2918,O
growth,2919,2925,O
medium,2926,2932,O
without,2933,2940,O
fetal,2941,2946,B-Developing_anatomical_structure
calf,2947,2951,O
serum,2952,2957,B-Organism_substance
(,2958,2959,O
FCS,2959,2962,O
),2962,2963,O
",",2963,2964,O
0,2965,2966,O
.,2966,2967,O
5,2967,2968,O
microl,2969,2975,O
1,2976,2977,O
.,2977,2978,O
5,2978,2979,O
M,2980,2981,O
sucrose,2982,2989,O
and,2990,2993,O
3,2994,2995,O
microl,2996,3002,O
X,3003,3004,O
-,3004,3005,O
tremeGENE,3005,3014,O
per,3015,3018,O
microgram,3019,3028,O
nucleic,3029,3036,O
acid,3037,3041,O
to,3042,3044,O
a,3045,3046,O
final,3047,3052,O
volume,3053,3059,O
of,3060,3062,O
22,3063,3065,O
.,3065,3066,O
5,3066,3067,O
microl,3068,3074,O
.,3074,3075,O
After,3076,3081,O
15,3082,3084,O
-,3084,3085,O
20,3085,3087,O
min,3088,3091,O
of,3092,3094,O
incubation,3095,3105,O
",",3105,3106,O
7,3107,3108,O
.,3108,3109,O
5,3109,3110,O
microl,3111,3117,O
0,3118,3119,O
.,3119,3120,O
4,3120,3121,O
%,3121,3122,O
gelatine,3123,3131,O
(,3132,3133,O
Type,3133,3137,O
B,3138,3139,O
",",3139,3140,O
G9391,3141,3146,O
",",3146,3147,O
Sigma,3148,3153,O
),3153,3154,O
was,3155,3158,O
added,3159,3164,O
to,3165,3167,O
give,3168,3172,O
30,3173,3175,O
microl,3176,3182,O
printing,3183,3191,O
solution,3192,3200,O
.,3200,3201,O
The,3202,3205,O
gelatine,3206,3214,O
solution,3215,3223,O
was,3224,3227,O
prepared,3228,3236,O
as,3237,3239,O
described,3240,3249,O
by,3250,3252,O
Ziauddin,3253,3261,O
and,3262,3265,O
Sabatini,3266,3274,O
(,3275,3276,O
1,3276,3277,O
),3277,3278,O
.,3278,3279,O
To,3280,3282,O
achieve,3283,3290,O
sufficient,3291,3301,O
level,3302,3307,O
of,3308,3310,O
expression,3311,3321,O
from,3322,3326,O
the,3327,3330,O
transfected,3331,3342,O
plasmids,3343,3351,O
",",3351,3352,O
25,3353,3355,O
-,3355,3356,O
50,3356,3358,O
ng,3359,3361,O
/,3361,3362,O
microl,3362,3368,O
pEGFP,3369,3374,O
-,3374,3375,O
N1,3375,3377,O
or,3378,3380,O
pDsRed,3381,3387,O
-,3387,3388,O
express,3388,3395,O
-,3395,3396,O
N1,3396,3398,O
and,3399,3402,O
50,3403,3405,O
-,3405,3406,O
75,3406,3408,O
ng,3409,3411,O
/,3411,3412,O
microl,3412,3418,O
of,3419,3421,O
CRE,3422,3425,O
or,3426,3428,O
NFkappaB,3429,3437,O
reporter,3438,3446,O
plasmids,3447,3455,B-Cellular_component
was,3456,3459,O
used,3460,3464,O
.,3464,3465,O
For,3466,3469,O
siRNA,3470,3475,O
studies,3476,3483,O
",",3483,3484,O
2,3485,3486,O
-,3486,3487,O
30,3487,3489,O
ng,3490,3492,O
/,3492,3493,O
microl,3493,3499,O
siRNA,3500,3505,O
in,3506,3508,O
the,3509,3512,O
final,3513,3518,O
printing,3519,3527,O
solution,3528,3536,O
was,3537,3540,O
used,3541,3545,O
.,3545,3546,O
Candle,0,6,O
wicks,7,12,O
Candles,13,20,O
with,21,25,O
a,26,27,O
lead,28,32,O
metal,33,38,O
core,39,43,O
contribute,44,54,O
to,55,57,O
lead,58,62,O
in,63,65,O
the,66,69,O
home,70,74,O
(,75,76,O
Nriagu,76,82,O
and,83,86,O
Kim,87,90,O
2000,91,95,O
;,95,96,O
van,97,100,O
Alphen,101,107,O
1999,108,112,O
),112,113,O
.,113,114,O
Exposure,115,123,O
occurs,124,130,O
both,131,135,O
from,136,140,O
air,141,144,O
and,145,148,O
from,149,153,O
hand,154,158,O
-,158,159,O
to,159,161,O
-,161,162,O
mouth,162,167,O
activity,168,176,O
.,176,177,O
However,178,185,O
",",185,186,O
to,187,189,O
date,190,194,O
",",194,195,O
no,196,198,O
children,199,207,O
',207,208,O
s,208,209,O
EBLs,210,214,O
traceable,215,224,O
to,225,227,O
candles,228,235,O
have,236,240,O
been,241,245,O
reported,246,254,O
.,254,255,O
In,256,258,O
2002,259,263,O
",",263,264,O
the,265,268,O
CPSC,269,273,O
banned,274,280,O
candlewicks,281,292,O
containing,293,303,O
>,304,305,O
0,306,307,O
.,307,308,O
06,308,310,O
%,310,311,O
lead,312,316,O
(,317,318,O
CPSC,318,322,O
2003,323,327,O
),327,328,O
.,328,329,O
Variables,0,9,O
Our,10,13,O
study,14,19,O
used,20,24,O
the,25,28,O
following,29,38,O
9,39,40,O
HRQOL,41,46,O
questions,47,56,O
from,57,61,O
the,62,65,O
2004,66,70,O
Rhode,71,76,O
Island,77,83,O
BRFSS,84,89,O
:,89,90,O
1,91,92,O
),92,93,O
self,94,98,O
-,98,99,O
rated,99,104,O
general,105,112,O
health,113,119,O
status,120,126,O
;,126,127,O
and,128,131,O
self,132,136,O
-,136,137,O
reported,137,145,O
number,146,152,O
of,153,155,O
healthy,156,163,O
and,164,167,O
unhealthy,168,177,O
days,178,182,O
in,183,185,O
the,186,189,O
previous,190,198,O
30,199,201,O
days,202,206,O
for,207,210,O
2,211,212,O
),212,213,O
physical,214,222,O
health,223,229,O
",",229,230,O
3,231,232,O
),232,233,O
mental,234,240,O
health,241,247,O
",",247,248,O
4,249,250,O
),250,251,O
physical,252,260,O
or,261,263,O
mental,264,270,O
health,271,277,O
-,277,278,O
related,278,285,O
activity,286,294,O
limitation,295,305,O
",",305,306,O
5,307,308,O
),308,309,O
pain,310,314,O
-,314,315,O
related,315,322,O
activity,323,331,O
limitation,332,342,O
",",342,343,O
6,344,345,O
),345,346,O
sad,347,350,O
",",350,351,O
blue,352,356,O
",",356,357,O
or,358,360,O
depressed,361,370,O
",",370,371,O
7,372,373,O
),373,374,O
worried,375,382,O
",",382,383,O
tense,384,389,O
",",389,390,O
or,391,393,O
anxious,394,401,O
",",401,402,O
8,403,404,O
),404,405,O
lack,406,410,O
of,411,413,O
rest,414,418,O
or,419,421,O
sleep,422,427,O
",",427,428,O
and,429,432,O
9,433,434,O
),434,435,O
lack,436,440,O
of,441,443,O
energy,444,450,O
(,451,452,O
1,452,453,O
",",453,454,O
2,454,455,O
",",455,456,O
15,456,458,O
),458,459,O
.,459,460,O
We,461,463,O
created,464,471,O
9,472,473,O
dichotomous,474,485,O
indicator,486,495,O
variables,496,505,O
.,505,506,O
The,507,510,O
responses,511,520,O
to,521,523,O
the,524,527,O
self,528,532,O
-,532,533,O
rated,533,538,O
general,539,546,O
health,547,553,O
status,554,560,O
question,561,569,O
were,570,574,O
dichotomized,575,587,O
into,588,592,O
"""",593,594,O
poor,594,598,O
"""",598,599,O
(,600,601,O
poor,601,605,O
or,606,608,O
fair,609,613,O
),613,614,O
health,615,621,O
or,622,624,O
"""",625,626,O
good,626,630,O
"""",630,631,O
(,632,633,O
good,633,637,O
",",637,638,O
very,639,643,O
good,644,648,O
",",648,649,O
or,650,652,O
excellent,653,662,O
),662,663,O
health,664,670,O
.,670,671,O
The,672,675,O
indicators,676,686,O
measured,687,695,O
in,696,698,O
days,699,703,O
were,704,708,O
dichotomized,709,721,O
at,722,724,O
a,725,726,O
cutoff,727,733,O
value,734,739,O
of,740,742,O
14,743,745,O
or,746,748,O
more,749,753,O
days,754,758,O
of,759,761,O
poor,762,766,O
health,767,773,O
in,774,776,O
the,777,780,O
previous,781,789,O
month,790,795,O
compared,796,804,O
to,805,807,O
less,808,812,O
than,813,817,O
14,818,820,O
days,821,825,O
(,826,827,O
3,827,828,O
),828,829,O
.,829,830,O
We,831,833,O
selected,834,842,O
the,843,846,O
14,847,849,O
-,849,850,O
day,850,853,O
minimum,854,861,O
period,862,868,O
because,869,876,O
most,877,881,O
of,882,884,O
the,885,888,O
publications,889,901,O
we,902,904,O
reviewed,905,913,O
that,914,918,O
use,919,922,O
the,923,926,O
BRFSS,927,932,O
HRQOL,933,938,O
indicators,939,949,O
(,950,951,O
outcomes,951,959,O
),959,960,O
use,961,964,O
the,965,968,O
cutoff,969,975,O
of,976,978,O
14,979,981,O
or,982,984,O
more,985,989,O
days,990,994,O
compared,995,1003,O
to,1004,1006,O
13,1007,1009,O
or,1010,1012,O
fewer,1013,1018,O
days,1019,1023,O
(,1024,1025,O
3,1025,1026,O
-,1026,1027,O
5,1027,1028,O
",",1028,1029,O
7,1029,1030,O
-,1030,1031,O
11,1031,1033,O
",",1033,1034,O
16,1034,1036,O
",",1036,1037,O
17,1037,1039,O
),1039,1040,O
.,1040,1041,O
Adopting,1042,1050,O
this,1051,1055,O
precedent,1056,1065,O
ensured,1066,1073,O
comparability,1074,1087,O
.,1087,1088,O
In,1089,1091,O
addition,1092,1100,O
",",1100,1101,O
clinicians,1102,1112,O
and,1113,1116,O
clinical,1117,1125,O
researchers,1126,1137,O
often,1138,1143,O
use,1144,1147,O
this,1148,1152,O
period,1153,1159,O
as,1160,1162,O
a,1163,1164,O
marker,1165,1171,O
for,1172,1175,O
clinical,1176,1184,O
depression,1185,1195,O
and,1196,1199,O
anxiety,1200,1207,O
disorders,1208,1217,O
",",1217,1218,O
and,1219,1222,O
long,1223,1227,O
symptomatic,1228,1239,O
durations,1240,1249,O
are,1250,1253,O
associated,1254,1264,O
with,1265,1269,O
high,1270,1274,O
levels,1275,1281,O
of,1282,1284,O
activity,1285,1293,O
limitation,1294,1304,O
(,1305,1306,O
2,1306,1307,O
",",1307,1308,O
18,1308,1310,O
),1310,1311,O
.,1311,1312,O
Detailed,1313,1321,O
definitions,1322,1333,O
of,1334,1336,O
the,1337,1340,O
9,1341,1342,O
indicators,1343,1353,O
are,1354,1357,O
available,1358,1367,O
in,1368,1370,O
our,1371,1374,O
previous,1375,1383,O
article,1384,1391,O
(,1392,1393,O
1,1393,1394,O
),1394,1395,O
or,1396,1398,O
are,1399,1402,O
accessible,1403,1413,O
through,1414,1421,O
the,1422,1425,O
Centers,1426,1433,O
for,1434,1437,O
Disease,1438,1445,O
Control,1446,1453,O
and,1454,1457,O
Prevention,1458,1468,O
',1468,1469,O
s,1469,1470,O
HRQOL,1471,1476,O
Web,1477,1480,O
site,1481,1485,O
(,1486,1487,O
2,1487,1488,O
),1488,1489,O
.,1489,1490,O
We,1491,1493,O
chose,1494,1499,O
12,1500,1502,O
predictors,1503,1513,O
for,1514,1517,O
the,1518,1521,O
analysis,1522,1530,O
:,1530,1531,O
5,1532,1533,O
standard,1534,1542,O
demographic,1543,1554,O
measures,1555,1563,O
(,1564,1565,O
age,1565,1568,O
",",1568,1569,O
sex,1570,1573,O
",",1573,1574,O
race,1575,1579,O
/,1579,1580,O
Hispanic,1580,1588,O
ethnicity,1589,1598,O
",",1598,1599,O
annual,1600,1606,O
income,1607,1613,O
",",1613,1614,O
and,1615,1618,O
employment,1619,1629,O
status,1630,1636,O
),1636,1637,O
;,1637,1638,O
4,1639,1640,O
health,1641,1647,O
conditions,1648,1658,O
(,1659,1660,O
asthma,1660,1666,O
",",1666,1667,O
diabetes,1668,1676,O
",",1676,1677,O
obesity,1678,1685,O
",",1685,1686,O
and,1687,1690,O
physical,1691,1699,O
disability,1700,1710,O
),1710,1711,O
;,1711,1712,O
and,1713,1716,O
3,1717,1718,O
health,1719,1725,O
risk,1726,1730,O
behaviors,1731,1740,O
(,1741,1742,O
smoking,1742,1749,O
",",1749,1750,O
chronic,1751,1758,O
alcohol,1759,1766,O
use,1767,1770,O
",",1770,1771,O
and,1772,1775,O
no,1776,1778,O
leisure,1779,1786,O
-,1786,1787,O
time,1787,1791,O
physical,1792,1800,O
activity,1801,1809,O
),1809,1810,O
.,1810,1811,O
These,1812,1817,O
predictors,1818,1828,O
paralleled,1829,1839,O
the,1840,1843,O
results,1844,1851,O
of,1852,1854,O
other,1855,1860,O
studies,1861,1868,O
that,1869,1873,O
have,1874,1878,O
examined,1879,1887,O
relationships,1888,1901,O
between,1902,1909,O
a,1910,1911,O
specific,1912,1920,O
HRQOL,1921,1926,O
indicator,1927,1936,O
and,1937,1940,O
various,1941,1948,O
predictors,1949,1959,O
(,1960,1961,O
17,1961,1963,O
",",1963,1964,O
19,1964,1966,O
),1966,1967,O
",",1967,1968,O
or,1969,1971,O
that,1972,1976,O
have,1977,1981,O
examined,1982,1990,O
multiple,1991,1999,O
HRQOL,2000,2005,O
indicators,2006,2016,O
in,2017,2019,O
relation,2020,2028,O
to,2029,2031,O
demographics,2032,2044,O
(,2045,2046,O
4,2046,2047,O
",",2047,2048,O
20,2048,2050,O
),2050,2051,O
",",2051,2052,O
health,2053,2059,O
risks,2060,2065,O
(,2066,2067,O
5,2067,2068,O
",",2068,2069,O
10,2069,2071,O
",",2071,2072,O
21,2072,2074,O
),2074,2075,O
",",2075,2076,O
or,2077,2079,O
specific,2080,2088,O
health,2089,2095,O
conditions,2096,2106,O
(,2107,2108,O
6,2108,2109,O
-,2109,2110,O
9,2110,2111,O
",",2111,2112,O
12,2112,2114,O
",",2114,2115,O
22,2115,2117,O
),2117,2118,O
.,2118,2119,O
We,2120,2122,O
dichotomized,2123,2135,O
some,2136,2140,O
predictors,2141,2151,O
for,2152,2155,O
the,2156,2159,O
analysis,2160,2168,O
(,2169,2170,O
ie,2170,2172,O
",",2172,2173,O
sex,2174,2177,O
",",2177,2178,O
current,2179,2186,O
smoking,2187,2194,O
",",2194,2195,O
alcohol,2196,2203,O
use,2204,2207,O
",",2207,2208,O
physical,2209,2217,O
activity,2218,2226,O
",",2226,2227,O
asthma,2228,2234,O
",",2234,2235,O
diabetes,2236,2244,O
",",2244,2245,O
obesity,2246,2253,O
",",2253,2254,O
and,2255,2258,O
disability,2259,2269,O
),2269,2270,O
",",2270,2271,O
whereas,2272,2279,O
other,2280,2285,O
predictors,2286,2296,O
had,2297,2300,O
multiple,2301,2309,O
categories,2310,2320,O
(,2321,2322,O
ie,2322,2324,O
",",2324,2325,O
age,2326,2329,O
",",2329,2330,O
race,2331,2335,O
/,2335,2336,O
Hispanic,2336,2344,O
ethnicity,2345,2354,O
",",2354,2355,O
income,2356,2362,O
",",2362,2363,O
and,2364,2367,O
employment,2368,2378,O
status,2379,2385,O
),2385,2386,O
.,2386,2387,O
The,2388,2391,O
definitions,2392,2403,O
of,2404,2406,O
the,2407,2410,O
12,2411,2413,O
predictors,2414,2424,O
are,2425,2428,O
available,2429,2438,O
in,2439,2441,O
our,2442,2445,O
previous,2446,2454,O
article,2455,2462,O
(,2463,2464,O
1,2464,2465,O
),2465,2466,O
.,2466,2467,O
Reference,2468,2477,O
groups,2478,2484,O
chosen,2485,2491,O
for,2492,2495,O
the,2496,2499,O
IRT,2500,2503,O
model,2504,2509,O
were,2510,2514,O
those,2515,2520,O
having,2521,2527,O
the,2528,2531,O
lowest,2532,2538,O
risk,2539,2543,O
for,2544,2547,O
poor,2548,2552,O
or,2553,2555,O
fair,2556,2560,O
general,2561,2568,O
health,2569,2575,O
and,2576,2579,O
usually,2580,2587,O
the,2588,2591,O
lowest,2592,2598,O
risk,2599,2603,O
for,2604,2607,O
the,2608,2611,O
other,2612,2617,O
HRQOL,2618,2623,O
variables,2624,2633,O
as,2634,2636,O
well,2637,2641,O
.,2641,2642,O
Results,0,7,O
1,0,1,O
.,1,2,O
Introduction,3,15,O
Phase,16,21,O
I,22,23,O
clinical,24,32,O
trials,33,39,O
of,40,42,O
new,43,46,O
anticancer,47,57,O
agents,58,64,O
have,65,69,O
been,70,74,O
commonly,75,83,O
conducted,84,93,O
using,94,99,O
the,100,103,O
method,104,110,O
of,111,113,O
modified,114,122,O
Fibonacci,123,132,O
[,133,134,O
1,134,135,O
],135,136,O
.,136,137,O
In,138,140,O
brief,141,146,O
",",146,147,O
3,148,149,O
patients,150,158,O
are,159,162,O
treated,163,170,O
at,171,173,O
a,174,175,O
starting,176,184,O
dose,185,189,O
which,190,195,O
is,196,198,O
typically,199,208,O
one,209,212,O
tenth,213,218,O
of,219,221,O
the,222,225,O
dose,226,230,O
that,231,235,O
is,236,238,O
lethal,239,245,O
to,246,248,O
10,249,251,O
%,251,252,O
of,253,255,O
animals,256,263,O
defined,264,271,O
in,272,274,O
preclinical,275,286,O
studies,287,294,O
.,294,295,O
If,296,298,O
none,299,303,O
of,304,306,O
the,307,310,O
3,311,312,O
patients,313,321,O
experiences,322,333,O
DLT,334,337,O
",",337,338,O
then,339,343,O
the,344,347,O
next,348,352,O
3,353,354,O
patients,355,363,O
will,364,368,O
be,369,371,O
treated,372,379,O
at,380,382,O
the,383,386,O
next,387,391,O
higher,392,398,O
dose,399,403,O
.,403,404,O
If,405,407,O
DLT,408,411,O
is,412,414,O
observed,415,423,O
",",423,424,O
additional,425,435,O
patients,436,444,O
will,445,449,O
be,450,452,O
treated,453,460,O
at,461,463,O
the,464,467,O
same,468,472,O
or,473,475,O
lower,476,481,O
dose,482,486,O
level,487,492,O
to,493,495,O
determine,496,505,O
MTD,506,509,O
according,510,519,O
to,520,522,O
a,523,524,O
predetermined,525,538,O
schema,539,545,O
.,545,546,O
The,547,550,O
MTD,551,554,O
is,555,557,O
defined,558,565,O
as,566,568,O
the,569,572,O
highest,573,580,O
dose,581,585,O
reached,586,593,O
for,594,597,O
which,598,603,O
the,604,607,O
incidence,608,617,O
of,618,620,O
DLT,621,624,O
occurs,625,631,O
in,632,634,O
less,635,639,O
than,640,644,O
33,645,647,O
%,647,648,O
of,649,651,O
the,652,655,O
subjects,656,664,O
.,664,665,O
Typically,666,675,O
",",675,676,O
intrapatient,677,689,O
dose,690,694,O
escalation,695,705,O
is,706,708,O
not,709,712,O
allowed,713,720,O
.,720,721,O
There,722,727,O
are,728,731,O
several,732,739,O
shortcomings,740,752,O
associated,753,763,O
with,764,768,O
the,769,772,O
modified,773,781,O
-,781,782,O
Fibonacci,782,791,O
design,792,798,O
.,798,799,O
It,800,802,O
has,803,806,O
long,807,811,O
been,812,816,O
recognized,817,827,O
that,828,832,O
a,833,834,O
substantial,835,846,O
number,847,853,O
of,854,856,O
patients,857,865,O
are,866,869,O
likely,870,876,O
to,877,879,O
be,880,882,O
treated,883,890,O
at,891,893,O
subtherapeutic,894,908,O
doses,909,914,O
[,915,916,O
2,916,917,O
",",917,918,O
3,919,920,O
],920,921,O
.,921,922,O
This,923,927,O
is,928,930,O
particularly,931,943,O
true,944,948,O
for,949,952,O
drugs,953,958,O
with,959,963,O
potential,964,973,O
anticancer,974,984,O
activity,985,993,O
.,993,994,O
Since,995,1000,O
the,1001,1004,O
primary,1005,1012,O
purpose,1013,1020,O
of,1021,1023,O
phase,1024,1029,O
I,1030,1031,O
trials,1032,1038,O
is,1039,1041,O
to,1042,1044,O
determine,1045,1054,O
DLT,1055,1058,O
and,1059,1062,O
MTD,1063,1066,O
",",1066,1067,O
the,1068,1071,O
efficacy,1072,1080,O
of,1081,1083,O
the,1084,1087,O
drug,1088,1092,O
may,1093,1096,O
not,1097,1100,O
be,1101,1103,O
evident,1104,1111,O
for,1112,1115,O
certain,1116,1123,O
tumor,1124,1129,B-Pathological_formation
types,1130,1135,O
as,1136,1138,O
there,1139,1144,O
are,1145,1148,O
only,1149,1153,O
a,1154,1155,O
small,1156,1161,O
number,1162,1168,O
of,1169,1171,O
patients,1172,1180,O
enrolled,1181,1189,O
into,1190,1194,O
the,1195,1198,O
trial,1199,1204,O
.,1204,1205,O
Furthermore,1206,1217,O
",",1217,1218,O
the,1219,1222,O
modified,1223,1231,O
-,1231,1232,O
Fibonacci,1232,1241,O
design,1242,1248,O
does,1249,1253,O
not,1254,1257,O
take,1258,1262,O
into,1263,1267,O
account,1268,1275,O
individual,1276,1286,O
variations,1287,1297,O
in,1298,1300,O
therapeutic,1301,1312,O
and,1313,1316,O
toxicologic,1317,1328,O
responses,1329,1338,O
due,1339,1342,O
to,1343,1345,O
genomic,1346,1353,O
polymorphisms,1354,1367,O
[,1368,1369,O
4,1369,1370,O
",",1370,1371,O
5,1372,1373,O
],1373,1374,O
.,1374,1375,O
In,1376,1378,O
addition,1379,1387,O
",",1387,1388,O
since,1389,1394,O
there,1395,1400,O
is,1401,1403,O
a,1404,1405,O
limit,1406,1411,O
of,1412,1414,O
3,1415,1416,O
subjects,1417,1425,O
allowed,1426,1433,O
for,1434,1437,O
each,1438,1442,O
cohort,1443,1449,O
",",1449,1450,O
a,1451,1452,O
waiting,1453,1460,O
period,1461,1467,O
of,1468,1470,O
up,1471,1473,O
to,1474,1476,O
four,1477,1481,O
weeks,1482,1487,O
is,1488,1490,O
commonly,1491,1499,O
required,1500,1508,O
before,1509,1515,O
enrollment,1516,1526,O
of,1527,1529,O
the,1530,1533,O
next,1534,1538,O
cohort,1539,1545,O
of,1546,1548,O
subjects,1549,1557,O
.,1557,1558,O
This,1559,1563,O
latter,1564,1570,O
requirement,1571,1582,O
creates,1583,1590,O
anxiety,1591,1598,O
of,1599,1601,O
waiting,1602,1609,O
for,1610,1613,O
eligible,1614,1622,O
patients,1623,1631,O
.,1631,1632,O
Several,1633,1640,O
alternative,1641,1652,O
phase,1653,1658,O
I,1659,1660,O
designs,1661,1668,O
have,1669,1673,O
been,1674,1678,O
proposed,1679,1687,O
which,1688,1693,O
limit,1694,1699,O
the,1700,1703,O
number,1704,1710,O
of,1711,1713,O
patients,1714,1722,O
accrued,1723,1730,O
at,1731,1733,O
each,1734,1738,O
dose,1739,1743,O
level,1744,1749,O
and,1750,1753,O
accelerate,1754,1764,O
the,1765,1768,O
dose,1769,1773,O
escalation,1774,1784,O
process,1785,1792,O
[,1793,1794,O
1,1794,1795,O
",",1795,1796,O
6,1797,1798,O
],1798,1799,O
.,1799,1800,O
There,1801,1806,O
has,1807,1810,O
also,1811,1815,O
been,1816,1820,O
an,1821,1823,O
increase,1824,1832,O
in,1833,1835,O
the,1836,1839,O
number,1840,1846,O
of,1847,1849,O
clinical,1850,1858,O
trials,1859,1865,O
that,1866,1870,O
include,1871,1878,O
a,1879,1880,O
component,1881,1890,O
of,1891,1893,O
intrapatient,1894,1906,O
dose,1907,1911,O
escalation,1912,1922,O
although,1923,1931,O
no,1932,1934,O
formal,1935,1941,O
validation,1942,1952,O
with,1953,1957,O
the,1958,1961,O
modified,1962,1970,O
-,1970,1971,O
Fibonacci,1971,1980,O
approach,1981,1989,O
has,1990,1993,O
been,1994,1998,O
reported,1999,2007,O
[,2008,2009,O
7,2009,2010,O
-,2010,2011,O
9,2011,2012,O
],2012,2013,O
.,2013,2014,O
We,2015,2017,O
have,2018,2022,O
pioneered,2023,2032,O
a,2033,2034,O
population,2035,2045,O
-,2045,2046,O
based,2046,2051,O
design,2052,2058,O
to,2059,2061,O
maximize,2062,2070,O
therapeutic,2071,2082,O
efficacy,2083,2091,O
",",2091,2092,O
to,2093,2095,O
provide,2096,2103,O
preliminary,2104,2115,O
efficacy,2116,2124,O
information,2125,2136,O
and,2137,2140,O
to,2141,2143,O
allow,2144,2149,O
derivation,2150,2160,O
of,2161,2163,O
a,2164,2165,O
pMTD,2166,2170,O
for,2171,2174,O
subsequent,2175,2185,O
phase,2186,2191,O
II,2192,2194,O
trials,2195,2201,O
.,2201,2202,O
Irinotecan,2203,2213,O
and,2214,2217,O
cisplatin,2218,2227,O
have,2228,2232,O
been,2233,2237,O
shown,2238,2243,O
to,2244,2246,O
have,2247,2251,O
promising,2252,2261,O
efficacy,2262,2270,O
in,2271,2273,O
patients,2274,2282,O
with,2283,2287,O
small,2288,2293,B-Pathological_formation
-,2293,2294,I-Pathological_formation
cell,2294,2298,I-Pathological_formation
lung,2299,2303,I-Pathological_formation
cancer,2304,2310,I-Pathological_formation
in,2311,2313,O
phase,2314,2319,O
III,2320,2323,O
trial,2324,2329,O
where,2330,2335,O
irinotecan,2336,2346,O
was,2347,2350,O
given,2351,2356,O
on,2357,2359,O
a,2360,2361,O
weekly,2362,2368,O
schedule,2369,2377,O
[,2378,2379,O
10,2379,2381,O
],2381,2382,O
.,2382,2383,O
We,2384,2386,O
wished,2387,2393,O
to,2394,2396,O
perform,2397,2404,O
a,2405,2406,O
population,2407,2417,O
-,2417,2418,O
based,2418,2423,O
phase,2424,2429,O
I,2430,2431,O
trial,2432,2437,O
of,2438,2440,O
irinotecan,2441,2451,O
",",2451,2452,O
given,2453,2458,O
every,2459,2464,O
3,2465,2466,O
weeks,2467,2472,O
",",2472,2473,O
and,2474,2477,O
carboplatin,2478,2489,O
",",2489,2490,O
a,2491,2492,O
platinated,2493,2503,O
anticancer,2504,2514,O
drug,2515,2519,O
which,2520,2525,O
is,2526,2528,O
generally,2529,2538,O
better,2539,2545,O
tolerated,2546,2555,O
than,2556,2560,O
its,2561,2564,O
cisplatin,2565,2574,O
analog,2575,2581,O
.,2581,2582,O
2,0,1,O
.,1,2,O
2,2,3,O
.,3,4,O
Iris,5,9,B-Multi-tissue_structure
and,10,13,O
Ciliary,14,21,B-Multi-tissue_structure
Body,22,26,I-Multi-tissue_structure
Serotonin,27,36,O
is,37,39,O
present,40,47,O
in,48,50,O
mammalian,51,60,O
iris,61,65,B-Multi-tissue_structure
-,65,66,I-Multi-tissue_structure
ciliary,66,73,I-Multi-tissue_structure
body,74,78,I-Multi-tissue_structure
complex,79,86,I-Multi-tissue_structure
(,87,88,O
ICB,88,91,B-Multi-tissue_structure
),91,92,O
at,93,95,O
higher,96,102,O
concentration,103,116,O
that,117,121,O
in,122,124,O
non,125,128,O
-,128,129,O
mammalian,129,138,O
species,139,146,O
[,147,148,O
5,148,149,O
",",149,150,O
45,151,153,O
",",153,154,O
73,155,157,O
",",157,158,O
129,159,162,O
",",162,163,O
137,164,167,O
],167,168,O
.,168,169,O
Moreover,170,178,O
",",178,179,O
the,180,183,O
presence,184,192,O
of,193,195,O
serotonergic,196,208,O
nerves,209,215,B-Multi-tissue_structure
has,216,219,O
been,220,224,O
demonstrated,225,237,O
in,238,240,O
studies,241,248,O
conducted,249,258,O
on,259,261,O
the,262,265,O
ICB,266,269,B-Multi-tissue_structure
of,270,272,O
various,273,280,O
species,281,288,O
[,289,290,O
102,290,293,O
",",293,294,O
137,295,298,O
",",298,299,O
138,300,303,O
],303,304,O
.,304,305,O
Experimental,306,318,O
evidence,319,327,O
and,328,331,O
radioligand,332,343,O
analyses,344,352,O
have,353,357,O
defined,358,365,O
the,366,369,O
presence,370,378,O
at,379,381,O
this,382,386,O
level,387,392,O
of,393,395,O
three,396,401,O
different,402,411,O
types,412,417,O
of,418,420,O
serotonin,421,430,O
receptors,431,440,O
[,441,442,O
10,442,444,O
",",444,445,O
28,446,448,O
",",448,449,O
85,450,452,O
",",452,453,O
136,454,457,O
",",457,458,O
137,459,462,O
],462,463,O
",",463,464,O
i,465,466,O
.,466,467,O
e,467,468,O
.,468,469,O
5,470,471,O
-,471,472,O
HT1A,472,476,O
",",476,477,O
5,478,479,O
-,479,480,O
HT2A,480,484,O
/,484,485,O
2C,485,487,O
and,488,491,O
5,492,493,O
-,493,494,O
HT7,494,497,O
[,498,499,O
98,499,501,O
],501,502,O
",",502,503,O
one,504,507,O
linked,508,514,O
to,515,517,O
a,518,519,O
stimulation,520,531,O
of,532,534,O
inositol,535,543,O
phosphates,544,554,O
(,555,556,O
5,556,557,O
-,557,558,O
HT2,558,561,O
subtype,562,569,O
),569,570,O
",",570,571,O
while,572,577,O
the,578,581,O
others,582,588,O
two,589,592,O
are,593,596,O
linked,597,603,O
to,604,606,O
cAMP,607,611,O
activity,612,620,O
.,620,621,O
The,622,625,O
plausibility,626,638,O
of,639,641,O
the,642,645,O
existence,646,655,O
of,656,658,O
more,659,663,O
than,664,668,O
one,669,672,O
5,673,674,O
-,674,675,O
HT,675,677,O
receptor,678,686,O
type,687,691,O
in,692,694,O
the,695,698,O
ciliary,699,706,B-Multi-tissue_structure
body,707,711,I-Multi-tissue_structure
is,712,714,O
confirmed,715,724,O
by,725,727,O
intraocular,728,739,B-Immaterial_anatomical_entity
pressure,740,748,O
(,749,750,O
IOP,750,753,O
),753,754,O
experiments,755,766,O
.,766,767,O
Topical,768,775,O
application,776,787,O
of,788,790,O
serotonin,791,800,O
has,801,804,O
been,805,809,O
reported,810,818,O
to,819,821,O
both,822,826,O
elevate,827,834,O
[,835,836,O
84,836,838,O
],838,839,O
and,840,843,O
lower,844,849,O
[,850,851,O
88,851,853,O
],853,854,O
IOP,855,858,O
in,859,861,O
rabbit,862,868,O
.,868,869,O
A,870,871,O
large,872,877,O
number,878,884,O
of,885,887,O
reports,888,895,O
have,896,900,O
shown,901,906,O
that,907,911,O
serotonin,912,921,O
agonists,922,930,O
and,931,934,O
antagonists,935,946,O
can,947,950,O
produce,951,958,O
increases,959,968,O
and,969,972,O
decreases,973,982,O
in,983,985,O
IOP,986,989,O
when,990,994,O
given,995,1000,O
orally,1001,1007,O
",",1007,1008,O
topically,1009,1018,O
to,1019,1021,O
the,1022,1025,O
eye,1026,1029,B-Organ
or,1030,1032,O
when,1033,1037,O
they,1038,1042,O
are,1043,1046,O
directly,1047,1055,O
injected,1056,1064,O
in,1065,1067,O
the,1068,1071,O
anterior,1072,1080,B-Multi-tissue_structure
chamber,1081,1088,I-Multi-tissue_structure
[,1089,1090,O
10,1090,1092,O
",",1092,1093,O
26,1094,1096,O
",",1096,1097,O
34,1098,1100,O
",",1100,1101,O
35,1102,1104,O
",",1104,1105,O
64,1106,1108,O
",",1108,1109,O
75,1110,1112,O
",",1112,1113,O
84,1114,1116,O
",",1116,1117,O
87,1118,1120,O
",",1120,1121,O
88,1122,1124,O
",",1124,1125,O
112,1126,1129,O
",",1129,1130,O
113,1131,1134,O
",",1134,1135,O
126,1136,1139,O
",",1139,1140,O
136,1141,1144,O
",",1144,1145,O
137,1146,1149,O
],1149,1150,O
.,1150,1151,O
A,1152,1153,O
rationale,1154,1163,O
for,1164,1167,O
such,1168,1172,O
apparently,1173,1183,O
contradictory,1184,1197,O
results,1198,1205,O
may,1206,1209,O
be,1210,1212,O
due,1213,1216,O
to,1217,1219,O
the,1220,1223,O
different,1224,1233,O
sites,1234,1239,O
of,1240,1242,O
action,1243,1249,O
",",1249,1250,O
i,1251,1252,O
.,1252,1253,O
e,1253,1254,O
.,1254,1255,O
which,1256,1261,O
class,1262,1267,O
of,1268,1270,O
serotonin,1271,1280,O
receptor,1281,1289,O
is,1290,1292,O
activated,1293,1302,O
.,1302,1303,O
In,1304,1306,O
fact,1307,1311,O
",",1311,1312,O
in,1313,1315,O
rabbit,1316,1322,O
the,1323,1326,O
administration,1327,1341,O
of,1342,1344,O
5,1345,1346,O
-,1346,1347,O
methyl,1347,1353,O
-,1353,1354,O
urapidil,1354,1362,O
(,1363,1364,O
a,1364,1365,O
combined,1366,1374,O
5,1375,1376,O
-,1376,1377,O
HT1A,1377,1381,O
agonist,1382,1389,O
/,1389,1390,O
alpha1,1390,1396,O
adrenoreceptor,1397,1411,O
antagonist,1412,1422,O
),1422,1423,O
and,1424,1427,O
8,1428,1429,O
-,1429,1430,O
OH,1430,1432,O
-,1432,1433,O
DPAT,1433,1437,O
(,1438,1439,O
8,1439,1440,O
-,1440,1441,O
hydroxydypropylaminotetralin,1441,1469,O
",",1469,1470,O
a,1471,1472,O
5HT1A,1473,1478,O
agonist,1479,1486,O
),1486,1487,O
reduces,1488,1495,O
IOP,1496,1499,O
",",1499,1500,O
while,1501,1506,O
the,1507,1510,O
administration,1511,1525,O
of,1526,1528,O
5,1529,1530,O
-,1530,1531,O
CT,1531,1533,O
(,1534,1535,O
5,1535,1536,O
-,1536,1537,O
carboxamidotryptamine,1537,1558,O
",",1558,1559,O
a,1560,1561,O
5,1562,1563,O
-,1563,1564,O
HT1A,1564,1568,O
and,1569,1572,O
5,1573,1574,O
-,1574,1575,O
HT7,1575,1578,O
agonist,1579,1586,O
),1586,1587,O
increases,1588,1597,O
IOP,1598,1601,O
[,1602,1603,O
36,1603,1605,O
",",1605,1606,O
84,1607,1609,O
",",1609,1610,O
99,1611,1613,O
],1613,1614,O
.,1614,1615,O
Chidlow,1616,1623,O
",",1623,1624,O
Le,1625,1627,O
Corre,1628,1633,O
and,1634,1637,O
Osborne,1638,1645,O
[,1646,1647,O
28,1647,1649,O
],1649,1650,O
have,1651,1655,O
recently,1656,1664,O
demonstrated,1665,1677,O
that,1678,1682,O
",",1682,1683,O
in,1684,1686,O
section,1687,1694,O
taken,1695,1700,O
through,1701,1708,O
the,1709,1712,O
whole,1713,1718,O
eye,1719,1722,B-Organ
and,1723,1726,O
ciliary,1727,1734,B-Multi-tissue_structure
body,1735,1739,I-Multi-tissue_structure
",",1739,1740,O
prominent,1741,1750,O
5,1751,1752,O
-,1752,1753,O
HT1A,1753,1757,O
and,1758,1761,O
5,1762,1763,O
-,1763,1764,O
HT7,1764,1767,O
receptor,1768,1776,O
messenger,1777,1786,O
ribonucleic,1787,1798,O
acid,1799,1803,O
signals,1804,1811,O
were,1812,1816,O
obtained,1817,1825,O
.,1825,1826,O
These,1827,1832,O
signals,1833,1840,O
were,1841,1845,O
evident,1846,1853,O
in,1854,1856,O
both,1857,1861,O
the,1862,1865,O
pigmented,1866,1875,O
and,1876,1879,O
non,1880,1883,O
-,1883,1884,O
pigmented,1884,1893,O
epithelial,1894,1904,B-Cell
cell,1905,1909,I-Cell
layers,1910,1916,O
of,1917,1919,O
the,1920,1923,O
pars,1924,1928,B-Multi-tissue_structure
plicata,1929,1936,I-Multi-tissue_structure
region,1937,1943,O
of,1944,1946,O
the,1947,1950,O
ciliary,1951,1958,B-Multi-tissue_structure
processes,1959,1968,O
",",1968,1969,O
but,1970,1973,O
not,1974,1977,O
in,1978,1980,O
the,1981,1984,O
pars,1985,1989,B-Multi-tissue_structure
plana,1990,1995,I-Multi-tissue_structure
or,1996,1998,O
in,1999,2001,O
the,2002,2005,O
ciliary,2006,2013,B-Multi-tissue_structure
musculature,2014,2025,I-Multi-tissue_structure
.,2025,2026,O
5,2027,2028,O
-,2028,2029,O
HT1A,2029,2033,O
and,2034,2037,O
5,2038,2039,O
-,2039,2040,O
HT7,2040,2043,O
signals,2044,2051,O
were,2052,2056,O
apparent,2057,2065,O
in,2066,2068,O
the,2069,2072,O
posterior,2073,2082,O
processes,2083,2092,O
but,2093,2096,O
not,2097,2100,O
in,2101,2103,O
the,2104,2107,O
iris,2108,2112,B-Multi-tissue_structure
processes,2113,2122,O
.,2122,2123,O
The,2124,2127,O
presence,2128,2136,O
of,2137,2139,O
both,2140,2144,O
receptors,2145,2154,O
in,2155,2157,O
the,2158,2161,O
ciliary,2162,2169,B-Multi-tissue_structure
body,2170,2174,I-Multi-tissue_structure
would,2175,2180,O
certainly,2181,2190,O
provide,2191,2198,O
an,2199,2201,O
explanation,2202,2213,O
for,2214,2217,O
the,2218,2221,O
shallow,2222,2229,O
displacement,2230,2242,O
curves,2243,2249,O
observed,2250,2258,O
in,2259,2261,O
[,2262,2263,O
3H,2263,2265,O
],2265,2266,O
5,2266,2267,O
-,2267,2268,O
HT,2268,2270,O
binding,2271,2278,O
studies,2279,2286,O
with,2287,2291,O
the,2292,2295,O
tissue,2296,2302,B-Tissue
[,2303,2304,O
110,2304,2307,O
],2307,2308,O
",",2308,2309,O
since,2310,2315,O
this,2316,2320,O
ligand,2321,2327,O
can,2328,2331,O
be,2332,2334,O
used,2335,2339,O
to,2340,2342,O
label,2343,2348,O
both,2349,2353,O
receptors,2354,2363,O
.,2363,2364,O
Because,2365,2372,O
the,2373,2376,O
ciliary,2377,2384,B-Tissue
epithelium,2385,2395,I-Tissue
of,2396,2398,O
the,2399,2402,O
pars,2403,2407,B-Multi-tissue_structure
plicata,2408,2415,I-Multi-tissue_structure
is,2416,2418,O
responsible,2419,2430,O
for,2431,2434,O
the,2435,2438,O
secretion,2439,2448,O
of,2449,2451,O
aqueous,2452,2459,O
humor,2460,2465,O
",",2465,2466,O
an,2467,2469,O
obvious,2470,2477,O
function,2478,2486,O
for,2487,2490,O
these,2491,2496,O
two,2497,2500,O
receptors,2501,2510,O
would,2511,2516,O
be,2517,2519,O
an,2520,2522,O
involvement,2523,2534,O
in,2535,2537,O
the,2538,2541,O
control,2542,2549,O
of,2550,2552,O
aqueous,2553,2560,O
production,2561,2571,O
and,2572,2575,O
",",2575,2576,O
consequently,2577,2589,O
",",2589,2590,O
of,2591,2593,O
the,2594,2597,O
IOP,2598,2601,O
level,2602,2607,O
.,2607,2608,O
Further,2609,2616,O
",",2616,2617,O
the,2618,2621,O
almost,2622,2628,O
identical,2629,2638,O
distribution,2639,2651,O
of,2652,2654,O
the,2655,2658,O
5,2659,2660,O
-,2660,2661,O
HT1A,2661,2665,O
and,2666,2669,O
5,2670,2671,O
-,2671,2672,O
HT7,2672,2675,O
messengers,2676,2686,O
ribonucleic,2687,2698,O
acid,2699,2703,O
indicate,2704,2712,O
that,2713,2717,O
the,2718,2721,O
receptors,2722,2731,O
may,2732,2735,O
be,2736,2738,O
co,2739,2741,O
-,2741,2742,O
localized,2742,2751,O
in,2752,2754,O
epithelial,2755,2765,B-Cell
cells,2766,2771,I-Cell
.,2771,2772,O
The,2773,2776,O
presence,2777,2785,O
of,2786,2788,O
two,2789,2792,O
serotonin,2793,2802,O
receptors,2803,2812,O
with,2813,2817,O
opposing,2818,2826,O
effects,2827,2834,O
on,2835,2837,O
cAMP,2838,2842,O
in,2843,2845,O
the,2846,2849,O
same,2850,2854,O
cell,2855,2859,B-Cell
layer,2860,2865,O
prompts,2866,2873,O
the,2874,2877,O
suggestion,2878,2888,O
that,2889,2893,O
they,2894,2898,O
could,2899,2904,O
act,2905,2908,O
antagonistically,2909,2925,O
.,2925,2926,O
The,2927,2930,O
agonism,2931,2938,O
of,2939,2941,O
5,2942,2943,O
-,2943,2944,O
HT1A,2944,2948,O
receptors,2949,2958,O
",",2958,2959,O
negatively,2960,2970,O
coupled,2971,2978,O
to,2979,2981,O
cAMP,2982,2986,O
",",2986,2987,O
reduces,2988,2995,O
IOP,2996,2999,O
by,3000,3002,O
decreasing,3003,3013,O
the,3014,3017,O
production,3018,3028,O
of,3029,3031,O
aqueous,3032,3039,O
humor,3040,3045,O
",",3045,3046,O
like,3047,3051,O
beta,3052,3056,O
-,3056,3057,O
receptor,3057,3065,O
antagonists,3066,3077,O
which,3078,3083,O
",",3083,3084,O
diminishing,3085,3096,O
the,3097,3100,O
content,3101,3108,O
of,3109,3111,O
cAMP,3112,3116,O
at,3117,3119,O
the,3120,3123,O
postjunctional,3124,3138,O
site,3139,3143,O
",",3143,3144,O
lowers,3145,3151,O
the,3152,3155,O
aqueous,3156,3163,O
humor,3164,3169,B-Organism_substance
secretion,3170,3179,O
with,3180,3184,O
a,3185,3186,O
consequent,3187,3197,O
decrease,3198,3206,O
in,3207,3209,O
IOP,3210,3213,O
[,3214,3215,O
98,3215,3217,O
],3217,3218,O
.,3218,3219,O
On,3220,3222,O
the,3223,3226,O
contrary,3227,3235,O
",",3235,3236,O
the,3237,3240,O
administration,3241,3255,O
of,3256,3258,O
5,3259,3260,O
-,3260,3261,O
CT,3261,3263,O
induces,3264,3271,O
a,3272,3273,O
rise,3274,3278,O
in,3279,3281,O
IOP,3282,3285,O
",",3285,3286,O
which,3287,3292,O
is,3293,3295,O
partly,3296,3302,O
or,3303,3305,O
entirely,3306,3314,O
caused,3315,3321,O
by,3322,3324,O
an,3325,3327,O
increase,3328,3336,O
in,3337,3339,O
aqueous,3340,3347,O
humor,3348,3353,B-Organism_substance
secretion,3354,3363,O
mediated,3364,3372,O
by,3373,3375,O
5,3376,3377,O
-,3377,3378,O
HT7,3378,3381,O
receptors,3382,3391,O
[,3392,3393,O
84,3393,3395,O
],3395,3396,O
.,3396,3397,O
The,3398,3401,O
other,3402,3407,O
type,3408,3412,O
of,3413,3415,O
serotonin,3416,3425,O
receptor,3426,3434,O
present,3435,3442,O
in,3443,3445,O
the,3446,3449,O
ICB,3450,3453,B-Multi-tissue_structure
is,3454,3456,O
a,3457,3458,O
5,3459,3460,O
-,3460,3461,O
HT2,3461,3464,O
type,3465,3469,O
.,3469,3470,O
Serotonin,3471,3480,O
stimulates,3481,3491,O
the,3492,3495,O
accumulation,3496,3508,O
of,3509,3511,O
inositol,3512,3520,O
phosphates,3521,3531,O
in,3532,3534,O
the,3535,3538,O
ICB,3539,3542,B-Multi-tissue_structure
and,3543,3546,O
this,3547,3551,O
effect,3552,3558,O
is,3559,3561,O
partially,3562,3571,O
counteracted,3572,3584,O
by,3585,3587,O
the,3588,3591,O
5,3592,3593,O
-,3593,3594,O
HT2,3594,3597,O
antagonists,3598,3609,O
ketanserin,3610,3620,O
",",3620,3621,O
methysergide,3622,3634,O
and,3635,3638,O
mianserin,3639,3648,O
[,3649,3650,O
98,3650,3652,O
],3652,3653,O
.,3653,3654,O
Studies,3655,3662,O
with,3663,3667,O
ketanserin,3668,3678,O
have,3679,3683,O
demonstrated,3684,3696,O
that,3697,3701,O
",",3701,3702,O
when,3703,3707,O
orally,3708,3714,O
or,3715,3717,O
topically,3718,3727,O
applied,3728,3735,O
",",3735,3736,O
it,3737,3739,O
lowers,3740,3746,O
IOP,3747,3750,O
in,3751,3753,O
animals,3754,3761,O
",",3761,3762,O
healthy,3763,3770,O
volunteers,3771,3781,O
and,3782,3785,O
in,3786,3788,O
glaucomatous,3789,3801,O
patients,3802,3810,O
[,3811,3812,O
26,3812,3814,O
",",3814,3815,O
34,3816,3818,O
",",3818,3819,O
37,3820,3822,O
",",3822,3823,O
64,3824,3826,O
",",3826,3827,O
75,3828,3830,O
",",3830,3831,O
88,3832,3834,O
",",3834,3835,O
113,3836,3839,O
",",3839,3840,O
126,3841,3844,O
],3844,3845,O
.,3845,3846,O
It,3847,3849,O
has,3850,3853,O
been,3854,3858,O
emphasized,3859,3869,O
that,3870,3874,O
ketanserin,3875,3885,O
also,3886,3890,O
possesses,3891,3900,O
an,3901,3903,O
affinity,3904,3912,O
for,3913,3916,O
alpha1,3917,3923,O
-,3923,3924,O
adrenoreceptors,3924,3939,O
[,3940,3941,O
27,3941,3943,O
",",3943,3944,O
36,3945,3947,O
",",3947,3948,O
139,3949,3952,O
],3952,3953,O
",",3953,3954,O
and,3955,3958,O
for,3959,3962,O
this,3963,3967,O
reason,3968,3974,O
the,3975,3978,O
effects,3979,3986,O
of,3987,3989,O
ketanserin,3990,4000,O
on,4001,4003,O
IOP,4004,4007,O
may,4008,4011,O
not,4012,4015,O
be,4016,4018,O
entirely,4019,4027,O
caused,4028,4034,O
by,4035,4037,O
its,4038,4041,O
action,4042,4048,O
on,4049,4051,O
5,4052,4053,O
-,4053,4054,O
HT2,4054,4057,O
receptors,4058,4067,O
.,4067,4068,O
However,4069,4076,O
",",4076,4077,O
data,4078,4082,O
from,4083,4087,O
human,4088,4093,O
studies,4094,4101,O
conducted,4102,4111,O
after,4112,4117,O
oral,4118,4122,O
or,4123,4125,O
topical,4126,4133,O
administration,4134,4148,O
of,4149,4151,O
ketanserin,4152,4162,O
",",4162,4163,O
in,4164,4166,O
which,4167,4172,O
were,4173,4177,O
determined,4178,4188,O
the,4189,4192,O
variations,4193,4203,O
of,4204,4206,O
IOP,4207,4210,O
",",4210,4211,O
total,4212,4217,O
outflow,4218,4225,O
facility,4226,4234,O
and,4235,4238,O
pupil,4239,4244,B-Multi-tissue_structure
diameter,4245,4253,O
",",4253,4254,O
demonstrated,4255,4267,O
that,4268,4272,O
the,4273,4276,O
alpha1,4277,4283,O
-,4283,4284,O
adrenoreceptor,4284,4298,O
blocking,4299,4307,O
effect,4308,4314,O
exerted,4315,4322,O
by,4323,4325,O
ketanserin,4326,4336,O
should,4337,4343,O
represent,4344,4353,O
a,4354,4355,O
further,4356,4363,O
aspect,4364,4370,O
of,4371,4373,O
its,4374,4377,O
mechanism,4378,4387,O
of,4388,4390,O
action,4391,4397,O
",",4397,4398,O
probably,4399,4407,O
due,4408,4411,O
to,4412,4414,O
a,4415,4416,O
functional,4417,4427,O
sharing,4428,4435,O
of,4436,4438,O
these,4439,4444,O
receptors,4445,4454,O
[,4455,4456,O
64,4456,4458,O
",",4458,4459,O
87,4460,4462,O
],4462,4463,O
.,4463,4464,O
Lastly,4465,4471,O
",",4471,4472,O
already,4473,4480,O
in,4481,4483,O
1992,4484,4488,O
Martin,4489,4495,O
and,4496,4499,O
co,4500,4502,O
-,4502,4503,O
workers,4503,4510,O
showed,4511,4517,O
the,4518,4521,O
occurrence,4522,4532,O
of,4533,4535,O
a,4536,4537,O
significant,4538,4549,O
correlation,4550,4561,O
between,4562,4569,O
the,4570,4573,O
content,4574,4581,O
of,4582,4584,O
serotonin,4585,4594,O
in,4595,4597,O
the,4598,4601,O
aqueous,4602,4609,O
humor,4610,4615,B-Organism_substance
and,4616,4619,O
IOP,4620,4623,O
in,4624,4626,O
the,4627,4630,O
human,4631,4636,O
eye,4637,4640,B-Organ
[,4641,4642,O
85,4642,4644,O
],4644,4645,O
.,4645,4646,O
In,4647,4649,O
1981,4650,4654,O
",",4654,4655,O
Moro,4656,4660,O
and,4661,4664,O
his,4665,4668,O
collaborators,4669,4682,O
found,4683,4688,O
that,4689,4693,O
intravitreal,4694,4706,O
injection,4707,4716,O
of,4717,4719,O
5,4720,4721,O
",",4721,4722,O
6,4723,4724,O
-,4724,4725,O
dihydroxytryptamine,4725,4744,O
",",4744,4745,O
a,4746,4747,O
serotonergic,4748,4760,O
neurotoxin,4761,4771,O
",",4771,4772,O
causes,4773,4779,O
miosis,4780,4786,O
[,4787,4788,O
91,4788,4790,O
],4790,4791,O
.,4791,4792,O
The,4793,4796,O
identification,4797,4811,O
of,4812,4814,O
5,4815,4816,O
-,4816,4817,O
HT7,4817,4820,O
",",4820,4821,O
but,4822,4825,O
not,4826,4829,O
of,4830,4832,O
5,4833,4834,O
-,4834,4835,O
HT1,4835,4838,O
receptors,4839,4848,O
in,4849,4851,O
the,4852,4855,O
rabbit,4856,4862,O
iris,4863,4867,B-Multi-tissue_structure
",",4867,4868,O
suggests,4869,4877,O
that,4878,4882,O
this,4883,4887,O
population,4888,4898,O
of,4899,4901,O
serotonergic,4902,4914,O
receptors,4915,4924,O
is,4925,4927,O
involved,4928,4936,O
in,4937,4939,O
the,4940,4943,O
relaxation,4944,4954,O
of,4955,4957,O
the,4958,4961,O
sphincter,4962,4971,B-Tissue
of,4972,4974,O
the,4975,4978,O
pupil,4979,4984,B-Multi-tissue_structure
.,4984,4985,O
In,4986,4988,O
fact,4989,4993,O
",",4993,4994,O
one,4995,4998,O
of,4999,5001,O
the,5002,5005,O
function,5006,5014,O
correlate,5015,5024,O
to,5025,5027,O
5,5028,5029,O
-,5029,5030,O
HT7,5030,5033,O
receptor,5034,5042,O
activation,5043,5053,O
includes,5054,5062,O
smooth,5063,5069,B-Tissue
muscle,5070,5076,I-Tissue
relaxation,5077,5087,O
observed,5088,5096,O
in,5097,5099,O
a,5100,5101,O
variety,5102,5109,O
of,5110,5112,O
isolated,5113,5121,O
tissue,5122,5128,B-Tissue
preparations,5129,5141,O
",",5141,5142,O
in,5143,5145,O
which,5146,5151,O
elevation,5152,5161,O
of,5162,5164,O
cAMP,5165,5169,O
concentration,5170,5183,O
was,5184,5187,O
also,5188,5192,O
detected,5193,5201,O
[,5202,5203,O
3,5203,5204,O
",",5204,5205,O
44,5206,5208,O
],5208,5209,O
.,5209,5210,O
Further,5211,5218,O
evidence,5219,5227,O
for,5228,5231,O
the,5232,5235,O
mediation,5236,5245,O
of,5246,5248,O
the,5249,5252,O
relaxant,5253,5261,O
response,5262,5270,O
via,5271,5274,O
the,5275,5278,O
5,5279,5280,O
-,5280,5281,O
HT7,5281,5284,O
receptor,5285,5293,O
is,5294,5296,O
provided,5297,5305,O
by,5306,5308,O
the,5309,5312,O
localization,5313,5325,O
of,5326,5328,O
messenger,5329,5338,O
ribonucleic,5339,5350,O
acid,5351,5355,O
transcripts,5356,5367,O
encoding,5368,5376,O
the,5377,5380,O
5,5381,5382,O
-,5382,5383,O
HT7,5383,5386,O
receptor,5387,5395,O
in,5396,5398,O
many,5399,5403,O
blood,5404,5409,B-Multi-tissue_structure
vessels,5410,5417,I-Multi-tissue_structure
[,5418,5419,O
67,5419,5421,O
],5421,5422,O
.,5422,5423,O
This,5424,5428,O
hypothesized,5429,5441,O
mechanism,5442,5451,O
of,5452,5454,O
action,5455,5461,O
is,5462,5464,O
also,5465,5469,O
supported,5470,5479,O
by,5480,5482,O
the,5483,5486,O
fact,5487,5491,O
that,5492,5496,O
various,5497,5504,O
other,5505,5510,O
receptor,5511,5519,O
types,5520,5525,O
",",5525,5526,O
also,5527,5531,O
positively,5532,5542,O
coupled,5543,5550,O
to,5551,5553,O
cAMP,5554,5558,O
",",5558,5559,O
in,5560,5562,O
the,5563,5566,O
iris,5567,5571,B-Multi-tissue_structure
cause,5572,5577,O
relaxation,5578,5588,O
of,5589,5591,O
the,5592,5595,O
sphincter,5596,5605,B-Tissue
muscle,5606,5612,I-Tissue
[,5613,5614,O
1,5614,5615,O
",",5615,5616,O
28,5617,5619,O
],5619,5620,O
.,5620,5621,O
Luciferase,0,10,O
Assay,11,16,O
For,17,20,O
Fig,21,24,O
.,24,25,O
1,26,27,O
",",27,28,O
10,29,31,O
ng,32,34,O
of,35,37,O
TORC1,38,43,O
",",43,44,O
5,45,46,O
ng,47,49,O
of,50,52,O
TORC2,53,58,O
",",58,59,O
and,60,63,O
15,64,66,O
ng,67,69,O
of,70,72,O
PKAalpha,73,81,O
expression,82,92,O
plasmids,93,101,B-Cellular_component
were,102,106,O
transfected,107,118,O
into,119,123,O
HEK293,124,130,B-Cell
cells,131,136,I-Cell
.,136,137,O
For,138,141,O
Fig,142,145,O
.,145,146,O
2,147,148,O
",",148,149,O
800,150,153,O
ng,154,156,O
of,157,159,O
total,160,165,O
DNA,166,169,O
consisted,170,179,O
of,180,182,O
200,183,186,O
ng,187,189,O
of,190,192,O
the,193,196,O
pMLHoxb1ARE,197,208,O
luciferase,209,219,O
reporter,220,228,O
and,229,232,O
100,233,236,O
ng,237,239,O
of,240,242,O
each,243,247,O
expression,248,258,O
plasmid,259,266,O
.,266,267,O
A,268,269,O
lacZ,270,274,O
reporter,275,283,O
was,284,287,O
co,288,290,O
-,290,291,O
transfected,291,302,O
to,303,305,O
normalize,306,315,O
transfection,316,328,O
efficiency,329,339,O
.,339,340,O
For,341,344,O
Fig,345,348,O
.,348,349,O
3A,350,352,O
",",352,353,O
the,354,357,O
amounts,358,365,O
of,366,368,O
pENTR,369,374,O
T2i,375,378,O
shRNA,379,384,O
(,385,386,O
TORC2,386,391,O
shRNA,392,397,O
),397,398,O
are,399,402,O
given,403,408,O
within,409,415,O
the,416,419,O
panel,420,425,O
.,425,426,O
For,427,430,O
Fig,431,434,O
.,434,435,O
3B,436,438,O
",",438,439,O
25,440,442,O
",",442,443,O
000,443,446,O
cells,447,452,B-Cell
per,453,456,O
well,457,461,O
were,462,466,O
plated,467,473,O
in,474,476,O
48,477,479,O
-,479,480,O
well,480,484,O
plates,485,491,O
and,492,495,O
transfected,496,507,O
using,508,513,O
Lipofectamine,514,527,O
2000,528,532,O
with,533,537,O
the,538,541,O
following,542,551,O
vectors,552,559,O
:,559,560,O
40,561,563,O
ng,564,566,O
of,567,569,O
pML5xUAS,570,578,O
",",578,579,O
40,580,582,O
ng,583,585,O
of,586,588,O
pGAL,589,593,O
-,593,594,O
DBD,594,597,O
or,598,600,O
pGAL,601,605,O
-,605,606,O
MEIS1A,606,612,O
(,612,613,O
335,613,616,O
-,616,617,O
390,617,620,O
),620,621,O
",",621,622,O
40,623,625,O
ng,626,628,O
of,629,631,O
pRSV,632,636,O
-,636,637,O
PBS,637,640,O
or,641,643,O
pRSV,644,648,O
-,648,649,O
PKA,649,652,O
",",652,653,O
40,654,656,O
ng,657,659,O
of,660,662,O
pENTR,663,668,O
U6,669,671,O
(,672,673,O
control,673,680,O
shRNA,681,686,O
),686,687,O
or,688,690,O
pENTR,691,696,O
T2i,697,700,O
shRNA,701,706,O
(,707,708,O
TORC2,708,713,O
shRNA,714,719,O
),719,720,O
",",720,721,O
and,722,725,O
100,726,729,O
ng,730,732,O
of,733,735,O
pRSV,736,740,O
-,740,741,O
beta,741,745,O
-,745,746,O
galactosidase,746,759,O
.,759,760,O
At,761,763,O
48,764,766,O
h,767,768,O
post,769,773,O
-,773,774,O
transfection,774,786,O
",",786,787,O
cell,788,792,B-Organism_substance
lysates,793,800,I-Organism_substance
were,801,805,O
prepared,806,814,O
using,815,820,O
100,821,824,O
mul,825,828,O
per,829,832,O
well,833,837,O
of,838,840,O
lysis,841,846,O
buffer,847,853,O
(,854,855,O
1,855,856,O
%,856,857,O
Triton,858,864,O
X,865,866,O
-,866,867,O
100,867,870,O
",",870,871,O
1,872,873,O
mm,874,876,O
dithiothreitol,877,891,O
",",891,892,O
92,893,895,O
.,895,896,O
8,896,897,O
mm,898,900,O
K2HPO4,901,907,O
",",907,908,O
pH,909,911,O
7,912,913,O
.,913,914,O
8,914,915,O
",",915,916,O
9,917,918,O
.,918,919,O
2,919,920,O
mm,921,923,O
KH2PO4,924,930,O
",",930,931,O
pH,932,934,O
7,935,936,O
.,936,937,O
8,937,938,O
),938,939,O
and,940,943,O
centrifuged,944,955,O
for,956,959,O
5,960,961,O
min,962,965,O
at,966,968,O
4,969,970,O
degreesC,971,979,O
.,979,980,O
A,981,982,O
20,983,985,O
-,985,986,O
mul,986,989,O
aliquot,990,997,O
of,998,1000,O
the,1001,1004,O
supernatant,1005,1016,B-Organism_substance
was,1017,1020,O
added,1021,1026,O
to,1027,1029,O
12,1030,1032,O
.,1032,1033,O
5,1033,1034,O
mul,1035,1038,O
of,1039,1041,O
assay,1042,1047,O
buffer,1048,1054,O
(,1055,1056,O
20,1056,1058,O
mm,1059,1061,O
ATP,1062,1065,O
",",1065,1066,O
40,1067,1069,O
mm,1070,1072,O
MgCl2,1073,1078,O
",",1078,1079,O
0,1080,1081,O
.,1081,1082,O
4,1082,1083,O
m,1084,1085,O
Tris,1086,1090,O
-,1090,1091,O
Cl,1091,1093,O
",",1093,1094,O
pH,1095,1097,O
7,1098,1099,O
.,1099,1100,O
8,1100,1101,O
),1101,1102,O
.,1102,1103,O
The,1104,1107,O
mixture,1108,1115,O
was,1116,1119,O
immediately,1120,1131,O
quantified,1132,1142,O
for,1143,1146,O
luciferase,1147,1157,O
activity,1158,1166,O
using,1167,1172,O
a,1173,1174,O
Lumat,1175,1180,O
LB,1181,1183,O
9507,1184,1188,O
luminometer,1189,1200,O
(,1201,1202,O
EG,1202,1204,O
&,1204,1205,O
G,1205,1206,O
Berthold,1207,1215,O
),1215,1216,O
that,1217,1221,O
dispensed,1222,1231,O
100,1232,1235,O
mul,1236,1239,O
per,1240,1243,O
reaction,1244,1252,O
of,1253,1255,O
luciferin,1256,1265,O
solution,1266,1274,O
",",1274,1275,O
which,1276,1281,O
contains,1282,1290,O
1,1291,1292,O
mm,1293,1295,O
d,1296,1297,O
-,1297,1298,O
(,1298,1299,O
-,1299,1300,O
),1300,1301,O
-,1301,1302,O
luciferin,1302,1311,O
(,1312,1313,O
catalogue,1313,1322,O
number,1323,1329,O
11626353001,1330,1341,O
",",1341,1342,O
Roche,1343,1348,O
),1348,1349,O
and,1350,1353,O
0,1354,1355,O
.,1355,1356,O
1,1356,1357,O
m,1358,1359,O
Tris,1360,1364,O
-,1364,1365,O
Cl,1365,1367,O
",",1367,1368,O
pH,1369,1371,O
7,1372,1373,O
.,1373,1374,O
8,1374,1375,O
.,1375,1376,O
Implications,0,12,O
for,13,16,O
Psychological,17,30,O
Models,31,37,O
of,38,40,O
Interval,41,49,O
Timing,50,56,O
Several,57,64,O
models,65,71,O
have,72,76,O
been,77,81,O
previously,82,92,O
applied,93,100,O
to,101,103,O
interpret,104,113,O
data,114,118,O
obtained,119,127,O
in,128,130,O
interval,131,139,O
-,139,140,O
timing,140,146,O
experiments,147,158,O
involving,159,168,O
gaps,169,173,O
(,174,175,O
retention,175,184,O
-,184,185,O
intervals,185,194,O
),194,195,O
.,195,196,O
A,197,198,O
switch,199,205,O
model,206,211,O
",",211,212,O
assuming,213,221,O
that,222,226,O
during,227,233,O
the,234,237,O
gap,238,241,O
time,242,246,O
fails,247,252,O
to,253,255,O
accumulate,256,266,O
due,267,270,O
to,271,273,O
the,274,277,O
opening,278,285,O
of,286,288,O
a,289,290,O
stimulus,291,299,O
-,299,300,O
controlled,300,310,O
switch,311,317,O
",",317,318,O
predicts,319,327,O
that,328,332,O
",",332,333,O
irrespective,334,346,O
of,347,349,O
gap,350,353,O
and,354,357,O
criterion,358,367,O
durations,368,377,O
",",377,378,O
subjects,379,387,O
should,388,394,O
use,395,398,O
a,399,400,O
stop,401,405,O
rule,406,410,O
[,411,412,O
14,412,414,O
],414,415,O
",",415,416,O
[,417,418,O
15,418,420,O
],420,421,O
",",421,422,O
[,423,424,O
30,424,426,O
],426,427,O
",",427,428,O
[,429,430,O
31,430,432,O
],432,433,O
.,433,434,O
In,435,437,O
contrast,438,446,O
",",446,447,O
the,448,451,O
present,452,459,O
data,460,464,O
indicate,465,473,O
that,474,478,O
rats,479,483,O
flexibly,484,492,O
change,493,499,O
their,500,505,O
behavior,506,514,O
with,515,519,O
both,520,524,O
gap,525,528,O
and,529,532,O
criterion,533,542,O
duration,543,551,O
.,551,552,O
An,553,555,O
instructional,556,569,O
-,569,570,O
ambiguity,570,579,O
model,580,585,O
proposing,586,595,O
that,596,600,O
subjects,601,609,O
perceive,610,618,O
the,619,622,O
gap,623,626,O
as,627,629,O
an,630,632,O
ambiguous,633,642,O
",",642,643,O
ITI,644,647,O
-,647,648,O
like,648,652,O
event,653,658,O
",",658,659,O
predicts,660,668,O
that,669,673,O
manipulations,674,687,O
that,688,692,O
render,693,699,O
the,700,703,O
gap,704,707,O
similar,708,715,O
to,716,718,O
the,719,722,O
ITI,723,726,O
should,727,733,O
reset,734,739,O
the,740,743,O
clock,744,749,O
",",749,750,O
while,751,756,O
manipulations,757,770,O
that,771,775,O
render,776,782,O
the,783,786,O
gap,787,790,O
dissimilar,791,801,O
from,802,806,O
the,807,810,O
ITI,811,814,O
should,815,821,O
stop,822,826,O
the,827,830,O
clock,831,836,O
[,837,838,O
37,838,840,O
],840,841,O
.,841,842,O
Because,843,850,O
in,851,853,O
our,854,857,O
experiment,858,868,O
the,869,872,O
gap,873,876,O
and,877,880,O
ITI,881,884,O
were,885,889,O
identical,890,899,O
(,900,901,O
dark,901,905,O
),905,906,O
this,907,911,O
hypothesis,912,922,O
predicts,923,931,O
the,932,935,O
use,936,939,O
of,940,942,O
the,943,946,O
same,947,951,O
rule,952,956,O
(,957,958,O
reset,958,963,O
),963,964,O
at,965,967,O
all,968,971,O
gap,972,975,O
and,976,979,O
criteria,980,988,O
durations,989,998,O
",",998,999,O
in,1000,1002,O
contrast,1003,1011,O
to,1012,1014,O
the,1015,1018,O
current,1019,1026,O
data,1027,1031,O
showing,1032,1039,O
the,1040,1043,O
use,1044,1047,O
of,1048,1050,O
different,1051,1060,O
rules,1061,1066,O
for,1067,1070,O
different,1071,1080,O
temporal,1081,1089,O
criteria,1090,1098,O
.,1098,1099,O
To,1100,1102,O
account,1103,1110,O
for,1111,1114,O
the,1115,1118,O
flexible,1119,1127,O
use,1128,1131,O
of,1132,1134,O
the,1135,1138,O
run,1139,1142,O
/,1142,1143,O
stop,1143,1147,O
/,1147,1148,O
reset,1148,1153,O
rules,1154,1159,O
by,1160,1162,O
rats,1163,1167,O
and,1168,1171,O
pigeons,1172,1179,O
",",1179,1180,O
Cabeza,1181,1187,O
de,1188,1190,O
Vaca,1191,1195,O
et,1196,1198,O
al,1199,1201,O
.,1201,1202,O
[,1203,1204,O
38,1204,1206,O
],1206,1207,O
proposed,1208,1216,O
a,1217,1218,O
passive,1219,1226,O
memory,1227,1233,O
-,1233,1234,O
decay,1234,1239,O
model,1240,1245,O
which,1246,1251,O
assumes,1252,1259,O
that,1260,1264,O
subjective,1265,1275,O
time,1276,1280,O
-,1280,1281,O
-,1281,1282,O
stored,1282,1288,O
in,1289,1291,O
WM,1292,1294,O
-,1294,1295,O
-,1295,1296,O
decays,1296,1302,O
passively,1303,1312,O
during,1313,1319,O
the,1320,1323,O
gap,1324,1327,O
.,1327,1328,O
This,1329,1333,O
model,1334,1339,O
predicts,1340,1348,O
that,1349,1353,O
the,1354,1357,O
effect,1358,1364,O
of,1365,1367,O
a,1368,1369,O
gap,1370,1373,O
should,1374,1380,O
depend,1381,1387,O
solely,1388,1394,O
on,1395,1397,O
absolute,1398,1406,O
gap,1407,1410,O
duration,1411,1419,O
",",1419,1420,O
but,1421,1424,O
not,1425,1428,O
on,1429,1431,O
criterion,1432,1441,O
duration,1442,1450,O
",",1450,1451,O
as,1452,1454,O
found,1455,1460,O
here,1461,1465,O
(,1466,1467,O
Fig,1467,1470,O
.,1470,1471,O
1B,1472,1474,O
-,1474,1475,O
D,1475,1476,O
),1476,1477,O
.,1477,1478,O
These,1479,1484,O
models,1485,1491,O
can,1492,1495,O
not,1496,1499,O
account,1500,1507,O
for,1508,1511,O
the,1512,1515,O
differential,1516,1528,O
effects,1529,1536,O
of,1537,1539,O
gaps,1540,1544,O
on,1545,1547,O
multiple,1548,1556,O
intervals,1557,1566,O
.,1566,1567,O
In,1568,1570,O
contrast,1571,1579,O
to,1580,1582,O
these,1583,1588,O
alternatives,1589,1601,O
",",1601,1602,O
the,1603,1606,O
present,1607,1614,O
resource,1615,1623,O
allocation,1624,1634,O
model,1635,1640,O
assumes,1641,1648,O
that,1649,1653,O
during,1654,1660,O
the,1661,1664,O
gaps,1665,1669,O
resources,1670,1679,O
are,1680,1683,O
re,1684,1686,O
-,1686,1687,O
allocated,1687,1696,O
(,1697,1698,O
diverted,1698,1706,O
away,1707,1711,O
from,1712,1716,O
timing,1717,1723,O
),1723,1724,O
",",1724,1725,O
each,1726,1730,O
clock,1731,1736,O
is,1737,1739,O
unable,1740,1746,O
to,1747,1749,O
maintain,1750,1758,O
its,1759,1762,O
current,1763,1770,O
subjective,1771,1781,O
time,1782,1786,O
in,1787,1789,O
WM,1790,1792,O
",",1792,1793,O
and,1794,1797,O
the,1798,1801,O
response,1802,1810,O
is,1811,1813,O
delayed,1814,1821,O
[,1822,1823,O
16,1823,1825,O
],1825,1826,O
",",1826,1827,O
[,1828,1829,O
17,1829,1831,O
],1831,1832,O
",",1832,1833,O
[,1834,1835,O
27,1835,1837,O
],1837,1838,O
in,1839,1841,O
proportion,1842,1852,O
to,1853,1855,O
the,1856,1859,O
perceived,1860,1869,O
salience,1870,1878,O
of,1879,1881,O
the,1882,1885,O
distracter,1886,1896,O
relative,1897,1905,O
to,1906,1908,O
the,1909,1912,O
times,1913,1918,O
signal,1919,1925,O
[,1926,1927,O
34,1927,1929,O
],1929,1930,O
",",1930,1931,O
[,1932,1933,O
35,1933,1935,O
],1935,1936,O
.,1936,1937,O
Indeed,1938,1944,O
",",1944,1945,O
the,1946,1949,O
effect,1950,1956,O
of,1957,1959,O
a,1960,1961,O
gap,1962,1965,O
is,1966,1968,O
affected,1969,1977,O
by,1978,1980,O
the,1981,1984,O
contrast,1985,1993,O
in,1994,1996,O
intensity,1997,2006,O
between,2007,2014,O
the,2015,2018,O
gap,2019,2022,O
and,2023,2026,O
the,2027,2030,O
timed,2031,2036,O
signal,2037,2043,O
[,2044,2045,O
27,2045,2047,O
],2047,2048,O
",",2048,2049,O
[,2050,2051,O
34,2051,2053,O
],2053,2054,O
",",2054,2055,O
[,2056,2057,O
39,2057,2059,O
],2059,2060,O
and,2061,2064,O
by,2065,2067,O
the,2068,2071,O
perceptual,2072,2082,O
acuity,2083,2089,O
of,2090,2092,O
the,2093,2096,O
subjects,2097,2105,O
[,2106,2107,O
27,2107,2109,O
],2109,2110,O
.,2110,2111,O
Importantly,2112,2123,O
",",2123,2124,O
the,2125,2128,O
predictions,2129,2140,O
of,2141,2143,O
this,2144,2148,O
resource,2149,2157,O
re,2158,2160,O
-,2160,2161,O
allocation,2161,2171,O
model,2172,2177,O
are,2178,2181,O
not,2182,2185,O
restricted,2186,2196,O
to,2197,2199,O
retention,2200,2209,O
-,2209,2210,O
intervals,2210,2219,O
(,2220,2221,O
i,2221,2222,O
.,2222,2223,O
e,2223,2224,O
.,2224,2225,O
",",2225,2226,O
gaps,2227,2231,O
),2231,2232,O
",",2232,2233,O
but,2234,2237,O
extend,2238,2244,O
to,2245,2247,O
distracters,2248,2259,O
presented,2260,2269,O
during,2270,2276,O
the,2277,2280,O
continuous,2281,2291,O
presentation,2292,2304,O
of,2305,2307,O
a,2308,2309,O
timed,2310,2315,O
signal,2316,2322,O
.,2322,2323,O
Previous,2324,2332,O
data,2333,2337,O
were,2338,2342,O
quantitatively,2343,2357,O
accounted,2358,2367,O
for,2368,2371,O
by,2372,2374,O
assuming,2375,2383,O
that,2384,2388,O
during,2389,2395,O
a,2396,2397,O
gap,2398,2401,O
and,2402,2405,O
/,2405,2406,O
or,2406,2408,O
distracter,2409,2419,O
the,2420,2423,O
accumulated,2424,2435,O
time,2436,2440,O
decays,2441,2447,O
at,2448,2450,O
a,2451,2452,O
rate,2453,2457,O
that,2458,2462,O
varies,2463,2469,O
with,2470,2474,O
the,2475,2478,O
relative,2479,2487,O
salience,2488,2496,O
of,2497,2499,O
the,2500,2503,O
distracter,2504,2514,O
to,2515,2517,O
the,2518,2521,O
timed,2522,2527,O
signal,2528,2534,O
[,2535,2536,O
25,2536,2538,O
],2538,2539,O
",",2539,2540,O
[,2541,2542,O
26,2542,2544,O
],2544,2545,O
",",2545,2546,O
[,2547,2548,O
35,2548,2550,O
],2550,2551,O
.,2551,2552,O
Here,2553,2557,O
we,2558,2560,O
found,2561,2566,O
that,2567,2571,O
the,2572,2575,O
comparison,2576,2586,O
between,2587,2594,O
the,2595,2598,O
gap,2599,2602,O
and,2603,2606,O
the,2607,2610,O
(,2611,2612,O
multiple,2612,2620,O
),2620,2621,O
timed,2622,2627,O
signal,2628,2634,O
(,2634,2635,O
s,2635,2636,O
),2636,2637,O
extends,2638,2645,O
to,2646,2648,O
the,2649,2652,O
temporal,2653,2661,O
domain,2662,2668,O
.,2668,2669,O
Simulations,2670,2681,O
indicate,2682,2690,O
that,2691,2695,O
both,2696,2700,O
the,2701,2704,O
differential,2705,2717,O
effect,2718,2724,O
of,2725,2727,O
the,2728,2731,O
gap,2732,2735,O
on,2736,2738,O
multiple,2739,2747,O
durations,2748,2757,O
",",2757,2758,O
and,2759,2762,O
the,2763,2766,O
gradual,2767,2774,O
hierarchical,2775,2787,O
reset,2788,2793,O
due,2794,2797,O
to,2798,2800,O
increasing,2801,2811,O
gap,2812,2815,O
duration,2816,2824,O
can,2825,2828,O
be,2829,2831,O
quantitatively,2832,2846,O
accounted,2847,2856,O
for,2857,2860,O
assuming,2861,2869,O
that,2870,2874,O
the,2875,2878,O
three,2879,2884,O
clocks,2885,2891,O
have,2892,2896,O
separate,2897,2905,O
resources,2906,2915,O
re,2916,2918,O
-,2918,2919,O
allocated,2919,2928,O
independently,2929,2942,O
during,2943,2949,O
a,2950,2951,O
gap,2952,2955,O
at,2956,2958,O
a,2959,2960,O
rate,2961,2965,O
proportional,2966,2978,O
to,2979,2981,O
the,2982,2985,O
ratio,2986,2991,O
g,2992,2993,O
/,2993,2994,O
Tk,2994,2996,O
between,2997,3004,O
the,3005,3008,O
duration,3009,3017,O
of,3018,3020,O
the,3021,3024,O
gap,3025,3028,O
and,3029,3032,O
each,3033,3037,O
criterion,3038,3047,O
duration,3048,3056,O
(,3057,3058,O
Fig,3058,3061,O
.,3061,3062,O
2A,3063,3065,O
:,3065,3066,O
D,3066,3067,O
-,3067,3068,O
Model,3068,3073,O
),3073,3074,O
.,3074,3075,O
SUMMARY,0,7,O
This,8,12,O
is,13,15,O
a,16,17,O
prospective,18,29,O
study,30,35,O
carried,36,43,O
out,44,47,O
to,48,50,O
determine,51,60,O
the,61,64,O
outcome,65,72,O
of,73,75,O
patients,76,84,O
who,85,88,O
refuse,89,95,O
cystectomy,96,106,O
after,107,112,O
receiving,113,122,O
neoadjuvant,123,134,O
chemotherapy,135,147,O
for,148,151,O
muscle,152,158,B-Pathological_formation
-,158,159,I-Pathological_formation
invasive,159,167,I-Pathological_formation
bladder,168,175,I-Pathological_formation
cancer,176,182,I-Pathological_formation
.,182,183,O
Sixty,184,189,O
-,189,190,O
three,190,195,O
patients,196,204,O
were,205,209,O
evaluated,210,219,O
between,220,227,O
1995,228,232,O
and,233,236,O
2001,237,241,O
who,242,245,O
declined,246,254,O
to,255,257,O
undergo,258,265,O
a,266,267,O
planned,268,275,O
cystectomy,276,286,O
because,287,294,O
they,295,299,O
achieved,300,308,O
a,309,310,O
complete,311,319,O
clinical,320,328,O
response,329,337,O
to,338,340,O
neoadjuvant,341,352,O
cisplatin,353,362,O
-,362,363,O
based,363,368,O
chemotherapy,369,381,O
.,381,382,O
Herr,383,387,O
assessed,388,396,O
patient,397,404,O
",",404,405,O
tumor,406,411,B-Pathological_formation
and,412,415,O
treatment,416,425,O
features,426,434,O
for,435,438,O
a,439,440,O
median,441,447,O
follow,448,454,O
-,454,455,O
up,456,458,O
of,459,461,O
86,462,464,O
months,465,471,O
",",471,472,O
all,473,476,O
patients,477,485,O
being,486,491,O
followed,492,500,O
-,500,501,O
up,501,503,O
for,504,507,O
more,508,512,O
than,513,517,O
5,518,519,O
years,520,525,O
.,525,526,O
Forty,527,532,O
patients,533,541,O
(,542,543,O
64,543,545,O
%,545,546,O
),546,547,O
survived,548,556,O
",",556,557,O
with,558,562,O
54,563,565,O
%,565,566,O
of,567,569,O
them,570,574,O
having,575,581,O
an,582,584,O
intact,585,591,O
functioning,592,603,O
bladder,604,611,B-Organ
.,611,612,O
The,613,616,O
number,617,623,O
and,624,627,O
size,628,632,O
of,633,635,O
invasive,636,644,O
tumors,645,651,B-Pathological_formation
were,652,656,O
strongly,657,665,O
associated,666,676,O
with,677,681,O
the,682,685,O
overall,686,693,O
survival,694,702,O
.,702,703,O
The,704,707,O
most,708,712,O
significant,713,724,O
treatment,725,734,O
variable,735,743,O
predicting,744,754,O
better,755,761,O
survival,762,770,O
was,771,774,O
complete,775,783,O
resection,784,793,O
of,794,796,O
the,797,800,O
invasive,801,809,O
tumor,810,815,B-Pathological_formation
on,816,818,O
restaging,819,828,O
transurethral,829,842,O
resection,843,852,O
(,853,854,O
TUR,854,857,O
),857,858,O
before,859,865,O
starting,866,874,O
chemotherapy,875,887,O
.,887,888,O
Of,889,891,O
23,892,894,O
patients,895,903,O
(,904,905,O
36,905,907,O
%,907,908,O
),908,909,O
who,910,913,O
subsequently,914,926,O
died,927,931,O
of,932,934,O
disease,935,942,O
",",942,943,O
19,944,946,O
(,947,948,O
30,948,950,O
%,950,951,O
),951,952,O
relapsed,953,961,O
with,962,966,O
invasive,967,975,O
cancer,976,982,B-Pathological_formation
in,983,985,O
the,986,989,O
bladder,990,997,B-Organ
.,997,998,O
Over,999,1003,O
90,1004,1006,O
%,1006,1007,O
of,1008,1010,O
the,1011,1014,O
surviving,1015,1024,O
patients,1025,1033,O
had,1034,1037,O
solitary,1038,1046,O
",",1046,1047,O
small,1048,1053,O
and,1054,1057,O
low,1058,1061,O
-,1061,1062,O
stage,1062,1067,O
invasive,1068,1076,O
tumors,1077,1083,B-Pathological_formation
completely,1084,1094,O
resected,1095,1103,O
and,1104,1107,O
83,1108,1110,O
%,1110,1111,O
survived,1112,1120,O
without,1121,1128,O
relapses,1129,1137,O
in,1138,1140,O
the,1141,1144,O
bladder,1145,1152,B-Organ
.,1152,1153,O
[,1153,1154,O
1,1154,1155,O
],1155,1156,O
COMMENTS,0,8,O
Recurrent,9,18,O
anterior,19,27,B-Multi-tissue_structure
vaginal,28,35,I-Multi-tissue_structure
wall,36,40,I-Multi-tissue_structure
prolapse,41,49,O
can,50,53,O
develop,54,61,O
in,62,64,O
more,65,69,O
than,70,74,O
20,75,77,O
%,77,78,O
of,79,81,O
patients,82,90,O
undergoing,91,101,O
traditional,102,113,O
anterior,114,122,O
colporrhaphy,123,135,O
.,135,136,O
In,137,139,O
light,140,145,O
of,146,148,O
this,149,153,O
high,154,158,O
recurrence,159,169,O
rate,170,174,O
many,175,179,O
surgeons,180,188,O
have,189,193,O
been,194,198,O
incorporating,199,212,O
synthetic,213,222,O
or,223,225,O
allograft,226,235,O
mesh,236,240,O
to,241,243,O
augment,244,251,O
the,252,255,O
repair,256,262,O
.,262,263,O
In,264,266,O
this,267,271,O
study,272,277,O
there,278,283,O
are,284,287,O
some,288,292,O
shortcomings,293,305,O
",",305,306,O
including,307,316,O
retrospective,317,330,O
design,331,337,O
",",337,338,O
short,339,344,O
follow,345,351,O
-,351,352,O
up,352,354,O
for,355,358,O
a,359,360,O
study,361,366,O
spanning,367,375,O
almost,376,382,O
six,383,386,O
years,387,392,O
and,393,396,O
a,397,398,O
lack,399,403,O
of,404,406,O
validated,407,416,O
questionnaires,417,431,O
.,431,432,O
Authors,433,440,O
report,441,447,O
a,448,449,O
negative,450,458,O
experience,459,469,O
with,470,474,O
porcine,475,482,O
dermis,483,489,B-Multi-tissue_structure
",",489,490,O
both,491,495,O
in,496,498,O
terms,499,504,O
of,505,507,O
success,508,515,O
and,516,519,O
extrusion,520,529,O
rate,530,534,O
.,534,535,O
However,536,543,O
",",543,544,O
others,545,551,O
have,552,556,O
reported,557,565,O
better,566,572,O
outcome,573,580,O
[,580,581,O
1,581,582,O
],582,583,O
which,584,589,O
may,590,593,O
be,594,596,O
due,597,600,O
to,601,603,O
different,604,613,O
follow,614,620,O
-,620,621,O
up,621,623,O
times,624,629,O
and,630,633,O
outcome,634,641,O
measures,642,650,O
.,650,651,O
Apart,652,657,O
from,658,662,O
this,663,667,O
",",667,668,O
biological,669,679,O
grafts,680,686,O
are,687,690,O
also,691,695,O
associated,696,706,O
with,707,711,O
allergic,712,720,O
reactions,721,730,O
and,731,734,O
disease,735,742,O
transmission,743,755,O
.,755,756,O
There,757,762,O
is,763,765,O
paucity,766,773,O
of,774,776,O
data,777,781,O
regarding,782,791,O
prospective,792,803,O
randomized,804,814,O
trials,815,821,O
on,822,824,O
the,825,828,O
use,829,832,O
of,833,835,O
these,836,841,O
biomaterials,842,854,O
prior,855,860,O
to,861,863,O
their,864,869,O
widespread,870,880,O
human,881,886,O
need,887,891,O
which,892,897,O
might,898,903,O
help,904,908,O
in,909,911,O
reducing,912,920,O
such,921,925,O
type,926,930,O
of,931,933,O
experiences,934,945,O
.,945,946,O
Unless,947,953,O
such,954,958,O
data,959,963,O
are,964,967,O
available,968,977,O
surgeons,978,986,O
should,987,993,O
give,994,998,O
serious,999,1006,O
thought,1007,1014,O
prior,1015,1020,O
to,1021,1023,O
embarking,1024,1033,O
on,1034,1036,O
the,1037,1040,O
use,1041,1044,O
of,1045,1047,O
such,1048,1052,O
biological,1053,1063,O
materials,1064,1073,O
.,1073,1074,O
[,1074,1075,O
2,1075,1076,O
],1076,1077,O
Background,0,10,O
Opioid,11,17,O
analgesics,18,28,O
are,29,32,O
generally,33,42,O
used,43,47,O
to,48,50,O
combat,51,57,O
the,58,61,O
pain,62,66,O
associated,67,77,O
with,78,82,O
cancerous,83,92,B-Pathological_formation
conditions,93,103,O
.,103,104,O
These,105,110,O
agents,111,117,O
not,118,121,O
only,122,126,O
inhibit,127,134,O
respiratory,135,146,B-Anatomical_system
function,147,155,O
and,156,159,O
cause,160,165,O
constipation,166,178,O
",",178,179,O
but,180,183,O
also,184,188,O
induce,189,195,O
other,196,201,O
significant,202,213,O
side,214,218,O
effects,219,226,O
such,227,231,O
as,232,234,O
addiction,235,244,O
and,245,248,O
tolerance,249,258,O
",",258,259,O
all,260,263,O
of,264,266,O
which,267,272,O
further,273,280,O
contribute,281,291,O
to,292,294,O
a,295,296,O
reduced,297,304,O
quality,305,312,O
of,313,315,O
life,316,320,O
for,321,324,O
cancer,325,331,B-Pathological_formation
patients,332,340,O
.,340,341,O
Thus,342,346,O
",",346,347,O
in,348,350,O
the,351,354,O
present,355,362,O
study,363,368,O
",",368,369,O
the,370,373,O
effects,374,381,O
of,382,384,O
electro,385,392,O
-,392,393,O
acupuncture,393,404,O
treatment,405,414,O
(,415,416,O
EA,416,418,O
),418,419,O
on,420,422,O
mechanical,423,433,O
allodynia,434,443,O
were,444,448,O
examined,449,457,O
in,458,460,O
a,461,462,O
cancer,463,469,B-Pathological_formation
pain,470,474,O
mouse,475,480,O
model,481,486,O
.,486,487,O
2,0,1,O
.,1,2,O
1,2,3,O
.,3,4,O
Biological,5,15,O
samples,16,23,O
Placental,24,33,B-Tissue
tissues,34,41,I-Tissue
from,42,46,O
the,47,50,O
first,51,56,O
trimester,57,66,O
legally,67,74,O
induced,75,82,O
abortions,83,92,O
(,93,94,O
8,94,95,O
-,95,96,O
12,96,98,O
weeks,99,104,O
of,105,107,O
gestation,108,117,O
),117,118,O
were,119,123,O
obtained,124,132,O
from,133,137,O
the,138,141,O
Department,142,152,O
of,153,155,O
Obstetrics,156,166,O
and,167,170,O
Gynecology,171,181,O
at,182,184,O
the,185,188,O
Broussais,189,198,O
",",198,199,O
Saint,200,205,O
Vincent,206,213,O
de,214,216,O
Paul,217,221,O
and,222,225,O
Cochin,226,232,O
Hospitals,233,242,O
.,242,243,O
Second,244,250,O
trimester,251,260,O
placental,261,270,B-Tissue
tissues,271,278,I-Tissue
were,279,283,O
collected,284,293,O
at,294,296,O
the,297,300,O
time,301,305,O
of,306,308,O
termination,309,320,O
of,321,323,O
pregnancy,324,333,O
at,334,336,O
15,337,339,O
and,340,343,O
25,344,346,O
weeks,347,352,O
of,353,355,O
gestation,356,365,O
(,366,367,O
in,367,369,O
weeks,370,375,O
of,376,378,O
amenorrhea,379,389,O
),389,390,O
in,391,393,O
trisomy,394,401,O
21,402,404,O
-,404,405,O
affected,405,413,O
pregnancies,414,425,O
.,425,426,O
Fetal,427,432,B-Developing_anatomical_structure
Down,433,437,O
syndrome,438,446,O
was,447,450,O
diagnosed,451,460,O
by,461,463,O
karyotyping,464,475,O
of,476,478,O
amniotic,479,487,B-Cell
fluid,488,493,I-Cell
cells,494,499,I-Cell
.,499,500,O
The,501,504,O
indication,505,515,O
of,516,518,O
amniocentesis,519,532,O
was,533,536,O
the,537,540,O
maternal,541,549,O
age,550,553,O
.,553,554,O
Term,555,559,O
placentas,560,569,B-Organ
were,570,574,O
obtained,575,583,O
after,584,589,O
elective,590,598,O
cesarean,599,607,O
section,608,615,O
from,616,620,O
healthy,621,628,O
mothers,629,636,O
near,637,641,O
term,642,646,O
with,647,651,O
uncomplicated,652,665,O
pregnancies,666,677,O
.,677,678,O
With,679,683,O
written,684,691,O
informed,692,700,O
consent,701,708,O
of,709,711,O
the,712,715,O
pregnant,716,724,O
woman,725,730,O
",",730,731,O
the,732,735,O
following,736,745,O
samples,746,753,O
were,754,758,O
collected,759,768,O
at,769,771,O
term,772,776,O
:,776,777,O
a,778,779,O
fragment,780,788,B-Organ
of,789,791,O
the,792,795,O
placenta,796,804,B-Organ
",",804,805,O
umbilical,806,815,B-Organism_substance
cord,816,820,I-Organism_substance
fetal,821,826,I-Organism_substance
blood,827,832,I-Organism_substance
and,833,836,O
maternal,837,845,O
blood,846,851,B-Organism_substance
.,851,852,O
The,853,856,O
placenta,857,865,B-Organ
biopsy,866,872,I-Organ
sample,873,879,I-Organ
was,880,883,O
collected,884,893,O
at,894,896,O
a,897,898,O
depth,899,904,O
of,905,907,O
1,908,909,O
cm,910,912,O
and,913,916,O
at,917,919,O
a,920,921,O
distance,922,930,O
of,931,933,O
8,934,935,O
cm,936,938,O
from,939,943,O
the,944,947,O
edge,948,952,O
of,953,955,O
the,956,959,O
placenta,960,968,B-Organ
",",968,969,O
with,970,974,O
the,975,978,O
maternal,979,987,O
side,988,992,O
facing,993,999,O
upward,1000,1006,O
.,1006,1007,O
The,1008,1011,O
use,1012,1015,O
of,1016,1018,O
these,1019,1024,O
biological,1025,1035,O
samples,1036,1043,O
was,1044,1047,O
approved,1048,1056,O
by,1057,1059,O
local,1060,1065,O
ethical,1066,1073,O
committee,1074,1083,O
.,1083,1084,O
Villous,1085,1092,B-Cell
cytotrophoblastic,1093,1110,I-Cell
cells,1111,1116,I-Cell
were,1117,1121,O
isolated,1122,1130,O
by,1131,1133,O
sequential,1134,1144,O
enzymatic,1145,1154,O
digestion,1155,1164,O
of,1165,1167,O
chorionic,1168,1177,B-Multi-tissue_structure
villi,1178,1183,I-Multi-tissue_structure
from,1184,1188,O
the,1189,1192,O
first,1193,1198,O
trimester,1199,1208,O
",",1208,1209,O
second,1210,1216,O
trimester,1217,1226,O
and,1227,1230,O
term,1231,1235,O
placenta,1236,1244,B-Organ
and,1245,1248,O
purified,1249,1257,O
on,1258,1260,O
a,1261,1262,O
discontinuous,1263,1276,O
percoll,1277,1284,O
gradient,1285,1293,O
",",1293,1294,O
as,1295,1297,O
described,1298,1307,O
previously,1308,1318,O
.,1318,1319,O
47,1319,1321,O
-,1321,1322,O
49,1322,1324,O
These,1325,1330,O
cells,1331,1336,B-Cell
were,1337,1341,O
positively,1342,1352,O
stained,1353,1360,O
for,1361,1364,O
cytokeratin,1365,1376,O
7,1377,1378,O
at,1379,1381,O
95,1382,1384,O
%,1384,1385,O
",",1385,1386,O
indicating,1387,1397,O
the,1398,1401,O
cytotrophoblastic,1402,1419,O
origin,1420,1426,O
of,1427,1429,O
the,1430,1433,O
cells,1434,1439,B-Cell
.,1439,1440,O
Placental,1441,1450,B-Cell
fibroblasts,1451,1462,I-Cell
were,1463,1467,O
isolated,1468,1476,O
by,1477,1479,O
prolonged,1480,1489,O
enzymatic,1490,1499,O
digestion,1500,1509,O
from,1510,1514,O
first,1515,1520,O
trimester,1521,1530,O
chorionic,1531,1540,B-Multi-tissue_structure
villi,1541,1546,I-Multi-tissue_structure
as,1547,1549,O
in,1550,1552,O
Malassine,1553,1562,O
et,1563,1565,O
al,1566,1568,O
.,1568,1569,O
50,1569,1571,O
Fibroblastic,1572,1584,B-Cell
cells,1585,1590,I-Cell
(,1591,1592,O
1,1592,1593,O
.,1593,1594,O
25,1594,1596,O
x,1597,1598,O
105,1599,1602,O
cells,1603,1608,O
/,1608,1609,O
mL,1609,1611,O
),1611,1612,O
were,1613,1617,O
plated,1618,1624,O
on,1625,1627,O
35,1628,1630,O
-,1630,1631,O
mm,1631,1633,O
plastic,1634,1641,O
dishes,1642,1648,O
(,1649,1650,O
TPP,1650,1653,O
",",1653,1654,O
Switzerland,1655,1666,O
),1666,1667,O
and,1668,1671,O
cultured,1672,1680,O
for,1681,1684,O
48,1685,1687,O
h,1688,1689,O
",",1689,1690,O
and,1691,1694,O
the,1695,1698,O
culture,1699,1706,O
medium,1707,1713,O
was,1714,1717,O
changed,1718,1725,O
daily,1726,1731,O
.,1731,1732,O
These,1733,1738,O
cultured,1739,1747,O
fibroblasts,1748,1759,B-Cell
were,1760,1764,O
characterized,1765,1778,O
using,1779,1784,O
immunocytochemistry,1785,1804,O
.,1804,1805,O
It,1806,1808,O
was,1809,1812,O
found,1813,1818,O
that,1819,1823,O
98,1824,1826,O
%,1826,1827,O
of,1828,1830,O
the,1831,1834,O
cells,1835,1840,B-Cell
were,1841,1845,O
vimentin,1846,1854,O
positive,1855,1863,O
and,1864,1867,O
also,1868,1872,O
positive,1873,1881,O
for,1882,1885,O
a,1886,1887,O
monoclonal,1888,1898,O
antibody,1899,1907,O
against,1908,1915,O
specific,1916,1924,O
fibroblast,1925,1935,B-Cell
antigen,1936,1943,O
(,1944,1945,O
clone,1945,1950,O
ASO2,1951,1955,O
",",1955,1956,O
Dianova,1957,1964,O
",",1964,1965,O
Hamburg,1966,1973,O
",",1973,1974,O
Germany,1975,1982,O
),1982,1983,O
.,1983,1984,O
Owing,1985,1990,O
to,1991,1993,O
the,1994,1997,O
limited,1998,2005,O
amount,2006,2012,O
of,2013,2015,O
cells,2016,2021,B-Cell
",",2021,2022,O
only,2023,2027,O
DNA,2028,2031,O
was,2032,2035,O
extracted,2036,2045,O
.,2045,2046,O
Methods,0,7,O
Therefore,8,17,O
",",17,18,O
we,19,21,O
developed,22,31,O
a,32,33,O
reciprocal,34,44,O
system,45,51,O
of,52,54,O
a,55,56,O
full,57,61,B-Cell
-,61,62,I-Cell
length,62,68,I-Cell
HIV,69,72,I-Cell
packaging,73,82,I-Cell
cell,83,87,I-Cell
line,88,92,I-Cell
and,93,96,O
a,97,98,O
shortened,99,108,O
HI,109,111,O
-,111,112,O
viral,112,117,O
shuttle,118,125,O
vector,126,132,O
.,132,133,O
The,134,137,O
Tat,138,141,O
-,141,142,O
deficient,142,151,O
packaging,152,161,O
construct,162,171,O
is,172,174,O
stably,175,181,O
integrated,182,192,O
in,193,195,O
a,196,197,O
VSVG,198,202,B-Cell
-,202,203,I-Cell
pseudotyped,203,214,I-Cell
cell,215,219,I-Cell
line,220,224,I-Cell
and,225,228,O
transactivated,229,243,O
by,244,246,O
the,247,250,O
shuttle,251,258,O
vector,259,265,O
by,266,268,O
expression,269,279,O
of,280,282,O
TATGFP,283,289,O
from,290,294,O
a,295,296,O
heterologous,297,309,O
promoter,310,318,O
which,319,324,O
also,325,329,O
indicates,330,339,O
positive,340,348,O
cells,349,354,B-Cell
.,354,355,O
Expression,356,366,O
of,367,369,O
the,370,373,O
HI,374,376,O
-,376,377,O
viral,377,382,O
structure,383,392,O
proteins,393,401,O
is,402,404,O
driven,405,411,O
by,412,414,O
a,415,416,O
natural,417,424,O
5,425,426,O
',426,427,O
LTR,428,431,O
promoter,432,440,O
and,441,444,O
a,445,446,O
3,447,448,O
',448,449,O
polyadenylation,450,465,O
signal,466,472,O
",",472,473,O
whereas,474,481,O
the,482,485,O
envelope,486,494,B-Cellular_component
expression,495,505,O
out,506,509,O
of,510,512,O
the,513,516,O
shuttle,517,524,O
vector,525,531,O
is,532,534,O
achieved,535,543,O
by,544,546,O
an,547,549,O
IRES,550,554,O
.,554,555,O
This,556,560,O
system,561,567,O
of,568,570,O
two,571,574,O
vectors,575,582,O
is,583,585,O
tightly,586,593,O
controllable,594,606,O
and,607,610,O
bypasses,611,619,O
the,620,623,O
problem,624,631,O
of,632,634,O
limited,635,642,O
packaging,643,652,O
capacity,653,661,O
into,662,666,O
HIV,667,670,O
-,670,671,O
1,671,672,O
virions,673,680,O
.,680,681,O
Percutaneous,0,12,O
coronary,13,21,B-Multi-tissue_structure
intervention,22,34,O
for,35,38,O
the,39,42,O
very,43,47,O
late,48,52,O
stent,53,58,O
thrombosis,59,69,O
in,70,72,O
right,73,78,B-Multi-tissue_structure
coronary,79,87,I-Multi-tissue_structure
artery,88,94,I-Multi-tissue_structure
.,94,95,O
A,96,97,O
:,97,98,O
a,99,100,O
balloon,101,108,O
angioplasty,109,120,O
was,121,124,O
performed,125,134,O
to,135,137,O
treat,138,143,O
total,144,149,O
occlusion,150,159,O
of,160,162,O
the,163,166,O
stented,167,174,O
right,175,180,B-Multi-tissue_structure
coronary,181,189,I-Multi-tissue_structure
artery,190,196,I-Multi-tissue_structure
.,196,197,O
B,198,199,O
:,199,200,O
final,201,206,O
coronary,207,215,B-Multi-tissue_structure
angiogram,216,225,O
showed,226,232,O
good,233,237,O
distal,238,244,O
flow,245,249,O
without,250,257,O
residual,258,266,O
stenosis,267,275,O
.,275,276,O
All,0,3,O
-,3,4,O
cause,4,9,O
mortality,10,19,O
in,20,22,O
RALES,23,28,O
and,29,32,O
EPHESUS,33,40,O
(,41,42,O
adapted,42,49,O
from,50,54,O
[,55,56,O
4,56,57,O
],57,58,O
and,59,62,O
[,63,64,O
5,64,65,O
],65,66,O
),66,67,O
.,67,68,O
Mean,69,73,O
follow,74,80,O
-,80,81,O
up,81,83,O
period,84,90,O
is,91,93,O
24,94,96,O
months,97,103,O
in,104,106,O
RALES,107,112,O
and,113,116,O
16,117,119,O
months,120,126,O
in,127,129,O
EPHESUS,130,137,O
Pre,0,3,O
-,3,4,O
publication,4,15,O
history,16,23,O
The,24,27,O
pre,28,31,O
-,31,32,O
publication,32,43,O
history,44,51,O
for,52,55,O
this,56,60,O
paper,61,66,O
can,67,70,O
be,71,73,O
accessed,74,82,O
here,83,87,O
:,87,88,O
http,89,93,O
:,93,94,O
/,94,95,O
/,95,96,O
www,96,99,O
.,99,100,O
biomedcentral,100,113,O
.,113,114,O
com,114,117,O
/,117,118,O
1471,118,122,O
-,122,123,O
2377,123,127,O
/,127,128,O
9,128,129,O
/,129,130,O
57,130,132,O
/,132,133,O
prepub,133,139,O
Magnetic,0,8,O
resonance,9,18,O
imaging,19,26,O
of,27,29,O
axial,30,35,O
plan,36,40,O
with,41,45,O
intravenous,46,57,B-Multi-tissue_structure
contrast,58,66,O
gadolinium,67,77,O
-,77,78,O
BOPTA,78,83,O
demonstrating,84,97,O
a,98,99,O
mass,100,104,O
adherent,105,113,O
to,114,116,O
the,117,120,O
right,121,126,O
ventricular,127,138,B-Multi-tissue_structure
wall,139,143,I-Multi-tissue_structure
.,143,144,O
Additional,0,10,O
file,11,15,O
3,16,17,O
Primers,18,25,O
used,26,30,O
in,31,33,O
this,34,38,O
study,39,44,O
.,44,45,O
All,46,49,O
of,50,52,O
the,53,56,O
primers,57,64,O
used,65,69,O
for,70,73,O
generating,74,84,O
PCR,85,88,O
products,89,97,O
for,98,101,O
microinjection,102,116,O
and,117,120,O
site,121,125,O
-,125,126,O
direct,126,132,O
mutagenesis,133,144,O
are,145,148,O
listed,149,155,O
.,155,156,O
2,0,1,O
.,1,2,O
Methods,3,10,O
We,11,13,O
conducted,14,23,O
a,24,25,O
systematic,26,36,O
study,37,42,O
of,43,45,O
patients,46,54,O
hospitalized,55,67,O
from,68,72,O
August,73,79,O
2006,80,84,O
until,85,90,O
September,91,100,O
2007,101,105,O
at,106,108,O
the,109,112,O
Yerevan,113,120,O
City,121,125,O
and,126,129,O
the,130,133,O
Republican,134,144,O
Dispensaries,145,157,O
",",157,158,O
the,159,162,O
two,163,166,O
reference,167,176,O
TB,177,179,O
hospitals,180,189,O
in,190,192,O
Armenia,193,200,O
.,200,201,O
Following,202,211,O
focus,212,217,O
group,218,223,O
discussions,224,235,O
and,236,239,O
pilot,240,245,O
testing,246,253,O
to,254,256,O
refine,257,263,O
the,264,267,O
survey,268,274,O
instrument,275,285,O
",",285,286,O
patient,287,294,O
interviews,295,305,O
began,306,311,O
in,312,314,O
the,315,318,O
fall,319,323,O
of,324,326,O
2006,327,331,O
and,332,335,O
were,336,340,O
conducted,341,350,O
by,351,353,O
trained,354,361,O
students,362,370,O
in,371,373,O
the,374,377,O
public,378,384,O
health,385,391,O
program,392,399,O
of,400,402,O
the,403,406,O
American,407,415,O
University,416,426,O
of,427,429,O
Armenia,430,437,O
.,437,438,O
Students,439,447,O
received,448,456,O
training,457,465,O
by,466,468,O
the,469,472,O
study,473,478,O
designer,479,487,O
(,488,489,O
SO,489,491,O
),491,492,O
on,493,495,O
principles,496,506,O
of,507,509,O
interview,510,519,O
ethics,520,526,O
and,527,530,O
interviewing,531,543,O
processes,544,553,O
.,553,554,O
Most,555,559,O
patient,560,567,O
interviews,568,578,O
were,579,583,O
conducted,584,593,O
at,594,596,O
the,597,600,O
Republican,601,611,O
Dispensary,612,622,O
in,623,625,O
Abovian,626,633,O
Marz,634,638,O
",",638,639,O
the,640,643,O
national,644,652,O
TB,653,655,O
diagnostic,656,666,O
and,667,670,O
treatment,671,680,O
facility,681,689,O
to,690,692,O
which,693,698,O
all,699,702,O
suspected,703,712,O
cases,713,718,O
throughout,719,729,O
the,730,733,O
country,734,741,O
are,742,745,O
referred,746,754,O
for,755,758,O
diagnostic,759,769,O
confirmation,770,782,O
.,782,783,O
In,784,786,O
the,787,790,O
past,791,795,O
several,796,803,O
years,804,809,O
",",809,810,O
strong,811,817,O
financial,818,827,O
support,828,835,O
has,836,839,O
been,840,844,O
provided,845,853,O
to,854,856,O
Armenia,857,864,O
by,865,867,O
a,868,869,O
number,870,876,O
of,877,879,O
international,880,893,O
organizations,894,907,O
",",907,908,O
such,909,913,O
as,914,916,O
the,917,920,O
German,921,927,O
Gesellschaft,928,940,O
fur,941,944,O
Technische,945,955,O
Zusammenarbeit,956,970,O
(,971,972,O
GTZ,972,975,O
),975,976,O
",",976,977,O
the,978,981,O
Global,982,988,O
Fund,989,993,O
to,994,996,O
Fight,997,1002,O
AIDS,1003,1007,O
",",1007,1008,O
Tuberculosis,1009,1021,O
and,1022,1025,O
Malaria,1026,1033,O
",",1033,1034,O
and,1035,1038,O
the,1039,1042,O
Red,1043,1046,O
Cross,1047,1052,O
",",1052,1053,O
which,1054,1059,O
has,1060,1063,O
enabled,1064,1071,O
both,1072,1076,O
microscopic,1077,1088,O
and,1089,1092,O
culture,1093,1100,O
examinations,1101,1113,O
for,1114,1117,O
each,1118,1122,O
TB,1123,1125,O
case,1126,1130,O
to,1131,1133,O
be,1134,1136,O
performed,1137,1146,O
at,1147,1149,O
the,1150,1153,O
National,1154,1162,O
Reference,1163,1172,O
Laboratory,1173,1183,O
located,1184,1191,O
at,1192,1194,O
the,1195,1198,O
Republican,1199,1209,O
TB,1210,1212,O
Dispensary,1213,1223,O
.,1223,1224,O
All,1225,1228,O
culture,1229,1236,O
-,1236,1237,O
confirmed,1237,1246,O
TB,1247,1249,O
cases,1250,1255,O
are,1256,1259,O
admitted,1260,1268,O
as,1269,1271,O
in,1272,1274,O
-,1274,1275,O
patients,1275,1283,O
while,1284,1289,O
undergoing,1290,1300,O
the,1301,1304,O
initial,1305,1312,O
phase,1313,1318,O
of,1319,1321,O
therapy,1322,1329,O
.,1329,1330,O
Because,1331,1338,O
all,1339,1342,O
confirmed,1343,1352,O
TB,1353,1355,O
patients,1356,1364,O
in,1365,1367,O
Armenia,1368,1375,O
are,1376,1379,O
referred,1380,1388,O
to,1389,1391,O
one,1392,1395,O
of,1396,1398,O
these,1399,1404,O
dispensaries,1405,1417,O
for,1418,1421,O
treatment,1422,1431,O
",",1431,1432,O
this,1433,1437,O
population,1438,1448,O
represents,1449,1459,O
all,1460,1463,O
known,1464,1469,O
TB,1470,1472,O
cases,1473,1478,O
in,1479,1481,O
the,1482,1485,O
country,1486,1493,O
.,1493,1494,O
Therefore,1495,1504,O
",",1504,1505,O
all,1506,1509,O
culture,1510,1517,O
-,1517,1518,O
confirmed,1518,1527,O
TB,1528,1530,O
in,1531,1533,O
-,1533,1534,O
patients,1534,1542,O
present,1543,1550,O
at,1551,1553,O
the,1554,1557,O
time,1558,1562,O
of,1563,1565,O
the,1566,1569,O
interviewer,1570,1581,O
visits,1582,1588,O
were,1589,1593,O
eligible,1594,1602,O
for,1603,1606,O
inclusion,1607,1616,O
in,1617,1619,O
the,1620,1623,O
study,1624,1629,O
(,1630,1631,O
the,1631,1634,O
study,1635,1640,O
group,1641,1646,O
included,1647,1655,O
both,1656,1660,O
new,1661,1664,O
and,1665,1668,O
relapsed,1669,1677,O
patients,1678,1686,O
),1686,1687,O
.,1687,1688,O
Our,1689,1692,O
systematic,1693,1703,O
sample,1704,1710,O
of,1711,1713,O
the,1714,1717,O
inpatient,1718,1727,O
TB,1728,1730,O
population,1731,1741,O
-,1741,1742,O
-,1742,1743,O
in,1743,1745,O
which,1746,1751,O
interviewers,1752,1764,O
visited,1765,1772,O
every,1773,1778,O
hospital,1779,1787,O
room,1788,1792,O
to,1793,1795,O
identify,1796,1804,O
patients,1805,1813,O
willing,1814,1821,O
to,1822,1824,O
participate,1825,1836,O
-,1836,1837,O
-,1837,1838,O
yielded,1838,1845,O
a,1846,1847,O
participation,1848,1861,O
rate,1862,1866,O
of,1867,1869,O
approximately,1870,1883,O
80,1884,1886,O
%,1886,1887,O
(,1888,1889,O
a,1889,1890,O
total,1891,1896,O
of,1897,1899,O
240,1900,1903,O
patients,1904,1912,O
),1912,1913,O
.,1913,1914,O
Interviewers,1915,1927,O
collected,1928,1937,O
demographic,1938,1949,O
information,1950,1961,O
and,1962,1965,O
asked,1966,1971,O
each,1972,1976,O
patient,1977,1984,O
to,1985,1987,O
recall,1988,1994,O
when,1995,1999,O
they,2000,2004,O
first,2005,2010,O
began,2011,2016,O
to,2017,2019,O
feel,2020,2024,O
ill,2025,2028,O
",",2028,2029,O
what,2030,2034,O
symptoms,2035,2043,O
they,2044,2048,O
experienced,2049,2060,O
",",2060,2061,O
how,2062,2065,O
long,2066,2070,O
after,2071,2076,O
symptom,2077,2084,O
onset,2085,2090,O
they,2091,2095,O
waited,2096,2102,O
to,2103,2105,O
see,2106,2109,O
a,2110,2111,O
doctor,2112,2118,O
",",2118,2119,O
their,2120,2125,O
reasons,2126,2133,O
for,2134,2137,O
delaying,2138,2146,O
medical,2147,2154,O
evaluation,2155,2165,O
",",2165,2166,O
the,2167,2170,O
type,2171,2175,O
of,2176,2178,O
facility,2179,2187,O
at,2188,2190,O
which,2191,2196,O
they,2197,2201,O
first,2202,2207,O
sought,2208,2214,O
care,2215,2219,O
",",2219,2220,O
the,2221,2224,O
initial,2225,2232,O
diagnosis,2233,2242,O
",",2242,2243,O
if,2244,2246,O
they,2247,2251,O
had,2252,2255,O
been,2256,2260,O
referred,2261,2269,O
for,2270,2273,O
further,2274,2281,O
evaluation,2282,2292,O
",",2292,2293,O
and,2294,2297,O
their,2298,2303,O
adherence,2304,2313,O
to,2314,2316,O
treatment,2317,2326,O
once,2327,2331,O
diagnosed,2332,2341,O
with,2342,2346,O
TB,2347,2349,O
.,2349,2350,O
In,2351,2353,O
2006,2354,2358,O
",",2358,2359,O
129,2360,2363,O
of,2364,2366,O
the,2367,2370,O
planned,2371,2378,O
250,2379,2382,O
surveys,2383,2390,O
were,2391,2395,O
completed,2396,2405,O
.,2405,2406,O
Data,2407,2411,O
collection,2412,2422,O
resumed,2423,2430,O
in,2431,2433,O
the,2434,2437,O
fall,2438,2442,O
of,2443,2445,O
2007,2446,2450,O
and,2451,2454,O
a,2455,2456,O
total,2457,2462,O
of,2463,2465,O
240,2466,2469,O
interviews,2470,2480,O
were,2481,2485,O
conducted,2486,2495,O
.,2495,2496,O
Summary,0,7,O
Kindt,8,13,O
et,14,16,O
al,17,19,O
.,19,20,O
1,20,21,O
published,22,31,O
a,32,33,O
report,34,40,O
entitled,41,49,O
"""",50,51,O
Intestinal,51,61,B-Multi-tissue_structure
immune,62,68,O
activation,69,79,O
in,80,82,O
presumed,83,91,O
post,92,96,O
-,96,97,O
infectious,97,107,O
functional,108,118,O
syspepsia,119,128,O
"""",128,129,O
in,130,132,O
the,133,136,O
August,137,143,O
issue,144,149,O
of,150,152,O
Neurogastroenterology,153,174,O
and,175,178,O
Motility,179,187,O
in,188,190,O
2009,191,195,O
.,195,196,O
By,197,199,O
comparing,200,209,O
the,210,213,O
signs,214,219,O
of,220,222,O
inflammation,223,235,O
and,236,239,O
the,240,243,O
degree,244,250,O
of,251,253,O
hyperplasia,254,265,O
of,266,268,O
the,269,272,O
enterochromaffin,273,289,B-Cell
cells,290,295,I-Cell
(,296,297,O
EC,297,299,B-Cell
),299,300,O
in,301,303,O
duodenal,304,312,O
biopsies,313,321,O
obtained,322,330,O
from,331,335,O
patients,336,344,O
with,345,349,O
presumed,350,358,O
post,359,363,O
-,363,364,O
infectious,364,374,O
functional,375,385,O
dyspepsia,386,395,O
(,396,397,O
PI,397,399,O
-,399,400,O
FD,400,402,O
),402,403,O
and,404,407,O
unspecified,408,419,O
-,419,420,O
onset,420,425,O
functional,426,436,O
dyspepsia,437,446,O
(,447,448,O
U,448,449,O
-,449,450,O
FD,450,452,O
),452,453,O
",",453,454,O
they,455,459,O
showed,460,466,O
that,467,471,O
PI,472,474,O
-,474,475,O
FD,475,477,O
is,478,480,O
associated,481,491,O
with,492,496,O
persistence,497,508,O
of,509,511,O
focal,512,517,O
T,518,519,B-Cell
-,519,520,I-Cell
cell,520,524,I-Cell
aggregates,525,535,O
",",535,536,O
decrease,537,545,O
in,546,548,O
CD4,549,552,B-Cell
+,552,553,I-Cell
cells,554,559,I-Cell
and,560,563,O
increased,564,573,O
macrophage,574,584,B-Cell
counts,585,591,O
surrounding,592,603,O
the,604,607,O
crypts,608,614,B-Multi-tissue_structure
",",614,615,O
without,616,623,O
any,624,627,O
significant,628,639,O
differences,640,651,O
in,652,654,O
the,655,658,O
numbers,659,666,O
of,667,669,O
EC,670,672,B-Cell
or,673,675,O
chromogranin,676,688,B-Cell
A,689,690,I-Cell
(,691,692,I-Cell
CA,692,694,I-Cell
),694,695,I-Cell
-,695,696,I-Cell
positive,696,704,I-Cell
cells,705,710,I-Cell
(,711,712,O
mast,712,716,B-Cell
cells,717,722,I-Cell
),722,723,O
.,723,724,O
This,725,729,O
finding,730,737,O
may,738,741,O
indicate,742,750,O
impaired,751,759,O
ability,760,767,O
of,768,770,O
the,771,774,O
immune,775,781,B-Anatomical_system
system,782,788,I-Anatomical_system
in,789,791,O
these,792,797,O
cases,798,803,O
to,804,806,O
terminate,807,816,O
the,817,820,O
inflammatory,821,833,O
response,834,842,O
after,843,848,O
an,849,851,O
acute,852,857,O
insult,858,864,O
.,864,865,O
Temporary,0,9,O
migration,10,19,O
module,20,26,O
A,27,28,O
temporary,29,38,O
migration,39,48,O
census,49,55,O
module,56,62,O
was,63,66,O
conducted,67,76,O
in,77,79,O
2002,80,84,O
and,85,88,O
2007,89,93,O
.,93,94,O
People,95,101,O
who,102,105,O
were,106,110,O
identified,111,121,O
as,122,124,O
temporary,125,134,O
migrants,135,143,O
were,144,148,O
entered,149,156,O
into,157,161,O
the,162,165,O
module,166,172,O
",",172,173,O
and,174,177,O
a,178,179,O
household,180,189,O
respondent,190,200,O
answered,201,209,O
questions,210,219,O
about,220,225,O
the,226,229,O
migration,230,239,O
.,239,240,O
Key,241,244,O
areas,245,250,O
included,251,259,O
the,260,263,O
duration,264,272,O
of,273,275,O
migration,276,285,O
",",285,286,O
destination,287,298,O
",",298,299,O
reasons,300,307,O
for,308,311,O
migration,312,321,O
",",321,322,O
return,323,329,O
pattern,330,337,O
",",337,338,O
communication,339,352,O
pattern,353,360,O
",",360,361,O
remittances,362,373,O
",",373,374,O
linked,375,381,O
moves,382,387,O
and,388,391,O
child,392,397,O
care,398,402,O
arrangements,403,415,O
.,415,416,O
MOR1K,0,5,O
expression,6,16,O
and,17,20,O
binding,21,28,O
pattern,29,36,O
.,36,37,O
(,38,39,O
A,39,40,O
),40,41,O
The,42,45,O
schematic,46,55,O
diagram,56,63,O
illustrates,64,75,O
the,76,79,O
exonic,80,86,O
composition,87,98,O
and,99,102,O
relative,103,111,O
positions,112,121,O
of,122,124,O
PCR,125,128,O
primers,129,136,O
designed,137,145,O
to,146,148,O
amplify,149,156,O
the,157,160,O
major,161,166,O
MOR1,167,171,O
isoform,172,179,O
and,180,183,O
the,184,187,O
newly,188,193,O
identified,194,204,O
alternative,205,216,O
MOR1K,217,222,O
isoform,223,230,O
.,230,231,O
The,232,235,O
relative,236,244,O
positions,245,254,O
of,255,257,O
translation,258,269,O
initiation,270,280,O
start,281,286,O
and,287,290,O
stop,291,295,O
codons,296,302,O
are,303,306,O
designated,307,317,O
by,318,320,O
ATG,321,324,O
and,325,328,O
TGA,329,332,O
",",332,333,O
respectively,334,346,O
.,346,347,O
The,348,351,O
predicted,352,361,O
protein,362,369,O
structure,370,379,O
of,380,382,O
MOR1,383,387,O
and,388,391,O
MOR1K,392,397,O
isoforms,398,406,O
is,407,409,O
schematically,410,423,O
presented,424,433,O
.,433,434,O
Translation,435,446,O
of,447,449,O
the,450,453,O
MOR1K,454,459,O
variant,460,467,O
results,468,475,O
in,476,478,O
a,479,480,O
6TM,481,484,O
receptor,485,493,O
",",493,494,O
truncated,495,504,O
at,505,507,O
the,508,511,O
N,512,513,O
-,513,514,O
terminus,514,522,O
.,522,523,O
(,524,525,O
B,525,526,O
),526,527,O
Real,528,532,O
-,532,533,O
time,533,537,O
PCR,538,541,O
was,542,545,O
performed,546,555,O
on,556,558,O
total,559,564,O
RNA,565,568,O
samples,569,576,O
from,577,581,O
the,582,585,O
human,586,591,O
brain,592,597,B-Organ
regions,598,605,O
known,606,611,O
to,612,614,O
express,615,622,O
MOR1,623,627,O
.,627,628,O
Primers,629,636,O
specific,637,645,O
for,646,649,O
exons,650,655,O
1,656,657,O
and,658,661,O
2,662,663,O
were,664,668,O
used,669,673,O
to,674,676,O
measure,677,684,O
MOR1,685,689,O
and,690,693,O
primers,694,701,O
specific,702,710,O
for,711,714,O
exons,715,720,O
13,721,723,O
and,724,727,O
exon,728,732,O
2,733,734,O
were,735,739,O
used,740,744,O
to,745,747,O
measure,748,755,O
MOR1K,756,761,O
[,761,762,O
32,762,764,O
],764,765,O
.,765,766,O
GAP3DH,767,773,O
was,774,777,O
used,778,782,O
as,783,785,O
a,786,787,O
control,788,795,O
for,796,799,O
cDNA,800,804,O
loading,805,812,O
and,813,816,O
PCR,817,820,O
efficiency,821,831,O
.,831,832,O
(,833,834,O
C,834,835,O
),835,836,O
Confocal,837,845,O
images,846,852,O
of,853,855,O
C,856,857,O
-,857,858,O
terminally,858,868,O
MYC,869,872,O
-,872,873,O
tagged,873,879,O
MOR1,880,884,O
or,885,887,O
FLAG,888,892,O
-,892,893,O
tagged,893,899,O
MOR1K,900,905,O
overexpressed,906,919,O
in,920,922,O
HEK293,923,929,B-Cell
cells,930,935,I-Cell
and,936,939,O
stained,940,947,O
with,948,952,O
either,953,959,O
Anti,960,964,O
-,964,965,O
MYC,965,968,O
-,968,969,O
Tag,969,972,O
Antibody,973,981,O
(,982,983,O
Alexa,983,988,O
Fluor,989,994,O
647,995,998,O
Conjugate,999,1008,O
),1008,1009,O
or,1010,1012,O
Anti,1013,1017,O
-,1017,1018,O
DYKDDDDK,1018,1026,O
Tag,1027,1030,O
Antibody,1031,1039,O
(,1040,1041,O
Alexa,1041,1046,O
Fluor,1047,1052,O
555,1053,1056,O
conjugate,1057,1066,O
),1066,1067,O
.,1067,1068,O
Cells,1069,1074,B-Cell
transfected,1075,1086,O
with,1087,1091,O
MOR1,1092,1096,O
showed,1097,1103,O
membrane,1104,1112,B-Cellular_component
expression,1113,1123,O
of,1124,1126,O
receptor,1127,1135,O
",",1135,1136,O
while,1137,1142,O
cell,1143,1147,B-Cell
transfected,1148,1159,O
with,1160,1164,O
MOR1K,1165,1170,O
express,1171,1178,O
receptor,1179,1187,O
only,1188,1192,O
intracellular,1193,1206,B-Immaterial_anatomical_entity
.,1206,1207,O
(,1208,1209,O
D,1209,1210,O
),1210,1211,O
Confocal,1212,1220,O
images,1221,1227,O
of,1228,1230,O
C,1231,1232,O
-,1232,1233,O
terminally,1233,1243,O
FLAG,1244,1248,O
-,1248,1249,O
tagged,1249,1255,O
MOR1K,1256,1261,O
overexpressed,1262,1275,O
in,1276,1278,O
Be2C,1279,1283,B-Cell
cells,1284,1289,I-Cell
and,1290,1293,O
stained,1294,1301,O
with,1302,1306,O
either,1307,1313,O
Anti,1314,1318,O
-,1318,1319,O
FLAG,1319,1323,O
M2,1324,1326,O
Antibody,1327,1335,O
Alexa,1336,1341,O
Fluor,1342,1347,O
Conjugate,1348,1357,O
or,1358,1360,O
fluorescent,1361,1372,O
-,1372,1373,O
labeled,1373,1380,O
naloxone,1381,1389,O
(,1390,1391,O
FNAL,1391,1395,O
),1395,1396,O
.,1396,1397,O
Cells,1398,1403,B-Cell
transfected,1404,1415,O
with,1416,1420,O
MOR1K,1421,1426,O
showed,1427,1433,O
intracellular,1434,1447,B-Immaterial_anatomical_entity
retention,1448,1457,O
of,1458,1460,O
FNAL,1461,1465,O
that,1466,1470,O
co,1471,1473,O
-,1473,1474,O
localized,1474,1483,O
with,1484,1488,O
antibody,1489,1497,O
-,1497,1498,O
labeled,1498,1505,O
receptor,1506,1514,O
.,1514,1515,O
(,1516,1517,O
E,1517,1518,O
),1518,1519,O
The,1520,1523,O
binding,1524,1531,O
of,1532,1534,O
naloxone,1535,1543,O
to,1544,1546,O
MOR1K,1547,1552,O
was,1553,1556,O
assessed,1557,1565,O
using,1566,1571,O
flow,1572,1576,O
cytometry,1577,1586,O
to,1587,1589,O
measure,1590,1597,O
FNAL,1598,1602,O
retention,1603,1612,O
.,1612,1613,O
Be2C,1614,1618,B-Cell
cells,1619,1624,I-Cell
transfected,1625,1636,O
with,1637,1641,O
either,1642,1648,O
MOR1,1649,1653,O
or,1654,1656,O
MOR1K,1657,1662,O
isoforms,1663,1671,O
showed,1672,1678,O
increased,1679,1688,O
retention,1689,1698,O
of,1699,1701,O
FNAL,1702,1706,O
at,1707,1709,O
concentrations,1710,1724,O
of,1725,1727,O
0,1728,1729,O
.,1729,1730,O
1,1730,1731,O
and,1732,1735,O
1,1736,1737,O
muM,1738,1741,O
.,1741,1742,O
FNAL,1743,1747,O
retention,1748,1757,O
was,1758,1761,O
abolished,1762,1771,O
in,1772,1774,O
the,1775,1778,O
presence,1779,1787,O
of,1788,1790,O
10,1791,1793,O
muM,1794,1797,O
unlabelled,1798,1808,O
naloxone,1809,1817,O
(,1818,1819,O
Nal,1819,1822,O
),1822,1823,O
.,1823,1824,O
In,1825,1827,O
panel,1828,1833,O
E,1834,1835,O
",",1835,1836,O
data,1837,1841,O
are,1842,1845,O
presented,1846,1855,O
as,1856,1858,O
mean,1859,1863,O
+,1864,1865,O
SEM,1866,1869,O
.,1869,1870,O
*,1871,1872,O
P,1872,1873,O
<,1874,1875,O
0,1876,1877,O
.,1877,1878,O
05,1878,1880,O
different,1881,1890,O
from,1891,1895,O
controls,1896,1904,O
),1904,1905,O
.,1905,1906,O
Authors,0,7,O
',7,8,O
contributions,9,22,O
MBH,23,26,O
made,27,31,O
the,32,35,O
pathological,36,48,O
diagnosis,49,58,O
and,59,62,O
was,63,66,O
responsible,67,78,O
for,79,82,O
conception,83,93,O
and,94,97,O
final,98,103,O
approval,104,112,O
of,113,115,O
the,116,119,O
manuscript,120,130,O
.,130,131,O
MB,132,134,O
carried,135,142,O
out,143,146,O
the,147,150,O
literature,151,161,O
search,162,168,O
and,169,172,O
drafted,173,180,O
the,181,184,O
manuscript,185,195,O
.,195,196,O
IC,197,199,O
carried,200,207,O
out,208,211,O
the,212,215,O
surgical,216,224,O
procedure,225,234,O
and,235,238,O
reviewed,239,247,O
the,248,251,O
manuscript,252,262,O
.,262,263,O
RM,264,266,O
carried,267,274,O
out,275,278,O
the,279,282,O
surgical,283,291,O
procedure,292,301,O
",",301,302,O
provided,303,311,O
clinical,312,320,O
details,321,328,O
",",328,329,O
followed,330,338,O
up,339,341,O
our,342,345,O
patient,346,353,O
and,354,357,O
obtained,358,366,O
her,367,370,O
consent,371,378,O
to,379,381,O
publish,382,389,O
this,390,394,O
case,395,399,O
report,400,406,O
.,406,407,O
All,408,411,O
authors,412,419,O
read,420,424,O
and,425,428,O
approved,429,437,O
the,438,441,O
final,442,447,O
manuscript,448,458,O
.,458,459,O
Breast,0,6,B-Pathological_formation
cancer,7,13,I-Pathological_formation
The,14,17,O
incidence,18,27,O
of,28,30,O
breast,31,37,B-Pathological_formation
cancer,38,44,I-Pathological_formation
is,45,47,O
no,48,50,O
higher,51,57,O
than,58,62,O
in,63,65,O
the,66,69,O
rest,70,74,O
of,75,77,O
the,78,81,O
population,82,92,O
.,92,93,O
Tamoxifen,94,103,O
should,104,110,O
not,111,114,O
be,115,117,O
used,118,122,O
as,123,125,O
it,126,128,O
may,129,132,O
worsen,133,139,O
symptoms,140,148,O
[,149,150,O
43,150,152,O
],152,153,O
.,153,154,O
Women,155,160,O
need,161,165,O
also,166,170,O
specific,171,179,O
management,180,190,O
for,191,194,O
treatment,195,204,O
of,205,207,O
HAE,208,211,O
.,211,212,O
Short,213,218,O
term,219,223,O
prophylaxis,224,235,O
:,235,236,O
three,237,242,O
options,243,250,O
are,251,254,O
available,255,264,O
:,264,265,O
attenuated,266,276,O
androgens,277,286,O
",",286,287,O
tranexamic,288,298,O
acid,299,303,O
or,304,306,O
C1Inh,307,312,O
concentrate,313,324,O
.,324,325,O
There,326,331,O
is,332,334,O
no,335,337,O
specific,338,346,O
problem,347,354,O
for,355,358,O
the,359,362,O
use,363,366,O
of,367,369,O
theses,370,376,O
drugs,377,382,O
for,383,386,O
short,387,392,O
course,393,399,O
in,400,402,O
female,403,409,O
patients,410,418,O
.,418,419,O
In,420,422,O
case,423,427,O
of,428,430,O
short,431,436,O
term,437,441,O
prophylaxis,442,453,O
with,454,458,O
attenuated,459,469,O
androgens,470,479,O
",",479,480,O
no,481,483,O
virilisation,484,496,O
has,497,500,O
been,501,505,O
observed,506,514,O
[,515,516,O
44,516,518,O
",",518,519,O
45,519,521,O
],521,522,O
.,522,523,O
Acute,524,529,O
attack,530,536,O
treatment,537,546,O
:,546,547,O
there,548,553,O
is,554,556,O
no,557,559,O
specific,560,568,O
problem,569,576,O
for,577,580,O
the,581,584,O
use,585,588,O
of,589,591,O
C1inh,592,597,O
concentrate,598,609,O
",",609,610,O
tranexamic,611,621,O
acid,622,626,O
",",626,627,O
icatibant,628,637,O
;,637,638,O
or,639,641,O
ecallantide,642,653,O
in,654,656,O
female,657,663,O
patients,664,672,O
.,672,673,O
RNA,0,3,O
extraction,4,14,O
and,15,18,O
reverse,19,26,O
transcription,27,40,O
Total,41,46,O
RNA,47,50,O
were,51,55,O
extracted,56,65,O
from,66,70,O
cells,71,76,B-Cell
using,77,82,O
either,83,89,O
Trizol,90,96,O
reagent,97,104,O
(,105,106,O
Invitrogen,106,116,O
),116,117,O
or,118,120,O
RNeasy,121,127,O
kit,128,131,O
(,132,133,O
Qiagen,133,139,O
),139,140,O
and,141,144,O
treated,145,152,O
with,153,157,O
DNaseI,158,164,O
reagent,165,172,O
(,173,174,O
Macherey,174,182,O
-,182,183,O
Nagel,183,188,O
),188,189,O
for,190,193,O
30,194,196,O
min,197,200,O
at,201,203,O
room,204,208,O
temperature,209,220,O
.,220,221,O
Reverse,222,229,O
transcriptions,230,244,O
were,245,249,O
performed,250,259,O
using,260,265,O
1microg,266,273,O
total,274,279,O
RNA,280,283,O
and,284,287,O
the,288,291,O
High,292,296,O
capacity,297,305,O
cDNA,306,310,O
reverse,311,318,O
transcription,319,332,O
kit,333,336,O
with,337,341,O
RNase,342,347,O
Inhibitor,348,357,O
(,358,359,O
Applied,359,366,O
Biosystems,367,377,O
),377,378,O
.,378,379,O
Statistical,0,11,O
results,12,19,O
showing,20,27,O
significant,28,39,O
differences,40,51,O
between,52,59,O
habitats,60,68,O
.,68,69,O
Definition,0,10,O
of,11,13,O
pathogens,14,23,O
It,24,26,O
remains,27,34,O
difficult,35,44,O
to,45,47,O
determine,48,57,O
whether,58,65,O
the,66,69,O
organisms,70,79,O
detected,80,88,O
by,89,91,O
the,92,95,O
DNA,96,99,O
Detection,100,109,O
Kit,110,113,O
are,114,117,O
true,118,122,O
pathogens,123,132,O
.,132,133,O
This,134,138,O
also,139,143,O
applies,144,151,O
",",151,152,O
although,153,161,O
to,162,164,O
a,165,166,O
much,167,171,O
lesser,172,178,O
degree,179,185,O
",",185,186,O
to,187,189,O
conventional,190,202,O
blood,203,208,B-Organism_substance
culture,209,216,O
analysis,217,225,O
.,225,226,O
However,227,234,O
",",234,235,O
detected,236,244,O
organisms,245,254,O
were,255,259,O
considered,260,270,O
to,271,273,O
be,274,276,O
pathogens,277,286,O
if,287,289,O
the,290,293,O
results,294,301,O
of,302,304,O
culture,305,312,O
tests,313,318,O
from,319,323,O
samples,324,331,O
of,332,334,O
the,335,338,O
suspected,339,348,O
infectious,349,359,O
sites,360,365,O
coincided,366,375,O
with,376,380,O
the,381,384,O
results,385,392,O
of,393,395,O
DNA,396,399,O
Detection,400,409,O
Kit,410,413,O
or,414,416,O
blood,417,422,B-Organism_substance
culture,423,430,O
analysis,431,439,O
.,439,440,O
The,441,444,O
culture,445,452,O
data,453,457,O
of,458,460,O
sputum,461,467,B-Organism_substance
",",467,468,O
urine,469,474,B-Organism_substance
",",474,475,O
pus,476,479,B-Organism_substance
and,480,483,O
drainage,484,492,O
fluid,493,498,B-Organism_substance
were,499,503,O
used,504,508,O
to,509,511,O
define,512,518,O
the,519,522,O
pathogens,523,532,O
.,532,533,O
A,534,535,O
decision,536,544,O
as,545,547,O
to,548,550,O
whether,551,558,O
an,559,561,O
identified,562,572,O
organism,573,581,O
was,582,585,O
a,586,587,O
pathogen,588,596,O
was,597,600,O
taken,601,606,O
based,607,612,O
on,613,615,O
the,616,619,O
decision,620,628,O
tree,629,633,O
shown,634,639,O
in,640,642,O
Figure,643,649,O
1,650,651,O
.,651,652,O
Thus,653,657,O
",",657,658,O
when,659,663,O
the,664,667,O
same,668,672,O
organism,673,681,O
was,682,685,O
detected,686,694,O
by,695,697,O
both,698,702,O
DNA,703,706,O
Detection,707,716,O
Kit,717,720,O
and,721,724,O
blood,725,730,B-Organism_substance
culture,731,738,O
analysis,739,747,O
",",747,748,O
the,749,752,O
detected,753,761,O
organism,762,770,O
was,771,774,O
considered,775,785,O
an,786,788,O
infectious,789,799,O
pathogen,800,808,O
.,808,809,O
If,810,812,O
there,813,818,O
was,819,822,O
a,823,824,O
discrepancy,825,836,O
between,837,844,O
the,845,848,O
organism,849,857,O
that,858,862,O
was,863,866,O
detected,867,875,O
by,876,878,O
SeptiFast,879,888,O
analysis,889,897,O
and,898,901,O
that,902,906,O
detected,907,915,O
by,916,918,O
blood,919,924,B-Organism_substance
culture,925,932,O
analysis,933,941,O
",",941,942,O
or,943,945,O
if,946,948,O
an,949,951,O
organism,952,960,O
was,961,964,O
only,965,969,O
detected,970,978,O
in,979,981,O
one,982,985,O
of,986,988,O
these,989,994,O
tests,995,1000,O
",",1000,1001,O
then,1002,1006,O
other,1007,1012,O
samples,1013,1020,O
taken,1021,1026,O
from,1027,1031,O
the,1032,1035,O
infection,1036,1045,O
site,1046,1050,O
were,1051,1055,O
analyzed,1056,1064,O
.,1064,1065,O
If,1066,1068,O
this,1069,1073,O
second,1074,1080,O
culture,1081,1088,O
test,1089,1093,O
of,1094,1096,O
the,1097,1100,O
suspected,1101,1110,O
infectious,1111,1121,O
site,1122,1126,O
revealed,1127,1135,O
the,1136,1139,O
presence,1140,1148,O
of,1149,1151,O
the,1152,1155,O
same,1156,1160,O
organism,1161,1169,O
",",1169,1170,O
this,1171,1175,O
organism,1176,1184,O
was,1185,1188,O
considered,1189,1199,O
to,1200,1202,O
be,1203,1205,O
a,1206,1207,O
pathogen,1208,1216,O
.,1216,1217,O
If,1218,1220,O
the,1221,1224,O
microbial,1225,1234,O
strain,1235,1241,O
was,1242,1245,O
only,1246,1250,O
detected,1251,1259,O
once,1260,1264,O
for,1265,1268,O
a,1269,1270,O
sample,1271,1277,O
",",1277,1278,O
we,1279,1281,O
then,1282,1286,O
checked,1287,1294,O
the,1295,1298,O
second,1299,1305,O
culture,1306,1313,O
results,1314,1321,O
in,1322,1324,O
the,1325,1328,O
suspected,1329,1338,O
infectious,1339,1349,O
sites,1350,1355,O
.,1355,1356,O
If,1357,1359,O
this,1360,1364,O
result,1365,1371,O
identified,1372,1382,O
the,1383,1386,O
same,1387,1391,O
strain,1392,1398,O
as,1399,1401,O
that,1402,1406,O
identified,1407,1417,O
by,1418,1420,O
SeptiFast,1421,1430,O
analysis,1431,1439,O
then,1440,1444,O
it,1445,1447,O
was,1448,1451,O
decided,1452,1459,O
that,1460,1464,O
this,1465,1469,O
strain,1470,1476,O
was,1477,1480,O
a,1481,1482,O
pathogen,1483,1491,O
.,1491,1492,O
However,1493,1500,O
",",1500,1501,O
if,1502,1504,O
the,1505,1508,O
strain,1509,1515,O
was,1516,1519,O
still,1520,1525,O
only,1526,1530,O
detected,1531,1539,O
in,1540,1542,O
some,1543,1547,O
of,1548,1550,O
the,1551,1554,O
assays,1555,1561,O
",",1561,1562,O
we,1563,1565,O
next,1566,1570,O
determined,1571,1581,O
if,1582,1584,O
the,1585,1588,O
patient,1589,1596,O
involved,1597,1605,O
suffered,1606,1614,O
from,1615,1619,O
sepsis,1620,1626,O
.,1626,1627,O
Sepsis,1628,1634,O
is,1635,1637,O
defined,1638,1645,O
as,1646,1648,O
SIRS,1649,1653,O
caused,1654,1660,O
by,1661,1663,O
infection,1664,1673,O
.,1673,1674,O
The,1675,1678,O
definition,1679,1689,O
of,1690,1692,O
sepsis,1693,1699,O
that,1700,1704,O
we,1705,1707,O
used,1708,1712,O
was,1713,1716,O
based,1717,1722,O
on,1723,1725,O
the,1726,1729,O
International,1730,1743,O
Sepsis,1744,1750,O
Forum,1751,1756,O
Definition,1757,1767,O
of,1768,1770,O
Infection,1771,1780,O
at,1781,1783,O
the,1784,1787,O
ICU,1788,1791,O
Consensus,1792,1801,O
Conference,1802,1812,O
[,1813,1814,O
7,1814,1815,O
],1815,1816,O
.,1816,1817,O
However,1818,1825,O
",",1825,1826,O
if,1827,1829,O
the,1830,1833,O
underlying,1834,1844,O
disease,1845,1852,O
is,1853,1855,O
acute,1856,1861,O
lymphoma,1862,1870,O
leukemia,1871,1879,O
(,1880,1881,O
ALL,1881,1884,O
),1884,1885,O
",",1885,1886,O
malignant,1887,1896,B-Pathological_formation
lymphoma,1897,1905,I-Pathological_formation
(,1906,1907,O
ML,1907,1909,B-Pathological_formation
),1909,1910,O
",",1910,1911,O
or,1912,1914,O
acute,1915,1920,O
myelogenous,1921,1932,O
leukemia,1933,1941,O
(,1942,1943,O
AML,1943,1946,O
),1946,1947,O
",",1947,1948,O
the,1949,1952,O
definition,1953,1963,O
of,1964,1966,O
infection,1967,1976,O
is,1977,1979,O
defined,1980,1987,O
as,1988,1990,O
the,1991,1994,O
ability,1995,2002,O
to,2003,2005,O
detect,2006,2012,O
infectious,2013,2023,O
organisms,2024,2033,O
by,2034,2036,O
blood,2037,2042,B-Organism_substance
culture,2043,2050,O
analysis,2051,2059,O
.,2059,2060,O
If,2061,2063,O
the,2064,2067,O
patient,2068,2075,O
was,2076,2079,O
not,2080,2083,O
defined,2084,2091,O
as,2092,2094,O
having,2095,2101,O
sepsis,2102,2108,O
when,2109,2113,O
whole,2114,2119,B-Organism_substance
blood,2120,2125,I-Organism_substance
was,2126,2129,O
administered,2130,2142,O
to,2143,2145,O
the,2146,2149,O
patient,2150,2157,O
",",2157,2158,O
we,2159,2161,O
decided,2162,2169,O
that,2170,2174,O
the,2175,2178,O
strain,2179,2185,O
detected,2186,2194,O
by,2195,2197,O
subsequent,2198,2208,O
DNA,2209,2212,O
Detection,2213,2222,O
Kit,2223,2226,O
or,2227,2229,O
blood,2230,2235,B-Organism_substance
culture,2236,2243,O
analysis,2244,2252,O
was,2253,2256,O
not,2257,2260,O
a,2261,2262,O
pathogen,2263,2271,O
.,2271,2272,O
Figure,2273,2279,O
1,2280,2281,O
Flowchart,2282,2291,O
for,2292,2295,O
pathogen,2296,2304,O
decision,2305,2313,O
.,2313,2314,O
Samples,2315,2322,O
were,2323,2327,O
defined,2328,2335,O
as,2336,2338,O
negative,2339,2347,O
for,2348,2351,O
pathogens,2352,2361,O
if,2362,2364,O
a,2365,2366,O
pathogen,2367,2375,O
could,2376,2381,O
not,2382,2385,O
be,2386,2388,O
detected,2389,2397,O
by,2398,2400,O
any,2401,2404,O
method,2405,2411,O
of,2412,2414,O
analysis,2415,2423,O
within,2424,2430,O
seven,2431,2436,O
days,2437,2441,O
",",2441,2442,O
and,2443,2446,O
if,2447,2449,O
another,2450,2457,O
type,2458,2462,O
of,2463,2465,O
culture,2466,2473,O
test,2474,2478,O
did,2479,2482,O
not,2483,2486,O
detect,2487,2493,O
this,2494,2498,O
pathogen,2499,2507,O
but,2508,2511,O
could,2512,2517,O
detect,2518,2524,O
other,2525,2530,O
organisms,2531,2540,O
.,2540,2541,O
CoNS,2542,2546,O
bacteria,2547,2555,O
",",2555,2556,O
which,2557,2562,O
are,2563,2566,O
represented,2567,2578,O
by,2579,2581,O
the,2582,2585,O
Staphylococcus,2586,2600,O
epidermidis,2601,2612,O
(,2613,2614,O
S,2614,2615,O
.,2615,2616,O
epidermidis,2617,2628,O
),2628,2629,O
and,2630,2633,O
Streptococcus,2634,2647,O
spp,2648,2651,O
.,2651,2652,O
are,2653,2656,O
indigenous,2657,2667,O
bacteria,2668,2676,O
and,2677,2680,O
often,2681,2686,O
cause,2687,2692,O
contamination,2693,2706,O
in,2707,2709,O
assays,2710,2716,O
of,2717,2719,O
pathogens,2720,2729,O
.,2729,2730,O
Therefore,2731,2740,O
",",2740,2741,O
when,2742,2746,O
CoNS,2747,2751,O
or,2752,2754,O
Streptococcus,2755,2768,O
spp,2769,2772,O
.,2772,2773,O
were,2774,2778,O
detected,2779,2787,O
by,2788,2790,O
blood,2791,2796,B-Organism_substance
culture,2797,2804,O
and,2805,2808,O
SeptiFast,2809,2818,O
analysis,2819,2827,O
",",2827,2828,O
the,2829,2832,O
following,2833,2842,O
criteria,2843,2851,O
were,2852,2856,O
applied,2857,2864,O
to,2865,2867,O
define,2868,2874,O
whether,2875,2882,O
these,2883,2888,O
strains,2889,2896,O
represented,2897,2908,O
a,2909,2910,O
pathogenic,2911,2921,O
infection,2922,2931,O
:,2931,2932,O
(,2933,2934,O
1,2934,2935,O
),2935,2936,O
Tests,2937,2942,O
were,2943,2947,O
performed,2948,2957,O
at,2958,2960,O
least,2961,2966,O
twice,2967,2972,O
within,2973,2979,O
48,2980,2982,O
hours,2983,2988,O
before,2989,2995,O
and,2996,2999,O
after,3000,3005,O
CoNS,3006,3010,O
were,3011,3015,O
detected,3016,3024,O
by,3025,3027,O
blood,3028,3033,B-Organism_substance
culture,3034,3041,O
or,3042,3044,O
SeptiFast,3045,3054,O
analysis,3055,3063,O
;,3063,3064,O
(,3065,3066,O
2,3066,3067,O
),3067,3068,O
CoNS,3069,3073,O
or,3074,3076,O
Streptococcus,3077,3090,O
spp,3091,3094,O
.,3094,3095,O
were,3096,3100,O
detected,3101,3109,O
in,3110,3112,O
two,3113,3116,O
different,3117,3126,O
blood,3127,3132,B-Organism_substance
culture,3133,3140,O
tests,3141,3146,O
that,3147,3151,O
were,3152,3156,O
separately,3157,3167,O
performed,3168,3177,O
twice,3178,3183,O
within,3184,3190,O
48,3191,3193,O
hours,3194,3199,O
;,3199,3200,O
and,3201,3204,O
",",3204,3205,O
(,3206,3207,O
3,3207,3208,O
),3208,3209,O
CoNS,3210,3214,O
or,3215,3217,O
Streptococcus,3218,3231,O
spp,3232,3235,O
.,3235,3236,O
were,3237,3241,O
detected,3242,3250,O
twice,3251,3256,O
or,3257,3259,O
more,3260,3264,O
in,3265,3267,O
tests,3268,3273,O
that,3274,3278,O
were,3279,3283,O
performed,3284,3293,O
three,3294,3299,O
times,3300,3305,O
[,3306,3307,O
11,3307,3309,O
-,3309,3310,O
15,3310,3312,O
],3312,3313,O
.,3313,3314,O
If,3315,3317,O
a,3318,3319,O
sample,3320,3326,O
',3326,3327,O
s,3327,3328,O
results,3329,3336,O
met,3337,3340,O
any,3341,3344,O
of,3345,3347,O
these,3348,3353,O
three,3354,3359,O
criteria,3360,3368,O
",",3368,3369,O
then,3370,3374,O
the,3375,3378,O
sample,3379,3385,B-Organism_substance
was,3386,3389,O
evaluated,3390,3399,O
as,3400,3402,O
a,3403,3404,O
pathogen,3405,3413,O
.,3413,3414,O
The,3415,3418,O
distinction,3419,3430,O
between,3431,3438,O
pathogen,3439,3447,O
and,3448,3451,O
contamination,3452,3465,O
was,3466,3469,O
also,3470,3474,O
determined,3475,3485,O
for,3486,3489,O
CoNS,3490,3494,O
or,3495,3497,O
Streptococcus,3498,3511,O
spp,3512,3515,O
.,3515,3516,O
from,3517,3521,O
the,3522,3525,O
crossing,3526,3534,O
point,3535,3540,O
(,3541,3542,O
Cp,3542,3544,O
),3544,3545,O
obtained,3546,3554,O
using,3555,3560,O
the,3561,3564,O
LightCycler,3565,3576,O
analysis,3577,3585,O
software,3586,3594,O
v4,3595,3597,O
.,3597,3598,O
05,3598,3600,O
.,3600,3601,O
The,3602,3605,O
Cp,3606,3608,O
represents,3609,3619,O
the,3620,3623,O
point,3624,3629,O
in,3630,3632,O
the,3633,3636,O
amplification,3637,3650,O
cycle,3651,3656,O
where,3657,3662,O
the,3663,3666,O
amplification,3667,3680,O
curve,3681,3686,O
crosses,3687,3694,O
the,3695,3698,O
detection,3699,3708,O
threshold,3709,3718,O
.,3718,3719,O
When,3720,3724,O
CoNS,3725,3729,O
or,3730,3732,O
Streptococcus,3733,3746,O
spp,3747,3750,O
.,3750,3751,O
were,3752,3756,O
detected,3757,3765,O
using,3766,3771,O
the,3772,3775,O
LightCycler,3776,3787,O
analysis,3788,3796,O
software,3797,3805,O
v4,3806,3808,O
.,3808,3809,O
05,3809,3811,O
",",3811,3812,O
a,3813,3814,O
Cp,3815,3817,O
of,3818,3820,O
less,3821,3825,O
than,3826,3830,O
20,3831,3833,O
was,3834,3837,O
defined,3838,3845,O
as,3846,3848,O
indicating,3849,3859,O
a,3860,3861,O
pathogen,3862,3870,O
and,3871,3874,O
a,3875,3876,O
Cp,3877,3879,O
of,3880,3882,O
over,3883,3887,O
20,3888,3890,O
was,3891,3894,O
defined,3895,3902,O
as,3903,3905,O
contamination,3906,3919,O
by,3920,3922,O
checking,3923,3931,O
the,3932,3935,O
amplification,3936,3949,O
curve,3950,3955,O
.,3955,3956,O
Conclusion,0,10,O
:,10,11,O
This,12,16,O
study,17,22,O
demonstrates,23,35,O
that,36,40,O
surgery,41,48,O
plus,49,53,O
chemotherapy,54,66,O
and,67,70,O
radiation,71,80,O
therapy,81,88,O
is,89,91,O
helpful,92,99,O
for,100,103,O
treating,104,112,O
patients,113,121,O
with,122,126,O
pelvic,127,133,B-Pathological_formation
Ewing,134,139,I-Pathological_formation
',139,140,I-Pathological_formation
s,140,141,I-Pathological_formation
sarcoma,142,149,I-Pathological_formation
",",149,150,O
particularly,151,163,O
in,164,166,O
achieving,167,176,O
local,177,182,O
control,183,190,O
.,190,191,O
Fractional,0,10,O
atomic,11,17,O
coordinates,18,29,O
and,30,33,O
isotropic,34,43,O
or,44,46,O
equivalent,47,57,O
isotropic,58,67,O
displacement,68,80,O
parameters,81,91,O
(,92,93,O
A2,93,95,O
),95,96,O
x,97,98,O
y,99,100,O
z,101,102,O
Uiso,103,107,O
*,107,108,O
/,108,109,O
Ueq,109,112,O
C1,113,115,O
0,116,117,O
.,117,118,O
3043,118,122,O
(,123,124,O
3,124,125,O
),125,126,O
0,127,128,O
.,128,129,O
1779,129,133,O
(,134,135,O
4,135,136,O
),136,137,O
0,138,139,O
.,139,140,O
79280,140,145,O
(,146,147,O
13,147,149,O
),149,150,O
0,151,152,O
.,152,153,O
0445,153,157,O
(,158,159,O
6,159,160,O
),160,161,O
C2,162,164,O
0,165,166,O
.,166,167,O
4358,167,171,O
(,172,173,O
4,173,174,O
),174,175,O
0,176,177,O
.,177,178,O
1697,178,182,O
(,183,184,O
5,184,185,O
),185,186,O
0,187,188,O
.,188,189,O
84058,189,194,O
(,195,196,O
17,196,198,O
),198,199,O
0,200,201,O
.,201,202,O
0604,202,206,O
(,207,208,O
8,208,209,O
),209,210,O
H2,211,213,O
0,214,215,O
.,215,216,O
4201,216,220,O
0,221,222,O
.,222,223,O
1476,223,227,O
0,228,229,O
.,229,230,O
8809,230,234,O
0,235,236,O
.,236,237,O
072,237,240,O
*,240,241,O
C3,242,244,O
0,245,246,O
.,246,247,O
5911,247,251,O
(,252,253,O
4,253,254,O
),254,255,O
0,256,257,O
.,257,258,O
1953,258,262,O
(,263,264,O
6,264,265,O
),265,266,O
0,267,268,O
.,268,269,O
8269,269,273,O
(,274,275,O
2,275,276,O
),276,277,O
0,278,279,O
.,279,280,O
0783,280,284,O
(,285,286,O
12,286,288,O
),288,289,O
H3,290,292,O
0,293,294,O
.,294,295,O
6811,295,299,O
0,300,301,O
.,301,302,O
1914,302,306,O
0,307,308,O
.,308,309,O
8584,309,313,O
0,314,315,O
.,315,316,O
094,316,319,O
*,319,320,O
C4,321,323,O
0,324,325,O
.,325,326,O
6130,326,330,O
(,331,332,O
4,332,333,O
),333,334,O
0,335,336,O
.,336,337,O
2267,337,341,O
(,342,343,O
6,343,344,O
),344,345,O
0,346,347,O
.,347,348,O
7670,348,352,O
(,353,354,O
2,354,355,O
),355,356,O
0,357,358,O
.,358,359,O
0773,359,363,O
(,364,365,O
11,365,367,O
),367,368,O
H4,369,371,O
0,372,373,O
.,373,374,O
7180,374,378,O
0,379,380,O
.,380,381,O
2427,381,385,O
0,386,387,O
.,387,388,O
7582,388,392,O
0,393,394,O
.,394,395,O
093,395,398,O
*,398,399,O
C5,400,402,O
0,403,404,O
.,404,405,O
4818,405,409,O
(,410,411,O
5,411,412,O
),412,413,O
0,414,415,O
.,415,416,O
2344,416,420,O
(,421,422,O
5,422,423,O
),423,424,O
0,425,426,O
.,426,427,O
7202,427,431,O
(,432,433,O
2,433,434,O
),434,435,O
0,436,437,O
.,437,438,O
0746,438,442,O
(,443,444,O
10,444,446,O
),446,447,O
H5,448,450,O
0,451,452,O
.,452,453,O
4980,453,457,O
0,458,459,O
.,459,460,O
2547,460,464,O
0,465,466,O
.,466,467,O
6798,467,471,O
0,472,473,O
.,473,474,O
090,474,477,O
*,477,478,O
C6,479,481,O
0,482,483,O
.,483,484,O
3257,484,488,O
(,489,490,O
4,490,491,O
),491,492,O
0,493,494,O
.,494,495,O
2121,495,499,O
(,500,501,O
4,501,502,O
),502,503,O
0,504,505,O
.,505,506,O
73293,506,511,O
(,512,513,O
15,513,515,O
),515,516,O
0,517,518,O
.,518,519,O
0562,519,523,O
(,524,525,O
7,525,526,O
),526,527,O
H6,528,530,O
0,531,532,O
.,532,533,O
2360,533,537,O
0,538,539,O
.,539,540,O
2200,540,544,O
0,545,546,O
.,546,547,O
7015,547,551,O
0,552,553,O
.,553,554,O
067,554,557,O
*,557,558,O
C7,559,561,O
0,562,563,O
.,563,564,O
1252,564,568,O
(,569,570,O
3,570,571,O
),571,572,O
0,573,574,O
.,574,575,O
3838,575,579,O
(,580,581,O
4,581,582,O
),582,583,O
0,584,585,O
.,585,586,O
90059,586,591,O
(,592,593,O
11,593,595,O
),595,596,O
0,597,598,O
.,598,599,O
0400,599,603,O
(,604,605,O
6,605,606,O
),606,607,O
C8,608,610,O
0,611,612,O
.,612,613,O
2051,613,617,O
(,618,619,O
4,619,620,O
),620,621,O
0,622,623,O
.,623,624,O
5522,624,628,O
(,629,630,O
4,630,631,O
),631,632,O
0,633,634,O
.,634,635,O
90920,635,640,O
(,641,642,O
13,642,644,O
),644,645,O
0,646,647,O
.,647,648,O
0484,648,652,O
(,653,654,O
6,654,655,O
),655,656,O
H8,657,659,O
0,660,661,O
.,661,662,O
2132,662,666,O
0,667,668,O
.,668,669,O
6288,669,673,O
0,674,675,O
.,675,676,O
8758,676,680,O
0,681,682,O
.,682,683,O
058,683,686,O
*,686,687,O
C9,688,690,O
0,691,692,O
.,692,693,O
2725,693,697,O
(,698,699,O
4,699,700,O
),700,701,O
0,702,703,O
.,703,704,O
6041,704,708,O
(,709,710,O
4,710,711,O
),711,712,O
0,713,714,O
.,714,715,O
96827,715,720,O
(,721,722,O
15,722,724,O
),724,725,O
0,726,727,O
.,727,728,O
0558,728,732,O
(,733,734,O
7,734,735,O
),735,736,O
C10,737,740,O
0,741,742,O
.,742,743,O
2645,743,747,O
(,748,749,O
4,749,750,O
),750,751,O
0,752,753,O
.,753,754,O
4935,754,758,O
(,759,760,O
4,760,761,O
),761,762,O
1,763,764,O
.,764,765,O
01861,765,770,O
(,771,772,O
14,772,774,O
),774,775,O
0,776,777,O
.,777,778,O
0590,778,782,O
(,783,784,O
8,784,785,O
),785,786,O
H10,787,790,O
0,791,792,O
.,792,793,O
3122,793,797,O
0,798,799,O
.,799,800,O
5293,800,804,O
1,805,806,O
.,806,807,O
0582,807,811,O
0,812,813,O
.,813,814,O
071,814,817,O
*,817,818,O
C11,819,822,O
0,823,824,O
.,824,825,O
1830,825,829,O
(,830,831,O
4,831,832,O
),832,833,O
0,834,835,O
.,835,836,O
3278,836,840,O
(,841,842,O
4,842,843,O
),843,844,O
1,845,846,O
.,846,847,O
00819,847,852,O
(,853,854,O
13,854,856,O
),856,857,O
0,858,859,O
.,859,860,O
0534,860,864,O
(,865,866,O
7,866,867,O
),867,868,O
C12,869,872,O
0,873,874,O
.,874,875,O
1118,875,879,O
(,880,881,O
3,881,882,O
),882,883,O
0,884,885,O
.,885,886,O
2699,886,890,O
(,891,892,O
4,892,893,O
),893,894,O
0,895,896,O
.,896,897,O
95062,897,902,O
(,903,904,O
12,904,906,O
),906,907,O
0,908,909,O
.,909,910,O
0480,910,914,O
(,915,916,O
6,916,917,O
),917,918,O
H12,919,922,O
0,923,924,O
.,924,925,O
0561,925,929,O
0,930,931,O
.,931,932,O
1577,932,936,O
0,937,938,O
.,938,939,O
9451,939,943,O
0,944,945,O
.,945,946,O
058,946,949,O
*,949,950,O
N1,951,953,O
0,954,955,O
.,955,956,O
0494,956,960,O
(,961,962,O
3,962,963,O
),963,964,O
0,965,966,O
.,966,967,O
3297,967,971,O
(,972,973,O
3,973,974,O
),974,975,O
0,976,977,O
.,977,978,O
84009,978,983,O
(,984,985,O
10,985,987,O
),987,988,O
0,989,990,O
.,990,991,O
0441,991,995,O
(,996,997,O
5,997,998,O
),998,999,O
H1N,1000,1003,O
0,1004,1005,O
.,1005,1006,O
038,1006,1009,O
(,1010,1011,O
4,1011,1012,O
),1012,1013,O
0,1014,1015,O
.,1015,1016,O
418,1016,1019,O
(,1020,1021,O
3,1021,1022,O
),1022,1023,O
0,1024,1025,O
.,1025,1026,O
8138,1026,1030,O
(,1031,1032,O
12,1032,1034,O
),1034,1035,O
0,1036,1037,O
.,1037,1038,O
053,1038,1041,O
*,1041,1042,O
O1,1043,1045,O
-,1046,1047,O
0,1047,1048,O
.,1048,1049,O
0021,1049,1053,O
(,1054,1055,O
3,1055,1056,O
),1056,1057,O
0,1058,1059,O
.,1059,1060,O
1298,1060,1064,O
(,1065,1066,O
3,1066,1067,O
),1067,1068,O
0,1069,1070,O
.,1070,1071,O
74998,1071,1076,O
(,1077,1078,O
9,1078,1079,O
),1079,1080,O
0,1081,1082,O
.,1082,1083,O
0527,1083,1087,O
(,1088,1089,O
5,1089,1090,O
),1090,1091,O
O2,1092,1094,O
0,1095,1096,O
.,1096,1097,O
1112,1097,1101,O
(,1102,1103,O
3,1103,1104,O
),1104,1105,O
-,1106,1107,O
0,1107,1108,O
.,1108,1109,O
0066,1109,1113,O
(,1114,1115,O
3,1115,1116,O
),1116,1117,O
0,1118,1119,O
.,1119,1120,O
85135,1120,1125,O
(,1126,1127,O
10,1127,1129,O
),1129,1130,O
0,1131,1132,O
.,1132,1133,O
0574,1133,1137,O
(,1138,1139,O
6,1139,1140,O
),1140,1141,O
Cl1,1142,1145,O
0,1146,1147,O
.,1147,1148,O
37237,1148,1153,O
(,1154,1155,O
16,1155,1157,O
),1157,1158,O
0,1159,1160,O
.,1160,1161,O
81541,1161,1166,O
(,1167,1168,O
13,1168,1170,O
),1170,1171,O
0,1172,1173,O
.,1173,1174,O
97944,1174,1179,O
(,1180,1181,O
5,1181,1182,O
),1182,1183,O
0,1184,1185,O
.,1185,1186,O
0927,1186,1190,O
(,1191,1192,O
4,1192,1193,O
),1193,1194,O
Cl2,1195,1198,O
0,1199,1200,O
.,1200,1201,O
16462,1201,1206,O
(,1207,1208,O
15,1208,1210,O
),1210,1211,O
0,1212,1213,O
.,1213,1214,O
18752,1214,1219,O
(,1220,1221,O
15,1221,1223,O
),1223,1224,O
1,1225,1226,O
.,1226,1227,O
07089,1227,1232,O
(,1233,1234,O
4,1234,1235,O
),1235,1236,O
0,1237,1238,O
.,1238,1239,O
0834,1239,1243,O
(,1244,1245,O
4,1245,1246,O
),1246,1247,O
S1,1248,1250,O
0,1251,1252,O
.,1252,1253,O
10584,1253,1258,O
(,1259,1260,O
7,1260,1261,O
),1261,1262,O
0,1263,1264,O
.,1264,1265,O
14095,1265,1270,O
(,1271,1272,O
9,1272,1273,O
),1273,1274,O
0,1275,1276,O
.,1276,1277,O
80800,1277,1282,O
(,1283,1284,O
3,1284,1285,O
),1285,1286,O
0,1287,1288,O
.,1288,1289,O
0412,1289,1293,O
(,1294,1295,O
3,1295,1296,O
),1296,1297,O
Crystal,0,7,O
data,8,12,O
C16H20N4,13,21,O
M,22,23,O
r,24,25,O
=,26,27,O
268,28,31,O
.,31,32,O
36,32,34,O
Monoclinic,35,45,O
",",45,46,O
a,48,49,O
=,50,51,O
12,52,54,O
.,54,55,O
819,55,58,O
(,59,60,O
4,60,61,O
),61,62,O
A,63,64,O
b,65,66,O
=,67,68,O
8,69,70,O
.,70,71,O
441,71,74,O
(,75,76,O
3,76,77,O
),77,78,O
A,79,80,O
c,81,82,O
=,83,84,O
13,85,87,O
.,87,88,O
310,88,91,O
(,92,93,O
4,93,94,O
),94,95,O
A,96,97,O
beta,98,102,O
=,103,104,O
95,105,107,O
.,107,108,O
462,108,111,O
(,112,113,O
5,113,114,O
),114,115,O
degrees,115,122,O
V,123,124,O
=,125,126,O
1433,127,131,O
.,131,132,O
7,132,133,O
(,134,135,O
8,135,136,O
),136,137,O
A3,138,140,O
Z,141,142,O
=,143,144,O
4,145,146,O
Mo,147,149,O
Kalpha,150,156,O
radiation,157,166,O
mu,167,169,O
=,170,171,O
0,172,173,O
.,173,174,O
08,174,176,O
mm,177,179,O
-,179,180,O
1,180,181,O
T,182,183,O
=,184,185,O
298,186,189,O
(,190,191,O
2,191,192,O
),192,193,O
K,194,195,O
0,196,197,O
.,197,198,O
33,198,200,O
x,201,202,O
0,203,204,O
.,204,205,O
28,205,207,O
x,208,209,O
0,210,211,O
.,211,212,O
21,212,214,O
mm,215,217,O
Crystal,0,7,O
data,8,12,O
C15H12ClN3O2S2,13,27,O
F,28,29,O
(,29,30,O
000,30,33,O
),33,34,O
=,35,36,O
752,37,40,O
Mr,41,43,O
=,44,45,O
365,46,49,O
.,49,50,O
85,50,52,O
Dx,53,55,O
=,56,57,O
1,58,59,O
.,59,60,O
507,60,63,O
Mg,64,66,O
m,67,68,O
-,68,69,O
3,69,70,O
Monoclinic,71,81,O
",",81,82,O
P21,83,86,O
/,86,87,O
n,87,88,O
Mo,89,91,O
Kalpha,92,98,O
radiation,99,108,O
",",108,109,O
lambda,110,116,O
=,117,118,O
0,119,120,O
.,120,121,O
71073,121,126,O
A,127,128,O
Hall,129,133,O
symbol,134,140,O
:,140,141,O
-,142,143,O
P,143,144,O
2yn,145,148,O
Cell,149,153,B-Cell
parameters,154,164,O
from,165,169,O
25,170,172,O
reflections,173,184,O
a,185,186,O
=,187,188,O
10,189,191,O
.,191,192,O
175,192,195,O
(,196,197,O
2,197,198,O
),198,199,O
A,200,201,O
theta,202,207,O
=,208,209,O
9,210,211,O
-,211,212,O
12degrees,212,221,O
b,222,223,O
=,224,225,O
8,226,227,O
.,227,228,O
4958,228,232,O
(,233,234,O
17,234,236,O
),236,237,O
A,238,239,O
micro,240,245,O
=,246,247,O
0,248,249,O
.,249,250,O
51,250,252,O
mm,253,255,O
-,255,256,O
1,256,257,O
c,258,259,O
=,260,261,O
19,262,264,O
.,264,265,O
318,265,268,O
(,269,270,O
4,270,271,O
),271,272,O
A,273,274,O
T,275,276,O
=,277,278,O
293,279,282,O
K,283,284,O
beta,285,289,O
=,290,291,O
105,292,295,O
.,295,296,O
01,296,298,O
(,299,300,O
3,300,301,O
),301,302,O
degrees,302,309,O
Block,310,315,O
",",315,316,O
yellow,317,323,O
V,324,325,O
=,326,327,O
1613,328,332,O
.,332,333,O
0,333,334,O
(,335,336,O
6,336,337,O
),337,338,O
A3,339,341,O
0,342,343,O
.,343,344,O
25,344,346,O
x,347,348,O
0,349,350,O
.,350,351,O
15,351,353,O
x,354,355,O
0,356,357,O
.,357,358,O
15,358,360,O
mm,361,363,O
Z,364,365,O
=,366,367,O
4,368,369,O
Results,0,7,O
and,8,11,O
Discussion,12,22,O
Figure,23,29,O
4,30,31,O
shows,32,37,O
the,38,41,O
frequency,42,51,O
response,52,60,O
of,61,63,O
the,64,67,O
device,68,74,O
before,75,81,O
and,82,85,O
after,86,91,O
plating,92,99,O
cells,100,105,B-Cell
.,105,106,O
In,107,109,O
the,110,113,O
frequency,114,123,O
range,124,129,O
measured,130,138,O
(,139,140,O
4,140,141,O
-,141,142,O
600,142,145,O
Hz,146,148,O
),148,149,O
",",149,150,O
only,151,155,O
two,156,159,O
clear,160,165,O
peaks,166,171,O
can,172,175,O
be,176,178,O
seen,179,183,O
in,184,186,O
the,187,190,O
bare,191,195,O
device,196,202,O
.,202,203,O
After,204,209,O
cells,210,215,B-Cell
had,216,219,O
adhered,220,227,O
to,228,230,O
the,231,234,O
surface,235,242,O
",",242,243,O
there,244,249,O
is,250,252,O
a,253,254,O
shift,255,260,O
in,261,263,O
both,264,268,O
the,269,272,O
resonant,273,281,O
frequency,282,291,O
and,292,295,O
the,296,299,O
height,300,306,O
of,307,309,O
these,310,315,O
peaks,316,321,O
.,321,322,O
Table,323,328,O
1,329,330,O
shows,331,336,O
the,337,340,O
results,341,348,O
for,349,352,O
this,353,357,O
trial,358,363,O
and,364,367,O
a,368,369,O
second,370,376,O
trial,377,382,O
where,383,388,O
the,389,392,O
experiment,393,403,O
was,404,407,O
repeated,408,416,O
to,417,419,O
confirm,420,427,O
the,428,431,O
initial,432,439,O
results,440,447,O
.,447,448,O
At,449,451,O
a,452,453,O
plating,454,461,O
density,462,469,O
of,470,472,O
1300,473,477,O
cells,478,483,B-Cell
/,483,484,O
mm2,484,487,O
",",487,488,O
there,489,494,O
were,495,499,O
approximately,500,513,O
140,514,517,O
cells,518,523,B-Cell
on,524,526,O
the,527,530,O
portion,531,538,O
of,539,541,O
the,542,545,O
cantilever,546,556,O
free,557,561,O
to,562,564,O
vibrate,565,572,O
(,573,574,O
dimensions,574,584,O
shown,585,590,O
in,591,593,O
Figure,594,600,O
1,601,602,O
),602,603,O
.,603,604,O
Table,605,610,O
1,611,612,O
Cantilever,613,623,O
response,624,632,O
data,633,637,O
from,638,642,O
two,643,646,O
trials,647,653,O
Experiment,654,664,O
#,665,666,O
1,666,667,O
Experiment,668,678,O
#,679,680,O
2,680,681,O
Freq,682,686,O
.,686,687,O
1,688,689,O
(,690,691,O
kHz,691,694,O
),694,695,O
Amp,696,699,O
.,699,700,O
1,701,702,O
(,703,704,O
deg,704,707,O
),707,708,O
Freq,709,713,O
.,713,714,O
2,715,716,O
(,717,718,O
kHz,718,721,O
),721,722,O
Amp,723,726,O
.,726,727,O
2,728,729,O
(,730,731,O
deg,731,734,O
),734,735,O
Freq,736,740,O
.,740,741,O
1,742,743,O
(,744,745,O
kHz,745,748,O
),748,749,O
Amp,750,753,O
.,753,754,O
1,755,756,O
(,757,758,O
deg,758,761,O
),761,762,O
Freq,763,767,O
.,767,768,O
2,769,770,O
(,771,772,O
kHz,772,775,O
),775,776,O
Amp,777,780,O
.,780,781,O
2,782,783,O
(,784,785,O
deg,785,788,O
),788,789,O
Initial,790,797,O
313,798,801,O
.,801,802,O
0,802,803,O
.,804,805,O
086,805,808,O
375,809,812,O
.,812,813,O
5,813,814,O
.,815,816,O
055,816,819,O
313,820,823,O
.,823,824,O
9,824,825,O
.,826,827,O
091,827,830,O
376,831,834,O
.,834,835,O
5,835,836,O
.,837,838,O
071,838,841,O
With,842,846,O
cells,847,852,B-Cell
307,853,856,O
.,856,857,O
5,857,858,O
.,859,860,O
031,860,863,O
371,864,867,O
.,867,868,O
0,868,869,O
.,870,871,O
018,871,874,O
308,875,878,O
.,879,880,O
052,880,883,O
370,884,887,O
.,887,888,O
5,888,889,O
.,890,891,O
043,891,894,O
Change,895,901,O
5,902,903,O
.,903,904,O
5,904,905,O
.,906,907,O
055,907,910,O
4,911,912,O
.,912,913,O
5,913,914,O
.,915,916,O
037,916,919,O
5,920,921,O
.,921,922,O
9,922,923,O
.,924,925,O
039,925,928,O
6,929,930,O
.,930,931,O
0,931,932,O
.,933,934,O
028,934,937,O
Figure,938,944,O
4,945,946,O
Phase,947,952,O
angle,953,958,O
vs,959,961,O
.,961,962,O
frequency,963,972,O
.,972,973,O
(,974,975,O
left,975,979,O
),979,980,O
Phase,981,986,O
angle,987,992,O
of,993,995,O
impedance,996,1005,O
with,1006,1010,O
linear,1011,1017,O
regression,1018,1028,O
line,1029,1033,O
.,1033,1034,O
(,1035,1036,O
right,1036,1041,O
),1041,1042,O
To,1043,1045,O
provide,1046,1053,O
an,1054,1056,O
easier,1057,1063,O
comparison,1064,1074,O
",",1074,1075,O
phase,1076,1081,O
angles,1082,1088,O
have,1089,1093,O
been,1094,1098,O
levelled,1099,1107,O
with,1108,1112,O
respect,1113,1120,O
to,1121,1123,O
the,1124,1127,O
linear,1128,1134,O
regression,1135,1145,O
line,1146,1150,O
that,1151,1155,O
passes,1156,1162,O
through,1163,1170,O
each,1171,1175,O
set,1176,1179,O
of,1180,1182,O
data,1183,1187,O
.,1187,1188,O
The,1189,1192,O
addition,1193,1201,O
of,1202,1204,O
cells,1205,1210,B-Cell
causes,1211,1217,O
the,1218,1221,O
peaks,1222,1227,O
to,1228,1230,O
shift,1231,1236,O
to,1237,1239,O
lower,1240,1245,O
frequencies,1246,1257,O
and,1258,1261,O
decrease,1262,1270,O
in,1271,1273,O
amplitude,1274,1283,O
.,1283,1284,O
The,1285,1288,O
two,1289,1292,O
peaks,1293,1298,O
shown,1299,1304,O
were,1305,1309,O
the,1310,1313,O
only,1314,1318,O
detectable,1319,1329,O
resonances,1330,1340,O
despite,1341,1348,O
the,1349,1352,O
relatively,1353,1363,O
wide,1364,1368,O
frequency,1369,1378,O
range,1379,1384,O
measured,1385,1393,O
.,1393,1394,O
The,1395,1398,O
electrical,1399,1409,O
detection,1410,1419,O
of,1420,1422,O
resonances,1423,1433,O
is,1434,1436,O
critically,1437,1447,O
compromised,1448,1459,O
by,1460,1462,O
the,1463,1466,O
strong,1467,1473,O
damping,1474,1481,O
imposed,1482,1489,O
by,1490,1492,O
the,1493,1496,O
cell,1497,1501,B-Cell
media,1502,1507,O
",",1507,1508,O
making,1509,1515,O
these,1516,1521,O
measurements,1522,1534,O
more,1535,1539,O
challenging,1540,1551,O
than,1552,1556,O
those,1557,1562,O
carried,1563,1570,O
out,1571,1574,O
in,1575,1577,O
air,1578,1581,O
or,1582,1584,O
in,1585,1587,O
a,1588,1589,O
vacuum,1590,1596,O
where,1597,1602,O
resonance,1603,1612,O
peaks,1613,1618,O
show,1619,1623,O
much,1624,1628,O
larger,1629,1635,O
amplitude,1636,1645,O
[,1646,1647,O
18,1647,1649,O
],1649,1650,O
.,1650,1651,O
In,1652,1654,O
the,1655,1658,O
desired,1659,1666,O
in,1667,1669,O
vivo,1670,1674,O
application,1675,1686,O
for,1687,1690,O
this,1691,1695,O
work,1696,1700,O
",",1700,1701,O
as,1702,1704,O
a,1705,1706,O
sensor,1707,1713,O
for,1714,1717,O
stent,1718,1723,O
healing,1724,1731,O
",",1731,1732,O
it,1733,1735,O
can,1736,1739,O
be,1740,1742,O
expected,1743,1751,O
that,1752,1756,O
in,1757,1759,O
the,1760,1763,O
course,1764,1770,O
of,1771,1773,O
normal,1774,1780,O
healing,1781,1788,O
the,1789,1792,O
stent,1793,1798,O
will,1799,1803,O
be,1804,1806,O
fully,1807,1812,O
populated,1813,1822,O
with,1823,1827,O
a,1828,1829,O
significantly,1830,1843,O
thicker,1844,1851,O
layer,1852,1857,O
of,1858,1860,O
endothelial,1861,1872,B-Cell
cells,1873,1878,I-Cell
.,1878,1879,O
In,1880,1882,O
the,1883,1886,O
case,1887,1891,O
of,1892,1894,O
restenosis,1895,1905,O
",",1905,1906,O
this,1907,1911,O
lining,1912,1918,O
would,1919,1924,O
be,1925,1927,O
even,1928,1932,O
thicker,1933,1940,O
.,1940,1941,O
This,1942,1946,O
may,1947,1950,O
hamper,1951,1957,O
any,1958,1961,O
movement,1962,1970,O
of,1971,1973,O
the,1974,1977,O
cantilever,1978,1988,O
and,1989,1992,O
cause,1993,1998,O
the,1999,2002,O
peaks,2003,2008,O
to,2009,2011,O
eventually,2012,2022,O
become,2023,2029,O
undetectable,2030,2042,O
.,2042,2043,O
Frequent,2044,2052,O
measurements,2053,2065,O
of,2066,2068,O
the,2069,2072,O
resonant,2073,2081,O
frequencies,2082,2093,O
will,2094,2098,O
differentiate,2099,2112,O
this,2113,2117,O
end,2118,2121,O
state,2122,2127,O
with,2128,2132,O
the,2133,2136,O
possibility,2137,2148,O
of,2149,2151,O
device,2152,2158,O
failure,2159,2166,O
.,2166,2167,O
The,2168,2171,O
noninvasive,2172,2183,O
nature,2184,2190,O
of,2191,2193,O
these,2194,2199,O
measurements,2200,2212,O
that,2213,2217,O
can,2218,2221,O
be,2222,2224,O
transmitted,2225,2236,O
wirelessly,2237,2247,O
to,2248,2250,O
an,2251,2253,O
external,2254,2262,O
device,2263,2269,O
make,2270,2274,O
this,2275,2279,O
an,2280,2282,O
attractive,2283,2293,O
and,2294,2297,O
low,2298,2301,O
risk,2302,2306,O
option,2307,2313,O
for,2314,2317,O
monitoring,2318,2328,O
healing,2329,2336,O
.,2336,2337,O
2,0,1,O
.,1,2,O
1,2,3,O
.,3,4,O
Genome,5,11,O
sequencing,12,22,O
",",22,23,O
assembly,24,32,O
and,33,36,O
validation,37,47,O
DNA,48,51,O
shotgun,52,59,O
libraries,60,69,O
with,70,74,O
average,75,82,O
insert,83,89,O
sizes,90,95,O
of,96,98,O
1,99,100,O
.,100,101,O
6,101,102,O
and,103,106,O
6,107,108,O
.,108,109,O
5,109,110,O
kb,111,113,O
were,114,118,O
constructed,119,130,O
in,131,133,O
pUC118,134,140,O
(,141,142,O
TaKaRa,142,148,O
),148,149,O
",",149,150,O
whereas,151,158,O
a,159,160,O
fosmid,161,167,O
library,168,175,O
with,176,180,O
average,181,188,O
insert,189,195,O
size,196,200,O
of,201,203,O
37,204,206,O
kb,207,209,O
was,210,213,O
constructed,214,225,O
in,226,228,O
pCC1FOS,229,236,O
(,237,238,O
EPICENTRE,238,247,O
),247,248,O
as,249,251,O
described,252,261,O
previously,262,272,O
.,272,273,O
18,273,275,O
",",275,276,O
19,276,278,O
A,279,280,O
total,281,286,O
of,287,289,O
50,290,292,O
400,293,296,O
clones,297,303,O
(,304,305,O
34,305,307,O
560,308,311,O
",",311,312,O
10,313,315,O
752,316,319,O
and,320,323,O
5088,324,328,O
clones,329,335,O
from,336,340,O
libraries,341,350,O
with,351,355,O
1,356,357,O
.,357,358,O
6,358,359,O
",",359,360,O
6,361,362,O
.,362,363,O
5,363,364,O
and,365,368,O
37,369,371,O
kb,372,374,O
inserts,375,382,O
",",382,383,O
respectively,384,396,O
),396,397,O
were,398,402,O
subjected,403,412,O
to,413,415,O
sequencing,416,426,O
from,427,431,O
both,432,436,O
ends,437,441,O
of,442,444,O
the,445,448,O
inserts,449,456,O
on,457,459,O
either,460,466,O
ABI,467,470,O
3730xl,471,477,O
DNA,478,481,O
Analyzer,482,490,O
(,491,492,O
Applied,492,499,O
Biosystems,500,510,O
),510,511,O
or,512,514,O
Base,515,519,O
Station,520,527,O
DNA,528,531,O
Fragment,532,540,O
Analyzer,541,549,O
BST,550,553,O
-,553,554,O
0100,554,558,O
(,559,560,O
MJ,560,562,O
Research,563,571,O
",",571,572,O
Inc,573,576,O
.,576,577,O
),577,578,O
.,578,579,O
Sequence,580,588,O
reads,589,594,O
were,595,599,O
trimmed,600,607,O
at,608,610,O
a,611,612,O
threshold,613,622,O
quality,623,630,O
value,631,636,O
of,637,639,O
20,640,642,O
by,643,645,O
Phred,646,651,O
and,652,655,O
assembled,656,665,O
by,666,668,O
Phrap,669,674,O
and,675,678,O
CONSED,679,685,O
assembly,686,694,O
tools,695,700,O
.,700,701,O
20,701,703,O
",",703,704,O
21,704,706,O
For,707,710,O
alignment,711,720,O
and,721,724,O
validation,725,735,O
of,736,738,O
contigs,739,746,O
",",746,747,O
Optical,748,755,O
Mapping,756,763,O
(,764,765,O
OpGen,765,770,O
),770,771,O
was,772,775,O
used,776,780,O
.,780,781,O
Gaps,782,786,O
between,787,794,O
contigs,795,802,O
were,803,807,O
closed,808,814,O
by,815,817,O
sequencing,818,828,O
PCR,829,832,O
products,833,841,O
",",841,842,O
which,843,848,O
bridge,849,855,O
two,856,859,O
neighboring,860,871,O
contigs,872,879,O
.,879,880,O
Finally,881,888,O
",",888,889,O
each,890,894,O
base,895,899,O
of,900,902,O
K,903,904,O
.,904,905,O
setae,906,911,O
NBRC,912,916,O
14216T,917,923,O
genome,924,930,O
was,931,934,O
ensured,935,942,O
to,943,945,O
be,946,948,O
sequenced,949,958,O
from,959,963,O
multiple,964,972,O
clones,973,979,O
and,980,983,O
from,984,988,O
both,989,993,O
directions,994,1004,O
with,1005,1009,O
Phrap,1010,1015,O
quality,1016,1023,O
score,1024,1029,O
>,1030,1031,O
=,1031,1032,O
70,1032,1034,O
or,1035,1037,O
from,1038,1042,O
one,1043,1046,O
direction,1047,1056,O
with,1057,1061,O
Phrap,1062,1067,O
quality,1068,1075,O
score,1076,1081,O
>,1082,1083,O
=,1083,1084,O
40,1084,1086,O
.,1086,1087,O
Chromosomal,1088,1099,O
terminus,1100,1108,O
was,1109,1112,O
determined,1113,1123,O
after,1124,1129,O
attaching,1130,1139,O
adenine,1140,1147,O
and,1148,1151,O
thymine,1152,1159,O
homopolymers,1160,1172,O
to,1173,1175,O
the,1176,1179,O
naked,1180,1185,O
3,1186,1187,O
',1187,1188,O
ends,1189,1193,O
of,1194,1196,O
the,1197,1200,O
chromosome,1201,1211,B-Cellular_component
as,1212,1214,O
described,1215,1224,O
previously,1225,1235,O
.,1235,1236,O
5,1236,1237,O
Correlation,0,11,O
matrix,12,18,O
for,19,22,O
ear,23,26,O
(,27,28,O
E,28,29,O
),29,30,O
traits,31,37,O
in,38,40,O
2006,41,45,O
;,45,46,O
data,47,51,O
from,52,56,O
water,57,62,O
stress,63,69,O
plots,70,75,O
(,76,77,O
lower,77,82,O
left,83,87,O
),87,88,O
and,89,92,O
well,93,97,O
-,97,98,O
watered,98,105,O
plots,106,111,O
(,112,113,O
upper,113,118,O
right,119,124,O
),124,125,O
of,126,128,O
350,129,132,O
maize,133,138,O
inbreds,139,146,O
FUNDING,0,7,O
National,8,16,O
Institutes,17,27,O
of,28,30,O
Health,31,37,O
grants,38,44,O
",",44,45,O
National,46,54,O
Institute,55,64,O
of,65,67,O
Environmental,68,81,O
Health,82,88,O
Sciences,89,97,O
and,98,101,O
the,102,105,O
National,106,114,O
Library,115,122,O
of,123,125,O
Medicine,126,134,O
(,135,136,O
R01,136,139,O
ES014065,140,148,O
and,149,152,O
R01,153,156,O
ES014065,157,165,O
-,165,166,O
04S1,166,170,O
to,171,173,O
CTD,174,177,O
),177,178,O
;,178,179,O
INBRE,180,185,O
program,186,193,O
of,194,196,O
the,197,200,O
National,201,209,O
Center,210,216,O
for,217,220,O
Research,221,229,O
Resources,230,239,O
(,240,241,O
P20,241,244,O
RR016463,245,253,O
),253,254,O
.,254,255,O
Funding,256,263,O
for,264,267,O
open,268,272,O
access,273,279,O
charge,280,286,O
:,286,287,O
NIEHS,288,293,O
grant,294,299,O
(,300,301,O
R01,301,304,O
ES014065,305,313,O
),313,314,O
.,314,315,O
Conflict,316,324,O
of,325,327,O
interest,328,336,O
statement,337,346,O
.,346,347,O
None,348,352,O
declared,353,361,O
.,361,362,O
Tarsoconjunctival,0,17,B-Multi-tissue_structure
flap,18,22,I-Multi-tissue_structure
after,23,28,O
division,29,37,O
MoClo,0,5,O
cloning,6,13,O
protocol,14,22,O
Restriction,23,34,O
-,34,35,O
ligations,35,44,O
were,45,49,O
set,50,53,O
up,54,56,O
by,57,59,O
pipetting,60,69,O
in,70,72,O
one,73,76,O
tube,77,81,O
approximately,82,95,O
40,96,98,O
fmol,99,103,O
(,104,105,O
~,105,106,O
100,106,109,O
ng,110,112,O
of,113,115,O
DNA,116,119,O
for,120,123,O
a,124,125,O
4,126,127,O
kb,128,130,O
plasmid,131,138,O
),138,139,O
of,140,142,O
each,143,147,O
DNA,148,151,O
component,152,161,O
(,162,163,O
PCR,163,166,O
product,167,174,O
or,175,177,O
plasmid,178,185,O
),185,186,O
",",186,187,O
10,188,190,O
U,191,192,O
of,193,195,O
the,196,199,O
required,200,208,O
restriction,209,220,O
enzyme,221,227,O
(,228,229,O
BsaI,229,233,O
or,234,236,O
BpiI,237,241,O
),241,242,O
and,243,246,O
10,247,249,O
U,250,251,O
T4,252,254,O
DNA,255,258,O
ligase,259,265,O
(,266,267,O
using,267,272,O
high,273,277,O
concentration,278,291,O
ligase,292,298,O
",",298,299,O
20,300,302,O
U,303,304,O
/,304,305,O
microl,305,311,O
),311,312,O
in,313,315,O
Promega,316,323,O
ligation,324,332,O
buffer,333,339,O
in,340,342,O
a,343,344,O
final,345,350,O
reaction,351,359,O
volume,360,366,O
of,367,369,O
20,370,372,O
microl,373,379,O
.,379,380,O
The,381,384,O
reaction,385,393,O
was,394,397,O
incubated,398,407,O
in,408,410,O
a,411,412,O
thermocycler,413,425,O
for,426,429,O
5,430,431,O
hours,432,437,O
at,438,440,O
37degreesC,441,451,O
",",451,452,O
5,453,454,O
min,455,458,O
at,459,461,O
50degreesC,462,472,O
and,473,476,O
10,477,479,O
min,480,483,O
at,484,486,O
80degreesC,487,497,O
.,497,498,O
The,499,502,O
reaction,503,511,O
mix,512,515,O
was,516,519,O
then,520,524,O
added,525,530,O
to,531,533,O
100,534,537,O
microl,538,544,O
chemically,545,555,O
competent,556,565,O
DH10b,566,571,B-Cell
cells,572,577,I-Cell
",",577,578,O
incubated,579,588,O
for,589,592,O
15,593,595,O
-,595,596,O
30,596,598,O
min,599,602,O
on,603,605,O
ice,606,609,O
and,610,613,O
transformed,614,625,O
by,626,628,O
heat,629,633,O
shock,634,639,O
.,639,640,O
800,641,644,O
microl,645,651,O
of,652,654,O
liquid,655,661,O
LB,662,664,O
was,665,668,O
then,669,673,O
added,674,679,O
to,680,682,O
the,683,686,O
transformation,687,701,O
",",701,702,O
and,703,706,O
the,707,710,O
cells,711,716,B-Cell
were,717,721,O
let,722,725,O
to,726,728,O
recover,729,736,O
45,737,739,O
min,740,743,O
at,744,746,O
37degreesC,747,757,O
.,757,758,O
Different,759,768,O
aliquots,769,777,O
of,778,780,O
the,781,784,O
transformation,785,799,O
were,800,804,O
plated,805,811,O
on,812,814,O
LB,815,817,O
plates,818,824,O
containing,825,835,O
the,836,839,O
appropriate,840,851,O
antibiotic,852,862,O
.,862,863,O
The,864,867,O
number,868,874,O
of,875,877,O
colonies,878,886,O
was,887,890,O
counted,891,898,O
for,899,902,O
one,903,906,O
or,907,909,O
two,910,913,O
selected,914,922,O
plates,923,929,O
(,930,931,O
containing,931,941,O
countable,942,951,O
number,952,958,O
of,959,961,O
colonies,962,970,O
),970,971,O
",",971,972,O
or,973,975,O
from,976,980,O
a,981,982,O
section,983,990,O
of,991,993,O
the,994,997,O
plates,998,1004,O
when,1005,1009,O
very,1010,1014,O
high,1015,1019,O
number,1020,1026,O
of,1027,1029,O
colonies,1030,1038,O
were,1039,1043,O
obtained,1044,1052,O
even,1053,1057,O
for,1058,1061,O
the,1062,1065,O
lowest,1066,1072,O
volume,1073,1079,O
plated,1080,1086,O
.,1086,1087,O
The,1088,1091,O
number,1092,1098,O
of,1099,1101,O
colonies,1102,1110,O
was,1111,1114,O
then,1115,1119,O
extrapolated,1120,1132,O
for,1133,1136,O
the,1137,1140,O
entire,1141,1147,O
transformation,1148,1162,O
.,1162,1163,O
For,1164,1167,O
level,1168,1173,O
2,1174,1175,O
-,1175,1176,O
2,1176,1177,O
cloning,1178,1185,O
",",1185,1186,O
two,1187,1190,O
type,1191,1195,O
IIS,1196,1199,O
enzymes,1200,1207,O
were,1208,1212,O
required,1213,1221,O
",",1221,1222,O
BpiI,1223,1227,O
and,1228,1231,O
BsaI,1232,1236,O
.,1236,1237,O
The,1238,1241,O
same,1242,1246,O
protocol,1247,1255,O
was,1256,1259,O
used,1260,1264,O
as,1265,1267,O
described,1268,1277,O
above,1278,1283,O
except,1284,1290,O
that,1291,1295,O
10,1296,1298,O
U,1299,1300,O
and,1301,1304,O
2,1305,1306,O
.,1306,1307,O
5,1307,1308,O
U,1309,1310,O
were,1311,1315,O
used,1316,1320,O
for,1321,1324,O
the,1325,1328,O
enzymes,1329,1336,O
BpiI,1337,1341,O
and,1342,1345,O
BsaI,1346,1350,O
",",1350,1351,O
respectively,1352,1364,O
.,1364,1365,O
To,1366,1368,O
optimize,1369,1377,O
efficiency,1378,1388,O
of,1389,1391,O
the,1392,1395,O
restriction,1396,1407,O
-,1407,1408,O
ligation,1408,1416,O
for,1417,1420,O
the,1421,1424,O
final,1425,1430,O
construct,1431,1440,O
containing,1441,1451,O
11,1452,1454,O
transcription,1455,1468,O
units,1469,1474,O
(,1475,1476,O
cL2,1476,1479,O
-,1479,1480,O
13,1480,1482,O
*,1482,1483,O
),1483,1484,O
",",1484,1485,O
a,1486,1487,O
variation,1488,1497,O
of,1498,1500,O
this,1501,1505,O
protocol,1506,1514,O
was,1515,1518,O
used,1519,1523,O
as,1524,1526,O
follows,1527,1534,O
.,1534,1535,O
The,1536,1539,O
reaction,1540,1548,O
mix,1549,1552,O
was,1553,1556,O
set,1557,1560,O
up,1561,1563,O
containing,1564,1574,O
20,1575,1577,O
U,1578,1579,O
ligase,1580,1586,O
",",1586,1587,O
5,1588,1589,O
U,1590,1591,O
BpiI,1592,1596,O
and,1597,1600,O
5,1601,1602,O
U,1603,1604,O
BsaI,1605,1609,O
",",1609,1610,O
in,1611,1613,O
a,1614,1615,O
total,1616,1621,O
reaction,1622,1630,O
volume,1631,1637,O
of,1638,1640,O
20,1641,1643,O
microl,1644,1650,O
.,1650,1651,O
The,1652,1655,O
mix,1656,1659,O
was,1660,1663,O
incubated,1664,1673,O
in,1674,1676,O
a,1677,1678,O
thermocycler,1679,1691,O
with,1692,1696,O
the,1697,1700,O
following,1701,1710,O
parameters,1711,1721,O
:,1721,1722,O
incubation,1723,1733,O
for,1734,1737,O
2,1738,1739,O
minutes,1740,1747,O
at,1748,1750,O
37degreesC,1751,1761,O
",",1761,1762,O
5,1763,1764,O
minutes,1765,1772,O
at,1773,1775,O
16degreesC,1776,1786,O
",",1786,1787,O
both,1788,1792,O
steps,1793,1798,O
repeated,1799,1807,O
45,1808,1810,O
times,1811,1816,O
",",1816,1817,O
followed,1818,1826,O
by,1827,1829,O
incubation,1830,1840,O
for,1841,1844,O
5,1845,1846,O
minutes,1847,1854,O
at,1855,1857,O
50degreesC,1858,1868,O
and,1869,1872,O
10,1873,1875,O
minutes,1876,1883,O
at,1884,1886,O
80degreesC,1887,1897,O
.,1897,1898,O
The,1899,1902,O
reaction,1903,1911,O
mix,1912,1915,O
was,1916,1919,O
transformed,1920,1931,O
in,1932,1934,O
E,1935,1936,O
.,1936,1937,O
coli,1938,1942,O
chemically,1943,1953,O
competent,1954,1963,B-Cell
cells,1964,1969,I-Cell
as,1970,1972,O
described,1973,1982,O
above,1983,1988,O
.,1988,1989,O
Observed,0,8,O
type,9,13,O
I,14,15,O
error,16,21,O
for,22,25,O
datasets,26,34,O
simulated,35,44,O
under,45,50,O
the,51,54,O
null,55,59,O
hypothesis,60,70,O
DNA,0,3,O
isolation,4,13,O
All,14,17,O
solutions,18,27,O
used,28,32,O
for,33,36,O
DNA,37,40,O
isolation,41,50,O
are,51,54,O
purged,55,61,O
with,62,66,O
nitrogen,67,75,O
(,76,77,O
immediately,77,88,O
prior,89,94,O
to,95,97,O
use,98,101,O
),101,102,O
and,103,106,O
supplemented,107,119,O
with,120,124,O
50,125,127,O
muM,128,131,O
phenyl,132,138,O
-,138,139,O
tert,139,143,O
-,143,144,O
butyl,144,149,O
nitrone,150,157,O
to,158,160,O
minimise,161,169,O
oxidative,170,179,O
damage,180,186,O
to,187,189,O
DNA,190,193,O
[,193,194,O
31,194,196,O
],196,197,O
.,197,198,O
Qiagen,199,205,O
DNAeasy,206,213,O
Kit,214,217,O
(,218,219,O
#,219,220,O
69506,220,225,O
),225,226,O
includes,227,235,O
:,235,236,O
Proteinase,237,247,O
K,248,249,O
",",249,250,O
AW1,251,254,O
",",254,255,O
AW2,256,259,O
",",259,260,O
AE,261,263,O
and,264,267,O
Spin,268,272,O
-,272,273,O
columns,273,280,O
Dithiothreitol,281,295,O
(,296,297,O
DTT,297,300,O
;,300,301,O
Sigma,302,307,O
),307,308,O
Ethanol,309,316,O
(,317,318,O
Ajax,318,322,O
Finechem,323,331,O
#,332,333,O
214,333,336,O
-,336,337,O
2,337,338,O
.,338,339,O
5L,339,341,O
),341,342,O
Nitrogen,343,351,O
(,352,353,O
for,353,356,O
purging,357,364,O
of,365,367,O
buffers,368,375,O
),375,376,O
Genes,0,5,O
related,6,13,O
to,14,16,O
signal,17,23,O
transduction,24,36,O
On,37,39,O
day,40,43,O
7,44,45,O
",",45,46,O
the,47,50,O
up,51,53,O
-,53,54,O
regulated,54,63,O
genes,64,69,O
related,70,77,O
to,78,80,O
signal,81,87,O
transduction,88,100,O
were,101,105,O
PDE1A,106,111,O
",",111,112,O
MYO10,113,118,O
",",118,119,O
APOB,120,124,O
",",124,125,O
and,126,129,O
so,130,132,O
on,133,135,O
",",135,136,O
and,137,140,O
down,141,145,O
-,145,146,O
regulated,146,155,O
genes,156,161,O
were,162,166,O
CYTL1,167,172,O
and,173,176,O
IL6,177,180,O
.,180,181,O
On,182,184,O
day,185,188,O
14,189,191,O
",",191,192,O
the,193,196,O
up,197,199,O
-,199,200,O
regulated,200,209,O
genes,210,215,O
were,216,220,O
ANGPTL4,221,228,O
",",228,229,O
EPHA3,230,235,O
",",235,236,O
RASL10B,237,244,O
",",244,245,O
etc,246,249,O
.,249,250,O
",",250,251,O
and,252,255,O
the,256,259,O
down,260,264,O
-,264,265,O
regulated,265,274,O
genes,275,280,O
were,281,285,O
CXCL12,286,292,O
",",292,293,O
CCL8,294,298,O
and,299,302,O
VLDLR,303,308,O
.,308,309,O
The,310,313,O
genes,314,319,O
up,320,322,O
-,322,323,O
regulated,323,332,O
on,333,335,O
both,336,340,O
days,341,345,O
were,346,350,O
LEP,351,354,O
",",354,355,O
RAC3,356,360,O
",",360,361,O
and,362,365,O
RASL11B,366,373,O
",",373,374,O
and,375,378,O
those,379,384,O
down,385,389,O
-,389,390,O
regulated,390,399,O
both,400,404,O
days,405,409,O
were,410,414,O
MX1,415,418,O
and,419,422,O
WISP2,423,428,O
.,428,429,O
Notably,430,437,O
",",437,438,O
up,439,441,O
-,441,442,O
and,443,446,O
down,447,451,O
-,451,452,O
regulated,452,461,O
genes,462,467,O
PDE1A,468,473,O
",",473,474,O
APOB,475,479,O
",",479,480,O
ALCAM,481,486,O
",",486,487,O
PSCD4,488,493,O
",",493,494,O
CYTL1,495,500,O
",",500,501,O
and,502,505,O
IL6,506,509,O
were,510,514,O
more,515,519,O
strongly,520,528,O
expressed,529,538,O
on,539,541,O
day,542,545,O
7,546,547,O
than,548,552,O
on,553,555,O
day,556,559,O
14,560,562,O
",",562,563,O
while,564,569,O
ANGPTL4,570,577,O
",",577,578,O
EPHA3,579,584,O
",",584,585,O
RAB12,586,591,O
",",591,592,O
CXCL12,593,599,O
",",599,600,O
CCL8,601,605,O
",",605,606,O
and,607,610,O
VLDLR,611,616,O
were,617,621,O
more,622,626,O
strongly,627,635,O
expressed,636,645,O
on,646,648,O
day,649,652,O
14,653,655,O
than,656,660,O
on,661,663,O
day,664,667,O
7,668,669,O
.,669,670,O
SUMMARY,0,7,O
Both,8,12,O
the,13,16,O
innate,17,23,O
and,24,27,O
adaptive,28,36,O
immune,37,43,B-Anatomical_system
subsystems,44,54,I-Anatomical_system
are,55,58,O
necessary,59,68,O
to,69,71,O
provide,72,79,O
an,80,82,O
effective,83,92,O
immune,93,99,O
response,100,108,O
whether,109,116,O
to,117,119,O
an,120,122,O
actual,123,129,O
pathogenic,130,140,O
agent,141,146,O
or,147,149,O
to,150,152,O
an,153,155,O
immunization,156,168,O
.,168,169,O
Further,170,177,O
",",177,178,O
effective,179,188,O
immunizations,189,202,O
must,203,207,O
induce,208,214,O
long,215,219,O
-,219,220,O
term,220,224,O
stimulation,225,236,O
of,237,239,O
both,240,244,O
the,245,248,O
humoral,249,256,O
and,257,260,O
cell,261,265,B-Cell
-,265,266,O
mediated,266,274,O
arms,275,279,O
of,280,282,O
the,283,286,O
adaptive,287,295,O
system,296,302,O
by,303,305,O
the,306,309,O
production,310,320,O
of,321,323,O
effector,324,332,B-Cell
cells,333,338,I-Cell
for,339,342,O
the,343,346,O
current,347,354,O
infection,355,364,O
and,365,368,O
memory,369,375,B-Cell
cells,376,381,I-Cell
for,382,385,O
future,386,392,O
infections,393,403,O
with,404,408,O
the,409,412,O
pathogenic,413,423,O
agent,424,429,O
.,429,430,O
At,431,433,O
least,434,439,O
seven,440,445,O
different,446,455,O
types,456,461,O
of,462,464,O
vaccines,465,473,O
are,474,477,O
currently,478,487,O
in,488,490,O
use,491,494,O
or,495,497,O
in,498,500,O
development,501,512,O
that,513,517,O
produce,518,525,O
this,526,530,O
effective,531,540,O
immunity,541,549,O
and,550,553,O
have,554,558,O
contributed,559,570,O
greatly,571,578,O
to,579,581,O
the,582,585,O
prevention,586,596,O
of,597,599,O
infectious,600,610,O
disease,611,618,O
around,619,625,O
the,626,629,O
world,630,635,O
.,635,636,O
Encoding,0,8,O
methods,9,16,O
of,17,19,O
SOLiDzipper,20,31,O
.,31,32,O
Notes,33,38,O
:,38,39,O
A,40,41,O
),41,42,O
The,43,46,O
quality,47,54,O
value,55,60,O
in,61,63,O
QV,64,66,O
files,67,72,O
from,73,77,O
ABI,78,81,O
SOLiD,82,87,O
system,88,94,O
ranges,95,101,O
from,102,106,O
-,107,108,O
1,108,109,O
to,110,112,O
40,113,115,O
",",115,116,O
which,117,122,O
requires,123,131,O
6,132,133,O
bit,134,137,O
space,138,143,O
.,143,144,O
The,145,148,O
remaining,149,158,O
2,159,160,O
bit,161,164,O
space,165,170,O
out,171,174,O
of,175,177,O
1,178,179,O
byte,180,184,O
can,185,188,O
be,189,191,O
used,192,196,O
for,197,200,O
storing,201,208,O
another,209,216,O
quality,217,224,O
value,225,230,O
in,231,233,O
part,234,238,O
.,238,239,O
B,240,241,O
),241,242,O
Csfasta,243,250,O
files,251,256,O
contain,257,264,O
the,265,268,O
sequence,269,277,O
information,278,289,O
in,290,292,O
four,293,297,O
digits,298,304,O
",",304,305,O
',306,307,O
0123,307,311,O
',311,312,O
",",312,313,O
which,314,319,O
require,320,327,O
2,328,329,O
bit,330,333,O
space,334,339,O
.,339,340,O
Provided,341,349,O
that,350,354,O
',355,356,O
0,356,357,O
',357,358,O
",",358,359,O
1,360,361,O
byte,362,366,O
character,367,376,O
in,377,379,O
csfasta,380,387,O
files,388,393,O
",",393,394,O
is,395,397,O
mapped,398,404,O
as,405,407,O
binary,408,414,O
data,415,419,O
',420,421,O
00,421,423,O
',423,424,O
",",424,425,O
',426,427,O
1,427,428,O
',428,429,O
as,430,432,O
',433,434,O
01,434,436,O
',436,437,O
",",437,438,O
',439,440,O
2,440,441,O
',441,442,O
as,442,444,O
',445,446,O
10,446,448,O
',448,449,O
",",449,450,O
',451,452,O
3,452,453,O
',453,454,O
as,455,457,O
',458,459,O
11,459,461,O
',461,462,O
",",462,463,O
4,464,465,O
byte,466,470,O
data,471,475,O
',476,477,O
0113,477,481,O
',481,482,O
can,483,486,O
be,487,489,O
encoded,490,497,O
into,498,502,O
1,503,504,O
byte,505,509,O
character,510,519,O
0x17,520,524,O
(,524,525,O
00010111,525,533,O
),533,534,O
through,535,542,O
shift,543,548,O
operation,549,558,O
.,558,559,O
C,560,561,O
),561,562,O
Sequence,563,571,O
IDs,572,575,O
are,576,579,O
extracted,580,589,O
from,590,594,O
QV,595,597,O
and,598,601,O
csfasta,602,609,O
files,610,615,O
",",615,616,O
combined,617,625,O
",",625,626,O
and,627,630,O
compressed,631,641,O
using,642,647,O
the,648,651,O
general,652,659,O
purpose,660,667,O
compression,668,679,O
methods,680,687,O
.,687,688,O
D,689,690,O
),690,691,O
Encoded,692,699,O
data,700,704,O
are,705,708,O
stored,709,715,O
as,716,718,O
data,719,723,O
blocks,724,730,O
of,731,733,O
fixed,734,739,O
size,740,744,O
.,744,745,O
This,746,750,O
allows,751,757,O
for,758,761,O
selective,762,771,O
decoding,772,780,O
.,780,781,O
CONCLUSION,0,10,O
Intra,11,16,O
-,16,17,O
operative,17,26,O
monitoring,27,37,O
of,38,40,O
partial,41,48,O
pressure,49,57,O
of,58,60,O
tissue,61,67,B-Tissue
oxygen,68,74,O
(,75,76,O
PtiO2,76,81,O
),82,83,O
is,84,86,O
a,87,88,O
very,89,93,O
sensitive,94,103,O
method,104,110,O
of,111,113,O
detecting,114,123,O
the,124,127,O
decrease,128,136,O
of,137,139,O
oxygen,140,146,O
for,147,150,O
cell,151,155,B-Cell
utilization,156,167,O
",",167,168,O
due,169,172,O
to,173,175,O
decreased,176,185,O
blood,186,191,B-Organism_substance
flow,192,196,O
",",196,197,O
during,198,204,O
temporary,205,214,O
clipping,215,223,O
and,224,227,O
after,228,233,O
definitive,234,244,O
clipping,245,253,O
",",253,254,O
in,255,257,O
middle,258,264,O
cerebral,265,273,B-Multi-tissue_structure
artery,274,280,I-Multi-tissue_structure
incidental,281,291,O
unruptured,292,302,O
aneurysm,303,311,B-Pathological_formation
surgery,312,319,O
.,319,320,O
"""",321,322,O
Basal,322,327,O
values,328,334,O
"""",334,335,O
",",335,336,O
obtained,337,345,O
without,346,353,O
the,354,357,O
influence,358,367,O
of,368,370,O
subarachnoid,371,383,B-Organism_substance
blood,384,389,I-Organism_substance
",",389,390,O
were,391,395,O
lower,396,401,O
than,402,406,O
expected,407,415,O
in,416,418,O
"""",419,420,O
uninjured,420,429,O
"""",429,430,O
brain,431,436,B-Organ
",",436,437,O
and,438,441,O
this,442,446,O
fact,447,451,O
",",451,452,O
although,453,461,O
unexplained,462,473,O
",",473,474,O
should,475,481,O
be,482,484,O
kept,485,489,O
in,490,492,O
mind,493,497,O
in,498,500,O
future,501,507,O
investigation,508,521,O
in,522,524,O
this,525,529,O
field,530,535,O
.,535,536,O
Although,537,545,O
values,546,552,O
that,553,557,O
could,558,563,O
be,564,566,O
predictive,567,577,O
of,578,580,O
brain,581,586,B-Organ
ischemia,587,595,O
could,596,601,O
not,602,605,O
be,606,608,O
established,609,620,O
",",620,621,O
an,622,624,O
incomplete,625,635,O
recovery,636,644,O
or,645,647,O
continuous,648,658,O
decrease,659,667,O
in,668,670,O
PtiO2,671,676,O
values,677,683,O
after,684,689,O
definitive,690,700,O
clipping,701,709,O
should,710,716,O
be,717,719,O
considered,720,730,O
an,731,733,O
indicator,734,743,O
of,744,746,O
high,747,751,O
risk,752,756,O
for,757,760,O
the,761,764,O
development,765,776,O
of,777,779,O
post,780,784,O
-,784,785,O
operative,785,794,O
brain,795,800,B-Organ
infarction,801,811,O
",",811,812,O
and,813,816,O
",",816,817,O
therefore,818,827,O
",",827,828,O
an,829,831,O
indication,832,842,O
for,843,846,O
verification,847,859,O
of,860,862,O
the,863,866,O
position,867,875,O
of,876,878,O
the,879,882,O
clip,883,887,O
.,887,888,O
View,0,4,O
of,5,7,O
the,8,11,O
structure,12,21,O
of,22,24,O
the,25,28,O
title,29,34,O
compound,35,43,O
along,44,49,O
the,50,53,O
a,54,55,O
axis,56,60,O
displaying,61,71,O
chains,72,78,O
alternating,79,90,O
with,91,95,O
amine,96,101,O
groups,102,108,O
.,108,109,O
Results,0,7,O
(,0,1,O
a,1,2,O
),2,3,O
Sequence,4,12,O
alignment,13,22,O
of,23,25,O
PY,26,28,O
-,28,29,O
NLSs,29,33,O
.,33,34,O
The,35,38,O
homologous,39,49,O
regions,50,57,O
of,58,60,O
C,61,62,O
-,62,63,O
NLS,63,66,O
of,67,69,O
the,70,73,O
EWS,74,77,O
protein,78,85,O
",",85,86,O
NLS,87,90,O
of,91,93,O
Sam68,94,99,O
and,100,103,O
FUS,104,107,O
/,107,108,O
TLS,108,111,O
protein,112,119,O
and,120,123,O
M9,124,126,O
NLS,127,130,O
of,131,133,O
hnRNP,134,139,O
A1,140,142,O
and,143,146,O
hnRNP,147,152,O
M,153,154,O
",",154,155,O
classified,156,166,O
as,167,169,O
PY,170,172,O
-,172,173,O
NLS,173,176,O
are,177,180,O
in,181,183,O
yellow,184,190,O
boxes,191,196,O
.,196,197,O
Phosphorylated,198,212,O
Y656,213,217,O
of,218,220,O
the,221,224,O
EWS,225,228,O
protein,229,236,O
and,237,240,O
Y440,241,245,O
of,246,248,O
Sam68,249,254,O
are,255,258,O
indicated,259,268,O
(,269,270,O
in,270,272,O
red,273,276,O
),276,277,O
.,277,278,O
Positions,279,288,O
of,289,291,O
identical,292,301,O
residues,302,310,O
in,311,313,O
SAM68,314,319,O
and,320,323,O
EWS,324,327,O
C,328,329,O
-,329,330,O
NLS,330,333,O
are,334,337,O
indicated,338,347,O
in,348,350,O
bold,351,355,O
and,356,359,O
residues,360,368,O
with,369,373,O
identical,374,383,O
charges,384,391,O
are,392,395,O
underlined,396,406,O
.,406,407,O
Known,408,413,O
positions,414,423,O
of,424,426,O
the,427,430,O
FUS,431,434,O
/,434,435,O
TLS,435,438,O
mutations,439,448,O
in,449,451,O
ALS,452,455,O
are,456,459,O
in,460,462,O
bold,463,467,O
.,467,468,O
(,469,470,O
b,470,471,O
),471,472,O
Subcellular,473,484,B-Cellular_component
localization,485,497,O
of,498,500,O
YFP,501,504,O
",",504,505,O
the,506,509,O
C,510,511,O
-,511,512,O
terminally,512,522,O
tagged,523,529,O
EWS,530,533,O
-,533,534,O
YFP,534,537,O
",",537,538,O
EWS,539,542,O
(,542,543,O
Y656A,543,548,O
),548,549,O
-,549,550,O
YFP,550,553,O
",",553,554,O
EWS,555,558,O
(,558,559,O
Y656F,559,564,O
),564,565,O
-,565,566,O
YFP,566,569,O
",",569,570,O
and,571,574,O
EWS,575,578,O
(,578,579,O
Y656D,579,584,O
),584,585,O
-,585,586,O
YFP,586,589,O
(,590,591,O
in,591,593,O
green,594,599,O
),599,600,O
.,600,601,O
Nuclei,602,608,B-Cellular_component
are,609,612,O
shown,613,618,O
by,619,621,O
DAPI,622,626,O
staining,627,635,O
(,636,637,O
in,637,639,O
blue,640,644,O
),644,645,O
.,645,646,O
Bars,647,651,O
",",651,652,O
15,653,655,O
mum,656,659,O
.,659,660,O
Conclusions,0,11,O
Myocardial,12,22,B-Multi-tissue_structure
ischaemia,23,32,O
during,33,39,O
DCMR,40,44,O
is,45,47,O
independently,48,61,O
predictive,62,72,O
of,73,75,O
cardiac,76,83,B-Organ
events,84,90,O
among,91,96,O
patients,97,105,O
with,106,110,O
previous,111,119,O
myocardial,120,130,B-Multi-tissue_structure
revascularisation,131,148,O
.,148,149,O
Importing,0,9,O
citations,10,19,O
in,20,22,O
different,23,32,O
formats,33,40,O
using,41,46,O
Google,47,53,O
Scholar,54,61,O
Subject,0,7,O
disposition,8,19,O
.,19,20,O
Data,21,25,O
from,26,30,O
110,31,34,O
enrolled,35,43,O
subjects,44,52,O
were,53,57,O
eligible,58,66,O
for,67,70,O
analysis,71,79,O
.,79,80,O
The,81,84,O
demographics,85,97,O
of,98,100,O
the,101,104,O
study,105,110,O
subjects,111,119,O
",",119,120,O
by,121,123,O
site,124,128,O
",",128,129,O
are,130,133,O
recorded,134,142,O
in,143,145,O
Table,146,151,O
1,152,153,O
.,153,154,O
The,155,158,O
population,159,169,O
studied,170,177,O
was,178,181,O
predominantly,182,195,O
not,196,199,O
HIV,200,203,O
infected,204,212,O
(,213,214,O
92,214,216,O
%,216,217,O
),217,218,O
",",218,219,O
and,220,223,O
by,224,226,O
the,227,230,O
study,231,236,O
entry,237,242,O
criteria,243,251,O
",",251,252,O
their,253,258,O
probability,259,270,O
of,271,273,O
infection,274,283,O
was,284,287,O
considered,288,298,O
to,299,301,O
be,302,304,O
low,305,308,O
.,308,309,O
The,310,313,O
risk,314,318,O
categories,319,329,O
assigned,330,338,O
at,339,341,O
the,342,345,O
time,346,350,O
of,351,353,O
study,354,359,O
entry,360,365,O
were,366,370,O
combined,371,379,O
into,380,384,O
groups,385,391,O
for,392,395,O
analysis,396,404,O
",",404,405,O
based,406,411,O
on,412,414,O
the,415,418,O
predisposition,419,433,O
for,434,437,O
PCP,438,441,O
.,441,442,O
The,443,446,O
analysis,447,455,O
groups,456,462,O
were,463,467,O
as,468,470,O
follows,471,478,O
:,478,479,O
(,480,481,O
i,481,482,O
),482,483,O
HIV,484,487,O
/,487,488,O
AIDS,488,492,O
",",492,493,O
(,494,495,O
ii,495,497,O
),497,498,O
lung,499,503,B-Organ
transplant,504,514,O
(,515,516,O
one,516,519,O
subject,520,527,O
with,528,532,O
a,533,534,O
dual,535,539,O
organ,540,545,B-Organ
transplant,546,556,O
[,557,558,O
lung,558,562,B-Organ
/,562,563,O
kidney,563,569,B-Organ
],569,570,O
was,571,574,O
included,575,583,O
in,584,586,O
this,587,591,O
category,592,600,O
),600,601,O
",",601,602,O
(,603,604,O
iii,604,607,O
),607,608,O
all,609,612,O
other,613,618,O
organ,619,624,B-Organ
transplants,625,636,O
and,637,640,O
allogeneic,641,651,B-Cell
hematopoietic,652,665,I-Cell
stem,666,670,I-Cell
cell,671,675,I-Cell
transplants,676,687,O
(,688,689,O
HSCT,689,693,O
),693,694,O
",",694,695,O
(,696,697,O
iv,697,699,O
),699,700,O
leukemia,701,709,O
",",709,710,O
other,711,716,O
hematological,717,730,O
disorders,731,740,O
",",740,741,O
and,742,745,O
autologous,746,756,O
HSCT,757,761,O
",",761,762,O
(,763,764,O
v,764,765,O
),765,766,O
other,767,772,O
solid,773,778,B-Pathological_formation
tumors,779,785,I-Pathological_formation
",",785,786,O
and,787,790,O
(,791,792,O
vi,792,794,O
),794,795,O
other,796,801,O
nonmalignant,802,814,O
conditions,815,825,O
.,825,826,O
Table,827,832,O
1,833,834,O
.,834,835,O
Subject,836,843,O
enrollment,844,854,O
",",854,855,O
disposition,856,867,O
",",867,868,O
and,869,872,O
demographics,873,885,O
by,886,888,O
sitea,889,894,O
Characteristic,895,909,O
Valueb,910,916,O
Site,917,921,O
1,922,923,O
Site,924,928,O
2,929,930,O
Site,931,935,O
3,936,937,O
Site,938,942,O
4,943,944,O
Enrollment,945,955,O
Unique,956,962,O
subjects,963,971,O
18,972,974,O
29,975,977,O
22,978,980,O
62,981,983,O
Subjects,984,992,O
entering,993,1001,O
into,1002,1006,O
primary,1007,1014,O
analysisc,1015,1024,O
18,1025,1027,O
22,1028,1030,O
22,1031,1033,O
48,1034,1036,O
Subjects,1037,1045,O
with,1046,1050,O
repeat,1051,1057,O
visits,1058,1064,O
0,1065,1066,O
0,1067,1068,O
0,1069,1070,O
16,1071,1073,O
No,1074,1076,O
.,1076,1077,O
of,1078,1080,O
samples,1081,1088,O
assayed,1089,1096,O
18,1097,1099,O
22,1100,1102,O
22,1103,1105,O
70,1106,1108,O
Gender,1109,1115,O
Male,1116,1120,O
7,1121,1122,O
10,1123,1125,O
13,1126,1128,O
29,1129,1131,O
Female,1132,1138,O
11,1139,1141,O
12,1142,1144,O
9,1145,1146,O
19,1147,1149,O
Race,1150,1154,O
Caucasian,1155,1164,O
12,1165,1167,O
4,1168,1169,O
0,1170,1171,O
48,1172,1174,O
Black,1175,1180,O
6,1181,1182,O
13,1183,1185,O
0,1186,1187,O
0,1188,1189,O
Other,1190,1195,O
(,1196,1197,O
nonwhite,1197,1205,O
),1205,1206,O
0,1207,1208,O
5,1209,1210,O
0,1211,1212,O
0,1213,1214,O
No,1215,1217,O
data,1218,1222,O
0,1223,1224,O
0,1225,1226,O
22,1227,1229,O
0,1230,1231,O
Mean,1232,1236,O
(,1237,1238,O
range,1238,1243,O
),1243,1244,O
age,1245,1248,O
(,1249,1250,O
yr,1250,1252,O
),1252,1253,O
57,1254,1256,O
(,1257,1258,O
26,1258,1260,O
-,1260,1261,O
78,1261,1263,O
),1263,1264,O
54,1265,1267,O
(,1268,1269,O
21,1269,1271,O
-,1271,1272,O
75,1272,1274,O
),1274,1275,O
52,1276,1278,O
(,1279,1280,O
26,1280,1282,O
-,1282,1283,O
74,1283,1285,O
),1285,1286,O
56,1287,1289,O
(,1290,1291,O
23,1291,1293,O
-,1293,1294,O
73,1294,1296,O
),1296,1297,O
Pretest,1298,1305,O
probability,1306,1317,O
of,1318,1320,O
PCP,1321,1324,O
Moderate,1325,1333,O
0,1334,1335,O
3,1336,1337,O
4,1338,1339,O
0,1340,1341,O
Low,1342,1345,O
18,1346,1348,O
19,1349,1351,O
18,1352,1354,O
48,1355,1357,O
Sample,1358,1364,O
type,1365,1369,O
BAL,1370,1373,O
18,1374,1376,O
20,1377,1379,O
20,1380,1382,O
43,1383,1385,O
Sputum,1386,1392,B-Organism_substance
0,1393,1394,O
1,1395,1396,O
1,1397,1398,O
0,1399,1400,O
Other,1401,1406,O
LRT,1407,1410,O
0,1411,1412,O
1,1413,1414,O
1,1415,1416,O
5,1417,1418,O
At,1419,1421,O
-,1421,1422,O
risk,1422,1426,O
group,1427,1432,O
HIV,1433,1436,O
/,1436,1437,O
AIDS,1437,1441,O
0,1442,1443,O
3,1444,1445,O
6,1446,1447,O
0,1448,1449,O
Lung,1450,1454,B-Organ
transplant,1455,1465,O
8,1466,1467,O
0,1468,1469,O
1,1470,1471,O
31,1472,1474,O
Other,1475,1480,O
transplants,1481,1492,O
1,1493,1494,O
7,1495,1496,O
3,1497,1498,O
0,1499,1500,O
Leukemia,1501,1509,O
1,1510,1511,O
1,1512,1513,O
7,1514,1515,O
0,1516,1517,O
Other,1518,1523,O
solid,1524,1529,B-Pathological_formation
tumors,1530,1536,I-Pathological_formation
2,1537,1538,O
1,1539,1540,O
1,1541,1542,O
7,1543,1544,O
Other,1545,1550,O
nonmalignant,1551,1563,O
conditions,1564,1574,O
6,1575,1576,O
10,1577,1579,O
4,1580,1581,O
10,1582,1584,O
a,1585,1586,O
The,1587,1590,O
testing,1591,1598,O
and,1599,1602,O
enrollment,1603,1613,O
sites,1614,1619,O
for,1620,1623,O
the,1624,1627,O
study,1628,1633,O
were,1634,1638,O
Duke,1639,1643,O
University,1644,1654,O
School,1655,1661,O
of,1662,1664,O
Medicine,1665,1673,O
",",1673,1674,O
Durham,1675,1681,O
",",1681,1682,O
NC,1683,1685,O
;,1685,1686,O
Albert,1687,1693,O
Einstein,1694,1702,O
College,1703,1710,O
of,1711,1713,O
Medicine,1714,1722,O
and,1723,1726,O
Montefiore,1727,1737,O
Medical,1738,1745,O
Center,1746,1752,O
",",1752,1753,O
Bronx,1754,1759,O
",",1759,1760,O
NY,1761,1763,O
;,1763,1764,O
Centre,1765,1771,O
Hospitalier,1772,1783,O
Universitaire,1784,1797,O
Vaudois,1798,1805,O
and,1806,1809,O
University,1810,1820,O
of,1821,1823,O
Lausanne,1824,1832,O
",",1832,1833,O
Lausanne,1834,1842,O
",",1842,1843,O
Switzerland,1844,1855,O
;,1855,1856,O
and,1857,1860,O
Medizinische,1861,1873,O
Universitat,1874,1885,O
and,1886,1889,O
Landeskrankenhaus,1890,1907,O
Natters,1908,1915,O
",",1915,1916,O
Innsbruck,1917,1926,O
",",1926,1927,O
Austria,1928,1935,O
.,1935,1936,O
b,1937,1938,O
Except,1939,1945,O
where,1946,1951,O
otherwise,1952,1961,O
indicated,1962,1971,O
",",1971,1972,O
values,1973,1979,O
are,1980,1983,O
numbers,1984,1991,O
of,1992,1994,O
patients,1995,2003,O
.,2003,2004,O
c,2005,2006,O
Subjects,2007,2015,O
were,2016,2020,O
excluded,2021,2029,O
from,2030,2034,O
analysis,2035,2043,O
if,2044,2046,O
they,2047,2051,O
withdrew,2052,2060,O
consent,2061,2068,O
or,2069,2071,O
if,2072,2074,O
there,2075,2080,O
was,2081,2084,O
inadequate,2085,2095,O
sample,2096,2102,O
left,2103,2107,O
for,2108,2111,O
PCR,2112,2115,O
testing,2116,2123,O
.,2123,2124,O
Acknowledgments,0,15,O
and,16,19,O
Funding,20,27,O
The,28,31,O
authors,32,39,O
thank,40,45,O
CRB,46,49,O
GADIE,50,55,O
(,56,57,O
Diane,57,62,O
Esquerre,63,71,O
),71,72,O
for,73,76,O
BAC,77,80,O
clones,81,87,O
handling,88,96,O
and,97,100,O
Brian,101,106,O
Smith,107,112,O
",",112,113,O
Renee,114,119,O
Fincham,120,127,O
and,128,131,O
Kristy,132,138,O
Shewbridge,139,149,O
for,150,153,O
microsatellites,154,169,O
genotyping,170,180,O
.,180,181,O
We,182,184,O
are,185,188,O
grateful,189,197,O
to,198,200,O
Yann,201,205,O
Guiguen,206,213,O
for,214,217,O
help,218,222,O
and,223,226,O
precious,227,235,O
contribution,236,248,O
to,249,251,O
fund,252,256,O
raising,257,264,O
for,265,268,O
this,269,273,O
study,274,279,O
.,279,280,O
This,281,285,O
work,286,290,O
was,291,294,O
made,295,299,O
possible,300,308,O
by,309,311,O
financial,312,321,O
support,322,329,O
of,330,332,O
Genoscope,333,342,O
.,342,343,O
We,344,346,O
acknowledge,347,358,O
Rene,359,363,O
Guyomard,364,372,O
for,373,376,O
his,377,380,O
initial,381,388,O
contribution,389,401,O
in,402,404,O
BAC,405,408,O
library,409,416,O
procurement,417,428,O
.,428,429,O
The,430,433,O
microsatellites,434,449,O
genotyping,450,460,O
was,461,464,O
supported,465,474,O
by,475,477,O
NRI,478,481,O
Grant,482,487,O
No,488,490,O
.,490,491,O
2007,492,496,O
-,496,497,O
35616,497,502,O
-,502,503,O
17875,503,508,O
from,509,513,O
the,514,517,O
USDA,518,522,O
National,523,531,O
Institute,532,541,O
of,542,544,O
Food,545,549,O
and,550,553,O
Agriculture,554,565,O
.,565,566,O
Confocal,0,8,O
and,9,12,O
scanning,13,21,O
microscopic,22,33,O
images,34,40,O
of,41,43,O
mammoth,44,51,O
',51,52,O
s,52,53,O
and,54,57,O
human,58,63,O
hair,64,68,B-Multi-tissue_structure
.,68,69,O
Taphonomic,70,80,O
changes,81,88,O
",",88,89,O
indicated,90,99,O
by,100,102,O
arrow,103,108,O
-,108,109,O
heads,109,114,O
and,115,118,O
straight,119,127,O
white,128,133,O
arrow,134,139,O
in,140,142,O
the,143,146,O
confocal,147,155,O
image,156,161,O
.,161,162,O
Bacterial,163,172,O
-,172,173,O
fungal,173,179,O
colonies,180,188,O
are,189,192,O
shown,193,198,O
by,199,201,O
broken,202,208,O
arrows,209,215,O
.,215,216,O
Red,217,220,O
arrow,221,226,O
indicates,227,236,O
space,237,242,O
between,243,250,O
cuticle,251,258,O
and,259,262,O
hair,263,267,B-Multi-tissue_structure
shaft,268,273,I-Multi-tissue_structure
due,274,277,O
to,278,280,O
shrinkage,281,290,O
.,290,291,O
Extensive,292,301,O
taphonomic,302,312,O
changes,313,320,O
in,321,323,O
YUK,324,327,O
are,328,331,O
evident,332,339,O
.,339,340,O
Note,341,345,O
the,346,349,O
preservation,350,362,O
of,363,365,O
the,366,369,O
cuticle,370,377,O
in,378,380,O
the,381,384,O
human,385,390,O
hair,391,395,B-Multi-tissue_structure
in,396,398,O
contrast,399,407,O
to,408,410,O
the,411,414,O
craters,415,422,O
in,423,425,O
the,426,429,O
cuticles,430,438,O
of,439,441,O
the,442,445,O
mammoth,446,453,O
',453,454,O
s,454,455,O
hair,456,460,B-Multi-tissue_structure
.,460,461,O
Bacterial,462,471,O
biofilms,472,480,O
are,481,484,O
a,485,486,O
feature,487,494,O
of,495,497,O
human,498,503,O
hair,504,508,B-Multi-tissue_structure
;,508,509,O
mammoth,510,517,O
',517,518,O
s,518,519,O
hair,520,524,B-Multi-tissue_structure
was,525,528,O
protected,529,538,O
from,539,543,O
bacterial,544,553,O
invasion,554,562,O
in,563,565,O
permafrost,566,576,O
.,576,577,O
Calculation,0,11,O
of,12,14,O
male,15,19,O
mating,20,26,O
success,27,34,O
In,35,37,O
order,38,43,O
to,44,46,O
compare,47,54,O
whether,55,62,O
males,63,68,O
',68,69,O
access,70,76,O
to,77,79,O
receptive,80,89,O
females,90,97,O
followed,98,106,O
the,107,110,O
predictions,111,122,O
of,123,125,O
the,126,129,O
PoA,130,133,O
model,134,139,O
",",139,140,O
we,141,143,O
calculated,144,154,O
mating,155,161,O
success,162,169,O
as,170,172,O
follows,173,180,O
.,180,181,O
For,182,185,O
all,186,189,O
the,190,193,O
mating,194,200,O
partners,201,209,O
a,210,211,O
female,212,218,O
had,219,222,O
during,223,229,O
the,230,233,O
receptive,234,243,O
period,244,250,O
of,251,253,O
her,254,257,O
conceptive,258,268,O
cycle,269,274,O
",",274,275,O
mating,276,282,O
success,283,290,O
of,291,293,O
each,294,298,O
mating,299,305,O
partner,306,313,O
was,314,317,O
calculated,318,328,O
as,329,331,O
the,332,335,O
number,336,342,O
of,343,345,O
mating,346,352,O
series,353,359,O
a,360,361,O
male,362,366,O
was,367,370,O
involved,371,379,O
in,380,382,O
divided,383,390,O
by,391,393,O
the,394,397,O
total,398,403,O
number,404,410,O
of,411,413,O
mating,414,420,O
series,421,427,O
the,428,431,O
female,432,438,O
was,439,442,O
involved,443,451,O
in,452,454,O
.,454,455,O
Overall,456,463,O
mating,464,470,O
success,471,478,O
of,479,481,O
each,482,486,O
male,487,491,O
was,492,495,O
calculated,496,506,O
as,507,509,O
the,510,513,O
sum,514,517,O
of,518,520,O
all,521,524,O
mating,525,531,O
successes,532,541,O
calculated,542,552,O
for,553,556,O
this,557,561,O
male,562,566,O
as,567,569,O
described,570,579,O
above,580,585,O
.,585,586,O
Tail,0,4,O
flick,5,10,O
test,11,15,O
CSLE,16,20,O
did,21,24,O
not,25,28,O
show,29,33,O
any,34,37,O
difference,38,48,O
compared,49,57,O
with,58,62,O
control,63,70,O
",",70,71,O
at,72,74,O
all,75,78,O
the,79,82,O
tested,83,89,O
doses,90,95,O
[,96,97,O
Figure,97,103,O
4,104,105,O
],105,106,O
.,106,107,O
Morphine,108,116,O
showed,117,123,O
a,124,125,O
significant,126,137,O
increase,138,146,O
of,147,149,O
latency,150,157,O
time,158,162,O
at,163,165,O
45,166,168,O
",",168,169,O
60,170,172,O
and,173,176,O
75,177,179,O
min,180,183,O
.,183,184,O
Figure,185,191,O
4,192,193,O
Effect,194,200,O
of,201,203,O
CSLE,204,208,O
(,209,210,O
100,210,213,O
",",213,214,O
200,215,218,O
and,219,222,O
500,223,226,O
mg,227,229,O
/,229,230,O
kg,230,232,O
),232,233,O
and,234,237,O
morphine,238,246,O
on,247,249,O
the,250,253,O
latency,254,261,O
response,262,270,O
of,271,273,O
mice,274,278,O
in,279,281,O
the,282,285,O
tail,286,290,B-Organism_subdivision
flick,291,296,O
test,297,301,O
.,301,302,O
Values,303,309,O
are,310,313,O
presented,314,323,O
as,324,326,O
the,327,330,O
mean,331,335,O
+,336,337,O
/,337,338,O
-,338,339,O
SEM,340,343,O
(,344,345,O
n,345,346,O
=,347,348,O
5,349,350,O
),350,351,O
*,352,353,O
P,353,354,O
<,355,356,O
0,357,358,O
.,358,359,O
05,359,361,O
",",361,362,O
significant,363,374,O
increase,375,383,O
from,384,388,O
control,389,396,O
Details,0,7,O
of,8,10,O
treatment,11,20,O
programs,21,29,O
A,30,31,O
and,32,35,O
B,36,37,O
in,38,40,O
respect,41,48,O
to,49,51,O
visits,52,58,O
to,59,61,O
different,62,71,O
health,72,78,O
care,79,83,O
professionals,84,97,O
and,98,101,O
treatment,102,111,O
activities,112,122,O
Genes,0,5,O
associated,6,16,O
with,17,21,O
nonsegmental,22,34,O
vitiligo,35,43,O
.,43,44,O
a,0,1,O
",",1,2,O
b,3,4,O
Radiographs,5,16,O
of,17,19,O
the,20,23,O
left,24,28,O
elbow,29,34,B-Organism_subdivision
and,35,38,O
forearm,39,46,B-Organism_subdivision
5,47,48,O
months,49,55,O
after,56,61,O
the,62,65,O
surgery,66,73,O
Discussion,0,10,O
The,11,14,O
two,15,18,O
most,19,23,O
important,24,33,O
factors,34,41,O
leading,42,49,O
to,50,52,O
the,53,56,O
development,57,68,O
of,69,71,O
hypoxia,72,79,O
are,80,83,O
biological,84,94,O
processes,95,104,O
that,105,109,O
determine,110,119,O
the,120,123,O
amount,124,130,O
of,131,133,O
organic,134,141,O
matter,142,148,O
available,149,158,O
to,159,161,O
be,162,164,O
degraded,165,173,O
and,174,177,O
physical,178,186,O
factors,187,194,O
creating,195,203,O
stratification,204,218,O
.,218,219,O
Stratification,220,234,O
in,235,237,O
most,238,242,O
areas,243,248,O
of,249,251,O
the,252,255,O
coastal,256,263,O
zone,264,268,O
of,269,271,O
the,272,275,O
Baltic,276,282,O
Sea,283,286,O
is,287,289,O
due,290,293,O
to,294,296,O
seasonal,297,305,O
temperature,306,317,O
changes,318,325,O
",",325,326,O
although,327,335,O
stratification,336,350,O
by,351,353,O
occasional,354,364,O
inflowing,365,374,O
saltier,375,382,O
water,383,388,O
does,389,393,O
occur,394,399,O
in,400,402,O
some,403,407,O
estuaries,408,417,O
.,417,418,O
(,418,419,O
14,419,421,O
),421,422,O
Hypoxia,423,430,O
is,431,433,O
common,434,440,O
in,441,443,O
estuaries,444,453,O
located,454,461,O
in,462,464,O
the,465,468,O
Danish,469,475,O
Straits,476,483,O
due,484,487,O
to,488,490,O
the,491,494,O
large,495,500,O
load,501,505,O
of,506,508,O
nutrients,509,518,O
sustaining,519,529,O
algal,530,535,O
production,536,546,O
and,547,550,O
the,551,554,O
strong,555,561,O
stratification,562,576,O
caused,577,583,O
by,584,586,O
large,587,592,O
differences,593,604,O
in,605,607,O
surface,608,615,O
and,616,619,O
bottom,620,626,O
water,627,632,O
salinity,633,641,O
.,641,642,O
(,642,643,O
5,643,644,O
),644,645,O
Hypoxia,646,653,O
in,654,656,O
the,657,660,O
Swedish,661,668,O
and,669,672,O
Finnish,673,680,O
archipelagos,681,693,O
are,694,697,O
influenced,698,708,O
by,709,711,O
phytoplankton,712,725,O
growth,726,732,O
stimulated,733,743,O
by,744,746,O
nutrient,747,755,O
loads,756,761,O
from,762,766,O
urban,767,772,O
and,773,776,O
agricultural,777,789,O
sources,790,797,O
",",797,798,O
but,799,802,O
also,803,807,O
by,808,810,O
restricted,811,821,O
water,822,827,O
circulation,828,839,O
.,839,840,O
The,841,844,O
Finnish,845,852,O
Archipelago,853,864,O
Sea,865,868,O
is,869,871,O
impacted,872,880,O
by,881,883,O
drifting,884,892,O
algal,893,898,O
mats,899,903,O
that,904,908,O
consume,909,916,O
oxygen,917,923,O
during,924,930,O
their,931,936,O
decomposition,937,950,O
when,951,955,O
they,956,960,O
sink,961,965,O
to,966,968,O
the,969,972,O
bottom,973,979,O
.,979,980,O
(,980,981,O
15,981,983,O
),983,984,O
By,985,987,O
contrast,988,996,O
",",996,997,O
hypoxia,998,1005,O
is,1006,1008,O
rare,1009,1013,O
in,1014,1016,O
the,1017,1020,O
northern,1021,1029,O
Baltic,1030,1036,O
Sea,1037,1040,O
estuaries,1041,1050,O
located,1051,1058,O
in,1059,1061,O
the,1062,1065,O
Bothnian,1066,1074,O
Sea,1075,1078,O
coastal,1079,1086,O
zone,1087,1091,O
where,1092,1097,O
nutrient,1098,1106,O
loads,1107,1112,O
are,1113,1116,O
lower,1117,1122,O
.,1122,1123,O
Hypoxia,1124,1131,O
is,1132,1134,O
uncommon,1135,1143,O
along,1144,1149,O
the,1150,1153,O
eastern,1154,1161,O
shore,1162,1167,O
from,1168,1172,O
Estonia,1173,1180,O
to,1181,1183,O
Poland,1184,1190,O
due,1191,1194,O
to,1195,1197,O
enhanced,1198,1206,O
circulation,1207,1218,O
of,1219,1221,O
water,1222,1227,O
in,1228,1230,O
open,1231,1235,O
areas,1236,1241,O
along,1242,1247,O
the,1248,1251,O
coastline,1252,1261,O
(,1262,1263,O
Figure,1263,1269,O
1,1270,1271,O
),1271,1272,O
.,1272,1273,O
There,1274,1279,O
are,1280,1283,O
very,1284,1288,O
limited,1289,1296,O
data,1297,1301,O
available,1302,1311,O
to,1312,1314,O
examine,1315,1322,O
how,1323,1326,O
far,1327,1330,O
back,1331,1335,O
in,1336,1338,O
time,1339,1343,O
hypoxia,1344,1351,O
has,1352,1355,O
occurred,1356,1364,O
.,1364,1365,O
A,1366,1367,O
key,1368,1371,O
question,1372,1380,O
in,1381,1383,O
this,1384,1388,O
ecosystem,1389,1398,O
affected,1399,1407,O
daily,1408,1413,O
by,1414,1416,O
over,1417,1421,O
85,1422,1424,O
million,1425,1432,O
people,1433,1439,O
could,1440,1445,O
be,1446,1448,O
"""",1449,1450,O
Is,1450,1452,O
hypoxia,1453,1460,O
a,1461,1462,O
natural,1463,1470,O
phenomenon,1471,1481,O
?,1481,1482,O
"""",1482,1483,O
.,1483,1484,O
(,1484,1485,O
16,1485,1487,O
),1487,1488,O
The,1489,1492,O
large,1493,1498,O
numbers,1499,1506,O
of,1507,1509,O
enclosed,1510,1518,O
areas,1519,1524,O
",",1524,1525,O
in,1526,1528,O
many,1529,1533,O
cases,1534,1539,O
with,1540,1544,O
shallow,1545,1552,O
sills,1553,1558,O
that,1559,1563,O
restrict,1564,1572,O
the,1573,1576,O
exchange,1577,1585,O
of,1586,1588,O
bottom,1589,1595,O
water,1596,1601,O
and,1602,1605,O
often,1606,1611,O
in,1612,1614,O
combination,1615,1626,O
with,1627,1631,O
large,1632,1637,O
irregular,1638,1647,O
changes,1648,1655,O
in,1656,1658,O
salinity,1659,1667,O
",",1667,1668,O
might,1669,1674,O
mean,1675,1679,O
that,1680,1684,O
hypoxia,1685,1692,O
has,1693,1696,O
always,1697,1703,O
been,1704,1708,O
present,1709,1716,O
in,1717,1719,O
the,1720,1723,O
coastal,1724,1731,O
zone,1732,1736,O
.,1736,1737,O
However,1738,1745,O
",",1745,1746,O
sediment,1747,1755,O
laminations,1756,1767,O
from,1768,1772,O
Stockholm,1773,1782,O
Archipelago,1783,1794,O
",",1794,1795,O
an,1796,1798,O
indicator,1799,1808,O
of,1809,1811,O
past,1812,1816,O
hypoxia,1817,1824,O
",",1824,1825,O
(,1825,1826,O
17,1826,1828,O
),1828,1829,O
have,1830,1834,O
been,1835,1839,O
shown,1840,1845,O
to,1846,1848,O
be,1849,1851,O
a,1852,1853,O
recent,1854,1860,O
phenomenon,1861,1871,O
with,1872,1876,O
very,1877,1881,O
few,1882,1885,O
areas,1886,1891,O
with,1892,1896,O
laminated,1897,1906,O
sediments,1907,1916,O
prior,1917,1922,O
to,1923,1925,O
1900,1926,1930,O
.,1930,1931,O
17,1931,1933,O
",",1933,1934,O
18,1934,1936,O
The,1937,1940,O
long,1941,1945,O
-,1945,1946,O
term,1946,1950,O
millennial,1951,1961,O
trends,1962,1968,O
in,1969,1971,O
coastal,1972,1979,O
hypoxia,1980,1987,O
remain,1988,1994,O
unknown,1995,2002,O
",",2002,2003,O
although,2004,2012,O
hypoxia,2013,2020,O
has,2021,2024,O
occurred,2025,2033,O
intermittently,2034,2048,O
throughout,2049,2059,O
the,2060,2063,O
last,2064,2068,O
8000,2069,2073,O
years,2074,2079,O
in,2080,2082,O
offshore,2083,2091,O
deep,2092,2096,O
waters,2097,2103,O
of,2104,2106,O
the,2107,2110,O
Baltic,2111,2117,O
Sea,2118,2121,O
.,2121,2122,O
(,2122,2123,O
10,2123,2125,O
),2125,2126,O
Further,2127,2134,O
sediment,2135,2143,O
studies,2144,2151,O
are,2152,2155,O
necessary,2156,2165,O
",",2165,2166,O
similar,2167,2174,O
to,2175,2177,O
those,2178,2183,O
carried,2184,2191,O
out,2192,2195,O
in,2196,2198,O
the,2199,2202,O
open,2203,2207,O
Baltic,2208,2214,O
Sea,2215,2218,O
",",2218,2219,O
(,2219,2220,O
10,2220,2222,O
),2222,2223,O
to,2224,2226,O
ascertain,2227,2236,O
how,2237,2240,O
far,2241,2244,O
back,2245,2249,O
in,2250,2252,O
time,2253,2257,O
hypoxia,2258,2265,O
was,2266,2269,O
observed,2270,2278,O
in,2279,2281,O
the,2282,2285,O
coastal,2286,2293,O
zone,2294,2298,O
.,2298,2299,O
Key,2300,2303,O
uncertainties,2304,2317,O
remain,2318,2324,O
including,2325,2334,O
how,2335,2338,O
have,2339,2343,O
the,2344,2347,O
driving,2348,2355,O
forces,2356,2362,O
for,2363,2366,O
hypoxia,2367,2374,O
",",2374,2375,O
e,2376,2377,O
.,2377,2378,O
g,2378,2379,O
.,2379,2380,O
",",2380,2381,O
climate,2382,2389,O
(,2389,2390,O
19,2390,2392,O
),2392,2393,O
and,2394,2397,O
nutrient,2398,2406,O
loading,2407,2414,O
",",2414,2415,O
changed,2416,2423,O
through,2424,2431,O
time,2432,2436,O
in,2437,2439,O
the,2440,2443,O
Baltic,2444,2450,O
Sea,2451,2454,O
coastal,2455,2462,O
zone,2463,2467,O
",",2467,2468,O
and,2469,2472,O
do,2473,2475,O
they,2476,2480,O
vary,2481,2485,O
during,2486,2492,O
the,2493,2496,O
same,2497,2501,O
time,2502,2506,O
periods,2507,2514,O
that,2515,2519,O
hypoxia,2520,2527,O
varies,2528,2534,O
in,2535,2537,O
the,2538,2541,O
open,2542,2546,O
waters,2547,2553,O
?,2553,2554,O
(,2554,2555,O
16,2555,2557,O
),2557,2558,O
An,2559,2561,O
important,2562,2571,O
consideration,2572,2585,O
in,2586,2588,O
determining,2589,2600,O
the,2601,2604,O
number,2605,2611,O
of,2612,2614,O
ecosystems,2615,2625,O
experiencing,2626,2638,O
hypoxia,2639,2646,O
is,2647,2649,O
the,2650,2653,O
size,2654,2658,O
of,2659,2661,O
the,2662,2665,O
assessment,2666,2676,O
unit,2677,2681,O
.,2681,2682,O
We,2683,2685,O
combined,2686,2694,O
numerous,2695,2703,O
monitoring,2704,2714,O
points,2715,2721,O
and,2722,2725,O
sites,2726,2731,O
to,2732,2734,O
form,2735,2739,O
a,2740,2741,O
coherent,2742,2750,O
coastal,2751,2758,O
unit,2759,2763,O
when,2764,2768,O
bottom,2769,2775,O
waters,2776,2782,O
were,2783,2787,O
physically,2788,2798,O
connected,2799,2808,O
to,2809,2811,O
each,2812,2816,O
other,2817,2822,O
.,2822,2823,O
This,2824,2828,O
means,2829,2834,O
that,2835,2839,O
assessment,2840,2850,O
units,2851,2856,O
considered,2857,2867,O
hypoxic,2868,2875,O
might,2876,2881,O
occur,2882,2887,O
in,2888,2890,O
the,2891,2894,O
same,2895,2899,O
geographical,2900,2912,O
region,2913,2919,O
and,2920,2923,O
could,2924,2929,O
be,2930,2932,O
in,2933,2935,O
close,2936,2941,O
proximately,2942,2953,O
to,2954,2956,O
each,2957,2961,O
other,2962,2967,O
",",2967,2968,O
if,2969,2971,O
their,2972,2977,O
bottom,2978,2984,O
waters,2985,2991,O
were,2992,2996,O
physically,2997,3007,O
disconnected,3008,3020,O
.,3020,3021,O
The,3022,3025,O
Baltic,3026,3032,O
Sea,3033,3036,O
archipelagos,3037,3049,O
have,3050,3054,O
a,3055,3056,O
complex,3057,3064,O
topography,3065,3075,O
with,3076,3080,O
many,3081,3085,O
basins,3086,3092,O
disjoined,3093,3102,O
by,3103,3105,O
shallow,3106,3113,O
sills,3114,3119,O
resulting,3120,3129,O
in,3130,3132,O
many,3133,3137,O
distinct,3138,3146,O
sites,3147,3152,O
",",3152,3153,O
although,3154,3162,O
they,3163,3167,O
are,3168,3171,O
all,3172,3175,O
affected,3176,3184,O
by,3185,3187,O
similar,3188,3195,O
mechanisms,3196,3206,O
.,3206,3207,O
In,3208,3210,O
fact,3211,3215,O
",",3215,3216,O
the,3217,3220,O
Stockholm,3221,3230,O
and,3231,3234,O
Finnish,3235,3242,O
archipelagos,3243,3255,O
contributed,3256,3267,O
21,3268,3270,O
%,3270,3271,O
of,3272,3274,O
the,3275,3278,O
total,3279,3284,O
assessment,3285,3295,O
units,3296,3301,O
",",3301,3302,O
a,3303,3304,O
relatively,3305,3315,O
large,3316,3321,O
share,3322,3327,O
compared,3328,3336,O
to,3337,3339,O
the,3340,3343,O
total,3344,3349,O
Baltic,3350,3356,O
Sea,3357,3360,O
coastal,3361,3368,O
zone,3369,3373,O
",",3373,3374,O
but,3375,3378,O
>,3379,3380,O
40,3380,3382,O
%,3382,3383,O
of,3384,3386,O
the,3387,3390,O
hypoxic,3391,3398,O
sites,3399,3404,O
.,3404,3405,O
The,3406,3409,O
coastal,3410,3417,O
stretches,3418,3427,O
of,3428,3430,O
the,3431,3434,O
Western,3435,3442,O
Gotland,3443,3450,O
Basin,3451,3456,O
and,3457,3460,O
Gulf,3461,3465,O
of,3466,3468,O
Finland,3469,3476,O
that,3477,3481,O
have,3482,3486,O
a,3487,3488,O
substantial,3489,3500,O
number,3501,3507,O
of,3508,3510,O
hypoxic,3511,3518,O
sites,3519,3524,O
are,3525,3528,O
also,3529,3533,O
archipelagos,3534,3546,O
",",3546,3547,O
which,3548,3553,O
are,3554,3557,O
more,3558,3562,O
prone,3563,3568,O
to,3569,3571,O
hypoxia,3572,3579,O
because,3580,3587,O
of,3588,3590,O
the,3591,3594,O
complex,3595,3602,O
topography,3603,3613,O
",",3613,3614,O
proximity,3615,3624,O
to,3625,3627,O
development,3628,3639,O
",",3639,3640,O
and,3641,3644,O
consequently,3645,3657,O
more,3658,3662,O
sensitive,3663,3672,O
to,3673,3675,O
enhanced,3676,3684,O
nutrient,3685,3693,O
inputs,3694,3700,O
from,3701,3705,O
land,3706,3710,O
.,3710,3711,O
Surprisingly,3712,3724,O
only,3725,3729,O
4,3730,3731,O
.,3731,3732,O
0,3732,3733,O
%,3733,3734,O
of,3735,3737,O
all,3738,3741,O
sites,3742,3747,O
were,3748,3752,O
classified,3753,3763,O
as,3764,3766,O
seasonally,3767,3777,O
hypoxic,3778,3785,O
according,3786,3795,O
to,3796,3798,O
our,3799,3802,O
definition,3803,3813,O
when,3814,3818,O
>,3819,3820,O
50,3820,3822,O
%,3822,3823,O
and,3824,3827,O
<,3828,3829,O
80,3829,3831,O
%,3831,3832,O
of,3833,3835,O
profiles,3836,3844,O
during,3845,3851,O
the,3852,3855,O
stratified,3856,3866,O
period,3867,3873,O
have,3874,3878,O
oxygen,3879,3885,O
concentrations,3886,3900,O
less,3901,3905,O
than,3906,3910,O
2,3911,3912,O
mg,3913,3915,O
L,3916,3917,O
-,3917,3918,O
1,3918,3919,O
.,3919,3920,O
A,3921,3922,O
statistically,3923,3936,O
rigorous,3937,3945,O
definition,3946,3956,O
of,3957,3959,O
what,3960,3964,O
constitutes,3965,3976,O
seasonal,3977,3985,O
hypoxia,3986,3993,O
does,3994,3998,O
not,3999,4002,O
currently,4003,4012,O
exist,4013,4018,O
and,4019,4022,O
in,4023,4025,O
fact,4026,4030,O
should,4031,4037,O
be,4038,4040,O
linked,4041,4047,O
to,4048,4050,O
ecological,4051,4061,O
consequences,4062,4074,O
for,4075,4078,O
it,4079,4081,O
to,4082,4084,O
be,4085,4087,O
ecologically,4088,4100,O
relevant,4101,4109,O
and,4110,4113,O
not,4114,4117,O
just,4118,4122,O
connected,4123,4132,O
to,4133,4135,O
absolute,4136,4144,O
concentrations,4145,4159,O
.,4159,4160,O
(,4160,4161,O
3,4161,4162,O
),4162,4163,O
Currently,4164,4173,O
coastal,4174,4181,O
marine,4182,4188,O
ecosystems,4189,4199,O
that,4200,4204,O
experience,4205,4215,O
hypoxia,4216,4223,O
for,4224,4227,O
a,4228,4229,O
period,4230,4236,O
of,4237,4239,O
days,4240,4244,O
to,4245,4247,O
months,4248,4254,O
every,4255,4260,O
year,4261,4265,O
are,4266,4269,O
often,4270,4275,O
considered,4276,4286,O
to,4287,4289,O
be,4290,4292,O
seasonally,4293,4303,O
hypoxic,4304,4311,O
",",4311,4312,O
although,4313,4321,O
we,4322,4324,O
have,4325,4329,O
categorized,4330,4341,O
them,4342,4346,O
here,4347,4351,O
as,4352,4354,O
being,4355,4360,O
episodic,4361,4369,O
",",4369,4370,O
because,4371,4378,O
we,4379,4381,O
required,4382,4390,O
the,4391,4394,O
monitoring,4395,4405,O
units,4406,4411,O
to,4412,4414,O
be,4415,4417,O
hypoxic,4418,4425,O
for,4426,4429,O
most,4430,4434,O
of,4435,4437,O
the,4438,4441,O
stratified,4442,4452,O
period,4453,4459,O
.,4459,4460,O
However,4461,4468,O
",",4468,4469,O
in,4470,4472,O
Limfjorden,4473,4483,O
",",4483,4484,O
Denmark,4485,4492,O
",",4492,4493,O
bottom,4494,4500,O
water,4501,4506,O
oxygen,4507,4513,O
concentrations,4514,4528,O
can,4529,4532,O
vary,4533,4537,O
greatly,4538,4545,O
between,4546,4553,O
weekly,4554,4560,O
samplings,4561,4570,O
(,4571,4572,O
SI,4572,4574,O
Figure,4575,4581,O
S6,4582,4584,O
),4584,4585,O
",",4585,4586,O
although,4587,4595,O
nearly,4596,4602,O
every,4603,4608,O
year,4609,4613,O
hypoxic,4614,4621,O
conditions,4622,4632,O
are,4633,4636,O
observed,4637,4645,O
somewhere,4646,4655,O
in,4656,4658,O
the,4659,4662,O
Limfjorden,4663,4673,O
.,4673,4674,O
Our,4675,4678,O
statistical,4679,4690,O
estimation,4691,4701,O
is,4702,4704,O
that,4705,4709,O
Limfjorden,4710,4720,O
is,4721,4723,O
episodically,4724,4736,O
hypoxic,4737,4744,O
.,4744,4745,O
Diaz,4746,4750,O
and,4751,4754,O
Rosenberg,4755,4764,O
(,4764,4765,O
1,4765,4766,O
),4766,4767,O
would,4768,4773,O
classify,4774,4782,O
Limfjorden,4783,4793,O
as,4794,4796,O
periodically,4797,4809,O
hypoxic,4810,4817,O
",",4817,4818,O
although,4819,4827,O
we,4828,4830,O
have,4831,4835,O
found,4836,4841,O
it,4842,4844,O
difficult,4845,4854,O
to,4855,4857,O
create,4858,4864,O
a,4865,4866,O
statistically,4867,4880,O
robust,4881,4887,O
indicator,4888,4897,O
that,4898,4902,O
would,4903,4908,O
classify,4909,4917,O
systems,4918,4925,O
as,4926,4928,O
periodically,4929,4941,O
hypoxic,4942,4949,O
.,4949,4950,O
Periodic,4951,4959,O
hypoxia,4960,4967,O
is,4968,4970,O
problematic,4971,4982,O
because,4983,4990,O
it,4991,4993,O
never,4994,4999,O
allows,5000,5006,O
for,5007,5010,O
re,5011,5013,O
-,5013,5014,O
establishment,5014,5027,O
of,5028,5030,O
benthic,5031,5038,O
communities,5039,5050,O
.,5050,5051,O
(,5051,5052,O
20,5052,5054,O
),5054,5055,O
Currently,5056,5065,O
",",5065,5066,O
there,5067,5072,O
are,5073,5076,O
416,5077,5080,O
areas,5081,5086,O
in,5087,5089,O
the,5090,5093,O
world,5094,5099,O
with,5100,5104,O
reported,5105,5113,O
coastal,5114,5121,O
hypoxia,5122,5129,O
with,5130,5134,O
about,5135,5140,O
30,5141,5143,O
previously,5144,5154,O
reported,5155,5163,O
sites,5164,5169,O
in,5170,5172,O
the,5173,5176,O
Baltic,5177,5183,O
Sea,5184,5187,O
region,5188,5194,O
",",5194,5195,O
which,5196,5201,O
includes,5202,5210,O
both,5211,5215,O
coastal,5216,5223,O
zone,5224,5228,O
hypoxia,5229,5236,O
and,5237,5240,O
deep,5241,5245,O
water,5246,5251,O
sites,5252,5257,O
in,5258,5260,O
the,5261,5264,O
Baltic,5265,5271,O
Sea,5272,5275,O
.,5275,5276,O
(,5276,5277,O
1,5277,5278,O
),5278,5279,O
We,5280,5282,O
have,5283,5287,O
identified,5288,5298,O
an,5299,5301,O
additional,5302,5312,O
96,5313,5315,O
sites,5316,5321,O
that,5322,5326,O
have,5327,5331,O
experienced,5332,5343,O
hypoxia,5344,5351,O
",",5351,5352,O
increasing,5353,5363,O
the,5364,5367,O
global,5368,5374,O
total,5375,5380,O
to,5381,5383,O
nearly,5384,5390,O
500,5391,5394,O
sites,5395,5400,O
.,5400,5401,O
Of,5402,5404,O
all,5405,5408,O
the,5409,5412,O
known,5413,5418,O
sites,5419,5424,O
around,5425,5431,O
the,5432,5435,O
world,5436,5441,O
",",5441,5442,O
around,5443,5449,O
20,5450,5452,O
%,5452,5453,O
of,5454,5456,O
the,5457,5460,O
sites,5461,5466,O
are,5467,5470,O
found,5471,5476,O
in,5477,5479,O
the,5480,5483,O
Baltic,5484,5490,O
Sea,5491,5494,O
region,5495,5501,O
.,5501,5502,O
Most,5503,5507,O
sites,5508,5513,O
experienced,5514,5525,O
episodic,5526,5534,O
hypoxia,5535,5542,O
",",5542,5543,O
which,5544,5549,O
is,5550,5552,O
a,5553,5554,O
precursor,5555,5564,O
to,5565,5567,O
development,5568,5579,O
of,5580,5582,O
seasonal,5583,5591,O
hypoxia,5592,5599,O
.,5599,5600,O
(,5600,5601,O
20,5601,5603,O
),5603,5604,O
The,5605,5608,O
large,5609,5614,O
number,5615,5621,O
of,5622,5624,O
sites,5625,5630,O
partially,5631,5640,O
reflects,5641,5649,O
the,5650,5653,O
fact,5654,5658,O
that,5659,5663,O
the,5664,5667,O
Baltic,5668,5674,O
Sea,5675,5678,O
is,5679,5681,O
one,5682,5685,O
of,5686,5688,O
the,5689,5692,O
most,5693,5697,O
data,5698,5702,O
rich,5703,5707,O
regions,5708,5715,O
of,5716,5718,O
the,5719,5722,O
world,5723,5728,O
with,5729,5733,O
no,5734,5736,O
tidal,5737,5742,O
mixing,5743,5749,O
and,5750,5753,O
complex,5754,5761,O
bottom,5762,5768,O
topography,5769,5779,O
creating,5780,5788,O
conditions,5789,5799,O
favorable,5800,5809,O
for,5810,5813,O
hypoxia,5814,5821,O
",",5821,5822,O
although,5823,5831,O
these,5832,5837,O
are,5838,5841,O
only,5842,5846,O
the,5847,5850,O
"""",5851,5852,O
monitored,5852,5861,O
areas,5862,5867,O
"""",5867,5868,O
and,5869,5872,O
many,5873,5877,O
more,5878,5882,O
hypoxic,5883,5890,O
sites,5891,5896,O
probably,5897,5905,O
exist,5906,5911,O
in,5912,5914,O
the,5915,5918,O
Baltic,5919,5925,O
Sea,5926,5929,O
coastal,5930,5937,O
zone,5938,5942,O
.,5942,5943,O
In,5944,5946,O
contrast,5947,5955,O
",",5955,5956,O
there,5957,5962,O
was,5963,5966,O
no,5967,5969,O
evidence,5970,5978,O
of,5979,5981,O
hypoxia,5982,5989,O
at,5990,5992,O
95,5993,5995,O
stations,5996,6004,O
in,6005,6007,O
estuarine,6008,6017,O
and,6018,6021,O
coastal,6022,6029,O
waters,6030,6036,O
around,6037,6043,O
Ireland,6044,6051,O
due,6052,6055,O
to,6056,6058,O
sufficient,6059,6069,O
tidal,6070,6075,O
mixing,6076,6082,O
.,6082,6083,O
(,6083,6084,O
21,6084,6086,O
),6086,6087,O
If,6088,6090,O
such,6091,6095,O
detailed,6096,6104,O
data,6105,6109,O
existed,6110,6117,O
for,6118,6121,O
other,6122,6127,O
coastal,6128,6135,O
regions,6136,6143,O
around,6144,6150,O
the,6151,6154,O
world,6155,6160,O
",",6160,6161,O
it,6162,6164,O
is,6165,6167,O
likely,6168,6174,O
that,6175,6179,O
the,6180,6183,O
number,6184,6190,O
of,6191,6193,O
areas,6194,6199,O
would,6200,6205,O
increase,6206,6214,O
globally,6215,6223,O
.,6223,6224,O
Oxygen,6225,6231,O
is,6232,6234,O
an,6235,6237,O
important,6238,6247,O
parameter,6248,6257,O
in,6258,6260,O
water,6261,6266,O
quality,6267,6274,O
assessments,6275,6286,O
since,6287,6292,O
sufficient,6293,6303,O
oxygen,6304,6310,O
is,6311,6313,O
essential,6314,6323,O
to,6324,6326,O
aquatic,6327,6334,O
life,6335,6339,O
and,6340,6343,O
is,6344,6346,O
necessary,6347,6356,O
to,6357,6359,O
support,6360,6367,O
healthy,6368,6375,O
biological,6376,6386,O
communities,6387,6398,O
.,6398,6399,O
(,6399,6400,O
3,6400,6401,O
),6401,6402,O
For,6403,6406,O
example,6407,6414,O
",",6414,6415,O
oxygen,6416,6422,O
concentration,6423,6436,O
is,6437,6439,O
a,6440,6441,O
supporting,6442,6452,O
element,6453,6460,O
to,6461,6463,O
the,6464,6467,O
biological,6468,6478,O
quality,6479,6486,O
elements,6487,6495,O
in,6496,6498,O
the,6499,6502,O
European,6503,6511,O
Water,6512,6517,O
Framework,6518,6527,O
Directive,6528,6537,O
",",6537,6538,O
(,6538,6539,O
21,6539,6541,O
),6541,6542,O
is,6543,6545,O
one,6546,6549,O
of,6550,6552,O
the,6553,6556,O
ecological,6557,6567,O
objectives,6568,6578,O
in,6579,6581,O
the,6582,6585,O
Helsinki,6586,6594,O
Commission,6595,6605,O
',6605,6606,O
s,6606,6607,O
(,6608,6609,O
HELCOM,6609,6615,O
),6615,6616,O
eutrophication,6617,6631,O
assessment,6632,6642,O
of,6643,6645,O
the,6646,6649,O
Baltic,6650,6656,O
Sea,6657,6660,O
",",6660,6661,O
and,6662,6665,O
is,6666,6668,O
included,6669,6677,O
in,6678,6680,O
the,6681,6684,O
European,6685,6693,O
Marine,6694,6700,O
Strategy,6701,6709,O
Framework,6710,6719,O
Directive,6720,6729,O
as,6730,6732,O
an,6733,6735,O
effect,6736,6742,O
parameter,6743,6752,O
of,6753,6755,O
eutrophication,6756,6770,O
.,6770,6771,O
Accurate,6772,6780,O
data,6781,6785,O
for,6786,6789,O
the,6790,6793,O
concentration,6794,6807,O
of,6808,6810,O
dissolved,6811,6820,O
oxygen,6821,6827,O
are,6828,6831,O
essential,6832,6841,O
for,6842,6845,O
documenting,6846,6857,O
environmental,6858,6871,O
changes,6872,6879,O
in,6880,6882,O
water,6883,6888,O
resources,6889,6898,O
resulting,6899,6908,O
from,6909,6913,O
natural,6914,6921,O
phenomena,6922,6931,O
and,6932,6935,O
human,6936,6941,O
activities,6942,6952,O
.,6952,6953,O
Reports,6954,6961,O
of,6962,6964,O
hypoxia,6965,6972,O
globally,6973,6981,O
are,6982,6985,O
increasing1,6986,6997,O
",",6997,6998,O
22,6998,7000,O
both,7001,7005,O
due,7006,7009,O
to,7010,7012,O
the,7013,7016,O
recognition,7017,7028,O
of,7029,7031,O
the,7032,7035,O
seriousness,7036,7047,O
of,7048,7050,O
hypoxia,7051,7058,O
on,7059,7061,O
ecosystem,7062,7071,O
functioning,7072,7083,O
and,7084,7087,O
as,7088,7090,O
decades,7091,7098,O
-,7098,7099,O
long,7099,7103,O
monitoring,7104,7114,O
records,7115,7122,O
become,7123,7129,O
available,7130,7139,O
in,7140,7142,O
databases,7143,7152,O
.,7152,7153,O
How,7154,7157,O
the,7158,7161,O
large,7162,7167,O
number,7168,7174,O
of,7175,7177,O
newly,7178,7183,O
identified,7184,7194,O
hypoxic,7195,7202,O
areas,7203,7208,O
influences,7209,7219,O
nutrient,7220,7228,O
biogeochemical,7229,7243,O
cycles,7244,7250,O
and,7251,7254,O
ecosystem,7255,7264,O
services,7265,7273,O
in,7274,7276,O
the,7277,7280,O
coastal,7281,7288,O
zone,7289,7293,O
in,7294,7296,O
the,7297,7300,O
Baltic,7301,7307,O
Sea,7308,7311,O
is,7312,7314,O
currently,7315,7324,O
unknown,7325,7332,O
",",7332,7333,O
although,7334,7342,O
the,7343,7346,O
functioning,7347,7358,O
of,7359,7361,O
the,7362,7365,O
coastal,7366,7373,O
filter,7374,7380,O
certainly,7381,7390,O
plays,7391,7396,O
an,7397,7399,O
important,7400,7409,O
role,7410,7414,O
in,7415,7417,O
how,7418,7421,O
adjacent,7422,7430,O
marine,7431,7437,O
systems,7438,7445,O
respond,7446,7453,O
to,7454,7456,O
changes,7457,7464,O
in,7465,7467,O
nutrient,7468,7476,O
loading,7477,7484,O
.,7484,7485,O
Presently,7486,7495,O
about,7496,7501,O
40,7502,7504,O
%,7504,7505,O
of,7506,7508,O
the,7509,7512,O
world,7513,7518,O
',7518,7519,O
s,7519,7520,O
population,7521,7531,O
lives,7532,7537,O
within,7538,7544,O
100,7545,7548,O
km,7549,7551,O
of,7552,7554,O
the,7555,7558,O
coastal,7559,7566,O
zone,7567,7571,O
strongly,7572,7580,O
impacting,7581,7590,O
ocean,7591,7596,O
health,7597,7603,O
",",7603,7604,O
(,7604,7605,O
24,7605,7607,O
),7607,7608,O
including,7609,7618,O
increasing,7619,7629,O
the,7630,7633,O
occurrence,7634,7644,O
of,7645,7647,O
hypoxic,7648,7655,O
areas,7656,7661,O
.,7661,7662,O
1,7662,7663,O
",",7663,7664,O
2,7664,7665,O
What,7666,7670,O
is,7671,7673,O
currently,7674,7683,O
lacking,7684,7691,O
is,7692,7694,O
the,7695,7698,O
link,7699,7703,O
to,7704,7706,O
the,7707,7710,O
driving,7711,7718,O
factors,7719,7726,O
of,7727,7729,O
hypoxia,7730,7737,O
including,7738,7747,O
nutrient,7748,7756,O
enrichment,7757,7767,O
",",7767,7768,O
organic,7769,7776,O
carbon,7777,7783,O
loading,7784,7791,O
and,7792,7795,O
climate,7796,7803,O
change,7804,7810,O
",",7810,7811,O
(,7811,7812,O
25,7812,7814,O
),7814,7815,O
and,7816,7819,O
a,7820,7821,O
determination,7822,7835,O
of,7836,7838,O
appropriate,7839,7850,O
nutrient,7851,7859,O
loading,7860,7867,O
targets,7868,7875,O
for,7876,7879,O
guidance,7880,7888,O
to,7889,7891,O
managers,7892,7900,O
to,7901,7903,O
ameliorate,7904,7914,O
the,7915,7918,O
devastating,7919,7930,O
impact,7931,7937,O
of,7938,7940,O
hypoxia,7941,7948,O
.,7948,7949,O
(,7949,7950,O
24,7950,7952,O
),7952,7953,O
Pharmacokinetic,0,15,O
-,15,16,O
pharmacodynamic,16,31,O
analysis,32,40,O
.,40,41,O
The,42,45,O
mean,46,50,O
(,51,52,O
90,52,54,O
%,54,55,O
CI,56,58,O
),58,59,O
slope,60,65,O
estimate,66,74,O
from,75,79,O
the,80,83,O
linezolid,84,93,O
concentration,94,107,O
-,107,108,O
R,108,109,O
-,109,110,O
R,110,111,O
interval,112,120,O
analysis,121,129,O
was,130,133,O
-,134,135,O
0,135,136,O
.,136,137,O
0017,137,141,O
(,142,143,O
-,143,144,O
0,144,145,O
.,145,146,O
0022,146,150,O
to,151,153,O
-,154,155,O
0,155,156,O
.,156,157,O
0011,157,161,O
),161,162,O
ms,163,165,O
/,165,166,O
ng,166,168,O
/,168,169,O
ml,169,171,O
.,171,172,O
This,173,177,O
translates,178,188,O
to,189,191,O
mean,192,196,O
(,197,198,O
90,198,200,O
%,200,201,O
CI,202,204,O
),204,205,O
predicted,206,215,O
decreases,216,225,O
in,226,228,O
heart,229,234,B-Organ
rate,235,239,O
of,240,242,O
approximately,243,256,O
1,257,258,O
.,258,259,O
5,259,260,O
(,261,262,O
1,262,263,O
.,263,264,O
0,264,265,O
to,266,268,O
2,269,270,O
.,270,271,O
0,271,272,O
),272,273,O
and,274,277,O
3,278,279,O
.,279,280,O
0,280,281,O
(,282,283,O
2,283,284,O
.,284,285,O
1,285,286,O
to,287,289,O
4,290,291,O
.,291,292,O
1,292,293,O
),293,294,O
beats,295,300,O
/,300,301,O
min,301,304,O
at,305,307,O
the,308,311,O
mean,312,316,O
Cmax,317,321,O
following,322,331,O
the,332,335,O
administration,336,350,O
of,351,353,O
600,354,357,O
-,357,358,O
and,359,362,O
1,363,364,O
",",364,365,O
200,365,368,O
-,368,369,O
mg,369,371,O
linezolid,372,381,O
doses,382,387,O
",",387,388,O
respectively,389,401,O
.,401,402,O
The,403,406,O
study,407,412,O
-,412,413,O
specific,413,421,O
mean,422,426,O
correction,427,437,O
factor,438,444,O
estimated,445,454,O
from,455,459,O
baseline,460,468,O
data,469,473,O
was,474,477,O
0,478,479,O
.,479,480,O
278,480,483,O
",",483,484,O
which,485,490,O
is,491,493,O
slightly,494,502,O
less,503,507,O
than,508,512,O
Fridericia,513,523,O
',523,524,O
s,524,525,O
correction,526,536,O
(,537,538,O
0,538,539,O
.,539,540,O
333,540,543,O
),543,544,O
.,544,545,O
Evaluation,546,556,O
of,557,559,O
the,560,563,O
various,564,571,O
correction,572,582,O
factors,583,590,O
showed,591,597,O
that,598,602,O
QTcF,603,607,O
most,608,612,O
appropriately,613,626,O
resolves,627,635,O
the,636,639,O
relationship,640,652,O
between,653,660,O
the,661,664,O
QT,665,667,O
interval,668,676,O
and,677,680,O
the,681,684,O
heart,685,690,B-Organ
rate,691,695,O
in,696,698,O
the,699,702,O
baseline,703,711,O
data,712,716,O
from,717,721,O
the,722,725,O
present,726,733,O
study,734,739,O
.,739,740,O
This,741,745,O
is,746,748,O
evident,749,756,O
upon,757,761,O
inspection,762,772,O
of,773,775,O
Fig,776,779,O
.,779,780,O
4,781,782,O
",",782,783,O
since,784,789,O
the,790,793,O
slope,794,799,O
between,800,807,O
the,808,811,O
QTcF,812,816,O
interval,817,825,O
and,826,829,O
the,830,833,O
R,834,835,O
-,835,836,O
R,836,837,O
interval,838,846,O
is,847,849,O
closest,850,857,O
to,858,860,O
zero,861,865,O
when,866,870,O
this,871,875,O
correction,876,886,O
is,887,889,O
applied,890,897,O
.,897,898,O
Fig,899,902,O
.,902,903,O
4,904,905,O
.,905,906,O
Evaluation,907,917,O
of,918,920,O
various,921,928,O
heart,929,934,B-Organ
rate,935,939,O
correction,940,950,O
factors,951,958,O
for,959,962,O
the,963,966,O
QT,967,969,O
interval,970,978,O
versus,979,985,O
the,986,989,O
R,990,991,O
-,991,992,O
R,992,993,O
interval,994,1002,O
.,1002,1003,O
The,1004,1007,O
predicted,1008,1017,O
line,1018,1022,O
in,1023,1025,O
each,1026,1030,O
figure,1031,1037,O
represents,1038,1048,O
the,1049,1052,O
fit,1053,1056,O
from,1057,1061,O
a,1062,1063,O
linear,1064,1070,O
mixed,1071,1076,O
-,1076,1077,O
effect,1077,1083,O
model,1084,1089,O
with,1090,1094,O
R,1095,1096,O
-,1096,1097,O
R,1097,1098,O
interval,1099,1107,O
as,1108,1110,O
a,1111,1112,O
fixed,1113,1118,O
effect,1119,1125,O
and,1126,1129,O
subject,1130,1137,O
-,1137,1138,O
specific,1138,1146,O
random,1147,1153,O
effects,1154,1161,O
for,1162,1165,O
intercept,1166,1175,O
and,1176,1179,O
slope,1180,1185,O
.,1185,1186,O
The,1187,1190,O
results,1191,1198,O
from,1199,1203,O
the,1204,1207,O
concentration,1208,1221,O
-,1221,1222,O
QTcF,1222,1226,O
analysis,1227,1235,O
are,1236,1239,O
graphically,1240,1251,O
depicted,1252,1260,O
in,1261,1263,O
Fig,1264,1267,O
.,1267,1268,O
5,1269,1270,O
.,1270,1271,O
The,1272,1275,O
mean,1276,1280,O
(,1281,1282,O
90,1282,1284,O
%,1284,1285,O
CI,1286,1288,O
),1288,1289,O
slope,1290,1295,O
estimate,1296,1304,O
from,1305,1309,O
the,1310,1313,O
linezolid,1314,1323,O
concentration,1324,1337,O
-,1337,1338,O
QTcF,1338,1342,O
analysis,1343,1351,O
was,1352,1355,O
-,1356,1357,O
0,1357,1358,O
.,1358,1359,O
0145,1359,1363,O
(,1364,1365,O
-,1365,1366,O
0,1366,1367,O
.,1367,1368,O
0768,1368,1372,O
to,1373,1375,O
0,1376,1377,O
.,1377,1378,O
0477,1378,1382,O
),1382,1383,O
ms,1384,1386,O
/,1386,1387,O
mug,1387,1390,O
/,1390,1391,O
ml,1391,1393,O
.,1393,1394,O
At,1395,1397,O
the,1398,1401,O
geometric,1402,1411,O
mean,1412,1416,O
Cmax,1417,1421,O
following,1422,1431,O
the,1432,1435,O
infusion,1436,1444,O
of,1445,1447,O
linezolid,1448,1457,O
at,1458,1460,O
600,1461,1464,O
mg,1465,1467,O
(,1468,1469,O
14,1469,1471,O
.,1471,1472,O
9,1472,1473,O
mug,1474,1477,O
/,1477,1478,O
ml,1478,1480,O
),1480,1481,O
and,1482,1485,O
1,1486,1487,O
",",1487,1488,O
200,1488,1491,O
mg,1492,1494,O
(,1495,1496,O
30,1496,1498,O
.,1498,1499,O
5,1499,1500,O
mug,1501,1504,O
/,1504,1505,O
ml,1505,1507,O
),1507,1508,O
",",1508,1509,O
the,1510,1513,O
mean,1514,1518,O
(,1519,1520,O
90,1520,1522,O
%,1522,1523,O
CI,1524,1526,O
),1526,1527,O
predicted,1528,1537,O
placebo,1538,1545,O
-,1545,1546,O
adjusted,1546,1554,O
changes,1555,1562,O
from,1563,1567,O
the,1568,1571,O
baseline,1572,1580,O
QTcF,1581,1585,O
were,1586,1590,O
-,1591,1592,O
0,1592,1593,O
.,1593,1594,O
217,1594,1597,O
(,1598,1599,O
-,1599,1600,O
1,1600,1601,O
.,1601,1602,O
14,1602,1604,O
to,1605,1607,O
0,1608,1609,O
.,1609,1610,O
710,1610,1613,O
),1613,1614,O
and,1615,1618,O
-,1619,1620,O
0,1620,1621,O
.,1621,1622,O
444,1622,1625,O
(,1626,1627,O
-,1627,1628,O
2,1628,1629,O
.,1629,1630,O
34,1630,1632,O
to,1633,1635,O
1,1636,1637,O
.,1637,1638,O
45,1638,1640,O
),1640,1641,O
ms,1642,1644,O
",",1644,1645,O
respectively,1646,1658,O
",",1658,1659,O
thus,1660,1664,O
confirming,1665,1675,O
a,1676,1677,O
lack,1678,1682,O
of,1683,1685,O
a,1686,1687,O
relationship,1688,1700,O
between,1701,1708,O
linezolid,1709,1718,O
concentrations,1719,1733,O
and,1734,1737,O
QTc,1738,1741,O
interval,1742,1750,O
.,1750,1751,O
Fig,1752,1755,O
.,1755,1756,O
5,1757,1758,O
.,1758,1759,O
QTcF,1760,1764,O
interval,1765,1773,O
versus,1774,1780,O
plasma,1781,1787,B-Organism_substance
linezolid,1788,1797,O
concentrations,1798,1812,O
.,1812,1813,O
Results,0,7,O
primary,8,15,O
pancreatic,16,26,B-Pathological_formation
sarcomas,27,35,I-Pathological_formation
are,36,39,O
extremely,40,49,O
rare,50,54,O
.,54,55,O
Pancreatic,56,66,B-Pathological_formation
sarcomas,67,75,I-Pathological_formation
are,76,79,O
more,80,84,O
aggressive,85,95,O
than,96,100,O
other,101,106,O
pancreatic,107,117,B-Pathological_formation
neoplasms,118,127,I-Pathological_formation
.,127,128,O
Introduction,0,12,O
Hip,13,16,B-Organism_subdivision
fractures,17,26,O
in,27,29,O
the,30,33,O
aged,34,38,O
constitute,39,49,O
a,50,51,O
major,52,57,O
health,58,64,O
problem,65,72,O
with,73,77,O
substantial,78,89,O
morbidity,90,99,O
[,100,101,O
1,101,102,O
],102,103,O
",",103,104,O
mortality,105,114,O
[,115,116,O
2,116,117,O
",",117,118,O
3,119,120,O
],120,121,O
",",121,122,O
and,123,126,O
",",126,127,O
as,128,130,O
the,131,134,O
ageing,135,141,O
population,142,152,O
increases,153,162,O
",",162,163,O
an,164,166,O
increasing,167,177,O
burden,178,184,O
on,185,187,O
the,188,191,O
health,192,198,O
care,199,203,O
system,204,210,O
[,211,212,O
4,212,213,O
],213,214,O
.,214,215,O
Fracture,216,224,O
risk,225,229,O
varies,230,236,O
markedly,237,245,O
between,246,253,O
countries,254,263,O
[,264,265,O
5,265,266,O
],266,267,O
.,267,268,O
In,269,271,O
a,272,273,O
study,274,279,O
by,280,282,O
Kanis,283,288,O
et,289,291,O
al,292,294,O
.,294,295,O
[,296,297,O
6,297,298,O
],298,299,O
",",299,300,O
comparing,301,310,O
10,311,313,O
-,313,314,O
year,314,318,O
probability,319,330,O
of,331,333,O
hip,334,337,B-Organism_subdivision
fracture,338,346,O
",",346,347,O
all,348,351,O
countries,352,361,O
except,362,368,O
Norway,369,375,O
had,376,379,O
lower,380,385,O
risk,386,390,O
than,391,395,O
Sweden,396,402,O
.,402,403,O
Other,404,409,O
countries,410,419,O
categorized,420,431,O
at,432,434,O
very,435,439,O
high,440,444,O
risk,445,449,O
(,450,451,O
>,451,452,O
75,452,454,O
%,454,455,O
of,456,458,O
the,459,462,O
risk,463,467,O
of,468,470,O
Sweden,471,477,O
),477,478,O
were,479,483,O
Iceland,484,491,O
",",491,492,O
Denmark,493,500,O
and,501,504,O
the,505,508,O
US,509,511,O
.,511,512,O
At,513,515,O
the,516,519,O
age,520,523,O
of,524,526,O
80,527,529,O
",",529,530,O
the,531,534,O
estimated,535,544,O
probability,545,556,O
of,557,559,O
sustaining,560,570,O
a,571,572,O
hip,573,576,B-Organism_subdivision
fracture,577,585,O
the,586,589,O
next,590,594,O
10,595,597,O
years,598,603,O
is,604,606,O
8,607,608,O
.,608,609,O
6,609,610,O
%,610,611,O
and,612,615,O
17,616,618,O
.,618,619,O
7,619,620,O
%,620,621,O
in,622,624,O
Norwegian,625,634,O
men,635,638,O
and,639,642,O
women,643,648,O
",",648,649,O
respectively,650,662,O
[,663,664,O
7,664,665,O
],665,666,O
",",666,667,O
and,668,671,O
a,672,673,O
report,674,680,O
from,681,685,O
the,686,689,O
Norwegian,690,699,O
capital,700,707,O
Oslo,708,712,O
calculated,713,723,O
an,724,726,O
overall,727,734,O
annual,735,741,O
fracture,742,750,O
rate,751,755,O
of,756,758,O
118,759,762,O
.,762,763,O
0,763,764,O
in,765,767,O
women,768,773,O
and,774,777,O
44,778,780,O
.,780,781,O
0,781,782,O
in,783,785,O
men,786,789,O
per,790,793,O
10,794,796,O
",",796,797,O
000,797,800,O
[,801,802,O
8,802,803,O
],803,804,O
.,804,805,O
Several,806,813,O
recent,814,820,O
studies,821,828,O
are,829,832,O
reporting,833,842,O
declining,843,852,O
fracture,853,861,O
incidence,862,871,O
[,872,873,O
9,873,874,O
-,874,875,O
14,875,877,O
],877,878,O
.,878,879,O
Although,880,888,O
the,889,892,O
Norwegian,893,902,O
hip,903,906,B-Organism_subdivision
fracture,907,915,O
rates,916,921,O
remain,922,928,O
the,929,932,O
highest,933,940,O
reported,941,949,O
in,950,952,O
the,953,956,O
world,957,962,O
",",962,963,O
data,964,968,O
from,969,973,O
Oslo,974,978,O
in,979,981,O
1996,982,986,O
-,986,987,O
1997,987,991,O
indicated,992,1001,O
no,1002,1004,O
increasing,1005,1015,O
incidence,1016,1025,O
rates,1026,1031,O
compared,1032,1040,O
to,1041,1043,O
the,1044,1047,O
1988,1048,1052,O
-,1052,1053,O
1989,1053,1057,O
[,1058,1059,O
8,1059,1060,O
],1060,1061,O
.,1061,1062,O
Within,1062,1068,O
Norway,1069,1075,O
",",1075,1076,O
considerable,1077,1089,O
geographic,1090,1100,O
differences,1101,1112,O
have,1113,1117,O
been,1118,1122,O
reported,1123,1131,O
",",1131,1132,O
with,1133,1137,O
substantially,1138,1151,O
lower,1152,1157,O
rates,1158,1163,O
in,1164,1166,O
smaller,1167,1174,O
cities,1175,1181,O
and,1182,1185,O
rural,1186,1191,O
areas,1192,1197,O
compared,1198,1206,O
to,1207,1209,O
Oslo,1210,1214,O
[,1215,1216,O
7,1216,1217,O
",",1217,1218,O
15,1219,1221,O
],1221,1222,O
.,1222,1223,O
However,1224,1231,O
",",1231,1232,O
these,1233,1238,O
are,1239,1242,O
reports,1243,1250,O
based,1251,1256,O
on,1257,1259,O
sporadic,1260,1268,O
studies,1269,1276,O
in,1277,1279,O
few,1280,1283,O
regions,1284,1291,O
and,1292,1295,O
in,1296,1298,O
limited,1299,1306,O
time,1307,1311,O
periods,1312,1319,O
[,1320,1321,O
16,1321,1323,O
",",1323,1324,O
17,1325,1327,O
],1327,1328,O
.,1328,1329,O
From,1330,1334,O
1985,1335,1339,O
to,1340,1342,O
2003,1343,1347,O
",",1347,1348,O
the,1349,1352,O
Norwegian,1353,1362,O
Institute,1363,1372,O
of,1373,1375,O
Public,1376,1382,O
Health,1383,1389,O
commissioned,1390,1402,O
four,1403,1407,O
Norwegian,1408,1417,O
hospitals,1418,1427,O
",",1427,1428,O
representing,1429,1441,O
10,1442,1444,O
%,1444,1445,O
of,1446,1448,O
the,1449,1452,O
population,1453,1463,O
",",1463,1464,O
to,1465,1467,O
run,1468,1471,O
a,1472,1473,O
national,1474,1482,O
injury,1483,1489,O
registry,1490,1498,O
[,1499,1500,O
18,1500,1502,O
],1502,1503,O
.,1503,1504,O
The,1505,1508,O
registry,1509,1517,O
collected,1518,1527,O
a,1528,1529,O
variety,1530,1537,O
of,1538,1540,O
data,1541,1545,O
connected,1546,1555,O
to,1556,1558,O
the,1559,1562,O
actual,1563,1569,O
injury,1570,1576,O
itself,1577,1583,O
and,1584,1587,O
the,1588,1591,O
event,1592,1597,O
leading,1598,1605,O
to,1606,1608,O
the,1609,1612,O
injury,1613,1619,O
.,1619,1620,O
In,1621,1623,O
the,1624,1627,O
city,1628,1632,O
of,1633,1635,O
Harstad,1636,1643,O
in,1644,1646,O
Northern,1647,1655,O
Norway,1656,1662,O
",",1662,1663,O
the,1664,1667,O
registration,1668,1680,O
continued,1681,1690,O
and,1691,1694,O
has,1695,1698,O
been,1699,1703,O
running,1704,1711,O
for,1712,1715,O
more,1716,1720,O
than,1721,1725,O
23,1726,1728,O
years,1729,1734,O
.,1734,1735,O
Throughout,1736,1746,O
the,1747,1750,O
years,1751,1756,O
of,1757,1759,O
the,1760,1763,O
National,1764,1772,O
Injury,1773,1779,O
Registry,1780,1788,O
",",1788,1789,O
the,1790,1793,O
injury,1794,1800,O
rates,1801,1806,O
in,1807,1809,O
Harstad,1810,1817,O
closely,1818,1825,O
resembled,1826,1835,O
the,1836,1839,O
rates,1840,1845,O
of,1846,1848,O
the,1849,1852,O
national,1853,1861,O
registry,1862,1870,O
[,1871,1872,O
18,1872,1874,O
],1874,1875,O
.,1875,1876,O
With,1877,1881,O
reference,1882,1891,O
to,1892,1894,O
the,1895,1898,O
recent,1899,1905,O
reports,1906,1913,O
suggesting,1914,1924,O
stabilizing,1925,1936,O
hip,1937,1940,B-Organism_subdivision
fracture,1941,1949,O
incidence,1950,1959,O
internationally,1960,1975,O
as,1976,1978,O
well,1979,1983,O
as,1984,1986,O
nationally,1987,1997,O
",",1997,1998,O
and,1999,2002,O
regional,2003,2011,O
differences,2012,2023,O
within,2024,2030,O
Norway,2031,2037,O
",",2037,2038,O
we,2039,2041,O
have,2042,2046,O
used,2047,2051,O
the,2052,2055,O
hip,2056,2059,B-Organism_subdivision
fracture,2060,2068,O
data,2069,2073,O
in,2074,2076,O
the,2077,2080,O
Harstad,2081,2088,O
Injury,2089,2095,O
Registry,2096,2104,O
to,2105,2107,O
:,2107,2108,O
Describe,2110,2118,O
age,2119,2122,O
-,2122,2123,O
and,2124,2127,O
sex,2128,2131,O
-,2131,2132,O
specific,2132,2140,O
incidence,2141,2150,O
of,2151,2153,O
hip,2154,2157,B-Organism_subdivision
fractures,2158,2167,O
in,2168,2170,O
Harstad,2171,2178,O
",",2178,2179,O
Northern,2180,2188,O
Norway,2189,2195,O
and,2196,2199,O
make,2200,2204,O
comparison,2205,2215,O
with,2216,2220,O
rates,2221,2226,O
from,2227,2231,O
the,2232,2235,O
Norwegian,2236,2245,O
capital,2246,2253,O
Oslo,2254,2258,O
Describe,2259,2267,O
time,2268,2272,O
trends,2273,2279,O
in,2280,2282,O
hip,2283,2286,B-Organism_subdivision
fracture,2287,2295,O
incidence,2296,2305,O
in,2306,2308,O
Harstad,2309,2316,O
from,2317,2321,O
1994,2322,2326,O
to,2327,2329,O
2008,2330,2334,O
Describe,2335,2343,O
place,2344,2349,O
of,2350,2352,O
injury,2353,2359,O
and,2360,2363,O
seasonal,2364,2372,O
variations,2373,2383,O
in,2384,2386,O
hip,2387,2390,B-Organism_subdivision
fracture,2391,2399,O
incidence,2400,2409,O
in,2410,2412,O
Harstad,2413,2420,O
Compare,2421,2428,O
3,2429,2430,O
-,2430,2431,O
month,2431,2436,O
",",2436,2437,O
6,2438,2439,O
-,2439,2440,O
month,2440,2445,O
",",2445,2446,O
and,2447,2450,O
1,2451,2452,O
-,2452,2453,O
year,2453,2457,O
mortality,2458,2467,O
after,2468,2473,O
hip,2474,2477,B-Organism_subdivision
fracture,2478,2486,O
between,2487,2494,O
women,2495,2500,O
and,2501,2504,O
men,2505,2508,O
in,2509,2511,O
Harstad,2512,2519,O
(,0,1,O
a,1,2,O
),2,3,O
The,4,7,O
Tn6087,8,14,O
target,15,21,O
site,22,26,O
within,27,33,O
S,34,35,O
.,35,36,O
oralis,37,43,O
F,44,45,O
.,45,46,O
MI,46,48,O
.,48,49,O
5,49,50,O
.,50,51,O
(,52,53,O
b,53,54,O
),54,55,O
The,56,59,O
left,60,64,O
end,65,68,O
and,69,72,O
(,73,74,O
c,74,75,O
),75,76,O
right,77,82,O
end,83,86,O
of,87,89,O
Tn6087,90,96,O
are,97,100,O
shown,101,106,O
in,107,109,O
bold,110,114,O
.,114,115,O
(,116,117,O
d,117,118,O
),118,119,O
The,120,123,O
joint,124,129,O
of,130,132,O
the,133,136,O
circular,137,145,O
intermediate,146,158,O
of,159,161,O
Tn6087,162,168,O
is,169,171,O
shown,172,177,O
.,177,178,O
The,179,182,O
transposon,183,193,O
',193,194,O
s,194,195,O
coupling,196,204,O
sequences,205,214,O
are,215,218,O
shown,219,224,O
in,225,227,O
bold,228,232,O
italics,233,240,O
.,240,241,O
As,242,244,O
can,245,248,O
be,249,251,O
seen,252,256,O
in,257,259,O
(,260,261,O
d,261,262,O
),262,263,O
",",263,264,O
the,265,268,O
coupling,269,277,O
sequence,278,286,O
at,287,289,O
the,290,293,O
joint,294,299,O
of,300,302,O
the,303,306,O
circular,307,315,O
form,316,320,O
is,321,323,O
a,324,325,O
heteroduplex,326,338,O
.,338,339,O
Breeding,0,8,O
of,9,11,O
p53,12,15,O
mice,16,20,O
with,21,25,O
BCCIP,26,31,O
conditional,32,43,O
knockdown,44,53,O
mice,54,58,O
The,59,62,O
heterozygous,63,75,O
p53,76,79,O
knockout,80,88,O
mice,89,93,O
[,94,95,O
36,95,97,O
],97,98,O
were,99,103,O
crossed,104,111,O
with,112,116,O
LoxPshBCCIP,117,128,O
+,128,129,O
/,129,130,O
+,130,131,O
-,131,132,O
4,132,133,O
mouse,134,139,O
and,140,143,O
EIIaCre,144,151,O
+,151,152,O
/,152,153,O
+,153,154,O
mouse,155,160,O
respectively,161,173,O
to,174,176,O
generate,177,185,O
p53,186,189,O
+,189,190,O
/,190,191,O
-,191,192,O
;,192,193,O
LoxPshBCCIP,193,204,O
+,204,205,O
/,205,206,O
-,206,207,O
",",207,208,O
and,209,212,O
p53,213,216,O
+,216,217,O
/,217,218,O
-,218,219,O
;,219,220,O
EIIaCre,220,227,O
+,227,228,O
/,228,229,O
-,229,230,O
mice,231,235,O
.,235,236,O
The,237,240,O
PCR,241,244,O
primers,245,252,O
used,253,257,O
to,258,260,O
genotype,261,269,O
p53,270,273,O
are,274,277,O
:,277,278,O
p53ex6F,279,286,O
:,286,287,O
5,288,289,O
',289,290,O
-,290,291,O
GTATCCCGAGTATCTGGAAGACAG,291,315,O
-,315,316,O
3,316,317,O
',317,318,O
",",318,319,O
p53neoF,320,327,O
:,327,328,O
5,329,330,O
',330,331,O
-,331,332,O
GCCTTCTATCGCCTTCTTGACG,332,354,O
-,354,355,O
3,355,356,O
',356,357,O
",",357,358,O
p53ex7RN,359,367,O
:,367,368,O
5,369,370,O
',370,371,O
-,371,372,O
AAGGATAGGTCGGCGGTTCATGC,372,395,O
-,395,396,O
3,396,397,O
',397,398,O
.,398,399,O
The,400,403,O
same,404,408,O
PCR,409,412,O
primer,413,419,O
pairs,420,425,O
as,426,428,O
described,429,438,O
earlier,439,446,O
in,447,449,O
this,450,454,O
report,455,461,O
were,462,466,O
used,467,471,O
for,472,475,O
BCCIPshRNA,476,486,O
and,487,490,O
EIIaCre,491,498,O
genotyping,499,509,O
.,509,510,O
The,511,514,O
p53,515,518,O
+,518,519,O
/,519,520,O
-,520,521,O
;,521,522,O
LoxPshBCCIP,522,533,O
+,533,534,O
/,534,535,O
+,535,536,O
mice,537,541,O
were,542,546,O
obtained,547,555,O
by,556,558,O
crossing,559,567,O
p53,568,571,O
+,571,572,O
/,572,573,O
-,573,574,O
;,574,575,O
LoxPshBCCIP,575,586,O
+,586,587,O
/,587,588,O
-,588,589,O
females,590,597,O
with,598,602,O
p53,603,606,O
+,606,607,O
/,607,608,O
-,608,609,O
;,609,610,O
LoxPshBCCIP,610,621,O
+,621,622,O
/,622,623,O
-,623,624,O
males,625,630,O
.,630,631,O
The,632,635,O
p53,636,639,O
+,639,640,O
/,640,641,O
-,641,642,O
;,642,643,O
LoxPshBCCIP,643,654,O
+,654,655,O
/,655,656,O
+,656,657,O
or,658,660,O
p53,661,664,O
+,664,665,O
/,665,666,O
-,666,667,O
;,667,668,O
LoxPshBCCIP,668,679,O
+,679,680,O
/,680,681,O
-,681,682,O
mice,683,687,O
were,688,692,O
crossed,693,700,O
with,701,705,O
p53,706,709,O
+,709,710,O
/,710,711,O
-,711,712,O
;,712,713,O
EIIaCre,713,720,O
+,720,721,O
/,721,722,O
-,722,723,O
mice,724,728,O
respectively,729,741,O
.,741,742,O
Biochemical,0,11,O
traits,12,18,O
ERK,0,3,O
signaling,4,13,O
is,14,16,O
involved,17,25,O
in,26,28,O
decreasing,29,39,O
BDNF,40,44,O
-,44,45,O
induced,45,52,O
gene,53,57,O
activity,58,66,O
via,67,70,O
Eph,71,74,O
receptors,75,84,O
Data,85,89,O
provided,90,98,O
so,99,101,O
far,102,105,O
suggest,106,113,O
that,114,118,O
ephrin,119,125,O
-,125,126,O
A5,126,128,O
might,129,134,O
counteract,135,145,O
BDNF,146,150,O
-,150,151,O
mediated,151,159,O
gene,160,164,O
expression,165,175,O
and,176,179,O
growth,180,186,B-Cellular_component
cone,187,191,I-Cellular_component
responses,192,201,O
via,202,205,O
decreasing,206,216,O
ERK,217,220,O
activity,221,229,O
and,230,233,O
nuclear,234,241,B-Cellular_component
localization,242,254,O
(,255,256,O
Figs,256,260,O
.,260,261,O
2,262,263,O
and,264,267,O
3,268,269,O
),269,270,O
.,270,271,O
To,272,274,O
test,275,279,O
this,280,284,O
hypothesis,285,295,O
more,296,300,O
directly,301,309,O
",",309,310,O
we,311,313,O
analyzed,314,322,O
whether,323,330,O
Eph,331,334,O
forward,335,342,O
signaling,343,352,O
can,353,356,O
still,357,362,O
suppress,363,371,O
BDNF,372,376,O
-,376,377,O
stimulated,377,387,O
IEG,388,391,O
induction,392,401,O
and,402,405,O
growth,406,412,B-Cellular_component
cone,413,417,I-Cellular_component
collapse,418,426,O
when,427,431,O
ERK,432,435,O
kinase,436,442,O
activity,443,451,O
was,452,455,O
experimentally,456,470,O
raised,471,477,O
.,477,478,O
For,479,482,O
this,483,487,O
",",487,488,O
ERK,489,492,O
activity,493,501,O
was,502,505,O
elevated,506,514,O
by,515,517,O
expressing,518,528,O
constitutively,529,543,O
-,543,544,O
active,544,550,O
MEK1,551,555,O
(,556,557,O
CA,557,559,O
-,559,560,O
MEK1,560,564,O
),564,565,O
",",565,566,O
an,567,569,O
ERK,570,573,O
upstream,574,582,O
activator,583,592,O
",",592,593,O
in,594,596,O
cortical,597,605,B-Cell
neurons,606,613,I-Cell
(,614,615,O
Fig,615,618,O
.,618,619,O
S3,620,622,O
),622,623,O
.,623,624,O
Subsequently,625,637,O
",",637,638,O
neurons,639,646,B-Cell
were,647,651,O
subjected,652,661,O
to,662,664,O
either,665,671,O
an,672,674,O
ephrin,675,681,O
-,681,682,O
A5,682,684,O
mediated,685,693,O
growth,694,700,B-Cellular_component
cone,701,705,I-Cellular_component
collapse,706,714,O
assay,715,720,O
(,721,722,O
Fig,722,725,O
.,725,726,O
5,727,728,O
),728,729,O
or,730,732,O
stimulated,733,743,O
with,744,748,O
guidance,749,757,O
cues,758,762,O
for,763,766,O
20,767,769,O
minutes,770,777,O
and,778,781,O
IEG,782,785,O
mRNA,786,790,O
levels,791,797,O
were,798,802,O
quantified,803,813,O
via,814,817,O
qRT,818,821,O
-,821,822,O
PCR,822,825,O
(,826,827,O
Fig,827,830,O
.,830,831,O
6,832,833,O
),833,834,O
.,834,835,O
10,836,838,O
.,838,839,O
1371,839,843,O
/,843,844,O
journal,844,851,O
.,851,852,O
pone,852,856,O
.,856,857,O
0026089,857,864,O
.,864,865,O
g005,865,869,O
Figure,870,876,O
5,877,878,O
Constitutively,879,893,O
-,893,894,O
active,894,900,O
MEK1,901,905,O
blocks,906,912,O
ephrin,913,919,O
-,919,920,O
A5,920,922,O
mediated,923,931,O
growth,932,938,B-Cellular_component
cone,939,943,I-Cellular_component
collapse,944,952,O
.,952,953,O
Wild,954,958,O
-,958,959,O
type,959,963,O
neurons,964,971,B-Cell
were,972,976,O
electroporated,977,991,O
with,992,996,O
vectors,997,1004,O
expressing,1005,1015,O
GFP,1016,1019,O
(,1020,1021,O
control,1021,1028,O
;,1028,1029,O
A,1030,1031,O
",",1031,1032,O
C,1033,1034,O
",",1034,1035,O
E,1036,1037,O
),1037,1038,O
or,1039,1041,O
expressing,1042,1052,O
a,1053,1054,O
FLAG,1055,1059,O
-,1059,1060,O
tagged,1060,1066,O
constitutively,1067,1081,O
-,1081,1082,O
active,1082,1088,O
MEK1,1089,1093,O
(,1094,1095,O
CA,1095,1097,O
-,1097,1098,O
MEK1,1098,1102,O
;,1102,1103,O
B,1104,1105,O
",",1105,1106,O
D,1107,1108,O
",",1108,1109,O
F,1110,1111,O
),1111,1112,O
.,1112,1113,O
Neurons,1114,1121,B-Cell
were,1122,1126,O
treated,1127,1134,O
with,1135,1139,O
ephrin,1140,1146,O
-,1146,1147,O
A5,1147,1149,O
-,1149,1150,O
Fc,1150,1152,O
for,1153,1156,O
30,1157,1159,O
min,1160,1163,O
followed,1164,1172,O
by,1173,1175,O
visualization,1176,1189,O
of,1190,1192,O
GFP,1193,1196,O
(,1197,1198,O
A,1198,1199,O
",",1199,1200,O
C,1201,1202,O
",",1202,1203,O
E,1204,1205,O
),1205,1206,O
or,1207,1209,O
CA,1210,1212,O
-,1212,1213,O
MEK,1213,1216,O
-,1216,1217,O
1,1217,1218,O
(,1219,1220,O
green,1220,1225,O
in,1226,1228,O
B,1229,1230,O
",",1230,1231,O
D,1232,1233,O
",",1233,1234,O
F,1235,1236,O
),1236,1237,O
",",1237,1238,O
F,1239,1240,O
-,1240,1241,O
actin,1241,1246,O
and,1247,1250,O
betaIII,1251,1258,O
tubulin,1259,1266,O
.,1266,1267,O
(,1268,1269,O
A,1269,1270,O
",",1270,1271,O
B,1272,1273,O
),1273,1274,O
Overexpression,1275,1289,O
of,1290,1292,O
CA,1293,1295,O
-,1295,1296,O
MEK1,1296,1300,O
(,1301,1302,O
B,1302,1303,O
),1303,1304,O
reduces,1305,1312,O
mean,1313,1317,O
neurite,1318,1325,B-Cellular_component
length,1326,1332,O
compared,1333,1341,O
to,1342,1344,O
a,1345,1346,O
control,1347,1354,O
GFP,1355,1358,O
-,1358,1359,O
expressing,1359,1369,O
neuron,1370,1376,B-Cell
(,1377,1378,O
A,1378,1379,O
),1379,1380,O
.,1380,1381,O
(,1382,1383,O
C,1383,1384,O
-,1384,1385,O
F,1385,1386,O
),1386,1387,O
A,1388,1389,O
control,1390,1397,O
growth,1398,1404,B-Cellular_component
cone,1405,1409,I-Cellular_component
without,1410,1417,O
ephrin,1418,1424,O
-,1424,1425,O
A5,1425,1427,O
application,1428,1439,O
(,1440,1441,O
C,1441,1442,O
),1442,1443,O
typically,1444,1453,O
protrudes,1454,1463,O
multiple,1464,1472,O
filopodia,1473,1482,B-Cellular_component
(,1483,1484,O
arrow,1484,1489,O
),1489,1490,O
.,1490,1491,O
CA,1492,1494,O
-,1494,1495,O
MEK,1495,1498,O
-,1498,1499,O
1,1499,1500,O
expressing,1501,1511,O
growth,1512,1518,B-Cellular_component
cones,1519,1524,I-Cellular_component
(,1525,1526,O
D,1526,1527,O
),1527,1528,O
were,1529,1533,O
indistinguishable,1534,1551,O
from,1552,1556,O
a,1557,1558,O
GFP,1559,1562,O
-,1562,1563,O
expressing,1563,1573,O
growth,1574,1580,B-Cellular_component
cone,1581,1585,I-Cellular_component
.,1585,1586,O
Note,1587,1591,O
that,1592,1596,O
CA,1597,1599,O
-,1599,1600,O
MEK1,1600,1604,O
was,1605,1608,O
expressed,1609,1618,O
in,1619,1621,O
a,1622,1623,O
dot,1624,1627,O
-,1627,1628,O
like,1628,1632,O
pattern,1633,1640,O
in,1641,1643,O
the,1644,1647,O
growth,1648,1654,B-Cellular_component
cone,1655,1659,I-Cellular_component
(,1660,1661,O
arrowheads,1661,1671,O
in,1672,1674,O
D,1675,1676,O
and,1677,1680,O
F,1681,1682,O
),1682,1683,O
.,1683,1684,O
Upon,1685,1689,O
ephrin,1690,1696,O
-,1696,1697,O
A5,1697,1699,O
application,1700,1711,O
",",1711,1712,O
a,1713,1714,O
control,1715,1722,O
growth,1723,1729,B-Cellular_component
cone,1730,1734,I-Cellular_component
(,1735,1736,O
E,1736,1737,O
),1737,1738,O
collapsed,1739,1748,O
resulting,1749,1758,O
in,1759,1761,O
only,1762,1766,O
few,1767,1770,O
filopodia,1771,1780,B-Cellular_component
.,1780,1781,O
In,1782,1784,O
contrast,1785,1793,O
",",1793,1794,O
a,1795,1796,O
CA,1797,1799,O
-,1799,1800,O
MEK1,1800,1804,O
expressing,1805,1815,O
growth,1816,1822,B-Cellular_component
cone,1823,1827,I-Cellular_component
(,1828,1829,O
F,1829,1830,O
),1830,1831,O
was,1832,1835,O
only,1836,1840,O
partially,1841,1850,O
collapsed,1851,1860,O
and,1861,1864,O
many,1865,1869,O
filopodia,1870,1879,B-Cellular_component
structures,1880,1890,O
were,1891,1895,O
preserved,1896,1905,O
after,1906,1911,O
ephrin,1912,1918,O
-,1918,1919,O
A5,1919,1921,O
induction,1922,1931,O
.,1931,1932,O
(,1933,1934,O
G,1934,1935,O
),1935,1936,O
Quantification,1937,1951,O
of,1952,1954,O
average,1955,1962,O
neurite,1963,1970,B-Cellular_component
length,1971,1977,O
.,1977,1978,O
(,1979,1980,O
H,1980,1981,O
",",1981,1982,O
I,1983,1984,O
),1984,1985,O
Quantification,1986,2000,O
of,2001,2003,O
growth,2004,2010,B-Cellular_component
cone,2011,2015,I-Cellular_component
area,2016,2020,O
(,2021,2022,O
H,2022,2023,O
),2023,2024,O
and,2025,2028,O
filopodia,2029,2038,B-Cellular_component
number,2039,2045,O
/,2045,2046,O
growth,2046,2052,B-Cellular_component
cone,2053,2057,I-Cellular_component
(,2058,2059,O
I,2059,2060,O
),2060,2061,O
in,2062,2064,O
the,2065,2068,O
four,2069,2073,O
conditions,2074,2084,O
.,2084,2085,O
Ephrin,2086,2092,O
-,2092,2093,O
A5,2093,2095,O
induces,2096,2103,O
a,2104,2105,O
growth,2106,2112,B-Cellular_component
cone,2113,2117,I-Cellular_component
collapse,2118,2126,O
",",2126,2127,O
resulting,2128,2137,O
in,2138,2140,O
reduced,2141,2148,O
growth,2149,2155,B-Cellular_component
cone,2156,2160,I-Cellular_component
area,2161,2165,O
and,2166,2169,O
filopodia,2170,2179,B-Cellular_component
number,2180,2186,O
in,2187,2189,O
GFP,2190,2193,O
but,2194,2197,O
not,2198,2201,O
CA,2202,2204,O
-,2204,2205,O
MEK1,2205,2209,O
expressing,2210,2220,O
neurons,2221,2228,B-Cell
.,2228,2229,O
Scale,2230,2235,O
-,2235,2236,O
bar,2236,2239,O
(,2240,2241,O
A,2241,2242,O
",",2242,2243,O
B,2244,2245,O
),2245,2246,O
=,2247,2248,O
10,2249,2251,O
microm,2252,2258,O
;,2258,2259,O
(,2260,2261,O
C,2261,2262,O
-,2262,2263,O
F,2263,2264,O
),2264,2265,O
=,2266,2267,O
2,2268,2269,O
microm,2270,2276,O
.,2276,2277,O
10,2278,2280,O
.,2280,2281,O
1371,2281,2285,O
/,2285,2286,O
journal,2286,2293,O
.,2293,2294,O
pone,2294,2298,O
.,2298,2299,O
0026089,2299,2306,O
.,2306,2307,O
g006,2307,2311,O
Figure,2312,2318,O
6,2319,2320,O
Ephrin,2321,2327,O
-,2327,2328,O
A5,2328,2330,O
suppresses,2331,2341,O
BDNF,2342,2346,O
-,2346,2347,O
induced,2347,2354,O
IEG,2355,2358,O
responses,2359,2368,O
via,2369,2372,O
MAP,2373,2376,O
kinase,2377,2383,O
signaling,2384,2393,O
.,2393,2394,O
Wild,2395,2399,O
-,2399,2400,O
type,2400,2404,O
cortical,2405,2413,B-Cell
neurons,2414,2421,I-Cell
",",2421,2422,O
mock,2423,2427,O
-,2427,2428,O
electroporated,2428,2442,O
(,2443,2444,O
black,2444,2449,O
bars,2450,2454,O
),2454,2455,O
or,2456,2458,O
with,2459,2463,O
a,2464,2465,O
vector,2466,2472,O
expressing,2473,2483,O
constitutively,2484,2498,O
-,2498,2499,O
active,2499,2505,O
MEK1,2506,2510,O
(,2511,2512,O
white,2512,2517,O
bars,2518,2522,O
),2522,2523,O
",",2523,2524,O
were,2525,2529,O
treated,2530,2537,O
with,2538,2542,O
guidance,2543,2551,O
cues,2552,2556,O
for,2557,2560,O
20,2561,2563,O
minutes,2564,2571,O
as,2572,2574,O
depicted,2575,2583,O
",",2583,2584,O
followed,2585,2593,O
by,2594,2596,O
mRNA,2597,2601,O
quantification,2602,2616,O
.,2616,2617,O
In,2618,2620,O
mock,2621,2625,O
-,2625,2626,O
electroporated,2626,2640,O
neurons,2641,2648,B-Cell
",",2648,2649,O
BDNF,2650,2654,O
induced,2655,2662,O
an,2663,2665,O
IEG,2666,2669,O
response,2670,2678,O
of,2679,2681,O
c,2682,2683,O
-,2683,2684,O
fos,2684,2687,O
(,2688,2689,O
A,2689,2690,O
),2690,2691,O
",",2691,2692,O
Egr1,2693,2697,O
(,2698,2699,O
B,2699,2700,O
),2700,2701,O
",",2701,2702,O
Egr2,2703,2707,O
(,2708,2709,O
C,2709,2710,O
),2710,2711,O
and,2712,2715,O
Arc,2716,2719,O
(,2720,2721,O
D,2721,2722,O
),2722,2723,O
.,2723,2724,O
Co,2725,2727,O
-,2727,2728,O
application,2728,2739,O
of,2740,2742,O
ephrin,2743,2749,O
-,2749,2750,O
A5,2750,2752,O
and,2753,2756,O
BDNF,2757,2761,O
reduced,2762,2769,O
mRNA,2770,2774,O
levels,2775,2781,O
of,2782,2784,O
all,2785,2788,O
four,2789,2793,O
IEGs,2794,2798,O
in,2799,2801,O
mock,2802,2806,O
-,2806,2807,O
electroporated,2807,2821,O
neurons,2822,2829,B-Cell
(,2830,2831,O
A,2831,2832,O
-,2832,2833,O
D,2833,2834,O
),2834,2835,O
.,2835,2836,O
In,2837,2839,O
contrast,2840,2848,O
",",2848,2849,O
expression,2850,2860,O
of,2861,2863,O
constitutively,2864,2878,O
-,2878,2879,O
active,2879,2885,O
MEK1,2886,2890,O
prevented,2891,2900,O
Eph,2901,2904,O
forward,2905,2912,O
signaling,2913,2922,O
from,2923,2927,O
suppressing,2928,2939,O
BDNF,2940,2944,O
-,2944,2945,O
evoked,2945,2951,O
IEG,2952,2955,O
responses,2956,2965,O
.,2965,2966,O
This,2967,2971,O
was,2972,2975,O
most,2976,2980,O
evident,2981,2988,O
for,2989,2992,O
the,2993,2996,O
IEGs,2997,3001,O
Egr1,3002,3006,O
(,3007,3008,O
B,3008,3009,O
),3009,3010,O
and,3011,3014,O
Egr2,3015,3019,O
(,3020,3021,O
C,3021,3022,O
),3022,3023,O
.,3023,3024,O
First,3025,3030,O
of,3031,3033,O
all,3034,3037,O
",",3037,3038,O
we,3039,3041,O
analyzed,3042,3050,O
the,3051,3054,O
impact,3055,3061,O
of,3062,3064,O
CA,3065,3067,O
-,3067,3068,O
MEK1,3068,3072,O
on,3073,3075,O
neurite,3076,3083,B-Cellular_component
outgrowth,3084,3093,O
and,3094,3097,O
ephrin,3098,3104,O
-,3104,3105,O
A5,3105,3107,O
mediated,3108,3116,O
growth,3117,3123,B-Cellular_component
cone,3124,3128,I-Cellular_component
responses,3129,3138,O
(,3139,3140,O
Fig,3140,3143,O
.,3143,3144,O
5,3145,3146,O
),3146,3147,O
.,3147,3148,O
The,3149,3152,O
average,3153,3160,O
neurite,3161,3168,B-Cellular_component
length,3169,3175,O
of,3176,3178,O
neurons,3179,3186,B-Cell
overexpressing,3187,3201,O
CA,3202,3204,O
-,3204,3205,O
MEK1,3205,3209,O
(,3210,3211,O
Fig,3211,3214,O
.,3214,3215,O
5B,3216,3218,O
),3218,3219,O
was,3220,3223,O
clearly,3224,3231,O
reduced,3232,3239,O
compared,3240,3248,O
to,3249,3251,O
control,3252,3259,O
GFP,3260,3263,O
expressing,3264,3274,O
neurons,3275,3282,B-Cell
(,3283,3284,O
Fig,3284,3287,O
.,3287,3288,O
5A,3289,3291,O
;,3291,3292,O
see,3293,3296,O
quantification,3297,3311,O
in,3312,3314,O
(,3315,3316,O
G,3316,3317,O
),3317,3318,O
),3318,3319,O
.,3319,3320,O
Growth,3321,3327,B-Cellular_component
cones,3328,3333,I-Cellular_component
of,3334,3336,O
GFP,3337,3340,O
(,3341,3342,O
C,3342,3343,O
),3343,3344,O
and,3345,3348,O
CA,3349,3351,O
-,3351,3352,O
MEK1,3352,3356,O
expressing,3357,3367,O
neurons,3368,3375,B-Cell
were,3376,3380,O
similar,3381,3388,O
and,3389,3392,O
protruded,3393,3402,O
many,3403,3407,O
filopodia,3408,3417,B-Cellular_component
(,3418,3419,O
arrows,3419,3425,O
in,3426,3428,O
Fig,3429,3432,O
.,3432,3433,O
5C,3434,3436,O
-,3436,3437,O
F,3437,3438,O
),3438,3439,O
.,3439,3440,O
CA,3441,3443,O
-,3443,3444,O
MEK1,3444,3448,O
expression,3449,3459,O
in,3460,3462,O
growth,3463,3469,B-Cellular_component
cones,3470,3475,I-Cellular_component
was,3476,3479,O
confined,3480,3488,O
to,3489,3491,O
individual,3492,3502,O
dot,3503,3506,O
-,3506,3507,O
like,3507,3511,O
structures,3512,3522,O
(,3523,3524,O
arrowheads,3524,3534,O
in,3535,3537,O
Fig,3538,3541,O
.,3541,3542,O
5D,3543,3545,O
",",3545,3546,O
F,3547,3548,O
),3548,3549,O
.,3549,3550,O
Ephrin,3551,3557,O
-,3557,3558,O
A5,3558,3560,O
application,3561,3572,O
on,3573,3575,O
a,3576,3577,O
GFP,3578,3581,O
expressing,3582,3592,O
control,3593,3600,O
growth,3601,3607,B-Cellular_component
cone,3608,3612,I-Cellular_component
(,3613,3614,O
Fig,3614,3617,O
.,3617,3618,O
5E,3619,3621,O
),3621,3622,O
resulted,3623,3631,O
in,3632,3634,O
a,3635,3636,O
growth,3637,3643,B-Cellular_component
cone,3644,3648,I-Cellular_component
collapse,3649,3657,O
as,3658,3660,O
revealed,3661,3669,O
by,3670,3672,O
reduced,3673,3680,O
overall,3681,3688,O
growth,3689,3695,B-Cellular_component
cone,3696,3700,I-Cellular_component
area,3701,3705,O
and,3706,3709,O
filopodia,3710,3719,B-Cellular_component
number,3720,3726,O
(,3727,3728,O
quantified,3728,3738,O
in,3739,3741,O
Fig,3742,3745,O
.,3745,3746,O
5H,3747,3749,O
",",3749,3750,O
I,3751,3752,O
),3752,3753,O
.,3753,3754,O
In,3755,3757,O
contrast,3758,3766,O
",",3766,3767,O
in,3768,3770,O
neurons,3771,3778,B-Cell
overexpressing,3779,3793,O
CA,3794,3796,O
-,3796,3797,O
MEK1,3797,3801,O
(,3802,3803,O
Fig,3803,3806,O
.,3806,3807,O
5F,3808,3810,O
),3810,3811,O
",",3811,3812,O
ephrin,3813,3819,O
-,3819,3820,O
A5,3820,3822,O
induced,3823,3830,O
only,3831,3835,O
a,3836,3837,O
partial,3838,3845,O
growth,3846,3852,B-Cellular_component
cone,3853,3857,I-Cellular_component
collapse,3858,3866,O
.,3866,3867,O
Thus,3868,3872,O
",",3872,3873,O
growth,3874,3880,B-Cellular_component
cone,3881,3885,I-Cellular_component
area,3886,3890,O
and,3891,3894,O
filopodia,3895,3904,B-Cellular_component
number,3905,3911,O
were,3912,3916,O
not,3917,3920,O
reduced,3921,3928,O
(,3929,3930,O
see,3930,3933,O
Fig,3934,3937,O
.,3937,3938,O
5H,3939,3941,O
",",3941,3942,O
I,3943,3944,O
),3944,3945,O
.,3945,3946,O
This,3947,3951,O
result,3952,3958,O
suggests,3959,3967,O
that,3968,3972,O
an,3973,3975,O
ephrin,3976,3982,O
-,3982,3983,O
A5,3983,3985,O
induced,3986,3993,O
signaling,3994,4003,O
cascade,4004,4011,O
targets,4012,4019,O
MAP,4020,4023,O
kinase,4024,4030,O
signaling,4031,4040,O
to,4041,4043,O
exert,4044,4049,O
a,4050,4051,O
full,4052,4056,O
growth,4057,4063,B-Cellular_component
cone,4064,4068,I-Cellular_component
collapse,4069,4077,O
.,4077,4078,O
This,4079,4083,O
result,4084,4090,O
is,4091,4093,O
in,4094,4096,O
contrast,4097,4105,O
to,4106,4108,O
a,4109,4110,O
recent,4111,4117,O
report,4118,4124,O
[,4125,4126,O
46,4126,4128,O
],4128,4129,O
which,4130,4135,O
excluded,4136,4144,O
ERK,4145,4148,O
signaling,4149,4158,O
downstream,4159,4169,O
of,4170,4172,O
an,4173,4175,O
ephrin,4176,4182,O
-,4182,4183,O
A5,4183,4185,O
mediated,4186,4194,O
growth,4195,4201,B-Cellular_component
cone,4202,4206,I-Cellular_component
collapse,4207,4215,O
.,4215,4216,O
Next,4217,4221,O
",",4221,4222,O
we,4223,4225,O
tested,4226,4232,O
whether,4233,4240,O
ephrin,4241,4247,O
-,4247,4248,O
A5,4248,4250,O
signaling,4251,4260,O
suppresses,4261,4271,O
ERK,4272,4275,O
kinase,4276,4282,O
signaling,4283,4292,O
also,4293,4297,O
to,4298,4300,O
interfere,4301,4310,O
with,4311,4315,O
BDNF,4316,4320,O
-,4320,4321,O
mediated,4321,4329,O
gene,4330,4334,O
expression,4335,4345,O
(,4346,4347,O
Fig,4347,4350,O
.,4350,4351,O
6,4352,4353,O
),4353,4354,O
.,4354,4355,O
In,4356,4358,O
agreement,4359,4368,O
with,4369,4373,O
previous,4374,4382,O
results,4383,4390,O
(,4391,4392,O
Fig,4392,4395,O
.,4395,4396,O
4,4397,4398,O
),4398,4399,O
",",4399,4400,O
in,4401,4403,O
mock,4404,4408,O
-,4408,4409,O
electroporated,4409,4423,O
neurons,4424,4431,B-Cell
",",4431,4432,O
ephrin,4433,4439,O
-,4439,4440,O
A5,4440,4442,O
incubation,4443,4453,O
reduced,4454,4461,O
the,4462,4465,O
BDNF,4466,4470,O
-,4470,4471,O
mediated,4471,4479,O
up,4480,4482,O
-,4482,4483,O
regulation,4483,4493,O
of,4494,4496,O
c,4497,4498,O
-,4498,4499,O
fos,4499,4502,O
(,4503,4504,O
Fig,4504,4507,O
.,4507,4508,O
6A,4509,4511,O
),4511,4512,O
",",4512,4513,O
Egr1,4514,4518,O
(,4519,4520,O
Fig,4520,4523,O
.,4523,4524,O
6B,4525,4527,O
),4527,4528,O
",",4528,4529,O
Egr2,4530,4534,O
(,4535,4536,O
Fig,4536,4539,O
.,4539,4540,O
6C,4541,4543,O
),4543,4544,O
and,4545,4548,O
Arc,4549,4552,O
(,4553,4554,O
Fig,4554,4557,O
.,4557,4558,O
6D,4559,4561,O
),4561,4562,O
mRNA,4563,4567,O
.,4567,4568,O
In,4569,4571,O
contrast,4572,4580,O
",",4580,4581,O
in,4582,4584,O
neurons,4585,4592,B-Cell
over,4593,4597,O
-,4597,4598,O
expressing,4598,4608,O
CA,4609,4611,O
-,4611,4612,O
MEK1,4612,4616,O
",",4616,4617,O
ephrin,4618,4624,O
-,4624,4625,O
A5,4625,4627,O
could,4628,4633,O
not,4634,4637,O
suppress,4638,4646,O
BDNF,4647,4651,O
-,4651,4652,O
induced,4652,4659,O
IEG,4660,4663,O
responses,4664,4673,O
to,4674,4676,O
the,4677,4680,O
same,4681,4685,O
degree,4686,4692,O
.,4692,4693,O
Particularly,4694,4706,O
Egr1,4707,4711,O
(,4712,4713,O
Fig,4713,4716,O
.,4716,4717,O
6B,4718,4720,O
),4720,4721,O
and,4722,4725,O
Egr2,4726,4730,O
(,4731,4732,O
Fig,4732,4735,O
.,4735,4736,O
6C,4737,4739,O
),4739,4740,O
mRNA,4741,4745,O
levels,4746,4752,O
were,4753,4757,O
almost,4758,4764,O
identical,4765,4774,O
when,4775,4779,O
comparing,4780,4789,O
neurons,4790,4797,B-Cell
treated,4798,4805,O
with,4806,4810,O
BDNF,4811,4815,O
alone,4816,4821,O
and,4822,4825,O
neurons,4826,4833,B-Cell
with,4834,4838,O
BDNF,4839,4843,O
and,4844,4847,O
ephrin,4848,4854,O
-,4854,4855,O
A5,4855,4857,O
together,4858,4866,O
.,4866,4867,O
Thus,4868,4872,O
",",4872,4873,O
ephrin,4874,4880,O
-,4880,4881,O
A5,4881,4883,O
represses,4884,4893,O
gene,4894,4898,O
activity,4899,4907,O
elicited,4908,4916,O
by,4917,4919,O
BDNF,4920,4924,O
at,4925,4927,O
least,4928,4933,O
in,4934,4936,O
part,4937,4941,O
via,4942,4945,O
MAP,4946,4949,O
kinases,4950,4957,O
.,4957,4958,O
Besides,4959,4966,O
IEGs,4967,4971,O
",",4971,4972,O
we,4973,4975,O
inspected,4976,4985,O
the,4986,4989,O
influence,4990,4999,O
of,5000,5002,O
both,5003,5007,O
guidance,5008,5016,O
cues,5017,5021,O
on,5022,5024,O
cytoskeletal,5025,5037,B-Cellular_component
genes,5038,5043,O
",",5043,5044,O
whose,5045,5050,O
gene,5051,5055,O
products,5056,5064,O
might,5065,5070,O
modulate,5071,5079,O
cytoskeletal,5080,5092,B-Cellular_component
dynamics,5093,5101,O
evoked,5102,5108,O
by,5109,5111,O
ephrin,5112,5118,O
-,5118,5119,O
As,5119,5121,O
and,5122,5125,O
/,5125,5126,O
or,5126,5128,O
neurotrophins,5129,5142,O
(,5143,5144,O
Fig,5144,5147,O
.,5147,5148,O
S4,5149,5151,O
),5151,5152,O
.,5152,5153,O
Therefore,5154,5163,O
",",5163,5164,O
the,5165,5168,O
filamentous,5169,5180,B-Cellular_component
actin,5181,5186,O
(,5187,5188,O
F,5188,5189,O
-,5189,5190,O
actin,5190,5195,O
),5195,5196,O
stabilizing,5197,5208,O
tropomyosins,5209,5221,O
(,5222,5223,O
Tpm1,5223,5227,O
and,5228,5231,O
Tpm2,5232,5236,O
),5236,5237,O
",",5237,5238,O
the,5239,5242,O
F,5243,5244,O
-,5244,5245,O
actin,5245,5250,O
cross,5251,5256,O
-,5256,5257,O
linker,5257,5263,O
alpha,5264,5269,O
-,5269,5270,O
actinin,5270,5277,O
1,5278,5279,O
(,5280,5281,O
Actn1,5281,5286,O
),5286,5287,O
and,5288,5291,O
the,5292,5295,O
motor,5296,5301,O
protein,5302,5309,O
dynein,5310,5316,O
light,5317,5322,O
chain,5323,5328,O
1,5329,5330,O
(,5331,5332,O
Dnal1,5332,5337,O
),5337,5338,O
were,5339,5343,O
analyzed,5344,5352,O
.,5352,5353,O
mRNA,5354,5358,O
levels,5359,5365,O
of,5366,5368,O
other,5369,5374,O
cytoskeletal,5375,5387,B-Cellular_component
genes,5388,5393,O
were,5394,5398,O
not,5399,5402,O
altered,5403,5410,O
by,5411,5413,O
any,5414,5417,O
of,5418,5420,O
the,5421,5424,O
guidance,5425,5433,O
cues,5434,5438,O
(,5439,5440,O
i,5440,5441,O
.,5441,5442,O
e,5442,5443,O
.,5443,5444,O
cofilin,5445,5452,O
",",5452,5453,O
filamin,5454,5461,O
A,5462,5463,O
",",5463,5464,O
mena,5465,5469,O
",",5469,5470,O
vinculin,5471,5479,O
and,5480,5483,O
smooth,5484,5490,B-Tissue
muscle,5491,5497,I-Tissue
actin,5498,5503,O
;,5503,5504,O
data,5505,5509,O
not,5510,5513,O
shown,5514,5519,O
),5519,5520,O
.,5520,5521,O
Short,5522,5527,O
-,5527,5528,O
term,5528,5532,O
stimulation,5533,5544,O
with,5545,5549,O
guidance,5550,5558,O
cues,5559,5563,O
did,5564,5567,O
not,5568,5571,O
result,5572,5578,O
in,5579,5581,O
major,5582,5587,O
alterations,5588,5599,O
of,5600,5602,O
cytoskeletal,5603,5615,B-Cellular_component
mRNA,5616,5620,O
levels,5621,5627,O
except,5628,5634,O
for,5635,5638,O
upregulation,5639,5651,O
of,5652,5654,O
Tpm1,5655,5659,O
by,5660,5662,O
ephrin,5663,5669,O
-,5669,5670,O
A5,5670,5672,O
(,5673,5674,O
Fig,5674,5677,O
.,5677,5678,O
S4A,5679,5682,O
),5682,5683,O
.,5683,5684,O
At,5685,5687,O
16h,5688,5691,O
of,5692,5694,O
incubation,5695,5705,O
",",5705,5706,O
both,5707,5711,O
tropomyosin,5712,5723,O
genes,5724,5729,O
were,5730,5734,O
induced,5735,5742,O
by,5743,5745,O
BDNF,5746,5750,O
and,5751,5754,O
ephrin,5755,5761,O
-,5761,5762,O
A5,5762,5764,O
alone,5765,5770,O
and,5771,5774,O
both,5775,5779,O
together,5780,5788,O
(,5789,5790,O
Fig,5790,5793,O
.,5793,5794,O
S4B,5795,5798,O
",",5798,5799,O
D,5800,5801,O
),5801,5802,O
.,5802,5803,O
Actn1,5804,5809,O
levels,5810,5816,O
were,5817,5821,O
induced,5822,5829,O
by,5830,5832,O
individual,5833,5843,O
application,5844,5855,O
of,5856,5858,O
ephrin,5859,5865,O
-,5865,5866,O
A5,5866,5868,O
and,5869,5872,O
BDNF,5873,5877,O
and,5878,5881,O
by,5882,5884,O
co,5885,5887,O
-,5887,5888,O
application,5888,5899,O
of,5900,5902,O
both,5903,5907,O
(,5908,5909,O
Fig,5909,5912,O
.,5912,5913,O
S4F,5914,5917,O
),5917,5918,O
.,5918,5919,O
A,5920,5921,O
similar,5922,5929,O
profile,5930,5937,O
was,5938,5941,O
observed,5942,5950,O
for,5951,5954,O
the,5955,5958,O
dynein,5959,5965,O
light,5966,5971,O
chain,5972,5977,O
(,5978,5979,O
Fig,5979,5982,O
.,5982,5983,O
S4H,5984,5987,O
),5987,5988,O
.,5988,5989,O
Taken,5990,5995,O
together,5996,6004,O
",",6004,6005,O
cytoskeletal,6006,6018,B-Cellular_component
gene,6019,6023,O
expression,6024,6034,O
was,6035,6038,O
modulated,6039,6048,O
by,6049,6051,O
ephrin,6052,6058,O
-,6058,6059,O
A5,6059,6061,O
and,6062,6065,O
BDNF,6066,6070,O
.,6070,6071,O
In,6072,6074,O
contrast,6075,6083,O
to,6084,6086,O
the,6087,6090,O
antagonistic,6091,6103,O
impact,6104,6110,O
on,6111,6113,O
the,6114,6117,O
IEG,6118,6121,O
gene,6122,6126,O
response,6127,6135,O
(,6136,6137,O
Figs,6137,6141,O
.,6141,6142,O
4,6143,6144,O
and,6145,6148,O
6,6149,6150,O
),6150,6151,O
",",6151,6152,O
ephrin,6153,6159,O
-,6159,6160,O
A5,6160,6162,O
and,6163,6166,O
BDNF,6167,6171,O
resulted,6172,6180,O
in,6181,6183,O
rather,6184,6190,O
synergistic,6191,6202,O
action,6203,6209,O
on,6210,6212,O
cytoskeletal,6213,6225,B-Cellular_component
gene,6226,6230,O
expression,6231,6241,O
.,6241,6242,O
This,6243,6247,O
difference,6248,6258,O
might,6259,6264,O
be,6265,6267,O
due,6268,6271,O
to,6272,6274,O
short,6275,6280,O
-,6280,6281,O
term,6281,6285,O
(,6286,6287,O
i,6287,6288,O
.,6288,6289,O
e,6289,6290,O
.,6290,6291,O
20,6292,6294,O
minutes,6295,6302,O
),6302,6303,O
vs,6304,6306,O
.,6306,6307,O
long,6308,6312,O
-,6312,6313,O
term,6313,6317,O
(,6318,6319,O
i,6319,6320,O
.,6320,6321,O
e,6321,6322,O
.,6322,6323,O
16h,6324,6327,O
),6327,6328,O
exposure,6329,6337,O
of,6338,6340,O
both,6341,6345,O
guidance,6346,6354,O
cues,6355,6359,O
in,6360,6362,O
the,6363,6366,O
IEG,6367,6370,O
and,6371,6374,O
cytoskeletal,6375,6387,B-Cellular_component
gene,6388,6392,O
response,6393,6401,O
",",6401,6402,O
respectively,6403,6415,O
.,6415,6416,O
Introduction,0,12,O
Yeast,13,18,O
infections,19,29,O
cause,30,35,O
significant,36,47,O
mortality,48,57,O
in,58,60,O
critically,61,71,O
ill,72,75,O
and,76,79,O
immunocompromised,80,97,O
patients,98,106,O
.,106,107,O
In,108,110,O
particular,111,121,O
",",121,122,O
Candida,123,130,O
species,131,138,O
are,139,142,O
the,143,146,O
4th,147,150,O
most,151,155,O
common,156,162,O
cause,163,168,O
of,169,171,O
nosocomial,172,182,O
bloodstream,183,194,B-Organism_substance
infections,195,205,O
in,206,208,O
the,209,212,O
United,213,219,O
States,220,226,O
",",226,227,O
and,228,231,O
Cryptococcus,232,244,O
neoformans,245,255,O
",",255,256,O
the,257,260,O
commonest,261,270,O
cause,271,276,O
of,277,279,O
fungal,280,286,O
meningitis,287,297,O
worldwide,298,307,O
[,308,309,O
1,309,310,O
],310,311,O
",",311,312,O
[,313,314,O
2,314,315,O
],315,316,O
.,316,317,O
Whilst,318,324,O
Candida,325,332,O
albicans,333,341,O
remains,342,349,O
the,350,353,O
leading,354,361,O
pathogenic,362,372,O
yeast,373,378,O
",",378,379,O
infections,380,390,O
due,391,394,O
to,395,397,O
non,398,401,O
-,401,402,O
C,402,403,O
.,403,404,O
albicans,405,413,O
species,414,421,O
such,422,426,O
as,427,429,O
Candida,430,437,O
glabrata,438,446,O
",",446,447,O
as,448,450,O
well,451,455,O
as,456,458,O
previously,459,469,O
rare,470,474,O
opportunists,475,487,O
such,488,492,O
as,493,495,O
Trichosporon,496,508,O
and,509,512,O
Geotrichum,513,523,O
species,524,531,O
",",531,532,O
are,533,536,O
increasingly,537,549,O
reported,550,558,O
[,559,560,O
1,560,561,O
],561,562,O
",",562,563,O
[,564,565,O
3,565,566,O
],566,567,O
-,567,568,O
[,568,569,O
6,569,570,O
],570,571,O
.,571,572,O
Novel,573,578,O
pathogenic,579,589,O
Candida,590,597,O
species,598,605,O
such,606,610,O
as,611,613,O
Candida,614,621,O
nivariensis,622,633,O
and,634,637,O
Candida,638,645,O
bracarensis,646,657,O
have,658,662,O
also,663,667,O
been,668,672,O
described,673,682,O
[,683,684,O
7,684,685,O
],685,686,O
.,686,687,O
Since,688,693,O
many,694,698,O
non,699,702,O
-,702,703,O
C,703,704,O
.,704,705,O
albicans,706,714,O
Candida,715,722,O
and,723,726,O
non,727,730,O
-,730,731,O
Candida,731,738,O
yeasts,739,745,O
are,746,749,O
resistant,750,759,O
or,760,762,O
less,763,767,O
susceptible,768,779,O
to,780,782,O
antifungal,783,793,O
agents,794,800,O
",",800,801,O
rapid,802,807,O
accurate,808,816,O
species,817,824,O
identification,825,839,O
is,840,842,O
central,843,850,O
to,851,853,O
timely,854,860,O
",",860,861,O
effective,862,871,O
antifungal,872,882,O
therapy,883,890,O
[,891,892,O
3,892,893,O
],893,894,O
-,894,895,O
[,895,896,O
6,896,897,O
],897,898,O
",",898,899,O
[,900,901,O
8,901,902,O
],902,903,O
",",903,904,O
[,905,906,O
9,906,907,O
],907,908,O
.,908,909,O
Conventional,910,922,O
phenotypic,923,933,O
-,933,934,O
based,934,939,O
methods,940,947,O
for,948,951,O
yeast,952,957,O
identification,958,972,O
",",972,973,O
however,974,981,O
",",981,982,O
are,983,986,O
slow,987,991,O
(,992,993,O
24,993,995,O
-,995,996,O
72,996,998,O
h,999,1000,O
),1000,1001,O
",",1001,1002,O
insensitive,1003,1014,O
and,1015,1018,O
often,1019,1024,O
unable,1025,1031,O
to,1032,1034,O
identify,1035,1043,O
more,1044,1048,O
unusual,1049,1056,O
species,1057,1064,O
.,1064,1065,O
Various,1066,1073,O
molecular,1074,1083,O
techniques,1084,1094,O
including,1095,1104,O
real,1105,1109,O
-,1109,1110,O
time,1110,1114,O
PCR,1115,1118,O
",",1118,1119,O
DNA,1120,1123,O
sequence,1124,1132,O
analysis,1133,1141,O
",",1141,1142,O
microarray,1143,1153,O
analysis,1154,1162,O
",",1162,1163,O
and,1164,1167,O
fluorescence,1168,1180,O
in,1181,1183,O
-,1183,1184,O
situ,1184,1188,O
hybridization,1189,1202,O
provide,1203,1210,O
accurate,1211,1219,O
identification,1220,1234,O
[,1235,1236,O
10,1236,1238,O
],1238,1239,O
",",1239,1240,O
[,1241,1242,O
11,1242,1244,O
],1244,1245,O
but,1246,1249,O
are,1250,1253,O
expensive,1254,1263,O
",",1263,1264,O
require,1265,1272,O
substantial,1273,1284,O
specimen,1285,1293,O
processing,1294,1304,O
time,1305,1309,O
(,1310,1311,O
hours,1311,1316,O
to,1317,1319,O
a,1320,1321,O
day,1322,1325,O
),1325,1326,O
and,1327,1330,O
are,1331,1334,O
not,1335,1338,O
easily,1339,1345,O
implemented,1346,1357,O
as,1358,1360,O
routine,1361,1368,O
techniques,1369,1379,O
in,1380,1382,O
the,1383,1386,O
clinical,1387,1395,O
laboratory,1396,1406,O
.,1406,1407,O
Matrix,1408,1414,O
-,1414,1415,O
assisted,1415,1423,O
laser,1424,1429,O
desorption,1430,1440,O
ionization,1441,1451,O
-,1451,1452,O
time,1452,1456,O
of,1457,1459,O
flight,1460,1466,O
mass,1467,1471,O
spectrometry,1472,1484,O
(,1485,1486,O
MALDI,1486,1491,O
-,1491,1492,O
TOF,1492,1495,O
MS,1496,1498,O
),1498,1499,O
has,1500,1503,O
emerged,1504,1511,O
as,1512,1514,O
a,1515,1516,O
powerful,1517,1525,O
and,1526,1529,O
rapid,1530,1535,O
tool,1536,1540,O
for,1541,1544,O
the,1545,1548,O
identification,1549,1563,O
of,1564,1566,O
bacterial,1567,1576,O
and,1577,1580,O
yeast,1581,1586,O
pathogens,1587,1596,O
[,1597,1598,O
12,1598,1600,O
],1600,1601,O
-,1601,1602,O
[,1602,1603,O
17,1603,1605,O
],1605,1606,O
.,1606,1607,O
Using,1608,1613,O
MALDI,1614,1619,O
-,1619,1620,O
TOF,1620,1623,O
MS,1624,1626,O
",",1626,1627,O
the,1628,1631,O
protein,1632,1639,O
spectral,1640,1648,O
"""",1649,1650,O
fingerprint,1650,1661,O
"""",1661,1662,O
of,1663,1665,O
an,1666,1668,O
isolate,1669,1676,O
is,1677,1679,O
compared,1680,1688,O
to,1689,1691,O
a,1692,1693,O
reference,1694,1703,O
spectral,1704,1712,O
database,1713,1721,O
for,1722,1725,O
identification,1726,1740,O
[,1741,1742,O
18,1742,1744,O
],1744,1745,O
.,1745,1746,O
Previous,1747,1755,O
studies,1756,1763,O
have,1764,1768,O
reported,1769,1777,O
species,1778,1785,O
identification,1786,1800,O
rates,1801,1806,O
of,1807,1809,O
92,1810,1812,O
-,1812,1813,O
99,1813,1815,O
%,1815,1816,O
amongst,1817,1824,O
collections,1825,1836,O
of,1837,1839,O
yeasts,1840,1846,O
and,1847,1850,O
yeast,1851,1856,O
-,1856,1857,O
like,1857,1861,O
organisms,1862,1871,O
[,1872,1873,O
14,1873,1875,O
],1875,1876,O
-,1876,1877,O
[,1877,1878,O
17,1878,1880,O
],1880,1881,O
",",1881,1882,O
[,1883,1884,O
19,1884,1886,O
],1886,1887,O
",",1887,1888,O
[,1889,1890,O
20,1890,1892,O
],1892,1893,O
.,1893,1894,O
However,1895,1902,O
",",1902,1903,O
taken,1904,1909,O
collectively,1910,1922,O
",",1922,1923,O
the,1924,1927,O
results,1928,1935,O
may,1936,1939,O
not,1940,1943,O
be,1944,1946,O
directly,1947,1955,O
comparable,1956,1966,O
since,1967,1972,O
these,1973,1978,O
studies,1979,1986,O
have,1987,1991,O
used,1992,1996,O
different,1997,2006,O
approaches,2007,2017,O
to,2018,2020,O
assign,2021,2027,O
species,2028,2035,O
-,2036,2037,O
from,2038,2042,O
comparing,2043,2052,O
spectra,2053,2060,O
from,2061,2065,O
test,2066,2070,O
organisms,2071,2080,O
to,2081,2083,O
reference,2084,2093,O
spectra,2094,2101,O
in,2102,2104,O
MALDI,2105,2110,O
-,2110,2111,O
TOF,2111,2114,O
MS,2115,2117,O
databases,2118,2127,O
[,2128,2129,O
16,2129,2131,O
],2131,2132,O
",",2132,2133,O
[,2134,2135,O
20,2135,2137,O
],2137,2138,O
",",2138,2139,O
to,2140,2142,O
enhancing,2143,2152,O
these,2153,2158,O
databases,2159,2168,O
",",2168,2169,O
and,2170,2173,O
in,2174,2176,O
some,2177,2181,O
instances,2182,2191,O
developing,2192,2202,O
study,2203,2208,O
-,2208,2209,O
specific,2209,2217,O
databases,2218,2227,O
",",2227,2228,O
with,2229,2233,O
"""",2234,2235,O
in,2235,2237,O
-,2237,2238,O
house,2238,2243,O
"""",2243,2244,O
spectral,2245,2253,O
signatures,2254,2264,O
[,2265,2266,O
14,2266,2268,O
],2268,2269,O
",",2269,2270,O
[,2271,2272,O
15,2272,2274,O
],2274,2275,O
.,2275,2276,O
There,2277,2282,O
also,2283,2287,O
is,2288,2290,O
a,2291,2292,O
continuing,2293,2303,O
need,2304,2308,O
to,2309,2311,O
extend,2312,2318,O
the,2319,2322,O
repository,2323,2333,O
of,2334,2336,O
reference,2337,2346,O
spectra,2347,2354,O
in,2355,2357,O
MALDI,2358,2363,O
-,2363,2364,O
TOF,2364,2367,O
MS,2368,2370,O
databases,2371,2380,O
.,2380,2381,O
We,2382,2384,O
therefore,2385,2394,O
undertook,2395,2404,O
the,2405,2408,O
present,2409,2416,O
study,2417,2422,O
to,2423,2425,O
evaluate,2426,2434,O
the,2435,2438,O
utility,2439,2446,O
of,2447,2449,O
the,2450,2453,O
MALDI,2454,2459,O
Biotyper,2460,2468,O
2,2469,2470,O
.,2470,2471,O
0,2471,2472,O
Microflex,2473,2482,O
LT,2483,2485,O
spectrometer,2486,2498,O
(,2499,2500,O
Bruker,2500,2506,O
Daltonik,2507,2515,O
GmbH,2516,2520,O
;,2520,2521,O
Bremen,2522,2528,O
",",2528,2529,O
Germany,2530,2537,O
),2537,2538,O
with,2539,2543,O
its,2544,2547,O
current,2548,2555,O
spectral,2556,2564,O
database,2565,2573,O
in,2574,2576,O
comparison,2577,2587,O
with,2588,2592,O
phenotypic,2593,2603,O
-,2603,2604,O
based,2604,2609,O
methods,2610,2617,O
for,2618,2621,O
the,2622,2625,O
identification,2626,2640,O
of,2641,2643,O
a,2644,2645,O
broad,2646,2651,O
range,2652,2657,O
of,2658,2660,O
yeasts,2661,2667,O
in,2668,2670,O
a,2671,2672,O
diagnostic,2673,2683,O
laboratory,2684,2694,O
.,2694,2695,O
The,2696,2699,O
first,2700,2705,O
part,2706,2710,O
of,2711,2713,O
the,2714,2717,O
study,2718,2723,O
comprised,2724,2733,O
testing,2734,2741,O
of,2742,2744,O
reference,2745,2754,O
and,2755,2758,O
clinical,2759,2767,O
strains,2768,2775,O
from,2776,2780,O
our,2781,2784,O
culture,2785,2792,O
collection,2793,2803,O
.,2803,2804,O
The,2805,2808,O
second,2809,2815,O
was,2816,2819,O
a,2820,2821,O
blinded,2822,2829,O
prospective,2830,2841,O
analysis,2842,2850,O
of,2851,2853,O
freshly,2854,2861,O
-,2861,2862,O
collected,2862,2871,O
yeast,2872,2877,O
isolates,2878,2886,O
recovered,2887,2896,O
during,2897,2903,O
routine,2904,2911,O
laboratory,2912,2922,O
work,2923,2927,O
flow,2928,2932,O
;,2932,2933,O
discrepant,2934,2944,O
results,2945,2952,O
between,2953,2960,O
MALDI,2961,2966,O
TOF,2967,2970,O
MS,2971,2973,O
and,2974,2977,O
phenotypic,2978,2988,O
methods,2989,2996,O
were,2997,3001,O
resolved,3002,3010,O
using,3011,3016,O
sequence,3017,3025,O
analysis,3026,3034,O
of,3035,3037,O
the,3038,3041,O
fungal,3042,3048,O
internal,3049,3057,O
transcribed,3058,3069,O
spacer,3070,3076,O
(,3077,3078,O
ITS,3078,3081,O
),3081,3082,O
regions,3083,3090,O
[,3091,3092,O
21,3092,3094,O
],3094,3095,O
",",3095,3096,O
[,3097,3098,O
22,3098,3100,O
],3100,3101,O
.,3101,3102,O
Results,3103,3110,O
obtained,3111,3119,O
by,3120,3122,O
preparation,3123,3134,O
of,3135,3137,O
yeasts,3138,3144,O
by,3145,3147,O
extraction,3148,3158,O
of,3159,3161,O
fungal,3162,3168,O
proteins,3169,3177,O
and,3178,3181,O
by,3182,3184,O
direct,3185,3191,O
application,3192,3203,O
of,3204,3206,O
yeast,3207,3212,O
colonies,3213,3221,O
onto,3222,3226,O
the,3227,3230,O
MALDI,3231,3236,O
TOF,3237,3240,O
MS,3241,3243,O
plate,3244,3249,O
were,3250,3254,O
also,3255,3259,O
compared,3260,3268,O
.,3268,3269,O
Classification,0,14,O
result,15,21,O
.,21,22,O
3,0,1,O
.,1,2,O
2,2,3,O
.,3,4,O
Molecular,5,14,O
Mechanisms,15,25,O
Mediating,26,35,O
the,36,39,O
Perinatal,40,49,O
Beta,50,54,B-Cell
-,54,55,I-Cell
Cell,55,59,I-Cell
Adaptive,60,68,O
Response,69,77,O
to,78,80,O
Early,81,86,O
-,86,87,O
Life,87,91,O
Stressors,92,101,O
Molecular,102,111,O
mechanisms,112,122,O
responsible,123,134,O
for,135,138,O
impaired,139,147,O
beta,148,152,B-Cell
-,152,153,I-Cell
cell,153,157,I-Cell
mass,158,162,O
formation,163,172,O
after,173,178,O
IUCR,179,183,O
or,184,186,O
IUPR,187,191,O
have,192,196,O
come,197,201,O
under,202,207,O
investigation,208,221,O
.,221,222,O
First,223,228,O
",",228,229,O
it,230,232,O
has,233,236,O
been,237,241,O
proposed,242,250,O
that,251,255,O
IUCR,256,260,O
can,261,264,O
result,265,271,O
in,272,274,O
a,275,276,O
reduction,277,286,O
of,287,289,O
the,290,293,O
embryonic,294,303,B-Cell
beta,304,308,I-Cell
-,308,309,I-Cell
cell,309,313,I-Cell
progenitor,314,324,O
pool,325,329,O
leading,330,337,O
to,338,340,O
inappropriate,341,354,O
postnatal,355,364,O
beta,365,369,B-Cell
-,369,370,I-Cell
cell,370,374,I-Cell
formation,375,384,O
.,384,385,O
Stanger,386,393,O
et,394,396,O
al,397,399,O
.,399,400,O
[,401,402,O
108,402,405,O
],405,406,O
demonstrated,407,419,O
that,420,424,O
selective,425,434,O
genetic,435,442,O
reduction,443,452,O
in,453,455,O
the,456,459,O
size,460,464,O
of,465,467,O
PDX,468,471,O
-,471,472,O
1,472,473,O
+,473,474,O
pancreatic,475,485,B-Organ
progenitors,486,497,O
during,498,504,O
the,505,508,O
fetal,509,514,B-Developing_anatomical_structure
period,515,521,O
results,522,529,O
in,530,532,O
impaired,533,541,O
beta,542,546,B-Cell
-,546,547,I-Cell
cell,547,551,I-Cell
formation,552,561,O
during,562,568,O
the,569,572,O
postnatal,573,582,O
period,583,589,O
with,590,594,O
consequent,595,605,O
development,606,617,O
of,618,620,O
glucose,621,628,O
intolerance,629,640,O
during,641,647,O
adulthood,648,657,O
.,657,658,O
Consistent,659,669,O
with,670,674,O
this,675,679,O
",",679,680,O
maternal,681,689,O
food,690,694,O
restriction,695,706,O
leads,707,712,O
to,713,715,O
significant,716,727,O
reduction,728,737,O
in,738,740,O
PDX,741,744,O
-,744,745,O
1,745,746,O
+,746,747,O
and,748,751,O
neurogenin,752,762,O
-,762,763,O
3,763,764,O
+,764,765,O
pancreatic,766,776,B-Organ
precursors,777,787,O
during,788,794,O
embryonic,795,804,B-Developing_anatomical_structure
development,805,816,O
in,817,819,O
rats,820,824,O
",",824,825,O
diminished,826,836,O
postnatal,837,846,O
beta,847,851,B-Cell
-,851,852,I-Cell
cell,852,856,I-Cell
formation,857,866,O
",",866,867,O
and,868,871,O
inability,872,881,O
to,882,884,O
expand,885,891,O
beta,892,896,B-Cell
-,896,897,I-Cell
cell,897,901,I-Cell
mass,902,906,O
in,907,909,O
response,910,918,O
to,919,921,O
pregnancy,922,931,O
[,932,933,O
47,933,935,O
",",935,936,O
94,937,939,O
],939,940,O
.,940,941,O
The,942,945,O
UPI,946,949,O
model,950,955,O
is,956,958,O
also,959,963,O
characterized,964,977,O
by,978,980,O
a,981,982,O
permanent,983,992,O
decrease,993,1001,O
in,1002,1004,O
islet,1005,1010,B-Multi-tissue_structure
PDX,1011,1014,O
-,1014,1015,O
1,1015,1016,O
mRNA,1017,1021,O
expression,1022,1032,O
.,1032,1033,O
This,1034,1038,O
decrease,1039,1047,O
has,1048,1051,O
recently,1052,1060,O
been,1061,1065,O
shown,1066,1071,O
to,1072,1074,O
be,1075,1077,O
due,1078,1081,O
to,1082,1084,O
progressive,1085,1096,O
epigenetic,1097,1107,O
silencing,1108,1117,O
of,1118,1120,O
the,1121,1124,O
Pdx1,1125,1129,O
gene,1130,1134,O
locus,1135,1140,O
secondary,1141,1150,O
to,1151,1153,O
proximal,1154,1162,O
promoter,1163,1171,O
methylation,1172,1183,O
[,1184,1185,O
69,1185,1187,O
",",1187,1188,O
109,1189,1192,O
],1192,1193,O
",",1193,1194,O
and,1195,1198,O
it,1199,1201,O
may,1202,1205,O
be,1206,1208,O
responsible,1209,1220,O
for,1221,1224,O
the,1225,1228,O
decreased,1229,1238,O
rate,1239,1243,O
of,1244,1246,O
beta,1247,1251,B-Cell
-,1251,1252,I-Cell
cell,1252,1256,I-Cell
replication,1257,1268,O
and,1269,1272,O
inappropriate,1273,1286,O
postnatal,1287,1296,O
beta,1297,1301,B-Cell
-,1301,1302,I-Cell
cell,1302,1306,I-Cell
mass,1307,1311,O
development,1312,1323,O
[,1324,1325,O
69,1325,1327,O
",",1327,1328,O
110,1329,1332,O
],1332,1333,O
.,1333,1334,O
In,1335,1337,O
the,1338,1341,O
same,1342,1346,O
way,1347,1350,O
of,1351,1353,O
thinking,1354,1362,O
",",1362,1363,O
studies,1364,1371,O
have,1372,1376,O
demonstrated,1377,1389,O
that,1390,1394,O
the,1395,1398,O
maintenance,1399,1410,O
of,1411,1413,O
methylated,1414,1424,O
histone,1425,1432,O
H3,1433,1435,O
Lys4,1436,1440,O
by,1441,1443,O
Set7,1444,1448,O
/,1448,1449,O
9,1449,1450,O
",",1450,1451,O
a,1452,1453,O
member,1454,1460,O
of,1461,1463,O
the,1464,1467,O
SET,1468,1471,O
methyltransferase,1472,1489,O
family,1490,1496,O
",",1496,1497,O
is,1498,1500,O
crucial,1501,1508,O
to,1509,1511,O
Pdx1,1512,1516,O
activity,1517,1525,O
in,1526,1528,O
beta,1529,1533,B-Cell
-,1533,1534,I-Cell
cell,1534,1538,I-Cell
lines,1539,1544,I-Cell
[,1545,1546,O
111,1546,1549,O
-,1549,1550,O
113,1550,1553,O
],1553,1554,O
.,1554,1555,O
This,1556,1560,O
led,1561,1564,O
to,1565,1567,O
the,1568,1571,O
hypothesis,1572,1582,O
that,1583,1587,O
Set7,1588,1592,O
/,1592,1593,O
9,1593,1594,O
may,1595,1598,O
represent,1599,1608,O
a,1609,1610,O
novel,1611,1616,O
chromatin,1617,1626,O
-,1626,1627,O
modifying,1627,1636,O
protein,1637,1644,O
that,1645,1649,O
functions,1650,1659,O
in,1660,1662,O
part,1663,1667,O
through,1668,1675,O
its,1676,1679,O
recruitment,1680,1691,O
to,1692,1694,O
target,1695,1701,O
genes,1702,1707,O
by,1708,1710,O
cell,1711,1715,B-Cell
-,1715,1716,O
specific,1716,1724,O
transcription,1725,1738,O
factors,1739,1746,O
such,1747,1751,O
as,1752,1754,O
Pdx1,1755,1759,O
.,1759,1760,O
Since,1761,1766,O
then,1767,1771,O
",",1771,1772,O
a,1773,1774,O
role,1775,1779,O
of,1780,1782,O
histone,1783,1790,O
methyl,1791,1797,O
transferases,1798,1810,O
",",1810,1811,O
particularly,1812,1824,O
set7,1825,1829,O
",",1829,1830,O
has,1831,1834,O
also,1835,1839,O
been,1840,1844,O
demonstrated,1845,1857,O
in,1858,1860,O
the,1861,1864,O
sustained,1865,1874,O
deleterious,1875,1886,O
effects,1887,1894,O
of,1895,1897,O
chronic,1898,1905,O
hyperglycemia,1906,1919,O
on,1920,1922,O
human,1923,1928,O
microvascular,1929,1942,B-Cell
endothelial,1943,1954,I-Cell
cells,1955,1960,I-Cell
[,1961,1962,O
114,1962,1965,O
],1965,1966,O
.,1966,1967,O
Such,1968,1972,O
an,1973,1975,O
epigenetic,1976,1986,O
change,1987,1993,O
could,1994,1999,O
potentially,2000,2011,O
be,2012,2014,O
involved,2015,2023,O
in,2024,2026,O
the,2027,2030,O
deleterious,2031,2042,O
effect,2043,2049,O
of,2050,2052,O
high,2053,2057,O
glucose,2058,2065,O
upon,2066,2070,O
the,2071,2074,O
fetal,2075,2080,B-Organ
pancreas,2081,2089,I-Organ
in,2090,2092,O
the,2093,2096,O
IUED,2097,2101,O
models,2102,2108,O
.,2108,2109,O
Another,2110,2117,O
mechanism,2118,2127,O
proposed,2128,2136,O
to,2137,2139,O
explain,2140,2147,O
reduced,2148,2155,O
beta,2156,2160,B-Cell
-,2160,2161,I-Cell
cell,2161,2165,I-Cell
formation,2166,2175,O
after,2176,2181,O
IUCR,2182,2186,O
is,2187,2189,O
related,2190,2197,O
to,2198,2200,O
prenatal,2201,2209,O
glucocorticoid,2210,2224,O
exposure,2225,2233,O
.,2233,2234,O
Administration,2235,2249,O
of,2250,2252,O
either,2253,2259,O
dexamethasone,2260,2273,O
or,2274,2276,O
carbenoxolone,2277,2290,O
(,2291,2292,O
to,2292,2294,O
inhibit,2295,2302,O
11,2303,2305,O
beta,2306,2310,O
-,2310,2311,O
hydroxysteroid,2311,2325,O
dehydrogenase,2326,2339,O
type,2340,2344,O
2,2345,2346,O
),2346,2347,O
to,2348,2350,O
normal,2351,2357,O
pregnant,2358,2366,O
rats,2367,2371,O
also,2372,2376,O
causes,2377,2383,O
fetal,2384,2389,B-Developing_anatomical_structure
growth,2390,2396,O
retardation,2397,2408,O
and,2409,2412,O
the,2413,2416,O
adult,2417,2422,O
offspring,2423,2432,O
are,2433,2436,O
hypertensive,2437,2449,O
and,2450,2453,O
hyperglycemic,2454,2467,O
",",2467,2468,O
with,2469,2473,O
hyperactive,2474,2485,O
hypothalamic,2486,2498,B-Organ
-,2498,2499,O
pituitary,2499,2508,B-Organ
-,2508,2509,O
adrenal,2509,2516,B-Organ
axis,2517,2521,O
[,2522,2523,O
115,2523,2526,O
],2526,2527,O
.,2527,2528,O
Maternal,2529,2537,O
undernutrition,2538,2552,O
significantly,2553,2566,O
increased,2567,2576,O
both,2577,2581,O
fetal,2582,2587,B-Developing_anatomical_structure
and,2588,2591,O
maternal,2592,2600,O
corticosterone,2601,2615,O
concentrations,2616,2630,O
in,2631,2633,O
rats,2634,2638,O
[,2639,2640,O
116,2640,2643,O
],2643,2644,O
.,2644,2645,O
Subsequently,2646,2658,O
",",2658,2659,O
maternal,2660,2668,O
and,2669,2672,O
/,2672,2673,O
or,2673,2675,O
fetal,2676,2681,B-Developing_anatomical_structure
overexposure,2682,2694,O
to,2695,2697,O
glucocorticoids,2698,2713,O
(,2714,2715,O
via,2715,2718,O
administration,2719,2733,O
of,2734,2736,O
dexamethasone,2737,2750,O
),2750,2751,O
impairs,2752,2759,O
both,2760,2764,O
fetal,2765,2770,B-Developing_anatomical_structure
and,2771,2774,O
postnatal,2775,2784,O
beta,2785,2789,B-Cell
-,2789,2790,I-Cell
cell,2790,2794,I-Cell
formation,2795,2804,O
in,2805,2807,O
rodents,2808,2815,O
and,2816,2819,O
nonhuman,2820,2828,O
primates,2829,2837,O
[,2838,2839,O
94,2839,2841,O
",",2841,2842,O
117,2843,2846,O
-,2846,2847,O
119,2847,2850,O
],2850,2851,O
.,2851,2852,O
Seckl,2853,2858,O
et,2859,2861,O
al,2862,2864,O
.,2864,2865,O
[,2866,2867,O
115,2867,2870,O
],2870,2871,O
have,2872,2876,O
shown,2877,2882,O
that,2883,2887,O
fetal,2888,2893,B-Developing_anatomical_structure
corticosterone,2894,2908,O
concentrations,2909,2923,O
are,2924,2927,O
inversely,2928,2937,O
correlated,2938,2948,O
with,2949,2953,O
fetal,2954,2959,B-Developing_anatomical_structure
insulin,2960,2967,O
content,2968,2975,O
and,2976,2979,O
postnatal,2980,2989,O
beta,2990,2994,B-Cell
-,2994,2995,I-Cell
cell,2995,2999,I-Cell
formation,3000,3009,O
in,3010,3012,O
rats,3013,3017,O
.,3017,3018,O
Evidence,3019,3027,O
suggests,3028,3036,O
that,3037,3041,O
glucocorticoids,3042,3057,O
can,3058,3061,O
exert,3062,3067,O
a,3068,3069,O
direct,3070,3076,O
effect,3077,3083,O
on,3084,3086,O
the,3087,3090,O
developing,3091,3101,O
fetal,3102,3107,B-Organ
pancreas,3108,3116,I-Organ
via,3117,3120,O
transcriptional,3121,3136,O
modulation,3137,3147,O
of,3148,3150,O
transcription,3151,3164,O
factors,3165,3172,O
involved,3173,3181,O
in,3182,3184,O
beta,3185,3189,B-Cell
-,3189,3190,I-Cell
cell,3190,3194,I-Cell
formation,3195,3204,O
and,3205,3208,O
differentiation,3209,3224,O
[,3225,3226,O
117,3226,3229,O
],3229,3230,O
.,3230,3231,O
Glucocorticoid,3232,3246,O
receptors,3247,3256,O
are,3257,3260,O
present,3261,3268,O
in,3269,3271,O
the,3272,3275,O
pancreas,3276,3284,B-Organ
during,3285,3291,O
embryonic,3292,3301,B-Developing_anatomical_structure
development,3302,3313,O
of,3314,3316,O
rodents,3317,3324,O
and,3325,3328,O
humans,3329,3335,O
[,3336,3337,O
117,3337,3340,O
],3340,3341,O
",",3341,3342,O
and,3343,3346,O
glucocorticoids,3347,3362,O
can,3363,3366,O
bind,3367,3371,O
to,3372,3374,O
the,3375,3378,O
Pdx1,3379,3383,O
promoter,3384,3392,O
and,3393,3396,O
thus,3397,3401,O
suppress,3402,3410,O
fetal,3411,3416,B-Cell
endocrine,3417,3426,I-Cell
cell,3427,3431,I-Cell
differentiation,3432,3447,O
[,3448,3449,O
117,3449,3452,O
],3452,3453,O
.,3453,3454,O
Glucocorticoid,3455,3469,O
treatment,3470,3479,O
has,3480,3483,O
been,3484,3488,O
shown,3489,3494,O
to,3495,3497,O
significantly,3498,3511,O
reduce,3512,3518,O
fetal,3519,3524,B-Developing_anatomical_structure
expression,3525,3535,O
of,3536,3538,O
key,3539,3542,O
endocrine,3543,3552,O
transcription,3553,3566,O
factors,3567,3574,O
such,3575,3579,O
as,3580,3582,O
Pdx1,3583,3587,O
and,3588,3591,O
Pax6,3592,3596,O
but,3597,3600,O
simultaneously,3601,3615,O
increase,3616,3624,O
expression,3625,3635,O
of,3636,3638,O
transcription,3639,3652,O
factors,3653,3660,O
that,3661,3665,O
regulate,3666,3674,O
development,3675,3686,O
of,3687,3689,O
the,3690,3693,O
exocrine,3694,3702,B-Organ
pancreas,3703,3711,I-Organ
[,3712,3713,O
119,3713,3716,O
],3716,3717,O
.,3717,3718,O
It,3719,3721,O
has,3722,3725,O
also,3726,3730,O
been,3731,3735,O
demonstrated,3736,3748,O
that,3749,3753,O
the,3754,3757,O
UPI,3758,3761,O
or,3762,3764,O
the,3765,3768,O
low,3769,3772,O
-,3772,3773,O
protein,3773,3780,O
IUPR,3781,3785,O
offspring,3786,3795,O
experience,3796,3806,O
increased,3807,3816,O
oxidative,3817,3826,O
stress,3827,3833,O
and,3834,3837,O
impaired,3838,3846,O
mitochondrial,3847,3860,B-Cellular_component
function,3861,3869,O
[,3870,3871,O
96,3871,3873,O
",",3873,3874,O
120,3875,3878,O
],3878,3879,O
.,3879,3880,O
The,3881,3884,O
mitochondrial,3885,3898,B-Cellular_component
dysfunction,3899,3910,O
was,3911,3914,O
not,3915,3918,O
limited,3919,3926,O
to,3927,3929,O
just,3930,3934,O
the,3935,3938,O
beta,3939,3943,B-Cell
cell,3944,3948,I-Cell
",",3948,3949,O
as,3950,3952,O
mitochondria,3953,3965,B-Cellular_component
from,3966,3970,O
both,3971,3975,O
the,3976,3979,O
liver,3980,3985,B-Organ
and,3986,3989,O
skeletal,3990,3998,B-Organ
muscle,3999,4005,I-Organ
exhibit,4006,4013,O
decreased,4014,4023,O
oxidation,4024,4033,O
of,4034,4036,O
pyruvate,4037,4045,O
",",4045,4046,O
subsequently,4047,4059,O
leading,4060,4067,O
to,4068,4070,O
the,4071,4074,O
development,4075,4086,O
of,4087,4089,O
features,4090,4098,O
commonly,4099,4107,O
found,4108,4113,O
in,4114,4116,O
T2D,4117,4120,O
[,4121,4122,O
100,4122,4125,O
",",4125,4126,O
121,4127,4130,O
],4130,4131,O
.,4131,4132,O
Also,4133,4137,O
exposure,4138,4146,O
to,4147,4149,O
a,4150,4151,O
Western,4152,4159,O
-,4159,4160,O
style,4160,4165,O
diet,4166,4170,O
before,4171,4177,O
and,4178,4181,O
during,4182,4188,O
pregnancy,4189,4198,O
(,4199,4200,O
an,4200,4202,O
IUEO,4203,4207,O
model,4208,4213,O
),4213,4214,O
alters,4215,4221,O
the,4222,4225,O
redox,4226,4231,O
state,4232,4237,O
as,4238,4240,O
early,4241,4246,O
as,4247,4249,O
preimplantation,4250,4265,O
development,4266,4277,O
",",4277,4278,O
leading,4279,4286,O
to,4287,4289,O
mild,4290,4294,O
oxidative,4295,4304,O
stress,4305,4311,O
associated,4312,4322,O
with,4323,4327,O
inflammation,4328,4340,O
.,4340,4341,O
The,4342,4345,O
finding,4346,4353,O
that,4354,4358,O
administration,4359,4373,O
of,4374,4376,O
antioxidants,4377,4389,O
to,4390,4392,O
the,4393,4396,O
dam,4397,4400,O
reverses,4401,4409,O
oxidative,4410,4419,O
stress,4420,4426,O
and,4427,4430,O
completely,4431,4441,O
prevents,4442,4450,O
the,4451,4454,O
development,4455,4466,O
of,4467,4469,O
glucose,4470,4477,O
intolerance,4478,4489,O
and,4490,4493,O
increased,4494,4503,O
adiposity,4504,4513,O
in,4514,4516,O
the,4517,4520,O
adult,4521,4526,O
offspring,4527,4536,O
suggests,4537,4545,O
that,4546,4550,O
oxidative,4551,4560,O
stress,4561,4567,O
plays,4568,4573,O
an,4574,4576,O
important,4577,4586,O
role,4587,4591,O
in,4592,4594,O
the,4595,4598,O
development,4599,4610,O
of,4611,4613,O
adiposity,4614,4623,O
in,4624,4626,O
this,4627,4631,O
case,4632,4636,O
[,4637,4638,O
122,4638,4641,O
],4641,4642,O
.,4642,4643,O
Some,4644,4648,O
studies,4649,4656,O
in,4657,4659,O
the,4660,4663,O
low,4664,4667,O
-,4667,4668,O
protein,4668,4675,O
IUPR,4676,4680,O
model,4681,4686,O
have,4687,4691,O
demonstrated,4692,4704,O
that,4705,4709,O
oxidative,4710,4719,O
stress,4720,4726,O
is,4727,4729,O
not,4730,4733,O
limited,4734,4741,O
to,4742,4744,O
just,4745,4749,O
mitochondrial,4750,4763,B-Cellular_component
DNA,4764,4767,O
damage,4768,4774,O
",",4774,4775,O
but,4776,4779,O
also,4780,4784,O
to,4785,4787,O
genomic,4788,4795,O
DNA,4796,4799,O
",",4799,4800,O
impacting,4801,4810,O
cell,4811,4815,B-Cell
-,4815,4816,O
cycle,4816,4821,O
regulation,4822,4832,O
and,4833,4836,O
gene,4837,4841,O
expression,4842,4852,O
[,4853,4854,O
123,4854,4857,O
],4857,4858,O
.,4858,4859,O
While,4860,4865,O
DNA,4866,4869,O
is,4870,4872,O
being,4873,4878,O
targeted,4879,4887,O
throughout,4888,4898,O
by,4899,4901,O
ROS,4902,4905,O
",",4905,4906,O
there,4907,4912,O
are,4913,4916,O
particular,4917,4927,O
regions,4928,4935,O
that,4936,4940,O
are,4941,4944,O
known,4945,4950,O
to,4951,4953,O
be,4954,4956,O
more,4957,4961,O
sensitive,4962,4971,O
to,4972,4974,O
ROS,4975,4978,O
-,4978,4979,O
mediated,4979,4987,O
damage,4988,4994,O
",",4994,4995,O
for,4996,4999,O
example,5000,5007,O
",",5007,5008,O
telomeres,5009,5018,O
.,5018,5019,O
Telomeres,5020,5029,O
comprise,5030,5038,O
GC,5039,5041,O
-,5041,5042,O
rich,5042,5046,O
repeats,5047,5054,O
and,5055,5058,O
are,5059,5062,O
found,5063,5068,O
at,5069,5071,O
the,5072,5075,O
ends,5076,5080,O
of,5081,5083,O
each,5084,5088,O
chromosome,5089,5099,O
.,5099,5100,O
They,5101,5105,O
are,5106,5109,O
known,5110,5115,O
to,5116,5118,O
shorten,5119,5126,O
with,5127,5131,O
each,5132,5136,O
cellular,5137,5145,B-Cell
division,5146,5154,O
and,5155,5158,O
",",5158,5159,O
hence,5160,5165,O
",",5165,5166,O
can,5167,5170,O
act,5171,5174,O
as,5175,5177,O
a,5178,5179,O
mitotic,5180,5187,O
clock,5188,5193,O
",",5193,5194,O
registering,5195,5206,O
the,5207,5210,O
number,5211,5217,O
of,5218,5220,O
replicative,5221,5232,O
divisions,5233,5242,O
to,5243,5245,O
have,5246,5250,O
taken,5251,5256,O
place,5257,5262,O
within,5263,5269,O
the,5270,5273,O
cell,5274,5278,B-Cell
.,5278,5279,O
Investigations,5280,5294,O
using,5295,5300,O
an,5301,5303,O
IUPR,5304,5308,O
model,5309,5314,O
have,5315,5319,O
indeed,5320,5326,O
reported,5327,5335,O
a,5336,5337,O
decrease,5338,5346,O
in,5347,5349,O
longevity,5350,5359,O
in,5360,5362,O
the,5363,5366,O
offspring,5367,5376,O
[,5377,5378,O
123,5378,5381,O
",",5381,5382,O
124,5383,5386,O
],5386,5387,O
accompanied,5388,5399,O
by,5400,5402,O
reduction,5403,5412,O
in,5413,5415,O
mitochondrial,5416,5429,B-Cellular_component
antioxidant,5430,5441,O
defences,5442,5450,O
[,5451,5452,O
96,5452,5454,O
",",5454,5455,O
125,5456,5459,O
],5459,5460,O
and,5461,5464,O
telomere,5465,5473,O
length,5474,5480,O
in,5481,5483,O
islets,5484,5490,B-Multi-tissue_structure
[,5491,5492,O
125,5492,5495,O
],5495,5496,O
.,5496,5497,O
Pancreatic,5498,5508,B-Multi-tissue_structure
islet,5509,5514,I-Multi-tissue_structure
development,5515,5526,O
has,5527,5530,O
been,5531,5535,O
shown,5536,5541,O
to,5542,5544,O
be,5545,5547,O
influenced,5548,5558,O
by,5559,5561,O
a,5562,5563,O
number,5564,5570,O
of,5571,5573,O
growth,5574,5580,O
factors,5581,5588,O
including,5589,5598,O
the,5599,5602,O
insulin,5603,5610,O
-,5610,5611,O
like,5611,5615,O
growth,5616,5622,O
factors,5623,5630,O
",",5630,5631,O
IGF,5632,5635,O
-,5635,5636,O
I,5636,5637,O
and,5638,5641,O
IGF,5642,5645,O
-,5645,5646,O
II,5646,5648,O
whose,5649,5654,O
expression,5655,5665,O
in,5666,5668,O
utero,5669,5674,O
is,5675,5677,O
regulated,5678,5687,O
by,5688,5690,O
nutrient,5691,5699,O
and,5700,5703,O
hormone,5704,5711,O
concentrations,5712,5726,O
.,5726,5727,O
IUPR,5728,5732,O
modifies,5733,5741,O
expression,5742,5752,O
of,5753,5755,O
both,5756,5760,O
IGF,5761,5764,O
genes,5765,5770,O
in,5771,5773,O
a,5774,5775,O
variety,5776,5783,O
of,5784,5786,O
fetal,5787,5792,B-Tissue
tissues,5793,5800,I-Tissue
.,5800,5801,O
In,5802,5804,O
an,5805,5807,O
IUPR,5808,5812,O
rat,5813,5816,O
model,5817,5822,O
with,5823,5827,O
a,5828,5829,O
decreased,5830,5839,O
beta,5840,5844,B-Cell
-,5844,5845,I-Cell
cell,5845,5849,I-Cell
mass,5850,5854,O
and,5855,5858,O
beta,5859,5863,B-Cell
-,5863,5864,I-Cell
cell,5864,5868,I-Cell
replication,5869,5880,O
and,5881,5884,O
an,5885,5887,O
increased,5888,5897,O
rate,5898,5902,O
of,5903,5905,O
beta,5906,5910,B-Cell
-,5910,5911,I-Cell
cell,5911,5915,I-Cell
apoptosis,5916,5925,O
",",5925,5926,O
gene,5927,5931,O
expression,5932,5942,O
for,5943,5946,O
IGF,5947,5950,O
-,5950,5951,O
II,5951,5953,O
but,5954,5957,O
not,5958,5961,O
IGF,5962,5965,O
-,5965,5966,O
I,5966,5967,O
was,5968,5971,O
found,5972,5977,O
reduced,5978,5985,O
in,5986,5988,O
the,5989,5992,O
fetal,5993,5998,B-Organ
pancreas,5999,6007,I-Organ
[,6008,6009,O
126,6009,6012,O
],6012,6013,O
.,6013,6014,O
In,6015,6017,O
a,6018,6019,O
different,6020,6029,O
IUPR,6030,6034,O
model,6035,6040,O
with,6041,6045,O
more,6046,6050,O
severe,6051,6057,O
global,6058,6064,O
food,6065,6069,O
restriction,6070,6081,O
which,6082,6087,O
induced,6088,6095,O
hyperinsulinemia,6096,6112,O
and,6113,6116,O
an,6117,6119,O
increase,6120,6128,O
in,6129,6131,O
beta,6132,6136,B-Cell
-,6136,6137,I-Cell
cell,6137,6141,I-Cell
mass,6142,6146,O
in,6147,6149,O
their,6150,6155,O
fetuses,6156,6163,B-Developing_anatomical_structure
[,6164,6165,O
90,6165,6167,O
],6167,6168,O
",",6168,6169,O
the,6170,6173,O
fetal,6174,6179,B-Developing_anatomical_structure
phenotype,6180,6189,O
was,6190,6193,O
unexpectedly,6194,6206,O
associated,6207,6217,O
with,6218,6222,O
an,6223,6225,O
increase,6226,6234,O
in,6235,6237,O
pancreatic,6238,6248,B-Organ
IGF,6249,6252,O
-,6252,6253,O
I,6253,6254,O
expression,6255,6265,O
",",6265,6266,O
islet,6267,6272,B-Multi-tissue_structure
IGF,6273,6276,O
-,6276,6277,O
1R,6277,6279,O
[,6280,6281,O
91,6281,6283,O
],6283,6284,O
",",6284,6285,O
and,6286,6289,O
IRS,6290,6293,O
-,6293,6294,O
2,6294,6295,O
[,6296,6297,O
92,6297,6299,O
],6299,6300,O
.,6300,6301,O
In,6302,6304,O
the,6305,6308,O
fetal,6309,6314,B-Developing_anatomical_structure
GK,6315,6317,O
/,6317,6318,O
Par,6318,6321,O
rat,6322,6325,O
exposed,6326,6333,O
to,6334,6336,O
mild,6337,6341,O
hyperglycemia,6342,6355,O
during,6356,6362,O
gestation,6363,6372,O
(,6373,6374,O
a,6374,6375,O
model,6376,6381,O
of,6382,6384,O
IUED,6385,6389,O
),6389,6390,O
",",6390,6391,O
data,6392,6396,O
from,6397,6401,O
our,6402,6405,O
group,6406,6411,O
suggest,6412,6419,O
that,6420,6424,O
the,6425,6428,O
beta,6429,6433,B-Cell
-,6433,6434,I-Cell
cell,6434,6438,I-Cell
deficit,6439,6446,O
(,6447,6448,O
reduced,6448,6455,O
by,6456,6458,O
more,6459,6463,O
than,6464,6468,O
50,6469,6471,O
%,6471,6472,O
),6472,6473,O
starts,6474,6480,O
as,6481,6483,O
early,6484,6489,O
as,6490,6492,O
fetal,6493,6498,B-Developing_anatomical_structure
age,6499,6502,O
E16,6503,6506,O
and,6507,6510,O
reflects,6511,6519,O
decreased,6520,6529,O
beta,6530,6534,B-Cell
-,6534,6535,I-Cell
cell,6535,6539,I-Cell
proliferation,6540,6553,O
",",6553,6554,O
a,6555,6556,O
limitation,6557,6567,O
of,6568,6570,O
beta,6571,6575,B-Cell
-,6575,6576,I-Cell
cell,6576,6580,I-Cell
neogenesis,6581,6591,O
from,6592,6596,O
precursors,6597,6607,O
",",6607,6608,O
and,6609,6612,O
increased,6613,6622,O
apoptosis,6623,6632,O
of,6633,6635,O
both,6636,6640,O
beta,6641,6645,B-Cell
cells,6646,6651,I-Cell
and,6652,6655,O
their,6656,6661,O
precursors,6662,6672,O
[,6673,6674,O
86,6674,6676,O
],6676,6677,O
.,6677,6678,O
Notably,6679,6686,O
",",6686,6687,O
Pdx1,6688,6692,O
and,6693,6696,O
Neurogenin3,6697,6708,O
expression,6709,6719,O
were,6720,6724,O
decreased,6725,6734,O
on,6735,6737,O
E18,6738,6741,O
but,6742,6745,O
normally,6746,6754,O
expressed,6755,6764,O
on,6765,6767,O
E13,6768,6771,O
[,6772,6773,O
86,6773,6775,O
],6775,6776,O
.,6776,6777,O
Defective,6778,6787,O
signalling,6788,6798,O
through,6799,6806,O
the,6807,6810,O
Igf2,6811,6815,O
/,6815,6816,O
Igf1,6816,6820,O
-,6820,6821,O
R,6821,6822,O
pathway,6823,6830,O
may,6831,6834,O
represent,6835,6844,O
the,6845,6848,O
primary,6849,6856,O
instrumental,6857,6869,O
anomaly,6870,6877,O
since,6878,6883,O
Igf2,6884,6888,O
and,6889,6892,O
Igf1,6893,6897,O
-,6897,6898,O
R,6898,6899,O
protein,6900,6907,O
expressions,6908,6919,O
are,6920,6923,O
already,6924,6931,O
decreased,6932,6941,O
within,6942,6948,O
the,6949,6952,O
GK,6953,6955,O
/,6955,6956,O
Par,6956,6959,O
pancreatic,6960,6970,B-Organ
rudiment,6971,6979,I-Organ
at,6980,6982,O
E13,6983,6986,O
",",6986,6987,O
at,6988,6990,O
a,6991,6992,O
time,6993,6997,O
when,6998,7002,O
beta,7003,7007,B-Cell
-,7007,7008,I-Cell
cell,7008,7012,I-Cell
mass,7013,7017,O
(,7018,7019,O
first,7019,7024,O
wave,7025,7029,O
of,7030,7032,O
beta,7033,7037,B-Cell
-,7037,7038,I-Cell
cell,7038,7042,I-Cell
expansion,7043,7052,O
),7052,7053,O
is,7054,7056,O
in,7057,7059,O
fact,7060,7064,O
normal,7065,7071,O
[,7072,7073,O
31,7073,7075,O
],7075,7076,O
.,7076,7077,O
Low,7078,7081,O
levels,7082,7088,O
of,7089,7091,O
pancreatic,7092,7102,B-Organ
Igf2,7103,7107,O
associated,7108,7118,O
with,7119,7123,O
beta,7124,7128,B-Cell
-,7128,7129,I-Cell
cell,7129,7133,I-Cell
mass,7134,7138,O
deficiency,7139,7149,O
are,7150,7153,O
maintained,7154,7164,O
thereafter,7165,7175,O
within,7176,7182,O
the,7183,7186,O
fetal,7187,7192,B-Organ
pancreas,7193,7201,I-Organ
[,7202,7203,O
87,7203,7205,O
],7205,7206,O
.,7206,7207,O
Crossbreeding,7208,7221,O
protocols,7222,7231,O
between,7232,7239,O
nondiabetic,7240,7251,O
W,7252,7253,O
and,7254,7257,O
diabetic,7258,7266,O
GK,7267,7269,O
rats,7270,7274,O
showed,7275,7281,O
that,7282,7286,O
",",7286,7287,O
in,7288,7290,O
late,7291,7295,O
gestation,7296,7305,O
(,7306,7307,O
E18,7307,7310,O
),7310,7311,O
",",7311,7312,O
pancreatic,7313,7323,B-Organ
Igf2,7324,7328,O
protein,7329,7336,O
expression,7337,7347,O
was,7348,7351,O
as,7352,7354,O
low,7355,7358,O
in,7359,7361,O
GKmother,7362,7370,O
/,7370,7371,O
GKfather,7371,7379,O
and,7380,7383,O
Wmother,7384,7391,O
/,7391,7392,O
GKfather,7392,7400,O
crosses,7401,7408,O
as,7409,7411,O
in,7412,7414,O
GKmother,7415,7423,O
/,7423,7424,O
GKfather,7424,7432,O
crosses,7433,7440,O
[,7441,7442,O
87,7442,7444,O
],7444,7445,O
.,7445,7446,O
These,7447,7452,O
findings,7453,7461,O
rather,7462,7468,O
support,7469,7476,O
the,7477,7480,O
hypothesis,7481,7491,O
that,7492,7496,O
the,7497,7500,O
pancreatic,7501,7511,B-Organ
Igf2,7512,7516,O
anomaly,7517,7524,O
in,7525,7527,O
the,7528,7531,O
GK,7532,7534,O
diabetic,7535,7543,O
model,7544,7549,O
is,7550,7552,O
linked,7553,7559,O
to,7560,7562,O
a,7563,7564,O
genetic,7565,7572,O
determinism,7573,7584,O
.,7584,7585,O
This,7586,7590,O
view,7591,7595,O
is,7596,7598,O
also,7599,7603,O
consistent,7604,7614,O
with,7615,7619,O
the,7620,7623,O
results,7624,7631,O
of,7632,7634,O
genetic,7635,7642,O
analyses,7643,7651,O
that,7652,7656,O
linked,7657,7663,O
a,7664,7665,O
locus,7666,7671,O
containing,7672,7682,O
the,7683,7686,O
gene,7687,7691,O
encoding,7692,7700,O
Igf2,7701,7705,O
to,7706,7708,O
diabetes,7709,7717,O
in,7718,7720,O
the,7721,7724,O
GK,7725,7727,O
rat,7728,7731,O
[,7732,7733,O
127,7733,7736,O
],7736,7737,O
.,7737,7738,O
The,7739,7742,O
Igf2,7743,7747,O
gene,7748,7752,O
is,7753,7755,O
subjected,7756,7765,O
to,7766,7768,O
paternal,7769,7777,O
genomic,7778,7785,O
imprinting,7786,7796,O
.,7796,7797,O
However,7798,7805,O
",",7805,7806,O
because,7807,7814,O
the,7815,7818,O
Igf2,7819,7823,O
expression,7824,7834,O
is,7835,7837,O
similarly,7838,7847,O
affected,7848,7856,O
in,7857,7859,O
fetuses,7860,7867,B-Developing_anatomical_structure
",",7867,7868,O
regardless,7869,7879,O
of,7880,7882,O
whether,7883,7890,O
the,7891,7894,O
father,7895,7901,O
is,7902,7904,O
W,7905,7906,O
or,7907,7909,O
GK,7910,7912,O
[,7913,7914,O
87,7914,7916,O
],7916,7917,O
",",7917,7918,O
we,7919,7921,O
cannot,7922,7928,O
conclude,7929,7937,O
with,7938,7942,O
a,7943,7944,O
simple,7945,7951,O
change,7952,7958,O
of,7959,7961,O
Igf2,7962,7966,O
gene,7967,7971,O
imprinting,7972,7982,O
in,7983,7985,O
the,7986,7989,O
GK,7990,7992,O
rat,7993,7996,O
.,7996,7997,O
Finally,7998,8005,O
",",8005,8006,O
our,8007,8010,O
understanding,8011,8024,O
of,8025,8027,O
the,8028,8031,O
underlying,8032,8042,O
mechanisms,8043,8053,O
for,8054,8057,O
reduced,8058,8065,O
BCM,8066,8069,O
in,8070,8072,O
response,8073,8081,O
to,8082,8084,O
inappropriate,8085,8098,O
perinatal,8099,8108,O
nutrition,8109,8118,O
is,8119,8121,O
growing,8122,8129,O
rapidly,8130,8137,O
.,8137,8138,O
However,8139,8146,O
",",8146,8147,O
the,8148,8151,O
relative,8152,8160,O
contribution,8161,8173,O
of,8174,8176,O
the,8177,8180,O
many,8181,8185,O
intrinsic,8186,8195,O
and,8196,8199,O
extrinsic,8200,8209,O
factors,8210,8217,O
which,8218,8223,O
contribute,8224,8234,O
to,8235,8237,O
the,8238,8241,O
adaptive,8242,8250,O
response,8251,8259,O
of,8260,8262,O
the,8263,8266,O
developing,8267,8277,O
endocrine,8278,8287,B-Organ
pancreas,8288,8296,I-Organ
is,8297,8299,O
still,8300,8305,O
to,8306,8308,O
be,8309,8311,O
established,8312,8323,O
.,8323,8324,O
Refinement,0,10,O
R,11,12,O
[,12,13,O
F,13,14,O
2,15,16,O
>,17,18,O
2sigma,19,25,O
(,25,26,O
F,26,27,O
2,28,29,O
),29,30,O
],30,31,O
=,32,33,O
0,34,35,O
.,35,36,O
052,36,39,O
wR,40,42,O
(,42,43,O
F,43,44,O
2,45,46,O
),46,47,O
=,48,49,O
0,50,51,O
.,51,52,O
132,52,55,O
S,56,57,O
=,58,59,O
1,60,61,O
.,61,62,O
02,62,64,O
3804,65,69,O
reflections,70,81,O
229,82,85,O
parameters,86,96,O
67,97,99,O
restraints,100,110,O
H,111,112,O
-,112,113,O
atom,113,117,O
parameters,118,128,O
constrained,129,140,O
Deltarhomax,141,152,O
=,153,154,O
0,155,156,O
.,156,157,O
56,157,159,O
e,160,161,O
A,162,163,O
-,163,164,O
3,164,165,O
Deltarhomin,166,177,O
=,178,179,O
-,180,181,O
0,181,182,O
.,182,183,O
38,183,185,O
e,186,187,O
A,188,189,O
-,189,190,O
3,190,191,O
Outcomes,0,8,O
The,9,12,O
primary,13,20,O
outcomes,21,29,O
of,30,32,O
this,33,37,O
study,38,43,O
are,44,47,O
smoking,48,55,O
abstinence,56,66,O
rates,67,72,O
post,73,77,O
release,78,85,O
as,86,88,O
well,89,93,O
as,94,96,O
number,97,103,O
of,104,106,O
days,107,111,O
to,112,114,O
first,115,120,O
cigarette,121,130,O
after,131,136,O
release,137,144,O
.,144,145,O
Seven,146,151,O
day,152,155,O
point,156,161,O
-,161,162,O
prevalence,162,172,O
abstinence,173,183,O
will,184,188,O
be,189,191,O
determined,192,202,O
by,203,205,O
combining,206,215,O
self,216,220,O
-,220,221,O
reported,221,229,O
tobacco,230,237,O
use,238,241,O
over,242,246,O
the,247,250,O
prior,251,256,O
seven,257,262,O
days,263,267,O
and,268,271,O
urine,272,277,B-Organism_substance
cotinine,278,286,O
assays,287,293,O
(,294,295,O
below,295,300,O
200,301,304,O
ng,305,307,O
/,307,308,O
ml,308,310,O
versus,311,317,O
200,318,321,O
or,322,324,O
above,325,330,O
),330,331,O
.,331,332,O
Participants,333,345,O
with,346,350,O
self,351,355,O
-,355,356,O
reported,356,364,O
abstinence,365,375,O
and,376,379,O
cotinine,380,388,O
levels,389,395,O
below,396,401,O
the,402,405,O
cut,406,409,O
-,409,410,O
off,410,413,O
will,414,418,O
be,419,421,O
classified,422,432,O
as,433,435,O
abstinent,436,445,O
.,445,446,O
Participants,447,459,O
lost,460,464,O
to,465,467,O
follow,468,474,O
-,474,475,O
up,475,477,O
will,478,482,O
be,483,485,O
considered,486,496,O
non,497,500,O
-,500,501,O
abstinent,501,510,O
.,510,511,O
A,512,513,O
secondary,514,523,O
analysis,524,532,O
will,533,537,O
examine,538,545,O
the,546,549,O
effect,550,556,O
of,557,559,O
length,560,566,O
of,567,569,O
forced,570,576,O
abstinence,577,587,O
on,588,590,O
quit,591,595,O
rates,596,601,O
.,601,602,O
Abbreviations,0,13,O
ARDS,14,18,O
:,18,19,O
acute,20,25,O
respiratory,26,37,B-Anatomical_system
distress,38,46,O
syndrome,47,55,O
;,55,56,O
CMV,57,60,O
:,60,61,O
conventional,62,74,O
mechanical,75,85,O
ventilation,86,97,O
;,97,98,O
HFOV,99,103,O
:,103,104,O
high,105,109,O
-,109,110,O
frequency,110,119,O
oscillation,120,131,O
ventilation,132,143,O
;,143,144,O
LPS,145,148,O
:,148,149,O
lipopolysaccharide,150,168,O
;,168,169,O
PEEP,170,174,O
:,174,175,O
positive,176,184,O
end,185,188,O
-,188,189,O
expiratory,189,199,O
pressure,200,208,O
;,208,209,O
VILI,210,214,O
:,214,215,O
ventilator,216,226,O
-,226,227,O
induced,227,234,O
lung,235,239,B-Organ
injury,240,246,O
.,246,247,O
TxA2,1,5,O
",",5,6,O
generated,7,16,O
from,17,21,O
arachidonic,22,33,O
acid,34,38,O
by,39,41,O
cyclooxygenase,42,56,O
1,57,58,O
(,59,60,O
COX,60,63,O
-,63,64,O
1,64,65,O
),65,66,O
and,67,70,O
Tx,71,73,O
synthase,74,82,O
",",82,83,O
further,84,91,O
amplifies,92,101,O
platelet,102,110,B-Cell
activation,111,121,O
.,121,122,O
COX,123,126,O
-,126,127,O
1,127,128,O
converts,129,137,O
arachidonic,138,149,O
acid,150,154,O
into,155,159,O
prostaglandin,160,173,O
endoperoxides,174,187,O
PGG2,188,192,O
and,193,196,O
PGH2,197,201,O
",",201,202,O
the,203,206,O
latter,207,213,O
being,214,219,O
",",219,220,O
in,221,223,O
turn,224,228,O
",",228,229,O
transformed,230,241,O
by,242,244,O
Tx,245,247,O
synthase,248,256,O
into,257,261,O
TxA2,262,266,O
",",266,267,O
a,268,269,O
potent,270,276,O
amplifier,277,286,O
of,287,289,O
platelet,290,298,B-Cell
aggregation,299,310,O
with,311,315,O
vasoconstrictive,316,332,O
properties,333,343,O
.,343,344,O
At,345,347,O
the,348,351,O
site,352,356,O
of,357,359,O
the,360,363,O
atheroma,364,372,B-Pathological_formation
rupture,373,380,O
",",380,381,O
platelet,382,390,B-Cell
-,390,391,O
released,391,399,O
TxA2,400,404,O
leads,405,410,O
to,411,413,O
downstream,414,424,O
micro,425,430,B-Tissue
-,430,431,I-Tissue
vessel,431,437,I-Tissue
contraction,438,449,O
and,450,453,O
thrombus,454,462,B-Organism_substance
propagation,463,474,O
(,475,476,O
7,476,477,O
),477,478,O
.,478,479,O
In,480,482,O
addition,483,491,O
to,492,494,O
its,495,498,O
role,499,503,O
in,504,506,O
coagulation,507,518,O
",",518,519,O
thrombin,520,528,O
at,529,531,O
extremely,532,541,O
low,542,545,O
concentrations,546,560,O
is,561,563,O
one,564,567,O
of,568,570,O
the,571,574,O
major,575,580,O
platelet,581,589,B-Cell
activators,590,600,O
(,601,602,O
8,602,603,O
),603,604,O
.,604,605,O
Human,606,611,O
platelets,612,621,B-Cell
express,622,629,O
two,630,633,O
cell,634,638,B-Cellular_component
surface,639,646,I-Cellular_component
G,647,648,O
-,648,649,O
protein,649,656,O
-,656,657,O
coupled,657,664,O
protease,665,673,O
-,673,674,O
activated,674,683,O
receptors,684,693,O
(,694,695,O
PARs,695,699,O
),699,700,O
for,701,704,O
thrombin,705,713,O
:,713,714,O
PAR,715,718,O
-,718,719,O
1,719,720,O
and,721,724,O
PAR,725,728,O
-,728,729,O
4,729,730,O
.,730,731,O
By,732,734,O
binding,735,742,O
the,743,746,O
hirudin,747,754,O
-,754,755,O
like,755,759,O
extracellular,760,773,B-Immaterial_anatomical_entity
amino,774,779,O
terminal,780,788,O
domain,789,795,O
(,796,797,O
the,797,800,O
so,801,803,O
-,803,804,O
called,804,810,O
thrombin,811,819,O
receptor,820,828,O
),828,829,O
",",829,830,O
thrombin,831,839,O
activates,840,849,O
platelets,850,859,B-Cell
and,860,863,O
smooth,864,870,B-Cell
muscle,871,877,I-Cell
cells,878,883,I-Cell
",",883,884,O
thus,885,889,O
promoting,890,899,O
platelet,900,908,B-Cell
pro,909,912,O
-,912,913,O
coagulant,913,922,O
activity,923,931,O
",",931,932,O
shape,933,938,O
change,939,945,O
",",945,946,O
secretion,947,956,O
and,957,960,O
release,961,968,O
of,969,971,O
agonists,972,980,O
(,981,982,O
ADP,982,985,O
and,986,989,O
TxA2,990,994,O
),994,995,O
",",995,996,O
expression,997,1007,O
of,1008,1010,O
P,1011,1012,O
-,1012,1013,O
selectin,1013,1021,O
",",1021,1022,O
activation,1023,1033,O
of,1034,1036,O
the,1037,1040,O
alphaIIbbeta3,1041,1054,O
integrin,1055,1063,O
receptor,1064,1072,O
",",1072,1073,O
and,1074,1077,O
aggregation,1078,1089,O
.,1089,1090,O
Thrombin,1091,1099,O
also,1100,1104,O
binds,1105,1110,O
to,1111,1113,O
GpIbalpha,1114,1123,O
on,1124,1126,O
the,1127,1130,O
surface,1131,1138,O
of,1139,1141,O
platelets,1142,1151,B-Cell
",",1151,1152,O
thought,1153,1160,O
to,1161,1163,O
act,1164,1167,O
as,1168,1170,O
a,1171,1172,O
co,1173,1175,O
-,1175,1176,O
factor,1176,1182,O
that,1183,1187,O
localizes,1188,1197,O
the,1198,1201,O
enzyme,1202,1208,O
on,1209,1211,O
the,1212,1215,O
platelet,1216,1224,B-Cellular_component
surface,1225,1232,I-Cellular_component
and,1233,1236,O
accelerates,1237,1248,O
the,1249,1252,O
hydrolysis,1253,1263,O
of,1264,1266,O
PAR,1267,1270,O
-,1270,1271,O
1,1271,1272,O
(,1273,1274,O
9,1274,1275,O
),1275,1276,O
.,1276,1277,O
PAR,1278,1281,O
-,1281,1282,O
1,1282,1283,O
and,1284,1287,O
P2Y12,1288,1293,O
cross,1294,1299,O
-,1299,1300,O
react,1300,1305,O
in,1306,1308,O
platelet,1309,1317,B-Cell
activation,1318,1328,O
",",1328,1329,O
and,1330,1333,O
Galphaq,1334,1341,O
and,1342,1345,O
Galphai,1346,1353,O
-,1353,1354,O
coupled,1354,1361,O
receptors,1362,1371,O
are,1372,1375,O
involved,1376,1384,O
in,1385,1387,O
this,1388,1392,O
process,1393,1400,O
.,1400,1401,O
Thrombin,1402,1410,O
-,1410,1411,O
dependent,1411,1420,O
platelet,1421,1429,B-Cell
aggregation,1430,1441,O
is,1442,1444,O
mediated,1445,1453,O
in,1454,1456,O
part,1457,1461,O
by,1462,1464,O
secreted,1465,1473,O
ADP,1474,1477,O
",",1477,1478,O
acting,1479,1485,O
on,1486,1488,O
the,1489,1492,O
Galphai,1493,1500,O
-,1500,1501,O
linked,1501,1507,O
ADP,1508,1511,O
receptor,1512,1520,O
.,1520,1521,O
By,1522,1524,O
blocking,1525,1533,O
Galphaq,1534,1541,O
via,1542,1545,O
PAR,1546,1549,O
-,1549,1550,O
1,1550,1551,O
and,1552,1555,O
Gbetai,1556,1562,O
via,1563,1566,O
P2Y12,1567,1572,O
",",1572,1573,O
combined,1574,1582,O
inhibition,1583,1593,O
of,1594,1596,O
thrombin,1597,1605,O
and,1606,1609,O
P2Y12,1610,1615,O
receptors,1616,1625,O
leads,1626,1631,O
to,1632,1634,O
a,1635,1636,O
synergistic,1637,1648,O
inhibitory,1649,1659,O
effect,1660,1666,O
on,1667,1669,O
thrombin,1670,1678,O
-,1678,1679,O
induced,1679,1686,O
platelet,1687,1695,B-Cell
aggregation,1696,1707,O
(,1708,1709,O
10,1709,1711,O
),1711,1712,O
.,1712,1713,O
5,1714,1715,O
-,1715,1716,O
HT,1716,1718,O
is,1719,1721,O
a,1722,1723,O
vasoconstrictor,1724,1739,O
agent,1740,1745,O
that,1746,1750,O
binds,1751,1756,O
to,1757,1759,O
5HT,1760,1763,O
-,1763,1764,O
2A,1764,1766,O
receptors,1767,1776,O
and,1777,1780,O
amplifies,1781,1790,O
the,1791,1794,O
platelet,1795,1803,B-Cell
response,1804,1812,O
by,1813,1815,O
stimulating,1816,1827,O
shape,1828,1833,O
change,1834,1840,O
and,1841,1844,O
enhancing,1845,1854,O
platelet,1855,1863,B-Cell
recruitment,1864,1875,O
at,1876,1878,O
sites,1879,1884,O
of,1885,1887,O
injury,1888,1894,O
(,1895,1896,O
3,1896,1897,O
),1897,1898,O
.,1898,1899,O
It,1900,1902,O
may,1903,1906,O
also,1907,1911,O
play,1912,1916,O
a,1917,1918,O
pro,1919,1922,O
-,1922,1923,O
coagulant,1923,1932,O
role,1933,1937,O
by,1938,1940,O
promoting,1941,1950,O
the,1951,1954,O
retention,1955,1964,O
of,1965,1967,O
fibrinogen,1968,1978,O
and,1979,1982,O
thrombospondin,1983,1997,O
on,1998,2000,O
the,2001,2004,O
platelet,2005,2013,B-Cellular_component
surface,2014,2021,I-Cellular_component
.,2021,2022,O
Intraplatelet,2023,2036,B-Cell
5,2037,2038,O
-,2038,2039,O
HT,2039,2041,O
stores,2042,2048,O
are,2049,2052,O
implicated,2053,2063,O
in,2064,2066,O
shear,2067,2072,O
-,2072,2073,O
induced,2073,2080,O
platelet,2081,2089,B-Cell
aggregation,2090,2101,O
and,2102,2105,O
thrombus,2106,2114,B-Organism_substance
propagation,2115,2126,O
(,2127,2128,O
3,2128,2129,O
),2129,2130,O
.,2130,2131,O
Methods,0,7,O
We,8,10,O
studied,11,18,O
3,19,20,O
",",20,21,O
574,21,24,O
Canadian,25,33,O
children,34,42,O
",",42,43,O
aged,44,48,O
7,49,50,O
-,50,51,O
8,51,52,O
yr,53,55,O
",",55,56,O
enrolled,57,65,O
in,66,68,O
a,69,70,O
population,71,81,O
-,81,82,O
based,82,87,O
birth,88,93,O
cohort,94,100,O
.,100,101,O
Standardized,102,114,O
questionnaires,115,129,O
were,130,134,O
completed,135,144,O
by,145,147,O
the,148,151,O
children,152,160,O
',160,161,O
s,161,162,O
parents,163,170,O
",",170,171,O
and,172,175,O
data,176,180,O
were,181,185,O
analyzed,186,194,O
by,195,197,O
multivariate,198,210,O
logistic,211,219,O
regression,220,230,O
.,230,231,O
(,0,1,O
iii,1,4,O
),4,5,O
HIV,6,9,O
testing,10,17,O
response,18,26,O
rate,27,31,O
by,32,34,O
educational,35,46,O
attainment,47,57,O
and,58,61,O
gender,62,68,O
.,68,69,O
Relative,0,8,O
phage,9,14,O
haplotype,15,24,O
frequencies,25,36,O
in,37,39,O
PAO1,40,44,O
samples,45,52,O
",",52,53,O
(,54,55,O
A,55,56,O
),56,57,O
planktonic,58,68,O
",",68,69,O
(,70,71,O
B,71,72,O
),72,73,O
biofilm,74,81,B-Cell
4,82,83,O
days,84,88,O
",",88,89,O
(,90,91,O
C,91,92,O
),92,93,O
biofilm,94,101,B-Cell
11,102,104,O
days,105,109,O
.,109,110,O
Collaxa,0,7,O
BPEL,8,12,O
Server,13,19,O
Screenshot,20,30,O
of,31,33,O
Collaxa,34,41,O
',41,42,O
s,42,43,O
bpelz,44,49,O
design,50,56,O
tool,57,61,O
",",61,62,O
building,63,71,O
a,72,73,O
choreography,74,86,O
of,87,89,O
GetHAPI,90,97,O
and,98,101,O
GetUMLS,102,109,O
web,110,113,O
services,114,122,O
Abbreviations,0,13,O
Ac,14,16,O
-,16,17,O
DEVD,17,21,O
-,21,22,O
AMC,22,25,O
=,26,27,O
N,28,29,O
-,29,30,O
acetyl,30,36,O
-,36,37,O
Asp,37,40,O
-,40,41,O
Glu,41,44,O
-,44,45,O
Val,45,48,O
-,48,49,O
Asp,49,52,O
-,52,53,O
7,53,54,O
-,54,55,O
amino,55,60,O
-,60,61,O
4,61,62,O
-,62,63,O
methylcoumarin,63,77,O
;,77,78,O
Ac,79,81,O
-,81,82,O
DEVD,82,86,O
-,86,87,O
CHO,87,90,O
=,91,92,O
N,93,94,O
-,94,95,O
acetyl,95,101,O
-,101,102,O
Asp,102,105,O
-,105,106,O
Glu,106,109,O
-,109,110,O
Val,110,113,O
-,113,114,O
Asp,114,117,O
-,117,118,O
aldehyde,118,126,O
;,126,127,O
COX,128,131,O
=,132,133,O
cyclooxygenase,134,148,O
;,148,149,O
Deltapsim,150,159,O
=,160,161,O
mitochondrial,162,175,B-Cellular_component
membrane,176,184,I-Cellular_component
potential,185,194,O
;,194,195,O
DAPI,196,200,O
=,201,202,O
4,203,204,O
',204,205,O
",",205,206,O
6,206,207,O
-,207,208,O
diamidino,208,217,O
-,217,218,O
2,218,219,O
-,219,220,O
phenylindole,220,232,O
;,232,233,O
DMEM,234,238,O
=,239,240,O
Dulbecco,241,249,O
',249,250,O
s,250,251,O
modified,252,260,O
Eagle,261,266,O
',266,267,O
s,267,268,O
medium,269,275,O
;,275,276,O
ELISA,277,282,O
=,283,284,O
enzyme,285,291,O
-,291,292,O
linked,292,298,O
immunosorbent,299,312,O
assay,313,318,O
;,318,319,O
FCS,320,323,O
=,324,325,O
fetal,326,331,B-Developing_anatomical_structure
calf,332,336,O
serum,337,342,B-Organism_substance
;,342,343,O
FLS,344,347,B-Cell
=,348,349,O
fibroblast,350,360,B-Cell
-,360,361,I-Cell
like,361,365,I-Cell
synoviocytes,366,378,I-Cell
;,378,379,O
IL,380,382,O
=,383,384,O
interleukin,385,396,O
;,396,397,O
JC,398,400,O
-,400,401,O
1,401,402,O
=,403,404,O
5,405,406,O
",",406,407,O
5,407,408,O
',408,409,O
",",409,410,O
6,410,411,O
",",411,412,O
6,412,413,O
',413,414,O
-,414,415,O
tetrachloro,415,426,O
-,426,427,O
1,427,428,O
",",428,429,O
1,429,430,O
',430,431,O
",",431,432,O
3,432,433,O
",",433,434,O
3,434,435,O
',435,436,O
-,436,437,O
tetraethylbenzimidazole,437,460,O
carbocyanide,461,473,O
iodide,474,480,O
;,480,481,O
MTT,482,485,O
=,486,487,O
3,488,489,O
-,489,490,O
(,490,491,O
4,491,492,O
",",492,493,O
5,493,494,O
-,494,495,O
dimethylthiazol,495,510,O
-,510,511,O
2,511,512,O
-,512,513,O
yl,513,515,O
),515,516,O
-,516,517,O
2,517,518,O
",",518,519,O
5,519,520,O
-,520,521,O
diphenyltetrazolium,521,540,O
bromide,541,548,O
;,548,549,O
PBS,550,553,O
=,554,555,O
phosphate,556,565,O
-,565,566,O
buffered,566,574,O
saline,575,581,O
;,581,582,O
PGE2,583,587,O
=,588,589,O
prostaglandin,590,603,O
E2,604,606,O
;,606,607,O
RA,608,610,O
=,611,612,O
rheumatoid,613,623,O
arthritis,624,633,O
.,633,634,O
Authors,0,7,O
',7,8,O
contributions,9,22,O
FR,23,25,O
initiated,26,35,O
and,36,39,O
designed,40,48,O
the,49,52,O
research,53,61,O
",",61,62,O
collected,63,72,O
and,73,76,O
analyzed,77,85,O
the,86,89,O
data,90,94,O
and,95,98,O
wrote,99,104,O
the,105,108,O
paper,109,114,O
.,114,115,O
FO,116,118,O
was,119,122,O
the,123,126,O
main,127,131,O
supervisor,132,142,O
",",142,143,O
helped,144,150,O
in,151,153,O
analysis,154,162,O
",",162,163,O
and,164,167,O
revised,168,175,O
and,176,179,O
edited,180,186,O
the,187,190,O
drafts,191,197,O
.,197,198,O
MN,199,201,O
was,202,205,O
co,206,208,O
-,208,209,O
supervisor,210,220,O
and,221,224,O
revised,225,232,O
the,233,236,O
drafts,237,243,O
.,243,244,O
Conclusion,0,10,O
Artificial,11,21,O
addition,22,30,O
of,31,33,O
siderophores,34,46,O
and,47,50,O
HSLs,51,55,O
may,56,59,O
be,60,62,O
a,63,64,O
possible,65,73,O
method,74,80,O
to,81,83,O
aid,84,87,O
in,88,90,O
the,91,94,O
identification,95,109,O
and,110,113,O
isolation,114,123,O
of,124,126,O
marine,127,133,O
bacterial,134,143,O
species,144,151,O
which,152,157,O
are,158,161,O
thought,162,169,O
to,170,172,O
be,173,175,O
unknown,176,183,O
.,183,184,O
